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anxiety

Molecular techniques
and advances in brain imaging
suggest new treatments
for mental illness

Cushing-Whitney Medical Library

Outreach Program

AYAM

To better communicate with our alumni/ae, the AYAM is pleased to announce
The Outreach Program, an effort to enhance and expand direct contact with our members.

REUNION

WEEKEND

Save the date: June 6 and 7 for the 1997
Alumni Reunion Weekend. Yale
University President Richard C. Levin. Ph.D.,
will address alumni/ae at the Saturday annual
meeting. Albert B. Deisseroth, M.D., Ph.D., chief
of medical oncology, will make a presentation on
new gene-therapy initiatives in cancer treatment.

NEW

DIRECTORY

Soon, locating fellow alumni/ae will be easier
with an updated Yale School of Medicine
Alumni Directory, last published in 1992.
Harris Publishing will be phoning to verify
individual listings during eight weeks
beginning December 9.

REGIONAL

EVENTS

On the heels of alumni/ae receptions in New
Haven, Boston, and San Francisco, the School
of Medicine will be hosting events in San Diego
in early February, Washington, D.C., in March and
Westchester, N.Y., in May. Details to follow in the mail.
Op
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REUNIONS

Members of the Class of 1945 will convene for
an informal reunion in April in Florida. If you and
classmates are planning a similar event, please call
the Office of Alumni Affairs at 203.785.4674.

Association of Yale Alumni in Medicine

house staff/fellow

Alumni /ae: Please use this space for news of your personal
and professional activities, for publication in Yale Medicine.
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Brain chemistry

Interview:
Carolyn Slayman

Remarkably close communi¬
cation at Yale between basic
scientists and the psychia¬
trists who treat patients for
mental illness has produced
a better understanding of
depression and provides the
basis for a new generation of
treatments.

A distinguished
researcher and leader in
genetics, Carolyn W.
Slayman. Ph.D.. is the
school’s first deputy dean
for academic and scien¬
tific affairs. On her mind: technology
transfer, new structures for supporting
faculty and research, and a streamlined
process for recruiting and teaching
graduate students.
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“Extreme stress,” says a Yale
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goal of one day providing treatments
that distinguish between reasonable
and unreasonable fear.

50 Alumni/ae News
52 Obituaries
53 Alumni/ae Affairs
54 Reunion Reports
65 Development
67 Letters

On the cover: New imaging techniques are
Love and obsession (p!4) Taking brain discoveries to market (p!6)

helping to explain the biochemical basis of
depression, anxiety and other brain disorders.
The SPECT brain images on the cover are
from a new Yale study that indicates patients
with panic disorder may have a significantly
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Pure medicine

reduced number of benzodiazepine receptors.
The bottom image highlights areas of the brain

Who are the physicians who care for
the people in that netherworld between
private health insurance and govern¬
ment-sponsored coverage for the poor?
Meet Richard and Patricia Gibbs, two
Yale medical alumni/ae who founded
the San Francisco Free Clinic.

with abnormally low numbers of these Valiumbinding receptors, averaged from a group of 15
patients with panic disorder as compared
to an equal number of healthy subjects.
Cover Illustration by Peter Casolino/design by Jack* Design
SPECT images: J. Douglas Bremner, Robert B. Innis, John P.
Seibyl and Dennis S. Charney
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PSYCHIATRY

Crosstalk between clinicians and basic scientists
at Yale is producing a new understanding of the
brain and novel treatments
—providing hope for the 30 percent of
depressed patients unresponsive to existing
medications.

Division of Molecular Psychiatry

More than one trillion neurons make up
the brain, its structures and pathways.
Three decades of intensive, basic scien¬
tific research at Yale have produced
evidence to decipher the mysteries of
the brain, providing the basis for ratio¬
nal treatments for mental disorders,
including anxiety and depression.
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Braih
chemistry
By Marc Wortman
Photographs by Frank Poole

I

t was a year ago that Susan S., a patient at the Con¬
necticut Mental Health Center (CMHC) in New
Haven, had fallen once again into a major depres¬
sion. She was tired and hopeless, exhausted by a
long battle with depressive illness that had been
severe enough to keep her from working during the
past five years.
Yale faculty on the staff of CMHC, the region’s
principal public mental health facility, had used all
the tools in their repertoire and were still unable to lift
the leaden shroud blanketing the life of this 56-yearold woman.
Her physician, Robert T. Malison, M.D. ’87, HS
’87-91, worried about her prognosis. “When the aver¬
age person feels depressed, he can soon push through
it,” says Dr. Malison, an assistant professor of psychia¬
try who heads the CMHC Depression Research Clinic.
“But a person with a major depression can’t pull him-

Marc Wortman is a free-lance writer in New Haven.
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self up by the bootstraps. It’s a much more severe,
unrelenting syndrome.”
As many as one quarter of all women and 12 per¬
cent of men will face at least one bout of major depres¬
sion in a lifetime. Of more than 15 million Americans
affected by major depression each year, about twothirds will respond to treatment with antidepressant
medication. Those who do not may face a lifelong, dis¬
abling disease, and one out of 10 people suffering from
long-term, major depression will commit suicide. In
1990, the economic costs of depression were estimated
to be $30 billion annually.
For Susan S., being under the care of Yale psychia¬
trists meant that the most advanced neuroscience
research in the world could be applied to her case.
Yale’s psychiatry department is uniquely positioned to
make new discoveries in the neurobiology of major
psychiatric disorders, including depression. With a vari¬
ety of specialized clinical centers (at Yale Psychiatric
Institute, the VA Connecticut Healthcare System cam¬
pus in West Haven, Yale-New Haven Hospital, and at
CMHC, a 31-year collaboration by Yale and the State
of Connecticut) Yale's world-renowned faculty treat
thousands of patients with mental disorders. These
clinicians often work literally across the hall from the
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world’s leading basic neuroscience
researchers.
With new and sophisticated
tools to help in the search for clues
to brain abnormalities, the depart¬
ment’s scientists work in a wide
range of disciplines encompassing
brain imaging, pharmacology,
genetics and molecular biology.
This massive effort to understand
the brain from multiple perspec¬
tives promises to uncover the
secrets of when and why the brain
malfunctions, causing mental ill¬
ness. In fact, the work has been so
successful that the combined
research program is ranked among
the top three nationally in terms of
research funding.
A few steps from the clinical
unit on the third floor of CMHC
where Susan S. was being treated,
a team of neuroscientists was
busily exploring the nervous sys¬
tem, mostly by studying the brains
of rats. That work is intended to
provide keys to unlocking the
secrets of the human brain, which
in most basic structures is very
similar to that of other animals.
During the past three decades,
researchers in those laboratories
have pioneered many of the funda¬
mental advances in knowledge

Recent findings about the influence
of stress on one area of the brain, the
hippocampus, suggest new ways of
thinking about the cause of depression

about depression and anxiety. Sci¬
entific data generated at Yale has
been instrumental in improving
treatment for the diseases, includ¬
ing groundbreaking work that
enabled the development of such
revolutionary antidepressants as
fluoxetine, better known by its
trade name of Prozac. “We’ve
been building a body of basic
knowledge for more than three
decades that serves as the basis for
many of today’s treatment
advances,” says Dennis S. Charney, M.D., HS ’77-81, professor
and deputy chair of psychiatry for
research and education.

The hippocampus, the curving
dark ridge outlined in black in the
brain images above, is the portion
of the brain that controls emotions
and memories. New studies show
that stress can shrink the hip¬
pocampus and that this damage
may contribute to the symptoms of
depression. Laboratory research
at Yale during the past three
decades, says Eric J. Nestler,
M.D., Ph.D., left, "provided some
of the basic knowledge that drove
the pharmaceutical companies to
look for a Prozac. ”
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RETHINKING SEROTONIN

Much remains unknown about
depression and especially about
cases such as Susan S., in which all
known forms of treatment do not
seem to help. Several members of
the neuroscience faculty are strug¬
gling to understand why Susan S.
and others like her might not
respond to treatment. Using
recently developed techniques for
studying brain cells at the molecu¬
lar level, Ronald S. Duman, Ph.D.,
and colleagues George Heninger,
M.D., and Eric J. Nestler, M.D.
’83, HS '83-87, Ph.D. ’82, had
been investigating the functions of
different brain structures believed
to be involved in depression. They
observed in rats that stress could
alter the function of certain brain
regions affected by serotonin, and
induce behaviors suggestive of
human depression.
Recent findings about the
influence of stress on one area of
the brain, the hippocampus, sug¬
gest new ways of thinking about
the cause of depression. Studies in
animals have shown that stress can
cause the shrinking or even death
of neurons in the hippocampus.
Moreover, brain imaging studies
have shown that the size of the hip¬
pocampus is reduced in patients
with depression or post-traumatic
stress disorder (PTSD). These find-
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New SPECT brain imaging techniques devel¬
oped by Robert B. Innis, M.D., Ph.D . left and
colleagues at Yale and the VA Connecticut
Healthcare System have made possible the
direct measurement of sites in the brain where
antidepressant and anti-anxiety drugs work.
Psychiatrists in the not-too-distantfuture may
be able to send a patient for tests to diagnose
or to monitor the treatment of patients with
depression, obsessive-compulsive disorder
and other neuropsychiatric illnesses.

Opening a window on the brain

A

s if a window had been cut
into a brick wall, the revolu¬
tion in brain imaging technology
has, for the first time, allowed
researchers to peer into the actu¬
al functioning of the human brain.
Yale is home to one of the world’s
leading centers for the use of
advanced brain imaging tech¬
nology for research into the neu¬
rochemical basis of mental disor¬
ders. “We can now get direct
measurements of target sites in
the brain,” says professor of psy¬
chiatry and pharmacology Robert
B. Innis, M.D., Ph.D., HS '81-84,
who directs the Neurochemical
Brain Imaging Program. The pro¬
gram boasts an extensive com¬
plement of state-of-the-art equip¬
ment at the medical school and
the West Haven campus of the VA
Connecticut Healthcare System.
“If we can understand what the
chemical imbalance is that is
causing an illness, that will help
in diagnosis and enable us to
design treatments for the specific
imbalance.”
The program forms “a nice
bridge between basic science and
clinical psychiatry,” says Ben¬
jamin S. Bunney, M.D., HS '6871, the department chairman,
who calls Dr. Innis the world
leader in SPECT brain imaging.

Yale medicine

"What makes it special is that
there's a foundation of basic sci¬
ence knowledge, derived from
animals, that allows Bob to corre¬
late changes in the brain with
the images. Because he’s first
done the work in animals, imag¬
ing and then measuring brain
function, he’s in a much better
position to correctly interpret
human images.”
The potential payoff is enor¬
mous. For instance, Dr. Innis and
colleagues at Yale have just
developed a brain imaging tech¬
nique for diagnosing Parkinson's
disease even before any physical
symptoms develop. Early detec¬
tion would allow for more effec¬
tive treatment to restore the
chemical imbalance in the
dopamine system known to be
responsible for the disease. A
multi-center clinical trial is now
under way to test this potentially
revolutionary technique diagnos¬
ing Parkinson’s with SPECT imag¬
ing. (SPECT stands for single pho¬
ton emission computed tomogra¬
phy and is similar to, though sig¬
nificantly less expensive than,
positron emission tomography or
PET scanning.)
Dr. Innis and his collabora¬
tors—Kenneth Marek, M.D.,
associate professor of neurology

and director of the Yale Move¬
ment Disorders Clinic; and John
P. Seibyl, M.D., associate profes¬
sor of diagnostic radiology and
psychiatry, and director of the
NeuroSPECT Center—developed
extremely low-dose radioactive
tracers to show the presence of
the dopamine imbalance presag¬
ing Parkinson’s disease.
While no clinical applications
for brain imaging have been
developed to date for depression
and anxiety disorders, the new
methods hold great promise. Psy¬
chiatrists in the not-too-distant
future may be able to send a
patient for tests to diagnose or
confirm clinical depression,
obsessive-compulsive disorder
and other brain maladies.
In association with Dr. Seibyl,
Robert Malison, M.D., J. Douglas
Bremner, M.D., and Dennis Charney, M.D., Dr. Innis has devel¬
oped brain imaging techniques to
directly measure sites in the
brain where antidepressant and
anti-anxiety drugs work. In
research that has yet to be pub¬
lished, the team produced brain
images demonstrating a reduc¬
tion in the number of benzodi¬
azepine receptors in regions of
the brain believed to be involved
in panic attacks. Dr. Innis specu¬
lates that a chemical imbalance
in these brain structures may trig¬
ger the onset of panic disorders.
“Eventually,” says Dr. Innis, "we’ll
be able to dissect types of mental
disorders and optimize treat¬
ments or detect an unknown
abnormality and develop a new
treatment.” ■
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Much about the brain and its
pathology still remains a vast,
tantalizing mystery. Unraveling
that complexity among the one
trillion neurons in the human
brain is overwhelmingly difficult.
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Christopher J. McDougle, M.D., left, and Robert T. Malison, M.D., treat
patients at the Connecticut Mental Health Center, literally across the hall
from the world's leading basic neuroscience researchers.

ings suggest that shrinking or dam¬
age to neurons in the hippocampus
may contribute to the symptoms of
depression. Interestingly. Dr.
Duman and colleagues have found
that antidepressant agents increase
nerve growth factors that may block
or reverse the damaging effects of
stress in the hippocampus.
The depressive effect of abnor¬
mally low serotonin levels, long
thought to be at the root of depres¬
sion, “may in fact be far removed
from its real cause,” says Dr.
Duman, associate professor of psy¬
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chiatry and pharmacology. This
marks a major change in the under¬
standing of depression, potentially
opening up a whole new and far
more effective approach to treat¬
ment. Adds colleague Dennis Charney: “We’re moving beyond the
hypothesis that suggests that a low
serotonin level by itself is the cause
of depression. There are 15 differ¬
ent serotonin receptors, all with dif¬
ferent functions.
“We know so much more now,
that it has become a question not
only of serotonin levels but also

where in the brain and which spe¬
cific part of the system,” says Dr.
Charney. “Bit by bit, we're pinning
down the biology of depression.”
Currently available antidepres¬
sant medications are effective in
most cases, but they work at an ago¬
nizingly slow speed, typically tak¬
ing two to four weeks before results
appear. “If you're suicidal,” says
Dr. Malison, “that delay can be
fatal.” Hospital care, an option that
is expensive and increasingly lim¬
ited by managed care contracts,
may be necessary to monitor treat¬
ment during the time it takes for the
drugs to work. (Psychiatric hospi¬
talization has been shortened so
drastically under managed care—
to an average of 9 days—that the
patient often has been discharged
before the medication has had an
opportunity to work.) And sadly and
often with tragic outcomes, a signif¬
icant number of all patients—as
many as 30 percent—never respond
at all to available medications.
New theories on the treatment
of depression—that slow process of
rebuilding and reregulating the
actual structure of the serotonin sys¬
tem and possibly other, yet uniden¬
tified, structures in the brain—may
explain why the medications take so
long to have an effect. And they
hold a key to improved treatments.
“What’s important,” says Dr.
Heninger, professor of psychiatry,
“is that we're making huge
advances in the chemistry of ill¬
nesses that corrode souls. With the
tools of science, we’re actually sav¬
ing souls.”

A NEW APPROACH

Dr. Duman, a basic scientist,
hypothesized that supplementing
antidepressant treatment with other
medications targeting the specific
rebuilding process might speed up
patient recovery. In his search for a
supplemental drug, he found
papaverine, which formerly had
been given to stroke patients to
increase blood flow to certain
regions of the brain that are now
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Psychiatry Chairman
Benjamin S. Bitnney,
M.D.: “Thefoundation
of knowledge now exists
to allow us to begin to
develop treatments ratio¬
nally, rather than relying
on serendipity’. ”

Psychophamacology
Tit Fcwtrth GrurraUo*

known to be associated with
depression. Papaverine had been
superseded by newer stroke med¬
ications and was no longer in regu¬
lar use. “It was essentially just sit¬
ting on the shelf,” recalls Dr. Mali¬
son. Dr. Duman suggested to his
clinical colleagues that they see
whether it might not help treat a
refractory case such as Susan S.'s,
knowing that papaverine also
increases the nerve growth factors
that impact the hippocampus.
Dr. Malison, a clinical psychi¬
atrist with a strong background in
neurobiology, immediately saw Dr.
Duman’s point. He treated Susan
S. with a combination of standard
antidepressant medications aug¬
mented with papaverine. Two
weeks after the papaverine was
first added to her medications,
Susan S., who had not been able to
get out of bed most days for
months, bounded down the hall
into Dr. Duman’s laboratory to
shake his hand. “She was so
happy,” he recalls. “It was the first
time she’d felt better in years.”
For Dr. Malison, it was a per¬
sonal triumph, as well as a poten¬
tial medical and research advance.
“To this day,” he says, “seeing a
depressed person get better is my

Yale medicine

most exciting experience. You
watch a person like Susan go from
bedridden—and unable to care for
herself—to a rebirth.”
That was in December 1995.
In the months since then, Susan S.
has remained free of major depres¬
sion and resumed many life activi¬
ties she had long abandoned. Drs.
Duman and Malison have begun to
explore whether, in fact, papaver¬
ine alone might not be an effective
treatment for certain forms of
depression. “That,” says Dr. Mali¬
son. “would be a major break¬
through.”

SEEING THE LIVING BRAIN

While the efficacy of treatment
with papaverine will not be known
until much more extensive trials
are undertaken, such potentially
promising advances are hallmarks
of an ongoing revolution in neuro¬
science. In this Decade of the
Brain, as the U.S. Congress desig¬
nated the century’s final years, our
understanding of depression and
other mental illnesses has
exploded. Still, the need for
improved treatments and preven¬
tion remains enormous.
Until just a quarter century

at Pr'Ogress

ago, the sort of investigations that
led to providing hope for someone
like Susan S. was not possible.
According to Benjamin S. Bunney,
M.D., HS '68-71, the Charles B.G.
Murphy Professor and chairman of
psychiatry and professor of phar¬
macology, discoveries about the
brain and treatments for mental ill¬
ness were largely serendipitous.
The brain's functions revealed
themselves only when patients suf¬
fered accidents causing welldefined, traumatic brain lesions
that changed or halted specific
behaviors and thus demonstrated
the operation of a region of the
brain. Autopsies also showed struc¬
tural abnormalities, hinting at pos¬
sible regions to serve as targets for
medications. Sometimes, as in the
case of antidepressants, a medica¬
tion employed for one health rea¬
son—in that instance, treatment of
tuberculosis with a monoamine
oxidase inhibitor—had an unex¬
pected therapeutic side effect for
another symptom.
Much about the brain and its
pathology still remains a vast, tan¬
talizing mystery. Unraveling that
complexity among the one trillion
neurons in the human brain is over¬
whelmingly difficult. Each neuron
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potentially interconnects with
untold numbers of other neurons,
multiplying the effect of any chem¬
ical interaction. That creates a
chain of possibilities in which the
pathology may lie at almost any
point in the linkage.
If that complexity were not
daunting enough, neuroscience
researchers have their hands tied in
a way that virtually no other med¬
ical field faces. “The problem,”
says Dr. Bunney, “is that in living
humans, you can’t go into the brain
and mess about. Biopsy isn’t an
option.” While autopsy does reveal
abnormalities in brain anatomy
after death, it comes too late to elu¬
cidate abnormal brain function.
A revolution in imaging
already has had a profound effect
in removing some of those obsta¬
cles. “Psychiatrists were frus¬
trated,” says Dr. Malison, “because
we couldn’t see directly into the
living brain.” Now, magnetic reso-

The generation
of scientific
knowledge during the
past two decades ...
has been aided by
the revolution in
laboratory tech¬
niques, especially in
molecular biology,
imaging technology
and genetics.

Shedding light on the baby blues
F
or most mothers, giving birth is
one of the great moments of
life. Nonetheless, nearly twothirds of new mothers experience
the blues, such as tearfulness,
sadness and anxiety, for a period
of a few days to two weeks after
childbirth.
For one in 10 new mothers,
however, the baby blues becomes
something more than just a pass¬
ing affliction. They develop a
full-blown depression needing
clinical treatment. In a few
cases—two in 1,000—the disor¬
der cascades into manic or occa¬
sionally depressive psychosis,
with some mothers committing
infanticide or suicide.
Although postpartum psychi¬
atric illness was first recognized
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and described in ancient Greece
more than 2,000 years ago, it
remains a poorly understood dis¬
order. It is not recognized by the
American Psychiatric Associa¬
tion’s Diagnostic and Statistical
Manual (DSM) as a disorder dis¬
tinct from depression occurring at
other times. The Postpartum
Mood Disorders Clinic on the Clin¬
ical Neuroscience Research Unit
at CMHC is now undertaking the
first controlled studies to further
our understanding of the neurobi¬
ology of the disorder and develop
the most effective treatments.
Under the direction of C. Neill
Epperson, M.D., a research fellow
in psychiatry, the clinic is looking
into the interplay between the nor¬
mal physiology of pregnancy and

nance imaging (MRI) provides
detailed views of the brain's struc¬
tures in thousands of cross-sec¬
tional views only millimeters thick.
PET and SPECT imaging, super¬
imposed over MR scans, now
record brain function. (See Open¬
ing a window on the brain)

The path to this technical peak
and its clearer view of the brain has
been a long one. Early in the his¬
tory of brain research, scientists
found they could alter behavior in
laboratory animals by removing
small sections of the brain associ¬
ated with those behaviors. The
problem was that these lesions
were non-specific. For example,
the destruction of fibers running
through one region of the brain
would affect functions controlled
by other regions.
Research advanced with the
discovery of neurotoxins that were
selective in destroying certain
types of neurons. And in 1963, a

the neurobiology of the disorder.
“Pregnancy,” says Dr. Epperson,
“seems to be a trigger for a num¬
ber of psychiatric illnesses. It’s
clearly a precipitant, but we’re not
sure why.” The extraordinary
changes the mother's body under¬
goes during pregnancy and deliv¬
ery may be a possible cause. The
10- and 100-fold elevation of the
sex hormones, estrogen and prog¬
esterone respectively, during
pregnancy followed by their rapid
decline after delivery is believed
to have a major impact on the
central nervous system. This may
make postpartum depression bio¬
logically unlike other depressions.
Establishing the nature of
that link may help shed light on
the baby blues and provide keys
to treating postpartum and post¬
menopausal depression. ■
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The running conversation between scientists
who work in the laboratoiy and clinicians
who see patients is the foundation of the Yale
Way of psychiatric research. Left: Jingshan
Chen, Ph.D, an associate research scientist,
presents his findings on molecular mecha¬
nisms of addiction at the regular Friday
morning molecular psychiatry conference
attended by clinical and basic science faculty.
It was at such a meeting that Ronald S.
Duman, Ph.D., (below), suggested to col¬
league Robert T. Malison, M.D., that supple¬
mental doses of a hypertension drug called
papaverine might help a patient who was not
responding to antidepressant therapy. The
treatment has worked in early studies.

Swedish team was able to visual¬
ize for the first time, in animal
brains, cells that contained neuro¬
transmitters, making it possible to
study the functions of the sero¬
tonin, dopamine and norepineph¬
rine systems in animals.
George K. Aghajanian, M.D.
'58, who has pursued basic neuro¬
science research at Yale for nearly
30 years, was the first American
researcher to apply these tech¬
niques. His work exploring the
serotonin system is only one of
numerous areas for which he has
laid the groundwork for many of
the major advances in the field. For
example, says colleague Eric
Nestler, the Elizabeth Mears and
House Jameson Professor of
Psychiatry and Pharmacology,
“work here provided some of the
basic knowledge that drove the
pharmaceutical companies to look
for a Prozac.”
The generation of scientific
knowledge during the past two
decades—with a dramatic increase
in speed over the last five years—
has been aided by the revolution in
laboratory techniques, especially in
molecular biology, imaging tech¬
nology and genetics. These
advances have made it possible to
map out some of those billions of
neurochemical pathways. The new
technologies permit neuroscientists
to tap and then measure the electri-

Yale medicine

Above: Postdoctoral fellow

William A.Carlezon, Ph.D., and
graduate student Vidita Vaidya,
discuss recent results that reveal
changes in the hippocampus pos¬
sibly related to depression.

cal firing of a single neuron, far too
small for the naked eye to see, in
the brains of animals. The func¬
tions and connections of the
healthy neuron can then be traced,
eventually pointing to possible
means of repairing damaged or
improperly functioning areas in
humans. "The foundation of
knowledge now exists,” says Dr.
Bunney, “to allow us to begin to
develop treatments rationally,
rather than relying on serendipity.”

FRUITS OF THE YALE WAY

New antidepressents such as fluox¬

etine, sertraline and paroxetine—
from a class known as selective
serotonin reuptake inhibitors—are
among the first generation of drugs
derived via this new means of
studying the brain. The develop¬
ment of many other highly tar¬
geted, so-called “designer" med¬
ications has followed. “They’re
scalpels in their precision,” says
Dr. Malison. (See Putting neuro¬
science research to work) Still bet¬
ter treatments for depressive disor¬
ders are on their way. "We’re
bringing out amazing new knowl¬
edge about how the nervous sys¬
tem is formed, connected and
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maintained,” says Dr. Aghajanian.
“With that new knowledge," he
explains, “we can then go back and
re-examine the different clinical
conditions. These advances have
the promise of identifying where
things are going wrong in the
brain.”
Not only do patients benefit

the molecular malfunction at work
in mental illness. “It clearly cuts
both ways,” says Lawrence H.
Price, M.D., HS ’78-82, former
director of CMHC’s Clinical Neu¬
roscience Research Unit and a
longtime Yale faculty member (he
took up a new position at Brown
University School of Medicine

credited with several seminal
advances in the understanding and
treatment of panic disorders and
depression. Those achievements,
he says, are a direct result of a
working style shared by researchers
that has come to be known as the
Yale Way. He explains: “This close
collaboration between the labora¬
tory and the clinic leads to funda¬
mental discoveries that have an
impact on the field.”
Most clinical researchers at
Yale learn the vocabulary of the
basic scientists, while the basic sci¬
entists familiarize themselves with
the issues faced by clinicians. In
many cases, individuals such as Dr.
Bunney carry out both functions on
an almost daily basis. Such close
ties between clinical practice and
basic research remain rare in most
medical schools. “We’re close to
unique in those interactions,” says
Dr. Bunney. Few have so deliber¬
ately structured themselves to
encourage cross-disciplinary inter¬
action. “Usually, these things take
place in different buildings and
even different departments. People
from other universities are amazed
to see in situ molecular hybridiza¬
tion being done across the hall from
clinical assessment of patients.”

A TRADITION OF CROSSTALK

Training the next generation: George K. Aghajanian, M.D., front, whose
basic work over the past 30 years has elucidated the function of neurotrans¬
mitters such as serotonin, was a mentor to psychiatry Chairman Benjamin
S. Bunney, M.D., lower right. Both in turn helped train Eric J. Nestler, M.D.,
Ph.D., left, and Ronald S. Duman, Ph.D., standing next to him. Drs. Nestler
and Duman have likewise shepherded the work of junior faculty David Self,
Ph.D., rear center, and David Russell, M.D., Ph.D..

from the neuroscience synergy.
Each new advance ih clinical
research sends the basic scientists
back to the bench with new insights
into how a medication works. This
gives them clues in their search for
further advances in understanding
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in July). “The clinicians are always
looking to the basic scientists
for the definitive word on how it
works, and they look to us in
the clinic to see whether it really
does work.”
Dr. Chamey’s research team is

When George Aghajanian joined
the psychiatry faculty in the early
1960s, very few people believed
that such interaction between basic
science and clinical application was
possible or even the appropriate
focus of a psychiatry program.
“Psychiatry used to be set off by
itself from the rest of medicine,”
says Dr. Aghajanian, professor of
psychiatry and pharmacology.
Most psychiatrists were devoted to
highly intense interpersonal and
behavioral modification therapies.
Whatever the many benefits of
those approaches may have been,
treatment of many serious mental
illnesses remained largely inade¬
quate. A visionary member of the
department at the time, the late
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Daniel Freedman, M.D., saw the
fertile possibilities in bringing
together the otherwise discon¬
nected talents of practicing clini¬
cians and laboratory-based investi¬
gators to study the brain and its ill¬
nesses. To open up doors to the
future, he established one of the
nation’s first medical training pro¬
grams in neuroscience research.
“The building blocks for our
present strength in biological psy¬
chiatry were established when Fritz
Redlich recruited Daniel Freed¬
man,” says Dr. Bunney. Frederick
C. Redlich, M.D., Yale’s chairman
of psychiatry for 19 years until he
became dean of the medical school
in 1967, saw early on that biologi¬
cal approaches would complement
the psychoanalytic work then in the
mainstream and supported both
models of inquiry.
As results from the neuro¬
science research began to accumu¬
late, funding agencies came to rec¬
ognize the value of the pioneering
approach to seeking out the causes
of mental illnesses. In the Yale
Department of Psychiatry, the
training program has since been
formalized via a longstanding,
multi-million dollar National Insti¬
tute of Mental Health (NIMH) Pro¬
gram Grant as the Clinical and
Basic Neuroscience Research
Training Program in Psychiatry. In
recent years other medical schools
have followed suit, establishing
their own versions of the Yale
model.
The program now covers a
wide spectrum of clinically rele¬
vant neuroscience domains at Yale.
Not only do clinicians and basic
scientists work together on research
projects, they also meet regularly
for formal talks and seminars of
mutual interest. Each week for the
past 25 years, faculty and students
alike have gathered for the “workin-progress” presentations known
as the Neuroscience Research Sem¬
inar in Psychiatry. Discussions
begun there often lead to collabora¬
tive experiments. “That kind of
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crosstalk is a priority and not an
accident here,” says Dr. Price.
Dr. Price remembers well a
dramatic moment when the benefits
of the Yale Way became clear to
him. He was chief resident on the
adult psychiatric service at YaleNew Haven Hospital in 1982. A
woman with a psychotic depression
on the unit was in very poor condi¬
tion, but her health insurance cov¬
erage had been exhausted. As a last
resort before her discharge. Dr.
Price scheduled electroconvulsive
therapy, a costly procedure which
has many undesirable side effects
such as short-term memory loss.
During that week’s Neuro¬
science Research Seminar in Psy¬
chiatry, Dr. Aghajanian discussed a
discovery from his laboratory
based on the work of a former post¬
doctoral fellow, Claude deMontigny, M.D., (now at McGill Uni¬
versity). As part of a broader study
of the neural actions of antidepres¬
sant medications. Dr. deMontigny
had looked at whether lithium
might also affect the serotonin sys¬
tem in the brain where antidepres¬
sants were known to bind. His sur¬
prising findings showed that
lithium actually boosted the effect
of the antidepressants in rats. He
then carried out a preliminary study
on human subjects at McGill,
which was followed by a controlled
study at Yale by Drs. Charney,
Heninger and Aghajanian, confirm¬
ing its benefits.
While those results were not
yet known to the field. Dr. Agha¬
janian discussed them with Dr.
Price, who thought that in the des¬
perate situation faced by his
patient, lithium should be added to
her medication. “The day after we
gave her lithium,” Dr. Price recalls,
“she was laughing for the first time
in seven or eight months. That was
the first change in her affect I’d
seen in 30 days.” What is termed
“lithium augmentation” became,
within a few years, a standard part
of treatment for major depression.
Despite such breakthroughs,

Dr. Aghajanian and colleagues con¬
tinue to struggle to understand the
mechanisms of depression and
develop a cure. “We still don’t
know what causes depression,”
says Dr. Bunney, “and we don't
know how to prevent it.” One thing
the basic scientists have learned is
that talking therapy, while it does¬
n’t necessarily cure mental illness,
can play a crucial role in the treat¬
ment of some patients. “In fact,”
says Dr. Bunney, “it has been
demonstrated that some forms of
psychotherapy can alter brain
chemistry.”

The goal of prevention is
far in the future and will
certainly require the
discovery of a genetic
basis for the disease. That
will be no simple matter

The goal of prevention is far in
the future and will certainly require
the discovery of a genetic basis for
the disease. That will be no simple
matter: researchers now recognize
that there are many different kinds
of depression. Studies are under
way to develop more targeted
forms of treatment for specific
types of depression. One day, there
may be biological tests to diagnose
different forms of depression. That
will also indicate the most appro¬
priate treatments.
In the nearer term, Yale investi¬
gators hope to reduce the delay in
the effect of treatment to a matter
of days instead of weeks. “The
field needs a new fundamental
advance to get beyond current
treatments,” says Dr. Charney.
“We’re focused like a laser beam
on finding it.” YM
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When

fear
is an

illness

Biological research sheds new light
on PTSD, other anxiety disorders.
By Marc Wortman
Photographs by Frank Poole

W

hen American soldiers moved through the jun¬
gles of Vietnam, their survival depended on a
constant state of anxiety. That anxiety kept
their bodies alert for warning signs of danger. When
threat proved real, fear prompted their bodies to sudden,
life-saving actions.
But after the war was over, some 15 percent of all
returning soldiers could not turn off the anxiety and fear.
While their lives were now at peace, their brains were
still at war. For some, moving about in public areas
became a terror-filled experience; for others, sudden
noises could send them diving for cover. Many suffered
nightmares, flashbacks and other involuntary memories
of traumatic battlefield scenes. Many became depressed
by the experience, while others turned to drugs and alco¬
hol to block their misery. With no visible war wound,
tens of thousands still emerged disabled by their combat
service, just as had the shell-shocked soldiers of World
War I and every war since.
War veterans are not alone in suffering anxiety and
panic disorders. Approximately 15 percent of all people
exposed to traumatic stress, such as child abuse, vio¬
lence, automobile accidents and natural cataclysms, will
develop the illness. Others who suffer from recurrent,
unprovoked and intense episodes of fear can point to no
single precipitating factor, and likely have an environ¬
mental or genetic predisposition to the disorder. While
some symptoms of anxiety disorders can be treated, no
cure exists. Thanks to dramatic advances in neuroscience
research, new hopes for treatment, cure and even preven¬
tion of anxiety disorders are emerging. Studies at Yale,
especially those undertaken at the National Center for
Post-Traumatic Stress Disorder (PTSD) at the VA Con-
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Approximately 15 percent of all people
exposed to traumatic stress will develop
panic or anxiety disorder. Researchers now
find that psychological trauma can change
the chemistry and structure of the brain,
says Dennis S. Charney, M.D., right,
deputy chairman of psychiatry for research
and education. “Whatyou want to do, ”
says colleague and mentor George
Heninger, M.D., left, “is develop a drug to
treat generalized anxiety disorder, but not
prevent the person from jumping out of the
way of an oncoming car. ”

necticut Healthcare System’s West Haven campus,
have begun to open up an entirely new understanding
about the nature of the disease, which afflicts between
three and six million Americans.
Dennis S. Charney, M.D., former psychiatry chief
at the West Haven VA and now a deputy chair of the
Department of Psychiatry, has led a team which has
taken laboratory findings about fear and anxiety in ani¬
mals, along with new technologies for studying brain
function, and applied them to the benefit of patients
suffering from panic and anxiety disorders.
Working from a theory of anxiety developed by
psychiatry department colleague D. Eugene Redmond
Jr., M.D., from his work with primates and patients
with anxiety. Dr. Charney found that patients suffering
from panic disorders are exquisitely sensitive to
chemical stimulation of the brain’s neuroadrenergic
system, which releases norepinephrine. The release
of norepinephrine is a necessary and even healthy
response to stress such as fear. It prepares the body
at a very rapid speed to respond to danger by increasing
blood pressure, raising the heart rate, elevating breath¬
ing and transferring energy to muscles. Once the
danger is past, the fear response subsides rapidly in
normal individuals.
Dr. Chantey’s research group has shown that peo¬
ple who suffer panic attacks do not shut off their neu¬
roadrenergic, or adrenaline-release, function. “Most of
us,” says Andrew Goddard. M.D., assistant professor of
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psychiatry and director of the Anxiety Disorders
Research Clinic at the Connecticut Mental Health Cen¬
ter and a collaborator in the studies, “have a stress
response which is time-limited, but those with an anxi¬
ety disorder have lost this capacity.”
In 1995, Dr. Charney along with Steven Southwick, M.D., director of Yale’s PTSD program; J. Dou¬
glas Bremner, M.D., an assistant professor of psychia¬
try and a fellow in diagnostic radiology who works
with brain imaging technologies; and Robert Innis,
M.D., Ph.D., HS ’81-84, director of the department’s
Neurochemical Brain Imaging Program, drew interna¬
tional attention with new studies of anxiety disorders
combining brain imaging with behavioral investiga¬
tions. They showed that long-term high levels of anxi¬
ety lead to actual physical changes in the brain. “Psy¬
chological trauma,” says Dr. Charney, “can change the
chemistry and structure of the brain. That was not
thought to be possible.”
Using magnetic resonance imaging (MRI) to com¬
pare anatomy while superimposing those images on
positron emission tomography (PET) scans that show the
brain's functioning as measured by metabolic changes,
Dr. Bremner can actually view size and functional differ¬
ences in the brains of patients who suffer anxiety disor¬
ders such as PTSD. His findings demonstrate that Viet¬
nam veterans suffering from PTSD as well as child abuse
victims with PTSD have a significantly shrunken hip¬
pocampus, an area of the brain that plays a crucial role in
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memory. PTSD involves intrusive
memories that lead to many symp¬
toms, including persistent panic
attacks, depression and night¬
mares. Investigators speculate that
traumatic stress sets off a process
that eventually cascades into the
chronic disorder. “Extreme stress,”
says Dr. Bremner, “may be toxic to
certain parts of the brain.” Dr.
Charney compares it to an immune
system disorder in which the
brain’s own survival processes

eventually damage its own cells.
Those findings in patients are
now being further refined using
animal models. Psychiatry profes¬
sor Michael Davis, Ph.D. ’69, has
recently shown in rats that two sep¬
arate systems in the brain with sim¬
ilar output connections may be
responsible for fear on the one
hand and anxiety on the other. That
would help explain the differing
time streams involved in the differ¬
ent behaviors. “You need a system

What's love got to do with it?
S
ome say love is an obses¬
sion. But is it a clinical
disorder?
According to research from
Yale’s obsessive-compulsive dis¬
order (OCD) clinics at the Child
Study Center and Connecticut
Mental Health Center, early
parental love and romantic infat¬
uation may share a common
neurochemical thread with the
obsessive fear of germs.
Scientists have known for
several decades that the hor¬
mone oxytocin plays a crucial
role in the birth process and in
nursing, and have have recently
discovered that central oxytocin
pathways are involved in pair¬
bonding and the initiation of
maternal behavior in animals.
Now, Yale researchers have
found cerebrospinal fluid levels
of oxytocin to be elevated in peo¬
ple with some forms of OCD, an
anxiety disorder that affects
nearly 2.5 million Americans.
James F. Leckman, M.D.,
director of research at the Child
Study Center, theorizes that
changes in oxytocin levels may
help explain why OCD patients
suffer the obsessive-thought
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preoccupations that also are
often experienced by people in
love and the parents of new¬
borns. Risk factors associated
with the onset of OCD include
the latter stages of pregnancy
and early days following delivery,
as well as major life changes
such as the loss of a loved one,
says Dr. Leckman, the Neison
Harris Professor of Child Psychi¬
atry, Psychology and Pediatrics.
Those findings are part of a
large, ongoing research and clin¬
ical treatment program in the
Child Study Center and the
Department of Psychiatry, fund¬
ed by a program project grant
from the National Institute of
Mental Health designed to shed
light on one of the most common
anxiety disorders. People with
OCD—about two to three per¬
cent of adults and about half
that rate in children and adoles¬
cents—experience repeated,
intrusive and unwanted thoughts
and compulsive behavior. The
bizarre ritualistic behaviors,
intended to reduce the anxiety
caused by the thoughts, include
cleaning and hand-washing even
to the point that skin bleeds,

that can react very rapidly to the
onset of danger,” explains Dr.
Davis, “but maybe you need
another system to respond in a sus¬
tained way.”
For clinicians, the implications
of Dr. Davis’s work are significant.
Brain imaging now focuses on the
separate systems, and pharmacolo¬
gists may be able to develop more
effective anti-anxiety medications
that bind to the anxiety center
rather than the fear center. Current

repeating phrases like a loved
one’s name over and over, con¬
stant checking and rechecking of
doors and switches, or driving
back over the same road many
times to make certain they had
not caused an accident.
“OCD is one of the most dif¬
ficult psychological conditions,”
says David L. Pauls, Ph.D., asso¬
ciate professor in the Child
Study Center, “because the per¬
son realizes the behavior is
bizarre. They feel they are
trapped and like there is no
help." Eventually, people with
severe OCD may find their
uncontrollable rituals make it
impossible for them to carry on
normal life functioning. Not sur¬
prisingly, depression is often
associated with OCD, which is
classified as an anxiety disorder.
Dr. Pauls is studying family
patterns of OCD to begin to look
for a genetic basis for the disor¬
der. His work is part of the
broader investigations directed
by Dr. Leckman to characterize
the disorder and seek out its
developmental antecedents. The
research is also looking at the
association between OCD and
Tourette’s syndrome, a tic disor¬
der involving abrupt body move¬
ments, inappropriate touching of
oneself and others, and the
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anti-anxiety drugs tend to cause
sedation, which can be a danger in
itself. As Dr. Davis says, quoting
his colleague Dr. George Heninger,
“What you want to do is develop a
drug to treat generalized anxiety
disorder, but not prevent the person
from jumping out of the way of an
oncoming car."
The discovery of such a med¬
ication would be of tremendous
benefit to Dr. Southwick’s patients
at the National PTSD Center in

need to shout out profanities.
While many of us carry out
personal rituals, such behavior
only becomes a disorder when it
interferes with normal function¬
ing. In fact, Yale researchers now
believe that OCD may be a nor¬
mal developmental stage seen in
young children, most often
between ages 2 and 3 when ritu¬
alized behaviors, such as the
need to hear stories over and
over, repeat songs or eat specific
foods, are common.
Yale has been at the forefront
of psychopharmacological
research on OCD, conducting
studies in the late 1980s that
provided evidence of the benefits
of fluvoxamine, one of the new
generation of antidepressants
known as selective serotonin
reuptake inhibitors.
Christopher J. McDougle,
M.D., associate professor of psy¬
chiatry and in the Child Study
Center, directs the adult OCD clin¬
ic. He says, “What we call OCD is
not one disorder but a syn¬
drome.” The team of Drs. Leckman, Pauls, McDougle and col¬
league C. Neill Epperson, M.D.,
have found that at least two dis¬
tinctive subtypes of OCD exist,
the Tourette’s-related and non-ticrelated. Onset of the tic-related
form is more common in child¬
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ln rats, two separate
systems in the brain
with similar output
connections may be
responsible for fear
on the one hand and
anxiety on the other

hood and most often seen in
boys. The non-tic-related form
begins more often during and
after puberty and afflicts women
more frequently. The abnormal
elevation of oxytocin is prevalent
in the peri-pubertal form.
Separating out the diagnoses
has helped improve OCD treat¬
ment. Dr. McDougle and col¬
leagues developed a new and far
more effective medication treat¬
ment for the tic-related form by
combining a neuroleptic, or
antipsychotic, medication with a
serotonin reuptake inhibitor, such
as fluvoxamine. Since the results
of their study were published two
years ago, the combination has
become the standard treatment
for the tic-related subtype of OCD.
For their work, researchers
draw on some of the nearly 60
children and 150 adults seeking
treatment for OCD each year at
Yale clinics. Most people afflicted
with OCD respond well to a com¬
bination of cognitive-behavioral
therapies and pharmacological
treatment with recently developed
serotonin reuptake inhibitors. But
just like those with a broken
heart, for some who suffer from
OCD, no cure has been found. ■

West Haven, one of four in the
United States. Chronic PTSD is
resistant to treatment, although
antidepressant medications do
reduce some symptoms. Drs.
Southwick and Charney are also
looking at drugs known as beta
blockers that may reduce the sever¬
ity of traumatic memories. “Rat
studies,” Dr. Southwick says, “sug¬
gest that interventions could be
used around the time of the trauma
itself before the memory becomes

Changes in levels of the hor¬
mone oxytocin may help explain
why OCD patients suffer the
obsessive-thought preoccupa¬
tions that also are often experi¬
enced by people in love and the
parents of newborns, says
James F. Leckman, M.D., direc¬
tor of research at the Yale Child
Study Center.

15

Putting neuroscience
research to work
M

Michael Davis, Ph.D., is one of
eight Yale faculty in psychiatry
who ser\’e as scientific advisers
to Neurogen Corp., a neuro¬
science drug development com¬
pany in Branford, Conn. “I’m
more interested in the basic sci¬
ence,

”

Dr. Davis says, “but I

want somebody to apply it. ”
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ost fundamental discoveries
about the brain that have
launched the neuroscience revo¬
lution have come in the highly
specialized laboratories of acade¬
mic research centers like Yale.
But taking those advances the
next, time-consuming and enor¬
mously costly step to develop
pharmaceutical compounds for
commercial sale is generally
beyond the scope and means of a
medical school. That’s where pri¬
vate industry steps in. And some¬
times, academic investigators
step out to help bring their knowl¬
edge to commercial application.
“The kinds of things we do
have applications for large num¬
bers of people with very debilitat¬
ing conditions,” says former psy¬
chiatry department professor
John Tallman, Ph.D. A neuroscien¬
tist, he left the medical school in
1989 to help found Neurogen
Corp., a neuroscience drug devel¬
opment company in Branford,
Conn. He is now the firm’s execu¬
tive vice president and scientific
director. His departmental col¬
league Dorothy Gallager, Ph.D.,
soon followed him into the firm’s
ranks. Eight of their former asso¬
ciates, all current faculty mem¬
bers, including Benjamin S. Bunney, M.D., Dennis Charney, M.D.,
D. Eugene Redmond, M.D.,
Michael Davis, Ph.D., George
Heninger, M.D., Eric Nestler,
M.D., Ph.D., Robert Roth, Ph.D.,
and George Aghajanian, M.D.,
serve as scientific advisers while
continuing their primary research
and educational roles at Yale.
Although university regulations
prohibit faculty from using acade¬
mic facilities for their own profit,
faculty are permitted to serve as
part-time consultants to firms.
Neuroscience faculty are fre¬
quently called upon by pharma¬
ceutical firms to serve as scien¬

tific advisers. The Yale faculty
thought their knowledge could be
put to even more direct use. "We
were tired of advising other com¬
panies who often did not follow
through,” says Dr. Bunney. “We
decided to put our expertise and
ideas to a real test and created
Neurogen.”
With an infusion of support
from several major pharmaceuti¬
cal firms, including Pfizer and
Schering-Plough, Neurogen has
grown into a publicly traded, high¬
ly respected pharmaceutical
research firm employing more
than 100 people. Pfizer Inc has
licensed Neurogen to develop an
anti-anxiety compound based on
laboratory findings. “We think we
can redefine therapies for anxiety
in the same way Prozac did thera¬
pies for depression,” says Dr.
Tallman. Neurogen has also
expanded to develop its own com¬
pounds. It now has a number of
other “designer” compounds cur¬
rently in development for the
treatment of disorders ranging
from schizophrenia to obesity.
“It’s a good illustration of what
can happen when you put basic
research to work in the service of
rational clinical drug develop¬
ment,” says Dr. Bunney.
For someone like Dr. Davis,
having Neurogen bring his work
out of the laboratory and into the
clinic makes his academic efforts
all the more rewarding. “I’m more
interested in the basic science,”
he says, “but I want somebody to
apply it. ” That’s the job for Dr.
Tallman and company. “There’s
an opportunity at Neurogen,” he
says, “to contribute directly to
the rapid development of
improved treatments for the mil¬
lions of people suffering from
severe, disabling neuropsychi¬
atric disorders.” ■
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Right: “ We 're bringing out
amazing new knowledge about
how the nervous system is
formed, connected and main¬
tained, ” says George K. Aghajanian, M.D., professor ofpsychiatry and phannacology.
Many of those advances have
been made possible by the tools
of molecular biology.

Below: Postdoctoral fellow
Maura Charlton, Ph.D., works
in the laboratory’ with Ronald S.
Duman, Ph.D.

Not only adults
suffer from PTSD.
Children exposed
to violence may
develop the
disorder as well.
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encoded and consolidated.” Future
studies may determine if beta
blockers, when given to emergency
medical workers who are exposed
to daily trauma, will attenuate trau¬
matic memories. “They have to be
given right after the event,” Dr.
Chamey says. "Timing is key.
After the memory is encoded, the
medication probably won't work.”
Not only adults suffer from
PTSD. Children exposed to vio¬
lence may develop the disorder as
well. Dr. Southwick is collaborat¬
ing with Steven Marans, Ph.D.,
director of the Yale Child Study
Center's Child Development-Com¬

munity Policing Program in New
Haven, and center Director Donald
J. Cohen. M.D. '66. on a wide
range of PTSD studies building on
the seminal work done with Viet¬
nam veterans. Plans include studies
of the neurobiological mechanisms
mediating symptoms in children
following stress and of the efficacy
of medication interventions for
children with PTSD. Says Dr.
Southwick, “We're trying to find
strategies to help a person w ithin a
short period after the trauma.”
For Department of Psychiatry
chair Dr. Bunney, the possibility
that psychiatrists might one day be
able to prevent children who have
been exposed to severe trauma
from developing lifelong disorders
represents a triumph of neuro¬
science. “The excitement,” he says,
“is that the potential is there. In a
lot of illnesses, we already have
pretty good treatments—compara¬
ble to what we have for physical
diseases like hypertension and dia¬
betes—but they’re not cures and
we can't prevent the disorders.
"We're a long way off from
that, but now we have the tools,”
he says. “It’s a question of apply¬
ing them to develop better treat¬
ments and. ultimately, cures and
prevention.” YM

17

I

Pure
I

medicine

!
I

I
I
I

'l
i

i
I

By turning down reim¬
bursement, Richard and
Patricia Gibbs of the
San Francisco Free
Clinic provide firstclass care for uninsured
patients and freedom
for physicians to do
what they do best.

By David Davison
Photographs by Matt Black
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hat would a physician’s fantasy be
if he or she won the lottery? “I
would still practice medicine,”
says Judith Mates, M.D., a San Francisco
obstetrician, “but I sure would toss out all
this paperwork.”
Several times a month she does just
that. Dr. Mates, who is president of the San
Francisco Medical Society, is one of dozens
of Bay Area physicians who volunteer their
services to treat patients referred by the
San Francisco Free Clinic. She is sharing
a little bit of a fantasy made real by a husband-and-wife team of Yale-educated physi¬
cians who are practicing medicine without
the paperwork.
Richard Gibbs, M.D. '86, and Patricia
Gibbs, M.D. ’87, founded the San Francisco
Free Clinic in 1993 as an alternative, perhaps
even an antidote, to their successful but
unsatisfying conventional practice in family
medicine. The mission of the clinic recalls
an era when doctors provided treatment in
the best interest of patients regardless of
their ability to pay, and without a utilization
review by a managed care provider. Patients
who could afford to do so paid in cash, or
perhaps with a couple of chickens from the
farm. Third-party payers didn't exist.
The clinic mission is simple, says Tricia
Gibbs, its medical director: "We are devoted
to taking care of patients without insurance.”
At the San Francisco Free Clinic, the doctors
have received expressions of appreciation
from patients in the form of a piece of
chocolate cake or a bit of carpentry work on
a sticky clinic bathroom door. A brightly
decorated metal box in the hallway receives
about $3,000 per year from patients who
have some change or a couple of dollars to
donate. Patients at times cannot under¬
stand—or accept the fact—that insurance
cards are useless and the services are free.
On the way out, there is nothing for patients
to sign, no forms to fill out.

David Davison, a development officer for the
School of Medicine, is a Yale Medicine colum¬
nist and contributor.

Inset: Patricia Heilman Gibbs, M.D., and
husband Richard D. Gibbs, M.D., work
together while examining a patient at the
San Francisco Free Clinic, which they
founded in 1993. The Gibbses met as med¬
ical students at Yale in the mid-1980s.
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A LIMITED AGENDA

Despite these seemingly quaint
characteristics, one should not
mistake the Free Clinic for a New
Age alternative medicine lodge, or
for a grassroots storefront dedi¬
cated to global health care reform.
Orthodox primary care medicine
is practiced here. At least half of
the patients are employed; most
are low-income families. Ninetythree percent have homes.
"We aren't political,” says
Tricia Gibbs, a Bay Area native
who grew up in Brooklyn,
N.Y. "We don’t want to save the
world. We don’t organize letter¬
writing campaigns. We just want
to keep going.”
They keep going on a budget
of $310,000 per year, raised mostly
through an annual fund-raising
event and occasional donations.
The San Francisco Free Clinic
works like a loosely organized
health maintenance organization
(HMO), with the focus on primary
and preventive care. It is located in
a converted, two-story, walk-up
apartment building on Clement

Patients at times cannot
understand—or accept
the fact—that insurance
cards are useless and the
services are free. On the
way out, there is nothing
for patients to sign, no
forms to fill out.
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Street in the Richmond neighbor¬
hood, a working-class community.
The facility consists of a waiting
room, three exam rooms, a patient
counseling room, an office and a
cramped lab.
“We do skin scrapings, skin
biopsies, gram stains—it saves
time and money to do these tests
here, rather than send them out,”
says Richard Gibbs. "As students,
we were expected to know how to
do these tests. Unfortunately, many
physicians do not get the chance to
use a lot of what they learned in
medical school.”
Since the clinic opened, word
of mouth has been enough to
attract patients. The word has got¬
ten around in the Bay Area philan¬
thropic community, too. Medica¬
tions, supplies and equipment are
donated from a network of 30
physicians and from a half dozen
pharmaceutical companies. In
almost all cases, patients are pro¬
vided with both short- and long¬
term medications without cost.
Recently, an acquaintance of the
Gibbses called to say he was
insulted that he hadn’t been asked
for a donation, then sent a check
for $5,000.
Richard Gibbs, the clinic’s
president, estimates that for every
dollar raised, three dollars worth of
care is delivered. Money goes into
services, not administration. From
the outset, the idea was simple—
just say no to all third-party pay¬
ments. The law says if you take
fees from any payer, you must

accept them from all payers,
including the government.
Private, non-profit health clin¬
ics number in the thousands across
the country. But the vast majority
are funded through governmentbacked third-party payments, pri¬
marily Medicaid. Since the mid1960s, the U.S. Public Health Ser¬
vice has provided funding for com¬
munity health centers in rural and
urban areas, designed to serve
those living near or below the
poverty line. These clinics now
serve approximately 9 million peo¬
ple with primary care-oriented
health services, but the system is
far from comprehensive. Millions
of Americans continue to fall
through the cracks.
San Francisco is also the home
of a large and well-known commu¬
nity health program. The HaightAshbury Free Clinic—which
started out in the 1960s as a store¬
front health clinic—now employs
an army of administrators to keep
up with the paperwork involved in
managing government grants and
in collecting Medi-Cal (state-run
Medicaid) and Medicare payments.
The politics of taking care of San
Francisco’s indigent and welfare
population is a big issue, and the
Haight-Ashbury Free Clinic is
often in the middle of it. The Gibb¬
ses acknowledge its important role
and they refer patients there who
are eligible for government med¬
ical insurance.
But the San Francisco Free
Clinic constituency is primarily the
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Leaving behind the insurance and billing paperwork of private practice has given

working poor—people and fami¬
lies caught between systems.
Richard Gibbs points out that one
out of four city residents has no
insurance, including an estimated
60,000 to 70,000 children. Nation¬
wide, the estimated number of peo¬
ple without insurance is 40 million.
When welfare is simply not an
option, and medical care is needed,
a place like the Free Clinic fills a
huge need.
The San Francisco Free Clinic
counted 3,024 patient visits in
1995. Thirty percent of the visits
were devoted to physical examina¬
tions, immunizations, pap smears,
breast exams, TB screenings and
smoking-cessation counseling. A
few paid, part-time physicians pro¬
vide the basic services, assisted by
volunteers. Typically, communitybased health clinics ask doctors to
volunteer their time on site, a
model that has in some cases
proven unworkable, as busy doc¬
tors can’t always follow through
every week with their commitment
to get to the clinic. That leaves
patients frustrated and the clinic
waiting room jammed.

THE SAME KIND OF CARE

The key to the San Francisco Free
Clinic system is the network of 60
volunteer physicians, specialists
and sub-specialists around the city,
who see patients right in their own
offices after a referral by the clinic
doctors. At the specialist’s office, a
patient from the Free Clinic
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the Gibbses (and physicians they’ve recruited into their network of specialists)
more time to focus on patients and the practice of medicine. Above, Richard Gibbs
listens to patient Manuel Tolibas describe a shoulder injury before examining him
and finding the muscles atrophied and weak. Dr. Gibbs teaches Mr. Tolibas
stretching exercises to regain the normal range of motion in his shoulder, and pre¬
scribes an anti-infammatory medication. Before leaving, Mr. Tolibas shares a joke
from his native Philippines.

receives the same care as any other
patient would. The only difference
is that no fee is charged. Several
radiology groups provide free
imaging studies, including CT and
MRI scans. X-rays and mammo¬
grams. A plastic surgeon donates a
morning a month on site.
One radiologist. Phillip Tirman, M.D., who volunteers with
obvious pleasure and pride,
remembers his reaction to being
asked to provide free services. “I
started thinking back to the old
medical school interview when I
said one of the reasons I wanted to
go into medicine was to help peo¬
ple,” he says. The Free Clinic pro¬
vides him with an opportunity to
make good on those words
expressed to interviewers in the
early 1980s. (According to surveys
by the Association of American
Medical Colleges, today’s medical
school applicants—faced with the
prospect of a career under the con¬
trol of huge health systems and
managed care—are more idealistic
than ever about their motivation to
enter medicine.)
“In San Francisco, there is no
shortage of specialists to take care
of patients,” says Richard Gibbs.

Filling a
gap in
care
T

he San Francisco Free Clinic’s
mission is to serve people who
are not covered by private health
insurance or eligible for care in gov¬
ernment-sponsored clinics. It
accepts no reimbursement, unlike
the approximately 2,600 federally
qualified community health centers
across the country. Most of those
are private, not-for-profit organiza¬
tions that rely heavily on a base of
federal funding to exist—typically 40
percent of a center’s annual budget
comes from grants from the Depart¬
ment of Health and Human Services.
The balance comes from a mixture of
private insurance and government
reimbursement, including Medicaid
and Medicare. These clinics, located
in rural and urban areas, serve more
than 9 million people nationwide.
There are more than 33.4 million
men, women and children who are
Medicaid beneficiaries in the U.S.
An estimated 43.2 million people
are without access to a primary
care provider.
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Medications, supplies and
equipment are donated from
a network of 30 physicians
and from a half-dozen
pharmaceutical companies.

Top: Anita Arora came to the San
Francisco Free Clinic for relief from
severe headaches. On a return visit,
after her symptoms have diminshed
with time and medication, she follows
Patricia Gibbs' hand with her eyes in a
test to rule out vision problems.

Middle: Dr. Gibbs takes a close look
at Ms. Arora's eyes for signs of
intracranial pressure, which could
indicate the presence of a tumor. The
exam, and an MRI study provided by a
local radiology practice, rule out both
tumor and stroke as a cause for the
headache pain.

Bottom: After talking about the test
results. Dr. Gibbs and Ms. Arora dis¬
cuss treatments that may help if her
headaches return.
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Specialists donate an average of
two patient visits per month. In a
sense, the clinic is an HMO-style
gatekeeper, but on its own terms.
No insurance overseer or govern¬
ment bureaucrat superimposes
rules and regulations. When
patients need hospital services,
four major San Francisco hospitals
are available to provide charity
care. One hospital has specifically
allocated $40,000 of services for
patients from the San Francisco
Free Clinic. And that doesn’t count
the donated time of hospital staff.
Practicing medicine without
middlemen “strips away every¬
thing that confuses doctors and
patients,” says Tricia Gibbs, who
had found, during her private prac¬
tice years, public trust in doctors to
be low. “Patients have become sus¬
picious. At the Free Clinic, the
patients know we’re here to help
them. There’s a trust and a bond
between the doctors and the
patients.” Tricia Gibbs has noticed
that her patients at the clinic are
twice as likely to follow doctors
orders than the patients she used to
see. Strong patient compliance
with smoking cessation and weight
loss programs are typical of the
clinic success story.
In a feature segment on a local
television newscast, a clinic patient
gave her point of view. “We're
treated with dignity and respect,”
said the 61-year-old woman, who
was being treated for pancreatitis.
Before coming to the clinic, she
held a job that carried no health
insurance, and she was too young

for Medicare. An acute attack
landed her in the hospital for an
operation and a nine-day stay. The
routine care she now gets from Tri¬
cia Gibbs would have easily spot¬
ted her condition and prevented a
painful, scary and expensive expe¬
rience. The question of paying off
her $31,000 hospital bill is unre¬
solved, exemplifying the risks and
the choices confronting many
uninsured Americans.
One-third of the patients at the
San Francisco Free Clinic are from
the city’s Asian community. An
Asian American social worker on
staff serves as both a language
translator and a vital interpreter of
cultural differences that can
impede the efficacy of health care
services for many people. Twenty
percent of the clinic work is pedi¬
atrics. Extended families are a
large part of the patient base. Word
of mouth is more than enough to
bring patients to the door. Media
coverage, while it has generated a
few donations, has also brought the
problem of too many new patients
seeking care. It is not a walk-in
clinic; appointments are required
and emergency care is still the
purview of the local area hospitals.
If a person has insurance, the clinic
staff gives assistance finding
another service provider.
Last year when California vot¬
ers passed legislation excluding
illegal immigrants from state ser¬
vices—including health care bene¬
fits—Richard and Tricia Gibbs
convened a brief staff meeting.
Everyone agreed that the clinic
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would proceed as if the vote hadn’t
happened, another luxury of being
free of Medi-Cal rules and reim¬
bursements. “Who wants sick peo¬
ple in the community?” says
Richard. The clinic takes care of
anyone who is uninsured, period.
As one would expect in a
clinic focused on preventive care,
child vaccinations, treatment for
high blood pressure and routine
exams are the norm. Volunteer
nurses are an essential part of the
medical team. According to both
Tricia and Richard Gibbs, the most
important and satisfying results
from their work come from identi¬
fying a major ailment in time to
effect preventive treatment. When
a complicated case comes up that
calls for expensive procedures or
specialty care, the volunteer net¬
work is called upon.

DRAWING ON THE YALE SYSTEM

Both Richard and Patricia Gibbs
attribute their self confidence and
their skills as physicians to the Yale
System of medical education. They
draw on their training at Yale as
they keep up with the rigors of
practicing and teaching medicine

in a challenging and complex clini¬
cal environment. They believe that
what they learned at Yale was ideal
preparation for their subsequent
family medicine training, and for
keeping up with advances in their
profession today.
“We let the literature guide
our practice,” says Richard Gibbs.
“Irrespective of primary-care train¬
ing or elaborate research, the
teaching at Yale is what I remem¬
ber most. It was great.”
“Yale provided me great role
models,” says Tricia Gibbs, recall¬
ing surgery professor Barbara
Kinder, M.D. ’71. and LeoM.
Cooney, Jr.. M.D., the Humana
Foundation Professor of Geriatric
Medicine. “He was a great teacher.”
remembers Tricia. Adds Richard:
“We met in Dr. Cooney’s class.”
The Gibbses have made the
Free Clinic an active center for
clinical training. It is a family prac¬
tice preceptor site for the Univer¬
sity of California, San Francisco,
and for the Physician Assistant
Program at Stanford University.
Students and residents are there
every day, providing invaluable
patient care and learning medicine
in the kind of ambulatory setting
that is in demand by teaching pro¬
grams nationwide. A visit by Dean
Gerard N. Burrow, M.D. '58, last

year launched a plan to enable
Yale medical students to train at
the clinic.
After meeting at Yale, Patricia
and Richard were married in 1984.
They both trained in family medi¬
cine at the University of Washing¬
ton. When they moved to the Bay

One hospital has
specifically allocated
$40,000 of services for
patients from the San
Francisco Free Clinic.
And that doesn Y count
the donated time of
hospital staff.

Area in 1990, Richard (a former
dancer) took a part-time job as
the physician for the San Fran¬
cisco Ballet, where he still enjoys
the orthopaedics dimension of
the work.
On a summer aftemon spent
with a visitor to the clinic for this
article. Richard and Tricia dart

Most specialty care for
patients at the clinic is
referred to physicians in
the community, who see the
Gibbses’ patients in their
offices. An exception is the
monthly appearance at the
clinic by Lars M. Vistnes,
M.D., chairman emeritus
of plastic surgery at Stan¬
ford University School of
Medicine. Left, Dr. Vistnes
and Ann Gilmore, R.N.,
prepare for surgery to
remove a growth from the
mouth of a patient.
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from room to room, taking care of
patients, supervising students and
fielding questions. Richard excuses
himself from the discussion to look
in on a patient exam being con¬
ducted by a student. Tricia takes a
moment to phone the baby-sitter
and make sure that their five chil¬
dren, who range in age from 4 to
10, can do without her for a little
longer that afternoon while she
takes the time for a serious jog.
A former member of the U.S. Ski
Team, she is training to run in a 50mile ultra-marathon.
Richard and Tricia readily
admit that their clinic model is not
instantly replicable. They were
able to throw off the collar of a
conventional career, take a huge
cut in income, and create the Free
Clinic thanks to some important
help. Tricia's father, a successful
investment banker, and her mother,
a well-connected philanthropist,
pulled together the private dona¬
tions needed to get the clinic
started. Her parents are key to
putting on the annual fund-raising
dinner that attracts a wide range of
corporate and individual support¬

The key to the San Francisco
Free Clinic system is the network
of 60 volunteer physicians,
specialists and sub-specialists
around the city.

ers. When asked for the formula to
succeed as a charity, Richard
bluntly advises, “Load your board
with heavy hitters.” When asked
what they see ahead, their long¬
term expectations are neither
grandiose nor unreasonable.
“We could use a little more
space,” says Tricia.
“We need an endowment so
we don’t have to fund-raise every
year,” says Richard.
“But we don't want to outgrow
our resources, either,” Tricia adds.
She also cites the ongoing need to
fill gaps with more volunteer ser¬
vices from sub-specialists.
Both Richard and Tricia qui¬
etly reiterate that they are not con¬
ducting a social experiment, nor do

The success of the San Francisco Free Clinic is measured, in part, by the
increasing number of medical students and residents who receive training
there. Above, Richard Gibbs and Alexander Z. Rivkin, a Yale medical stu¬
dent now in his final year, talk during Mr. Rivkin’s primary care clerkship
at the clinic in September.
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they hope to treat all of the people
all of the time. “We’re not doing
this just for the patients,” says Tri¬
cia Gibbs. "In the evening when
we go home we usually feel good
about the way we spent the day.” It
seems like a simple wish. Ask the
average doctor in private practice
about his or her work and the dis¬
cussion usually revolves around
the frustrations of dealing with
insurance middlemen, the disap¬
pearance of the doctor’s autonomy
and the gloomy prospects of
shrinking incomes.
The medical students, the resi¬
dents, the staff doctors and volun¬
teer specialists involved with the
Free Clinic all show a different
face. “It’s free for the physicians as
well as for the patients,” is how
one cardiologist put it to a televi¬
sion reporter. He wore a look of
immense delight and satisfaction
as he talked about the patients he
treats as a volunteer. “If Dr. Gibbs
wants me to do a test on a patient, I
say, ‘Sure.’ I don’t have to get on
the phone and call some bureau¬
crat. I don’t need an extra $100.
What I need is an opportunity to
fulfill my need to be a giver, and to
be appreciated for it.”
“We still have paperwork, but
it’s not annoying paperwork,” says
Tricia Gibbs. “We take notes and
keep charts. But we don’t fill out
forms.” The time they gain by not
arguing with insurance companies
or shuffling Medi-Cal forms saves
about an hour a day, time that they
invest in seeing more patients.
What may seem like a fantasy to
some physicians in private practice
is the routine at the San Francisco
Free Clinic. YM
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INTERVIEW

Carolyn W. Slayman, Ph.D
“My job is to be the catalyst, ”
says the school's first deputy dean
for academic and scientific affairs.
Photographs by Peter Casolino

C

arolyn W. Slayman had completed her Ph.D.
training in biochemical genetics at the Rocke¬
feller University and taught in Western Reserve
University’s biology department for three years
when she started her career as an assistant profes¬
sor at the Yale University School of Medicine
in 1967.
Since then, her accomplishments have been
characterized by firsts: the first woman to chair a
medical school department at Yale and the first
woman to become a deputy dean at the school.
She was appointed chair of the Department of
Human Genetics, later renamed the Department
of Genetics, in 1984, and she was named deputy
dean for academic and scientific affairs last fall
when the school’s administration was restructured
in response to the increasingly complex demands
placed on academic medicine. In 1991, Yale Uni¬
versity recognized her academic excellence by
naming her Sterling Professor of Genetics.
Born in Portland, Maine, Dr. Slayman gradu¬
ated from Swarthmore College in 1958 with high¬
est honors in biology and chemistry. She received
her Ph.D. degree in 1963 from Rockefeller Uni¬
versity, and spent the following year as a National
Science Foundation postdoctoral fellow at Cam¬
bridge University. After serving on the Western
Reserve University faculty in Cleveland, she
came to Yale, where she has centered her research
on the proteins that transport nutrients across cell
membranes and the genes that code for those pro¬
teins. During this time, she has been a mentor and
role model to many graduate students and post¬
doctoral felloes alike.
She is active in professional organizations,
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having recently completed a term
on the National Advisory General
Medical Sciences Council at the
National Institutes of Health. She
serves on the Scientific Review
Board of the Howard Hughes Med¬
ical Institute and is a trustee of
Bowdoin College in Brunswick.
Maine.
In this Yale Medicine inter¬
view, Dr. Slayman talks with
Helaine Patterson, director of the
School of Medicine’s Office of
Public Information, about the
direction of the school's academic
and scientific affairs.
YALE MEDICINE: LAST FALL,

THE OFFICE OF THE DEAN WAS
RESTRUCTURED AND THE POSI¬
TION AND OFFICE OF DEPUTY
DEAN FOR ACADEMIC AND SCI¬
ENTIFIC AFFAIRS WAS ESTAB¬
LISHED. WHAT ARE THE
OFFICE'S STRUCTURE AND
MAJOR PROGRAMMATIC
THRUSTS?

The office
has a number of broad responsibili¬
ties for academic and scientific
programs, and for the faculty of the
medical school. Before describing
them, though, let me begin by
emphasizing my close working
relationship with the other Deputy
Deans: Joseph B. Warshaw, M.D.,
(clinical affairs) and Stephen M.
Cohen (financial affairs and
administration). As you can imag¬
ine, much of the planning and deci¬
sion-making that goes on at the
medical school cuts across all three
areas. When a senior faculty mem¬
ber is being recruited or a major
new academic program is being
launched, all three of the deputy
deans work together. Likewise, all
three of us are deeply involved in
financial and space planning, and
we meet regularly with the chairs
and business managers of each of
the medical school’s departments
to make sure that thinking at the
department level is woven into a
Carolyn slayman:

broader picture for the school as a
whole. In fact, it was exactly this
kind of interweaving and sharing
of responsibilities that Dean Bur¬
row had in mind when he reorga¬
nized the dean’s office last year.
you mentioned that your
OFFICE HAS A SPECIAL
RESPONSIBILITY FOR THE
FACULTY OF THE MEDICAL
SCHOOL. COULD YOU
DESCRIBE IT?

As you know, the medical school
has a large and extraordinarily tal¬
ented faculty who teach, do
research and care for patients. In a
very real sense, these people define
the excellence of the place, and it’s
critical to use the highest possible
standards as we make decisions
about appointments and promo¬
tions. It’s also critical to offer help
and encouragement to the faculty
as they cope with professional
challenges and career decisions
that can be quite stressful: how to
find the next research grant, for
example, or how to juggle respon¬
sibilities toward students, patients
and co-workers.
Last year, I learned a lot about
the scope and structure of the med¬
ical school faculty by chairing both
the Tenure Allotment Committee
and the Senior Appointment and
Promotions Committee. I also
worked closely with Norman
Siegel, M.D., [acting chairman
of pediatrics] who headed a task
force to examine our faculty ranks
and tracks. The task force’s report
will be ready soon, and it will
recommend the creation of two
new tracks—a clinician-educator
track and an investigator track—
to respond to the changing envi¬
ronment in health care and bio¬
medical research.

Carolyn W. Slayman, Ph.D., discusses opportunities for technology transfer

WE UNDERSTAND THAT

with Jon Soderstrom, Ph.D., and Ben Muskin, new members of the expanded

THERE HAVE ALSO BEEN

Office of Cooperative Research. The University opened a branch office at

CHANGES IN THE OFFICE OF

the medical school in July. The office guides faculty who have made discov¬

FACULTY AFFAIRS.

eries in their work to translate those discoveries into a form that can be
patented and marketed.
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Yes, we’ve recruited a new associ-
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“In a very real sense, the faculty
define the excellence of the place,
and it’s critical to use the highest
possible standards as we make
decisions about appointments
and promotions.”

ate dean for faculty affairs to head
what Yale informally calls the
faculty office: Morton G. Glickman, M.D., a member of the
Department of Diagnostic Radiol¬
ogy since 1973.
The faculty office is where all
of our appointments and promo¬
tions are handled and faculty
records are kept. It does an enor¬
mous amount of advising of chairs
and faculty members about matters
of appointments, promotions and
career development—questions
that range from rather specific
ones: “Am I eligible for sabbati¬
cal?” “What if I want to take a
leave of absence?” to much more
complicated ones, such as: “I am
an assistant professor in a clinical
department. I love research, but I
also love working with patients.
I’m not sure yet whether it makes
sense for me to plan my career to
advance through what Yale would
call the academic track, where
there’s a lot of emphasis on
research, or along the clinical
track, where there’s more emphasis
on direct work with patients.”
In addition, the school’s Office
of Academic Development, headed
by Associate Dean Merle Waxman,
M.A., enhances academic growth
and career development of faculty,
fellows and students. Merle
arranges educational programs
and oversees mentoring opportuni¬
ties at the school, and works
closely with other components of
my office.
Both Merle and Mort have
wonderful opportunities to meet

Yale medicine

our faculty members at very early
stages in their time at Yale and to
help guide them in their careers.
That’s also part of what comes
under the heading of academic
and scientific affairs.
Dr. Slay man talks with Ira Mellman, Ph.D.,
COULD YOU BRIEFLY DISCUSS
SCIENTIFIC AFFAIRS, BOTH
PROGRAMATICALLY AND
ADMINISTRATIVELY?

In scientific affairs, we are recon¬
figuring the school’s grants and
contracts and technology-transfer
activities to make resources avail¬
able to our faculty from the dean’s
office as they seek external support
for their work. The new director of
our grants and contracts office is
Jill Schneider, who holds an M.S.
degree from Massachusetts Insti¬
tute of Technology’s Sloan School
of Management. Jill has experience
in the pharmaceutical industry and
more recently as business manager
of the Yale Department of Derma¬
tology, so she knows the Univer¬
sity very well. She works closely
with the departments to streamline
the process of submitting grants
and to improve the way in which
we disseminate information about
grant possibilities. The faculty are
very busy doing their own
research, and yet they’re totally
dependent on being able to gener¬
ate external support for it. We want
to be sure that all faculty members
are notified very quickly of new
funding opportunities that may be
relevant to their work. Jill will
devise better systems, we hope

about the new Biological and Biomedical
Sciences program, which has streamlined
the application process for graduate stu¬
dents and broadened their opportunities
within Yale. Dr. Mellman, professor of cell
biology, is director of the new program.

electronically, to get word out to
our faculty when a new foundation
is formed or the National Institutes
of Health (NIH) announces a new
program of research support on a
particular disease or a particular
problem in biomedical research.
There’s a lot of re-engineering
under way in the grants and con¬
tracts process.
The second key person is Sara
Rockwell, Ph.D., a radiation biolo¬
gist and faculty member since
1974. Sara’s research has centered
on the biology of cancer cells in
solid tumors and on using that
information to improve cancer
therapy. She’s remaining active in
the laboratory but will spend half
of her time as director of our Office
of Scientific Affairs. She’ll work
very closely with Jill. Where the
main emphasis of Jill’s work will
be on administrative procedures,
Sara will work more directly with
the faculty. This spring, for exam¬
ple, Sara and others set up a series
of well-attended workshops that
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“The traditional
department-based way of
recruiting faculty has
been a rigorous one, and
it has allowed the
medical school to build
an enormously strong
faculty of scientists and
teachers, of whom we're
very proud. ”

focused on how to prepare an NIH
grant application, how to describe
a proposed scientific project, how
to formulate the budget, and how
to respond to criticisms that may
come from the study section. She
will continue these workshops and
has others in mind—for example,
to help postdoctoral fellows find
ways to get fellowship support and
apply for jobs. So, there’s an edu¬
cational function to the Office of
Scientific Affairs.
The other important compo¬
nent of Sara’s job is to serve as an
active liaison between my part of
the dean’s office and the medical
school's various research support
functions, including core research
laboratories that offer our scientists
access to modern technology such
as confocal microscopy, DNA and
protein sequencing, and the con¬
struction of transgenic mice. Sara
will be a link from the dean’s
office to help those core research
laboratories improve their services.
She also interacts in a very impor¬
tant way with the Yale Animal
Resource Center. Because so much
of our research involves laboratory

animals, Sara works both with
users of animals and with Robert
Jacoby, D.M.V., Ph.D., professor
and chairman of comparative med¬
icine and director of the Division
of Animal Care, and his staff to be
sure that we’re doing everything
we can possibly do to keep our ani¬
mal facilities and practices up-todate. And she is our link with the
regulatory committees: the
Human Investigation Committee,
the Animal Care and Use Commit¬
tee, the Biosafety Committee, the
Radiation Safety Committee—all
of those committees which have
critical functions in overseeing
various aspects of medical research
to make sure it’s done properly
and safely.
COOPERATIVE RESEARCH IS
THE THIRD COMPONENT OF
YOUR OFFICE. WHAT IS THE
MEDICAL SCHOOL DOING TO
FORM NEW PARTNERSHIPS
WITH INDUSTRY?

Quite a lot. On July 1, a branch of
the University’s Office of Coopera¬
tive Research opened at the med¬
ical school. This office, set up in
1982 through the efforts of the
Provost, helps the faculty with
matters of technology transfer. It
guides people who have made dis¬
coveries in their work to translate
those discoveries into a form that
can be patented and marketed. As
an example, one might cite Lyme

Chair of the Department of Genet¬
ics before assuming her new role
in the dean s office. Dr. Slayman
remains active in research. “My
laboratory is, fortunately, immedi¬
ately downstairs from my adminis¬
trative office, so a favorite thing to
do when I get a break of even 15 or
20 minutes is to pop downstairs
and talk to a postdoctoral fellow
about an experiment. It’s a nice
way to punctuate the day. ”
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disease, a very active area of
study at Yale. Work on a Lyme
disease vaccine has been helped
by the efforts of the Office of
Cooperative Research, putting
Yale faculty members who work
in this area in contact with a com¬
pany interested in testing and pro¬
ducing the vaccine.
For more than 10 years, the
cooperative research office has
been based on the main campus,
and we’ve all felt that it was a lit¬
tle too distant from the medical
school. There’s a figure worth
quoting here: more than 80 per¬
cent of Yale discoveries reported
to the cooperative research office
have come from the School of
Medicine. All of this activity has
prompted the need for a more
prominent presence on Cedar
Street. Yale is very fortunate this
year to have recruited a new
director for the Office of Cooper¬
ative Research, Gregory E. Gar¬
diner, Ph.D., who arrived in Febru¬
ary. Greg has set up a branch office
in the medical school headed by E.
Jonathan Soderstrom, Ph.D., who
comes to us from Oak Ridge
National Laboratory. Jon and his
co-worker, R. Bennett Muskin,
have begun to walk around the
halls of the medical school,
introducing themselves to our sci¬
entists and getting to know people
who are doing work that is poten¬
tially transferable into the private
sector. Their aim is to be as helpful
as possible at an early stage in
the research.
Greg Gardiner, Jill Schneider
and Sara Rockwell have been
meeting together and meeting
with me to think about ways in
which their efforts can be inte¬
grated. Often people’s work is
supported at the beginning by
grants and later by contracts, so
there should be a seamless flow
in the availability of information
and support to our faculty. As
the three administrators work
together to improve access to
information and help, next year
will be a key time when these
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Dr Slayman meets with Jill Schneider, right, director of the Office of Grants and
Contracts. New systems are being devised to get word of finding opportunties to
faculty quickly, says Dr Slayman: “There’s a lot of re-engineering under way in the
grants and contracts process. ”

efforts will begin to pay off in a
way that’s visible to our faculty
and research staff.

well as with Graduate School Dean
Thomas Appelquist, Ph.D. So,
there’s an educational side of the
office as well.

ARE THERE OTHER AREAS IN
WHICH YOUR OFFICE IS

DURING THE NEXT FOUR

INVOLVED?

YEARS, WHICH WILL END THE

Yes, I’ve also been working with a
number of other key people in the
medical school. I work directly
with Nancy Roderer, M.L.S., who
heads our medical library; with
John Paton, Ph.D. who heads acad¬
emic computing; with James D.
Jamieson, M.D., Ph.D., head of the
M.D./Ph.D. program, and I’m
looking forward to working with
Ira S. Mellman, Ph.D., director of
the combined graduate program in
biological and biomedical sciences
established this summer as a result
of two years of very hard work
throughout the University. We’re
going to have a much better inte¬
grated Ph.D. program at Yale, and
Ira will work closely with me, as

ANY PROGRAMMATIC GOALS

20th

CENTURY, ARE THERE

OR PARTICULAR AREAS OF
RESEARCH OR SCIENTIFIC
AFFAIRS THAT YOU THINK WILL
BE EMPHASIZED?

Absolutely. Let me talk about sev¬
eral things here. The first is the
very important question of how the
School of Medicine sets its scien¬
tific direction. This should not be
the purview of any one person. It
should be the result of collective,
careful, wise thinking on the part
of the academic leaders of our
school. My job is to be a catalyst. I
try to bring people together and
foster active discussion that will
guide us, as faculty positions
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Dr. Slayman discusses an experi¬
ment with members of her labora¬
tory’ in Sterling Hall of Medicine.
Her research has centered on the
proteins that transport nutrients
across cell membranes and the
genes that code for those proteins.

become available, to recruit new
people in directions that are the
most exciting ones we can possibly
think of.
The traditional, departmentbased way of recruiting faculty has
been a rigorous one, and it has
allowed the medical school to
build an enormously strong faculty
of scientists and teachers, of whom
we're very proud. But as science
becomes more interdisciplinary,
it’s important for departments to
work together in defining areas
that the school wants to sustain and
strengthen. An example would be
cancer research. Many parts of the
medical school have a current
strength in cancer research, and an
interest to make sure that we
remain at the forefront of that field.
Included would be the Cancer Cen¬
ter, which is an integrating struc¬
ture for the school; clinical depart¬
ments such as internal medicine
and pediatrics, bridge departments
such as pathology and genetics,
and basic science departments like
cell biology and pharmacology.
Instead of having each department
think separately about how it wants
to sustain its strength and search
for young faculty members when
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the opportunity arises, we want to
encourage discussion across
departments, to get people talking
about the future of cancer research,
the most promising directions, and
where we should put our resources
as we recruit new faculty members.
To follow that particular example a
step further, there’s a growing con¬
sensus that one of the most excit¬
ing areas in cancer research has to
do with the regulation of the cell
cycle. How are cells regulated as
they go through cell division? We
need to be stronger in this area. By
coordinating recruitment of junior
people over the next few years, the
opportunity exists for us to build
that kind of strength together more
effectively than any one depart¬
ment would be able to do by itself.
Along with the recruitment of
faculty, we need to offer them an
absolutely outstanding scientific
environment. In particular, we
must have first-rate laboratory
space. It’s no secret that we are not
happy with the current state of lab¬
oratory space at the medical
school, although some is new and
handsome, such as the Boyer Cen¬
ter, and some of the older areas
have been nicely renovated over

the past few years. There’s a lot of
deferred maintenance, and we must
embark on a program of renovation
and modernization of our laborato¬
ries if our scientists are going to be
able to do their best work. We’ll be
modernizing existing laboratories,
starting this year with the first floor
of the B-Wing of Sterling Hall of
Medicine. It is an old building but
still has scientific life in it. The
walls and basic structure are very
sound, but the interior, particularly
in the B-Wing and C-Wing labora¬
tories. has not been renovated for
30 years and is really suffering.
The air handling is inadequate, and
other aspects of the infrastructure
are limiting. The laboratories
themselves, the benches and the
sinks, even the layout, are a bit
antiquated. The tendency now is
for people to want to work in open
laboratories in order to encourage
cross fertilization between labora¬
tory groups.
THE BOYER CENTER WOULD BE
A GOOD EXAMPLE.

Yes, the Boyer Center has doors
that connect laboratories, so stu¬
dents and staff members from one
group are always talking with peo¬
ple in the neighboring groups. In
older space, this is simply not pos¬
sible. People didn’t recognize the
value of that interconnectedness
for a long time, and our older labo¬
ratories are laid out like separate
little boxes, inhibiting discussion
and the sharing of equipment and
ideas. Not only do we want to
upgrade the labs physically and
make them function better, we also
want to lay them out differently,
more in tune with modern ways of
doing research.
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ANOTHER TOPIC. FOR MANY
YEARS, PEER REVIEW HAS
BEEN PART OF THE SCIENTIFIC
TRADITION. ARE ANY MODIFI¬
CATIONS NEEDED?

IF SO,

WHAT NEEDS TO BE DONE FOR
THE 21ST CENTURY?

NIH, under the leadership of
Harold Varmus, has been looking
carefully at the peer review process
recently, evaluating it and making
changes. Yale medical school fac¬
ulty members have been very
active in that evaluation. We have
more than 50 scientists who sit on
advisory councils of NIH institutes
or serve on study sections. Our sci¬
entists are well-connected in Wash¬
ington and very much part of the
self-examination that NIH has
been going through.
But I’ll focus my remarks on
the medical school. We need not
only to keep up-to-date with what’s
going on in Washington, partici¬
pate in it and help it where we can,
but we also need to think about our
own local procedures. Discussions
are under way about the possibility
of a pre-review process that could
help our scientists submit really
strong, competitive applications
for funding. Several other universi¬
ties and medical schools have a
system in place where a faculty
member who wants to submit a
grant doesn’t send it directly
through the grants and contracts
office to Washington, but rather
prepares it early enough so it can
be read critically either by a col¬
league in the same department, by
members of a large and diverse
committee, operating out of the
grants and contracts office. If one
or two colleagues were to look at
an early draft of a grant application
and send it back with constructive
criticism, this would be a kind of
peer pre-review that would help
the scientists realize: “Maybe that
experiment has a flaw, and I’ll
think about it again.” By having
the benefit of constructive criti¬
cism, the application that goes
down to NIH would be stronger
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and have a better chance of being
funded. So, we'll be thinking very
hard during the next year about
whether we want to set up that kind
of mechanism, at least on an exper¬
imental basis. We’ll be talking with
our scientists to see whether
they're interested in it.
On the one hand, people are
nervous about submitting grant
applications these days. They
know how competitive the situa¬
tion is at NIH, and they will want
to do whatever they can to make
their own applications as strong as
possible. On the other hand, people
are awfully busy. Anything that
requires preparing an application,
not just for the deadline but maybe
a month ahead, and asks you to
take a turn serving on one of these
review committees and to give
some of your time to help your col¬
leagues is a serious undertaking,
and would have to be organized
very carefully.
FEDERAL SUPPORT FOR BIO¬

process. Many of our scientists are
active in professional societies,
which are trying to educate the
Congress. Many people in top
administrative posts at Yale have
themselves been quite active in
making the case as strongly as
they possibly can that this coun¬
try’s system of biomedical
research, which has evolved over
the past 50 years, shouldn't be
allowed to go downhill because of
lack of funding.

“We need not only to keep
up-to-date with what's
going on in Washington,
participate in it and help it
where we can, but we also
need to think about our own
local procedures

MEDICAL RESEARCH CONTIN¬
UES TO BE A MAJOR CONCERN
IN WASHINGTON AND ON UNI¬
VERSITY CAMPUSES. HOW IS

AS A GENETICIST AND FORMER

THE DEBATE IN WASHINGTON

CHAIR OF GENETICS, ARE YOU

AFFECTING YALE?

STILL INVOLVED IN GENETIC
RESEARCH?

There’s an enormous amount of
nervousness at Yale and in other
research-intensive universities and
medical schools, as you can imag¬
ine. We heaved a collective sigh of
relief earlier this year when, some¬
what surprisingly, Congress was
persuaded to give a healthy
increase of 5.7 percent to the NIH
budget for fiscal year 1996. That
was terrific, and the funds are
being very well used. But, as we all
know, the political process in
Washington works one year at a
time, and it’s very hard to know
what’s in store.
The budget forecasts that
we’ve seen for the future don't
look good. Requests for funds for
biomedical research are going to
have to compete with other priori¬
ties, and it’ll be a very political

I’m determined to stay active as a
faculty member in the Department
of Genetics, and I have a research
lab that is still going strong. We’ve
done research for a number of
years now on genes that code for
transport proteins that move ions
back and forth across the cell
membrane. We’re making muta¬
tions and looking at the effect of
mutations on ion transport. It’s
very basic research.
My laboratory is, fortunately,
immediately downstairs from
my administrative office, so a
favorite thing to do when I get a
break of even 15 or 20 minutes is
to pop downstairs and talk to a
postdoctoral fellow about an
experiment. It’s a nice way to
punctuate the day. YM
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The haunted faces
of mental illness

T

Madness as satanic possession
marks the earliest images of mental
illness from the Whitney/Cushing
Medical Library’s exhaustive

Clements C. Fry Collection of Med¬
ical Prints and Drawings. Exorcism
was long believed a cure for mental
illness. This 16th-century German
woodcut, based on the story of a
young, mentally ill woman believed
possessed by the devil, shows the

he face of madness,” wrote
the late French philosopher
and historian Michel Fou¬
cault, “haunts the imagination of
Western man.” Haunts is the correct
metaphor. The words commonly
used to describe mental illness con¬
vey this sense of invasion by pow¬
erful, malevolent forces: unhinged,
plagued, possessed, weighted down,
imbalanced and worse, often far
worse. The artistic, religious and
medical representations of mental
illness turn these metaphors into
terror-filled visual images. Devils
and ghouls invade, stones grow
from skulls, faces contort, objects
crush, spikes pierce heads, brains
spill forth. In image after image, the
faces contort in the agony of being
besieged by forces beyond control.
Artists have long been drawn to
the subject of mental illness.
Images of fools, witches, madmen
and demonic possession can be
traced back to 14th-century illumi¬
nated manuscripts. Later artists,
including Durer, Breughel, Hoga¬
rth, Goya and Van Gogh, found sub¬
ject matter there, too. This survey of
historical images is culled from the

“therapy ” at work. Background
image: An 1880 etching by Paul
Richer portraying a demonic attack.

This engraving from Tony Robert-Fleury's
1876 painting, Pinel Freeing the Insane,
shows the release of patients at the
Salpetriere asylum in Paris from their
restraints by Philippe Pinel. The reformminded Pinel was the first psychiatrist to
attempt more humane treatment after more
than two centuries of isolation cells and
chains for the mentally ill.

Clements C. Fry Collection of Med¬
ical Prints and Drawings of the
Historical Library of the Harvey
Cushing/John Hay Whitney Med¬
ical Library.
In part, they document a history
of viewing mentally ill people as
bizarre medical exhibits. They also
show how the treatment and image
of mental illness develop hand in
glove. The medieval exorcism of
devils (that failing, burning at the
stake was common) gave way in the
1600s to removal by “enlightened”
physicians of “stones of folly” from
the heads of the mentally ill. Pseu¬
doscience, quackery and cruelty
were long part of treating the men¬
tally ill. During the late 1600s, con¬
finement and isolation of the men¬
tally ill began. The notoriety of
Bedlam—popular name for Lon¬
don’s Hospital of St. Mary of Beth¬
lehem—soon came to express the
horrors of life with mental illness.
Beginning in the 19th century,
the study of mental illness began to
take on its modem, scientific cast.
Lacking adequate tools for treat¬
ment, however, the diagnostic and
artistic focus remained the experi-

Left: Quackery has long plagued treatment of
the mentally ill. Note the assistant’s hand draw¬
ing out “stones of folly” from his pouch to be
“extracted” by the surgeon from the patient’s
head in Claes Janz Weydtmans early 17th-cen¬
tury Flemish engraving.

Below: Spanish artist Daniel Urrabieto y Vierge
worked in France in the late 19th century. Yard
of an Asylum depicts the more humane condi¬
tions of the open, if walled, yard.

ence of possession and the face of
the possessed. Paul Richer, a
superb draftsman as well as clini¬
cian working with Jean-Martin
Charcot at the Salpetriere asylum
in Paris, drew images of stages in
mental illness, such as the
“demonic attack” phase of hysteria
reproduced here. Even the 20thcentury American artist Boris
Artzybasheff pictures the face of
Anxiety as contorted and mon¬
strous as uncontrollable outside
forces terrorize and overwhelm.
Today’s representation of men¬
tal illness, the brain scan, goes
beyond the face for the first time.
Treatment and image remain insep¬
arable. As one gains a clearer pic¬
ture of the many environmental and
biological forces at work in mental
illness, the ancient fear of posses¬
sion and the possessed loses its
force. One day, through research,
the haunted faces of the mentally ill
will disappear into artistic and
medical history altogether.

Above: English illustrator George Cruishank
depicted various forms of mental disorders in
his popular caricatures. The Blue Devils of
1836 shows the overwhelming weight of
depression. As comic as the figure appears,
the very real threat of suicide plagues him.

Left: The 20th-century’ American artist Boris
Artzybasheff continues the tradition repre¬
senting the mentally ill as besieged by terrify¬
ing outside forces. A detail from his 1947
work Anxiety portrays the victim as trapped,
unable to move.

Marc Wortman
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YCC launches
new program in
cancer genetics
The Yale Cancer Center has estab¬
lished a new program in cancer
genetics to help patients with the
dilemmas raised by advances in
genetic research.
"Testing positive for genetic
predisposition to cancer does not
necessarily mean a patient will get
cancer, but rather that the patient
has a genetic mutation that
increases the likelihood,” explains
Allen Bale, M.D., director of the
Cancer Genetics Program.
“There is very little genetic
testing being done now,” says
Susan Mayne, Ph.D., associate
director for cancer prevention and
control at the Yale Cancer Center,
the first Connecticut institution to
offer a cancer genetics program.
"For the most part, family histories
have been relied upon to determine
a course of action.”
Initially, the Yale program is
offering testing only to those peo¬
ple with a family history of cancer.
But it is the role of the genetic
counselor to help prospective
patients decide whether they even
want to have a test.
“It’s important to educate
patients before testing so they can
decide what’s right for them,”
says Yale Cancer Center coun¬
selor Ellen Matloff, M.S. “Some
patients don't want to know—it
would impair their quality of life.
For others, knowledge is empow¬
ering; it helps them plan and
make important life and lifestyle
decisions.” She adds that the
stress of not knowing is often the
worst part.
Dr. Mayne says that once a

34

genetic predisposition to cancer is
determined, the big question is
what to do with the knowledge.
“Just knowing you have this
genetic susceptibility doesn’t do
much good if you can’t do any¬
thing about it. That’s why our can¬
cer prevention and control efforts
and cancer genetics efforts are
closely linked.”
By focusing on families,
researchers find broader implica¬
tions because these families may
hold the key to the genetics of can¬
cer as a whole. In pursuit of under¬
standing how cancer develops and

how to prevent and treat it, scien¬
tists at the Yale Cancer Center are
trying to learn more about carriers
with and without the disease.
The study of genetic suscepti¬
bility also presents the challenge of
defining effective approaches for
counseling individuals from highrisk families concerning genetic
testing. “We do not yet know the
best way to counsel people with a
familial predisposition to cancer,”
says Dr. Mayne. “An approach that
works for prenatal diagnostics, for
example, may not be optimal when
dealing with cancer.

Medical van brings care
to the community

A

cross New Haven, a new 36foot van is delivering medical
care to residents who in the past
may have fallen through the
cracks of the health system.
The new Community Health
Care Van is the centerpiece of
an innovative research and eval¬
uation project, one of the newest

Community

Health Care

national models to provide
health care to drug users and
other medically underserved city
residents, says Frederick L.
Altice, M.D., assistant professor
of medicine at Yale School of
Medicine and a member of the
Yale AIDS Program.
With this new van, Dr. Altice

Yale investigators clone
a gene for skin cancer
Researchers from the U.S., Aus¬
tralia, and Sweden have combined
forces to isolate the gene for basal
cell carcinoma of the skin, accord¬
ing to findings published recently
in the journal Cell. These findings
could lead to skin cream that
would cure the disease, and to
genetic testing for susceptibility to
skin cancer.
The newly identified gene,
called PTCH, is essential for keep¬
ing skin cells under control.
“Genetic mutation of PTCH is the
key step in development of skin
cancer,” says Allen E. Bale,
M.D., senior author of the Cell
paper and director of the Cancer
Genetics Program at the Yale Can¬
cer Center.
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health clinic program began in
1993, more than 1,800 men and
women between the ages of 20
and 45 have been served. Dr.
Altice hopes to more than double
that amount with the new van.
As part of this federally fund¬
ed project, the Yale team will fol¬
low 500 drug users and look at
the way they use health care ser¬
vices. “We will see if people who
have repeated interaction with the
van change from episodic and
fragmented care to primary
care. We also will explore how dif¬
ferent people perceive health
care, and how and why drug users
use certain kinds of care,” adds
Dr. Altice.
The van and related aspects
of the research and evaluation
project are supported by a fouryear, $3 million grant made to the
Yale School of Medicine by the
National Institute on Drug Abuse.
Dr. Altice is this grant’s principal
investigator. ■

and may also have birth defects
and childhood brain tumors. He
mapped the NBCCS gene to
human chromosome 9, and after
sorting through 40 other genes,
reported isolation of PTCH, a
human gene similar to a previ¬
ously reported fruit fly gene. “No
one had a clue that this gene had
anything to do with human cancer,
but some of the features in fruit
flies were strangely similar to the
birth defects in NBCCS,” says Dr.
Bale, associate professor of genet¬
ics and medicine at Yale.
The researchers found that
individuals with NBCCS are
born with a mutation of PTCH
in all of their cells. Further inves¬
tigation revealed the same muta¬
tion in non-inherited tumors,
which account for the vast major¬
ity of basal cell carcinomas. In
those tumors, the mutation was

Peter Casolino

and his colleagues hope to dis¬
cover whether this care and other
directed efforts will help decrease
or alleviate emergency depart¬
ment visits for acute health care
problems and increase the use of
primary care services. The project
is sponsored by the School of
Medicine, the Hospital of St.
Raphael, the City of New Haven
and its health department, YaleNew Haven Hospital, the Hill
Health Center, Fair Haven Commu¬
nity Health Clinic and the APT
Foundation.
“We aim to do preventive out¬
reach as a model to reflect the
needs of the community,” says Dr.
Altice. The van will travel through¬
out New Haven in tandem with the
city’s Needle Exchange Program.
The van also will be used by
another Yale program, the Medical
Residents Training Program,
which provides medical services
one day a week to individuals at
city soup kitchens.
Since the mobile medical

This discovery paves the way
for novel approaches to prevent¬
ing and treating basal cell carci¬
noma, according to David J. Leffell, M.D. HS '84-87, associate
professor of dermatology at Yale
and a co-author of the report.
“Although it’s still several
years away, it’s not unreasonable
to imagine an ointment that, when
applied to the skin, may control
the growth of the cancer,” says Dr.
Leffell. “Because skin cancers
occur externally, a dose of a med¬
ication that can replace the func¬
tion of the faulty gene could be
applied directly to the cancer
while minimizing side effects.”
In 1992, Dr. Bale began stud¬
ies on the nevoid basal cell carci¬
noma syndrome (NBCCS) gene, a
gene connected to a rare heredi¬
tary disorder where sufferers
develop thousands of skin cancers

! 1
U.S. Rep. Rosa DeLauro congratulates
Frederick L. Altice, M.D., assistant pro¬
fessor of medicine, at the dedication cer¬
emony for a new community health van
serxing New Haven neighborhoods. The
van, left, is the centerpiece of a project
to provide health care to city residents
who max not otherwise receive it.
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often caused by exposure to ultra¬
violet light.
A second Yale study, reported
in the September 1996 issue of
Nature Genetics, expanded on
these findings. Assistant professor
of pediatrics Mae Gailani. M.D.,
and colleagues reported a larger
test of the notion that genetic muta¬
tions may cause non-inherited
basal cell cancers.
They discovered by means of a
screening test that the gene was
damaged in about a third of noninherited basal cell tumors, and that
these mutations had occurred
within the tumors rather than being
inherited. Then researchers took a
closer look at the gene in two
tumors where no genetic damage
had been found. In both cases, the
gene turned out to be mutated.
According to Dr. Bale, the
screening test probably overlooked
most mutations in the gene. The
gene may be damaged in most if
not all non-inherited basal cell can¬
cers, he said.

Cheryl Carlson’s sculpture of the pink
breast cancer awareness ribbons serves as
the basis for the pictorial cancellation
used on the first day of issue of a new U.S.
postal stamp. The stamp, of which one mil¬
lion have been printed, draws attention to
the importance of early detection and
treatment of breast cancer. Ms. Carlson,
an East Lyme, Conn., woman who lost her
battle with breast cancer in November
1995, was honored at a first-day-of-issue
ceremony at the Yale Cancer Center on
June 15, which would have been her 45th
birthday. ■

Medical, graduate
schools streamline
Ph.D. programs
The School of Medicine, together
with the Graduate School of Arts
and Sciences, this fall initiated a
combined, interdepartmental pro¬
gram for students who wish to pur¬
sue a Ph.D. degree in preparation
for careers in the biological and
biomedical sciences.
Ira S. Mellman, Ph.D.. profes¬
sor of cell biology at the School of
Medicine, has been named the first
director of the Program in Biologi¬
cal and Biomedical Sciences
(BBS), an amalgamation of 10
major departments, sections and
academic programs based at the
School of Medicine. This program
recognizes the excellence of the
school’s research environment and
the fact that research in the bio¬
medical sciences has become
inherently interdisciplinary, no
longer conforming to traditional
departmental boundaries. It also
coordinates programs and stream¬
lines the application process to
attract outstanding students who
are interested in the flexible and
interdisciplinary program of study.
More than 40 students entered
the following interest-based tracks:
genetics and development, cell
biology and molecular physiology,
neuroscience, molecular bio¬
physics, microbiology, immunol¬
ogy, pharmacology and molecular
medicine, each of which draw
their faculties from multiple
departments.
"Their first year is devoted to
course work, hands-on training in
high-technology areas, and a series
of three laboratory rotations during
which students are introduced to a
wide range of research problems,
faculty and methodological
approaches,” says Dr. Mellman.
“By the second year, students
choose a mentor in whose labora¬
tory they perform their dissertation
research.”
Although degrees are ulti¬

mately awarded by existing depart¬
ments, the BBS program provides
educational, administrative and
social support for Ph.D. students.
M.D.-Ph.D students also are inte¬
grated into this larger group during
their laboratory research period.
Conversely, BBS encourages its
Ph.D. students to explore the
emerging interface between funda¬
mental research and molecular
medicine or human biology.
Stipends and tuition for all students
are provided from one of several
sources, including NIH-sponsored
training grants, private fellowships
and endowed fellowships.
Dr. Mellman is a Yale gradu¬
ate, having received his Ph.D.
degree from the Department of
Genetics in 1978. After spending
three years as a fellow and assistant
professor at Rockefeller Univer¬
sity, he returned to Yale and has
been a faculty member ever since.
For six years, he served as director
of graduate studies in the Depart¬
ment of Cell Biology.

Study shows that preemies
fare better when fed earlier
A new study suggests that feeding
even the tiniest babies soon after
birth helps stimulate a wide variety
of important physical changes that
promote growth and development.
In a 12-center trial sponsored
by the National Institute of Child
Health and Human Development,
researchers studied the effects of
early feeding of milk or formula on
1,665 premature infants, bom
weighing between 1 to 3 pounds.
They found babies under the age of
nine days who received small
amounts of dilute formula or breast
milk through a nasogastric tube,
gained weight faster than those
who received no tube feedings.
Delaying those feedings by as
little as a week was associated with
a lag in weight gain of 2 to 4 grams
per day.
"Keeping babies solely on
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Researchers explore the
quality control of the cell

W

ithin the body’s billions of
cells exists a system so intri¬
cate that each protein manufac¬
tured must undergo a series of
tests to ensure its quality. Yale
cell biologists have taken on the
challenge of unraveling this quality
control system in an effort to
better understand the cell’s
behavior and its relationship to
genetic diseases.
According to Ari H. Helenius,
Ph.D., professor and chairman of
cell biology, the production of pro¬
teins in the human cell can be
compared to a factory assembly
line. “In a factory, before a new
product is sent out, it has to pass
quality control checks that are
necessary to find error,” explains
Dr. Helenius. “Similarly, when
defects are discovered by the
cell’s quality control, the proteins
are noted and given time to cor¬
rect themselves. If no improve¬
ment occurs, the protein is
removed and dismantled.” The

system recycles the good compo¬
nents within the body.
Also called architectural edit¬
ing, this system depends on the
cell’s ability to recognize, retain
and destroy incompletely assem¬
bled proteins, ensuring the struc¬
tural integrity of protein products.
Sometimes, however, a functional
protein with a minor defect is
rejected resulting in more damage
to the body than if the cell had
allowed the slightly defective pro¬
tein through the system.
When the blueprint for a given
protein is defective, as in inherit¬
ed diseases such as cystic fibro¬
sis, some liver diseases and
blood-clotting disorders, the pro¬
tein is destroyed, leaving no agent
to perform necessary functions.
Dr. Helenius says it is specifically
these cases that make it so
important for researchers to find
ways of relaxing the stringency by
which quality control works and
thus, hopefully, eliminating the

intravenous feedings appears to
result in atropy of the gastrointesti¬
nal tract, which usually doesn’t last
long,” says Richard A. Ehrenkranz,
M.D., HS ’72-74, professor of
pediatrics at Yale and lead author
of the study. He continues to say
that when premature babies are fed
small amounts of formula or breast
milk from an early age, the feed¬
ings seem to prime the gastroin¬
testinal tract and make it more
ready to accept full feedings of
milk or formula.
These findings were presented
in June at the annual meeting of the
American Pediatric Society, the
European Society for Paediatric
Research and the Society for Pedi¬
atric Research.

Research targets anxiety
in children facing surgery

Yale medicine

A two-year study is under way at
Yale focusing on the anxiety chil¬
dren suffer prior to surgery.
According to Zeev N. Kain,
M.D., assistant professor of anes¬
thesiology and pediatrics and head
of this research, preoperative anxi¬
ety poses a threat to more than half
a million children every year in the
United States.
"This psychological phenome¬
non may result in increased length
of time to induce anesthesia, slow
recovery from the anesthetic, slow
wound-healing and a delayed
release from the hospital,” says Dr.

Ari H. Helenius, Ph.D.

causes of such diseases.
Using viral and cellular pro¬
teins as their tools, Dr. Helenius
and his co-workers are analyzing
the rules that govern the cell’s
quality control system. They are
identifying the various molecular
players involved, and searching for
drugs that could be used to regu¬
late the process in patients with
hereditary diseases or infections.
“We need to tell the quality control
not to be so picky and to let cer¬
tain proteins go, even though the
cell thinks it's the wrong thing to
do. In certain cases, it will cause
less difficulty to the body," says
Dr. Helenius. ■

Kain. The children may also suffer
long-term negative behavioral
changes, including nightmares and
other sleep disturbance, eating dis¬
orders and aggression against
authority.
Through this study. Dr. Kain
hopes to better understand the root
causes and risk factors for preoper¬
ative anxiety and discover ways to
alleviate it so the psychological
and physiological problems that
children who undergo surgery face
will not continue to grow.
Collaborating with Dr. Kain
are Linda C. Mayes, M.D., the
Arnold Gesell Associate Professor
of Child Development and Pedicontinued on page 40 ►
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Defusing
a time bomb
At Yale, home of
the nation’s first
HHT clinic, there’s
help for patients
with rare bleeding
syndrome.

By John Green

A

century ago, a Parisian internist named Henri
Rendu examined a patient who had been sent
to him for recurrent bleeding. The cause, according
to the referring physician, was hemophilia.
A blood test, however, showed normal clotting,
and a skeptical Dr. Rendu found blood vessels in
the patient’s nose that were abnormal. Hemophilia
was not the cause, he decided, and on Oct. 23,
1896, he presented the case to a group of his
colleagues as a new phenomenon, a rare syn¬
drome known today as hereditary hemorrhagic
telangiectasia (HHT).
Mistaking HHT for hemophilia was understand¬
able, says Robert I. White Jr., M.D., professor of
diagnostic radiology, who founded the nation’s first
clinic for HHT at Yale in 1988. “It’s a disease that
masquerades as many things.”
For some patients, unaware of the disorder
and its sometimes-fatal consequences, HHT is a
timebomb, says Dr. White, director of the Yale
Vascular Malformation Clinical and Research
Group. Its most common symptom is frequent
nosebleeds. In addition to hemophilia, HHT is fre-
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Yale physicians and researchers at an international meeting in
Edinburgh last May to mark the Rendu centennial, clockwise
from bottom: Robert White, M.D.; Joel Wirth, M.D.; Joshua
Korzenik, M.D.; and Pierre Fay ad, M.D.

quently misdiagnosed as stroke, ulcers, epilepsy
or anemia.
The multi-disciplinary, clinical approach devel¬
oped at Yale is crucial to identifying and managing
the disease, says Dr. White. Patients are screened
for family history and obvious symptoms. If the dis¬
ease is suspected in the lungs or brain, the two
most vulnerable organs in HHT, high-resolution
computed tomography (CT) or magnetic resonance
(MR) scans are used to confirm the diagnosis.
Since 1988, Yale’s Vascular Malformation clin¬
ic has screened and treated approximately 250
patients with HHT. "Although it’s difficult to diag¬
nose,” says Dr. White, “it’s very treatable and all
the serious complications can be prevented.” A
genetic test is in development.
HHT, also known as Osler-Weber-Rendu Syn¬
drome, results from congenital malformations of
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the blood vessels. These
defects, called telangiectasias, are direct connec¬
tions between arteries and
veins without intervening
capillaries, as in the normal
circulation. The telangiectasias are prone to hemor¬
rhage, and new ones form in
critical target organs through¬
out the patient’s life.
HHT is an autosomal
dominant disorder, which
means that a child born to a
parent with HHT has a 50
percent chance of inheriting the mutated gene and
some form of the disease. Sir William Osier
demonstrated the hereditary nature of the syn¬
drome and Frederick P. Weber added significantly
to its description. It was previously estimated to
affect some 5,000 Americans. But after recent
population studies, the estimate has been revised
upwards to as many as 50,000 Americans.
Dr. White’s timebomb analogy is apt because
in more than half of those affected, the symptoms
can progress from minimal to mortal. By the age of
30, most people with HHT have nosebleeds, which
become more severe as they get older and often
require blood transfusions in later life. The telangiectasias that show up as relatively minor signs
like red spots on tongue, lips and fingers often do
not appear until after the age of 30.
More deadly complications may develop.
Approximately one-third of people with HHT devel¬
op gastrointestinal bleeding, one-fourth have
abnormal vessels in the lungs, and close to 20
percent develop a cerebral form of the disease
that can lead to brain hemorrhage and stroke.
Treatment strategies for HHT involve develop¬
ing new and better ways to stop bleeding, a prob¬
lem that is tackled from many angles at the multi¬
disciplinary clinic. Joshua Korzenik, M.D., instruc¬
tor of internal medicine, has developed a new way
of treating gastrointestinal bleeding using a hor¬
mone effective in up to 50 percent of patients.
And with Pierre Fayad, M.D., assistant professor of
neurology, Dr. Korzenik is studying the effects of a
soybean extract on controlling the frequent nose¬
bleeds associated with HHT. He is also studying
whether lasers can be used to treat telangiectasia
of the stomach and duodenum.
Dr. White developed a technique for treating
the lung manifestation of the disease, using sili¬
cone balloons containing radiologic dye to strategi¬
cally close circulation in areas prone to bleeding.
Douglas Ross, M.D., assistant professor of

surgery, is studying the
effect of using skin grafts
to stop the most severe
nosebleeds. David Leffell,
M.D., associate professor
of dermatology, has had
excellent results removing
cosmetically prominent
skin telangiectasias using
tunable dye laser. Issam
Awad, M.D., professor of
neurosurgery, along with
John Chaloupka, M.D.,
assistant professor of
radiology, are studying
methods of first blocking circulation to vascular
malformations in the brain, then surgically remov¬
ing them.
Other key members of the HHT clinic staff are
Jeffrey Poliak, M.D., associate professor of radiol¬
ogy; John Persing, M.D., professor of surgery; Joel
Wirth, M.D.; assistant professor of medicine; and
Catherine Burdge, R.N., the clinical nurse coordi¬
nator who helps screen and track some 500
patients involved with the center.
The HHT Foundation International, established
by Dr. White and others to reach and help patients
worldwide, has evolved from 15 original members
who visited Yale in 1990 into an active organiza¬
tion of more than 500. The group publishes an
upbeat quarterly newsletter, Direct Connection, and
maintains a World Wide Web site on the Internet
(http://www.hht.org) and an electronic mail
address (hhtinfo@hht.org).
The foundation also sponsors an annual con¬
ference that this year brought 125 families to Salt
Lake City, home of the nation’s second HHT center
of excellence, at the University of Utah. To mark
the Rendu centennial this year, an international
meeting of HHT physicians and researchers was
held in Edinburgh last May. Participants at both
gatherings heard some very good news:
researchers have found that HHT is caused by
defects in genes on chromosomes 9 and 12 that
are crucial to the formation of blood vessels. Sci¬
entists also have identified the biochemical mech¬
anism for HHT in some patients.
With chapters in the Netherlands, Australia
and Denmark, the foundation actively raises funds
for research into the genetics, new diagnosis,
treatment and management of HHT. ■

Treatment strategies for
HHT involve developing
new and better ways to
stop bleeding, a problem
that is tackled from many
angles at the multidisci¬
plinary clinic.
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John Green is a free-lance writer in New London, Conn.
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AN EASY MATTER AND IN
ANY MAN’S POWER. BUT
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GIVE IT, AND HOW LARGE
AND WHEN, AND FOR
WHAT PURPOSE AND
HOW, IS NEITHER IN
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NOR AN EASY MATTER.

Aristotle

Assuming you would
consider the School of
Medicine as one of your
intended beneficiaries,
we stand ready to help you
with when, for what purpose,
and how.
Planned giving
is one of our specialties.
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atrics at Yale, and Marc H. Bornstein,
Ph.D., chief of the child and family
research section at the National Insti¬
tute of Child Health and Human
Development in Bethesda, Md.
The Arthur Vining Davis Foun¬
dations grant will support two com¬
panion studies conducted by Dr.
Kain. The first seeks to determine the
various factors that predispose par¬
ents and children to preoperative anx¬
iety. Based on this information, the
second study will examine different
types of programs to prepare children
and their parents for surgery.

Biomedical engineering
supported by new grant
With support from The Whitaker
Foundation, a major new program in
biomedical engineering has been
established within Yale University’s
Faculty of Engineering and its School
of Medicine by consolidating sepa¬
rate activities in biomedical imaging,
molecular bioengineering and tradi¬
tional biomedical engineering.
Yale University President
Richard C. Levin said: “Significant
expansion of the undergraduate bio¬
medical engineering curriculum, as
well as a cohesive graduate program,
will greatly enhance Yale’s general
strength in science and engineering.
Within the School of Medicine, the
expansion of biomedical engineering
will influence the future careers of
physicians trained at Yale and provide
many of them with the opportunity to
realize the potential applications of
engineering within medicine.”
Yale is at the forefront of many
research areas in which engineering
is applied to medicine, according to
John C. Gore, Ph.D., professor of
diagnostic radiology, who has a joint
appointment in the applied physics
department and is the grant’s princi¬
pal investigator. “This grant will
accelerate the implementation of bio¬
medical engineering at Yale, expand
its scope and provide the resources to
achieve many of the aims of this

major new initiative,” he said.
Teaching graduate students
engaged in applications of physics
and engineering to medicine will be
more formally organized. Dr. Gore
notes. “More importantly,” he said,
“these students will undertake
research in a multidisciplinary envi¬
ronment on important research prob¬
lems in biomedical engineering.”
The Whitaker Foundation grants
made to Yale and seven other educa¬
tional research institutions are
designed to help enhance biomedical
engineering by developing perma¬
nent, high-quality programs that
will benefit education and research in
the field.

Yale, Bridgeport hospitals
establish partnership
The parent corporations of Yale-New
Haven Hospital and Bridgeport Hos¬
pital have completed an affiliation
that will allow them to compete
more effectively in managed care and
will provide patients with broader
access to high quality, cost-effective
medical services.
As part of the affiliation, the two
hospitals will retain separate staffs,
governing boards and financial struc¬
tures. “For our employees, this is a
transparent change and will not make
a difference day-to-day on their roles
and activities,” says Joseph A.
Zaccagnino, president and CEO of
Yale-New Haven Hospital. “This is
not a merger or acquisition.”
There will, however, be a merg¬
ing of two physician residency pro¬
grams, in general surgery and a
newly created residency for emer¬
gency medicine.
The hospitals together employ
8,600, with a medical staff of over
close to 3,000. There are 900 beds at
Yale-New Haven and 425 at Bridge¬
port; about 38,000 patients are dis¬
charged from Yale-New Haven annu¬
ally, and an additional 19,000 from
Bridgeport.
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High honors for the
discovery of snurps
Cellular particle research
brings Yale a second City
of Medicine Award
Joan A. Steitz, Ph.D., the Henry Ford II
Professor of Molecular Biophysics and
Biochemistry and a Howard Hughes
Medical Institute investigator, was one
of four medical researchers to receive
the 1996 City of Medicine Award.
Dr. Steitz was honored for her dis¬
covery of cellular particles that read the
genetic code in cells to make proteins.
Her work in identifying these small
nuclear ribonucleoproteins, called snurps,
Joan Steitz, Ph.D.
served as a springboard for understanding
the mechanics of gene expression.
The awards program was established in 1988 to recognize out¬
standing achievements in medicine throughout the nation and the
world. Recipients include six Nobel Laureates. Of the 33 recipients in
nine years, two have been from Yale. Vincent T. DeVita Jr., M.D., HS
’66, professor of medicine and director of the Yale Cancer Center,
was a 1995 award winner.

Stephan Ariyan, M.D., HS
’70-76, M.B.A., clinical pro¬
fessor of plastic surgery and
otolaryngology and former
chief of plastic surgery, has
been awarded the Essay prize
from the Educational Founda¬
tion of the American Society of
Plastic and Reconstructive Sur¬
geons. Dr. Ariyan presented
the essay Restructuring of Ac a-

Stephan
Ariyan, M.D.

demic Departments of Surgery
at University Medical Centers: Administrative
and Financial Considerations, at the society's

annual meeting in Dallas in November.
Bruce Fichandler, PA. ’73, lecturer in plastic
surgery and director of admissions for the Yale
Physician Associate program, was re-elected
treasurer of the American Academy of Physi¬
cian Assistants (AAPA). His two-year term
began in June.
Two other Yale physician assistants were
honored by the AAPA in May at its annual
conference in New York City. J. Jeffrey
Heinrich, Ed.D., P.A., lecturer in plastic
surgery, was named civilian PA. of the
year; and Shepard B. Stone, M.P.S., lecturer
in anesthesiology, was named military PA.
of the year.
continued on page 44 ►

Healing powers
Among the speakers and special guests at the
1996 Yale Sports Medicine Seminar in New
Haven were Frank Jobe, M.D., of the KerlanJobe Orthopaedic Clinic in Los Angeles, and
Kartmut Krahl, M.D., Ph.D., an orthopaedic
surgeon in Essen, Germany. From left, front
row, are Dr. Jobe and Krahl, and Jacek
Cholewicki, Ph.D., assistant professor or
orthopaedics and rehabilitation at Yale. Rear,
from left: Yale Sports Medicine Center physi¬
cians Marc T. Galloway, M.D., John
Daigneault, M.D., Patrick Ruwe, M.D., and
Director Peter Jokl, M.D.
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Honoring Paul Beeson
Those he trained, and those whose lives he touched, pay a last¬
ing tribute to the distinguished chairman emeritus of medicine.

Photographs by Harry Bishop

T

he dedication of the Paul B. Bee¬
son Medical Service at Yale-New
Haven Hospital in May was a chance
for many to pay homage to a consum¬
mate medical practitioner and
researcher who influenced a genera¬
tion of physicians, and whose values
still shape the attitudes, decision-mak¬
ing and actions of physicians-in-training today.
“Naming the Medical Service at
Yale-New Haven Hospital after Dr. Paul
B. Beeson is a seminal event in our
institutional history,” reads the dedi¬
cation. “Dr. Beeson, who unified and
defined the position of chairman of the
Medical School Clinical Department
and chief of the Hospital Clinical Ser¬
vice during his 13 years at Yale, repre¬
sents the values of professional
integrity, educational dedication, and
the primacy of patient care that are
being emphasized throughout our
medical service."
A Montana native, Paul Beeson
graduated from McGill Medical School
and completed a two-year rotating
internship at the Hospital of the Uni¬
versity of Pennsylvania before joining
his father in general practice in Ohio.
In 1939, Dr. Beeson became Dr. Soma
Weiss’ first chief resident at the Peter
Bent Brigham Hospital, and in 1942
joined Dr. Eugene Stead at Emory Uni¬
versity as an assistant professor of
medicine. After Dr. Stead left for Duke
in 1946, Dr. Beeson became profes¬
sor and chairman of the Department
of Medicine at Emory, where he stud¬
ied the pathogenesis of fever and the
dynamics of bacteremia in patients
with subacute bacterial endocarditis.
Dr. Beeson was named chair¬
man/chief of the Department of Medi¬
cine at Yale and Ensign Professor of
Medicine in 1952. Dr. Beeson appreci-
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ated the importance of
the dual roles of acade¬
mic chairman and chief
of service. His hospital
rounds, which were visi¬
ble and influential, con¬
veyed the powerful
image of an intelligent,
prudent physician who was caring,
polite and dedicated to his individual
patients. When Dr. Beeson left Yale in
1965, the Department of Medicine at
Yale was among the strongest in the
country, and Yale-New Haven Hospital
had become one of American medi¬
cine’s most desired internships.
Dr. Beeson moved to Oxford as
Nuffield Professor of Clinical Medicine
in 1965. When he resigned his posi¬
tion in 1974, he accepted an appoint¬
ment as Distinguished Physician of the
U.S. Veterans Administration in Seat¬
tle. Dr. Beeson co-edited, with WalshMcDermott, the Cecil-Loeb Textbook of
Medicine, was an editor of Harrison’s
Textbook of Medicine, edited the Jour¬
nal of the American Geriatrics Society
and co-edited the Oxford Companion
to Medicine. He is a member of the
National Academy of Sciences, a mas¬
ter of the American College of Physi¬
cians, and recipient of diverse honors
and awards. He has received honorary
doctor of science degrees from Emory,
McGill and Albany and is an Honorary
Knight Commander of the Order of the
British Empire.
Yale-New Haven Hospital officials
say the Beeson Medical Service will
play an essential role in meeting hos¬
pital goals by uniting community and
university physicians in a common
devotion to patients, students and
physicians in training. In October, Dr.
Beeson was named an honorary
trustee of the Associates of the Har¬
vey Cushing/John Hay Whitney Med¬
ical Library. ■
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Left: Participants in
the inaugural sympo¬
sium come together
for a photograph in
the Medical Historical
Library. Held for the
first time in May 1996,
The Beeson Sympo¬
sium is planned as an
annual event.

Above: Martin Gordon,
M.D. '46, left, chairman of
the medical library trustees,
and Alvan R. Feinstein,
M.D. HS '52-57, Sterling
Professor of Medicine.

Left: Ralph 1. Horwitz,
M.D. chairman of the
Department of Medicine
and the Harold H. Hines Jr.
Professor of Medicine and
Epidemiology, listens to
Dr. Lee’s comments on the
language of the doctorpatient relationship.

Above: Paul B. Beeson, M.D., who left an indelible mark at Yale
as chairman of the Department of Medicine from 1952 to 1965,
listens to the discussion at the first Beeson Symposium in the His¬
torical Library of Harvey Cushing/John Hay Whitney Medical
Library’ in May. Seated next to Dr. Beeson are his wife, Barbara
Beeson, and Richard V. Lee, M.D. '64, now professor of pedi¬
atrics at Buffalo Children's Hospital.

Above: Yale professor Howard M. Spiro, M.D.,

Left: Yale professor John N. Forrest Jr., M.D., HS '64-70, who

recruited by Dr. Beeson in 1955 to start the depart¬
ment's section of gastrointestinal medicine, chats with
Lewis Landsberg, M.D. '64, HS '65-70, a Beeson

trained under Dr. Beeson and today heads the medical school’s
Office of Student Research, provides an overview for participants
at the symposium.
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trainee who is now the chairman of medicine at
Northwestern University in Chicago.
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Thomas E. Hughes, Ph.D.,
assistant professor of oph¬
thalmology and visual sci¬
ence, will serve as a member
of the Visual Science C
Study Section, Division of
Research Grants, for a threeyear period. Study sections
review grant applications
submitted to the National
Institutes of Health.

rhomas E.
iughes, Ph.D.

Thomas R. Kosten, M.D., HS ’81,
professor of psychiatry and director

of the division of substance abuse,
has been named chief of psychiatry
service at the VA Connecticut
Healthcare System. In his new posi¬
tion, Dr. Kosten will be responsible
for VA Connecticut's clinical, educa¬
tional and research programs in psy¬
chiatry at both the West Haven and
Newington campuses.

the Detection, Evaluation and
Treatment of High Blood Pressure
of the National Heart, Lung and
Blood Institute.
The Pew Charitable Trusts of
Philadelphia has selected Hong Sun,
Ph.D., assistant professor of genet¬
ics, as one of 22 Pew Scholars in the
Biomedical Sciences for 1996. The
$200,000 award, intended to encour¬
age scholars to be innovative in their
research, will support Dr. Sun’s
work in mitogen-activated protein
kinases and cell signaling.

Marvin Moser, M.D., clinical pro¬
fessor of medicine, has been
appointed a member of the Sixth
Joint National Committee on
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Doctor,; how can I
thank you?”

H

ow many times have you heard this question from
your patients? Your answer can lead to a way to
help the Yale School of Medicine. A gift from your
patient to the School honors you and guarantees
the continuation of our tradition of excellence in
teaching and patient care into the 21st century.

“Yale School of Medicine was and remains
extremely important to me in the ongoing development of
my busy practice. I am proud of my close relationship with the School,
even though I am geographically far from New Haven. My patients
regularly take an interest in my research and clinical activities, and I
am more than happy

to share with them my fondness

for Yale in order to stimulate their interest in the School’s mission.”
Dudley Seth Danoff, M.D. ’63, F.A.C.S.
Beverly Hills, California

I am a proud graduate of Yale
School Of Medicine and an active participant in the teaching

“My patients know that

program. They also know that one of the best ways to make me
happy is

to give to my alma mater.”
Mary Jane Minkin, M.D. 75
New Haven, Connecticut

Brochures promoting the School are available for
display in your office, to generate the revenue
needed to continue our standard of excellence.
Free copies are available from:
Bonnie Sargent
Office of Development
Yale University School of Medicine
P.0. Box 7611
New Haven, Connecticut 06519-1714
Or call:
203.785.6760
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Stephen G. Waxman,
M.D., Ph.D.

Yale neurologist elected
to institute of Medicine
Stephen G. Waxman, M.D., Ph.D.,
professor and chairman of neurology,
has been elected to the Institute of
Medicine, the health-care arm of the
National Academy of Sciences.
In addition to serving as profes¬
sor of neurology, neuroscience and
pharmacology at Yale, Dr. Waxman
founded and is the director of the
PVA/EPVA Neuroscience Research
Center, VA Connecticut Healthcare
System on its West Haven campus.
He is recognized internationally for
elucidating the molecular architec¬
ture of nerve fibers and the glial cells
that surround them, and the mecha¬
nisms by which nerve fibers in the
brain and spinal cord adapt to injury.
He has published more than 300
scientific papers and edited five
books on neuroscience. He is the
author of Spinal Cord Compression
and Correlative Neuroanatomy, and
is the editor of The Neuroscientist.

Fall/Winter 1996

NEW

BOOKS

Multivariable Analysis: An Introduc¬
tion, by Alvan R. Feinstein, M.D.,
HS ’52-54, Sterling Professor of
Medicine and Epidemiology, Yale
University Press 1996.

Sexual Harassment in the Work¬
place and Academia: Psychiatric
Issues, edited by Diane K. Shrier,
M.D. ’64, American Psychiatric
Press, Inc. (Washington) 1996.

Facing Death, edited by Howard M.
Spiro, M.D., professor of medicine;
Mary G. McCrea Curnen, M.D.,
Dr.P.H., clinical professor of epi¬
demiology and pediatrics; and Lee
Palmer Wandel, associate profes¬
sor of history and religious stud¬
ies, Yale University Press 1996.

A Primer of Gynecologic Oncology
by Robert C. Wallach, M.D. ’60,
IDI Publications (Omaha) 1995.

Children are ... Images of Grace: A
Pediatrician's Trilogy of Faith,
Hope, and Love, by Diane M.
Komp, M.D., professor of pedi¬
atrics, Zondervan Publishing
House (Mich.) 1996.

Women’s Sexual Health by Ruth
Steinberg, M.D., assistant clinical
professor of obstetrics and gyne¬
cology, and Linda Robinson, Pen¬
guin (New York) 1996.

Dumplings: A Collection of Poems,
by James W. Lancaster, M.D., HS
’50-53, Lancaster (Fla.) 1996.
A Practical Approach to Cardiac
Arrhythmias, by Stephen C. Vlay,
M.D. ’75, Little, Brown & Co.
(Boston) 1996.
Clinical Management of Hyperten¬
sion, by Marvin Moser, M.D.,
clinical professor of medicine,
Professional Communications
(N.Y.) 1996.

Skin Changes and Diseases in
Pregnancy by Robert C. Wallach,
M.D. ’60, and M. Harahap, Marcel
Dekker Publisher (New York) 1996.

Treatment Planning for Psy¬
chotherapists by Richard B.
Makover, M.D., assistant clinical
professor of psychiatry, American
Psychiatric Press Inc. (Washing¬
ton) 1996.
Transjugular Intrahepatic
Portosystemic Stent Shunts
(TIPS), Harold 0. Conn, M.D. ’72,
HS '51-56, was the coordinating
editor with J. Palmaz, J. Rosch and
M. Rossle as coeditors, Igaku
Shoin Medical Publishers (New
York) 1996.

A Charitable
Annuity:
The YSM gift
that rates
In exchange for a gift of
$5,000 or more, the School of
Medicine can offer you, or you
and your spouse, a fixed annual
income for life.
Your age(s) and market
rates of interest determine
your income level.
Current sample rates:
Age(s)

Rate

One life
55

66
77

4.8%
5.9%
8.2%

Two lives
66/65
75/74
82/79

4.9%
5.9%
7.1%

Please allow us to tailor
a proposal to your
philanthropic
and financial goals.

Now I Know Better, edited by
David Bachman, M.D., director of
pediatric emergency medicine at
the Children’s Hospital at YaleNew Haven, Millbrook Press
(Conn.) 1996.
Dear Bruno by Alice Trillin, a volun¬
teer at The Hole In The Wall Gang
Camp affiliated with the Yale
School of Medicine, The New
Press (New York) 1996.

Yale University
School of Medicine
Office of Planned Giving
P.O. Box 2038
New Haven, CT 06521-2038
1-800-445-6086
Fax: 1-203-432-7901
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Light for the new millennium
Class of 2000 a many-faceted group of students

The following is adapted
from Director of Admissions
M. Lynne Wootton’s September
report to the Medical School
Council on the entering class.

N

ot long ago, the Thousand
Points of Light program was
established. I would like to share
with you information on our
own 101 points of light—a term
you will see these first-year
students in the Class of 2000 cer¬
tainly deserve.
That light first shone in many
different places—in this hemi¬
sphere as well as in Europe, Asia,
the Middle East and Africa. Our
entering students have won numer¬
ous awards, prizes, scholarships,
grants and fellowships, and more
than 70 percent have already pub¬
lished and presented research find¬
ings, on topics ranging from
Cloning the Whirligig Gene to
The Disenchantment of Nature:
The Naturalist Temper of Robert
Lowell.

They have given their time in
shelters, nursing homes, cancer
outreach centers, a home for pedi¬
atric AIDS patients, intensive care
units, senior citizen centers, homes
for teen-aged mothers and a
domestic violence center here in
New Haven. They have volun¬
teered as emergency medical tech¬
nicians (EMTs), translators. Big
Brothers and Sisters, camp coun¬
selors for emotionally disturbed
children, and firefighters. They
have taught English to non-English
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speakers, jet skiing to 12-year-old
campers and biochemistry to Yale
students. One student helped start a
program to provide cuddling and
nurturing to newborns in over¬
crowded neonatal units. Another
taught music to more than 400
inner-city children.
One student worked in a Chi¬
natown health clinic, another in a
medical clinic in Haiti. A third is a
writer who has published two nov¬
els and is under contract for four
more. They are composers and
arrangers, ballet and ballroom
dancers, and choreographers. They
sing gospel and enjoy jazz. One
performed in a summer-stock the¬
ater group, another is a cantor, still
another paints. One student was
drafted by the Boston Bruins—but
chose to come to New Haven
instead!
The story of one young man's
road to Cedar Street helps to
answer an often-asked question:
What makes a Yale medical stu¬
dent? This medical student is
exceptional, but no more so than
his 100 colleagues.
He earned a 4.0 GPA as an
undergraduate majoring in both
economics and political science,
then did his premedical work five
years later. He authored a section
for a Lonely Planet guide to Brazil,
and was the recipient of Rotary,
Elks, Masons and Presidential
Leadership scholarships. He was
an Eagle Scout and wrote a thesis
on U.S.-Cuban relations during the
Castro era.

While in college, he founded
and owned a coffeehouse. He was
one of three undergraduate stu¬
dents selected to teach and consult
at the Wharton Small Business
Development Center. An EMT, he
volunteered as a victim's advocate
for a Colorado county sheriff.
He organized a mountain¬
climbing expedition to Venezuela,
and secured sponsorship from four
companies. He is a board member
of the Search for Genghis Khan
Expedition—a non-profit corpora¬
tion seeking the burial site of
Genghis Khan and increase aware¬
ness of 13th-century and presentday Mongolia. He was nominated
by undersea explorer Robert Bal¬
lard for membership in the
Explorer’s Club, and was accepted
in 1994. He raised over $100,000 to
help low-income families establish
businesses in an economically
depressed area of Philadelphia.
This aspiring physician volun¬
teered in Ecuador with Amigos de
las Americas after nine months of
training in language, culture and
public health. During his threemonth stay, he traveled to remote
villages and vaccinated over 600
people for yellow fever. He is now,
together with 100 others, a firstyear Yale medical student—all
members of an extraordinary
class—the Class of 2000. We wel¬
come all of you with great pride.

more student news on page 48 ►
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Contribute to the
School of Medicine’s
Future and Invest in
Your Own

Yale University’s life income
program offers graduates of the
School of Medicine the oppor¬
tunity to:
■

Help ensure the future
of a great institution

• Receive quarterly

A welcome
to medicine

income payments
for life
■

T

he white jacket that 101 firstyear medical students in the
Class of 2000 donned during ori¬
entation in August symbolizes
their entry into a rich and satisfy¬
ing life of service to others. “I
can’t think of any better way to
spend a professional life than as a
physician,” Robert H. Gifford,
M.D., H.S. ’66-67, associate dean
for education and student affairs,
told the new students, their par¬
ents and friends at the Harkness
ceremony. “To be able to combine
a love for science with a concern
for people is the ultimate privilege
for any individual.” This ceremony
was one of two major events for

Below: The presentation of jackets
followed remarks by Associate
Dean Robert H. Gifford, M.D.

Increase your income
from low-yielding stock with¬
out incurring capital gains
taxes

■

Reduce federal and
state taxes

Top: Forrester A. Lee, M.D., associate pro¬
fessor of medicine and assistant dean for
multicultural affairs, helps first-year med¬
ical student LaLisa Anderson into her white
jacket during a ceremony welcoming the

Please call or write to see if
you can use these benefits to
the mutual advantage of you
and the School of Medicine.

entering class to the profession of medicine.

Above: Stephanie Eisenbarth, a first-year
M.D./Ph.D. student, walks across Harkness
Courty’ard after the White Jacket Ceremony.

the new students. More than 90
percent of them and several of
their spouses/significant others
also attended an October retreat
to enhance communication. They
enjoyed being with colleagues in a
relaxed atmosphere at the Her¬
itage Inn, took part in activities to
heighten knowledge of themselves
and others, and participated in
exercises to develop more effec¬
tive communication skills with col¬
leagues, partners and patients in
the medical community. ■

Yale University
School of Medicine
Office of Planned Giving
P.O. Box 2038
New Haven, CT 06521-2038
1-800-445-6086
Fax: 1-203-432-7901
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A runner’s training inspires
air-quality research in Iran

I

n 1979 at the age of 7, Maryam
Asgari found herself far from her
native Iran and unable to return.
When she did go back 14
years later as a Yale medical stu¬
dent, the purpose of the trip was
to renew family ties. But she
made an observation that result¬
ed in a three-month study of air
quality in Tehran and the sur¬
rounding countryside. Her
research was the basis of her stu¬
dent thesis at Yale and for recom¬
mendations to scientists and offi¬
cials in Iran.
Ms. Asgari, now in her final
year of medical school at Yale,
presented the findings of her
study at Student Research Day
last May, a year early. She also
presented her research in poster
form at the American Lung
Association/American Thoracic
Society International Conference
in New Orleans.
Ms. Asgari came to the Unit¬
ed States with her mother in
1979 at the age of 7 to visit her
brother, then a student at the Uni¬
versity of California at Berkeley.
The revolution in Iran delayed
their return for more than a
decade. “We lived in California
until I finished college at Stanford
in 1992,” says Ms. Asgari. Her
mother returned to Iran as
Maryam began medical school at
Yale. In 1993, she returned to a
much-stabilized Iran after 14
years abroad.
In New Haven, before the jour¬
ney, Ms. Asgari had been running
6 miles a day to train for a
marathon. Two miles in Iran was
enough to leave her short of
breath and wheezing. “If someone
like myself, in fairly good health,
was affected by the air quality,"
she asked herself, “what was it
like for people who were breathing
this on a daily basis?”
After that first visit, Ms.
Asgari returned to New Haven and
searched the literature for infor¬
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mation on air quality and
public health in Iran. She
found very little.
In collaboration with
Yale faculty Arthur B.
Dubois, M.D., and William
Beckett, M.D., physicianscientists in environmen¬
tal health at the Yale-affili¬
ated John B. Pierce Laboratory,
Ms. Asgari embarked on her own
study. She collected the neces¬
sary equipment and supplies and
set off to Iran, from June to Sep¬
tember of 1994.
Her father, a physician, made
introductions at the University of
Tehran School of Public Health,
where she gained access to
patients and won the support of
Iranian researchers. They helped
her navigate the politics of Iran’s
decentralized health system and
its “houses of health,” communi¬
ty-based clinics where research
may be conducted if one knows
how to go about asking.
Despite the doors opened to
her as a native of Iran, Ms. Asgari
encountered problems, starting at
the airport with the confiscation
of her air-monitoring equipment,
which was held for a week, then
returned to her. To conduct
research in the houses of health,
she was required to bring along
an escort—married and male.
She believes that the effort
was well spent. The results of the
tests among 400 children in
Tehran and in rural villages
showed the poor air quality was
clearly detrimental to the chil¬
dren’s lung function.
“We looked at several differ¬
ent variables to explain the differ¬
ence in lung function among the
rural and urban children,” says
Ms. Asgari. “We analyzed their
nutritional status and the over¬
crowding situation among urban
kids, but the only constant we
found to explain lung detriment
was the difference in air quality.”

Maryam Asgari, left, now in her
final year of medical school at Yale,
stands next to the poster presenta¬
tion of her air-quality research, con¬
ducted in Iran. With her is Aina
Puce, Ph.D., Ms. Asgari's adviser
for another research project on
brain imaging and perception.

While Ms. Asgari found slight¬
ly higher rates of detriment among
children in urban areas, she dis¬
covered that all the children in the
study were affected by the poor
air-quality. She limited the
research to children because their
lungs are still developing, making
it easier to measure the detrimen¬
tal effects.
Tehran is one of the world’s
most polluted cities, she says,
“but many things can be done to
raise the air-quality standards—if
the government would just pay
more attention to this problem.”
She hopes that her work will inter¬
est and inspire scientists in Iran,
and lead to air-quality controls for
factories, cars, trucks and trains.
Ms. Asgari, who spent part of
the summer on a clinical clerkship
in obstetrics and gynecology in
Ireland, will visit Surinam in South
America this year for a primary
care elective. She plans to train in
dermatology and plastic surgery
after graduating in May. ■
Rosalind D’Eugenio
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Immunobiology student
awarded fellowship
Lynn Hannum, a third-year gradu¬
ate student in the department of
laboratory medicine, has been
awarded the 1996-1997 Richard K.
Gershon Fellowship to encourage
biomedical careers.
Ms. Hannum, who works in
the laboratory of Mark J. Schlomchik, M.D., Ph.D., assistant profes¬
sor of laboratory medicine, con¬
centrates her research on better
understanding the conditions
required to maintain immunity to
diseases, known as immunological
“memory.” Memory cells develop
during the initial immune response
to an infectious agent and are
responsible for rapid, effective

clearance of that pathogen upon
subsequent encounters. In particu¬
lar, Ms. Hannum focuses on the
memory in B lymphocytes, the
cells that produce antibodies.
“We know that memory can be
long-lasting,” explains Ms. Han¬
num, “since vaccination as a child
can confer life-long immunity to
some diseases. Still, we don't
understand the mechanism by
which memory cells persist over
such long periods of time.”
One theory she is examining is
that the antibodies produced dur¬
ing an immune response are
retained in the spleen and lymph
nodes, and that periodic encounter
with these stored antigens is neces¬
sary to re-stimulate memory B
cells. To test this hypothesis, Ms.
Hannum developed transgenic

mice which do not produce anti¬
bodies, and lack the proposed viral
and bacterial fragments. “We are
beginning to analyze immune
responses in these transgenics to
determine whether or not stored
antigen is actually necessary for
long-term maintenance of memory
B cells.”
The fellowship is named in
memory of Dr. Richard K. Ger¬
shon, a Yale professor of pathol¬
ogy, immunology and biology
who died in 1983. He was a
leader in the exploration of the
immune system. The fellowship
is funded by contributions from
Dr. Gershon’s family, friends
and alumni.
Ms. Hannum received her B.S.
degree in 1987 from Bates College
in Lewiston, Maine.

Physician Associate Program graduates
32, honors first distinguished alumna
Left: Dean Gerard N. Bur¬
row, M.D. ’58, and Elaine
E. Grant, P.A., M.PH,
assistant dean for the PA
Program, congratulate Bar¬
deen Camp, P.A.-C, center,
who received the program's
first Distinguished Alumnus
Harry Bishop

Award. Ms. Camp gradu¬
ated with honors as a mem¬
ber of the program’s first
class in 1973, and today is
manager of the hematol¬
ogy/oncology infusion ther¬
apy unit at the Hospital of
St. Raphael in New Haven.
She is one of526 indi¬
viduals who have completed

Above: Surgeon and author Richard
Selzer, M.D., above, addresses grad¬
uates of the Yale Physician Associate
Program at their Commencement in
August. Dr. Selzer, author of the best¬

the 24-month educational program in the medical model. Responsible to

selling Mortal Lessons and Down

their supen’ising physicians, they practice in urban and rural settings in
emergency rooms, hospitals, health maintenance organizations, clinics, and

from Troy: A Doctor Comes of Age,

private and group practices throughout the United States. Thirty-two gradu¬

sowed on the medical school faculty
for 25 years, spoke to the graduates

ates received their certificates at Commencement this year.

about the language of medicine.
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Opportunities abroad
The new Office for International Health
welcomes information from alumni/ae,
faculty and friends of the School of Medi¬
cine on opportunities at international
sites, ranging from clinical service oppor¬
tunities overseas in developing countries
to research projects to which students or
faculty could provide assistance.
“The Office for International Health is
committed to helping faculty and students
network with overseas sites interested in
Yale collaboration,” says Michele Barry,
M.D., HS ’77-81, professor of medicine

Maxwell Bogin. M.D. '26, recently
relinquished his position as class agent
after decades of service, and now resides
at the retirement community, 3030 Park
[3030 Park Ave., Bridgeport, CT 06604],
While somewhat limited in his physical
activities, he is mentally and psychologi¬
cally as keen as ever. His daughter,
Debby Bogin Cohen, of Boston, reports
that a Bogin niece doing research in the
Museum of the Jewish Diaspora in Tel
Aviv found the citation that “among
distinguished bearers of the Jewish fam¬
ily name Bogin includes the 20th-cen¬
tury American physician Maxwell
Bogin." For decades. Dr. Bogin was
chairman of pediatrics at Bridgeport
Hospital, an affiliate of the School of
Medicine. His wife, Edith, resides with
him at 3030 Park.

and director of this office. Any faculty, stu¬
dent or alumnus/a who has knowledge of a
potential collaboration may contact Linda
Limauro, the office’s administrative man¬
ager, at (203) 785-5937.
This office, established in the spring
of 1996, serves medical, nursing and pub¬
lic health students and faculty interested
in global health issues. In September, a
bimonthly seminar series was started. ■

Bradley R.
Straatsma, M.D.
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Morris A. Wessell, M.D. '43, HS '4851, clinical professor of pediatrics,
became the first recipient of the New
London (Conn.) Native Son Award by
his hometown Rotary Club. The club
created this honor to recognize some¬
one who grew up in New London and
accomplished much in his professional
life elsewhere. Dr. Wessell also
received the Paul Harris Lellowship.
the highest honor given by the Rotary.
R.M. Fasanella, M.D. '43, HS '43-44,
chairman of ophthalmology at Yale
from 1951 to 1961, writes to report
on the careers of two of his former
students: Bradley R. Straatsma, M.D.
'51. has been named editor-in-chief of
the American Journal of Ophthalmol¬
ogy. Dr. Straatsma formerly was direc¬
tor of the Jules Stein Eye Institute and
professor and chairman of the depart¬

ment of ophthalmology at University of
California-Los Angeles School of Med¬
icine. Javier Servat, M.D.. HS '62. a
chief resident under Dr. Lasanella. has
had a distinguished career in ophthal¬
mology in Trujillo, Peru. A coinciden¬
tal communication received from Dr.
Servat is noted below.
B. Herold Griffith, M.D. '48, HS 4849, retired from the practice of plastic
surgery in March. Dr. Griffith was pro¬
fessor of surgery from 1959 to 1996,
and chief of plastic surgery from 1970
to 1991, at Northwestern University
Medical School in Chicago. He also
was chairman of the American Board of
Plastic Surgery from 1981 to 1982.

Harry C. Miller, M.D. 54, of Great
Palls, Va., and a summer resident of
Canandaigua Lake, N.Y., is professor
emeritus and former chair of the urol¬
ogy department at George Washington
University Medical Center.
William H. Hindle, M.D. ’56, has
been appointed to the National Acad¬
emy of Sciences' Institute of Medi¬
cine’s Committee on Breast Cancer
Research, the National Cancer Institute
Breast PNA (fine-needle aspiration)
subcommittee on training and credentialing, and the editorial advisory board
of the medical journal Cancer Cytopathology. Dr. Hindle is professor of
clinical obstetrics and gynecology at the
University of Southern California
School of Medicine and director of the
Breast Diagnostic Center at Women’s
and Children's Hospital.
Brian Crowley, M.D. '57, president of
the Washington (D.C.) Psychiatric Soci¬
ety, was recently named a life fellow of
the American Psychiatric Association.
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Marcia Kraft Goin, M.D. 58, Ph D.,
HS ’58-62, clinical professor of psy¬
chiatry at the University of Southern
California (USC) School of Medicine,
has been nominated as a trustee-atlarge of the American Psychiatric
Association. Dr. Goin is director of res¬
idency training in the psychiatric out¬
patient clinic at Los Angeles County/
USC Medical Center, and is in parttime private practice.

dents in ophthalmology from all
throughout Latin America, the institute
was recently renamed the Javier Servat
Univajo Institute of Ophthalmology.
Dr. Servat remembers his years of
training at Yale fondly and sends salu¬
tations to all of his old friends.

Max Pepper, M.D., M.P.H. ’59, of
Montague, Mass., retired professor and
founding chair of community medicine
at St. Louis University, is clinical pro¬
fessor of family and community health
at Tufts University Medical School and
consultant to the community-oriented
primary care training program for
internal medicine residents at Baystate
Medical Center in Springfield, Mass.
Dr. Pepper also traveled to Ramallah,
near Jerusalem, to help Palestinian col¬
leagues launch a new graduate program
in public health at Bir Zeit University
for medical professionals from the
West Bank and Gaza. He is also serv¬
ing a two-year term as president of the
Physicians Forum. His wife, Anita
Golden Pepper, M.P.H. ‘60, Ph.D. ’72,
is also clinical professor at Tufts Med¬
ical School.

Juan Larah. M.D. ’82, was named
director of Adult Medicine at the Mis¬
sion Community Health Clinic, which
provides care to the under served His¬
panic community of San Francisco.

Leon G. Smith, M.D. '56, HS ’59-62,
chairman of medicine at Seton Hall
University School of Graduate Medical
Education, and director of medicine
and chief of infectious diseases at Saint
Michael’s Medical Center in Newark,
N.J., was voted one of the top five
infectious disease specialists in a New
Jersey statewide poll published by the
New Jersey Monthly.

Javier Servat, M.D., HS ’62, in a
recent letter to AYAM Vice President
Nicholas Passarelli, M.D. ’59, HS ’5965, reported on 34 years of practice and
teaching at the Institute of Ophthalmol¬
ogy at the National University of Tru¬
jillo in Peru. As a tribute to his service
and to his training of more than 80 resi¬
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Heidi Boerstler, Dr.P.H. ’87, M.P.H.
’81, J.D., is department chair for health
administration programs and a profes¬
sor at the College of Business and

Administration at the University of
Colorado in Denver.
David Seifer. M.D., fellow in Ob/Gyn
'89-91, has joined the Ohio State Uni¬
versity College of Medicine as director
of the division of reproductive
endocrinology and infertility.

John T. Chang. M.D., M.P.H. ’95, has
graduated from Northwestern Univer¬
sity Medical School and is a housestaff physician in internal medicine at
Georgetown University Medical Cen¬
ter in Washington. Dr. Chang published
an article in the September 1995 issue
of CHEST.

ALUMNI /ae

A

lumni/ae of
our medical
school, achieving
distinction in
other academic
centers, are fre¬
quent lecturers at
Alvin Friedmandepartment con¬
Kien, M.D.
ferences on our
campus.
We wish to report of such visits
briefly in such a column in order to
inform classmates and colleagues of
these events. Department chairmen
and alumni/ae speakers are urged
to inform Yale Medicine of such
visits so that this mission may be
accomplished.
On April 25, Alvin E. FriedmanKien, M.D. ’60, presented medical
grand rounds and subsequent house
staff colloquies on The Viral Etiol¬
ogy and Pathogenesis of Kaposi’s
Sarcoma, and related aspects of the

AIDS epidemic. Dr. Friedman-Kien
is professor of dermatology and
microbiology at New York Univer¬
sity Medical Center. He is an inter¬
national authority on Kaposi's sar¬
coma, and his research has centered

on

campus

on the pathogenesis of viral and
infectious agents in dermatologic
disease and oncology.
Dr. Friedman-Kien presented a
comprehensive review of the history
and pathogenesis of Kaposi’s sar¬
coma (KS) with a summary of the
evolution of our knowledge since
1981 in the era of AIDS. The associ¬
ation of this malignancy with the
herpes virus and the ultimate identi¬
fication of human herpes virus 8
(HHV8) as the probable etiologic
agent of KS was described. The
complex and enigmatic epidemiol¬
ogy and pathogenic elements in
the expression of this malignancy
were discussed.
Dr. Friedman-Kien is, coinci¬
dentally, a renowned and eclectic
collector of modern art and authority
on artistic antiquities. His collec¬
tions are celebrated ones. A profile
of Dr. Friedman-Kien on this subject
appeared in the March 1996 issue of
Art and Antiques.
Nicholas P.R. Spinelti, M.D. ’44
Consultant, Alumni Affairs
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Richard L. Frank
Richard L. Frank, M.D., died of a
stroke in February in New York. He
was 90.
Dr. Frank graduated from Yale
College in 1926 and received a
master’s degree from Yale in 1930;
he graduated from the Yale School
of Medicine in 1931. Dr. Frank
served in the Army during World
War II. He completed his residency
in psychiatry and child psychiatry
at New York Psychiatric Institute at
Columbia University, and from
1945 to 1946 he taught psycho¬
analysis at the Long Island College
of Medicine.
Dr. Frank continued his train¬
ing in psychoanalysis and child
analysis with the New York Psy¬
choanalytic Society. He later taught
at Columbia University’s Psycho¬
analytic Clinic. Dr. Frank joined the
faculty at Mount Sinai School of
Medicine in New York, where he
led the work that established the
adolescent service in psychiatry. He
was also in private practice in Man¬
hattan for more than 30 years.

William F. Stephenson
William F. Stephenson, M.D., died
April 23 at his home in Denver. He
was 72.
Dr. Stephenson served in the
medical corps during World War II.
He graduated from the University
of Oklahoma, and received his
medical degree from Yale in 1952.
Dr. Stephenson completed an
internship on Staten Island, N.Y.,
and at the Public Health Service in
Fort Worth, Texas. He completed
residency training in psychiatry at
the University of Colorado Health
Sciences Center.
Dr. Stephenson practiced psy¬

chiatry in Denver for more than 30
years and was a clinical instructor
at the University of Colorado
Health Sciences Center.

Raymond S. Duff
Raymond S. Duff, M.D., M.P.H.,
died on June 21 in Connecticut
from complications from a stroke.
He was 72.
Dr. Duff served in the Army
from 1943 to 1946. In 1948, he
received a bachelor’s degree from
the University of Maine. He gradu¬
ated from the Yale School of Medi¬
cine in 1952. Dr. Duff served a
pediatric internship and residency
at Yale-New Haven Hospital from
1952 to 1955. In 1959, he received
a master’s of public health degree
from Yale.
From 1955 to 1956, Dr. Duff
was director of the Bureau of Med¬
ical Services for the New Haven
Health Department. In 1956, he
joined the Yale faculty as instructor
in pediatrics and public health.
He also was director of ambulatory
services for Yale-New Haven
Hospital. Dr. Duff retired from Yale
in 1988 as professor emeritus of
pediatrics.

tary to the Committee on Drugs and
Medical Supplies of the National
Research Council, and in 1946 was
executive secretary to the National
Academy of Sciences' Board of
Coordination of Malaria Studies.
In 1948, Dr. Carden was pre¬
sented with a presidential certifi¬
cate of merit for outstanding ser¬
vice toward the war effort as chief
of the wartime Office of Scientific
Research and Development’s
malaria division. In 1982, he retired
as a clinical professor of medicine
at the Columbia University College
of Physicians and Surgeons, after
36 years on the clinical faculty. He
practiced medicine at ColumbiaPresbyterian Medical Center from
1946 until his death.
Yale established the George A.
Carden Jr. Fellowship for research
in virology and immunology in his
honor. Dr. Carden also received a
Distinguished Service Award in
1992 from the Association of Yale
Alumni in Medicine.

IN

MEMORIAM

Robert M. Cushing, M.D. ’32
June 20, 1996
Hugh Richard Hoopes, M.P.H. ’79
April 22, 1996

George A. Carden Jr.
George A. Carden Jr., M.D., died at
his home in New York City on Aug.
10. He was 89.
Dr. Carden received a bache¬
lor’s degree in 1931 and a medical
degree in 1935, both from Yale.
During World War II, he was a
member of an American research
team investigating tropical dis¬
eases, especially malaria, in both
the laboratory and in the field. He
served in 1945 as executive secre¬

Milton Malev, M.D. ’26
November 16, 1995
Lucien M. Pascucci, M.D. ’34
July 2, 1995
Milber Bedford Pope, M.P.H. ’70
August 11, 1995
Donald H. Schultz, M.D. ’52
May 23, 1996
Theodore H. Sills, M.D. ’27
June 12, 1996
Marc A. Weisblatt, M.P.H. ’91
December 12, 1995
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Expanding on a happy tradition
W

hat makes a great reunion
program a little bit better?
Feedback from alumni/ae that lets
us try a few new ideas, plus two
days of great weather. Thanks to
the excellent response to our
alumni/ae survey in late 1995 (not
to mention blue skies), this past
June’s Alumni/ae Reunion Week¬
end program was a tremendous hit.
As we plan the 1997 reunion, we
would appreciate hearing more of
your ideas and preferences for this
special weekend in New Haven.
The 1996 reunion was a happy
mixture of traditional and new
activities. On the Friday night,
after a day of meetings and semi¬
nars around the medical campus, a
convivial reception in the Histori¬
cal Library was hosted by Dean
Gerard N. Burrow, M.D. ’58, fol¬
lowed by a Mexican-themed buffet
dinner in the Harkness Courtyard.
Shuttle vans whisked revelers
to the Shubert Theater a few blocks
away, to see comic legend Jerry
Lewis in the touring musical pro¬
duction Damn Yankees. Other
groups made their way from cam¬
pus to Yale Field to watch the New
Haven Ravens AAA baseball club
play the Portland Seadogs, an
experience made all the more
exciting by the hooting and stomp¬
ing of the Elm City’s younger
fans (a collection of glove-wield¬
ing, 12-year-olds hoping to catch a
fly ball).
The next day we set up golfers
with convenient tee-times at the
Yale Golf Course and made free
court time available at the Yale
Tennis Center. And the weather
was clear, hot and dry.
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reunion
weekend
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These additions to the program
were your suggestions and they
complemented the traditional com¬
ponents of reunion—individual
class programs, parties and semi¬
nars, as well as special presenta¬
tions by faculty. As always, the
Friends of the 50th Dinner, hosted
by the Association of Yale Alumni
in Medicine (AYAM) at the Gradu¬
ates Club, was an evening of relax¬
ation and good cheer—and very
short speeches. The dean did stand
up and thank the Class of 1946
for its record accomplishment of
raising a reunion gift of more than
$1 million.
Seafood Newburg, beef ten¬
derloin and strawberry shortcake
were also at their traditional places
on the Saturday lunch buffet
table—staples of comfort for many
in this ever-changing world we live
in! And while we can count on
some familiarity in the menu this
coming June, the backdrop for the
meal will be dramatically different:
The entire first floor of Harkness
will be new, the result of a top-tobottom renovation of the cafeteria
into a food court with new seating,
a private dining room and a recon¬
figured Spinelli Lounge.
An important tradition that

was maintained in 1996 was the
presentation of the Distinguished
Alumni Service Award, to two
recipients: Marie-Louise T. John¬
son, Ph.D., M.D. ’56, HS ’56-59;
and Dwight F. Miller, M.D. ’56,
HS ’58-59. Both Drs. Johnson and
Miller are former presidents of the
AYAM, and have worked tirelessly
for the good of the school and all
its alumni/ae. Continuing a rela¬
tively new tradition started in
1994, Dean Burrow presented the
Peter Parker Medal to Arthur
Crovatto, M.D. ’54, HS ’54-61
who stepped down this summer as
director of alumni affairs. Dr.
Crovatto remains closely involved
with students as instructor of
anatomy.
Next year, Alumni/ae Reunion
Weekend will be Friday and Satur¬
day, June 6 and 7. Since we will
not mail a survey this year, I would
be very grateful to hear from
people at any time, by mail, fax,
phone or e-mail. We are especially
interested in finding ways to meet
the needs and expectations of
younger alumni/ae to encourage
their participation.
William K. Jenkins
Managing Director
Office of Alumni Affairs

Write to Bill Jenkins at the Office
of Alumni Affairs, PO. Box 7613,
New Haven, CT06519-0613 (Tel:
203-785-4674, Fax: 203-7375153), or via e-mail at
williain.jenkins@yale.edu
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1941
55TH REUNION
By Willvs M. Monroe, M.D.

Attending our 55th reunion, with
spouses, were Peter Duncan,
John Fenton, Fred Glike, Willys
Monroe and Ed O’Connell.
Willys, acting for class secretary
Bob Ollayos (who was in northern
Wisconsin at the time), took notes
and reported on the activities of
class members since our 50th
reunion. He sadly announced the
deaths of nine classmates since that
occasion: Acpua, Areson,
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Helen P. Langner, M.D. '22,

REPORTS

genetic research. If there are oth¬
ers, please make this known to Bob
Ollayos or Willys Monroe.
In honor of the 55th anniver¬
sary of our graduation, despite our
diminishing numbers (but under
the persuasive leadership of Peter
Duncan), our class subscribed its
largest gift ever to the Medical
Alumni Fund. Although most of
the returnees came from nearby,
Willys and Louise Monroe came
from Virginia. In fact, Louise con¬
ducted pediatric cardiology clinics
in Roanoke, Va., on Friday, June 7,
until noon and still made it to the
barbecue supper at Harkness Hall
that evening. Saturday’s activities
for our class followed the tradi¬
tional pattern of morning medical
seminars and the meeting of the
Association of Yale Alumni in
Medicine, followed by sherry and
lunch on the Harkness lawn. But
the day culminated in the “attitude
adjustment” hour at the Graduates
Club, with plenty of good fellow¬
ship and nostalgic reminiscences
of days gone by, followed by a
sumptuous dinner with Friends of
the 50th. After dinner we said our
fond farewells, promising to keep
in touch and to return, God willing,
in 2001 for our 60th.

responds to a gift of flowers from
Arthur C. Crovatto, M.D. '54.

1946
50TH REUNION
By Franklin C. Behrle, M.D.

Cheney, Ed Harvey, Lasell, Murfitt, Parrella, Simmonds and
Rogers, leaving 24 still alive. We
understand that Randy Bell was
unable to attend the festivities
owing to failing health. It also
appears that the only one of us still
active professionally is Peter Dun¬
can, who is pursuing a project in
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On Friday, June 7, the Class of
1946 assembled at the Colony Inn
where an early afternoon cocktail
party set the tone for a happy, hec¬
tic and high-calorie 50th reunion.
Further fortified by the dean’s
reception in the Historical Library,
we wove our way to the New
Haven Hotel where we encoun¬

tered our first of several sumptuous
feasts, immediately followed by a
smash performance by Jerry Lewis
in Damn Yankees at the Shubert.
Saturday morning brought us
up to speed on state-of-the-art radi¬
ology and the state of the School
of Medicine. At noon. Dean Bur¬
row, mind-boggled by the report of
the windfall class gift, went for
broke in providing the most lavish
buffet the Harkness Hall tents have
ever hosted.
After a brief session for the
class picture on the steps of Ster¬
ling (marked by a not-too-successful attempt to place us in the identi¬
cal positions of our original gradu¬
ation shot), we embarked on a rol¬
licking bus trip to the Gordon
estate, the highlight of the trip
being Betsy (Reilly) Sullivan’s
skirmish with a plate of buffet
Newburgh, which inevitably ended
up in Jud Hoover’s lap. The after¬
noon at the Gordons’ placed
another jewel in the crown of this
established tradition and provided
a much-needed chance to renew
old ties in a warm and relaxed
atmosphere. Hoover was the
solitary sampler of the lake, osten¬
sibly to elute the remains of the
Betsy buffet.
The class dinner on Saturday
night at the Graduates Club was
nothing short of gourmet and was a
fitting climax to the air of gemutlichkeit prevailing throughout the
weekend. Sunday morning rolled
around with startling quickness.
Amid parting salvos of “See you at
the 55th,” the party was over.
Those fortunate enough to
make it were: Molly Albrink, Joe
and Virginia Arminio, Bill and
Joan Banfield, Tim and Phyllis
Beck, Frank and Peg Behrle,
Sandy Bluestein, Linus and Dusty
Cave, Tom and Babette Coleman,
Fall/Winter 1996

Left: Members of the Class of 1946 visit
together during the Dean's Reception in
the Medical Historical Library’, 50 years

after their graduation from the School of
Medicine. From right: Vincent Pepe,
M.D., Julian A. Sachs, M.D., James N.
Harten, M.D., and June Pepe.

Below: John L. Sullivan, M.D., left,
pation. The previous high had
been $350,000. A class act?

1951
45TH REUNION
By John J. Sullivan, M.D.

It was 1951 all over again—Fri¬
day, June 7th, we had all assem¬
bled during the day, registered and
had been greeted by Lycurgus
Davey, our AYAM president and
Gerard Burrow, our dean.
We had attended and enjoyed
radiology chairman Bruce
McClennan’s presentation The XRay: 100 Years Of Progress, an indepth historical study.
Now, conviviality took over
and we were at the dean's recep¬
tion. Our next stop was Mory’s for
cocktails and dinner. We were
John and Ruth Berg, Jocelyn
Malkin. Sid and Ina Furst. John
and Betty Lou Haxo. Wally Mor¬

Reunion on a small scale
The fourth, irregular, mid-term, New England mini-reunion for
the Class of 1945 convened on Oct. 10, 1996, at the Publick
House in Sturbridge, Mass. Eight classmates (Atwood,
Breck, Daniels, Gardam, Jenney, Jones, Naumburg and Rein¬
er) and six wives attended.
The class will hold its next mini-reunion April 5 to 9 at
Howie-in-the-Hill, Fla. Ray Gagliardi has been planning this
event for the entire class. Having celebrated our 50th reunion
in 1995, the year 2000 looks a long way off—hence a mid¬
term meeting for this loyal and loving group.
R.W. Breck, M.D.

Yale medicine

Harry Bishop

Tom and Harriet Doe, Marty and
Evelyn Gordon, Jim and Ruth
Harten, Jud Hoover, Jim and
Micki Kleeman, Vinnie and
Rosina Longo, Hugh MeLane,
Jack and Laura Neville, Bob and
Marge Owens, Vinnie and Babe
Pepe, Julie Sachs, Don and Char¬
lotte Shedd, Dick and Mitzi
Sisson, Bob and Mary Wagner,
William P. Walsh (Class of
’43)and Frances, Bill and Midori
Wedemeyer, and Eli and Emma
Sue Wing.
We were most pleasantly sur¬
prised to welcome three widows:
Rosalie Collier, Muriel Murphy
and Betsy (Reilly) Sullivan. Sadly,
the Whelans and their daughter,
Sharon, John Morton, Ruth (Sviborgsen) Kempe and Joe Morris
were all looking forward to coming
but had to cancel due to unforeseen
circumstances.
The class gift to Yale shot out
all the lights—a grand total of
$1,155,059 with 76 percent partici¬

and John V. Haxo, M.D., members of
the Class of 1951, share a happy
moment during their 45th reunion.

gan, Mai and Muriel Bagshaw.
Carrold and Luanna Iverson.
Lowell and lone Goodman. Tom
and Barbara Amatruda, John and
Mary Sullivan. Andy and Irene
Wong, and A1 and Donna
Mowlem.
It was a casual, happy evening.
There were two long tables. At the
one I was at. the old boys and girls
were having a delightful time. I
glanced happily at the other long
table. The group was even more
excited. It was just what a reunion
should be!
The program on Saturday was
again outstanding. Radiology was
featured, all the way through the
latest in teleradiology. It would
make you proud of the old school.
Again, it was time for convivi¬
ality—libations and dinner at the
Graduates Club! Our group was
now joined by Paul and Polly
Bruch. Frank and Dolly Allen,
and Brad and Ruth Straatsma.
This party was even better. As
Ernest Hemingway said: “We ate
well and we drank well."
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1956
40TH REUNION
By John H. Gardner, M.D.

Thirty-two of us gathered in New
Haven for our 40th reunion. Fortyeight percent of the living mem¬
bers of our class attended, a pretty
good record for a 40th reunion. It
was good to see some old friends
at the unstructured class gathering
Friday afternoon, but it was not
very well attended. A fair number
of us attended the teaching ses¬
sions on the past and future of
radiology, and the meetings of the
Association of Yale Alumni in
Medicine, but attendance was cer¬
tainly best at the dinner meetings.
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Sid Furst was the master of
ceremonies. He remembered the
15 classmates we had lost, and
added the name of Mike Walken,
our almost-classmate. We had a
moment of silent prayer for our
old friends.
Sid reviewed our corres
pondence from classmates unable
to be with us. Tom Amatruda
discussed plans for the 50th.
We shall hear more from him later
on this.
The 50th sounds great. The
one and only Lowell Goodman is
forming a class band for this one,
so stiffen up your embouchure. We
all want another great affair. You
have to come back.

Commencement + 70
Elizabeth Ross Harrison, M.D. '26, attended reunion in June with her
nephew, Ross G. Harrison III. Dr. Harrison's father, Ross Granville Harri¬
son, M.D., Ph.D., was a leader in the field of tissue culture and the first to
develop a method for growing tumor cells in flasks. When the elder Dr.
Harrison moved his family to New Haven in 1907from Johns Hopkins
University in Baltimore, the family lived in the building on York Street that
is now Mory’s. Dr. Harrison celebrated her 97th birthday this year.
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A high point of these reunions has
always been the Friday evening
informal dinner at Helen and
Steve Downing’s house in Guil¬
ford, when one gets to relax with
old friends and suffer through
slides and movies of previous
reunions. The more formal cock¬
tails and dinner at the New Haven
Lawn Club on Saturday was some¬
what better attended and the cui¬
sine was very good, especially if
one were lucky enough to obtain
the entree requested through the
alumni office. Bill Lewit and
Charlie Zigun were only able to
make it to the luncheon on Satur¬
day—sorry not to have seen more
of them.
This reunion was preceeded
by a questionnaire which had been
answered by 54 of us, or 81 per¬
cent—again an excellent record.
Most of us are near or past the age
of 65 and it is therefore not sur¬
prising that 20 of us have retired, 4
more are on the verge, and 10
more have sharply curtailed their
professional duties, often by relin¬
quishing department chairman¬
ships, and sound as though they
are enjoying the situation much
better. That leaves only 20 of the
respondents, 37 percent, who are
still in the full-time active practice
of medicine and planning to
remain so. Perhaps the most thor¬
oughly retired is Bob McDivitt,
who gives his address as the yacht
Charade, out of Trinidad. Many
respondents commented on the
excellence of a Yale medical edu¬
cation and the joys of practicing
medicine tempered somewhat,
however, by the current tendency
to have one's practice run by
insurance companies. In the
same spirit, spurred onward by
the uniquely generous matching
grant offered by Bill Hindle,
our class made a substantial con¬
tribution to the Yale Medical
Alumni Fund. We left New Haven
with rekindled warmth of spirit
and a desire to return in another
five years.
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1961
35TH REUNION
By Sally L. Marchesi, M.D.

A dinner, hosted by Vincent T. and
Sally Lockwood Marchesi and
Robert I. and Ellen Levy, was held
on Saturday evening at the Marchesi’s Guilford home. Enjoying the
evening were Robert S. and Joyce
Briggs, David W. and Judith
Brook, Lawrence T. Chiaramonte, Royal C. Hudson Jr.,
Joseph E. and Joanne Jasaitis,
George M. and Christa Lordi,
Anoush Miridjanian, Roy E.
Ronke Jr., Robert N. Taub and
Warren D, and Myra Widmann.
Elaine Pitt sent her regrets.
A poem of thanks was sent by
George and Christa Lordi reflect¬
ing the feelings of the evening.
Many thanks for
... the view of the ocean and the bay,
the poppies on the driveway;
... the evening sun,
many old friends for fun;
...a house of warmth and delight,
where childrens’ touches are
still in sight;
... some tales of intervening years,
some changes, disappointments
and cheers;
... good cooking and great tastes,
such organization didn’t go to
waste;
... these special moments we shall
treasure,
as proof of extending friend¬
ships ’ measure.

Distinguished alumni/ae
Dwight F. Miller, M.D., and Marie-Louise T. Johnson, M.D., Ph.D.,
both members of the Class of 1956, received the Distinguished Alumni
Sennce Award at reunion in June. Dr. Miller, a Connecticut pathologist,
was president of the AYAM from 1984 to 1989. Dr. Johnson, a derma¬
tologist who treated patients and conducted research in Hiroshima,
Japan, during the 1960s, was AYAM president from 1993 to 1995.

berg popped in from various urban
and rural areas in Connecticut.
Our class dinner was in the
Library Room at the Graduates
Club on the New Haven Green and
we had laughs and fond memories,
sharing news of all our classmates.
Our 35th reunion in 2001 will coin¬
cide with Yale’s 300th Anniver¬
sary—think about it.

1971
25TH REUNION

1966
30TH REUNION
By Arne Youngberg, M.D.

A small transcontinental contingent
gathered in New Haven for our
30th. Phil and Arlene Bernstein
flew in from San Francisco. Gene
Cassidy drove cross-country from
the Iowa heartland. Joel and Cyn¬
thia Singer, Jim and Victoria Sansing, Jim and Pat Brown, Donald
Cohen, and Arne and Patti Young-
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By Barry Perlman, M.D.

Graying but still largely unbowed,
approximately 31 members of the
Class of ’71 celebrated their 25th
graduation reunion. The class din¬
ner, an excellent clambake, was
held on Saturday evening, as it
often has been in the past, at the
beautiful home of John and Ellen
Ebersole on Long Island Sound. A
brunch was held on Sunday morn¬
ing at the home of Barbara
Kinder, who planned the class

reunion along with Elton Cahow,
her husband, and Richard Moggio.
Many of those who enjoyed the fes¬
tivities were “reunion groupies”
who had attended most of the prior
class gatherings. They were joined
by several first-time attendees,
including Sten Lofgren, Stuart
Phillips, Tim Jette (who has left
anesthesiology for psychiatry) and
Steve Moffic. Geographically, too,
the group arrived from all parts of
the country and included John
Cieply from Hawaii, Andy Cook
from Maine, Doug Schmidt from
Colorado, and Paul Vignola from
Florida. As might be expected, the
largest contingent in attendance
was from Connecticut, Massachu¬
setts and New York. They included
Albert Weihl (who has founded
an emergency medicine residency
at Yale), Richard Kaufman.
Fred Cohn, Burns Woodward.
John Patti and Barry Perlman
(who was appointed chair of the
New York State Mental Health Ser¬
vices Council by Gov. George
Patakai, himself a graduate of Yale
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College). Others who made the
pilgrimage to New Haven were
David Lippman (who had just
recently returned from a self-con¬
ferred sabbatical of a year’s dura¬
tion with his family, during which
time he spent some months practic¬
ing in New Zealand and he visited
with Elizabeth Morgan), John
Mills (who regaled us with adven¬
tures from his continuing military
involvement), John Smiarowski
(who has infiltrated New England
culture into rural Louisiana), Rich
Travers, Semeon Tsalbins, Lenny
Eisenfeld, Jonathan Stewart, and
Marian and Bruce Block (the
only intra-class marriage and still
going strong).

Alumni/ae listen to a presentation on 100
years of radiology at Yale by Bruce McLen¬
nan, M.D., chairman of diagnostic radiol¬
ogy. In the front row, from right, are Robert
R. Wagner, M.D. ’46, Mary Wagner, Minn
Sisson and Richard G. Sisson, M.D. '46.

While the mood was bright,
those who came together took the
opportunity to offer condolences
and support to Lenny Eisenfeld
whose son tragically died in a ter¬
rorist bombing while studying in
Israel earlier in the year. Long-term
spouses were congratulated on
their achievement and new spouses
were warmly welcomed. Unlike
prior reunions, proud talk was as
much about the accomplishments
of children who are beginning to
take their place in the world as
about the doings of the class mem¬
bers themselves. Beyond nostalgia.
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other prominent topics were
news of those not present and
changes in the landscape of medi¬
cine since graduation.

1976
20TH REUNION
By Alfredo Axtmayer, M.D.

Attending the 20th reunion were a
select few, including Roger and
Meredith Boshes, Peter Swanson,
Ken Dobuler, Cindy Mann, and
Pat and Alfredo Axtmayer. Quot¬
ing Roger: “I am completely
bummed. Where are Cullen and
Schottenfeld. Kremer, Sladky?
The only good thing is the upgrad¬
ing of the wine at dinner, which
was a lively, albeit intimate, meal.”
He predicts the 25th will be big. He
is practicing psychiatry and teach¬
ing psychiatry in Rhode Island.
Ken Dobuler and Sue report
their daughter, Zoe, is now a year
old. He is chief of medicine at
Griffin Hospital, continuing his
pulmonary practice. His newfound
aspiration is to become an expert
sea kayaker, which he is doing now
with dedication.
Peter Swanson is still practic¬
ing family medicine in Shelton,
Conn., and is searching for docu¬
mentation of our second-year show
to present at the 25th reunion. Last
we heard. Bob Taylor had the
sound and Rick Morin had the
film, so maybe we can get these
together.
Cindy Mann is still practicing
pediatrics in New Haven at CHCP,
which is no longer a closed-panel
HMO. She is concerned now that
she has to pay attention to the part
of medicine she never liked. She is
still in love with pediatrics and
reports the adoption of her son,
Michael, now 4 years old, from El
Paso, who “is the light of my life.”
She also wants those who didn't
show up this year to know the
seven of us who dined together had
a great time talking about the rest
of you!

I keep wondering why I do this
every five years, since we seem to
be having diminishing returns. I
continue to practice orthopaedics
in the Meriden/Wallingford area,
and do some limited work at YaleNew Haven and St. Raphael's. Am
enjoying life with my wife, Pat,
and my four children, Alfredo,
Patrick, Aileen and Caitlin.

1981
1 5TH REUNION
By Barbara Ross, M.D.

Nine members of the Class of ’81,
along with spouses and friends,
returned to New Haven for our
15th reunion. We got together for
dinner at the Colonial Tymes
restaurant, for what turned out to
be great food and a comfortable
place to catch up with each other.
As before, our New York con¬
tingent was well represented.
Dovelet Shashou and husband,
Jon Trambert, hail from Riverdale.
Dovelet practices pediatric oph¬
thalmology and is on the go with
Steven, 6, and Emily, 3. Ines Carrasquillo is also back in New
York, practicing plastic surgery,
after a brief stint in Florida. She
much prefers the Big Apple.
Frank Yeomans’ psychiatry prac¬
tice in the city focuses on the bor¬
derline patient, and he’s recently
published a book on the subject.
David Lebwohl and Sally have
recently moved back to Connecti¬
cut and now live in the shoreline
town of Madison—welcome to
the suburbs!
Other classmates had to travel
a bit farther to reunion. Tony
Urbano and Camille came back
from Bethlehem, Pa., where Tony
is an interventional cardiologist.
Their children are Angela, 7,
Camille, 5, and Anthony, 3. Susan
Burdette lives in Montreal with
husband, Victor Radoux, and step¬
daughter, Catherine, 11. Susan is a
continued on page 62 ►
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With honors
Arthur C. Crovatto, M.D. ’54, awarded Peter Parker Medal

A

Yale medicine

ceed beyond grammar school, he
entered Columbia University in
1945, where he was a premed¬
ical student and a junior-varsity
basketball player. He first visited
New Haven for a game against
Yale in the Payne Whitney Gymna¬
sium. He returned again for foot¬
ball games at the Yale Bowl,
filled to capacity, trolley cars run¬
ning. In February 1946, he
entered the Army.
When he later interviewed
for admission to the School of
Medicine, he was welcomed by
Bill Whalen, then a first-year
medical student, and spent two
hours touring the school. The
friendly and inviting atmosphere
he found, and the Yale System of
medical education, galvanized his
love of medicine and of Yale. He
participated in the Aesculapian
Student Frolic Dance, the pro¬
ceeds of which paid for the daily
student-faculty teas (a wonderful
aspect of the student life of the
era), and he played on the medical
school basketball team.
During his internship, Arthur
met Janet Herrold, who was pursu¬
ing a master’s degree at the Yale
School of Nursing and graduated
with the Class of 1955. They mar¬
ried in York, Pa., and moved there
in 1961. He established a private
practice as a urological surgeon,
and served as chief of the division
of urology at York Hospital. Dr.
Crovatto was chairman of the York
County Medical Society Scholar¬
ship Committee, which he and his
colleagues founded in 1962. Free
polio vaccinations were being
offered at the time to the York
community, and donations were
collected in a bucket at the clinic.
These proceeds became the core
of the scholarship and loan fund
which today makes annual awards
of $30,000 to students aspiring to
a career in medicine.
After 29 years in York, the
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rthur C. Crovatto, M.D. ’54,
who retired this year as direc¬
tor of alumni affairs, has been
honored with the Peter Parker
Medal for his service and special
contributions to the school, and
for his loyalty as an alumnus.
The Parker Medal is named
for the Yale medical missionary
who devoted his life’s work to
China, where his breakthrough
achievements in transcultural rela¬
tions wrought truly historic
changes in the worlds of medicine,
religion and international diploma¬
cy in the mid-1800s. Peter Parker
was a graduate of Yale College,
Yale Medical College and Yale
Divinity School.
“Dr. Crovatto has done a
superb job in building alumni/ae
relations and has been the archi¬
tect of wonderful alumni/ae
reunions during the past six
years,” Dean Gerard N. Burrow,
M.D. ’58, said as he presented
the medal to Dr. Crovatto at
reunion in June. “Arthur has
been one of the driving forces in
the anatomy lab and his anec¬
dotes to the students have figured
prominently in the second-year
class show.” The Class of 1999
honored Dr. Crovatto with his own
song (Art Crovatto, to the tune of
the Eagles’ Desperado) in the
1996 show.
Born at home in Union City,
N.J., Dr. Crovatto chose medicine
as a goal early in life. Interviewed
this summer, he recalled that his
mother offered him two career
choices—those of minister or
physician. Possibly influenced by
his godfather, a doctor, he chose
the latter. From Union City, he was
able to enjoy the pleasures of New
York City for the cost of a 5-cent
subway token, and recalls watch¬
ing in fascination as the Lincoln
Tunnel connecting New Jersey and
Manhattan was excavated.
The first in his family to pro¬

Arthur C. Crovatto, M.D. '54, left, receives
the Peter Parker Medal from Dean Gerard
N. Burrow, M.D. '58, at reunion in June.

Crovattos returned to New Haven
in 1990, and Dr. Crovatto
assumed the directorship of the
medical school Office of Alumni
Affairs. Working with the medical
students as an instructor in anato¬
my, he has enjoyed connecting
these future alumni/ae to the
Association of Yale Alumni in Medi¬
cine (AYAM). He and his wife have
four children, two of whom now
live on the Upper West Side of
New York City. From his son’s
apartment he can see his child¬
hood home of Union City. Five
young grandchildren keep the
Crovattos busy, and Dr. Crovatto is
devoting time to tennis, gardening,
the appreciation of basketball,
and weekends at his summer
home on Martha’s Vineyard. He
remains connected to Yale and
medicine, and to another genera¬
tion of aspiring physicians, as an
instructor of anatomy.
Bonnie Sargent
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Sharing light
Was the Greek inscription above the door to Sterling about
the handing down of knowledge, ora more collegial enterprise?
A search of the past suggests the latter.

Where the runners outwear each other
but running with lampless hands. No man takes light from his brother
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till blind at the goal he stands.
Swinburne, Hymn of Man

A

s we crossed Cedar Street
last fall on our way into Ster¬
ling Hall of Medicine, Bill Collins,
M.D. ’47, asked if I could trans¬
late the Greek inscription on the
architrave over the entry portal to
the rotunda. Knowing nothing of
the history of the portal and its
architecture, my rendition was:
Those having brightness (of
knowledge) will pass it on to each
other. This idea of sharing
seemed quite appropriate to the
collegial atmosphere that most of
us experienced and enjoyed at the
Yale School of Medicine. Col¬
leagues pointed out soon enough
that the first word of the inscrip¬
tion referred not to brightness but
to torches.
But of course, for there above
the inscription was the symbol of
the torch with the owl of wisdom
behind it, sculptured in the frieze
as in an ancient Aesculapian tem¬
ple, clearly a fascination of the
architect. This symbolism had to
have an historical significance, so
my answer to the original question
only raised more questions.
A visit to the Yale Medical His¬
torical Library produced two publi¬
cations showing the entry portal:
The Yale Alumni Magazine of Janu¬
ary 1959 and the Yale Memorials
from the Office of the Secretary,
1963. In both, the rendition of the
Greek inscription in English was
as follows: Those who have torch¬
es shall pass them on to others.
This translation did not seem sat¬
isfactory, as the last word of the
inscription, AAAHAOIX, means
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not “to others" but “to each
other” or “to one another."
My next stop was at the Ster¬
ling Memorial Library on the main
campus. There, the electronic text
section provided, with just a few
keystrokes on the computer, the
source of the quotation. It flashed
on the screen, identified as
Republic, I 328 a 2. It was about
horse racing! A novel idea it was,
a relay race on horseback. Refer¬
ence was made to the Jowett
translation, which proved to be: ...
Will horsemen carry torches,
and pass them one to another
during the race? This literary
translation is quite appropriate to
the context of the passage, but a
review of the original Greek text
would permit, if we remove the
question mark, a more literal
translation known to us today:
Those having torches will pass
them on to one another.
How were these words cho¬
sen for the entry portal of the Yale
School of Medicine and the Insti¬
tute of Human Relations? There
had to be a story. Researching
the files of Dean Milton C. Winternitz, the entire story of the portal
was revealed, finally, in the folder
labeled Miscellaneous.
Dean Milton Winternitz, who
had instituted the medical
school’s full-time faculty system,
had felt for some time that the
medical school was carrying a dis¬
proportionate share of the social
problems of the community. With
his friend, the 28-year old dean of
the Law School, Robert M.

Hutchins, the dean embarked
upon an effort to bring multiple
disciplines, including law, sociolo¬
gy, psychology, psychiatry, medi¬
cine and even engineering, to
share in these sociological
endeavors. The president of Yale
University, James Rowland Angell,
described the project as a com¬
munity of scholars. It was to be
called the Institute of Human
Relations, for which the dean had
obtained a generous Rockefeller
grant, both for its construction
and its support for the next five
years. Precursor to the the pre¬
sent-day Yale Psychiatic Institute,
the Institute of Human Relations
originally occupied the left side of
Sterling Hall of Medicine.
The architect chosen for the
project was Grosvenor Atterbury,
a member of the Yale College
Class of 1891 and a close friend
and classmate of Harvey Cushing,
M.D. Among the items found were
a letter from Mr. Atterbury to Dr.
Winternitz and a reprint of the
architect’s article, Hospitals
and Esthetics (from the Journal of
the American Medical
Association, 1915).
Searching through these
items, one uncovers a clear expla¬
nation for a choice of the inscrip¬
tion. To Mr. Atterbury, the esthet¬
ics of the hospital were more a
function of the art than of the sci¬
ence of architecture. He believed
that there was a human side to
every medical problem and that
this was epitomized by the sen¬
tence suggested for the entrance
to the Virchow Hospital in Berlin:
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Architect Grosvenor Atterbury’s enchantment with the ancient Aesculapian temples of healing is seen in the sculptured frieze, above the
inscription, at the portal to Sterling Hall of Medicine. The sculpture
exhibits a small torch (the literal meaning in the singular of the first
word of the inscription) behind which is the figure of an owl. The owl,
the favorite bird of Athena/Minerva, was the bird of wisdom.
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“In treating the patient, do not for¬
get the man." His admiration of
this inscription probably motivated
him to have a similarly telling
inscription over the portal of
entry of the Institute of Human
Relations.
In a letter to Dean Milton Wintern itz dated November 13, 1930,
Mr. Atterbury enclosed a copy of
Hospitals and Esthetics and an
explanation for the inscription. His
translation of the quotation is
close, but not quite literally correct:
Carrying torches they passed them
on, one to another. His interpreta¬
tion was that there are “times
when in the brotherhood of all the
arts and sciences one profession
should take the torch from another,
as did the Greek runners ... eager
to advance it toward the goal.” This
interpretation, like mine, implies a
sharing or horizontal transmission
of knowledge. He continues to say
that.the quotation is taken from a
description of ancient Olympic
Games. He was unable to recall the
author and suggested that the
dean inquire of “one of the Greek
Professors in the University."
Dean Winternitz did write to
Professor Austin M. Harmon, who
replied promptly in a letter of
November 18, 1930. Professor
Harmon identified the source of the
quotation and corrected Mr. Atter¬
bury’s translation thus: “Carrying
torches, they will pass them on,
one to another.” He described
torch races as a feature of the
Panathenaic Festival at Athens as
there were no torch races in the
Olympic Games. The last paragraph
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of Professor Harmon’s letter is wor¬
thy of quotation:
“Since the torch race was a
relay race, in which each team of
runners passed a torch from hand
to hand precisely as modern run¬
ners pass a short staff, and since
it was the duty of each runner in
the relay to keep alight the torch
which he received and passed, the
transmission of the torch, by
repeated figurative use, has come
to be almost synonymous with the
transmission of learning from one
generation to the other. In that
sense, the words of Plato are
applicable to the activity of any
school in the University. It is diffi¬
cult, however, to share what seems
to be the view of Mr. Atterbury that
they adequately symbolize coopera¬
tion and are therefore especially
applicable to the Institute of
Human Relations. There was no
exchange of torches in the race
and the runner received from some¬
one else the torch that he kept
lighted and passed on.”
Conclusively, then, Professor
Harmon makes it clear that the

passing of the torch is a vertical
transmission of knowledge from
one generation to another and not
a sharing or horizontal transmis¬
sion. To emphasize Professor Har¬
mon’s words that the object was
that the torch “be kept lighted and
passed on,” I quote the definition
of the quotation from Brewer's
Dictionary of Phrase and Fable
first published in 1870: “To main¬
tain and transmit knowledge,
learning, etc., to the succeeding
generation.”
Dean Winternitz accepted Mr.
Atterbury’s proposal and reasons
for the inscription, but being dean
of the medical school, he also
accepted Professor Harmon’s
interpretation, which was so
applicable to the medical school.
He was right, for ironically the Insti¬
tute of Human Relations exists his¬
torically in name only while the
inscription persists as a fitting
expression of the mission of the
Yale Medical School.
Lycurgus M. Davey, M.D. '43
President. AY AM
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hematologist-oncologist at McGill
University. Neil Gross lives in
Bethesda now, and has set his sight
on business school in the fall. And
Alicia Barela gets the “longest
journey” award, having traveled
from California where she is in
Ob/Gyn with the Kaiser healthcare
system. She was accompanied by
her son Robb—many of us remem¬
ber him as a toddler 15 years ago.
Many thanks to all who submit¬
ted information for our reunion
booklet—watch the mail for your
copy. And I hope to see all at the
20th reunion in 2001.

1986
1 OTH REUNION
By Eric P. Suan, M.D.

Fifteen members of the Class of
1986 returned to New Haven to cel¬
ebrate the class’s 10th reunion.
Most of the activities centered
around food, drinks and good con¬
versation. A cool summer’s night
was perfect for the Friday evening
barbecue on the patio of Harkness
Hall. Kudos to Mike Miller for
arranging a tour of his old Harkness

dormitory room. A feast at Mory’s
on Saturday completed the week¬
end's events. Oh yes, the lectures
were very stimulating as always. In
attendance were Catharine Arnold
(now in medicine in New Haven),
Cristina Brunet (Class of ’87)
(medicine, New Haven), Sophie
Cole (cardiology, San Francisco),
Colleen Collins (primary care,
Chelsea, Mass.), Amanda Dill
(medicine, Danbury, Conn.),
Daniel Fierer (research, NIH in
Bethesda, Md ), Jeremy Holtzman
(medicine, Minneapolis), Betty
Klein (vitreoretinal surgery. Red¬
ding, Conn.), Cynthia (Hall)
McCraven (Ob/Gyn, Cheshire,
Conn.), Tim McGowen (pediatric
orthopaedics, Winston-Salem,
N.C.), Michael Miller (Pfizer,
Alexandria, Va.), Ilena Norton
(psychiatry, Denver, Colo.), Eric
Suan (vitreoretinal surgery. Camp
Hill, Pa.), Miriam Tatum (primary
care, Derby, Vt.), Julia WhitesideMichel (glaucoma, Little Rock,
Ark ), and John Wysolmerski
(endocrinology. New Haven).

1991
5TH REUNION

Harry Bishop

By Frank Lobo, M.D.

John H. Gardner III, M.D. '56, and his wife,
Anne L. Gardner, right, visit an exhibit on
A.C. Gilbert, M.D. '09, at the Eli Whitney
Museum in Hamden, Conn., on a tour added
this year to the reunion weekend events.
Guiding them is Helaine Patterson, president
of the museum and director of public infor¬
mation at the School of Medicine.
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The Class of ’91, encompassing not
only those who actually graduated
in 1991, but also some who arrived
at YSM in 1987, reunited, in part,
over Alumni/ae Reunion Weekend.
At the dean’s reception on Friday,
Funda Meric (finishing research
fellowship at NIH, returning to
Michigan for chief year in general
surgery), Rick Ihnat and Denise
Kung Ihnat (attendings in internal
medicine in St. Louis), and I con¬
gratulated each other on the kind¬
ness that time had shown us and
traded any gossip that was available
about our classmates. Rick already
has turned down a chairmanship of
a department—likely a ’91 first! At
the barbeque later that evening, the
ever great-looking wife and hus¬
band Gaetane Francis (Ob/Gyn

attending in Greenwich) and Larry
Hirsch (epilepsy fellowship at
Columbia) arrived. The evening
was warm, and so was the food.
Saturday evening brought us
together with the 50th reunion class
for the Friends of the Fiftieth dinner
at the Graduates Club. There we
were joined by Dan Saal (finishing
Ph.D. work in physiology, likely
headed for psychiatry—behind the
desk) and wife. Dr. Denise Alba. On
the other side of the table, and just
out of conversation range, was
Peter Bernstein (perinatology fel¬
lowship at Einstein) and wife, Cathleen Bernhart. Peter and Cathleen
economized on reunion expenses
by attending three at once (Yale
College, YSM, and along with Gae¬
tane, Yale Ob/Gyn residency). The
bar was welcoming, the food
yummy and the company terrific,
but the big hit was the Class of
1991 Update booklet, featuring bios
on those who returned the forms
and world-premiere cartoons
by Marc Agronin (assistant profes¬
sor of psychiatry at Minnesota).
The enthusiasm for the Update
has prompted a second mailing
of forms, which should be
arriving now, in order to make
an addendum.
On Sunday, reunion attendees
indulged me by coming to my
house for brunch. Although
described in the invitation as a “ren¬
ovated” old house, it actually is
somewhat short of that. Nonethe¬
less, the yard was large enough to
contain the crowd, which swelled
with the arrival of John Phillips
(chief year in urology at Yale),
Steve Ugent (finished dermatology
at Tufts, now assistant professor at
Boston U.), and Steve’s fiancee, Dr.
Randy Berger. Finally, Carl Henningson (finished Ph.D., matched
at Penn for internal medicine)
brought his infectious smile to the
brunch. Bernstein, Ihnat and
Phillips’ children were perfect
angels and were overheard asking
how old they would have to be to
apply to Yale Medical School.
Maybe by the 20th reunion.
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Healing the world from home
Y

ale medical alumni/ae learned
of an innovative way to
develop world medical aid without
leaving their own hospitals, in a
reunion presentation by William H.
Rosenblatt, M.D., assistant profes¬
sor of anesthesiology and one of
five winners of the 1996 Interna¬
tional Rolex Awards for Enterprise.
Dr. Rosenblatt described the
prize-winning REMEDY program,
a system for recovering discarded
surgical supplies from U.S. hospi¬
tals and donating the materials to
developing countries. REMEDY,
for Recovered Medical Equipment
for the Developing World, was
developed in 1991 at Yale and is
now in place in more than 60
hospitals throughout the United
States, including Yale-New
Haven Hospital.
The program teaches hospitals
a thoroughly tested protocol to
recover discarded but unused oper¬
ating room supplies in affluent
countries and distribute them
through well-known charities to
the needy in developing countries.
Physicians, nurses and technicians
thereby contribute to global health
care during their daily routine, Dr.
Rosenblatt told returning
alumni/ae gathered in a Jane Ellen
Hope seminar room in June.
According to David G. Silverman, M.D., professor of anesthesi¬
ology and vice president of REM¬
EDY, this program also includes a
research component, whereby U.S.
hospitals are able to learn costeffective measures to save money
and reduce waste. Drs. Silverman
and Rosenblatt have published
extensively on this issue, including
articles in the Journal of the Amer¬
ican Medical Association.

As standard practice, Ameri¬
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can hospitals throw away surgical
supplies prepared for operating
room procedures—even if they
remain intact—because they are
no longer covered under the
manufacturer’s single-use-only
warranty. These supplies can
then be sent to developing coun¬
tries, which have extremely lim¬
ited materials.
In addition, REMEDY is
looking at effective methods to
donate materials overseas and
developing communication sys¬
tems, including use of the Inter¬
net, about the materials that are
available in the United States and
that are needed in developing
countries.
“REMEDY, in cooperation
with the Yale Office of Interna¬
tional Health, is developing AIREmail. Agencies for International
Relief e-mail list. This list will be a
free means by which not-for-profit
agencies can offer donated goods
or make urgent requests,” Dr.
Rosenblatt says. “REMEDY
already has filled one urgent
request for a skin graft mesher in
Belarusk and has distributed items
for which REMEDY had no over¬
seas request,” he adds.
“With funds from Rolex and
other corporations, REMEDY is
encouraging more hospitals to par¬
ticipate in this program,” Dr.
Rosenblatt says. In the past, hospi¬
tals had approached REMEDY for
programmatic information, and
now REMEDY is able to request
hospitals to join this global effort.
To extend REMEDY’S work,
the program has developed a link¬
age with the Albert Schweitzer
Institute for the Humanities, based
in Wallingford, Conn., to dissemi¬
nate the REMEDY program

William H. Rosenblatt. M.D.. holds a tray of
disposable items—still intact and sterile—
recovered from the operating room at YaleNew Haven Hospital and bound for Albania
and Nicaragua. No longer covered by the
manufacturers' single-use-only warranties,
the items are used in developing countries
with limited materials.

more widely in the United States
and elsewhere.
The Rolex awards program
was created in 1976 to encourage a
spirit of enterprise in individuals
worldwide by providing them with
the financial support and recogni¬
tion that they need to bring their
original ideas to fruition.
Dr. Rosenblatt and four others,
selected from more than 2,500
applications in 116 countries, each
received $50,000 cash awards and
solid gold Rolex chronometers at
ceremonies in Geneva and New
York City in May.
Helaine Patterson
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Reflections on
the beginning
of coeducation
at Yale

Bovary, or that I would always
fight as did the revolutionaries in
Les Miserable s, or hoping that
our world was not as suffocating
as that of Stendhal’s The Red and

By Vivian Reznik, M.D. ’75
s I reflect on my history at
Yale—as a transfer student
to Yale College in 1969,
four years at Yale School of Medi¬
cine and a marriage to someone in
the class of 1970—what I remember
best is that first year of coeducation.
I came to Yale College in the
fall of 1969.1 was one of 40 women
at Davenport College, all transfers
from some other college—Sarah
Lawrence in my case. We all came
to New Haven in the spirit of a great
adventure, few of us with specific
goals. I remember thinking it was
better than a junior year abroad.
(Imagine choosing New Haven
over Paris!)
Some of us had lofty dreams—
to become a Supreme Court justice,
design great buildings, discover the
bones of prehistoric man, win the
Nobel prize. Others had more lim¬
ited aspirations—to meet a nice guy,
fulfill a family legacy, get a good
education. We didn't immediately
break any barriers that first year. We
didn't run the Yale Daily News, or
start our own sports program, or get
membership to Mory’s. Those
changes would come from future
classes. But we showed the institu¬
tion that women could be produc¬
tive, intellectual, interactive partici¬
pants without diverting the men in
some sexual frenzy.
We became lawyers (did we
ever!), doctors, parents, writers,
artists, filmmakers, judges, profes¬
sors, scientists and CEOs. We
changed history and the environ-
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the Black.

Vivian Reznick, M.D., a 1975
graduate of the School of Medi¬
cine, is professor and vice chair
of pediatrics at the University of
California, San Diego School of
Medicine. She returned to New
Haven in May for the 25th-year
reunion of the Yale College
Class of 1971, the University’s
first undergraduate class to
include women. Yale School of
Medicine has admitted women
since 1916.

ment at Yale. The administration of
Yale at that time should be congrat¬
ulated not only for its vision but
also for the way it achieved coedu¬
cation. Yale applied the same stan¬
dards it used for men and admitted
women who had the capacity, desire
and talent to change the world,
whether through leadership, schol¬
arship or athleticism. Yale helped
those women, as well as the men,
discover their inner strength and
taught them to use it productively.
At Yale College, I was swept
away by the world of 19th-century
French literature. It was romantic,
expansive, beautiful and inaccessi¬
ble. Did that help me become a bet¬
ter professor of pediatrics today?
Maybe, because I remember how I
felt daydreaming that I would never
allow myself to become a Madame

My liberal arts education awak¬
ened in me the idea that change is
possible and perhaps inevitable. But
the critical lesson I learned at Yale
was that individuals change society.
Perhaps that idea has been germi¬
nating in me through my years of
scrambling to succeed at academic
medicine, raising children and sur¬
viving managed care changes in
medicine. But hopefully I have
imparted that lesson to my children,
students, interns, residents, peers
and superiors. I have proceeded
through these past 25 years as if it is
my birthright to succeed. That atti¬
tude came in part from my parents
but was refined, ignited and nur¬
tured at Yale.
I think about young people I see
now growing up in San Diego who
feel that they have no future. No one
may have ever told them that they
are important, that they have inner
talents and strengths that should and
will be cultivated. This lack of self
esteem is critical in the epidemic of
teen violence, pregnancy and drug
addiction in our society. Perhaps a
Yale education cannot be promised
to this large, youthful population.
But the lessons we learned at Yale
and the way in which we were
treated as women and students
there—with respect, honesty,
commitment and enthusiasm—
should serve as a model for youth
development and our individual
interactions with young people in
our communities. YM
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Anatomy lesson
The problem: limited and antiquated laboratory;
space for the core course of a medical student’s
first year. The answer: a teaching center grounded
in tradition and the best in new technology.

Frank Poole

During an informal discussion at
Alumni/ae Reunion Weekend this
year, a group of alumni/ae from the
'40s and '50s asked the dean what
the school’s most important needs
are right now.
“Do you remember the
anatomy laboratory when we were
students?’’ Dean GerardN. Burrow,
M.D. '58, responded dryly. “Well, it
hasn’t changed a bit. ”

Above: This depiction of an anatomy lesson
from a 15th-century work in Johannes de
Ketham’s Fasciculus Medicinae shows that
dissection has been basic to medical educa¬
tion for centuries, although not always with
the same attention to detail or degree of
understanding. The picture of today's Yale
students crowding around a cadaver will
soon change. In the next century’s anatomy
laboratory, the scene will incorporate
advanced computer simulation, integrated
with traditional dissection of real cadavers.
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ach morning during the
school year, more than 130
people can be found in the
human anatomy laboratory standing
elbow to elbow (or ulna to ulna),
breathing in formaldehyde, squint¬
ing under old lamps, trying to get
the most out of an important med¬
ical school rite of passage. Four or
five students share each cadaver.
The changing rooms are makeshift
and shabby. The 101 medical stu¬
dents who entered Yale School of
Medicine this fall are learning
human anatomy in a laboratory
that was originally built in the
1930s to accommodate a class of
about 50. Add in the students from
the Physician Associate Program,
plus the faculty, and the lab on Ster¬
ling Hall of Medicine’s third floor
is crammed.
Furthermore, the other basic

science teaching labs scattered
throughout the school are also inad¬
equate. Students and faculty need a
central facility that is dedicated to
teaching and learning, and w'hich
incorporates modem technology.
“It felt as if our medical educa¬
tion was being delayed by some¬
thing other than our own igno¬
rance,” student Alicia Arbaje said at
the end of her first year in June.
“Don’t get me wrong, I love it here.
But honestly, the anatomy lab was
hard to deal with. Just improving
the ventilation would improve on
student morale.”
Dr. Burrow had more to say on
the subject during a formal presen¬
tation at reunion weekend. “The old
labs are beyond renovation,” he told
the returning alumni/ae. "We have
plans to build a new Student Labo¬
ratory and Teaching Center. It will
feature modern anatomy labs, com¬
puter workstations, conference
space and a lecture hall. But we
need to have the funding commit¬
ments in hand in order to build it.”
Medical students have studied
human anatomy since antiquity—
often with great difficulty. Since
before the time of Hippocrates, reli¬
gious and cultural injunctions
against dissection and autopsy have
impeded the advance of the science
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The cadaver ceremony
At the end of the first year of study, in a cer¬

of medicine. Students at all medical
schools in the early 1800s, including
this one, paid grave robbers to obtain
the cadavers they needed, causing
more than a few conflicts with the
local citizenry. In his book Doctors,
The Biography of Medicine, Sherwin
B. Nuland, M.D. ’55, wrote that it
was Galen, the second-century
Greek physician who “introduced
physicians to the anatomical concept
. . . that a detailed knowledge of the
body’s structure is the foundation
upon which understanding of disease
must be based." Some 1,400 hun¬
dred years later in Italy, Dr. Nuland
adds, Andreas Vesalius published De
Humani Corporis Fabrica, and
“paved the way for modern scientific
medicine by presenting to the world
the first accurate knowledge of
human anatomy and a method by
which it might be studied.”
Today, in the Yale System of
medical education, the study of
anatomy, cell biology, microbiology,
pathology, laboratory medicine and
neurobiology provide the grounding
for the clinical training that follows.
Learning is driven by individual ini¬
tiative and close cooperation with
one's colleagues and mentors. While
scalpels, probes and Gray’s Anatomy
are still in use, the teaching of
anatomy and physiology is far from

static. Technology is rapidly driving
adaptation and change.
Three-dimensional models,
video microscopy and interactive
computer tutorials are already
employed at Yale, enhancing and
complementing traditional learning
methods. They fit perfectly in the
Yale System that fosters self-motiva¬
tion and individual responsibility.
"When we weren't in the
anatomy lab, our class invaded the
library computers,” says Ms. Arbaje,
now a second-year student. “At peak
time, that was difficult.”
Experts now debate whether
high-tech teaching methods of the
future, such as virtual reality, will
make the need for human cadavers
and dissection labs obsolete. Most
teachers agree that the human
cadaver will never completely
become superfluous. The new Stu¬
dent Laboratory and Teaching Cen¬
ter will include a discrete computer
lab to incorporate new technologies
to compliment the traditional
cadaver dissection experience.
The proposed Student Labora¬
tory and Teaching Center will bring
together faculty, students and new
technologies under one roof and
ensure that Yale continues its leader¬
ship role in teaching and scholarship
in the decades ahead. The center will

Campaign for the Student Laboratory and Teaching Center
Named Gift Opportunities
To Name the Student Laboratory
and Teaching Center
Anatomy and Experimental Surgery
(laboratory facilities)
Lecture Hall
Exhibition Hall and Atrium Lounge
Computer/Telemedicine Lab
Basic Science Teaching Labs (6)
Cold Room
Men’s Locker Room
Women’s Locker Room
Faculty Office
Model Storage
Dissection Tables (36)

$6 million

emony that is both poignant and life-affirm¬
ing, Yale medical students honor the people
who helped teach them anatomy by donating
their bodies to their medical education. They
eulogize people they never met while they
were alive, but whom they came to know in
the most intimate detail through the tactile
inspection of gallstones, coronary arteries,
muscle fiber and arthritic joints. The dissec¬
tion of each cadaver reveals much about
that individual, and about humanity in gen¬
eral. A good physician must be trained to be
responsive to both.

be constructed within the shell of a
former industrial building, and will
cost an estimated $6 million to com¬
plete. These plans are part of Yale
University’s $ 1.5 billion capital
campaign to restore and construct
facilities throughout the campus.
If the funds are raised by the end
of the capital campaign next June, it
is expected that the new center
would be in operation by the fall of
1999, in time for the anatomy lec¬
tures to the Class of 2003. Here is an
opportunity for alumni/ae who are
interested in making a major com¬
mitment to the campaign to desig¬
nate their gifts to the new Student
Laboratory and Teaching Center. ■
David Davison
Director, Individual Major Gifts

$2.5 million
$1 million
$500,000
$250,000
$100,000 (each)
$75,000
$50,000

Write to David Davison at the Office
of Medical Development, 100
Church Street South, Suite 211, New
Haven, Connecticut 06519, or via email at david.davison @yale.edu

$50,000
$50,000
$25,000
$15,000 (each)
FallAVinter 1996

LETTERS

Remembering Ray Duff
To the editor:

Yale medicine

Morris A. Wessel, M.D. ’43,
HS ’48-51
New Haven, Conn.

No place for guns?
To the editor:

Dr. Sarah Knutti’s seeing “... no
excuse for guns in the hands of the
ordinary citizen,” (Letters, Spring
1996) puts me in mind of the fol¬
lowing similar sentiment: “That
ordinary persons of no official sta¬
tus be allowed to own firearms is
antithetical to our new philosophy
of freedom with order.” Reichsfuhrer, A. Hitler.

tion of my graduate training that
included two years as assistant res¬
ident at what was then Yale-New
Haven Hospital. The pathologist at
the Meriden Hospital was Dr. Rolf
Katzenstein who had been a stu¬
dent of Dr. Zimmerman.
In my practice I was perform¬
ing surgery, at that time chiefly
radical mastectomies, on many
women with breast cancer. To help
determine prognosis for these
women we counted the lymph
nodes removed (as many as 100 in
some cases) and determined the
percent that showed microscopic
evidence of metastasis since we
felt that the outlook for more dis¬
tant and undetected spread was
dependent on the potential of the
particular cancer for independent
growth. Dr. Katzenstein suggested
that there was an even better
method to determine this potential
that he had learned from Dr. Zim¬
merman. This was to take a small
piece of the primary cancer and
transplant it into the anterior cham¬
ber of a rabbit's eye. If the poten¬
tial was sufficient it would grow
there and this could be determined
by examining the eye after seven to

Chester Johnson, M.P.H. '68
Santa Fe, N.M.

Zimmerman’s day
To the editor:

I was very interested to read the
obituary of Harry Zimmerman
M.D. '27, HS '27-30, in your Fall
1995 issue because I feel that I
owed him a debt of gratitude. I
am a general surgeon, active in
practice in Meriden and Walling¬
ford 1946-1965 following comple¬

Harry Bishop

The death on June 21 of Raymond
Duff, M.D. ’52, HS '52-55 (pedi¬
atrics)—postdoctoral fellow in
pediatric cardiology '54-55 and
professor emeritus of pediatrics—
terminated the career of a valiant
leader in improving the welfare of
children everywhere.
Few individuals delved into
the intricacies of so many disci¬
plines with the determination and
respect as he did: clinical pedi¬
atrics, pediatric cardiology, hospi¬
tal administration, neonatology,
ethics, sociology, religion! He
studied these diverse approaches.
He was appreciated and respected
by eminent members in each of
these fields. He never shirked what
he saw as his duty, which in
essence was exemplified by his
conviction that a “Responsible man
does what needs to be done.” His
idea of what “needed to be done”
was at a higher level than most of
us ever dreamed of!
The book Sickness and Soci¬
ety, co-authored with Professor
August Hollingshead of Yale Soci¬
ology Department and published in
1968, opened the door for consid¬
eration of “who gets what kind of
care where.” The conceptualiza¬
tions are as applicable now as
when the study was undertaken 30
years ago. Assessing Pediatric
Practice, a study begun in 1970
and edited for publication in
1990 by Dr. C.D. Cook, deals
with pediatric care in the New
Haven community.
Ray Duff liked the term
“physician of record.” He always
did what he thought was right and
good for the patient and all con¬

cerned. Countless students, house
officers and colleagues appreciated
his “being there.”
As a clinician, teacher, physi¬
cian of record, social scientist
and ethicist, Ray Duff led the way.
I doubt that anyone can achieve
the eminent way in which he
assumed this role. The least we can
do is to try.

Harry Zimmerman, M.D., center, watches a
video presentation with fellow alumni/ae at
reunion in 1994.
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1996-97
10 days. We began to perform this
test, and if it proved positive it
helped to make the decision to fol¬
low mastectomy with radiation
therapy to the chest.
Our results persuaded me of
the advantage of this post-opera¬
tive irradiation which was con¬
firmed by the collected follow-up
study on the treatment of breast
cancer which I performed for what
used to be The Cancer Study Com¬
mittee of the Connecticut Medical
Society in conjunction with the
State Health Department’s long¬
term follow-up on the treatment of
all types of cancer under the direc¬
tion of Dr. Matthew Griswold. The
5- and 10-year survivals on my
patients were better than those
reported by Dr. Cushman Haagerson who was a great champion of
extensive lymph node removal.
Unfortunately because we did not
have available the best technical
management for the control of the
radiation therapy that is now avail¬
able we had some cases of compli¬
cations that included degrees of
pulmonary fibrosis. Some cases of
lymphedemia in the affected arm
were probably due more to the
extensive dissection, which in my
later cases included the internal
mammary nodes.
Dr. Katzenstein died about 20
years ago, but if he were alive

How to reach us
Yale Medicine welcomes
news and commentary.
Please send letters to the edi¬
tor and news items to Yale
Medicine, P.D. Box 7612,
New Haven, CT 06519-0612,
or via electronic mail to

ymm@yale.edu, and include
a daytime telephone number.
Submissions may be edited
for length, style and content.
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would, I feel sure, join me in this
little tribute to a great man.
Allan J. Ryan, M.D., HS ’43-45
Edina, Minn.
Dr. Kashgarian replies:

Association of Yale
Alumni in Medicine
Officers
Lycurgus M. Davey, M.D. ’43
President

Dr. Katzenstein’s advice to
Dr. Ryan probably came not from
Dr. Zimmerman but from Dr.
Harry Sylvester Nutting Greene,
Anthony N. Brady Professor and
Chairman of Pathology at that
time. It was in 1938 that Dr.
Greene first published in Science
the method of heterologous trans¬
plantation of mammalian tumors to
the anterior chamber of the guinea
pig’s eye. He demonstrated that
human malignant tumors, but not
the normal tissue from which they
were derived, were able to grow in
an alien species and he reasoned
that this was the biological demon¬
stration of the autonomous growth
that characterizes malignancy.
Being a pathologist, he was aware
of the vagaries that exist in
attempting to identify malignant
potential merely by peering
through the microscope and he felt
that heterologous transplantation
could be a true biological test for
malignant potential. It is of interest
that transplantation of human
tumors to sites other than the ante¬
rior chamber in alien species
required treatment with radiation
or corticosteroids. The anterior
chamber provided a uniquely pro¬
tective environment for tumors to
grow since no adjuntive treatment
was necessary. We now know that
this is directly related to the cellu¬
lar immune response to tumors.
Thus these early (in this age of
molecular biology some would say
crude descriptive) experiments
identified two of the most impor¬
tant characteristics of malignancy
and its behavior, neither of which
have yet been fully elucidated,
even today nearly 60 years after its
first observation.

Nicholas M. Passarelli, M.D. ’59
Vice President

Gilbert F. Hogan, M.D. ’57
Secretary
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The Program for Humanities in Medicine
Listed below are the remaining lectures in the 1996-1997 Humanities in
Medicine series, held Thursdays at 5 p.m. in the Beaumont Room at the
School of Medicine. Refreshments at 4:30 p.m. Free and open to all.

January 9

March 20

HEALING ART: DOCTOR LOOKING
AT SCULPTURES

FROM PHARAOH TO DNA: CHANGING
VIEWS OF CANCER

Wayne O. Southwick, M.D.

David J. Leffell. M.D.

Professor Emeritus of Orthopaedics & Rehabilitation,
Yale University School of Medicine

Professor of Dermatology, Yale University School of
Medicine

January 23

April 3

FALSE CHILDHOOD MEMORIES:
EPIDEMICS OR BACKLASH?

MEDICINE FOR FUN, NOT FOR FUND:
WORKING FOR A HEALTHY WORLD
FOR CHILDREN

Sara Gamble, PhD

Staff Psychologist, Traumatic Stress Institute,
South Windsor, Connecticut

Patch Adams, M.D.

Founder/Director, Gesundheit Institute, Arlington,
Virginia

January 30

THE NUREMBERG CODE 50
YEARS LATER
David J. Rothman, PhD

Bernard Schoenberg, Professor of Social Medicine,
Columbia University, New York, New York
February 6

ART & THE CALLING: BEDSIDE
STORIES
David J. Elpern, M.D.

April 17

MYTH, LITERATURE & THE
EXPERIENCE OF SCHIZOPHRENIA
THE ROBERT PENN WARREN LECTURE
Anne Hunsaker Hawkins, PhD

Associate Professor of Humanities, The Penn State
University College of Medicine, Hershey, Pennsylvania
May 1

Dermatologist, Williamstown, Massachusetts

NO COLOR IS MY KIND: FIGHTING MEN¬
TAL ILLNESS & CIVIL RIGHTS
the McGovern lecture

February 20

Thomas R. Cole, PhD

“YOU LIE LIKE A DOCTOR!”
PETRARCH’S ATTACK ON MEDICINE
George A. Trone, MA

Professor of Preventive Medicine & Community Health,
University of Texas, Institute for Medical Humanities,
Galveston, Texas

Doctoral Candidate, Department of Italian,
Yale University

May 8

March 6

COLOR OF WATER: GROWING UP
WITH A JEWISH MOTHER

BEING POSITIVE: THE LIVES OF
MEN AND WOMEN WITH HIV

Andrew McBride, M.D.
Director of Health

William McBride, M.D.
Senior Medical Director

Robert Klitzman, M.D.

Stamford City Health Dept.
Stamford, Connecticut

Merck Corporation
Atlanta, Georgia

Assistant Professor of Psychiatry, Columbia University,
New York, New York

May 15
March 13

HUMANISTIC CHALLENGES FOR THE
PHYSICIANS OF THE 21ST CENTURY
Lester Feldman, D.O.

Retired Community Physician & Amateur Historian,
Hamden, Connecticut

HEARING THE S.O.S. OF A YOUTH
IN DISTRESS
Ghislaine Godenne, M.D.

Professor of Psychiatry, Pediatrics & Mental Hygiene,
Johns Hopkins University, Baltimore, Maryland
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Gene therapy trials at Yale open up new
avenues for treatment and prevention page 13
ALSO
Gene hunters: Richard Litton
and the genetics of hypertension page 2

FDA Commissioner David Kessler is named dean page 29

AYAM

Outreach Program

To better communicate with our alumni/ae, the AYAM is pleased to announce

The Outreach Program, an effort to enhance and expand direct contact with our members.

REUNION

WEEKEND

Save the date: June 6 and 7 for the
1997 Alumni Reunion Weekend. Yale
University President Richard C. Levin will
address alumni/ae at the Saturday annual
meeting. Albert B. Deisseroth, M.D., Ph.D.,
chief of medical oncology, will make a pre¬
sentation on new gene-therapy initiatives in
cancer treatment. See page 39 for details.

NEW

DIRECTORY

Soon, locating fellow alumni/ae will be easier
with an updated Yale School of Medicine Alumni
Directory, last published in 1992. Those who
ordered the new directory will receive it soon by
mail. New orders may be placed while supplies last
by calling Harris Publishing at 1.800.877.6554.

REGIONAL

EVENTS

Meet fellow alumni/ae face-to-face at a series
of receptions around the nation. A May 17 wine¬
tasting and tour of North Salem Vineyard in
Westchester County, N.Y. (hosted by George W.

V''LbAl°,C'A77°h of

Naumburg Jr., M.D. ’45) follows recent events in
Washington, San Diego, San Francisco, New Haven

1,11'Iter

and Boston.
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REUNIONS

Members of the Class of 1945 are meeting for
an informal April reunion in Florida. If you and
classmates are planning a similar event, please call
the Office of Alumni Affairs at 203.785.4674.
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DISCOVERY

Gene hunters
Richard Lifton s search for the genes behind rare forms
of hypertension is good news for more than 50 million people
with high blood pressure.

By Julie Miller

F

Photographs by Peter Casolino

ifteen years ago, Richard P. Lifton, M.D.,
Ph.D., was puzzled by an observation he made
while visiting a dialysis unit at Stanford Uni¬
versity, where he was a third-year medical student.
Although 99 percent of Palo Alto's population was
white, all of the patients in the dialysis unit younger
than 40 were African American.
“In the back of my mind, I wondered whether or
not there was an inherited susceptibility among African
Americans to end-stage kidney disease,” says Dr.
Lifton, now associate professor of medicine and genet¬
ics at Yale School of Medicine and investigator at the
Howard Hughes Medical Institute.
Scientists at the time did not have the knowledge
of human genetics that would have allowed them to
explore possible links between genes and hyperten¬
sion, which can cause kidney failure. But Dr. Lifton’s
experience at Stanford fed his curiosity and planted a
seed that has led to important discoveries during the
past five years about the genetic basis of hypertension.
Today, armed with the powerful tools of molecular
genetics, he leads a team of researchers who since
1992 have found mutations in eight genes that alter
blood pressure by changing salt and water reabsorption
in the kidney. They have looked specifically at rare
forms of disease, where blood pressure is remarkably
high, with the strategy of applying these lessons to
more common forms of hypertension affecting large
numbers of people. And they are applying the same
reasoning to better understand rare types of
low blood pressure.

Fifty million Americans age 6 and older suffer
from hypertension, according to the American Heart
Association. Although the cause of most hypertension
is unknown, it may lead to heart attack, stroke or kid¬
ney failure. In February of last year. Dr. Lifton was
awarded a $4.5 million grant from the National Insti¬
tutes of Health (NIH) to fund a specialized center of
research in the molecular genetics of hypertension.
Scientists have long recognized a predisposition in
some families to hypertension and other diseases
affecting the heart, the kidneys and the cardiovascular
system. Only in the last five years have they been able
to use that information to identify the origins of those
diseases, says Dr. Lifton.
Using blood samples and a technique known as
positional cloning, in which a gene causing a disease is
identified by genetic mapping, Dr. Lifton’s team
tracked the inheritance of the rare hypertension genes
through approximately 300 families from around the
world participating in the studies. In the last two years.
Dr. Lifton’s research team has received 2,500 blood
samples from 40 states and 17 countries, including
Saudi Arabia and Israel.

Richard P. Lifton, M.D., Ph.D., has focused attention on
rare and severe forms of hypertension, with the ultimate
goal of finding better treatments for the millions of peo¬
Julie Miller is a free-lance writer in North Stonington, Conn.
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ple with more common types of high blood pressure.
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Identifying the rare genes that
cause severe disease can provide
key insight into the molecular
causes of more common forms of
the same disease. These findings.
Dr. Lifton says, will allow scien¬
tists to develop genetic tests that
identify people with inherited sus¬
ceptibilities to hypertension and
specific treatments to prevent
the disease.
At 42, with an occasional fleck
of gray in his light brown hair. Dr.
Lifton is again pursuing the ques¬
tion he pondered 15 years ago at
Stanford and searching for genes
that contribute to the development
of end-stage kidney disease among
young African Americans. Thus

far, he and colleagues have located
a large number of families with
two or more members with endstage kidney disease and have
begun genetic analysis.
The research team has identi¬
fied genes linked to two uncom¬
mon types of severe hypertension,
glucocorticoid-remediable aldos¬
teronism (GRA) and Liddle’s syn¬
drome. GRA is the result of expres¬
sion of a key gene in the wrong
part of the adrenal gland, leading to
high levels of aldosterone, a steroid
hormone that regulates the balance
of salt and water in the body.
Richard Shimkets, a graduate stu¬
dent in the lab, identified the gene
mutation in Liddle’s syndrome,
which activates the epithelial
sodium channel in the nephron of
the kidney, increasing the reab¬
sorption of salt and water and thus
raising blood pressure.
The nephrons, responsible for
removing waste from the body’s
blood supply and regulating the

composition and volume of blood,
are central to the hypertension
studies. The outer cortex of the
kidney contains more than a mil¬
lion nephrons, each made up of
convoluted tubules and a glomeru¬
lus. The glomeruli, spheres of
coiled blood vessels inside a thin,
membranous sac, act as filter units.
The arrangement of nephrons in
the kidney, resembling the kernels
of com on a cob, forms a large sur¬
face area for collecting fluid.
The focus on severe hyperten¬
sion is highly useful to researchers
because the effects of therapy are
dramatically apparent in patients
with high readings. "We’re cutting
our teeth,” Dr. Lifton says, “on
these relatively simple forms of
high blood pressure.” Now, new
findings suggest that variants in the
gene encoding angiotensinogen
contribute to more common forms
of hypertension in the general pop¬
ulation as well.
Angiotensinogen is a protein
secreted by the liver that causes
blood vessels to constrict. Changes
in its level can raise or lower blood
pressure. The identity of the func¬
tional variants, the magnitude of
their effects on blood pressure, and
their mode of action have not yet
been defined.

Above left: Blood samples are cata¬
loged by research associate Carol Nel¬
son-Williams, right. Graduate student
Traci Mansfield, left, prepares patient
DNAfor analysis by polymerase chain
reaction, a technique used to narrow the
chromosomal location of suspected
gene mutations.

Left: The painstaking process of identi¬
fying genes responsible for disease
often begins with a single patient and
widens to a study of the person's
extended family. Anita Farhi, R.N., right,
who oversees patient recruitment for Dr.
Lifton’s studies, and Janet Budzinack
hold a family tree outlining an inherited
predisposition to Liddle’s syndrome, a
rare form of hypertension.

Most cases of hypertension are
probably due to a combination of
genetic and environmental factors,
including diet and salt intake. Dr.
Lifton says. “Our early ancestors
evolved in the interior of sub-Saha¬
ran Africa, an extremely salt-poor
environment,” he adds. “Genes
that promoted the body’s conserva¬
tion of salt and water conferred a
selective advantage.” Today, in the
salt-rich environment of industrial¬
ized societies, those same genes
now may contribute to hyperten¬
sion and other disease.
Genetic susceptibilities to
hypertension help explain why
some people who eat salt do not
develop high blood pressure.
“We’re spending a lot of money in
public health getting people to stop
eating too much salt,” Dr. Lifton
says. “We believe there are many

Advances in genetics,
says Dr. Lifton, have
made “this phase
of the understanding
of human disease
one of the most pro¬
ductive in the history
of medicine. ”

people for whom it doesn’t matter,
as well as a subset in whom it may
be a matter of life and death.
“If we learn more about
genetic susceptibility, then we
can say, ‘You, feel free to eat the
nachos (fat-free, of course).

An ethical paradox

W

hile better understanding of
the genetic basis of disease
holds the hope of new diagnostic
tests to identify people at risk
early in life, it also raises compli¬
cated, troubling questions.
“We need to consider whether
making a genetic diagnosis will do
more harm than good,” says
Richard P. Lifton, M.D., Ph.D,,
associate professor of medicine
and genetics at Yale School of
Medicine and investigator at the
Howard Hughes Medical Institute.
A person whose genetic test for
Huntington’s disease is positive,
for example, faces a slow death
at a young age. “There’s slow
deterioration in physical and men¬
tal capabilities. At present, we
can’t do anything about it."
People who learn they have
the disease through genetic
screening at least have time to
plan and put their lives in order.
Some may decide not to have chil¬
dren. There may be enormous dis¬
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advantages, however, because
the genetic information may be
used against those who are seek¬
ing jobs or applying for health and
life insurance.
By contrast, patients with
GRA (glucocorticoid-remediable
aldosteronism), an inherited type
of severe hypertension, face the
same risks but have the benefit of
available treatment. They, too,
may have difficulty obtaining
insurance. “You may be able to
give patients information benefi¬
cial to their health,” Dr. Lifton
says. “The paradox is that until
recently this information could
be used against the interests of
the patient.”
Some progress has been
made in finding solutions to these
problems. Health insurance
should be easier to obtain and
keep under a law signed recently
by President Clinton. The Health
Insurance Portability and Account¬
ability Act of 1996 prevents the

But you, stick to the carrots.’”
But are high-blood-pressure
genes entirely responsible for that
susceptibility? Among the families
participating in Dr. Lifton's stud¬
ies, some members who inherited
the mutated genes were nonethe¬
less free of hypertension. The clus¬
tering of these patients within par¬
ticular families suggested that they
might also have inherited genes
that protect them from developing
hypertension. These observations
prompted efforts to identify such
blood-pressure-lowering genes.
The researchers began with dis¬
eases causing life-threatening low
blood pressure in children.
Sue Chang, a nephrology fel¬
low in the lab, found that PHA-1,
which causes life-threatening
continued on page 7 ►

loss or denial of insurance cover¬
age due to pre-existing medical
conditions. “One important mes¬
sage is that we all have inherited
susceptibilities to one disease or
another, and we shouldn’t decide
who is insurable and who is not
on the basis of this kind of infor¬
mation,” Dr. Lifton says.
Another question that arises
is whether or not to inform partici¬
pants in scientific studies that
they have inherited susceptibili¬
ties to fatal diseases. “We look to
the individual for guidance,” says
Maurice J. Mahoney, M.D., profes¬
sor of genetics, pediatrics, obstet¬
rics and gynecology. Dr. Mahoney
is a member of the medical
school’s Human Investigation
Committee, which approves clini¬
cal research projects and handles
issues involving the protection of
human subjects. “If there are no
benefits in the immediate future,
we have to decide how important
it would be to their health to know.
We often will say there is no rea¬
son to inform them, although we
give some leeway if they want the
information.” ■
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Building on a tradition of kidney research
Left: Richard P. Lifton, M.D., Ph.D., talks
with colleagues Gerhard H. Giebisch,
M.D., and Peter S. Aronson, M.D.
Dr. Lifton's work has provided a clinical
link for more than 70 years of kidney
physiology research at Yale, says Dr.
Aronson, the chief of nephrology.

O

ne reason scientists at Yale
have embraced the work of
Richard P. Litton, M.D., Ph.D., is
that it links a tradition of worldrenowned research in kidney physi¬
ology directly to patient care. Dr.
Litton became associate professor
of medicine and genetics at the
medical school in 1993 and inves¬
tigator at the Howard Hughes Med¬
ical Institute the following year. His
collaboration with the Yale physiol¬
ogy group made it possible for him
to identify gene mutations that
alter blood pressure by changing
salt and water reabsorption in
the kidney.
In discovering a number of the
inherited factors that affect blood
pressure, Dr. Lifton is building
upon more than 70 years of excel¬
lence in kidney research at Yale.
In 1921, John Peters, M.D., came
to Yale from the Rockefeller Insti¬
tute in New York to establish a
research program in metabolism.
In the years that followed, the pro¬
gram attracted many gifted young
investigators, who were inspired

6

by Dr. Peters’ leadership in
metabolism studies and skill
in the laboratory.
“Every medical student,
whether he knows it or not, is a
student of Peters,” wrote Donald
D. Van Slyke, a chemist, who
worked with Dr. Peters at the Rock¬
efeller Institute in the 1920s and
enjoyed a friendship and collabora¬
tion with him for decades. “His
contributions to the pathologic
physiology of the circulatory,
respiratory, excretory and endo¬
crine systems, of the metabolism
of proteins, fats, carbohydrates,
electrolytes and water have been
integrated into the science
of medicine."
Dr. Peters played a primary
role in the development of kidney
research in America. He was at the
forefront in applying basic science
to problems in clinical medicine, a
practice that continues at Yale
today. His research group devel¬
oped new techniques of analyzing
body fluids to measure the
changes brought on by metabolic

disorders. Of particular interest
were nutritional and endocrine dis¬
turbances, kidney disease and tox¬
emia of pregnancy. Along with his
investigative work and teaching,
Dr. Peters also devoted much of
his attention to the overall care of
his patients.
As more was learned about
metabolism during the 30 years
after Dr. Peters’ arrival at Yale, it
became clear that the kidney was
crucial in maintaining the balance
of fluids and electrolytes in the
body. In addition to excreting
waste products, the kidney con¬
trols acid/base balance and regu¬
lates transport of a number of
electrolytes, such as sodium, chlo¬
ride and potassium.
The period from the 1930s to
the 1950s marked the beginning
of quantitative kidney physiology,
which involves measuring the
amounts or proportions of sub¬
stances that are excreted. A para¬
meter of kidney function known as
“clearance,” first introduced in
1928, was used to characterize
the excretion of urea by the kidney.
Clearance studies by scientists
including Robert W. Berliner, M.D.,
professor emeritus of physiology
and medicine and former dean of
the medical school, laid the foun¬
dation for the knowledge of renal
transport of salt, water, bicarbon¬
ate, acid and potassium. Dr.
Berliner conducted studies at the
National Institutes of Health on
the handling of potassium in the
kidney and trained many people
who later became section chiefs in
nephrology across the nation.
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According to Dr. Giebisch, Dr.
Lifton's patient-focused research
“gives us a new direction in which
to look at a basic research level. ”

Studies of the processes with¬
in the kidney that account for renal
excretion, namely the transport of
fluid and electrolytes across cell
membranes along the nephron,
began in the late 1950s. Gerhard
H. Giebisch, M.D., Sterling Profes¬
sor of Cellular and Molecular Phys¬
iology, who came to the medical
school in 1968, has spent his
career studying renal function in
single cells. Turning to molecular
mechanisms, he is now examining
the effect of genetic manipulation
on the transport of ions across the
cell membrane.
In 1971, the medical school’s
section of metabolism in the
Department of Internal Medicine
was divided into two parts,
nephrology and endocrinology.
Nephrology, a subspecialty devel¬
oped in the 1960s along with dial¬
ysis and kidney transplantation,
encompasses faculty interested in
kidney function and disease. John
P. Hayslett, M.D., HS ’60-65, pro¬
fessor of medicine, became the
first nephrology section chief.
Research is progressing in a
number of other areas of kidney
physiology. As an example, Dr.
Hayslett is studying sodium trans¬
port and sodium channels in the
distal portion of the nephron.
PeterS. Aronson, M.D., professor
of medicine and cellular and mole¬
cular physiology and the present
chief of nephrology, is characteriz¬
ing some of the proteins that
transport sodium and chloride

yale medicine

across cell membranes in the
proximal tubule of the kidney.
“I can envision a day when
newborns are screened for genes
that cause susceptibility to differ¬
ent sodium transport disorders,
such as hypertension, and we
develop interventions to prevent
these,” says Dr. Aronson.
The traditions established by
Dr. Peters continue in kidney
research today. Several current
faculty members—Drs. Berliner,
Giebisch, Aronson and Emile L.
Boulpaep, M.D., professor of cellu¬
lar and molecular physiology—
have been recipients of the most
prestigious research honor in kid¬
ney physiology, the Homer Smith
Award. Dr. Lifton is taking the
research in a new direction, as he
unravels the mystery of the role
that genes encoding renal trans¬
porters play in clinical disorders.

Says Dr. Aronson: “I can envision a
day when newborns are screened for
[disease-susceptibility] genes ...
and we develop interventions to pre¬
vent these [disorders]. ’’

For example, “one of the
potassium channels Dr. Giebisch
has been working on we have just
implicated in Bartter’s syndrome,”
Dr. Lifton says, referring to a dis¬
ease in children that causes
potassium wasting and lowers
blood pressure. Adds Dr. Giebisch:
“In this case, there is some
aspect of the disease that we can¬
not explain with the current state
of knowledge. This [information
from the Lifton lab] gives us a new
direction in which to look at a
basic research level.” ■

continued from page 5

dehydration and low blood pressure
in newborns, is caused by mutations
that decrease activity of the same
sodium channel mutated in Liddle’s
syndrome. David Simon. M.D.. a
nephrology fellow and now assis¬
tant professor of medicine, found
that Gitelman’s and Bartter’s syn¬
dromes, diseases that also cause low
blood pressure, are caused by muta¬
tions in three different genes that are
also involved in the reabsorption of
salt by the kidney.
“When we started work in this
area,” says Dr. Lifton, “hyperten¬
sion was variously proposed to be a
disease arising from primary abnor¬
malities in the brain, the heart, the
blood vessels, the kidney or the
adrenal gland. Intriguingly, all the
mutations identified thus far change
blood pressure by altering how
much salt the kidney retains. These
findings place renewed emphasis on
the role of the kidney in blood pres¬
sure regulation.”
“Dr. Lifton has done ground¬
breaking work in identifying the
genetic causes of the extremes of
blood pressure,” says Francis S.
Collins, M.D.. Ph.D., director of the
National Human Genome Research
Institute in Bethesda, Md. "Thanks
to his efforts, we are dramatically
closer to a complete explanation of
the heritable factors that determine
blood pressure.” Dr. Collins was a
postdoctoral fellow in genetics and
pediatrics at the School of Medicine
from 1981 to 1984.
"Dr. Lifton’s findings may
allow diagnostic tests to identify
people at highest risk early in life, as
well as new treatments based on a
better understanding of the regula¬
tory pathways in the kidney,” adds
Dr. Collins, who heads the Human
Genome Project to map and
sequence each of the approximately
100,000 human genes.
The genetic studies reflect a
blending of clinical investigation,
molecular genetics and collabora¬
tion with a close network of col¬
leagues in kidney research, includ-
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The genetic studies
reflect a blending of
clinical investigation,
molecular genetics
and collaboration
with a close network
of colleagues in
kidney research.

While working as a nephrology fel¬
low in Dr. Lifton's laboratory, David
Simon, M.D., identified three gene
mutations responsible for rare forms
of low blood pressure.
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ing John P. Hayslett, M.D., HS
'60-65, professor of medicine in
the section of nephrology; Peter S.
Aronson, M.D., professor of medi¬
cine and cellular and molecular
physiology and chief of nephrol¬
ogy; and Gerhard H. Giebisch,
M.D., Sterling Professor of Cellular
and Molecular Physiology.
“I have a wonderful opportu¬
nity here at Yale to collaborate with
the physiology groups,” Dr. Lifton
says. “One consequence of the rev¬
olution in human genetics will be a
renaissance in both basic and
human physiology. We will be able
to identify specific causes of dis¬
eases, make animal models of them,
study their physiology in extensive
molecular detail and bring this to
the bedside.”
For many years, Yale has been
recognized as one of the world’s
premier research centers in the
basic science of kidney physiology,
particularly the mechanisms by
which the kidney regulates body
salt content, says Dr. Aronson.
“This research has now been
linked by Dr. Lifton’s work to
human disease.”
Dr. Lifton came to Yale from
Harvard in 1993 as an assistant pro¬
fessor of medicine. He became an
associate professor and a Howard
Hughes Medical Institute investiga¬
tor in 1994 and this year was named
director of cardiovascular genetics
at the medical school’s Boyer Cen¬
ter for Molecular Medicine and
director of the Department of Inter¬
nal Medicine's Program in Molecu¬
lar Genetics. He serves on NIH
advisory committees on large-scale
sequencing of the human genome
and the special emphasis panel for
the study of the genetics of heart,
lung and blood disease. He has pub¬
lished more than 50 journal articles,
reviews and textbook chapters.
At Yale, his teaching style is
immensely popular. Rather than
delivering a talk, he leads a discus¬
sion by constructing a problem and
calling on his listeners to suggest
answers. “When he’s discussing his
research, he has tremendous enthu¬

siasm,” Dr. Aronson says. Adds Dr.
Simon: “Even though I’ve heard
the same talk many times, it’s
always fresh.”
The same energy is in the air in
Dr. Lifton’s laboratory. His buttondown shirts and khaki trousers
blend with the informal dress of
students who stop to talk with him.
He listens intently as Holly Duncan
Craig, a student in the M.D./Ph.D.
program, brings him up-to-date on
her work on genes related to vascu¬
lar malformations in the brain,
which can cause stroke. Delighted
with her progress, Dr. Lifton smiles
and peppers his comments with,
“That’s incredibly exciting ... that’s
great... fantastic.”
His fascination with genetics
grew out of a curiosity about hered¬
ity that began in high school in sub¬
urban Washington, D.C. In college
and later in graduate school, he
began to understand that there were
things to be learned from genetics
that could be applied to human dis¬
ease. “The union between science
and medicine seemed a very natural
route to take,” he says.
After receiving a bachelor’s
degree with highest distinction in
biology from Dartmouth College in
1975, Dr. Lifton focused his gradu¬
ate study on the genetics of the fruit
fly Drosophila melanogaster. He
earned his medical degree in 1982
and a doctorate in biochemistry in
1986 from Stanford before training
as a resident at Harvard Medical
School and Brigham and Women’s
Hospital in Boston.
From the time he first became
fascinated by heredity in a high
school biology lab until he com¬
pleted his medical residency in
1987, major changes had taken
place in genetics. These started
with the introduction of recombi¬
nant DNA technology in the early
1970s by Stanley Cohen, M.D., and
Herbert W. Boyer, Ph.D., the for¬
mer Yale postdoctoral fellow who
endowed the molecular medicine
building in which Dr. Lifton now
pursues his research. The revolution
in human genetics accelerated in
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Dr. Lifton and research associate
Carol Nelson-Williams study pho¬
tographs of children for signs of
bone malformation that may be due
to renal tubular acidosis. Dr.
Lifton’s team is working to identify
a gene mutation that may be linked
to the disease.

the early 1980s with new tech¬
niques for mapping genes.
The human genome consists
of 3 billion base pairs of genes,
resembling beads on a string.
Although the sequence of the
beads, or their locations on the
chromosomes, is remarkably simi¬
lar from one person to the next, the
exact sequence can vary. Dr.
Lifton explains. Comparison of the
DNA sequences of two unrelated
people will reveal differences in
the DNA sequence in approxi¬
mately one of every 1,000 posi¬
tions. While all people share simi¬
larities, the cumulative effects of
these small differences are
believed to account for the diver¬
sity among humans.
“These differences in DNA
sequence permit us to follow
the inheritance of any segment
of the human genome through
families,” says Dr. Lifton. “I had
been interested in heredity for a
long time. Now, I had training in
medicine and the knowledge of
molecular genetics that I could
apply to the investigation of com¬
mon diseases that I saw in the hos¬
pital every day.”
Dr. Lifton collaborates with
scientists and clinicians world¬
wide, who help him locate the
families who participate in his
studies. DNA for the studies is
extracted from blood samples from
family members. Using detailed
genetic maps. Dr. Lifton compares
the inheritance of the disease to the
inheritance of genetic markers
spanning the genome, and looks
for the portion of the genome that
travels with the disease. Relatives
who are healthy are as important to
the studies as those with hyperten¬

Yale Medicine

sion, he says. “You get information
from knowing what gene they
didn’t inherit.”
An especially rewarding aspect
of the research, he adds, is the con¬
tact with families who appreciate
the search for solutions to these rare
diseases. An 8-year-old girl had
been suffering for three years from
what her physician thought were
migraine headaches. Another doc¬
tor who examined her questioned

that diagnosis and attributed her
headaches to hypertension. “With
genetic testing, we diagnosed her as
having GRA, a rare form of severe
hypertension. We went back
through the family and found more
relatives with this disease,” Dr.
Lifton says. The girl and her rela¬
tives were treated with medication
that counteracts the effects of the
high levels of aldosterone in GRA.
and they responded well.
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Genetic clues to
a brain disorder
L.K. was 40 when she suffered a
stroke. She had complained of
headaches for some time, but
none were as bad as that day
when she could no longer move
her left arm and leg. She felt
numbness throughout her body
and experienced double vision.
She always feared she might suf¬
fer a stroke at a young age, espe¬
cially since strokes seemed to
run in her family.
Her father, grandfather and
two uncles also experienced
severe headaches. Her four
cousins had strokes when they
were in their 30s, and one died at
the age of 38. The teen-age chil¬
dren of two cousins were diag¬
nosed with epilepsy. L.K.’s broth¬
er had a mild stroke and experi¬
enced double vision and difficulty
walking a few weeks before her
own stroke. Her sister was diag¬
nosed as harboring a brain lesion,
and she, too, suffered from
severe headaches.

Neurosurgeon Issam A. Awad, AID., has collaborated with Dr. Lifton in genetic
studies of cerebral cavernous malformation, an inherited disorder that can pre¬
cipitate stroke in young adults.

Yale physicians used mag¬
netic resonance imaging to diag¬
nose her condition as cavernous
malformation, an inherited vascu¬
lar disease of the brain.
Six months after brain opera¬
tions for resection of the two cav¬
ernous malformations which had
hemorrhaged, L.K. is able to play
the organ and ride her exercise
bicycle. She spends much of her
time caring for and counseling
numerous relatives with cav¬
ernous malformations.
A team of researchers led by
Richard P. Lifton, M.D., Ph.D., has
identified a gene linked to this
devastating disease. Dr. Lifton’s
studies of cavernous malforma¬
tion were conducted in collabora¬
tion with Issam A. Awad, M.D.,
professor of neurosurgery, and
Murat Gunel, M.D., a resident in
neurosurgery and research fellow
at the Boyer Center for Molecular
Medicine.

Cavernous malformations in the
blood vessels of the brain are
depicted in an artist’s rendering, a
magnetic resonance image and a
photograph. One in every 200 people
is likely to have the disease, and
many will not have warning symp¬
toms. Identification of the gene muta¬
tions responsible will allow those at
risk to receive preventive treatment.
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“We found that this type of
lesion exists in one out of every
200 people. Some have symp¬
toms, and others do not,” says
Dr. Awad. “It’s important for us to
understand who will have this
lesion and, of those people, who
will bleed from it.”
The researchers found that
Hispanic Americans have a higher
incidence of cavernous malforma¬
tion than do other ethnic groups.
In fact, all cases among Hispanic
Americans of Mexican descent
were traced to the same mutation
from an apparently common
ancestor. The gene is probably
related to abnormal formation of
blood vessels in the brain, Dr.
Awad says. The next step is to
determine how the abnormal ves¬
sels occur and whether or not
there is a second gene that
makes some lesions bleed.
Cavernous malformations
cause headaches, seizures and
cerebral hemorrhage. They
account for up to a third of hemor¬
rhagic strokes in young people.
Ultimately, these lesions can
cause disability and death.
“Identifying the gene provides
a model for understanding, in bio¬
logical terms, how some patients
are predisposed to stroke,” Dr.
Awad says. "In a practical way, it
will enable population screening
for this lesion, with the aim of pre¬
venting stroke in these patients.”■
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Another participant in the
studies, a 13-year-old boy, had
lived with severe hypertension
since infancy. He came to the hos¬
pital because of a seizure at the
age of 6 weeks. His blood pres¬
sure was found to be 240/120, one
of the highest ever recorded in a
child of that age. The boy had
been treated with enalapril and
nifedipine, both medications
for hypertension, but neither
controlled his blood pressure
effectively.
Genetic studies showed that
he had the characteristic mutation
causing GRA. The genetic studies
of his family revealed 24 relatives
with the disease, six of whom had
cerebral hemorrhages before age
45. “This was the first case in
which genetic testing was used to
diagnose a specific cause of hyper¬
tension,” Dr. Lifton says. Affected
family members have been suc¬
cessfully treated.
A year after this discovery.
Dr. Lifton gave a talk on GRA to
a group of physicians at the Uni¬
versity of Toronto. Some of them
had described the disease 25 years
before. Also in the audience was
the physician who had reported
the first known case of GRA.
Dr. Lifton came full circle at this
meeting, first finding a patient
with GRA and performing a clini¬
cal investigation and then con¬
tributing the results to the molecu¬
lar basis of the physician’s disease.
“It was a lovely experience to
listen to the people who had done a
careful investigation 25 years pre¬
viously,” Dr. Lifton says. “We
were able to bring new informa¬
tion to bear on problems that have
been recognized for years.”
When he began his work in
genetics, Dr. Lifton says, many
colleagues doubted that he would
find genes that affect blood pres¬
sure, since there are so many sys¬
tems in the body that interact with
one another. “Our understanding
of physiology takes us only so far
in identifying the fundamental
mechanisms of disease.
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Top: Dr. Lifton listens to
a progress report from
researchers in his Boyer
Center lab.

Right: He leads a semi¬
nar on human genetics
for internal medicine
residents at the West
Haven campus of the
VA Connecticut Health¬
care System.

‘'If we learn more about genetic susceptibility,
then we can say, ‘You, feel free to eat the
nachos ... but you, stick to the carrots.
Richard P. Lifton, M.D., Ph.D.

“It’s exciting to know that
many diseases have an underlying
genetic basis,” he adds. “Now we
can identify their specific causes.
That’s what makes this phase of
the understanding of human dis¬
ease one of the most productive in
the history of medicine.”
Dr. Lifton’s pioneering work
in molecular genetics has placed
him in high demand, but he has
resisted offers to move on. When
he was invited to head a new car¬
diovascular research program on

the West Coast earlier this year,
he declined. Taking on an adminis¬
trative role at this point in his
career, he says, would take him
away from the work that drew
him into the field—seeking
answers to some of the fundamen¬
tal problems in clinical medicine.
"This job is the one I always
wanted,” he says. “The outstand¬
ing clinical medicine, genetics
and physiology at Yale make the
environment perfect for what I
want to do.” YM
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CANCER

New rules
of engagement
By altering cell-to-cell communication,
gene therapy has the potential to wage an information war
against cancer at the molecular level.
By John Green

T

Photographs by Frank Poole

wist slowly ... He’s a runner, so he’s got hard
bones, so you’re going to have to twist. Just
slowly pull back the trochar ... otherwise we’re
going to get a shooting pain.”
Clad in a white coat, Albert Deisseroth is watching
over a young cancer patient as a resident physician
extracts a sample of bone marrow. The marrow will be
tested to see whether the young man's leukemia has
resurfaced after a period of remission.
The patient gets a liberal dose of local anesthetic
before the resident draws the marrow out through a
rather wicked-looking needle inserted in the hipbone.
In relaxed fashion. Dr. Deisseroth accomplishes at least
three things at once:
He imparts good biopsy technique to the resident,
who is new to the procedure, gently prefacing each sug¬
gestion with the words: “What I usually do is ...”
He steadily solicits the patient for feedback:
“How are you doing, Mike? ... If you feel the faintest
hint of any pain, let us know. If we do it slowly, there’s
no pain.”
And he keeps one eye on the lab technician to
make sure she prepares the blood and marrow samples
as he wants them: “Squirt it in. Shake it up. I’m afraid
it’s gonna clot.”
At the end of the session, Mike, a Yale graduate
student who has endured the procedure in a variety of
other clinics, hops off the table almost smiling. Today’s
ordeal, the relief in his face suggests, was easier than it
could have been.
Albert Deisseroth's enthusiasm for gene therapy is tem¬
pered by the day-to-day hurdles of its development, yet he

Dr. Deisseroth, Yale’s newly arrived chief of med¬
ical oncology and the Ensign Professor of Medicine,
acquired this gentle efficiency by performing bone
marrow harvests for transplants six or seven times a
week over a period of years. What he sees in the faces
of patients and their families motivates him in his
search for new cancer treatments, especially in the fast¬
growing field of gene therapy. “We are painfully aware
of the importance of minimizing the time for imple¬
menting new therapies,” he says, “especially those that
can help people who are facing potentially fatal dis¬
eases. It’s a major driving force.”

A HISTORY OF INVENTION

Albert B. Deisseroth, M.D., Ph.D.. has come to Yale to
implement gene therapy, giving the university a major
stake in an exciting and controversial new approach to
cancer treatment. Recruited in 1995 by Vincent T.
DeVita Jr., M.D., HS ’66, director of the Yale Cancer
Center, and Ralph I. Horwitz, M.D., chairman of the
Department of Internal Medicine, Dr. Deisseroth came
to New Haven from the M.D. Anderson Cancer Center
in Houston. There he served as chief of hematology and
was principal investigator in a variety of promising
gene therapy trials for patients with leukemia and can¬
cers of the ovary and breast.
Dr. DeVita offers unqualified praise. “He’s an out¬
standing scientist and doctor, and a very inventive per¬
son who is always on the edge of the envelope,” he
says. “Every time something new is happening, if you
pick up the literature you'll see Dr. Deisseroth's name.”
Dr. DeVita, director of the National Cancer Insti¬
tute (NCI) from 1980 to 1988, recalls that Dr. Deis¬
seroth was involved in hemoglobin synthesis in his
early career, while training in molecular biology.

can’t help being excited by the future: “We have powerful
new tools that will allow us to help people in ways we
couldn’t before. ”
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John Green is a free-lance writer in New London. Conn.
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Then he became “very much
involved in chronic leukemias and
the effect interferon had on them.”
Dr. DeVita, who has known
Dr. Deisseroth for two decades and
worked with him at the NCI,
recalls how some 20 years ago Dr.
Deisseroth was the first person to
set up autologous bone marrow
transplantation—first in lab ani¬
mals and then in humans. The pro¬
cedure, says Dr. DeVita, “sat
around a while before people
picked up on it, and it's now
become a very useful tool.” The
procedure preserves a quantity of
the cancer patient's stem cells
through a bone marrow harvest,
saving the cells from destruction
by chemotherapy. Stem cells are
progenitor cells which develop into
the variety of blood cells that com¬
prise the immune system.
After the toxic effects of
chemotherapy have diminished,
the stem cells are reintroduced to
restore the patient’s immune sys¬
tem. The technique allows muchhigher-than-normal doses of

Three new clinical
gene therapy studies
to be launched
this spring at Yale
will target prostate,
breast and
ovarian cancers.
chemotherapy agents, thereby
increasing the survival of patients
who would not benefit from con¬
ventional doses. This early work
done with stem cells is the spring¬
board to a number of the strategies
Dr. Deisseroth and his team are
developing for clinical gene ther¬
apy trials at Yale.

OPENING THE DOOR

Gene therapy is a rapidly evolving
approach to medicine that makes
use of more than 20 years of
genetic engineering techniques to
attack disease in new ways. By
altering cell-to-cell communica¬
tion, gene therapy has the potential

to wage an information war against
cancer at the molecular level. Ini¬
tially conceived of as a means to
treat inherited disorders—either by
replacing or inactivating harmful
gene mutations—gene therapy is
now being researched in trials for a
wide range of diseases, including
cancer, vascular disease, arthritis,
neurodegenerative disorders, AIDS
and other acquired diseases. There
are currently more than 150 clini¬
cal gene therapy trials worldwide,
including 125 protocols approved
by the National Institutes of
Health’s (NIH) Recombinant DNA
Advisory Committee (RAC),
which monitors gene therapy
research in the United States. At
the beginning of 1996, more than
1,000 patients had been treated
with some form of gene therapy.
An example of a trial with
encouraging results is Dr. Deisseroth’s own work begun at M.D.
Anderson. The trial tested a strat¬
egy for improving the body’s abil¬
ity to tolerate extremely high doses
of chemotherapy agents used to

treat breast and ovarian cancer. The
method involves making an ally of
a gene known to foil chemother¬
apy, the multi-drug resistance gene
type 1. The MDR-1 gene produces
a kind of “molecular pump” that
has enabled cancer cells to rid
themselves of the toxic drugs.
One important key to the
process of gene therapy is engi¬
neering a means of transmission, or
vector, to carry a particular gene to
the target cells. For the breast and
ovarian trials. Dr. Deisseroth’s
team engineered a vector that
transfers the MDR-1 gene to
healthy bone marrow cells, making
them less vulnerable to the toxic
effects of chemotherapy. “Albert’s
study with the MDR-1 gene into
stem cells in fact works,” Dr.
DeVita says. “He shows that you
can make the marrow resistant to
chemotherapy.”
Dr. Deisseroth brought two
active gene therapy treatment pro¬
tocols with him to Yale from M.D.
Anderson. In late January, he and
colleagues were finishing the work
necessary to launch three new clin¬
ical studies this spring. One of the
new treatments being evaluated
promises to make radiation therapy
more effective in patients with
prostate cancer. The second is
designed to selectively kill off
malignant cells in the marrow of
patients with breast cancer, while
the third would similarly cleanse
tumor cells from the abdominal
membrane of patients with ovarian

In the “clean room” where viral
vectors are designed for new treat¬
ments for prostate, breast and ovar¬
ian cancer. Dr. Deisseroth confers
with post-doctoral fellows
Thanyaphong Nanakorn, M.D., left,
and Lianhua Yin, Ph.D. The racks
contain frozen common cold
viruses, altered so they cannot
spread disease. Instead, these vec¬
tors are used to deliver a therapeu¬
tic gene to its target inside the body.
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cancer. Corresponding studies in
laboratory animals were nearing
completion in January, with espe¬
cially promising results in the
prostate cancer trial, according to
Dr. Deisseroth, who was prepar¬
ing to seek approval for human
trials from the Food and Drug
Administration and Yale’s Human
Investigation Committee.

THE NECESSARY VISION

For the gene therapy field as a
whole. Dr. Deisseroth says, the
qualified successes of some of the
early trials are only small steps
toward a much larger goal. “For
the past 50 years in cancer treat¬
ment,” he says, “we have been lim¬
ited to basically destructive treat¬
ments: We cut things out, burn
them [with radiation] or destroy
them with toxic chemicals. The
problem is that these destructive
treatments are not very selective,
so they’re very toxic to the normal
tissues.”
Genetic therapy. Dr. Deis¬
seroth explains, has very different
goals. “We want to use genetic
modification to protect the normal
tissues of the body, or to sensitize
the tumor cells to the therapy,
thereby improving the perfor¬
mance of existing methods of ther¬
apy. And ultimately we want to
develop genetic therapy as a pri¬
marily corrective approach to treat¬
ment—without harm to patient.”
Driving this, in his mind, are
the dramatically rising costs of
health care. By the year 2000, can¬
cer will be the leading consumer of
the health care dollar in the U.S.,
he says, adding that much of the
cost of cancer therapy is spent
bringing patients through the very
difficult, sometimes life-threaten¬
ing complications of therapy.
Advances in molecular biol¬
ogy, genetics and bioengineering,
he says, have “opened the door for
corrective therapies—not only for
cancer, but for all human diseases.
“In terms of the national bud¬
get, nothing could be more useful

Thanyaphong Nanakorn, M.D.,
cultures cells in a flask as part of
the development of a vector for
prostate cancer therapy.

than to convert very expensive
chronic therapy into single deci¬
sive therapeutic interventions that
have a lifelong impact and that can
be carried out simply—even out¬
side the hospital.”
In the future. Dr. Deisseroth
can imagine traditional lab tests
being replaced by a profile of what
he calls “the parts of the machin¬
ery,” the genes of the cell and their
products. “If the products are not
being produced normally, one
could say, for example, ‘Element B
is not working, we're going to
replace it.' You give somebody a
nose spray, and in goes a vector
and takes care of it. In this vision
of the future, the vectors, or what¬
ever methods of delivery are being
utilized, can target themselves to
specific cells or to specific loca¬
tions or addresses within the cells
or within the genome and just
replace the problem elements.”
This kind of future-gazing
inspires the progress of scientists
who solve the day-to-day problems
of gene therapy development and
negotiate its inevitable blind alleys,
but such vision may also cause
problems. Patients and their fami¬
lies may grasp it as a promise of
something just around the corner.
And entrepreneurs of startup
biotech and drug companies under
pressure to raise millions in ven¬
ture capital are tempted to oversell
the promise and understate the dif-

15

At a weekly lab journal club. Dr.
Deisseroth and his research team
report on recent findings relevant to
their oncology work.

Eight days a week
Albert Deisseroth brings a record of innovation, passion and
scientific rigor to Yale’s application of gene therapy.

A

lbert Deisseroth was born and
raised in Middletown, N.Y.,
where he remembers “a distin¬
guished family physician who
came to the house with a bag of
pills and a three-piece suit and
made me feel good.” His friend¬
ship with the family doctor kindled
an interest in medicine.
Dr. Deisseroth earned his
undergraduate and medical
degrees at the University of
Rochester, where he also
received a Ph.D. degree in bio¬
chemistry. He then served his
residency at Harvard’s Beth Israel
Hospital in Boston. From there he
went to the National Institutes of
Health as a clinical trainee and
then chief resident physician in
the National Heart Institute. It
was during his sojourn there that
Yale first came calling in the form
of biology and genetics professor
Frank H. Ruddle, Ph.D.
Recalls Dr. Deisseroth: “I was
sitting there—just a young investi¬
gator in the lab—and in walks
Frank Ruddle, and says, ‘I read
one of your papers. I’ve got things
that we’ve made that could be
useful to you in the project you’re
working on. Let’s collaborate.’
And we did over about a threeyear period.”
So began a key period of
accomplishment in Dr. Deisseroth’s career. During this time
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he moved to Harvard’s Dana Farber Cancer Center as a clinical fel¬
low while continuing the collabora¬
tion at Yale. “Each week I’d com¬
plete all my clinical duties at Farber. Then I’d hop on the train on
Friday night and come down from
Boston to New Haven. And I’d
work in Frank Ruddle’s biology lab
all weekend and then go back on
Sunday night to Boston. My wife
and three children would see me
off on the train every Friday night.
This went on for a whole year.”
The work paid off: “It was a
major breakthrough in mapping
the elements of the genetic mate¬
rial. Together we opened up a new
way of mapping.”
Dr. Deisseroth calls that early
work at Yale “a very vivid imprint¬
ing experience.” And it was defi¬
nitely part of what drew him back.
“Life is a struggle. When you get a
chance to revisit an important
period in your life, that’s always a
very attractive option.”
After the Farber, Dr. Deis¬
seroth was offered a job running
a section at the National Cancer
Institute, then headed by Dr. DeVita. Dr. Deisseroth worked in bone
marrow transplantation and inten¬
sive therapy, and began experi¬
ments introducing genetic ele¬
ments into cancer and normal
cells to make therapy work better.
A seven-year stint followed at

the University of California at San
Francisco, where a colleague was
Harold Varmus, M.D., now a
Nobel laureate and current head
of the NIH. Dr. Deisseroth’s last
stop before his new post at Yale
was the M.D. Anderson Cancer
Center at the University of Texas
in Houston, where he served as
chief of hematology.
Dr. Deisseroth’s wife, Louise,
is a high school science teacher,
and their three children have also
all become scientists: Kate works
at a Silicon Valley biotech compa¬
ny in California, Karl is a medical
student at Stanford, and Karen is
a graduate student in clinical psy¬
chology at Ohio State University.
Reflecting on a life in science,
Dr. Deisseroth recalls the opening
of the Henry James novel Wash¬
ington Square, and the notion that
“a physician is an individual
grounded in the practical but
touched by the light of science.”
He decided early on that “! want¬
ed my life to not be directed to
possessing things, but to be a
vehicle through which things of
value were created for others.”
In response to a question
about what he does to relax, Dr.
Deisseroth replies, “I’m relaxed
all the time. I’m so interested in
what I’m doing that it becomes
the central focus. When I wake
up, no matter how late I’ve been
up the night before, I drag myself
out of bed, and I’m so interested
in pursuing what I’ve been work¬
ing on that every minute of life is
exciting for me. I don’t have to
worry about going on vacation.
My life is a vacation. There’s no
downtime, [although] I’ve been
stumped a lot of times by prob¬
lems I couldn’t solve.
“I’ve been lucky to live my life
in a time of great and momentous
change. And that change is con¬
tinuing, and has driven my work
forward from the very day I first
set foot in medical school.” ■
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In the future, Dr. Deisseroth can imagine
traditional lab tests being replaced by a profile
of what he calls uthe parts of the machinery, ”
the genes of the cell and their products.
ficulties and timeframe of a new
approach. So as with all new treat¬
ments, gene therapy is a source of
controversy both within and out¬
side the research community.
“There is no question that gene
therapy will eventually prove itself
as it matures over a period of years
and decades,” says Dr. Deisseroth.
“We have powerful new tools that
will allow us to help people in
ways we couldn’t before. How¬
ever, years of basic research and
careful clinical trials will be
required before these new treat¬
ments will be beneficial.”
As for potential hazards,
Dr. Deisseroth says the therapies
he envisions will be safer than
existing treatments. “We’re inter¬
ested in replacing a therapy [cur¬
rent chemotherapy] that is muta¬
genic and highly toxic and invasive
with a harmless intervention that
has a lifelong impact and no risk,”
he says.
“None of these vectors go into
cells used in reproduction and fer¬
tilization; they go into the differen¬
tiated cells,” he adds. "There is no
risk to the evolution of the human
species because these interventions
are not transmitted from generation
to generation.”

“WE HAVE EVERYTHING”

Gene therapy by its nature must
involve a wide-ranging team of

clinicians and research scientists.
And Yale has strength in many of
the required disciplines. A team
might include oncologists, molecu¬
lar and structural biologists, geneti¬
cists, immunologists, pharmacolo¬
gists, structural chemists, X-ray
crystallographers and a variety of
other bioengineering and biotech
specialists.
Says Dr. DeVita: “I think
what attracted Dr. Deisseroth to
Yale is similar to why I came: The
science base here is extraordinary.
We have a large number of very
talented scientists in molecular
biology and structural biology.”
Dr. Deisseroth agrees: “You want
to be at an institution where the
best minds, the leading minds are
available in the areas that are
needed—and we’re basically there.
We have everything.”
How will these intellectual
resources be applied to gene ther¬
apy? During the first half of 1997,
a team will be working on what Dr.
Deisseroth refers to as the “sensiti¬
zation” or “pro-drug activation”
trial, a pre-clinical trial targeting
breast cancer cells. One problem of
treatments today involving autolo¬
gous bone marrow transplants is
that in advanced breast cancer
patients, tumor cells have metasta¬
sized to the marrow. So when har¬
vested stem cells are reintroduced,
so may be the cancer. To combat
this the team has designed a virus

that infects the breast cancer cells
in vitro but not the hematopoeic
cells (stem cells). The introduced
gene produces an enzyme and a
protein which convert a fairly
harmless drug (5 fluoro cytosine,
or 5FC) that normally is used to
treat fungal infections into a highly
toxic substance—all within the
genetically altered cancer cells. As
Dr. Deisseroth puts it, “you just
flood the petri dish culture with the
drug and only the cancer cells will
convert it to a deadly toxin.”
Although this trial takes place out¬
side the body, its implication could
be “broad and profound.” Says Dr.
Deisseroth: “We’re thinking ahead
to how we can develop something
like this for the whole body and
avoid all harmful therapies.”
He immediately, though, offers
the caveat: “It sounds great, but it's
tough to implement.” One problem
is producing enough of the viral
particles to get the element in all
the cancer cells in all parts of the
body. Another problem is that this
particular vector, although it doesn’t
infect stem cells, would infect other
cells of the body in vivo. Dr. Deis¬
seroth, though, looks forward to a
successful in vitro trial that would
offer a "proof of principle.”
Another trial will target ovar¬
ian cancer, and a more specific
viral vector has already been
designed. When an ovarian cancer
is removed, some microscopic
amounts of the tumor cells remain
in the peritoneum, the membrane
that lines the walls of the abdomi¬
nal cavity. The viral vector devel¬
oped for this trial infects the nor¬
mal peritoneal cells as well as the
ovarian cancer cells. But it will not
produce the converting enzyme
that changes the non-toxic drug to
the toxin—unless it’s inside the

Srinivasan Srimatkandada. Ph.D,
develops a gel image as part of a
related study. Much of the current
work is directed toward making exist¬
ing therapies function better.
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Special delivery, with the help of a virus

B

roadly defined, gene ther¬
apy sounds simple: alter a
patient’s genes to achieve a ther¬
apeutic benefit. If you’re dealing
with a genetic disorder, replace the
mutated gene with the correct
gene. If you want to cure a cancer,
make a change in the cancer cell
genes that allows you to kill them
with a drug that’s harmless to nor¬
mal cells.
The hard part is applying the
theory to patients, but already
there have been some qualified
successes and the techniques are
rapidly evolving. W. French Ander¬
son, M.D., is a gene therapy pio¬
neer in whose NIH laboratory
Albert Deisseroth worked early in
his career and whom he credits for
kindling his interests in the field.
In 1990, a team led by Dr.
Anderson performed the first feder¬
ally approved gene therapy, an
effort to help a 4-year-old girl with a
genetic disorder that blocked pro¬
duction of a vital enzyme. The team
genetically altered some of her
white blood cells outside the body

Siqing Fu, M.D., Ph.D., an expert in
the design of viral vectors, came to
Yale with Dr. Deisseroth from the
M.D. Anderson Cancer Center in
Houston.
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to produce the missing enzyme
and then transfused the white cells
back into her bloodstream. The
treatment worked and she now
leads a normal life, although she
needs regular treatments as the
altered white cells die off.
At Yale, gene therapy re¬
searchers hope to improve treat¬
ments for cancer—either by in¬
creasing the efficacy of current
therapies or developing new ones.
All strategies of gene therapy
require a means of altering genetic
material in target cells. To do this,
researchers have made an ally of
an ancient enemy, the virus. Virus¬
es are tailor-made for the job
because they have evolved to
invade cells and then commandeer
the cells’ genetic material for the
manufacturing of more viruses.
The process of tailoring viral
vectors is an art in itself. At Yale’s
new viral-vector production lab,
postdoctoral associate Siqing Fu,
M.D., Ph.D., is the vector designer
who presides over the process.
Dr. Fu came with Dr. Deisseroth
from M.D. Anderson Cancer Cen¬
ter in Houston to continue their
collaboration.
Dr. Fu uses a variety of bio¬
chemical processes and gene
splicing techniques to both cripple
the virus so that it can’t replicate,
and to attach to it the gene that will
be delivered to the target cell. The
viruses most often tapped to be
vectors are the adenoviruses,
associated with colds, and retro¬
viruses.
Yale’s vector production facility
was created last year in two rooms
in Sterling Hail of Medicine, with an
elaborate filtering apparatus and
positive- and negative-air-pressure
systems to keep dust out and vec¬
tor material in the lab. The FDA
considers viral vectors to be drugs
and tightly regulates the process.
As a result, Dr. Fu says that devel¬
oping a vector can take as little as
six months or longer than a year. ■

ovarian cancer cells. Developed at
Stanford University, the vector is
called a “tumor-specific transcrip¬
tional promoter.”
Dr. Deisseroth sums up: “The
gene doesn’t read out its product
unless it’s in the cancer cell. So this
is good, it's another step forward.”
The third trial will target
prostate cancer, also by using a
viral vector to infect tumor cells.
With the insertion of a new gene
into the tumor cell, the drug 5FC is
converted to the more toxic 5FU,
making the cell more susceptible to
radiation therapy.

MELANOMA RESEARCH

Yet another gene therapy team at
Yale is targeting one of the fastest
rising and deadliest of cancers.
According to Sancy Leachman.
M.D., Ph.D, if melanoma is
detected early it is nearly 100 per¬
cent curable. Once it metastatizes
to other parts of the body, the
10-year survival rate drops to
between 5 and 10 percent. That’s
why. Dr. Leachman says, “you
can’t find a more rewarding or
important area of research in der¬
matology than melanoma.” Dr.
Leachman, a molecular biologist
who worked in Dr. Deisseroth’s
laboratory last year, is an NIH fel¬
low in dermatology at Yale.
Dr. Deisseroth and other senior
investigators are attempting to har¬
ness the patient’s own immune sys¬
tem to fight metastatic melanoma.
They designed a protocol for bone
marrow transplantion with the
desired effect of inducing a “graftversus-tumor" reaction against the
spreading melanoma cells. Accord¬
ing to this protocol, not yet tested,
immune cells from the donor mar¬
row would attack the melanoma.
By modifying the foreign immune
cells genetically before transplan¬
tation, researchers also might be
able to tag the foreign cells and
selectively destroy them once the
job is done.
Dr. Leachman, who was
involved in the design of the
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Dr. Deisseroth with his laborary team: "There is no question, ’’ he says,
“that gene therapy will eventually prove itself as it matures over a period of
years and decades. ”

melanoma protocol, says that Dr.
Deisseroth “is one of the few peo¬
ple who really bridge the gap
[between laboratory and clinic],”
she adds. “You know you actually
have the potential to treat patients
with some of the most exciting and
potentially helpful treatment regi¬
mens that are becoming available.”
As to the quality of the
research team: “The higher caliber
principal investigator you have in a
lab, the higher caliber postdocs you
recruit, that’s just the way it works,
so of course he’s got an excellent
group of people working with
him.” They have come to New
Haven from as far away as China,
Thailand, Spain, India and Korea.
Among the gene therapy
group’s members are Injae Chung,
Ph.D.; Takuma Fujii, M.D., Ph.D.;
Siqing Fu, M.D., Ph.D.;
Thanyaphong Nanakorn, M.D.;
Felix Garcia-Sanchez, Ph.D.;
Srinivasan Srimatkandada, Ph.D.;
Lianhua Yin, Ph.D.; and medical
students Michael Wang and Matt
Cooperberg. Dr. DeVita credits Dr.
Deisseroth as being a key factor in
the recent recruitment to the Can¬
cer Center of Edward Chu, M.D.,
“an outstanding molecular pharma¬
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cologist,” and Frank Hsu, M.D., an
immunologist who has developed a
new approach to vaccination.

HOPE, HYPE, HELP

For a number of reasons, not the
least of which is that it alters the
genetic code in human cells, gene
therapy is under intense scrutiny
from the NIH and the Food and
Drug Administration (FDA). The
FDA, for instance, has developed
stringent guidelines for the produc¬
tion of viral vectors to be used in
humans. Yale has built for Dr.
Deisseroth’s team a vector produc¬
tion facility (one of the few at an
academic institution) according to
the FDA guidelines.
Last year, a scientific advisory
panel convened by NIH Director
Harold Varmus, M.D., reported
that a swirl of hyperbole and exag¬
geration has created “the mistaken
and widespread perception that
gene therapy is further developed
and more successful than it actu¬
ally is.” As co-chairman Stuart
Orkin, M.D., told a reporter,
“this is a young field with much
in front of it, but there is no
established efficacy of any gene

therapy today.”
Dr. Orkin and his colleagues
questioned the efficacy of the gene
viral vectors currently being used,
saying "none is ideal or perhaps
even nearly ideal” in its ability to
transfer genes into the target cells.
They criticized redundancy in
experiments and “a lack of suitable
controls,” while saving some of
the harshest rebukes for the bio¬
tech industry: “Uncritical gene
therapy reports [from companies]
are used by industry to promote
investment and perceived research
dominance.”
Nonetheless, the group sees
“extraordinary potential for the
long term" in gene therapy. The
NIH currently grants about 2 per¬
cent, $200 million, of its annual
budget to gene therapy projects
and is a funding source for a por¬
tion of the work at Yale. What, if
any, effect the recent critique will
have on current grant proposals is
still unknown.
As far as the criticism within
the research community goes, for
Dr. DeVita it’s a case of deja vu.
"There is usually about a decade of
controversy surrounding [new
fields in medicine), even the most
promising of them,” he says. "In
the case of gene therapy, there are
people who say, ‘Well it can’t
work, we shouldn't do it now, we

Felix Garcia-Sanchez, Ph.D.
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should wait until we know more
before we do it.’” When Dr. DeVita
and collegues introduced a new
chemotherapy for Hodgkins disease
two decades ago, critics were equally
skeptical. But the four-drug combi¬
nation known as MOPP raised the
survival rate for patients with
advanced disease from near zero to
65 percent. “So we’ve faced the
same sort of thing in the past,” Dr.
DeVita says.
At the same time, neither he nor
Dr. Deisseroth downplays the chal¬
lenges, hurdles and overall difficulty
of the work ahead to realize even a
small part of the promise of gene
therapies. As Dr. Deisseroth puts it,
“In the beginning of a field like this,
the number of things that you don't
know is very high and so the chances
that you’ll not have a perfect system
the first time out are also very high.”
The hurdles facing gene therapy
are not trivial, agrees Maurice J.
Mahoney, M.D., professor of genet¬
ics, pediatrics, and obstetrics and
gynecology. “The basic biologic
problems are quite significant—
inserting a gene at a place where it
will be expressed and ensuring that
expression continues over some rea¬
sonable length of time, and then per¬
haps having to repeat the therapy at
intervals,” he says. “It seems very
unlikely if you only transform one
percent of cells that you are going to
affect the course of a disease—at
least for most disease states. But if
you affect 10 percent you may be
able to.”
Will gene therapy research pay
off? Dr. DeVita, while emphasizing
that gene therapy is only one
approach to cancer research and
treatment at Yale, says, “Things are
moving very fast and the tools are
extraordinary. You can do things that
are really quite unbelievable. When
you used to make predictions—if
you were enticed to make a predic¬
tion—it usually took longer. These
days when you predict something it
usually takes less time, not more.
So my guess is that we’ll be able to
find ways to make gene therapy a
useful tool.” YM
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Eight questions

F

rancis S. Collins, M.D., Ph.D.,
earned his doctorate at Yale in
1977 and spent three years at
the medical school as a postdoc¬
toral fellow in genetics and pedi¬
atrics. Today he heads the
National Human Genome
Research Institute (NHGRI) in
Bethesda, Md., the federal insti¬
tute overseeing the effort to map
the human genome.
In November, Dr. Collins
spoke at the annual meeting of
the Association of American Med¬
ical Colleges in San Francisco on
The Ethical and Social Implica¬
tions of the Human Genome Pro¬
ject. “If s exciting to have the abili¬
ty to predict who is individually at
risk for which diseases. That is
the kind of opportunity for individ¬
ualized preventive medicine that
we have dreamed about,” he told
the gathering of more than 3,000
academic physicians and medical
administrators from around the
nation. But he posed a further
question: “Are we ready for the
consequences of that revolution?”
To consider the question care¬
fully, Dr. Collins offered eight
more:
1. Will the complexity of whole
genome biology overwhelm us?
2. Will we successfully shepherd
new genetic tests from research
into clinical practice?
3. Will effective legislative solu¬
tions to genetic discrimination be
found?
4. Can health care providers and
the public become genetically liter¬
ate in time?
5. Will the therapeutic promise of
genetics be realized?
6. Will the benefits of advances in
genetics be available only to a
privileged few?
7. Will we succumb to genetic
determinism?
8. Will we arrive at consensus on
the limits of genetic technology?

In his discussion, Dr. Collins
offered some answers and a hint
of things to come as researchers
around the world endeavor to
record more than 3 billion bits of
information about the estimated
100,000 human genes. He said
that many physicians may not be
equipped to implement sophisti¬
cated new tests now available for
susceptibility genes such as
BRCA1 and BRCA2, which indicate
a higher risk for developing breast
cancer, and that many doctors are
currently quite uncomfortable pro¬
viding genetic counseling to their
patients.
To increase the genetic litera¬
cy of both health care profession¬
als and the public, Dr. Collins said
that a coalition convening this
spring will help substantially by
providing a clearing house for edu¬
cational materials. He expressed
concern about genetic determin¬
ism, as science offers more evi¬
dence for the biological causes of
both illness and behavior: “We
have to work at not slipping into
that narrow slot, the idea that
‘genes are us.’”
Finally, Dr. Collins spoke elo¬
quently of the need for laws to pro¬
tect individuals from genetic dis¬
crimination. “We are all walking
around with four or five seriously
misspelled genes,” he said. “We
are all at risk of having that infor¬
mation used against us.”»
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75 years of Yale pediatrics
Medical school marks
the occasion with
dedication of new
research center.

A

century ago, the industrial
building at the comer of
Howard and Congress
avenues in New Haven was a rub¬
ber factory. A generation ago, it
was the place women shopped for
a bargain on coats.
In November, a portion of 464
Congress Ave. reopened as a
dynamic new facility for research
in pediatrics. Five state-of-the-art
laboratories provide new space for
eight principal investigators and
their research teams, who are prob¬
ing research questions in areas
from cancer genetics and genetic
imprinting to the developmental
biology of the immune system.
The 17,000-square-foot Yale
Child Health Research Center was
dedicated Nov. 1 with a ribbon cut¬
ting by the mayor, medical school
and hospital administrators, and
community leaders from the Hill
neighborhood that surrounds the
new facility.
The dedication also marked 75
years of pediatrics at Yale.
“The center will take an inter¬
disciplinary approach to improving
the understanding of normal devel¬
opment and the abnormalities that
continue to result in injury, handi¬
caps and death to children,” said
Joseph B. Warshaw, M.D., chair¬
man and chief of pediatrics at Yale.
Scientists in the Department of
Pediatrics will interact with col¬
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leagues in the departments of Biol¬
ogy, Cell Biology, Genetics, and
Cellular and Molecular Physiol¬
ogy, the sections of Immunobiol¬
ogy and Neurobiology and other
basic science programs, participat¬
ing in research designed along pro¬
grammatic lines. Yale medical fac¬
ulty are pursuing pediatric research
projects:
■ advancing our understanding of
information processing in children
with learning disabilities, using
functional magnetic resonance
imaging, and functionally defining
male and female brain differences
■ pioneering, using imaging tech¬
nologies, the diagnosis in congeni¬
tal heart disease prenatally
■ carrying out molecular studies to
define cystic fibrosis
■ attempting to identify the gene
that is defective in the disease
hemochromatosis, a common

Top: Tours of the Child Health Research
Center were a hot ticket in November,
when the 17,000-square-foot facility’ was
dedicated during an open house and sci¬
entific symposium.

Above: Immunology fellow Jose
Calderon, M.D., and research assistant
Beth Cooper are among two dozen people
engaged in research in the center’s five
state-of-the-art laboratories.
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A history of
advances in
children’s health

S

eventy-five years ago last
November, Yale launched one
of the first departments of pedi¬
atrics in the country. Its mission
was to increase clinical scholarship
in pediatrics and to decrease the
vulnerability of children to injury and
disease.
From the beginning in 1921,
the Yale Department of Pediatrics
has done a remarkable job of carry¬
ing out that mission. “It’s always
had an impact, far out of proportion
to its size, on American pediatrics,"
says Howard A. Pearson, M.D., who
chaired the department from 1972
to 1985.
Today, many once-devastating
diseases are under control, and
effective programs that were once
unheard of are standard. As the
department marks its 75th anniver¬
sary, Dr. Pearson notes some of the
ways in which, over the decades,
department members have indeed
had an impact. For instance, they:
■ conducted pioneering work on
the causes, prevention and treat¬
ment of rickets, a disease that in
the 1920s affected thousands of
American children, especially in
cities like New Haven.

■ encouraged the State of Connecti¬
cut to build a residential facility,
the Southbury Training School, for
mentally retarded youngsters.
■ refined fluid and electrolyte ther¬
apy for diarrhea, long a major killer
of children.
■ brought about a better under¬
standing of polio.
■ helped produce a vaccine against
German measles.
■ showed that the practice of pedi¬
atrics should include attention to
psychological and social issues.
■ demonstrated that rooming-in
arrangements for new mothers and
their babies served both better than
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did the long-standard practice of
separating newborns from their
mothers.
■ revolutionized the care of prema¬
ture infants by showing that they
could be safely cared for in nurs¬
eries that let staff and parents have
more access instead of isolating
them in cubicles, and established
the country’s first modern inten¬
sive-care unit for premature infants.

genetic disease that can cause
liver and heart problems, arthritis
and diabetes
■ developing experimental models
to examine gene therapy of a rare
immune deficiency disease and
examining the effect of this genetic
defect on immune function
■ studying the regulation of expres¬
sion of interferon-gamma, a key fac¬
tor in the immune response that is
poorly produced by lymphocytes in
newborns, in order to understand the
basis of the susceptibility of new¬
borns to severe infections

■ helped establish separate, appro¬
priate hospital facilities for
children.
■ helped to start and maintain
New Haven’s Hill Health Center,
where pediatrics is an important
part of medical services for urban
residents.
■ launched the country’s first com¬
prehensive program for testing for
sickle-cell anemia in newborns and
demonstrated that mortality from
the disease could be reduced.
■ advanced knowledge in ped¬
iatric research through work at
the Children’s Clinical Research
Center and in other major programs
at Yale.
Joseph B. Warshaw, M.D., who
has chaired the department since
1987, calls it “poised to advance
even further in the next 75 years.”
The current explosion in molecular
science, coupled with new technolo¬
gies, is giving pediatric researchers
and practitioners “an improved
understanding of what’s going on,”
he says.
Recent work in the department
has helped make it possible to diag¬
nose many cases of congenital
heart disease prenatally. Current
topics under study include the mole¬
cular mechanisms of cystic fibrosis.
“These projects and others,” he
adds, “will be in the forefront as the
growth of knowledge in pediatrics
increases logarithmically.” ■
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Above: A view of the building at 464
Congress Ave. as it appeared in the
19th century, when it was a rubber fac¬
tory. Later the building became an out¬
let for women's apparel. The Child
Health Research Center occupies
renovated space on the second floor.
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■ studying how different proteins
are transported to different areas
within the cell, and attempting to
dissect out the mechanisms by
which protein trafficking is
achieved in health, disrupted in dis¬
ease states, and restored during
recovery
■ studying how the expression of
some genes is determined by
whether they are inherited from the
mother or the father and how this
regulation may affect organ devel¬
opment, as well as the development
of inherited diseases. YM

Above: Myron Genel, M.D., associate
dean for government and community
affairs, greets Courtland Seymour
Wilson, executive director of the Hill
Development Corp.

Right: Mayor John DeStefano and
other community leaders, including
U.S. Rep. Rosa DeLauro, Alderman
Tony Dawson and Hill Development
Corp. Chairwoman Cathy Sutton
Dawson, spoke at the dedication.

John M. Leventhal, M.D., HS ’73-76, left, stands with the participants
in the scientific symposium he organized to mark 75 years of pedi¬
atrics at Yale. From left: Dr. Leventhal, professor of pediatrics and in
the Child Study Center; Richard P. Litton, M.D., Ph.D., associate pro¬
fessor of medicine (nephrology) and genetics at Yale and a Howard
Hughes Medical Institute investigator; Nancy C. Andrews, M.D., Ph.D.,
assistant professor of pediatrics at Harvard Medical School; Michael
S. Kramer, M.D., professor of pediatrics, epidemiology and biostatis¬
tics at McGill University School of Medicine; and Leon E. Rosenberg,
M.D., HS ’73-76, former dean of the Yale School of Medicine and
senior vice president, scientific affairs, at Bristol-Meyers Squibb.

Above: Joseph B. Warshaw,
M.D., left, and Howard A.
Pearson, M.D., are among the
physicians who have chaired
the department during its 75year history. They are pictured
before one of the center’s six
murals created by New Haven
public school students. Fourthgraders at the Lincoln-Bassett
School made this colorful
mosaic reproduction of Edward
Hopper’s Railroad Sunset.
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All the right moves
Yale Sports Medicine Center moves to
expanded quarters at One Long Wharf.

W

ith fanfare, food and an a
cappella performance by a
group of Yale undergraduates, the
Yale Sports Medicine Center
opened its doors in a new facility in
November at One Long Wharf
Drive in New Haven.
The new location has expanded
clinical facilities, including special¬
ized athletic splint, brace, orthotic
and casting rooms, and on-site Xray. A bioskiils laboratory and
sports medicine library comple¬
ment the new center, which has
twice the space of the previous Sar¬
gent Drive location.
“The new sports medicine cen¬
ter allows us to provide state-of-theart specialized medical care for all
athletes at one location,” says Peter
Jokl, M.D. ’68, HS '69-73, chief of

sports medicine at both at the Yale
School of Medicine and Yale-New
Haven Hospital. Dr. Jokl served as
medical commissioner for the 1995
Special Olympics World Games.
Four full-time physicians at
the Yale Sports Medicine Center
provide treatment for men and
women who suffer musculoskele¬
tal injuries, both athletes and non¬
athletes alike. In addition, trainer
O. William Dayton serves a
vital role in this comprehensive
program.
High school coaches, athletic
directors and school health-care
providers in the Greater New
Haven area got to see the new cen¬
ter first-hand at a seminar in
December, taught by the sports
medicine staff.

Dr. Jokl says the program is
“especially fortunate to be located
adjacent to the physical therapy
services of Gaylord Hospital,”
which are next door. “Since reha¬
bilitation is often a key to recovery
in orthopaedic injuries, it is great to
have an outstanding physical ther¬
apy program so available.” ■

Above: John Daigneault,
M.D., shows a series of
magnetic resonance images
to Linda Fischer, an ath¬
letic trainer who visited the
Sports Medicine Center
during a December semi¬
nar for coaches and train¬
ers in the community.

Left: The center’s four full¬
time faculty physicians,
from left: John Daigneault,

-o Director Peter Jokl,
| Patrick Ruwe and Marc
on
|zr Galloway.
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Left: The Yale Sports Medicine
Center's new home is on the sixth
floor of the renovated One Long
Wharf building, overlooking
Long Island Sound.

Above: Dr. Jokl greets Joseph A. Zaccagnino, center, president and
chief executive officer of Yale-New Haven Hospital, and Paul H. John¬
son, president and chief executive officer of Gaylord Hospital in
Wallingford, Conn.

Left: At the opening
Above: Ceremonies during the
Yale-Princeton weekend also
marked the retirement of Carm
Cozza, the legendary Yale football
coach. At the Sports Medicine Cen¬
ter opening, he spoke apprecia¬
tively of the long relationship
between the center and Yale athlet¬
ics. Behind him is a sculpture by
former chairman and professor

reception, Gary E.
Friedlaender, M.D.,
chairman of ortho¬
paedics and rehabilita¬
tion, spoke of the cen¬
ter \s growth and suc¬
cess since its founding
a decade ago by Direc¬
tor Peter Jokl, M.D.
(standing to his left).

emeritus Wayne O. Southwick,
M.D., which Dr. Southwick dedi¬
cated to the center.

Above: The Yale College a cappella group
Whim W Rhythm sing a football fight song at
the opening, which coincided with the YalePrinceton game.

Right: Coach Cozza with O. William Dayton,
Yale’s former head athletic trainer, who sees
patients at the Sports Medicine Center.
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GALLERY

Painless
150 years ago, the use of ether brought
a fundamental change to medicine.

H

By Marc Wortman

ow much will it hurt? These
days, surgeons can answer
their patients’ standard ques¬
tion precisely: not at all. But until
Oct. 16, 1846, any invasive proce¬
dure was likely to hurt very much
indeed. That was the day on which
surgeons first demonstrated the use
of inhaled ether as a general anes¬
thetic and liberated the surgical
patient from pain—at least until the
effects of the magic vapors wore off.
This past Oct. 16, an interna¬
tional meeting in Boston marked the
150th anniversary of that historic
moment, now celebrated as Ether
Day. On that date a century and a
half ago at Massachusetts General
Hospital, surgeon John Collins War¬
ren. M.D., operated on a patient
anesthetized by Boston dentist
William Thomas Green Morton
using inhaled ether. “That was a
thunderclap in medical history,”
says Yale clinical
professor of surgery
and medical historian
Sherwin B. Nuland,
M.D. ’55, HS ’55-61,
author of The Origins
of Anesthesia. “Noth¬
ing was the same
afterwards.”
Not only for the
surgeon. Prior to the
first use of ether, alco¬
4 //£■/
hol and the proverbial
Above: A young Hartford dentist,
Horace Wells (1815-1848), received
scant credit for his use of nitrous
oxide for dental operations.
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biting the bullet were the only
weapons in the pain-fighting arse¬
nal. Any surgery required a number
of strong men on hand to restrain the
patient. Needless to say, delicate
surgery was inconceivable under
such circumstances.
Nicholas M. Greene, M.D.,
professor emeritus and former chair¬
man of anesthesiology at Yale,
organized a milestone exhibit on
anesthesia’s history this fall at the
Harvey Cushing/John Hay Whitney
Medical Library.
While Dr. Morton is credited
with introducing inhaled ether’s
anesthetic properties to the world,
Dr. Greene points out that Crawford
W. Long, M.D., of Georgia began
using ether in his surgical practice
four years earlier, but did not pub¬
lish his findings until after Drs. War¬
ren and Morton had made their

Top: Wick vaporizers controlled the
respiratory volume passing through the
vaporizer and thus the concentration of
ether. This instrument was widely used
for surgery during the 1940s and '50s.

Above: The first public demonstration
of surgery’ performed on an etherized
patient was a “thunderclap ” in med¬
ical history. Surrounded by colleagues.
Boston dentist William Thomas Green
Morton gives the patient ether.

demonstration in 1846. In fact, Hart¬
ford dentist Horace Wells should
also be credited for the advance,
since he had previously experi¬
mented with nitrous oxide inhalation
in his practice. He shared the con¬
cept of inhalation anesthesia with
Morton, who then brought it to the
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the first use of inhaled ether as an
anesthetic, written by Henry Jacob
Bigelow, M.D., a Harvard colleague
of surgeon John Collins Warren,
M.D., brought worldwide attention.

Read before the IJoston Society of Medical Improvement, Nov. Uth, I84G, an nbstraci having been
previously read before the American Academy of Arts and Sciences, Nov. 3d, 1846.
By Honry Jacob Bigelow, M.D., one of the Surgeons of the Massachusetts General Hospital.
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M.D., as a local anesthetic and alter¬
native to ether and chloroform. (Dr.
Freud himself eventually would be
proclaiming the wonderful painrelieving qualities of cocaine.) Pro¬
caine, the first synthetic local anes¬
thetic, was introduced in 1902.
Thiopental became the first widely
used intravenously administered gen¬
eral anesthetic, beginning in 1935,
allowing for much more precise mon¬
itoring of the anesthetic effect.
While these landmark events
have revolutionized the operating
room, anesthesia as a medical spe¬
cialty was much slower in develop¬
ing. Only during the past half-century
did it become a recognized medical
specialty. Yale appointed Dr. Greene
as its first professor of anesthesiology
in 1955. He guided the field toward
its emergence as an intellectual disci¬
pline in its own right. At the Boston
Ether Day celebration, he was given
the Massachusetts General Hospital
Trustees Medal to honor his contribu¬
tions to the field. While the section of
anesthesiology didn't become a
department until 1971, it has since
been recognized as among the best in
the country, with 58 attendings, 56
residents, six fellows and five nurses,
in a program credited with numerous
scientific and medical advances.
“Finally,” says Dr. Nuland, “anesthe¬
sia has taken its place among our most
meticulous specialties and the most
technologically advanced of all.” ■

Above: Surgery was cptick and brutish
before the advent of anesthesia. Av this
18th-century engraving from the
Clements C. Fry Print Collection at Yale
shows, it took muscle to get the job done.

Below: Dripping ether or chloroform
on a cloth or mask such as these held
over a patient's mouth and nose was
the most widely used form of inducing
anesthesia during the first century of
its use.
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Images from the Harvey Cushing/John Hay Whitney

attention of Dr. Warren. Dr. Warren’s
announcement of the successful surgi¬
cal use of inhaled ether brought
tremendous worldwide attention. It is
regarded as the first major American
contribution to medicine.
The immediate effect of the dis¬
covery of anesthesia was in fact lim¬
ited and sometimes downright danger¬
ous. It would be another 40 years
before the germ theory was pro¬
pounded, and many operations under¬
taken with the new freedom permitted
by anesthesia resulted in deadly infec¬
tions and some wildly speculative sur¬
gical experiments. Wide objections to
its use quickly arose. Other anesthet¬
ics were tried. Chloroform was dis¬
covered as an anesthetic in 1847,
but quickly demonstrated the poten¬
tially lethal quality of a deep sleep
as a number of early fatalities
were reported.
However, the great medical value
of anesthesia was readily apparent and
its use spread rapidly. Peter Parker,
M.D., a Yale-trained physician and
minister, went to China in 1837. Only
a year after inhalation ether was first
used by Dr. Warren at Massachusetts
General, Dr. Parker performed an
amputation in Canton using the gen¬
eral anesthetic. This is believed to be
the first use of anesthesia in Asia.
By the turn of the century, new
forms of anesthesia were being devel¬
oped. Cocaine was first used by Sig¬
mund Freud’s assistant, Karl Koller,

SCOPE

Harold Shapiro

Yale expands partnership with New Haven city schools
Leaders from the New Haven
Public Schools and Yale Univer¬
sity signed an agreement in early
December establishing a formal
partnership to enrich educational
opportunities for New Haven
students.
The partnership builds on work
initiated in recent years between the
Yale schools of medicine and nurs¬
ing and Career High School, which
in 1998 will open a new regional
facility on the Route 34 connector
near the Yale medical complex.
The high school offers concentra¬
tions in allied health, business
and computing.
“In creating this partnership, we
recognize our common interests and
shared educational responsibilities
to our students, and today join
together to form one intergenerational community of learners,” said
Reginald Mayo, Ph.D., superinten¬
dent of schools in New Haven. He
was joined by Yale Secretary Linda
K. Lorimer, medical school Dean
Gerard N. Burrow, M.D. ’58, HS
’58-66, nursing school Dean Judith
B. Krauss, R.N., and Career High
School Principal Charles Williams.
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Since January of 1995, anesthe¬
siology professor J.G. Collins,
Ph.D., has coordinated an effort to
identify ways to share University
resources with Career faculty as
they move forward in their efforts to
revise curriculum. Medical librari¬
ans at Yale have trained Career
High teachers, students and the
school librarian in use of the Inter¬
net and other electronic information
reference tools. The library training
program will continue during the
coming school year, and Career fac¬
ulty now have full borrowing privi¬
leges at the medical library.
“The partnership was designed
to encourage more contact and
informal communication between
the students and staff at Career with
medical and nursing students and
faculty,” says partnership coordina¬
tor Claudia R. Merson. To that end,
the Yale Medical Shuttle will
expand its route to include regular
stops at the new Career High School
when it opens, and Yale participants
will have access to the high school
swimming pool and other sports and
recreation facilities.
Career students also have had

opportunities to learn about a vari¬
ety of career options through partic¬
ipation in a medical careers course
at the high school and internships at
the medical and nursing schools,
where Career students observe med¬
ical faculty and other health profes¬
sionals in research and clinical
areas. Yale medical faculty and
postdoctoral fellows also lecture at
the high school on career options
and paths.
An educational program started
in 1993 continues to best exemplify
the kinds of enrichment that this
partnership has been designed to
produce. Career students come to
the medical school for an innovative
human anatomy program, con¬
ducted in the medical school’s
human anatomy laboratory and
taught by medical students and
William B. Stewart, Ph.D., associ¬
ate professor of surgery and chief of
the gross anatomy section, and his
colleagues at Yale. The highly moti¬
vated Career students have learned
more about human anatomy, earned
higher grades and increased their
interest in the sciences by partici¬
pating in this program.
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Dr. Kessler’s appointment as dean was made
as Yale Medicine was going to press. Additional
coverage of the announcement is included in a
Yale Medicine Bulletin mailed in early March.

FDA commissioner

becomes 15th dean
P

resident Richard C. Levin
announced on Feb. 13 that David
A. Kessler, M.D., J.D., commis¬
sioner of the U.S. Food and Drug
Administration, will become dean of
the Yale University School of Medi¬
cine, effective July 1.
Dr. Kessler is a graduate of
the Harvard Medical School, the
University of Chicago Law School
and Amherst College. Appointed
in 1990, Kessler served as FDA com¬
missioner under Presidents Bush and
Clinton. Before that. Dr. Kessler was
medical director of the Hospital of
the Albert Einstein College of Medi¬
cine from 1984 until 1990.
During his six-year tenure at the
FDA, Dr. Kessler successfully tack¬
led difficult issues as he sought to
meet critical public health needs.
Under his leadership, the FDA’s
accomplishments were wide-rang¬
ing, from the introduction of the
Nutrition Facts food labels to
tobacco regulation, and from mam¬
mography standards to world-record
times for drug approvals. During his
tenure, the FDA reduced by 50 per¬
cent the median time required to
evaluate new drugs it approved.
“This is one of the great days of
my life,” Dr. Kessler told more than
450 people who filled Mary S. Harkness Auditorium for the announce¬
ment. “This is one of the world’s
great institutions and it is a high
honor to be your dean.” In his com¬
ments in Harkness and at a press
conference that followed.
Dr. Kessler repeatedly stressed the
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importance of delivering worldclass care to people who cannot
receive it elsewhere. “What is
magic at other places,” he told a
room full of reporters, “they have
to be able to do here every day.”
President Levin introduced the
school’s 15th dean with the obser¬
vation that medicine is simultane¬
ously facing enormous challenge
and opportunity. “It is a perfect
time for us to have a dean with Dr.
Kessler’s vision and intelligence,
and openness to new ideas,” said
President Levin. “I think this is the
right man at the right time for taking
the school forward.”
To more applause. President
Levin vowed that “the provost and I
are going to make it possible for Dr.
Kessler to do these things. We are
supplying him with ample resources
to develop new educational pro¬
grams, to take new clinical initia¬
tives, to recruit new and outstanding
faculty, and to improve the quality of
our laboratory facilities.”
Gerard N. Burrow, M.D. ’58,
dean of the School of Medicine since
1992, will return to the medical fac¬
ulty and will serve as special advisor
for health affairs to President Levin.
He will also write a history of Yale
medicine for the University’s 300th
anniversary celebration in 2001.
Dr. Kessler completed his
internship and residency training in
pediatrics at The Johns Hopkins
Hospital. He has been elected a
member of the Institute of Medicine,
which is part of the National Acad-

Top: Dr. Kessler addresses a packed
Harkness Auditorium on Feb. 13.
Above: Dr. Kessler and President
Levin at a press conference following
the announcement.

emy of Sciences. Dr. Kessler's many
honors have included the American
Cancer Society’s Medal of Honor,
the American Heart Association's
National Public Affairs Special
Recognition Award, the American
Federation for AIDS Research Shel¬
don W. Andelson Public Policy
Achievement Award, the American
Academy of Pediatrics Excellence in
Public Service Award, and the March
of Dimes Franklin Delano Roosevelt
Leadership Award.
Dr. Kessler is married to Paulette
Kessler, a lawyer, and they have two
children, Elise, 14, and Ben. 11. ■
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Christopher J. McDougle, M.D.

Yale contributes
to new advances
in autism research
Three new studies, including two
by Yale researchers, are opening the
door to significant advances in the
understanding and treatment of
autism, according to an editorial in
the November issue of the Archives
of General Psychiatry.

In the first of the three studies,
Christopher J. McDougle, M.D.,
associate professor of psychiatry
and in the Child Study Center, and
colleagues studied 30 adults with
autistic disorder. Half were given
placebo, the other half were given
a potent and selective serotonin
reuptake inhibitor called fluvoxamine maleate.
After 12 weeks, eight (53 per¬
cent) of the 15 patients in the fluvoxamine-treated group showed
improvement, compared to none in
the placebo group.
The authors concluded that
“fluvoxamine was superior to
placebo in reducing repetitive
thoughts and behavior, maladap¬
tive behavior, and aggression,
and in improving some aspects
of social relatedness, especially
language use.”
Other than mild sedation and
gastrointestinal distress in a few
patients, fluvoxamine was well tol¬
erated, according to the researchers.
They say their results warrant con¬
trolled studies using fluvoxamine
and other drugs of the same class
in children and adolescents
with autism.
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A second study, also by
Dr. McDougle and colleagues,
confirms a dysregulation in sero¬
tonin function in some patients
with autism.
The synthesis of serotonin is
dependent upon the dietary intake
of the essential amino acid trypto¬
phan, according to information
cited in the study. Seventeen drugfree patients with autistic disorder
received a 24-hour, low-tryptophan
diet followed the next morning by
an amino-acid drink. A second test
was conducted with placebo in a
randomized order.
Other Yale authors of the two
papers were Susan T. Naylor, R.N.,
M.S.N.; Donald J. Cohen, M.D. ’66;
Fred R. Volkmar, M.D.; George R.
Heninger, M.D.; and Lawrence H.
Price, M.D., HS '78-82.
In the third paper, researchers
at Stanford University studied the
involvement of the X chromosome
in the etiology of autism. They
found that while there was no mod¬
erate to strong gene effect causing
autism on the X chromosome,
smaller gene effects could not be
excluded.

research in women's health, better
integrate women’s health and gen¬
der-related concepts into the med¬
ical school curriculum, and enhance
the education and training of physi¬
cians in women's comprehensive
care,” she says.
With the national designation
and $330,000 in federal support for
women’s health, the Yale program
will initially concentrate in two
main areas:
» Expansion of the interdisciplinary
training and service model of com¬
prehensive, integrated patient care
for New Haven-area women that
started in 1995 in Yale-New Haven
Hospital’s Primary Care Center.
Physicians in internal medicine,
obstetrics and gynecology, and
psychiatry will collaborate on
this project.
■ Development of a framework to
facilitate interdisciplinary research
on women’s health.
Coordinating the program’s
research component is Carolyn M.
Mazure, Ph.D., associate professor

Women’s Health
Program at Yale
designated a center
of excellence
The Women’s Health Program at
Yale has been designated by the
U.S. Department of Health and
Human Services (HHS) as one of
six National Centers of Excellence
in Women’s Health to serve as
models for improving the health
care of American women.
“This new center will strengthen
and expand the Women’s Health
Program at Yale that was estab¬
lished in 1992,” says program
and center director Janet B. Henrich, M.D., associate professor
of medicine and of obstetrics
and gynecology.
“Our program strives to
improve the quality of health care
for women, foster and generate

Janet B. Henrich, M.D.
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of psychiatry and editor of the
book Does Stress Cause Psychi¬
atric Illness? Dr. Mazure will help
stimulate research in women’s
health that will encompass the
fields of clinical medicine, basic
science, public health and behav¬
ioral science.
According to HHS Secretary
Donna E. Shalala, the national cen¬
ters, announced Oct. 1, “are just
one step in a broad cooperative
effort to improve our health
research and services for women,
and to improve the career
prospects for women in the health
professions.”

Surgical technique may
prompt heart disturbance
Certain surgical techniques appear
to increase the risk of atrial fibrilla¬
tion in patients after coronary
artery bypass graft surgery
(CABG), according to a study
conducted at Yale and 23 other
university-affiliated medical
centers across the United States.
In a study of 2,417 patients
undergoing CABG surgery, an
average of 27 percent of them
experienced this common heart
rhythm disorder. The condition
more likely occurs in older male
patients with a history of heart fail¬
ure, says Joseph P. Mathew, M.D.,
assistant professor of anesthesiol¬
ogy at the School of Medicine and
the study’s first author. Dr. Mathew
and his colleagues reported the
findings in the Journal of the
American Medical Association.
“In an effort to decrease costs,
people who have had CABG
surgery often are discharged from
the hospital as early as three to five
days after their surgery, which is
just about the same time that this
common rhythm disturbance
shows up,” says Dr. Mathew. “The
occurrence of atrial fibrillation will
limit these cost-containment
efforts. In this era of decreasing
reimbursement for medical costs, it
is important that this heart rhythm
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Yale one of three
centers testing new
HIV therapy
Yale physicians have begun clinical
research on an anti-HIV therapy
that uses a novel approach to fight
the AIDS virus. Yale is one of three
sites in the United States to study
this new medication that a Japan¬
ese pharmaceutical company has
developed.
“This drug may provide an
additional new treatment to the
expanding and exciting array of HIV
therapies,” says Gerald Friedland,
M.D., director of the Yale AIDS Pro¬
gram and its Clinical Trials Unit.
Researchers now understand
that the virus that causes AIDS
multiplies in the human body even
early on in HIV infection, according
to Dr. Friedland. Millions of viruses
are produced daily in the human
body and eventually render a per¬
son’s disease-fighting immune sys¬
tem helpless against infections.

Gerald Friedland, M.D.

Previous anti-HIV therapies,
like AZT or the new protease
inhibitors, act by interrupting one
of two enzymes that help the virus
multiply. The new therapy that Yale
physicians are evaluating acts by
preventing the virus from fusing
with uninfected cells in the body
and by preventing infected cells
from fusing to uninfected cells,

thereby limiting the ability of HIV to
spread. The medication accumu¬
lates in the lymph nodes where the
highest level of virus replication
and infection of new cells occurs.
In the Yale study, patients
are being given the new medication
once or twice a month in addition
to their other HIV therapies, and
health professionals are monitor¬
ing certain lymphocytes and
viral counts.

A yardstick for
HIV prevention
A team of Yale researchers will
play a major role in a comprehen¬
sive analysis of programs designed
to halt the spread of HIV, in an
effort to test the effectiveness
of different approaches to AIDS
prevention.
A novel component of the fiveyear project will be its reliance on
techniques from operations
research, statistics and economics
to create mathematical models of
the impact of HIV prevention pro¬
grams, according to School of Man¬
agement professor Edward Kaplan,
Ph.D. Dr. Kaplan will collaborate
with David Paltiel, Ph.D., assistant
professor of health policy and man¬
agement in the Department of Epi¬
demiology and Public Health, and
other Yale management and public
health faculty, as well as col¬
leagues at two other universities.
“Decisions regarding how
much money to spend on HIV pre¬
vention programs are made hap¬
hazardly," Dr. Kaplan says. “Most
prevention programs are not evalu¬
ated at all, those that are studied
typically do not involve serious
attempts to estimate the number
of new infections prevented, and
precious few studies report the
actual costs of intervening. Yet,
given that the goal of HIV preven¬
tion is, in fact, to prevent HIV infec¬
tions, one would think that a wiser
approach would be to figure out
how prevention dollars can be
spent more effectively.” ■
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disturbance be identified and the
patients treated before they go
home,” Dr. Mathew says.
Patients who develop atrial fib¬
rillation after CABG surgery spend
an average of 13 extra hours in the
intensive care unit and two extra
days in the hospital. The extra time
is usually needed to control the fast
heart rate, to treat patients with
blood-thinning medication, or to
treat the complications associated
with this condition. The current
study indicates that the occurrence
of atrial fibrillation after surgery
was strongly associated with neuro¬
logical injury.
Using approximate estimates of
cost, the occurrence of atrial fibril¬
lation after this type of surgery
increases the overall cost of surgery
by at least $1,616, the researchers
found. In the United States, where
350,000 CABG surgeries annually
are performed, the additional costs
of the prolonged hospitalization,
excluding treatment costs, is $153
million per year.

Prognosis excellent
for children with
Lyme disease
Two Connecticut researchers
reported in the New England Jour¬
nal of Medicine that the prognosis
is excellent for children with Lyme
disease who are promptly treated
with antibiotics.
Results of the study should put
to rest many parents’ fears that their
children who have Lyme disease
will suffer chronic disease or dis¬
ability—even after treatment with
antibiotics.
The research was conducted by
Eugene D. Shapiro, M.D., professor
of pediatrics and of epidemiology
at Yale, and Michael A. Gerber,
M.D. ’74, professor of pediatrics at
the University of Connecticut
School of Medicine and director.
Division of Pediatric Infectious
Diseases, Connecticut Children's
Medical Center.
The study was conducted over
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20 months in five pediatric prac¬
tices in southeastern Connecticut.
Children who went to the physi¬
cians’ offices and were diagnosed
with Lyme disease were eligible for
inclusion in the study. Two hundred
and one patients enrolled in the
study, which was reported in the
journal’s Oct. 16 issue.
All but four of the children
were treated with a single course of
conventional antibiotics for two to
four weeks, and almost all began to
feel better shortly after beginning
therapy. At a two-month checkup,
94 percent were free of Lyme dis¬
ease symptoms. About two years
later, all patients were free of any
objective evidence of either chronic
or recurrent Lyme disease.
Drs. Shapiro and Gerber said
the non-specific symptoms associ¬
ated with Lyme disease play a role
in the reactions of parents to the
disease. Many fear that a short
course of oral antibiotics—daily
dosages for two to four weeks—is
insufficient. Later, if the children
complain of headaches, tiredness or
aches and pains, the parents often
believe the cause is recurrent or
chronic Lyme disease. The scien¬
tific evidence shows these concerns
are unfounded.

Yale biochemists
report new role
of enzyme activity
Two medical school biochemists
have reported a new role for
changes in the activity of the
enzyme glycogen synthase (GSase)
that reverses a long-held belief
about its function.
The Yale scientists have shown
that the well-known changes in
activity of GSase do not control the
flow of carbohydrate synthesis
through the enzyme, as has gener¬
ally been assumed, but instead help
the enzyme to control the concen¬
trations of small molecules in the
cell. The enzyme is changed when
the flow through it changes in order
to keep the other molecules in the

cell at a constant level.
This work has significant
implications for other changes in
enzyme activity, such as those stim¬
ulated by genetic engineering, the
Yale researchers believe. In provid¬
ing an additional role for the bind¬
ing of phosphates to enzymes
which changes its activity, this new

Robert G. Shulman, Ph.D.

research provides a base for under¬
standing the numerous phosphory¬
lations being reported.
Robert G. Shulman, Ph.D., and
Douglas L. Rothman. Ph.D., pre¬
sented their findings in the Pro¬
ceedings of the National Academy
of Sciences. Dr. Shulman is profes¬

sor of molecular biophysics and
biochemistry, while Dr. Rothman is
associate professor of research in
medicine. In conducting their
research, they employed magnetic
resonance spectroscopy techniques
and mathematical models.
‘‘We showed that the enzyme
GSase does not control the rate of
carbohydrate synthesis, as scientists
have long believed, but rather that
the flow is controlled at the first
step, when glucose enters the mus¬
cle cell,” Dr. Shulman explains.
“The activity of GSase is itself con¬
trolled by phosphorylation in order
to maintain constant concentrations
in the cell.”
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Edward Chu, M.D., associate pro¬
fessor of medicine (oncology), has
been named director of the newly
established VA Cancer Center at
the VA Connecticut Healthcare
System in West Haven. Dr. Chu is
chief of medical
oncology-hema¬
tology at the VA
and co-director
of the Develop¬
mental Thera| peutics Program
? at the Yale Cano
I cer Center.

Michael S. Conte, M.D., associate
research scientist in surgery,
received the fellowship award of
the American Surgical Association
Foundation for his research pro¬
posal on Endothelial Restoration
and Vascular Remodeling. This
national two-year fellowship is pre¬
sented annually to new faculty.

NEWS

James P. Comer, M.D., HS '64-67, Maurice
Falk Professor in the Child Study Center and Psy¬
chiatry, whose School Development Program has
become a model for improving the quality of
American education, has received the 1996 Heinz
Award in the category of the Human Condition.
Dr. Comer’s program, which addresses the innercity problems of drug abuse, teen-age pregnancy
and crime, has made a decisive difference in the
J role of public schools in many communities. The
| Heinz Awards were established in memory of the
I late U.S. Sen. John Heinz and measure the excel¬
lence of an individual’s achievements, as well as
less tangible qualities such as intellectual curiosity, willingness to take
risks, concern for humanity, optimism and commitment to making the
world a better place. Dr. Comer also was presented an award for outstand¬
ing service to the field of education at Lehigh University’s College of
Education Alumni Day, held in October in Pennsylvania.

Joseph S. Elman, M.D., clinical
instructor in ophthalmology and
visual science, has been elected
president of the Connecticut Soci¬
ety of Eye Physicians.

Michael D. Ezekowitz, M.D.,
Ph.D., professor of medicine (car¬
diovascular), addressed the Interna¬
tional Symposium on Atrial Flutter
and Fibrillation in September in
Heidelberg, Germany. His topic
was Prevention of Stroke in
Patients with Atrial Fibrillation.

NEW

The Yale Guide to
Children’s Nutrition,

Critical Operative Maneuvers
in Urologic Surgery, by Harry

William V. Tamborlane, M.D., profes¬
sor of pediatrics,
editor-in-chief, et
al., Yale University
Press 1997.

C. Miller Jr., M.D. ’54, and
George W-K. Yu, M.D., Mosby
(St. Louis, Mo.) 1996.

Return from Madness, by
Kathleen Degen, M.D., assis¬
tant clinical professor of psy¬
chiatry, and Ellen D. Nasper,
Ph.D., assistant clinical pro¬
fessor of psychiatry, Jason
Aronson Inc. (Penn.) 1996.
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The Prostate Cancer Answer
Book: An Unbiased Guide
to Treatment Choices, by
Marion Morra, associate
director of the Yale Cancer
Center and associate
research scientist in epi¬
demiology and public health,
and Eve Potts, Avon Books
(New York) 1996.

Frank Hsu, M.D., assistant profes¬
sor of medicine (oncology), has
been appointed co-director of the
Immunology Research Program at
the Yale Cancer Center. Dr. Hsu's
research interests focus on immuno¬
therapy of malignancies, especially
regarding lymphoma. Much of his
work centers on the use of vaccine
therapies for various forms of cancer.
The National Institutes of Health
(NIH) working group on new inves¬
tigators met in September for the
first time. John Krystal, M.D.,
associate professor of psychiatry, is
one of the eight-member group des¬
ignated to review the current poli¬
cies and practices of the NIH for
new investigators.
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Harlan M. Krumholz, M.D.,
assistant professor of medicine
(cardiology) and epidemiology, and
director of the Center for Outcomes
Research and Evaluation at YaleNew Haven Hospital, received a
William Harvey Award for excel¬
lence in magazine writing on the
subject of high blood pressure. The
award is sponsored by the Ameri¬
can Medical Writers Association,
the National Heart, Lung, and
Blood Institute of the National
Institutes of Health, and BristolMyers Squibb Co.
Marion E. Morra,
M.A., associate director
of the Yale Cancer Cen¬
ter, received the Ameri¬
can Cancer Society’s
Distinguished Service
Award for her writing
and production of sev¬
eral publications on
cancer topics, and for
her numerous contri¬
butions in relation to
quality-of-life issues for cancer
patients.
Howard A. Pearson, M.D., pro¬
fessor emeritus of pediatrics,
received the Distinguished Career
Award from the American Society
of Pediatric Hematology/Oncol¬
ogy at its ninth annual conference
in Chicago in October. Dr. Pearson
was recognized for his career in
pediatrics and his identification of
two diseases: chronic neutropenia,
a congenital form of anemia; and
Pearson syndrome, a blood disor¬
der caused by mitochondrial dis¬
ease. Pearson syndrome appears in
infancy and is usually fatal. There
have been 30 to 40 cases diagnosed
around the world.
Robert A. Rosenheck, M.D., HS
’73-77, clinical professor of psychi¬
atry at Yale and director of the
Northeast Program Evaluation
Center of the VA Connecticut
Healthcare System in West Haven,
has been honored by the Vietnam
Veterans Assistance Fund for his

34

distinguished service to homeless
veterans and veterans with serious
mental illness.
Tracy A. Smith-Leiker, Ph D.,
postdoctoral fellow in genetics, was
honored in November at the Zeneca
Pharmaceuticals Life Science Sym¬
posium. Dr. Smith-Leiker was a
winner in the Burroughs Wellcome
Fund Life Science Research Fel¬
lowship program, which recognizes
the achievements of young scien¬
tists, for research on a protein
involved in intercellular transport
during Drosophila oogenesis.
Merle Waxman, associate dean for
academic development, received
the Association of American Med¬
ical College’s (AAMC) 1996
Women in
Medicine
Leadership
Award in
November.
She is the first
non-physician
to receive the
award since it
was estab¬
lished four
years ago. Ms.
Waxman, who
also serves as
director of the
Office for Women in Medicine and
ombudsperson, was recognized by
the AAMC for her institutional
leadership at Yale, and for her
role throughout the country as an
advocate of women in medicine
and science.
Eiji Yanagisawa, M.D., HS ’5659, clinical professor of otolaryn¬
gology, was the guest speaker at the
97th annual meeting of the Otorhinolaryngological Society of Japan
held last May in Fukuoka. His pre¬
sentation was titled Video Docu¬
mentation in Otorhinolaryngology.

Lorrin Yee, M.D., associate
research scientist in medicine, has
joined the Yale Cancer Center’s
developmental therapeutics team.

Barry L. Zaret, M.D., Robert W.
Berliner Professor of Medicine and
Diagnostic Radiology, and his son,
Elliot, were one of two pairs of
Yale father-and-son exhibitors at
the Greene Art Gallery & New
England Sculptors’ Guild in Guil¬
ford, Conn., in September. The
exhibit benefited the Neighborhood
Music School of New Haven.

ACE appointments
Michael B. Bracken, Ph.D.,
professor of epidemiology
and obstetrics and gynecolo¬
gy, was installed as presi¬
dent of the American College
of Epidemiology in Balti¬
more. At the college’s recent
annual meeting, fellowship
status was conferred upon
Robert W. Ryder, M.D., the
John Rodman Paul Professor
of Epidemiology and Medi¬
cine, and Susan T. Mayne,
Ph.D., assistant professor of
epidemiology. Audrey F.
Saftlas, Ph.D., associate
research scientist in epi¬
demiology, was elected as a
member of the college. At
the same meeting, Lisbet
Lundsberg, Ph.D. ’95, asso¬
ciate research scientist in
epidemiology, was awarded
the Student Prize for her doc¬
toral thesis, Low to Moder¬

ate Drinking During Pregnan¬
cy and Intra-Uterine Growth
Retardation, Low Birth
Weight and Preterm
Delivery.
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Yale alumnus takes
the reins at Tufts

J

ohn T. Harrington, M.D. ’62, a
nephrologist who has served as
interim dean of Tufts University
School of Medicine for the past
year, has been appointed the 15th
dean of the 103-year-old medical
school by the university’s Board
of Trustees.
Dr. Harrington, who has been
professor of medicine at Tufts since
1979, was chosen after a year-long
search. Before being appointed the
medical school’s dean ad interim in
November 1995, he had served
as the school's academic dean
since 1994.
Tufts President John DiBiaggio
called Dr. Harrington “uniquely
qualified” to strengthen the univer¬
sity and the medical school’s rela¬
tionship with its teaching hospitals.
He received his undergraduate
degree from the College of the Holy
Cross in Worcester, Mass., in 1958.
A beloved teacher and mentor, Dr.
Harrington has been cited for teach¬

Edith M. Jurka, M.D. ’44, was
the keynote speaker at an interna¬
tional conference on the applica¬
tion of the arts in psychiatric ther¬
apy in August. Her topic was Path¬
ing excellence by seven of the med¬
ical school’s graduating classes and
received the school's Distinguished
Faculty Award in 1994. The new
dean and his wife, Gertrude R. Har¬
rington, live in West Roxbury,
Mass., where they raised seven
children.

Alumni/ae on campus

O

n May 30, 1996, Robert A.
Chase, M.D,, the Emile Holman
Professor of Surgery at Stanford
University, presented surgical grand
rounds at Yale. The presentation
was done in 3-D and was entitled

Stereoscopy: History and Medical
Applications. Dr. Chase graduated in the Class of ’47
at the School of Medicine and completed his specialty
training in surgery at the Yale-New Haven Hospital in
1954. After military experiences in reconstructive and
plastic surgery, he completed further training in that
specialty and returned to Yale in 1957 to initiate its
first Division of Plastic and Reconstructive Surgery.

Yale medicine

Rocko M. Fasanella, M.D. 43,
HS ’43-44, chief of ophthalmology
at Yale from 1951 to 1961, was
honored with a video tribute out¬
lining his contributions to medi¬
cine and the American Society of
Ophthalmic Plastic and Recon¬
structive Surgery as part of the
society’s 27th annual scientific
symposium held in October. The
purpose of the annual video tribute
is to introduce a society colleague
who has made major contributions
to his profession.

ways Through the Brain Which
Lead to Enhancement of Intuition
and Creativity’. The group of inter¬

national therapists, which included
six from the United States, met in
St. Petersburg, Russia; Vilnius,
Lithuania; and Prague, Czech
Republic.

continued on next page ►

In 1963, Dr. Chase was appointed chairman of
the Department of Surgery at Stanford and became
the Emile Holman Professor of Surgery. He has spent
the rest of his surgical career at Stanford, except for
three years during which he served as president and
director of the National Board of Medical Examiners.
Currently, Dr. Chase serves as a professor in the
anatomy division at Stanford. During his Yale visit, he
had the opportunity to carry on seminars with housestaff and to visit with medical school faculty members
from several departments.
Dr. Chase is currently working on the development
of computer-assisted interactive educational pro¬
grams within the computer laboratories which he
helped to develop at Stanford.
Nicholas P.R. Spinelli, M.D. ’44
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David A. Page, M.D. ’56, writes to
say that he is semi-retired in Savan¬
nah, Ga., “part time at the Georgia
Eye Institute and part time on a
golf course.”

George E. Vazakas, M.D., HS
'61-63, retired in July after 29
years in private practice in urology.
Dr. Vazakas will continue teaching
University of Massachusetts med¬
ical students and surgical residents
at Berkshire Medical Center in
Pittsfield, Mass.

Charles Zigun, M.D. ’56, is
resuming his long career in private
psychiatric practice after a fiveyear appointment with the Con¬
necticut Department of Mental
Health as an attending psychia¬
trist in the psychiatric intensive
care unit.

Joseph F.J. Curi, M.D. 64, of
Torrington, Conn., writes with
news of his four children. His two
oldest daughters, Anne and Sarah,
are practicing attorneys in Boston.

Overseas reunion

His younger children, Katheryn
and Michael, both made U.S. Row¬
ing’s 1996 Collegiate All-America
Team. Katheryn is an adolescent
counselor and women’s novice
crew coach at the University of
Vermont. Michael is a senior at
Yale College and varsity heavy¬
weight crew captain. He was
accepted early admission to the
University of Connecticut School
of Medicine.
M. Harvey Brenner, Ph.D. ’67,
professor in behavioral sciences
and health education at the Johns
Hopkins University School of
Hygiene and Public Health, was
presented the American Public
Health Association's Award for
Excellence at the annual meeting in
November in New York City. Dr.
Brenner was recognized for his
studies on relationships between
economic factors and public health.
Patricia D. Mail, M.P.H. ’67,
writes to say, “Never give up!”
Twenty-nine years after earning her
master’s degree, she finally—on
the third try—received a Ph.D.
degree from the University of
Maryland. Her research on Ameri¬
can Indians and Alcohol began at
Yale and was her dissertation topic.

Members of the Class of 1954

bridge colleges and gardens and

met in Cambridge, England, for
an interim reunion and confer¬

made day trips to London, Ely
and Lavenham, in addition to

ence in September. Their head¬

journeys to Bath, Scotland and

quarters were in Lucy Cavendish

Paris. In the picture are, seated
left to right: JoAnn Vosskuhler,

College, just a short walk from
the Backs of Cambridge colleges,
where the group is pictured with
King’s College Chapel (A.D.
1485) in the distance. There was
a meeting at the university’s hos¬
pital and, on one evening, Cam¬
bridge general practitioners and
hospital specialists joined the
group at a buffet supper. The
Yale classmates toured the Cam¬

36

Eva Henriksen, Barbara Olson,
John Rose, Barbara Pullen,
Audrey Nora and Jeanne Davis.
Standing, left to right: Phyllis
Paule, Esther McMillin, Lowell

Olson, Elizabeth Lockett, Donald
Davis, Jack Vosskuhler, Richard
Pullen, Janet Crovatto, Arthur
Crovatto, James Nora and
William Paule.

Sidney C. Smith Jr., M.D. ’67,
professor of medicine, chief of car¬
diology and director of the Acade¬
mic Center for Cardiovascular Dis¬
ease at the University of North Car¬
olina at Chapel Hill, was guest
speaker at a special American
Heart Association (AHA) presi¬
dent’s reception celebrating
research, held at the Yale School of
Medicine in October. Dr. Smith is
past president of the AHA’s
National Center.
Harry S. Holcomb III, M.D. ’68,
orthopaedic surgeon at Eastern
Shore Physicians & Surgeons Inc.
of Nassawadox, Va., addressed the
16th annual Symposium on South¬
ern New England Maritime History
in November. His talk chronicled
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A special report from Yale Medicine and the Yale Cancer Center

We’ve come farther than we ever dreamed

In 1971, cancer was a
black box. We could exam¬
ine it, turn it over in our
hands, weigh it, but could
not look inside. Today the
lid of the box has been
pried open, and we are
gazing at an incredibly
complex and beautiful
piece of machinery, a
facsimile if you will of a
normal cell. The cancer
cell has gone from a
black box to a blueprint."

Vincent T. DeVita Jr, md
Director
Yale Cancer Center

years of progress
since passage of the
National Cancer Act
on Dec. 23,1971

Twenty-five years ago. President Nixon
signed a hard-fought yet momentous piece
of legislation, the National Cancer Act. The
new law launched a massive campaign of
basic scientific research to better understand
cancer, and it promoted the wide application
of those discoveries to help patients. With
new funding and independence, the National
Cancer Institute (NCI) was expected to
work vigorously and efficiently to reduce the
suffering caused by a disease then considered
to be fatal in most cases.
Has the War on Cancer been successful?
A quarter century later, the profound impact
of the National Cancer Act is easily measured
in human terms. More than 10 million
survivors owe their lives to cancer research,
and, among children, the results have been
truly remarkable. Most cases of childhood
leukemia are now curable and death rates
for children’s cancers have declined by more
than 62 percent since 1950, according to
the NCI.
Dramatic proof of the measure’s success
came last November with a study in the
journal Cancer. For the first time since
record-keeping began in 1901, overall cancer
mortality in the United States had dropped
by 2.6 percent. This decline, observed during
the years 1991 to 1995, is likely to continue
well beyond the year 2000.
“We have come farther than the people
who framed the act ever dreamed,” says Yale
Cancer Center Director Vincent T. DeVita
Jr., MD, who headed the NCI for eight years

under Presidents Carter and Reagan. The
next 25 years, Dr. DeVita says, promise
a more fundamental shift: the beginning of
the end of cancer.
While mortality rates for certain cancers
have shown sharp declines in the past,
appreciation ot those numbers otten was
overshadowed by the rising cancer death toll
overall. But now the field has shifted, says
Dr. DeVita. “I think these declines are going
to be steady and they will continue to
deepen.You can attribute this reduction in
mortality, and the remarkable molecular
revolution we are now experiencing, to the
foresight of those involved with framing
the National Cancer Act.”
Since its passage Dec. 23, 1971, the act
has provided more than $30 billion for
cancer research and treatment. At the time
of passage, annual governmental funding
for cancer was $176 million, a budget that
today has expanded to approximately $2
billion. Says Dr. DeVita, “It is probably one
of the best investments ever made by the
U.S. government.”
Dr. DeVita joined the NCI in 1966,
after his residency at Yale-New Haven
Hospital. Six years later, he won the Albert
and Mary Lasker Prize for Medicine, for
development of the four-drug combination
known as MOPP. This chemotherapy
regimen raised the cure rate for patients with
advanced Hodgkins disease from near zero
to 65 percent.
(continued on page 2)

Present at the creation: The evolution of modern cancer research and treatment at Yale
1960s

1943

1953-1967

Yale gives birth to the field of chemotherapy

Arnold D. Welch, md, PhD, chairman of

Drs. Welch and Beeson establish the

with the work of Louis S. Goodman, md,

pharmacology, and Paul Beeson, md,

first medical oncology department at

Alfred Gilman, md, and Gustaf E. Lindskog, md,

chairman of the department of medicine,

a university under Dr. Paul Calabresi,

when they use nitrogen mustard in the

help lay the groundwork for the field of

MD, PhD.

treatment of a patient with lymphosarcoma.

medical oncology in the United States.

Yale forms statewide cancer network
New treatments being pioneered at the Yale

Oncology/Hematology Associates. Under

Cancer Center are now available to patients

the arrangement, many of the Yale Cancer

throughout Connecticut at medical centers

Center’s clinical research trials are open

participating in the newly formed Yale

to patients of these facilities and practices,

Oncology Network. The network is designed

allowing them to undergo treatment in a

to combine the expertise of the Yale Cancer

familiar setting and under the direction of

Center with that of community oncologists

their own physicians.

The Yale Oncology
Network expands on
a tradition begun in

in all corners of the state.

f

Yale Cancer Center Director Vincent

l|

1941 with the establish¬

Danbury Hospital and Bridgeport

ment of the Connecticut

Hospital are the first two affiliate cancer

network of about eight hospitals. “By

centers in the network. In addition, official

coupling the powerful research engine at

partnerships have been formed with the

Yale with the sphere of influence of commu¬

Norwich Cancer Center and two medical

nity affiliates,” he says, “advances in cancer

Tumor Registry, the
oldest defined-population
cancer database.

T. DeVita Jr.,

md,

envisions an eventual

practices, Hematology, Oncology, P.C. in

care will be more readily available to

Stamford and Northwestern Connecticut

patients all across Connecticut.”

“We’ve come farther than we ever dreamed”
(cont. from page 1)

Dr. DeVita became director of the

clinical trials, which were provided for in the

National Cancer Institute in 1980, a position

act. And the results of that funding can be

he held until 1988. Director of Yale Cancer

seen in the successful treatment of many

Center since 1993, he has assembled a

types of cancers, including breast, colon,

team and organized programs to integrate

leukemias and Hodgkins disease. Many treat¬

the world-class basic research of Yale with

ments now are less radical and less toxic and

advanced clinical treatments to benefit

have fewer side effects.

cancer patients in Connecticut and around
the world.

“The morbidity of the disease has changed
radically because of clinical trials,” says

Much of the significance of the National

Dr. DeVita, “and now we are also seeing the

Dr. DeVita with Dr. Jose

Cancer Act arises from one unique feature:

Costa, deputy director

For the first time, there was a mandate to

of Yale Cancer Center.

support the application of research, which

understanding of the differences in cellular

Dr. Costa directs the

decrease in mortality.”
Researchers are gaining a greater

expanded the NIH’s previous focus on basic

mechanisms, and the actual genes that

Shared Resource, which

research. In order to speed transfer of cancer

differentiate cancer cells from normal cells

is designed to bridge

research to the treatment of cancer patients,

have become specific targets of treatments.

basic research knowledge

the National Cancer Act established compre¬

In the future, these treatments will make

hensive cancer centers (there are 26 today)

cancer the most curable of chronic diseases,

Critical Technologies

with clinical medicine.
"Through this program,

to perform basic research and transfer that

thanks in large part to the molecular biology

the most advanced

research to the clinic. The Yale Cancer

revolution that was virtually funded by

cancer diagnostics,"

Center, founded in 1974, was one of the first

the National Cancer Act.

Dr. Costa says.

of these “matrix” centers established at major

patients will benefit from

medical schools in the United States.
Many of the advances in cancer care have
come directly from the ability to conduct

“The tools now available for us to analyze
the cancer cell machinery are breathtaking,”
says Dr. DeVita. “Seeing cancer go from
incurable to curable has been a great thrill.”

1974

1975

1970s-1980s

1986

Yale Comprehensive Cancer Center is

The Cancer Information Service is

Yale continues as an international

Yale recei'

established by the National Cancer

established by the NCI at Yale under

leader in basic cancer research and

research i gGr

Institute under the provisions of the

the leadership of Marion Morra, SCD,

drug development under the leader¬

becomes (

1971 National Cancer Act.

who shapes the international cancer

ship of Directors Joseph R. Bertino,

prevention jitlit

information field.

md, Jack W. Cole, md, and Alan C.
Sartorelli, PhD.

ok

Edward Chu: A marriage of science and nature
Edward Chu, md, arrived at Yale in 1996

developed from natural products,” says Dr.

alter working nearly 10 years at the National

Chu. Camptothecins, the most recent class of

Cancer Institute, where his background

compounds to have demonstrated impressive

in biochemical pharmacology led him to

clinical activity, come from the bark and

investigate how cancer drugs work and how

wood of a tree found in China. A number of

cancer cells become resistant to certain

herbal medicines have recently been shown

medications.

to have interesting anti-cancer properties. For

Dr. Chu’s research focuses on the anti-

example, the active ingredient inYun zhi,

metabolites and fluoropyrimidines, major

derived from the willow wood tree in China,

drugs used to treat colon and breast cancer.

recently was identified as a small protein mol¬

In particular, he applies molecular approaches

ecule that appears to have striking anti-cancer

to better understand why cancer cells be¬

activity against a number of malignancies.

come resistant to these agents.

“It is an exciting possibility,” says Dr. Chu,

It may come as a surprise to some that Dr.

“that these agents may work, in part, by

Chu is interested in the development ot drugs

causing the cancer cells to differentiate into

with a natural and herbal base. But that is one

a state that is no longer malignant. It is also

component of his research. “Many of the

possible that they help to stimulate the body’s

anti-cancer agents now in use originally

own immune system.”

Susan Mayne: Prevention and public health
For scientists pursuing state-of-the-art
research in cancer prevention and control,
Connecticut provides one of the best popu¬

causation. Dr. Mayne is working with lead

lation laboratories anywhere in the world:

investigator Tongzhang Zheng, scd, assistant

It has a statewide cancer registry that has

professor of epidemiology, to test the hypoth¬

been in operation since 1935, a relatively

esis that women with breast cancer have

large population concentrated in a small

higher-than-normal levels of organochlorine

geographic region, and a wealth of resources

compounds in their body fat. Drs. Zheng

at the Yale Cancer Center.

and Mayne, along with epidemiologist

This synergy attracted Susan T. Mayne,

Robert Dubrow, md, PhD, and breast cancer

PhD, to Yale to broaden her research in the

surgeon Barbara Ward, md, are combining

role diet may play in cancer causation.

chemical analyses of women’s fat tissue with

As assistant professor of epidemiology and

in-depth patient interviews focused on diet

the Cancer Center’s associate director for

and lifestyle.

prevention. Dr. Mayne works with colleagues
to isolate and assess the risk factors associated

and
icer

For example, little is known about the
role of environmental factors in breast cancer

For some cancers, the role of dietary
patterns is unclear, suggesting a need for

with cancer. A new tool, the Rapid Case

observational studies. One such project led

Ascertainment Shared Resource, allows

by Harvey Risch, PhD, associate professor

Yale Cancer Center investigators to identify

of epidemiology, is aimed at investigating the

cancer patients across Connecticut within

role of diet and other factors in a cancer

a few weeks of their initial diagnosis.

that is rapidly increasing, adenocarcinoma of

Following these patients from an early date

the esophagus. “These studies are needed

provides valuable data to better understand

to identify low- and high-risk behaviors,”

what causes various cancers and how they

says Dr. Mayne, “to set the stage for future

may be prevented.

prevention efforts.”

1993

1995

1994-1997

Vincent! DeVita Jr., md, pioneer
clinical oncologist and director of the
National Cancer Institute from 1980
to 1988, becomes the fourth director
of Vale Cancer Center.

The Yale Oncology Network is
formed as a framework for statewide
clinical trials conducted at Yale and
medical centers around Connecticut.

Dr. DeVita and Jose Costa, md,
deputy director of Yale Cancer
Center, establish a new program
structure at Yale Cancer Center
strongly linking basic and clinical
research.

Y

ale
Cancer
Center

lc

The Yale Cancer Center is
one of 26 comprehensive
cancer centers designated
by the National Cancer
Institute. If you would like to
support its programs, please
write to Yale Cancer Center,
Yale University School of
Medicine. PO Box 208028,
New Haven. CT 06520-8028

or

telephone 203-785-2144.
Quartermark is a special joint
publication of Yale Medicine,
the magazine of the Yale
University School of
Medicine, and the Yale
Cancer Center. Contributors:
Michael Fitzsousa, Judith
Winslow, llene Shub Lefland,
Pat Janowski. Design:
Cheney & Company

Albert Deisseroth: Cracking cancer’s genetic code
Each of us carries within our cells frag¬

The current gene therapy program at

ments of DNA that are less than perfect.

Yale is directed toward removing some of the

Some of these errors in programming will

obstacles to that long-term vision. Clinical

result in cancer.
What if we could correct those coded

trials will soon be launched for patients with
breast, ovarian and prostate cancer, to test

mistakes before a malignancy grows large

genetic interventions designed to improve

enough to threaten life, or before it occurs?

chemotherapy and radiation treatments.

Perhaps even before birth itself?
That is the long-term goal of Albert

“Gene therapy,” says Dr. Deisseroth, “will
lead to drug discovery efforts and to a whole

B. Deisseroth, MD, PhD, and his team of

new generation of medications. The way

researchers and clinicians, who are pursuing

human diseases are treated will dramatically

promising leads in the burgeoning field of

change. It also may lead someday to better

gene therapy. The development of a single

cancer prevention, by enabling clinicians to

treatment that lasts a lifetime may one day

identify and repair gene defects before

alter the field of cancer therapy at its core.

disease develops.”

Frank Hsu: A vaccine against cancer
The most common objective of a vaccine
is prevention: getting a flu shot is supposed

against non-Hodgkins lymphomas.
At Yale, Dr. Hsu is working to refine and

to protect against contracting the disease.

improve the vaccine techniques. Most of his

Oncologist Frank Hsu, MD, is engaged in

work is focused on dendritic cells, which

developing quite a different type of vaccine

provoke a strong immune response in the

to fight cancer.

body. In a clinical trial now under way, Dr.

Unlike standard vaccines, cancer

Hsu harvests blood cells from a patient, then

vaccines are meant to be therapeutic. They

isolates and purifies dendritic cell precursors

are designed not to prevent cancer, but to

from the blood.

help train the immune system to attack and

These precursors are mixed in culture

destroy existing cancerous cells. At Stanford

with tumor proteins from the same patient.

University, Dr. Hsu worked to develop and

After a few days in culture, the dendritic cells

test this approach by incorporating pieces of

mature and incorporate the tumor proteins.

cancerous cells into vaccines formulated to

By returning these cells back to the patient

stimulate the immune system. Preliminary

these modified dendritic cells can then stim¬

results from this work have shown promise

ulate response against the cancerous tumor.

the origin and operational expan¬
sion of the Benedict-Manson
Transportation Co. of New Haven.
Dr. Holcomb is a direct descendant
of the Manson Family.
Charles A. Dinarello, M.D. ’69,
HS ’69-75, professor of medicine
at the University of Colorado
School of Medicine in Denver,
received the Ludwig Heilmeyer
Gold Medal for his contributions to
progress in molecular biology for
medicine. Until 1996, he was pro¬
fessor of medicine and pediatrics at
Tufts University School of Medi¬
cine, where he established the
Sheldon M. Wolff Professorship.
Dr. Dinarello is past-vice president
of the American Society of Clinical
Investigation and president of the
International Cytokine Society. In
1993, he received the Ernst Jung
Prize in Medicine and donated the
$125,000 award to universities in
the U.S. and Israel.

Morris B. Mellion, M.D. ’70, has
been named senior vice president
of health care policy and chief
medical officer at BlueCross
BlueShield of Nebraska. Dr. Mel¬
lion is also clinical associate pro¬
fessor of family practice and
orthopaedic surgery (sports medi¬
cine) at the University of Nebraska
Medical Center, and serves as team
physician for men’s and women's
sports and as adjunct professor in
the School of Health, Physical
Education and Recreation at the
University of Nebraska
at Omaha.
Stephan Ariyan, M.D., HS ’70-76,
clinical professor of surgery (plas¬
tic) at Yale, was selected as the
1996 National Visiting Professor
for the Society of Head and Neck
Surgeons. As national visiting pro¬
fessor, Dr. Ariyan has lectured at
the universities of Toronto, Miami,
Tennessee and Louisville. He pre¬
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viously served as the society’s
president from 1992 to 1993.
Thomas W. Chapman, M.P.H.
’71, chief executive officer of the
George Washington University
Hospital and senior vice president
for network
development
of the George
Washington
Medical Cen¬
ter, has been
presented the
1996 Distin¬
guished
Alumni
Award by the
Association
of Yale
Alumni in Public Health. The cere¬
mony was part of festivities at the
Yale Club of New York City in
November at a dinner, held during
the American Public Health Asso¬
ciation annual meeting.
Mr. Chapman also serves as a
senior health advisor to the Clinton
administration on health care
reform. He is currently the national
program officer for Opening
Doors, a program to reduce socio¬
cultural barriers to health care
sponsored by the Robert Wood
Johnson Foundation and the Henry
J. Kaiser Family Foundation. He
also received the CEO of the Year
Award from the American Hospital
Association in 1989.
Harvey Fernbach, M.D. ’71,
M.P.H. ’71, of Washington, D.C.,
has a private psychiatry practice in
Maryland and is a consultant for
the American Psychiatric Associa¬
tion’s Council on Economic
Affairs. Dr. Fernbach is also on the
Medical and Chirurgical Faculty of
Maryland and a member of the
Physicians for National Health
Program, which is involved in a
national effort to establish a single¬
payer health care system.

TO GIVE AWAY MONEY IS
AN EASY MATTER AND IN
ANY MAN’S POWER. BUT
TO DECIDE TO WHOM TO
GIVE IT, AND HOW LARGE
AND WHEN, AND FOR
WHAT PURPOSE AND
HOW, IS NEITHER IN
EVERY MAN’S POWER
NOR AN EASY MATTER.

Aristotle

Assuming you would
consider the School of
Medicine as one of your
intended beneficiaries,
we stand ready to help you
with when, for what purpose,
and how.

Planned giving
is one of our specialties.

Yale University
School of Medicine
Office of Planned Giving
P.O. Box 2038
New Haven, CT 06521-2038
1-800-445-6086
Fax: 1-203-432-7901

Michael A. Kaufman, M.D. 73,
J.D., has been appointed medical
officer and senior vice president of
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BlueCross of California, the Cali¬
fornia operating subsidiary of Well¬
Point Health Networks Inc.

Columbia University, announce
the birth of their son, Devin Natan,
in August.

Harry S. Romanowitz, M.D. '73,
chairman of the department of
pediatrics at Stamford (Conn.)
Hospital, has been instrumental in
founding the new Roslyn and
Leslie Goldstein Children’s Health
Center, an outpatient primary and
specialty care pediatric clinic.
Dr. Romanowitz was the keynote
speaker at the center’s dedication.
Stephen I. Kramer, M.D., HS ’7883, was promoted to associate pro¬
fessor of psychiatry and behavioral
medicine at Bow¬
man Gray School
of Medicine in
Winston-Salem,
N.C., in Septem¬
ber. Dr. Kramer
has been an assis¬
tant professor of
psychiatry and
behavioral medi¬
cine at Bowman
since 1989.
Shannon C. Kenney, M.D. ’79, HS
'79-83, associate professor of medi¬
cine, was one of four recipients of
the 1996 Philip and Ruth Hettleman
Prizes for Artistic and Scholarly
Achievement by Young Faculty at
the University of North Carolina at
Chapel Hill. Dr. Kenney is known
worldwide among Epstein-Barr
virus researchers as a leader in the
field of regulation of viral gene
expression.

Thomas D. Fogel, M.D., HS '8285, vice president of Coastal Radia¬
tion Oncology Medical Group in
California, has been elected secre¬
tary of the 1996-97 Board of Direc¬
tors of the American Cancer Soci¬
ety’s California Division at the 50th
annual meeting held at the Fairmont
Hotel in San Francisco. Dr. Fogel
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Leila A. Mankarious, M.D. ’90,
has joined the pediatric ear, nose
and throat service at the Harvard
Medical School, Massachusetts Eye
and Ear Infirmary, in Boston.
Thomas D. Fogel M.D.

also received the division’s annual
Quality of Life Award for starting a
prostate cancer support group for
patients and families.
Kristine M. Napier, M.P.H. 84,
nutritional consultant and medical
writer, was presented a William
Harvey Award for excellence in
magazine writing on the subject of
cholesterol at the 21st annual South¬
eastern Conference on Cardiovascu¬
lar Health, hosted by the North Car¬
olina State Division of Health Pro¬
motion. The award is sponsored by
American Medical Writers Associa¬
tion, the National Heart, Lung and
Blood Institute of the National Insti¬
tutes of Health; and Bristol-Myers
Squibb Co. Ms. Napier previously
received a William Harvey Award
in 1994.
Larry Amsel, M.D. ’88, of New
York City, has been awarded a
$400,000 grant from the National
Institutes of Health’s Human
Genome Project to produce an edu¬
cational video for primary care clin¬
icians on caring for and counseling
patients facing genetic tests and
struggling with questions of testing
for genetic risks. The project is in
collaboration with the Hastings
Center for Bioethics.
Elan D. Louis, M.D. ’89, HS ’8990, and Vinita Sehgal, M.D. ’90,
both assistant professors at the Col¬
lege of Physicians and Surgeons,

Margaret R. Stevens O’Neill,
M.D. ’91, married Michael E.
O'Neill, J.D. ’90, in June 1991,
and moved to Baltimore, where
she spent two years in internal
medicine and three in dermatology
at Johns Hopkins. Dr. Stevens
O’Neill has now joined a private
practice near Washington, D.C.,
while her husband is clerking for a
Supreme Court justice. She would
love to see her classmates if they
are in the area.
Deborah A. Dillon, M.D. ’92, a
fellow in molecular pathology, was
selected to received a $25,000 fel¬
lowship as part of the College of
American Pathologists Foundation
1996-1997 Scholars Award Pro¬
gram. Dr. Dillon’s research project
will focus on the detection of tumor
DNA in the blood of patients with
tumors of the colon and pancreas.
Kathryn M. Ryder, M.D. ’92,
has been appointed assistant profes¬
sor of medicine at the University
of Nevada School of Medicine.
Dr. Ryder practices general internal
medicine and is a diplomate of
the American Board of Internal
Medicine.
Bruce G. Freeman, M.D., HS ’9396, has joined Edward H. Gleich,
M.D., HS ’75-77, at Shoreline Pedi¬
atrics and Adolescent Medicine,
which has offices in Madison and
Clinton, Conn. Dr. Freeman is
engaged to Tina M. Roman, M.D.,
a resident in pediatrics at Yale-New
Haven Hospital.
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alumni reunion weekend
PRELIMINARY

SCHEDULE

FRIDAY, JUNE 6, 1997

SATURDAY, JUNE 7, 1997

8:00 a.m. to 7:00 p.m.

7:30 a.m. to 7:00 p.m.

MEDICAL SCHOOL ALUMNI/AE REGISTRATION

MEDICAL ALUMNI/AE REGISTRATION

Sterling Hall of Medicine, Rotunda

Sterling Hall of Medicine, Rotunda

1:00 to 2:30 p.m.

7:30 to 10:00 a.m.

SCHOOL OF MEDICINE ALUMNI FUND

CONTINENTAL BREAKFAST

CLASS AGENTS AND REUNION GIFT CHAIRS LUNCHEON

Sterling Hall of Medicine, Beaumont Room

Sterling Hall of Medicine, Steiner Room
9:45 to 11:00 a.m.
1:00 to 2:45 p.m.

FACULTY SEMINAR

YALE SCHOOL OF MEDICINE

New Directions in the Treatment of Cancer
Introduction: Albert B. Deisseroth, M.D., Ph.D.
Participants: Edward Chu, M.D., Ph.D.,
Frank Hsu, M.D., Ph.D., and Barbara Burtness, M.D.
Hope Building, Room 110

CLASS REUNION PROGRAM

Hope Building
3:00 to 4:00 p.m.
ASSOCIATION OF YALE ALUMNI IN MEDICINE

Executive Committee Meeting
Sterling Hall of Medicine, Beaumont Room

11:15 a.m.
ANNUAL MEETING OF THE ASSOCIATION
OF YALE ALUMNI IN MEDICINE

4:15 p.m.
WELCOME TO REUNION 1997

Greetings and Remarks
Lycurgus M. Davey, M.D. ’43 March
President, Association of Yale Alumni in Medicine
Gerard N. Burrow, M.D. ’58
Dean, School of Medicine
YALE SCHOOL OF MEDICINE SPECIAL PRESENTATION

Albert B. Deisseroth, M.D., Ph.D.,
Ensign Professor of Medicine
Chief, Section of Medical Oncology
Hope Building, Room 110

Welcome and Remarks
Lycurgus M. Davey, M.D. ’43 March,
President of the Association
Greetings
Richard C. Levin
President, Yale University
State of the School Address
Gerard N. Burrow, M.D. ’58
Dean, School of Medicine
Alumni in Medicine Distinguished
Service Award Presentation
Brady Auditorium, 310 Cedar Street
12:15 p.m.
SHERRY

5:15 p.m.
DEAN’S RECEPTION

12:30 p.m.

Historical Library
333 Cedar Street
Open to all alumni/ae, faculty, students and guests

Edward S. Harkness Hall, 367 Cedar Street

6:15 p.m.

2:45 p.m.

BARBECUE/BUFFET

GUIDED TOURS

Edward S. Harkness Hall
367 Cedar Street
Open to all alumni/ae, faculty, students and guests
Pre-paid advance registration required

Yale Center for British Art 3:00 to 4:00 p.m.
Historic Sections of New Haven 3:00 to 4:15 p.m.
Yale-New Haven Children’s Hospital
3:00 to 4:00p.m.

BUFFET LUNCHEON

For additional information, call 203-785-4674
Yale medicine
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OBITUARIES

Ralph D. Alley
Ralph D. Alley, M.D., died Sept. 7
at his home in Loudonville, N.Y. He
was 78.
Born in India, the son of mis¬
sionary parents. Dr. Alley spent his
first 15 years there and attended the
Woodstock School at the base of
the Himalayas. He graduated from
the University of Virginia in 1939
and from Yale School of Medicine
in 1943.

From 1973 to 1983, he was the
head of the division of cardiotho¬
racic surgery at Albany Medical
College and visiting professor on
the faculty of the University of Vir¬
ginia. Dr. Alley was a founding
member of the Society of Thoracic
Surgeons and served as president in
1976. He also served as regent to
the American College of Surgeons
for a nine-year period and was a
member of the American Board of
Thoracic Surgery.

Louise Bates Ames

Dr. Alley served in the U.S.
Navy as a medical officer aboard
the LST 292 during the Normandy
invasion of Omaha Beach on DDay, June 6, 1944. He completed
residencies in general and cardiothoracic surgery at Yale-New
Haven Hospital and, in 1952,
moved to Albany. In 1954, he was
the first surgeon to repair a trau¬
matic aneurysm of the aortic arch
using external shunts developed in
his surgical laboratory, and he
became internationally known as a
pioneer in cardiothoracic surgery.
Dr. Alley, along with David S.
Sheridan of Argyle, N.Y., invented
numerous catheters and medical
devices still widely used today.
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Louise Bates Ames, born in Port¬
land, Maine, died from thyroid can¬
cer on Oct. 31 at the home of her
granddaughter in Cincinnati. She
was 88.
Dr. Ames received her B.A. and
M.A. degrees from the University
of Maine and her Ph.D. degree from
Yale University in 1936. She was
on the staff of the Yale Clinic of
Child Development from 1933 to
1948 as a personal research assis¬
tant to Dr. Arnold Gesell. In 1950,
she and two other collaborators of
Dr. Gesell—Dr. Frances Ilg and Dr.
Janet Rodell—established the
Gesell Institute in Child Develop¬
ment in New Haven, which later
became the Gesell Institute of
Human Development.
Dr. Ames was one of the first
researchers to track the develop¬
mental phases of childhood. From
1976 to 1985 she wrote a series of
guides, beginning with Your One
Year Old, that helped parents feel
that they were on target even while
their children seemed in turmoil.
Dr. Ames wrote 25 books,
many scientific articles and a syndi¬
cated newspaper column. She
appeared on the Phil Donahue and
Oprah Winfrey shows and, for a

time, her own weekly television
program. From 1944 to 1950, she
was curator of Yale Films of Child
Development. In 1991 she became
a lecturer at the Yale Child Study
Center and since 1993, an assistant
professor emeritus at Yale.

C. Elton Cahow
C. Elton Cahow, M.D., died Jan. 2
at his home in Branford, Conn. He
was 65.
Dr. Cahow was born in Fort
Pierce, Fla. He graduated in 1952
from Davidson College in North
Carolina with a bachelor’s degree
in chemistry and received a medical
degree from the Cornell University
School of Medicine in 1956. He
served internships in both surgery
and medicine at New York Hospital-Cornell Medical Center and
completed his residency in general
and cardiothoracic surgery under
the late Frank Glenn, M.D., at the
New York Hospital.
In 1963, Dr. Cahow joined the
faculty at Yale as an instructor in
the Department of Surgery. During
his 33 years at Yale, he served from
1964 to 1970 as assistant professor,
from 1970 to 1977 as associate pro¬
fessor and from 1977 to 1987 as
professor of surgery. In 1987, Dr.
Cahow was named the William H.
Carmalt Professor of Surgery and
was also appointed vice chairman
of the department and chief of the
section of general surgery at the
medical school and at Yale-New
Haven Hospital. He was also pro¬
gram director of surgical residency
at the hospital.
Dr. Cahow’s wife, Barbara
Kinder Cahow, M.D., is chief of
surgery at the VA Connecticut
Healthcare System in West Haven.
In December, Dr. Kinder was
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named the William H. Carmalt Pro¬
fessor of Surgery.
Although his clinical interests
spanned the entire field of general
surgery, he developed particular
interest in the areas of liver, pancre¬
atic and biliary tract surgery. In
recent years. Dr. Cahow embraced
the techniques of laparoscopic
surgery and became an interna¬
tional leader in the performance,
critical evaluation and teaching of
these techniques. He was a fellow
of the American College of Sur¬
geons and belonged to a multitude
of professional associations. He
was past president of the Connecti¬
cut Society of the American Board
of Surgeons.
Memorial contributions may
be made to the C. Elton Cahow
Endowment Fund, c/o Larry
Jerome, Senior Development Offi¬
cer for Medical Development, 100
Church St. South, P.O. Box 7611,
New Haven, CT 06519. A memor¬
ial service will be held May 23 in
Battell Chapel.

Louis A. Cohen
Louis A. Cohen, Ph.D., of West
Bethesda, Md., died after a heart
attack Sept. 12 at a hospital in
Edinburgh, Scotland, while attend¬
ing a conference. He was 70.
Dr. Cohen, a Boston native,
was a 1949 organic chemistry grad¬
uate of Northeastern University and
received a doctorate in organic and
biological chemistry from Massa¬
chusetts Institute of Technology.
He was on the biochemistry faculty
at Yale medical school from 1952
to 1954.
In 1955, he moved to
Bethesda, Md., while working as
an organic chemist for the National
Institutes of Health (NIH). From
1957 to 1960, he was an adjunct
professor of chemistry at Howard
University. Since 1966, Dr. Cohen
had been director of the NIH’s
Graduate School of the Foundation
for Advanced Education in
the Sciences.

YALE MEDICINE

Donald S. Dock
Donald Stone Dock, M.D., died
Dec. 3 at Connecticut Hospice. He
was 69.
Bom in New York City, Dr.
Dock was a graduate of Princeton
University and the Johns Hopkins
University School of Medicine. He
had post-graduate training at Yale
University and Harvard. Dr. Dock
lived in Madison, Conn., for 26
years before moving to Branford
in 1986.
He was a New Haven cardiolo¬
gist for 36 years, most recently
with the Connecticut Heart Group.
Dr. Dock was chief of medicine at
the Hospital of Saint Raphael from
1963 to 1981, except for the years
1972 to 1974, when he was chief of
medicine at the Atomic Bomb
Casualty Commission in Hiroshima
and Nagasaki, Japan. More
recently. Dr. Dock was director of
the coronary care unit, director of
the Take Heart cardiac rehabilita¬
tion program and director of elec¬
trocardiography and Holter moni¬
tors at St. Raphael’s. He was a clin¬
ical professor of medicine at Yale
and an associate fellow at Berkeley
College. Dr. Dock was awarded the
Dr. Oscar Roth Award in 1996 by
Saint Raphael’s for his many years
of dedication and service to his
patients and to the hospital.

A Charitable
Annuity:
The YSM gift
that rates
In exchange for a gift of
$5,000 or more, the School of
Medicine can offer you, or you
and your spouse, a fixed annual
income for life.
Your age(s) and market
rates of interest determine
your income level.
Current sample rates:
Age(s)

Rate

One life

55
66
77

4.8%
5.9%
8.2%

Two lives

66/65
75/74
82/79

4.9%
5.9%
7.1%

Please allow us to tailor
a proposal to your
philanthropic
and financial goals.

William R. Goff
William Richard Goff, Ph.D., of
Branford, Conn., died Sept. 10 at
Connecticut Hospice. He was 66.
Dr. Goff was born in Provi¬
dence, R.I., and received a doctor¬
ate from the University of Virginia.
He was professor emeritus of neu¬
rology and psychology at Yale
School of Medicine and former
director of the neuro-psychology
laboratory at the VA Connecticut
Healthcare System in West Haven.
Dr. Goff helped design and build
the first analog computer to
study electrical activity of the
human brain.

Yale University
School of Medicine
Office of Planned Giving
P.O. Box 2038
New Haven, CT 06521-2038
1-800-445-6086
Fax: 1-203-432-7901
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Contribute to the
School of Medicine’s
Future and Invest in
Your Own
Yale University's life income
program offers graduates of the
School of Medicine the oppor¬
tunity to:
■ Help ensure the future
of a great institution

■ Receive quarterly
income payments
for life

■ Increase your income
from low-yielding stock with¬
out incurring capital gains
taxes

■ Reduce federal and
state taxes

Please call or write to see if
you can use these benefits to
the mutual advantage of you
and the School of Medicine.

At the time of his retirement in
1986, he was professor of neurology
at Yale and a research career scien¬
tist at the VA.

Frederick R. Hine
Frederick R. Hine, M.D., died Sept.
12 at Duke University Medical Cen¬
ter in Durham, N.C. He was 70.
Born in Cincinnati, Ohio, Dr.
Hine received a bachelor’s degree
from Yale in 1946 and graduated
from the medical school in 1949. He
was a psychiatric intern at Charity
Hospital in New Orleans and a resi¬
dent at Tulane University School of
Medicine, where he was later a
member of the faculty. In 1953, he
became affiliated with the Southeast
Louisiana Hospital in Mandeville.
In 1959, Dr. Hine joined the
staff at Duke University and began a
long tenure, beginning as an assis¬
tant professor of psychiatry, becom¬
ing an associate professor in 1963
and full professor in 1971. During
his 37 years at Duke, he was chair¬
man of the medical school training
committee for the Department of
Psychiatry from 1962 to 1974, and
director of medical student educa¬
tion in psychiatry until the time of
his death. He is the only three-time
recipient of Duke University
medical school’s Honored
Teacher Award.

J. Louis Jack

Yale University
School of Medicine
Office of Planned Giving
P.O. Box 2038
New Haven, CT 06521-2038
1-800-445-6086
Fax: 1-203-432-7901
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J. Louis Jack, M.D., died Nov. 19 at
his home in North Haven, Conn. He
was 103.
Dr. Jack, born in New York
City, attended Brown University
and graduated in 1915 from Rhode
Island State College in Kingston,
now known as the University of
Rhode Island. He taught science and
coached at East Providence High
School. From 1917 to 1919, Dr.
Jack served in France as a member
of the Second Field Artillery. In
1923, he graduated from Yale
School of Medicine and interned at

Bellevue and Staten Island hospitals
in New York. He was a surgeon at
the former Grace-New Haven Hos¬
pital, retiring in 1950, and was also
in private practice with his brother,
the late Gabriel J. Jack, M.D.
In October 1948, his painting
Young Men In Green was featured in
TIME magazine. In 1992, on his
100th birthday, he was honored with
a Doctor of Humane Letters degree
by the University of Rhode Island
and was also the first recipient of
its Distinguished Alumni Award
in 1990.

Warren R. Johnson
Warren R. Johnson, M.D., died Aug.
28 of cancer at his home in Fairway
Falls, Pike Creek, Del. He was 65.
Dr. Johnson graduated in 1953
from Colby College in Waterville,
Maine, and in 1957 from the Yale
School of Medicine. He completed
his pediatric internship and resi¬
dency at Delaware Hospital, Wilm¬
ington Medical Center, and was a
fellow in pediatrics at Johns Hop¬
kins Hospital in Baltimore from
1960 to 1961. Dr. Johnson served as
secretary of the Delaware Hospital
medical staff from 1963 to 1970,
senior attending physician in the
department of pediatrics from 1970
to 1973, and chairman of the depart¬
ment of pediatrics credentials com¬
mittee from 1973 to 1980. Since
then, he had been in private practice
and was director of medical educa¬
tion for pediatrics at the Medical
Center of Delaware. Dr. Johnson
was also active in the Health Care of
the Homeless Program at Henrietta
Johnson Clinic.

John W. King
John Weaver King, M.D, Ph.D.,
died Oct. 9 at his Cleveland
Heights, Ohio, home. He was 80.
Born in Bakerton, Pa., Dr. King
earned a master’s degree in dairy
science from Pennsylvania State
University and a doctorate in bacte-
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riology from Yale in 1941 before
completing his medical degree at
Yale in 1944. After an internship in
Philadelphia, he taught at the Ver¬
mont Medical School in Burlington
for four years. In 1950, Dr. King
joined the Cleveland Clinic, where
his devotion to upgrading the labo¬
ratories led to the naming of the
medical technology department
after him following his retirement.
He headed the hospital medical lab¬
oratory for the Cleveland Clinic
Foundation and, in 1980, retired
as director of the foundation’s
blood banks.
Dr. King served in the Army in
active duty in San Antonio, Texas,
during the 1950s and as a reservist
in the 1970s. He was commanding
officer of the 256th General Hospi¬
tal in Parma, Texas, from 1973 until
he retired in 1975.

Leonard Parente
Leonard Parente, M.D., died Nov. 9
in the Hospital of St. Raphael in
New Haven.
Dr. Parente was born in New
Haven and received a bachelor’s
degree from Yale in 1927. After
earning his medical degree from
Emory University, he completed an
internship and residency in pedi¬
atrics, and entered private practice.
In 1942, Dr. Parente earned an
M.P.H. degree from Yale. He was a
lecturer in public health at the med¬
ical school and director of health
for the town of Hamden, Conn., for
28 years. Dr. Parente was the first
medical director of the Connecticut
Department of Welfare. He was
president of the Connecticut
Public Health Association and
a fellow of the American Public
Health Association.

Earl J. Rhoades
Earl J. Rhoades, M.D., died Oct. 8
in the Dover Rehabilitation and
Living Center, Dover, N.H. He
was 83.
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Dr. Rhoades was bom in West
Pittston, Pa., and attended Lafayette
and Wilkes colleges. He received an
M.D. degree from Yale in 1943.
After an internship at Henry Ford
Hospital, he received further
orthopaedic training at Northwest¬
ern University, the Bronx Veterans
Administration Hospital and the
Hospital for Special Surgery in
New York City. He served as a cap¬
tain in the Army’s 375th
Orthopaedic Detachment from
1944 to 1947 and was chief of
orthopaedics at Tripler Army Med¬
ical Center in Honolulu at the time
of discharge.
Dr. Rhoades was a specialist in
orthopaedic surgery in New Haven
for 32 years, attending at Yale-New
Haven and St. Raphael’s hospitals.
He served as an associate attending
at Newington Children’s Hospital.
Dr. Rhoades was also on the clinical
faculty at Yale School of Medicine,
a member of the Yale Orthopaedic
Association and a past editor of the
Yale Journal of Biology and Medi¬
cine. He lived in Woodbridge and

Orange for many years before mov¬
ing to New Durham, N.H., in 1994.

IN

MEMORIAM

Ralph D. Alley, M.D. '43
September 7, 1996

George A. Carden Jr., M.D. '35
August 10, 1996

Raymond S. Duff, M.D. ’52, M.P.H. ’59
June 21, 1996

Eugene Field, M.D., HS ’36
May 1995

Richard L. Frank, M.D. ’31
February 10, 1996

Frederick R. Hine, M.D. ’49
September 12, 1996

Warren R. Johnson, M.D. ’57
August 28, 1996

Ferdinand G. Kojis, M.D. '28
April 1991

Margaret J. Lindsay, M.P.H. ’68
July 6, 1996

Murray Z. Rosenberg
Murray Z. Rosenberg, M.D., died
Sept. 1 at the home of his son in
Asheville, N.C. He was 71.
Dr. Rosenberg formerly lived
in Storrs, Conn., and had a home in
Longboat Key, Fla. He graduated in
1946 from Harvard University and
in 1949 from Yale School of Medi¬
cine. For 30 years until his retire¬
ment in 1986, Dr. Rosenberg served
as chief of pathology and as direc¬
tor of the clinical laboratory at
Windham Community Memorial
Hospital in Willimantic, Conn. He
also had clinical appointments at
Yale University and the University
of Connecticut medical schools.
Dr. Rosenberg served in the
U.S. Navy during World War II and
served as an Army physician at the
406th Laboratory in Tokyo from
1951 to 1953.

Leonard Parente, M.D., M.P.H. ’42
November 9, 1996

Earl J. Rhoades, M.D. '43
October 8, 1996

Murray Z. Rosenberg, M.D. ’49
September 1, 1996

William F. Stephenson, M.D. ’52
August 23, 1996

David C. Sundmacker, M.P.H. ’75
October 11, 1996

Constance B. Thomas, M.P.H. '53
August 28, 1996
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Sarah A. Schleck

in 1991, both from Yale School of
Medicine's Department of Epidemi¬
ology and Public Health. Dr.
Schleck worked as an associate in
research and a laboratory supervisor
at Yale. At the time of her death, she
was the operating room scheduling
coordinator for heart surgery at
Duke University Medical Hospital.
Dr. Schleck was past president
of the Yale Epidemiology and Pub¬
lic Health Doctoral Student Organi¬
zation and had served on a Yale

Sarah Ann Schleck, Ph.D., died
Nov. 16 at Duke University Medical
Hospital. She was 45.
Bom in Morristown, N.J., Dr.
Schleck lived in Madison, Conn.,
from 1979 until moving to North
Carolina in 1992. She received a
B.A. degree from Mount Holyoke
College in South Hadley, Mass., in
1973. She received a master’s
degree in 1985 and a Ph.D. degree

“Doctor,; how can I
thank you?”
ow many times have you heard this question from
your patients? Your answer can lead to a way to
help the Yale School of Medicine. A gift from your
patient to the School honors you and guarantees
the continuation of our tradition of excellence in
teaching and patient care into the 2ist century.

“Yale School of Medicine was and remains
extremely important to me in the ongoing development

of

my busy practice. I am proud of my close relationship with the School,
even though I am geographically far from New Haven. My patients
regularly take an interest in my research and clinical activities, and I
am more than happy

for Yale

to share with them my fondness

in order to stimulate their interest in the School’s mission."
Dudley Seth Danoff,

M.D. ’63, F.A.C.S.

Beverly Hills, California

I am a proud graduate of Yale
School of Medicine and an active participant in the teaching

“My patients know that

program. They also know that one of the best ways to make me
happy is

to give to my alma mater.”
Mary Jane Minkin,

M.D. 75

New Haven, Connecticut

Brochures promoting the School are available for
display in your office, to generate the revenue
needed to continue our standard of excellence.
Free copies are available from:
Bonnie Sargent
Office of Development
Yale University School of Medii

P.0. Box 7611
New Haven, Connecticut

Or call:
203.785.6760

06519-

Graduate Professional Student
Senate committee.

Constance B. Thomas
Constance Bancroft Thomas, M.N.,
M.P.H., died Aug. 28 at her home in
Frederick, Md. She was 79.
Mrs. Thomas, bom in New
Haven, earned two master’s degrees
from Yale University, one in nursing
in 1944 and one in public health in
1953. She received her bachelor’s
degree in music from the University
of Pennsylvania. Before her mar¬
riage, Mrs. Thomas worked as a
public health educator for the Den¬
ver Tuberculosis Society and as a
head nurse at Yale-New Haven Hos¬
pital and later at the State University
of New York at Geneseo.

Edward M. Wakeman
Edward Maurice Wakeman, M.D.,
died Oct. 12 at the M.D. Anderson
Hospital Cancer Center in Houston,
Texas.
Dr. Wakeman, bom in New
Haven, was a graduate of Yale Col¬
lege and the University of Pennsyl¬
vania School of Medicine. Follow¬
ing an internship at the Mary Imogene Bassett Hospital in Cooperstown, N.Y., and a tour in the Navy
as a flight surgeon, he returned to
New Haven for his pediatric resi¬
dency at Grace-New Haven Hospi¬
tal and was named chief resident in
1962. Dr. Wakeman was in a private
pediatrics practice in Guilford,
Conn., for 33 years until the time of
his death. He was a fellow of the
American Academy of Pediatrics,
an associate clinical professor of
pediatrics at Yale and was recently
named a member of the board of
directors of Yale Preferred Health.
Dr. Wakeman served on the
Guilford Board of Education and
founded the Guilford Center for
Children, the first state-supported
day care center for children in Con¬
necticut and served as chairman
from 1971 to 1975.
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From the dean of the School of Medicine

A

Dean Gerard N. Burrow, M.D. '58

s change touches our research-intensive medical school, it is reassur¬
ing to note that two rich traditions continue to prevail and even flour¬
ish. These are, of course, the Yale System of medical education, which
remains the framework of our dynamic curriculum, and the original
research that our students conduct for their theses, an academic require¬
ment at Yale for more than 150 years.
During this transitional period for both the practice and profession of
medicine, another impressive tradition continues as well, in the form of
loyal support from Yale alumni/ae.
Just as you and your classmates did, Yale medical students today excel
in academics and community service. And your contributions to the
School of Medicine help to support their education.
Last year, your gifts and pledges to the Medical School Alumni Fund
totaled more than $2 million. For this generosity, my deep appreciation
goes to fund chairman Daniel L. Arons, M.D. ’67, his committee, the
reunion gift chairs, class agents and to the hundreds of Yale alumni/ae who
support this school.
As dean of the Yale School of Medicine, I cherish the interactions with
the students, our future alumni/ae, and delight in interactions with current
Yale alumni/ae, who have given so much to our profession, the health of
many who live in America, and to this school.

From the chairman of the Medical School Alumni Fund

T

his has been a very impressive
year for the Yale Medical School
Alumni Fund. I have enjoyed getting
to know many of the volunteers and
donors who are so loyal to our alma
mater. Our support of the medical
school has gained prominent recog¬
nition within the entire Yale Alumni
Fund program, and I am very proud
to serve as your representative.
There is a great deal of excite¬
ment in the air as we are in the final
year of Yale’s remarkable $1.5 bil¬
lion campaign. Hundreds of medical
school graduates will be counted in
the campaign honor roll, having
made special reunion gifts toward
the many worthy needs at the School
of Medicine and having supported

Yale medicine

the Annual Fund generously each
year. In particular, I am very grateful
for those who have made contribu¬
tions toward the renovation of Harkness Hall and new student laboratory
facilities. As Dean Burrow has told
us, these two projects especially
need alumni/ae backing, and it has
been heartening to see so many grad¬
uates stepping forward to make the
school an even better place for future
generations of students.
Thank you very much to more
than 2.000 alumni/ae who made gifts
or pledges in 1995-96. You brought
us to 50 percent participation, help¬
ing us to be a leader among our peer
institutions at Yale. Our reunion
continued on next page ►

Daniel L. Arons, M.D. '67
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classes had an extraordinary year, raising
more than $2 million. We were led by the
Class of 1946, which achieved a reunion
giving record of more than $1.1 million
and reached the highest percentage of
participation among reunion classes with
80 percent. The Class of 1971 also had a
great reunion gift effort, raising more
than $300,000 for the school.
I would like to recognize and thank
the reunion gift chairs who did such great
work to make all of this possible: John
Ogilvie, M.D., for the classes of 1926,
1931 and 1936; Peter Duncan, M.D., for
1941; Frank Behrle, M.D., 1946; Arthur
Pava, M.D., 1951; Dwight Miller, M.D.,
1956; Anoush Miridjanian, M.D., 1961;
John Baxter, M.D., 1966; Richard Moggio, M.D., 1971; Alfredo Axtmayer,
M.D.. 1976; Anthony Urbano, M.D.,
1981; Eric Suan, M.D., 1986. We are also
grateful for the wonderful leadership of
Andrew McGowan, M.D. '58, and the
Reunion Gift Program Committee on the
YSM Alumni Fund Board.
Annual Fund gifts from alumni/ae
and friends remain a vital source of fund¬
ing for the School of Medicine, and raised
well over $400,000 last year to benefit
current medical students. Thanks to the
dedication and hard work of more than
100 class agents, the school is able to
make personal contact with its graduates
to sustain this wonderful support. Special
thanks go to Howard Minners, M.D. '57,
the class agent who achieved the highest
participation rate (for the second year in a
row), with almost 90 percent of his group
of classmates contributing.
All of the donors for 1995-96 are
listed with their classes, and those who
made leadership contributions also are
recognized in the Sterling Association
listing.
Please join me again this year in
building the extraordinary legacy of the
Yale Medical School Alumni Fund.
Through our annual and reunion giving,
we are making an important and tangible
difference in the lives of current and
future medical students as we give some¬
thing back to the school where we began
our lives as physicians.

Medical School Alumni Fund
The names and data included on the fol¬
lowing pages reflect contributions made
and endowment income accumulated
between July 1, 1995, and June 30, 1996.
The class members recognized made a gift
to the fund during that period. Endowment
income is not reflected in the class partici¬
pation percent. If we have inadvertently
omitted your name, please accept our
apologies and contact Mr. William K.
Jenkins in care of this magazine so that
we may correct this omission.

1938
Gift: $6,498
Participation: 60%
Agent:
Nelson K. Ordway

1925

1933

Gift: $650

Gift: $2,353

Participation: 100%

Participation: 57%

Samuel Reback

1926
Gift: $556

Maxwell Bogin

1927
Gift: $1,452

Agent:
Fred W. Base

Fred W. Buse
Warren P. Cordes
John G. Martin
Francis M. Woods

Participation: 76%
Agent:

Participation: 57%
Agent:

Participation: 100%

Edward R Kearney
Nathan E. Ross

1929
Gift: $3,014
Participation: 67%

John B. Ogilvie

Joseph Budnitz
Knowles B. Lawrence
Herbert C. Miller
John B. Ogilvie
Harry Sherman

1935
Gift: $8,530

Olive Gates
George S. Goldman
John A. Hangen

1930
Gift: $702

Knox H. Finley

1931
Gift: $6,427
Participation: 50%
Agent:
Thomas C. Jaleski
Reunion Gift
Chairman:
John B. Ogilvie

Paul A. Harper
Thomas C. Jaleski

1932
Gift: $3,213

Participation: 27%
Agent:
James Q. Haralambie

H. Hoffman Groskloss
James Q. Haralambie
Samuel D. Kushlan

1936
Gift: $42,219
Participation: 25%
Agent:
Nicholas D. D 'Esopo
Reunion Gift Chairman:
John B. Ogilvie

Albert W. Diddle
Margaret C. Gildea
Philip M. LeCompte
Stephen F. Nagyfy
Margaret Sommers

1937
Gift: $12,133

Frank Carroll
Lee E. Farr
Myron E. Wegman

1939
Gift: $164,743

1934

1928
Gift: $1,423

Benjamin E. Lyons
John J. McGillicuddy
Nelson K. Ordway
James Radcliffe Jr.
George E. Roberge
Theodore W. Steege
Lester J. Wallman

Gift: $5,290

William C. Meredith

Participation: 38%
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William G. Cooper Jr.
Guido A. Deblasio
Alfred E. King
Dunham Kirkham
Julia MehlmanGreenhut
James P. Morrill
T. Dennie Pratt
Morgan Sargent
Albert D. Spicer
John M. Thomas
Jean Wells

Participation: 53%
Agent:
Wilbur D. Johnston

Rebecca Z. Solomon

Harold H. Coppersmith
Norman L. Cressy
William H.
Druckemiller
John P. Ferguson Jr.
Joseph B. Forman
S. Jerome Greenfield
Arthur E. Laidlaw
Margaret A. Lennox
Buchthal
James P. Murphy
Douglas S. Riggs
Ernest L. Sarason
Bradford Simmons
Rebecca Z. Solomon
John D. Tobin
Douglass W. Walker
John H. Wentworth

1940
Gift: $7,040
Participation: 65%
Agent:
James F. Ferguson Jr.

Theodore E. Allen
Joseph V. Baldwin
Ronald S. Beckett
Jack S. Blaisdell
Wynant Dean
Richard E. Dormont
James F. Ferguson Jr.
Eugene J. Fitzpatrick
Henry D. Humphrey
Donald G. Johnson
Ira D. LeFevre Jr.
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Paul D. MacLean
Edward Martin
Robert T. Rowe
Lee S. Sannella
Bryce A. Smith
Patricia E. Wanning
Helen H. Woods

1941
Gift: $31,320
Participation: 65%
Agent:
Willys M. Monroe
Reunion Gift Chairman:
Peter Duncan

Sophia C. Alway
W. Randal Bell
Charles B. Cheney
Herbert W. Diefendorf
Peter A. Duncan
Lloyd D. Flint
Frederick P. Glike
Thomas S. Harvey
William Lee
Bjom Lih
F. Eugene Martin
Willys M. Monroe
Edward B. O’Connell
Robert W. Ollayos

1942
Gift: $20,400
Participation: 74%
Agent:
Walter J. Burdette

William E. Bloomer
James M. Bunce
Walter J. Burdette
Robert E. Carroll
Donald S. Childs Jr.
Vincent J. Collins
Hendrik DeKruif
Davitt Felder
William Harrison Jr.
Leo Kellerman
John R. Lincoln
Samuel Ritvo
Lois K. Rogers
Charles F. Scholhamer
Richmond W. Smith Jr.
Carter Stilson
Maurice Tulin
Irving N. Wolfson

1943-March
Gift: $15,778
Participation: 74%
Agent:
Dorothea R. Peck

Ralph D. Alley
John R. Brobeck
Lycurgus M. Davey
Gerard Fountain
R. Leonard Kemler
J, Philip Loge
Henry E. Markley

Yale medicine

Dorothea R. Peck
Edward F. Rabe
Earl J. Rhoades
Henry A. Riedel
Bernard R. Rowen
Marcus E. Sanford
Edward H. Soule
Hilliard Spitz
Nicholas M. Stahl
Oliver G. Stonington
Sophie C. Trent-Stevens
Morris A. Wessel
Robert H. Wyatt

Edwin F. Lang Jr.
Ronald E. Losee
Ellen P. MacKenzie
Katharine H. Martin
Joseph Massaro
A. Reese Matteson
Russell R. Monroe
Lawrence K. Pickett
Laurence G. Roth
Sarah P. Sherwood
Nicholas P. Spinelli
Priscilla D. Taft
Anthony Varjabedian

1943-December

1945

Gift: $6,140

Gift: $21,651

Participation: 58%

Participation: 67%

Agent:

Agent:

S. Brownlee Brinkley

John R. Almklov
David G. Borden
Robert F. Bradley
S. Brownlee Brinkley
Henry B. Bruyn Jr.
Thomas L. Bucky
Jane B. Cadbury
Donald G. Clark
Hunter H. Comly
Norman I. Condit
Thomas D. Cook
Ronald W. Cooke
Joseph I. Epstein
Robert H. Furman
Henry H. Jones
Joseph F. Kell
Benjamin R. Robinson Jr.
Donald W. Seldin
W. Keasley Welch

1944
Gift: $88,138
Participation: 83%
Agent:
Nicholas P.R. Spinelli

Carl E. Andrews
Edward J. Conway
Robert E. Cooke
John C. Coolidge
George B. Corcoran Jr.
Frank W. Countryman
Charles H. Crothers
Lawrence G. Crowley
Sanford R. Dietrich
John H. Doherty
Robert W. Frelick
Carol Goldenthal
Howard B. Hamilton
Robert I. Hinkley
Donald H. Holden
W. Raymond James
Ward S. Jenkins
Edith M. Jurka
Harvey W. Kausel
Jerome J. Kaye
John W. King
Frederick F. Krauskopf

Richard W. Breck

George H. Allison
Albert S. Atwood
Richard W. Breck
Louise H. Burr
Alice S. Cary
Thomas P. Cotter
Richard R. Dyer
Robert S. Easton
Alice D. Friedman
Raymond A. Gagliardi
James D. Gardam
Philip S. Good
Herbert S. Hamed Jr.
Isao Hirata Jr.
O. Roger Hollan
Hans R. Huessy
Leland W. Jones
Michael W. Lau
William E. Laupus
Mark M. Lindsey
Charles U. Lowe
James R. Mason
Charles E. McLean
George W.
Naumburg Jr.
Fitzhugh C. Pannill
Charles E. Sherwood
Joseph R. Stanton
Kenneth C. Steele

1946
Gift: $1,155,059
Participation: 80%
Agents:
Franklin C. Behrle
Joe D. Morris
Reunion Gift Chairman:
Franklin C. Behrle

Margaret J. Albrink
Joseph A. Arminio
William G. Banfield Jr.
Aaron T. Beck
Franklin C. Behrle
Sanfurd G. Bluestein
Linus W. Cave
Thomas J. Coleman
George C. Cusick

Thomas A. Doe
Edward F. Edinger
Martin E. Gordon
John C. Hoover
Ruth S. Kempe
Harold King
James A. Kleeman
Vincent J. Longo
Hugh J. McLane
Joe D. Morris
John H. Morton
John F. Neville Jr.
Laura W. Neville
Robert H. Owens
Vincent Pepe
David H. Riege
Phillips E. Roth
Julian A. Sachs
Donald P. Shedd
Richard G. Sisson
R. Bruce Thayer
Robert R. Wagner
William P. Walsh
William J.
Wedemeyer Jr.
Elihu S. Wing Jr.

1947
Gift: $37,838
Participation: 77%
Agents:
George R. Barnes Jr.
W. Roy Breg Jr.

George R. Barnes Jr.
Henry N. Blansfield
John E. Bowers
W. Roy Breg Jr.
Rocco A. Calandruccio
John L. Cannon
Betty P. Carlin
M. Richard Carlin
John C. Carpenter
Charles R. Cavanagh Jr.
Robert A. Chase
Amoz I. Chemoff
William F. Collins Jr.
Robert P. Darrow
Archie L. Dean Jr.
Owen W. Doyle
Franklin H. Epstein
Richard K. Friedlander
Frank L. Golbranson
Frank H. Horton
Robert J. Kerin
Brock Lynch
Victor A. Machcinski
William K. McClelland
Robert F. Newton
Myron K. Nobil
Philip H. Philbin
Olive E. Pitkin
Irving Rudman
Alvin Somberg
Patricia B. Tudbury
Ellis J. Van Slyck
M. Henry Williams Jr.

1948
Gift: $6,300
Participation: 64%
Agent:
Anne Godley

George F. Batten
Edith M. Beck
Jonathan S. Bishop
Richard S. Buker Jr.
Elizabeth F. Eisner
Albert A. Fisk
Emil Frei
Julian Frieden
Anne Godley
Paul S. Goldstein
B. Herold Griffith
Sylvia P. Griffiths
Richard M. Hannah
Ross R. Harcus
Paul B. Koehler
Robert E. Lempke
John P. Morris
John B. Morrison
David E. Morton
Richard C. Peterson
George P. Rostel
Lewis P. Rowland
Benjamin F. Rush Jr.
Jerome H. Shapiro
William A. Sibley
Jessie P. Spear
Paul Talalay
Wallace W. Turner
Paul W. Weld

1949
Gift: $5,136
Participation: 67%
Agent:
Daniel W. Elliott

William G. Anlyan
DeWitt C. Baldwin Jr.
Jonathan S. Bishop
Mary P. Couchman
Phillip G. Couchman
N. Joel Ehrenkranz
Daniel W. Elliott
Albert A. Fisk
Eleanora C. Gordon
Frederic W. Gray
Daniel K. Halvorsen
Jackson Harris
Frederick R. Hine
Gordon D. Jensen
Benjamin A. Johnson
Frank D. Law
Orlando J. Miller
Timothy F. Nolan Jr.
Julian I. Pichel
Charles L. Rennell Jr.
Murray Z. Rosenberg
Carl M. Russell
Lawrence E.
Shulman
Martha Vaughan
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Vernon T. Watley
Mary-Agnes P. Wine

Elihu M. Schimmel
Leonard M. Silverman
Robert L. Stein
Martin B. Vita
John W. Vosskuhler

1950
Gift: $35,751
Participation: 65%
Agent:
Jane B. Shumway
Lyal D. Asay
Sylvia L. Axelrod
Malcolm A. Bagshaw
John E. Borowy
William H. Bucher
Alvin Davis
Claude W. Delia
Marie C. Duncan
Kent Ellis
Thomas J. Ferraro Jr.
Daniel Fine
Lawrence R. Freedman
David A. Frucht
Carl A. Gagliardi
Lucian S. Lapinski
Janus C. Lindner
Margaret S. Lyman
Harold March
Harry L. McClelland
Robert T. McSherry
John H. Meyers
Orlando J. Miller
Charles A. Nugent Jr.
Robert T. Sceery
Cynia B. Shimm
Jane B. Shumway
John S. Strauss
Myra D. Tyler

1951
Gift: $110,013
Participation: 49%
Agent:
Lowell I. Goodman
Reunion Gift Chairman:
Arthur A. Pava
Frank R. Allen
Thomas T. Amatruda Jr.
Muriel H. Bagshaw
John W. Berg
Eleanor C. Bigley
Paul R. Bruch
John J. Egan
Sidney S. Furst
Lowell I. Goodman
John T. Groel
Robert N. Hamburger
John V. Haxo
Carrold K. Iverson
Robert D. King
Jocelyn S. Malkin
Walter S. Morgan
Albert R. Mowlem
Richard S. Munford
Ismail N. Nevin
Alfred Owre Jr.
Arthur A. Pava
Harold M. Sterling
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1955
Gift: $27,040
Participation: 55%
Agent:
Robert A. Kramer

John H. Sullivan
Andrew S. Wong

1952
Gift: $6,134
Participation: 70%
Agent:
Sidney N. Paly
Maurice L. Bogdonoff
Frank R. Coughlin Jr.
Richard N. deNiord Jr.
Richard D. Floyd
Robert P. Gerety
Marvin H. Goldberg
Arthur P. Hustead
William J. Johnson
Thomas S. Kelly
James K. Luce
Joseph A. Montimurro
N. Karle Mottet
Robert L. Nolan
Robert F. Owen
Sidney N. Paly
Robert G. Petersdorf
Leon A. Phillips
John M. Roberts
Elizabeth M. Rush
Leonard Rush
Mary W. Schley
Donald H. Schultz
Robert B. Schultz
John H. Wagner Jr.
Doris L. Wethers
John L. Wolff

1953
Gift: $20,647
Participation: 65%
Agent:
Vincent L. Gott

Seth F. Abramson
Harold D.
Bomstein Jr.
Remi J. Cadoret
William R. Chaffee
Allen Chetrick
Rex B. Conn
John L. Doppman
James P. Dunn
Thomas O. Gentsch
Vincent L. Gott
Robert E. Hamlisch
A. Daniel Hauser
George L. Hoffmann
David P. Holman
Peter B. Hukill
Richard R. Knowles
Frederick M. Lane
Hildegard M. Leslie
Preston L. Leslie
Robert N. Melnick
Harvey M. Peck
Warwick Potter Jr.
Paul G. Quie
Jose Ramirez-Rivera
John C. Roberts
Barbara F. Rosenberg
Irwin K. Rosenberg
Virginia C. Saft
Richard A. Sinnott Jr.
Ora K. Smith
John F. Snyder
Lynn C. Stoker
William J. Vandervort
William A. Wilson
James F. Young

1954
Gift: $6,764
Participation: 82%

Agent:
John K. Rose
Frank P. Berg
George W. Bostwick
Richard J. Bouchard
George N. Bowers Jr.
Ralph K. Campbell
John R. Cole
Alan H. Covey
Arthur C. Crovatto
Donald D. Davis
Walter J. Freeman
Orlando F. Gabriele
John A. Gariepy
Edward J. Gerety
Samuel T. Giammona
Frank L. Gruskay
Nicholas A. Halasz
Katherine H. Halloran
Robert P. Hatch
Walker R. Heap Jr.
Eva H. Henriksen
Samuel J. Hunter
Herbert S. Hurwitz
Robert F. Hustead
Robert J. Joy
Robert M. Keith
Donald S. Komfeld
Lowell A. Kristensen
Richard Lamb
Harry C. Miller Jr.
Paul N. Neufeld
James J. Nora
William S. Palmer
William J. Paule
Anthony V. Piccirillo
Richard D. Pullen
Jacques M. Quen
John K. Rose

John B. Atwater
John C. Bailar III
George E. Becker
E. Edward Bittar
Jerome Bobruff
Douglas G. Boyden
Irwin M. Braverman
Padraic Burns
Paul Calabresi
Joseph A. Camilleri
Leo R. Cardillo
Nicholas A. Coassin
Pasquale J. Costa
Robert G. Crounse
John G. Daley
Fred W. Doyle
Leroy Engel
Edwin G. Fernand
Mahlon V. Freeman
James C. Garlington
Paul Gonick
Dicran Goulian Jr.
Ion Gresser
Milton J. Hirshberg
John H. Hodge
D. Franklin Johnson Jr.
Harry O. Kendall
David R. Kessler
Robert A. Kramer
Edward A. Krull
Roger Lester
James Lum
Alexander Maitland III
Joseph S. McGuire Jr.
David J. Nelligan
James P. Nolan
Edward J. Ottenheimer Jr.
Robert H. Peters Jr.
Robert A. Reich
Paul J. Robinson
Alan A. Stone
Paul R. Stowell
Vito J. Zupa

1956
Gift: $108,123
Participation: 78%
Agents:
John H. Gardner III
Donald J. Dalessio
Reunion Gift Chairman:
Dwight F. Miller
Suzanne S. Becker
Alvin D. Benjamin
Levon Z. Boyajian
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Thomas M. Brown
Rosalie A. Burns
John F. Carroll
Joseph C. Cerny
Edwin L. Child
James C. Collias
Chandler Dawson
S. Evans Downing
Mitchell Edson
Gilbert M. Eisner
Thomas F. Ferris
John H. Gardner III
Sumner H. Gochberg
Val S. Greenfield
Robert H. Groves
Alan R. Gurwitt
Armen C. Haig
Joan M. Hardenbergh
John H. Hart
Robert L. Hill
William H. Hindle
Charles L. Hopper
Marie-Louise T. Johnson
George T. Kammerer
Jerome O. Klein
William V. Lewit
Jacob Mainzer Jr.
Preston C. Manning
Dwight F. Miller
Norman F. Moon
Donald J. Nalebuff
William M. Narva
A. Frederick North Jr.
William M. O’Brien
David A. Page
James R. Patrick
George W. Paulson
Robert L. Powell
Stewart E. Pursel
Robert J. Rice
Robert Scheig
James Scheuer
Edward C. Senay
Benjamin A. Shaver Jr.
Donald W. Sherrick
Daniel R. Silbert
Bruce Trembly
Theodore K. Tseu
Marion B. Warbasse

1957
Gift: $32,325
Participation: 70%
Agents:
Harry C. Briggs
Howard A. Minners

Donald Agostinelli
Joseph S. Amenta
Jack N. Blechner
Richard I. Breuer
Harry C. Briggs
John P. Carey
Albert K. Chun-Hoon
Louis Z. Cooper
Harold D. Cross
Brian Crowley

Yale medicine

Thomas H. Danaher
James R. Dorr
Salvatore Falbo
Elizabeth H. Forsyth
Gary A. Fry
Robert H. Glass
Anne H. Good
Jack P. Green
Malcolm Hill
Gilbert F. Hogan
Warren R. Johnson
Richard L. Kahler
Stanley E. Kilty
William L. Kissick
Edgar H. Levin
Jack Levin
Bennett F. Markel
Mark D. Marshall
David E. Martin III
Howard A. Minners
Robert K. Modlin
Hugh L. Moffet
George A. Nelson Jr.
Herbert A. Newman
Thomas F. O'Brien Jr.
Joseph S. Pagano
Raymond E. Phillips
Clifford B. Reifler
Arnold Schoolman
Stanley Simbonis
Charles A. Slanetz Jr.
Gilbert B. Solitare
Donald C. Stahl
Arthur Taub
Romeo Vidone
William J. Waskowitz
James G. Zimmer

1958
Gift: $77,752
Participation: 59%
Agents:
Andrew J. McGowan Jr.
Paul A. Rudnick

George K. Aghajanian
Don P. Amren
Joseph E. Angelo
John P. Arnot
Frederick Baekeland
Peter A. Benson
William C. Branscome
A. Russell Brenneman
Gerard N. Burrow
Benjamin Bursten
David A. Carlson
John A. Carlston
Joseph J. Cillo
Robert V. Diserens
Robert J. Donohue Jr.
Lawrence Dubin
Donald A. Duncan
Joel C. Eberlin
Philip R. Fazzone
Michael E. Fishman
Raymond A. Gaito
Marcia K. Goin

William M. Gould
James Greenwald
Charles A. Hall Jr.
Stanley Harris
Roger C. Herdman
Michael Kashgarian
Haskins K. Kashima
Jay W. Kislak
Morton M. Kligerman
Theodore W. Lieberman
Myron Lotz
Jack W. Love
Thomas J. Mauro Jr.
Michael J. McCabe
Andrew J. McGowan Jr.
John A. Merritt Jr.
Richard C. Miller
Robert S. Neuwirth
Carol F. Phillips
David M. Pugh
William B. Radcliffe
Paul A. Rudnick
Bruce H. Sklarew
Edward L. Socolow
Arlene Sweedler
Raymond W. Turner
Margaret S. Wenzel
John P. Wood
Pauline B. Wood
Robert W. Wroblewski

1959
Gift: $19,573
Participation: 56%
Agents:
Asa Barnes Jr.
Muriel D. Wolf

Scott I. Allen
Carol J. Amick
Robert M. Amick
Asa Barnes Jr.
Jack F. Bowers
William C. Butterfield
Edwin M. Clayton
Sidney M. Cohen
Martin Colodzin
Ronald C. De Conti
William L. Donegan
Gerald Fenichel
Robert L. Fisher
Paul J. Friedman
Eric Gillett
Gerald B. Gordon
W. Keith Hadley
James H. Halsey Jr.
H. Rodney Hartmann
William H. Heydom
C. Richard Hinckley
Leonard Inker
William J. Jablonski
John J. Jasaitis
Edvardas Kaminskas
Herbert J. Kaufmann
Kristaps J. Keggi
David W. Kingsbury
Parry B. Larsen

Myron S. Lee
Kathryn H. Lewis
John C. Marsh
Brian J. McGrath
Peter M. Molloy
James A. O'Neill Jr.
Nicholas M. Passarelli
Lincoln T. Potter
James D. Prokop
James R. Ralph
David P. Reed
Joseph D. Saccio
Constantine J. Sakles
Marc D. Schwartz
Owen A. Shteir
David B. Skinner
Carl H. Smith
Gene W. Spector
James J. Stagnone
Lisa A. Steiner
John S. Strauss
Leo H. Von Euler
Robert B. Whitney Jr.
Muriel D. Wolf

1960
Gift: $17,753
Participation: 63%
Agent:
Thomas P. Kugelman

Victor A. Altshul
Alan W. Ames
Jack D. Barchas
Colin M. Bloor
Stuart P. Bowne
Donald P. Buebendorf
Thomas E. Carson
Francis D. Cogliano
Neil R. Cooper
Jon E. Courtney
John M. Davis
Malin Dollinger
Caldwell B. Esselstyn Jr.
Warren H. Fisher
Paul J. Friedman
Eugene C. Gaenslen Jr.
Gary E. Gathman
James I. Gilman
Irving Guttenberg
Daniel M. Jones
William S. Kaden
Eric P. Kindwall
Frank J. Kleeman
Susan T. Kleeman
Thomas P. Kugelman
Alcide M. LaNoue
Edward R. Lang
Robert Marcus
Donald L. Miller
Richard G. Morrill
Buford L. Nichols Jr.
Fred Palace
Jerrold M. Post
Martin L. Reite
Albert M. Ross
Daniel J. Rubin

John J. Schrogie
Ross L. Snyder Jr.
Fred L. Stargardter
Robert C. Wallach
May Y. Wang
Ronald A. Yankee

1961
Gift: $65,578
Participation: 58%
Agent:
Robert S. Briggs
Reunion Gift Chairman:
Anoush Miridjanian

Earl L. Baker
Frank H. Baker
Albert A. Bechtoldt Jr.
Robert S. Briggs
David W. Brook
Ralph J. DePonte
Orson R. Dee
Paul D. Deiter
Jon D. Dorman
John E. Fenn
Charles F. Gibbs
David D. Griffith
Walter J. Hierholzer Jr.
Royal C. Hudson Jr.
Louis D. Hunt
Richard L. Keefe
Robert I. Levy
George M. Lordi
Hugh J. Lurie
Sally L. Marchesi
Vincent T. Marchesi
David B. Matloff
Anoush Miridjanian
Richard A. Moore
John K. Pearce Jr.
Elaine Pitt
Bruce C. Robinson
William M. Rogoway
Roy E. Ronke Jr.
Shaun Ruddy
Thomas H. Sakoda
Stanley G. Schade
John H. St. Andre
Robert N. Taub
Franklin H. Top Jr.
David E. Weaver
Warren D. Widmann
Murray Wittner

1962
Gift: $34,524
Participation: 55%
Agents:
Fredric K. Cantor
A. Richard Pschirrer

Michael H. Alderman
Charles B. Anderson
Frederic P. Anderson
Spencer J. Brody
Fredric K. Cantor
Ray A. Carlsen
Thomas N. Chase
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Oliver T. Dann
Arnold J. Eisenfeld
I. Bruce Elfenbein
Joseph D. Ferrone Jr.
John W. Foreman
Stephen J. Fricker
John N. German
David H. Groth
Roderick C. Haff
John H. Hageman
John T. Harrington
Patricia C. Hassakis
Cornelis Heijn
Gary Jacobson
Walter W. Karney
Glenn L. Kelly
David E. Knoop
Bernard Kosto
Manuel J. Lipson
Richard E. Marshall
Allan L. Mattem
Stanley E. Matyszewski
David J. McConnell
William A. Miller
David D. Nicholas
A. Richard Pschirrer
Joseph Ross
James A. Spencer
Nancy A. Staley
Larry L. Stewart
Seth U. Thaler
William F. Weber
Stewart R. Wright

1963
Gift: $16,696
Participation: 44%
Agent:
Craig H. Llewellyn

Barbara R. Almond
Miguel R. Alonso
V. Richard Back
Wayne D. Brenckman Jr.
Charles W. Carl Jr.
Theodore J. Chu
Gordon S. Cohen
John E. Conte Jr.
James S. Dalsimer
Dudley S. Danoff
Andrew Edin
John P. Eliopoulos
Jon M. Fessel
Alan L. Folsom
David H. Fram
William T. Friedewald
David H. Fulmer
Vincent F. Geremia Jr.
Lee D. Goldberg
Peter B. Gregory
Benjamin K. Harris
Stephen C. Joseph
Brian C. Judd
Harold P. Kaplan
Constantine D.Kyropoulos
Edward C. Larkin
William B. Lehmann
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Craig H. Llewellyn
Edward G. Lund Jr.
John L. Mahoney
Robert H. Margulis
Herbert Y. Meltzer
Robert E. Mueller
Sheldon R. Pinnell
Jay M. Pomerantz
William F. Porter Jr.
Berkeley L. Rich
Gaylord Rockwell
Thomas A. Savignano
Alan E. Shapiro
Marvin R. Skolnick
Lee B. Talner
Richard M. Thompson
Thomas W. Tillack
Peter V. Tishler
Lawrence Tremonti
Helen N. Walsh
Peter G. Weiner
Seth M. Weingarten
James G. Wepsic
Charles S. Wilson
Edward F. Wilson
Jerome A. Winer
Alfred J. Wise

1964
Gift: $10,197
Participation: 48%
Agents:
Berton W. Ashman
Robert W. Lyons

Berton W. Ashman
Sidney M. Baker
Philip Blume
Anthony J. Bravo
William V. Brown
Thomas A. Cardella
Joseph F. Curi
Paul F. Dodd
Anthony A. Ferrante
Norman C. Fost
Barry Gault
Peter A. Gross
John F. Haney
Christopher W. Hauge
Richard Hockman
Lawrence Horwitz
William J. Houghton
Sue Y. Kimm
William E. Knight
Lewis Landsberg
Richard V. Lee
Thomas L. Lentz
David B. Leof
James S. Levine
Paul R. Lightfoot Jr.
Robert W. Lyons
Andrew E. MacMahon
William F. Matched
Robert L. Mitchell
Alan H. Morris
James J. Murphy
Donald A. O’Kieffe Jr.

William B. Pratt
Jack S. Rice Jr.
Stanley J. Rosenberg
Richard P. Saik
SaulM. Schanberg
Norman Scher
A. Thomas Snoke
Sigrid L. Tishler
Lee Van Lenten
Stephen Waltman
Oscar Wand

1965
Gift: $45,553
Participation: 62%
Agent:
David A. Hill

Jon R. Almquist
Susan A. Aoki
Thomas T. Aoki
John H. Austin
Paul Balter
Hector R. Bird
Victor J. Burner
Thomas B. Caldwell III
David G. Campbell
Grant L. Christian
Robert M. Cohn
Michael J. Cummings
Carl Ellenberger Jr.
David S. Fedson
Robert I. Finkel
Michael P. Flynn
Richard 1. Frankel
Christopher C. Gates
Gary L. Gross
James K. Gude
Reid R. Heffner Jr.
David A. Hill
Carl E. Hunt
Virginia B. Johnson
Ronald J. Karpick
Mohandas M. Kini
Robert H. Koehl
Richard J. Kozera
Sandra C. Levine
Mark W. Lischner
Michael B. Mayor
David Murdock
Walter W. Noll
A. Lawrence Ossias
Robertson Parkman
John A. Parrish
Robert L. Pickens
Alan N. Rachleff
William A. Renert
George B. Rowland
John F. Schilke
Margretta A.R.
Seashore
David P. Simmons
Robert T. Solis
Harlan Spitz
Alan W. Stone
Jonathan Titus
Robert G. Weiner

1966
Gift: $93,220
Participation: 53%
Agents:
Mary A. Houghton
Gary L. Townsend
Reunion Gift Chairman:
John D. Baxter

Benjamin F. Balme
John D. Baxter
Patricia Bazemore
Robert P. Bazemore
Frank C. Bell
Philip Bernstein
James E. Brown
Eugene P. Cassidy
Donald J. Cohen
Thobum A. Dadisman Jr.
Joseph A. Donadio
Robert N. Frank
Peter D. Gibbons
Stanley I. Greenspan
J. McLeod Griffiss
Robert A. Gunn
Henry G. Hanley
Jay G. Hayden
Mary A. Houghton
Richard J. Howard
Stuart M. Kotler
Wilbur L. Kukes
Lynne L. Levitsky
Henry B. Mann
David B. Melchinger
Harold Mellin
William Y. Moores
Eli H. Newberger
Edward J. O'Keefe
William D. Peterson
James D. Slavin Jr.
Reynold Spector
Parker J. Staples
Lawrence J. Toder
Arne S. Youngberg

Peter R. Egbert
Dennis G. Egnatz
Herbert W. Felsenfeld
Melvin V. Goldblat
Richard J. Hart Jr.
Richard L. Heppner
Peter N. Herbert
George P. Herr
David L. Ingram
Mary Jurbala
J. Robert Kirkwood
Melvyn Korobkin
Carl E. Lane
Anthony P. Lovell
Carl K. Marling
James V. Miller
Stephen W. Miller
Joseph L. Morris
John O. Pastore
William E. Perkins
Daniel F. Phillips
Brian F. Rigney
Jonathan L. Saveli
Alfred Q. Scheuer
Stephen C. Schimpff
Sidney C. Smith Jr.
Helen L. Smits
Lewis S. Solomon
Robert S. Steinberg
Richard B. Swett
M. David Tilson III
Karen H. Toker
Robert A. Vogel
Robert A. Vollero
Joseph F. Walter
Martin Wand
Redford B. Williams Jr.
Robert J. Winer
Robert S. Young
Ihor G. Zachary
Peter M. Zeman

1968
Gift: $12,370
Participation: 52%

1967

Agents:

Gift: $16,943

Rutledge W. Currie

Participation: 58%

Donald O. Lyman

Agent:
Richard B. Swett

Daniel L. Arons
Arthur L. Beaudet
Richard S. Bockman
Arthur W. Boddie Jr.
Daniel J. Booser
Gary C. Burget
William T. Cave Jr.
Mary W. Clark
Cynthia J. Curry
Marian C. Davidson
James L. Davis III
James J. Dineen
Timothy J. Dondero Jr.
Alexander F. Dora
James M. Dowaliby
John A. Drews

Philip L. Barry
Daniel I. Becker
Bernard D. Beitman
Grace J. Boxer
William Catalona
Donald R. Coustan
Rutledge W. Currie
Robert G. Dillard
Edward M. Druy
Barbara M. Egbert
Alan G. Finesilver
William F. Flynn
Richard A. Getnick
Mark G. Grand
Leonard Grauer
Ralph S. Greco
John R. Hill
Thomas R. Johnson

Spring 1997

Peter Jokl
William F. Keane
Daniel E. Keim
Peter A. Kirkpatrick
Jeffrey S. Lee
Marc E. Lippman
Frank E. Lucente
Donald O. Lyman
Stephen I. Marglin
Rodrigo Martinez
John A. McCutchan
Harmon Michelson
David P. Millett
Richard P. Mills
Richard M.
Morehead Jr.
James B. Morris
Peter Nicholas Jr.
Margot Onek
Henry F. Panek
Jackson B. Pickett III
Charles T. Post Jr.
Ralph J. Rauch
Joseph L. Renda
Gordon H. Sasaki
Peter W. Scherer
Frederick C. Sherman
Elizabeth M. Short
Howard W. Siegel
Gerald L. Springer
Lee H. Strohl
Edmund C.
Tortolani Jr.
James L. Weiss
Per H. Wickstrom
Creed W. Wood

1969
Gift: $413,410
Participation: 56%
Agent:
Adrian M. Schnall

Charles S. Angell
David G. Ansel
David W. Barry
Robert E. Belliveau
Donald H. Buchholz
Thomas E. Ciesielski
Joseph P. Cleary
N. Roger Cooke
Leo M. Cooney Jr.
Richard J. Daly
Michael W. Dennis
Charles A. Dinarello
Douglass T. Domoto
Daniel M. Eichenbaum
Ralph J. Falkenstein
Gary S. Farnham
B. Graeme Fincke
Lesley F. Fishelman
Anna S. Gail
Royal J. Gay
Sander G. Genser
Robert O. Gordon
John F. Hiatt
Thomas C. Howard
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Lee M. Jampol
Joel M. Kaufman
Paul H. Kelker
John J. Kelly Jr.
Rowena Korobkin
Lynn G. Lagerquist Jr.
Michael R. Liebowitz
Elliot M. Livstone
C.E. Long III
Robert L. Marier
Arnold F. Mazur
Ellen B. Milstone
Thomas F. Minehan
Bruce K. Nagle
Lionel M. Nelson
Nancy Olmsted
Timothy A. Pedley
Deborah A. Putnam
Joseph D. Robinson
Joseph M. Rochford
Jonelle C. Rowe
Dennis J. Rudzinski
Lutz H. Schlicke
Adrian M. Schnall
David J. Schulak
Andrew Schwartz
Gerald J. Smallberg
Robert J. Walat
Stephen R. Webb
Carolyn K. Wells

1970
Gift: $29,319
Participation: 52%
Agent:
James R. Missett

Elissa B. Arons
John W. Blanton Jr.
Paul E. Braun Jr.
Henry Chessin
M.J. Chusid
Anne M. Curtis
Michael H. Cynamon
James E. DeLano Jr.
Daniel F. Dedrick
W. Montague Downs
Jonathan Ecker
Richard L. Edelson
Robert A. Epstein
Bruce A. Fabric
Harvey Fembach
Robert D. Gilbert
Thomas H. Gouge
Paul C. Hessler
Jay H. Hoofnagle
Jonathan D. Katz
Gerard T. Kennealey
Mark A. Korsten
Thomas L. Lewis
Robert B. Litman
Anne W. Lucky
Roger A. Mason
Leonard M. Milstone
James R. Missett
William K. Mueller
Lynn W. Reiser

Bruce A. Reitz
Joel F. Rubinstein
Dennis E. Shield
Stuart S. Shorr
Richard A. St. Onge
Robert S. Stem
Daniel A. Symonds
Ray W. Tripp III
C. Brace Wenger
Joellen Weme
Daniel Wuensch
Karl O. Wustrack
Marc O. Yoshizumi

1971
Gift: $301,308
Participation: 70%
Agents:
John L. Cieply
Barbara K. Kinder
Reunion Gift Chairman:
Richard A. Moggio

Judith L. Bader
Gregory W. Bartha
Michael J. Beierle
Bruce Block
Marian H. Block
John L. Cieply
Frederick L. Cohn
Andrew D. Cook
David Cossman
Edward C. Cottle
John S. Ebersole
Leonard I. Eisenfeld
Thomas Etkin
Daniel E. Feldman
Fred Finkelman
John W. Foster Jr.
Jared J. Gardner
Richard B. Gloor
Allan W. Graham
Jerold A. Haber
Michael J. Hart
William W. Hay Jr.
W. Robin Howe
N. Timothy Jette
Richard Katzman
Robert M. Kessler
Barbara K. Kinder
Ralph J. Kirmser
Stuart R. Kleeman
Michael E. Klein
William L. Krinsky
Gary M. Lande
Laurence W. Levinger
David H. Lippman
Robert A. Mackey
William J. Mangione
Samuel S. Masters
Patrick T. Minihan
Steven H. Moffic
Richard A. Moggio
Martin Paris
John A. Patti
Barry B. Perlman
Stuart B. Phillips

Michael C. Piercey
Irving G. Raphael
Joan M. Reese
David M. Rinzler
Douglas R. Schmidt
John Smiarowski
James P. Southwick
Jonathan W. Stewart
Daniel R. Synkowski
Semeon G. Tsalbins
Paul A. Vignola
Robert B. Vranian
Albert C. Weihl
Jerold C. Woodhead
Burns Woodward
Daniel G. Wright

1972
Gift: $10,424
Participation: 59%
Agent:
Harry L. Malech

Robert D. Arbeit
R. Michael Buckley Jr.
Leonard H. Cohen
Philip L. Cohen
Norman M. Dinerman
William H. Drackemiller Jr.
M. Felix Freshwater
John P. Fulkerson
Robert D. Glassman
Dorothy M. Gohdes
Robert F. Goodman
Andrew H. Greenhill
Bruce B. Haak
Thomas L. Horn
Vernon H. Humbert Jr.
Anthony H. Jackson
Jesse B. Jupiter
Frank M. Kahr
Roy A. Kaplan
Michael A. Kaufman
Donald L. Kent
Philip W. Lebowitz
Theodore M. Levin
Paul A. Lucky
Harry L. Malech
John E. Mayer Jr.
Jeffrey S. Menkes
Jerome H. Meyer
David B. Moyer Jr.
John P. O'Grady
Edward J. Olinger
Marc B. Osias
William L. Risser
Richard S. Robbins
David H. Ronrond
Philip M. Rothfeld
Charles F. Scholhamer
Frederick D. Stockwell
Gary M. Strauss
Lawrence P. Temkin
Philip J. Weyman
Brooke M. Wolf
Michael W. Yogman
Steven M. Zeldis

1973
Gift: $8,022
Participation: 60%
Agents:
John F. McQuade
Jerrold F. Rosenbaum

David A. Adler
David A. Baggish
David N. Bailey
Mary Ann
Brunstetter-Shafer
James N. Campbell
Marvin M. Chassin
William T. Choctaw
F. Sessions Cole III
Joseph M. Connors
David L. Coulter
Carolyn G. Dedrick
Christopher M. Doran
Jane H. Ferguson
Richard J. Fingeroth
Robert A. Florin
Lee Goldman
Gary V. Gordon
Gary T. Grimes
Neal Handel
Frederick M.
Henretig
Jorge L. Hernandez
Howard S. Honig
John M. Kirkwood
Michael S. Kramer
Lynne M. Liptay
George Lister Jr.
Harold R.
Mancusi-Ungaro Jr.
John A. McDowell
John F. McQuade
Jerry Nagler
James A. Neviackas
Claes M. Nilsson
David E. Peach
John W. Popp Jr.
Robert H. Posteraro
Thomas J. Romano
Harry S. Romanowitz
Jerrold F. Rosenbaum
John P. Sherck
George D. Shoup
Joseph F. Simeone
Robert A. Sirota
Carole H. Stashwick
Charles F. Stroebel
James F. Sullivan
Thomas F. Sweeney
Robert J. Ursano
Christine A. Walsh
Marc A. Weinberg
Richard S. Young

1974
Gift: $8,275
Participation: 49%
Agents:
Robert J. Schechter
Amy Starr
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Irving M. Asher
Leonard I. Banco
Ralph E. Binder
Neil Blumberg
Ronald C. Brown
Peter J. Buchin
Robert A. Caine
Richard A. Cazen
Richard F. Clarke
Bert D. Collier Jr.
Paul David
Vincent A. Di Maria
Irl L. Extein
Allan B. Friedland
Michael A. Gerber
Harvey Gerhard
Alan A. Halpern
Robert F. Hempton
Edward O. Janosko
Robert M. Jarrett
Robert C. Jimerson
Marie T. Kelly
Dahlia V. Kirkpatrick
Robert M. Kolodner
Saul Lande
Edward L. Marut
Andrew R. Mayrer
James R. McMonagle
Daniel A. Moros
Marjorie A. Oda
Richard C. Pasternak
Andrew L. Ries
David Z. Ritvo
John D. Schrumpf
Harry Shamoon
Alan B. Silken
Barry S. Solof
Amy Starr
James A. Strom
George H. Talbot
Carol C. Teitz
Edward M. Wolin

1975
Gift: $9,713
Participation: 27%
Agents:
Mary Jane Minkin
Phillip J. Rich

Yvonne L. Burnett
William S. Bush
Rodney J. Butch
Chau V. Dang
Jeffrey J. Davis
Robert G. Drake Jr.
Stanley W. Gale
Elizabeth R. Gawron
Alfred C. Gaymon
Paul A. Johnson
Kevin Kane
George D. Knowles
Richard J.
Loewenstein
Bruce McLucas
Hyman J. Milstein
Mary Jane Minkin
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Robert G. Nankin
Andrew B. Newman
Kwaku Ohene-Frempong
George J. Pardos
Mary L. Polan
Vivian Reznik
Philip J. Rich
Robert S. Sandler
Frederick S. Sherman
Thomas W. Smith
Morris J. Westfried
Henry S. Willner
David W. Wiltse

1976
Gift: $93,915
Participation: 51%
Agent:
William K. Levy
Reunion Gift Chairman:
Alfredo L. Axtmayer

Alfredo L. Axtmayer
Alan B. Bloch
Sharon L. Bonney
Roger A. Boshes
William D. Carlson
Randall D. Cebul
Helen Y. Chang
Pauline Y. Chao
Richard S. Childs Jr.
Joseph Ciabattoni
John D. Clemens
Ellen C. Cooper
Kenneth J. Dobuler
Gary S. Dorfman
John A. Elefteriades
Geoffrey Etherington
Richard A. Frank
Susan R. Gaynon
Ira H. Gewolb
Rose H. Goldman
Randall S. Hawkins
Clarion E. Johnson
JoelKabak
David T. Kawanishi
Richard D. Kayne
Carol H. Lee
William K. Levy
Sidney Mandelbaum
Cynthia F. Mann
Josefina V. Marin
Frederick C. Morin III
Jon S. Morrow
Richard L. Neubauer
O’dell M. Owens
N.T.S. Quao
Daniel W. Rahn
Paul R. Ramirez
Emanuel R. Reinitz
Mark C. Ruchntan
Lawrence E. Samelson
Richard S. Schottenfeld
Charles R. Swenson
Peter M. Ting
Robert C. Ward
John C. Wiles

Jerome B. Zeldis
Carol M. Ziminski

1977
Gift: $9,806
Participation: 59%
Agents:
Maryheth Ezaki
Ronald J. Vender

Michael G. Adelberg
Marcia C. Arent
Phyllis August
Diane M. Barnes
George Bolen
John J. Boronow
Gerald M. Brody
Richard D. Bucholz
Christopher S. Clark
Mark A. Dillingham
Stuart B. Dubin
Sybil E. Duchin
Marybeth Ezaki
Thomas W. Ferguson
Anne H. Flitcraft
James A. Fox
Julia B. Frank
Barbara K. Gehrett
Gary G. Griffieth
Steven R. Hahn
Robert W. Hand
Bruce L. Innis
Howard K. Koh
Wilhelmina C. Korevaar
Don A. Marshall Jr.
Margaret S. McKenna
Robert J. Mitchell
Alan S. Penziner
Richard E. Peschel
Theodore M. Pitts
Jordan S. Pober
Rachel Z. Ritvo
Steven J. Scheinman
Ricky M. Schneider
Susan B. Schneider
Simeon A. Schwartz
Jeffrey L. Sklar
Ronald J. Vender
Steven L. Warsof
Sharon R. Weinstein
John E. Whitcomb
J. Douglas White
Daniel Wohlgelernter

1978
Gift: $7,445
Participation: 51%
Agents:
Michael J. Anderson
Duke E. Cameron
Seth M. Powsner

Kathy L. Ales
Richard J. Baron
Ronald J. Berenson
Booker T. Bush Jr.
Duke E. Cameron
David F. Cawthon

Jesse M. Cedarbaum
Henry R. Desmarais
Mark J. Di Nubile
James N. Dreyfus
Eric B. Einstein
James T. Elder
Emily A. Fine
Mark L. Finklestein
Eugene G. Fong
Stuart M. Forman
Maija G. Freimanis
Robert A. Gelfand
George M. Golenwsky
Linda J. Hall
Jeffrey N. Hausfeld
Alexandra N. Helper
Robert Hershfield
Elizabeth S. Hodgson
Anne A. Knowlton
Robert L. Kraft
Cynthia S. Kretschmar
Sanford D. Markowitz
Jose L. Martinez
Robert K. McLellan
Michael J. Mitchell
Kurt K. Nakaoka
Yvette L. Piovanetti
Barbara H. Pober
Seth M. Powsner
Jeffrey D. Roth
Sally Rudicel
Neal D. Ryan
Steven M. Shoum
Donald C. Simonson
Thomas J. Smith
Gerson M. Stemstein
Rebecca A. Taub
Caroline R. Taylor
Marcia J. Wade
Jonathan D. Weinberg
David L. Wessel
Susan Wong

1979
Gift: $10,510
Participation: 41%
Agents:
David E. Golan
Cynthia A. Sherman

Frederick R. Aronson
Guthrie S. Birkhead III
Gershwin T. Blyden
J. Kenneth Burkus
Stuart L. Bursten
Sarah E. Carpenter
Paul E. Collier
Kerry Cooper
Jeffrey N. Dornbusch
Norman L. Elliott
Lu-Jean Feng
John A. Fox
John J. Gargus
David E. Golan
Bruce Halperin
Edward C. Halperin
Arthur C. Johnson III

Heather L. Johnson
Leslie J. Katz
Roxanne E. Kendall
Jonathan Kolitz
Forrester A. Lee Jr.
Wing-Yin Leong
Michael K. Lindsay
Shirley McCarthy
Timothy W. McKeithan
S. Kwante Ofori-Kwakye
Barbara A. Peters
Jean Rosenthal
Lynn K. Rudich
Gary L. Schaer
Eric A. Schwartz
Cynthia A. Sherman
Laurie Smaldone
Pamela E. Smith
Candace S. Thurston
Duane C. Tucker
Gary C. Vitale
John T. Woo
Jeffrey W. Work

1980
Gift: $5,503
Participation: 44%
Agents:
Eduardo C. Alfonso
Steven I. Rosenfeld

David E. Adelberg
Eduardo C. Alfonso
Seth L. Alper
Alan B. Astrow
David A. August
Milton F. Austin
Jay M. Baraban
Jean B. Bolognia
Patricia C. Brown
Michael W. Champeau
Michael M. Chang
Thomas F. Deering
Deborah D. Desir
Gary V. Desir
Claudia Dinan
Francis W. Drislane
Stephen G. Emerson
Paul A. Epstein
Barbara G. Fallon
Todd J. Garvin
Marc F. Glickstein
David J. Goldberg
Jonathan L. Jacobs
Barry M. Kacinski
Mary C. Komei
Ethan A. Lemer
Theodore W. Marcy
Suzanne M. Matsui
Cesar R. Molina
Eric J. Nestler
Mark J. Ratain
Steven I. Rosenfeld
Alan E. Schlesinger
Gerri A. Schulman
John A. Selling
Jeffrey N. Siegel

Spring 1997

Hillel D. Skoff
Leslie W. Sojka
Kim R. Swartz
James A. Talcott
Joseph L. Tate
Marcia R. Taylor
Nancy T. Taylor
Mary C. Wise
Lawrence H. Young
Raphael Zahler
Laurel E. Zollars

1981
Gift: $33,949
Participation: 45%
Agent:
Anthony M. Urbano
Reunion Gift Chairman:
Anthony M. Urbano

Jane E. Asch
Cynthia B. Aten
Robert B. Bailey Jr.
Alicia I. Barela
Sherri L. Brown
Patricia A. Burke
Colleen Bursten
Nelson J. Chao
Chee C. Chow
Francis Chui
Marc D. Coltrera
Jonathan M. Fine
Paula M. Fracasso
Robert S. Goldman
Laurie J. Gordon
Jeffrey A. Gruskay
Alan Heimann
Scott A. Hundahl
Thomas Kievan
Brian K. Kobilka
Mark J. Koruda
Richard E. Kravitz
Thomas S. Kupper
Elliot Lach
Aiziz Laurent
David E. Lebwohl
Bernard Lewin
Philip A. Lowry
David Y. Lu
Yvedt L. Matory
Barton N. Milestone
Robert M. Milstein
David A. Paly
Robert B. Portney
Susan B. Radoux
Barbara A. Roach
Barbara A. Ross
Dovelet Shashou
Bernard H. Shen
Martin H. Teicher
Anthony M. Urbano
Alan B. Wagshal
David S. Weiss
Stephen B. Wilson
David H. Wohns
Aizik L. Wolf
John C. Wong
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1982
Gift: $5,408
Participation: 33%
Agents:
Muriel Cyrus
Stephanie WolfRosenblum

Sylvia R. Beck
Paula K. Braverman
Thomas J. Brennan
Muriel Cyrus
Fred M. Drennan
Liba E. Goldblum
Daphne T. Hsu
Henry D. Jampel
Laurie B. Katz
Patricia Kellner
Teresa L. Massagli
Kathleen A. Nolan
Joyce A. O'Shaughnessy
Christopher N. Otis
Robert Pierattini
Carrie A. Redlich
Steven D. Resnick
Robert J. Rizzo
Paula C. Schlesinger
William M. Sikov
Lynn T. Tanoue
Patrick J. Toth
Albert L. Ungricht
Stephanie WolfRosenblum
N. Bruce Yager
Mary E. van der Velde

1983
Gift: $4,851
Participation: 31 %
Agents:
David Schwartz
Michael B. Tom

Amos Bodner
Robert E. Bookstein
Michael Brines
Elena Citkowitz
Sean W. Dowling
Dianne Edgar
Tammy C. Harris
Donald R. Johns
William Kadish
Robert M. Kotloff
Ana M. Lamas
Scott R. Lambert
Charles Lim
David Lindgren
Frederic R. Martin
Lois A. Morton
David P. Norton
Dan A. Oren
Moshe Rubin
Daniel Sabbeth
Leonard B. Saltz
Maria E. Schmidt
Susan O. Seward
Michael Silverberg

Philip M. Spiro
Nancy K. Terrell
Pamela L. Zeitlin

1984
Gift: $5,000
Participation: 43%
Agents:
Hingge Hsu
Jay R. Kostman

Martha R. Arden
Deborah J. Arrindell
David I. Astrachan
Susan J. Baserga
Leonard Bell
Troyen A. Brennan
Barbara A. Coda
David J. Fillmore
David A. Frank
Paul Gagliardi
Peter M. Glazer
John L. Gwin Jr.
Bruce G. Haffty
Robert J. Havlik
Sabra L. Jones
Emilio J. Juncosa
Jeffrey N. Katz
Michel Kliot
Daniel M. Kolansky
Jay R. Kostman
Philip R. Krause
John H. Krystal
Margaret L. Lancefield
Richard L. Leff
James G. Linakis
Alison C.
Lindsay-Beltzer
Frederick A. Paola
Dominic D. Pennachio
Jill S. Ratain
Terri L. Richardson
William A. Rios
Kenneth S. Rosenblum
Paul B. Rothman
Saul Sadka
Ana M. Salazar
Joshua D. Schor
David A. Shrier
Theodore A. Silver
Edwina E. Simmons
Michael Simons
Paul M. Snyder
Mark Stein
Andrew L. Stemlicht
Susan P. Tredwell

1985
Gift: $4,375
Participation: 45%
Agent:
Fred Santoro

Barry D. Bergquist
J. Alexander Bodkin
Jane E. Carter
Elizabeth A. Chamey
Alice S. Chi

Bryan X. DeSouza
Carol F. Farver
Guy L. Fish
Guy Fried
Richard B. Garber
Michael W. Gilbert
Samuel D. Goos
Daniel Greenwald
Barbara J. Guillette
Jacqueline Gutmann
Robert S. Higgins
Marie Hobart
Stuart N. Isaacs
Michael R. Johnson
Robert L. Klitzman
Ellen R. Kolarik
Susan A. Korrick
Shirley J. Lee
Jonathan S. Lewin
Ted W. Love
Jeffrey A. Lowell
Anthony Marks
Mary C. Nakamura
Jon C. Parker
Richard G. Parker
Leslye C. Pennypacker
Samuel R. Pesin
Anne Regenstein
Richard A. Ruiz
Greg A. Sachs
Fred Santoro
Edward B. Savage
Gary L. Shapira
Timothy A. Shapiro
Robert C. Smith
Louis J. Tesoro
Yonina C. Weiss

1986
Gift: $20,817
Participation: 41 %
Agents:
Eric Bernstein
Clinton L. Undo
Eric P. Suan
Reunion Gift Chairman:
Eric P. Suan

Margaret N. Alexander
Catharine A. Arnold
David Atkins
Samir M. Bhatt
Richard L. Bridgewater
Cristina M. Brunet
Danilo D. Castro
Paul Chang
Raymond T. Chung
Andrew R. Conn
Suzanne D. Conzen
Raymund S. Cuevo
John A. Detre
Amanda B. Dill
Jay A. Gates
Michael Grossbard
Barbara J. Harvey
Gary S. Hirshfield
Jeremy L. Holtzman

Robert A. Jackson
Roberto LewisFernandez
Clinton L. Lindo
Manuel B. Litchman
Antoinette L. Lloyd
Thomas J. Lynch Jr.
Stacey Mandelbaum
Cynthia A. McCraven
Timothy W. McGowen
Michael D. Miller
Elizabeth A. Plotkin
George M. Sachs
Jeffrey G. Schneider
Dae Y. Song
Kimberlee A. Sorem
Andrew W. Steele
Eric P. Suan
Steven J. Waisbren
Terry Watnick
Reginald O. Windom
John J. Wysolmerski
Alan Yamada

1987
Gift: $4,664
Participation: 33%
Agents:
Subba R. Gollamudi
Mindy G. Schuster
Barry Weinstock

Andrew N. Bazos
Gregory M. Brown
Michael J. Caplan
Jerome H. Chin
Richard Diana
Ellen Dolnansky
Robert Englander
Eugene S. Fu
Steve M. Gaskin
John M. Gaziano
Laurence A. Greenbaum
Hugh C. Hemmings Jr.
Robert J. Homer
Amy C. Justice
Rebecca E. Kadish
Christopher King
Joseph T. King Jr.
Elliott Levy
Kenneth E. Newhouse
Patricia T. Powell
Lauri R. Robertson
Seth A. Rosenthal
Patrick A. Ruwe
Mindy G. Schuster
Michael H. Solon
Odett R. Stanley-Brown
Richard P. Tierney
Robert C. Urban Jr.
Leslie Vogel
Barry Weinstock
Mark D. Widmann

1988
Gift: $3,891
Participation: 36%
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Agents:
Michael E. Mockovak
Susan A. Valley
Hedayatollah Zaghi

Larry Amsel
Linda W. Armstrong
Joi Barrett
Jonathan A. Borden
Martha Brochin
Robert K. Brown
Kathleen CarneyGodley
Martin L. Chenevert
Laura M. Dember
Joshua E. Freedman
Irene J. Freeman
Jonathan S. Friedes
Leslie K. Jacobsen
Ellen Kommehl
Frederick F. Lang Jr.
Lisa C. Larkin
Frederick Long
Michael E. Mahig
Elizabeth E. Mannick
Theodore Miclau
Kelle H. Moley
Autry J. Parker Jr.
Donna Richman
Michael O. Rigsby
Michael A. Rothschild
Jonathan A. Sherman
Mitchell J. Sklar
Lenore K. Soodak
Philip A. Stull
Susan A. Valley
Hedayatollah Zaghi

1989
Gift: $3,878
Participation: 44%
Agents:
Stephen Bharucha
Lewis Lipsey
Melissa T. Myers

Katherine A. AlbertHemmings
Jennifer F. Bock
Susan K. Bonar
Maura J. Brennan
Ira Cheifetz
Cherise M. Dyal
Dina B. Eisinger
Alexandra FlatherMorgan
Craig E. Fleishman
Yvonne 1. Frei
Susan Garetz
Virginia J. Greenbaum
Adam L. Greene
Colin K. Grissom
Joni H. Hansson
Lisa R. Ide
Howard Kesselman
Lawrence R. Kleinberg
Robert L. Levin
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Amy Lewis
Howard Morningstar
Melissa T. Myers
Viviann M. Rubin
Thomas J. Silva
Leslie M. Sims
Stephen M. Smith
Robert Spiera
David M. Stier
Sanjoy Sundaresan
Amy A. Tyson
Andrew T. Walker
Marjorie S. Webster
John T. Whalen
Roger F. Widmann
Christopher Wolf-Gould

1990
Gift: $1,881
Participation: 30%
Agents:
Ercem S. Atillasoy
Thomas J. Christopher
Jonathan T. Foster
Tracy D. Nelson
Chancier N. Samy
Roberto Soto
Dan Stryer

Susan G. Anderson
Nancy R. Angoff
Ercem S. Atillasoy
Thomas J. Christopher
Mark A. Dettelbach
Mittie E. Doyle
Jonathan T. Foster
Douglas M. Freedman
Alan S. Hilibrand
Betty S. Kim
Stephen Knight
Toshiko F. Magnus
Ira Meisels
Mark A. Miller
Tracy D. Nelson
Erika H. Newton
Jullie W. Pan
Jane E. Rasmussen
Chander N. Samy
Andrew H. Schulick
Daniel Stryer
Karl G. Wagner Jr.
Samuel C. Wang
Marc J. Warman
Siu-Long Yao
Keith A. vom Eigen

1991
Gift: $6,560
Participation: 30%
Agents:
Stephen Bell
Carl Henningson
Richard G. Ilmat
FrankM. Lobo
Karen Hsieh Lu
Funda Meric
Andrew F. Phillips

John Phillips
Reunion Gift Chairman:
Frank M. Lobo

Jeanne B. Ackman
Marc E. Agronin
William T. Andrews
Mark G. Barad
Stephen Bell
Steven B. Care
Jeffrey D. Carter
Daryl K. Daniels
Vivek David
Sarah A. Davidson
Scott E. Edwards
Helen L. Egger
Jean L. Fraser
Bernice K. Glover
Gwendolyn Grant
Lawrence J. Hirsch
Richard G. Ihnat
Thomas S. Kupper
James S. Levine
Francis M. Lobo
Charles Lu
Karen Hsieh Lu
Margaret R. O'Neill
Robert Z. Orlowski
Eleanor S. Poliak
Pablo A. Quintela Jr.
Marc A. Seltzer
Robert M. Spillane
Stacy B. Stryer
Margaret M. Toth
Paula I. Watnick
Ellis L. Webster

1992
Gift: $1,135
Participation: 23%
Agents:
Karen J. Anted

1993

1995

Gift: $1,270

Gift: $680

Participation: 28%

Participation: 30%

Agents:

Agents:

Juan Bartolomei

Jeffrey I. Algazy

Ann Dolinsky

Alice Y. Chang

Stephanie A. Falcone

Steven L. Craig

Robert lannone

Steven M. Kawut

Julie Miner

Anthony J.
Adrignolo III
Albert Assad
Elizabeth S. Auld
Michael C. Brown
Sarah S. Demtrak
William D. Dockery III
Elizabeth D. Elguera
Stephanie A. Falcone
Christopher P. Fey
Blair W. Fosburgh
Lawrence B. Gardner
Adriane M. Guerin
Deborah M. Jotkowitz
William F. King Jr.
Lisa A. Kotler
Elizabeth D. Le
David M. Lee
Matthew L. Lerner
Gayle Lesnieski
Michael C. Locker
Samer Najjar
Lisa J. Nelson
Michael I. Oppenheim
William R. Rodriguez
Jaclyn A. Ryan
Denver Sallee III
David A. Tendler
Antonio F. Vinals
Joan M. Walker-Biskup
Edward M. Weaver

J. Mathieu Massicotte

1994

Robin A. Perlmutter

Gift: $760

Darrick J. Alai mo
Karen J. Antell
Douglas M. Dahl
Frederic W. Deleyiannis
Ann S. Denehy
Anne T. Egan
Michael Girardi
Andrew J. Griffith
Israel R. Grossman
Nancy L. Harthun
Doris M. Iarovici
Joanna Y. Jen
Robert B. Johnson
Alan B. Jotkowitz
Lauren E. Krieger
Joseph M. Massicotte
Robin A. Perlmutter
Kenneth E. Rosenzweig
Mary E. Savage
John L. Walsh
Teresa L. Wooten
James S. Yeh

Participation: 17%
Agents:
Kevin E. Bishoff
Constantino S. Pena

David S. Aghassi
Kevin E. Bishoff
Emily J. Davidson
Katherine E. Dee
Emil D. Engels
Kirk R. Essenmacher
Anuj Gupta
Victoria L. Holloway
Debra H. Howard
Lauren D. Hyman
Robert lannone
Michael G. Kaiser
Constantino S. Pena
Marc N. Potenza
Karen M. Rosewater
Martina M. Schulz
Heather K. StanleyChristian

Hyun W. Bae
Alice Y. Chang
Cheng-Chieh Chuang
Steven L. Craig
Sameer P. Desai
Barbara M. Garcia Pena
Timothy J. Hong
Walter O. Jackson
Stephanie A. Kapfer
Steven M. Kawut
Larry T. Khoo
Margot B. Kushel
Benjamin H. LeBlanc
Alex L. Madlener
Dorothy R. Novick
Nicholas A. Schwartz
K.R. Shen
Mary R. Shoemaker
Lawrence W. Solomon
Dara E. Thomas
Kenneth P. Vives

Former House Officers
Neville Alleyne
Frederick L. Altice
Floyd L. Atkins
John M. Aversa
Ronald J. Bailey
Arnold M. Baskin
Malcolm S. Beinfield
Michael R. Berman
Jacques L. BonnetEymard
Hubert B. Bradbum Jr.
Christine Brahney
Myron Brand
Richard A. Brand Jr.
Ronald W. Braun
John M. Brogden
Sorin J. Brull
Julian H. Capps II
Richard S. Casden
Scott Evans Casper
Richard A. Chase
Chang Song Choi
Charles R. Clark
James C. Cobey
Edward J. Collins Jr.
Harold O. Conn
Frederick G. Dalzell
Marlene De Maio
Ralph J. De Vito
Donald S. Dock
John M. Duncan Jr.
Pierre B. Fay ad
Dale J. Federico
Jeffrey C. Femyhough
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Peter Casolino

Louis B. Fierman
Stephen V. Flagg
John S. Goetcheus
John W. Goldkrand
Jacob D. Goldstein
Isaac Goodrich
Scott Andrew Hoffinger
Eric A. Hyson
Robert Gordon Kalb
Moreson H. Kaplan
David J. Keller
Dae Un Kim
Robert Kim
Arthur H. Knowlton
Kenneth M. Kramer
Gail Landy
Randi Leavitt
John D. Lewis
Donald T. McAllister
William McCullough
John R McGovern
Robert M. McLean
Jan Evans Patterson
Thomas F. Patterson
Stanley M. Polansky
David Poverman
Gary Price
Jane E. Rasmussen
Gordon V.K. Reid
David L. Rimm
Patrick A. Ruwe
Herbert S. Sacks
Enzo J. Sella
Carlton C. Sexton
Thomas E. Shaffer
Robert E. Silverman
Sanan Simarak
Leon G. Smith
Stephanie S. Spangler
V.I. Sreenivas
Robert A. Stanton
Barry S. Strauch
Herbert Suesserman
Herbert Tabor
Franklin T. Wetzel
Douglas G. Wright
Leonard H. Zamore
Joseph H. Zelson
Bernard Zuckerman

The Historical Library of the Harvey Cushing/John Hay Whitney Medical Library.

F. Warren Heilman
Gloria F. Holmes
Kenneth P. Kinney
Sean Lynch
Natesh Magge
Virginia G. Mannick
Harry Meisels
Mr. & Mrs. Lewis Nankin
Mr. & Mrs. Victor M.
Newman
Cecile Portney
R. Donald Reich
Harold & Frances
Sampson
Henry S. Sanematsu
Leon G. Smith. M.D.
Argyle Stoute, M.D.
David D. Strachan
Jack Weingold

Parents

Friends

Anne M. Asher
Gail Steinmetz Broder
Frederic D. Brown
Howard Chin
Judy Coppola
Mr. & Mrs. Kenneth T.
Doran
Mrs. Vincent A. Doroszka
Dorothy M. Ference
Max Finkelman
Conrad Fischer
Jenifer Rawson Grant
Dr. Myron Greengold
Wei Jen Hsia
Dr. Earl Hellerstein

Irwin Abouaf
Mr. & Mrs. Donald E.
Adams
Thomas H.G. Aitken
Mr. & Mrs. Mark
Anderson
Sally C. Anderson
James W. Andrews
Nancy H. Andrews
Ellen Hope Angus
Kathleen M. Annicelli
Charles S. Atzbach
Sally T. Bailey
Diana Balmori
Fred L. Barber
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Waddell Barnes, M.D.
Mr. & Mrs. Morton
Barrow
Mr. & Mrs. Jack Barry
Ms. Kerry A. Bartolini
Mrs. Arnold M. Baskin
Dr. & Mrs. Ramon A.
Batson
Randy S. Berger
Billie Anne Berman
Mr. & Mrs. John P.
Beveridge
David F. Bindelglass, M.D.
Margaret T. Bixler
Mr. & Mrs. William
Bolling
Stanley N. Botwinik
Malcolm B.
Bowers Jr., M.D.
Mr. & Mrs. Joseph L.
Bowes
Timothy Brandt
Robert B. Brooks
John W. Browder
William Brown
Dr. Sonja Buckley
Grace T. Burket
Maryanne Y. Butler
Dr. & Mrs. Harold Byrdy
Edwin C. Cadman, M.D.
C. Elton Cahow, M.D.
Esther Capasse
Geraldine B. Carroll
Christopher Carrozzella,
Esq.
Andrew M. Casden

Mr. & Mrs. C. Nick
Catrini
Salvador Chaparo
Ana Maria Chiesa
Horacio P. Chiesa
Horachio P. Chiesa Galy
Mr. & Mrs. Harry E.
Chinn
L. Dawn Christian,
D.D.S.
William Chudnovsky
Joanne Chvisuk
Mr. & Mrs. Charles
Ciambriello
Pasqual Civitillo
Mr. & Mrs. Charles A.
Clancy
Mr. & Mrs. Donald Clum
Jeanne F. Cobey
Mr. & Mrs. James G.
Coclin
Mrs. Henry Cohen
Louis Cohen
LeBaron C. Colt Jr.
James P. Comer, M.D.
Jamie Condon
Joseph P. Conte
Melvin P. Coolidge, M.D.
Carole L. Cooper
James E. Coppage
Mr. & Mrs. Sidney Corob
Emily S. Coventry
David E. Crabb
Edward T. Creamer Jr.
Mr. & Mrs. Joseph
Cristiano

Mr. & Mrs. John M.
Cunningham
Edward D'Amico
Nancy M. Daly
Mel Damelio
Dr. & Mrs. J. Sanford
Davis
Robert V. Dawe, M.D.
Mr. & Mrs. Peter
Delehanty
Priscilla F. Delehanty
Robert Delnickas
Edward F. Delvecchio
Mary Dimando
Mikel T. Dodd & Lauren
Biszewski
Mr. & Mrs. Joseph J.
Dolan
William T. Donohue
Phyllis G. Donzelli
Rev. and Mrs. Raymond
Downs
Mr. & Mrs. Donald J.
Doyle
Thomas P. Duffy, M.D.
Kathleeen L. Dunn
Mr. & Mrs. Stanley K.
Durkin Jr.
Jerry Ehrenwald
Mrs. Gunnar O. Eng
Mr. & Mrs. Frank C.
Ennever Jr.
Mrs. Ellin F. Ente
Lucretia Faulk
Patricia A. Faulkner
John Ferranti
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Lori-Ann Fickie
Mr. & Mrs. Peter W. Finck
David S. Fischer
Stephen Fleck. M.D.
Ruth K. Forgione
Mr. & Mrs. Edward L.
Forte
Cheri Fox
Dr. & Mrs. Gerald
Freedman
Karen J. Freedman
Robert J. Freeman
Flarry I. Freund
Mrs. James T. Friss
Prof. Joseph S. Fruton
Paula A. Furo
Karyn Gabbinelli
Laurie A. Gagne
Mr. & Mrs. Charles W.
Gannon
Alphonse F. Gencarelli
Gary Gerard, M.D.
Mrs. John R. Geyer
Nancy P. Gillis
Mr. & Mrs. Thomas S.
Giuffrida
Theodore P. Giuliano
William W.L. Glenn. M.D.
Mr. & Mrs. Asher
Gluckman
Arlene S. Gold
Estelle K. Goldman
Dr. Herbert 1. Goldman
Mr. & Mrs. Irving M.
Goldman
Arthur Goldzweig, Esq.
Daniel Goleman
Mr. & Mrs. Donald E.
Goodrich
Mr. & Mrs. John H.
Gorman
Anton Graham
Beverly M. Grasso
Maurice D. Grasso
Ruth E. Greenblatt
Mr. & Mrs. Charles A.
Grillo
John M. Grobman, M.D.
Florence S. Grodin
Mr. & Mrs. Zola Grona
Barbara S. Gross
Jeffrey L. Gross, M.D.
Eileen Rockefeller
Growald
Helen D. Haller
Michael B. Hammond
Mr. & Mrs. Paul M.
Harpin
Sylvia Heisman
Herbert Hermele, M.D.
Fred H. Hibberd
Tommy Hilfiger
Donald & Audrey Hill
Philip & Rose Hoffer
Holocaust Survivorsof
New Haven
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Mr. & Mrs. William M.
Homich
Lillian S. Howard
Joseph T. Hughes
Alice Hummel
Mr. & Mrs. James J.
Imbrogno
Janet Impellitteri
Raymond J.
lppolito, M.D.
Virginia B. Isakson
Susan B.Jacobson
Daniel James
Robert L. James
Henry A. Jensen
Mr. & Mrs. Robert Jess
Ann M. Johnson
Earl or Jean Johnson
Mrs. Charles S. Judd Jr.
Foster Kay, M.D.
Mr. & Mrs. Dan Kearney
Kenneth M. Kearns, M.D.
Mr. & Mrs. Thomas Keefe
Thomas J. Keenan, M.D.
Robert S. Keller
Nancy M. Kenny
Tina Khentigan
Mrs. Charles P. Kingsland
Susan T. Kirchhof
Lucille S. Kirsch
Gerald H. Knecht
Vincent A. Koblish
Uwe Koepke, Ph.D., M.D.
Lindsay P. Koester
Mr. & Mrs. Jay B.
Korman
Mr. & Mrs. Jerome D.
Korman
Dawne M. Kornhass
Pearl A. Kramer
Shelley G. Kreiger
Pamela Kriger-Feinberg
R.S. Kronheim
Dorothy P. Kuehl
Robert Lapham
Michael Lavoie
Leonard H. LeMarri
Mrs. Elliot Lehman
Aaron B. Lerner,
M.D., Ph.D.
Eleanor M. Leventhal
Morton A. Levin
Po-Huang Liang
Karlys Merry Lightheart
Richard S. Lovelace
Mrs. Leslie A. Lowerson
Elizabeth B.T. Lozier
Richard H. Lustberg
John M. Lyons
Jean Magi
Daniel C. Maguire
Edyth W. Maibrunn
Veronica M. Malcomson
Mr. & Mrs. Peter L.
Malkin
Candida Mancusi

Ted Mann
Anthony Marino
Doris McDermott
Mr. & Mrs. N. Heath
McDowell
Geraldine B. McGinty
Estelle McKiernan
Mr. & Mrs. Roger
McMahon
Mr. & Mrs. Joseph F.
McVerry
Mr. & Mrs. Steen M.
Melby
The Mendillo Family
Foundation Inc.
Nicole Meo
Ronald C. Merrell
Helen Messina
Arthur Meyer
Mr. & Mrs. Salvatore
Milardo
Richard J. Miller
Mr. & Mrs. Steve Milligan
Mr. & Mrs. I.E. Millstone
Murray A. Morrison, M.D.
Mr. & Mrs. Thomas P.
Nacinovich
Amelia J. Nash
Mrs. Nathaniel L.
Nathanson
Charles Needham, M.D.
Ruth & Naomi Nelson
Mr. & Mrs. Brian J.
Newman
Jason D. Newman
Thomas C. Nichol
Judith S. Novak
Mr. & Mrs. Henry W.
O'Brien
John M. O'Leary
Mr. & Mrs. William L. Ohr
Katharine Odell
Carole A. Orlosk
Dianne Fina Otteson
Anne M. Pacelli
Mr. & Mrs. Harry Panzer
Irene Papaminas
Paul S. Pariser
Je Guk Park
Ellen M. Paternoster
Mr.& Mrs. Joseph F.
Pauloski Sr.
George F. Pavarini Sr.
Lisa Pearsall
James & Dorothea Pelkey
Edith Perelmutter
Elizabeth M. Pfriem
Mr. & Mrs. Philip P.
Piskura
C.L. Polite
Mr. & Mrs. Stewart G.
Pollock
George G. Posener
Nancy R. Pugsley
Anna Rabinowitz
John F. Raycroft, M.D.

Mr. & Mrs. Christopher J.
Regan
Robert S. Reger
Jean K. Regnier
Mr. & Mrs. Ronald Reis
Mildred Renert
Mr. & Mrs. John M.
Reshotnik
Dana A. Ricker
Mr. & Mrs. Morton
Rietberg
Mr. & Mrs. David
Rockefeller
Robert A. Roda
Luis F. Rodriguez
William J. Roos Jr.
Mr. & Mrs. Arthur J. Root
Rev. Ruby M. Rose
Roger D. Rosenfeldt
Richard & Hinda
Rosenthal
Victoria Roth
Prof. Shoichi Royama
Barbara Rubin
David T. Russell
Russell J. Ryan
Nona C. Saling
Hector Sandoval
Charles V. Schaefer Jr.
Lori Schmidt
Mr. & Mrs. Alfred Schnog
Mrs. Norbert Schnog
Bette Scovil
Barbara S. Segaloff
Mr. & Mrs. Wally Seidon
Arthur M. Seigel, M.D.
Toni Mendez Shapiro
Bernard Shectman
Marc Sheerin
S.K. Shenay
Mary C. Shortelle
Stanley Paul Shuler
Craig M. Sidoti
Suzanne E. Siegel
Mr. & Mrs. Edward A.
Silver
Bruce Singer
Nicholas Skovran
Rosalind Slifkin
Barbara R. Smith
Walter Sofian
Jonathan Sonneborn
Mr. & Mrs. James V.
Sorrentino
Mr. & Mrs. Howard B.
Sosin
Mr. & Mrs. John F.
Spellman
Constance E. Spencer
Mrs. F. Donald Sperry
Howard M. Spiro, M.D.
Mr. & Mrs. David Squires
Tracey C. St. Louis
Carmella Stankiewicz
Mr. & Mrs. Bernard
Starkey

Mr. & Mrs. Charles
Starkey
Mr. & Mrs. James Starkey
Mr. & Mrs. Walter
Starkey
Helene L. Stearns
Nina Stearns-Surfus
Deborah J. Steeves
Elizabeth K. Steiner. M.D.
Helen Z. Steinkraus
Mr. & Mrs. Ronald
Stevens
Sadie Stren
A. Walter Stubner
Anne M.Svoboda
Brian Sweeney
Cynthia Sweeney
Alma Mary Tait
Dr. & Mrs. T.E.H. Talma
Trudy L. Talner
Mr. & Mrs. Barney
Tarinelli
Fleurette Thibodeau
Anthony M. Timpanelli
Ernest C. Todd
Lisa A. Todd
Adin M. Tooker
Richard J. Toole
Mr. & Mrs. Louis R.
Tortora
Robert Traurig
R. Leanne Trout
Mr. & Mrs. John E. Ulicki
Helen Ullman
Behrouz Vafa
Janine VautaretMarconnet
Lisetta J. Verrastro
Irene Voynick
Magdalena W. Wagner
Mr. & Mrs. George J.
Wallace
Dr. James K. Wallman
George D. Ward
William A. Ward
Eileen M. Weingarten
Marion U. Weinstein
Seth P. Weinstein
Prof. Stanley Weinstein
Mr. & Mrs. Gunther Weiss
Faye Whaley
Diane M. Whelan
Harold T. White
Martha White
Mr. & Mrs. Russell
Wilkinson
Scott R. Williams
Arthur J. Willner
Irwin & Margo Winkler
Mr. & Mrs. Billy R.
Woolbright
Leonard H. Zamore, M.D.
Marilyn Zimmerman
Mrs. Sarah B. Zusman
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STERLING

STERLING ASSOCIATION

The School of Medicine Alumni Fund’s
Sterling Association recognizes donors who
have made gifts at the following levels:
Benefactor

$ 50,000 and above

Sponsor

25,000-49,999

Patron

10,000-24,999

Fellow

5,000-9,999

Associate

1,000-4,999

Member

200 - 999

ASSOCIATION

Rosalie A. Bums ’56
Paul Calabresi ’55
Pasquale J. Costa ’55
Anne M. Curtis '70
Claude W. Delia’50
Lee E. Farr’32
John E. Fenn ’61
William P. Ferretti M.P.H. '71
Lowell I. Goodman '51
William Harrison Jr. '42
Barbara K. Kinder ’71
William L. Kissick ’57
Patrick T. Minihan ’71
Anoush Miridjanian ’61
Morgan Sargent ’37
Albert C. Weihl ’71
AizikL. Wolf’81
Robert H. Wyatt '43

Sponsor

Alumni/ae

Alumni/ae

John D. Baxter ’66
Sanfurd G. Bluestein '46
Thomas J. Coleman ’46
John A. Elefteriades ’76
John P. Ferguson Jr. '39
Martin E. Gordon ’46
Robert N. Hamburger ’ 51
Liselotte & Samuel S. Herman
M.P.H. ’48
William H. Hindle ’56
Morton M. Kligerman ’58
Margaret A. Lennox
Buchthal ’39
Richard A. Moggio ’71
Joe D. Morris '46
Nicholas PR. Spinelli ’44
Robert R. Wagner '46
William J. Wedemeyer Jr. ’46

Frederic P. Anderson ’62
John W. Foster Jr. ’71
Mohandas M. Kini ’65
Willys M. Monroe ’41
Myron K. Nobil ’47
Friends

Phil N. Allen Charitable Trust
Harry I. Freund
Mary P. Hines
Po-Huang Liang
Mr. & Mrs. David Rockefeller
Luis F. Rodriguez
Nona C. Saling
Christopher Timpanelli
& family
Patron

Friends
Alumni/ae

Sabra M. Hamilton Foundation
Tommy & Susan Hilfiger
Estate of Marion G. Howard
Thomas J. Keenan, M.D.
Ted Mann
George G. Posener
Alma Mary Tait
Irene Voynick
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Carl E. Andrews ’44
Alfredo L. Axtmayer ’76
Gregory W. Bartha ’71
Franklin C. Behrle ’46
Bruce Block ’71
& Marion H. Block ’71
Harold D. Bornstein Jr. ’53

Former House Officers

Richard A. Chase
V.I. Sreenivas
Friends

Fellow

Fred L. Barber
Ana Maria Chiesa
Carole L. Cooper
Mikel T. Dodd & Lauren
Biszewski
Jerry Ehrenwald
Philip & Rose Hoffer
Earl & Jean Johnson
Arthur Meyer
Richard J. Miller
Ruth & Naomi Nelson
James & Dorothea Pelkey
Elizabeth M. Pfriem
Richard & Hinda Rosenthal
Victoria Roth
Charles V. Schaefer Jr.
Magdalena W. Wagner
Irwin & Margo Winkler

Alumni/ae

Associate

Friends

Benefactor

William A. Renert ’65
Julian A. Sachs ’46
Mary Jo P. Shepard M.P.H. ’76
John Smiarowski ’71
Charles D. Spangler M.P.H. ’42
Kenneth C. Steele ’45
Franklin H. Top Jr. ’61
Paul A. Vignola ’71
Robert B. Vranian ’71
Warren D. Widmann ’61

Nancy M. Daly
Dr. & Mrs. J. Sanford Davis
Mr. & Mrs. Dundas I. Flaherty
James A. & Jane C. Folger
Foundation
Fred H. Hibberd
Robert L. James
Mr. & Mrs. Steve Milligan
Mr. & Mrs. I.E. Millstone
Amelia J. Nash
Elizabeth K. Steiner, M.D.
Seth P. Weinstein

Frank C. Bell ’66
John L. Cieply ’71
Donald J. Cohen ’66
Frederick L. Cohn ’71
Allan W. Graham ’71
William D. Harkins M.P.H. ’68
Michael J. Hart ’71
Thomas C. Jaleski ’31
Marie-Louise T. Johnson '56
Thomas Kievan '81
William E. Laupus ’45
Benjamin E. Lyons ’38
A. Frederick North Jr. ’56
Nancy Olmsted ’69
John A. Patti ’71
Vincent Pepe '46
Michael C. Piercey ’71
Jerrold M. Post ’60
Irving G. Raphael ’71

Alumni/ae

Seth F. Abramson ’53
Michael G. Adelberg ’77
Theodore E. Allen ’40
Ralph D. Alley ’43
Thomas T. Amatruda Jr. ’51
Carol J. Amick ’59
Robert M. Amick ’59
Elissa B. Arons ’70
David Atkins ’86
Alicia I. Barela ’81
Aaron T. Beck '46
Suzanne S. Becker’56
Philip Bernstein ’66
John E. Borowy ’50
Thomas J. Brennan ’82
Richard L. Bridgewater ’86
Robert S. Briggs ’61
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Class of 1946 Sets Reunion
Gift Campaign Record
The Class of 1946 broke the $1 million barri¬
er and set a new record for reunion gift cam¬
paigns in the School of Medicine. A total of
$1,155,059 was counted in gifts and
pledges, with a participation rate of 80 per¬
cent. Leadership gifts included a charitable
remainder trust in the amount of $590,000
established by Dr. and Mrs. William J. Wedemeyer Jr.; two current gifts by Dr. Sanfurd G.
Bluestein for unrestricted use and for HHT
research in diagnostic radiology; and a gift of
$67,405 to Yale’s Pooled Income Fund from
Dr. Robert R. Wagner. ■

David W. Brook '61
James E. Brown '66
Gerard N. Burrow '58
Rocco A. Calandruccio '47
Fredric K. Cantor '62
John A. Carlston '58
Randall D. Cebul '76
Helen Y. Chang'76
Paul Chang '86
Joseph Ciabattoni ’76
Andrew D. Cook '71
David Cossman '71
Lawrence G. Crowley '44
Michael J. Cummings '65
Rutledge W. Currie '68
Paul D. Deiter '61
Herbeit W. Diefendorf '41
Thomas A. Doe '46
Malin Dollinger '60
Robert J. Donohue Jr. '58
S. Evans Downing '56
Fred W. Doyle '55
Owen W. Doyle '47
William H. Druckemiller '39
John S. Ebersole ’71
Jonathan Ecker ’70
Mitchell Edson '56
Elizabeth F. Eisner '48
Lee E. Farr '32
Fred Finkelman '71
Michael P. Flynn ’65
Eugene C. Gaenslen Jr. '60
Olive Gates '29
Peter D. Gibbons '66
Richard B. Gloor '71
Anne Godley '48
Carol Goldenthal '44
Thomas H. Gouge '70
Leonard Grauer'68
Ralph S. Greco '68
Peter B. Gregory '63
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Peter A. Gross '64
Joan M. Hardenbergh '56
Armen C. Haig '56
Randall S. Hawkins '76
John V. Haxo '51
Jay H. Hoofnagle '70
John C. Hoover '46
W. Robin Howe '71
Royal C. Hudson Jr. '61
N. Timothy Jette '71
Jonathan D. Katz '70
Richard Katzman '71
Harvey W. Kausel '44
Ruth S. Kempe '46
Alfred E. King '37
Stuart R. Kleeman '71
Jerome O. Klein '56
Lucian S. Lapinski '50
Hildegard M. Leslie '53
Preston L. Leslie '53
Lynne L. Levitsky '66
William K. Levy '76
Bernard Lewin '81
Michael K. Lindsay '79
Manuel B. Litchman '86
Vincent J. Longo '46
George M. Lordi '61
Edward G. Lund Jr. '63
Margaret S. Lyman '50
Robert W. Lyons '64
Sidney Mandelbaum '16
Preston C. Manning '56
Robert Marcus '60
Edward L. Marut '74
Harry L. McClelland '50
Hugh J. McLane '46
Jerome H. Meyer '12
Dwight F. Miller '56
Orlando J. Miller "49
Robert L. Mitchell '64
Steven H. Moffic'71

William Y. Moores '66
Albert R. Mowlem '51
Robert E. Mueller '63
William K. Mueller '70
Donald J. Nalebuff '56
Robert G. Nankin 75
George W. Naumburg Jr. '45
Richard L. Neubauer '16
Andrew B. Newman '75
James A. O’Neill Jr. ’59
Margaret R. O'Neill '91
Marjorie A. Oda '74
S. Kwame Ofori-Kwakye '19
John B. Ogilvie ’34
O'dell M. Owens '16
David A. Paly '81
Martin Paris '71
George W. Paulson '56
Arthur A. Pava '51
John K. Pearce Jr. '61
Alan S. Penziner 'll
Robert G. Petersdorf '52
Charles T. Post Jr. '68
Stewart E. Pursel ’56
James R. Ralph ’59
Emanuel R. Reinitz ’76
John M. Roberts ’52
Nathan E. Ross '28
MarkC. Ruchman '16
Shaun Ruddy '61
Thomas H. Sakoda '61
Leonard B. Saltz '83
Stanley G. Schade '61
Robert Scheig ’56
Douglas R. Schmidt '71
Bernard H. Shen '81
Harry Sherman '34
Richard G. Sisson '46
David B. Skinner ’59
Ora K. Smith '53
A. Thomas Snoke '64
Michael H. Solon ’87
John H. St. Andre '61
Amy Starr '74
Robert S. Steinberg '67
Harold M. Sterling ’51
Gerson M. Stemstein '78
Charles R. Swenson '16
Priscilla D. Taft '44
Martin H. Teicher '81
Seth U. Thaler ’62
Peter M. Ting ’76
Bruce Trembly '56
Theodore K. Tseu ’56
Raymond W. Turner '58
Ronald J. Vender 'll
Leo H. Von Euler'59
Marcia J. Wade '78
Joseph F. Walter ’67
Robert C. Ward ’76
W. Keasley Welch '43
Morris J. Westfried '75
Ronald A. Yankee '60
James F. Young ’53
Arne S. Youngberg ’66

Former House Officers

Jacob D. Goldstein
John P. McGovern
Parents

Mrs. Vincent A. Doroszka
Conrad Fischer
F. Warren Heilman
Argyle Stoute, M.D.
Friends

Thomas H.G. Aitken
James W. Andrews
Kathleen M. Annicelli
Dr. & Mrs. Ramon A. Batson
Randy S. Berger
Malcolm B. Bowers Jr., M.D.
John W. Browder
Geraldine B Carroll
Mr. & Mrs. C. Nick Catrini
Horacio P. Chiesa
Horachio P. Chiesa Galy
Mrs. Henry Cohen
James P. Comer, M.D.
Melvin P. Coolidge, M.D.
Mr. & Mrs. Sidney Corob
Robert Delnickas
Rev. & Mrs. Raymond Downs
Mrs. Ellin F. Ente
Lori-Ann Fickie
Robert J. Freeman
Mrs. James T. Friss
Professor Joseph S. Fruton
Nancy P. Gillis
Mr. & Mrs. Thomas S.
Giuffrida
Theodore Paul Giuliano
Mr. & Mrs. Asher Gluckman
Daniel Goleman
Eileen Rockefeller Growald
Sylvia Heisman
Donald & Audrey Hill
Joseph T. Hughes
Daniel James
Lucille S. Kirsch
Mrs. Elliot Lehman
Eleanor M. Leventhal
Richard H. Lustberg
Geraldine B. McGinty
Ronald C. Merrell
Mr. & Mrs. Brian J. Newman
Judith S. Novak
Anne M. Pacelli
George F. Pavarini Sr.
Mildred Renert
Mr. & Mrs. Alfred Schnog
Arthur M. Seigel, M.D.
Walter Sofian
Jonathan Sonnebom
Mr. & Mrs. James V. Sorrentino
Mr. & Mrs. John F. Spellman
Howard M. Spiro, M.D.
Helen Z. Steinkraus
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Anne M.Svoboda
Trudy L. Talner
Anthony M. Timpanelli
R. Leanne Trout
George D. Ward
Faye Whaley
Harold T. White
Martha White
Mr. & Mrs. Russell Wilkinson
Member
Alumni/ae

David E. Adelberg ’80
George K. Aghajanian '58
Donald Agostinelli ’57
Margaret J. Albrink ’46
Michael H. Alderman ’62
Kathy L. Ales ’78
Margaret N. Alexander '86
Frank R. Allen 51 ’
George H. Allison ’45
Jon R. Almquist ’65
Miguel R. Alonso ’63
Victor A. Altshul ’60
Sophia C. Alway ’41
Joseph E. Angelo '58
David G. Ansel ’69
Martha R. Arden ’84
Joseph A. Arminio ’46
Catharine A. Arnold ’86
Daniel L. Arons ’67
Frederick R. Aronson ’79
Deborah J. Arrindell ’84
Jane E. Asch ’81
Irving M. Asher ’74
Berton W. Ashman '64
David I. Astrachan ’84
Cynthia B. Aten ’81
Albert S. Atwood ’45
Phyllis August ’77
Milton F. Austin '80
Judith L. Bader ’71
David A. Baggish ’73
Muriel H. Bagshaw ’51
John C. Bailar III ’55
David N. Bailey ’73
Earl L. Baker '61
Sidney M. Baker ’64
Paul Balter ’65
William G. Banfield Jr. ’46
Jack D. Barchas '60
Asa Barnes Jr. '59
George R. Barnes Jr. ’47
Richard J. Baron ’78
Andrew N. Bazos ’87
Albert A. Bechtoldt Jr. '61
Daniel I. Becker ’68
Ronald S. Beckett ’40
Ronald J. Berenson ’78
Frank P. Berg '54
John W. Berg ’51
Samir M. Bhatt ’86
Eleanor C. Bigley ’51
Jonathan S. Bishop ’48
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Jonathan S. Bishop ’49
Henry N. Blansfield ’47
Jack N. Blechner ’57
Neil Blumberg ’74
Jerome Bobruff ’55
Richard S. Bockman ’67
J. Alexander Bodkin ’85
Maurice L. Bogdonoff ’52
Maxwell Bogin '26
George Bolen ’77
Sharon L. Bonney ’76
Robert E. Bookstein '83
David G. Borden ’43
Roger A. Boshes’76
Richard J. Bouchard ’54
Stuart P. Bowne ’60
Levon Z. Boyajian ’56
Douglas G. Boyden ’55
W. Roy Breg Jr. ’47
TroyenA. Brennan ’84
Richard I. Breuer ’57
Ronald C. Brown ’74
William H. Bucher’50
Donald P. Buebendorf ’60
Richard S. Buker Jr. '48
Patricia A. Burke ’81
J. Kenneth Burkus ’79
Padraic Burns ’55
Williams. Bush’75
Remi J. Cadoret '53
John L. Cannon ’47
Charles W. Carl Jr. ’63
Ray A. Carlsen ’62
David A. Carlson ’58
John F. Carroll '56
Jeffrey D. Carter ’91
Alice S. Cary '45
Eugene P. Cassidy ’66
Danilo D. Castro ’86
Charles R. Cavanagh Jr. ’47
Linus W. Cave ’46
Richard A. Cazen '74
Joseph C. Cemy ’56
William R. Chaffee ’53
Michael W. Champeau ’80
Michael M. Chang ’80
Robert A. Chase '47
Thomas N. Chase ’62
Alice S. Chi ’85
Richard S. Childs Jr. '76
Jerome H. Chin ’87
Albert K. Chun-Hoon ’57
Raymond T. Chung ’86
Joseph J. Cillo ’58
Elena Citkowitz ’83
Mary W. Clark ’67
John D. Clemens ’76
Robert M. Cohn ’65
John R. Cole ’54
James C. Collias ’56
William F. Collins Jr. ’47
Martin Colodzin ’59
Marc D. Coltrera ’81
Edward J. Conway ’44
Thomas D. Cook ’43
Ronald W. Cooke ’43

John C. Coolidge '44
Kerry Cooper '79
Edward C. Cottle ’71
David L. Coulter ’73
Frank W. Countryman ’44
Jon E. Courtney ’60
Arthur C. Crovatto ’54
Brian Crowley '57
Joseph F. Curi ’64
Cynthia J. Curry ’67
Richard J. Daly '69
Oliver T. Dann ’62
Robert P. Darrow '47
Lycurgus M. Davey ’43
Alvin Davis ’50
James L. Davis III ’67
Jeffrey J. Davis ’75
Chandler Dawson '56
James E. DeLano Jr. ’70
Bryan X. DeSouza '85
Wynant Dean ’40
Orson R. Dee ’61
Michael W. Dennis ’69
John A. Detre '86
James J. Dineen ’67
Paul F. Dodd ’64
John H. Doherty ’44
Joseph A. Donadio ’66

Gary S. Dorfman ’76
Richard E. Dormont ’40
Jeffrey N. Dornbusch '79
James R. Dorr ’57
James M. Dowaliby ’67
Sean W. Dowling ’83
Fred M. Drennan ’82
John A. Drews ’67
Stuart B. Dubin '77
Peter A. Duncan ’41
Cherise M. Dyal '89
Robert S. Easton ’45
Dianne Edgar’83
Andrew Edin ’63
Scott E. Edwards ’91
Helen L. Egger ’91
N. Joel Ehrenkranz ’49
Gilbert M. Eisner ’56
I. Bruce Elfenbein ’62
John P. Eliopoulos ’63
Carl Ellenberger Jr. ’65
Daniel W. Elliott ’49
Norman L. Elliott ’79
Kent Ellis '50
Leroy Engel ’55
Franklin H. Epstein ’47
Irl L. Extein ’74
Marybeth Ezaki ’77

Tommy and Susan Hilfiger
fund MS research

T

ommy Hilfiger’s name is recognized
around the world for his popular men’s
and women’s fashions. His company is also
well-known for its support of charitable
organizations, such as the Fresh Air Fund in
New York. Tommy Hilfiger and his wife,
Susan, have personally committed them¬
selves to biomedical research. Among other
activities, they have made a gift of $50,000
to support a research fellowship in the Yale
Multiple Sclerosis Program.
Mr. Hilfiger’s sister, Dorothy Clapp, who
has multiple sclerosis, is a participant in
clinical treatment studies sponsored by Yale
under the direction of Joseph B. Guarnaccia, M.D., co-director of the Yale MS Pro¬
gram. She has also worked with patients
and their families to ease the devastating
effects of this disease.
The Hilfiger family helped the Yale MS
Program become the fifth participating aca¬
demic center in the Nancy Davis Center
Without Walls, a unique collaboration creat¬
ed and supported by the Nancy Davis Foun¬
dation for MS. ■
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MEMORIALS

D

eceased medical alumni/ae and friends may be memorialized by a
gift at any time to the School of Medicine Alumni Fund endowment
in the name and class of the person so honored. The next-of-kin of a
deceased medical alumnus/a is advised about the In Memoriam Pro¬
gram by a mailing from New Haven some weeks after the School of
Medicine receives notification of the death. The letter of information
includes a copy of the Testament of Remembrance, in which the names
of all persons so memorialized are listed in the medical section by
class, thus establishing a lasting memorial. Your inquiries and interest
are welcome.

YALE UNIVERSITY
Office of the Alumni Fund-Memorials
Rev. James R. Blanning and
Rev. William E. Bliss, directors
P.O. Box 1890
New Haven, CT 06508-1890
(203)432-5853
Deceased alumni and friends
so honored in 1995-1996 were:
Alfred E. Bacon ’49
Lester W. Burket ’36
Charles B. Cheney ’41
Vincent A. Doroszka '30
David Paul Dunn ’60
James Philip Dunn ’53
Gunnar O. Eng ’49
Kevin N. Hennessey ’68
Robert Corlett Howard ’49
Charles Sheldon Judd ’46
Sidney L. Lasell '41
Charles L. Mache Jr. '47
John C. Mendillo ’30
Herbert C. Miller ’34
Kenneth R. Morgan ’42
Edward Nichols '38
Edward T. O’Donnell ’34
Edward W. Pinkham Jr. ’38
Max R. Smimow ’06
Lewis Thorne ’36
Philip Caeser Viscidi ’42
Darrell G. Voorhees ’39
Wesley Watson ’43
Harry M. Zimmerman ’27
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Salvatore Falho ’57
Ralph J. Falkenstein '69
Carol F. Farver ’85
Philip R. Fazzone ’58
Davitt Felder ’42
Herbert W. Felsenfeld ’67
Lu-Jean Feng ’79
Gerald Fenichel ’59
Thomas J. Ferraro Jr. '50
Thomas F. Ferris ’56
Jonathan M. Fine ’81
Alan G. Finesilver '68
Richard J. Fingeroth ’73
Robert I. Finkel ’65
Knox H. Finley ’30
Lesley F. Fishelman '69
Robert L. Fisher '59
William F. Flynn '68
Alan L. Folsom '63
John W. Foreman ’62
Robert N. Frank ’66
Jean L. Fraser’91
Lawrence R. Freedman '50
Robert W. Frelick ’44
M. Felix Freshwater ’72
Guy Fried ’85
Jonathan S. Friedes '88
Alice D. Friedman ’45
Paul J. Friedman ’60
Paul J. Friedman ’59
David H. Fulmer ’63
Sidney S. Furst '51
Raymond A. Gagliardi '45
Raymond A. Gaito ’58
Jared J. Gardner '71
John H. Gardner III ’56
John A. Gariepy ’54
Jay A. Gates ’86
Barry Gault '64
Elizabeth R. Gawron ’75
Royal J. Gay ’69
Alfred C. Gaymon ’75
Susan R. Gaynon ’76
Sander G. Genser ’69
Michael A. Gerber ’74
Vincent F. Geremia Jr. '63
John N. German '62
Margaret C. Gildea ’36
Bernice K. Glover '91
Sumner H. Gochberg ’56
Dorothy M. Gohdes ’72
David E. Golan ’79
Lee Goldman ’73
Anne H. Good ’57
Eleanora C. Gordon '49
Gary V. Gordon ’73
Gwendolyn Grant ’91
S. Jerome Greenfield ’39
Andrew H. Greenhill ’72
Stanley I. Greenspan '66
James Greenwald ’58
J. McLeod Griffiss '66
B. Herold Griffith ’48
David D. Griffith ’61
Gary T. Grimes ’73
David H. Groth ’62
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Michael Fitzsousa

The Office of Alumni Affairs, as part of its new Outreach Program, sponsored a reception in San Francisco in November
1996 during the annual meeting of the Association of American Medical Colleges. Brothers John A. Anlyan, M.D. '45,
right, and William G. Anlyan, M.D. '49, second from left, are pictured with Dean Gerard N. Burrow, M.D. '58, left, and
John’s wife, Betty.

Robert H. Groves ’56
James K. Gude ’65
Robert A. Gunn '66
Irving Guttenberg ’60
John L. Gwin Jr. ’84
Bruce B. Haak '72
Linda J. Hall ’78
James H. Halsey Jr. '59
John A. Hangen ’29
Henry G. Hanley ’66
James Q. Haralambie ’35
Ross R. Harcus '48
Paul A. Harper ’31
John T. Harrington ’62
Stanley Harris ’58
John H. Hart '56
Richard J. Hart Jr. ’67
Barbara J. Harvey ’86
Patricia C. Hassakis '62
Christopher W. Hauge '64
A. Daniel Hauser '53
William W. Hay Jr. ’71
Jay G. Hayden '66
Richard L. Heppner '67
Peter N. Herbert '67
George P. Herr '67
William H. Heydom '59
David A. Hill '65
C. Richard Hinckley '59
Lawrence J. Hirsch ’91

Yale medicine

Gary S. Hirshfield "86
Elizabeth S. Hodgson '78
Gilbert F. Hogan '57
O. Roger Hollan '45
Charles L. Hopper '56
Thomas L. Horn '72
Mary A. Houghton '66
William J. Houghton '64
Thomas C. Howard '69
Daphne T. Hsu '82
Vernon H. Humbert Jr. '72
Carl E. Hunt '65
Herbert S. Hurwitz '54
Richard G. Ihnat '91
Leonard Inker '59
Carrold K. Iverson '51
Jonathan L. Jacobs '80
W. Raymond James '44
Robert M. Jarrett ’74
Arthur C. Johnson III '79
Benjamin A. Johnson '49
Paul A. Johnson '75
Thomas R. Johnson ’68
Virginia B. Johnson ’65
William J. Johnson ’52
Daniel M. Jones ’60
Henry H. Jones ’43
Brian C. Judd ’63
Emilio J. Juncosa ’84
Amy C. Justice ’87

Rebecca E. Kadish ’87
Richard L. Kahler '57
George T. Kammerer '56
Kevin Kane '75
Harold P. Kaplan '63
Roy A. Kaplan '12
Walter W. Kamey '62
Ronald J. Karpick '65
Michael Kashgarian '58
Michael A. Kaufman ’72
Richard L. Keefe '61
Robert M. Keith '54
Leo Kellerman '42
R. Leonard Kemler '43
Donald L. Kent ’72
Robert J. Kerin '47
David R. Kessler ’55
Harold King '46
Joseph T. King Jr. '87
Robert D. King ’51
David W. Kingsbury '59
J. Robert Kirkwood '67
Ralph J. Kirmser '71
Jay W. Kislak’58
James A. Kleeman ’46
George D. Knowles ’75
Richard R. Knowles ’53
Anne A. Knowlton ’78
Paul B. Koehler ’48
Howard K. Koh ’77

WilhelminaC. Korevaar '77
Donald S. Komfeld '54
Melvyn Korobkin '67
Mark A. Korsten '70
Robert A. Kramer '55
Frederick F. Krauskopf '44
Edward A. Krull '55
Thomas P. Kugelman "60
Thomas S. Kupper ’81
Samuel D. Kushlan ’35
Constantine D. Kyropoulos '63
Lynn G. Lagerquist Jr. ’69
Scott R. Lambert '83
Saul Lande '74
Lewis Landsberg '64
Edward R. Lang '60
Michael W. Lau '45
Frank D. Law '49
Philip W. Lebowitz '72
Carol H. Lee '76
Forrester A. Lee Jr. '79
Richard V. Lee '64
Jack Levin '57
James S. Levine '64
Sandra C. Levine '65
William V. Lewit '56
Theodore W. Lieberman '58
Michael R. Liebowitz '69
Paul R. Lightfoot Jr. ’64
Bjorn Lih ’41
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David Lindgren ’83
Janus C. Lindner '50
Clinton L. Lindo ’86
Elliot M. Livstone ’69
Francis M. Lobo ’91
J. Philip Loge '43
Jack W. Love ’58
Anthony P. Lovell '67
Jeffrey A. Lowell '85
Frank E. Lucente '68
James Lum '55
Hugh J. Lurie '61
Brock Lynch '47
Michael E. Mahig ’88
John L. Mahoney ’63
Jocelyn S. Malkin ’51
Stacey Mandelbaum ’86
William J. Mangione ’71
Harold March ’50
Vincent T. Marchesi ’61
Robert H. Margulis ’63
Robert L. Marier '69
Josefina V. Marin ’76
John C. Marsh ’59
Edward Martin ’40
Frederic R. Martin '83
John G. Martin ’33
Jose L. Martinez ’78
Teresa L. Massagli ’82
William F. Matched ’64
David B. Matloff’61
Allan L. Mattem '62
A. Reese Matteson '44
Stanley E. Matyszewski '62
Thomas J. Mauro Jr. ’58
William K. McClelland '47
Cynthia A. McCraven ’86
John A. McDowell ’73
Andrew J. McGowan Jr. '58
Timothy W. McGowen ’86
Joseph S. McGuire Jr. ’55
Robert K. McLellan ’78
John F. McQuade ’73
Harold Mellin ’66
Herbert Y. Meltzer ’63
Barton N. Milestone ’81
Donald L. Miller ’60
Harry C. Miller Jr. '54
Mark A. Miller'90

Michael D. Miller’86
Richard C. Miller’58
Stephen W. Miller ’67
William A. Miller’62
Richard P. Mills ’68
Hyman J. Milstein ’75
Robert K. Modlin '57
Hugh L. Moffet ’57
Cesar R. Molina ’80
Russell R. Monroe '44
Norman F. Moon ’56
Richard A. Moore '61
Frederick C. Morin III '76
Joseph L. Morris '67
Jon S. Morrow '76
David E. Morton ’48
N. Karle Mottet ’52
James J. Murphy '64
Jerry Nagler '73
Stephen F. Nagyfy ’36
William M. Narva ’56
George A. Nelson Jr. ’57
Paul N. Neufeld '54
John F. Neville Jr. ’46
Laura W. Neville ’46
Ismail N. Nevin '51
Kenneth E. Newhouse '87
James P. Nolan ’55
Timothy F. Nolan Jr. ’49
Walter W. Noll ’65
David P. Norton ’83
Edward B. O’Connell ’41
John P. O'Grady ’72
Donald A. O'Kieffe Jr. ’64
Joyce A. O’Shaughnessy ’82
Kwaku Ohene-Frempong ’75
Robert W. Ollayos ’41
Margot Onek ’68
Nelson K. Ordway ’38
A. Lawrence Ossias ’65
Robert H. Owens ’46
David A. Page ’56
Fred Palace ’60
Sidney N. Paly ’52
Henry F. Panek ’68
Robertson Parkman '65
Nicholas M. Passarelli ’59
John O. Pastore '67
James R. Patrick ’56

Ted Mann Foundation Funds
Lymphoma Research
The Ted Mann Foundation pledged
$500,000 over five years to establish
the Ted Mann Lymphoma Research Pro¬
gram Fund in the Yale Cancer Center. Mr.
Mann, producer and founder of Mann
Theaters in California, supports a variety
of education and medical research caus¬
es through the foundation.
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Harris Brothers Support
Yale Child Study Center
Two brothers, both Yale College graduates,
pledged a $4 million gift to construct a new
facility and support programs at the Yale
Child Study Center. The gift from Irving B.
Harris, Yale College Class of ’31, and Neison Harris, Yale College ’36, will help con¬
struct the Neison and Irving Harris building,
a new wing attached to the center.

Timothy A. Pedley ’69
Barry B. Perlman ’71
Richard E. Peschel '77
Barbara A. Peters ’79
Richard C. Peterson ’48
Carol F. Phillips '58
Leon A. Phillips ’52
Julian I. Pichel ’49
Lawrence K. Pickett '44
Sheldon R. Pinnell ’63
Olive E. Pitkin '47
Elizabeth A. Plotkin ’86
Robert L. Powell ’56
William B. Pratt '64
James D. Prokop ’59
David M. Pugh ’58
Richard D. Pullen ’54
Susan B. Radoux ’81
Daniel W. Rahn ’76
Paul R. Ramirez ’76
Jose Ramirez-Rivera ’53
David M. Raskind '24
Carrie A. Redlich ’82
Clifford B. Reifler ’57
Lynn W. Reiser ’70
Bruce A. Reitz ’70
Jack S. Rice Jr. ’64
Henry A. Riedel '43
Brian F. Rigney ’67
William A. Rios '84
Samuel Ritvo ’42
Barbara A. Roach ’81
Richard S. Robbins ’72
Joseph D. Robinson '69
Joseph M. Rochford '69
Lois K. Rogers ’42
Thomas J. Romano ’73
Roy E. Ronke Jr. ’61
John K. Rose ’54
Albert M. Ross ’60
Paul A. Rudnick '58
Benjamin F. Rush Jr. '48
Carl M. Russell ’49
George M. Sachs '86
Virginia C. Saft ’53
Gary L. Schaer ’79
James Scheuer ’56

Stephen C. Schimpff ’67
Mary W. Schley '52
Ricky M. Schneider ’77
Charles F. Scholhamer '72
Richard S. Schottenfeld ’76
John J. Schrogie ’60
David J. Schulak ’69
Donald H. Schultz ’52
Russell B. Scobie ’29
Margretta A.R. Seashore '65
Donald W. Seldin ’43
Jerome H. Shapiro ’48
Dovelet Shashou ’81
Donald P. Shedd ’46
Cynthia A. Sherman ’79
Jonathan A. Sherman ’88
Charles E. Sherwood ’45
Sarah P. Sherwood ’44
Cynia B. Shimm ’50
Stuart S. Shorr ’70
Jane B. Shumway ’50
Leonard M. Silverman ’54
Donald C. Simonson ’78
Richard A. Sinnott Jr. ’53
HillelD. Skoff’80
Laurie Smaldone ’79
Gerald J. Smallberg ’69
Pamela E. Smith ’79
Sidney C. Smith Jr. ’67
Thomas W. Smith '15
Helen L. Smits ’67
Robert T. Solis ’65
Kimberlee A. Sorem ’86
Edward H. Soule '43
James P. Southwick ’71
Gene W. Spector ’59
James A. Spencer ’62
Robert Spiera ’89
Robert M. Spillane ’91
Hilliard Spitz '43
Richard A. St. Onge ’70
Donald C. Stahl '51
Nicholas M. Stahl ’43
Nancy A. Staley ’62
Fred L. Stargardter ’60
Mark Stein ’84
Robert L. Stein ’54
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Jonathan W. Stewart ’71
Lee H. Strohl ’68
Eric P. Suan ’86
James F. Sullivan ’73
Thomas F. Sweeney '73
Richard B. Swett ’67
Daniel R. Synkowski ’71
Paul Talalay ’48
Lee B. Talner ’63
Robert N. Taub ’61
Caroline R. Taylor ’78
Carol C. Teitz ’74
Lawrence P. Temkin ’72
R. Bruce Thayer '46
Jonathan Titus ’65
Patrick J. Toth '82
Susan P. Tredwell ’84
Lawrence Tremonti '63
Ray W. Tripp III '70
Semeon G. Tsalbins ’71
Patricia B. Tudbury ’47
Maurice Tulin ’42
Albert L. Ungricht ’82
Anthony M. Urbano ’81
Ellis J. Van Slyck '47
Martha Vaughan '49
Gary C. Vitale ’79
Robert A. Vollero '67
John W. Vosskuhler ’54
Karl G. Wagner Jr. '90
Helen N. Walsh ’63
William P. Walsh ’46
Martin Wand ’67
May Y. Wang '60
Patricia E. Wanning ’40
Steven L. Warsof ’77
Stephen R. Webb ’69
Myron E. Wegman ’32
Marc A. Weinberg ’73
Peter G. Weiner ’63
Robert G. Weiner ’65
Seth M. Weingarten ’63
James L. Weiss '68
Carolyn K. Wells '69
C. Bruce Wenger ’70
James G. Wepsic ’63
Doris L. Wethers ’52
Robert B. Whitney Jr. ’59
Per H. Wickstrom ’68
Henry S. Willner ’75
ElihuS. Wing Jr. ’46
Alfred J. Wise ’63
Daniel Wohlgelemter ’77
David H. Wohns ’81
Brooke M. Wolf ’72
Stephanie WolfRosenblum '82
John L. Wolff ’52
Irving N. Wolfson ’42
Edward M. Wolin ’74
Andrew S. Wong ’51
Jeffrey W. Work ’79
Stewart R. Wright ’62
Karl O. Wustrack ’70
John J. Wysolmerski ’86
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Friends

Marc O. Yoshizumi ’70
Richard S. Young ’73
Pamela L. Zeitlin ’83
Steven M. Zeldis ’72
Former House Officers
Frederick L. Altice
Christine Brahney
Ronald W. Braun
Richard S. Casden
Edward J. Collins Jr.

Harold O. Conn
John W. Goldkrand
Herbert S. Sacks
Sanan Simarak
Leon G. Smith
Robert A. Stanton
Parents
R. Donald Reich
Henry S.
Sanematsu

Mr. & Mrs. Mark Anderson
Ellen Hope Angus
Diana Balmori
Waddell Barnes, M.D.
Timothy Brandt
William Brown
Dr. Sonja Buckley
Grace T. Burket
Edwin C. Cadman, M.D.
L. Dawn Christian, D.D.S.
Joanne Chvisuk
Mr. & Mrs. Charles Ciambrielh
David E. Crabb
Thomas P. Duffy, M.D.
David S. Fischer
Cheri Fox
Karyn Gabbinelli
Alphonse F. Gencarelli
Gary Gerard, M.D.
Arthur Goldzweig, Esq.
Beverly M. Grasso
Maurice D. Grasso
Holocaust Survivors of
New Haven
Helen D. Haller
Michael B. Hammond
Mr. & Mrs. James J. Imbrogno
Mrs. Charles S. Judd Jr.
Foster Kay, M.D.
Nancy M. Kenny
Uwe Koepke, Ph.D., M.D.
Mr. & Mrs. Jay B. Korman
Robert Lapham
Aaron B. Lerner, M.D., Ph.D
Richard S. Lovelace
The Mendillo Family
Foundation Inc.
Daniel C. Maguire
Edyth W. Maibrunn
Mr. & Mrs. Peter L. Malkin
Candida Mancusi
Charles Needham, M.D.
Jason D. Newman
Katharine Odell
John M. O’Leary
Mr. & Mrs. Harry Panzer
Je Guk Park
Anna Rabinowitz
Mr. & Mrs. Ronald Reis
Dana A. Ricker
Robert A. Roda
Roger D. Rosenfeldt
Mrs. Norbert Schnog
Suzanne E. Siegel
Mr. & Mrs. Howard B. Sosin
Mr. & Mrs. Ronald Stevens
Sadie Stren
A. Walter Stubner
Dr. & Mrs. T.E.H. Talma
Ernest C. Todd
Robert Traurig
Behrouz Vafa
Leonard H. Zamore. M.D.
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ALUMNl/AE

FUND

From the chairman of
the Public Health Alumni Fund

T

From the dean for public health

T

he faculty and students join me in thanking our
alunmi/ae for their outstanding support this year
for financial aid through the EPH Alumni Fund. We
have an extraordinary group of students, many of
whom have great financial needs. Being able to help
them relieve some of their financial burdens is very
rewarding.
We have opened the new student center across the
street from the Laboratory of Epidemiology and Public
Health. It includes the Student Affairs and Career Ser¬
vices offices, a student lounge, computer facilities and
a magnificent new library. Moving those activities has
allowed us to develop the first floor of the main build¬
ing with new classrooms and a thoroughly renovated
Winslow Auditorium.
The faculty is implementing our strategic plan,
including needed revisions of the curriculum. The first
classes in our new Health Management and Regulatory
Affairs programs are here and doing well. We are
strengthening our relationships with other schools at
Yale and the cross-fertilization of ideas makes EPH a
lively place. We are also recruiting several new faculty
in a wide range of areas.
But as we enjoy academic life, we cannot forget
the enormous public health problems facing popula¬
tions close to us in the city of New Haven and as far
away as the most distant point on the globe. It is on
these problems that we must focus our educational and
research activities and programs.
On behalf of the entire school, I extend our grati¬
tude to those alumni/ae who have generously sup¬
ported our efforts.
Michael H. Merson, M.D.
Dean for Public Health
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his spring at our alumni
weekend we will cele¬
brate the 50th anniversary of
organized alumni/ae involve¬
ment in Epidemiology and
Public Health at Yale.
Throughout all of these
years, we have shared a tradi¬
tion of loyalty and devotion
to EPH. The enthusiasm of
our dean, the new renovation
of the student and teaching
facilities and the heightened
activity of our faculty—in research and service areas
such as emerging infectious disease, managed care and
urban health—have increased the visibility of public
health at Yale.
One result has been the recruitment of an outstand¬
ing group of master’s and doctoral students who repre¬
sent our real investment in the field. Alumni/ae gen¬
erosity has made financial support available to many of
these students who could otherwise not attend Yale. In
fact, last year our level of alumni/ae participation in
giving was at an all-time high of 41 percent, and EPH
gifts and pledges to the Annual Fund and Yale’s capital
campaign totaled more than $400,000.
I want to express my congratulations and sincere
thanks to everyone who worked on these fund-raising
activities, as well as to those who so generously con¬
tributed. Adequate financial aid for students remains
our most important financial priority as we address the
challenges of educating students for the demands of
public health in the future. If EPH is guided by our
mission to train leaders, we must be able to attract and
retain the very best students and allow them to plan
careers that address the needs of the field. As EPH
alumni/ae and public health professionals, we all
appreciate the importance of this mission. It is fitting,
in this next anniversary year, that we renew our com¬
mitment to advancing the field by continuing our sup¬
port of those who will be our future colleagues.
Eric W. Mood, M.P.H. ’43
Chairman
Public Health Alumni Fund
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EPH Alumni/ae Fund
The names and data included on the following
pages reflect contributions made and endow¬
ment income accumulated between July 1,
1995, and June 30,1996. The class members
recognized made a gift to the find during that
period. Endowment income is not reflected in
the class participation percent. If we have
inadvertently omitted your name, please
accept our apologies and contact Mr. William
K. Jenkins in care of this magazine so that we
may correct this omission.

Dorothea S. LaBelle
Hiram Sibley

1949
Gift: $1,150
Participation: 69%
Agent:
Edgar L. Geibel

Eleanor C. Connolly
Edgar L. Geibel
Eleanor P. Kostant
Edmund R. Mattos
M. Christine R. Owre
William B. Parsons
Joyce L. Reiss
Elizabeth Robinton
Ernest M. Sable
Mary T. Springer
Kathryn K. Venning

1933

1944

Gift: $20

Gift: $1,078

1950

Participation: 33%

Participation: 67%

Gift: $1,987

Miriam M. Campbell

1934
Gift: $1,338
Participation: 100%

Iwao M. Moriyama

Agent:

Participation: 62%

Eric W. Mood

Agent:

Paul E. Gagnon
Jean F. Heston
Jane Y. Parker
Einar H. Raysor

1937

1945

Gift: $100

Gift: $200

Participation: 50%

Participation:

Howard West

Roslyn R. Bilford
Naomi Barer Golden
Mrs. Joe Bales Graber
Lois M. Jund
Hazel M. Whitesel

1938
Gift: $185
Participation: 100%

Willard H. Boynton
Andrew S. Wong

1941
Gift: $1,376
Participation: 50%

Margaret H. Hyde Moore
Roslyn L. MacNish

1942
Gift: $5,455

56%

1946
Gift: $600
Participation: 33%

Dorothy B. Hamilton
D. Patricia Nelson

1947

Agent:

Lester M. Bornstein
Amy L. Cawley
Evelyn S. Farnsworth
Morris London
Mary McC. Mogan
Frances R. Ogasawara
Gerald Rosenblatt
Daniel E. Ross

Gift: $3,255

Yolande F. Lyon

Participation: 53%
Agent:

Mary M. Del Piero
Howard Dunphy
Joanna Adele Henry
Malcolm C. Hope
Charles Holway Lawrance
Helen Kardys Loria
Yolande Lyon
Brena B. Wolff

Participation: 62%

1953

Agent:

Gift: $865

John B. Dibeler
Mary L. Ellis
Joseph Hanford Gerber
Samuel S. Herman
Mrs. Richard E. Johnson
Beatrice H. Kaasch

Dorothy M. Wilson

Frances R. Ogasawara

Marvin A. Lavenhar
Hugh J. Maher
Feme G. Moore
Ellwyn D. Spiker
Mattie Lee D. Wade
Kenneth J. Williams

1960
Gift: $2,205
Participation: 53%

Participation: 75%
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Participation: 40%
Agent:

Dorothy Reese Bloomfield 1956
Ida M. Bucher
Gift: $2,705
Austin J. Evans
Participation: 75%
Jerome M. Glassman
Agent:
Dorothy R. Granoff
David D. Boyd
Eugene K. Harris
Ruth D. Bartling
Frances K. Reynolds
Dorothy Carol
Nathan M. Simon
Blumer
1951
David D. Boyd
Gift: $640
Marvin H. Burton
Participation: 42%
Lois Blatchford Fuller
Kathleen H. Howe
Norton G. Chaucer
John E. Ives
Homer Hopkins Jr.
Paul I. Kaufman
Robert L. Johnson
John F. Mullett
Virginia E. Torres
Julia R. Nole
James M.A. Weiss
Mary K. Ochiai
1952
George R. Walker

Agent:

Samuel S. Herman

1959
Gift: $965

Participation: 67%

1957

Gift: $120,875

Helen H. Davenport
Normand E. Girard
Patricia P. Grimaila
Philip B. Hallen
J. Philip Keeve
Edward H. Noroian
Joseph A. Scorpion
Mary K. Spiker
Irene N. Sweeny
Robert Kenneth Wood

Gift: $465

Gift: $2,025

Gift: $1,327

Julius Elston
Carolyn S. Koffler
Eric W. Mood
Amelia F. Roe
Miriam H. Rohde
Adele P. Schlosser

1955

Participation: 47%

1948

Eric W. Mood

Donald R. Cowan
Jo Ann G. Graves
Alvin Hamburg
William A. Markey
Ruth M. Taber

Agent:

1943

Eric W. Mood

Eric W. Mood

Participation: 58%

Henry F. Canby
Leonard Parente
Charles D. Spangler

Agent:

Pa rticipation: 71%
Agent:

Gift: $3,390

Sidney S. Chipman
Anne E. Fulton
Lillian L. Konick
Leah Lehrer
Jean M. Pinder
Cecil G. Sheps
Samuel Zibit

Participation: 100%

Eric W. Mood

1954
Gift: $610

Participation: 45%

Abraham Cutcher
Cecilia Frances
Di Cicco
Barbara J. Lee
Milton H. Sisselman
Constance B. Thomas

Edward R. DeLouise

Anne M. Anzola
Lee de Cady Jr.
William A. Clermont
Edward R. DeLouise
Sheldon Selig King
Shirley T. Steidel
Paul W. Sternlof
Patricia A. Viscosi

Charles W. Burchard
Kathryn L. D'Amico
Wouter Ekker
Maxine Geeslin
Rose A. Iannotta
John J. Kwasnowski
Salvatore Miano
R. John C. Pearson
Hannah Clark Russell

1961
Gift: $3,425
Participation: 71%
Agent:
Joseph T. Prekup

Gordon R. Beem
Mary S. Blackburn
Martin Donabedian
Alfred E. Fletcher
Yoh Ok Lee
Helen M. O’Connell
Margaret P. Parker
Joseph T. Prekup
Angela M. Russo
William R. Slivka

1962
Gift: $1,050
Participation: 22%

Thomas A. Blumenthal
Thomas R. Mayhugh

1963

1958

Gift: $3,125

Gift: $4,845

Participation: 47%

Participation: 55%
Agent:
Joseph Scorpion

Eduardo Anzola
Josephine Blanchett

Jordan Braverman
Hamp Coley
Raul R. Cuadrado
Stephen F. Davie
Frank M. Isbell
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Edward M. Kenney
Jean M. Maynard
Samuel B. Webb Jr.

Irma Willner
Robert L. Woodward

1964

Gift: $12,910

Gift: $2,755

Participation: 53%

1968

Participation: 39%
Agent:
Allen Cohen

James J. Culhane
Katherine Maria Detre
Martin Hirsch
Carter L. Marshall
Estelle Siker
Monroe W. Spero
Claudewell Sidney
Thomas

1965
Gift: $2,225
Participation: 50%

Edgar W. Francisco III
Monte Nelson Frazier
James F. Jekel
Michael E. Kove
Peter J. Levin
Charlotte Miller
Mary K. Murphy
Francia M. Pagano
Elliot A. Segal
Viola J. Spinelli
Alice J. Turek
Sarah L. Turner
David S. Weiner

1966
Gift: $1,820
Participation: 36%

Richard W. Benfer
Allen Cohen
Anne B. Collart
Richard H. Ferraro
Jennifer L. Kelsey
Robert C. Lowrie Jr.
Mrs. Birch H.
Milliken
Nancy Alfred Persily
Gary J. Robinson

1967

Sonia M. Colon
Joseph L. Dorsey
Elizabeth Schwartz Elliot
Robert R. Everett
L. Carol Fernow
Carl R. Fischer
Michael J. Geaney Jr.
Francis J. Greaney
William D. Harkins
Chester H. Johnson
R. Elizabeth Leif
Margaret J. Lindsay
Jean C. MacCorison
John M. Patton
Richard L. Petrelli
Cornell Scott
Doreen P. Sharabati
Martha F. Steel
Doris Storms
Elizabeth C. Wright

1969
Gift: $2,773
Participation: 45%

Susan S. Addiss
Janet A. Albrecht
Jean Parker Cobb
Victor Crown
James M. Dawson Jr.
Charles W. Felix
Sister Mary Anne
Fitzmaurice
Sharon A. Garcia
David P. Johnson
Samuel P. Korper
John N. Parker
Samuel D. Rowley
Marva Serotkin
Edward P. Tantorski
Wanda Vierthaler

1970
Gift: $12,820
Participation: 56%

Gift: $4,341
Participation: 59%
Agent:
James M. Malloy

Gerard M. Barber
Rosalie M. Berberian
Caroline Fong-Cheng
Ann Gomez
Joel Kavet
Dennis J. Magid
Patricia D. Mail
James M. Malloy
Joseph A. Mangiafico
Charles Petrillo Jr.
Nancy Ruth Phillips
Bruce J. Steinhardt
Elgin Wayne Watkins

66

Robert G. Alexander
Susan W. Balter
Katherine Benesch
Arthur A. Berarducci
Michael B. Bracken
Hamilton B. Brown Jr.
Shan Cretin
Ruth C. Edelson
Walter M. Gawlak
Robert S. Gureasko
Martin James Kandes
J. Kevin Kinsella
Shirley O. Labium
Scott W. Lite
Russell F. Martin
C.P. Noel McCarthy
Andrea W. Nevins

Peter Orris
Saro Palmeri
William L. Pedersen
Carol B. Phillipy
Nancy Norton Reitz
Stephen Skorcz
Joseph A. Zaccagnino

1971
Gift: $17,460
Participation: 52%

John Bihldorff
Evelyn J. Bromet
Willard Cates Jr.
Katrina H. Clark
Dale A. Culp
Chester L. Davis II
Harvey Fembach
William P. Ferretti
Anne-Marie Foltz
Marilyn S. Halper
Dennis R. Hamilton
Wanda Hatmaker Decker
Mohamed Ismail Johnson
William P. Koughan Jr.
Joseph S. McManus
Nancy P. Mogielnicki
Wan Hin Ooi
Carol L. Paul
Marcia Russell Prado
John M. Ryan
Anna Caroline Schildroth
Jane Silver
Rev. Robert E. Steele
David L. Stockton
Victor J. Tucci
Judith Whitcomb

1972
Gift: $6,085
Participation: 67%
Agent:
Dorothy J. Nicoll Lewis

David P. Barone
Stephen B. Baruch
Steven H. Beloff
Michael L. Benjamin
Frances L. Bushnell
Paul G. Bushnell
C. Gene Cayten
Catherine A. Connolly
John A. Drew
James P. or
Anne S. Fenhagen
Daphne Dej. Gemmill
Susanne Harris
Russell E. Holmes
Selby Campbell Jacobs
Dorothy N. Lewis
Steven M. Lipsius
Marilyn Marie Massey
Eugene A. Richardson
Sergio Ruschel
Jo Ann Silverstein
Joyce R. Waksman
Owen L. Wood
Carol H. Simpson Yee

1973
Gift: $8,575
Participation: 57%
Agent:
Gaty D. Sax

Emily M. Barclay
Eva Danielsson Cohen
Bernice E. Coleman
Etekamba E. Ekwo
Bruce Goldman
Schula Russell Hobbs
Helen B. Hubert
Shirley A. Jackson
James L. Mason
Dennis P. May
Dwight N. McNeill
Stanley D. Miller
George A. Million
Eugene C. Nelson
Marjorie E. Nelson
Eugene Robertson
Gary Dean Sax
Janet B. Schoenberg
Andrew Edmund Slaby
Alice S. Stark
Thomas J. Stranova
Irene Trowell-Harris
Larry S. Webber
Bonnie C. Yankaskas
Carl J. Zack

Ann C. Cunningham
Linda K. Demlo
Jack A. Eiferman
Joyce H. Glazer
Gerard R. Goulet
William J. Grego Jr.
Donna Brown Grossman
Anne H. Hall
Mary F. Johnson
Barbara R. Unterman
Jones
James E. Knoben
Matthew A. Kurs
Stuart L. Lefkowich
Sheldon M. Levy
Marsha Alex Lubick
Hillary Dernby Malafronte
Laurence F. McMahon Jr.
Dennis W. Mesenhimer
Mary W. Palshaw
Dale P. Sandler
Edward V. Sargent
Nancy E. Stroup
Raymond Chiu-Ping Tang
John H. Tobin
Maura M. Tobin
Franziska U. Ulrich
Vera B. Walline

1976
Gift: $15,860
Participation: 55%

1974
Gift: $3,033

Agent:
Elaine P. Anderson

Participation: 44%
Agent:
Thomas A. Benoit

Gregory Belok
Thomas A. Benoit
Ian B. Berger
Roger H. Bernier
Olga Brown-Vanderpool
Beth G. Crocker
Robin Gilleland
Elizabeth M. Helming
George L. Kelley
Evelyn B. Mostow
Edward J. Mullen
Thomas P. Pipicelli
Shirley M. Pripstein
Nils R. Richardson
Elaine Ron
Donald R. Showalter
Abigail L. Smith
Meredith E. Spear
J. Lawrence Tanenbaum

1975
Gift: $6,355
Participation: 42%
Agent:
Linda K. Broker

Christine P. Antaya
Edith N. Baum
Ralph E. Binder
Gerald E. Bisbee Jr.
Linda K. Broker

Elaine P. Anderson
William F. Appicelli
Helen Y.Y. Chang
Janet Cobey
Mary P. Cowmeadow
Darryl E. Crompton
Agueda N. Deans
Joanna M. Erikson
Paul H. Etkind
Robert H. Frazier
Berton D. Freedman
Wendy Corn Friedman
Annette B. Garofalo
Linda J. Goodhart
Karen A. Gordon
Cleve Lee Killingsworth
Janina Levy
Eric Malz
Robert C. Marquardt
Karen E. McClelland
Lawrence V. Meagher Jr.
Gino A. Nalli
Arthur J. Orloske
Ruth Fitch Quah
Robert Risdon Schwarz
Mary Jo P. Shepard
Martha Ann Teitelbaum
Gladys A. Williams
Thomas S. Wingardner Jr.
Frances L. de Peyster

1977
Gift: $9,227
Participation: 42%
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Richard B. Burford Jr.
Patrick F. Carone
Jeffrey Allen Cassis
Steven R. Cohen
Bruce D. Cummings
Marsha E. Dunn
Gerard J. Foley
Joanne Godley
Travis K. Hedrick
Susan J. Kennedy
Teri J. Klein
Ronald F. FaPensee
Wendy K. Lefkowich
Angela Manns
Polly W. Marvin
Rosanne B. McTyre
Sharon A. Mulgrew
Kristin K. O’Connor
Veronica C. Oestreicher
Harris Pastides
Finda Mendelsohn Pottem
Marilynn S. Robinson
Deborah Rose
Fynne E. Rosenwald
Abby Rothschild
Carroll Schilling
Susan M. Silverman
Gail M. Sullivan
Virginia R. Towle
Leon F. Vinci
Ellen J. Waldman
Paula Y. Yaney Gambill

1978
Gift: $10,650
Participation: 57%
Agent:
Ann T. Freedman

Vijaya V. Bapat
Kathleen M. Berman
William Harvey Blitz
Alan B. Bloch
Bradford A. Buxton
Constance C. D’Atri
Robert J. Fensterheim
Ann T. Freedman
Janice R. Gold
Celestine Grace
Olympia Hadjimichael
Nancy G. Hildreth
Stephen W. Hildreth
Jane E. Hill
David W. Houck
William A. Howard
Jean Crum Jones
Margaret Fong Karis
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Amy Schein Kondo
Rosalyn S. Fiss
Christopher M. Maylahn
Robert K. McFellan
H. James Myers
Marguerite Nelligan
Patricia Fynn Noeker
Peter F. O'Connor
David W. Osborne
Elizabeth L. Pantelick
Trudee C. Parenteau
Ellen D. Rothberg
Karen C. Schneider
Michelle D. Schoenberger
Robert E. Schwartz
Roberta Jo Shapiro
Patricia A. Shea
Alan J. Siniscalchi
Marie Stoeckel
Rolando Antonio Thorne
Bernadette S. Vissani
R. Bradford Walker
Fucy Ellen Weiger
Karen W. Wolchuck-Sher

1979
Gift: $13,985
Participation: 47%
Agent:
Ralph Tartaglione Jr.

Virginia P. Bainbridge
Marianne Berwick
Joann N. Bodurtha
Jonathan Brenn
Dennis A. Brogan
Christopher M. Cannon
Elizabeth S. Carter
Ralph J. Cobum
James F. Consedine II
Susan De Renzo
Frances D. Dwyer
Terry Edelstein
Nurit Erger
Lynn Fielden-Smith
Laura Meisler Finkelstein
Delores A. Franks
Judith B. Gancher
Shelley Helfer-Amira
Karen G. Hellenbrand
Joseph D. Henn-Demayo
Lucinda H. Hogarty
Susan Kananovich
Phillip S. Katz
Karen A. Kmetzo
Paul Anthony Kowalski
Benjamin Krevsky

Renee S. Leary
William McCune IV
Patricia J. Moore-Pastides
Laure C. Nichols
Helen O'Brien
S. Kwame Ofori-Kwakye
Betty J. Reid
Lisa Klar Rosenfeld
George B. Rowland
William E. Schweizer III
Audrey P. Silvey
Ilene B. Wachs Fache
Jonas Zucker

1980
Gift: $8,925
Participation: 47%

Phillip R. Aaron
Frederick R. Aronson
Diane Denis Aye
Curtis S. Breslin
Antoinette M. Brooke
Gary L. Busack
Sheila L. Conneen
Martha G. Dale
Anne Morrison Danaher
Alfred E. Fasulo Jr.
Audrey L. Fetter
Barbara H. GrangerRussota
Ellen B. Greif
John Halleran
Samuel S. Hamilton
James P. Harisiades
Virginia S. Humphrey
Johanna C. Hunt
Helen E. Kelly
Michael J. Kremer
Robert V. Levine
Paul A. Locke
Leroy F. Ludwig
Kristina Obom Maldarelli
Steven Morrow
Glenn S. Newsome
Benita J. O’Colmain
Jane Ungate O'Connor
Ann L. Prestipino
Christina P. Quinn
James E. Rawlings
Christie Michele Reed
Jeri Ann Rose
Beth F. Schaier
Susan L. Schwartz
Kathleen F. Scribner
Lydia A. Selling
Marsha L. Silverman
Judith S. Stavisky
Carolyn K. Wells
Tal Ben-Dashan Widdes

1981
Gift: $10,015
Participation: 43%

Agents:
Angelo J. DeVita
Barbara Gaugler
Pennebaker

Linda F. McCaig
William F. McKeon
Tsuneki Mizuta
David L. Mork
Susan G. Rice
Christopher J. Rogers
Scott David Stratton
Michele T. Visconti
Sandra Michaelson
Warren
Maud Helen White
Theodore J. Witek Jr.
Jill Okrent Zaheer

Robert M. Anderson Jr.
Barbara M. Aufiero
Heidi Boerstler
Janet L. Brandsma
Harold J. Burdo Jr.
Lionel K. Chadwick
Patricia J. Checko
Rollin C. Chew
Angelo J. Devita
1983
Richard T. Forsley
Gift: $7,824
Robert Fox
Participation: 40%
Peggy A. Gallup
Agents:
Marie F. Gavula
Jeffrey Hughes
Louis M. Gonzalez
Marybeth McNemey
Joan Urquhart Goodman
Roslyn Hamilton-McGraw
Barbara W. Abraham
Gerlinde B. Kehlenbach
Gail Ellen Alexander
Cindy F. Kleiman
Joseph A. Amatruda Jr.
Thomas J. Krause
Carolyn R. Anderman
Charles R. Lawson
Lisa A. Bowie
Neal A. Lustig
Benjamin Obi
Katherine M. McCormack
Chukwumah
William R. McLaughlin
Eileen Conlon
Blackford Middleton
Linda K. Contreras
Marlee D. Mooney
Peggi Matzkin Czinger
Ellen Gallagher Parsons
Lorraine Denicola
Frederick V. Peterson Jr.
Mark L. Dembert
Idalia Ramos-Sanchez
Robert A. Duncan
Kimberly Chauncey
D.J. Safiya Edwards
Shadur
Eileen McDonald Egan
Elizabeth N. Shapiro
Ellen M. Ginzler
Karin Swanson
Judith S. Goldstein
Keith D. Tait
Trerotola
Kathleen R. Yager
James D. Gonzales
Nancy C. Yedlin
Halesteen Graham
1982
Daniel A. Graybill
Gift: $10,860
Virginia C. Hiland
Participation: 36%
James M. Lehane III
Agent:
Allen F. Levy
Jean Milton Ellis
Scott K. Mock
Judith F. Nelson
Jamie L. Amaral
Suzanne Nutt
Gretchen D. Biemesderfer
Barbra G. Rabson
Francis L. Crowley
Keith A. Radcliffe
Kathleen K. Devine
Julie A. Russem
Jean M. Ellis
Lynn St. Germaine
Paul Garbe
Saphire
James L. Hadler
PaulM. Schur
Denise Heinemann
Ina L. Silverman
George R. Hession Jr.
Claudia Smith
Karla A. Hitchcock
Elizabeth C.H.
Nancy Pitt Hopkins
Stevenson
Catherine Sullivan Jaquith James G. Uberti
Constance M. Jarowey
Nancy K. Wright
Annette Kenney
1984
David P. Klarberg
Gift: $7,170
Susan Eberle Levy
Participation: 39%
George J. Mandes
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Agent:
Leslie A. Batch

Deborah J. Arrindell
Leslie A. Balch
John R. Beecher
Rhonda L. Bohn
Troyen A. Brennan
Timothy J. Callahan
Jean G. Concannon
Rudy Glen Davis
Christopher Fenger
Jean L. Freeman
Marcia Lipkind Hirsch
Suzanne S. Horn
Sarah M. Horwitz
Robert C. Hughes
Gregory R. Huth
Catherine S. Jackson
Mehrdad Jalali
Georgia Jennings
J. Kutcher-Henchel
Andrea McCrenskyKrerner
Stephen T. McGarvey
Marta E. Moret
Lloyd M. Mueller
Cathy F. Nager
Donna Niedzwiecki
Theresa Marie O'Connor
Jessica L. Richer
Stephen Marc Schwartz
Phillip J. Screen
Dennis G. Shrauger
Robin Kupfer Spencer
Pamela Parise Suan
Marie Ann Tobin
Carey Vames

1985
Gift: $4,660
Participation: 32%
Agents:
Katherine S. Fitzpatrick
Joan M. Cleary Miron

Lisa R. Anthony
Christine D. Berman
William P. Buick
Rene S. Cabral-Daniels
Lawrence M. Chesny
Joan M. Cleary Miron
Kathleen M. Craig
Loretta Dipietro
Marjorie M. Eichler
Grace P. Erickson
Katherine S. Fitzpatrick
Elizabeth Hale Frayne
Barbara K. Gottlieb-Ware
Tatsuyuki Kakuma
Julie M. Marshall
P. Douglas McConatha
Rona Janis Mogil
Beverly-Jane Perry
Adrian J. Pinsince
Martha J. Santini
Eric Scalettar
James V. Soscia
David Steffen
Heidi Roberta Sulis
Anne Harmon Sweeney
68

Samuel P. Wertheimer
Nathan D. Wong
Terry Martin Zingman

1986
Gift: $7,734
Participation: 34%
Agents:
Incht B. Ahluwalia
AricR. Wilt

Mark J. Pereira
Lynn Pezak Malloy
Elizabeth J. Philippe
Anita A. Roth
Judith Natale Sabino
Catherine Leda Seibyl
Mary C. Sherwin
Peter C. Tortora
Joel A. Wasserman

1988
Indu B. Ahluwalia
Maria Rosario G. Araneta
Judith Ann Bell
Andrea Lee Boissevain
Lewis P. Bower Jr.
Marijane L. Carey
Julia E. Clark
Reid M. Davis
A. Richard Dooley Jr.
John M. Esdaile
Nancy E. Fithian
Robert B. Goetzinger Jr.
Stephen B. Gruber
Michael S. Huncharek
Denise R. Lewis
David C. Lowy
Adrienne Marks
Karen C.P. Milliken
Bernadette M. Mosellie
Daphne M. Nielsen
Tracey M. Orloff
Clare F. Pegues
Philip O. Renzullo
Maria J. Schymura
Janet M. Sgro
Carrie Shepard
Eric Triffin
Marie Irene Tsivitis
Katherine Burdick Wilson
Lynn D. Wilson
Nancy Borstelman Winer

Gift: $6,885
Participation: 30%
Agent:
Joseph Della Plica

Ellen S. Bass
Giselle Charlotte Bleecker
Jayne Bonner-Gary
Sharon Marie Christie
James Joseph Cullen
April R. Dworetz
Sylvia Blackburn Farrell
Aden Carlos Jackson
Ellen Lucy Kraftsow
Lydia Jeanne Landis
Mark William Legnini
Paul Alan Lindia
Saifuddin Taiyeb Mama
Susan S. Merrill
Carolyn Andrea Nunley
Mary E. Haesche Okero
Madhusudan G. Rao
Carrie A. Redlich
Lawrence Vincent Silvia
Carol Ann Strycharz
Howard S. Teitelbaum
Thomas Aaron
Wellington
Lisa Wilson-Foley
Darlene Uten
Zimmermann

1987

1989

Gift: $14,425

Gift: $6,635

Sophie Helene
Tworkowski
Whei-Kuo Wu

1990
Gift: $8,015
Participation: 36%
Agent:
Jennifer Jennings Miller

Participation: 29%

Participation: 27%

1991

Agent:

Gift: $7,513

Joy Misako St. Germain

Participation: 30%

Melissa Paige BarbyByers
Donald G. Cofrancesco
Murat Dayanikili
Shannon Green Hanson
Nancy A. Malone
Lisa Newell
David Max Senior
Steave Hon-Shen Su
William D. Wamester
William Robert White

1993
Gift: $1,270
Participation: 22%

Deirdre D. Hardrick
David L. Katz
Chinaro M. Kennedy
Lynn M. O’Connor
Mark B. Russi
Nadeem S. Siddiqui

1994
Gift: $3,350
Participation: 18%

Kathleen A. Cameron
Linda C. Degutis
Cynthia D. Ho
Robyn M. Hoffmann
Ellis K. Johnson
Gwendolyn A. Myers
Eric H. Opin
Mary-Elizabeth M. Reeve
Helaine E. Resnick
Kenneth C. Rondello
Nicole T.C. Vecchi

Agent:

Elizabeth A. Wennar

Hilda Chaski Adams
Margaret B. Corbae
Barbara L. Decesare
Meg B. Domino
Robin N. Eastman
Cecelia EdwardsRandolph
Stephen A. Frayne
Bridgid M. Garrison
John Ginnetti Jr.
Elizabeth Grottole
Carol Guardiano
Priscilla Ann Halloran
Sara A. Holdcroft
Michael T. Koff
Mary Ann Lillie
Laurie B. Logan
Deirdre McDonald
John C. McLaughlin
Barbara J. Moggio
Maureen Brady Moran
Joseph J. Napolitano

1992
Gift: $2,665
Participation: 21%

Lorraine M. Almo
Ethan N. Arnold
Alisa M. Bellantonio
Linda V. Bergonzi King
Andrew K. Bhak
Phyllis F. Boynton
Patricia Campbell
Michael Anthony
Carrozza
Nicholas A. Daniels
Jerilyn A. Deveau
Deborah L. Fulton-Kehoe
Donna Mae Gruskay
Brenda Y. Hernandez
Jennifer W. Hincks
Reynolds
Alfredo A. Lardizabal
John Martin Lavin
Barbara A. Leonard
Susan Patricia Lustig
Rebecca J. Mark
Julie Ann Medulan
Janet Amy Munroe
Karyn J. Nair
Angela B. Nimsgem
Rochelle Enid Oberwetter
Karen A. Oliver
Gary D. Perlman
Edward M. Rafalski
Jeanne Marie Danzi Scinto
Heralio G. Serrano
Brian Yong-Seop Shin
Salim Ramzan Ali Surani
Stacey H. Wills

Agents:
Hilda Chaski Adams

Sanjeev K. Srivastava
Stacy M. Susman
Mitchell S. Tepper
Victoria Valdez
Lucie L. Wilkins
Patreece T. Williams

Christine Appel
Holly Anne Ardito
Judy Gardner Audette
Perry David Cohn
Marybeth Durkin
Agnes B. Edwards
Michael Joseph Gillespie
Elizabeth Harrison Hadley
Clifton Ping Lee
Lydia M. Lodynsky
Angela S. Mattie
Kathleen Louise Moore
Joanne Susan Mosca
Deena Beth Myers
David Dean Peete
Elizabeth Ann Platz
Theresa L. Raphael
Joseph Robinson
Robert P. Sbriglio
Nipon Sermpanich
William Benjamin Shatz
Joy Misako St. Germain
James Gordon Trexler

Patricia J. DeFelice

1995
Gift: $1,135

Benjamin O. Adetola
Lisa A. Amerino
Sharon Lee Carlton
Barbara A. Casey
Sandra S. Childress
Maureen P. Corry
Patricia J. DeFelice
Dymphna J. Egglin
Seth R. Frank
Brenda J. Goldstein
Catherine M. Heer
Rani A. Hoff
Katie B. Horton
Timothy A. Jacobs
Kathryn S. Katz
Anne M. Lane
Sally J. Malech
Laura Elizabeth Mitchell
Andrea Mary Orane
Andrew P. Owens
Louise P. Roumagoux

Participation: 21%
Agent:
Nicole Herczfeld

Donna J. Boehm
Michelle L. Canham
Suzanne C. Fickett
Shelley D. Geballe
Julie Huang
Brad M. Ingegneri
Saima Iqbal
Marjan Javanbakht
Unni K. Karunakara
Elizabeth G. Kemper
Bonnie D. Kerker
Hans-Helmut Koenig
Rama G. Melkote

Friends
Frederic Holtzberg
Michael H. Merson
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Reaching out
T

he impressive honor roll of names
that precedes this page is testa¬
ment to the support that alumni/ae
and friends of the School of Medicine
have provided in just a single year.
There are dozens of other ways,
too, that alumni/ae strengthen the
school and its programs every day.
Many of those efforts are focused
on students and the school’s educa¬
tional program. For example,
alumni/ae on the clinical faculty vol¬
unteer their time to teach medical stu¬
dents in lectures and small groups.
Alumni/ae endow academic chairs,
fellowships and special programs.
And in smaller ways, too, alumni/ae
support the activities and spirit of
medical students. At this writing in
late February, the Second-Year Show
is gearing up with support from
alumni/ae who bought ads in the pro¬
gram. Likewise, the yearbook went to
press this month with similar
alumni/ae backing.
The cycle of giving does not end
there. Yale medical students are cer¬
tainly among the nation’s most gener¬
ous with their time and resources.
Students have initiated community
service programs, ranging from
The HOPE Project, which brings
medical care to people at New Haven
shelters, to the ASAP initiative, in
which medical students spend time
in city schools talking to pupils about
substance abuse. An extraordinary
number of first- and second-year
students volunteer in one of these
many programs.
Last fall, in what has become an
annual tradition, the students staged
the fourth Hunger and Homelessness
Auction, raising more than $13,000
for the benefit of New Haven area
shelters, soup kitchens and other
community programs. Students and
YALE MEDICINE

Lycurgus M. Davey, M.D. ’43
President

Nicholas M. Passarelli, M.D. '59
other auction-goers paid top dollar for
the chance to go bowling with the
directors of student affairs and admis¬
sions, or for three days roughing it at
Dr. Tom Lentz’s Vermont cabin.
This kind of outreach eventually
comes full circle, as students graduate
and become alumni/ae themselves.
By encouraging alumni/ae to nurture
the next generation of physicians and
scientists and to remain in touch with
one another, we are strengthening a
community that is greater than the
sum of its parts.
AYAM President Lycurgus “Bill”
Davey, M.D. ’43 March, and I invite
you to become involved in the AYAM
Outreach Program, which is
described on the inside front cover of
this magazine. Watch the mail for
announcements of regional receptions
and programs near you. We hope to
see you at these events, and we
encourage you to order the new Yale
School of Medicine Alumni Direc¬
tory. We also hope you will make
every effort to attend reunion this
year on June 6 and 7, even if your
class reunion year (ending in a 2 or 7)
isn't here yet. This year’s program
will be fantastic, with a presentation
by gene therapist Albert B. Deisseroth, M.D., Ph.D., (who is profiled
on Page 12) and a chance to tour the
school and medical center and his¬
toric New Haven.
We look forward to seeing you in
New Haven or in your hometown.
William K. Jenkins

Vice President

Gilbert F. Hogan, M.D. ’57
Secretary’

Marie-Louise T. Johnson.
Ph.D., M.D. ’56
Past President

Executive Committee
Albert S. Atwood, M.D. '45
Jean L. Bolognia, M.D. ’80
Joseph F.J. Curi, M.D. ’64
John W. Foster Jr., M.D. ’71
Peter N. Herbert, M.D. ’67
JocelynS. Malkin, M.D. ’51
Ellen B. Milstone, M.D. ’69
Donald E. Moore,
M.D. ’81.M.P.H.
Lynn W. Reiser. M.D. ’70
Arne S. Youngberg, M.D. '66
Ex-officio

Gerard N. Burrow, M.D. ’58
Dean

William K. Jenkins
Managing Director, Alumni Affairs

Daniel L. Arons, M.D. ’67
Chair, YSM Alumni Fund

Samuel D. Kushlan, M.D. ’35
YSM Bequest and Endowment

Representatives to the
Association of Yale Alumni
Alfredo L. Axtmayer, M.D. ’76
Harold D. Bornstein Jr.. M.D. ’53
Frank R. Coughlin Jr., M.D. ’52
Martin E. Gordon, M.D. ’46
Michael Kashgarian, M.D. ’58
Theoharis C. Theoharides,
M.D., Ph.D. ’83

Managing Director
Office of Alumni Affairs
Write to William Jenkins at the Office
of Alumni Affairs, P.O. Box 7613,
New Haven, CT 06519, or via e-mail
at william.jenkins @yale. edu

AYAM Representative,
Medical School Council
William K. Jenkins

69

DEVELOPMENT

Mission statement
Defining a family financial philosophy is the first step toward effective planning.

' Because of constant harassment by

investment sales personnel your phone
call is being screened. If your call is
personal and you would like a
response, please leave a message.
Thank you. ”

T
■

1
■

i

i
1

I
a

I

he above is taken verbatim
from the home answering
machine of a Yale medical alum¬
nus who graduated more than 30
years ago. He is a surgeon with
an active practice. Like many suc¬
cessful professionals, he is beset
by junk phone calls from sales
people trying to pitch their com¬
pany’s product.
Usually, this means life insur¬
ance, mutual funds or advice on
investing. Most of these calls are
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made by young college graduates
working on commission for wellknown brokerage houses. The
callers get a phone, a desk and a
list of names and numbers provided
by direct marketing firms that
collect information from numer¬
ous sources.
This is a real nuisance for
many people, but a very serious
interference for a physician on-call
who expects to hear from patients
or colleagues.

MATTERS OF TRUST

The Yale alumnus who uses his
message machine to block sales
calls has found a way to deal with
this aggravation. However, many

people are not immune to quacks
posing as competent investment
advisors. One retired physician in
her 80s who has her financial plan¬
ning in good order (thanks to a
skilled and reputable financial
planner), went to a “free seminar"
on how to set up living trusts to
avoid probate. A high-pressure
salesman promised to help her set
up a trust with assets that, she later
found out, she could not legally use
for that purpose. The physician
gave him a $250 deposit on the
spot. Fortunately, she consulted
her trusted financial planner for
advice. He intervened and got the
money back.
The general advice that this
financial advisor gives is as fol-

Spring 1997

lows: “Get professional help you
can trust. Work out your objectives
before you take action, but don’t
procrastinate.”
LIFE PLANNING

Most Yale alumni/ae are not likely
to confide in strangers about their
investments and estate plans (or
lack thereof). However, the exis¬
tence of bothersome callers should
not become an excuse to avoid
seeking out competent help to put
your financial house in order. Even
the most successful and savvy
investor may not have a coordi¬
nated overall financial plan that
takes advantage of opportunities to
maximize retirement income
stream, minimize the estate tax
burden for children, or guarantee
college funds for grandchildren.
“I know I need to make out a
will,” said one alumnus to a Yale
development officer on three sepa¬
rate occasions over a period of a
year and a half. “I just can’t seem
to face my own mortality.” Amaz¬
ingly, an estimated 70 percent of
Americans do not have a will.
“People think that estate plan¬
ning means death planning,” says
Tom Rogerson of State Street
Global Advisors, “and they want to
avoid the subject. Actually it’s life
planning.” Mr. Rogerson’s point is
that a good estate plan should ben¬
efit you while you are alive, as well

Do-it-yourself guide to stopping
junk mail and phone calls.
Yale School of Medicine has a
policy never to rent or share its
list of names, addresses and
phone numbers with any outside
person or company: reputable
or not. For information on how
you can stop junk solicitations
of all kinds, try this Internet
website:
www.obviously.com/junkmail —
or contact the National Fraud
Information Center at
1-800-876-7060, or via e-mail
at nfic@internetMCI.com

Yale medicine

as provide for the disposition of
your property when you are
through using it. A good plan can
increase current income, assure
financial security during retirement
or disability, minimize taxes, cut
costs and reduce aggravation.
Planning is for people with a lot
to live for.
State Street Global Advisors is
making a series of presentations on
estate planning exclusively for
Yale alumni/ae around the country.
The AYAM sponsored a presenta¬
tion in New Haven in December
that was attended by 45 medical
alumni/ae, spouses and friends.
Several of those present had been
to seminars put on by other institu¬
tions, so it was a demanding and
attentive audience.
The primary points of the
State Street Global Advisors
seminar are:
■ Determine your goals and
objectives.
■ Get expert help and formulate a
plan that accomplishes those goals
and objectives.
■ Recognize that planning is a team
effort that should include your
attorney, your accountant and your
investment counselor.

TO GRAT OR NOT TO GRAT

Some people think that reducing
taxes is the only goal, but it is best
not to let that consideration distort
your real objectives. If it is one of
your goals to be charitable, and the
time is right, you may wish to
include a development officer on
your planning team. There are sim¬
ple ways to afford to be more gen¬
erous, such as by donating appreci¬
ated securities instead of cash.
The acronymns GRAT and
CRUT are simply jargon used to
describe different kinds of trusts.
Choosing among these and other
financial planning vehicles is a
matter of finding the best means to
reach the desired end. The more
important first step is determining
a family financial philosophy that
will define your values—a per-

The AYAM is sponsoring
a series of estate planning
seminars by State Street Global
Advisors, designed as a financial
planning sen’ice to alumni/ae,
with find-raising issues rele¬
gated to the background.
No one is solicited for a gif
at these events.
For more information, contact:

William Jenkins
Office of Alumni Affairs
(203)785-3304
or David Davison
Office of Medical Development
(203)785-5577

sonal mission statement that helps
you map out good decisions.
For example, some wealthy
people who could arrange to give
their children a free ride for life,
don't. They might have a philoso¬
phy that includes paying for their
children's education, but no more,
expecting each child to make it in
the world on merit and initiative. In
their estate plans, they might fund
a charitable family foundation that
their children would be responsible
for administering. Their goal is to
enable the family to work together
to preserve a legacy of philan¬
thropy in the community.
To begin to develop your fam¬
ily financial philosophy, ask your¬
self some life planning questions.
What are my values? What do I
want to accomplish with my
assets? How do I want to benefit
my spouse, my children or grand¬
children—now and later?
David Davison
Director, Individual Major Gifts

Write to David Davison at the
Office of Medical Development,
100 Church Street South, Suite 211,
New Haven, CT 06519, or via email at david.davison@yale.edu
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LETTERS

The organ bind
To the editor:

As a Yale alum, husband of a liver
transplant recipient of 10 years, and
co-founder with that recipient of a
chapter of TRIO (the
Transplant Recipi¬
ents International
Organization), I was
extremely pleased
to see your Summer
1996 issue [cover
story. Second
chance at life.]

It wonderfully sup¬
ports our message
that transplanta¬
tion works. Your
plea for organ
donation is most welcome, for
without donation, transplantation
will not have the opportunity
to work.
Signing a donor card, although
in many states a legally binding
document, is not enough. No doctor
will violate the wish of the family
of the departed, no matter what.
Thus we plead for everyone to dis¬
cuss their wish with their family
before the tragedy occurs. This is

vital. The emergency room is no
place to consider the gift of life for
the first time. Without donors, (or
until artificial or xenographic trans¬
plants become practical) thousands
who could live will not.
I was, however, troubled by the
comment that people are “ ... asked
for consent to use the organs of a
dying person.” That is never done.
Consent is only asked for the use of
the organs of those who are in fact
dead and whose organs at that time
are being maintained in a viable
state by mechanical means. The
usual term is “brain dead," an
unfortunate and misleading term. It
is important for potential donor
families to know that their loved
one is in fact dead, that no one
involved with their care has had
anything to do with the process of
potentially using their organs,
and their “left-over items” are
actually capable of saving the life
of another.
Donal R. Treffeisen, M.Eng. ’52
Transplant Recipients
International Organization
New York

Let us be precise
To the editor:

How to reach us
Yale Medicine welcomes
news and commentary.
Please send letters to the edi¬
tor and news items to Yale

Medicine, P.O. Box 7612,
New Haven, CT 06519-0612,
or via electronic mail to

ymm@yale.edu, and include
a daytime telephone number.
Submissions may be edited
for length, style and content.
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I was seated in the waiting room.
Knowing no doctor’s appointment
ever starts on time, I looked for
reading matter more interesting
than the paperback I had with me.
Then I spotted Ycde Medicine with a
tick on the cover featuring Lyme
disease. I know Lyme disease cases
actually were first found in La
Crosse, Wise., but Lyme, Conn.,
scooped the pool with the investi¬
gators at the Ivy League schools.
My eyes stopped on page 15.
Oh, my fur and whiskers! “Ticks,

like other insects, have a decided
sense of taste.” Perhaps, but ticks
and mites are not insects, not even
in New Haven. This Midwestern
native, product of the University
of Wisconsin, cannot ignore
this statement.
Yes, ticks and insects are both
arthropods, a large phylum, but the
class Insecta have 6 legs, and 3
body segments, head, thorax and
abdomen. Ticks have 8 legs, 2 body
segments, a cephalothorax and
abdomen. Ticks, mites and scorpi¬
ons are the class Arachnoidea.
Ticks and insects are as closely
related as ticks and lobsters.
M.H. Schmidt, M.D.
Marshall, Wise.
Ticks most definitely are not
insects. Unfortunately one such
reference slipped into print.
Apologies to entomologists (and
ticks) everywhere.

Extra credit
To the editor:

I was gratified to read your com¬
ment in the Fall/Winter 1996 issue
of Yale Medicine. Harry Greene,
not Harry Zimmerman, did the het¬
erologous tumor transplantation.
In 1947-49,1 did my thesis
with Harry Greene [the Anthony N.
Brady Professor of Pathology from
1949 until his death in 1969], trans¬
planting embryonic chicken giz¬
zard to anterior chambers of guinea
pig eyes. In recent years I have
been amused at work coming out of
Boston concerning tumor angio¬
genesis. This would be nothing new
to Harry. Credit should go where
credit is due.
Richard D. Otis, M.D. ’49
East Falmouth, Mass.
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Continuing Medical
Education at Yale
June 2
Monday

Update in Hepatology
Course Director: Victor J. Navarro, M.D.

A

Assessment and implementation of current therapies for hepatitis C and new
diagnostic categorizations and therapies for autoimmune liver diseases.
Jane Ellen Hope Building, Room 110

June 13
Friday

Yale Alumni in Ophthalmology:
The Yale Spring Symposium
Course Directors: Craig A. Sklar, M.D. and M. Bruce Shields, M.D.

B

A broad range of topics in ophthalmology including treatment of retinal disease,
contemporary cornea surgery, neuro-ophthalmology, oculoplastics, strabismus and
glaucoma basic and clinical research.
New Haven Lawn Club, New Haven, CT

July 12-13
SaturdaySunday

Medical Problems in the Performing Arts
Course Director: Martin W. Sklaire, M.D.

C

Traumatic injuries in musicians (special focus on the hand, and
ear, nose & throat), performance anxiety, and alternative medicine.
Yale Summer School of Music, Norfolk, CT

August 11-13
MondayWednesday

7th Annual Cardiovascular Symposium
Atrial Fibrillation: The Arrhythmia of the Elderly
Course Director: Michael D. Ezekowitz, MBCHB, Ph.D.

D

Mechanisms of atrial fibrillation, and relevant treatment approaches.
Jane Ellen Hope Building, Room 110

August 15
Friday

1997 Annual Yale Sports Medicine Seminar
Women in Sports
Course Director: Peter Jokl, M.D.
Focus will be on epidemiology and treatment. Special presentation on National
Institutes of Health’s role in studying and assessing the impact of athletic activities
on female health.
Mary S. Harkness Auditorium

For information, contact the Office of Postgraduate and Continuing Education,Yale University School
of Medicine, 333 Cedar Street, P.0. Box 208052, New Haven 06520-8052; Tel: (203) 785-4578
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Continuing Medical
Education at Yale
Sept. 6-7
Sat-Sun

Yale at Mystic: An Ultrasound Review

A

Course Director: Kenneth J.W. Taylor, M.D., Ph.D.

Mystic Hilton, Mystic, Conn.

Sept. 6-13
Sat-Sat

The Third Anaesthesia & Critical Care Symposium

B

Course Director: Sorin Brull, M.D.

Killarney, Ireland

Sept. 13
Saturday

Glaucoma Symposium

C

Program Chairman: M. Bruce Shields, M.D.

Marriott, Rocky Hill, Conn.

Sept. 18-21
Thurs-Sun

The 21st Yale Physician Assistant Certification/Recertification
Preparatory Conference

D

Course Coordinator: Christiane Nockels, P.A.

Mary S. Harkness Auditorium, New Haven

Sept. 20
Saturday

First Annual Michael S. Voynick Neuro-Oncology Symposium

E

Course Director: Joseph M. Piepmeier, M.D.

Jane Ellen Hope Building, New Haven

Oct. 9
Thurs

7th Annual Dual Diagnosis Committee Conference

F

Course Director: Douglas Ziedonis, M.D.

Jewish Community Center, New Haven

Oct. 31
Friday

Diabetes Complications: Mechanisms and Management

G

Course Director: Rosa Hendler, M.D.

New Haven Lawn Club, New Haven

Nov. 14
Friday

H

Uveitis Update
Program Chairman:

I. Willard Abrahams, M.D.

Boardman Building, Room 307, New Haven

Dec. 12
Friday

Advances in HIV Therapeutics
Course Director: Gerald Friedland, M.D.

Mary S. Harkness Auditorium, New Haven

For information, contact the Office of Postgraduate and Continuing Education,Yale University School
of Medicine, 333 Cedar St., P.0. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578
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Lessons in managed care
Managed care has cut into the clinical
income that helps support medical
schools such as Yale’s, and it threatens
to limit the number of patients that
students and residents may see as part
of their education. The challenge is
also an opportunity to reassess and
improve teaching.

VANTAGE

POjNTj/J

Pages 5-19

A dean, a student, a hospital administra¬
tor, a U.S. senator and a managed care
executive look at the issue from a range
of perspectives.
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20 How we live
Sherwin Nuland follows his 1994
bestseller on the lessons of death
with a new book about the
endurance and wonder of
human life.
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Mission critical
Anesthesia is branching out far beyond
the operating room, as the specialists
of sleep find new challenges in intensive
care, pain management and hospitalbased screening and prevention.
An interview with Roberta Hines, M.D.,
the department chair.

37 Through the past, darkly

America’s problems with narcotics and
other drugs began long before the heroin
epidemic of the 1950s, the use of
psychedelics in the 1960s, or cocaine in
the ’70s and ’80s. In New Haven,
scholars from around the nation gathered
to explore why.

41

Gallery

42

Scope

47

Faculty News

53

Student News

55

New Books

58

Alumni/ae News

62

Obituaries

64

In Memoriam

65

Alumni Affairs

66

Development

68

Letters

Page 47

_

A NE ARL IER EPIDEMIC

Page

41

J

EDUCATION

Medical students are acutely aware of
the mounting influence of economics
upon physicians, says Steve Kavic,
M.D. ’p7, who graduated in May.
“ There’s no question, ” he says, “that
the style of medicine I’ll practice
will be very different from that of
my father’s and grandfather’s
generations. ”

Lessons in
managed care
Say what you will about the assault on medical education by a changing economy.
Managed care has Yale and other academic medical centers reassessing
the way they do business.

By Marc Wortman

Speaking to a team of community physicians last fall, one longtime
Yale faculty member joked ruefully, “Were thinking about changing
the name from the School of Medicine to the School for Health Care
Cost-Containment. Were hoping eventually to squeeze the medical
part out altogether.” He may have been exaggerating wildly to make
2
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a point, but as anyone around a

medical service delivery and costs—

medical school can testify, cost-

has forced across-the-board rethink¬

Dr. Burrow: “Every medical school

containment has indeed taken its

ing of how Yale goes about training

dean in the United States is search¬

place as part ol the curriculum.

its students and residents to be the

ing for a new funding paradigm.”

Faculty and administrators at Yale

physicians of tomorrow. No depart¬

once focused solely on preparing

ment or clinical program has been

students and residents to treat

untouched, and many have em¬

patients while carrying out their

barked on major reorganization.

own clinical practices and research.

The need for these changes results in

centers around the country, says

THE MARKET’S IMPACT

The story of the rise of managed

These days, the School of Medicine

part because the in-patient hospital

care has been widely told, but what

must not only teach them how best

unit—the longstanding principal

is less well-known is its impact on

to care for patients, but also how to

training ground for medical students

medical education. With medical

care for them while keeping an eye

and residents—is no longer the

costs spiraling upwards with no

fixed firmly on costs.

comprehensive training center it

systemic economic brake, market

was. More and more medicine takes

controls were asserted over the

As a result, says Dean Gerard
N. Burrow, M.D. ’58, “There has

place in ambulatory settings, and

freedoms physicians previously

been a fundamental and profound

students and trainees must be where

enjoyed to direct patient care—and

change in the way we go about our

the patients are.

effectively set their own fees. Fears

business. Diminishing clinical

Because medical education has

of potential liability, along with the

income and diminishing research

been supported for decades by

absence of economic oversight, often

support,” he says, “are forcing

clinical revenue generated by faculty,

led fee-for-service physicians to pre-

“There has been a fundamental and profound change in the way
we go about our business.”

medical schools to abandon the

managed health care and its cost¬

scribe high-cost tests and procedures

privileged monastic life of the ivory

cutting agenda have quickly under¬

of marginal medical benefit. Hospi¬

tower for the secular world.” [On

mined the funding basis for teaching

tal-based care proved especially

July 1, Dean Burrow will become

programs across the United States,

prone to upward price pressures.

special advisor for health affairs to

especially in areas where managed

Health care spending reached astro¬

Yale President Richard C. Levin,

care has become the dominant

nomical levels, with no end in sight.

and David A. Kessler, M.D., former

insurance model. Faculty and

commissioner of the U.S. Food and

administrators at Yale and elsewhere

control costs presented by changes

Drug Administration, will assume

are sounding the alarm as they look

in insurance laws during the late

the deanship.j

for new ways to support teaching.

1980s and the early part of this

Jumping at the opportunity to

“Managed care,” says Joseph B.

decade, employers rapidly moved

isolation to the rough-and-tumble

Warshaw, M.D., chair of the

employees out of traditional fee-for-

reality of modern medical practice

Department of Pediatrics and the

service individual insurance coverage

reflects the swiftly changing environ¬

medical school’s deputy dean for

and into health care plans, such as

ment for health care delivery around

clinical affairs, “has the potential to

health maintenance organizations

the nation and at Yale. The advent

wreak havoc on medical schools.

(HMOs) and other managed care

of managed care—the term most

And, in many cases, it is extracting

plans. There, physicians work as

often used to describe the reorgani¬

money from the health care system

paid employees or profit-sharing

zation of managerial control of

that would otherwise be available for

associates answering to administra¬

patient care and medical education.”

tors responsible for containing costs.

Marc Wortman is a free-lance writer

Yale faces many of the same difficul¬

in New Haven.

ties as other academic medical

The move from academic
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The future of managed care
If we’re fortunate, insurers will see that the health of medical schools,
not to mention patients, is in their best interest.
By Gerard N. Burrow, M.D. ’58

wptimal care is cost-effective
care" is a statement that underlies
the interest in managed care.
Unfortunately, at present, cost is
being managed rather than care.
The dollar amount of patient care is
called the medical-loss ratio by the
managed care companies, a
pejorative term. As the managed
care companies drive down this
ratio, drive-by deliveries and $12
million bonuses for the CEO are
the result.
In the United States, the costs
of medical care had been increasing
at a level that could not be sus¬
tained, and change was necessary.
While the Clinton Health Care Reform
plan was directed toward costcontainment to control this increase,
the plan also was directed toward
access for 45 million Americans
without health insurance. The
ultimate failure of the Clinton plan
stimulated the rapid incursion of
managed care companies, which
have successfully managed cost,
albeit at the expense of quality,
but have net at all addressed the
problem of access.
The health of the public and the
pathophysiology of the individual
patient represent a continuum.
However, in the past, this concept
has been given lip service rather
than serious attention. A positive
aspect of managed care is that
there is a premium on wellness and
a resulting financial advantage in
preventive medicine. Unfortunately,
under the current system of man¬
aged care, patients change providers
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so frequently that there is little
financial advantage for the provider
to emphasize the preventive aspects
of health care.
Managed care, as presently
constituted with the intense down¬
ward pressure on clinical income,
presents a real threat to medical
schools. The managed care organiza¬
tions have been reluctant to provide
teaching opportunities because of
increased cost, and have been
equally unwilling to support medical
education in general. At Yale, we
have estimated that the faculty
donates about $15 million from its
clinical income to pay for education
and the under-recovered costs of
research. As the reimbursement
decreases, faculty members have
increasing difficulty supporting
themselves, much less donating
clinical income for education
and research.
Yale School of Medicine requires
sufficient patients for teaching and
research, sufficient academic control
to carry out teaching and research
and, from somewhere, sufficient
resources to support education
and research. The managed care
organizations must play a role in this
support. If they continue to ignore
the issues of access and medical
education, managed care organiza¬
tions will ultimately wither.

FRANK POOLE

A range of voices Here and on
the pages that follow, 10 short
commentaries shed light on the
effects of economic change upon
the teaching of medicine. These
opinions and analyses come from
physicians and leaders in academic
medicine and public health, a
student, a U.S. senator, and two
executives in managed health care.

Dean Gerard N. Burrow, M.D. fS,
becomes the David Paige Smith Professor
of Medicine and special advisor for health
affairs to President Levin on Jidy i.
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Doing the right thing
We need to safeguard academic values from the distractions of finance.
By Joseph B. Warshaw, M.D.

Academic medicine in the United

Why, at a time when our

States faces a conflict of values

students show so much promise

that threatens our contribution to

and there is so much excitement in

the health enterprise, and to

medicine, is there such a serious

American society more broadly.

threat to our values? One of our

We are forgetting who we are and

major problems is the need to

why we are. We are in danger of

sustain huge academic programs,

becoming part of a culture of

the result of the phenomenal growth

commercialism in medicine and in

that has occurred over the past

the biologic sciences that threatens

30 to 40 years.

core values of our tradition: teach¬

The money that medical

ing to educate, carrying out

schools receive from clinical activi¬

research for the pure exhilaration

ties alone has increased from $28

of discovery, and practicing medi¬

million in 1960 to $14.5 billion in

cine because of our commitment

the late 1990s. From 1960 to 1990,

to serve the public, especially the

medical school revenues grew at

underserved of our communities.

more than twice the rate of other

These pressures are coming

U.S. institutions of higher education,

from the financial constraints

due in large part to clinical income

imposed by managed care and an

opportunity. We have benefited

increasingly competitive clinical

enormously from these clinical

and research environment. In res¬

revenues, and we contributed to and

ponse, medical schools should

bear some responsibility for a

indeed have sound, efficient, and

health care system in which costs

competitive practice operations that

were viewed as running amok.

provide the revenues to support

While managed care has slowed

medical education and clinical

the rate of increase in health costs,

research. In many respects, how¬

the values behind this trend are

ever, we have gone over the cliff

not those of academic medicine.

and have reached a level of destruc¬

Commercial managed care organiza¬

tive preoccupation with the busi¬

tions and their officers have ex¬

ness of practice. Academic discus¬

tracted huge profits from the health

sions among chairmen about

care system, and they have bene¬

issues relating to education,

fited enormously from the educa¬

research and innovative programs

tional programs, clinical research

of care increasingly take a back

and medical innovation that have

seat to an almost compulsive

originated in our medical schools.

fixation on managed care, physician

Yet they have contributed relatively

networks, price competition, and

little to the academic enterprise

clinical income in a capitated

itself. There is little incentive for the

environment. Our faculties are

companies to invest.

taking sabbaticals in the business

There are recent additional

school rather than the biology

pressures on academic health

department.

centers, with perhaps a new zenith
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“Terms such as gate¬
keeper, covered lives
and provider should
be abolished from
our vocabularies.
We are physicians,
caring for patients.”
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reached by the audits on Medicare

departments from the practice, we

tion in a way that reinforces the

billing being conducted by the Office

anticipate that, in this very competi¬

traditional values inherent in the

of the Inspector General and the

tive health care marketplace,

physician-patient relationship. These

implicit presumption that American

revenues generated will be used

are the values that resulted in the

medical schools have defrauded

primarily to support the physicians

overturning of gag rules for physi¬

the American public of hundreds

in the practice itself. The goal of the

cians in HMOs that forbade them

of millions of dollars in excessive

practice will be to provide the

from discussing treatment options

charges. Audit squads are now

patient base necessary for our

with their patients. It was practicing

extracting huge back payments and

medical education and clinical

physicians and enlightened consum¬

penalties from our nation’s schools.

research.

ers who challenged inappropriate

This not only risks damage to the

► Given the explosive growth in

limits on hospitalization after

American medical educational

faculty size over the past 30 years,

establishment, but also creates a

we must carefully evaluate the size

mastectomy and delivery, and other
restrictions imposed by HMOs

public mistrust that is unfounded.

of our programs. It is likely that

seemingly more interested in profits

All of this has contributed to our

many of them have grown beyond

than in quality. It is surprising how

new academic commercial vocabu¬

our abilities to support them and, in

complacent the broader medical

lary and a quest for dollars that is

many cases, beyond what is

community has been.

distorting our mission and our

required for our academic mission.

► We should reject the notion

values. We need to refocus and

Right-sizing will, in many instances,

that patients are clients or custom¬

remember that we do not build our

mean a downsizing of our faculty.

ers. Terms such as gatekeeper,

medical school practices to sustain

Critical mass will be achieved both

covered lives and provider should

the business of medicine, but rather

through programmatic development

be abolished from our vocabularies.

as the means by which we meet

and by collaborations across

We are physicians, caring for

our mission of service, education,

traditional departmental boundaries

patients. We must convey to our

and scholarship.

and with community physicians in

students the values that make

So what can we do? There are
a number of steps that we can take.
► First, we must create some

the clinical areas.
For managed care organizations

medicine the caring profession, and
those values should be no different

to bear some of the responsibility

under managed care. We must

distance between the business of

for sustaining the medical enter¬

continue to emphasize the values

medicine and the practice of

prise, our system needs a tax on

inherent in the doctor-patient

medicine. We are spending too

gross revenues of these organiza¬

relationship.

much academic energy on the

tions as a kind of reinvestment

Most importantly, we should be

former. Our medical school prac¬

capital to support medical educa¬

mindful of why we do what we do.

tices should be centralized, competi¬

tion and clinical research. Post¬

Why are we physicians and medical

tive vehicles for care that are

graduate medical education has in

scientists? What attracted us to

professionally managed, with service

large part been funded by monies

medicine? In most cases, it was not
to do battle with insurance compa¬

and performance standards that

linked to Medicare reimbursements.

can compete with the private sector

We need new paradigms for the

nies and HMOs. We must continue

and which support, not detract from,

distribution of the direct and indirect

to practice the values that attracted

our academic responsibilities.

costs of medical education that

us to medicine, those values that

have traditionally gone to hospitals

always put the patient first and give

We are about to launch a new
integrated group practice that will

as a component of Medicare

us joy from our students and from

be organized as an “arms-length,”

reimbursement. Allocation of these

discovery. The values of medicine

not-for-profit corporation, in which

monies to medical schools for

have served society well. We must

all medical practice activities of

support of the faculty actually

protect them.

the school will be carried out. The

providing education for postgradu¬

practice will be responsible for all

ate medical education would ease

contracting and credentialing, for

financial pressure to our schools.

setting performance standards and

► Our medical students and

for funds flow to the school and

house staff must be educated

departments. While there may be

about issues in medical economics

some financial margin coming to the

and practice structure and organiza¬
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Joseph B. Wars haw, M.D., is deputy dean
for clinical affairs and chairman of the
Department of Pediatrics.
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For the next generation of doctors,
a chance to make change count
The following is excerpted from
the commencement address
delivered in May by Robert H.
Gifford, M.D., HS '65-66, associ¬
ate dean for medical education
and student affairs.

I don’t have to tell you that it’s an
unsettled time in American medicine.
There are a lot of negative feelings
and tensions out there, I am sorry to
say. But we had better get used to
the fact that our profession will no
longer be business as usual. The
individual, fee-for-service, unrestricted,
entrepreneurial system that my
generation so short-sightedly fostered
and protected essentially broke
the bank. It simply couldn’t go on.
Something had to be done to contain,
and even to reduce, the ever-escalat¬
ing costs of medical care. And, like
it or not, managed care has been
the answer, and it’s not likely to go
away soon.

Graduating students
with Dr. Gifford at
Commencement in
May. “Somehow, ” he
told the class 0/1997,
“your generation must
find a way to convince
our leaders and
political representatives
that health care is not
just another product. ”

You have an opportunity to do
something about it. But my genera¬
tion has so resisted the concept of
managed care that we have failed to

disregard for the care of the poor

preoccupied with its most egregious

embrace the enormous potential for

and, at times, an assembly-line-like

negative feature that we have

better health care that it might offer,

depersonalization of health care.

overlooked its many positive virtues?

and we have failed to take respon¬

In fact, one of the major objections to

We seem to have developed an

sible leadership in its explosive

managed care as it is now evolving

almost automatic negative response

development and management.

under business management is that

to managed care.

We have allowed it to be sold out to

physicians are losing control of the

big business, where the profit motive

precious doctor-patient relationship

corporate takeover of medicine has

has undermined the quality-of-care

that has defined us for so many years

caused many of us to lose perspec¬

Our anger and distrust at the

motive and where health care has

and which was one of the major

tive about the good that managed

become a huge new business venture

reasons that we went into medicine in

care might otherwise be able to offer

to make fortunes for corporate

the first place.

executives and shareholders. The

But is the concept of managed

if responsible, cost-effective, quality
care ever became the driving force.

result of this corporate takeover by

care really all bad? Isn’t it possible

In fact, there is much to be said in

primarily nonmedical people has been

that we might be damning the whole

support of the concept of managed

indiscriminate cost-cutting in a fiercely

because of some of its flawed parts?

care that could be markedly better

competitive market, an almost total

Isn’t it possible that we may be so

than what we have had.
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ers, and should not be just another
entry on the listings in the stock
exchange. The principal beneficiaries
of a managed care business should

“There has never
been a more exciting
time in biomedical
science. It is
going to be a time
for enlightened
leadership.”

be the patients, not the owners.
To help restructure the goals and
financing of managed care will be one
of your greatest challenges in the
years ahead.
Although cost-cutting will be
essential under any system, this
preoccupation with cost reduction has
come just at a time when medical
education must further expand into
the ambulatory setting outside of the
teaching hospital. Unfortunately, the
education of medical students and
residents has been consciously and
specifically excluded from most
managed care organizations, under
the belief that they bear no responsi¬
bility for medical education and that it
would be too expensive to take it on.
Since there are no available funds to
pay for this kind of training, it will
remain a major problem for medical
education at all levels, and also will
require creative solutions from you in
the years ahead.
Managed care has also come at
a time of unprecedented research

by centralizing services, by utilizing

advances in technology and human

care have never been better to

health care teams, by reducing

biology, many of which hold out

provide more of our citizens with

redundancy, and by increasing

phenomenal possibilities for the

The opportunities of managed

efficiency. There have been outstand¬

treatment of disease and the mainte¬

concept made to order for an empha¬

ing examples of well-run managed

nance of health, but which by their

sis on primary care and for the

care organizations in this country

nature will be very expensive. There

development of long-overdue, effective

where quality-of-care has been

has never been a more exciting time

programs of preventive medicine

central, but unfortunately, many of

in biomedical science. Physicians and

through routine screening and better

those are now being bought out by

the public will demand to have these

immunizations. It also promises to

huge corporate structures where

new discoveries applied. But, unless

centralize medical-record-keeping and

profit, once again, will be the

they can be shown to save money,

foster new opportunities for clinical

driving force.

they are likely to come into deadly

comprehensive health care. It is a

research. The opportunities to cut

Somehow, your generation must

ethical and financial conflict with the

costs legitimately are also greatly

find a way to convince our leaders

current limits being placed on spend¬

enhanced by managed care. Costs

and political representatives that

ing by managed care. It is going to be

can be significantly reduced by

health care is not just another

a time for enlightened leadership, and

practicing evidence-based medicine,

product like automobiles or comput¬

I hope that you will be up to it.
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Continued from page 4

come to dominate the practice
of medicine.

Fees are often based on total patient

Amid the changes, no one is

possible through the system.
“The pressure to spend all your
working moments in practice rather

population rather than on services

quite sure what to do about medical

than teaching and research is real,”

performed, placing a premium on

education. Most health care plans

says Dr. Burrow, himself a clinical

lower-cost forms of care and a focus

would consider educating future

practitioner in endocrinology and a

on prevention. Between 1985 and

physicians and supporting clinical

leading expert in thyroid disease.

1995, the number of Americans

research at best part of what they

Given the time-consuming demands

enrolled in HMOs tripled to 58

call the medical-loss ratio, that is,

of education, students can only
decrease the physician’s efficiency.

million. Another 91 million now

money spent providing service and

belong to preferred provider organi¬

not profit. Phis causes serious

A conflict of cultures has

zations (PPOs), a looser form of

dilemmas for medical schools.

ensued within medicine. “Educa¬

managed care.

Robert H. Gifford, M.D., HS

tion can’t be rushed,” says David J.

’66-67, associate dean for medical

Leffell, M.D., B.S. ’77, HS ’84-87,

costs has indeed slowed dramatically

education and student affairs, is

associate professor of dermatology

around the nation and at Yale, with

partly responsible for seeking out

and surgery. He is medical director

massive decreases in hospitalizations

clinical training settings for third-

of the Yale Faculty Practice, the

credited for much of the change.

and fourth-year medical students.

umbrella organization for the

As a result, the rise in medical

Market-bound health care plans

As he looks for new ambulatory

clinical faculty practices in 16 of

have proved far more resistant to

clinics to take on students, he says

the medical school’s departments.

paying the relatively high cost of

he has heard a similar refrain from

“If there is increased pressure on the

hospitalization and certain high-tech

several HMOs: ‘“Doc,’ they say,

physician, something has to give.

medical procedures, forcing medical

'we’ve got a bottom line to meet.

I worry that it will probably be

providers to seek lower-cost settings

Teaching costs us money.’” Yale

education.”

for service delivery. Physicians now

must struggle—and in some cases

To ensure that this does not

undertake less expensive procedures

pay—to place students into real-

happen ultimately, and that its

or must receive approval for order¬

world settings to learn medicine.

physicians remain in charge of

ing tests and procedures from an
administrator. To the chagrin of

Flistorically, medical education
at Yale has been carried out by most

medical decision-making, the school
has taken steps to bolster its posi¬

utDoc,’ they say, we’ve got a bottom line to meet. Teaching costs
us money.’”

many in the medical community,

faculty as an activity supported by

tion in the changing health care

as a profit incentive has entered the

their primary work as clinicians and

economy. In 1995, it established a

system, administrators and share¬

researchers. They taught or pro¬

managed care organization of its

holders battle to keep costs down

vided teaching facilities because

own in partnership with Yale-New

and returns high. In many cases,

they enjoyed doing it and found it

Haven Hospital’s parent corpora¬

clinicians have changed the style

rewarding, while it also enhanced

tion, Yale New Haven Health. The

of their medical practices to increase

their professional reputation, freed

new entity, Yale Preferred Health,

the number of patients seen and

them from bureaucratic hassles,

was launched in response to the

have had to decrease the amount

kept them at the forefront of

introduction of Medicaid managed

of time and service provided to

medical science and gave them

care in Connecticut, which threat¬

individuals. Group practices,

access to a medical and intellectual

ened the traditional access Medicaid
patients had to Yale services.

HMOs and associated ambulatory

community of enormous depth and

clinics, as well as day-surgery

breadth. Now, a managed care

centers, medical hotels, home-care,

organization is urging the physician

hospices and day hospitals, have

to move each patient as rapidly as

IO

Continued on page 12
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That was then. This is now
It is up to physicians to strengthen the teaching of medicine.
By David J. Leffell, M.D.

IVIedical education is a complex,
integrative process. It involves not
only the acquisition of knowledge,
but also the development of skill in
its application and the cultivation of
wisdom in its execution. It is
typically a gentle, ongoing process
that is increasingly ill-fitted to the
rigid and inflexible demands of the
medical care environment.
The traditional clinical teaching
encounter, in which several
patients might be seen and evalu¬
ated in morning clinic, with ample
time for discussion among several
faculty members and students, is
quickly becoming a relic of the
past. Increasingly, we are being
forced to compress the transmission
of knowledge, skill and wisdom into
time intervals that more resemble
med-bites, analogous to sound-bites,
than the interactive episodes that
foster disposition to inquiry. And
guess what? The payers don’t care.
It is therefore left to us, who are
most committed to teaching the next
generation of physicians, to be
creative, innovative and flexible in
finding new ways to teach the
practice of medicine. In fact, the
challenge to medical education goes
beyond the constriction of time
available for teaching. The challenge
extends to the very degree of clinical
activity permitted students and
residents. A third-year resident
remarked recently that the biggest
concern among her peers is the fact
that they are “not allowed to do
anything anymore." This, a direct
consequence of aggressive enforce¬
ment of teaching-physician billing
regulations, is likely to affect pro¬
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foundly our ability to train residents,
especially when it comes to proce¬
dural activities.
Yale must take a leadership role
in helping to define how medical
education can accommodate the
legitimate concerns of government
and the pressures of the changing
marketplace. Managing education
must remain as much a priority as
managing care.

“It is left to us to be
creative, innovative
and flexible in
finding new ways
to teach.”

David J. Leffell, M.D., HS ’84-87,
associate professor of dermatology and
surgery, is medical director of the Yale
Faculty Practice.

II

The plan has succeeded in
enrolling almost 25 percent of
Medicaid patients in New Haven
and its surrounding towns, and up
to 10 percent statewide, says Ellen
Skinner, director of managed care
and marketing for the Yale Faculty
Practice. Now it is courting employ¬

entity that will enable quicker
decision-making while reducing
the school’s financial risk. “We are
being aggressive about ensuring
access to patients for teaching,”
says Dr. Feffell. “Our core mission
is at stake, so we can’t afford to
be passive.”

The private sector
must help with
the training of
physicians

ers throughout the region with the

By Edwin C. Cadman, M.D.

goal of continued growth. In early
May, Yale Preferred Health an¬

MOVING PAST THE HOSPITAL

nounced plans to merge with
Farmington-based HealthChoice,

Financing for medical education

When funds for training physicians

the managed care organization of

historically has been cobbled

were included in the Medicare

Hartford's St. Francis Hospital, to

together from a variety of sources

budget in 1965, the federal govern¬

create the largest provider-owned

not solely dedicated to training the

ment opened a new chapter in

health care plan in Connecticut.

next generation of doctors. In a

American medicine and made an

“The faculty have to
run faster and see

sense, the budget for medical

open-ended commitment to help pay

education has been the cream

the costs of training hospital interns,

skimmed off the top of the ad¬

residents and fellows after their

vanced medical and research services

graduation from medical school.

provided at the medical center. Out

In addition to usual inflationary

of the School of Medicine’s $434

increases, two factors have in¬

million budget for 1995-96, less than

more patients.

creased the costs more dramatically

$17 million came from student

than economists had predicted—

tuition. A little over 40 percent of

a more than doubling of medical

They have less time

the remaining amount was covered

school graduates annually (from

by overhead charged to faculty

7,500 in 1965 to 17,000 today)

for teaching.1’

clinical practices, while 53 percent

and an influx of foreign medical

came from overhead charged against

graduates. The average cost to the

faculty research grants and con¬

federal government is $70,000 per

tracts. A small percentage also comes

trainee, and with nearly 100,000

Since November 1994, Yale New

from endowment income. In other

trainees, the dollars are substantial.

Haven Health has owned a 50

words, says Dr. Gifford, “For years,

Of the $10 billion spent annually

percent share of HealthChoice.

students were educated by someone

training physicians, $7 billion comes

To further meet the economic
challenges, Yale is developing
networks of providers through
agreements with specialty and
primary care practices across
Connecticut and even into Rhode
Island and New York. These
networks, particularly in cardiology,
oncology and psychiatry, will help
ensure an adequate flow of patients
to the medical center for teaching,
and will bolster clinical revenues by
aggressively negotiating contracts
with managed care organizations.
The school also is considering the
migration of the Faculty Practice
physicians into a new, free-standing

paid to do something else.”

from the federal government.
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The two major sources of
income, clinical revenue and
research funding, remain stable for
the time being, but all indications
are that both will decline in the
future. At the same time, access for
students and residents to both
faculty and patients is becoming
more restricted. “The handwriting,”
Dr. Gifford says, “is on the wall.
It used to work fine. Now, it’s not so
fine. The faculty have to run faster
and see more patients. They have
less time for teaching. That is even

As a cost-saving measure, the
government wishes to reduce its
payment to support graduate
education for physicians. A current
pilot program developed by the
Health Care Financing Administration
(HCFA) in February will gradually
eliminate funds for 25 percent of all
resident physicians over the next five
years in New York. It is likely that
this, or a similar proposal, will be
enacted in the future that will affect
the entire country.
Reducing these federal pay¬
ments will have a substantial effect

Continued on page 14
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Medical education. Dr. Cadman argues, is a shared
responsibility that benefits the nation as a whole.

would also bear this additional cost
of education. We feel that this
educational responsibility is a
shared one with the country and,
therefore, we favor a universal
educational pool, the source of
funds for which should come from
those who benefit from a high-quality
physician workforce—namely all
health care providers, the insurance/HMO industry, the states
(teaching hospitals provide a
disproportionate share of care to
the uninsured) and the federal
government.
The private sector must assume
a greater responsibility in preserving
the national resource of excellence
in physician education, since the
ultimate beneficiaries of a highly
competent physician workforce are
major commitment to education.

cases, on-call rooms for residents

Yale-New Haven Hospital has

who stay overnight in the hospital

a universal payment methodology for

approximately 500 residents and

(we have 110), conference rooms

training doctors, the burden would

200 fellows. Our total direct costs

and additional computer resources.

reside in communities such as ours,

related to resident training exceed

Clearly, should the federal

the citizens of this country. Without

which would be required to accept

$25 million, primarily in salaries and

government choose to eliminate

benefits to support both residents

reimbursement of educational

and faculty. We currently receive

costs for post-graduate education

Medicare reimbursement of only

of physicians, the impact would

$5.7 million. (The formula for

be greatest among the 100 or

Medicare reimbursement for direct

so hospitals that train the majority

and professor of medicine at the School

costs is related to the percent of

of our nation’s new generation

of Medicine.

Medicare patients cared for at the

of doctors.

training hospital.) In addition,

educational mission, and we desire

hospitals to compensate for the

to remain a center for educational

indirect costs associated with

excellence. Therefore, if we were to

teaching, such as overhead related

fund this education mission by

to medical records, complexity of

ourselves, the cost of care here

MEDICINE

Edwin C. Cadman, M.D., is chief of
staff and senior vice president of medical
affairs at Yale-New Haven Hospital

We are deeply devoted to our

Medicare reimburses teaching

YALE

the complete financial obligation.
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Continued from page 12

Single-payer system may be
the only cure

more true out in the community.
The one thing lost too often

I

By John C. Marsh, M.D. ’59

is teaching.”
While faculty time and financial
support are being squeezed, the
setting for medical education also

While some may argue that we

has had to change. “A lot of figuring

need only let the marketplace take

out what's wrong is done long before

care of medical practice and the

the patient arrives in the hospital,”

problems will sort themselves out,

says Dr. Gifford. “If you restrict

I am not persuaded that we have

education to the hospital, you miss

made progress in the last few years.

way more than half of the patient’s

As for the impact that managed

story.” For medical schools, this

care has had on the practice of

has been a particular challenge.

medicine, the current situation

“Hospitals made it easy for us,”

is deplorable.

says Dr. Gifford. “Patients were

Increasing numbers of patients

accessible. There was time for

and physicians (and I speak as one

students to be involved and it didn’t

belonging to both categories) are

cost the hospital or the doctor

being moved around in systems of

rejected because it was a Phase I

anything.” Says Faculty Practice

increasing complexity and inconsis¬

clinical trial.

director Dr. Leffell: “You can’t lose

tency. Patients are being forced to

Nonprofit hospitals are being

leave established physician relation¬

absorbed by huge organizations and

ships because of a change in

becoming for-profit organizations,

money anymore.”
Dr. Burrow estimates that
clinical faculty already donate $15

insurance plan at their or their

reducing still further the opportuni¬

million worth of time to the school

spouses’ place of employment.

ties for uninsured patients to receive

annually. Still more is being de¬

I have had the experience of both

care and for medical education for

manded of them. “We have a

gaining new patients and losing old

house staff and medical students.

dedicated group of people who have

ones for this reason. The physician-

What can be done? Physicians

taken a personal hit,” says Deputy

patient relationship has about as

and the general public must agree

Dean Warshaw. Some resent the loss

much stability as that between a

on specific goals and convince

of freedom and the decrease in

professional athlete and his team

politicians of their merit. These

income that managed care has

during the period of free agency.

should include equal access to

demanded. Indeed, some faculty

medical care by all citizens and free

members have opted out of medical

access to medical care, top CEOs of

choice of physicians by all. This will

education altogether.

managed care plans pocket millions

probably mean a single-payer

in bonuses and salaries. Medicine

system, similar to that practiced in

has become a commodity, subject to

Canada. In such a system, pricing for

low bids, incentives to physicians for

medical services would be regulated

While 45 million people have no

A TIME OF ADJUSTMENT

non-referral, and even to gag rules.

by the government and would be

The large majority of faculty

Clinical research and medical

universal. I am aware of the objec¬

members, however, have been

education have become step¬

tions, especially from physicians,

coping with the changing nature of

children, even orphans, in the current

but, I ask, would such a system be

their profession—and have changed

system. I recently experienced the

worse, and less fair than the current

their practices, courses and depart¬

refusal by an insurance company of

hodgepodge of inconsistencies

ments to meet the new demands.

support for a patient with a unique

and inequities?

For medical students at Yale,
preparation for managed care now

cancer (carcinoid) for a specific,
uniquely suitable form of therapy

John C. Marsh, M.D. yy, is a Yale

begins in the very first days on

(radioactive somatostatin analog).

oncologist and professor of medicine.

campus. Thanks in part to a $2.5

This is similar to radioactive iodine

million grant from the Robert Wood

for thyroid cancer, but it was

Johnson Foundation, the curricu-
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lum has undergone a major review
and reorganization. Formerly
separate and overlapping rather than
complementary, departmental
offerings are now integrated to bring
basic science and clinical medicine
into closer relationship. Several
courses for first-year students have
been coordinated to create what is

Focus on
prevention
will aid medical
students and their
future patients

called the Medicine, Society and
Public Health Program, to help

By Michael H. Merson, M.D.

them better understand the forces
and issues underlying contemporary
medical practice. For Steve Kavic,

Two phenomena occurring in the
health care world are having a
profound effect on medical

“Hospitals made it

education.
The first is the realization that,

easy for us .. .There

despite our extraordinary progress

was time for students

technologies and more effective

to be involved and it

with communicable and non-commu¬

in the development of new medical
drugs, we cannot deal effectively
nicable diseases, such as AIDS and

didn’t cost the

hypertension, through treatment
alone. We have demonstrated that

hospital or the doctor

prevention—achieved through health
promotion programs and appropriate

anything.”

public health laws and policies—

HARRY BISHOP

can have a dramatic impact on
M.D. ’97, who graduated from the
School of Medicine in May and is
starting his surgical residency at
YNHH this summer, the training in
the business of medicine was a
necessary evil. “You’re caught,” he
says. “As a student you want to learn
only medicine, but you have to learn
the bytes, bits and buzzwords of
managed care. It’s very clear to all of
us students that it’s an important
part of medicine and will only
become more important.”
Some things, however, do not
change. The school’s unique, 155year-old thesis requirement, accord¬
ing to Dr. Gifford, remains “sacro¬
sanct and will continue so.” But the
settings in which students receive
much of their clinical education are
diversifying rapidly. Numerous new
affiliations with HMOs share the

YALE
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such diseases.

treat disease and guide all their

The second is that managed

patients on how to stay healthy in

care, in the ideal, puts enormous

the increasingly “managed” health

stock in the role of prevention and in

care environment. We encourage

confronting health issues on a

students with a strong interest in

population basis—rather than

acute or chronic disease epidemiol¬

looking only at treatment of individu¬

ogy or public health policy to enter

als. The very phrase “health mainte¬

our master’s program. We believe

nance organization" implies maintain¬

that all medical doctors of the future

ing good health as a priority. The

will, one way or another, need to be

best way of reducing health care

practitioners of good public health.

costs is to prevent disease from
occurring at all.
Here at Yale, Epidemiology and

Michael H. Merson, M.D,, is dean for
public health and chairman of the

Public Health is responsible for

Department of Epidemiology and

teaching epidemiology, biostatistics

Public Health.

and prevention to medical students.
Our task is to help ensure that all
medical school graduates, regardless
of their specialty, enter their resi¬
dency training with a populationbased perspective, so they can both
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goal of assuring sufficient ambula¬

time and the impending decrease in

and reorganized previous clinical

tory clerkships lor third- and lourth-

support Irom the lederal govern¬

operations to meet the changing

year students.

ment, according to Dr. Merrell,

demands. “Over half our patients

“Residency programs will have to

come in the same day as their

mental residency training programs,

Within Yale's individual depart¬

shilt, close or taper. We need to

surgery,” says Roberta Hines, M.D.,

managed care has necessitated

figure out another formula.” Adds

HS ’78-84, chair of anesthesiology.

radical restructuring. Since Medicare

Dr. Cadman: “Our responsibility is

“We now have a pre-admission

was created in 1965, it has provided a

to make sure the change is lor the

testing center. It’s educational for

salary to support all residents. The

better, not the worse.” Several

patients and residents, and has

expectation is that residency pro¬

departments have already scaled

management benefits for us

grams will lace significant cuts to

back the size of their residency

as well.”

help reduce the Medicare budget.

programs.

Not all departments have found

Not all view change as a threat to

One way to reduce costs is to

the changes beneficial. Some have

quality. “You can't make improve¬

improve the delivery of care while

struggled to deal with truly global

ment without change,’’ says Edwin

finding cost-saving means to reduce

changes in treatment practices. In

C. Cadman, M.D., chief of staff and

duplication of services and stop

psychiatry, for instance, some

senior vice president lor medical

waste. Efficiency has become the

facilities that once treated patients in

alfairs at YNHH and prolessor of

watchword for the school as a

a hospital setting lor 90 days or

medicine. He is director ol the

whole. Yale Faculty Practice director

more now have average stays ol

hospital’s residency training pro¬

Dr. Leffell says, “There are things

seven to 10 days, as dictated by

grams, covering 500 residents and

we’ve done out of habit that we need

managed care companies’ rules.

200 fellows training in subspecialty

to stop. Managed care is making us

Department chair Benjamin S.

areas. “These are opportunities for

look in the mirror.”

Changes in Medicare have
lorced attending physicians to

Bunney, M.D., the Charles B.G.
Murphy Professor ol Psychiatry and

improvement.”

professor of pharmacology, says, “It
CHANGE AND OPPORTUNITY

supervise daily care—to approve the

often takes more than seven days for
the disorders we treat to respond to

tests and treatments that formerly

Throughout the School ol Medi¬

medication, and we cannot predict

were the residents’ responsibilities.

cine, clinical training programs have

who will respond and who won’t.

While this may assure better

been reorganized to reduce costs and

We also used to work with the

oversight, it greatly taxes the

reflect the new realities ol medical

patient’s lamily and community

teaching possibilities within resi¬

practice. “We are changing drasti¬

environment. We have very little

dency programs. “The simple things

cally,” says Dr. Merrell, echoing his

time lor that now.”

in the past were the domain of

fellow department heads. “We’re

nurses and trainees,” says Ronald C.

training a dilferent kind of practitio-

The transition now under way
may be enormously difficult and the

uIn managed care, the devil is in the detail. A large number of points
that are not clinically critical but financially important must now be
managed by the attending physician.”
outcome unclear, but some believe it

Merrell, M.D., chair and Lampman

ner. We re training surgeons to work

Professor of Surgery. “In managed

in a managed care environment and

is healthy for medicine. Theodore

care, the devil is in the detail. A

to be accountable for consumption

Marmor, Ph.D., author of Under-

large number ol points that are not

of resources and to work as part of a

standing Health Care Reform and

clinically critical but financially

large group. We’re sharply focused

other books on health policy, is a

important must now be managed by

on outcome."

professor of politics and public

the attending physician.” Given the
squeeze on attending physicians’
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Individual academic depart¬

policy at the Yale School of Manage¬

ments have established new services

ment. “It may be painful but, in the
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Sorry,
your time is up
By Angelo Volandes

Please pay on your way out.
That was my subtle hint to
patrons to vacate the restaurant
booth for the next hungry bunch.
My dad gave me three booths at our
Manhattan restaurant to wait on
during the busy lunch hour, and I
quickly learned that, given limited
seats and time, the more customers
I served, the more money I could
make. It’s ironic that today as a
medical student the same principle
will be used to determine my income
as a future physician.
Many physicians under managed
care will be paid more if they see
more patients and will receive
bonuses for spared medical proce¬

“Managed care has

business sense, it seems at odds

altered the teaching

with the basic tenets of medicine.
The unique problems of a particular

of medicine to

of physicians will not have the
freedom that previous generations

students at a

New issues complicating the
patient-physician relationship are

a fundamental level. It is dishearten
ing to think that the next generation

patient may require added effort
and time.

Managed care has altered the
teaching of medicine to students at

dures. While that may make logical

enjoyed to exercise sound clinical
judgment. Telling a patient that you

fundamental level.”

have to cut his or her visit short

bound to surface when salaries are

because of the HMO has more dire

tied to patient care. Will patient care

consequences than the indigestion

be compromised in our hastiness to

experienced from an unexpectedly

squeeze in extra bodies? Will certain

tients to be seen. Often frustrated,

patients become stigmatized if their

I ask myself: Toward what purpose?

health care consumes an inordinate

The call to medical efficiency, and

amount of time? It would be naive to

thus the popularity of HMOs, is

think that somehow physicians are

based in part on concerns about

immune to the personal financial

equitable health care, namely the

incentives by which non-medical

45 million Americans who are

professions often function.

without access. Are any of the

Clinical teaching is now suffused

45 million? If there has been any

does a week pass whereby a mentor

redistribution of resources, it is to

fails to mention that an HMO would

the executives and stockholders of

look askance at the list of proce¬

insurance companies. Why should

dures ordered, or that the amount of

quality time with a patient be

time spent on a patient is simply not

subjugated to the demands of a

realistic, given the number of pa-

profit-interested business?

MEDICINE

Angelo Volandes is entering his fourth
year at the School of Medicine.

savings redistributed to those

with issues of economics. Rarely
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long run, it’s good for education.

One thing is clear: the changes

grandfather’s generations,” he says.

It encourages people to think about

have already been enormous and

But medicine has always adjusted to

the worth of medical education on

have only begun. For resident Steve

the changing realities of the society

its own rather than as a by-product

Kavic, setting out on his career in

it serves. For Dr. Kavic, that makes a

of service delivery. Treating the

surgery, this evolution has been part

career in medicine an especially

educational activity within a context

of his education at Yale. “There’s no

inviting opportunity. “I’m very

of a budget is better than having it

question that the style of medicine

happy with my career choice.” YM

clawed and scratched away on the

I’ll practice will be very different

periphery of care and treatment.”

from that of my father’s and

Redefining the relationship between managed care
organizations and academic medical centers
By Mike Cardillo and Nicholas A. Hanchak, M.D.

IVIanaged care has triggered farreaching changes in the way health
care is provided and financed. More
efficient management of costs and
an emphasis on preventive health
care and disease management have
been important positive contribu¬
tions. Still, new financial arrange¬
ments have created challenges for
academic medical institutions
seeking to fulfill their mission of
excellence in patient care, education
and research.
Although the agendas of
managed care organizations and
academic medical centers appear to

nity-based providers and physicians.
By virtue of their role in managing
the health of defined patient
populations, the mission of IDSs
combines the delivery of acute care
with an emphasis on disease
prevention and health maintenance.
These networks can benefit from
alliances with managed care organi¬

Nicholas A. Hanchak, M.D.

zations, which are already armed
with information systems and
targeted interventions that support

Healthcare established the Aca¬

disease prevention and manage¬

demic Medicine and Managed Care

ment of chronic disease across the

Forum. Representatives from

continuum of care.

academic medical centers including

Member-based payment models,

Yale, teaching hospitals, and man¬

be in conflict, we share an interest in

as opposed to fee-for-service

aged care organizations convene to

using the best programs possible to

payments, encourage IDSs to

discuss issues such as the funding

improve the quality and affordability

achieve cost savings by delivering

of graduate medical education,

of care. We likewise share an

care more efficiently and promoting

medical research, and managed

interest in preserving the medical

health management. The resulting

Medicare and Medicaid. Together

savings can be used to support

we can find solutions that preserve

made American health care the best

medical education and research to

the excellence of our medical

in the world. By combining our

the same or even greater extent that

education and research and fulfill

strengths, we can improve the

excess fee-for-service revenues have

the promise of managed care and

quality of health care while also

in the past.

academic medicine—to improve the

education and research that have

delivering it efficiently so it can be
widely afforded.
One reason our interests are

In addition, partnerships
between academic medical centers

quality and efficiency of health care
in America.

and managed care organizations can

coming together is the development

contribute to the training of medical

of integrated delivery systems (IDSs),

students. Because we view such

U.S. Healthcare; Nicholas A. Hanchak,

which are strategic alignments of

partnerships as critical to the future

M.D., is president of Aetna subsidiary

academic medical centers, commu¬

of our health care system, Aetna U.S.

U.S. Quality Algorithms, Inc.
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“A good from
which everyone
benefits”
The following is excerpted from the
floor speech given by U.S. Sen.
Daniel Patrick Moynihan, D-N.Y., on
Jan. 21, introducing a bill to create
a Medical Education Trust Fund
financed by Medicare, Medicaid and
the private sector. The trust fund
would provide support to America’s
medical schools and teaching
hospitals, which Senator Moynihan
describes as threatened by
increasing competition and the
growth of managed care. Payments
from the trust fund would average

IVIedical education is one of
America’s most precious public
resources. Within our increasingly
competitive health care system, it is
rapidly becoming a public good—
that is, a good from which everyone
benefits but for which no one is
willing to pay. Therefore, it would be
explicitly financed with contributions
from all sectors of the health care
system, not just the Medicare Pro¬
gram as is the case today. The
fiscal pressures of a competitive
health market are increasingly
closing off traditional implicit
revenue sources (such as additional
payments from private payers) that
have supported medical schools,
graduate medical education and
research until now.
The Medical Education Trust
Fund established in the legislation I

U.S. Sen. Daniel Patrick Moynihan

additional sources of medical
education financing; alternative

have just reintroduced would receive

methodologies for financing medical

funding from three sources broadly

education; policies designed to

representing the entire health care

maintain superior research and

system: a 1.5 percent tax on health

educational capacities in an

insurance premiums (the private

increasingly competitive health

$17 billion each year, roughly

sector’s contribution), Medicare and

system; the appropriate role of

doubling the federal commitment to

Medicaid (the latter two sources

medical schools in graduate

medical education. The legislation
is still pending.

comprising the public sector’s

medical education; and policies

contribution). The relative contribu¬

designed to expand eligibility for

tion from each of these sources will

graduate medical education pay¬

be in rough proportion to the

ments to institutions other than

medical education costs attribut¬

teaching hospitals.

able to their respective covered
populations.
This legislation is only a first
step. It establishes the principle

Mr. President, the services
provided by this nation’s teaching
hospitals and medical schools—
ground-breaking research, highly

that, as a public good, medical

skilled medical care, and the

education should be supported by

training of tomorrow’s physicians—

dedicated, long-term federal funding.

are vitally important and must be

To ensure that the United States

protected in this time of intense

continues to lead the world in the

economic competition in the

quality of its medical education and

health system.

its health system as a whole, the
legislation would also create a
Medical Education Advisory Commis¬
sion to conduct a thorough study
and make recommendations,
including the potential use of
demonstration projects, regarding
the following: alternative and
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PROFILE

Yale surgeon and historian Sherwin Nuland explored the troubling medical and
personal issues surrounding death in ways never done before in the best-selling
1994 book How We Die. His new book, The Wisdom of the Body, applies his multiple
talents to a new understanding of

How we live

By Marc Wortman
Photographs by Gale Zucker
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ew of us ever experience a truly radical change in

Those questions aren’t the result of idle speculation.

our lives. Sherwin Nuland has. Twice. The first

They come at the end of a long career devoted to caring

came early in his life, when, as an n-year-old, he

and operating on thousands of patients and learning as

watched his mother die of colon cancer, turning his

much as possible about how to help them. “I loved being

household and his life upside down. “All that I have

a doctor,” he says. “Caring for the sick validated me.

become,” he has written, “and much that I have not

Being a writer is secondary to the thousands of hours I

become, I trace directly or indirectly to her death.”

spent at the bedside.”

The second change would come a half-century later
when the surgeon and clinical professor wrote How We

Dr. Nuland retired from active surgical practice at
the beginning of 1992, on the very day he began writing

Die: Reflections on Life’s Final Chapter. Published early in

How We Die. He continues to serve on faculty commit¬

1994, it became an instant bestseller. The book’s crystal-

tees, advises students on their thesis work and meets

clear explanations of the physiological conditions leading

frequently with groups at Yale and elsewhere. He now

to death and deeply felt, personal narratives of deaths he

spends large parts of his days researching at the Medical

had witnessed struck an unsuspected nerve in the reading

Historical Library, or writing at home in the recently

public, a craving for understanding and perspective

restored neo-Colonial house just outside New Haven

about the often obscure and much-feared physical reality

that he shares with his wife, actress Sarah Peterson, and

of modern death and dying. The book sold hundreds of

their two teen-age children. (He also has two grown

thousands of copies, spending a total of 34 weeks on the

children from a previous marriage.) Sitting in his serene,

hardcover and paperback New York Times bestseller lists.

book-lined study, he is a slim, robust man with a pierc¬

It won the 1994 National Book Award for nonfiction and

ing look in his blue eyes. He appears younger than his 66

made Dr. Nuland a high-profile writer and a frequently

years. “I’m very egotistical about my physical self,” he

heard voice on end-of-life issues.

admits with a laugh. He credits regular games of tennis, a

“We have 75 trillion cells in our bodies,” Dr. Nuland says. “Every one
of them has something going on constantly. Why don’t things
go wrong? Why don’t we die?”

Given the book’s obvious subject, however, many

daily regimen of push-ups, and a young family for his

readers overlooked an important emphasis: Despite

hardy physical condition. He also recognizes his luck in

being what could be termed a layman’s anatomy of

the roll of the genetic dice: “People in my family die of

death, How We Die also amounts to a remarkable portrait

cancer, or live unscathed to late age." So far, he appears

of human life in both its physiological and spiritual

to be on the fortunate path. He sits forward on one of

glories. The book again and again points out how, even

the two small couches near a fireplace in his study where

in the throes of dying, the human body and mind are

he carries out interviews. The National Book Award

astoundingly resistant to their biological demise. Dr.

certificate is displayed on the mantel.

Nuland’s true concern in How We Die is not death but,

In his 1988 book on the history of medicine, Doctors:

in many respects, just the opposite. Much of what he

The Biography of Medicine, he wrote that, “The story of

explains is the human body’s vast power to ward off

medicine is ... the story of my professional life.” While

death in all but the most overwhelming circumstances—

he has stopped his medical practice, he finally has a

and the ways in which death fits into the wider patterns

chance to try to understand what those years in the

of human development. Published this spring, his new

operating room meant. Writing, he finds, is his way ol

book, The Wisdom of the Body, explores this idea, provid¬

knowing what he thinks about the life he has experi¬

ing a biological explanation for the endurance and

enced. “I’m like a little kid,” he says. “I want to find out

development of human life.

things and then share it with others.” His writings reflect

“We have 75 trillion cells in our bodies,” Dr. Nuland

an astounding amount of knowledge in a wide variety of

says. “Every one of them has something going on con¬

fields, and the hundreds oi books lining his wall evidence

stantly. Why don’t things go wrong? Why don’t we die?”

a mind of extraordinary reach. Since the 1980s, Dr.
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Shep Nuland in the Medical Historical
Library, where he spends much of his
Nuland has edited the Classics of

the Medical Historical Library at

time researching. Page 20: At home in

Medicine Library, a series of hand¬

the School of Medicine’s Harvey

some gilt-edged and leather-bound

Cushing/John Hay Whitney

his study a few miles away, Dr. Nuland
works amid stacks of books and papers.

reissues of every major work in

Medical Library, one of the greatest

He usually speaks his words as he sets

medical history, all with his intro¬

collections of its kind in the world.

them out in longhand.

ductions. When asked about his

Now retired, Ferenc Gyorgyey

polymathic pursuits, he demurs,

directed the Historical Library for

unpleasant will come out of it. If

“1 have always felt I was not well-

many years and worked closely with

he believes in something, he will

educated. Virtually from the cradle,

Dr. Nuland, serving as translator on

tell it.”

I have wanted to learn more.”

a volume in the History of Medicine

Always a reader in medical

series. They are now close friends.

One of the most embracing of
those hypotheses grew directly out

history, he began researching,

Mr. Gyorgyey says, “He has a

of his professional experiences as a

editing and writing for the Classics

fantastic brain. He works at incred¬

surgeon and the most personal

of Medicine series during the early

ible speed, and he brings a fresh

aspects of his own life. “Biology and

1980s. In the odd free moments

perception to things. He has the

the human condition are the same

he found at the medical center, he

courage to build a hypothesis, and

would run over from the hospital to

he’s not afraid that something
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From The Wisdom of the Body
The following passages are
taken from the introduction to

The Wisdom of the Body, by
Sherwin B. Nuland, M.D.

Centuries ago, when little was
known of science, the mystery of
the body’s internal machinery
enthralled ordinary people and
tantalized the educated. It seemed
a miracle, this bustling edifice of
thought and action—beyond the
capacity of mere mortals to compre¬
hend, and yet providing here and
there a hint that the inscrutable
might somehow be understood if
only properly directed efforts were
made. In time, the right direction
was indeed found and the efforts
were rewarded, yet the tantalizing
and the mystery not only did not
lessen; they actually grew. The more
became known, the more miracu¬
lous seemed the intricacies of the
whole and the more urgent the drive
to expand our knowledge of organs
and tissues.
As knowledge grew of cells and
the turbulence of chemistry within
them, it became evident that the
seeming chaos of our tissues has
about it an overarching purpose—
in this sense, not a theological or
philosophic purpose, but one based
on the simple biological principle of
survival. If an organism is to survive,
every activity within it must in some
way be part of the effort. Moreover,
it is imperative that there be total
coordination if the outcome is to be
the singular momentum that is
ongoing life.
The integration of all parts of
this effort has a seeming wisdom
about it, by which the multiplicity of
processes is somehow guided into
a harmonious whole. The essence of
success is the dynamism that
allows each cell to respond instanta¬
neously to even the most minor
threat to its integrity and therefore
to the integrity of the entire organ¬
ism. There can be no chemical
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complacency. A high degree of
radical readiness—to the point of
instability, in fact—is required to
allow the immediate change that
corrects a tendency toward imbal¬
ance. Every disturbance sets off
the calling forth of compensatory
mechanisms that neutralize it. Our
steadiness is a dynamic equilibrium.
To coordinate all of the instabili¬
ties in all of the cells requires that
the far-flung parts of an organism
be in constant communication with
one another, over long distances
as well as locally. In the scale of
animals that includes humankind,
this is accomplished by messages
sent via nerves, in the form of
electrical energy we call impulses;
via the bloodstream, in the form of
the chemicals we call hormones;
and—to nearby groups of cells—
via the specialized substances we
call local signaling molecules.
As each of these methods of
communication was discovered,
researchers became increasingly
impressed with how well integrated
is the entire array of apparently
disparate activities. They came to
recognize the inherent wisdom of
the body. Not only did they recog¬
nize it; the term also began to
appear in their writings.
The first scientist to use the
metaphor of wisdom to characterize
the body’s seemingly intuitive
integration of its diverse faculties
was Ernest Starling, one of the two
codiscoverers of hormones. Deliver¬
ing the prestigious Harveian Oration
of the Royal College of Physicians
in 1923, he spoke of the regulation
of bodily processes, their adaptabil¬
ity, and the contribution of hor¬
mones toward integrating them into
a single unified system. For his
epigraph, Starling chose a verse
from the Book of Job (38:36):
“Who hath put wisdom in the inward
parts? or who hath given under¬
standing to the heart?"
He entitled his oration “The
Wisdom of the Body.”
There is a certain irony in
Professor Starling’s epigraph. In the

Hebrew original, the word translated
as “heart” is sechvi, a term so
distinctive that this is the only place
in the entire Bible where it occurs;
and the term’s precise definition has
been the focus of much learned
discussion. According to some
rabbinical authorities, it is equiva¬
lent to “mind,” perhaps from the
belief, shared with Aristotle, that the
heart is the seat of the mind. The
wonder of the human body is not
only the wisdom of its physiology
but also the breadth of its mind.
Nine years after Starling's
oration, the great explicator of the
body’s automatic control over
vegetative functions (such as
digestion, circulation, and tempera¬
ture control) Walter B. Cannon, of
Harvard University, used the same
title for a popular book he wrote. He
chose to follow Starling’s lead as a
way of recognizing the contribution
made by the English scientist to the
understanding of the body’s regula¬
tory mechanisms. In the introduc¬
tion to his book, Cannon quoted the
French physiologist Charles Richet,
who in 1900 had stated that “in¬
stability is the necessary condition
for the stability of the organism.”
A stable system is not a system
that never changes. It is a system
that constantly and instantly
adjusts and readjusts in order to
maintain such a state of being that
all necessary functions are permit¬
ted to operate at maximal efficiency.
Stability demands change to
compensate for changing circum¬
stances. Ultimately, then, stability
depends on instability.
“The Wisdom of the Body” was
to appear one more time, as the
title of the fourth of a series of
twelve Gifford Lectures presented by
Sir Charles Sherrington at the
University of Edinburgh in 19371938, several years after he won a
Nobel Prize for his studies of the
ways in which the nervous system
coordinates bodily functions. He
began the fourth lecture by suggest¬
ing to his audience that they see
the human body as he did after a
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long career of studying it: “Wonder
is the mood in which I would ask to
approach it for the moment." The
lectures have been collected into a
single volume which encapsulates
the quest on which Sherrington
based his life's work; it is called

Man on His Nature.
The book you are holding is
written by yet another man awe¬
struck with the amazement that is
us. I offer it not in imitation of the
great scientists who have preceded
me, but in homage to their vision.

It is my thesis that we are
greater than the sum of our biologi¬
cal parts. Not only that, but we have
it in us to be still better than we
are—and the choice lies to a
significant degree in our own hands,
as I have tried to demonstrate by
telling the stories of people whom I
have been privileged to know during
my surgical career.
No matter how similar our parts
to those of other animals, there are
to be found within them some char¬
acteristics that make us uniquely
human. Whether as overtly evident
as the power of the brain that has
been given us or as taken for grant¬
ed as certain adaptations within our
skeletal system, we are possessed
of elements that make us different
from any other living thing that has
ever existed on this earth.
If this is true of our bodies, how
much more must it be true of the
qualities of emotion and thought
that we alone of all the animal
kingdom possess? Although fo¬
cused primarily within the coordinat¬
ing tissues of the brain, powers
such as these originate in the
contributions of every segment of
us. Like everything else about
human function, the myriad frag¬
ments that coalesce to form human
feeling arise from the workings of
the physical structure that has been
given to us. The uniquely human
mind is a property of the organic
characteristics of the uniquely
human body, just as all function is
the accompaniment of the physical
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structure from which it arises. There
is no duality of mind and body—all
is one. Were it possible for Rene
Descartes to reappear at this hour,
today’s neuroscience would quickly
convince him of the unity. In that
one, which is the summation of our
humanness, I include the quality
that I find most remarkable, the
quality which above all else makes
us distinctively what we are. By this,
I mean a biologically inherent
particularity that is both miracle and
mystery, the particularity I choose to
call the human spirit.
Notwithstanding the tragedies
that humankind has visited on itself
individually and collectively, and the
havoc we have wreaked on our
planet, we have become endowed
nevertheless with a transcendent
quality that expands generation
upon generation, overcoming even
our tendency toward self-destruc¬
tion. That quality, which I call spirit,
has permeated our civilization and
created the moral and esthetic
nutriment by which we are sus¬
tained. It is a nutriment, I believe,
largely of our own making. Without
it, we would wither and lose our way
in the wilderness.
As I define it, the human spirit
is a quality of human life, the result
of living, nature-driven forces of
discovery and creativeness; the
human spirit is a quality that Homo
sapiens by trial and error gradually
found within itself over the course of
millennia and bequeathed to each
succeeding generation, fashioning it
and refashioning it—strengthened
ever anew—from the organic
structure into which our species
evolved so many thousands of
years ago. It lives while we live; it
dies when we die. Whatever else of
a man may remain to join the
consciousness of eternity, this
magnificence I call the human spirit
does not exist a moment beyond
the moment of death. It is neither
soul nor shade—it is the essence
of human life.

to me,” he says. His eyes brighten at
the notion that our biological
existence has evolved to thrive
despite constant threats from
virtually every direction. “I live in
awe of human physiology. The body
is a wondrous mechanism with so
many fail-safe devices. We are
always in danger of death, and yet
we don’t die until old age or massive
infection or trauma.” With life¬
saving redundancy in virtually every
organ system, the body has an

How We Die shows
just how much it
really takes to kill a
person. The Wisdom
of the Body shows
how capable our
biology is to develop
and maintain itself.

innate capacity for nearly instanta¬
neous communication and correc¬
tion when any life-threatening event
occurs. Instability is an environmen¬
tal constant—the world is always
changing—yet the body is continu¬
ously restoring the necessary
equilibrium to the whole that
promotes survival. Hormonal,
neural and intercellular reactions
course throughout the body,
integrating into a single, selfsustaining organism.
How We Die shows just how
much it really takes to kill a person.
The Wisdom of the Body shows how

Excerpts from The Wisdom of the Body

capable our biology is to develop
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and maintain itself. All of these
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biological functions taken together
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can be directly equated with what
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Dr. Nuland chats with longtime friend
would generally be seen as the

This is something Dr. Nuland

evolutionally highest-order capabil¬

believes we know with our bodies,

ity: wisdom.
In The Wisdom of the Body,

and colleague Robert J. Levine, M.D.,
a medical ethicist and chairman of the
Human Investigation Committee.

if not always with our minds. It
governs our lives. And it is even

Dr. Nuland explains: “If an organ¬

found in the types of more spiritual

ism is to survive, every activity

questions that we ask about life. The

within it must in some way be part

very title ol the book evolves from

tions such as circulation and

of the effort. Moreover, it is impera¬

early questions about the relation¬

digestion, used it as the title of a

tive that there be total coordination

ship between biology and the

popular book on the body’s regula¬

if the outcome is to be the singular

human spirit. The words originate

tory mechanisms. Finally, Nobel

momentum that is ongoing life.

in the Book of Job: “Who hath put

laureate Sir Charles Sherrington so

The integration ol all parts of this

wisdom in the inward parts?” The

titled a lecture he gave as part of a

effort has a seeming wisdom about

words were taken up earlier in this

series of talks in 1937-1938, building

it, by which the multiplicity of

century by other medical writers,

on his studies of the nervous

processes is somehow guided into a

starting with Ernest Starling. He

system’s coordination of bodily

harmonious whole.”
As he writes in the prologue to

the body’s control over basic func¬

used them as the title of a lecture he

functions. Dr. Nuland says, “All

gave in 1923 on the role of hormones

three men and I have been fasci¬

The Wisdom of the Body, he, like

in integrating bodily processes into a

nated by the wonders of human

many others who have studied

unified system. Then, in 1932,

biology and the human mind.”

human biology, finds that a won¬

Walter B. Cannon, a Harvard

drous wisdom governs the body.

physician who had helped explain
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He extends the notion of bodily
wisdom to equate those higher-order

2.5

qualities that make us human with

Yiddish moniker in the Jewish

the small living room between the

basic biological functions. “What

village of Eastern Europe from

two bedrooms while the life of the

we are in the human spirit,’ he says,

which his family came. Most people

family swirled around him. Dr.

“is simply a reflection of our cellular

who know him personally call him

Nuland has an uncanny ability to

life." Life is in constant conflict

“Shep.” “Sherwin” was a name his

focus closely on whatever matter is

with the forces that would destroy

mother, Vitsches, heard in a Broad¬

before him, perhaps a skill learned

it—and we endure by building an

way show tune and then gave to the

in the chaos of that teeming house¬

order that prevents or reduces the

officials when she enrolled her son

hold and community.

“Knowledge makes me feel part of something larger. I have an
immigrants mentality: Nothing is ever enough.”

threat of death. Our communal

in school. For the young boy, his

Gifted with a photographic

lives celebrate this biological fact.

mother’s death caused enormous

memory capable of comprehending

“We create a culture that is a

grief and set him on a course to

and retaining large chunks of

reflection of the biological victory

fight disease through medicine.

over death,” he says. “Beauty is the

After his mother’s death—his

material at a glance (“I studied in
college by photographing’ pages

order and evidence of our ability to

father labored from early in the

and they stayed in my mind”), he

stay alive.” The book traces out this

morning until late at night in the

came to the Yale School of Medicine

notion, beginning at the cellular

garment industry—the crowded

in 1951, graduating in 1955. He

level and following it through

household was left in the charge of

remained in New Haven as a

various physiological systems, and

his elderly grandmother. “Bubbeh”

surgical resident, between 1955 and

finally to the brain and then the

as he affectionately called her, raised

1961, at what was then Grace-New

human spirit. “The human spirit,”

the boys until, at age 96, she too

Haven and is now Yale-New Haven

he says, “is the essence of the book.

died when the future surgeon and

Hospital. He was in the same

There’s a biological basis for the

author was 18 and a precocious

surgical residency group as another

human spirit.”

college student at New York Univer¬

promising young surgeon, Richard

Memoir is very much at the

sity. His description of the elderly

Selzer, M.D., and succeeded him as

core of Dr. Nuland’s writings about

yet extraordinarily strong woman’s

chief resident. The following year’s

biology, and, not surprisingly, his

physical decline and the series of

surgical residents included Bernie

biological theory for human whole¬

strokes that eventually killed her is

Siegel, M.D. The trio remained in

ness grows in part out of a child¬

among the most moving chapters in

New Haven as general surgeons and

hood in which the struggle for

How We Die.

at Yale as clinical professors. While

survival was continuous and death a

No member of his family had

Dr. Nuland went into practice by

very real threat. However, the cele¬

ever had formal schooling other

himself, Drs. Selzer and Siegel

bration of life was also a constant.

than for religious purposes. “Our

worked together for 20 years. All

Dr. Nuland spent his childhood in a

household valued learning,” he

three crossed paths regularly in the

four-room tenement apartment in a

recalls, “even though no one had

operating rooms.

teeming immigrant neighborhood

any. It was not learning for the sake

in the Bronx. He shared that tiny

of achievement, but for developing a

surgeon, but together they have

space with an aunt, his parents, his

sense of oneself.” To this day, he

gone on to something that may be

brother, a cousin for a period and

avers, “Knowledge makes me feel

unprecedented among American

his grandmother. Yiddish was the

part of something larger. I have an

surgeons. Although many individual

household language. His parents

immigrant’s mentality: Nothing is

physicians have certainly become

could neither read nor write

ever enough. I’m always in a search

famous writers, never have three

English. Even his name was what he

to understand more.” He remem¬

close surgical associates found fame

terms “an afterthought.” Everyone

bers well spending each evening

as writers. “It’s unique,” says Dr.

called him “Shepsel,” a common

studying at a folding card table in

Selzer, author of several nonfiction
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Each made his mark as a
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books, including Confessions of a

poses: one to learn, the other is to

deal with death is helping people

Knife and, most recently, Raising the

find out what I think about what

to live.”

Dead. “The surgeons of Yale have

I’ve learned. Siegel writes to get his

turned out to be writers. Surgeons

message out. I’m a little in between

disagree with Dr. Siegel’s ap¬

are supposed to be mute as grass,

Siegel and Selzer. There’s something

proaches, he has indeed found

and here we are singing arias.”

in us that makes writing our life’s

himself, through his medical

All three have now retired from

blood at this point.” Adds Dr.

experience, needing to bring wider

active medical practice to devote

Selzer: “It was to surgery that we

knowledge and understanding about

themselves to their writing and

bound ourselves, but writing was

the wonders of life. “All of us,” he

related activities.

our destiny.”

says, “need to be aware that we are a

That destiny has made them

Each of the three writes in an

While Dr. Nuland may still

magnificent mystery. There is a

entirely different vein than the

public figures, on occasion in open

treasure everywhere we look. We can

others. “I don’t think any jealousy

conflict with each other. Dr. Siegel

study all the embryology we want,

exists among the three of us,” says

recalls that Dr. Nuland went on

but every time a kid comes out, it’s a

Dr. Selzer. His work mines the

Oprah Winfrey’s television talk

brand-new miracle.”

literary possibilities in his experi¬

show a decade ago to argue against

ences. “I’m a 19th-century throw¬

Dr. Siegel’s work with cancer

medicine has, in part, lost sight of

back,” he says. “I write for the

patients. “I got criticized,” says

the humanity of its patients and the

language.” With a vast following,

Dr. Siegel, “for what was seen as

human spirit he believes essential to

Dr. Siegel is author of the best¬

the guilt, shame and blame I was

medical practice. He has written

selling Love, Medicine and Miracles

causing.” The Oprah experience

articles criticizing the biotechnically

and other works aimed at changing

still resonates with Dr. Siegel, who

based and managed-care-induced

attitudes in cancer patients as a

felt his work had been misrepre¬

move to apply objective standards of

means of curing or helping them to

sented. “He doesn’t have a photo¬

evidence to each case. He believes

cope with their diseases. He also

graphic memory,” he says, “because

this undermines the human essence

heads a national self-help organiza¬

he misquoted me.” He terms

of the doctor-patient relationship.

tion called ECaP, Exceptional

Dr. Nuland the most intellectual

He says, “The physician’s art of

Cancer Patients, that supports

and least emotional of the three,

taking a patient’s history and

cancer patients and their families in

and suggests that he devote his

developing a sense of who it is

bringing changes to their lives.

next book “to miracles and things

they’re taking care of is being lost.”

“The only one of us who is a literary

you can’t explain.” Despite these

He asserts that a surgeon should

Dr. Nuland fears that modern

talent is Dick,” says Dr. Nuland,

differences, Dr. Siegel believes

grasp the individual wisdom of each

who recalls being impressed by Dr.

that the three have grown much

body being treated. “Basic decisions

Selzer’s command of language even

closer in their outlooks in recent

now are coming from secondary

when they were residents. “I used to

years. “The key,” he says, “is

sources—what the literature says.

“The surgeons of Yale have turned out to be writers,” says colleague
Richard Selzer, M.D. “Surgeons are supposed to be mute as grass, and
here we are singing arias.”
read Dick’s patient charts just for

humanizing education. Selzer

Medicine should be about individu¬

the writing.” Given the rigors of a

helped me see my patients as people.

alization of diagnosis, care and

surgical practice, however, none of

Out of that came a way of helping

follow-up. Objectification under¬

the three began writing seriously

people. That’s the path we’ve each

mines this.”

until reaching his 40s.

taken now. All three of us feel that

Dr. Nuland explains the varying

Death and end-of-life issues

we can do more with words than

remain an important concern. He

intentions among the remarkable

with a knife.” Dr. Siegel says of

blames medicine’s ethos for some of

threesome: “I write for two pur-

How We Die, “Helping people to

the great difficulties modern society
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has in dealing with death. The

Harvey—and memories of their

have a necessity to soak up the

profession’s constant need to

mother’s death of the same disease.

goodness available to us every day.

diagnose and treat mistrusts the

Many readers have experienced an

Our lives are sprinkled with sorrow,

body’s own wisdom at the end of

anguish similar to Dr. Nuland’s own

but we transcend those periods. I’ve

life. “Dying is very hard,’’ he says.

about the questionable medical and

had my sorrows, but somehow

“However, the dreadfulness of death

personal decisions he made to

things roll back." Those who have

is to a significant extent due to

extend a battle, on behalf of his

read his books—or been under his

attempts to stave it off. At certain

brother, that he knew could not

medical care—know that our ability

points we have to step back, and

be won.

to overcome even our deepest losses,

death won't he so bad.”
Dr. Nuland knows death

It is the humane character of

too, comes from the wisdom of the

Dr. Nuland's own response to his

body. It’s a wisdom to which he has

intimately. Hoiv We Die begins with

brother’s and others’ deaths that has

devoted a lifetime. YM

the drama surrounding the death

led thousands of readers to call or

from myocardial infarction—a

write him about the book and their

massive heart attack—of his very

own experiences with the deaths of

first patient as a medical student at

loved ones. Three years after the

Yale, including his own despair

book appeared, he continues to hear

when his heroic efforts at open-chest

daily from readers. “It has become a

heart massage failed to revive the

ministry,” he says. “People just need

reminded by the poster of a lecture he

man. Closing the circle, he brings

to talk about death."

gave in China on two successive

the book to its uneasy conclusion

The lessons Dr. Nuland takes

At work in his study, Dr. Nuland is

days. ‘At the second, there was standing

with reflections provoked by the

from the life he has led—-and its

1989 colon-cancer death in New

coming end one day in death—is

room only and I was very impressed
with my popularity, ” he says. “ When

York of his beloved older brother

that “because of that ending, we

I got home, I asked a friend to translate
the poster. It says, among other things,
‘Attendance mandatory.
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INTERVIEW:

ROBERTA

HINES,

M.D.

Mission critical
The field of anesthesiology looks beyond its traditional role in the OR and finds the
future lies also in intensive care, pain management and, unexpectedly, prevention.

FRANK POOLE

R

oberta L. Hines, M.D., an energetic and enthusi¬

approach to patient care, expand pain management and

astic champion of anesthesiology, became chair

offer diverse practice opportunities for young men

of the Department of Anesthesiology at Yale

and women.

School of Medicine and chief of anesthesiology at YaleNew Haven Hospital (YNHH) in the fall of 1995. This

A New Hampshire native, Dr. Hines came to Yale in
1978 as a surgical intern after receiving a degree from

outstanding clinician, educator and clinical investigator

Dartmouth Medical School. Following internship, she

has seen the field of anesthesiology take a more global

completed residency training at YNHH in surgery and
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Previous page: Roberta L. Hines, M.D., in an operating room at Yale-New Haven
Hospital, leads a department of 72 attending and 76 resident physicians.
Above: The department opened its pre-admission testing center in 1997, directed
by Richard Wiklnnd, M.D., to better prepare patients for surgery. The screening
that takes place there ofien reveals conditions, such as hypertension, that might
otherwise go undetected and untreated.

anesthesiology, serving one year as
chief resident in anesthesiology. She
joined the Yale faculty as an instruc¬
tor in 1982, and in May 1994 she was
named professor upon her appoint¬
ment as acting department chair.
Dr. Hines’ research interests
include critical care medicine, right
ventricular function of the heart,
cardiovascular and respiratory
physiology, platelet function, new
inotropic agents and renal function.
This work parallels Dr. Hines’ work
at YNHH, where she has served as
director of the recovery room,
cardiothoracic anesthesia and the
cardiothoracic intensive care unit.
The department that Dr. Hines
leads comprises 72 attending and 56
resident physicians, one physician
associate and six certified registered
nurse anesthetists, and provides
anesthesia services annually for more
than 30,000 surgical procedures.
When the section of anesthesiology
was established as part of the
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Department of Surgery in 1955,
there were six attending physicians
and five residents; by 1971 it had
become a department.
Dr. Hines spoke recently with
Helaine Patterson, director of
the Office of Public Information.
A portion ol their conversation
follows.

WHAT CHALLENGES ARE FACING
ANESTHESIOLOGY TODAY?

Anesthesiology is at a critical point
in its identity as a specialty. Tradi¬
tionally, we have identified our role
as intraoperative physicians. We’ve
spent so much time in the operating
room—obviously important—in
reducing overall operative mortality
and allowing surgical subspecialties
to develop. That’s the good news.
But the downside is that the
specialty’s growth has been ham¬
pered by the fact that we were not
really known by many other special¬

ists except surgeons, so the full
breadth and the intensity of what we
do has not been appreciated by
internists and pediatricians. Only
within the last 10 years—when
many of us have begun to look
outside the operating room for new
avenues to expand anesthesiology—
have other medical specialties and
the population, in general, begun to
appreciate what we do. The classic
line, put people to sleep, has become
a very small part of what we do.
We are, in a true sense,
intensivists, caring lor severely ill
patients, managing multisystem
diseases and relieving pain. Most
people don’t understand the other
aspects of anesthesiologists’ work.
Much of what we do outside the
operating room has just begun to
become focused, particularly in pain
management, intensive care and
pre-admission testing. Many
anesthesiologists also are taking a
more primary care role. That’s going
to raise people’s eyebrows, and
they’re going to say, “What is
someone who’s really in tertiary care
doing giving primary care to the
sickest patients?”

WHAT, IN FACT, ARE
ANESTHESIOLOGISTS DOING IN
PRIMARY CARE?

This developed as more and more
of our patients—more than 40
percent—are coming into the
hospital either the day or morning
of surgery. It became clear that we
couldn’t see patients who are ill or
have multisystem organ disease at
6 o’clock in the morning and have
them appropriately prepared by
7:30 a.m. for their surgery. As a
specialty, we said that’s unaccept¬
able. We couldn’t understand
people’s medical conditions and get
them optimized, so the field of
preoperative testing and evaluation
developed.
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dure, but we also impacted his

optimally match testing with the

anesthesia pre-admission testing

longevity and other factors by

procedures. Part of the interest has

center with the premise that we

identifying a fairly significant

been cost-motivated, and we now

would want to see everyone, doing

cardiovascular risk factor that no

do things in a more structured

thorough history and physical

one ever knew he had.

fashion. Ongoing research here

In October 1995, we opened our

specifically has looked at tests a

examinations, reviewing the appro¬
priateness of laboratory evaluations,
and optimizing their care in a
prospective fashion—seeing patients
seven to 10 days before surgery so
they could come back at 6:30 a.m.
and have their surgery at 7:30 a.m.
the same day.

WITH THE ADVENT OF
LAPAROSCOPIC SURGERY, DO
ANESTHESIOLOGISTS HAVE A
NEW OR DIFFERENT ROLE?

particular patient would need for a
particular surgery. Does every
patient need an electrocardiogram
(EKG)? Does that affect outcome?
We’ve recently revised our

The role is not really different,

policy. We’ve been able to show that

but again it’s a challenge. When

a large group of patients don’t need

laparoscopic surgery began, we

routine bloodwork or routine

taken a much more primary care

thought that patients were going to

electrocardiograms. Basically, people

role. We’re now identifying people’s

do better because the surgery was

thought it was heresy to discard

primary hypertension—diseases that

less invasive and that they would go

those practices, but we’ve been able

people didn’t know they had. Many

home sooner. The patients would

to show that there’s no increase in

of these people didn’t have a primary

come in, be healthy, have their

anesthetic complications if appropri¬

care physician. A case in point: A

gallbladders taken out laparo-

ate guidelines are followed.

67-year-old gentleman who didn’t

scopically, and go home. We’ve

go to the doctor regularly was

begun to realize that our surgeons

laboratory tests and more specifi¬

referred by a surgeon for hernia

are getting so proficient with

cally matching them with outcomes

repair. We were the first people to

laparoscopic procedures that we re

in patient diseases and, therefore,

identify that patient’s profound

no longer seeing just healthy

taking an epidemiological ap¬

diastolic hypertension and to

patients. Were seeing sicker patients

proach—once again, working in an

control blood pressure with the aid

for laparoscopy, and we re beginning

area where anesthesiologists tradi¬

In assuming that role, we’ve

Similarly, we’re looking at other

of our cardiologist. We not only

to realize that, just like before, the

tionally would not. We’re making

lessened the likelihood of adverse

surgical procedure may simplify

choices every day with testing

events occurring during the proce-

some aspects of anesthetic manage¬

modalities, and we’re repeating them

ment. Dealing with patients with

in a more structured, systematic,

advanced medical conditions, our

research approach based upon

“We’re now
identifying
people’s primary
hypertension—
diseases that people

role is much greater in maintaining

patients’ histories, exercise tolerance

those patients in an optimal state

and other disease states, particularly

for the surgeons to do their proce¬

emphasizing patients with cardiovas¬

dures, because special physiologic

cular disease. Does everybody who

derangements occur with laparo¬

has angina need a stress test? Does

scopic surgery that aren’t a major

everybody need invasive testing to

concern in healthy patients. In sick

evaluate cardiac disease before

patients, particularly those with

coming for surgery? We clearly

cardiovascular disease, they can be

know that’s not true, and we can

quite profound.

stratify those patients who then
need to move on to catheterization

didn’t know they

SHIFTING AWAY FROM CLINICAL

had. Many of these

PRACTICES IN ANESTHESIOLOGY,

people didn’t have

CLINICAL RESEARCH IN

a primary care
physician.”
YALE MEDICINE

PLEASE DESCRIBE CURRENT
ANESTHESIOLOGY AT YALE.
One of the hottest areas is appropri¬

or certain medications versus those
who could be taken to the operating
room on their already-charted
medical management. We’ve made
decision trees based upon ongoing
epidemiological work.
The other area akin to pre¬

ate testing for patients undergoing

admission testing is in pediatrics,

surgical procedures, and how to

where controversy has focused on
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parental presence during pediatric
anesthesia and anxiety-related issues
with parental presence. Zeev Kain,
M.D., director of pediatric anesthe¬
siology, has been working with
Linda C. Mayes, M.D., in the Child
Study Center, on a battery of issues
related to preoperative anxiety and
ways to reduce it in parents and
children. Dr. Kain published data

“Without Luke
Kitahatas discovery
... pain management
as we know it today
would not exist.”

notion that we could take medicines
that we traditionally used, like
morphine and other opiates, and
put them in the spinal cord directly
to affect it. At a much lower dose,
these medicines have exquisite and
sensitive pain relief. Dr. Kitahata’s
basic science work led to the entire
field of patient-controlled analgesia
using opiates and epidural opiates.

showing that parental presence may

Without his discovery that anesthe¬

not always be good during pediatric

siologists can put opiates in the

inductions—a conclusion that, once

central nervous system, reduce the

again, has forced us to evaluate our

cardiologists use to evaluate cardiac

old norms. The old school of

function and brought that into the

thereby reduce the potential for side

thought was that parents would

operating room. This provides

effects of respiratory depression,

quiet their children. He’s shown in

instantaneous appreciation of what

urinary retention, nausea, vomiting

children less than four years of age

cardiac performance is during

and other negatives, pain manage¬

that the presence of parents—

cardiac surgery and helps our

ment as we know it today would

particularly if the parents are

surgical colleagues judge the

not exist.

anxious—actually increased the

adequacy of their valve replacement.

need for anesthetic agent and

Does the patient need a replace¬

increased anxiety during awakening.

ment? Can he or she have a repair?

His ideas are interesting and clearly

We work with them in a close

controversial. Most children’s

relationship to formulate their

amount given to patients, and

IS PAIN MANAGEMENT ALSO
MOVING FROM THE OPERATING
ROOM AND POST-OPERATIVE
CARE INTO OTHER AREAS OF

hospitals like to say that parents can

surgical plan and give them an idea

be present, and clearly we do at Yale,

of how successful they can expect it

but situations may arise where

to be. It’s a more sensitive indicator

Pain management has divided itself

having parents present is not best

that a patient is having problems

into two factions. Acute pain

for their children. Having child

during cardiac surgery based upon

management focuses more on the

psychiatry involved in anesthesiol¬

information we get from this

time of surgery and deals with the

ogy is another area one wouldn’t

monitor than we’ve ever had before.

pain in surgical incisions and related

have imagined, historically.

That’s clearly innovative, and we

issues. The second area takes a

were actually the first anesthesia

multidisciplinary center approach to

IN WHAT OTHER AREAS ARE
YALE ANESTHESIOLOGISTS
CONDUCTING CLINICAL
RESEARCH?
We are very active in cardiac

department in the country to report

manage chronic pain syndromes,

on the use of this modality in the

such as reflex sympathetic dystrophy

operating room. Paul G. Barash,

(a chronic syndrome that occurs

M.D., professor of anesthesiology,

following work-related injuries or

reported that work in 1984, and we

trauma) and low-back pain.

now use it for all adult cardiac cases.

anesthesia because that parallels our
clinical activities. We re a leading
center in cardiac surgery, which
extends itself into anesthesia. Were

PATIENT CARE?

Our Center for Pain Manage¬
ment, located at Temple Medical

WHAT’S HAPPENING IN BASIC
RESEARCH?

Center in New Haven, has physi¬
cians from neurology and psychia¬
try, psychologists, as well as anesthe¬
siologists who have special creden¬

one of a handful of centers around

Luke M. Kitahata, M.D., the

the country that routinely does

professor of anesthesiology who

tials in pain management. Here,

intraoperative transesophageal

founded Yale’s pain center, contin¬

we diagnose the patients’ pain.

echocardiography. This is an

ues to be an international leader in

But because many chronic pain

advanced method of imaging the

spinal opiate receptors and research

syndromes are difficult to diagnose

heart while surgery is actually taking

in pain management. He is world-

from a traditional view, we are

place. We have taken the same

renowned for being one of the first

looking at new modalities specifi¬

principles and technology that

investigators to come up with the

cally to help diagnose more
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“Pain, ”says Dr. Hines, “is still the
largest black box. ’’Above she consults
complex pain processes, and then,

by something going on in the

with Lloyd Saberski, M.D., a faculty

secondarily, look at new ways to

central nervous system, and that it

member at the department’s Center for

treat them, maybe even non-

had to be at that specific location.

pharmacologically.

As we know, low-back pain has

Pain Management, where clinical
research is helping to uncover the

been very difficult to treat by

sometimes-mysterious pathology

clinical professor of anesthesiology,

surgery and traditional pain man¬

behind symptoms.

performs a procedure called

agement. In spite of surgery and

epiduroscopy. With this procedure,

narcotics, the patient may not get

new and innovative diagnostic

much symptomatic relief. Anatomi¬

techniques for the management of

cally, the surgeon goes in, takes out

back pain have been developed. In

the disc, and things look like they

addition, he and his colleagues are

ought to be fine. But the patient still

sophisticated sense as we know it,

looking at whether certain syn¬

has incapacitating pain, can't go

has developed within the last io

dromes previously thought to affect

back to work, has weakness in his or

years. Pain is the area that, I

only peripheral nerves may have a

her legs or other problems. It may

think, is still the largest black box.

central etiology. With pain syn¬

be that, indeed, more than the

We’ve been traditionally focused on

dromes, particularly in the extremi¬

anatomical component is occurring.

treating the symptoms, making

ties, many people have thought

These are the patients that may

patients feel better. Now were

they couldn’t possibly be mediated

benefit from epiduroscopy.

taking a step back to examine the

Lloyd Saberski, M.D., associate
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Pain management, in the
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real pathology causing this pain

blood pressure, diabetes or other

steps toward bringing the profes¬

and to understand the complex

factors are well under control.

sional pendulum back. Moving

mechanisms eliciting pain in order

One of the newest areas of interest,

into a much more perioperative

to interrupt those pathways.

as you can imagine, is geriatrics in

approach clearly has helped. If we

WITH THE POPULATION AGING
AND BABY BOOMERS TURNING 50,
SURGERY IS BEING PERFORMED AT
A LATER AGE. IS THIS PRESENTING

anesthesiology because patients over

traditionally were going to keep our

70 present some unusual problems,

focus in the operating room, the

such as greater risk for hypothermia

number and kind of physicians

and a decreased ability to metabo¬

that we train would be very differ¬

lize drugs.

ent from sending people out into
the intensive care units, pain

MORE CHALLENGES AND RISKS
FOR ANESTHESIOLOGY?
It clearly is. Because of patients’
ages, they get significant cardiovas¬
cular disease. Even patients who
aren’t coming for cardiovascular
surgery present an issue because

WHO WILL TREAT THESE PATIENTS
AND OTHERS? WHAT IS THE
PHYSICIAN SUPPLY IN
ANESTHESIOLOGY? WHO’S
INTERESTED? ARE MORE WOMEN
ENTERING THE FIELD?

centers and pre-admission testing
centers. Since the specialty has
evolved and grown, it has aided that
supply situation. We’re putting
different kinds of people into the
specialty and helping with issues of
resident training.

they have to be managed as if they

I should preface this by saying that

have significant cardiac disease, and

you’re obviously getting one

it changes our approach to inter¬

woman’s opinion: I’m very optimis¬

Zeev Kain, M.D., left, and colleagues

operative management and moni¬

tic, but not all my colleagues share

have found evidence that questions some
long-held beliefs about children

toring them. That also has been part

my optimism. The data shows that

of the impetus for us to see these

we have been training too many

undergoing surgery. In some cases,

patients earlier in our pre-admission

physicians and too many anesthesi¬

especially among children younger than

testing center to make sure their

ologists in general. We have finally

underlying cardiac conditions, high

recognized that and taken good

four years, parental presence may
increase the child’s anxiety before and
after surgery and increase the need for
anesthetic agent.
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This, combined with the specialty’s

for me is how we can maintain our

anesthesiologists every year, which is

multidisciplinary nature, allows a

academic presence outside of the

the number we’ve been training

great deal of career flexibility.

OR in a fiscally responsible way.

nationally for several years. Realisti¬

Opportunities exist to combine

cally, we need to train between 800

conventional kinds of practice with

and 900 per year, and the model is

the newer, expanded areas of the

set that people are going to move

specialty. A person can tailor

out of the operating room and into

practice, spending 50 percent of

perioperative management, pain

his or her time in the operating

We do not need to train 1,400

management or ICU as part of their

room and the other 50 percent

practice techniques.

in ICU or in pain management.

LAST OCTOBER, ANESTHESIA
CELEBRATED THE 150th
ANNIVERSARY OF THE FIRST USE
OF ETHER. COULD YOU PROJECT
WHAT ANESTHESIA MAY BE LIKE IN
THE FUTURE?

It also provides an opportunity

In pain management, we’re clearly

for people entering the field. Their

to develop a practice that utilizes

going to see great development,

interests are much broader. They

all aspects of one’s medical and

both in finding the mechanisms for

possess an eager sense to look at all

surgical expertise.

some pain syndromes and in

I also see a different outlook

identifying the mechanisms and

aspects of patient management, not
just traditional anesthesia in the
operating room. They have greater
interest in basic science and under¬
standing the modalities of pain

IS MANAGED CARE HAVING
A MAJOR IMPACT ON
ANESTHESIOLOGY?

developing specific and sophisti¬
cated ways to treat them. More
specific modalities, pharmacologi¬
cally, may not have any pain relief

management. We’re seeing a differ¬

In the operating room, we are being

properties per se, but they may

ent kind of individual coming into

forced to practice in a more effi¬

prevent the transmission of the

anesthesia, one with more diversi¬

ciency-based model. The major

painful stimulus, offering an

fied interests. They still have a keen

impact is on activities outside of the

entirely new approach to pain

interest in clinical anesthesia, but

operating room. We no longer are

management.

now clinical anesthesia with some¬

getting reimbursed at the same level

thing added—that little bit of basic

for pain management, pre-admis¬

science, pain management or ICU

sion testing and intensive care work.

care. This is positive and will help us
develop into multidisciplinary
practice, where we’ve been for many
years in the operating room. Now
we’re multidisciplinary out of the
operating room.
I’m very, very optimistic.

OTHER ADVANCES?
The other area where we re going to

IT SEEMS, THOUGH, THAT THE
PROFESSION IS SHOWING THAT
THESE ACTIVITIES ARE EXTREMELY
VALUABLE.

have a great impact as anesthesiolo¬
gists is in patient outcome following
surgery. We’ve already had a dra¬
matic impact in reducing death
during surgery, but what we haven’t

They’re phenomenally valuable, but

done as well as we will over the next

Applications from people interested

the insurers don’t always see things

few years is in looking at much

in anesthesia last year are beginning

as we do in terms of value-added.

more specific endpoints. With the

to take an upswing. We’ve done a

One of the difficult situations that

physiological work going on in our

good job of marketing ourselves and

we re facing is that we’re getting

perioperative group, we will be able

letting people know that things are

paid less for those outside-of-the-

to treat more specifically renal

not the doom and gloom that were

operating-room activities. Just at the

dysfunction and mesenteric dys¬

painted a few years ago. We are

time when we’re blossoming outside

function, some of those more

seeing a more diverse group of

of the OR, people want us to return

specific end-organ problems that we

people interested in the specialty,

to the OR, or at least they’re telling

haven’t been able to focus our

particularly with women coming in.

us that they’re not going to pay us

attention on.

for activities that we do outside of
WHY ARE MORE WOMEN
ENTERING THE FIELD?

I see us getting much more

the OR. That’s a real challenge for

directed and pre-emptive. In the

the department, which is commit¬

past we’ve said, “This is a problem,

ted to maintaining those outside

let’s work at treating the problem

activities. We’re not going to

when the patient has it.’’ Now we’re

increased visibility of female role

retrench into the OR only, so one of

saying we’ve done that very well. We

models in academic anesthesia.

the most difficult juggling matches

need to look at the mechanisms for

The major reason has been the
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“I m very, very
optimistic. We’ve
done a good job of
marketing ourselves
and letting people
know that things
are not the doom
and gloom that
were painted a
few years ago.”

these problems and prevent them

looking at the areas outside of the

it’s less expensive. But, as physicians,

from happening. I see us taking a

traditional operating room setting

we will have to be the patients’

much more basic and scientific

where anesthesia is being per¬

advocates. We need to get that data

approach to some modalities.

formed. Such areas include: radiol¬

and assess whether it really is as safe

ogy, radiation therapy and

to give anesthesia for arthroscopy in

I also think that we’re going to
see in the near future that very

electroconvulsant therapy. People

the office as it is to give it in an out¬

healthy patients probably aren’t

are actively looking at whether we

patient anesthesia facility with a

going to come into hospitals any

can safely give anesthesia for

recovery area and nurses trained to

more for their anesthesia. There is

arthroscopy in physicians’ offices.

monitor those patients. As we move

an increasing interest in the mode

Does everyone who comes for an

outside of traditional operating-

of office-based anesthesia. The

arthroscopy have to come into the

room anesthesia, we have to take

geography of where we provide

hospital? That may not be the case.

what we’ve learned and see whether

anesthesia, I believe, is going to

Similarly, can we provide some

it can be modified appropriately.

change, and people who practice in

gynecological anesthesia in the

These principles clearly can’t be

hospital settings are going to be

office for in vitro fertilization, or do

abandoned.

treating sicker and sicker patients,

patients have to come into the

with more complex and sophisti¬

hospital OR? We re just begin¬

going to say that just because

cated disease processes.

ning—with the epidemiological

anesthesiologists are not in the

evidence that we’ve gotten with

operating room, we don’t need to do

outcome studies in our pre-admis¬

all the things that we’ve learned over

sion testing area—to see whether we

the last 150 years. That challenge will

can safely perform anesthesia in

provide us with our next opportu¬

WILL A NEW FIELD OF
AMBULATORY ANESTHESIOLOGY
EVOLVE?
Not a new field, but an expansion
and diversification of our present
role. This is best demonstrated by

36

My concern is that people are

nonhospital locations. That will be

nity to demonstrate our excellence

the issue.

and commitment to patient care. YM

My concern is that managed
care will want us to do that because
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Through the past, darkly
Lessons from an earlier American drug epidemic show hyperbole, not fact,
often dominates public discourse.

By Michael Fitzsousa
Photographs by Harold Shapiro

I

n the early 1970s, medical historian David F. Musto,

That moment came last fall, when 15 scholars from

M.D., MA ’6i, HS ’64-67, charted new territory

around the nation gathered in New Haven for Historical

with his book The American Disease, a history of

Perspectives on the Use and Abuse of Illicit Drugs in the

illegal drug use in the United States that toppled as¬

United States. Chaired by Dr. Musto, professor of child

sumptions about substance abuse, law and public policy.

psychiatry and of the history of medicine at Yale, the

It would be a decade before the next major book on the

meeting brought together senior scholars David F

topic was published, and more than 20 years before the

Courtwright, Ph.D., author of the 1982 book Dark

number of researchers in the field would grow large

Paradise; Peter Bourne, M.D., drug czar under President

enough to warrant a major conference.

Carter and author of a recent Carter biography; John C.
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Learning the rules of political football
iter G. Bourne, M.D., witnessed
the collision of drugs and politics
first-hand as director of the U.S.
Office of Drug Abuse Policy during
the Carter years. First recruited by
then-Georgia Gov. Jimmy Carter
while on the psychiatry faculty at
Emory University, Dr. Bourne quickly
learned just how crucial a savvy
understanding of politics is to
making progress in drug policy.
At the Yale conference last
October, he told a story illustrating
this point. “I started off with the
rather naive view that, if you had
access to the president, you could
do whatever you wanted,” said Dr.
Bourne, author of Jimmy Carter: A
Comprehensive Biography from
Plains to Post-Presidency, published
in February. But he recalled one
early meeting between President
Carter and California state Sen.
(and ’60s radical) Tom Hayden, in

which Mr. Hayden steadily berated
the president for failure to exert
more power over corporations.
"Carter finally said, ‘Listen, I’m
just the President of the United
States. I don’t have that much
power!”’ Dr. Bourne recalled,
smiling. “And I thought, if the
president does not have the power
to achieve what he wants, how
can I? ... If you can’t propose things
that will draw support, or at least
co-opt the opposition, you really
don’t get anywhere.” He concluded
that one of the greatest obstacles
was the entrenched interests of
career administrators. “The sub¬
stance of the issue was really very
secondary to their goal of building
political power,” said Dr. Bourne.
“For example, I thought the DEA
[Drug Enforcement Agency] would be
overjoyed to see declining rates of
overdose mortality, but that was the

last thing they wanted. They wanted
the threat to grow and grow and
grow so their budget would grow
and grow and grow.”
But even that explanation can
be elaborated upon. Dr. Musto
recalled that while interviewing Harry
J. Anslinger, the federal narcotics
commissioner from 1930 to 1962,
he asked why the Narcotics Bureau
never used social scientists to
estimate the number of addicts.
Mr. Anslinger replied that that
number was “dynamite” and the
Bureau was not about to let its
estimation escape control. "If the
number went up, we weren’t doing
our job,” Mr. Anslinger said, “and if
it went down, our budget was in
danger.” As a result, Dr. Musto
concluded, many of the estimates
in the Anslinger era remained
remarkably stable.

“[Declining overdose
mortality] was the
last thing they
wanted. They wanted
the threat to grow
and grow and grow
so their budget
would grow and
grow and grow.”
When he was named drug czar under President Jimmy Carter, Peter Bourne, M.D.,
thought that anything was possible. He quickly learned how politics interfered with
discussion of the substance of issues.
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Ruth Engs, Ph.D., of Indiana
University, has proposed that there are

Burnham, Ph.D., professor of
history ar Ohio Srare University;
and Ruth C. Engs, Ed.D., professor
of applied health science at Indiana
University. A dozen more historians
delivered papers on topics ranging
from Captain Hobsons Horror Stones
to Women and Addiction in the
United States to Opiate Use in the

peaked between the years 1900 and

Jazz Age.

United States 1880-1915. Jill Jonnes,

Drug abuse has been a powerful
political issue in the U.S. for more
than ioo years, and several of the
conference presenters described the
remarkable rhetoric used at both
ends of the spectrum for political
gain. “For many people,’ says Dr.
Musto, “there is no sense of history
about drugs; many are not aware
that this is our second drug epi¬
demic this century.” (The first one

Ph.D., a journalist and the author

1920 and produced the Harrison Act

especially target drugs and alcohol.

of 1914, restricting what had been an

Page 37: David F. Musto, M.D.,

open trade in opiates and cocaine.)
Joseph Spillane, Ph.D., assistant
of Florida, oudined this early period
in his paper on Cocaine Before
Prohibition: Patterns of Use in the

the 1920s,” Susan L. Speaker, Ph.D.,

of Hep Cats, Narcs, and Pipe Dreams:

of Bucknell University said during

A History of America's Romance with

her account of the crusade of Capt.

Illegal Drugs, detailed the spread of

Richmond P. Hobson, who drew

drug culture in post-World War II

much of his own anti-narcotics

Baltimore.

rhetoric from the temperance

In both these periods, as in the

movement of the 19th century. On

more recent past, law enforcement

the other side of the debate, advo¬

agencies have sought greater author¬

cates of a more lenient drug polity

ity to control drugs. At times, they

also have favored hyperbole over

consolidated power by exaggerating

scientific and historical accuracy.

the dangers of illicit drug use, Dr.

“The historian is often caught
in the middle,” Dr. Musto says.
“Trvins;
to be accurate makes both
J
O

Musto and his colleagues argue.

Yale Medicine.

“The talk hasn’t changed much since

MEDICINE

moderated discussion among 15 scholars
from across the United States.

professor of history at the University

Michael Fitzsousa is the editor of

YALE

recurrent cycles of “clean living”
movements in the United States that
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Scholars met in the
Beaumont Room to
present papers and
discuss the history of
illicit drug use in the
United States, a field
that began two
decades ago with the
publication of Dr.
Musto’s The American
Disease.

sides uneasy. Neither can under¬

“There’s a religious

the Yale Child Study Center and

stand why, after studying it for so

the National Institute on Drug

many years, you don't agree with

intensity in the

Abuse.) “It’s just beginning as a

their side. There’s a religious inten¬
sity in the polarization that occurs

field. These [scholars] delve into

polarization that

over drug policy.”
In uncovering primary source

talk to among most history facul¬

occurs over drug

material, drug-policy historians have
demonstrated that:
► The power of laws to control

policy.”

had great swings, with the peaks and

contact and cooperation."
For those who came to New
Haven, the conference was a chance

had been assumed in the decades
► The use of illicit drugs has

ties,” says Dr. Musto. “It has been
good to facilitate this kind of

drug use has been more modest than
before the 1960s.

areas where there’s no one else to

to meet the pioneer scholars of the
potential, either by using drugs

field. Dr. Courtwright, whose

or abstaining.”

Dark Paradise was the second book

► Drug use is viewed as an

published on the topic, said Dr.

valleys relatively far apart. The

epidemic especially when the

period from one low point to the

middle class is affected. On the

into the archives, look at the

next may be a lifetime.

other hand, drug use frequently has

evidence using primary sources and

► Widespread use of a drug

Musto was “the first person to go

had a false or exaggerated link with

write a balanced account of U.S.

can fall dramatically ii it is perceived

ethnic minorities, “and this link

drug policy.” Added Dr. Burnham:

to be dangerous.

intensifies the punishments man¬

“This conference is a tribute to

dated by laws.”

David Musto and his work." YM

► Americans oscillate from
viewing illicit drugs as a useful tool

A second conference is planned

for self-realization to seeing them as

for 1998 to further encourage

so dangerous that any use would

collaboration among researchers in

reduce one’s full potential. “The

this growing discipline. (The 1996

underlying theme,” Dr. Musto says,

conference was sponsored by the

“is maximizing one’s individual

Section of the History of Medicine,

40

SUMMER

1997

GALLERY

An earlier epidemic

F

or Americans born
after World War I,
it may come as a

surprise that the experi¬
ence with now-illicit
drugs is rooted further

BHVeR'

back in history than the

PHARMACEUTICAL PRODUCTS.

psychedelic 1960s or even
the 1950s heroin epidemic

ASPIRIN

of Claude Brown’s
Manchild in the Promised

The substitute for the Salicylate-, ugreeable of taste, free from unpleasant after¬
effects.

Land. Turn-of-theshow the public’s early

HEROIN

embrace of narcotics,

HEROIN HYDROCHLORIDE

century advertisements

The Sedative tor Coughs,

Its water-soluble salt,

including heroin and

J

You will have call for them. Crier
a supply from your jotber.

cocaine; portraits of anti¬
drug crusaders give a

FARBEHFABRIKEN OF ELBERFELD CO.
40 Stone Street, New York,

human face to the harsh
rhetoric of temperance
and punitive movements

Heroin and Aspirin were

against drug use.

trademarks of the Bayer Co.,
which introduced the drugs

Source:

David F.

Musto,

to the medical profession in

M.D.

1898 and 1899, respectively.
Ownership of the names
was lost in the afiermath
Above: Capt. Richmond Pearson Hobson, a naval hero of the

of World War I.

Spanish-American War, campaigned against alcohol until the
success of Prohibition, and then turned his energies against
heroin and later marijuana.

In 1889, coca wine was
recommended for baseball
players and other athletes.
The most popular coca wine,
vin Mariani, offered a discount
to clergy and orphanages.

Above: Harry J. Anslinger, head of the Federal Bureau
of Narcotics for three decades, testifying before Congress
in the early 1960s. He had a profound faith in the
deterrent effect severe penalties had upon drug use.
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Neurosurgery
becomes a department

Neurosurgery continued
to expand at Yale, and during
the 1940s a three-year train¬
ing program was formalized
at the New Haven Hospital.

Dennis Spencer named first

T

Dr. John Fulton, a Yale
neurophysiologist, conceived

chairman and chiefi

the idea of a journal and in
he School of Medicine and Yale-New Haven

1944 he published the first

Hospital (YNHH) have established a Depart¬

issue of the Journal of Neuro¬

ment of Neurosurgery and named Dennis D.

surgery with Dr. Eisenhardt

Spencer, M.D., to be the first leader of this free-standing
department. Neurosurgery previously had been a section
within the Department of Surgery.
Dr. Spencer, also the Harvey and Kate Cushing

as editor.
Dr. Spencer became head of neurosurgery in 1987,
replacing Dr. William F. Collins, chief from 1967, who
had become chairman of the Department of Surgery in

Professor of Neurosurgery at Yale and an attending

1985. Dr. Spencer developed a widely used surgical

surgeon at YNHH, is internationally known for the

approach for patients with temporal lobe epilepsy and,

surgical treatment of neurological diseases causing

together with D. Eugene Redmond, Jr., M.D., Yale

medically intractable epilepsy.

prolessor of psychiatry, pioneered stereotactic cellular

I he new department’s program encompasses
epilepsy surgery, neuro-oncology, neuropsychology,

replacement therapy for patients with Parkinson’s disease.
Dr. Spencer also directs the surgical component of

neurovascular surgery, pediatric neurosurgery, stereotac¬

the comprehensive Yale Epilepsy Program, in which

tic radiosurgery, and stereotactic and functional neuro¬

faculty and fellows conduct research, train surgeons and

surgery. The Functional Imaging/Neuropsychology

other health professionals, and treat patients from

Laboratory supports many of these activities.

throughout the world. The interdisciplinary epilepsy

Dr. Spencer envisions that in future years neurosur¬
gery at Yale will provide an environment in which basic
discovery remains the driving force, increasingly high

program embraces neurosurgery, neurology, neuropsy¬
chology, psychiatry, social work and neuroradiology.
Dr. Spencer has centered his own research on the

standards of patient care will be the expected outcome,

neurobiologic study of human tissue involved in epilepsy.

and the highest quality of education will result. “As our

In this work, he and his colleagues have employed in

laculty neurosurgeons and surgeons-in-training deliver

vivo and in vitro electrophysiology, microdialysis,

increasingly complex treatments for patients with many

confocal ana electron microscopy studies, molecular

neurological diseases, they will combine clinical and

biology and magnetic resonance spectroscopy to examine

basic science experience to provide a unique appreciation

brain tissue removed during surgery. Laboratory discov¬

and understanding of the human nervous system and its

eries have helped to define the pathogenesis of human

disorders,” the new chair/chief predicts.

epilepsy and to place basic research into the context of

Neurosurgery at Yale was organized in 1918 under
Drs. Samuel Harvey and William German. Both men
trained under Dr. Harvey Cushing, considered to be the

human disease.
A native of Iowa, Dr. Spencer received a B.S. degree
in 1967 from Grinnell College in Iowa, a B.M.S. degree

father of American neurosurgery. In 1934, Dr. Cushing

in 1969 from the University of South Dakota Medical

and Dr. Louise Eisenhardt, a longtime collaborator in

School, and an M.D. degree in 1971 from the Washing¬

neuropathology, came to Yale, which was developing a

ton University School of Medicine. He completed his

strong tradition in surgery of the nervous system. Later

six-year neurosurgery residency training and his fellow¬

in the decade, Dr. Cushing, with two other colleagues,

ship at Yale in 1977, the same year he joined the Yale

established the Medical Historical Library.

medical school faculty and YNHH medical staff.

4*

SUMMER

1997

Routine care and oral
medication reduce spread
of HIV to infants

infected mothers who were treated

tremendous implications in prevent¬

at Yale-New Haven Hospital’s high-

ing the transmission of HIV from

risk obstetrical unit during their

mothers to children. This approach

pregnancy with the medication

is especially significant for pregnant

zidovudine (AZT). The rate of HIV

women in developing countries,

with the AIDS-causing virus may

infection transmitted from the

where neither financial resources nor

dramatically reduce the rate of

mothers to their babies was reduced

the technical sophistication exists to

transmission of the virus to their

from 19 percent to 5 percent, Dr.

undertake a rigorous program of

unborn infants if they receive

Andiman says.

administering intravenous medica¬

Pregnant women who are infected

The study is one of a handful of

routine obstetrical care and take the

tions during labor and delivery.

medication zidovudine orally during

U.S. studies that have begun to

their pregnancy, according to Yale

show this same phenomenon, notes

$1.50 per pill, so five 100 mg pills a

University School of Medicine

Dr. Andiman. “Our results are more

day would cost only $7.50 per day

robust because all of the data were

to prevent infection in a child.

researchers.

Oral AZT costs approximately

collected at a single institution,

Compared with the tens of thou¬

the Journal of Acquired Immune

where delivery of care was uniform.”

sands of dollars needed to treat an

Deficiency Syndromes and Human

The study bolsters efforts “to

HIV-infected infant for life, oral

The Yale findings, reported in

Retrovirology, represent a different

encourage widespread, perhaps

AZT taken daily during the last part

way of counseling, testing and

universal, education and counseling

of pregnancy represents a cost of less

treating pregnant women who are

about HIV infection,” Dr. Andiman

than $1,000.

infected with the human immuno¬

concludes. “All women of childbear¬

deficiency virus (HIV) causing AIDS,

ing age need to be offered an oppor¬

part, by grants from the National

says Warren A. Andiman, M.D.,

tunity to be tested for HIV. Those

Institute of Allergy and Infectious

HS ’76, professor of pediatrics.

found to be infected should then be

Diseases and the National Institute

offered treatment with AZT.”

on Drug Abuse.

From 1990 to 1993, a total of
267 infants were born to 245 HIV-

The research also contains

This research was supported, in

Co-authors with Dr. Andiman

Medicine at NASA

Left: Daniel S. Goldin, administrator
of the National Aeronautics and Space
Administration (NASA), gave the
keynote address at the annual meeting
of the Associates of the Cushing/Whitney
Medical Library in April. Above: He
attends the opening of the exhibit
Medical Benefits of Aerospace
Research with Martin E. Gordon,
M.D. ’46, chairman of the Associates
and clinical professor of medicine. The
exhibit, at the medical library during
April and May, highlighted NASA
contributions to medicine, including
advanced imaging and monitoring
techniques and telemedicine initiatives
to deliver care to remote regions.
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are B. Joyce Simpson, R.N.,

along with colleagues at the Yale

Ehrenkranz, M.D., HS ’72-74,

a research nurse and administrative

Child Study Center, are evaluating a

professor of pediatrics and of

coordinator of the pediatric AIDS

new technique designed to promote

obstetrics and gynecology, who

program in the department of

the growth of infants with very low

directs the three-year study funded

nursing at YNHH, and Eugene D.

birth weights.

by a $4,500 gift from Ronald

Shapiro, M.D., professor of pediat¬

Kangaroo Care for Premature

McDonald House Charities.

rics and of epidemiology and public

Infants, or skin-to-skin care, was

Adds colleague Michael D.

health at Yale medical school and an

first pioneered in 1979 in Bogota,

Kaplan, M.D., a research fellow at

attending physician at YNHH.

Colombia, in an effort to reduce the

the Child Study Center: “This

mortality among premature infants.

allows us to learn more about

Wearing only a diaper, the infant is

mechanisms of growth in the early

“Kangaroo Care” may help
infants born prematurely
Premature infants may get a boost if

placed on a parent’s chest and

neonatal period, and it gives parents

remains in that position for up to

an opportunity to provide direct

several hours per day.

care for their infants and increase

“We are comparing it to our

their parents spend an extended

standard parent-infant interaction to

period each day holding them close.

see if some of the same developmen¬

feelings of competence.”
Other researchers include Mario
Rojas, M.D., a neonatology fellow,

To explore this idea, health profes¬

tal complications that occur in

and Linda C. Mayes, M.D., the

sionals in pediatric neonatology at

preterm babies can be decreased

Arnold Gesell Associate Professor of

the School of Medicine and Yale-

through a few hours of skin-to-skin

Child Psychiatry, Pediatrics and

New Haven Children’s Hospital,

contact each day,” says Richard A.

Psychology.

Asthma research expands at Yale

‘orchestra leaders’ of the inflamma¬
tory response in the airways of
people with asthma.
“Thirdly, intense studies will be
undertaken of a particular type of

sthma is so common now

team of Yale physicians in internal

occupational asthma seen in

medicine, pulmonary medicine,

patients who are exposed to

care issue,” says Jack A. Elias, M.D.,

critical care medicine, and occupa¬

chemicals frequently found in

director of the new Specialized

tional and environmental medicine.

plastics and spray paint. A subset of

Center of Research to understand

They join scientists from the section

people are sensitive to and experi¬

the causes of asthma. “In the last

of immunobiology, the departments

ence asthma attacks when they

15 years, asthma has become an

of pathology, laboratory medicine

come in contact with these chemi¬

increasingly severe health problem,

and comparative medicine, and the

cals. A particularly high frequency of

even reaching epidemic proportions.”

John B. Pierce Laboratory to con¬

this type of asthma has been noted

duct studies designed to under¬

in sick patients who are auto-body

and adults in the United States

stand the inflammation in airways of

workers in Connecticut.

suffer from asthma, and its fre¬

patients with asthma.

that it has become a major health

Approximately 15 million children

quency appears to be particularly

The research’s major focus

“We hope that these molecular
studies will lead to an improved

prominent in inner-city areas. Since

deals with the cellular and molecu¬

understanding of the basic science

the early 1980s, national statistics

lar biology of asthma. “Our research

of asthma and to the development

show that the prevalence of and

centers on three main themes,” Dr.

of improved treatments for it,” Dr.

death rates due to asthma have

Elias notes. “The first is the study of

Elias says. “The ultimate goal of all

increased by approximately 40

cytokines, small proteins that cells

of the studies will be to generate

percent.

make to communicate with one

the type of knowledge upon which

another. Secondly, we are exploring

new treatments for asthma can
be based.”

Dr. Elias, professor of medicine
and chief of pulmonary and critical

certain kinds of cells, called T

care medicine at the School of

lymphocytes, which are small cells

Medicine, heads a multidisciplinary

that are considered to be the
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Public lectures examine
21st-century germs

dean for postgraduate and continu¬

Last Breath; Robert W. Ryder, M.D.,

ing medical education. “Our global

John Rodman Paul Professor of

society faces new vulnerabilities due

Epidemiology and Medicine,

Exotic-sounding microorganisms

to these microorganisms, some of

Emerging Hemorrhagic Fevers: The

like hanta and ebola viruses, mad

which are resistant to medication,

Crimson Tide; Frank J. Bia, M.D.,

cow disease and hemorrhagic

suppress the human immune

professor of medicine and laboratory

fevers have commanded attention

system, and can pose threats of

medicine, Parasites for the 21st

in newspapers, novels and films.

epidemic proportion.” Educational

Century; Howard Levitin, M.D.,

This spring, Yale medical faculty

support for the Pathogens 2000 series

professor of medicine, Chronic

presented medical perspectives on

was provided by The Patrick and

Fatigue Syndrome: Still the Enigma;

these global-village germs in an

Catherine Weldon Donaghue

Robert T. Schoen, M.D., associate

eight-evening lecture series, titled

Medical Research Foundation, based

clinical professor of medicine, Tick-

Pathogens 2000: Rising Tides of

in Hartford, Conn.

Virulent Diseases, to more than
100 individuals.

Speakers and topics included
Jose R. Santana, M.D., internal

Borne Diseases: Present Siege; Michael
O. Rigsby, M.D., assistant professor
of medicine, The New Threat of

medicine resident physician, Diseases

Tuberculosis: Biological and Social

today and tomorrow present

of Travelers: Unexplained Pulmonary

Modifiers; and John Booss, M.D.,

problems that are just as complex as

Hemorrhage in Nicaragua; Lynn

associate professor of neurology and

“The pathogens or germs of

those of previous centuries,” said

Tanoue, M.D., assistant professor of

laboratory medicine, The Vulnerable

James D. Kenney, M.D., associate

medicine, Viral Pneumonias: Your

Brain: Prions and AIDS.

Institute, a component of the

in the United States for a research

► Molecular Analysis of IL-5
Gene Transcription. Anuradha Ray
Ph.D., assistant professor of
medicine (pulmonary). Dr. Ray's

center and awarded $8.6 million to

study is focusing on a cytokine

► Cytokines and Adhesion
Molecules in Hapten-Induced
Airways Hyperresponsiveness.
Gregory P. Geba, M.D., assistant
professor of medicine (pulmonary).

the school over the next five years.

called interleukin-5 (IL-5) that plays

This study is concentrating on the

an important role in asthma.

development of a new model of

National Institutes of Health,
selected Yale as one of seven sites

The Yale Asthma Research
Program encompasses six major

Interleukin-5 recruits a particular

asthma in laboratory mice, based

projects, with these leaders:

type of white blood cells, called

on generating a delayed form of

► Interleukin-11 in Viral
Asthma. Dr. Elias. These studies

eosinophils, to the lungs of people

airway inflammation. Dr. Geba and

with asthma. These cells are

his colleagues will be determining

investigate the role that the

believed to be responsible for many

what triggers the inflammatory

cytokine interleukin-11 plays in viral

of the manifestations of asthma.

response and what turns it off.
In addition, they will explore the

infections and the mechanism by

Her studies are designed to deter¬

which viral infections lead to

mine what processes regulate the

mechanisms by which inflammatory

asthma attacks.

production of interleukin-5.

cells enter the airways of these

► Regulation of Th2 Effector
Function in the Airways. Kim
Bottomly, Ph.D., professor of
immunobiology and biology and
associate investigator at the Howard
Hughes Medical Institute. These

► Transgenic Modeling of
Airway Inflammation in Asthma.
Dr. Elias. This study is centering on

animals.

planted into laboratory mice. These

► T Cells in the Pathogenesis
of Human Isocyanate Asthma.
Carrie A. Redlich, M.D., associate
professor of medicine (occupational
and environmental medicine). This

studies will allow Dr. Elias and his

research is designed to study the

that regulate the generation and

colleagues to determine which

mechanisms of inflammation in the

function of a specific lymphocyte

genes are likely to generate asthma¬

airways of adults exposed to

population, known as Th2 lympho¬

like features, such as inflammation,

chemicals used in the auto-body

cytes, and the role that they play in

wheezing and mucous production,

industry in Connecticut.

mediating asthma.

that people with asthma experience.

studies investigate the processes
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the use of transgenic technology, in
which human genes can be im¬

—Helaine Patterson
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Two days, two surgeons general
The two physicians to hold the post of U.S. Surgeon General most
recently visited the School of Medicine this winter, drawing
standing-room-only crowds of students, faculty and administrators
at their respective presentations on two consecutive days. These
high-profile, outspoken individuals continue to command the
attention of both the public and the Yale medical community.
Joycelyn Elders, M.D., who stepped down as surgeon general in
1994, addressed the topic Medical Education and Personal
Responsibilities. She frankly told the hundreds gathered in Sterling
Hall’s Mary S. Harkness Auditorium, “We’ve got the best doctors
and the best nurses. We all know we have those things. But we do
not have the best health. Health is more than the absence of
disease.” The previous day, at Yale’s Medical School Council,
C. Everett Koop, M.D., Sc.D., who frequently speaks out on contem¬
porary health issues, described the educational program of the
Koop Institute, based at Dartmouth. This summer, Dr. Koop adds
yet another position to his active schedule when he becomes
visiting professor of public
health (health policy) in the
Department of Epidemiol¬
ogy and Public Health
at Yale.

mrmn
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A new vision for ophthalmology
Bruce Shields becomes chairman and first Sears professor

T

he new chair of the

Durham, N.C., Veterans Affairs

Department of Ophthal¬

Medical Center, and as a consultant

mology and Visual Science,

at the Veterans Affairs Medical

M. Bruce Shields, M.D., credits his

Center at Asheville. He trained at

early interest in the field to two

Duke, completing his residency

uncles who were ophthalmologists.

there in 1974.

He was attracted, he says, “because

Dr. Shields, who succeeds Dr.

ophthalmology combines medical

Sears as chairman, plans to build

and surgical aspects, and also deals

on the strengths of the department

with a wide range of patients, from

that Dr. Sears created in 1971 and

children to the elderly.

led until 1993. During his chairman¬

“As a physician,” he says, “you
can establish long-term relationships

ship, the Yale Eye Center opened at
330 Cedar St. Here, the Boardman

with patients, just as family physi¬

Building houses clinical services,

cians do, getting to know them

and the Brady Laboratory and

and helping them deal with their

Brady/Boardman connector

visual conditions.”

provide adjoining space for basic

This spring, the Yale Corpora¬
tion voted Dr. Shields to become
the first recipient of the Marvin L.

M. Bruce Shields, M.D.

science vision research and visual
neurobiology.
Dr. Sears, now in his 36th year

degree in 1966 from Oklahoma

Sears Professorship. Drs. Shields

at Yale, continues to teach clinical

University School of Medicine. He

and Sears, both internationally

medicine to resident physicians and

took a one-year rotating internship

known leaders in ophthalmology,

basic research to postdoctoral

at the U.S. Naval Hospital in

share a strong professional interest

fellows, treat patients, and direct his

Philadelphia and served three years
in the U.S. Navy, being discharged

in the multifaceted problem of

own research laboratory studies. His

glaucoma, a condition in which

work in adrenergic pharmacology

in 1970 as a lieutenant commander.

individuals lose their vision because

resulted in the development and

He completed his residency in

of abnormally high pressure in the

approval of timolol, which has

ophthalmology at Duke University

eye. There are more than ioo types

become the mainstay for the

and a fellowship in glaucoma at the

of glaucoma, and approximately i to

medical therapy of glaucoma.

Massachusetts Eye and Ear Infir¬

2 percent of the population suffer

Foundations, professional colleagues

mary in Boston.

from it.

and grateful patients contributed

Dr. Shields, who also is chief of
ophthalmology at Yale-New Haven
Hospital, joined the medical faculty

funds toward establishing the Sears
professorship.
Dr. Shields, a native of

in November after serving 22 years

Okmulgee, Okla., received a B.S.

as a faculty member at Duke

degree in 1962 from Phillips Univer¬

University, as staff surgeon at the

sity in Enid, Okla., and an M.D.
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During his career, Dr. Shields
has centered his clinical practice,
research and teaching on glaucoma
and directed Duke’s glaucoma
service. In recent years, he has been

Continued on page 50
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Orthopaedics chair
follows mentor as the first
Southwick professor

department of orthopaedics and
rehabilitation when it was estab¬
lished in 1986. He has been director
of orthopaedic research at the
medical school since 1981 and has
directed the orthopaedic oncology
and transplantation immunobiology

Gary E. Friedlaender, M.D., chair

research laboratory since 1976.

of the Department of Orthopaedics

Dr. Friedlaender serves as a

and Rehabilitation, has been

surgical consultant at several area

named the first Wayne O.

hospitals and an adviser to many

Southwick Professor of Ortho¬

national and international organiza¬

paedics and Rehabilitation, an

tions. Last year, he received a

endowed professorship established

Distinguished Service Award from

last year in honor of one of his

the American Association of Tissue

mentors.

Banks. He has been awarded fellow¬

The Wayne O. Southwick

ships and grants from the National

Professorship, the first endowed

Cancer Institute and the Ortho¬

chair in the department of ortho¬

paedic Research and Education

paedics and rehabilitation, was

Foundation, among others.

established through contributions
from Dr. Southwick’s former
trainees, colleagues, friends and

and bone allografts, and coedited

patients. Dr. Southwick, who

three textbooks on these subjects.

became chief of orthopaedic surgery

A 1969 graduate of the Univer¬

at Yale in 1958, was named professor

sity of Michigan School of Medi¬

emeritus of orthopaedics and

cine, Dr. Friedlaender completed his

rehabilitation in 1993.

internship and assistant surgical

Dr. Friedlaender, who also is

resident training at the University of

chief of orthopaedics and rehabilita¬

Michigan Medical Center. He first

tion at Yale-New Haven Hospital

came to Yale in 1972 as a National

(YNHH), specializes in oncology

Institutes of Health postdoctoral

reconstruction. He and his Yale

research fellow in orthopaedic

colleagues pioneered a bone trans¬

surgery, oncology and immunology.

plant procedure that has helped

After completing his orthopaedic

spare the limbs of hundreds of

residency training at Newington

individuals who have had cancer,

Children’s Hospital and YNHH in

other diseases or injuries. An expert

1974, he became director of the

on the influence of chemotherapy

Naval Medical Research Institute’s

and radiation therapy on intact

Tissue Bank Division, a post he

bone, fracture repair and bone

held until 1976.

grafts, immune responses to bone

Surgeon Barbara Kinder
appointed to Carmalt chair

Dr. Friedlaender became an

transplants, and the safe and

instructor in surgery (orthopaedics)

Barbara Kinder, M.D. ’71, HS ’71-

efficient banking of bone for

in 1974 and was promoted to

76, a specialist in endocrine surgery

transplantation, Dr. Friedlaender

assistant professor in 1976, associate

and chief of surgery at the West

founded the Yale Bone Bank and

professor in 1979 and professor of

Haven campus of the VA Connecti¬

served as its first director from 1979

surgery in 1984. He became profes¬

cut Healthcare System, has been

to 1988. He has written extensively

sor of orthopaedics and rehabilita¬

named the William H. Carmalt

on tissue banking, fracture healing

tion and the first chair of the

Professor of Surgery.
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Dr. Kinder, who has spent her

The Carmalt chair previously

research fellow in 1990 after com¬

entire career at Yale, completed her

was held by Dr. Kinder’s late

pleting his general psychiatry

internship and residency training in

husband, C. Elton Cahow, M.D.,

residency training at Massachusetts

surgery at Yale-New Haven Hospital

who died Jan. 2.

General Hospital. From 1992 to

and also was a postdoctoral fellow in

1994, he continued work at the

pharmacology. She became an

Child Study Center on a child

instructor in surgery at the medical

psychiatry clinical fellowship. He

school in 1976, was promoted to

was named director of neuroimaging

assistant professor a year later, and

at the center in 1993 and became

became professor of surgery in 1990.

an assistant professor of child
psychiatry there a year later, when

She served as chief of surgery
for Yale University Health Services

he was also named director of

from 1985 to 1989 and chief of the

clinical research.
Dr. Peterson has authored or

division of endocrine surgery in the
medical school’s Department of

co-authored more than two dozen

Surgery from 1987 to 1992. She has

articles for medical journals, many

been chief of surgery at the VA

of which deal with the pathogenesis

since 1989.

and treatment of Tourette’s syn¬
drome. He also has written chapters

Dr. Kinder has authored or co¬
authored numerous articles pub¬

in a number of books, including

lished in medical and scientific

Advances in Neurology, the second

journals on topics both in her field

edition of the Handbook of Child
and Adolescent Psychiatry (in press)

(such as hyperparathyroidism and
thyroid cancer) and about her field
(such as the differences that male
and female surgeons experience

Psychiatrist Bradley
Peterson holds MeersJameson chair

and Treatment Resistant ObsessiveCompulsive Disorder (also in press).
He authored a chapter for Child
Psychiatry Clinics of North America:

during their careers). When she was
appointed to her VA post, she was

Bradley S. Peterson, M.D., director

Neuroimaging (in press), which he

one of fewer than a dozen female

of neuroimaging and of clinical

also edited.

chiefs of surgery at VA hospitals

research at the Child Study Center,

nationwide.

has been named the Elizabeth Meers

Peterson has received numerous

and House Jameson Assistant

awards for his research. These

Dr. Kinder is a founding
member of both the American and
International Associations of

Professor in Child Psychiatry.
Dr. Peterson has focused his

Since coming to Yale, Dr.

include two Eli Lilly Pilot Research
Awards from the American Academy

Endocrine Surgeons. She also is a

research on the neuroimaging of

of Child and Adolescent Psychiatry,

member of the New England

developmental neuropsychiatric

the Dean’s Young Faculty Award

Surgical Society, Eastern Surgical

disorders, the role of risk and

from the School of Medicine, and

Society, The Endocrine Society,

protective factors in developmental

Independent Investigator awards

Connecticut Society of American

psychopathologies, and the neurobi¬

from the March of Dimes Birth

Board Surgeons, New England

ology and treatment of Tourette’s

Defects Foundation, the Tourette

Cancer Society and the Association

syndrome and obsessive-compulsive

Syndrome Association, the Dana

of VA Surgeons, among others. She

disorder. In addition, he is interested

Foundation and Janssen

is a fellow of the American College

in exploring the psychoanalytic

Pharmaceutica. In addition, he has

of Surgeons; her other honors

perspectives of these disorders.

been presented a Young Investigator

include the Leah Lowenstein Award

A 1987 graduate of the Univer¬

Award from the National Associa¬

sity of Wisconsin Medical School,

tion for Research on Schizophrenia

and the Association of Women

Dr. Peterson came to the Child

and Depression and a Career

Surgeons’ Distinguished Members

Study Center as a National Institute

Development Award from the

Award in 1996.

of Mental Health postdoctoral

National Institutes of Health.

for medical student teaching in 1987
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At Dartmouth, a preview of historic things to come

developing glaucoma treatments
Ethical and Social Issues Arising

involving the application of laser

Dartmouth has called upon a Yale

technology in which he concen¬

medical professor and two luminar¬

Out of Advances in the Biomedical

trates on treating the most advanced

ies from Yale’s alumni body for a

Sciences, will take place Sept. 5 to 7

types of glaucoma.

three-day international symposium

in Hanover, N.H. Half-day sessions

this fall to celebrate Dartmouth

will focus on genetics, neuroscience,

Medical School’s bicentennial.

health care and world population.

A prolific author, Dr. Shields
has written more than 25 chapters
and 130 scientific journal articles.

Pasko T. Rakic, M.D., Sc.D.,

Dr. Rakic is chair of the session on

However, his best-known work is

chair of Yale’s Section of Neurobiol¬

neuroscience and will deliver an

the Textbook of Glaucoma, now in its

ogy and the Dorys McConnell

address titled The Importance of

fourth U.S. edition. It also has been

Duberg Professor of Neuroscience;

Being Well Placed and Havitig the

translated into German, Japanese,

Francis S. Collins, Ph.D., who

Right Connections. Dr. Collins will

Portuguese and Spanish.

earned his doctorate in physical

be one of several people delivering

chemistry at Yale, was a fellow in

addresses in the genetics session.

the American Glaucoma Society, a

genetics and pediatrics at the

And Dr. Callahan is among half a

director of the American Board of

medical school, and now heads the

Dr. Shields serves as president of

HOOD MUSEUM OF ART. DARTMOUTH COLLEGE; GIFT OF EDMUND RANDOLF PEASLEE, CLASS OF 1836

National Human Genome Research
Institute; and Daniel J. Callahan,

Dr. Shields plans to

Ph.D., who earned his B.A. degree
from Yale and is a noted medical

place a major

ethicist and director of the Hastings
Institute, will be among more than

emphasis on the

two dozen major figures from
science, medicine, ethics, and

educational programs

related fields taking part in the
Dartmouth symposium.

at Yale for both

Dartmouth Medical School’s
founder, Dr. Nathan Smith, left

students and

Hanover, N.H., in 1813 to become
one of the founding faculty mem¬

physicians-in-

bers of the Yale School of Medicine.

training.

community of that day is captured

Dr. Smith’s standing in the medical
in the statement of a member of the

«

f
m

Nathan Smith, by Ulysses Dow Tenney.

Yale faculty who said Dr. Smith “was
Ophthalmology, and a member of

more extensively known than any

the program committees for the

other medical man in New England,

dozen individuals representing

American Academy of Ophthalmol¬

or indeed than any man in any

different perspectives on the health

ogy and the Association for Research

profession.” That was high praise

care community who will participate

in Vision and Ophthalmology.

indeed for the son of a farmer who

in a panel discussion on the ration¬

had till that point spent his entire

ing of health care.

In the years ahead, Dr. Shields,
who considers himself first and

career in rural northern New

foremost to be an educator, plans to

England. Dr. Smith actually had a

admission charge for attendance at

place a major emphasis on the

hand in the founding of no less than

the symposium, and it has been

educational programs at Yale for

four New England medical schools,

certified for AMA Category I CME

both students and physicians-in-

later being active in the establish¬

credit. Those wishing more informa¬

training, and to provide quality

ment of medical schools at Bowdoin

tion about the full program for

continuing medical education for

and the University of Vermont.

community ophthalmologists.

—Helaine Patterson
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The Dartmouth symposium,

There is no registration or

Dartmouth’s Bicentennial Sympo¬
sium may call the Dartmouth

Great Issues for Medicine in the 21st

Medical School Bicentennial Office

Century: A Consideration of the

at (603) 650-4037.
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He saved the day; now he’s a knight
Yale physiologist Boulpaep honored by King of Belgium

I

_

n Belgium, a knight is correctly

% Wr,

called chevalier in French, or

__

A-i

ridder in Dutch. So might
people address Emile L. Boulpaep,
M.D., as Chevalier Boulpaep?

Belgium, where America still reaps

“In principle, yes, but I hope

the good will sown by the post-war

they don’t,” says Dr. Boulpaep.

relief effort.

A genial professor of cellular and

Dr. Boulpaep first came to the

molecular physiology at the School

United States in 1964 on a Belgian

of Medicine, he was knighted last

American Education Foundation

summer by King Albert II of Bel¬

fellowship. When the foundation

gium, who customarily grants

faced financial problems a few years

titles of nobility. Last year, the

later, he led efforts to revamp its

King honored only n individuals

organization and add to its assets.

with titles.

He has been involved ever since,

The title of knight honors

taking on tasks from interviewing

Dr. Boulpaep for his work with the
Belgian American Educational
Foundation Inc., which has pro¬

prospective fellows to serving—
Emile L. Boulepaep, M.D., and his
salamander-adorned coat of arms.

vided nearly 3,000 graduate and

since 1976—as president. “I wanted
to save this foundation,” he says.
In 20 years as the foundation’s

postdoctoral fellowships for Bel¬

to aid a hungry nation deprived of

president, he has increased its

gians and Americans. The Belgian

food during the German occupa¬

assets tenfold.

title—rarely given to anyone outside

tion. After the 1918 Armistice, the

Belgium—also presents him with a

commission’s remaining funds were

understanding” that the foundation

challenge rarely faced by anyone in

used to rebuild Belgian universities

has fostered between Belgium and

the United Sates: the need to come

and to launch the fellowship

the United States, and of the many

up with a coat of arms and a motto.

program. “The foundation is the

fellows who have become leaders in

daughter of the C.R.B.,” says Dr.

science, business and other fields.

the Commission for Relief in

Boulpaep. Although he’s been a

Four fellows went on to become

Belgium (C.R.B.), organized by

resident of the United States for 30

prime ministers of Belgium; two

Herbert Hoover during World War I

years, he remains a citizen of

have won Nobel prizes.

AAAS members honored
for contributions
to science

February during the AAAS

M.D., professor of medicine and

Annual Meeting in Seattle: Emile L.

epidemiology (microbiology);

Boulpaep, M.D., professor of

Michael Kashgarian, M.D.,

cellular and molecular physiology;

professor of pathology and

The foundation is a successor to

Dr. Boulpaep talks of the “good

►

The American Association for the

Edwin C. Cadman, M.D.,

biology; Robert J. Levine, M.D.,

Advancement of Science (AAAS)

professor of medicine and senior

professor of medicine and chairman

elected 283 members as fellows.

vice president of medical affairs

of the Human Investigation

The following individuals from the

and chief of staff at Yale-New

Committee; and Vincent T.

School of Medicine were recognized

Haven Hospital; Peter Jatlow, M.D.,

Marchesi, M.D., the Anthony N.

for their contributions to medical

professor of laboratory medicine

Brady professor of pathology, cell

science at the Fellows Forum in

and psychiatry; Keith A. Joiner,

biology and biology.
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January at the National Institutes of

Since his knighthood was

Health. His topic was Cell Biology of

announced by royal decree on

Myron Genel, M.D., prolessor ol

Belgian Independence Day, July 21,

Antigen Presentation: MHC Class II

pediatrics and associate dean for

Transport, Dendritic Cell Develop¬

1996, Dr. Boulpaep has been busy as

government and community affairs,

ment, and Other Strange Tales.

usual, directing medical studies in his

was one of the speakers at the

department, co-editing a new

American Medical Association’s 1997

Marvin Moser, M.D., clinical

physiology textbook, and conduct¬

National Leadership Conlerence in

professor of medicine, is the keynote

ing kidney research. In November he

Philadelphia in March. Dr. Genel’s

speaker at a 10-month series of

traveled to Belgium to meet with the

topic was The Role of the American

hypertension symposia, which began

Council of the Nobility, a group that

Medical Association in Support of

in February. The symposia are

has helped him create his motto and

Clinical Research.

sponsored by the National Heart

coat ol arms. The motto can be in

Lung & Blood Institute and are

French, Dutch or Latin; he’s chosen

Robert J. Levine, M.D., professor

being held in cities throughout the

Latin (which he studied in school).

ol medicine and chairman of the

United States, including Boston,

His motto is Educatio Iungit Popidos,

Human Investigation Committee,

Chicago, Los Angeles, Houston,

which translates as education unites

led a delegation

Indianapolis, Seattle and Miami.

people. “The foundation is a link

of the Citizen

Dr. Moser has been the senior

between two countries.

Ambassador

medical consultant for the past

Program on

23 years.

His coat of arms incorporates the
themes of education and medicine,

Medical Ethics

with three rings in the center repre¬

on a 15-day visit

Howard A. Pearson, M.D.,

senting the three roles of a university:

to the Czech

professor of pediatrics, received

teaching, research and service.

Republic,

the distinguished career award last

Poland and

fall from the American Society of

salamander—functionally, to

Hungary in

Pediatric Hematology/Oncology.

represent his research in physiology

September. This

The award is given in recognition

(“I’m known as the guy who uses

predominately American group of

of outstanding service and signifi¬

salamanders as a model to work with

physicians and other health profes¬

cant scientific contributions to

and to study renal/kidney function.”)

sionals, lawyers and clergy met with

the understanding and treatment

“Symbolically, the salamander in

their Central European counterparts

of blood diseases and cancer

Europe is the symbol ol fire,” Dr.

to exchange information and

in children.

Boulpaep explains. “It is thought that

perspectives.

His coat of arms also includes a

the salamander can separate good fire

Wilfred Reguero, M.D., clinical

from bad fire, and this animal is

Theodore Lidz, M.D., Sterling

professor of obstetrics and gynecol¬

associated with distinguishing good

Professor Emeritus of Psychiatry,

ogy, was recipient of the first

from bad—just as is done in the

received the 1997 Distinguished

Wyeth-Ayerst Hera Gold Award

interpretation of scientific data and

Service Award Irom the American

for Improvement in Women’s and

in the evaluation of students.”

College of Psychiatrists in March.

Children’s Health Outcomes. The

In accepting the award, Dr. Lidz

presentation was made during the

symbolic, too. His coat of arms’

said that he viewed his selection as

Zitter Group’s 1996 Congress on

background is blue for Yale. The

“an affirmation ol the importance

Health Outcomes and Accountabil¬

council artists have created some¬

of psychotherapy and sociotherapy,

ity in November in San Francisco.

thing that “looks like a coat of arms,

and particularly the critical role ol

Dr. Reguero, who is chairman of

not like objects placed together

the family in understanding and

the Department of Obstetrics and

In heraldry, the background is

surrealistically.”

treating patients,” especially those

Gynecology at the Hospital of

with schizophrenic disorders.

Saint Raphael, was honored for the

arms this summer, is pleased with the

Ira S. Mellman, Ph.D. ’78, profes¬

Mobile Clinic.

way that his Yale colleagues address

sor of cell biology and director of

him. “They still call me Emile,”

the Biological and Biomedical

he says.

Sciences Program, lectured in

Meanwhile, Chevalier Boulpaep,

Project MotherCare Neighborhood

who anticipates receiving his coat of

52.
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‘Physician: Impossible’
With stage talent to rival their MCAT scores, the second-year class proves that nearly
anything can he accomplished. Only dont give up that career in medicine just yet.
Photographs by Peter Casolino

I

t has become as predictable a
part of second year as the
national board exams in June

and premonitions of life on the
wards. For medical students, the
second-year show is the exhilarating
product of time and effort that
culminates in two rollicking perfor¬
mances each spring semester.
For faculty and administrators,
the experience is even more hairraising, since it is tradition to
lampoon the most familiar and
respected figures on campus. For
the audience (even for those who
miss half the inside jokes) the
second-year show is unfailingly
entertaining.
This year’s offering by the Class
of 1999, Physician: Impossible, took
the shape of an episode of the tele¬
vision series Nova documenting
the making of a physician. Kerri
Cavanaugh, playing the part of the
filmmaker, led viewers through the
admissions process, first-year classes,
anatomy, Dr. Emile Boulpaep’s
shower, Match Day and a 12-step
meeting of Academicians Anony¬
mous. And as now seems obligatory,
they satirized one faculty member in
particular with the following (to the
tune of Rogers and Harnrnersteins

The cast prays in supplication, with a nod to The Sound of Music, while singing

How Do You Solve a Problem Like

How Do You Solve a Problem Like Frank Bia?
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Maria? From the musical
The Sound of Music):
...He tells jokes that we all like
And he seems to like the mike
He could keep us all in lecture for a year.
Cause his slides are nice and gory,
And we know his whole life story:
He’s from Cornell,
He did real well,
Now he’s here.
(refrain)
How do you solve a problem like Frank Bia
Dr. Bia, a much-beloved teacher with a
reputation for being a ham, then hopped up
on stage and tap-danced.

Cast members occupy a backstage corner of Harkness Auditorium before the
premiere of Physician: Impossible in February. Clockwise from rear: Geoff
Emerson, Michelle Sanders, Richard Torres, Alison Days, Gilbert Ortega
and Danica Barron.

In a skit titled My Fair Angela, Shahram
Salami counsels Jessica Harberer (as legal eagle
and pronounced Southerner Angela Holder) on
how to speak proper English.

Josh Broder, left, and choreographer Sherri Sandifer in the opening

Matt Cooperberg, left, co-producer Jose Prince, right,

number, (Never Seen a) Place Like Yale, sung to the tune of a song
from the musical Aladdin.

and fellow cast members look for their places during
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the final rehearsal.
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Cynthia A. Brandt, M.D., M.P.H.,
fellow in medical informatics,
received the Best Traditional Poster
Award from the American Medical
Informatics Association (AMIA).
The award and a check for $250
were presented at the 1996 AMIA
Annual Fall Symposium in Wash¬
ington. Dr. Brandt’s poster was
Visualizing Immunization Logic in a
Rule-Based Expert System.

Camille Hylton, right front, and the chorus launch into the dance number,
Miss Histology (to the tune of the Miss America Pageant theme).

“Hello
Harkness, my
old friend, ”
sings David
Gershfield (as
Art Garfunkle),
accompanied by
Richard Torres
(as Paul Simon)
in The Sounds
of Sirens.

Ruth A. Potee, Class of 1998, has
been awarded the 1996 Family
Medicine Interest Group (FMIG)
Leadership Award by the American
Academy of Family Physicians
during its annual National Congress
of Family Practice Residents and
National Congress of Student
Members meeting held in Kansas
City, Mo., in August 1996. The
award recognizes medical students
for their outstanding leadership
abilities and invaluable contribu¬
tions to their local FMIG.

Becoming Gay: The Journey
to Self Acceptance, by
Richard A. Isay, M.D. ’61, FIS
'62-65, Pantheon Books
(New York) 1997.
But the real show-stopper,
according to co-producer Jose
Prince, was the surprise appearance
Saturday evening by Deans Gerard
N. Burrow and Robert Gifford, who
played themselves in one of the
show’s three twist endings. In this
version, the school is revealed to be
a front for the federal witness pro¬
tection program, run locally by the

YALE
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two deans. Their scene ends with
the two of them sunning themselves
on a beach, waxing nostalgic about
good old New Haven.
“We sure had it great,” mused
Dr. Gifford. “Yes,” Dr. Burrow
replied, “but after an appearance in
the second-year show, I just had to
call it quits.”
—Michael Fitzsousa

Waiting for a Miracle: Schools Are Not
the Problem, by James P. Comer, M.D.,
HS ’64-67, Maurice Falk Professor in
the Child Study Center and Psychiatry,
Dutton (New York) Fall 1997
The Cancer Chemotherapy Hand¬
book, Fifth Edition, by David S.
Fischer, M.D., clinical professor of
medicine, Mosby (St. Louis, Mo.) 1997.
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Yale student edits
national newsletter
Medical students are primary readers
of paper or electronic versions of IMpact

^A^hat can happen when medical
students try to organize a commu¬
nity gun-exchange program? When
employers have access to employ¬
ees’ computerized medical records?

As editor of IMpact, Yale medical student Nirav Shah entices readers

When an experienced physician is

with an electronic version of the newsletter on the Internet.

called to a scene that, as he puts it,
“could weaken you at the knees”?
Nirav R. Shah, who this fall will
begin his fourth year as a Yale
medical student, hopes that his

Yale—that are linked to the informa¬

on how Yale was revamping curricu¬

tion superhighway.

lum in the first two years. In the

“Medicine itself is moving

issue on computers, his Editor's

fellow students around the country

toward more dissemination of

Letter noted that computerized

will consider these matters—and

information online,” he notes, adding

patient records could be misused,

read about them in IMpact, the

that the American College of

but he stressed that good medical

Internal Medicine Newsletter for
Medical Students, established in

Physicians (ACP), which sponsors

care requires good information and
called for measures (like better

1994 to show medical students

IMpact, was moving parts of the
Annals of Internal Medicine onto the

that internal medicine is an exciting

World Wide Web when he proposed

and meaningful career.

the electronic version.

IMpact, a quarterly newsletter,

Each issue of IMpact has a

software) to protect confidentiality.
The activism issue included
one student’s report on a successful
program to feed the hungry and

covers all kinds of issues related to

theme, such as innovations in

another's wry account of an ardu¬

"internal medicine and medicine in

medical education, computers in

ous—and unsuccessful—effort to run

general,” says Mr. Shah, who

medicine, or student activism.

a community gun-exchange program

became editor about two years ago.

Generally, each includes feature

as part of local crime prevention

IMpact was then fairly new, and he

articles, Questions and Answers,

efforts. A recent humanities piece

set out to increase circulation by

focused on a story about a doctor

consistently offering interesting,

Significant Figures (statistics) and
Humanities. (Mr. Shah says, “It’s too

relevant and accessible material.

easy to forget the humanistic side

who had just committed murder.

He soon added an electronic

when you’re studying science at

who received a call from a patient
Mr. Shah, whose parents are

edition to the regular eight-page

3 a.m.”) He also writes an Editor’s

from Bombay, grew up near Buffalo,

printed one. He put the printed

Letter on the theme of each issue.

N.Y. He plans a career of research

version of IMpact on the Internet,

“I try to do ‘pro-and-con,’ then say,

and practice in internal medicine.

he says, because online reading is

This is what I think’,” he says.

He’s pleased that IMpact’s print

convenient—indeed, downright

“Editors have to take a stand.”

circulation is now more than 10,000

natural—for today’s medical stu¬

He includes material from Yale

per issue, that 200 users accessed

dents. (The Internet address is:

medical faculty and especially

the electronic table of contents in

http://www.acponline.org/journals/

students, as well as from the ACP.

one recent month, and that so far

impact/impmenu.htm). He points

“I get submissions from medical

more than 250 medical students

out that many have used computers

students from all around the world

have joined the American College of

since they were youngsters, and

via e-mail,” he says.

Physicians as a result of the

they’re familiar with facilities—like
his own Harkness dormitory at
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Mr. Shah’s first issue featured a
fourth-year medical student’s report

electronic edition’s offer of free
membership.
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“Lift Every Voice”
Photographs by Michael Marsland

Actor, playwright and civil rights
activist Ossie Davis, right,
spoke to students and faculty
who filled Mary S. Harkness
Auditorium in recognition of
Martin Luther King Jr. Day in
January. Mr. Davis, author of the
Tony Award-winning play Purlie
Victorious, has appeared in
Raisin in the Sun and I’m Not
Rappaport on Broadway, The
Client and four films by Spike
Lee, including Do the Right
Thing. He spoke about his life
as an actor closely involved in
the civil rights movement in an
address titled Scenes from Our
Story: We Are Still Marching,
following a performance by the
Yale undergraduate singing
group Shades, middle right.

Robert H. Gifford, M.D., associate dean for medical
education and student affairs, presents one of 11
Distinguished Community Service Awards during
the observance. Among the recipients were medical
and public health students AJ. Babineau, Kathryn
Cunningham, Alison Days, Benjamin Doolittle,
Dionne Otey, Scott Porter, Neda Sharghi and
Obinwanne Ugwonali.
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Mr. Davis is
greeted by James P.
Comer, M.D.,
M.P.H., a friend of
many years and the
Maurice Falk
Professor of Child
Psychiatry.

Third-year
medical student
Sherri Sandifer
plays and sings
the African
American anthem
Lift Every Voice
to close the
program.
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Marier named dean at LSU

dean and chairman of the
Department oi Public

Robert L. Marier, M.D. ’69,

medical director

Health and Preventive

and chief administrative officer at the Medical Center of

Medicine. Dr. Marier,

Louisiana, has been appointed dean ot Louisiana State

whose undergraduate

University (LSU) School oi Medicine in New Orleans.

degree is from Boston

Dr. Marier, who assumed the deanship last Novem¬

College, earned a master’s

ber after serving for a year as acting dean, graduated

degree in health services

from Yale School ol Medicine in 1969 before taking his

administration from the

residency in internal medicine at Massachusetts General

Tulane School of Public

Hospital. He returned to Yale as a postdoctoral fellow in

Health in 1990.

inlectious disease from 1974 to 1975. He served in the

He was a founding

U.S. Public Health Service as an epidemic intelligence

member of United

officer at the U.S. Centers lor Disease Control before

Services for AIDS in Louisiana and has served on the

joining the Yale faculty as assistant professor of medicine

Governor’s Commission on Telecommunications and the

from 1975 to 1978.
Dr. Marier moved to New Orleans in 1978 to join
the medicine faculty at LSU. He also served as associate

Louisiana Health Care Commission. He and his wife,
Joanne, are the parents ol two daughters, Rebecca
and Alicia.

Beck Institute honors a founder
of cognitive therapy

portrait at the University of

Aaron T. Beck, M.D. ’46, professor emeritus and direc¬

Medicine.

Aaron T. Beck, M. D., in a
Pennsylvania School of

tor ol the Center for Cognitive Therapy at the University
ol Pennsylvania, was honored by the department ol
psychology of Assumption College in Worcester, Mass.,
with the establishment of the Aaron T. Beck Institute for
Cognitive Studies. The Beck Institute will sponsor
education and training projects in cognitive therapeutic
skills for students and postgraduate professionals.
Dr. Beck established an international reputation as
a lounder of cognitive therapy by pioneering the
formulation of cognitive models of various psychiatric

Inventory, Beck Hopelessness Scale, and Beck Suicide

disorders and by developing and testing specific psycho¬

Ideation Scale.

therapeutic applications to the disorders. His research in

Annual conlerences at the new institute will address

psychopathology has identified specific risk factors lor

research and therapeutic developments in cognitive

suicide and specific psychological configurations in

therapy, as well as ethical and moral issues faced by both

depression, anxiety disorders and personality disorders.

therapists and clients. For the community at large, the

Three of the various inventories and questionnaires that

institute will strive to provide information that illumi¬

Dr. Beck developed are among the most widely used in

nates the contributions ol cognitive factors to the

research and clinical practice: the Beck Depression

resolution oi problems in living.
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from Raymond A. Gagliardi, M.D.

40s

’45, HS ’48-51, of Boca Raton, Fla.
“Though retired from practice, I

Earl J. Simburg, M.D., HS 41-43,

continue as historian of the Ameri¬

was appointed to the Mental Health

can Roentgen Ray Society (ARRS).

Advisory Committee of the Hem¬

I have just published, as editor-in-

lock Society in November. He also

chief, the third volume of History of

was awarded a Meritorious Service

the Radiologic Sciences. [Chairman]

Award by the Community of the

Bruce McClennan from Yale was

Alta Bates Medical Center in

editor of the volume of Diagnosis

Berkeley, Calif., at its annual

(the others being Radiation Oncology

meeting in February, and was

and Radiation Physics). Ray orga¬

reappointed to a three-year term on

nized a mini reunion for classmates

the Alta Bates Foundation Board

of 1945 in Orlando on April 6.

of Trustees.

Contribute to the
School of Medicine’s
Future and Invest in
Your Own
Yale University’s life income
program offers graduates of the
School of Medicine the oppor¬
tunity to:
■

O. Roger Hollan, M.D. ’45,
Donald W. Seldin, M.D. 43, HS

HS ’45-46, has been honored by

’43-46, Sc.D.H. ’88, was profiled

the establishment of a professorship

in a recent issue of Science. The

in his name at the University of

article recounts how his efforts in

Texas Health Science Center in

mentoring talented students at the

San Antonio.

■

Receive quarterly
income payments
for life

■

Increase your income
from low-yielding stock with¬

University of Texas Southwestern

out incurring capital gains

Medical School at Dallas, his vision

taxes

of the school as a top research
center, and his commitment to

Help ensure the future
of a great institution

50s

excellence were major factors in
Southwestern’s rise from an obscure,

Leonard S. Krassner, M.S. ’51,

eight-year-old medical school in 1951

M.D., HS ’57-59, recently marked

to the front rank of medical schools

10 years as medical director at

and university research centers. Dr.

Choate Rosemary Hall in

Seldin retired in 1987 after 36 years

Wallingford, Conn. Dr. Krassner

of service and now serves as a part-

continues to serve as president of

time advisor to the school.

Yale Alumni in Pediatrics.

Edith M. Jurka, M.D. 44, was a

Joseph S. Pagano, M.D. ’57, the

featured speaker at the first Interna¬

Lineberger Professor of Cancer

tional Conference on the Psychology

Research and director of the

of Consciousness in April in

Lineberger Comprehensive Cancer

Monterey, Calif. Her talk was titled

Center at the University of North

Brain Determinants of Personality

Carolina (UNC) at Chapel Hill,

Characteristics.

received the 1996 North Carolina

■

Reduce federal and
state taxes

Please call or write to see if you
can use these benefits to the
mutual advantage of you and
the School of Medicine.

Award in Science, the state’s highest

Yale University

Reese A. Matteson, M.D. ’44,

civilian honor. The award was

School of Medicine

reports his impending retirement

presented by Gov. Jim Hunt. Dr.

Office of Planned Giving

from his ENT practice in Danville,

Pagano was cited for his internation¬

RO. Box 2038

Ill. He is enjoying travel, having

ally recognized research into viruses

New Haven, CT 06521-2038

recently returned from Thailand and

and human cancer, for founding the

Nepal. A trip to Poland, Slovakia

UNC cancer center, and for his

and Hungary is in the works.

leadership of cancer initiatives.

Samuel D. Kushlan, M.D. ’35, HS

Donald H. Harter, M.D., HS and

’35-37, passes along this note

postdoctoral fellow ’57-58, is a senior
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scientific officer for the Howard

the University of Colorado School

tional, has traveled during the last

Hughes Medical Institute (HHMI),

of Medicine, was awarded the

five years as a medical missionary to

director of the HHMI’s National

Ludwig Heilmeyer Gold Medal for

Nicaragua, Cuba, Russia, India and

Institutes of Health Research

his contributions to cytokine

China. He also set up programs to

Scholars Program, and clinical

biology in internal medicine. The

provide ongoing care to children

professor of neurology at George

medal, presented at the annual

with disabilities and handicaps in

Washington University School

meeting of the Heilmeyer Society

Mexico and India. Dr. Lerer was one

last November, is the highest award

of the original founders of the Fair

of Medicine.

granted by this organization of

Haven Community Clinic in New

internal medicine professors in

Haven in 1971.

Germany, Austria and Switzerland.

60s

Dr. Dinarello has published more

Frederick L. Greene, M.D., HS

than 400 original research articles

’70-76, professor of surgery at the

on cytokines, particularly on

University of South Carolina School

executive director of the Medical

interleukin-i. He serves on the AIDS

of Medicine, was awarded the 1996

College of Virginia Hospitals for the

Program Advisory Council of the

Distinguished Service Award by the

past ii years, was elected chairman

National Institutes of Health and

Columbia (S.C.) Medical Society

of the board of the University

the Board of Scientific Advisors of

for his introduction of an anti¬

HealthSystem Consortium (UHC),

the National Institute of Allergy and

violence program into that city’s

a national alliance of 77 academic

Infectious Diseases.

school system.

Carl R. Fischer, M.P.H. '68,

health centers. Mr. Fischer has been
an active member of the consortium

John R Docherty, M.D., HS

since its inception, most recently
serving a second term as chair of one

’71-74, professor and administrator

70s

of its governing committees.

at New York Hospital-Cornell
Medical Center, was named chief

Robert J. Lerer, M.D., HS ’70-73,

medical officer and executive vice

Charles A. Dinarello, M.D. 69,

an Ohio pediatrician and board

president of Merit Behavioral Care

HS ’69-75, professor of medicine at

member of Caring Partners Interna¬

Corp. in Park Ridge, N.J., a
managed behavioral health care
organization.

Alumni/ae on campus

Jerry H. Morewitz, M.D., post¬
doctoral fellow ’77-79, director of
geriatric psychiatry at Eastern

Lewis Landsberg, M.D. ’64, HS

on the faculty at Harvard Medical

Virginia Medical School in Norfolk,

’65-70, was guest speaker at

School, becoming professor of

was named chairman of its depart¬

Medical Grand Rounds in Febru¬

medicine there in 1986. His

ment of psychiatry and behavioral

ary. Dr. Landsberg discussed

research has focused on catechola¬

sciences in January. Dr. Morewitz

Obesity-Related Hypertension and

mines and the sympatho-adrenal

had served as interim vice chairman

the Insulin Resistance Syndrome.

system, as well as nutrition, obesity

of the department since 1994.

Informal teaching sessions followed

and hypertension.

with house officers and attending
staff throughout the day.

Dr. Landsberg’s son, Judd W.

Paul E. Collier, M.D. ’79, was a

Landsberg, M.D. ’96, is a resident

speaker at the Society for Clinical

in medicine at the Yale-New Haven

Vascular Surgery in Sewickley, Pa.,

been the Irving S. Cutter Professor

Hospital. [See related alumni/ae

in March. His topics were: How

and chairman of the Department

news item on opposite page.]

Essential Is the Intensive Care Unit

Since 1990, Dr. Landsberg has

of Medicine at Northwestern
University Medical School in
Chicago, where he was director of

—Nicholas P.R. Spinelli, M.D. ’44
Send news of alumni/ae on campus to

after Carotid EndarterectomyI;
Do Clinical Pathways for Major

Dr. Spinelli in care of the Office of Alumni

Vascular Surgery Improve Outcomes

the Center for Endocrinology from

Affairs, P.O. Box 7613, New Haven, CT

and Reduce Costs?; Office Removal

1990 to 1993. From 1972, he served

06519-0613.

of Silastic Catheters and Ports Is
Safe and Cost Effective; and Are

60

SUMMER

1997

Preoperative Antibiotics Administered
Preoperatively?

80s

control in Vietnam in 1993 and
Port-au-Prince, Haiti, in 1994 and
1995. Dr. Jacobs is profiled in Who’s

A Charitable

Who in America, in Medicine, and in

Annuity:

the South and Southwest. He and his

The YSM gift

wife, Carolyn, adopted a daughter,
Jenny, in Hanoi in 1993.

that rates

Eric Holm, P.A.
’80, was elected

Sujai D. Nath, M.D., HS 92-95, in

to the board of

private practice of general neurology,

trustees of the

has joined the medical staff of South

new clinician-led,

Florida Baptist Hospital in Plant City.

multi-specialty

In exchange for a gift of $5,000
or more, the School of Medi¬
cine can offer you. or you and
your spouse, a fixed annual
income for life.

group practice

Joseph Kwangho Choo, M.D. 93,

created by the

married Je Un Kim in December in

reorganization of Harvard Pilgrim

Memorial Church at Harvard

Health Care’s Health Centers

University. Dr. Choo completed his

Division in Metro Boston. Mr.

residency in internal medicine at

Holms is a physician associate in

Brigham and Women's Hospital and

orthopaedics at the Copley and Post

has begun a fellowship at Massachu¬

Office Square Health Centers.

setts General Hospital.

Your age(s) and market
rates of interest determine
your income level.

Current sample rates:
Age(s)

Rate

One life
Marian T. Hannan, M.P.H. ’81, is

Debra Howard, M.D. ’94, and

president-elect of the Association of

Adam Schussheim, M.D., were

Rheumatology Health Professionals,

married in December. Dr. Howard is

a division of the American College

an assistant chief resident in internal

55
66
77

of Rheumatology, and also senior

medicine at New York Hospital-

Two lives

research associate at the Hebrew

Cornell Medical Center, and in July

Rehabilitation Center for the Aged

begins an endocrinology and me¬

in Boston.

tabolism fellowship at Columbia-

66/65
75/74
82/79

5.0%

6.1%
8.3%

5.0%

6.1%
7.3%

Presbyterian Medical Center.
Glenn C. Isaacson, M.D., HS 82-

Please allow us to tailor

83, has been appointed professor and

Andreas Klein, M.D. ’95, and his

chairman of the Department of

wife, Jen, announce the birth of

Otorhinolaryngology at Temple

their son, Aaron Rothwell Cameron

University Health Sciences Center

Klein, on April 1, 1996, in Boston,

in Philadelphia. Dr. Isaacson was

where Dr. Klein is a junior resident

appointed deputy chair of otorhino-

at the New England Medical Center.

a proposal to your
philanthropic
and financial goals.

laryngology/bronchoesophagology
at Temple in 1993, and was named

Judd W. Landsberg, M.D. 96, a

acting chairman of the department

resident in internal medicine at Yale-

in 1995.

New Haven Hospital, was married
last year in Houston to Sarita I.

90s

Ordonez, a recent graduate of New

Yale University

York University School of Taw.

School of Medicine
Office of Planned Giving

Timothy A. Jacobs, Ph.D., M.P.H.
’91, ofTampa, Fla., is a consultant in
international public health and
infectious disease epidemiology. He

P.O. Box 2038
New Haven, CT 06521-2038
1-800-445-6086
Fax: 1-203-432-7901

practiced public health and disease
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OBITUARIES

Anne S. Bittker

Arthur L. Coleman, Jr.

Anne Stern Bittker, 78, a former

Arthur L. Coleman Jr., M.D., of

and Southwestern Connecticut
Rehabilitation Center.
Dr. D’Andrea retired from

Yale Medicine editor and School of

Clean, N.Y., died on Dec. 23. He

practice in 1974, moving to Ver¬

Medicine public relations officer,

was 73.

mont with his daughter and her

died Feb. 2 at Connecticut Hospice
in Branford. She was 78.
Mrs. Bittker received a

Dr. Coleman graduated from

family. He then served as a volun¬

Phillips Academy Andover in 1941,

teer medical missionary with the

Amherst College in 1945 and the

Catholic Medical Mission Board for

bachelor’s degree from Connecticut

Yale School of Medicine in 1948.

10 years, teaching anesthesiology

College and began a career in

He completed his radiology and

and practicing medicine in Papua,

advertising and public relations in

pediatrics internships at Lenox Hill

New Guinea; Guyana; and Colom¬

New York City. She later worked for

Hospital in New York City and his

bia. In 1995 Dr. D’Andrea’s achieve¬

Research Publications Inc. and was

residency at the Mallinckrodt

ments were honored in a video

a public relations officer for the

Institute of Radiology and Barnes

celebrating the 100th anniversary of

New Haven Foundation. The wife

Hospital in St. Louis. He served

Stamford Hospital, with which he

of Boris I. Bittker, Sterling Professor

in the U.S. Army Medical Corps.

was affiliated for 45 years.

Emeritus of Law at Yale, Mrs.

Dr. Coleman was the director of

Bittker joined the news bureau of

radiology in several New York

Yale School of Medicine in 1966.

hospitals, including the French-

From 1968 to 1970, she was associate

Polyclinic and Sisters of Charity.

managing editor of Yale Medicine.

Iza Sznejerson Erlich
Iza Sznejerson Erlich, M.S.W., died
Feb. 9 at Yale-New Haven Hospital.

Frank H. D’Andrea
Howard D. Christiansen

She was 77.
Mrs. Erlich, an assistant clinical

Frank H. D’Andrea, M.D., died

professor of psychiatry in social

Howard D. Christiansen, M.P.H.,

on Nov. 27 in Shoreham, Vt. He

work in the Department of Psychia¬

of Moreland, Idaho, died Dec. 21

was 90.

try, was born in Russia and raised in

of an apparent heart attack. At the

Dr. D’Andrea was accepted into

Poland, immigrating to the U.S. at

time of death, he and his wife,

Yale University at age 16 and

the outbreak of World War II. She

Morita, were serving a mission for

received a bachelor’s degree in 1926

received bachelor’s and master’s

the Church of Jesus Christ of

at the age of 19. He continued on at

degrees in psychology from the New

Latter-day Saints in Indianapolis.

Yale and received a medical degree

School for Social Research in New

He was 63.

in 1929. After interning at Stamford

York City. She then earned a

Dr. Christiansen received a

Hospital in Connecticut, he began

master’s degree in social work at the

bachelor’s degree in agronomy from

his anesthesiology practice in 1935.

University of Washington School of

Brigham Young University and, in

He was one of the first 100 board-

Social Work. From 1963 to 1983 she

1967, a master’s degree in public

certified anesthesiologists in the

was a psychotherapist with Yale

health from the Yale School of

country. Dr. D’Andrea was director

University Health Services in the

Medicine. He worked in the nuclear

of the anesthesia departments at

Department of Mental Health. In

weapons industry for various

both Stamford and St. Joseph’s

1983 she graduated from Western

contractors of the Department of

hospitals and was a consultant for

New England Institute for Psycho¬

Energy. For two years, he worked

Greenwich and Norwalk hospitals.

analysis, where she became the first

for the Montana Board of Health,

He served as chairman of the

social worker to be admitted for

retiring in 1995.

medical board at Stamford Hospital

psychoanalytic training. After
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graduating from the institute, she

Telephone Support Service for

went into private practice as a

people in distress. In a recent list of

psychoanalyst in New Haven.

the Queen’s Birthday Honours, he
was recorded among the Members

TO GIVE AWAY MONEY IS

of the Order of Australia.

AN EASY MATTER AND IN

Sarah M. Ferguson
Sarah M. Ferguson,

ANY MAN’S POWER. BUT

died

J. Wister Meigs

GIVE IT, AND HOW LARGE

Nov. 23 at Hartford Hospital in
Connecticut. She was 85.
Miss Ferguson received a

TO DECIDE TO WHOM TO

J. Wister Meigs, M.D., of North

AND WHEN, AND FOR

Branford, Conn., died March 19 at

WHAT PURPOSE AND HOW,

bachelor’s degree in nursing from

the Evergreen Woods Health

IS NEITHER IN EVERY

Columbia University, an R.N.

Center. He was 82.

MAN’S POWER NOR AN

degree from Boston Children’s

Dr. Meigs was a 1936 graduate

Hospital, and then a master’s degree

of Princeton University and in 1940

in public health in 1955 from the

received a medical degree from

Yale School of Medicine. She was

Harvard Medical School. He

head of pediatric services for

completed his internship at Pennsyl¬

Cornell Medical Center in New

vania Hospital in Philadelphia and

York City for 20 years. Miss

his residency at Massachusetts

Ferguson also worked as a visiting

General Hospital. From 1945 to

nurse in Connecticut. In 1987 she

1947, Dr. Meigs served in the office

was honored as Woman of the Year

of the surgeon general of the Army

for Rocky Hill, Conn.

as a major attached to the industrial
hygiene laboratory. In 1947 he
joined the faculty of Yale as an

Paul F. Finlayson

instructor in the Department of

EASY MATTER.

Aristotle

Assuming you would
consider the School of
Medicine as one of your
intended beneficiaries,
we stand ready to help you with
when, for what purpose, and
how.

Epidemiology and Public Health
and served as director of residency

Planned giving

died March 1 at his home in

training in preventive medicine

is one of our specialties.

Wahroonga, Australia. He was 60.

while at Yale. Between 1953 and

Paul F. Finlayson, M.D., M.P.H.,

Dr. Finlayson received a

1968, Dr. Meigs was chief of

medical degree and a diploma in

medical services to the New Haven

psychological medicine from the

Works of the U.S. Steel Corp.

University of Sydney, and a master’s

During the mid-1970s, his

degree in public health from Yale in

studies in occupational medicine led

1972. In 1989 he was awarded a

to a six-month research trip to Japan

doctorate in medicine from Sydney

to work at the Atomic Bomb

University. Dr. Finlayson worked as

Casualty Commission. After 1973,

a staff psychiatrist for public

Dr. Meigs’ work focused mostly on

hospitals for 36 years until his early

cancer epidemiology. He became

retirement in 1994 because of ill

director of the Connecticut Cancer

health. At the time of his death, he

Epidemiology Unit at Yale, where he

Yale University
School of Medicine
Office of Planned Giving

was a clinical senior lecturer in

expanded the use of the Connecticut

psychiatry for the University of

Tumor Registry as a source of reliable

Sydney Medical School and a

data for cancer researchers. Dr. Meigs

consultant psychiatrist. Dr.

also worked as a consultant on safety

Finlayson pioneered and worked on

and health to the United Illuminat¬

1-800-445-6086

three unique community programs:

ing Co., the Upjohn Co. and the

Fax: 1-203-432-7901

the Ku-ring-gai Neighbourhood

Olin Corp., and was a founder of the

Service, the Grief Support Tele¬

Occupational Medical Association

phone Service and Dial-A-Mum

of Connecticut.
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David M. Pugh

professor in 1964. From 1969 until
his retirement, he was a professor

David M. Pugh, M.D., died Jan. 29

of pathology and head of a section

at his home in Mission, Kan. He

of surgical pathology.

IN

MEMORIAM

was 67.
After receiving his bachelor’s
degree from the University of

Robert K. Watson

Rochester in 1951, he served as an

Arthur L. Coleman Jr., M.D. ’48

officer during the Korean conflict.

Robert K. Watson, Ph.D., died Feb.

Dr. Pugh received his medical

21 at Yale-New Haven Hospital.

degree from Yale in 1958. He

He was 55.

completed his internship at

Dr. Watson received a bachelor’s

Bethesda Naval Hospital and his

degree in psychology from Antioch

residency and a cardiology fellow¬

College in Ohio in 1964 and a

ship at the University of Washing¬

Ph.D. degree in clinical psychology

ton. Dr. Pugh had been a professor

from the University of Chicago in

of cardiology at Kansas University

1972. He opened the first sleep

Medical Center since 1964. He was

disorders center in Connecticut at

instrumental in starting CPR

Griffin Hospital in Derby in 1980

training in the Kansas City area and

and, in 1983, opened the New

in training medical professionals in

Haven Sleep Disorders Center. Dr.

advanced cardiac life support.

Watson held a clinical appointment
at Yale in the Department of
Medicine from 1988 to 1992 and was

Edward H. Soule

December 23, 1996

Frank H. D’Andrea, M.D. ’29
November 27, 1996

Kent Ellis, M.D. ’50
December 1, 1996

Sarah M. Ferguson, M.P.H. ’55
November 23, 1996

Alice Dershimer Friedman, M.D. ’45
February 5, 1997

a lecturer in the Department of
Psychiatry from 1983 until his death.

Edward H. Soule, M.D., died

Henry H. Henstell, M.D. ’33
December 26, 1996

Dec. 1 at his home in Rochester,
Minn. He was 80.

Benjamin Wiznia

Dr. Soule received a bachelor’s
degree from Bowdoin College in

Benjamin Wiznia, M.S.W., died

Maine in 1939, a medical degree

Feb. 22 at Yale-New Haven Hospi¬

from Yale in 1943, and completed

tal. He was 86.

his internship at Maine General

Mr. Wiznia emigrated from

Hospital in Portland in 1944. From

Poland to the United States in the

1944 to 1946, he served in the Navy

early 1920s. He graduated from City

Medical Corps. After his discharge,

College of New York and received a

he returned to Maine General

master’s degree in history from

Hospital as a resident in pathology.

Columbia University and a master’s

In 1948 Dr. Soule became a resident

degree in social work from Fordham

in pathology at the Mayo Clinic

University. Mr. Wiznia was a

and entered the Mayo Graduate

psychiatric social worker for nearly

School of Medicine. He served as an

50 years. Early in his career, he

assistant to the staff from 1951 to

worked on American Indian

1952, and was appointed to the

reservations in Arizona and, subse¬

permanent staff as a consultant in

quently, with the Veterans Adminis¬

surgical pathology in 1952, a post he

tration there. He was the chief

held until his retirement. Dr. Soule

psychiatric social worker at the VA

joined the faculty of the Mayo

Connecticut HealthCare System’s

Graduate School of Medicine in

West Haven campus and a clinical

1956 and was promoted to assistant

instructor of psychiatry at the Yale

professor in 1959 and associate

School of Medicine.
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Sidney Hurwitz, M.D. ’54, HS ’69-71
November 13, 1993

Louise G. Hutchins, M.D. ’36
September 3, 1996

Louis Jack, M.D. ’23
November 19, 1996

Gerald R. Nowlis, M.D. ’48
September 30, 1996

Dorothy G. Pederson, M.P.H. ’55
September 18, 1996

Edward Hersey Soule, M.D. ’43
December 1, 1996
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A letter from the AYAM president
By Lycurgus Davey, M.D. ’43M

I

t is with reflective pleasure that

medical school representatives to the

more pressing needs of the school

I view my past two years as

Association of Yale Alumni convoca¬

kept secret. When Dean Gerard

president of the Association of

tions on the main campus.

Burrow was able to be present, he

Yale Alumni in Medicine (AYAM).

The alumni affairs office still

reported on the state of the school

The term started on a note of

has a desk for our consultant and

and usually mentioned in passing

uncertainty within the Office of

former director, Nick Spinelli, M.D.

the crying need to refurbish the

Alumni Affairs. Art Crovatto, M.D.

’44. On Mondays, he is joined with

Harkness dormitory as well as the

’54, H.S. ’54-61, was stepping down

a degree of regularity by Jack

antiquated anatomy laboratories.

as director. As an alumnus, he

Ogilvie, M.D. ’34, along with Sam

They have changed from their

showed both a special dedication to

Kushlan, M.D. ’35, chairman of

origins in the 1930s only in being

the medical students—our future

bequests and endowment on the

more crowded, with well over too

alums—and a faculty for promoting

Alumni Fund Board. Their com¬

students cramped in the same stuffy

greater communication among

bined wisdom represent an impor¬

space that once housed 50.

alumni groups. We feared a real gap

tant contribution to our efforts to

in our activities would be created

improve contact and service to

thanks must be extended to Patty

with his leaving. Bill Jenkins came

all alumni.

DiNatale who has filled in ably in

over from the Office of Develop¬

Contact with alumni has been

For our day-to-day needs,

the past six months for the ailing

ment and filled in that gap with

enhanced by the Outreach Program,

Connie Tolliver, the perennial

such energy, enthusiasm, expertise

which was launched in Boston in

mother of all alumni activities.

and cooperative spirit that he fairly

the spring of 1995. Meetings have

Connie is recovering nicely from a

blew away all doubts. His long

extended west to San Francisco and

stroke suffered in January of this

hours of work and effort have put

San Diego, south to Orlando, and

year—fortunately not a severe one.

an indelible personal stamp on

locally in New Haven and West¬

With the aid of a rehabilitation

the results.

chester County, N.Y. Except for a

program, an early return to the

tremendous turnout in Washington,

office may be possible.

In our Executive Committee
meetings, attended by upwards of

D.C., these gatherings have been

20 people three times a year, we’ve

intimate in scale with camaraderie,

and pleasure in having served as

Finally, I must express my pride

noticed growing attendance and a

spirit and general good feeling.

your president. With justifiable

wider geographical mix, with

This program has been my favorite,

confidence built on long association,

attendees more often traveling from

as I could share with others my

I pass on the “torch” to my succes¬

afar. For me, the most refreshing

gratitude and obligation to the

sor, Nicholas M. Passarelli, M.D.

part of these meetings has been the

school for fostering, in our medical

’59, HS ’59-65.

presentations by the president of the

education, the ideals and principles

Student Council, Alicia Arbaje ’99.

that have boosted our professional

The exceptional quality of Yale

lives a cut above others.

medical students is exemplified by

No effort was made to solicit

their activism. Another special

funds at these gatherings, as this was

group at the meetings are the

not our duty, but neither were the
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Lycurgus “Bill”Davey, M.D. ’43M
is the outgoing president of the
Association of Yale Alumni in
Medicine.
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Grateful patients, grateful doctors
Stethoscope, syringe, scalpel, clamp, tin cap.

By David Davison

May I have $110 million please?

school. It acted almost

(Pause)

as a third party

Yes.

between Dr. Stone

Kjmgjm

created in consultation

and his patient. The
t was probably not this simple

result was a $1,000

for Jon Huntsman, a cancer

contribution sent to

patient who expressed his grati¬

Yale School of

tude to his physician by contribut¬

Medicine by a

ing this record-breaking sum a few

grateful patient.

years ago to fund a building now

doctor-patient

Huntsman Cancer Institute at the

relationship

University of Utah.

contaminated by

A more likely scenario in today’s

with the board of directors
of the Yale Alumni Fund
in Medicine. The brochures
are available free by

Mj,

Is the

known, not surprisingly, as the

This brochure was
conceived by Andrew
McGowan, M.D. ’78, and

Jwlg! i ' |L

contacting: Bonnie Sargent,
Office of Development, P.O. Box
7611, New Haven, CT 06719.
E-mail bonnie.sargent@yale.edu
or call (207) 787-6760.

such an exchange? Since it was

world was experienced recently by

the patient who brought up the

Alan W. Stone, M.D. ’65, a Wash¬

subject, Dr. Stone saw no problem.

the Yale Cancer Center, has had the

ington, D.C., internist, who was

“In that circumstance I was com¬

unusual experience of acting first in

asked by a patient, “Doctor, what is

fortable answering ‘Yale School of

the role of grateful patient, then as a

your favorite charity?” In the past,

Medicine.’ I found it was helpful to

dedicated volunteer, and finally, this

Dr. Stone had been unsure how to

have the brochure available. It’s

past year, as a full-time professional

respond. On this occasion, he pulled

something tangible to use.”

out of his desk drawer a brochure

The brochure served Dr. Stone

development officer. Ms. Winslow,
who was treated successfully for

titled Your Doctor Graduated from

and the patient/donor as a useful

fibrosarcoma more than 20 years

Yale University School of Medicine

tool, explaining the reasons why a

ago, helped found the Patient to

and mailed it to his patient. In a

donation to Yale is worthwhile,

Patient group at Memorial Sloan-

straightforward and low-key style,

representing the school’s message of

Kettering Hospital and served on

the brochure provides information

need for support of its teaching and

the board of its fund-raising auxil¬

about making a donation to the

David Davison is director of
development for the School of
Medicine. Write to him at the Office
of Medical Development, 100 Church
Street South, Suite 211, New Haven,

research missions, and providing the

iary. When Vincent T. DeVita Jr.,

simple but essential details about

M.D., director of the Yale Cancer

where to send a gift.

Center, decided he wanted a full¬

In certain circumstances, it can
be helpful to both the doctor and

increase fund-raising activity for

the patient for the third-party

cancer research, he invited Ms.

intermediary to be a volunteer or a

Winslow to join his team.

CT 06719, or via e-mail at

professional development officer.

da vid. da viso n @yale. edu.

Judith Winslow, associate director of
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time development specialist to help

As a development officer
representing the school and the

SUMMER

1997

Volunteer support groups are

Yale Cancer Center, she can ask
appropriate and essential questions

from grateful patients and their

often formed to provide platforms

families since before coming to Yale

that might be awkward for the

for activity and outlets for people

from Stanford in 1986. He points

physician to ask the grateful patient,

dedicated to supporting biomedical

out his responsibility to communi¬

or vice versa. For example, a patient

research and patient care. Benefit

cate in depth with each patient

might not want to ask the doctor

dinners, charity auctions and

about their disease, and emphasizes

about either the tax advantages of- a

theater parties are the common

the ongoing dialogue that often

particular method of giving, or the

result.

develops with chronic-disease

Once in a while, gratitude

gift recognition policies and oppor¬

patients. For example, multiple

walks through the door unan¬

sclerosis (MS) patients need to know

and public praise are probably not

nounced. Early this year, George

about upcoming drug-trial options,

the reason the person wants to make

Zepko walked into the Develop¬

as well as the long-range potential

a gift, but with the right answers

ment Office and introduced

for research progress. Dr. Waxman

available through a tactful inter¬

himself. Seven years ago, suffering

has taken the time to keep former

preter like Judith Winslow, a more

from Marfan syndrome, he received

patients regularly informed about

generous gift can result that benefits

a new ascending aorta and aortic

the progress of his own research in

everyone involved.

valve from Dr. John Elefteriades.

MS and spinal-cord injury. In special

tunities provided by Yale. Tax breaks

Dr. Lawrence S. Cohen was, and

cases, where patients have asked for

cies of the doctor-patient relation¬

still is, his cardiologist. Now Mr.

more information regarding gift

ship cannot be generalized, there

Zepko wanted assistance in devising

possibilities, he has involved the

often may be very appropriate times

the best tax-wise strategy for leaving

Development Office to write
proposals and make personal visits.

While the nuances and intima¬

to ask for gifts. What if a physician

a large portion of his estate to Yale

has a very trusting, long-term

in honor of his doctors. The

relationship with a patient, and

development officer asked him what

care possible to every patient,

knows that the patient’s family is

had motivated the decision. He

irrespective of the ability to pay,”

generous and philanthropic in the

replied, “It’s my way of thanking

says Dr. Waxman. “No one thinks

community. When and how is it

Dr. Cohen and Dr. Elefteriades for

about gifts or gratitude. However,

okay to ask?

what they have done for me.”

we educate patients about their

“If a patient undergoing

Much of the time, a patient’s

“Yale physicians give the best

disease and about the importance of

treatment brings up the subject of a

interest and generosity is more than

training and research in medicine.

contribution with the physician,

a case of personal gratitude. It can

When it’s appropriate, we let

then it’s appropriate,” Ms. Winslow

be a long-term involvement devel¬

patients and families know that if

offers. “If time has passed since suc¬

oped through an understanding of

they wish, they can help in the effort

cessful treatment, and a physician is

the needs and the opportunity to

to advance the frontiers. We’ve

trying to fund expanded research in

cure disease.

found that once they understand

his laboratory, for example, it might

Stephen G. Waxman, M.D.,

that progress is being made, they

be fine to reach out to former

Ph.D., chairman of the Department

often want to become partners.”

patients and ask for help.”

of Neurology, has received support

Gratitude, obviously, cuts both
ways for Dr. Waxman and Yale.
“The gifts of private individuals,
including patients, are invaluable to

ARTICLE THIRD.
(b)

I

give

DOLLARS
in

and

neurosurgery

This

bequeath

($500,000)

bequest

is

EDWARD NIXDORFF,

in

the

sum

of

FIVE

HUNDRED

THOUSAND

to establish and maintain a professorship
the

made

Yale

University

in memory

of my

School

late

succeed without that help.”

of Medicine.

husband,

CHARLES

and the net income therefrom to be expended

to establish and maintain a professorship in recognition of
the many contributions to medicine of DR.

our research efforts. We couldn’t

WILLIAM J.

GERMAN;

Left: From the last will and testament of
Elizabeth S. Nixdorff, who died in 1974Dr. German, a renowned professor at Yale
(and father of John German, M.D. '62),

sorship shall be designated by the University as THE NIXDORFF-

had treated her husband. When she
created her will in 1966, she consulted her
personal physician, Nicholas P.R. Spinelli,

GERMAN PROFESSOR OF NEUROSURGERY.

M.D. ’44, who helped her decide to fund

accordingly,

it is my request that the holder of this profes¬

a professorship at Yale.
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1997-98
letters

It’s a Yale thing
To the editor:

Association of Yale
Alumni in Medicine

Officers

How to reach us

Nicholas M. Passarelli, M.D. ’59

Yale Medicine welcomes news and

President

commentary. Please send letters to

Gilbert F. Hogan, M.D. ’57

I read with interest your article

the editor and news items to

Vice President

about the free clinic in San Fran¬

Yale Medicine, P.O. Box 76x2,

Peter N. Herbert, M.D. ’67

cisco started by two Yale medical

New Haven, CT 06519-0612, or via

Secretary

school graduates (Pure Medicine,

electronic mail to ymm@yale.edu,

Lycurgus M. Davey, M.D. ’43

Fall/Winter 1996). You may be

and include a daytime telephone

Past President

interested to know that about the

number. Submissions may be edited

time the Drs. Gibbs started their

for length, style and content.

clinic, I started one in Biddeford,

Executive Committee
Joseph F.J. Curi, M.D. ’64

Maine. I am a graduate of Yale

Mary V. Digangi, M.D. ’64

College 1956 and the medical school
John W. Foster, Jr., M.D. ’71

i960. I have also had two sons
graduate from Yale College, in

clinic, as well as a copy of our

1986 and 1994.

annua! report.

R. Leonard Kemler, M.D. ’43
Robert J. Kerin, M.D. ’47

I much enjoyed your clear and

Jocelyn S. Malkin, M.D. ’51

from that of the Drs. Gibbs in that

concise article. Perhaps free clinics

Dwight F. Miller, M.D. ’56

our staff is all volunteer, and we

are a Yale thing.

Our clinic is slightly different

Donald E. Moore, M.D., M.P.H. ’81

are open three evenings a week.
We see only patients without health
insurance and we provide free
general medical care on site as well
as free non-narcotic medications.
I have enclosed a recent article
from Parade magazine about our

Lynn W. Reiser, M.D. ’7°

Francis J. Klee man, M.D. 56o
Biddeford, Maine

Ex-officio
David A. Kessler, M.D.
Dean
William K. Jenkins
Managing Director, Alumni Affairs
Daniel L. Arons, M.D. ’67
Chair, YSM Alumni Fund
Samuel D. Kushlan, M.D. ’35
YSM Bequest and Endowment

Representatives to the
Association of Yale Alumni
Frank R. Coughlin, Jr., M.D. b2
Martin E. Gordon, M.D. ’46
Michael Kashgarian, M.D. ’58
Benjamin E. Lyons, M.D. ’38
James D. Prokop, M.D. ’59
Theoharis C. Theoharides, M.D., Ph.D. ’83

AYAM Representative,
Medical School Council
William K. Jenkins
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Avenues
for innovation

ISSUE

New dean speaks at EPH opening

Yale’s position on the commercial¬
ization of university-based scientific
research has evolved from modest
support to active encouragement in
recent years. Now, with a new
branch of the University’s Office of
Cooperative Research on the
medical campus, biomedical
discoveries made at Yale are more
likely than ever to be developed for
the practical advantage of patients.

David A. Kessler, M.D., above right, talks with Dean for Public Health
Michael H. Merson, M.D., before the dedication of renovated space for
Epidemiology and Public Health in early June, as Yale Medicine went
to press. Dr. Kessler, who addressed the public health assembly and met
alumni/ae at a reception later in the day in the Medical Historical
Library, becomes the 19th dean of the School of Medicine on July i.
Additional coverage in the Fall issue of Yale Medicine.

Commencement
and the ’97 Match
Medical and public health graduates
marched forth under a clear blue sky in
May, as Commencement exercises
recognized the best and the brightest.

Reunion fun

Residency placement results on Match

What does it take to get
a reunion rolling?

Day also brought good news for many.
The complete list next issue.

This June it was

Above: Members of the
Class of 195y pose for a
photograph on the steps

The Cellmates, a

of Sterling Hall of

band of rocking Yale
researchers that includes

Medicine at the end of
Alumni Reunion

BBS Program Director

Weekend.

Ira Mellman, Ph.D.,
left, on bass and
Pharmacology Chair
Leonard Kaczmarek,
Ph.D., on guitar.
PHOTOGRAPHS BY PETER CASOLINO
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id Kessler arrives as dean

A new pharmaceutical firm

Health on the reservation

Good Ideas

cover story

After years of skepticism and modest support for partnerships with
industry, Yale has thoroughly reinvented its approach to the commercialization
of University research. Ideas hatched at the medical school have spawned more
than three dozen startup companies and contributed significantly to the
University’s patent royalties in recent years. But more importantly, new
therapies based on these innovations will reach patients faster.
By Karen Schmidt

Profile: David W. Barry
Leader of the teams that developed the AIDS drug AZT and the anti-viral
acyclovir, alumnus David W. Barry left industry giant Glaxo Wellcome to
launch his own pharmaceutical company in North Carolina’s Research
Triangle. In the pipeline: a stable of promising anti-cancer and anti-viral
drugs, including five for HIV.
Yale Medicine
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Notes From a Navajo Winter
The landscape and people of northeastern Arizona bring a Yale medical student
face to face with new concepts of health and medicine—and an appreciation
for the complexities of delivering care in a remote setting.
By Gregory Raskin ’p8
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Yales expanded
Office of Cooperative

w. Ira Mellman, Ph.D., and his colleagues
began studying the biology of dendritic cells and their

Research links the realms

role in the immune system, like most basic scientists
they didn’t have a specific clinical goal in mind.
“We got involved because they looked like interest¬

ofacademia and industryy

ing cell-biologic creatures,” says Dr. Mellman, professor
of cell biology and director ol the Program in Biological
and Biomedical Sciences. Dendritic cells change shape
and function dramatically as they develop through dis¬

translating scientific

tinct stages, first capturing a loreign protein, then taking
information about the invader to the lymph nodes to
educate T-cells. “They play a critical role in initiating the

discoveries into better care

immune response,” Dr. Mellman says.
It became clear that the ability to control the devel¬
opment of dendritic cells might lead to new therapies to

for patients and support

treat autoimmune disorders such as rheumatoid arthritis
and Crohn’s disease. The next step, Dr. Mellman
thought, would be a genomic study to determine “what

for future research.

genes were being turned on and turned off at each of the
three stages of dendritic cell development.” That re¬
quires highly specialized technology, so he approached a
genomics company and spoke to a pharmaceutical firm
about funding the work.

By Karen Schmidt

But when Gregory E. Gardiner, Ph.D., director ol
the University’s Office of Cooperative Research, heard
about the work, he proposed a different approach to the
funding. Dr. Gardiner suggested establishing a new drug
discovery company based on Dr. Mellman's techniques

Photographs by Frank Poole

for exploiting dendritic cells’ unique properties. The
Office of Cooperative Research has already drafted a
business plan for Dendritic Cell Sciences Inc., and is
working on securing investors.
When Dr. Gardiner arrived in February 1996 from a
position as group director of research and development

When cell biologist Ira Mellman, second from left, uncovered new
knowledge about the properties of dendritic cells, Jon Soderstrom,
Ben Muskin and Gregory Gardiner, from left, of the Office of
Cooperative Research saw the seed of a new business venture.
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operations for Pfizer Central Research in Groton,
Conn., he brought scientific expertise and more than
two decades of experience in the pharmaceutical indus¬
try. His goal: to promote the University’s intellectual as-

3

“We got involved
because they looked like
interesting cell-biologic
creatures. ... They play a
critical role in initiating
the immune response, ”

Recent discoveries about dendritic cells, Ira Mellman says, may lead
to better treatments for autoimmune disorders such as rheumatoid
arthritis and Crohn’s disease.

sets and find the best ways to manage and develop them.

have a bridge that can take laboratory results and, with

The idea is to take the discoveries and inventions

appropriate academic safeguards, carry them into the

hatched inside the halls of academia and put them out

clinical domain.”

in the world where they can earn the University some
revenue, and more importantly, do some good.
“One reason a major research university like Yale
must concern itself with technology transfer has to do

NURTURE AND NATURE

with revenues, to be sure,” says Yale Provost Alison F.
Richard, Ph.D. “But of equal importance is the value

“University researchers have always wanted their results,

of making discoveries quickly available to the benefit

their ideas, their discoveries, to flower in the commu¬

of society.”
For example, Stephen G. Waxman, M.D., Ph.D.,

nity,” says Carolyn W. Slayman, Ph.D., deputy dean for
academic and scientific affairs at the medical school. In

chair of the neurology department, is working on tech¬

the past it was publication in a journal, not commercial¬

nology that could be used to treat cerebral edema and

ization, that served as the transfer point. “You put your

glioma, a kind of brain cancer. “If we’re going to use

results out there and you hoped people would see them

society’s dollars, we should try to deliver something for

and use it.”

society,” says Dr. Waxman, professor of neurology,

That doesn’t work anymore, Dr. Gardiner says. If a

pharmacology and neurobiology. The marketplace, he

company can’t be assured of exclusive rights to a new in¬

adds, is often the vehicle that brings new discoveries to

vention, it has no incentive to spend, say, $350 million

the public. “If you discover penicillin and keep it in the

to bring a new drug to the market. That reality has led

laboratory, it can’t benefit society. It is important to

academic scientists into a sometimes unfamiliar world of
patents, licensing, start-up companies and venture capi¬

Karen Schmidt is a New Haven-based writer specializing

tal. But some universities, including Yale, have been slow

in science and medicine and a student in the Department

to embrace the idea that academia can work with indus¬

of Epidemiology and Public Health.

try without losing sight of its educational mission.

4
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“In my 27 years at Yale, I have seen a very gradual
evolution in the attitudes of the University’s scientists,
engineers and administration toward the commercializa¬

The right chemistry

tion of University-based scientific research,” says Yale
President Richard C. Levin, “an evolution of attitudes

Sometimes the idea for a new

from skepticism, to modest support, to active encour¬

therapeutic compound comes from a

agement.” Former medical school Dean Leon E.

biologist. Sometimes the idea comes

Rosenberg, M.D., HS ’63, now senior vice president for

from a medicinal chemist. At Yale,

scientific affairs at Bristol-Myers Squibb Co., has

close collaboration between the two

observed the same progression. “I think that Yale was

has led to the design of some

certainly very cautious about the involvement of its

remarkable drugs.

faculty with the private, for-profit world.”
Involvement with business was not supposed to be

From the first antiviral com¬
pound, discovered by William H.

the scientist’s role in society, says Alan C. Sartorelli,

Prusoff, Ph.D., professor emeritus

Ph.D., the Alfred Gilman Professor of Pharmacology.

and senior research scientist, to the

Instead, the scientist was encouraged to cultivate a kind

more recent anti-AIDS drug d4T,

of noble detachment. “We were supposed to be pure

licensed to Bristol-Myers Squibb Co.

and they not so pure because they were interested in

in 1986 and now marketed under

money,” he says.

the brand name Zerit, Yale research
has benefited from such a collabora¬
tion. Zerit, a reverse transcriptase
inhibitor, grew from a collaboration
between Dr. Prusoff and the late TaiShun Lin, Ph.D., a medicinal chemist.
In 1985, Dr. Prusoff and Dr. Lin
began investigating whether the
compound would inhibit the growth
of HIV.
“It’s an interactive process,”
says Yung-Chi Cheng, Ph.D., the
Henry Bronson Professor of Pharma¬
cology, professor of medicine, and
director of the Developmental
Therapeutics program of the Yale
Cancer Center. The program links
researchers from labs throughout
the medical school. Licensed
inventions in just the past few years
include an anti-hepatitis B compound
that is in Phase III clinical trials, two
anti-cancer treatments in Phase I
clinical trials, and two other antivirals
expected to go into clinical trials
within a year, Dr. Cheng says.
Dr. Cheng stresses the
importance of maintaining the
department’s strength in chemistry.
“Our chemistry strength is weaken¬
ing,” he says. “The situation needs
to be addressed in order to continue

“Our mission is primarily an educational one, ” says OCR leader Gregory
Gardiner. “As long as any business arrangement furthers that mission in more than
just a monetary way, we’ll consider it. ”

YALE

MEDICINE

discovering compounds.”

S

"In my 27 years at Yale, I have seen a very gradual evolution in the
attitudes ... toward the commercialization of University-based
scientific research, an evolution of attitudes from skepticism, to
modest support, to active encouragement.”

Yale President Richard C. Levin

But two of Yale’s biggest biomedical successes in
recent years were developed in close partnership with
industry: the anti-AIDS drug Zerit and Lyme disease
vaccines lor people and animals. The newly expanded
Office of Cooperative Research, which now has a branch
in the Sterling Hall ol Medicine, has been working
closely with Yale scientists to develop and, where
appropriate, commercialize their discoveries.
For example, the office is formulating a business
plan for a drug discovery company based on the work of
Prolessor Yung-Chi Cheng, Ph.D., the Henry Bronson
Prolessor of Pharmacology, professor ol medicine, and
director ol the Developmental Therapeutics program ol
the Yale Cancer Center. Dr. Cheng’s work on antiviral
drugs has already led to numerous patents, and his
current work could lead to antiviral agents that could be
used against hepatitis, herpes, Epstein-Barr virus and
cytomegalovirus.
Richard L. Edelson, M.D. ’70, chairman ol the
Department of Dermatology, is continuing work on
improving a photopheresis treatment for a type ol
lymphoma; his new discoveries about the process ol
photopheresis could lead to treatments for leukemia and
chronic inflammatory and autoimmune diseases.
Technology transfer is the only practical way to take
these discoveries out ol the lab and into a clinical setting
where they may someday help treat patients, says Jon
Soderstrom, Ph.D., associate director of the Office ol
Cooperative Research and one ol three people who staff
the medical school branch.
“If we re doing research in the life sciences, I would
say we have an obligation to see it receives the broadest
exposure possible,” Dr. Soderstrom says. The office’s job
is to link the worlds ol business and academia, and to
take the burden off scientists, who may not have the
business savvy to know which strategy is best to develop
a particular discovery.
“The scientists,” Dr. Soderstrom says, “can continue
to be the scientists.”

6

FROM ACADEMIA TO INDUSTRY

Yale scientists have been studying Lyme disease since the
malady was identified here in 1975. But when the team
working on a Lyme vaccine was ready to move into
clinical trials, it was time to transfer the technology out
of academia and into the private sector. It wasn’t just a
matter ol money, says team member Richard A. Flavell,
Ph.D., chief of immunobiology and a Howard Hughes
Medical Institute investigator. It was common sense.

Deputy dean Carolyn Slayman with OCR representatives
Soderstrom, left, and Muskin. “ They have been so successful at
generating interest among the faculty that they have more potential
startup companies than there is space for in New Haven. ”
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“We did what you should do and can do in a

ethical issues that may crop up when discoveries made

university. We proved the concept to be correct,” says

on campus succeed commercially. University administra¬

Dr. Flavell. After showing the vaccine worked in ani¬

tions may be concerned that a faculty member’s commit¬

mals, it was up to a pharmaceutical company—

ment to an outside, private enterprise could mean less

SmithKline Beecham, in this case—to handle the

time and energy devoted to classroom, clinical or

clinical trials and regulatory approvals.

scholarly pursuits.

“I want to be doing research,” Dr. Flavell says, as
opposed to “writing the standard operating procedures

The reluctance could also stem from unfamiliarity
with industry. Until about a quarter-century ago,

for how a drug should be made.” Dr. Flavell, who

biologists didn’t have to concern themselves with

previously served as chief scientific officer and vice

conflicts of interest or conflicts of commitment because

president for research and development at Biogen, one

commercialization was often not even a possibility, Dr.

of the first biotechnology companies, knows the tech¬

Flavell says. The reason was simple: Unlike engineers or

nology transfer field from both sides.

chemists, “biologists had never been involved in any¬

“The university is the place where basic research is
done, and it’s not the place where applied research is

thing that would lead to a commercial product,” he says.
Even though great discoveries, such as the structure

done,” he says. “Most basic research is done in universi¬

of DNA, were being made, until gene cloning became

ties, so technology transfer is an essential component

possible in the early 1970s there was a general belief that

of the development of applications of publicly

molecular biology would not lead to anything truly

funded research. It’s a natural process, and it should

useful. “Biologists just weren’t used to that kind of

be encouraged.”

thing,” he says.

But even top research universities like Yale have
been reluctant to tackle the complicated financial and

In addition, until 1980 federal law gave universities
only limited rights to license inventions that resulted

Cumulative Royalty income to Yale University, 1977-1997 (in millions of dollars)

30 —I

Most of the growth is
attributable to Zerit, an
AIDS drug discovered at Yale
that has been used to treat
hundreds of thousands of
people with HIV.
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from government-funded research. Says Dr. Gardiner:

The best way to develop a particular discovery may

“What really started the university technology transfer

be a traditional licensing arrangement. It may involve

offices going is that the federal government said univer¬

contract research with a pharmaceutical company, or a

sities can take title to a patent.”

corporate alliance to benefit both a company and the

The Bayh-Dole amendments, enacted by Congress

university. And the best way to market a discovery may

in the early 1980s, led to the establishment of technology

be with a brand-new business venture, funded by

transfer offices, including Yale’s. But the offices carried a

outside venture capital. “We’re essentially trying to

heavy burden of paperwork and tended to focus on

perform a business development function,” Dr.

regulatory compliance instead of business development.

Soderstrom says.

“The Bayh-Dole amendments have had the net

Jeff Collinson, managing partner of Collinson

effect of causing all invention disclosures to be treated

Howe & Lennox in Stamford, is an investor in Neuro¬

equally,” Dr. Gardiner said in a presentation to the Yale

gen and Alexion, two companies based on Yale discover¬

Corporation in February. But all inventions are not

ies. Both of those ventures, he says, were established

alike: Of more than 850 invention disclosures made at

with little or no help from the University. “There was

Yale since the office was established, 75 percent of the

really no interface with technology transfer on either of

revenue earned through fiscal 1997 (close to $30 million)

those investments,” says Mr. Collinson, a 1963 Yale

was generated by just 10 inventions.

College graduate.

Instead of treating all discoveries the same, the new
model of technology transfer is designed to actively
identify the best opportunities for academic/private
partnerships. The technology transfer office works
closely with Yale scientists to find potentially marketable
discoveries, then develops a plan.
“There’s a broader approach to how ideas and
discoveries should flow from a university to the corpo¬
rate world,” says Dr. Slayman, the deputy dean who
works closely with the office. The technology transfer
office also is able to provide an essential degree of
business sophistication. “Yale has to be known as a place
to be taken very seriously.”

WHO’S

WHO

Now there is more of an effort to facilitate the
process. “They’re far more proactive than they were,”
he says. “There is a focal point, a catalyst to make these
things happen, an organization to surface potentially
fundable technologies.”
Science and business require two very different sets
of skills, and the Office of Cooperative Research staff is
equipped to bridge the gap. Dr. Soderstrom says that
when a scientist comes to him with a new discovery
“the question I have to ask is, what can I do with it?”
Dr. Soderstrom has to determine first how to keep
potential competitors away from a discovery. Then he
has to figure out what product or service might result

AT

OCR

When Gregory E. Gardiner, Ph.D.,

research opportunities for the

took the helm of the Office of

company’s pharmaceutical busi¬

Cooperative Research in 1996, he

ness, Dr. Gardiner already had

was quickly followed by an expan¬

brought expertise from both the

extensive hands-on experience

sion of the office and the opening

corporate and scientific worlds.

building partnerships between

of a branch in the medical school.

As group director of research
and development operations for

universities and industry.
Dr. Gardiner has impressive

Dr. Gardiner’s appointment

Staffing that office are Jon
Soderstrom, Ph.D., who came to
Yale from Oak Ridge National

Pfizer Central Research in Groton,

research credentials as well: He

Conn., Dr. Gardiner designed and

holds a doctorate in physical

Laboratory, and R. Bennett Muskin,

implemented Pfizer’s external

chemistry from Fordham University

who was vice president and director

biotechnology investment strategy.

and was a Sterling Fellow in Chemis¬

of JCL Clinical Research Corp. in

Since his job at Pfizer was to

try at Yale from 1969 to 1972,

Knoxville, Tenn., a small biotechnol¬

evaluate potential licensing and

before joining Pfizer in 1974.

ogy company.
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from it and, finally, whether the need for the product or

Center for Technology Transfer at the University of

service is large enough to pay for its development. The

Pennsylvania. “They want to see the results of their

idea, he says, is to translate a discovery into something

research benefit the public.”

that makes sense in terms of a product. It isn’t always

The income can also help support continuing

easy for the scientist to determine what might form the

research, both by established professors, junior faculty

basis for a profitable business.

and students. “Here’s a source of money for us as a

“You see all sorts of ideas,” Mr. Collinson says, “and

university to assist young people, as well as to help

a number of them are quite interesting. But they don't

more senior people who need carry-over grant funds,”

all form the basis for starting a company.” He is looking

says Dr. Sartorelli.

for discoveries that have a good chance of producing

Development of Yale-based businesses benefits the

salable goods or services, ones that will offer an investor

city and state, too. “Yale’s intentions are to be an active,

a good return. “From the perspective of a scientist in

helpful and contributing partner in the growth of the

his lab, that’s a difficult distinction,” he says. But Dr.

high-tech industry in our state,” Yale President Levin

Gardiner and his staff have a good sense of a discovery’s

says. “Although the commercialization of new research

business potential, says Mr. Collinson. “It’s a useful

discoveries cannot always be transformed into more local

screening process.”

jobs, Yale is generating new economic vitality near the
University." Yale scientists have established eight public
companies and more than 30 private companies, em¬
ploying more than 750 people; about 25 of the compa¬

RECRUIT, RETAIN, REWARD

nies are located in greater New Haven.

A strong, business-like program to find partners to

the Office of Cooperative Research. A lack of space is a

develop technology offers clear financial rewards for

problem that could be greatly alleviated by the develop¬

the University. What may be less clear are the ways

ment of a new business incubator on land in the Route

that program can help recruit, retain and reward

34 corridor, a project that's still in the pre-planning

faculty members.

stages. A technology incubator provides a supportive

Keeping companies in the city is one objective of

“Our best and brightest faculty need technology
transfer,” says Louis Berneman, managing director of the

Gregory E. Gardiner

Dr. Soderstrom, who holds
a Ph.D. in Psychology/Industrial

Jon Soderstrom

environment to attract and retain young, start-up firms,
usually offering tax and other incentives. Science Park,

R. Bennett Muskin

John S. Swartley

Muskin brings to the office first¬

planning for two small biotechnology

hand experience as an entrepreneur

companies specializing in
immunodiagnostics.

Engineering from Northwestern

in technology-based health care

University, worked as director

companies. Prior to joining Yale, he

of program development and,

put together the business plan and

office's medical school staff is

before that, director of technology

financing for his first company in

John S. Swartley, Ph.D., who arrived

licensing in Oak Ridge’s Technology

1991 and later licensed the technol¬

in September. He left the Emory

Transfer office.

ogy to a leading medical device and

Medical School faculty, where he

supply company. Subsequent to this

studied the genetics of bacterial

Mr. Muskin holds a degree in

The newest member of the

physics and engineering and did

experience, Mr. Muskin was re¬

pathogens. He also consulted for

graduate work in biomedical engi¬

cruited to be the director of busi¬

Emory’s technology transfer office.

neering at Drexel University. Mr.

ness development and strategic
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A fertile

electrospray mass spectrom¬
etry, a key biotechnology tool

► Genaissance Pharmaceuti¬
cals, a company that applies

ground

DNA sequencing to drug
discovery, which started in
Science Park in 1993 and

for new

continues to grow

► CuraGen, a New Haven
bioinformatics company

technology
Yale has always been a fertile
source for new technology, but
medical scientists have scored a
couple of major successes in
recent years.
Two of the biggest suc¬

started with four people in

Yale technology. The publicly

1993 that has since seen

traded firms are valued at more

employment rise to 100

than $1 billion, and include: Enzo

► Exelixis, a developmental

Biochem, Neurogen, GeneLabs
Technologies, Ariad Pharmaceu¬
ticals, Alexion, Vion Pharmaceu¬
ticals, Sparta Pharmaceuticals,
and Innovir Laboratories.
Neurogen is an example of a
company that developed Yale

biology company in
Cambridge, Mass.

► Gene Logic, a genomics
company started in New
Haven and recently relocated
to Baltimore

► International Biotechnologies,

cesses—the anti-AIDS drug Zerit

intellectual assets through

a medical imaging company

and Lyme disease vaccine under

venture capital. “When the

located in Science Park that

development—might never have

founders left Yale, they didn’t

went public but was acquired

happened if not for partnerships

even have a patentable invention

with pharmaceutical companies.

to license,” said Office of Coop¬

Both the reverse transcriptase

by Kodak in 1995

► Molecular Diagnostics, a

erative Research Director Gregory

biotech diagnostics venture

inhibitor Zerit (d4T) and the Lyme

E. Gardiner, Ph.D., speaking in

started in 1980 in West

disease vaccine required enormous

February to the Yale Corporation.

Haven and acquired by

amounts of capital to bring them

“But they did have some excel¬

Bayer in 1989.

through development and to the

lent ideas about GABA receptors

market (a process still under way in

which could lead to new drugs in

The development of new
companies can be expected to

the case of the Lyme vaccine).

at least four different therapeutic

continue at a steady pace, says

Since new ventures don't have that

categories.”

Jon Soderstrom, Ph.D., the OCR’s

kind of capital, both of those

The ideas needed to be

associate director. About another

discoveries were licensed to large

proven in a research-intensive

10 companies are now in

drug companies—Bristol-Myers

environment, Dr. Gardiner says,

development, with two “fairly far

Squibb for Zerit and SmithKIine

and the move paid off: Eight

along in the process,” Dr.

Beecham for the Lyme disease

years later, Neurogen has four

Soderstrom says.

vaccine. Both companies had the

drugs in clinical development and

capital and the necessary experi¬

at least three more in the

ence to develop the drugs.

immediate pipeline.

Licensing to existing compa¬

Among the private

nies isn’t always the best way to

companies developed with Yale

bring a discovery to market, though.

technology are:

Eight public companies and more

► Analytica of Branford, founded

than 30 private ones have been

io

formed over the years to develop

by the discoverers of

The work of Yale scientists was the
basis for Zerit, above, one of the new
generation of highly effective AIDS
medications. Medical school investigators
also invented a vaccine for Lyme disease,
which is spread by the deer tick, Ixodes
scapularis, background.
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a technology incubator and research park with close ties

family has a significant ownership interest; or if a

to Yale, is a model for that sort of development. Located

faculty member steers a graduate toward a research

in a state-designated Enterprise Zone in New Haven,

project that could substantially enhance the value of a

Science Park is home to about ioo companies that

company in which the faculty member has a significant

employ 2,000 people.

ownership interest.

“Greg and his staff have been so successful at generat¬

Some situations would be allowed with proper

ing interest among the faculty that they have more

disclosure and oversight, such as if a scientist who is a

potential startup companies than there is space for in

member of a company’s scientific advisory board

New Haven,” Dr. Slayman says. “The most visible thing

conducts research sponsored by that company. The

that could happen in the future, besides the steady

clearly defined policies alleviate concerns by letting

growth, would be if we could successfully develop the

faculty members know what’s appropriate and what isn’t.

Route 34 corridor.”

“I think it’s healthy that we’ve put these mechanisms in

“Yale University, working closely with the city and
state, intends to step up to the plate and do its part to

place,” Dr. Slayman says.
The real concern, Dr. Gardiner says, would be if

generate new business opportunities in the New Haven

scientists lacking business savvy tried to start companies

area,” says Dr. Richard, the provost. “There truly is local

completely on their own to commercialize discoveries.

urgency to Yale’s engagement in technology transfer in

“The companies we’re talking about have sophisticated

order to generate revenue and jobs.”

investors who put money into them,” he says. With

Even if the Route 34 complex spurs new businesses
to start up nearby, and even if Yale has a strong connec¬

plenty of attorneys and other professionals monitoring
operations, the potential for problems is greatly reduced.

tion to many of the companies, University officials
are clear that business interests will not be allowed to
overshadow Yale’s primary mission, which is academics.
“Yale remains deeply committed to student educa¬

THE FUTURE

tion, which we consider to be our central responsibility
and defining mission,” Dr. Richard says. “One of the

Looking ahead, Dr. Soderstrom projects conservatively

tensions in forming industrial collaborations is to make

that new businesses will be formed at a judicious rate of

sure they enhance rather than detract from student

about three a year. “We are going to focus a lot of time

education.” But alliances with industry can enhance

and energy on spinning out companies,” he says.

education by exposing students to the latest technologies

So far, Dr. Gardiner says, technology transfer has

and lab techniques, and better prepare students for

not had an enormous impact on the University’s research

careers in the pharmaceutical and biotechnology

budget. The royalties for the fiscal year that ended June

industries. “It’s less a case of academia adopting an

30, 1997, totaled about $13.5 million—equal to about 5

industrial approach to education,” she says, “than it is

percent of the university’s $280 million research budget,

a case of industry adopting an academic approach to

and up from about 2 percent the previous fiscal year.

scientific discovery.”

The average for all U.S. universities stands at about 1

“Our mission is primarily an educational one,”
Dr. Gardiner says. “As long as any business arrangement
furthers that mission in more than just a monetary way,
we’ll consider it.”
Though some may worry that faculty members
could get caught in conflicts when they work too closely

percent, Dr. Gardiner says.
“When you get in the neighborhood of 10 percent,
you can say, ‘I’m having an impact,’ ” Dr. Gardiner says.
“I think we ought to try to get to 10 percent, then look
and see, has this been good for the University?”
With experience, the difference between the mission

with moneymaking enterprises, policies on conflict of

of industry and the mission of a university will become

interest and conflict of commitment are strictly spelled

more clearly defined, Dr. Flavell says. “Drawing a clear

out, Dr. Slayman says.

line will allow for a more flexible attitude toward

The policy lists some examples that would be a clear
violation: If a scientist uses a Yale laboratory to do

technology transfer.”
Neurology chair Stephen Waxman agrees. “I’d like

product-testing research, paid for by a company in

to see closer interactions between Yale and industry, but

which he is a 20 percent owner and founder, seeking to

they have to be structured in a way that enhances and

validate advertising claims made about a product sold

respects the academic mandate,” he says. “If structured

by that company; if a clinician makes patient referrals

in the right way, the interface can benefit our patients

to a diagnostic company in which she or her immediate

and our trainees, as well as the University.”
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From Salmonella,
a potential
cancer treatment

i g

Yale researchers, Vion take
a novel approach to
gene therapy.

0 of the technologies to emerge
from Yale recently is a potential gene
therapy agent for cancer treatment. School
of Medicine researchers John M. Pawelek,
Ph.D. and K. Brooks Low, Ph.D. have
worked hand-in-hand with David
Bermudes, Ph.D., and a team of scientists
at New Haven-based Vion Pharmaceuticals
Inc. to prepare their invention for possible
clinical trials.
The Yale technology, licensed to Vion
December 1995 and named TAPET
(for tumor amplified protein expression
therapy), is one of the first uses of a bacterium, rather
than a virus, as the mechanism for delivering genes
to cells.
The Yale concept, described in the Oct. 15 issue
of the journal Cancer Research, involves the use of
engineered strains of the common Salmonella bacte¬
rium, the same bacterium that, in its unaltered or
wild-type form, can cause food poisoning and septic
shock. The altered Salmonella, stripped of its
pathogenicity, is nonetheless able to target solid
tumors in laboratory animals in a fashion similar to
the wild-type parent, according to Dr. Pawelek, senior
research scientist in dermatology and a lecturer
in pharmacology.

The view inside a melanoma tumor, as seen through the electron
microscope. A tumor-bearing mouse was injected with Salmonella.
After 24 hours the bacteria were located within the tumor, where
they had multiplied. Salmonella were found both inside and outside
the melanoma cell. Also seen are melanosomes, pigment-laden
granules characteristic of melanoma cells.
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The three inventors
of the engineered
Salmonella vector;
from left: K. Brooks Low,
Ph.DDavid Bermudes,
Ph.D.; and John M.
Pawelek, Ph.D.

“In fact," he says, “we can now significantly

on an old theory on how metastatic cancer cells seem

prolong the life of mice with melanoma by injecting

to behave like white blood cells as they spread

them with our attenuated bacteria. Although as few as

through the body, and encouraged Dr. Pawelek to

10 wild-type

Salmonella

are sufficient to kill a mouse,

we can inject 10 million cells of our attenuated strains
and the mice show no symptoms of infection. After
the

Salmonella

are introduced into the mouse blood¬

pursue the theory experimentally.
After a few weeks Dr. Bermudes returned to Dr.
Pawelek with an idea for a new type of therapy: the
use of white-blood-cell-specific parasites to seek out

stream, they seek out tumors, multiply selectively

cancer cells. They tested several parasites for their

there in great numbers, and—by mechanisms yet to

ability to infect human melanoma cells in culture, and

be unraveled—dramatically slow the rate of tumor

soon settled on further work with

growth and prolong life. Furthermore, because the

Salmonella.

Approached because of his expertise in bacterial

bacteria multiply within the tumor itself, anti-tumor

genetics, Dr. Low was supportive and also favored

genes that we introduce genetically into the bacteria

testing the potential of

also are multiplied.”

weeks, Dr. Pawelek began a sabbatical in Dr. Low’s

The use of engineered

Salmonella,

says gene

Salmonella

in this way. Within

lab, where the trio pursued the development of safe

therapist Albert B. Deisseroth, M.D., Ph.D., chief of

Salmonella

the section of medical oncology and associate director

later they obtained their first laboratory animal data,

of the Yale Cancer Center, “could represent a powerful

and Terrence W. Doyle, Ph.D., vice president for

new approach to cancer therapy. They have geneti¬

research and development at Vion, became interested

cally transformed a pathogenic bacterium into one

in the Yale-developed technology. Vion entered into a

as an anti-cancer vector. A few months

that is safe in laboratory animals, yet still retains its

license agreement with Yale in December 1995,

tumor-targeting properties.”

assisted with the patent filing and employed Dr.

Dr. Pawelek, a cancer biologist who studies

Bermudes as associate director of biology in Septem¬

melanoma; Dr. Bermudes, a parasitologist; and Dr.

ber 1995. Vion has also supported this and other

Low, a bacterial geneticist and professor of research

research at Yale through grants.

in therapeutic radiology, began collaborating in late
1992 on this project when a University of Massachu¬

“We are obviously most excited about the potential
use of this technology for human cancer therapy,” Dr.

Salmonella

setts colleague introduced Dr. Pawelek to Dr.

Pawelek says. “We’ve made the

Bermudes, who was then a Yale associate research

and effective for laboratory animals, and now the

scientist working only three floors above him in the

challenge is to do the same for humans. The safety

Infectious Diseases Section of Internal Medicine. Dr.

issue seems under control, and the potential effective¬

Bermudes became interested in Dr. Pawelek’s views

ness seems highly promising.”
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David W. Barry
Leader of the team that discovered AZT, a former Burroughs Wellcome
executive strikes out on his own in pursuit of new
anti-viral treatments.

By Terrance Noland

Photographs by Corey Lowenstein

E

arly in his career as a physician-scientist, David W. Barry, M.D. ’69,
H.S. 69-72, survived two close calls with tropical viruses. In the first,
he was exposed to the African arbovirus Germiston, a strain of

bunyamwera, and briefly lapsed into a coma. A week later, he returned
to work. In the second, two of his colleagues were infected by the virus
that causes deadly Lassa fever. One colleague died, but doctors saved the
other with serum from the blood of a nurse who had survived the disease
in Africa.
For Dr. Barry, his co-worker’s recovery was a revelation. “It was,” he says
today, “a very tangible demonstration that viral infections could be treated.
Back in those days, people looked at serious virus infections a lot like we look
at metastatic cancer now. They just sort of gave up.”
That attitude has changed with advances in research and drug develop¬
ment over the past three decades. In fact, Dr. Barry, 54, has made a career—
and now a business—of developing treatments for viruses once thought
untreatable. Consider his track record. At Burroughs Wellcome, where he
eventually headed worldwide research and development for British parent
Wellcome PLC, he developed the herpes drug acyclovir, the first blockbuster
anti-viral. He also led the team that discovered AZT, the first treatment for
HIV. Now chairman and CEO ofTriangle Pharmaceuticals Inc., a Durham,
N.C.-based company he started two years ago, he is developing a stable of
promising anti-cancer and anti-viral drugs, including five for HIV.
“Even as a young resident it was clear he had the potential to make a
contribution to society. And he has done that,” says Yale professor of

Terrance Noland is managing editor ^/ Business North Carolina magazine
in Charlotte.
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medicine Vincent A. Andriole, M.D. ’57, Dr. Barry’s

consequential drugs could be lucrative, too. Acyclovir’s

attending physician during his internship and residency

sales reached as high as $1.3 billion a year, and AZT’s

at Yale-New Haven Hospital. Dr. Barry graduated

profits spurred many other drug companies to develop

from the School of Medicine in 1969 and from Yale

their own HIV treatments. “Now it’s very clear that in

College in 1965.

those areas where there is the biggest human need,

Perhaps better than anyone, Dr. Barry has mastered

there’s likely to be the biggest return on investment.

the blending of benevolence with business in the field of

If you can find a treatment for cancer, you will make

drug development. From the start of his career, he was

money. It’s only fairly recently that it has coincided.”

attracted to what he calls the “tough nuts to crack” in

His new company is a perfect example. Though

illnesses. “I just wasn’t interested in drugs that treat

Triangle is still in its infancy and won’t have a product

trivial diseases, even though that’s where the biggest

on the market for at least two years, Dr. Barry has

markets were at the time.” Dr. Barry helped prove more

managed to raise $98 million in public and private

David W. Barry, M.D.,
decided to start his own
company, Triangle
Pharmaceuticals Inc.,
after industry giant
Glaxo merged in 199$
with Burroughs
Wellcome, where
Dr. Barry headed
worldwide research and
development. Dr. Barry
holds a model showing
the molecular structure
of FTC, the company’s
anti-viral nucleoside
analogue, which is
being evaluated for
the treatment of HIV
and hepatitis B.
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capital. One reason? The products in its pipeline. They

the University of North Carolina’s cancer center in

have shown potential against such serious diseases as

nearby Chapel Hill. “He is a very canny man.”

HIV, herpes, hepatitis B, and lung and brain cancer—all
lucrative markets Or drug development.
I here’s another reason investors have been keen on
Triangle. Dr. Barry has assembled a remarkable team.

“QUADRUPLE A”

His 43-person staff: includes several key players who
helped him build Wellcome into an anti-viral power¬

Initially, Dr. Barry’s interest in medicine was sparked by

house. Among them: Phil Furman, Ph.D., one of Dr.

his frequent bouts of illness as child. Growing up in the

Barry’s four AZT co-inventors; Nick Ellis, Ph.D., former

mill town of Nashua in southern New Hampshire, he

AZT global brand director; and Franck Rousseau, M.D.,

developed rheumatic fever at age 6. That was followed

former director of infectious diseases and HIV clinical

by a case of scarlet fever.

research at Wellcome France.
At Wellcome, Dr. Barry had a reputation as an

As an undergraduate, he attended Yale College.
He majored in French literature but took several science

innovative and strong-willed leader who wasn’t afraid to

classes, including organic chemistry and advanced

butt heads with other executives. He got away with it

biology. “They seemed interesting and I did well in

because of the results he delivered. His group's anti-viral

them” he recalls. After graduating magna cum laude,

work helped turn the company into a drug power¬

he chose medicine over literature for graduate studies.

house—something he’s not shy about pointing out.

“I thought I’d be a better doctor than a writer” he quips.

Today, no one in the pharmaceutical industry can claim

Dr. Barry credits the School of Medicine’s

a longer track record in AIDS drug development.

thesis requirement with “getting me set off in my

“Hands down,” says David Molowa, a biotech analyst

career in science and virology.” His topic? How quickly

with Bear, Stearns & Co. in New York, “he’s Mr. HIV.”

certain viral vaccines protect experimental animals

With much of the same team in place at Triangle,
Dr. Barry is ready to repeat history. “David is the kind

from infection.
When he graduated from medical school in 1969, he

of guy who simply succeeds,” says fellow Yale alumnus

took his internship and residency at Yale-New Haven

Joseph S. Pagano, M.D. ’57, a friend and the director of

Hospital, specializing in internal medicine. There he
continued his virology research,
working with renowned Yale scien¬
tist Gueh-Djen Edith Hsiung,
Ph.D., now professor emeritus of
laboratory medicine. They were
testing the drug IdUrd, a herpes eyeinfection treatment developed by
Yale professor emeritus William
Prusoff, Ph.D., to see if it worked
against brain infections.
“It subsequently turned out not
to work,” Dr. Barry says. “But it was
a tremendous learning experience to
be at the forefront of a new thera¬
peutic area. Until that time, most
people thought viruses were
untreatable. And Yale was the place
that thought, 'No, they probably are
treatable.’ And that was a tremen¬
dous help to me. By the time I left
residency, I had been exposed to the

As CEO, Dr. Barry assembled a team of top researchers from his group at Burroughs

best of virology in America and

Wellcome, among them Phil Furman, Ph.D., one of the four co-inventors of AZT.
He also recruited Chris A. Rallis, in background, to be Triangle’s vice president for

probably the world.”

business development and its general counsel and secretary.

At Yale, Barry also got interested
in clinical work through his exposure
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to two top infectious-disease clinicians. Dr. Andriole
and Elisha Atkins, M.D., professor emeritus of medi¬
cine. Dr. Andriole recalls Barry as an “outstanding
resident. He was very bright and worked very hard.”
He also remembers his intensity: “Quadruple A person¬
ality. He always was that way.” Dr. Andriole used to get
him to lighten up some by cracking jokes. “There were
times when I could get him to laugh, and his laugh was
a small smile on his face. One side of his mouth would
go up a little higher than the other. When I saw that,
I knew I had gotten him to relax a little bit.”

FROM THE FDA TO WELLCOME

Dr. Barry considered doing postdoctoral work in Dr.
Andriole’s lab, but when he Finished his residency in

David W. Barry, M.D
Chairman and chief executive officer, Triangle
Pharmaceuticals, Durham! N.C.

1972, the Vietnam War was still raging. “My brother had
just come back from Vietnam and said it really wasn’t a
great place to be,” he says. “So I was looking for alterna¬
tives.” He found one. He joined the Food and Drug
Administration’s Bureau of Biologies. That fulfilled his
draft requirement. The bureau was in need of an expert
on yellow fever, and Dr. Barry had studied the disease
for his thesis. The next year, he became deputy director
of the bureau’s virology division.

Yale College, Class of 1965
Yale School of Medicine, Class of 1969
Intern and resident, Yale-New Haven Hospital,
1969-72
Married to Gracia Chin Barry (Mount Holyoke
’66); father of two adult children

But Dr. Barry’s career there faltered in 1976, after
leading the FDA’s role in a swine-flu immunization
program conducted by the Centers for Disease Control

Avid fly fisherman and quail hunter, owns two
English pointers

and Prevention. When the vaccine caused neurological
damage in some people, Dr. Barry saw the handwriting
on the wall. “They didn’t throw me out, but it was clear

Member Yale School of Medicine Dean’s
Advisory Council since 1988

my chances for promotion were limited."
In 1977 he joined Burroughs Wellcome, based in
Research Triangle Park, N.C. A year later he was made
head of clinical investigation. At the time, the company
had a herpes drug in early pre-clinical stages. One of his

testing had eliminated the virus in her petri dishes.

first tasks was to develop it. That drug was acyclovir, the

It was AZT, a compound made from herring sperm that

hugely successful anti-viral agent.

Burroughs Wellcome had first tried against bacterial

In 1983, after becoming head of the virology depart¬
ment, he led Burroughs Wellcome’s push into finding an

infections. At first the researcher couldn’t believe her
eyes. “She said, ‘Maybe I forgot to put the virus in it,’ ”

AIDS treatment. At the time, few other drug companies

Dr. Barry recalls. But they repeated the experiment and

were interested in pursuing the market. “Nobody thought

found the compound worked in even smaller amounts.

anybody would make any money on it whatsoever,”

Dr. Barry and his staff uncorked a bottle of white

Dr. Barry says. “When we started, it was a relatively rare

wine to celebrate. There was little time to revel. Working

disease affecting a disenfranchised population.”

closely with the FDA, they raced the drug through the

Dr. Barry organized a team that began working with

clinical and review stages in only 22 months. They

a similar retrovirus that grew in mice. They began

presented their data to the FDA in September 1986 and

testing compounds against it. The breakthrough came in

got approval for AZT’s commercial use in March 1987.

November 1984. A Burroughs Wellcome scientist came

The team’s efforts became a model for fast-track approval

to Dr. Barry’s office with news: The compound she was

of breakthrough treatments for life-threatening diseases.
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HUNG IN EFFIGY

Using venture capital and money from his separa¬
tion package, Dr. Barry started Triangle in July 1995.

Rather than being celebrated. Dr. Barry and his group ran

With a steady stream of employees leaving Glaxo

into a storm of controversy at first. At $10,000 a year, the

Wellcome after the merger, he had a deep talent pool to

initial price of the drug angered AIDS activists. Dr. Barry,

choose from in staffing his company. His first 12 em¬

promoted to vice president of research in 1986, was a

ployees were all former Wellcome people. Last Novem¬

visible target. When the group Act Up stormed the floor

ber, he took the company public. Since then, the stock

of the New York Stock Exchange in protest in 1989, they

price has doubled from $10 to $20 per share in late

hung him in effigy. As AZT’s price came down, the

September. (Dr. Barry’s share of the company, 6.5

controversy faded some. Dr. Barry and the man who led

percent, is worth about $20 million.)

the stock-exchange demonstration, Peter Staley, are now

Dr. Barry is aiming to run Triangle as a full-fledged

friends and have participated together in case studies of

pharmaceutical company, offering a diversified slate of

the issue at Harvard Business School.

products that it will develop and market itself. That’s

With the success of acyclovir and AZT, Wellcome’s
sales swelled. In 1994, Dr. Barry was named director of

unlike many biotech startups, often built around one
promising compound. It’s an ambitious goal for such a

worldwide research, development and medical affairs.

small company, but Dr. Barry is counting on finding

He oversaw 3,200 researchers. Some thought he was on

ways to streamline operations, such as contracting out

track to become the next CEO.

manufacturing and some clinical work.
The company will also save time and money by
bypassing the inventing stage. Instead, it will acquire
compounds. This summer, for instance, Triangle beefed
up its stable of products by buying Avid Corp., a small
Philadelphia drug-research company. The main draw
was rights to a protease-inhibitor HIV drug Avid has
had in early-stage clinical trials.
That gives Triangle eight products. Its furthest
one along is the HIV drug MKC-442, a nonnucleoside
reverse transcriptase inhibitor. “It inhibits the key
enzyme of the virus, but chemically is different from
things like AZT and 3TC.” Two other HIV drugs,
CS-92, similar to AZT, and FTC, also a nucleoside
analogue, are scheduled to begin clinical trials
this year.

MANY LINES OF ATTACK

The reason Dr. Barry has so many HIV treatments in
That all changed in March 1995. That’s when British

development is that he doubts any one drug will ever

rival Glaxo bought Wellcome, creating Glaxo Wellcome.

conquer the disease. At Burroughs Wellcome in the early

Glaxo had its own research czar, and Dr. Barry was

1990s, he was one of the early proponents of combina¬

offered a secondary position. He turned it down, taking

tion therapy, in which two or three drugs are given at a

a sizeable retirement package instead. “Wellcome had a

time and new ones are rotated in as soon as patients

way of thinking that I liked,” he told Business North

develop resistance. That is now generally considered the

Carolina magazine last year. “It was always trying to do

best way to treat HIV.

the impossible, to handle the most difficult diseases in
the world. Glaxo was different. They were focused on

Even with 11 HIV drugs on the market, there will be
a need for many more, Dr. Barry says. “Because they’re

certain areas that were less life-threatening, where they

used in combination and because each one of the drugs

produced incremental medical improvements and

has some disadvantage—either toxicity, intolerance,

significant financial returns. I still wanted to go and cure

efficacy, drug resistance, drug-drug interactions—there’s

the incurable diseases.”

plenty of room for improvement.”
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For example, he is hoping his MKC-442 won’t cause
the kind of rashes common with similar treatments.
Early tests in patients have been promising, both in

tive. “Academic people are very, very conscious of their
need to be precise."
He has also heard the criticism in recent years that

terms of effectiveness and low rates of rashes. “We know

drug companies, particularly those with HIV treat¬

that the dose we tested so far, when used alone, will

ments, are price-gouging patients. The cost is indeed

make the virus fall immediately 90 percent or more in

high. Most HIV combination regimens run about

about 80 percent of the patients,” Dr. Barry says.

$13,000 to $15,000 a year. But Dr. Barry defends the

Starting later this year, Triangle plans to test the com¬

high cost. For one thing, the drugs are expensive to

pound to see how well it works with other drugs. If that

make. For another, their effectiveness has brought down

goes well. Dr. Barry expects to get approval by late 1999,

hospitalization costs considerably.

at the earliest.
Also scheduled for clinical trials this year is Triangle’s

Besides, he argues, profits are what push companies
to develop new treatments. “Profit motive is clearly the

alanosine, a brain- and lung-cancer drug. The VA

reason there are now 11 drugs on the market and why

Connecticut Healthcare System’s West Haven campus is

combination therapy is making such a great improve¬

slated to take part in that trial. Dr. Barry says he’d like to

ment in people’s lives. You’re changing the whole face of

find more anti-cancer agents to develop but is interested

the disease from being rapidly fatal to one where we’re

only in those that are selective—that will harm the

talking realistically about decades of health. And all of

tumor but not the body. “Anti-cancer therapy is just

that is based on companies getting involved and making

starting to get into that area,” he says. “I see that we are

profits. That’s a pretty straightforward equation.”

“You need the research, which universities provide, to really be able to
understand the basic mechanisms of whats wrong. And once you’ve
got a tentative idea of how to fix it, you really need the industrial
partner to bring the scientific concept to a reality.”
starting to have enough science, a lot of it generated at

Companies are also attracted to the HIV market

Yale, to show that it is possible to take advantage of

by its growth. In 1995 the market was about $250

subtle differences in the way tumors metabolize things

million worldwide. Last year it quadrupled to just over

and normal cells do. Metastatic cancer in the future is

$1 billion. This year it could hit $2 billion. The main

going to be less and less a certain and rapid death

reason: Increased effectiveness and reduced side-effects

sentence.”

have caused more people to seek treatment. Little more

Many ol Triangle’s compounds were discovered by

than a year ago, 20 percent of those infected were

scientists at Emory University and the University of

getting treated. Now it’s 30 percent to 40 percent,

California at San Diego, which now have royalty

Dr. Barry says.

agreements with the company. Dr. Barry thinks such

So what can we expect to see next in the war on

links are critical. “We provide—that is, industry and

AIDS? “The biggest issue now is thinking about the

academia—two different and needed aspects. You need

long-term management of AIDS. We’ve got short-term,

the research, which universities provide, to really be able

year-level management under our belts pretty well, but

to under-stand the basic mechanisms of what’s wrong.

now, more and more, there will be new strategies to

And once you’ve got a tentative idea of how to fix it, you

approach decades-long management. It may be using

really need the industrial partner to bring the scientific

drugs that counteract the resistance of other drugs. It

concept to a reality.”
Their relationship, he says, “should be as close as
possible.” He sees great value in private companies
sponsoring university research. And though he has heard
the arguments about potential conflicts of interest, he

may be treating more aggressively or slightly less aggres¬
sively early on. It’s hard to say. But that will be the talk
in AIDS over the next couple of years.”
And it’s safe to say, David Barry will be doing much
of the talking.
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from a
Navajo
winter
20

In the sparsely populated canyon country
of northeastern Arizona, a medical
student makes discoveries about life on a
different scale (and finds a little piece
of Ne w Haven).

By Gregory Raskin
FALL
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sun in wintertime, plus a great experience in rural
medicine—it seemed perfect. Alas, all the spots in
March were filled when I inquired the previous year,
so I settled for a baseball-free January slot in Chinle, a
small town at nearly 6,000 feet in elevation. No spring
training, no warm weather, but definitely a whole
different ballgame.
By the time I finally left for this out-of-New-Haven
experience in the middle of my third year, I was raring
to go. I was in search of many answers. What was the
reservation like, and how was it different Irom what I

I

had known? Could I retain my (admittedly tenuous)
sanity so far from the frenzied confines of the Northeast?
t’s not that you can’t get there from here. You can,

What would it be like to drive thousands of miles alone,

but it’s not easy.

across plains, deserts and the mighty Mississippi? How

It is entirely possible to take a commercial flight to

long could I go without a bagel? With these questions in

the edges of the Navajo Nation—a Native American

mind, along with the distant exhortations of Horace

reservation approximately the size of West Virginia that

Greeley ringing in my ear, this young man went west.

encompasses parts of Utah, Arizona and New Mexico.
This positions you more than too miles from Chinle,
Ariz., your final destination, which falls smack dab in
the center of the reservation. From there, you can take a

Left: The snow-dusted Canyon de Chelly is only a few miles from
the center of Chinle, Ariz., where the author found a new perspective
on medicine.

bus (one trip daily, approximate time to Chinle: four
hours) or rent a car.
If you take the bus, which doesn’t run on week¬
ends, you’re pretty much stranded when you arrive,
because Chinle [pronounced CHIN-lee] lies in the
absolute middle of nowhere. In fact, it’s farther than
that; go to the middle of nowhere, take a right, and
drive for another hour—now you’re in Chinle. Of
course, when you’re 24 years old renting a car is not an
option, so if you’re my age and want to get there from
here you have to pack up your own car, get some good
music and hit the road. This was my plan exactly as I set
out last New Year’s Day to begin a month-long elective
in primary care at the Indian Health Service (IHS)
hospital in Chinle.

After spending six straight years in New Haven (I was an
undergraduate just down the road at Yale College), I
knew by the middle of the second year of medical school
that I would be aching for a break come winter of 1997.
I thought I would go somewhere warm after a brutal
winter last year. Also, I calculated that by placing myself
in Arizona in March I would be poised to see some
Grapefruit League spring training games. Baseball and

Gregory Raskin is a fourth-year medical student at Yale.
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The journey started with questions about culture, and one
imponderable: How long could I go without a bageli

And the open range does not spare the towns on the
reservation, which means that finding a parking space at
The Silver Coin launderette involves avoiding the horses
strolling casually across the parking lot. Coupled with
the innumerable stray dogs that roam the town in search
of food or perhaps something to do, Chinle can seem
like one part zoo, one part obstacle course. I’m con¬
vinced that—assuming this nickname has not been
taken already by another city or town—Chinle could be
known as The Stray Dog Capital of the World. From
any random vantage point in the parking lot of the local
supermarket it was usually possible to spot at least a
couple of ownerless mutts; my personal record was six.
Of course, these are country dogs—they couldn’t sniff
in New Haven.

The Navajo Nation reservation is entirely open range:
cows and horses and sheep graze anywhere they please.
What this means for Navajo ranchers is that they must
brand their livestock, herd them communally, and then
sort them from time to time when animals are to be
sold, shorn or slaughtered. What this means to the
intrepid traveler is that one must be careful while driving
on the reservation because it is extremely common to see
animals walking on the road. Who wins in a battle
between my little red Honda Civic, barreling 70 miles
an hour up Arizona Route 191, and a half-ton cow
chewing its cud on the double yellow line? No one.

The commercial
strip running
through the center
of Chinle is the
center of Chinle.
A few fast-food
restaurants, a
supermarket and a
general store make
up the business
district, which
serves a population
spread out over
many hundreds of
square miles.
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Aside from the launderette, Chinle contains a
supermarket, a post office, three fast-food restaurants,
a few gas stations, several other stores and the Chinle
Comprehensive Healthcare Facility, where I worked.
A road sign at the city limits displays a transliterated
Navajo greeting: Yd’dt’eeh. The back of the sign says
Hdgoonee’, Navajo for goodbye.
During my time in Chinle I lived in a small house
adjacent to the hospital with a physical therapy student
from Virginia. The house and the hospital sit on a
plateau above the main road. Out the back window of
the house lies a plain on which horses and cows graze,
and beyond looms a mesa—snow-covered during my
month-long stay. Though the street directly in front of
our house was paved, it quickly turned to ice and mud a
few hundred feet away. Driving home always presented
the intriguing possibility of getting stuck.
The hospital itself is a relatively modern facility in
the process of being outfitted with a new computer
system. I spent mornings in the outpatient clinic,
seeing both children and adults for urgent visits and
follow-up appointments. Sore throats and back pain are
as common out there as at Yale-New Haven. Dozens of

patients are seen each morning and afternoon, some

Pacific Theater. The language is so complex that it

of whom have traveled for more than an hour to come

served as a code the Japanese were never able to crack.

to the clinic.

In New Haven many of my patients speak Spanish, a

The other half of my day was usually spent in the

language in which I have at least mediocre proficiency;

emergency room, sewing up lacerations and learning

I can usually be sure to get my point across. On the

how to cast broken bones. Between patients, I got to

reservation I had to have faith in my translators.

know the ER staff fairly well, an interesting mix of

Coupled with the language gap was a different

Navajo and non-Indian health care workers. The

view of physiology held by the Navajo people I met.

emergency medical technicians are Navajo and provide

On more than one occasion, I provided the second

ambulance transport from the field (for example, from

opinion after a patient had already visited a traditional

motor vehicle collisions), translation for the non-

medicine man. (Bizarrely, I treated a medicine man in

Navajo-speaking staff (all the physicians in the hospital),

the ER once, the entire time managing to stifle my urge

and patient screening in the ER. The nurses in the ER

to utter the line “Medicine Man, heal thyself.”) As a

are either non-Navajo employees of the National Health

former molecular biophysics and biochemistry major in

Service or Navajo women trained locally. There is an

college and a man who lists magnetic resonance angiog¬

attending physician in the ER at all times—the one with

raphy and spiral computed tomography as two of his

whom I spent most of my time was a former trauma

favorite things in the world, traditional Navajo beliefs

surgeon from Los Angeles who claimed to have “seen

about the workings of the human body hinging on a

everything.” Patients who have medical problems too

sense of balance and beauty in the universe seemed as

difficult to be handled by the Chinle hospital are sent by

foreign to me as their language. Consequently, I often

helicopter or small plane to larger hospitals in Albuquer¬

was uncertain how my patients understood my ques¬

que, Phoenix or Denver.

tions, explanations and advice.
Patient compliance is clearly a challenge for the
IHS, not only for cultural and linguistic reasons, but
also for physical ones. While some Navajos live in the

The language barrier was the first of several challenges to
medical care that I did not foresee. As mentioned above,
English is not the Navajos’ first language. The younger
generations learn English in school and speak it; the
older people do not and require a translator. But the
translator has to turn English medical terms into a
language with literally thousands upon thousands of
verb conjugations, a language that even declines nouns.
During World War II, Navajo men drafted into the
Army were employed to transmit radio messages in the

town near the hospital, many more have homes far from
the town, miles even from a paved road. Addresses are
listed in the medical records with descriptions like “Six
miles NW of Antelope House Overlook, left side of
road”or, my favorite, “29 miles NW of Pinon Trading
Post, blue hogan with dirt roof, right side of road.”
It’s not as though I could call my patients to see if they
were OK or were taking their medicine—most don’t
have telephones.
In bad weather, 29 miles of dirt road equals insur¬
mountable mud and ice. Despite a patient’s best inten¬
tions, he or she will not be able to make his hyperten¬
sion follow-up appointment, perhaps for a week.

The IHS hospital in Chinle, better known as the Chinle Comprehensive Health Care Facility. A place to learn about
lacerations, broken bones and the Navajo approach to life and health.

In inclement weather the clinic can be nearly empty.
When the roads finally clear up, the waiting room packs

Furthermore, the reservation is one of the poorest
areas in the country. Unemployment compounds the

wall to wall. During one particularly bad snowstorm

problems of alcoholism and poor diet of the younger

while I was there, the National Guard was called in to

generations and can often lead to depression and despair.

help people get out ol their homes.

But the difference that I found between the poverty on
the reservation and the poverty that cripples much of
urban America is that the family structures remain
intact. In U.S. cities, people who are poor and troubled

Learning the ways of the whites has had an impact on
the Navajos’ health in detrimental as well as positive
ways. While access to medical care and technology
undoubtedly has been beneficial, the Navajos seem to
have fallen prey to some seductive yet decadent parts
of our society. These days, because of their diet and
lifestyle, the Navajo have one ol the country’s highest
incidences ol diabetes, a disease all but absent Irom the
reservation 60 years ago. In Chinle all three restaurants
serve fast lood, and there is probably more canned meat

by alcoholism, drug addiction or psychiatric problems
often find themselves out on the street. In the Navajo
Nation, large families take care of their own. If a family
member ends up battling alcoholism, someone will
inevitably come down to the supermarket parking lot,
transport the sleeping relative home and tuck him into
bed. Somehow it seems to make the poverty—while
certainly still a desperate situation—slightly more
tolerable, knowing that your family will be there to
catch you should you fall.

in aisle six of the Chinle supermarket than in the entire
state of Connecticut. Canned meat doesn’t need refrig¬
eration, impossible for Navajos without electricity.
Although it is illegal to buy, sell or consume alcohol on

Another distinctive facet of the Navajo culture is that it

the reservation, alcoholism is another scourge. The

is a term of respect to call older people “grandmother’’

problem is severe enough that the supermarket stocks

and “grandfather” when you address them. It was

hairspray, vanilla extract and mouthwash (items contain¬

proper, then, to “give 500 mg ol Tylenol to the grandma

ing alcohol) behind a special counter. Purchase ol these

in Bed Four.” I’m pretty sure that if you addressed my

items requires the blessing ol a highly wary store clerk.

own grandmother in this manner, she would kick you
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in the teeth and then instruct you to take your own

could seem deafening in the driver’s seat but wouldn’t

damn Tylenol.

have carried for 100 yards into the vast plains, I felt like

It is well known that medical charts are littered with
acronyms and condensed wording for common prob¬

the road (not a natural phenomenon, to be sure, but
representative) let me drive on it.

lems. In Chinle, while sore throats are quite prevalent,
they have a few problems that I had never before
encountered; these problems might just merit their own
abbreviations. In one week, I tended to two patients
who arrived in the emergency room, one FOH or “Fell
Off Horse.” I also saw a 75-year-old grandmother who
came in BKWTS, which you might think rather un¬
likely, given her advanced age, provided you knew that
BKWTS stood for “Broke Knee While Tending
Sheep.’’Apparently she slipped on the ice, fell on a rock,
and fractured her patella, an injury that I could not see
happening to my aforementioned, Reebok-wearing,
contract-bridge-playing grandma in Livingston, N.J.

By the end of the trip, I developed an appreciation for
the complexities of the Navajo Nation and the difficulty
of providing health care across long distances and varied
cultures. To be sure, understanding the problem is but
the first step to creating a solution. I ruminated on this
during the long drive home, and can claim not to have
been bored in the least despite the thousands of miles.
Of the many questions I had set out to answer,
there was one I couldn’t. Isolated as it is, the Chinle
supermarket’s frozen-food section is copiously stocked
with Lender’s bagels (one ol New Haven’s many contri¬
butions to the world). My bagel-deprivation study thus
will have to wait until I make my way to a more remote

Before I left for the trip, I was under the impression
that the landscape out west would be beautiful. Driving

corner of the globe.
I wonder, could I drive to Nepal? YM

through Arizona along Interstate 40, I was not so sure.
The scenery is indisputably impressive. Snow-covered
red mesas jut abruptly into the skyline along the infinite
horizon, and bizarre rock formations—Rough Rock
and Round Rock are two towns north of Chinle, while
Window Rock is the Navajo Nation capital—have been
tortured from the earth by time, rivers and wind. The
clean air and blue sky invariably produce a sense of
majesty in anyone who has lived in a city penned in by
soot, tenements and highway interchanges. But I
found that the landscape was too vast, too intimidating
to be beautiful. Driving on endless roads (Chinle is
over an hour’s drive north of I-40) in my compact car,
I felt alienated, as though I were merely an afterthought
to nature.
I think this gave me a little sense of the way the
Navajo language and culture have developed, which also
points to the problems of providing medical care for this
population. My life—with its landscape of skyscrapers,
indoor parking lots and domed sports arenas, its sounds
of sirens and jackhammers, its smells of gasoline and
Dunkin’ Donuts—seems as different from a Navajo’s life
as English does from the Navajo language.
In the Navajo language, nature reigns supreme.
It does not make sense to say in Navajo that “the boy
drank the water,”or even “the water was drunk by the
boy.” Instead, the closest English translation to the act of
drinking water is “the water let the boy drink it.” In my
tiny car, with my little car radio blaring out tunes that
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Paul Muni starred
as the medicalscientist-hero in
the Academy
Award-winni ng
The Story of
Louis Pasteur.

Medicine
at the movies
Hollywood's fascination with the
healing profession is fertile ground
for a series of history of
medicine seminars.

By Marc Wortman

I

n the climactic scenes of the 1931 film
Arrowsmith, the driven medical
researcher-hero, played by Ronald

Coleman, is testing his new and promising
plague vaccine in a disease-ridden tropical
village. Hewing to a Hollywood version of
the scientific method, he injects half the
villagers with the vaccine while the other
half go without. He faces a moral dilemma
upon realizing that the vaccine may indeed
work. If it does, those who went without
could have been saved, but will instead
surely die. Torn between his quasi-religious calling of
advancing scientific knowledge and his moral imperative
as a doctor to save lives, he abandons his experiment and
gives the vaccine to all the villagers. Doing so, however,
likely ruins his research findings
and perhaps his career.
That basic clash of medical cultures—between
medicine as rigorous, authoritative and sometimes
inhumane science and as personal devotion to saving
lives—marks hundreds of films Hollywood has made
exploring the role of medicine in American society.
Arrowsmith is remarkable because it is one of the earliest
feature films to portray that conflict so unambiguously.
Through the 1950s, whether in the laboratory or the

With horrific images of a mental institution.
The Snake Pit represents one of the first attacks on
the public image of the medical community.

4

clinic, medicine as shown on the silver screen was almost

There’s the doctor-experimenter—in a nonconsensual

always a saintly calling. Physicians and scientists were

way—the doctor-slasher, the doctor-patient-abuser.’’

carrying on a heroic battle against disease on behall of

That historical transformation of the image of the

people from all walks of life. Then a gradual but pro¬

physician is just one aspect of the representation of

found shift took place. Along with the scientific power

medicine in film covered by Dr. Warner and Charles

of medicine and the social authority of its practitioners,

Andrew Morgan III, M.D., associate professor of

Hollywood showed there also came potential for great

psychiatry, in a seminar they taught together this year to

corruption and a chilling loss of humanity among

some two dozen medical students, residents and fellows,

physicians. “Now,” says John Harley Warner, Ph.D.,

on Medicine at the Movies: Historical Perspectives on Film

professor of the history of medicine, “you walk into any

and the Culture of American Medicine. (They expect to

video store and you’ll find scores of villain doctors.

repeat the course soon.)
It wasn’t just a chance for participants to kick back
and watch movies, but an opportunity to explore their
own place in the wider culture. “Popular perceptions of
the profession as a whole are profoundly influenced by
Hollywood,” says Dr. Warner. In watching films ranging
from Thomas Edison’s pioneering public health films on

V l

tuberculosis, such as Hope (1912), to medical-scientist-as-

1

hero films like The Story of Louis Pasteur (1936), to more
recent versions of the potential abuses of medical care,
including One Flew Over
the Cuckoo's Nest (1975),

V

f
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Thomas Edison’s Motion Picture Studio released several
dramatic films aimed at improving public health. Here, the
director instructs the actors in Hope, released in 1912, one
of the first films to present an image of the physician.

MUST-SEE MOVIES
FOR PHYSICIANS
Arrowsmith (1931)
Men in White (1934)
The Story of Louis Pasteur (1936)
Dr. Ehrlich’s Magic Bullet (1940)
Madame Curie (1943)
Sister Kenny (1946)
The Snake Pit (1948)
The Magnificent Obsession (1954)
The Hospital (1971)
Coma (1978)

the Yale students had a
chance to reflect on how
their chosen field is
viewed in the popular
eye. “Accuracy isn’t the
issue,” says Dr. Warner.
“You might want to say,
‘That’s not what we’re
like,’ but the depictions
are very powerful.”
Viewing the repre¬
sentation of medicine in
film gave the students an
opportunity to reflect on
how the public perceives

THE BUST
Doctor X (1932)
The Body Snatcher (1945)
Suddenly Last Summer (1959)
Freud (1962)
M*A*S*H (1970)
The Elephant Man (1980)
Zelig (1983)
The Doctor and the Devils (1985)
Flatliners (1990)
Lorenzo’s Oil (1992)

their powers and how
much those powers grow
out of real capabilities.
“Where does the
physician’s authority
come from?” Dr. Warner
wanted students to ask.
“It’s too easy to fall back
solely on the belief in the
power to heal. As these
films show, it’s as much a
function of changes in
culture. It’s not only in

Source: John Harley Warner, Ph.D.
care giving.

medicine. It’s out there in
American culture.”
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Dr. Kessler comes to New Haven
Trading Washington
for the Ivy League,
the medical school's 15th
dean gets his bearings
and begins to fix his gaze
“squarely ahead. "

T

he first day was a whirlwind
tour of sorts, down the
hallways of Sterling Hall of

Medicine and beyond, across Cedar
Street and into laboratories and
departmental offices, even the coffee
nook oft the rotunda at the School

Above: Dean David A. Kessler,

of Medicine’s main entrance.

M.D., unpacks books in his
office in Sterling Hall of

David A. Kessler, M.D., Yale’s

Medicine in early July.

15th dean of medicine, took office
July 1 and spent his first days

Right: The dean meets with

introducing himself to students,

college students visiting Yale for
a program organized by the

faculty and staff. “It’s been two
weeks of getting to know every¬

medical school's Office of
Multicultual Affairs.

body,” he said in mid-July, unpack¬
ing boxes in the stark white sur¬
roundings of his freshly painted
office on the second floor of
Sterling’s C-Wing. The shelves held
one book (Principles and Practice of
“We’re enormously fortunate to

Oncology, 5th edition), the desk

served for 15 years as chief financial

empty except for a computer

officer at Montefiore Medical

equipped with headset and micro¬

Center in New York and became the

Dr. Kessler, who stepped down as

phone. “You can tell by looking

medical school’s first chief operating

Food and Drug Administration

around,” he said smiling, “that I’ve

officer on July 1; and Ruth J. Katz, a

commissioner in February after six

public health expert and attorney

years in office. He has remained in

spent very little time in this office.”

have both of them with us,” said

with extensive federal government

the public eye as co-chairman of a

his impromptu rounds were two

experience, who was named assis¬

congressional panel that evaluated

newly appointed senior administra¬

tant dean for administration.

the proposed $368.5 billion tobacco

tors: Irwin M. Birnbaum, who

(See Faculty News, Page 37).

settlement announced in June.

Accompanying Dr. Kessler on

z8
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“By joining forces with the existing
team here,” he said, “especially

Lyme researchers roll out new tool against ticks

deputy deans Carolyn Slayman
and Joseph Warshaw, we re begin¬

Ticks beware: That gentle, doe-eyed

New Jersey and Maryland, the deer

ning to understand the breadth and

creature you planned to feast upon

will brush up against paint rollers

scope of this institution and the

may be hosting your last meal.

challenges, and to fix our gaze
squarely ahead.”

Lyme disease researchers in five
states will use deer as a magnet for

Dr. Kessler said he planned to

coated with pesticide, which in turn
will kill the ticks that feed on deer.
The results of the program will

ticks as part of a $2 million experi¬

not be clear until 1999 or 2000,

discuss his outlook on the school

ment that has the potential to

because the deer tick has a two-year

and priorities for his deanship in an

dramatically reduce or even elimi¬

life cycle, says Durland Fish, Ph.D.,

interview later this fall. He briefly

nate new cases of Lyme disease.

the project coordinator and a

described the challenges ahead as

Last year, physicians across the

research scientist in epidemiology

falling in the categories “fiscal,

United States reported more than

and public health. But, he says,

facilities and scientific—building on

18,000 new cases of the debilitating

based on a similar program in Texas

the extremely strong basic science

affliction, which causes joint pain

targeting tick-borne illness among

tradition and translating those

and can damage the heart and

cattle, the potential is enormous. In

discoveries into the clinic.”

nervous system. Most cases of

the Texas study, the tick population

Lyme disease are treated successfully

dropped by 90 percent.

Regarding finances, “There are
significant infrastructure issues that
absolutely have to be addressed,” he

with antibiotics.

A Lyme disease vaccine

The five-year program, spon¬

created by Yale medical faculty and

added. The school also is sorting

sored by the U.S. Department of

developed by SmithKline Beecham

out a shortfall in clinical revenues

Agriculture, targets deer as a critical

Inc. was shown effective in clinical

related to the introduction of a new

link in the tick life cycle and

trials earlier this year, as was a

computer billing system in 1996 and

subsequent bacterial infection that

separately developed vaccine also

to diminished reimbursement under

occurs when the tick takes its blood

tested at Yale. SmithKline submitted

managed care.
In the first weeks of his fiveyear term, however, Dr. Kessler was

meal from humans. At specially

its application to the FDA in

designed feeding stations in Rhode

September.

Island, Connecticut, New York,

Michael Fitzsousa

focused on students and faculty,
attending a lunch one day with a
group of minority medical and
public health students, and meeting
the next with department chairs and
faculty. The last week in July, on a
trip organized by Ms. Katz, a group
of 10 students accompanied him to
Washington as he testified before
Congress on the proposed tobacco
settlement. “It was incredible,”
third-year medical student Gregory
Raskin said of the experience. (See
Student News,

Page 42)

(Coinci¬

dentally, Dr. Kessler’s co-chair on
the tobacco panel, former Surgeon
General C. Everett Koop, M.D.,
began a one-year term as a visiting
professor in Yale’s Department of
Epidemiology and Public Health,
also on July 1.)

Continued, on Page 30
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EPH scientist Durland Fish, Ph.D., above, and colleagues in five states are using deer to
target Lyme disease-causing ticks.

29

Continued from Page 29

ae several weeks before arriving, as
a speaker at the dedication ol new

Dr. Kessler said his role as an
anti-tobacco advocate is clearly

Alumni News,

secondary to his responsibilities as

spoke of retaining the resolution of

dean. (As FDA chief, he succeeded in

youthful idealism and quoted the

banning the sale of tobacco to

educator Horace Mann, “who said

There, he

minors and in classifying nicotine as

that you should be ashamed to die
until you have won some victory

FDA regulation, a policy upheld in

for humanity. He could have been

federal court in April.) “Issues don't

talking about the road that you

go away overnight,” he said, “espe¬

have chosen.”
“I am thrilled,” he added, “to be

has worked for years, but it is not

coming to Yale to be part of training

where I am focused now. My primary

of the next generation, who will be

focus is being dean here at Yale."

able to try and make a difference in

While he vowed to make “no

Bruce I. McClennan, M.D., professor
and chair of diagnostic radiology.

Page 54.)

an addictive substance subject to

cially important issues on which one

During a meeting with administrators
this summer. Dr. Kessler talks with

EPH facilities in early June. (See

speeches, no pronouncements”

people’s lives, who know that there
are no miracles in the promotion of

during his first month as dean, Dr.

the public welfare, only hard work

Kessler did have occasion to address

and compassion.”

public health and medical alumni/

Michael Fitzsousa

Yale scientists exploring neurobiology of autism
The National Institute of Child

improved treatment,” says Fred R.

Health and Human Development

Volkmar, M.D., the Harris Associ¬

(NICHD) has selected Yale as one

ate Professor of Child Psychiatry,

of three universities to initiate a

Pediatrics and Psychology, who will

major research project on the

direct the research program.

neurobiology of autism, the most

In most cases, infants who are

severe developmental disorder of

born with this disorder lack the

childhood. To conduct this research,

usual disposition to form social

the NICHD has awarded $5.3

relationships. Profound deficits in

million to the School of Medicine

social interaction and communica¬

over the next five years.

tion are associated with unusual

Autism, which arises as a result

behaviors such as repetitive move¬

of neurobiological factors, affects

ments, difficulties in dealing with

the development and behavior ol

change, and abnormal responses to

one in 1,000 children. Although the

the non-social environment.

disorder results from some insult to

The new grant builds upon five

Fred R. Volkmar, M.D.

advocates, who appreciate that only

the developing brain, its cause or

decades of autism research and

through such study can the progno¬

causes remain unknown. Less

treatment within the Yale Child

sis of autism really be improved.”

information is known about other

Study Center, according to center

pervasive developmental disorders,

Director Donald J. Cohen, M.D.

Faculty at the Child Study
Center will join colleagues at the

such as Asperger’s syndrome, which

'66, the Irving B. Harris Professor of

University of Chicago and Univer¬

shares several features with autism.

Child Psychiatry. He says that the

sity of California at Los Angeles

project, “the largest research com¬

(UCLA) to conduct studies on the

provide greater understanding ol

mitment in the history of the field,

molecular and family genetics of

autism and also enable us to develop

is truly welcomed by parents and

autism and its related conditions

“We hope that this research will
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and of brain imaging projects. The
scientists also will study develop¬
mental changes when individuals
with autism receive treatment.
“Even though early intervention
and detection have improved the
outcome, the human and financial
costs of autism and related condi¬
tions remain very high,” says Dr.
Volkmar, who will collaborate with
Catherine Lord, Ph.D., at the
University of Chicago, and Susan
Smalley, Ph.D., at UCLA. “Since our
research focuses on addressing the
neurobiological factors which cause
autism and related disorders, we will
conduct work that ranges from the
level of the gene to the brain and the
expression of these conditions
behaviorally in individuals.”
Researchers will concentrate on
four interrelated areas:
Role of genetic factors in autism.
Genetic factors play a role in at least
some cases of autism. As part of this
project, Edwin Cooke, M.D., of the
University of Chicago; David L.
Pauls, Ph.D., associate professor in
the Yale Child Study Center; and
Dr. Smalley of UCLA will attempt

to identify the gene or genes
involved in some cases of autism by
studying families in which more
than one child has autism or closely
related conditions.
Data will be pooled with an
international genetic study of
autism directed by Professor
Michael Rutter of the University of
London. Collaborating with him
will be several Yale medical profes¬
sionals, including Domenic V.
Cicchetti, Ph.D., senior research
scientist in psychiatry and in the
Child Study Center; Ami Klin,
Ph.D., assistant professor in the
Child Study Center; Robert
Schultz, Ph.D., assistant professor
in the Child Study Center, and
Drs. Cohen and Pauls.
Related genetic and psychiatric
conditions in family members of
persons with autism and Asperger’s
syndrome, a condition similar to
autism. Drs. Pauls and Smalley will
assess the relationship of other
conditions, such as Tourette's
syndrome, obsessive-compulsive
disorder and depression, to autism
and Asperger’s syndrome in patients

and family members. Previous
research has suggested that family
members may be at increased risk
ior some of these conditions.
Asperger’s syndrome, however,
seems to be associated with a
different developmental profile,
including more preserved language
skills. Related problems also appear
more frequently in family members.
Neuroimaging of brain areas
that may be involved in autism.
Jennifer Levitt, M.D., (UCLA) and
Dr. Schultz hope to identify ways in
which the brain processes informa¬
tion differently in individuals with
autism and other conditions. They
plan to use both structural and
functional brain imaging methods
to examine anatomical brain
differences.
Ways in which the development of
individuals with autism develop and
change as they are treated. Drs. Lord,
Klin, and Volkmar will assess the
range of outcomes and patterns of
these individuals’ developmental
course as they relate to intensity of
intervention, age at diagnosis and
other clinical factors.

Longer steroid treatment helps some spinal patients
A Yale-led, national study of spinal
cord injuries has concluded that
extending the standard steroid
treatment an extra day improves the
odds for patients who do not receive
medication right away.
Michael B. Bracken, Ph.D.,
professor of epidemiology and of
obstetrics and gynecology, led the
scientists and physicians from 16
centers in the National Acute Spinal
Cord Injury Study (NASCIS III).
They reported that giving the
steroid methylprednisolone for 48
hours results in improved function
in patients with spinal cord injury—
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if treatment begins within three to
eight hours after injury. Standard
treatment is 24 hours.
The study, funded primarily by
the National Institute of Neurologi¬
cal Disorders and Stroke (NINDS),
and in part by Pharmacia and
Upjohn Inc., was published in the
May 28 issue of the Journal of the
American Medical Association.
The study compared three
treatments: methylprednisolone
given over a 48-hour period; an
antioxidant drug, tirilazad mesylate,
administered over a 48-hour period;
and, as a control, 24-hour treatment

Michael B. Bracken, Ph. D.

with methylprednisolone. Nearly
500 patients were evaluated in
emergency rooms in New Haven
and throughout the United States
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and again six weeks and six months

24 hours of methylprednisolone if

kind of secondary damage, called

later as part of the randomized,

treatment is begun within three

lipid peroxidation, that eats away at

controlled trial.

hours after injury," says Dr.

highly vulnerable cell membranes.

Bracken, the report's lead author.

They think this secondary damage
becomes more difficult to interpret

Patients who began treatment
three to eight hours after injury

“If patients cannot be treated within

showed significantly better long¬

the first three hours, however, they

the longer initial treatment is

term recovery if they received

should receive methylprednisolone

delayed, which may explain why

methylprednisolone for 48 hours

for 48 hours.”

extending methylprednisolone

than if they received it for 24 hours,

The researchers measured

treatment is useful in patients

or if they received tirilazad. Patients

improvements in patients’ ability to

treated three hours or more after

who were treated within the first

move, perceive sensation, and take

injury. While tirilazad and methyl¬

three hours after injury, however,

care of themselves without assis¬

prednisolone are both powerful

showed about the same degree of

tance. Approximately 60 percent of

inhibitors of lipid peroxidation,

recovery regardless of which drug

patients treated with 48-hour

methylprednisolone may inhibit

they received or how long they

methylprednisolone starting at three

other kinds of secondary damage,

received it. Researchers found that

to eight hours recovered a substan¬

such as the release of chemicals that

patients who received tirilazad three

tial degree of independence, com¬

cause inflammation, the researchers

to eight hours after injury developed

pared with nearly 40 percent of

say. “Researchers still need to

slightly fewer complications than

those given the standard treatment

discover if tirilazad given in differ¬

patients in either methylpredniso¬

or tirilazad. Ultimately, recovery

ent doses, and perhaps for a longer

lone group, but they did not regain

also depended upon the extent of

period, could be more effective,”

as much of their physical ability.

the initial injury.

says Dr. Bracken.

“Based on these results, we
recommend that patients receive

Scientists believe both medica¬
tions work by interfering with a

Scientists probe links between PCP, schizophrenia and dopamine
Scientists at the School of Medicine
have taken a major step toward
understanding cognitive deficits in
sufferers of schizophrenia. Their
findings were reported in the Aug.
15 issue of the journal Science.
Robert H. Roth, Ph.D.,
professor of psychiatry and pharma¬
cology, led a neuroscience research
team that studied the behavior of
African green monkeys that were
given repeated doses of phencyclid¬
ine (PCP), a drug that is often
abused by humans. They found that
PCP induces similar cognitive
dysfunction as that found in
patients diagnosed with schizophre¬
nia. The team found the schizophre¬
nia medication clozapine successful
in partially reversing the cognitive
dysfunction in primates treated
with PCP.
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“The results of this study open
up countless possibilities for future
treatment strategies,” says Dr. Roth.
“It could lead to better drugs for
cognitive brain dysfunction and poor
response inhibition, which are com¬
mon symptoms of schizophrenia.”
Team members include J. David
Jentsch, a graduate student in
neurobiology; D. Eugene Redmond
Jr., M.D., professor of psychiatry
and neurosurgery; John D.
Elsworth, Ph.D., research scientist
in psychiatry; Kenneth D.
Youngren, a graduate student in
neuroscience; and Dr. Roth.
“Until now, researchers have
used only acute doses of PCP in
their studies of behavioral effects
brought on by PCP injections into
laboratory animals,” says Mr.
Jentsch, the report’s first author.

“We used chronic or repeated doses
of PCP to more closely parallel the
same symptoms of schizophrenia
that a PCP abuser develops.”
The scientists showed that
cognitive deficits are associated
with an alteration of the neurotrans¬
mitter dopamine, already linked
to schizophrenia.
The team found that primates
treated with PCP were significantly
less successful at retrieving bananas
from a transparent box than salinetreated primates, indicating poor
response inhibition. The scientists
looked for chemical changes in
PCP-treated primates by measuring
the amounts of dopamine in their
brains. “We saw a reduction of
dopamine in the dorsolateral
prefrontal cortex, the brain area
responsible for working memory,
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and the prelimbic cortex, a brain

ine and in the degree of cognitive

section thought to control behav¬

dysfunction.”

ioral inhibition,” says Mr. Jentsch.

When the primates treated with

“There is a strong link between

PCP were given the drug clozapine,

the degree of inhibition of dopam¬

they showed a marked improvement

in the object retrieval task. The
results are similar to the effects of
clozapine that have been observed
in schizophrenic individuals.

Karen Peart

Access to Internet 2 will speed ‘Visible Human collaboration
The Yale Center for Advanced

Visible Human Project, according

neurobiology professor Gordon M.

Instructional Media (C/AIM) at the

to C/AIM academic director C.

Shepherd, M.D., D.Phil., professor

School of Medicine will be among

Carl Jaffe, M.D. The Visible

of neuroscience and neurobiology,

the first programs to benefit from

Human Project is a 40-gigabyte

will share maps of neural activity

Yale’s participation in Internet 2, a

collection of three-dimensional

patterns with his colleagues at other

nationwide consortium of ioo

digital images of male and female

institutions, showing how neurons

research universities involved in the

human bodies compiled from

development of a new computer

microscopic studies of cadavers.

network more than ioo times faster
than the Internet.
Yale will receive $350,000
from the National Science Founda¬

Two other Yale projects will
make early use of the vBNS connec¬
tion. One, Computational Neuro¬
science and Optical Imaging of Visual

tion over the next two years to

Cortex, is a collaboration between

connect to the very high speed

Steven W. Zucker, professor of

Backbone Network Service (vBNS),

computer science and electrical

which now links 64 research

engineering, and colleagues at the

institutions across the United

University of California at San

States. The University will spend an

Francisco. The second will bring

equal amount upgrading the

together physicists engaged in

campus network.

particle research at Yale and sites in

The faster connection to

Illinois, New York, California and

vBNS—the basis for the Internet 2

Switzerland. Other prospective

consortium, of which Yale is a

vBNS applications at Yale include a

charter member—will enable

project in which neuroscience and

E. Carl Jaffe, M.D.

collaboration among institutions in
such bandwidth-hungry fields as
genetic mapping and sequencing,
modeling of weather systems, and
high-resolution imaging for medi¬
cine, scientific research and the arts.
The collaboration between
C/AIM, established in 1987 to
develop new media for medical

School of Medicine
faculty are collaborators
on the Visible Human
Project, a massive
online database of
anatomical images.

education, and the National
Library of Medicine (NLM) was
one of three programs cited in
Yale’s grant application. Staff at
C/AIM have been limited by
connection speed in their work
with NLM colleagues conducting
detailed image analysis for the
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in olfactory bulbs react to specific

Many other projects are ex¬

odors. His group also is participat¬

pected to receive vBNS access once

with an eventual capacity of 2.4

(bps) to as much as 622 million bps,

ing in the multi-agency Human

installation is complete and its

billion bps. By comparison, the

Brain Project, under which research¬

availability becomes more widely

typical computer modem runs at
only 28,800 bps.

ers are creating databases lor the

known. The service will increase

sharing and archiving of a wide

network speed from the current

range of neuroscience data.

average 1.5 million bits per second

Michael Fitzsousa

City children learn the basics of bicycle safety, helmet use
A School of

United States, especially among

with bicycle helmets and given a

Medicine initiative

children ages 5 to 19. These injuries

four-hour class on helmet usage,

launched during

account for over 900 deaths, 20,000

basic rules of the road, signaling and

the summer may

hospital admissions and 580,000

other cycling skills. A pre-test

save lives by

emergency department visits

measured their knowledge of bicycle

teaching young

nationwide each year.

safety and a post-test measured what

bicyclists safety

Despite a 1993 Connecticut law

they had learned by participating in

skills and promot¬

requiring children under age 12 to

ing helmet use

wear helmets when bicycling, many

among children in

continue to ride without helmets,

New Haven.

putting themselves at risk for serious

programs, was taught by a certified

head injury. “This grant provides a

bicycle safety instructor with the

great opportunity to devise new and

assistance of four local teen-agers,

Greater New Haven awarded

creative ways to prevent head injuries

whose participation was key. “It was

$10,000 to the New Haven Re¬

in children,’’ says Dr. Degutis,

important for the younger children

gional Injury Prevention Program

assistant professor of surgery.

participating in the program to get

Linda Degutis, Dr. P.H.

The Commu¬
nity Foundation for

(NHRIPP), part of the Department

Dr. Degutis explored different

the program.
The course, based on two
national bicycle skills and safety

instruction from teens because

of Surgery’s section of emergency

ways to reach city children with

they’re looked up to as role models,”

medicine, to implement the

the bicycle safety message and

says Laura L. Fawcett, NHRIPP

FreeWheels project developed by

came up with the FreeWheels

program coordinator. “If they see

NHRIPP co-director Linda

project. During the first phase,

older children wearing helmets,

Degutis, Dr. PH.

which took place this past summer,

they’ll begin to view helmets as a

135 children attending New Haven

natural part of riding bicycles.”

Bicycle-related injury is a major
cause of death throughout the

Karen Peart

summer day camps were provided

Yale-New Haven announces alliance in Greenwich
Yale New Haven Health

Greenwich Health Care System, the

quality clinical support for its key

to advanced cancer treatments

parent corporation for Greenwich

programs. The affiliation also

under the direction of their own

Hospital, and Yale New Haven

strengthens its long-established

local Greenwich physicians.
The alliance with Greenwich is

Health System, the state’s largest

collaborative arrangements with

integrated health care delivery and

Yale-New Haven Hospital and the

similar to the one between Bridge¬

financing system, have announced an

Yale University School of Medicine.

port Hospital and the Yale New

agreement to form a strategic alliance.

The most recent example of this is

Haven Health System, which was

Greenwich Hospital’s association

completed in July 1996. The boards

agreement, Greenwich Hospital will

earlier this year with the Yale

of directors and medical staffs will

preserve its local direction while

Cancer Center’s Oncology Network,

remain separate.

gaining improved access to high-

in which cancer patients gain access

Under the proposed affiliation
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At Childrens Hospital, bring in the clowns
A troupe of professional clowns

special medical treatments include

has moved into Yale-New Haven

an eye exam using two rubber

Children’s Hospital and added new

chickens (one large, one small), a

meaning to the phrase alternative

cardiac accelerator (a hairy spider)

medicine.

and plate-spinning platelet tests.

The Big Apple Circus Clown

That’s what brought us into the

in July, has introduced such unor¬

hospital. Once we got in there, we

thodox treatments as red nose

realized that parents of sick children

transplants, kitty cat scans and

need to laugh and that staff who are

chocolate milk transfusions. The

taking care of sick children need to

program, unique to Connecticut, is

laugh as well,” says Michael

based upon similar Big Apple

Christensen, co-founder of the Big

Circus units in Boston, Washington

Apple Circus and originator of the

and New York.

hospital program.
Unit was provided through the

cheering children with juggling,

Greenwich-based Garrett B. Smith

mime, magic and music. Their

Foundation, established by Scott

wins four awards

cancer at Yale-New Haven
Children’s Hospital.

Ken Best

Funding for the Clown Care

visit the hospital three days a week,

Yale Medicine

son Garrett, who was treated for

“Sick children need to laugh.

Care Unit, which took up residence

Professionally trained clowns

and Heidi Smith in memory of their

Excellence in the Robert G. Fenley

research by Yale scientist Peter Hotez,

Writing Awards-Medical Science Writing

M.D., Ph.D., and colleagues might

competition for his Spring 1996 article

interrupt the cycle of infection.

Lowly Worm, High Stakes. It described

Yale Medicine also won two Merit

Fall brought good news to Yale

the impact of hookworm disease, which

Awards in the National Health Informa¬

Medicine in the form of four national

can be especially devastating to

tion Awards Competition for the

awards for coverage during 1996.
On Nov. 1, Mary Kathleen Figaro,

children, in developing countries around

magazine’s Special Reports series.

the globe. The article explained how

The judges recognized the Spring

M.D. ’96, received an Award of Distinc¬

1996 Special Report by writer Marc

tion from the Association of

Wortman on Lyme disease research

American Medical Colleges’

and treatment at Yale (where the

Group on Institutional
Advancement (AAMC/GIA) for

disease was first identified in
1975) and the Summer

her Summer 1996 article

1996 Special Report by

The Beginning, Again. Her first-

Mr. Fitzsousa on

person story was the final

transplantation and

installment in a four-year

organ donation.

series chronicling a student’s

The Special Report

journey though medical school.

series was launched in

Dr. Figaro is a second-year

1995 to bring medicine

resident in internal medicine at

and health news from Yale

The New York Hospital-Cornell

to a wider audience and to

Medical Center.
Editor Michael Fitzsousa
received the AAMC/GIA Award of
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stimulate interest in and
support for medical school
programs and initiatives.
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Eating disorders expert proposes fat tax on foods
Burgers, fries and other high-fat

NEW

BOOKS

Obesity exacts a public health

foods consumed literally by the

toll of approximately $40 billion a

The Best Interests of the Child

ton are making Americans sick and

year due to higher rates of heart

by Albert J. Solnit, M.D.; Sterling

should be slapped with a high-fat

disease, cancer, diabetes, hyperten¬

Professor Emeritus and senior

supertax, says Kelly D. Brownell,

sion and stroke. Instead of blaming

research scientist in the Child Study

Ph.D., director of the Yale

the victims, society should recognize

Center; Free Press (New York) 1996.

University Center for Eating and

that Americans are being seduced

Weight Disorders.

by “our toxic food environment,”

“A whopping 7 percent of

which offers up “a diet that is high

Americans eat at McDonald’s on

in fat, high in calories, delicious,

any given day and the average child

widely available and low in cost,”

sees 10,000 food commercials a year

according to Dr. Brownell.

Biochemistry and Disease: Bridging
Basic Science and Clinical Practice
by Robert M. Cohn, M.D. ’65, and
Karl S. Roth, M.D.; Williams &
Wilkins (Baltimore) 1996.

candy, fast food, soft drinks and

regarded as a potential disease-

Epidemiology, Biostatistics and
Preventive Medicine by James F.

sugared cereals,” says Dr. Brownell,

causing agent, just like tobacco or

Jekel, M.D., M.P.H., the C.-E.A.

professor of psychology and of

alcohol, the researchers conclude.

Winslow Professor of Public Health;

epidemiology and public health. He

“Junk-food advertisements should

Joann G. Elmore, M.D., M.P.H.,

notes that obese children have more

be regulated and excise taxes

assistant professor of

than six times the risk of becoming

imposed on high-fat foods, just as

medicine; and David L.

overweight adults. “Is it any wonder

they are on tobacco and alcohol,”

Katz, M.D., M.P.H.,

on television, 95 percent of them for

Therefore, food should be

that the prevalence of obesity in

Dr. Brownell says. “Taxing ciga¬

lecturer in epidemiology

America has increased 25 percent in

rettes has a clear and predictable

and public health; W.B.

the last 15 years alone to an unprec¬

impact on sales and per capita

Saunders Company

edented level of 35 percent of

consumption, so it would seem

(Philadelphia) 1996.

women and 31 percent of men?”

logical that a high-fat tax, combined

The Ethical Way:
Challenges and Solutions for
Managed Behavioral Healthcare

In a recent issue of the journal

with increased physical activity,

Addictive Behavior, Dr. Brownell

might have a positive effect on

and graduate student E. Katherine

eating disorders and obesity.”

Battle underscore the public health

The Yale researchers advocate

by H. Steven Moffic, M.D. ’71;
Jossey-Bass (San Francisco) 1997.

significance of obesity and recom¬

that revenues from a high-fat tax be

mend policies that would subsidize

used to provide more opportunities

healthy foods, tax unhealthy foods,

and incentives for physical activity

and funnel the proceeds into

in the community, such as bicycle

Donald J. Cohen, M.D. ’66, Director

nutrition education and public

paths, recreation centers and

of the Yale Child Study Center and

exercise programs.

exercise programs. A food tax also

Irving B. Harris Professor of Child

could help fund nutrition education

Psychiatry, and Fred R. Volkmar,

“The next new frontier to be
explored in the eating disorders and
obesity field is that of prevention

programs in public schools.

Cynthia Atwood

Handbook of Autism and Pervasive
Developmental Disorders edited by

M.D., the Harris Associate Professor
of Child Psychiatry in the Child Study

rather than treatment. The policy

Center; Wiley Publishers (New York)

arena is an area of enormous

Second edition 1997.

potential,

Spiritual Passages: Embracing Life’s
Sacred Journey by Drew Leder, M.D.

Dr. Brownell says.

“Legislation and regulations aimed
at the price structure of foods,

'86; Putnam/Jeremy P. Tarcher

opportunities and incentives for

(New York) 1997.

increased physical activity, and
control of exposure to messages

The Therapist Is the Therapy by Louis

leading to unhealthy eating could

B. Fierman, M.D., HS ’53; Jason

have a considerable public health

Aronson Inc. (Northvale, N.J.) 1997.

impact—at very little cost.”
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Dean makes 2 senior appointments

D

ean David A. Kessler,
M.D., announced the
appointment of two senior

administrators in July.
Irwin M. Birnbaum, who
served for 15 years as chief financial
officer at Montefiore Medical
Center and since 1986 as a health
care attorney and partner in the
New York City offices of Proskauer
Rose LLP, became the school’s
new chief operating officer. Mr.
Birnbaum is responsible for all of
the school’s financial, business and
operating aspects, ranging from the
budget to the Yale Faculty Practice.

Mr. Birnbaum, who was awarded

Institutes of Health, Medicaid,

Pie also will be a key interface with

a B.S. degree in 1956 from Brooklyn

maternal and child health, repro¬

the Yale New Haven Health Care

College and a J.D. degree in 1961

ductive health and long-term care.

System, in going forward with the

from New York University School of

During a four-month leave, starting

health care system to meet the

Law, started his career in hospital

in November 1992, she served as a

enormous challenges of the changes

administration as a budget officer at

member of the Clinton-Core

taking place in health care delivery

Montefiore in 1962. By 1970, he had

Transition Team for Health Care

been named chief financial olficer, a

Policy. She has worked as a legisla¬

position he held until he left in 1986.

tive aide for health affairs in the

expert who was counsel to the

As a senior member of Proskauer

Office of U.S. Rep. James H.

Subcommittee on Health and the

Rose’s health law group, he has

Scheuer (D-N.Y.), and a policy

Environment, Committee on

represented hospitals, hospital medical

analyst and staff attorney for the

Energy and Commerce in the U.S.

staff, physician practice groups, and a

U.S. Department of Health and

House of Representatives, was

range of health care organizations

Human Services’ Select Panel for

named assistant dean for adminis¬

across the country. Among his

the Promotion of Child Health. She

tration, with responsibility for day-

publications is the four-volume

also has served as director of public

to-day administrative programs of

Treatise on Health Care Law, which

health programs at the Henry J.

the dean’s office. Ms. Katz, who has

he co-edited.

Kaiser Family Foundation.

and health care education.
Ruth J. Katz, a public health

lectured on public health policy,
and health care policy and politics

Ms. Katz served as counsel to
the Health Subcommittee between

An Atlantic City, N.J., native,
Ms. Katz received a B.A. degree,

at several universities, including

November 1982 and January 1995,

magna cum laude, in 1973 from the

Harvard and Johns Hopkins, also

analyzing policy, developing and

University of Pennsylvania, a J.D.

anticipates teaching in the depart¬

drafting legislation, and managing

degree in 1977 from Emory Univer¬

ment of epidemiology and public

the subcommittee’s considerations

sity, and an M.P.H. degree in 1980

health at Yale.

of such issues as the National

from Harvard University.
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Yale scientists chosen as HHMI

largest philanthropic organization in

investigators

was the result of an intensely

the United States. “Their selection
competitive process and is a tribute

rhe

Howard Hughes Medical

to their ability and promise as

Institute (HHMI) has announced

research scientists.”

that two Yale medical school

HHMI investigators conduct

scientists are among the 70 research¬

biomedical research in five areas:

ers selected in a national competi¬

cell biology, genetics, immunology,

tion to become HHMI investiga¬

neuroscience and structural biology.

tors. I he appointments bring the

In recent years they have made

number of HHMI investigators at

significant discoveries related to

Yale to 21.

obesity, AIDS, cancer, diabetes,

The Yale researchers are
Gerald I. Shulman, M.D

hypertension, cardiac arrhythmias,
associate

cystic fibrosis, muscular dystrophy

Gerald I. Shulman

professor of medicine (endocrine)

and many other medical problems.

and of cellular and molecular

HHMI, which was founded in 1953

physiology; and Tian Xu, Ph.D,

and is headquartered in Chevy

assistant professor of genetics.

Chase, Md., enters into long-term

HHMI also selected two Yale

research agreements with universi¬

faculty based on Science Hill,

ties and other academic research

Jennifer Anne Doudna, Ph.D.,

organizations where its investigators

assistant professor of molecular

hold faculty appointments. HHMI

biophysics and biochemistry, and

investigators conduct their scientific

G. Shirleen Roeder, Ph.D.,

research in institute laboratories

professor of biology. HHMI is the

located on the various campuses.

Book fund
honors professor
The Harvey Cushing/John Hay

Tian Xu

Biochemists join National Academy
of Sciences

Whitney Medical library has
received a gift to establish a

Three medical school

chemist and physicist John

folding into three-dimen¬

book fund honoring Leonard

biochemists were elected

C. Tully, Ph.D., also was

sional molecules. Dr.

R. Farber, M.D., clinical

recently to the National

elected to the academy’s

Moore studies the structure

professor of medicine. The

Academy of Sciences,

membership.

and function of RNA

donor, who wished to remain

bringing the total number

anonymous, is the husband of

of Yale University research¬

researchers use molecular

one of Dr. Farber’s patients

ers who are academy

imaging to reveal how key

research focuses on genetic,

and made this gift in apprecia¬

members to 62. The three

proteins transcribe genetic

molecular biological and

tion for the care given his wife

new members are: Donald

information, how genetic

biochemical studies of the

during her final illness.

M, Engelman, Ph.D., and

code is deciphered, and

function of transfer RNAs

Dieter G. Soli, Ph.D.,

how that deciphered code is

in various organisms.

contain bookplates crediting

both of whom are profes¬

translated into the proteins

the Leonard R. Farber, M.D.,

sors of molecular biophys¬

of human cells. Dr.

organization of scientists
and engineers dedicated to

Books purchased will

The three MB&B

molecules and ribonucleoproteins. Dr. Soil’s

The academy, a private

Book Fund. Such funds enable

ics and biochemistry

Engelman is working with

the library to acquire books

(MB&B); and Peter B.

cell membrane proteins to

the furtherance of science

and periodicals that could not

Moore, Ph.D., professor of

understand how the one¬

for the general welfare, has

be purchased from the

chemistry and of molecular

dimensional information

advised the federal govern¬

library’s operating budget.

biophysics and biochemis¬

found in gene sequences is

ment since its establish¬

try. A fourth Yale scientist,

converted through protein

ment in 1863.
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Dr. Burrow assumes new roles as advisor, professor, historian
Gerard N, Burrow, M.D. ’58, who has
completed his term as 14th dean of
the School of Medicine, was named
the David Paige Smith Professor of
Medicine by vote of the Yale Corpora¬
tion. Yale President Richard C. Levin
announced the appointment in June
at the annual meeting of the Asso¬
ciation of Yale Alumni in Medicine.
Dr. Burrow, who will serve the
University as special advisor on
health affairs to President Levin, is
working on a history of the School
of Medicine, one of a series of six
books commissioned for Yale’s
300th anniversary in 2001. In
addition, he was appointed a senior
advisor to the World Health
Organisation’s Programme on
Maternal and Newborn Health/
Safe Motherhood.
The Smith professorship,
established by an anonymous
bequest in 1912, focuses on the
theory and practice of medicine. Mr.
Smith, who died in 1880, received a
B.A. degee in 1851 from Yale College.

A graduate of
the Yale School of
Medicine and a
member of its faculty
for 15 years, Dr.
Burrow returned to
Yale in 1992 from the
University of California
at San Diego, where
he served as vice
chancellor for health
sciences and dean of g
the School of Medi8<
cine for four-and-ag
half years. In addition s
to his leadership in American
academic medicine, Dr. Burrow
possesses extensive experience in
the Canadian healthcare system. He
spent 12 years in Toronto as physi¬
cian-in-chief and director of the
division of endocrinology and
metabolism at Toronto General
Hospital, and the Sir John and Lady
Eaton Professor and chair of the
department of medicine at the
University of Toronto.

Alumni!ae attending the AYAM reunion
in June rise to give Dr. Burrow a standing
ovation.

As an endocrinologist, Dr.
Burrow has centered his research
interests on the thyroid, emphasizing
how the growth of the gland is
controlled. His clinical interests have
centered on thyroid disease in
pregnant women, particularly the
treatment of hyperthyroidism.

Hematologist awarded endowed chair
Dr. Berliner has been examin¬

took her residency training at the

Nancy Berliner, M.D. ’79, the first

ing the molecular basis of granulo¬

Peter Bent Brigham Hospital and

Arthur H. and Isabel Bunker

cyte differentiation in bone-marrow

Brigham and Women’s Hospital in

Associate Professor of Medicine

cells to gain insights into the factors

Boston, and served as an instructor

(Hematology). The new chair was

leading to the development of acute

at Harvard Medical School for a

created in memory of businessman

leukemia. She and her laboratory

year before joining the Yale faculty

Arthur H. Bunker, a 1916 graduate

colleagues also are focusing on the

as an assistant professor in 1986. In

of Yale’s Sheffield Scientific School,

genetic mechanisms governing

addition to her professorship in

and his wife, journalist Isabel

enzymes in the blood that are

hematology, Dr. Berliner also holds

Leighton Bunker. Mr. Bunker, a

believed to contribute to tissue

an appointment in the Department

partner with Lehman Brothers and

remodeling in inflammatory injury

of Genetics. She has been honored

chairman of American Metal

and repair, and to tumor metastases.

by the National Cancer Institute,

The Yale Corporation has named

Climax Corp., died of leukemia in

A 1975 summa cum laude

the American Cancer Society and

1964. The new chair in hematology

graduate of Yale College, Dr.

was established through a bequest

Berliner earned her medical degree

She was vice president of the

from the estate of Isabel Bunker, a

at Yale in 1979, winning prizes for

American Society for Clinical

magazine and science writer who

best thesis and best qualifications

Investigation in 1995.

passed away earlier this year.

for a successful practitioner. She
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A Yale surgical team visited the

distinguished academic achievement

Nasser Institute in Cairo, where team

by the Alumni Association of the

members perlormed 16 major cardiac

New York Medical College in May

Michael B. Bracken, Ph.D., head

operations in six operating sessions

lor his dedication to the health and

of the chronic disease epidemiology

in March. Future visits are planned

lile of children and their families.

division ol the Department of

as part ol a program to transfer

Epidemiology and Public Health and

Yale expertise to the region.
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prolessor of obstetrics and gynecol¬

The multidisciplinary team was

Marc I. Lorber, M.D., professor ol
surgery (transplantation) and chief of

ogy, spoke belore the Royal College

led by John A. Elefteriades, M.D.,

the section of organ transplantation

ol Surgeons ol Canada in May. His

pro lessor and chief of cardiothoracic

and immunology, was elected

topic was the pharmacologic treat¬

surgery, and included anesthesiolo¬

treasurer ol the American Society of

ment ol acute spinal cord injury and

gist Jane Fitch, M.D., and

Transplant Surgeons at its 23rd

the results ol the recently completed

cardiothoracic surgeon Robert

annual scientific meeting held in

third National Acute Spinal Cord

Gottner, M.D. Dr. Elefteriades was

Chicago in May.

Injury Trial, which he directed.

honorary lecturer at the 5th AlpeAdria Cardiology Symposium at the

James C. Rosser Jr., M.D., assistant

J.G. Collins, Ph.D., and Steven

University of Grax in Austria in May

prolessor ol surgery, was nominated

Marans, Ph.D., were recipients ol

and served as visiting professor at the

for a Computerworld Smithsonian

1997 Ivy Awards presented in May at

University Hospital ol Wales in July.

Award for his Operation Outreach.

the annual Elm-Ivy Awards Lun¬

Also in July, Dr. Elefteriades and

The project is a combination of CD-

cheon hosted by the City ol New

Graeme L. Hammond, M.D.,

ROM multimedia tutorials, objec¬

Haven and Yale University.

professor of surgery (cardiothoracic),

tive-based skill training and remote

lectured at the First International

guidance, which Dr. Rosser created

Dr. Collins is associate professor
ol anesthesiology. As past-chairman

Congress on Thorax in Athens.

ol Connecticut United for Research

to promote the teaching and practice
of minimally invasive surgery.

Excellence Inc., he has helped focus

Myron Genel, M.D., associate dean

The project became part of the

the state’s interests in the field of

for government and community

Smithsonian Institution’s Permanent

biotechnology and has spurred the

affairs, has been elected to the board

Research Collection ol Inlormation

development of educational pro¬

of directors of ResearchlAmerica.

Technology Innovation at the

grams for elementary and secondary

The national organization was

National Museum of American

school students. He also helped craft

founded eight years ago to build

History in June.

a partnership among the Yale Schools

support lor medical research.

of Medicine and Nursing and New

Dr. Genel’s three-year term

Haven’s Career High School.

began in March.

Maria J. Trumpler, Ph.D., assistant
professor of the History of Medicine,
was the primary consultant for The

Dr. Marans is primary leader lor
Peter Igarashi, M.D., associate

Body and Its Image: Art, Technology,

Policing Program, which integrates

professor of medicine, will serve as a

and Medical Knowledge, an exhibi¬

the resources of the Yale Child Study

member of the General Medicine B

tion at Dartmouth College’s Hood

Center and the New Haven Depart¬

Study Section, Division of Research

Museum ol Art. The exhibit explores

the Child Development-Community

ment of Police Service. The

Grants for the National Institutes of

how representations of human

program’s goals are to improve the

Health (NIH) Department of Health

anatomy and disease have changed

skills of law enforcement personnel

and Human Services lor a three-

and developed since the 16th century

in responding to situations where

and-a-hall-year term that began in

and how they have affected the

children are exposed to violence and

January. Study sections review grant

practice of medicine. Dr. Trumpler

to develop research that will

applications submitted to the NIH.

also presented a slide lecture at the
museum entitled Gender and the

strengthen public policy and clinical
care. The U.S. Justice Department

Charles S. Kleinman, M.D.,

Body in Anatomy and Pathology

has provided funds to replicate the

professor of pediatrics, diagnostic

Textbooks, 1500-1990.

program in four other cities across

radiology, and obstetrics and gyne¬

the United States.

cology, was awarded a citation for
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Emperor s new clues?
A medical sleuth searches
for the secret of Napoleons
death and finds there
isn’t one.

By Rachel Engers

T

he death mask of Napoleon
Bonaparte that belongs to
Philip F. Corso, M.D.,

captures in haunting detail the face
of the emperor, with its hooked
nose and asymmetrical mouth,
but gives no hint of the cause of
his demise.
Alive, Napoleon was the subject
of intense medical scrutiny. From

Philip F. Corso, M.D., a Yale College graduate who serves on the medical school’s clinical

1815, the time of his exile to a rocky,

faculty, holds a 19th-century death mask from his collection of Napoleona.

barren isle in the southeast Atlantic,
until his death in 1821, Napoleon was

with the Federal Bureau of Investiga¬

the study of the French emperor.

chronically ill, attended by no fewer

tion as well as one of the world’s

His home in Fairfield County,

than four physicians.

leading authorities on arsenic

Conn., is flush with Napoleona,

poisoning, Dr. Thomas Hindmarsh

including letters in Napoleon’s own

still sealed in a series of four coffins,

of the biochemistry laboratory at

hand, Napoleonic coins, and

has become a topic of medical debate

Ottowa General Hospital.

sketches, paintings and statues of

In death, the emperor, his body

and mystery. Dr. Corso, a 1948

After researching the medical

the emperor. He is writing a book,

graduate of Yale College and assistant

accounts and autopsy reports

tentatively titled The Death of

clinical professor of surgery (plastic)

recorded by Napoleon’s doctors, as

Napoleon: A Medical Inquest, with

at the School of Medicine, has

well as the results of atomic absorp¬

the aim of settling the controversy

turned the question of how he died

tion testing that determined the level

definitively by proving that Napo¬

into a life’s avocation.

of arsenic in strands of Napoleon’s

leon died from natural causes.

One theory holds that Napoleon

hair, Dr. Corso came to the same

“The whole idea of conspiracy

was the victim of arsenic poisoning,

conclusion as Napoleon’s physicians:

lives on forever,” he admits resign¬

murdered by Count Charles de

The emperor was not murdered, but

edly. But to those scholars who insist

Montholon, the French general and

died of stomach cancer complicated

Napoleon was done in, he responds,

aide-de-camp who accompanied him

by a perforating ulcer.

“It’s much easier to write a book

in exile to the island of St. Helena.

Dr. Corso, now emeritus chief

when everyone is dead and no one

Among the alleged motives:

of plastic surgery at Norwalk and

is there to question you strongly.”

Montholon was a major beneficiary

Bridgeport hospitals and St.

For Dr. Corso, the first solution to

of Napoleon’s estate and may have

Vincent’s Medical Center in Bridge¬

this Napoleonic mystery was the

harbored bitterness over the

port and the emeritus president of

correct one.

emperor’s rumored affair with

the Connecticut Society of Plastic

Montholon’s wife. While investigat¬

and Reconstructive Surgeons, has

Rachel Engers is a writer based in

ing this thesis, Dr. Corso consulted

devoted much of the past 25 years to

Hartford.
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STUDENT

NEWS

A window on health policy
(Through which our
student correspondent leaps
head-first fior a behind-thescenes look at the tobacco
settlement debate.)

By Gregory Raskin

B

eing an active medical
student, and in the business
of being in close contact

with the Office of Student Affairs—
even though I am admittedly treated
with skepticism and something just
short of revulsion when I go to
bother them—I saw nothing unusual
when I was paged by those fine folks
from Harkness early one Monday
morning in July. Returning the page,

enough to have been chosen, I

I was extremely surprised to find

offered that the Student Affairs

it the feeling of a private charter.

out that Dean David Kessler and

Office was probably ecstatic over the

The students checked into a hotel

Assistant Dean Ruth Katz were

possibility of a 24-hour window in

on Capitol Hill and went out for a

taking io students to Washington

which they could be assured I would

late dinner of Ethiopian food.

that very evening for a crash course

not come and harangue them.)

on the making of federal health

After a dash to J. Press for a tie

people to National Airport, giving

Early the next morning, the
students met over breakfast to discuss

policy. If I sprang into action, I

worthy of Our Nation’s Capital and

the briefing material that had greeted

would get to be one of those stu¬

an emergency meeting with a cobbler

us at check-in the night before. We

dents. (Later, on the flight home, as

(my size-12 penny loafers, which I

perused the recommendations of the

we students were sitting around

have had since the eighth grade, had

Koop/Kessler report on the proposed

wondering how we had been lucky

developed an unsightly and cavern¬

tobacco settlement, which was the

ous hole on the left sole), I raced to

unifying theme for our daylong

school to meet the group. Dean

experience. Next we walked to the

medical student at Yale. Notes From

Kessler, Ms. Katz, seven fellow

Hart Senate Building on Capitol Hill

a Navajo Winter, his account of a

medical students and two public

for a wonderful session led by Ms.

month-long elective in primary care

health students got to know each

Katz titled Seminar on Federal

at the Indian Health Service hospital

other on the small turboprop shuttle,

Legislative Process. The meeting was

in Arizona, appears on Page 20.

which was ferrying only two other

held in the Senate Judiciary

Gregory Raskin is a fourth-year

42

FALL

1997

Committees conference room. As

on the tobacco issue, discussed his

portraits of past chairmen (all the

take on the morning session in the

way from Martin Van Buren to

Senate. We talked about the role of

Alison Days was awarded the

Orrin Hatch) gazed down on us,

the media in helping to shape public

Novastis Award (previously known

Ms. Katz took us through the entire

health policy. With a deadline

at the Ciba-Geigy Award) at the

ordeal: from the smallest inkling of a

looming large, we were sent scurry¬

Student/Faculty Tea in May for

bill in a senators or representative’s

ing from the Post building and over

laudable extracurricular activity

mind, through the various subcom¬

to the White House.

within the community. She received

mittees, to the floor of Congress, to

I had been to the White House

STUDENT

NOTES

a complete set of the Netter Atlas.

the presidents desk and back again,

once before, for a tour with my

if necessary.

family. This time, though, it would

Pezhman Eliaszadeh, a graduate

be for a meeting in the Old Execu¬

student in public health, was one

knowledge of government, we

tive Office Building, where the vice

of 10 outstanding college students

attended the Commerce Committee

president has his office and many

throughout the U.S. to receive a

oversight hearings regarding the

presidential staffers work. We walked

$1,000 Public Service Scholarship.

tobacco settlement. Staunchly on the

through the interior of the build¬

These awards are donated by the

side of public health, we smiled at

ing—whose 20-foot ceilings, pink

Federal Physicians Association (FPA)

the compelling arguments of Drs.

pillars and huge spiral staircases

in honor of Dr. Gerold Van der

Emboldened with our new

Kessler and Koop, whose testimony

could have been designed by Lewis

Vlugt, past president of the FPA, and

spoke to the faults of the settlement.

Carroll—to a dark conference room.

are designated for students planning

We jeered silently when selected

Waiting for us in the appropriately

a health-related government career.

senators came out on the side of

not smoke-filled back room were

Big Tobacco.

Dean Kessler, Dr. Koop and an

Most senators started off by

David Gershfield was presented the

adviser to the president. The meeting

Marguerite Rush Lerner Award at

saying something obvious, benign

seemed to have two purposes: the

the Student/Faculty Tea in May for
his poem entitled Retrospection.

and noncontroversial, like that they

adviser explained the president’s role

were morally outraged and despon¬

in the tobacco issue, and then the 14

dent to find out that children in

of us had a discussion about what

Jason R. Klenoff was awarded the

America were smoking cigarettes.

message the students thought

Alpha Omega Alpha Honor Medical

I was surprised to see several senators

President Clinton should bring to

Society Student Research Fellowship

far more interested in their constitu¬

the people. Of course, we were

Award in the amount of $3,000 for

ents (tobacco farmers, they claimed,

appropriately unanimous in the

his research entitled Developmental

but I suspected Big Tobacco cam¬

preeminence of public health to steer

Morphometries of Olfactory Receptor

paign donors) than in the public

our government. Even if we hadn’t

Axonal Arbors. Supporting faculty

health of our nation. Also, it ap¬

agreed, it’s probably not that easy to

mentor Charles A. Greer, Ph.D.,

peared that, despite having large

argue with C. Everett Koop.

associate professor of surgery

staffs of countless legislative aides,

By the end of the day, as we

(neurosurgery) and neurobiology,

many of the senators seemed misin¬

walked out into the humid D.C.

formed regarding the particulars of

sunshine, we were all pretty worn

both the tobacco settlement and

out. We had learned about the

Rachel

the public health risks of smoking.

tobacco issue as a model for federal

Villanueva

We left the hearing after the testi¬

health policy and viewed it from

was one of 50

mony of Michael Moore, the

many angles: that of the public

outstanding

Mississippi attorney general spear¬

health community, the legislature,

young medical

heading the settlement.

the media and even the executive

professionals

After a quick interview with the

was recognized as well.

branch. When I popped into the

presented the

New Haven Register (I was even

Office of Student Affairs the next

American

quoted in the following day’s paper),

day to tell them how the trip went,

Medical Association (AMA)/Glaxo

we students and Ms. Katz headed

I could tell by the looks on their

Wellcome Achievement Award by

over to the editorial offices of the

faces they were already hard at work,

the AMA at its annual national

Washington Post for a lunch meeting.

trying to think of another excuse to

leadership conference in March.

John Schwartz, the Posh main writer

send me away from New Haven.

Dr. Villanueva was recognized for

YALE

MEDICINE

43

her work as president of

the Association of Ameri¬

the Student National

can Medical Colleges:

Medical Association.

Alan Cheng, Novel
Strategies in Retroviral-

The letter, please
Match Day, an annual exercise in anxiety,
ends with smiles all around.

For the nth year, Yale has

Mediated Gene Correction

received a generous gilt

of SCID; Jessica Haberer,

from the Howard Hughes

Epitope Mapping of the

Cheers and toasts filled the Ebbert Lounge on Match Day

Medical Institute to

L.pifanoi Amastigote

last March as the members of the Class of 1997 opened

support graduate medical

Antigen P-4 Involved in

education in the biological

T-cell Responsiveness to

sciences. This year’s gilt

Human Cutaneous Leish¬

amounts to $330,000. A

maniasis' Abike James,

long-anticipated letters from the National Resident Match¬
ing Program. Inside was the answer to the question that
hovers over most of fourth year: Where will I train?
The Match uses a weighted formula to pair graduating

portion of the funds has

A Critical Analysis of

been used to create

Interpregnancy Intervals as

students with residency programs around the country. After

graduate fellowships, held

an Explanation for the

applications, visits and interviews, students and residency

in 1996-97 by jin Xie

Persistent Disparities in

(molecular biophysics and

Small for Gestational Age

biochemistry), Karl

Births Between Black and

Hagland (microbiology),

White Women; and Mark

positions were offered in the 1997 Match, with more than

and Qiu-Xing Jiang and

Skirgaudas, Expression of

13,550 U.S. medical school seniors and 3,430 interna¬

Leon Isales-Suarez

Angiogenesis Factors and

tional medical school graduates securing positions. As has

(cellular and molecular

Selected Vascular Wall

been the case for the third consecutive year, more than half

physiology). The remain¬

Matrix Proteins in Intracra¬

the nation’s graduating seniors will pursue training in one

der is contributing to the

nial Saccular Aneurysms.

stipends of 200 students

programs each submit ranked choices, with a computer
sorting out the matches. Some 20,209 first-year residency

of the generalist specialties for at least the first year of
residency, reflecting an increasing trend toward primary

throughout the biological

Volunteers and performers

sciences at Yale.

are needed for the 1998

care training. Among the Yale graduates, more than half are

Peter A.T. Grannum

entering subspecialty training programs this year.

At the 1997 national

Scholarship Jamboree, a

convention of the Ameri¬

variety show consisting of

can Medical Student

poetry, singing and ethnic

Association (AMSA) in

dances. The 1997 jambo¬

Orlando, Yale medical

ree, sponsored by the

students were among those

Student National Medical

presenting award-winning

Association, raised $10,000

research abstracts. Daniel

for scholarships to be given

Coghlin presented his

to New Haven high school

work, Discussing Advance

sophomores or juniors.

Directives in the Outpatient

Students interested in the

Setting: Who Wants to Talk

1998 jamboree may contact

About It Any way? at the

third-year M.D./Ph.D.

presentation of Medical

student Helena Hansen

Student Projects &

at 772-2239.

Marc Wortman

Research session sponsored
by the National Health
Service Corps. The
following students’ work
was presented at the Basic
and Clinical Science poster
session, which is sponsored
by AMSA, the National
Institutes of Health and
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1997 residency
placements for Yale
medical students
The Office of Student Affairs has
provided the following list, which
outlines the results of the National
Resident Matching Program for Yale's
medical school graduates.

Daniel Saal, psychiatry

University of California—Irvine Medical
Center
Monique Lawrence, emergency medicine

University of California—Los Angeles
Medical Center

Emory University School of Medicine,
Atlanta
Peter Ferren, psychiatry
Christiana Muntzel, pediatrics

Daniel Lee, diagnostic radiology
Joseph Wu, internal medicine

University of California—San Diego
Medical Center
Susannah Ehret, medicine/pediatrics
Anil Panackal, internal medicine
Alexander Rivkin, otolaryngology, surgery

ARIZONA

GEORGIA

Susan Wolf, dermatology

LOUISIANA
Earl K. Long Medical Center, Baton Rouge
Carlos Caceres, medicine

Tulane University School of Medicine,
New Orleans
Shawn Nakamura, orthopaedics

University of California—San Francisco
Andrew Haskell, orthopaedics

Good Samaritan Hospital, Phoenix

Mark Skirgaudas, diagnostic radiology

MARYLAND

Frank Moya, transitional

Johns Hopkins Hospital

CONNECTICUT
Hospital of Saint Raphael
California Pacific Medical Center,
San Francisco
Mark Skirgaudas, medicine

Childrens Hospital, Oakland
K. Leslie Avery, pediatrics

Kaiser Foundation Hospital, San Francisco
Jeffrey Tseng, medicine

Los Angeles County-University of Southern
California Medical Center
Mark Spicer, neurosurgery

Stanford Health Services
Melissa Berhow, general surgery
Kristina Crothers, internal medicine
Matthew Klein, plastic surgeiy
Adetokunbo Oyelese, neurosurgery

Tamara Dildy, emergency medicine

University of Maryland, Baltimore

CALIFORNIA

Katherine Day, otolaryngology, surgery

Laertes Manuelidis, medicine
KentTa, transitional
Susan Wolf, medicine

MASSACHUSETTS

Middlesex Hospital, Middletown
David Walker, family practice

Yale-New Haven Hospital
Maryam Asgari, dermatology (research)
John Beiner, orthopaedics
Sumeet Bhanot, otolaryngology, surgery
Robert Camp, pathology
Malabika De, internal medicine
Nina Fisher, dermatology
Janette Gaw, general surgery
Jason Gold, general surgery
Jonathan Grauer, orthopaedics
Anu Gupta, internal medicine
Basem Jassin, otolaryngology, surgery
Stephen Kavic, general surgery
Chang Soo Kim, plastic surgery
Kathryn Leinhardt, internal medicine
Dana Loo, internal medicine
Raburn Mallory, internal medicine
Laertes Manuelidis, dermatology
Frank Moya, ophthalmology
Helena Nolasco, internal medicine
Mark Rubinstein, medicine
Lisa Sanders, internal medicine/primary

FLORIDA
Jackson Memorial Hospital, Miami
Richard Pigeon, orthopaedics

Beth Israel Deaconess Medical Center,
Boston
Carlos Caceres, idiagnostic radiology
Daniella Courban, obstetrics and gynecology
Eric Fan, internal medicine
Nina Fisher, medicine
Jeffrey Meyerhardt, internal medicine

Boston Combined Residency Program in
Pediatrics (Children’s Hospital)
Kelly Cant, pediatrics

Boston Medical Center
Winifred Agard, emergency medicine
Wendy Kuohung, obstetrics and gynecology

Brigham & Women’s Hospital, Boston
Anthony Aizer, internal medicine
Michael Fischer, internal medicine/primary
Joshua Fogelman, medicine
Pieter Pil, general surgery

Deaconess Hospital, Boston
Winifred Agard, medicine
Willis Chou, internal medicine
Jeremiah O’Regan, medicine

Harvard Combined Medicine/Pediatrics
Program (Massachusetts General
Hospital), Boston
Carole Smarth, medicine/pediatrics

Harvard Longwood Psychiatry, Boston
Michele Baker, psychiatry

Massachusetts General Hospital, Boston
Jill Fischer, pediatrics
Peter Siekmeier, psychiatry

Urjeet Patel, left, and Chang Soo Kim toast the
good news. Dr. Patel matched in otolaryngology
and surgery at Washington University and
Bames-Jewish Hospital in St. Louis. Dr. Kim
was selected for his plastic surgery residency at
Yale-New Haven Hospital.
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Barnes-Jewish Hospital, St. Louis
Urjeet Patel, surgery
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Monique Lawrence, now in the University
of California-Irvine Medical Center’s
emergency medicine program, shares a hug
with a friend upon hearing the news.
Behind them is Kevin Daly of the Class of
1998, who has Match Day to look forward
to as a fourth-year student next March.

Nirit Weiss, lefi, of the Class of1998 joins
a delighted Susannah Ehret, who learned
of her placement at the University of
California-San Diego Medical Center for
a residency in medicine and pediatrics.

Washington University, St. Louis
Urjeet Patel, otolaryngology

Presbyterian Hospital, New York

St. Vincents Hospital, New York
Noah Scheinfeld, medicine

NEW JERSEY
St. Barnabas Medical Center, Livingston
Lisa Park, transitional

TEXAS

Brigitte Kerpsack, pediatrics

SUNY—Buffalo Affiliated Hospitals

University of Texas Health Science Center,
San Antonio
W. Randy King, general surgery

Amos Dare, neurosurgery
SUNY—Buffalo/Graduate Medical Center
Julian Anthony, surgery, urology

VIRGINIA
University of Virginia, Charlottesville

NEW MEXICO

Santosh Krishnan, general surgery

PENNSYLVANIA

Julia MacRae, plastic surgery

University of New Mexico School of
Medicine, Albuquerque
Basia Holub, emergency medicine

Abington Memorial Hospital
Elizabeth Benstock, medicine
Childrens Hospital, Philadelphia
Jennifer Femiano, pediatrics

NEW YORK

Eric Frehm, pediatrics
Hospital of the University of Pennsylvania,

Beth Israel Medical Center
Janel Hackney, medicine
Einstein/Jacobi Medical Center, Bronx
Noah Scheinfeld, dermatology
Einstein/Montefiore Medical Center, Bronx
Rani Spudich, plastic surgery
Lenox Hill Hospital
Amos Dare, surgery
Daniel Lee, medicine
Manhattan Eye, Ear & Throat
Lisa Park, ophthalmology

Rachel Rothschild, pediatrics
Rachel Villanueva, obstetrics and gynecology
New York University Medical Center
Joshua Fogelman, dermatology

Karen Kiang, family practice
University of Washington Affiliated
Hospitals, Seattle

Phillip Cheng, internal medicine

Andrea Edwards, internal medicine

Stanford Peng, internal medicine

Shelagh Houghton, internal medicine

Rachel Rapaport, general surgery

Dana Meinke, internal medicine

Amal Sawires, internal medicine

Jeremiah O’Regan, diagnostic radiology

Thomas Jefferson University Hospital,

Jeffrey Tseng, diagnostic radiology

Philadelph ia
Jerome Zink, surgery, urology
Elizabeth Benstock, dermatology
University Health Center of Pittsburgh
Abike James, obstetrics and gynecology

Bradley Ekstrand, internal medicine

Celia Golden, internal medicine

Tacoma Family Medicine

Philadelphia

The Mount Sinai Hospital

The New York Hospital

WASHINGTON

Some names appear twice because the
graduate is entering a one-year program before
beginning a specialty residency.

RHODE ISLAND

The transitional designation is a one-year
program with three-month rotations in

Memorial Hospital, Pawtucket

different specialties.

Christopher Bositis, family practice
Rhode Island Hospital/Brown University,
Providence
Jane Kim, plastic surgeiy

David Meyer, general surgery
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Questions
that open
new fields
Scientific authority is often
not the last word, aspriring
scientists learn on Student
Research Day.
When Judah Folkman, M.D., first
proposed his novel theories of
tumor growth, many leading investi¬
gators of the day scorned his work.
Eventually they were forced to
acknowledge the validity of his
findings on the crucial role blood
vessels play in tumor growth, which
proved to be the basis of an entirely
new area of biology. Learning about
his experiences was just the sort of
inspiration the many aspiring
researchers among Yale’s medical
students needed for their own
required student research projects.
They had the chance to examine the
work of graduating students and to
hear Dr. Folkman first-hand when he

For many. Student Research Day marks the formal entry of medical students
into the research community.

delivered the Lee E. Farr Lecture to
close out the annual Student

part of the Yale System since 1839,

Research Day in May.

making it the longest-standing

Student Research Day also
gave Dr. Folkman, the Julia Dyckman

requirement of its kind among the

Andrus Professor of Pediatric

projects have frequently pointed

Surgery at Children’s Hospital in

students in what prove to be lifelong

Boston, a chance to learn what

career directions.

some of tomorrow’s challengers of

Prior to delivering his talk on

pursued by some 45 medical and

Strategies for the Discovery of
Endogenous Inhibitors of Angiogen¬
esis, Dr. Folkman listened to

public health students were dis¬

presentations by five students

played on posters or presented

selected by the Thesis Awards

scientific authority have been doing.
The findings from original research

orally. Student Research Day

Committee for special honors.

celebrates the conclusion of the

They were:

students’ original research and

► Anthony Aizer, Genetic Variants of

thesis projects. Required research
projects have been a continuous
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►

nation’s medical schools. Past

the Angiotensinogen Gene and
Their Effects on Blood Pressure

►

►

►

Regulation Among People of
African Descent
K. Leslie Avery, Containing the
Backlash against Managed Care
Limits: A Rational Approach
Towards Legislating Mandated
Health Benefits Coverage
Kelly Cant, Genetic and Biochemi¬
cal Characterization of Drosophila
Singed, a Homolog of the Actin
Bundling Protein Fascin
Michael A. Fischer, Excess Sample
Size and the Delta Wobble' in
Randomized Controlled Trials
Dana Meinke, Tat-dependent
Regulation of 3’-End Processing
Efficiency in HIV-1
Marc Wortman
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Only beginning his research, Robert Kadoko, Class of 2000, learns
from Wendy Kuohung what she found in her biochemical work in
obstetrics and gynecology.

Lee E. Farr, M.D., a pioneer in the field of nuclear
medicine and a 1933 graduate of the School of
Medicine, died on July 16. Dr. Farr established the
annual lectureship that has brought Nobel laureates
and other distinguished physicians and scientists to
campus on Student Research Day each year since
1988. Dr. Farr and his wife, Miriam, pictured above
on Student Research Day 1996, often traveled to
New Haven from their home in Walnut Creek,
Calif., to attend the lecture, but they were unable to
do so this May due to his failing health. These pages
Carolyn W. Slayman, Ph.D., deputy dean for academic and scientific

are dedicated to his memory.

affairs, and Bruce I. McClennan, M.D., chair of the Department of
Diagnostic Radiology, listen as Julia MacRae, left, explains her study

Dr. Farr’s obituary appears on Page 70.

of REMEDY, an international program founded at Yale to redistribute
medical supplies to developing nations.
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Pictured with John N. Forrest Jr., M.D.; Farr lecturer Judah
Folkman, M.D.; and associate dean of medical education and student
affairs Robert Gifford, M.D., are five students honored for their
outstanding theses. From left, they are: Anthony Aizer, Dana Meinke,
K. Leslie Avery, Kelly Cant and Michael Fischer.
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Farr lecturer Judah Folkman, M.D., left, and John N. Forrest, M.D.,
director of the OJfice of Student Research, pause among the posters.
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A time for enlightened leadership
The members of the Class 0/1997 face unprecedented challenges as they graduate.
But there has never been a more exciting time in biomedical science.

C

ommencement is a time to
both celebrate accomplish
ment and take a big step

toward the future. For the members
of the Class of 1997, that step is
filled with exceptional uncertainty.
In his Commencement address
May 26, Robert H. Gifford, M.D.,
HS ’65-66, associate dean for
medical education and student
affairs, warned of the potential for
“deadly ethical and Financial conflict
with the current limits being placed
on spending by managed care.”
It was in the spirit of overcoming
conflict that he called upon the
Class of 1997 to be creative in their
approach to this problem as they
embarked upon their careers. “It is
going to be a time for enlightened
leadership,” he said, “and I hope
you will be up to it.”
Whatever thorny issues may lie

Dana Loo, right, shares her delight at finishing her medical degree with ipp6 YSM graduate
Julie Rothstein.

ahead, there was no conflict, only
smiles, apparent as 97 medical

who has returned to the faculty

Campus, Alfred G. Gilman, a 1962

students were awarded diplomas

(See Faculty News, Page 37). As is

graduate of Yale College and 1994

under a tent in Edward S. Harkness

custom, many students and profes¬

Nobel laureate in medicine, was

Hall Courtyard. The class was the

sors were honored for their achieve¬

awarded an honorary doctor of

last to receive its diplomas from

ments. At the University Com¬

medical sciences degree.

Dean Gerard N. Burrow, M.D. ’58,

mencement exercises on Old

Marc Wortman

Class co-president Heather Lynch presents Robert H. Gijford,
M.D., HS ’6j, with the class yearbook dedicated to him.
The much-loved Dr. Gijford had planned to leave his post as
dean of medical education and student affairs at the end of the
academic year, but he was asked by Dean David A. Kessler, M.D.,
to stay on for an additional year.
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Tamara R. Dildy, Society for
Academic Emergency Medicine
Award
Stephen M. Kavic, Connecticut
Society of Board Surgeons Prize
Adetokunbo A. Oyelese and Rachel
Villanueva, Peter A.T. Grannum
Award
Rachel R. Rothschild, Lauren
Weinstein Award
David E. Walker, Connecticut
Academy of Family Physicians
Award
Danica Barron and Michelle Pinto,
Milton C. Winternitz Prize in
Pathology
Urjeet Patel, Endocrine Society
Medical Student Achievement
The color and pageantry of Commencement include a bouquet and smiles for family and

Award

friends as Tamara R. Dildy parades into the Harkness Hall Courtyard.

Thesis prizes
Student honors
and prizes

Malabika De and Jeffrey A.
Meyerhardt, American Cancer
Society Prize

Santosh N. Krishnan, Parker Prize
Benjamin R. Doolittle, Miriam
Kathleen Dasey Award
Joshua P. Fogelman, Norma Bailey
Berniker Prize
Anthony Aizer, Jeffrey A.
Meyerhardt and Rachel
Villanueva, Dean’s Prize lor
Community Service

Curran Prize
Phillip M. Cheng, Ferris Prize
Dana S. Meinke, William U.
Gardner Thesis Prize
Abike T. James, Nicholas J.
Giarman Prize
Maryam M. Asgari, International
Health Prize

David B. Meyer, Campbell Prize

David E. Walker, Keese Prize

Phillip M. Cheng, Perkins Prize

K. Leslie Avery, Dr. Harold H.

Stephen M. Kavic and Rachel
Rapaport, Merck Book Awards
John M. Beiner, Lange Book Award
Kelly Cant and Adetokunbo A.
Oyelese, M.D./Ph.D. Award
Rachel Villanueva, Connecticut
Society of American Board of
Obstetricians and Gynecologists
Prize
From left. Commencement marshals
Lawrence S. Cohen, M.D. ’yo, HS ’

Shelagh A. Houghton, Peter F.

Brigitte F. Kerpsack, New England
Pediatric Society Prize

Lamport Biomedical Research
Prize
Kelly Cant, M.D./Ph.D. Thesis
Prize
Jeffrey R. Tseng, Dr. Louis H.
Nahum Prize
Michael A. Fischer, John P. Peters
Prize
Peter J. Siekmeier, Lidz Prize in
Psychiatry
Anthony Aizer, Louis G. Welt Prize

65, Robert H. Gifford, M.D., HS '6y,
James Jekel, M.D., and Gary Friedlander,
M.D., sing out during the University
Commencement ceremony on Old Campus.
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Faculty Honors
Each year, faculty are honored for
particular contributions to the
education and lives of the graduat¬
ing class. The recipients of the
Class of 1997 prizes were:
► Bohmfalk Prize: James Jekel,
M.D., the C.-E.A. Winslow

► Dean’s Medical Education Farr

Program at Yale and serves as a

Prize: Faculty who have made

master ofTrumbull College.
► American Medical Women’s

special efforts to organize, coordi¬

Association Gender Equity

nate and implement successful

Award: Presented to medical

courses and clerkships receive this

faculty around the country, this

honor. This year’s recipients:

prize honors faculty who have

Walter N. Kernanjr., M.D.,

promoted gender-fair environ¬

assistant professor of medicine,
and Frederick

ment for education and training.

Haeseler, M.D.,

Shanta Kapadia, M.D., lecturer in

Professor of
Public Health,
and Vincent

surgery (gross

associate clinical

anatomy), and

professor of

Laura Ment,

medicine.

M.D., professor

Quagliarello,
M.D., associate

of pediatric

professor of

neurology, shared

medicine, were

the 1997 prize.

honored for
outstanding contributions to
the teaching program, Dr. Jekel
for his clinical teaching, Dr.
Quagliarello for his efforts in the
basic sciences.
► The Francis Gilman Blake Award:
Thomas Duffy, M.D., professor
of medicine and in the Cancer

i f
$ :/ z. /

M*

'jSjgk

B j
v

Center, was recognized as the
most outstanding teacher in the
medical sciences.
► The Betsy Winters House Staff
Award: This honor, which went to
Pauline Chen, M.D., honors the
member of the house staff of YaleNew Haven Hospital who has
made the most significant contri¬
bution to the education of the
students, as designated by the

Jeffrey Meyerhardt feels the warmth of completing his Yale tnedical studies.

graduating class.
► The Leah M. Lowenstein Award:
Women’s health expert Janet B.
Henrich, M.D.,
associate profes¬
sor of medicine
and obstetrics
and gynecology,
received the prize
for being the

Following
presentation of
degrees, graduates,
from left, Daniella
Courban, Kristina
Crothers, Amos
Dare, Katherine
Day and Malabika
De, recite the Yale
Physicians Oath

nonsexist education. Dr. Henrich

authored by Alan C.
Mermann, M.D.,
the school chaplain
and clinical
professor of

also directs the Women’s Health

pediatrics.

full-time faculty
member whose work represents
the highest degree of excellence in
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EPH

A time-honored celebration
Photographs by Melanie Stengel

w

1th its roots in medieval

challenges they face after leaving

Health and is a 1965 EPH alumnus,

pageantry and its

Yale. Dean for Public Health

gave the (acuity address during the

graduates moving

Michael H. Merson, M.D., con¬

ceremony held on the lawn outside

ferred master’s of public health

the Laboratory of Epidemiology
and Public Health.

toward a new millenium, com¬
mencement 1997 lor the graduates

degrees upon 93 students. Ten

ol Epidemiology and Public Health

graduates received doctor of phi¬

(EPH) was a festival of ancient

losophy degrees. James F. Jekel,

pomp and circumstance and a time

M.D., who has retired as the C.-

for more sober thoughts about the

E.A. Winslow Professor of Public

James F. Jekel

Facidty share the joy of students. Here, Peter
Hotez, M.D., Ph.D., associate professor

Asifa Nurani delivered the student address to an audience of several hundred

of epidemiology, shows his pride in the
achievement ofNeda Shargi, whose student
research focused on Dr. Hotez’s hookworm

parents, friends and students.

vaccine project.
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From left: Yu- Ting Lin, Ya-Pei Liu,
Jennifer Meltzer, Garth Rausher and
Winfield Ellis Rehmus listen during the
ceremony under the tent.

Elena Lingas, recipient of the E. Richard Weinerman Fellowship for her involvement in social
and political justice efforts, was the EPH banner-bearer.

Faculty and
student awards

Kathryne Baisley, Nora LabianoAbello, Pia MacDonald, Asifa
Nurani, Veronica Pinell-Salles and
Lara Vu received support to

The recipient of- this year’s Award

undertake research on public

for Excellence in Teaching at EPH

health problems in developing

had a slight problem getting to

countries.

the stage on Commencement
Day to pick it up. She was across

► Kathleen Hara Howe Scholarship:
Garth Rauscher received this

town, receiving her own doctoral

award, given to an incoming

degree from the Graduate School

student who enrolls mid-career or

of Arts and Sciences. Nonetheless,

several years after receiving a

Elizabeth Bradley, Ph.D., M.B.A,

baccalaureate degree.

admired by students for her

► Merit Scholarships: April Bell,

Spring brought Keqin Qi a Ph.D. degree
and a bundle in the form of her infant
son, Raymond.

Jennifer Meltzer and Romericus
Stewart were selected based upon

teaching style as an assistant

Stella Chang and Meike

their interest in health policy or

professor of epidemology and

Hensmann were recognized for

management.

public health in the division of

their outstanding work.

Health, Policy and Administration,

► Richard H. Schlesinger Fellow¬

► E. Richard Weinerman Fellow¬
ships: April Bell, Romeo Caringal,

might have been able to hear the

ships: Marcus Heifetz, Alice Ruby

Kiran Cherla, Elena Lingas,

applause that rose from the tent

and Teri Schreiner were chosen on

Veronica Pinell-Salles and Alice

at EPH.

the basis of their academic

Ruby were chosen for their

achievements and interest in

commitment to social justice,

community-based public health.

awareness oi community needs

Student awards announced at
Commencement this year were:
► The Wilbur G. Downs Interna¬
tional Travel Fellowships:

YALE
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► John Devereaux Thompson
Scholarships: Hyun-Ju Lee,

and involvement in social and
political action.
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’40s

NEWS

William G. Anlyan, M.D. 49, B.S.

North American Society for Pediat¬

’45, chancellor emeritus of Duke

ric Gastroenterology and Nutrition

University and a trustee of the Duke

for her accomplishments in the field

March, forwards the following news

Endowment, was presented the

of pediatric gastroenterology.

from classmate Fred O’Connell,

Lifetime Achievement Award by

Richard W. Breck, M.D. 45

M.D. “Sandy and I had a wonderful

Research!America at its first Re¬

Gene W. Spector, M.D. ’59, a

time at the reunion with a mixture

search Advocacy Awards dinner in

radiologist in private practice in St.

of joy and sadness that we left—joy

March in Washington, D.C. Dr.

Louis, is opening his third imaging

at being able to be and it was with

Anlyan was honored for his career

center with its own magnet.

you again, if only so briefly, and

accomplishments and his lifetime

sadness at having to part. One of

commitment to improving health

my seven daughters, the youngest,

and well-being.

’60s

said when her older sisters were
always leaving for school ‘the
trouble with this world is that there
are too many goodbyes and not

Augustus A. White III M.D.,

’50s

enough hellos.’ Too true! Well, it

Dr.Med.Sci., HS ’63-66, professor
of orthopaedic surgery at Harvard

was a wonderful reunion/renewal

James C. Garlington, M.D. 55,

and we will long remember all of

traveled to Africa in February

MIT Division of Health Sciences

you as you were at Howie in the

with the Association of Yale

and Technology, and orthopaedic

Hills—remarkable you all still

Alumni Educational Programs on

surgeon-in-chief, emeritus, at Beth

Medical School and the Harvard/

looked young and vital, just like

the East Africa safari. “A must for

Israel-Deaconess Medical Center,

those days when the earth was green

animal lovers and adventurers,”

was awarded an honorary Doctor of

and we were young and callow

says Dr. Garlington.

Medical Science degree from Brown

fellows. We had a great trip, driving

University on the 40th anniversary

all over Germany, Austria, Bavaria,

Harold J. Fallon Jr., B.A. 53, M.D.

Switzerland, Italy, with a day in

’57, associate dean for graduate

Brussels. Came back exhausted from

medical education and professor of

Julian Katz, M.D., a post-doctoral

jet lag but full of memories of

medicine at the University of

fellow in internal medicine at Yale

fabulous places and nice people.’’

Alabama School of Medicine in

from 1965 to 1967, was installed as

Birmingham, has assumed his

the 136th president of the Philadel¬

of his college graduation.

Joseph R. Stanton, M.D. 45, has

responsibilities as chair of the Board

phia County Medical Society in

donated his vast library on life

of Regents of the American College

June at the Union League of

issues to the Sisters for Life in

of Physicians (ACP). His one-year

Philadelphia.

New York City, a new religious

term began during the ACP’s 78th

order of women established to

annual session in March in Philadel¬

assist pregnant women. A library

phia. An ACP Regent since 1991,

has been built in a former bomb

Dr. Fallon was awarded mastership

shelter at the convent and was

in ACP in 1989, an honor reserved

dedicated The Dr. Joseph R.

for highly distinguished internists.

Stanton Human Life Issues and
Resource Center. Dr. Stanton

Joyce D. Gryboski, M.D. ’57, HS

also co-authored a restatement

’57-60, professor emeritus of

of the Hippocratic Oath entitled

pediatrics at Yale, was presented the

A Modern Hippocratic Oath.

1966 Schwachman Award of the
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William G. Baxt, M.D. ’67, chair

trauma.” Dr. Morgan, who was

sity, was elected to the Oak Ridge

of emergency medicine at the

profiled in the Summer 1990 issue

Associated Universities (ORAU)

University of Pennsylvania Medical

of Yale Medicine, spent 25 months in

Board ol Directors at the 52nd

Center and associate editor of

prison for refusing to reveal the

meeting of the ORAU Council

Annals of Emergency Medicine, has

whereabouts of her daughter, who

of Sponsoring Institutions. Dr.

been appointed to the Board of

she alleged was abused by the girl’s

Putman was an assistant and

Trustees of the Children’s Seashore

father. Dr. Morgan left the United

associate professor of radiology

House, Philadelphia Center for

States from 1989 to 1997.

and internal medicine at Yale

Health Care Sciences.

from 1973 to 1977.
Siang Yong Tan, M.D., J.D., HS

David P. Millett, M.D. '68, FAA

’71, professor of medicine at the

Morris A. Flaum, M.D., M.B.A.,

Southern Regional Flight Surgeon,

University of Hawaii John A. Burns

HS ’74-77, chairman of internal
medicine at St. Joseph Mercy

a fellow of the Aerospace Medical

School of Medicine in Honolulu,

Association and a trustee of the

and director of both medical

Hospital in Ann Arbor, Mich.,

Civil Aviation Medical Association,

education and the ethics center

has been named senior vice presi¬

made two presentations at the 68th

for the St. Francis Medical Center,

dent of medical and academic affairs

annual scientific meeting of the

was appointed governor of the

for Mercy Health Partners in

Aerospace Medical Association in

Hawaii chapter of the American

Toledo, Ohio.

Chicago in May. His topics were

College of Physicians (ACP) during

The Stresses of Commercial Flight and

the society’s 78th annual session in

O’dell M. Owens, M.D. ’76,

Medical In-Flight Emergencies and

March in Philadelphia. Dr. Tan

M.P.H. ’76, director of reproductive

Oxygen Systems and Their Use in

was elected for a four-year term

endocrinology at Cincinnati’s

Commercial Aviation. Dr. Millett is

and also represents ACP members

Christ Hospital, delivered the main

retired from both the Air Force and

on the National ACP Board

address during June commencement

from Eastern Airlines, where he was

of Governors.

exercises at the University of

director of flight medicine.

Cincinnati. During the ceremony,
Charles E. Putman, M.D., senior

he was awarded an honorary Doctor

vice president for research adminis¬

of Humane Letters degree.

tration and policy at Duke Univer¬

’70s
Frederick L. Greene, M.D., HS
’70-76, director of surgical oncology
at the University of South Carolina
since 1980 and tenured professor of
surgery since 1987, has been named
chairman of the Department of
General Surgery at the Carolinas
Medical Center in Charlotte, N.C.
Elizabeth Morgan, M.D. ’71, HS
’71-77, writes from Washington:
“Have now returned from seven
years’ exile in New Zealand and a
decade of career disruption as a
result of family court disruption of
my life. I am now able to resume
my career, I hope, and with good
fortune to be able to combine my
interests in surgery and severe
physical trauma with those in
psychology and severe psychological
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Neurosurgeon elected to Yale Corporation
Nationally renowned neurosur¬
geon Dr. Benjamin S. Carson
was elected in May as alumni
trustee of the Yale Corporation
in a worldwide balloting of
University alumni/ae.
Dr. Carson, who graduated
from Yale College in 1973, has
achieved recognition both for his «
skill as a surgeon and as an
g
inspiring role model for disad»
x
vantaged young people. He
heads the department of
pediatric neurosurgery at the
Johns Hopkins Medical Institutions and is associate
professor of neurosurgery, oncology, plastic surgery

Patrick F. Carone, M.D., M.P.H.
’77, director of psychiatry at Long
Island’s Mercy Medical Center, was
appointed in April to chair the New
York State Board for Professional
Medical Conduct. Dr. Carone, first
appointed to the board in 1993, has
served on numerous hearing panels
and is a member of the Physician
Retraining Subcommittee and the
Advisory Committee.
K. Randall Young Jr., M.D., HS
’78-85, writes to say: “After three
years at the National Institute of
Allergy and Infectious Diseases,
I joined the faculty here at the
University of Alabama at Birming¬
ham, where I direct the Division
of Pulmonary and Critical Care
Medicine and hold the Ben
Vaughan Branscomb Chair in
Medicine in Respiratory Diseases.”
He has been in touch with house
staff colleagues Shawn Skerrett, Bob

56

and pediatrics at the Johns Hopkins
School of Medicine.
Two years ago, Dr. Carson and his
wife, Lacena, a 1975 Yale graduate,
founded the USA Scholars Fund, a national
program that makes annual awards to
students in grades 1 to 12 who both have
the highest marks in their schools and
who participate in community activities or
demonstrate humane concern.
Dr. Carson has been recognized by
the Alpha Omega Medical Honor Society,
the Academy of Achievement, and by the
Horatio Alger Society of Distinguished
Americans. In 1996 he received an honorary Doctor
of Medical Sciences degree from Yale University.

Silverman and Randi Leavitt. “If
anyone gets down to the heart of
Dixie (as it says on Alabama’s license
plates), we ll show them the best of
Southern hospitality.”

’80s
Aziz L. Laurent, M.D. ’81, staff
physician in the student health
center at the University of Texas at
Austin, is a principal investigator for
Phase I drug studies at Pharmaco
International. Dr. Laurent also is
house physician for the Four
Seasons hotel in Austin and a
member of the ethics committee of
the Travis County Medical Society.
Jed B. Gorlin, M.D. ’82, was
named associate medical director of
Memorial Blood Centers of Minne¬
sota in July.

Amanda Dill, M.D. 86, was
elected a fellow of the American
College of Physicians last
November.
Leo K. Mills, M.D., post-doctoral
fellow in internal medicine (cardiol¬
ogy) from 1988 to 1991, is a cardiolo¬
gist at Green River Heart Institute
in Owensboro, Ky.

’90s
Chai Kulsakdinun, M.D. ’93, a
resident in orthopaedic surgery at
Yale-New Haven Hospital, and Julie
Wang, B.A. ’87, an investment
banker, were married on May 30 at
the Loeb Boathouse in Central Park
in New York.

FALL

1997

ALUMNI

REUNION

WEEKEND

1997

As world changes, reunion remains a constant

I

f you attended Alumni Reunion

reception in the Historical Library,

M.D. ’71. Both Dr. Davey and Dr.

Weekend this past June, you

the group was off to the Harkness

Foster have devoted much of their

may have noticed that the event

Hall courtyard, where the patio

time and energy to the Alumni

followed a pattern that has become

had been transformed for a New

Association and the Alumni Fund.

comfortably familiar: handshakes,

England-style clambake that

hugs, strawberry shortcake, nostal¬

featured lobster and shrimp.

reunion classes spread out among

gia, photos of children and grand¬

Entertainment was provided by The

various restaurants and private

children, applause for reunion gift

Cellmates, a rock band composed

homes for their class dinners. The

chairmen and class volunteers—and

of Yale scientists and researchers.

Friends of the 50th dinner was held

Saturday morning’s program

at the Graduate Club, honoring the

a standing ovation for Helen

Saturday evening found the

Langner, M.D. ’22, at age 105 our

began with a faculty seminar on

Class of 1947. Also in attendance

most senior alumna! As you will

New Directions in Treatment of

were graduates senior to their 50th

read in detail in the following

Cancer. Participants included Dr.

reunion year, members of the five-

reports, it was a truly memorable

Deisseroth; Edward Chu, M.D.,

year-reunion class, and members of

and special weekend for everyone.

Ph.D.; Frank Hsu, M.D., Ph.D.;

the administration. It was a evening

and Barbara Burtness, M.D.

of lighthearted conviviality, high¬

class is celebrating a five-year

Following the seminar, the annual

lighted by members of the class

reunion next June—and even if it

meeting of the Association of Yale

playing the piano—and one tap

isn’t—that you will join us for this

Alumni in Medicine was held. The

dancing for the group during dessert.

special weekend. Here is a rundown

group was honored to have greet¬

All of us here hope that if your

of what happened this year:
More than 250 alumni/ae and

ings and remarks from Yale Presi¬

Plans for next year’s reunion
weekend, scheduled for June 5 and

dent Richard C. Levin. Dr. Burrow

6, are now under way. Alumni/ae

guests attended. The weekend

gave his final State of the School

who graduated in years ending in a

started with seminars where class¬

address and reviewed his years as

3 or an 8 will be celebrating their

mates discussed the paths of their

dean. The meeting concluded with

anniversaries. We look forward to

careers and their thoughts and

the presentation of the Distin¬

seeing you in New Haven.

opinions on the future of medicine,

guished Alumni Service Awards to

remembering fondly the Yale System

Dr. Davey and John W. Foster,

William K. Jenkins
Managing Director, Office of Alumni Affairs

of medical education. The formal
welcome and introduction were
presented by Lycurgus M. Davey,
M.D. ’43 March, president of the
Association of Yale Alumni in
Medicine (AYAM). Outgoing Dean
Gerard N. Burrow, M.D. ’58,
welcomed the group and introduced
Albert B. Deisseroth, M.D., Ph.D.,
chief of the section of medical
oncology and associate director of
the Yale Cancer Center, who
discussed The Revolution in Genetics
and Health Care. After the dean’s
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The new slate of
AYAM officers,
from left: President
Nicholas M.
Passarelli, M.D.
ft; Secretary Peter
N. Herbert, M.D.
'6y; Vice President
Gilbert F. Hogan,
M.D. ft; and Past
President Lycurgus
M. Davey, M.D.
43

March.
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1922
75th reunion

REPORTS

resources. My main interests always

would not be able to come.

were science and medicine and they

I personally have been suffering

remain so.

recently from an unsolved neuro¬

By Helen P. Langner, M.D.

logical disorder that is partially
disabling my left hand and arm.

I always attend the Yale Alumni
Reunion and this year was my big
75th Reunion, which made it more
special for me.

1937

It must be that old age is creeping

60th reunion

up on the Class of 1937! I sincerely

By Albert D. Spicer; M.D., D.M.D.

represented this year.

regret that the Class of 1937 was not

1 look forward to and always
enjoy meeting and having conversa¬

The Class of 1937 consists of 18

tion with the distinguished scien¬

living members. I enthusiastically

tists who have made noteworthy

hoped to contact enough members

research findings. The scientific

for a fair representation of the class

seminars that are presented, report¬

at our 60th reunion. I made a few

ing their more recent developments

calls, but received no commitments.

in research, are one of the highlights

There always seemed to be one

The reunion was an enjoyable

of my day.

reason or another why they prob¬

experience in every respect except

The company and conversation

1942
55th reunion
By Samuel Ritvo, M.D.

ably wouldn’t be able to attend. The

for the small turnout of the Class of

of my alumni is always pleasant and

outlook was not very encouraging

1942. The program coordinated by

enlightening. By the day’s end I feel

since there were only three of us at

the alumni association provided a

up-to-date on all of the Yale activi¬

the 55th reunion: Wilbur Johnston,

gala setting with interesting talks on

ties and what is expected to come.

Dennie Pratt and myself. Wilbur

the cutting edge of medical science,

After a long, wonderful day, I return

lives in New Haven and at the

followed by Dean Burrow’s recep¬

home with all my memories to

present time is not too well. Dennie

tion with an opportunity to greet

recuperate. Then it is back to my

Pratt, who lives in Bass Harbor,

Dr. David Kessler, the incoming

interests of conservation and natural

Maine, telephoned me to say he

dean. The excellent New England
clambake, which followed, was
further enlivened by the faculty
rock band playing and singing their
“molecular biological neuro¬
scientific” creations. At the reunion
dinner at the Graduate Club on
Saturday, we were the oldest class,
represented by Bill Harrison,
Leo Kellerman, IrvWolfson, my
wife, Lucille, and me. Jim Bunce
attended the Friday activities, but
could not be there Saturday. Moe
Tulin, who reported by telephone,
keeps up a keen interest in medi¬

PETER CASOLINO

cine. He particularly enjoys having a

Helen P. Langner, M.D. '22, receives an
ovation and bouquet of flowers during the
annual meeting of the Association of Yale
Alumni in Medicine in June.
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seat designated for him as the senior

The name tags were very helpful in

member of the medical staff when

lots of cases!

he attends grand rounds at his old

Friday evening we met at

hospital. We are grateful to whom¬

Mory’s for lifestyle updates, a good

ever had the idea of seating the

deal of reminiscing and a great

three members of the youngest

dinner. There were no speeches, no

class, 1992, at the same table. It

assigned seats—a very informal

was refreshing to partake of their

affair. Bob Chase presented a

enthusiasm for what they were

videotape he’d produced from

doing. All our class members who

classmates’ photos current and past.

attended are retired, enjoying their

It was a delight and served as a

special interests, except for me. I am

springboard ior a multitude of

fortunate to be in a field (psychiatry

comments, some memorable, some

From left: Evelyn Gordon, Martin E.

and psychoanalysis) where I can

best forgotten! Bob had copies for

Gordon, M.D. ’46, and Lucille Ritvo.

continue to practice and to teach at

all. This was a very generous task in

the Yale Child Study Center, where

time and expense on his part, and

remarks on the part of some of the

I enjoy the stimulation provided by

many thanks were extended. As we

participants.

students and colleagues.

were leaving, we encountered the
’92 Whiffenpoofs assembled with

1947
50th reunion
By Philip H. Philbin, M.D.

Saturday night the good times
went on at the Graduate Club.

their Great Mug on high. Happily

Preceding dinner were cocktails,

responsive to requests, they were

conversation and exquisite music,

truly outstanding, an unexpected

the latter thanks to Vic

bonus, a proper conclusion for a

Machcinski, the official class

notable occasion.

pianist. During dinner, between

The program at the medical

courses, Dean Burrow and Drs.

Our class experienced what was

school and the luncheon that

easily the most enjoyable of all of

followed on Saturday were ex¬

Drs. Olive Pitkin Tamm, Jack

our reunions. The good times

tremely well received. At that time

Cannon, Frank Epstein and Bill

began at registration, which was

the class picture, shepherded by a

Collins then captivated the audi¬

painlessly expeditious and where

nervous but tolerant (almost

ence with comments that can only

many familiar, albeit somewhat

weeping) photographer, was com¬

be described as hysterical rather

different, faces started to shape up.

pleted despite several acerbic

than historical. Moving to the

Davey and Spinelli spoke briefly.

ballroom after the repast, the group
was fortunate that classmate Brock
Lynch had agreed to a dance
exhibition accompanied by a singalong by those present. Dancing is
stressful enough; trying to dance
during the resultant cacophony
would tax anyone’s concentration!
Brock hung in there, did a profes¬
sional, totally enjoyable perfor¬
mance. The night seemed a happy
time for everyone.
On a gorgeous, sunny Sunday
morning Bob and Martha Newton
opened their beautiful home to the
class for the perfect reunion finale—
Brock Lynch, M.D. ’47, left, catches up
with Rocco M. Fasanella, M.D. ’44, HS ft,
during the Dean’s Reception in the Medical
Historical Library during reunion weekend.
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a tasty, informal brunch under the

and Gwen, Phil and Jo Philbin,

and our shared stories, enthusiasms

most attractive of circumstances. It

Irving (Billy) Rudman, Ellis Van

and experiences. Actually our happy

was another grand memory of our

Slyck with his wife, Ann; Olive

band of reunion celebrants con¬

50th, which I’m sure we ll recall

Pitkin Tamm, Hank Williams and

sisted of 17 persons: Maurice L.

many times. The class owes a debt

last, but certainly not least, Root

Bogdonofif, Prank R. and Barbara

of thanks to Bob Newton, Bob

and Marie Ziegra.

Coughlin Jr., Richard D. and

Kerin and those thoughtful, ever
helpful staffers in the alumni office.

Bill Thompson, Rocco

Mary Botts Lloyd, Arthur P. and

Calandruccio, Dick and Betty

Catherine Hustead, Joseph A. and

Carlin, Archie Dean, Arthur

Sarah Montimurro, Robert L. and

attending our 50th were George

Chapman, Steve Gehrs and Pat

Janiece Nolan, Robert F. and Edith

and Ellie Barnes, Hank Blansfield

Tudbury tried their best, but just

Trugly Owen, Robert G.

and Lorraine, Roy and Margaret

couldn’t make it. Hope we see all of

Petersdorf, John M. Roberts and

Breg, Jack Cannon and Doris, Jack

them next time.

Louise Regan, and John L. Wolff.

Those of the Class of 1947

Carpenter and Casey, Charlie

In preparation for the reunion,

Cavanaugh and Elizabeth, Bob and

John Wagner, class secretary,

Ann Chase, the Chernoffs, Amos

assembled and distributed a folio of

and Renate; Bill Collins and Gwen,
the Darrows, Bob and Sue; Jean
Daugherty, Frank and Sherrie
Epstein, Dick Friedlander and

1952

Class of 1952 profiles contributed by

45th reunion
By Frank Coughlin, M.D.

Nancy, Frank and Ann Horton,

24 of our classmates. Most of our
class have retired from active
medical teaching and practice after
busy careers with active community

Bob and Claire Kerin, Anton

Forty-five years and one day after

and family lives. The folio memori¬

Lethin and Bonnie Ayers. Mary,

our diplomas were presented to us,

alized seven others who had died

Brad Colwell’s widow, was nice to

signed by President Alfred Whitney

since 1992: Siggie Centerwall, Bill

come. Also present were Dick Levy

Griswold, 11 of 27 living classmates,

Minturn, Bill Klatchko, Bob

and his wife, Barbara; Brock

out of our original 66 students,

Zeppa, Bill Stephenson, Don

Lynch, Vic and Barb Machcinski,

returned to Yale. Over two days we

Schultz and Ray Duff. Dick and

Willie McClelland and Jean, Bob

enjoyed a delightful reacquaintance

Ruth de Niord Jr. were unable to

and Martha Newton, Mike Nobil

with our school, our fellow students

attend this year.
With the able support of the
Alumni Affairs Office we partici¬
pated in a program that showed us

In the
steps of
Peter Parker

something new and helped us to
appreciate something old: The Yale
System is alive and well! Students are
selected on the basis of intelligence,
performance and compassion;

Arthur Ebbert Jr., M.D.,
received the Peter Parker
Medal during reunion for his

students come from diverse back¬
grounds and share a commitment to

long and remarkable service
to the School of Medicine.

excellence and life-long learning.

Dr. Ebbert, a former deputy
dean and founding editor

sion that we were fortunate to have

of Yale Medicine magazine,

Uniformly, we came to the conclu¬
the opportunity to commence our

is professor emeritus of

life’s work at Yale University School

medicine. The medal,
awarded periodically by

of Medicine.

the dean, is named after
the Rev. Peter Parker, an

On the first day of class reunion
we assembled in the Hope Building.

1834 Yale medical graduate
and missionary who

Each of us reviewed something

established the first Western
hospital in China.

of Yale, and our hopes and concerns

about our careers, our impressions
for the direction in which the
school will move in this era of
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managed care, advanced medical

June 7. We had our traditional class

technology and electronic commu¬

meeting, following luncheon at

nication. In the afternoon we were

Harkness Hall, on Saturday after¬

welcomed by AYAM president Bill

noon in a pleasant room in the Hope

Davey. Outgoing Dean Gerard N.

Building. Hal Fallon (a dean at the

Burrow, M.D. ’58, then spoke to us

University of Alabama School of

optimistically about the state of the

Medicine), Stan Kilty (public health

school. We enjoyed Professor Albert

and HMOs), and Ron Fishbein

B. Deisseroth’s dramatic presenta¬

(life as a surgeon in private practice)

tion on the Revolution in Genetics

thoughtfully shared their interesting

and Health Care.

professional experiences with us. A

After the Dean’s Reception in

sad moment was spent remembering

the Historical Library, which looks

the eight members of the class who

pleasingly familiar, we adjourned to

had passed away.

a New England clambake.
On the following day after

In contrast to the two previous

breakfast, we attended a faculty

pleasant, adding to the great success
of a new event—an excellent clam¬

and then concluded the morning

bake in the courtyard of Harkness

with the annual meeting of the

Hall on Friday evening—and to the

AYAM led by Bill Davey (who was

enjoyment of the class dinner on

Dr. Bill German’s chief neurosurgi¬

Saturday evening, held at the

cal resident when we were in our

Stony Creek home of a cousin of

clinical years!). At the meeting,

Carol Hogan.
The following classmates were

concerning school finances, the Yale

present: Vince and Daria Andriole;

System, student selection and

Jane Battaglia and her granddaugh¬

performance, and the school’s need

ter, Jessica Harris; Jack and Barbara

for alumni support.

Blechner; Richard and Laurel

Our final evening together as a

Breuer; Harry and JoAnn Briggs;

class featured a class dinner at

Ed Eyerman and Janet Vitt; Hal and

Barkie’s restaurant. This provided

Jo Ann Fallon; Bob and Joan

another opportunity to renew old

Fishbein; Ron and Estelle Fishbein;

friendships, to share life stories and

Tony and Mary Fons; Liz and Ben

to talk about Yale.

Forsyth; Gil and Carol Hogan;

We came away refreshed and

Yale University’s life income
program offers graduates of the
School of Medicine the oppor¬
tunity to:
■

reunions, the weather was clear and

seminar led by Professor Deisseroth,

questions were asked and answered

Contribute to the
School of Medicine’s
Future and Invest in
Your Own

Help ensure the future
of a great institution

■

Receive quarterly
income payments
for life

■

Increase your income
from low-yielding stock with¬
out incurring capital gains
taxes

■

Reduce federal and
state taxes

Please call or write to see if you
can use these benefits to the
mutual advantage of you and
the School of Medicine.

Dick Kahler; Stan and Carol Kilty;

appreciative of the good fortune

Bill and Priscilla Kissick; Jack

that brought us to a superb place of

Levin; Howie and Gretchen

education at the early stage of our

Minners; Bob and Jill Modlin;

adult lives and the knowledge that

Herb and Ann Newman; Ray

Yale continues to offer others the

Phillips; Cliff and Barbara Reifler;

same opportunity today.

Mel and Marianne Roberts; Don

Yale University

Stahl; Bill and Barbara Waskowitz.

School of Medicine

As usual, Carol and Gil Hogan

1957
40th reunion
By Jack Levin, M.D.

Office of Planned Giving

provided a lovely evening, in a very

P.O. Box 2038

attractive setting overlooking the

New Haven, CT 06521-2038

Thimble Islands. The food was good
and plentiful, and everyone enjoyed
the opportunity for extensive conver¬

1-800-445-6086
Fax: 1-203-432-7901

sations with their classmates. Over
The Class of 1957 held its 40th

one-third of those who attended

reunion activities on Saturday,

were retired, emphasizing that 40
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Distinguished by service
Lycurgus M. Davey, M.D., ’43 March, left, and John W Foster Jr., M.D.
’71, HS ’72-76, above, received the Distinguished Alumni Service Award
during reunion in June.
Dr. Davey, who worked for legendary neurosurgeon Harvey Cushing as a
Yale undergraduate, was lauded as “a living bridge to a golden era of
medicine at Yale. "He practiced neurosurgery in New Haven for five
decades and was president oftheAYAM from 1993 to 1997.

o

Dr. Foster, chief of radiology at Westerly Hospital in Rhode Island, served
the school for many years, most recently as chair of the YSM Alumni

o
<S)
<
o
cr

Fund, and remains an active member of the AYAM executive committee.

CL

years had actually passed since

serious talk were Bill and Anne

from traveling to New Haven. John

graduation.

Miller, John and Trudy

Godley had a daughter graduating

Harrington (John is now dean of

from medical school in Chicago.

updated class book that will provide

Tuffs Medical School), Arnold and

Tom Dann wrote that his oldest

current addresses and telephone

Nancy Eisenfeld, John and Carol

child, Sara, is a second-year resident

numbers. With retirement, many

German, Steve and Kate Fricker,

in child psychiatry at Johns Hopkins

members of the class have moved and

Fred and Jane Cantor, Dave Seil

and his youngest child is in high

can no longer be found at their usual

(Dave had a video he had made

school. Pat Hassakis sent her best

I am planning to prepare an

locations. In addition, it might he

from old class pictures of our

wishes and regrets from Santa

very helpful to know who now lives

fourth-year picnic—everyone had

Monica. Dick Collins was moving

(or has a vacation home) in places

more hair), Jim and Joyce Spencer,

from the U.S. Embassy in New

one might be visiting! If anyone has

Stan and Maureen Matyszewski,

Delhi to the U.S. consulate in Hong

news that they would like to have in¬

Dick and Peggy Pschirrer (thanks

Kong. The week before reunion,

cluded in this publication, please

for being the on-site hosts!), Bruce

while on vacation, John Foreman

write to me at 87 Shore View Av¬

Elfenbein, (Bruce came up by train

was thrown from a horse and suf¬

enue, San Francisco, CA 94121.

from Philadelphia Saturday just to

fered back injuries; luckily he has re¬

1962
35th reunion
By Michael Alderman, M.D.

join us for dinner) and Alan and

turned to the practice of pediatrics

Rhona Fieberson. Mickey Aider-

with a body brace and gadgets that

man had expected to join us but the

enable him to get around.

pressure of an early morning

Not many of us got to New

departure for Europe kept him away

Haven this year for our 35th Re¬

at the last minute.

union. Five years seems such a long

Several classmates (Manny

time until the 40th, so some of us

Fipson, Glenn Kelly and Tom

thought that a reunion midway

In New Haven for fun, laughs,

Chase) had family and/or practice

might be in order—in sunnier

memories, good food and some

commitments that prevented them

climes, of course. Perhaps that will
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persuade more of you to join us.
We missed the rest of you and

husband, Roger LeCompte; Dick
Swett and his daughter, Diana;

trust that you are well and thriving.

Bob Young, Ihor Zachary and

Let us hear from you!

Peter Zeman.
The mood was a little different
this time, a little more earnest, as be¬

A Charitable
Annuity:
The YSM gift
that rates

fits our age. After all, we’re all about

1967

55 years old now (except for
Dowaliby, who against all advice

In exchange for a gift of $5,000

stubbornly persists in remaining 13

or more, the School of Medi¬

years older than the rest). Time’s

cine can offer you, or you and

wing has brushed us all. Two of the

your spouse, a fixed annual

At our five-year reunion in 1972 we

members are retired on disability.

income for life.

started talking Friday noon and did

Another is about to have surgery

not slow down until Saturday

for prostate cancer, and a fourth

Your age(s) and market

midnight. It was as if we had never

has just been diagnosed as having

rates of interest determine

been apart, as if we had just come in

significant valvular heart disease.

your income level.

from anatomy or pathology and had

There was a flurry of informal con¬

sat down to have a beer and talk

sultations as we sought to confirm

over the day. The ease with which

our down-home physicians’ opin¬

we slipped back into a comfortable

ions with classmates—the people we

and confiding relationship with

really trust.

30th reunion
By Janies Dowaliby III, M.D.

each other was astonishing—and
gratifying.
Twenty-five years after that first

Current sample rates:
Age(s)

Rate

One life
55

5.0%

talk. Of children, of work, of the

66

6.1%

medical climate, of retirement, of

77

8.3%

Above all, the talk, the endless

reunion I am no longer surprised,

travel, of adventure. When our din¬

but I am still gratified. Now I know

ner on Saturday night in the private

Two lives

that it happens every time. At our

back room at Adriana’s was over and

66/65

5.0%

30-year reunion we started talking

the talking had finally wound down,

75/74

6.1%

Friday noon and did not slow down

the furniture in the main dining

82/79

7.3%

until Saturday midnight. Tony

room was stacked up and the restau¬

Lovell says that we have the Yale

rant staff were quietly waiting for us

System to thank. Since we were not

to leave so that they could shampoo

a proposal to your

set in grim competition with each

the carpets. It was a little before

philanthropic
and financial goals.

other, we spent the first two years

midnight. Everyone had to get up

working together, helping each

and head for home in the morning.

other and forging bonds of confi¬

We had not run out of things to

dence and friendship. I suspect that

talk about. I can assure you of that.

he is right. In any event, it is clear

We never will.

Please allow us to tailor

that those bonds are powerful and
indissoluble.
There were 27 present for our
30th: Dan and Elissa Arons, Rich¬
ard Bockman, Mary Williams

1972

Yale University

25th reunion

School of Medicine

By Harry L. Malech, M.D.

Office of Planned Giving

and Lilian Hart, Peter and Maureen

June 1997 marked a quarter-century

New Haven, CT 06521-2038

Herbert, Tony and Kathy Lovell,

since our class finished what already

1-800-445-6086

Bill Perkins, Brian and Robin

is an ancient historical version of

Fax: 1-203-432-7901

Rigney, Stephen and Carol

the Yale “new” curriculum. The

Schimpff, Helen Smits and her

25th-year reunion of our class was

Clark and her husband, Jerry Lee
King; Alex Dora, Jim and JoAnne

P.O. Box 2038

Dowaliby, John Drews, Richard
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very well attended. Though not

the end ofTwin Coves Road in

rie of our medical school days. Talk

everyone could participate in all the

Madison. We are very grateful to the

ranged from juggling family issues

events, I am pleased to report that

Haaks for their hospitality, provid¬

to managed care to the whereabouts

30 of our classmates (more than a

ing a comfortable and informal

of other classmates.

third of our class) were in atten¬

gathering for at least 20 classmates

dance at one or more reunion

and some spouses.

events. Felix Freshwater’s generous

Some of those at Bruce’s house

matching gift challenge to our class

included Paul and Ann Lucky,

Present were: Gerald Brody
(and wife, Pat), Harriet Comite,
Sybil Duchin (and husband, Art),
Julia Frank, Attilio Granata (and

provided a special theme and

Charles Scholhamer, Larry and

wife, Claudia Dinan, YMS ’80),

significance to our reunion. I also

Barbara Temkin, Marc and Lesley

Alan Penziner (and wife, Pat),

was impressed with the enthusiasm

Osias, John Fulkerson, Bob and

and Gail Sullivan (and husband,

of a large group of our fellow

Louise Glassman, Lenny and Linda

Victor Peplau). Those present

classmates, particularly the leader¬

Cohen, Mike and Sally Buckley,

heard regrets sent from Steve

ship of Don Kent, for taking on

Dave Moyer and Bob Goodman.

Scheinman (who promises to

this challenging opportunity both

In the evening, we had an excellent

attend the 25th), Alice Matoba,

to help the medical school and at

dinner at the Graduate Club. It was

Margaret McKenna (in the middle

the same time use this occasion

so popular that we needed to

of moving to D.C.), and Marybeth

to renew old friendships among

squeeze in a few extra place settings

Ezaki. Time moves swiftly, but the

our classmates.

and chairs. Some of those in atten¬

recollection of old friends and good

dance at the dinner were Dorothy

times adds a unique dimension of

lectures on Friday and Saturday.

There were excellent reunion

Gohdes and Neil Kaminsky, Don

meaning. We promise an all-out ef¬

Among those seen attending the lec¬

and Ellen Kent, Phil and Susan

fort to break all attendance records

tures were Mary Charlson and Fred

Lebowitz, Phil and Barbara

for the 25th!

Hyde. Jesse Jupiter gave a lecture to

Rothfeld, Gary and Meda Strauss,

members of the orthopaedics and re¬

Bill Druckemiller, Dave Moyer

habilitation department during his

and Frank Kahr.

1982

reunion visit. Following the lectures
of Saturday morning, there was a

15th reunion

chance to meet over a buffet lun¬
cheon at Harkness. It was interesting
to note that a number of our class¬
mates have children who are under¬
graduates at Yale, thus providing ex¬

1977

By Stephanie Wolf-Rosenblum,

20th reunion

M.D.

By Attilio V. Granata, M.D.

A small but enthusiasic group from
the Yale School of Medicine Class of

tra opportunities to give generously

1982 met to celebrate their 15th

to Yale. These include Mark Osias,

The special festivities of the Class of

Philip Cohen and Harry Malech.

1977’s 20th reunion took place at

reunion in June. Hats off to Lynn

Phil did note that because he had

Mory’s on Saturday evening, June 7.

Tanoue and Carrie Redlich for

twins at Yale he had a special deal

After drinks in the library, a small

planning the weekend’s events,

on paying tuition in that he only

but hearty number of classmates

which began with a clambake Friday

needed one stamp to send both

and spouses met for dinner in the

night. On Saturday, classmates and

tuition checks.

Captain’s Room. Julia Frank

their families enjoyed an afternoon

brought the album of snapshots

of sun and tennis at the Ridgetop

Some others seen at the lunch
were Steven Zeldis, Tony Jackson,

from our second-year show,

Club in Hamden, followed by

Michael Charney and Fred

Mefistofollies, in December 1974.

dinner at Scoozi’s in New Haven

Henretig. Dick Robbins and Helen

(For younger alumni, in our day we

while the kids had a massive pajama

were there, and it was so much fun

had three semesters of basic science

party at Carrie’s. The weekend

to be able to appreciate his timing

and introductory clinical medicine,

culminated with brunch at Lynn’s on

and humor again as he joked about

then began our clerkships in the

Sunday. The weekend’s participants

his home state of Georgia. Later that

middle of the second year!)

afternoon we all migrated to Bruce

After posing for our official class

included: Lynn Tanoue (pulmonary
and critical care faculty at Yale),

Haak’s home on a beautiful point

photo (plus 20 years), dinner found

Daphne Hsu (pediatric cardiology

overlooking Long Island Sound at

us all easily renewing the camarade¬

faculty at Columbia), Jed Gorlin
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(about to assume the helm at the

in New York and Connecticut. Nick

Blood Centers of Minnesota), Patty

Burke and his wife, Sue, described

Kellner (family practice, University

life with their three children in

Heights in Cleveland), Jessica

Minneapolis, where Nick is busy as

TO GIVE AWAY MONEY IS

Herzstein (occupational medicine/

a cardiologist. Pat Ruwe and his

AN EASY MATTER AND IN

toxicology consultant, Massachu¬

wife, Stacy, joined the festivities. Pat

setts), Carrie Redlich (occupational

is assistant professor of orthopaedics

and pulmonary medicine faculty at

and rehabilitation at Yale. Rich

Yale), JeffTepler (hemotology/

Diana also is an orthopaedist in the

oncology at New York Hospital,

New Haven area but could not

AND WHEN, AND FOR

womens health), Stu Gardner

attend the reunion. Joe King and

WHAT PURPOSE AND HOW,

(pediatric practice, Connecticut),

Amy Justice attended from Cleve¬

IS NEITHER IN EVERY

and Stephanie Wolf Rosenblum

land, where Amy is doing HIV

MAN’S POWER NOR AN

(pulmonary/critical care/sleep and

research and primary care while Joe

medical director, Lahey Hitchcock,

is a busy neurosurgeon. They have a

New Hampshire). Prize for longest

io-month-old boy. Linda and Jon

distance traveled goes to Bert

Lewin also arrived from Cleveland

Ungricht (ophthalmology, Salt Lake

to join the class for dinner along

City). There in spirit were Paula

with Mike Solon, who is practicing

Braverman (pediatrics in Philadel¬

primary care in the Baltimore area.

phia, recovering from surgery), and

Donna Klimowicz is a psychiatrist

Dan Odenheimer (Israel).

in south Jersey and is busy raising a

We are looking forward to a

3-year-old with her husband, Rick.

ANY MAN’S POWER. BUT
TO DECIDE TO WHOM TO
GIVE IT, AND HOW LARGE

EASY MATTER.

Aristotle

Assuming you would
consider the School of
Medicine as one of your
intended beneficiaries,

record crowd at our 20th in the

Tarik Ramahi couldn't attend the

year 2002! In the meantime, a

reunion but is assistant professor of

partial list of e-mail addresses has

medicine/cardiology at Yale,

been tabulated. For information,

specializing in heart failure and

or to add your name, contact

transplantation. Steve Gaskin and

me at: Stephanie. Wolf¬

his wife, Diane, are busy raising four

Planned giving

Rosenblum @Hitchcock. org.

children in Charlotte, N.C., where

is one of our specialties.

we stand ready to help you with
when, for what purpose, and
how.

Steve is an emergency-room physi¬
cian. Larry Amsel is handling in¬
patient psychiatry at Columbia in

1987
10th reunion
By Barry Weinstock, M.D.

New York, where Leslie Vogel is
taking care of out-patient psychiatry.
Leslie and her husband, Luciano,
attended the reunion with their
daughter, Paola. Lisa Straus at¬

The Class of 1987 met informally

tended and is practicing primary care

during the day on Friday, enjoying

in New York. Rebecca Kadish is an

the reception in the Medical

anesthesiologist in New Hampshire.

Historical Library. Many enjoyed

Eric Jankelovits is an anesthesiolo¬

the clambake in front of Harkness

gist in Stamford, Conn. He and his

Hall. On Saturday most re-explored

wife, Monica, have two little girls.

Yale and then convened at Mory’s

Although Eric could not attend the

for a dinner of exchanging stories,

reunion, I did track him down on I-

pictures of children and e-mail

95 by cellular phone and enjoyed a

addresses. Andy Bazos and his wife,

quick visit with him at a McDonalds!

1-800-445-6086

Ann, recently finished renovating a

Seth Rosenthal won the award for

Fax: 1-203-432-7901

250-year-old home and are now

longest trip (from California, where

ready to start thinking about kids.

he is practicing radiation oncology).

Andy is an orthopaedist practicing

Mark Widmann and his wife, Kim,
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won the best excuse award for not

I have some news of the class,

attending the reunion. Kim gave

which is strictly via the grapevine, so

birth to Sara Hirsh Widmann on

the details are shaky, if not down¬

May 28, 1997—all 6 lb, 6 oz of her.

right fictitious. I apologize in ad¬

Mike Gaziano and his wife, Ann,

vance for any omissions (or commis¬

attended the reunion from Boston,

sions). Since graduation, the

1997-98
Association of Yale
Alumni in Medicine

but unfortunately spent much of the

following have gotten married:

trip caring for their children, who

Mimi Blaurock, Jeb Blaugrund,

both had colds. Mike reports that

Barry Birch, Jim Chang and

Matthew Miller and John Keaney

Harriet Roeder, John Barash, Sara

are both alive and well and living in

Dobbs, Stephanie Goodman,

Boston, but were unable to attend

Suresh Karne, Bob Johnson, Chai

the reunion this year. John is a

Kulsakdinun (I saw the announce¬

Secretary

cardiologist at Boston University.

ment in the New York Times, so it

Lycurgus M. Davey, M.D. ’43

Mindy Schuster is practicing

must be true), Julie Lund, Dan

Past President

infectious disease at Penn. Barry

Philbin, Sean Roddy (REALLY!!),

Weinstock is a cardiologist in

and Fred Welt. New parents since

Florida. He and his wife, Jodi, have

graduation include: Ahmed Abou-

two sons. Goals for future reunions

Zamzam (daughter Aida), Rick

are more and better programming

Alaimo (son), Karen Antell and

and better attendance. We also will

Mitch Saltzberg (son Ethan), Ken

be trying to establish a Class of 1987

Rosenzweig and Stacey Berg

e-mail directory. If you have an e-

Rosenzweig (daughter Olivia),

Officers
Nicholas M. Passarelli, M.D. ’59
President
Gilbert F. Hogan, M.D. ’57
Vice President
Peter N. Herbert, M.D. ’67

Executive Committee
Joseph F.J. Curi, M.D. ’64
Mary V. Digangi, M.D. ’64
John W. Foster, Jr., M.D. ’71
R. Leonard Kemler, M.D. ’43
Robert J. Kerin, M.D. ’47

mail address, send it to Barry

Nancy and Mike Girardi (son),

Jocelyn S. Malkin, M.D. ’51

Weinstock at bweinstock@csi.com.

Nahum Goldberg (daughter

Dwight F. Miller, M.D. ’56

I apologize in advance for any

Shoshana joins big sister), Laura

Donald E. Moore, M.D., M.P.H. 81

omissions or errors!

Marks (son Jake), Julie Lund (son

Lynn W. Reiser, M.D. ’7°

Will), Nate Schmiechen (twins
Alexandra and Zoe), Bill Sharpe

Ex-Officio

(son), Claudia Showalter Reynders

David A. Kessler, M.D.

(twins really recently), Annie Towe

Dean

5th reunion

Egan (twin sons), and Teri Wooten

William K. Jenkins

Daily (daughter Emma). Also, con¬

Managing Director, Alumni Affairs

By Robin A. Perlmutter, M.D.

gratulations to Anne Wolf on her

Daniel L. Arons, M.D. ’67

recent engagement.

Chair, YSM Alumni Fund

1992

There were only three I992’ers at

If anyone has more accurate or

our fifth-year reunion dinner

additional news of our class and

(Elizabeth A. Mullen, Tom

wants to share it, e-mail me (Robin)

Davenport and Robin Perlmutter)

at mta. dr.perr@mahbosp. org.

Samuel D. Kushlan, M.D. ’35
YSM Bequest and Endowment

Representatives to the

because rumor had it the other 97

Association of Yale Alumni

were on call. Mike and Nancy

Frank R. Coughlin, Jr., M.D. 52

(Dingott) Girardi attended the

Martin E. Gordon, M.D. ’46

weekend with their little boy, but

Michael Kashgarian, M.D. ’58

left before the class dinner. We

Benjamin E. Lyons, M.D. ’38

enjoyed meeting members of the
Class of 1942 (our dinner compan¬

James D. Prokop, M.D. ’59
Theoharis C. Theoharides, M.D., Ph.D. 83

ions) and realized that their experi¬
ences at Yale were pretty similar to
ours. The Yale System may look a
little different than it did in 1942,
but it’s still alive and kicking.
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REUNION:

EPIDEMIOLOGY

AND

PUBLIC

HEALTH

Buildings matter
At the dedication of renovated facilties for EPH, a commitment to the future.

D

uring reunion festivities in

member Eric Mood, LLD, M.P.H

M.P.H. ’57; Joel Kavet, M.P.H. ’67,

early June, the alumni/ae,

’43, received the Distinguished

Sc.D.; and Rosemary Hurzeler,

Service Award. An emotional and

M.P.H. 77.

faculty and students of
Epidemiology and Public Health

joyful tribute to the late John D.

found added cause for celebration in

Thompson, M.S. ’50, included

honored James F. Jekel, M.D.,

the dedication of renovated facilities

reminiscences by Jack O’Connor,

M.P.H. ’65, who served as the

in the Laboratory of Epidemiology

A special retirement observance

C.-E.A. Winslow Professor of Public

and Public Health (LEPH) and at

Health. Dr. Jekel spoke at the EPH

47 College Place.

commencement in May and re¬

The renovation produced

ceived the Bohmfalk teaching award

comfortable new space for a student

at the medical school ceremony.

center, library, computer rooms and
a redesigned C.-E.A. Winslow
Auditorium, as well as office
renovations on the first three floors
of LEPH. Several hundred members
of the EPH, medical school and
New Haven communities turned
out to mark the occasion, high¬
lighted by the cutting of both a
ribbon and a cake, the latter taking
the distinctive form of the towering
LEPH building.
The program began with an
invocation by the Rev. Bonita
Grubbs, M.P.H. ’85, and remarks by
EPH Dean Michael H. Merson,
M.D.; Yale President Richard C.
Levin; then-Dean Gerard N.
Burrow, M.D. ’58; and incoming
Dean David A. Kessler, M.D.
Later in the day, awards were
presented by Travis Hedrick,
M.P.H. ’77, Ph.D., president of the
Association of Yale Alumni in
Public Health. Longtime alumni/ae
leader and retired EPH faculty

YALE

MEDICINE

(Culinary) art
imitates life
Every celebration needs a
cake, and the dedication of
renovated EPH facilities in
June was no exception.
EPH Dean and Chairman
Michael H. Merson, M.D.,
cut both the cake and the
proverbial blue ribbon, the
latter with the help of
outgoing medical school
dean Gerard N. Burrow,
M.D. ’$8, now the David
Paige Smith Professor of
Medicine and special advisor
to President Levin.

Speakers for the day’s final
program, Retrospectives: Missions and
Milestones During the Last 50 Years at
EPH, included former EPH chairs
Robert McCollum, M.D., D.P.H.,
and Adrian Ostfeld, M.D., and
alumni/ae David Pearson, Ph.D.,
’70; Rosemary Stevens, Ph.D. ’68;
Jennifer Kelsey, Ph.D. ’69; Kathleen
Howe, M.P.H. ’56; and George
Silver, M.D., M.P.H. ’69; professor
emeritus of public health and a
former HEW undersecretary.
Listening to the tribute to
John D. Thompson, from
left: Darlene Zimmerman,
M.P.H. 88; Gerlinde
Herman-Kehlenback,
M.P.H. 81; Dorothy M.
Horstmann, M.D., John
Rodman Paul Professor
Emeritus of Epidemiology
and a senior research
scientist in epidemiology;
James Niederman, M.D.,
recently retired clinical
professor of epidemiology
and public health; and
Arthur Ebbert, M.D.,
former deputy dean of the
medical school.

Cardiologist Forrester Lee, M.D., assistant
dean for multicultural affairs, and
Courtland Seymour Wilson, executive
director oj the Hill Development Corp.

David Pearson, Ph.D. Jo, former associate dean for public health, was among the speakers

Medical school Dean David A. Kessler,
M.D., spoke with former Connecticut health

discussing EPH milestones over the past 90 years. He is now chairman of Health Policy and

commissioner Susan Addiss, M.P.H. ’69.

Management at the University of New Hampshire.
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Excerpts from the dedication ceremony

“These newly renovated facilities are
not the school of public health.
That school exists in the minds, and

“By the time a person reaches my

the hearts, and the spirits of all of

age, he is supposed to have lost the

you who are participating in this

urgency of his ideals. Reality is

fine institution. On the other hand,

supposed to have dulled the sharp

it would be naive to suggest that

edge of his resolution. But it hasn’t

buildings don’t matter. ... The new

worked that way with me and I

and renovated facilities are symbolic

know it hasn’t worked that way with

of Yale’s recommitment to research

you. I’d like each of you to turn

and education in the field of

back the clock for a moment; I’d

epidemiology and public health. ...

like all of you to think back to the

It has been enormously hearten¬

time when you took your first step

watch what Mike [Merson] has been

profession. I’d like you to think

able to do in a very brief period

what motivated you then. ... It

Kathleen Howe, M.P.H. ’36, presents the
Distinguished Alumni Award medallion to
Adriana Natale, M.D., in recognition of
the contribution of Dr. Natale’s late

with the school, the energy he has

certainly wasn’t social prestige, and

husband, John D. Thompson, M.S. '30.

brought to it, the tremendous

it certainly wasn’t the money. It was

commitment, the opening up to an

simply a desire to make a difference

international horizon. He has

in people’s lives, to do some good in

simple recognition that problems

shown extraordinary leadership.

the world.

can be solved if we are willing to

ing from the other side of town to

I know that you all believe that.

on the road to public health as a

Horace Mann, the educator,

face our responsibility. It doesn’t

I think great times are ahead for

said that you should be ashamed to

matter whether your degree is an

the school."

die until you have won some victory

M.P.H., a doctor of public health,

for humanity. He could have been

an M.D., or a Ph.D. in nursing. ...

President Richard C. Levin

Travis Hedrick, M.P.H. 77, Pb.D.,
president of the Association of Yale Alumni
in Public Health, presents the Distinguished
Service Award to Eric Mood, LLD,
M.P.H. ’43.

talking about the road that you have

The lines between medicine and

chosen. ... Accomplishments in the

public health should be nonexistent.

field of public health, as in any hu¬

Prevention knows no boundaries,

manitarian endeavor, rest in the

infectious disease knows no bound¬
aries, the death and disability from
tobacco knows no boundaries. ...
The public health challenges of
today are no less formidable than
those of years past. In this country
polio, diphtheria and rickets have
been replaced by heart disease, can¬
cer and stroke. Our professions cry
out for men and women who view
public health not as a profession,
but as their calling, who are willing
to touch what others see as untouch¬
able, who are willing to sign up for
nothing less than the Churchillian
promise of blood, toil, sweat and
tears in return for nothing more
than the privilege of promoting the
common good.”
Dean David A. Kessler, M.D.

YALE

MEDICINE

69

OBITUARIES

W. Randal Bell

completed a six-year surgical

medical department and physician-

residency in New Haven and served

in-chief of the Medical Research

W. Randal Bell, M.D., formerly of

as chief surgical resident. In 1946

Center at Brookhaven National

Marblehead, Mass., died April i of

Dr. Brezina opened a general

Laboratory in Upton, N.Y. While at

metastatic prostate cancer at his

surgery practice in Bristol and did

Brookhaven, he pioneered the

home in Peterborough, N.H. He

pioneering work in vascular surgery.

design and construction of the

was 85.

He also served as chief of surgery at

world’s first nuclear reactor built

Bristol Hospital for more than 30

and used primarily for medical

Bell graduated from Rensselaer

years. In 1965 he volunteered his

purposes.

Polytechnic Institute and received

surgical skills at the Albert

his medical degree from Yale in

Schweitzer Hospital in Haiti.

in Houston appointed Dr. Farr chief

Dr. Brezina and his wife,

of the section of nuclear medicine at

Born in Brooklyn, N.Y., Dr.

1941. After a year’s internship at

In 1962 the University of Texas

New Haven Hospital, he spent four

Frances, traveled worldwide pursu¬

M.D. Anderson Hospital and

years in the Army medical corps on

ing their special interest in birds.

Tumor Institute, and as professor of

the West Coast and with the 313th

He was an avid fisherman and a

nuclear and environmental medi¬

General Hospital in the Philippines,

master at fly tying.

cine and chairman of the Depart¬

retiring as a major.

ment of Environmental Health at

For 30 years, Dr. Bell was a

the University of Texas School of

Lee E. Farr

Public Health.

Children’s Hospital, where he was

Lee E. Farr, M.D., one of the

Department of Public Health

an active participant in the building

nation’s preeminent physicians in

appointed Dr. Farr chief of emer¬

pediatrician in Massachusetts. He
was chief of staff at North Shore

In 1968, the California State

of a new hospital facility. He also

nuclear and environmental medi¬

gency health services and head of

was on the staff at Salem Hospital

cine, died of cancer in Walnut

disaster health services. He worked

and the former Mary Alley Hospital

Creek, Calif., on July 16. He was 89.

to establish the California Bureau

in Marblehead.
After retiring, Dr. Bell worked

A native of Albuquerque, N.M.,

of Emergency Medical Services

Dr. Farr was a 1929 graduate of Yale

and was named its first chief in

with Dr. Robert Grassi, seeing

College. He received his M.D.

1970, a post he held until his

patients at Monadnock Community

degree from the School of Medicine

retirement in 1973.

Hospital in Peterborough, and with

in 1933 and remained as an assistant

the Visiting Nurse Association and

professor of pediatrics. In 1934 he

served with the Navy as a medical

Crotched Mountain Rehabilitation

was appointed an associate in

officer aboard the U.S.S. Tryon, an

Center.

medicine at the Hospital of the

armed hospital transport ship in

Philip S. Brezina

During World War II, Dr. Farr

Rockefeller Institute for Medical

the Pacific assigned to remove

Research in New York City. From

casualties from Guadalcanal. Dr.

1940 to 1949 he served as director of

Farr was a consultant to the Navy

research and physician-in-chief at

and to the Atomic Energy Commis¬

Philip S. Brezina, M.D., of Bristol,

the Alfred I. DuPont Institute of the

sion and was a member of the U.S.

Conn., and East Orleans, Mass.,

Nemours Foundation in

Delegation to the International

died June 10. He was 82.

Wilmington, Del., where he

Conference on Atomic Energy in

researched and developed a treat¬

Geneva in 1955.

Dr. Brezina received a bachelor
of arts degree from Trinity College
in Hartford in 1936 and his medical
degree from Yale in 1940. He
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ment for nephrosis in children.
In 1949 Dr. Farr was named
medical director, chairman of the

He also was selected in 1955 to
be a member of the advisory
committee to the Atomic Bomb
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Casualty Commission, analyzing

George L. Hoffman

Dr. Huessy was one of the
first researchers to recognize that

medical effects on atomic bomb
victims. He served as its chairman

George L. Hoffman, M.D., of

the behavior patterns observed in

from 1955 to 1968.

Scottsdale, Ariz., died May 16.

children with attention deficit

He was 71.

disorder continued through life,

Dr. Farr was awarded the Gold
Cross Order of Phoenix by Queen

Born in Pittsburgh, Dr.

Frederika of Greece in i960 for his

Hoffman studied at the Virginia

and that the disorder presented

consulting work in nuclear medi¬

Military Institute and the University

different from those in females.

cine. West Germany bestowed the

of Pittsburgh before graduating

A maverick in his profession, he

Order of Merit upon him in 1963.

from Haverford College. He served

was also one of its most outspoken

He authored more than 200 papers

as a second lieutenant during World

critics, opposing the influence

and articles on nuclear medicine,

War II, the youngest commissioned

of psychoanalysis on American

nuclear reactors, protein metabo¬

officer in the Army, according to his

psychiatry.

symptoms in males that were very

lism, emergency medical services,

family. In 1953 he graduated from

and radioactive and chemical

Yale School of Medicine. Dr.

Germany, Dr. Huessy came to the

environmental contaminants.

Hoffman was an intern in Philadel¬

United States in 1934 at the age of

phia, where he met his wife, Jewel

13, when his father became an

Delores Hunt, a nurse. In 1954 he

instructor at Harvard University.

served a surgical residency at the

Dr. Huessy graduated from

Cleveland Clinic Hospital.

Dartmouth College in 1942,

Franklin M. Foote
Franklin M. Foote, M.D., Dr.P.H.,

In 1958 Dr. Hoffman moved to

Born in Frankfurt am Main,

received his M.D. degree from Yale

formerly of Wethersfield, Conn.,

Mesa, Ariz., where he was a well-

in 1945 and interned in pediatrics at

died June 29 at Fairview Manor in

known and respected surgeon until

the Johns Hopkins Hospital. He

Pittsfield, Mass. He was 89.

his retirement several years ago. He

was a psychiatric resident and staff

was chief of staff at Mesa Lutheran

psychiatrist for the U.S. Public

Yale, where he earned three de¬

Dr. Foote was a graduate of

Hospital and a member of the

Health Service before receiving a

grees—bachelor of science in 1930,

Arizona Board of Medical Examin¬

master of science degree from the

doctor of medicine in 1933 and

ers. Dr. Hoffman served as president

University of Colorado in 1951.

doctor of public health in 1935. He

of the Maricopa County Medical

was certified in public health by the

Society, the Arizona Chapter of the

colonel and senior surgeon, serving

American Board of Preventive

American College of Surgeons and

Colorado, Utah, Idaho, Wyoming

Medicine in 1949. Dr. Foote served

the Phoenix Surgical Society. His

and Montana. He returned to

in the Army medical corps during

most outstanding honor was

Vermont in 1958 and began a 30-

World War II and for many years in

election to the Board of Regents of

year career with Spring Lake Ranch,

the Army Reserve before retiring as

the American College of Surgeons

a therapeutic community in

a colonel.

in 1975.

Cuttingsville.

Dr. Foote was executive director

Dr. Hoffman owned a dude

Dr. Huessy was a lieutenant

In i960 Dr. Huessy began

of the National Society for the

ranch in Yavapai County for 15 years

teaching at the University of

Prevention of Blindness in New

and brought his family there to

Vermont Medical School. He

York City before his appointment in

escape city life and experience the

became a full professor in 1967 and

1959 as Connecticut’s health com¬

West of times past. He retired in

chaired the Department of Psychia¬

missioner. He served in that posi¬

1993 and moved to Scottsdale,

try from 1967 to 1970. Between

tion for 15 years under three differ¬

where he enjoyed riding his horse

1967 and 1971 he headed the Inter-

ent governors.

and playing tennis daily.

Dr. Foote had been honored by
the New England Public Health
Association, the Connecticut Public

University Forum for Educators in
Community Psychiatry. He was a
fellow of the American Public

Hans R. Huessy

Health Association and the Con¬

Health Association and of the
American Psychiatric Association.

necticut Society for the Prevention

Hans R. Huessy, M.D., died May 9

Dr. Huessy retired from the medical

of Blindness. He was also made a

from complications of a brain

school in 1985, but continued

Paul Harris Fellow by the Rotary

aneurysm at his home in Jericho,

consulting work with St. Lawrence

Club of Hartford.

Vt. He was 75.

Psychiatric Center in Ogdensburg,
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N.Y., and several halfway houses

ate of the College of the Holy Cross

throughout the state.

and, in 1928, from Yale School of

Dr. Huessy was an avid skier

Medicine. During World War II he

George L.H. Le Bouvier
George L.H. Le Bouvier, M.D., of

and became the youngest U.S.

served in the 57th Signal Battalion

Portland, Ore., died March 12

amateur certified ski instructor. He

of the Army Medical Corps in

following a stroke. He was 75.

was a justice of the peace in Jericho

Africa, Italy and France. He was

from 1958 to 1967.

awarded the Purple Heart twice.
Dr. Kearney was director of the
medical staff at St. Vincent’s

Robert H. Jordan

Born in Constantinople, Dr. Le
Bouvier was educated at Oxford
University, St. Bart’s in London and
the University of Glasgow. At Yale,

Hospital in Montclair and main¬

he was a research associate in

tained a private practice there for 35

epidemiology from 1966 to 1970

Robert H. Jordan, M.D., formerly

years before retiring in 1962. He was

and a senior research associate in

of North Haven, Conn., died April

honored as a Knight of St. Gregory

epidemiology from 1970 to 1977.

11 at his home in Juno Beach, Fla.

in i960 at the Sacred Heart Cathe¬

He also served on the faculty at the

He was 88.

dral in Newark.

University of Glasgow.

Dr. Jordan was a graduate of the

Dr. Le Bouvier retired in 1977

University of Richmond and the
Medical College of Virginia. He

to the island of Maui, where he

Norman J. Kelman

served his internship at Chesapeake

pursued his interest in plants and
trees and learned to speak the

and Ohio Hospital in Huntington,

Norman J. Kelman, M.D., formerly

W. Va., from 1933 to 1934 and took

of Wallingford and Branford,

Portland in 1992 and was an active

his residency at Pinecrest Sani¬

Conn., died April 20 from leukemia

volunteer at the Hoyt Arboretum

tarium in Farmingdale, N.Y., and

at his home in New York City. He

and the Rose Test Gardens.

the former Grace Hospital in New

was 82.

Haven from 1936 to 1937. He served

Hawaiian language. He moved to

Dr. Kelman graduated Phi Beta

in the Army Medical Corps from

Kappa from Wesleyan University in

1942 to 1946.

Middletown, Conn., and earned a

Morgan Sargent

Dr. Jordan was a practicing

master of arts degree from Colum¬

Morgan Sargent, M.D., formerly of

physician in New Haven from 1938

bia University and an M.D. degree

Quincy, Mass., died May 30 of

until his retirement in 1980. He

from Harvard Medical School.

pulmonary stenosis at the Harbor

was also a clinical instructor in

During World War II, he served as a

House Nursing Home in Hingham,

medicine at the School of Medicine.

major in the Army and was assigned

Mass. He was 87.

After retirement from private

to Gen. George C. Patton’s division

practice, he served at Connecticut

when it entered Berlin.

Hospice in Branford from 1980

After the war, Dr. Kelman

Born in Quincy, Dr. Sargent
graduated in 1932 from Williams
College and in 1937 from Yale

until 1982, when he moved to Juno

began a private practice in New

Beach. He was a former president of

York and studied under Dr. Karen

School of Medicine. He served his
internship at Hartford Hospital for

the Connecticut Society of the

Horney at the American Institute of

two years and at Pondville Hospital

American Board of Internists, a

Psychoanalysis. He taught at the

in Massachusetts for one year. From

fellow of the American College of

institute for more than 50 years and

1941 to 1946 he was chief of surgery

Physicians and the American

served as an assistant dean and

at the Don CeSar Rehabilitation

College of Chest Physicians, and a

board member. He also played a

Hospital in St. Petersburg, Fla., for

diplomate of the American Board

major part in the formation of the

the Army Air Corps.

of Internal Medicine.

New York School of Psychoanalysis
in the 1950s.
Dr. Kelman taught at other

Edward R Kearney

Dr. Sargent practiced medicine
in Quincy from the 1940s until his
retirement in 1986. He was also

institutions, including the New

chief of surgery at Quincy Hospital

School for Social Research, Albert

from 1946 to i960 and chief of

Edward P. Kearney, M.D., died June

Einstein College of Medicine, the

staff at the hospital for many years.

21 at his home in Montclair, N.J.

University of Miami Medical School

Dr. Sargent was a past president

He was 95.

and, from 1958 to 1959, the Yale

and longtime director of the

School of Medicine.

City of Quincy Hospital Corp.,

Dr. Kearney was a 1924 gradu-
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a director at the former Quincy
Savings Bank, a trustee of the

As a family physician, Dr.
Thayer practiced in the Enfield and

Delcevare King Trust and the John

Somers area from 1949 to 1968. He

Quincy Adams Foundation, and

served in various positions with

director and past president of the

Blue Cross & Blue Shield of

Rice-Eventide Home.

Connecticut from 1968 until his

IN

MEMORIAM

W. Randal Bell, M.D. ’41

retirement as senior vice president
in 1984.

Clyde A. Swift

Dr. Thayer was a former trustee
of the Connecticut Medical

Clyde A. Swift, M.D., of Guilford,

Services and a member of the

Conn., died April 15 at Connecticut

American Medical Association,

Hospice in Branford. He was 67.

the Connecticut State Medical

Dr. Swift served in the U.S.

Medical Association. He was a

World War II and in the Massachu¬

former member and president of the

setts Air National Guard. He

medical staff at Johnson Memorial

received a bachelor of science degree

Hospital in Stafford.

June 10, 1997

Gyla E. Brooks, M.P.H. ’60
March 1, 1997

May 9, 1997

M.D. degree in 1958 from Tufts

Laura B. Weed

internship and residence at

Arthur J. Orloske, M.P.H. ’76

Dartmouth-Hitchcock Medical

Laura B. Weed, M.D., died on

Center in Hanover, N.H.

March 29 in Burlington, Vt.

(N.Y.) Hospital, and at Memorial

HS ’40-46

Hans R. Huessy, M.D. ’45

in 1954 from Bates College and an

He held positions at Glen Falls

Philip S. Brezina, M.D. ’40,

Society and the Tolland County

Marine Corps, 2nd division, during

University. Dr. Swift served his

April 1, 1997

January 21, 1997

She was 75.
Born in Cleveland, Dr. Weed

Morgan Sargent, M.D. ’37

Hospital of Martinsville and Henry

graduated from Vassar College in

County, Va., before joining the

1943 and from Yale School of

faculty in anesthesiology at Yale

Medicine in 1947. At Peter Bent

School of Medicine in 1982. While

Brigham Hospital in Boston, she

Eugene Smith, M.D. ’44

at Yale, he was a member of the

made important contributions to

March 13, 1997

Impaired Physician Committee of

medical research on the metabolic

the Connecticut State Medical

response to surgery. In Bangor,

Society, the Committee on Physi¬

Maine, and in Cleveland she

cian Health of the New Haven

worked on developing medical

Medical Society and was chairman

record systems and on providing

of the Yale Medical Center Task

clinical care to the underserved

Force on the Impaired Health

and the poor. Dr. Weed was one

Care Provider.

of the founders and principals of

May 70, 1997

Robert L. Stein, M.D. ’54
May 10, 1997

R. Bruce Thayer, M.D. ’46
June 11, 1997

The Given Health Care Center in
Burlington in 1970, and was

R. Bruce Thayer

instrumental in building one of

Laura B. Weed, M.D. ’47
March 29, 1997

Vermont’s first rural healthcare
Ralph B. Thayer, M.D., died June

facilities, the Grand Isle Health

11 at his home in Enfield, Conn.

Center.

He was 75.
Dr. Thayer graduated from
Bowdoin College in 1943 and from
Yale School of Medicine in 1946.
As an Army veteran of World War

She was an associate professor

Malvin F. White, M.D. ’39
April 8, 1996

of medicine at the University of
Vermont College of Medicine.

Peter T. Wotton, M.P.H. ’67
November 3, 1996

II he served as a captain in the
medical corps.
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DEVELOPMENT

Non-profit or not?
Managed care, a flurry of mergers, and the growth of for-profit health care has left the
public confused about academic medicine. Where does this leave philanthropy?
By David Davison

Y

ale School of Medicine is renowned as one of the
HARVEY CUSHING/JOHN HAY WHITNEY MEDICAL LIBRARY

world’s great research institutions. The school’s
deep and extensive commitment to community

service and care for the people of New Haven and the
surrounding region may be less well known.
Each morning on National Public Radio’s Morning
Edition program, the local announcer acknowledges
the support of a few select organizations, including
the following:
Yale-New Haven Hospital, caring for Connecticut’s
citizens for 171 years. Yale-New Haven Hospital is a
non-profit organization.
This is not an incidental tag line. People often are

The New Haven Dispensary, known today as the ]ane Ellen Hope

not aware that the hospital is a not-for-profit, tax-exempt

Building, was erected in 1901. It provided care for poor children and
became the Ambulatory Service of the Department of Pediatrics in

charitable organization, as is the School of Medicine.

1922. Currently it is used for lectures and meetings.

Both entities are big, complex and changing with the
times, all the while retaining their charitable missions.

large academic medical centers don’t always take credit for

Both raise funds to help provide health care to the

the free services they provide. With an estimated 45

community and to conduct research and training.

million Americans uninsured and falling reimbursement

The hospital recognizes the need to make the point to

rates from Medicaid, Medicare and managed care, a lot of

its local constituency.

unreimbursed care is being delivered.

Decades ago—before the explosive growth of medical

In health care, everyone knows that the times are

centers, health insurance and government programs—

rapidly changing. According to the American Hospital

voluntary hospitals operated under fewer regulations.

Association, nearly 1,200 hospitals have been sold or

Many clearly served the community by providing what at

merged with other institutions in the past two years.

the time was called charity care to the poor. Last year,

Thirty percent of those transactions involved for-profit

Yale-New Haven Hospital provided more than $25

institutions. Medical schools have even struck deals with

million in free care and uncompensated services. Today,

for-profit corporations. Tulane School of Medicine has a
complex agreement with Columbia/HCA that essentially

David Davison is director of development for the School of

puts the health care delivery management side of the

Medicine. Write to him at the Office of Medical Development,

business in the hands of a for-profit entity, while leaving

100 Church Street South, Suite 211, New Haven, CT 06519-1/14,

teaching and research under the continued control of

or via e-mail: david.davison@yale.edu.

the academic leaders and non-profit board members.
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These mega-mergers are occurring as patients, physicians
and insurance payers are reorienting their relationships
with each other.
Where does this leave philanthropy? It is definitely
not a good idea for hospitals and medical schools to
assume that the traditions of charitable giving will always
endure. According to the Chronicle of Philanthropy, donors
are questioning the philanthropic process at large health
care institutions, especially if there is real or imagined
potential that it might become a profit-making business.
Some donors are reportedly demanding that hospitals
return donations that were made years before.
Yale School of Medicine has been around since
1813, the hospital since 1826. Neither is changing its
identity or mission, and both institutions rely on dona¬
tions to accomplish their goals in patient care, research
and teaching.
The not-for-profit status of our institutions cannot be
taken for granted. It must be made clear to the public, in

Citizens of New Haven awaiting treatment at the New Haven

compelling ways, that we have critically important goals

Dispensary (c. 1920). The charity care it provided was made possible
in part by grants from the charitable Community Chest and from

for teaching, research and the delivery of care.
We must broadcast the news about our research

other donors.

programs, and our commitment to improving health care
in the community. For example, Yale medical students

Schools, the AIDS Care Program for children and

and faculty volunteer their time to deliver a variety ol

families, and free care lor the homeless.

outreach services such as free vaccines and immunizations
for children, substance abuse prevention in New Haven

In other words: good old-fashioned care, provided
regardless of the patient's ability to pay.

What the public thinks
People responded in similar

As for the public’s appreciation

To obtain some useful data on

fashion to statements defining

of our free-care mission: 55 percent

public perceptions, a comprehensive

medical schools and teaching

of respondents believed that an

survey was commissioned by the

hospitals as the “backbone of

academic medical center “provides

Association of American Medical

innovation” that play a “critical

health care services for low income

Colleges last year.

role ... training doctors in cutting-

people who otherwise could NOT

It turns out that the public
does care about teaching and

edge knowledge.”
Yet the survey showed that

afford care.” Only 39 percent of
those respondents living in cities

research in general. Survey respon¬

most Americans don’t understand

where there are academic medical

dents were asked whether they

how these institutions function,

centers believed that their local

thought the following statement

or the role of medical faculty and

institutions were not-for-profit.

was true or false:

students in providing care and

“New drugs, medical devices,

A large segment of the public

conducting research. It is not

needs to know more about the

and surgical techniques not only

clear to the public that revenues

array of community service

improve the quality of health care,

for the research and teaching

programs at the School of Medicine,

they can also save money for you

missions are shrinking, as well as

and the free medical care provided

and your family.” Sixty-seven percent

the funds that are needed to

by our dedicated faculty

said true.

provide free care.

and students.
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LETTERS

Divine inspiration
To the editor:
Your issue on managed care and
medical education (Lessons in
Managed Care, Summer 1997) un¬
derscores the fact that medical care
has been infiltrated by a new group
of decision-makers who lack medical
training. These events signal a
stinging rebuke, inflicted by the
marketplace, on the recent practice
of medicine.
I bis has brought an end to
what may be termed “the laissez-care
era of medicine,” a time when a
patient’s care and welfare were a
doctor’s sole concern. Sadly, those
responsible for this achievement had
an ostrich's view of cost-contain¬
ment. As a result, responsibility for
patient care is now shared.
All of this brings to mind the
fifth book of The Iliad, in which
Homer described a wound suffered
by Aeneas (apparently an open frac¬
ture of the hip and a crush injury to
the acetabulum).

day is that while managed care
administrators often are not physi¬
cians, neither are they gods. We
should leave medical decisions to

How to reach us
Yale Medicine welcomes news

doctors—mere mortals, to be sure,
but highly trained ones—while be¬

and commentary. Please send

ing certain as physicians to address

letters to the editor and news

the cost issues that gave rise to

items to Yale Medicine, P.O.

managed care.

Box 7612, New Haven, CT

Perhaps our dilemma may af¬
ford an opportunity for us to be¬
come more efficient on the federal
level—namely to consolidate exist¬
ing resources, such as the Veterans

06519-0612, or via electronic
mail to ymm@yale.edu, and
include a daytime telephone
number. Submissions may

Affairs health system. Medicare and

be edited for length, style

Medicaid. The VA system might be

and content.

expanded to care for all patients
funded with federal monies. And if
these same facilities were made avail¬
able to the nation’s 45 million unin¬
sured, a large step would be achieved
in streamlining medical care.
While divine inspiration pre¬
vailed in Homer’s day, today we may
have to rely upon human adapta¬
tion. Laissez-care is gone.

Robert J. Kerin, M.D. ’47
Milford, Conn.

Aeneas’ management may give

Arachnida. The ending “-oidea”
refers only to superfamily designa¬
tions. Furthermore, although spiders
and scorpions do have two body
segments, a cephalothorax and
abdomen, mites and ticks do not.
Mites and ticks, which comprise the
subclass Acari, have a single body

us our first glimpse of an early

that is not separated into discrete

HMO prototype since, from the

sections. The mouthparts are at¬

start, his care was seen to by medical

tached directly to the compact,

and non-medical personnel. It was

Lobsters, indeed!

initiated by Apollo, the patron deity

To the editor:

of medicine, who removed the pa¬

I was ready to ignore the tick vs.

oval, round, or cylindrical body of
the arthropod. The fusion of the
various body parts is suggested by

tient from the battlefield to the

insect slip in your Lyme disease ar¬

the presence of sutures and annula-

sanctuary of his temple. Further care

ticle, because in the popular press,

tions, but no distinct separations

was rendered by Artemis, the twin

ticks are often lumped with insects

are easily visible.

sister of Apollo, and Leto, their

in the Aristotelian-derived sense of

mother, who “healed his wound and

“entoma”; however, Dr. M.H.

are more closely related to lobsters

restored his strength completely.”

Schmidt’s letter (Let Us Be Precise,

than to insects!

All those involved in the care of
Aeneas were endowed with divine
attributes, a gift that helps in the
care of humans. The difference to¬
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Spring 1997) has compounded the
problem and forced me to write.
Ticks, mites, scorpions, spiders
and their relatives are in the class

Finally, to be more precise, ticks

William L. Krinsky, M.D. ’71, Ph.D.
Division of Entomology
Peabody Museum of Natural History
New Haven, Conn.
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THE PROGRAM FOR HUMANITIES IN MEDICINE
Lectures at 5 PM on Thursday in the BEAUMONT ROOM, Yale University School Medicine,
333 Cedar Street, New Haven. Refreshments at 4:30 PM. The lectures are free and open to the public.
For more information, call Howard Spiro or Clara Gyorgyey at (203) 783-3494.

DECEMBER 4

MARCH 19

SIR WILFRED THOMASON GRENFELL,
THE LABRADOR DOCTOR
Charles P. Stetson, BS
Chairman, US Fund for Leadership Training
Southport, Connecticut

MEDICINE ON TRIAL: COURTROOM STORIES
OF MEDICINE, LAW & MORALITY
Hon. Barry R. Schaller, JD
Judge, Connecticut Appellate Court
Hartford, Connecticut

DECEMBER 18

MARCH 26

CHAOS THEORY & FRACTALS IN MEDICINE,
MUSIC & ART
Ary Goldberger, MD
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

“ONE WORD: THE POETRY OF MEDICINE”
THE ROBERT PENN WARREN LECTURE
MarkJ. Straus, MD
Professor of Medicine & Poet
New York Medical College
New York, New York

JANUARY 8

APRIL 9

HOW TO STAY HUMAN IN MEDICINE:
THE HOUSE OF GOD & MOUNT MISERY
Steven J. Bergman (Samuel Shem), MD, PhD
Writer, Comic & Psychiatrist
Harvard Medical School
Boston, Massachusetts

OLD MAPS: GUIDES TO THE GEOGRAPHY
OF THE EARTH, BODY & MIND
Harold L. Osher, MD
Cardiologist, Cartographer
& Director of Osher Map Library
University of Southern Maine
Portland, Maine

JANUARY 22
‘HOW I GOT TO BE WFLAT I WANTED TO BE”
Morris Wessel, MD
Clinical Professor Emeritus of Pediatrics
Yale University School of Medicine

FEBRUARY 5
OVER THE RIVER THROUGH THE WOODS:
TAKING THE MEDICAL HIGH ROAD
THE BAYER LECTURE
Richard “Buzz” Goodstein, MD
Vice President for Scientific Relations
Bayer, Pharmaceutical Division
West Haven, Connecticut

APRIL 16
SENSIBILITY, MEDICINE & THE SPECTACLE OF THE
BREAST IN THE 18TH-CENTURY NOVELS
Nina A. Prytula, MPhil
Doctoral Candidate, Department of English
Yale University

APRIL 30
RICHARD SELZER: POET OF THE BODY
Mahala Yates Stripling, PhD
Texas Christian University
Fort Worth, Texas

MAY 7
FEBRUARY 19
THE BEAUTY OF MY ANOMALOUS NATURE:
A BOOK OF MEMORIES KY PETER NADAS
Ivan Sanders, PhD, Professor of English
Suffolk Community College & The New School
New York, New York

MARCH 5
HISTORY OF MEDICINE & HEALING IN SOUTH ASIA*
Maneeshal Lai, PhD
Visiting Professor, History of Medicine
University of Wisconsin
Madison, Wisconsin

JAMES JOYCE: MANIC GENIUS & THE FAMILY TRIANGLE
James R. Merikangas, MD
Clinical Professor of Psychiatry & Neurology
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Federal audit shows Yale’s Medicare billing
practices in good health

T

he Office of Inspector General of the U.S. Depart¬

Medicare payments to teaching physicians in academic

ment ol Health and Human Services (HHS) has

medical centers lor care provided before the new regula¬

given the School ol Medicine a clean bill of health

tions were issued. Many academic medical centers have

regarding its Medicare billing practices at Yale-New

complained that the PATH audits are unfairly

Haven Hospital. The School of Medicine was

.pplying the new rules retroactively,

one ol 49 institutions nationwide notified

finding innocent errors caused by

that they would be audited under the

confusion and unfairly calling

HHS Physicians at Teaching Hospitals

them fraud.

(PATH) audit program.

The audit at Yale began in

Under Medicare rules, teaching

August 1996, and auditors re¬

physicians are permitted to bill for

viewed a sample of Medicare

care they directly provide to patients.

payments to Yale School of Medi¬

In addition, il the care is provided by a

cine for patients seen by Yale faculty

resident, the teaching physician super¬

physicians in 1994. The HHS auditors’

vising the resident can bill for those ser¬

conclusion: Yale is in compliance. “The

vices only if he or she is sufficiently involved in the

results of this audit show Yale’s commitment

care, and if that involvement is appropriately docu¬

to compliance,” said Dean David A. Kessler,

mented. How much involvement was sufficient and

M.D. “Compliance is difficult at times because the rules

what kind of documentation was required were matters

and regulations are complex and sometimes unclear.

of debate and confusion until HHS adopted new regula¬

For Yale to have come through this audit so well is a

tions in 1996 that attempted to clarify these issues.

tribute to the doctors and administrators at the School

The HHS PATH audit program has focused on

Urban health program
broadens community
outreach efforts
The U.S. Department of Health and

of Medicine.”

topics include The Effects of Pesticides on

and the community. According to

Children, School Health, Prevention of

Dr. Groce, the program aims to bring

HIV Among Drug Users in New Haven,

more community practitioners into the
University to share their experiences

and Prenatal Cocaine Exposure.
According to Nora E. Groce, Ph.D.,

and expertise.

Human Services’ Health Resources and

assistant professor of public health, the

Services Administration (HRSA) has

lecture series highlights some critical

H. Merson, M.D., dean for public

awarded nearly half a million dollars to

issues facing the urban community

health; Ralph I. Horwitz, M.D., chair of

the Yale Urban Health Program over a

today, including violence prevention,

three-year period. One of 16 Public

homelessness and abuse.

internal medicine; and Margaret Grey,
Dr.P.H., associate dean for research and

Health Special Projects funded by

“The HRSA grant will help us get

Executive advisors include Michael

doctoral studies at the School of Nurs¬

HRSA this year, the Urban Health

some of the most talented and moti¬

Program will use the grant to expand

vated public health, medical and nurs¬

ing. The co-directors include Dr. Groce,
Patrick G. O’Connor, M.D., M.P.H.,

collaborations within the Yale medical

ing students working together to im¬

associate professor, general medicine,

center, the University and the greater
New Haven area.

prove the well-being of people in urban

and Martha Swartz, R.N., M.S., associ¬

communities,” says Dr. Groce, principal

ate professor of nursing. The program’s

The grant allows the program’s leaders
to expand curricula and create new pro¬
grams, including student internships
and a minority fellows program. Funds
will also be used to sponsor the second
annual Urban Health Lecture Series,
which began in late October. Lecture
i

investigator for the grant and one of

coordinating director is Wanda

three co-direcrors of the Urban Health
Program.

Anderson Harris, M.Ed., M.P.A.

The Urban Health Program, created

“We want the program to produce a
generation of students who can leave

in 1995 with a planning grant from the

Yale with invaluable experiences on the

Pew Charitable Trusts, fosters interac¬
tion between students at Yale, faculty

cutting edge of urban health chal¬
lenges,” says Wanda Harris.
W I N T E R / S P R I N G
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Study documents
dumping of psychiatric
patients
Two-thirds of psychiatric hospitals pro¬

nomically motivated transfers of patients

growth of managed care and other meth¬

in relation to competitive pressures, hos¬

ods implemented to reduce the cost of

pital ownership and managed care prac¬

health care delivery, such as the use of

tices.
“This form of patient dumping ap¬

the prospective payment system for
Medicare and other insurers, utilization

viding inpatient mental health care in

pears to be substantially exacerbated by

review by insurance companies, and re¬

the United States are reported to dump

increased competition among hospitals

duced public compensation pools.

patients for economic reasons, according

and reductions in the capacity of state-

to a Yale/Harvard study published in the

run psychiatric hospitals,” Mark J.

of the survey respondents (directors of

Schlesinger, Ph.D., associate professor

CMHCs) reported a great deal of

journal Health Services Research.

The researchers found that 25 percent

of public health at Yale, and colleagues

dumping occurred in their service area,

which hospitals transfer unprofitable

from Harvard University’s Kennedy

with slightly more than half of those pa¬

patients, specifically those without in¬

School of Government wrote in the

tients transferred on economic grounds.

surance coverage, to public hospitals

journal’s December issue.

Twenty-two percent of the CMHCs re¬

Patient dumping is the practice by

and community mental health centers

In addition to tax exemptions, the

ported substantial adverse effects on

(CMHCs), which are required by law to

primary way hospitals subsidize care for

their agencies due to dumping. Seventy-

care for these patients after private fi¬

patients without coverage is through

five percent reported that transfers based

nancial resources have been exhausted.

profits made by treating insured pa¬

on economic grounds were more likely

This is the first national analysis of the

tients. This practice has become increas¬

to occur from for-profit hospitals.

factors that promote or constrain eco¬

ingly difficult in recent years with the

About face
The brain’s prefrontal cortex may hold
the key to our ability to recognize
and remember one another.

P

atricia S. Goldman-Rakic, Ph.D.,
professor of neurobiology, and
her colleagues have pinpointed an

area of the brain that retrieves informa¬
tion about faces and facial expressions

“This study has revealed that infor¬

from memory. Their findings were

mation related to faces is processed in a

reported in the Nov. 7 issue of the

specific region of the prefrontal cortex,”

journal Science.

says Dr. Goldman-Rakic, the study’s

The research team showed macaque

principal investigator. “This shows not

monkeys pictures of human faces and

only that the prefrontal cortex is modu¬

objects, and measured the electrical

lar and specialized by domain, but that

impulses in different areas of the brain.

each of its neurons has a dedicated

Research results showed that neurons

function, since individual neurons code

clustered in an area of the inferior pre¬

individual types of information—for

frontal cortex responded only to pic¬

example, different faces.”

tures of faces and to no other stimuli.

Past studies of brain function have

Researchers measured and compared neural
activity as the subject looked at a rendering
of a face, above left, and at a non-face image.

“Our study indicates that the pre¬
frontal cortex is modular, like other
brain areas that have been more closely

The team further found that the pre¬

focused mostly on sensory and motor

frontal cortex was able to maintain in¬

areas, which have been found to be

research has brought us closer to under¬

formation about the faces even after the

modular and specialized. Some scientists

standing how the higher centers of the

stimuli were removed.

have theorized that the prefrontal cortex

human brain work.”

Scientists know that the prefrontal
cortex is the most advanced part of the

might function in a different way.

examined,” says Dr. O Scalaidhe. “This

Dr. Goldman-Rakic’s team included

Seamas P. O Scalaidhe, Ph.D., associate

Dr. O Scalaidhe and Fraser A.W.

human brain and is responsible for cog¬

research scientist in neurobiology and

Wilson, Ph.D., now an assistant profes¬

nitive functions such as memory, rea¬

the study’s first author, points out that

sor at the University of Arizona. The

soning, mental computation and lan¬

in this respect, the organization of the

National Institute of Mental Health

guages, but it has been unclear how the

prefrontal cortex resembles that of other

and the McDonnell Foundation funded

prefrontal cortex processes information.

brain areas.

the study.
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Yale, Scirex Corp. open
unit for psychiatric
drug research

and potentially reduce the time it takes

some of the most revolutionary new ad¬

for new therapeutic discoveries to reach

vances in medical science. Yet over the

the market.”

past decade, health care management

Scirex, a contract research organiza¬

and dwindling government dollars have

The Department of Psychiatry and

tion headquartered in Blue Bell, Pa.,

eroded the financial base needed to sup¬

SciREX Corp. have announced a new

performs drug development services

port this critical work,” says Benjamin

collaboration to conduct clinical re¬

for pharmaceutical and biotechnology

S. Bunney, M.D., chairman of the De¬

search on potential new drugs for psy¬

companies. The company will work

partment of Psychiatry and the Charles

chiatric disorders. The Scirex Clinical

closely with Yale psychiatry faculty

B.G. Murphy Professor of Psychiatry

Research Unit at Yale, which opened

members to plan and conduct central

and Pharmacology.

Nov. io in a 6,000 square-foot facility

nervous system clinical studies. Faculty

“By working together, we gain not

at 320 Congress Ave., will conduct

expertise centers on basic neuroscience,

only the freedom to search for new dis¬

studies of central nervous system-

molecular neurobiology and genetics,

coveries, but also earlier access to novel

focused drugs.

neuropsychopharmacology and clinical

therapeutic compounds which could

biological psychiatry. Current research

lead to increased understanding of both

“New treatments for psychiatric disor¬
ders are desperately needed, and the

projects concentrate on depression,

normal and diseased brain function,' he

complexity of drug approval require¬

anxiety disorders including post-trau¬

said. “Ultimately, our patients will bene¬

matic stress disorder, obsessive compul¬

fit because our combined efforts may

Choukas, Scirex s president and chief

ments is significant,

says Michael

sive disorders, schizophrenia and sub¬

result in decreasing the time it takes

executive officer. “By collaborating with

stance abuse.

for new therapeutic discoveries to reach

full-time Yale faculty psychiatrists, we
hope to speed clinical drug development

“University medical schools have tra¬

This is only a test
Patients have questions, Yale physicians have answers.

W

hen faced with medical tests,

diagnostic imaging. Dr. Zaret, the

patients and their families

Robert W. Berliner Professor of Medi¬

generally have questions ga¬

cine and chief of cardiovascular medi¬

lore. Yale faculty have teamed up to pro¬

cine, also was an editor of The Yale Uni¬

vide answers in a new book, The Yale

versity School of Medicine Heart Book,

University School of Medicine Patient’s

published five years ago.

Guide to Medical Tests, published in

the market.”

ditionally been the proving ground tor

The book’s first section covers topics

The Yale University
School of Medicine
Patient’s Guide
to Medical Tests
Detailed Descriptions
of the Most Common
DIAGNOSTlC PROCEDURES
T The most valuable screening tests
for every age and stage of life

T What you should know before
undergoing a test

December by Houghton Mifflin Co.

important to all readers. It discusses pa¬

The book's 620 pages are packed

tients’ rights and informed consent, ex¬

\ Advice from the doctors, nurses, and
technicians who actually perform the tests

with information on common and not-

amines the role of screening, and pro¬

T A guide to helpful home tests

so-common diagnostic procedures.

vides overviews of current diagnostic

Each of its 29 chapters is written by a

imaging techniques (like CT scans) and

Yale School of Medicine full-time

laboratory tests, from finger-stick blood

faculty physician who specializes in

tests to bone marrow biopsies. The sec¬

the field being covered.

ond section deals with testing as it re¬

“The book helps patients through the

Barry L. Zaret, M.D., Senior Editor
I. Jatlow, M.D., & Lee D. Katz, M.D.. Associate Editors

Peter

lates to specific organs, organ systems or

tests—often, more specific or less inva¬

diagnostic process; it lets them and their

diseases, or to groups of people, such as

sive than older ones—are regularly

families know what the process is, what

children or women.

pointed out. Charts supply basic infor¬

to expect, how to prepare,” says Barry L.

The authors explain how particular

mation, such as where the test is done,
how long it takes, what equipment is

Zaret, M.D., the book’s senior editor.

systems work, what happens when they

“We want to demystify the process and

don’t work right, what doctors look for,

used, what discomfort or pain may

help patients to be a greater part of

and how they go about looking. They

occur, what risks or complications

include short case histories, describe

may be involved, and the average cost

that process.”
The associate editors are Peter 1.
Jatlow, M.D., HS ’65, professor and

common disorders, and list signs and

(lower than $100, $100 to 500, or more

symptoms that indicate problems.

than $500).
“The book is very comprehensive,”

chairman of laboratory medicine, and

Tests are presented in a logical se¬

Lee D. Katz, M.D., HS '86, associate

quence, from the simplest to the most

says Dr. Zaret, “and it’s designed to be

professor of radiology and director of

complicated. Dr. Zaret notes. Newer

exquisitely reader-friendly.”
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Breaking bread with the new brass

E

tween the medical school and the
VA Connecticut Healthcare Sys¬

very other Thursday throughout

care billing practices, and

tem in West Haven, and worked

the academic year, students, fac¬

NIH grant income rose

on several fund-raising projects.

ulty and staff file into the Beau¬

“On a daily basis, I work with

nearly 8 percent this year

mont Room for an experience that is

with larger growth an¬

the department chairs and fac¬

half culinary and half food for thought.

ticipated in future years.

ulty members to help address the

During its lunch-hour meetings, Medi¬

issues they face in getting their

“This is a great institu¬

own jobs done,” she said. “In

cal School Council hosts sessions on ev¬

tion, and it has a long

ery topic from curriculum development

history,” Dr. Kessler said.

brief, I work to make the dean’s

to cancer research to the latest in com¬

“And we will do well,

office the user-friendly place it

puter-based teaching.

better than well. But we

can and should be.”

Last fall this elegant, wood-paneled

Mr. Birnbaum, who Dr.

have to get certain things
in order, so I am spend¬

Kessler introduced as “the best in

watchers. In October and November,

ing a portion of my time

the field of medical and hospital

Dean David A. Kessler, M.D., and two

on the fiscal side of the

finance,” was the long-time chief

newly appointed top administrators

house, making sure this

financial officer of New York’s

made presentations to overflow crowds.

place is vibrant and can

Montefiore Medical Center.

“If ever there was a case for new facili¬

compete with the best,

He recalled meeting Dr. Kessler

ties, I think you’ve made it,” the dean

and have the resources to

there in 1982, when Dr. Kessler

joked as they squeezed into the first of

do that.”

was applying for the job of spe¬

room was the place to be for dean-

the two sessions. “There’s not a lot of
oxygen left, but come on in.”

The medical school

cial assistant to the president. “In

needs additional space,

came a guy with red hair and a

including a new anatomy

scraggly red beard, and I asked

M.P.H., the new associate dean for ad¬

lab and new research

him, ‘Why do you want this

ministration, spoke Oct. 16, followed

quarters, issues that will

job?’ He told me that in 10 or 15

Nov. 20 by Irwin M. Birnbaum, J.D.,

be addressed in a facilities

years, he wanted to be the head

Dr. Kessler and Ruth J. Katz, J.D.,

the school’s new chief operating officer.

plan now being formu¬

of a major medical center or

They introduced themselves, discussed

lated, he said. New build¬

dean of a medical school.”

some of the school’s most pressing is¬

ings are part of that plan,

sues, and answered questions about

as well as renovations of

said, Dr. Kessler was sidetracked.

school finances, faculty appointments,

existing space following

They prepared together for Dr.

teaching, clinical care and student life.

the model of the physiol¬

Kessler’s Senate confirmation

ogy wing of Sterling Hall

testimony before he was sworn in

“I am here, I believe, to serve the col¬

Along the way, Mr. Birnbaum

Irwin M. Birnbaum

lective wisdom, and I want to be doing

of Medicine that was

what you want me to be doing, focusing

completed in the fall. (See Page 8.) Other

as U.S. food and drug commis¬
sioner in 1990. After Dr. Kessler an¬

on the things you think I should be fo¬

priorities for the medical school include

nounced in late 1996 that he would

cusing on,” Dr. Kessler told the group.

aggressive searches for a number of de¬

leave the Food and Drug Administra¬

“I’m good at getting things done, but

partment chairs, recruitment of senior

tion, and accepted the deanship at Yale,

what we get done needs to come from

women to the faculty, new fund-raising

he phoned Mr. Birnbaum in late March

those who have the best ideas—whether

initiatives, and improvements for students.

1997 to ask him to come to New Haven.

it’s someone in the mailroom, a firstyear student, or someone on the senior

“I take our responsibility to teach very

“The No. 1 reason

1

wanted to do it was

seriously,” Dr. Kessler said, “I care less

David Kessler,” Mr. Birnbaum said. “He

faculty. The best ideas deserve the

about what we teach as opposed to how

just wants to make change, and make

most attention.”

we teach. There is a core of knowledge

change in the right direction. I wanted

that keeps changing. You’re not going to

to be a part of it.”

In order for Yale to remain at the
forefront of American medicine, “there

learn everything. But I’d like everybody

Mr. Birnbaum said the financial

are some major infrastructure issues that

to be well trained. There is no reason to

challenges to the medical school are

we need to address,” he said, referring to

sit in any lecture, go to any course that

significant but manageable. Beyond the

the school’s operating deficits over the

isn’t excellent here.”

bottom-line concerns, he said, are fun¬

past two years. Yale has seen a decline in

Dr. Kessler and Ms. Katz, a former

damental questions about how to edu¬

clinical income under managed care

congressional counsel and an expert in

cate students and residents in the era

compounded by problems with the

health policy, have been meeting with

of managed care, when patients are

school’s computerized billing system.

students to discuss financial aid, hous¬

discharged earlier from the hospital.

On the positive side, the federal office

ing, security and other issues. Since ar¬

“The question is not whether Yale will

of the Inspector General gave the school

riving in July, Ms. Katz has coordinated

survive. Yale will not only survive, it

a clean bill of health in November sub¬

the formation of new student affairs

will thrive,” he said. “The changes will

sequent to an audit regarding its Medi-

committees, served as the liaison be¬

be in how we teach.”
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University of California professor named dean of nursing school

C

atherine Lynch Gilliss, D.N.Sc.,

during recovery from life-threatening

chair of the Department of Fam¬

illnesses such as coronary bypass surgery.

ily Health Care Nursing at the

Most recently, she completed an enu-

University of California, San Francisco,

merative study of the primary care work

has been named dean of the Yale School

force in the state of California.

of Nursing for a five-year term begin¬

During her tenure, Dean Krauss has

ning July i. She will succeed Judith B.

made several key appointments to the

Krauss, M.S.N., who joined the nursing

faculty and overseen the expansion of

school faculty 26 years ago and has

the school’s research programs. A new

served as dean for nearly 13 years.

doctoral program was added in 1994,

Dr. Gilliss, a certified adult nurse

and the school moved to newly reno¬

practitioner, has taught at the University

vated state-of-the-art teaching facilities

of California since 1984, where she re¬

in 1995. In addition, the school has

ceived her doctor of nursing science de¬

strengthened and developed new clinical

gree and completed a postdoctoral fel¬

partnerships with several clinical agen¬

lowship. She previously held teaching

cies throughout Connecticut. A noted

positions at several universities includ¬

Catherine L. Gilliss

ing The Catholic University of America
in Washington, D.C., the University of

authority on the care of people with
serious and persistent mental disorders,

Her research has focused on innova¬

Dean Krauss will return to a teaching

Maryland and the University of Port¬

tive models of nursing intervention for

and mental health policy role on

land, where she serves as a trustee.

patients and their families, especially

the faculty.

Grant from insurer funds
two outcomes research
projects

care to the elderly individuals, and this

pediatrics and medical director of the

grant will allow us to evaluate how well

program, which has served 115 families

it serves elderly patients after heart at¬

in greater New Haven during the past

tacks,” said Harlan M. Krumholz,

three years. Added Elizabeth Demir,

Insurance giant Aetna Inc. has awarded

M.D., who will lead the study. Dr.

chair of the Bright Beginnings advisory

more than $750,000 to the School of

Krumholz is associate professor of medi¬

committee: “This Aetna grant will allow

Medicine to fund research aimed at im¬

cine (cardiology) and director of the

us to expand the number of successful

proving health outcomes. The grants are

Center for Outcomes Research at Yale-

matches between mothers and mentors

among $6 million awarded to 13 institu¬

New Haven Hospital.

tions through the company’s Quality
Care Research Fund.

► $300,000 to the School of Medi¬

this promising program can sustain each
year and, if study results substantiate

cine to study the effectiveness of Bright

our early findings, we should be able to

The two grants are as follows:

Beginnings. This volunteer-based

attract continued funding.”

► $468,066 to the School of Medi¬

mentoring program that encourages vul¬

The program was launched in 1995

cine and Yale New Haven Health

nerable, young mothers to develop

System in collaboration with Aetna sub¬

healthy lifestyles for themselves and

tal, a volunteer organization affiliated

sidiary U.S. Quality Algorithms to com¬

their children and to make good use of

with the Department of Pediatrics.

pare managed care and tee-for-service

illness prevention resources. The study

insurance in the care and outcomes of

will examine the effectiveness of this

elderly patients with heart attacks. This

broad-based, parent support program by

study will build on the Cooperative

evaluating such measures as completion

Cardiovascular Project (CCP), a na¬

of well-baby check-ups, inappropriate

tional Medicare quality improvement

use of the emergency department, the

project, to compare tests, procedures,

number of preventable injuries and each

specialty care, readmissions and mortal¬

mother’s sense of parenting competency.

by the Friends of the Children’s Hospi¬

Psychiatric hospitals
may be deluged
with sex offenders
When convicted sex offenders finish

ity among those elderly heart attack

“We believe that Bright Beginnings

patients treated under managed care

could serve as a model to help alleviate

serving prison time, many of them will

and those treated under traditional fee-

some of the substantial health problems

go directly from a jail cell to a psychiat¬

for-service.

faced by underserved, inner-city chil¬

ric ward. A June 1997 U.S. Supreme

dren and their families,” said John M.

Court ruling says that prisoners who fit

Leventhal, M.D., HS ’76, professor of

the profile of “sexually violent preda-

“Managed care is emerging as an im¬
portant system of administering medical
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tors” will immediately be committed to
hospitals for psychiatric care.
At an estimated annual cost of be¬
tween $60,000 to $130,000 per patient,

EPH, Hospice Institute
work to improve
access to care

Ph.D., assistant professor of public
health at Yale, the project is offering a
formal education program to physicians,
nurses and other health care providers at
acute-care hospitals in Connecticut.

this will drain a psychiatric system that

The John D. Thompson Hospice Insti¬

is already strapped for funds, says

tute in Branford, Conn., and experts

“We will measure the impact of the edu¬

Howard V. Zonana, M.D., professor of

from Yale’s Department of Epidemiol¬

cational program on medical profession¬

psychiatry at the medical school and

ogy and Public Health have launched a

als’ knowledge and attitudes about hos¬

clinical lecturer at Yale Law School.

three-year educational program to im¬

pice, as well as utilization of hospice

prove access to palliative care for the

services,” says Dr. Bradley, research di¬

“Society certainly has a right to be
protected from sexual violence,” says

terminally ill.

rector for the hospice project. The edu¬

Dr. Zonana, who chairs the American

“Our partnership with Yale will pro¬

cational program was designed by the

Psychiatric Association’s Task Force on

vide a much-needed educational effort

John D. Thompson Hospice Institute

Sexually Dangerous Offenders. “But I

about hospice and palliative care,” says

for Education, Training and Research

am also concerned with the enormous

Rosemary Johnson-Hurzeler, R.N.,

Inc. (named for a late Yale EPH faculty

cost and the impact on the quality of

M.P.H. ’75, the institute’s president and

member) and its affiliate, the Connecti¬
cut Hospice, the nation’s first hospice

care this ruling will have on patients

chief executive officer. “The care pro¬

with severe incapacitating mental

vided, as well as the related educational

program. In future years, the two groups

illnesses whose ability to survive in

and research programs, will focus on

anticipate making this educational

the community requires extensive

life, not death,” she adds.

resources.”

According to Elizabeth H. Bradley,

program available to all hospitals in
Connecticut.

According to Dr. Zonana, whose
views were expressed in the Nov. 14 issue
of the journal Science, treatment for sex
offenders requires maximum-security fa¬

Physician’s award will support end-of-life AIDS care

cilities that are not usually found in hos¬

A

pital settings.
“If sex offenders are unable to control
their behavior, they should be given
longer prison terms and those who need

s a patient’s life comes to an end,
physicians and care providers are
faced with the unique task of

psychiatric treatment should have it

tending to the spiritual as well as medi¬

available before the end of their criminal

cal needs of their patients. Yale physi¬

sentences,” says Dr. Zonana.

cian Peter A. Selwyn, M.D., M.P.H., as¬

The U.$. Supreme Court ruling

sociate director of Yale’s AIDS Program

found that “sexually violent predators”

and associate professor of medicine, has

can be hospitalized after and only after

dedicated a significant part of his career

they have served their entire criminal

to improving end-of-life care for AIDS

sentence. Dr. Zonana maintains that

patients. In September, he was one of 12

these statutes provide a very low thresh¬

physicians chosen to receive the Faculty

old for people to be determined men¬

Scholars Award from the Open Society

tally ill. The court’s decision makes it

Institute’s Project on Death in America

Peter A. Selwyn

possible for sex offenders to be hospital¬

(PDIA), funded by the financier

Selwyn. “This grant will aid in the im¬

ized based on remote past behavior and

George Soros.

provement and development of new

any mental abnormality or personality

Dr. Selwyn will receive up to $65,000

strategies for end-of-life care and to help

disorder that makes them likely to re¬

for three years from PDIA, a nationwide

increase awareness about this often over¬

peat their behavior.

program aimed at advancing medical

looked area of medicine for doctors in

education, awareness and clinical care in

training.”

According to Dr. Zonana, this issue
raises tough questions such as what

end-of-life care. Dr. Selwyn will use the

mental illnesses or conditions are suffi¬

award to help develop curricula at the

cient to meet the sexually violent preda¬

School of Medicine on end-of-life care.

viving the Fall: The Personal Journey of

tor requirement.

He will also help develop a model clini¬

an AIDS Doctor, to be published by Yale

“This law is so broadly drawn that

Dr. Selwyn has chronicled his experi¬
ences in a book of memoirs entitled Sur¬

cal program at Leeway, a 30-bed skilled

University Press this spring. The book

rapists who display anti-social behavior

nursing facility for people with HIV

explores the early days of the AIDS epi¬

or traits could be hospitalized,” says

and AIDS in New Haven, where he is

demic, when Dr. Selwyn worked at

Dr. Zonana. “This is transforming

medical director.

criminal behavior into mental illness,

“Despite recent advances in therapy,

Montefiore Medical Center in New
York City, and focuses on the ways in

further stigmatizing the mentally ill

the AIDS epidemic is still affecting

which working with dying patients led

and serving a primary function of pre¬

people in the prime of their lives with a

him to come to terms with his own per¬

ventive detention.”

life-threatening illness,” says Dr.

sonal history of grief and loss.
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Study explores
connections between
menopause and mood
1 he number ol women experiencing
menopause is expected to triple over the
next decade, causing an increased de¬
mand for more effective treatment oi
symptoms such as mood changes. To
address this situation, Angela Cappiello,
M.D., Ph.D., chief oi the Menopause
Mood Disorders Clinic and co-director
ol the Behavioral Gynecology Program
at the School of Medicine, has launched
a series ol studies on mood disorders in
MICHAEL FITZSOUSA (2)

menopausal women that may offer relief
for some symptoms ol menopause.
“My goal is to understand the con¬
nection between the brain and the
female hormone estrogen,” says Dr.
Cappiello, whose study is funded by
the Lilly Center for Women’s Health.
“Female hormones may protect women
front stress. Loss ol estrogen could cause
women to be more vulnerable to stressiul life changes that usually occur
around the time of menopause, includ¬
ing changes in employment, marriage,
and children leaving home.’’
Dr. Cappiello is studying how healthy
menopausal women respond to a seroto¬
nin depletion induced by a low tryp¬

“This is something I got very good at

school’s main building originally

in Washington,” Dean David A.

constructed in 1924, was supported,

Kessler, M.D., above left, joked as he

in part, by a $1.5 million grant from

joined in the ribbon-cutting cer¬

the National Science Foundation.

emony celebrating the renovation of

Architecturally, the renovation

15,000 square feet in the Department

changed a series of small, often oddly

of Cellular and Molecular Physiology.

shaped rooms into six larger flexible

The $4.9 million project, the first of

laboratory modules, two flexible

several that are anticipated to reno¬

core facilities (one for microscopy

vate existing space in the medical

and another for graphics), and several
smaller laboratory support spaces,

tophan diet. She expects that meno¬

including cold room, equipment

pausal women treated with estrogen will

rooms and biological and radioactive

have a more stable mood and will be less

waste storage areas. With Dr. Kessler

sensitive to the mood changes of a low

are, above from left: Virginia M.

tryptophan diet. In addition. Dr.

Chapman, department Chair

Cappiello is also testing whether the

Walter F. Boron, M.D., Ph.D., John

most effective treatment for depressed

Giovannone, former Dean Gerard

menopausal women is estrogen alone,

N. Burrow, M.D., architect Barry

fluoxetine (Prozac) alone, or the combi¬

Svigals, and John Bollier. Listening

nation of both fluoxetine and estrogen.

to the dedication were former Dean

“If we can prove that estrogen regu¬

Robert W. Berliner, M.D., far left,

lates serotonin (unction, then that will

and Emile L. Boulepaep, M.D., both

be a big finding,” says Dr. Cappiello.

members of the physiology faculty.

An estimated 30 million women are
expected to reach menopause in the
next 10 years, and more than one-third
of a woman’s life is post-menopausal,

“We want women to know that treat¬

Clinic is part of the Yale Behavioral Gy¬

according to Dr. Cappiello. Previous re¬

ment is available,” says Dr. Cappiello

necology Program operated jointly by

search has shown that estrogen regulates

who will use her study to inform

the departments of Psychiatry and of

brain activity and that loss of estrogen

women that they do not have to suffer

Obstetrics and Gynecology at the

can affect mood and behavior. Approxi¬

in silence. “Research on menopause is

School of Medicine.

mately 85 percent of women have some

relatively new. It is getting more

kind of reaction to estrogen loss, such as

attention because more and more

Contributors: Helaine Patterson,

mood changes, depression, hot flashes

women are becoming menopausal and

and insomnia. Fifteen percent of

there is greater interest in women’s

Karen Peart, Michael Fitzsousa, Judith
Winslow, Cynthia Atwood, llene Shub

menopausal women suffer from more

health issues.”

severe symptoms.
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The Menopause Mood Disorders

Lefland, Susan Alksnis and Carolyn
Battista.
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New research finds link between religion
and health in the elderly

F

or the elderly, religion may do

tion, they were more likely to have cel¬

ued attending religious services were

more than ease the soul. In fact,

ebrated the winter holidays with more

able to maintain higher levels of func¬

attendance at religious services

than one group of people.

tioning and psychological health

may actually improve physical health
and psychological well-being. That ac¬

► Improved emotional well-being:
Subjects reported increased feelings of

through 1988,” says Dr. Idler, who re¬
ceived a Ph.D. degree in 1985 from Yale.
“Even after we took out the other

cording to two new reports, co-authored

optimism and happiness and fewer

by Stanislav V. Kasl, Ph.D., professor of

symptoms of depression. The impact

variables such as friendship, leisure ac¬

epidemiology in the Department of Epi¬

was the greatest for people experiencing

tivities and social support, there was still

demiology and Public Health, and Ellen

functional disability due to chronic ill¬

evidence that attendance at religious ser¬

Idler, Ph.D., associate professor of soci¬

ness. Functional disability is defined as

vices had a positive impact on health,

ology at Rutgers’ Institute for Health,

difficulty handling such daily activities

particularly for those who experienced

Health Care Policy and Aging Research.

as climbing stairs, using the toilet or

some level of disability at the beginning

carrying groceries.

of the survey,” she adds. Some of the

The reports reveal the findings of a
12-year study conducted by

subgroups studied, such as

Yale public health faculty and

people who already had some

funded by the National Insti¬

disability, continued to experi¬

tute on Aging (NLA). The

ence the positive effects

study sampled 2,812 people

through 1994, but the overall

age 65 and over from Protes¬

numbers were lower due to a

tant, Catholic, Jewish and

decline in the subject pool.

other religious backgrounds in

“There were so many reasons

New Haven. Subjects were in¬

for thinking that we should ex¬

terviewed annually from 1982

pect better health among
people who are religiously in¬

to 1989 and again in 1994.

volved, but until now it wasn’t

The two reports were pub¬
lished in the Nov. 15 issue of

anything we were able to

the Journal of Gerontology. The

quantify,” says Dr. Idler.

first report, Religion Among

“We also found that it wasn’t a

Disabled and Nondisabled Per¬

person’s individual feelings of

sons I: Cross-sectional Patterns in Health

The report is important because it

religiousness that made the difference, it

Practices, Social Activities and Well-being,

measured many other kinds of resources

was acting as part of the larger worship

explores the impact of participating

in elderly people’s lives, and found that

group that fostered positive health.”

in religious services on risky health

attendance at religious services was con¬

behaviors, friendships and family ties,

sistently associated with most of these

has a large representative sample of

“This study is important because it

resources. “Attendance acted as a linch¬

community-living elderly, a longitudinal

pin because it was associated with better

follow-up to study changes over time

people who participated in religious

overall health practices, more friends

and rigorous statistical adjustments for

services are:

and relatives, more social activities

the influence of many other variables so

and higher levels of well-being,” notes

that the unique effect of religiousness

Dr. Idler.

can be better identified,” adds Yale’s

and depression.
The three major findings for elderly

► Lower frequency of unhealthy be¬
haviors: Subjects are healthier because
they are more likely to engage in good

The second report, Religion Among

health habits, such as exercise, and are

Disabled and Nondisabled Persons II:

less likely to have participated in risky

Attendance at Religious Services as a

Dr. Kasl.
The study was commissioned as part
of the NIA-Established Populations for

behaviors, such as excessive smoking

Predictor of the Course of Disability, ex¬

the Epidemiologic Study of the Elderly,

and heavy drinking, due in part to

plores how religious involvement can in¬

which included separate studies con¬

social and behavioral guidelines set

fluence changes in physical health over a

ducted by Harvard University, Duke

forth and reinforced by the religious

12-year period. These findings show that

University and the University of Iowa.

organizations.

attendance at religious services was a

► Stronger support systems and so¬
cial ties: Subjects reported more friend¬

good predictor of functional ability in
later life by comparing a person’s func¬

ships, closer relationships with more

tional ability in 1982 to the changes that

family members, and participation in

occurred during each follow-up year.

more leisure activities, such as visits to

“Over the long-term, people who had

museums and sporting events. In addi¬

better health levels in 1982 and contin¬
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GALLERY

When house calls
were horse calls
By John Curtis
Saddlebags
tell the story
of a physician’s
day in the early
19th century.

Photographs by Terry Dagradi

I

Biomedical Communications

n a box in an office at the Medical Historical Library
sit a pair of leather saddlebags, stiff with age, frayed
from use and still holding some of the nostrums and

powders that made up a physician’s pharmacopoeia in
the first half of the 19th century.
Small glass bottles and yellowed paper packets con¬
tain such remedies as ergot to strengthen uterine con¬
tractions during childbirth and Peruvian bark to treat
fevers. They belonged to Asaph Leavitt Bissell, M.D.,
one of Yale’s earliest medical graduates. Dr. Bissell, a
member of the school’s second class, practiced in
Suffield, Conn., a tobacco-farming community where
his parents had once lived and where his family still
plays a prominent role. Charles Bissell Jr., the physician’s
great-great-grandson and a member of the Yale College
Class of 1945W, surmises that the saddlebags were always
near the door ready for use. “He would hop on his
horse,” says Mr. Bissell, a present-day resident of
Suffield, “and go out to take care of someone."
After Asaph Bissell’s death in 1850, the saddlebags
were handed down from father to son until 1996, when
Mr. Bissell donated them to the medical school. “I
thought it was the appropriate place to have them.”

Above: A portrait of Dr. Bissell, and his signature, taken from his copy of a
medical journal. Below: Medicines of the time would have included emetics
and cathartics, which Dr. Bissell kept in small glass bottles or wrapped in paper,
tied with string and labeled in his own hand.

Asaph Bissell was born in 1791 in Hanover, N.H.,
and began medical studies at Dartmouth in 1811. Two
years later he went to New Haven with Dr. Nathan
Smith, who had been lured away from Dartmouth to
become the founding dean of the medical faculty at Yale.
Dr. Bissell graduated in 1815.
According to John Harley Warner, Ph.D., professor
of the history of medicine, a medical kit of the time
“would have included emetics and cathartics, and
purgatives like calomel. It would probably have included
some opiates. I would be very surprised if he wouldn’t
have had a lancet for letting blood [although no instru¬
ments remain in the bags today]. Anything having to do
with surgery would have been very superficial.”
According to Historical Librarian Toby Appel,
Ph.D., the bags will join surgical instruments and other
artifacts of medical history on display there. YM
John Curtis is a staff writer.
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DISCOVERY

Navigating the spinal

Myelinated healthy axons, above, and demyelinated
axons, right, as they appear after injury to the spinal
cord. Determining how to restore this protective coat¬
ing to injured nerve cells is central to Yale’s spinal
cord research effort.
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Once injured, the spinal cord cannot heal—at least that’s what medicine
has long believed. Now Yale scientists are mapping this terra incognita
and providing real hope to people with paralysis.

By Rachel Engers

cord

riginating in the brain,
stretching down the back and
extending its reach through the
peripheral nerves to every part of the
body from the toes to the fingertips,
the spinal cord is the body’s informa¬
tion highway. Despite its importance,
it is smaller than one might expect:
just 18 inches long and about half an
inch wide. It’s also quite vulnerable.
All it takes is a motor vehicle acci¬
dent or a miscalculated dive into a
swimming pool for the spinal cord to
be compressed or twisted. In an in¬
stant, sensation and movement may
cease altogether.
Each year in the United States,
spinal cord injury deprives close to
14,000 people of the ability to walk,
to use their arms and hands, or in
some cases, to breathe unaided. Of
the approximately 250,000 Ameri¬
cans who are paralyzed, a dispropor¬
tionate number have been injured in
the prime of their lives. Many, like
actor Christopher Reeve, who was
paralyzed from the neck down after
falling from a horse in 1995, are trau¬
matized at the peak of an active and
vigorous life.
Although physicians have be¬
lieved for thousands of years that an
injured spinal cord could not be repaired, new scientific
evidence indicates that this might not be true. “For
about the past 10 years,” says Stephen G. Waxman,
M.D., Ph.D., professor and chair of the Department of
Neurology, “we have had the sense that restoration of
function after spinal cord injury is not an unrealistic
goal.” Applying new understanding of how nerve cells
Rachel Engers is a writer in Simsbury, Conn.

die and how they might he re¬
vived, Yale scientists have made
important steps toward the goal of
someday reversing paralysis.
Much of this work has been
done in partnership with the Para¬
lyzed Veterans of America and its
largest chapter, the Eastern Para¬
lyzed Veterans Association. In co¬
operation with the federal Depart¬
ment of Veterans Affairs, these two
groups helped establish the PVA/
EPVA Center for Neuroscience
and Regeneration Research at Yale,
which opened in 1988 at the VA
medical facility in West Haven.
In the decade that has followed,
PVA/EPVA Center scientists have
gained ground in several areas.
They demonstrated that damage
to the protective coating of nerve
cells plays a key role in producing

Neurology chair and center Director Stephen Waxman: “The goal of repairing the injured
spinal cord, at least in some patients, is a realistic one.”

paralysis after spinal cord injury,
and have focused their efforts on finding ways to restore

Recent discoveries at Yale and around the world have

nerve function where this myelin layer has been stripped

changed that picture significantly. In 1988, Dr. Waxman

away. They also uncovered the molecular mechanism by

put together two crucial pieces of information that,

which remissions occur in patients with multiple sclero¬

while previously known, had never been connected. One

sis, a disease that also attacks the protective coating of

was the observation that among paralyzed patients, some

nerve cells. And they have developed the basis for new

nerve cells were found to survive at the site of injury—

treatments for pain and muscle spasticity specific to spi¬

even in patients who had no function below the injury.

nal cord injury. The major goal of the program is to re¬

The second was the knowledge that myelin was part of

store total function in individuals who have sustained

the puzzle in paralysis.

spinal cord injuries. Along the way, this research pro¬

Myelin is a fatty sheath that insulates nerve cells and

gram is aimed at finding ways to improve quality of life

speeds the conduction of impulses along the spinal cord.

for patients while the search for a cure progresses.

When a spinal cord is damaged, some axons are severed.

A DECADE OF ADVANCES

Waxman set out to find why the surviving axons were

These milestones and others were celebrated during a

unable to function, and, in doing so, made the connec¬

two-day program in late September marking 10 years of

tion to the critical role of myelin in spinal cord injury.

Others survive, but their myelin is stripped away. Dr.

collaboration among Yale, the VA, and the PVA and

His research showed that nerve fibers within the spinal

EPVA. Speaking to more than 100 members of the veter¬

cord work somewhat like electrical cords—when their

ans groups who came to New Haven for the event, Dr.

protective coating is removed, conduction is impaired.

Waxman said their support has provided not only fund¬

He discovered that it is this demyelination that prevents

ing but, through interaction between patients and scien¬

the surviving axons from properly carrying information.

tists, motivation to work hard for a breakthrough. “We

“In addition to the strategy of regrowing axons, this dis¬

don’t yet have a cure in hand,” he told the group, “but

covery opened up the possibility of repairing existing

we’ve made enough progress that I know we will come

ones,” says Dr. Waxman, the Helen Wilshire Walsh

up with more effective treatments. A cure is now a

Director of the PVA/EPVA Center. “Damage to the my¬

realistic goal.”

elin had been talked about even in 1906, but had been

Because scientists thought that nerves in the central

buried in the literature.” This finding focused attention

nervous system (unlike those in the peripheral nervous

on the goal of restoring nerve impulse conduction in de-

system) were incapable of regrowing after injury, they

myelinated axons, an approach to promoting functional

believed the only way to restore function would be to re¬

recovery in spinal cord injury.

build an entire spinal cord, surely a formidable task.
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Is the theory correct? To find out, scientists at Yale
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are experimenting with ways to mend the damaged my¬
elin sheath in an injured spinal cord. Jeffery D. Kocsis,
Ph.D., associate director of the PVA/EPVA Center and a
professor of neurology and neurobiology, has
carried out studies using the transplantation of
glial cells to stimulate the renewed production
of myelin and restore the conduction of electri¬
cal impulses through the nerve cells. Glia,
whose name is derived from the Greek word
for glue, are cells that fill in the spaces in the
nervous system not occupied by nerve cells.
Outnumbering nerve cells io to one, glia pro¬
vide support for nerve cells, with complex
functions ranging from producing myelin to
regulating the metabolism.
Dr. Kocsis began work on the transplanta¬
tion of cells four years ago. His interest was
sparked by other research done in the 1980s in
France and England showing that when glial
cells were injected into the spinal cords of my¬
elin-deficient rats, the cells produced anatomi¬
cally correct myelin. “When I learned of the re¬
search, I wondered if the myelin would work
properly,” says Dr. Kocsis. To find out, he bred
his own colony of myelin-deficient rats at the
PVA/EPVA Center and injected two types of
cultured glial cells—oligodendrocytes and as¬
trocytes—into their spinal cords. He found
that injecting glial cells not only produced myelin but
restored impulse conduction.
Now, Dr. Kocsis is looking for ways to make this
discovery useful to humans with spinal cord injuries.
His research was spurred on by an important finding
made by William F. Blakemore, D.V.M., a fellow col¬
laborator in The Myelin Project. (This Washingtonbased organization was founded by Augusto and
Michaela Odone of Fairfax, Va., after their son con¬
tracted adrenoleuko-dystrophy, a myelin-attacking dis¬
ease. The 1992 film Lorenzo’s Oil was based on their
story.) Dr. Blakemore, of the University of Cambridge,
found a way to demyelinate the spinal cord of a rat and
this paved the way for Dr. Kocsis and others to experi¬
ment with the insertion of cells from the central and
peripheral nervous systems, as well as genetically engi¬
neered cells. In these experiments, Dr. Kocsis found that
extensive remyelination occurred when Schwann cells
(from the peripheral nervous system) were mixed with
astrocytes (from the brain).
The newest and most exciting aspect of this research
is focused on the olfactory ensheathing cell, a peripheral
glial cell located in the nose. “These cells are unique,”
Dr. Kocsis says. “Under different conditions, they can
differentiate either into Schwann cells or astrocytes. We
have found that they make myelin and migrate tremenYALE
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Joel Black is associate director of the PVA/EPVA Center.
Jenny Fjell, below, is a predoctoral fellow who came to Yale
from Karolinska Institute in Sweden, another of the world’s
leading centers for spinal cord injury research.

ter injury,” says Joel A. Black, Ph.D., associate director
of the PVA/EPVA Center. The next step is to find a way
to induce the insertion of these critical sodium channels
into demyelinated nerve fibers. “My job,” says Dr.
Black, “is to tell the physiologists what I find so that
they can design a drug.” Success in this area may be
applicable to those with paralyzing spinal cord injuries
as well. “It’s just a matter of time before we make signifi¬
cant advances that improve the lives of people with
spinal cord injuries,” says Dr. Black.
Another strategy has emerged from the work of Drs.
Kocsis, Waxman and colleagues. They have furthered the
development of a drug called 4-aminopyridine (4-AP),
which improves impulse conduction in damaged nerve
fibers. The drug, now in Phase III clinical trials for mul¬
tiple sclerosis, works to reverse symptoms such as weak¬
ness and visual loss in MS patients. Early clinical trials
<S)

have started to test 4-AP’s benefits for patients with spi¬

cc

o
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Jeffery Kocsis found that injecting glial cells into the spinal cords
of rats not only produced new myelin but also restored impulse
conduction.

nal cord injury. These initial studies suggest that treat¬
ment with 4-AP may reduce pain and spasticity. “The
patients who have responded to 4-AP know it is not go¬
ing to cure them, but it appears to improve the quality
of their lives,” says Dr. Kocsis. These inquiries into pain

dously.” This is encouraging because it may mean that

and spasticity were prompted by discussions with mem¬

only one type of cell is needed to restore myelin (elimi¬

bers of the PVA, who had approached Dr. Waxman’s

nating the cumbersome process of mixing Schwann cells

team several years ago in search of answers.

and astrocytes, as well as the need tor the removal of as¬

Although it is not a cure and despite side effects that

trocytes trom the brain via a biopsy). Dr. Kocsis is also

may include trembling and seizures, 4-AP has been met

collaborating with Alexion Pharmaceuticals in New

with enthusiasm. “We feel that science is on the verge of

Haven to develop transgenic pig cells for transplantation

a breakthrough, especially with 4-AP, which has really

into human spinal cords.

meant a lot to those of us with spinal cord injuries,” says

CLUES ABOUT MS

early studies on 4-AP. “The return that some people have

Multiple sclerosis, a disease that affects more than

experienced has given us a great deal of hope.”

Kenneth Huber, president of the PVA, which funded

300,000 people in this country and an estimated 2.5 mil¬
lion worldwide, also results from neurological damage.

Scientists at the PVA/EPVA Center and in Yale’s
Department of Pharmacology played an important role

As with spinal cord injury, the myelin surrounding the

in the development of 4-AP by identifying the molecules

axons is destroyed, preventing them from transmitting

that prevent nerve impulses from traveling through the

signals to the brain. But unlike most neurological dis¬

spinal cord in the aftermath of an injury. In axons, nerve

eases, in which injury to the brain or spinal cord is gen¬

activity is modulated by specialized molecules called

erally irreversible, multiple sclerosis (MS) often includes

potassium channels, which were discovered in the 1950s

remissions in which patients regain lost vision or move¬

by Nobel prize winners Alan Hodgkin and Sir Andrew

ment spontaneously. Scientists have long been mystified

Huxley. Hodgkin and Huxley did their research on

as to the causes of these remissions.

squids, which have very large nerve fibers. Three decades

A team of researchers, assembled by Dr. Waxman at

later, Yale researchers showed that, in mammals, the

the PVA/EPVA Center, has dissected nerve fibers mol¬

potassium channels are located beneath the myelin,

ecule by molecule to identify the molecular basis for MS

which covers and masks them.

remission. They found that injured nerve fibers can heal

Working in separate laboratories at Yale but commu¬

themselves by inserting new sodium channels into the

nicating closely, the PVA/EPVA Center’s team and J.

cell membranes. These sodium channels act like molecu¬

Murdoch Ritchie, Ph.D., the Eugene Higgins Professor

lar batteries, powering the flow of impulses through the

of Pharmacology, showed that when axons lose their my¬

nerve fibers despite the absence of myelin at the site of

elin, these potassium channel molecules are exposed and

injury. “We are trying to determine where the sodium

halt nerve conduction, acting as “locked brakes.” This

channels are produced and how they are redistributed af16
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Solutions to pain
Unlike a broken arm or leg, a dam¬
aged spinal cord does not stop hurt¬
ing once the body heals. An esti¬
mated 60 percent of those with
spinal cord injuries suffer from
chronic pain for which there is cur¬
rently no treatment. At the PVA/EPVA
Center, Marco A. Rizzo, M.D., Ph.D.,
assistant professor of neurology, and
Sulayman Dib-Hajj, Ph.D., an associ¬
ate research scientist, are part of a
team that is developing the basis for
drugs that will end post-spinal cord
injury pain, again exploiting the prop¬
erties of sodium channels.
After injury, the genes that pro¬
duce some types of sodium chan¬
nels are turned on, producing too
many of these channels. The genes
for other sodium channels are
turned off, and these channels
disappear. The work of Dr. Rizzo
and Dr. Dib-Hajj suggests that this
change is a root cause of pain.
Unlike potassium channels, which
YALE
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Marco Rizzo

Sulayman Dib-Hajj

block the transmission of impulses
after injury, sodium channels pro¬
duce an abnormal “repetitive firing”
of impulses. The challenge now is to
identify the varying types of sodium
channels and determine how to in¬
hibit those that trigger pain. Two
dozen sodium channels have been
identified in organisms from jellyfish
to humans, and scientists believe
there may be many more. Using com¬
puterized sequence analysis, Dr. DibHajj has studied their development
over the course of evolution, charting
the differences that are evident be¬
tween species. “We can learn a lot
by comparing the sequences,” he ex¬
plains. “The idea is that if function is
conserved over evolutionary time, we
may be able to identify a similarly
conserved amino acid sequence and

determine experimentally if it under¬
lies that function of the protein.
Which amino acid residues cause
the sodium channel to open and
close or to be fast or slow? These
are important issues for rational
drug design that targets specific
channels."
In addition to pain, most patients
with spinal cord injuries and MS ex¬
perience debilitating muscle spasms
caused by damage to axons in the
spinal cord. Scientists at Yale are
examining the physiological basis
for spasticity and are developing
the basis for new drugs to alter the
opening of sodium channels or
modulate the level of GABA, a neu¬
rotransmitter produced by the body
that prevents hyperactive uninhibited
nerve activity.
17

Laboratory meets
real life

A

discoveries at the PVA/EPVA Center

tors. He is a third-year graduate stu¬

that are bringing a cure for spinal

dent in the interdisciplinary neuro¬

cord injuries closer.
broken spinal cord cannot be

science program at Yale. Martin

Hearing Dr. Waxman explain how

Young, treasurer of the EPVA, was

healed. Case closed. That was

lengthy and complicated the process

the message James Peters re¬

of discovery can be actually was en¬

place in the world,” he said, “where

couraging to Chris A. Timpanelli, an

they are doing this as intensively as

nal cord was injured during an explo¬

attorney in Stratford, Conn., who was

at Yale."

sion at an army base in 1967. Until

diagnosed with multiple sclerosis 10

ceived from physicians when his spi¬

one of those listening. “I know of no

The partnership between scien¬

recently, he and other paralyzed vet¬

years ago. “Some people would be

erans had no reason to believe they

disheartened by this,” he says, “but I

beneficial to both groups. “When

would ever walk again.

look at it another way. We are lucky

we’re working at the bench, designing

tists and non-scientists has been

to have people this dedicated. Know¬

an experiment or building a model,

hope,” said Mr. Peters, executive di¬

ing this has been more therapeutic

we are thinking in very abstract ways.

rector of the Eastern Paralyzed Veter¬

than any drug.”

But when we are interacting with

“Now, there is a renewed sense of

Currently, about 30 scientists

people, it gives us a better perspec¬

the laboratories at the PVA/EPVA

work at the PVA/EPVA Center. More

tive,” said associate research scien¬

Center for Neuroscience and Regen¬

than 50 scientists have trained

tist Sulayman Dib-Hajj, Ph.D. “It’s not

eration Research at Yale. “The tunnel

there, many continuing their own spi¬

just science for the sake of science,

now has a light.”

nal cord research in laboratories

but science that may eventually

ans Association, who recently visited

around the world. “The work of this

lead to improvements in the lives

pus of the VA Connecticut Healthcare

lab is very relevant to the clinic and

of people with these injuries. This is

System, the PVA/EPVA Center was

the concerns of patients. That’s what

a very powerful motivation.”

founded as a collaborative effort

attracted me as a student,” Mark

among the University, the Paralyzed

Baccei, who was explaining his stud¬

Veterans of America, the Eastern

ies on calcium channels, told the visi¬

Located on the West Haven cam¬

Paralyzed Veterans Association, and
the Department of Veterans Affairs in
1987. It opened the following year.
During two days of lectures, tours
and gatherings at Yale and the VA

Last fall’s celebration of the PVA/EPVA Cen¬
ter was a chance for scientists to discuss
their work with members of the two veterans
organizations, and to listen to their views and
ideas. Sulayman Dib-Hajj, left, and Karen
Lankford, below, were among those explaining
recent research findings. Below left: Joseph
Segarra, right, president of the EPVA, talks
with Stephen Waxman, left, Peter Addesso
and IVlary Segarra during a tour of the lab.

campus in late September, the
founding partners celebrated a de¬
cade of advances in neuroscience
research. As part of the celebration,
Stephen G. Waxman, M.D., Ph.D.,
gave the first annual Helen Wilshire
Walsh lecture, From Molecules to

Background: Astrocytes, the star-shaped gtial celts that outnumber
nerve cells in the spinal cord 10 to 1, traditionally have been thought
responsible for scarring. Yale scientists have produced new evidence
that these cells play a role in restoring nerve conduction.
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STEPHEN WAXMAN (BACKGROUND)

PETER CASOLINO (3)

Man: Approaching a New Neurology
of the Spinal Cord, summarizing the

CONTINUED FROM PAGE 16

discovery provided a target—if the potassium chan¬
nels could be turned off, the brakes would no
longer be locked. The drug 4-AP turns off these un¬
masked potassium channels, thereby improving
transmission of impulses and restoring some lost
functions.
STOPPING CELL DEATH

One of the latest and most innovative investiga¬
tions at the PVA/EPVA Center involves the preven¬
PETER CAS0L1N0 (4)

tion of nerve cell damage before it occurs. When
the spinal cord is traumatized, nerve cells die, but
not all at once.
Research at the PVA/EPVA Center has indi¬
cated that cell death is caused by a process akin to
sabotage. The initial blow to the spinal cord kills
some cells instantaneously and then sets off some
secondary processes which cause the body to attack
itself. An abnormal influx of calcium, a byproduct
of the first round of cell death, gnaws away at
nearby nerve cells. Death occurs in waves, taking
hours or even days to complete. The timing of cell
destruction, however, leaves a window of opportu¬
nity in which damage might be limited. Yale scien¬
tists have targeted the specific molecules that release
calcium to the axons and are working to develop
the foundation for drugs which will inhibit these
molecules and stem the tide of calcium at the time
of injury. If this research is successful, scientists may
be able to prevent a spinal cord injury from result¬
ing in paraplegia or quadriplegia by intervening in
the process of cell death and “rescuing” nerve cells.
In the last decade, advances at the PVA/EPVA
Center at Yale and other research institutions
around the world have been made on such a broad
front that the field of neurology is undergoing a
dramatic change. “Traditionally, neurology has been
an intellectually beautiful discipline, but we did not
have therapies,” says Dr. Waxman. “A neurologist
would go through a meticulous mental exercise and
arrive at a diagnosis. But, we would have nothing
to offer the patient, and that has to change.”
Dr. Waxman believes that neuroscientists will
very soon be able to help patients in ways that were
once thought impossible. He is optimistic that
within the next decade researchers at Yale or else¬
where will find a vaccine for MS and a cure for spi¬
nal cord injuries. “We’re approaching a new—and
much more hopeful neurology of the spinal cord,”
Dr. Waxman says. “The goal of repairing the in¬
jured spinal cord, at least in some patients, is a
realistic one and we’re moving as fast as we can in
this direction.” YM
YALE
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A celebration of progress A
Michael Delaney, past president of the PVA,
talks to a fellow visitor to Yale during the
celebration last fall of the 10th anniversary
of the PVA/EPVA Center.
Yale President Richard C. Levin, left, with
PVA President Kenneth Huber, right, and
Executive Director Gordon Mansfield.

►

Stephen Waxman, left, and Langdon Clarke
at the announcement of the Helen Wilshire
Walsh Directorship at the PVA/EPVA Center
for Neuroscience and Regeneration Re¬
search. Dr. Waxman gave the first annual
lecture in Mrs. Walsh’s honor as part of the
program celebrating the 10-year partnership
that built and continues to support the
►
center. The endowment was established
through a bequest from the estate of Mrs.
Walsh, an advocate of research in spinal
cord injury who supported the work of the
PVA, the EPVA and Yale for many years.
Mr. Clarke, grandson of the late Mrs. Walsh,
was instrumental in creating the endow¬
ment and directing the use of the funds
for research in neurology at Yale.
Last year Yale University honored the execu¬
tive director of EPVA by naming the James
J. Peters Conference Room at Yale in the
PVA/EPVA Center for Neuroscience and
Regeneration Research. The plaque that
commemorates the occasion reads: “Jim
Peters is a repository of knowledge and a
source of inspiration. He is central to the
►
battle against spinal cord dysfunction.”
Center Director Stephen Waxman hosted a
dinner at the Yale Club of New York in June.
From left, Gerard Kelly, deputy executive
director; Vivian Beyda, Dr.P.H., director of
research and education; Joseph Segarra,
president; Dr. Waxman, and Mr. Peters.
Stephen Waxman, backed by the founders
of the PVA/EPVA Center. From left: Gerard
Kelly, John Bollinger, Joseph Segarra, Paul
Hoffman, Kenneth Huber, Gordon Mansfield
and James Peters.
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Music
and
me

Musical aptitude and a gift for
healing coincide more often than one

By Karen Schmidt

ILLUSTRATION BY PE'

might imagine.

W

hat was the first human music? A whistled

cally inspired music. Thanks to a mix of musical cultures

imitation of a bird call? A rhythmic pound¬

and generations, they play everything from Jerry Lee

ing that mimicked a heartbeat or hoof beat?
A croon to soothe a crying baby or comfort a sick friend?
Music was probably born of the natural rhythms of
life. So it shouldn’t come as a surprise when people who
dedicate themselves to life science release their creative
energy in music.

Lewis to The Pretenders to Phish, a contemporary band
that contributed the tunes Golgi Apparatus and Down
With Disease to the Cellmates’ repertoire.
Their venues have ranged from departmental parties
to the American Museum of Natural History in Wash¬
ington, the site of the 1995 annual meeting of the Ameri¬

Both music and medicine are strict disciplines, even

can Society for Cell Biology. “We do it because it’s won¬

though one is considered an art and one a science. Both

derful fun. It’s incredible fun,” says Dr. Flavell, a leading

demand practitioners who learn complex skills, practice

Lyme disease researcher. “It’s an enormous release.”

them exhaustively, then impose a set of rules on what’s

In addition to Drs. Mellman and Flavell, the group

naturally messy—a disease, an injury, a series of unre¬

includes guitarist Leonard K. Kaczmarek, Ph.D., chair

lated sounds. And both require enormous dedication,

of the Department of Pharmacology; drummer William

so much that it would seem impossible for one person

M. Philbrick, Ph.D., associate professor of medicine;

to do both.

lead vocalist Tamar Boursalian, an immunobiology

But some scientists manage. They realize medicine
and music aren’t mutually exclusive. Not only can the
two disciplines coexist; given the right conditions, they

graduate student; and the group’s only non-scientist,
Madlyn Flavell (Richard’s wife) on keyboards.
Since the band members are best known for their
lab work, audiences aren’t always sure what they’re going

can coalesce.

to see and hear. “People have expectations that it will be
ROCKING

RESEARCHERS

Consider the lyrics of the original love song/lab song

just useless,” Dr. Flavell says. But since the members
have strong musical backgrounds, the band’s sound is re¬

She’s a Knockoutby Ira Mellman, Ph.D., bass player for

markably sophisticated. “The level of musicianship is

Yale’s biorocking band, the Cellmates. “She knows how

very good,” Dr. Mellman says. “Enough of us have done

to get into your genes/And what recombination means.

this professionally or close to professionally that we

She’s got the magic touch/And I need her oh so much.

know what the expectations are.”

She’s a knockout.”
Only a medical scientist is likely to catch the refer¬

Dr. Mellman trained as a classical musician from
childhood, and went to Oberlin College in Ohio to con¬

ence to an experimental mouse known as a “knockout,”

tinue his music studies. During his college years, he fre¬

but an average listener would still hear a love song.

quently traveled to New York to play saxophone in re¬

“It’s kind of an interesting niche,” says Dr. Mellman,

cording studio gigs, produced songs, and played with a

professor of cell biology and director of the Program in

group he calls “the best managed and best produced

Biological and Biomedical Sciences. “You write about

band that never made it.”

what you know.”
Dr. Mellman’s musical colleague Richard A. Flavell,
Ph.D., chief of the Section of Immunobiology and a

But on a tour playing with Paul Anka’s orchestra,
Dr. Mellman decided he didn’t want to be a professional
musician if it meant ending up like some of his col¬

Howard Hughes Medical Institute investigator, writes

leagues. “You could see that they were automatons, they

songs that are more unabashedly scientific. Dr. Flavell

were dead, and I did not want that.” He quit the music

has penned the ROl Blues, tracking the trials of an in¬

program, and ended up majoring in biology.

vestigator trying to win a National Institutes of Health

Dr. Kaczmarek began playing guitar while he was

grant, Molecular Millionaire, about a postdoc who

growing up in London. He once played Albert Hall,

wants to earn big money doing biotechnology research,

and as a member of a group called The Exiles, opened

and DNA, to the tune of the Sex Pistols’ punk-rock

for Eric Clapton at the London club Eel Pie Island.

anthem EMI.
Though the Cellmates call their niche biorock, the
six-member group doesn’t limit itself to its own biologi-

“The trouble is, there were so many bands in
London in the ’60s. It was incredibly competitive,”
Dr. Kaczmarek says. So he decided against music as a
career. “It’s easier to be a scientist playing music on the

Karen Schmidt is a writer in New Haven and a first-year
graduate student in Epidemiology and Public Health.
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side than a musician doing science on the side.”
Dr. Flavell started playing guitar as a teen-ager in
ZI

Mitosis

Norfolk, England, and formed his first band at age 15.

i.
There was a girl from a midwest town,
She didn’t smile, she didn't frown
When other children went out to play
She stayed inside and watched the
cells all day

over the years, and one even played on the same bill as

“We were pretty awful,” he admits. His bands improved
The Animals. But Dr. Flavell says he never seriously
considered a career in music, and grew away from it dur¬
ing his postdoc years.
Then in the mid-’8os, he bought a new guitar and
set up a recording studio in his home in Boston so he

This made her momma very sad,
It made her poppa very mad,
To see their beautiful little girl
Have the cells become her whole world

and his wife, Madlyn, could record music together with
occasional vocal help from their children.
Some time after Dr. Flavell arrived at Yale, he
learned that both Dr. Mellman and Dr. Kaczmarek had

But with the cells she did stay
On the microscope she all day
What she watching was lots of fun,
She see mitosis, mon!
And she say:
Chorus
One cell will get you two cells,
Two cells will get you four
Unless one dies then,
You have just three cells
But these make six cells
Before your eyes
II.
The girl she grow now day by day
Until a Ph.D. she did say,
Is just the very right thing for me
If a scientist I am to be

played professionally and invited them to dinner. “The
ulterior motive,” Dr. Mellman recalls, “was to play.”
The Cellmates’ first real performance was a New
Year’s Eve party, Dr. Flavell recalls. Eventually the band
replaced its mechanical rhythm box with Dr. Philbrick
on drums, and recruited Ms. Boursalian as a vocalist.
“It just clicked,” says Dr. Mellman, who describes her as
Leonard Kaczmarek, left, is chair
of pharmacology at Yale. Cellmate
Richard Flavell heads the immuno¬
biology section and is co-inventor of
a Lyme disease vaccine. Both came
to the United States from England,
where they performed in rock bands
during the 1960s.

the best singer he’s ever performed with. “It was obvious
that if we wanted to work on it, it could be more than
just junk.”
The Cellmates played at immunology and neuro¬
science parties and retreats. The first national gig came a
couple of years ago, at the official opening of the Massa¬
chusetts Institute of Technology’s new biology building.
“That was fun,” Dr. Flavell says. “We actually had the
faculty of MIT singing a chorus on the stage.” Since
then, they’ve played at a retreat for the drug company

So she went to San Francisco,
All the way from O-hi-o
She took a bike, she took a train,
Still she got there all the same

Merck, an anniversary party for Princeton’s molecular
biology department, and at the 1996 Cold Spring Har¬
bor Symposium, where James Watson himself (of the
team that discovered the structure of DNA) enjoyed

When she saw those hills so high,
And the bridges that touched the sky,
It brought a tear right to her eye,
But she say:
Chorus

rocking to the music. The musicians even get paid for
their work—usually more, Dr. Kaczmarek says, than
they’re paid for giving scientific talks. “The idea of hav¬
ing scientists play music is rarer than having scientists
give talks,” he says.

III.
Lots of people she got to know,
Lots of cells in San Francisco,
The cell divisions she got to see,
Were more beautiful than the sea
This made her momma very proud
Her poppa too would sing out loud
Still it made her kind of sad,
For the life she never had
Her university the best in the land
She wanted more or she'd throw it
in the can
So she joined a rock and roll band,
She’s singing:
Chorus

— Ira Mellman

Though they only manage to rehearse every few
weeks and play about six times a year, the Cellmates
hope to keep going, and possibly make a real recording.
“It’s a very good outlet,” Dr. Mellman says. “You have
to pay attention. It’s one of the few things you can do that
just wipes the slate clean, reformats the hard disk.”
A

PHYSICAL

EXPERIENCE

A singer—the one musician whose own body acts as
the instrument—may come closest to linking music
The Cellmates may lose lead singer
Tamar Boursalian, right front, later
this year when she completes her
graduate studies. “Unfortunately,”
jokes one of the senior Cellmates,
“none of us is on her thesis
committee.”

and biology.
“Music, when it really works, is a physical experi¬
ence,” says Kyle D. Pruett, M.D., a child psychiatrist at
Yale’s Child Study Center. “It takes over your entire body.”
Dr. Pruett, a professional tenor who has performed
throughout the region, discovered the phenomenon while
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singing centuries-old music in a madrigal group in high
school. “When you get it right, even if you’re 15 years old,
it’s not an experience your body forgets,’’ he says.
And Dr. Pruett says the musician’s need to listen and
be patient has helped “incredibly” in his medical prac¬
tice. He even saw the disciplines merge neatly years ago
before one of his first opera performances, Benjamin
Britten’s Prodigal Son. Another performer, a young boy
suffering from stage fright, had locked himself in a bath¬
room before the show, and Dr. Pruett managed to con¬
vince him to perform.
“I think after that experience,” he says, “I had
become convinced there was a way for me to become
a good doctor and a good musician.”
Dr. Pruett grew up in an Indiana household in
which “music was a given, it was not an add-on.” He
started singing in a church choir as a boy, and studied
voice with the choir director. In high school, he sang in
the madrigal group and performed musical comedy. At
the same time, his interest in biology was sparked by a
CONTINUED ON PAGE 25

Kyle Pruett, a child psychiatrist well known for his work on father¬
hood, also sings opera and performs professionally. He recently
collaborated with composer Fenno Heath and soprano Judith Caldwell
on the CD I’ll Sing and Ever Shall: Songs for Judy and Kyle. “There are
occasionally moments,” he says of his choice of career and avocation,
“where I wonder, ‘What if I had not tried to ride both these horses?’”

The ear’s amplifier
Using sound and music to study the delicate workings of hair cells
may provide answers about hearing loss.

T

he body’s musical sense might

When hair cells in the inner ear

go all the way down to the

detect a mechanical disturbance—a

cellular level.

sound wave—they respond by send¬

Well, maybe it isn’t music in the

ing information about the sound to

traditional sense. But Joseph

the auditory nerve and on to the

spond to the cells’ motion. If the re¬

Santos-Sacchi, Ph.D., professor of

brain. There are two types of hair

searchers can figure out how to

surgery (otolaryngology) and of neu¬

cells: inner and outer.

robiology, is studying cells in the in¬

“Most of the information you hear

modulate that motility, it may be a
step towards understanding how the

ner ear that seem to dance in re¬

comes from the inner hair cells,” he

sponse to music. He even has a

says. But Dr. Santos-Sacchi studies

That’s important because the

videotape of the cylindrical cells

the outer hair cells, which have very

outer hair cells seem to be part of a

dancing to the sound of the William

few direct connections to the audi¬

sort of “cochlear amplifier” that uses

Tell Overture.

tory nerve but still play a role in

a mechanical feedback mechanism

sound reception.

to boost the vibration of the basilar

“This cell movement is unique.
It’s unlike any other movement found

The outer hair cells seem to actu¬

outer hair cells work.

membrane of the cochlea.

in the body.” says Dr. Santos-Sacchi

ally change their length—by chang¬

(who denies any real musical talent

ing the surface area of their cell

first to go in response to any insult,

but has a saxophone, clarinet and

membranes—in response to sound.

such as disease or loud noises. They

keyboards at home.) Since hair cells

“Presumably, they start jumping up

don’t regenerate in mammals, so the

allow us to hear, understanding how

and down,” he says. “At least, that’s

result can be hearing loss.

this unusual dancing movement re¬

what happens in vitro."

lates to cell function could be a key

Dr. Santos-Sacchi takes the outer

Outer hair cells tend to be the

“Presumably, the way that works,”
Dr. Santos-Sacchi says, “is that the

to eventually unlocking treatments

hair cells from guinea pigs and stud¬

inner hair cells are no longer getting

for certain forms of hearing loss.

ies the electrical signals that corre¬

that boost.”

At Norfolk festival, the hills are alive with remedies
Yale physicians, musicians target problems of performance.

T

he physical sensations of fear
are familiar to all of us: the dry
mouth, queasy stomach,
pounding heart and shaky muscles.
Kyle D. Pruett, M.D., describes it
as the sympathetic nervous
system’s primitive fight-or-flight re¬
sponse, as the human body pre¬
pares for the moment when the
campfire goes out and the circling
saber-toothed tiger decides to strike.
But that cascade of symptoms is
precisely the last thing a musician
wants in the moments before a per¬
formance, when small-muscle coordi¬
nation is critical.
“You do not want Pleistocene-era
feelings flowing through your body,”
Dr. Pruett, a clinical professor at the
Yale Child Study Center and a profes¬
sional tenor, told a group of fellow
physicians and performers last sum¬
mer. Dr. Pruett was one of the
speakers and coordinators for the
fourth annual Medical Problems in
the Performing Arts conference, held
at the Norfolk Chamber Music Festi¬

val in northwestern Connecticut in
collaboration with the Yale Summer
School of Music.
Dr. Pruett talked about perfor¬
mance anxiety or, as he prefers to
call it, performance awareness. It’s
one of the most disabling health
problems a performer can face, and
can cripple a career if left untreated.
The conference was designed to ex¬
plore performance anxiety and other
medical problems that plague per¬
forming artists, especially musicians.
These “small-muscle Olympians,” as
Dr. Pruett calls them, suffer from
health problems ranging from ten¬
dinitis to hearing loss, and as a
group of patients, tend to be ne¬
glected.
“It’s basically a misunderstood,
undertreated group," says Peter Jokl,
M.D. ’68, HS ’69-73, professor of
orthopaedics and rehabilitation
and chief of the section of sports
medicine.
Dr. Jokl, Dr. Pruett and Martin W.
Sklaire, M.D., HS '62, coordinated

Otolaryngologist David Astrachan works with performers at Norfolk on ways to prevent
and manage ear, nose and throat injuries. Hearing loss tops the list.
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the conference, along with festival
manager Elaine Carroll and director
Joan Panetti. The sponsors were the
Yale Summer School of Music, the
Child Study Center and the sports
medicine section.
About 10 years ago, Dr. Sklaire,
clinical professor of pediatrics, took
a course in Aspen, Colo., about medi¬
cal injuries to performers. As an
amateur piano, clarinet and cello
player, he had some idea of the
physical stresses musicians face. As
a specialist in pediatric and adoles¬
cent medicine with extensive experi¬
ence in sports medicine, he saw a
clear connection. “A lot of injuries to
musicians are similar to injuries to
athletes,” many stemming from over¬
use, Dr. Sklaire says.
The very act of playing an instru¬
ment can force the body into unnatu¬
ral positions, Dr. Sklaire says. “If
you’re spending enough time, you’re
going to have aches and pains as a
result,” he says. For professional
musicians whose livelihoods depend
on playing, injuries can be more than
a nuisance.
Paul W. Brown, M.D., clinical pro¬
fessor of orthopaedics and rehabili¬
tation and of plastic surgery, spoke
at the conference about some of the
upper extremity problems musicians
can face. These include overuse inju¬
ries, such as tendinitis, nerve com¬
pression or entrapment, and focal
dystonia, the loss of control over an
individual or group of muscles.
In some cases, a cure can be as
simple as a small change in practice
habits, such as taking regular rests,
or a change in musical technique.
Dr. Brown described one patient, a
French horn player, who had been
complaining of arm pain. He found
she was gripping her instrument
white-knuckle tight. “The cure here
was not medical,” he explained. “It
WINTER/SPRING
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was just a matter of changing her

CONTINUED FROM PAGE 23

musical technique."

teacher who “taught science with the passion of a Shakespearean actor.”

Some cases are more difficult,
as when the only real treatment is
rest, “which professional musicians
don’t take kindly to at all,” he said.

“He had such respect for science as a discipline and, really, an art,”
Dr. Pruett says.
Dr. Pruett came to Yale College and majored in history and music. “I
didn’t see any point in doing medicine twice. I would do college once and

Part of the reason musicians may be

medicine in medical school,” he says. He continued to sing, and traveled to

undertreated is that their livelihood

Europe with the Yale Glee Club in his junior year. He was invited to sing in

is threatened: They don’t want to be

Europe, but was told he would have to work harder at his music. “So I spent

told they have to stop playing. On

a summer thinking about it very seriously,” he says. “But, in the end, the

the other hand, musicians tend to be

service commitment had deeper roots in me.”

highly motivated, hardworking and in¬
terested in their own treatment, pre¬

While in medical school at Tufts University, he got a position singing in
an Episcopal church. “I think it kept me sane,” he says. “It was such a heal¬

cisely because the stakes are so

ing environment for me compared to medical school.” When he returned to

high, Dr. Brown said.

Yale for his residency, he went back to his old music teacher, and began sing¬

David I. Astrachan, M.D. '84, a

ing opera. “I didn’t like opera,” he admits. “I liked lieder and musical com¬

clinical instructor in otolaryngology,

edy and oratory and sacred music.” Now, most of his musical work is in op¬

talked about ear, nose and throat in¬

era, which he describes as “a true mega-art form.” Though Dr. Pruett says he

juries to performers. One of the

loves being a physician, he sometimes wonders what a musical career might

most serious health problems

have been like. “There are occasionally moments,” he says, “where I wonder,

among musicians can be hearing

‘What if I had not tried to ride both of these horses?’ ”

loss. It’s most common in percus¬
sionists and violinists, but can affect

ORDER

anyone in an orchestra, and it's of¬

As the most mathematical of the arts, music seems to hold a particular fasci¬

ten irreversible, he said.
Wind instruments can peak at
123 decibels. “That’s jet aircraft

AND

EXPRESSION

nation for scientific thinkers seeking the creative without straying too far
from the rational.
“There is certainly creativity in medicine, in the thinking process,” says

noise,” Dr. Astrachan said. Using ear¬

Fredric O. Finklestein, M.D., a nephrologist and clinical professor of medi¬

plugs can reduce the noise by 25

cine. But that creativity is constrained by the structures of science. For a

decibels. “That can be all you need

physician, it is often difficult if not impossible to get “that spark of original¬

to take a potentially damaging sound

ity” that happens in the arts, he says.

and make it less damaging,” he
said; musicians who don't want to

Dr. Finklestein majored in history of music as part of Yale’s undergradu¬
ate Class of 1963, doing pre-med work at the same time. His senior thesis

use earplugs in performance are

addressed the creative process in 20th-century music and how composers im¬

encouraged to at least use them

posed a variety of rigorous external forms to achieve freedom of expression.

in rehearsals.
The conference also included a

Though Dr. Finklestein still plays piano and clarinet, he doesn’t per¬
form. He sees music as a creative respite from his clinical work, and says he

panel discussion with members of

doesn’t regret choosing medicine over music as a career. “I really enjoy medi¬

the Vermeer String Quartet, which

cine. I really love the work, so I don’t really have second thoughts about it in

performed at the festival the night

that sense.”

before the conference. Afternoon

Besides, he sees a clear link between the two fields. Both require rigor,

workshops examined hearing prob¬

practice and discipline. “In medicine we have to pay endless attention to de¬

lems, rehabilitation of hand injuries,

tail,” Dr. Finklestein says. “If you’re seeing a patient, you have to impose this

and relaxation techniques.

external rigorousness on taking the history and the physical.”

Though attendance at the confer¬

Only after gathering that information can the creative part of medicine

ence has been modest, Dr. Sklaire

begin, leading to the diagnosis. “You have to have an ordered framework in

says he and his colleagues want to

order to have this creative expression,” he says. But even in that process, the

continue organizing it. “I think we’re

freedom must be tempered. “You have to impose these external forms on

all committed to perpetuating this,”

what you do.”

he says.

He compares the rigor of medicine to what the great, early 20th-century

“As an academic institution, this
is the type of thing we should do,” Dr.

composer Igor Stravinsky said about music: Freedom of expression in music
can only be achieved by imposing strict form. Stravinsky, who was born in

Jokl says. “A university should be a

1882, explained it like this: “The more art is controlled, limited, worked

repository of this kind of knowledge.”

over,” he wrote, “the more it is free.” YM
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To create this composite of the body. Alexander
Tsiaras assembled photographic slices from the
Visible Man images, then rotated and manipulated
the data set to achieve the desired effect.
Opposite: The lungs, liver, intestines and skeleton
are visualized in this composite of the upper body.

Armed with powerful new
imaging devices, clinicians and
researchers can peer into the
body more clearly than ever

W

hen something goes seriously wrong

before. What they are seeing

inside the body, there’s only one
course of action: look inside, identify

is revolutionizing

the problem and then figure out how best to fix it.
For most of medical history, that crucial first step
of making a correct diagnosis

medicine.

has required penetrating the
living person’s sealed physi¬
ological system, inherently a
dangerous and complex sur¬

By Marc Wortman

gical process. Then, a cen¬
tury ago, the arrival of the Xray gave medicine the ability
It

M*

to see through the body’s sur¬
face without cutting it open.
While X-ray images in
various forms continue to be
one of medicine’s diagnostic
mainstays, they offer a lim¬
ited, static portrait of the liv¬
ing human organism. Over
the last io years, imaging
technology has traveled light

years from the world in which X-rays were the
only means of looking into humans without
resorting to the knife. An explosion of advances
in other forms of imaging technology has given
physicians new eyes, allowing them to peer into
the most minute recesses of the body and observe
dynamic physiological and biochemical processes
in action. As a result, for the first time clinicians
and researchers can ask biological questions
directly and watch the living, fully awake body
as it responds.
Marc Wortman, a regular contributor to Yale Medicine,
received an award of merit in the National Health Information
Awards Competition for his 1996 article on Lyme disease.
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For patients, this has meant vast improvements in care and
raised hopes for better diagnosis and cure where none existed be¬
“Radiologists are like abstract expressionists,'’
says Alexander Tsiaras, the LIFE magazine photog¬
rapher whose work illustrates this issue's cover
story on advances in medical imaging. “They have
a special talent for looking at a fragment of infor¬
mation in two dimensions and extrapolating it to
three. In their mind’s eye, they can create a whole
from a single section or slice.”
Mr. Tsiaras’ art is more dazzling to the eye than
the workaday images that radiologists use to diag¬
nose disease and guide treatment. But advances
in imaging technology, a field that traces its ori¬
gins to the discovery of the X-ray in 1895, are
closing the gap between the of ten-cryptic images
that are a radiologist’s stock-in-trade and the
artist’s more comprehensible, if less concrete, ren¬
dering of anatomy.
Working with specialists in other disciplines—
surgery, neurology, psychiatry, computer science,
physics, photography and the graphic arts—radi¬
ologists are developing ways to better visualize
the body, its structures and its metabolism. New
techniques such as helical CT, PET and functional
MRI (See An Imaging Glossary), and the overlaying
of these images into composites, are beginning
to resemble the high-tech special effects of
Hollywood.
“Art and diagnostic imaging converge daily and
will do so increasingly in the next century,” says
department Chair Bruce L. McClennan, M.D.
“There’s a long tradition of artists who combine
physical reality with the ideal, and the desire to
find beauty in the real world as it exists in flesh
and blood.”
It is this last quality, says surgery Chair Ronald
C. Merrell, M.D., that distinguishes Mr. Tsiaras’
data-derived images from the work of many artists.
“You can go back to his original image and reinter¬
pret it yourself. It’s all there in his database.”
This highly graphic and accessible presentation
of anatomy, he adds, provides a common language
for imaging specialists and surgeons. “His visual¬
ization of actual structures could be enlightening
to diagnostic radiologists, and his translation of
radiographic images makes radiology far more
comprehensible to surgeons. It could potentially
do some great good.”
Mr. Tsiaras spent six months last year collabo¬
rating with the Department of Surgery, through a
grant from NASA, to promote the visualization of
abstract disease processes and human anatomy.
He is the founder and principal in the New York
City-based Anatomical Travelogue, and the author
of Body Voyage: A Three-Dimensional Tour of a Real
Human Body (1997, Warner Books).

fore. From knee injuries to Parkinson’s disease, the advanced imag¬
ing technology provides a means of rapidly and precisely measuring
the extent of tissue damage and locating functional disturbances.
Armed with such knowledge, specialists can then choose the least
invasive and most effective treatment option. There is less need for
exploratory surgery, less possibility of causing inadvertent harm
and increased likelihood of rapid recovery.
Investigators in a wide range of fields now employ a great
wealth of advanced imaging tools—computed tomography, func¬
tional magnetic resonance imaging, single photon emission com¬
puted tomography, and positron emission tomography scans. (See
An Imaging Glossary.) Through the eyes of this technology, investi¬
gators can visualize human physiology in action and, increasingly,
explain how it works at the most basic levels, from thought to
movement. “Most people think of imaging as something static,”
says Bruce L. McClennan, M.D., chair of the medical school De¬
partment of Diagnostic Radiology and chief of diagnostic imaging
at Yale-New Haven Hospital. “But those days are gone forever.
More and more, physicians want not just form but function.
And we can deliver it. It’s brought about a revolution in how we
practice medicine. Already we’ve cut down drastically on the use
of X-rays and X-ray films, and they’ll virtually disappear in the
next century. And that’s just the beginning.
“Just one example: we’re now developing interventional imag¬
ing magnets to do medical procedures while the patient is actually
inside the magnet. The information will be right there for the clini¬
cian. For the patient, it means less waiting, more accurate diagnosis
and treatment, less surgery and swifter recovery.”
For researchers, seeing the body through the new imaging de¬
vices has begun to answer ages-old questions about what actually
goes on in almost every imaginable bodily functions. Anatomical
structures and their respective biological functions can be studied
simultaneously. For example, the contracting walls of the heart and
the firing cells in the brain can be observed in action so that nor¬
mal and abnormal behaviors of the body’s essential functions can
be charted and compared. Equipped with the findings, physicians
and scientists can develop new therapies for disorders. The observ¬
ing eye of the investigator can zoom without resistance through
every passage and wall in the body to uncover otherwise hidden
disease processes. The imaging technology needed to do this is
enormously complex, yet its effect is to simplify treatment and
greatly ease and speed the healing process.
While the diagnostic imaging field is now so wide that no in¬
stitution can command a full range of applications, Yale is a leader
in an exceptionally high number. An especially important area is
breast needle localization, in which biopsies of suspicious lumps
can be accomplished with much greater accuracy. This may prove
to be an invaluable tool for cancer patients, most importantly
in the diagnosis of breast cancer. “Breast imaging,” says Dr.
McClennan, “is a huge problem facing our field.” Eventually, he
believes, the emerging capability to image breast tissue accurately

Michael Fitzsousa, Editor
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while simultaneously removing suspicious lumps “will obviate the
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u[With the next generation of
imaging applications] the
information will be right there for
the clinician. For the patient, it
means less waiting, more accurate
diagnosis and treatment, less
surgery and swifter recovery.”
— Bruce L. McClennan
need to go to the operating room. Were going to even¬
tually eliminate the knife.”
Improvements in high-speed diagnostic imaging
tools have already saved many lives, countless hours of
suffering, and enormous amounts of money by shorten¬
ing the time needed to come up with an explanation for
patients’ woes. One recent example is a new kidney
stone diagnostic procedure, developed at Yale, that has
eliminated the need for long waits to
determine the cause of severe side
pain. (See Throwing Stones.) Patients
who only three years ago would have
endured as much as 24 hours of un¬
relieved suffering before the source
of their pain could be determined
and treatment begun can now begin

Better imaging techniques, says department Chair Bruce L. McClennan,
“have brought about a revolution in the way we practice medicine.”

treatment within five minutes of arrival in
the Emergency Department.
Many of the advances have been made
possible by the application of computing
technology to imaging devices. In its turn,
the computerization of diagnostic imaging
is rapidly reshaping the nature of medical
communications. Yale is part of a nation¬
wide movement exploring the possibilities
for computer networking among physi¬
cians, allowing for faster diagnosis, the
sharing of information between specialists
and clinicians over long distances and im¬
proved storage of patient data.
While the newer imaging technologies
have opened up new possibilities for inves¬

On January 27,1896, Yale
physicist Arthur W. Wright,
above, made the first X-ray
image in the United States
after Wilhelm Conrad
Roentgen’s discovery in
Wurzburg the month be¬
fore. Within days, American
physicians were using the
new technology to peer in¬
side the human body, re¬
vealing buckshot, for ex¬
ample, in the hand of a
New York attorney injured
in a hunting accident.

tigation and improved clinical care, they
also serve the recent priorities of managed
care for holding down costs for therapies
and preventing more serious, and more ex¬
pensive, medical problems. For instance,
advances made possible by imaging tech¬
nology, such as the high-speed diagnosis of
kidney stones and needle localization biop¬
sies, reduce time patients need to spend in
the hospital and often end the need for
multiple and redundant procedures. They

also potentially lower the number of patients whose con¬
ditions worsen, resulting in the need lor extended care.

fundamental mental processes, such as memory, vision,
reading, attention, hearing and even smell, as well as dis¬
orders in those processes. These conditions include dys¬
lexia, schizophrenia, autism and brain trauma from

WATCHING

THE

BRAIN

WORK

stroke, alcoholism and epilepsy. “Brain imaging has be¬

In the federally designated Decade ol the Brain, it is in¬

come one of the hottest fields in the biological sciences.

side the skull that the frontiers of medicine have been

There are always new applications for MR being found,”

pushed furthest by applications of imaging technology.

says medical physicist R. Todd Constable, Ph.D., an as¬

Perhaps more than any other institution, Yale is noted

sistant professor of diagnostic radiology, who works

for using its imaging technology to learn more about

closely with clinicians on magnetic resonance imaging

how the brain functions. Investigators are mapping out

(MRI) projects. “Our research imager is swamped. It’s

brain structures and exploring the biochemistry of many

tough to book time.”

Irena Tocino, opposite
page, head of the radiology
department’s breast
imaging section, has
demonstrated new uses
of magnetic resonance
imaging in detecting
tumors. The original X-ray
film, right, suggested
the presence of a small
cancer but was not
conclusive. The subsequent
MR image, center, was easy
to interpret and allowed a
definitive diagnosis, says
Dr. Tocino. A breast biopsy
confirmed the diagnosis.

An imaging glossary
Looking into the human body

through a virtual, 3D image
of an organ allow physicians

subject’s body to take a

without opening it up has

X-rays are beams of radia¬
tion that pass through differ¬

cross-sectional image, or

been a tool for medicine for

ent kinds of tissue in varying

slice. The X-rays from the CT

more than a century. Expos¬

amounts. On photographic

scanner are picked up by

to study areas of the body re¬
quiring reconstructive surgery

ing film to X-ray beams

film, air and soft tissue will

sensors linked to a computer

prior to operating or to in¬

passed through the body pro¬

register in different shades of

that generates a highly de¬
tailed video image. A signifi¬

the colon to determine appro¬

vided readable images of
solid structures like bones

black while bone will show up
as white. In dense organs

cant technical advance, a he¬

and masses of dense, soft

like breast tissue, a radiolo¬

lical CT scanner moves over

tissue, such as muscle and

gist will read the film for

the patient, taking rapid,
overlapping images of large

brain. In many ways, the ba¬
sic concepts in imaging tech¬
nology have changed remark¬
ably little.
Discovered by Wilhelm
Conrad Roentgen in 1895,
30

subtle gradations to spot
anomalies that are potential
indicators of disease.
Computed tomography

portions of the body. When
rendered on the computer,

(CT) takes an X-ray camera

the images can be viewed
from any angle and perspec¬

and spins it about the

tive. For instance, tours

spect precancerous polyps in
priate treatment.
Using pharmaceuticals
“tagged" with nuclear trace
elements, single photon
emission computed tomog¬
raphy (SPECT) and positron
emission tomography (PET)
scanners can detect and
measure the site, speed and
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Much of that work involves mapping out brain

then reflected through a series of mirrors to the supine

anatomy and function. In order to observe the brain in

subject. Headphones can be used for delivering sound

action, study subjects enter the machine and then are

tasks, or an air circulation system for olfactory studies.

given a battery of tests while their brain activity is im¬

Anyone who has undergone an MR scan knows the

aged and recorded. “Any task you can perform on a

magnet’s hollow rhythmic beat can be unnerving. Sub¬

computer or a video player,” says John C. Gore, Ph.D.,

jects can’t move about inside the tube and anyone prone

director of the NMR Physics Research Group and pro¬

to claustrophobia would be better off skipping the exer¬

fessor of diagnostic radiology and applied physics, “can

cise. While the subjects perform tasks, whether it’s bend¬

be projected, controlled and recorded.” Study subjects

ing a finger or reading a word, their brain activity can

lie down inside the functional MRI (fMRI) machine,

then be imaged and sites mapped for specific activities,

which is specially outfitted for research. It may have a

from muscle activation to language usage.

video screen placed just outside it from which images are

With all that data as a baseline for normal brain

Antibodies surround breast cancer cells, above, in
an image captured by a confocai laser scanning
electron microscope.

quantity of absorption of the

early enough, in many cases,

radiopharmaceutical. The
minute change can be re¬

to prevent the most devas¬

around the body that causes
hydrogen atoms to line up

metabolic activity, through
sensitivity to blood oxygen¬

uniformly. When the magnetic

ation. When a portion of the
brain is activated, an fMRI

Resonance Imaging (MRI)—

field is switched off, the at¬
oms relax back to their nor¬

tures in bone structure or the

first used clinically in 1986,

mal patterns, giving off de¬

scan can detect increased
blood flow. By overlaying an

rate of uptake of neurotrans¬
mitters in the brain. Yale re¬

followed by a giant leap for¬
ward with the arrival of func¬

tectable signals as they do.
A computer records the pro¬

anatomical with a functional
study, researchers can map

searchers have used PET

tional MRI (fMRI) in 1990—

cess, which occurs at varying

out which sites in the brain

and SPECT to develop a
new method for detecting

made the dynamism of life
visible for the first time with¬

rates depending on the tis¬
sue, and then generates
highly detailed images. Radi¬
ologists can set the magnet

corded to show, for instance,
the body repairing tiny frac¬

tating symptoms altogether.
The advent of Magnetic

Parkinson’s disease prior to

out significantly interfering

the onset of the shaking and
other behavioral symptoms

with that dynamic. The tube¬
shaped magnet of the MRI

associated with it. Physicians
can now begin treatment
YALE
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serve to control different ac¬
tivities, or they can compare
function in a normal brain
versus that of a person with

machine creates a massive

for study of anatomy through
sensitivity to tissue or they

a mental illness or such dis¬
orders as learning disabilities

yet harmless magnetic field

can observe function, or

or autism.
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Using a new technique for rapid, total-body MRI, the entire human
body can be imaged in as little as 18 seconds.

anatomy and function, investigators then begin to ob¬

clinical fMRI, has shown that stroke, epileptic seizures

serve differences in the brains of those with cognitive

and other neuronal activity change the way water mol¬

and mental disorders, from learning disabilities, post-

ecules move in the brain. Diffusion weighted imaging,

traumatic stress syndrome and epilepsy to schizophrenia,

an MRI technique that measures these changes, is now

alcoholism and stroke. (See What the Brain Thinks While

regarded as the most sensitive way to detect stroke in pa¬

Reading) The investigators hope eventually to develop

tients during the first few hours after symptoms occur.

reliable diagnostic tools and therapies for these disorders

Actual scanning can take less than a minute, with results

that remain among the most difficult to diagnose and

following within a half hour. “We can rule out hemor¬

most resistant to treatment.
Already, neurosurgeons and neurologists have begun

rhages and tumors and detect stroke very, very early.
This gives us a tool for rapid treatment and for develop¬

to find practical tools derived from these experimental

ing new treatments. New drugs are now in development

studies. For instance, Dennis Spencer, M.D., the Harvey

to limit damage from, or even prevent stroke.”

and Kate Cushing Professor and chair of neurosurgery,
has been testing fMRI as a noninvasive, extremely rapid
method of examining the brain prior to surgery. Patients
with seizure disorders or tumors who need surgery may

NEW WAYS TO

soon be able to have their brain anatomy mapped out

The advantages for clinical care and medical research the

IMPROVE CARE

without the extended preoperative procedures that are

newer technologies offer are easy to imagine. The reality

now necessary. (See Peeling Back the Skull without a

of their application is much tougher.

Knife) The potential savings in time, money and pain are
almost incalculable.

Much about how MRI works is simply not under¬
stood, and the process of getting readable images from

Stroke is another area in which new applications of

machines can be enormously complex. It’s not like an

imaging technology hold great promise. By understand¬

X-ray in which the tube shoots, film gets exposed to ra¬

ing which areas of the brain have been damaged by

diation on the other side of the body and a photographic
negative of anatomical structures follows. Even the most
basic MRI scan requires a highly specialized team to op¬

neuroradiology Robert K. Fulbright, M.D., director of

erate it and process the data emerging from it. The more

ELIZABETH MCFARLAND/MALLINCKRODT INSTITUTE OF RADIOLOGY

trauma or stroke, more appropriate therapies can be
prescribed for individuals. Assistant professor of

Imaging techniques have been used to diag¬
nose cancer since the application of the X-ray.
Now, the digital reconstruction of data gener¬
ated by helical CT provides a view of structures
from a vantage point inside the body. This
frame from a virtual flythrough of the colon
reveals a 1-centimeter polyp.

32.
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complex the question the less certain are the data and
the more post-processing must take place to clarify just
what the eye of the scanner has seen. “You don’t just get
an area of the brain to light up,” says medical physicist
Dr. Constable of studies of brain activation. “Nobody
knows why functional MRI works or why images
change,” adds Dr. Gore.
That is why many of the frontiers of diagnostic im¬

What the brain thinks
while reading

I

f men and women sometimes seem like they come
from different planets, the difference in how their
brains go about reading may help explain just how far

apart those planets are. Husband-and-wife team of pedi¬
atric neurologist Bennett A. Shaywitz, M.D., and develop¬

aging are being explored as much by physicists as by ra¬

mental pediatrician Sally E.

diologists. Dr. Gore, who is himself a physicist, directs a

Shaywitz, M.D., together with

large team comprising physicists, neuroscientists, radi¬

their team of investigators,

ologists and computer scientists who work with re¬

electrified the neuroscientific

searchers throughout the School of Medicine and indeed

world when they reported in

the entire University using MRI for their research. Bio¬

1995 in the journal Nature

logical investigators need Gore’s group to help them de¬

that female subjects had ar¬

velop imaging methods and then explain just what it is

eas in both brain hemispheres

they’re seeing. Says Dr. Gore: “We continually find that

active during reading while

what we think are simple tasks—like listening to a tone

male subjects had only one.

in the ear for example—may also evoke a transient re¬

This was the first time func¬

sponse in areas of the brain that we were not expecting. ”

tional differences in the brains of men and women had

Figuring out what causes those responses and eliminat¬

been shown. While it demonstrates important anatomi¬

ing “noise” from small movements or individual varia¬

cal differences between the brains, it also may help ex¬

tions in brain structure require complex calculations.
The future of imaging technology promises to alter

plain why neurologists report that women with strokes
tend to recover language abilities more rapidly than men.

medicine radically, from diagnostic and treatment meth¬

The Shaywitzs’ finding was in fact a byproduct of a

ods to administration of care. Some of the most specula¬

much larger investigation of reading and language usage

tive uses already developed for the new imaging tech¬

designed to identify neurological differences in the

nologies seem to have jumped from the screens of

brains of non-impaired readers and those with dyslexia.

science fiction movies.
Eventually, patients will very likely be able to walk

“We’re developing a much more in-depth picture of how
the brain works in non-impaired readers and people with

into a clinic, get a complete body scan in a matter of

reading difficulties,” says Robert K. Fulbright, M.D., direc¬

minutes, have it diagnosed for problems and then stored

tor of clinical fMRI and a collaborator with the Shaywitzs.

away for future reference. Kevin M. Johnson, M.D., a

Use of language for reading is an enormously com¬

diagnostic radiologist doing MR research, has already

plex mental activity involving motor-speech areas and

perfected a new technique for rapid total body MRI, in

language reception regions in the brain. Investigators

which a patient’s entire body can be imaged without

ask study subjects to sound out nonsense words pro¬

great blurring in as little as a scant 18 seconds. Using an

jected on a screen that is reflected to them while they

adaptation to the scanner, Johnson can move his study

undergo functional imaging. Areas of activation are then

subjects on a sliding table swiftly through the MRI ma¬

overlapped with anatomical scans. The results of each

chine, getting 180 cross-sectional images along the way.

subject are “averaged" out to create a common brain

The complete picture gives a much wider scope for diag¬

space to account for individual differences in size and

nosis than current procedures. The images can also be

anatomy. The researchers are analyzing the data to de¬

stacked for animated tours. While many questions re¬

termine differences between non-impaired readers and

main, Dr. Johnson believes that the new technique is es¬

those with disabilities. Eventually, clinicians will diagnose

pecially promising for detecting the spread of cancers,

children with various learning disabilities early on and be¬

which now is usually done in limited regions using a CT

gin treatment to prevent a lifetime of difficulties. “Read¬

(computed tomography) body scanner and an ingested

ing disability is a circumscribed deficit surrounded by

or injected nuclear tracer. “We can do a workup faster

strengths,” says Dr. Sally Shaywitz, professor of pediat¬

and with less inconvenience and suffering for the pa¬

rics and a faculty member in the Child Study Center.

tient,” says Dr. Johnson, assistant professor of diagnostic

[Bennett Shaywitz is a professor with appointments in

radiology. “And you get to see the entire body and not

pediatrics, neurology and the Child Study Center.] “You

just a limited area.” He believes that, when coupled with

need to identify those strengths, make the child aware

existing tests, the rapid total body MRI will eventually

of those strengths, and then maximize them to help

provide better cancer detection.

overcome the disability.”
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The three-dimensional quality of computer ani¬

tered, radiologists will soon rely upon virtual equiva¬

mated graphics has given viewers playing video games or

lents. And the virtual tour will be a better diagnostic

watching movies a feeling of entering into a world of

tool than current invasive procedures. Colorized, ani¬

virtual reality. A similar experience is now possible in

mated, volumetric renderings on the computer of CT

traveling at high speed through the body. Where now a

scans provide a realistic image of the interior of the

viewing scope must be inserted into the partially anes¬

body’s passages. Using a joystick, the viewer can travel

thetized body and passed through the colon, aortic ves¬

up and down or zoom in on sites, such as polyps, ath¬

sels or bronchial tubes until an obstruction is encoun¬

erosclerotic plaque buildup or ulcers. There are major

Peeling back the
skull without a knife

U

nderstanding what transpires
inside another person’s
head may be difficult for

anyone, but for a surgeon about to
operate on the brain, that knowledge
can be a matter of life and death.
New applications of functional MRI
may make it a far less dangerous
process.
For the past decade, patients
undergoing brain surgery have bene¬
fited from a procedure pioneered at
Yale. Before removing tumors, vascu¬
lar malformations or other lesions
that might cause seizure disorders,
surgeons must carefully map the
surface of the brain to pinpoint

Neurosurgeon Dennis Spencer prepares
to lay down a grid of electrodes on the
exposed surface of the brain during a pro¬
cedure that will map functional locations
to be avoided during epilepsy surgery.

areas vital to language, and the
organization of motor function, sen¬
sation and vision. Prior to surgery,
the surgeon removes a portion of
the patient’s skull and lays a grid of
electrodes over the cortex, the outer
layer of gray matter at the brain’s
surface. The fully conscious patient
then completes a series of tasks,
during which critical regions of the
cortex are identified and mapped
as areas to avoid during surgery.
The entire process lasts about a
week and takes place in the Yale
Epilepsy Unit.
The chairman of the Department
of Neurosurgery, Dennis D. Spencer,

Ph.D., an assistant professor who is
working on the imaging technology
with Dr. Spencer. To test this capabil¬

M.D., is exploring the use of the fMRI

ity, the research team is correlating

to achieve results superior to those

fMRI data with the already-proven

from the electrode grid. A one-hour

electrode techniques. Says Dr.

fMRI exam may eventually replace

Spencer: "Surgeons will eventually be

the week-long monitoring process

able to understand where language

that is now the state of the art, says

is controlled without having to invade

medical physicist R. Todd Constable,

the brain and physically map it.”

The map shown above left is produced
from data gathered during a week of ob¬
servation and EEG recording. The color
outlines indicate areas of the cortex that
control motor function (red), language and
speech (yellow) and sensory ability (blue).
The area outlined in black shows sur¬
geons where they can most safely operate
to remove the epileptic focus without
causing a permanent neurological deficit.
Spencer and colleagues are now using
functional MRI studies like the one above
to map the brain non-invasively.

advantages to the virtual colonoscopy, angioscopy

Function over form

and bronchoscopy beside not subjecting patients to

Positron emission tomography (PET) is es¬
pecially useful as a tool to visualize me¬
tabolism, to see not only the form of a
structure but its function as well. The im¬
age at left allowed surgeons to diagnose a
brain tumor without opening the skull. The
patient had been treated for a previous tu¬
mor, and the dark area could have been
dead tissue from the prior radiation
therapy. PET imaging detected metabolic
activity consistent with a new tumor.
“Only PET can show that difference,” says
VA PET Center Director Robert Soufer.

unpleasant, invasive and potentially hazardous pro¬
cedures. When an obstruction is encountered that
would halt an actual physical exam, the virtual ex¬
amination simply passes right through it. Using
color processing, blood can be “drained” from the
heart and vessels to examine walls and valves,

A virtual image bank

I

agnostic imaging. Dr. Mutalik, along

already has a partial network estab¬

with fellow associate research scien¬

lished within the hospital. Funding is

mages of all sorts can be digi¬

tist Vladimir P. Neklesa, M.D., is in

in place to begin creating the com¬

tized, then manipulated, com¬

charge of bringing PACS online at

plete PACS. As with any investment

pressed, archived and sent be¬

Yale. Eventually, teams of radiologists

in new high-tech systems, the risks

tween computer workstations over

based at the medical center will re¬

of undertaking the $8-10 million

huge distances at speeds limited

view images sent from satellite sites,

build-out of the system are substan¬

only by the bandwidth of the line.

clinics and private practices through¬

tial. Some pioneering hospitals cre¬

For radiology and all aspects of

out a large region.

medicine dependent on its services,

ated early versions of PACS before

The completion of PACS will elimi¬

the technology was adequately de¬

that means a revolution in service

nate the need for storing medical

veloped, and soon had to scrap the

delivery is about to take place. Over

film. Where now a vast film archive

whole thing. “Timing is everything,”

the next several years, Yale-New

holds medical records—with only the

says Dr. Neklesa. “We think now is a

Haven Hospital plans to put its own

most recent images kept at the hos¬

good time to get in.” Department of

imaging systems online and link into

pital and the rest warehoused off¬

Diagnostic Radiology chair Bruce L.

a network within the center. It will

site—a theoretically infinitely ex¬

McClennan, M.D., agrees: “We’ll be

very likely be accessible to physi¬

pandable digital-storage system will

able to display, store and share infor¬

cians outside the hospital who hold

keep images at constant ready. Wor¬

mation in a high-speed, secure fash¬

authorization codes as well. The Pic¬

ries about confidentiality appear mis¬

ion. The clinical networking revolution

ture Archiving and Communications

placed. One of the major complaints

is here.”

System, or PACS, will allow referring

all physicians make today is

physicians and radiologists to down¬

that when they need patient

load and discuss patient images at

images, all too often they’re

their workstations simultaneously.

simply not to be found. Says

When radiology goes online, medi¬

Dr. Mutalik of PACS-based

cine will change dramatically.

storage: “Unlike film, where

“PACS and teleradiology,” says
Howard P. Forman, M.D., vice chair

there is only one copy, it
doesn’t sprout legs and walk

for finance and administration in

away.” Only those with au¬

the Department of Diagnostic

thorization will be able to en¬

Radiology, “will make more of a

ter the secure Web site or

change in medical practice in the

the PACS system. For those

next 10 years than anything else

physicians, however, image

now on the horizon.”

retrieval will be almost in¬

PACS will go a long way toward

stantaneous, even for much

making the computerized world of

older images. Eventually, all

medicine, now only partially imple¬

of an individual’s medical

mented, complete. “We can call up

records could be down¬

any number of images anyplace, any¬

loaded onto a “smart card”

time,” says Pradeep Mutalik, M.D.,

that the person might carry

while sitting at a double monitor

like a credit card.

workstation specially designed for di¬
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Yale-New Haven Hospital

For Vladimir Neklesa, right, and Pradeep Mutalik, the
future of radiology does not require film.
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For the past six decades, physicans have relied on a technique called intravenous pyelogram, left,
to determine treatment for patients arriving with a sharp pain in the side. The problem was that
IVP can take as long as 24 hours for results. Four years ago, Yale physicians developed a faster,
more precise technique—made possible by the advent of helical CT—that in five minutes can dis¬
tinguish between a kidney stone, indicated by the arrow above left, and an aortic aneurysm,
above right. In the case of the aneurysm, immediate surgery saved the patient’s life.

Throwing stones

E

very day in any large emer¬

ureters, the tubes that run from

cases or even prevent correct

gency department around the

the kidneys to the bladder. These

diagnosis.

country at least one person,

kidney stones can get stuck, block¬

For 60 years, physicians had only

and usually far more, arrives in

ing urine flow and causing a horrific

one method at hand for deciphering

terrible agony caused by a sharp

pain that has been likened to child¬

whether the pain originated with a

pain in the side. Getting a correct

birth in its severity. The trouble is

blockage caused by a kidney stone,

diagnosis for the source of the pain

that other possible causes for

or not. They injected patients intrave¬

is the first, all-important, step in

such pain—from appendicitis to

nously with an iodine solution that is

relieving the misery. The likeliest

tumorous masses—while less likely,

rapidly excreted by the kidneys, and

cause for most cases of what

are not rare. Until doctors find the

which then would appear white when

physicians call “acute flank pain” is

actual cause of the pain, there is

exposed to X-rays. If there was a

a kidney stone. Hardened collections

virtually nothing they can do to

blockage, the stone itself might not

of mineral salts, literally rocks, build

help. Pain relief medication might ac¬

be visible, but the distended section

up in the kidneys and then enter the

tually make matters worse in some

of ureter above it would be, giving

which would otherwise be obscured, for damage. Even¬

the same time, it enhances access by allowing those

tually, a completely animated, virtual tour of the body

with appropriate entry codes to download information.

may be possible. “The potential is great,” says James

“Theoretically,” says Pradeep G. Mutalik, M.D., who

Brink, M.D., vice chair for clinical affairs and associate

is director of radiology information technology and is

professor of diagnostic radiology, who is working with

developing medical communications systems for the

the technology. “Is it ready for primetime? It’s too early

Department of Diagnostic Radiology, “the day has ar¬

to tell.”

rived when we can dispense with film.” Already some
military hospitals have gone entirely filmless. Since 1993,
digital transfer of images has been possible to the inten¬

IMAGES

WITHOUT

FILM

sive care units at Yale-New Haven Hospital. Eventually,

The most far-reaching impact from diagnostic imaging

the entire hospital complex will be wired for digital in¬

advances, however, may be through communication

formation sharing.

technology. Digitizing imaging allows for high-speed

Dr. Mutalik and his colleague Vladimir P. Neklesa,

computer link ups among specialists and clinicians.

M.D., are responsible for setting up Yale’s Picture

Doctors on opposite sides of the world will be able to

Archiving and Communications System (PACS), includ¬

work together to come up with the best diagnosis and

ing a Web-based system in which authorized physicians

treatment lor patients. Digital imaging also reduces the

will be able to log on from their office workstation and

space needed for storage of images and the number of

download archived images. (See A Virtual Image Bank)

personnel necessary for maintaining film archives. At

The future of radiology as a profession and medicine
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physicians some good evidence

make each image, or cross-sectional

as well. We were able to see the

about the site and potential danger

slice, with any extended region of

stone in virtually every case.” And

represented by a stone. If it wasn’t a

the body, such as a flank being ex¬

the helical CT scan could detect

stone, then other procedures could

amined for a source of pain, requir¬

appendicitis, masses in ovaries

begin, such as exploratory surgery, to

ing 20 to 30 minutes. The patient

and other less common sources

figure out what was wrong. Depend¬

needs to hold completely still

of flank pain.

ing on the degree of obstruction, it

throughout. As such, it wasn’t a prac¬

would take anywhere from 10 min¬

tical tool for figuring out why a pa¬

Over the next two years, Dr.

utes to 24 hours to get a clear pic¬

tient was writhing in agony. The new

scans on more than 800 patients

ture of the ureters. Moreover, in a

helical CT scanner, however, took the

experiencing acute flank pain. Diag¬

small number of cases, patients de¬

basic CT technology and sped it up

nostic accuracy proved higher than

veloped adverse reactions to the in¬

enormously. A partial body scan that

IVR and the scans provided much

Smith’s team performed helical CT

jected contrast material, and in rare

previously took a half-hour can now

more exact information about the

cases, those reactions were life-

be completed in less than a minute.

size and location of any stones that

threatening. Even when the pictures
came in, at best, this long-standard

Beginning that summer, a team of

were found, making treatment deci¬

Yale radiologists and urologists,

sions more effective. Patients who

diagnostic method, called intrave¬

headed up by Robert C. Smith, M.D.,

once may have waited more than a

nous pyelogram (IVP), provided only

associate professor in the Depart¬

day in the hospital before diagnosis

a partial map to the stone. Whether

ment of Diagnostic Radiology, took

could be made now start treatment

urologists should try an intervention

patients arriving with symptoms of

in a matter of minutes. “Usually,”

of some sort or just wait to let the

kidney stones and ran them through

says Dr. Smith, “we have an answer

stone pass on its own was often a

the new helical CT machine. They

within five minutes. No matter how

matter of educated guess work.

then compared them with a similar

you look at it, CT is more accurate

Then, in 1993, Yale-New Haven Hos¬

number who underwent a standard

and faster, and there is no known

pital acquired a new helical com¬

diagnostic procedure. Kidney stones

harm other than the necessary low-

puted tomography (CT) scanner.

will never look the same again. With¬

level radiation exposure." As a result

out using any contrast material, soft

of the Yale study, helical CT scan is

A standard CT scanner employs a
doughnut-shape X-ray camera

tissue appears gray and all stones

now the standard diagnostic proce¬

adapted to a computer to achieve

white under CT scans. “We not only

dure for flank pain in most major

high-resolution images quickly. It

see the blockage,” says Dr. Smith,

hospitals around the world.

takes from three to five seconds to

“we can see the stone perfectly fine

as a whole will be radically altered by so-called

“It used to be a new technology

“teleradiology,” in which radiologists will provide service
to a large region from a single center. “People now see

came along and we looked for

the world through their computers,” says Howard P.
Forman, M.D., vice chair for finance and administration

ways to apply it. Now, we develop

in diagnostic radiology. “We constantly ask ourselves,
How can we deliver information and images to physi¬

applications from the technology

cians in a seamless manner?”

that has stabilized. The cutting
SOFTWARE

VERSUS

HARDWARE

edge has slowed down.”

While the tremendous value of many of the technologies
is now readily apparent, not all high-tech medical equip¬
ment has proven its worth. For many years, promising

— Howard P. Forman

and extremely expensive new imaging technology
seemed to arrive at the medical marketplace every few
months. Medical centers invested huge sums to acquire
advanced equipment and systems, in some cases only to
see it superseded within months. The almost crazed pace
YALE
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Imaging the eye
New diagnostic tool offers
insight into glaucoma

L

aser technology that produces
a three-dimensional image of
the optic nerve may help oph¬

thalmologists detect the subtle
changes that signal the earliest
stages of glaucoma. The process,
known as confocal scanning laser
tomography, is undergoing clinical
trials at Yale and the University of
California at Los Angeles.

Confocal laser scanning produces detailed images of the optic nerve head, which is only 1.5
millimeters in diameter. Computer analysis of the data generated during scanning provides
information critical to the management of glaucoma.

Glaucoma is a condition in which
people lose their vision because of
abnormally high pressure in the eye.

brain. Although glaucoma encom¬

The pressure is the result of fluid

passes a large group of disorders,

lyzes data and integrates the im¬

buildup caused by blockage in the

the common denominator is gradual

ages into a three-dimensional model

drainage channel between the back

deterioration of the optic nerve, lead¬

on a monitor.

of the cornea and the iris.

ing to blindness.

"Early detection and appropriate

The visible end of the nerve, re¬

tached to a computer, which ana¬

For more than a decade, begin¬
ning in the 1980s, Dr. Shields and

treatment are the only methods of

ferred to as the optic nerve head,

Dr. Caprioli corresponded with each

preventing blindness due to glau¬

may be compared to the eraser end

other about the separate studies

coma. Both depend on our ability to

of a pencil, Dr. Shields explains. The

they were conducting in glaucoma.

analyze the optic nerve to determine

nerve extends backward from the

During that time, Dr. Shields was a

if early atrophy is taking place,” says

eye to the brain, and the portion that

faculty member at Duke University

M. Bruce Shields, M.D., chair of the

can be seen resembles a disc. As

and Dr. Caprioli was director of the

Department of Ophthalmology and

nerve fibers die, changes occur in

glaucoma service at Yale. They first

Visual Science at Yale School of

the contour of the optic nerve head.

discussed collaborating on clinical

Medicine. His collaborator is Joseph

The actual loss of nerve fiber

measurements of optic nerve dam¬

Caprioli, M.D., HS '83, who left Yale

bundles and a posterior deformity—

age in late 1996 and early 1997.

last year to become director of the

in which the disc bows backward,

Glaucoma Division of the Jules Stein

creating a cup-like malformation—

Eye Institute at UCLA School of

are two changes that may be visible.

Medicine. “There never has been

During examination with the con¬

Dr. Shields, who also is chief of
ophthalmology at Yale-New Haven
Hospital, recently completed a term
as president of the American Glau¬
coma Society. He is author of the

technology sophisticated enough for

focal scanning laser, the patient’s

early diagnosis and careful follow¬

head rests in a device similar to a

Textbook of Glaucoma, now in its

up,” says Dr. Shields. “That is what

slit lamp, the standard instrument in

fourth U.S. edition. The book has

this laser offers."

every ophthalmologist’s office. The

been translated into German, Japa¬
nese, Portuguese and Spanish.

The purpose of the Yale-UCLA

laser is housed in a camera-like de¬

study is to build scientific evidence

vice in front of the patient’s eye. The

confirming that the confocal scan¬

beam is focused on a small portion

tutions around the world, including

ning laser is able to reveal optic

of tissue in the eye. The reflected

Japan and Finland, are conducting

Scientists at about a dozen insti¬

nerve damage more accurately than

light passes through an opening said

research similar to the Yale-UCLA

current methods. The scanning laser

to be confocal to the laser focus, so

study, says Dr. Shields. “Even though

would aid in screening patients for

that the photodetector “sees” only

we feel strongly that this new tech¬

glaucoma and guiding treatment of

the small area. The beam scans

nology does offer something we

those with established disease more

back and forth across the nerve.

don't have today,” he adds, “we

precisely. The optic nerve contains

Probing deeper with each scan, it

need long-term clinical trials to

nearly a million fibers that send vi¬

completes 32 images of nerve tis¬

prove its value.”

sual signals from the retina to the

sue in one second. The laser is at¬
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“The powers that be say, ‘How much faster is it?’ ‘How much cheaper?’
Were constantly sorting out the hype from what will really bear fruit.”
— Bruce McClennan

of imaging technology development that took place in
the 1980s has slowed considerably as the hardware revo¬
lution seems to have crested for the moment. Most re¬
cent advances have come about through development of
software, new applications of existing technologies and
the convergence of a variety of techniques rather than
the creation of another new generation of machines.
“It used to be,” explains Dr. Forman, “the field devel¬
oped things in what could be seen as a backward way.
A new technology came along and we looked for ways
to apply it. Now, we develop applications from the
technology that has stabilized. The cutting edge has
slowed down.”
Part of that slowing has occurred because of eco¬
nomics. The arrival of managed care has meant that the
high cost of purchasing high-tech care systems must be
justified through improved patient outcomes over exist¬
ing forms of treatment. With a new, high-power fMRI
machine costing more than $4 million just to purchase
and millions more to operate, clinicians and researchers
need to prove that it will not only provide better clinical
outcomes for patients, but will pay its own way. Clini¬
cians must now think both like healers and like business

Magnetic resonance images of the brain, shown
above, along with electrophysiology recordings,
are used to identify the approximate locations of
seizure-generating brain tissue. Using a stereotac¬
tic frame, the tissue to be studied is targeted (in¬
tersection of yellow lines) and a trajectory plot¬
ted. An electrode may then be inserted precisely.

managers. Says department chair Dr. McClennan: “It’s a
different world. The assessment of technology is much
more demanding because there is such a constraint on
resources. The powers that be say, ‘How much faster is
it?’ ‘How much cheaper?’ and ‘Show me the outcome
studies before I’ll spend a dollar.’ We re constantly sort¬
ing out the hype from what will really bear fruit.”

Healthy Control

Parkinson’s Disease

Given the enormous costs of equipment and the
rapid sweep of technological change in diagnostic imag¬
ing, the risks of doing a high-tech belly flop are great.
The School of Medicine is continuously bombarded by

P%

companies seeking testing and adaptation of their equip¬
•

ment. The capabilities claimed by the manufacturers of
these new technological wonders sometimes vastly out¬
pace reality. There are occasions when new systems can
do more than the current state of patient care and aca¬
demic research actually demand. Says Dr. McClennan:
“We need to ask, where is the technology leading us and
who is in charge? The challenge is to keep medicine and
technology married and not get distracted.” Like most
marriages, the road has sometimes been bumpy, but it’s
a marriage that all believe will continue. YM
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Essential Tremor

Progressive Supranuclear
Palsy

These SPECT images of the brain pinpoint
locations where dopamine transport occurs.
The images compare healthy individuals to
patients with Parkinson’s disease and two other
disorders in which dopamine tranfer is impaired,
progressive supranuclear palsy and essential
tremor. The technique is being evaluated for the
diagnosis and monitoring of Parkinson's and
related diseases.
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Faculty join Institute of Medicine

T

hree medical school faculty
members are among the 60
new members elected to the

Institute of Medicine. They are:
► Mark R. Cullen, M.D. ’76, pro¬
fessor of medicine (occupational and
environmental medicine) and of pub¬
lic health, and director of the Yale
Occupational and Environmental
Medicine Program. Dr. Cullen has
centered his work on strategies for
investigation of toxic agents causing
Mark

health effects in humans. Two of his
current research areas focus on occu¬
pational asthma, particularly due to
diisocyanates, and host factors in
asbestos-related pulmonary fibrosis
and lung cancer.
► Ralph 1. Horwitz, M.D., the
Harold H. Hines Jr. Professor of

George Miller

Medicine and Epidemiology and
chair of the Department of Internal
Medicine. Dr. Horwitz has conducted
clinical research on a wide range of
topics, including the link between
Reye’s syndrome and aspirin, heart

► George Miller Jr., M.D., the John
F. Enders Professor of Pediatric Infec¬
tious Diseases and professor of epidemi¬

attacks, asthma and the use of inhal¬

ology and of molecular biophysics and
biochemistry. Dr. Miller concentrates

ers, prostate gland and surgical treat¬

his research on tumor viruses, including

ment, and the epidemiologic aspects
of disease.

viruses.
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the Epstein-Barr and Kaposi’s sarcoma

Hoffman-LaRoche Symposium held in
September at the National Museum of

Ralph I. Horwitz

come the first fellows of Connecticut
United for Research Excellence Inc.

James J. Abrahams, M.D., associate
professor of diagnostic radiology and

American History in Washington. Dr.

(CURE). Dr. Collins was recognized for

Burrow’s talk was titled Preparing for the

his efforts, inspiration, leadership and

surgery (otolaryngology), presented an

Information Age in Health Care.

vision as a past chair of CURE and his
role as founding father of BioRAP, a life

Liza Cariago-Lo, M.S., Ed.D., has
been named director of the Office of

sciences learning publication for middle

abstract titled Augmentation Procedures
of the Jaw in Patients with Inadequate
Bone for Dental Implants: Radiographic

school students sponsored by CURE.

Appearance, at the annual meeting of the
Radiological Society of North America

Multicultural Affairs and will work un¬

Ms. Patterson was recognized for her

der the direction of Assistant Dean

in Chicago in December.

Forrester A. Lee, M.D. ’79.

public relations advice and editorial
oversight on many CURE publications.

Gerard N. Burrow, M.D. ’58, the

J.G. Collins, Ph.D., professor of anes¬

James P. Comer, M.D., HS ’64-67, the

David Paige Smith Professor of Medi¬

thesiology and lecturer in pharmacology,
and D. Helaine Patterson, director of

Maurice Falk Professor in the Child
Study Center and Department of Psy¬

cine (endocrinology) and special advisor
to the president for health affairs, was

medical school public information, are

chiatry and director of the School De¬

among the speakers at a Smithsonian/

among seven individuals selected to be-

velopment Program, was one of three
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recipients of the Camille O. Cosby-

Bruce C. Fichandler, PA-C ’73, physi¬

World of Children Award in November.

cian assistant in surgery, lecturer in sur¬

The award, given by the Judge Baker

gery (plastic), and director of admissions

Children’s Center in Boston, is named

for the Yale Physician Associate (PA)

in honor of the wife of entertainer

Program, was presented the Second

Bill Cosby and recognizes outstanding

Annual Alumni Award at PA graduation

achievement in improving the lives of

ceremonies in August. He also received

disadvantaged children. The other two

the Jack Cole Society Award for his

recipients were children’s advocate

significant contributions in support of

Tipper Gore and BankBoston CEO

the physician associate profession.

Chad Gifford.

Society namesake Jack W. Cole, M.D.,
former chair of surgery and a founder of

Vincent T. DeVita, M.D., director of

the PA Program, gave the Commence¬

the Yale Cancer Center and professor of

ment address.

medicine (oncology) and epidemiology
and public health, received the Key to

Myron Genel, M.D., associate dean for

the Cure Award at the Cure for Lym¬
phoma Foundation’s third annual Caba¬

government and community affairs and
professor of pediatrics, was re-elected to

ret for a Cure dinner in November at

the American Medical Association’s Sci¬

assistant dean and director of the Physician

the Plaza Hotel in New York City. He

entific Council and named to its execu¬

Associate Program.

was also presented the Presidential

tive committee by the AMA House of

Award from the New England Cancer

Delegates at the annual meeting in June.

Beeson Physician Faculty Scholars in
Aging Research Award from The Ameri¬

Society at its annual meeting this fall in
New Haven.

Alumnus Bruce Fichandler with Elaine Grant,

can Federation for Aging Research. This

Gerhard H.
Giebisch,

$450,000 award is funded by the John

John Elefteriad.es, M.D. ’72, professor

M.D., Sterling

A. Hartford Foundation, the Common¬

and chief of cardiothoracic surgery, was

Professor of

wealth Fund, and the Alliance for Aging
Research on behalf of donor friends.

named College Governor-Elect for Con¬

Cellular and

necticut by the Board ofTrustees of the

Molecular

He also received a $240,000 Generalist

American College of Cardiology. After a

Physiology,

Physician Faculty Scholars Award from

one-year term, he will become College

was awarded
an honorary

The Robert Wood Johnson Foundation,

Governor for the state until the year
2002. Dr. Elefteriades also served as vis¬

doctorate from

voted exclusively to health and health

the nation’s largest philanthropy de¬

iting professor in August in Japan,

the University

where he spoke on minimally invasive

of Vienna in

research on identifying the precipitating

cardiac surgery and left ventricular re¬

June. The award was given in conjunc¬

events leading to new dependence in ac¬

modeling by aneurysmectomy and

tion with a symposium entitled Renal

tivities of daily living among frail, com¬

Batista operations.

Electrolyte Metabolism Physiology and

munity-living elderly persons. “This re¬

Pathophysiology, on the occasion of Dr.

search,” says Dr. Gill, “will lead to an

Gerhard H. Giebisch

care. Both awards will support Dr. Gill’s

Janine Evans, M.D., assistant professor

Giebisch’s 70th birthday. The event

improved understanding of the dis¬

of medicine (rheumatology), has been

was organized by John P. Geibel, M.D.,

abling process and, in turn, will enable

appointed medical director of the Yale-

Ph.D., associate professor of surgery

investigators to better design effective

New Haven Physician Hospital Organi¬

(gastroenterology) at Yale, and Jurg

and efficient strategies to prevent, slow

zation and the Yale-New Haven Medical

Graf, M.D., of the department of gen¬

or reverse functional decline.”

Staff Independent Practice Association

eral and experimental pathology at the

(IPA). In this dual role, Dr. Evans will

University of Austria. Speakers from

collaborate with Yale University, Yale

Yale included Walter F. Boron, M.D.,

M.D., professor

Faculty Practice and community physi¬

Ph.D., professor and chairman of cellu¬

of ophthalmol¬

cians on the IPA to coordinate effective

lar and molecular physiology, and

ogy, was one of

medical management, utilization and

Peter S. Aronson, M.D., C.N.H.

five pediatric

quality assurance in the delivery of

Long Professor of Internal Medicine

ophthalmologists
to receive the

health care. She will also work with phy¬

(nephrology) and of cellular and mo¬

sicians to develop programs and policies

lecular physiology, and chief of the sec¬

that support high-quality, cost-effective

tion of nephrology.

Caleb Gonzalez,

Honor Award
from the Ameri¬
can Association

health care to the patients who are cov¬

Caleb Gonzalez

ered through health plans that have con¬

Thomas M. Gill, M.D., assistant pro¬

tracted with the Yale New Haven

fessor of medicine (geriatrics), was one

for Pediatric Ophthalmology and Stra¬
bismus (AAPOS) at its annual meeting

Health System.

of 10 junior faculty to receive the Paul

in April in Charleston, S.C. This award
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is to recognize outstanding achievement

1997 Clinical Investi¬

was based on early work on sleep depri¬

and distinguished service to the

gator Award by the

vation, as well as on intensive CCTV/

AAPOS. Dr. Gonzalez received a similar

American Epilepsy

EEG monitoring studies.

honor in 1992 from the American Acad¬

Society/Milken Fam¬

emy of Ophthalmology.

ily Foundation Epi¬

The Albert Schweitzer Institute for the

lepsy Research Award

Humanities sponsored James R.

Martin E. Gordon, M.D. ’46, clinical

Program. The award

Merikangas, M.D., lecturer in psychia¬

professor of medicine and chairman of

was given in Boston

the Board of Trustees of the Associates

in December for his

of the Harvey Cushing/John Hay

epilepsy research over

to present seminars in child psychiatry

Whitney Medical Library, was one of

a 35-year period. In another presenta¬

and neurology to the faculties of Vilnius
University Center for Children with

try and attending in psychiatry and
Richard H. Mattson

neurology at Yale-New Haven Hospital,

the three Deans of the Academy, finalist

tion, Dr. Mattson was awarded the

judges for more than 600 entries to the

Novartis Epileptology Prize for 1997 at

Developmental Disorders in Lithuania

American Medical Association’s 1997

the 22nd International Epilepsy Con¬

and the universities ofTartu and Tallinn

International Health and Medical Film

gress in Dublin last July. The prize was

in Estonia. These seminars, funded

Competition in November in San Fran¬

given in recognition of his outstanding

by the Open Society Institute/Soros

cisco. Dr. Gordon was a John Muir Film

achievements in the field of epilepsy

Foundation, were held from June 27

Festival winner in 1976 and has received

with a particular interest in researching

to July 3, 1997.

numerous other awards as a director/

the optimal use of anti-epileptic drugs.

producer of medical films.

Dr. Mattson was also selected as the

Marvin Moser, M.D., clinical professor

Hans Berger Lecturer at the 25th Hans

of medicine, was recognized for out¬

Berger Symposium in June. This honor

standing contributions to hypertension

Charles A. Greer, Ph.D., professor of
neurosurgery and neurobiology, orga¬
nized and chaired the joint meeting of
the International Symposium on Olfac¬
tion and Taste XXI and the Association
for Chemoreception XIX meeting in
San Diego. The joint meeting, which
occurs every 12 years in the U.S., was
the largest to date and included 652 pre¬
sentations from around the world.

Pasko Rakic, M.D., chairman and
Dorys McConnell Duberg Professor of
Neurobiology, was honored during the
meeting with the 19th Givaudan-Roure
Lectureship.

Donald W. Kohn, M.D., clinical pro¬
fessor of surgery (dental) and pediatrics,
and chief of dentistry at Yale-New
Haven Hospital, was named president
of the International Association of Pedi¬
atric Dentistry at the Association’s XVI
Congress in Buenos Aires in September.

New chair for Cell Biology
Keat-Jin Lee, M.D., associate clinical
professor of surgery (otolaryngology),
spoke on the Advanced Points of Ear
Surgery at the annual Chilean Congress
of Ear, Nose, Throat Conference in
Chile in November. He is also Secre¬
tary-Treasurer of the American Academy
of Otolaryngology until 1999.

Richard H. Mattson, M.D. ’53, profes¬
sor of neurology and vice chair for aca¬
demic affairs, was honored with the
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When Pietro De Camilli, M.D., returned to Italy in 1981 after three years as a
postdoctoral fellow and assistant professor at the School of Medicine, chairing
a department at Yale was the furthest thing from his mind. But events brought
him back to New Haven in 1987, and last Nov. 1, after another decade on the
faculty, he assumed the leadership of the Department of Cell Biology for a twoyear term. Since his postdoctoral days in the late 1970s, he has focused his re¬
search on synapses, the junctions which transmit information between neurons
in the brain. “These studies have a direct impact in the fields of neurological
and psychiatric diseases, but also have general relevance in cell biology,” says
Dr. De Camilli, who studied medicine and endocrinology at the universities of
Milan and Pavia. Dr. De Camilli is a Howard Hughes Medical Institute investigator
and serves on the boards of a half-dozen journals including the Journal of Neuro¬
science. The department has 11 primary investigators and 43 graduate students.
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treatment and control by the National

in July in Helskini, is awarded to stimu¬

Heart, Lung & Blood Institute at the

late innovation in the field of diabetes

25th anniversary dinner of the National

research leading to practical advances in

High Blood Pressure Education Pro¬

prevention, detection, treatment and

gram in November in Washington.

cure for diabetes and its complications.

NEW

BO

K S

Rallying the Whole Village: The Comer
Process for Reforming Education edited by
James P. Comer, M.D., HS ’64-67,

Dr. Moser has been the senior medical
consultant to the national program for

Scott W. Wolfe, M.D., associate profes¬

Maurice Falk Professor of Psychiatry;

24 years.

sor of orthopaedic surgery and director

Norris M. Haynes,

of the orthopaedic and rehabilitation

Ph.D., associate

Eric J. Nestler, M.D. ’83, Ph.D. ’82,

department’s hand and upper extremity

professor; Edward

professor of psychiatry, neurobiology,

service, is the recipient of the 1997-1998

T. Joyner, Ed.D.,

and pharmacology, and Benjamin S.

Bunnell Traveling Fellowship in Hand

M.A.T., lecturer;

Bunney, M.D., the chair and Charles

Surgery, awarded annually by the

and Michael Ben-

B.G. Murphy Professor of Psychiatry

American Society for Surgery of the

Avie, M.A.,

and professor of pharmacology, partici¬

Hand. This award provides funds for

M.Phil., associate

pated in the Consensus Development

travel to international and/or domestic

research scientist,

Conference on Effective Medical Treat¬

medical centers to pursue educational

all in the Child

ment oi Heroin Addiction in November

interests in the study of the hand. Dr.

Study Center,

at the National Institutes of Health in

Wolfe will report on his educational ex¬

Teachers College

perience at the 1997-1998 residents and

Press (N.Y.) 1996.

Bethesda, Md.

Rallying the
Whole Village
The Comer Process for
Reforming Education

James P. Comer
Norris M, Haynes
Edward T. Joyner
Michael Ben-Avie

fellows conference and annual meeting
Herbert S. Sacks, M.D. ’52, clinical

of the society.

professor of child and adolescent psy¬

Some Chose to Stay: Faith and Ethics in

chiatry at the Child Study Center, be¬

a Time of Plague by Alan C. Mermann,

came president of the 42,000-member
American Psychiatric Association in
July. Dr. Sacks will use his office to
speak out on behalf of children and for
reforms in the juvenile justice system.

Gerald I. Shulman, M.D., Ph.D., pro¬
fessor of medicine (endocrinology), and
of cellular and molecular physiology,
was one of two researchers awarded the
Boehringer Mannheim and the Juvenile
Diabetes Foundation International Dia¬
betes Care Research Award for 1997.
The $100,000 prize, presented at the In¬
ternational Diabetes Federation Meeting

Eiji Yanagisawa, M.D., clinical profes¬
sor of surgery (otolaryngology), was
guest of honor at the 77th Annual

M.D., M.Div. ’79, medical school chap¬
lain and clinical professor of pediatrics,
Humanities Press (N.J.) 1997.

Scientific Meeting of the American
Broncho-Esophagological Association
in Scottsdale, Ariz., last May. He also

Sports and Exercise for Children with

served as one of two judges from the

Chronic Health Conditions edited by

United States at the World Video Festi¬

Barry Goldberg, M.D., HS ’71, director

val held in conjunction with the XVIth

of sports medicine at the University

World Congress of Otorhinolaryngol¬

Health Services, clinical professor of

ogy and Head and Neck Surgery in

pediatrics. Human Kinetics Publishers,

Sydney, Australia, last March. In Febru¬

Inc. (Ill.) 1995.

ary 1997, he was guest lecturer at the
International Symposium on Endo¬
scopic Surgery in Otolaryngology in
Mexico City.

Reverie and Interpretation: Sensing
Something Human by Thomas H.
Ogden, M.D. ’72, Jason Aronson Inc.
(N.J.) 1997.

The Yale University School of Medicine
Patient’s Guide to Medical Tests by faculty
members at the Yale University School
of Medicine. Senior editor Barry L.
Zaret, M.D. is Robert W. Berliner
Professor of Medicine and professor of
diagnostic radiology. Peter 1. Jatlow,
M.D., HS ’65, professor oflaboratory
medicine and psychiatry, and Lee D.
Katz, M.D., HS ’86, associate professor
of diagnostic radiology, orthopaedics
and rehabilitation and medicine, are
associate editors. Houghton Mifflin
Company (Boston/N.Y.) 1997.
Entrance to Sterling Hall of Medicine, Winter 1998
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Medical school chaplain promotes
a curriculum of caring
By Carolyn Battista

I

t’s a rare medical school that has its

theme is how important it is to be with

own chaplain, especially a chaplain

and for people. “This is something that

who frequents the anatomy lab and

can be taught,” he says. “You can learn

writes about Albert Camus. But at Yale,

how to do it, and it’s something that

that personage is Alan C. Mermann,

should constantly be a part of medical

M.D., M.Div. ’79 who trained and

education.” His essay goes on to de¬

practiced as a pediatrician and is now a

scribe his seminar in which first-year

clinical professor of pediatrics. He’s also

medical students are paired with seri¬

an author whose varied writings include

ously ill patients—often, people who are

a new book of essays entitled Some

dying. It’s a seminar with much to teach

Chose to Stay: Faith and Ethics in a Time

about being with and for others. “The

of Plague, published in December by

patients teach the students,” he says.

Humanities Press.
Ordained as a minister in 1979
after 25 years in pediatric practice,

Dr. Mermann also includes students in

Dr. Mermann says that he often visits

meetings where parents and physicians

the first-year anatomy lab, “just to be

discuss painfully difficult decisions—-for

there.” He knows how hard it is for

example, how long to provide extended

young medical students to deal with

life support when a 3-year-old has suf¬

that first cadaver. His essays describe

fered serious brain damage in a car acci¬

his own experiences in finding a foun¬

dent. “We just sit and talk, until all

dation on which to build a life of con¬

comments and opinions have been

viction and commitment. This is the

voiced,” he says. “It can take a while.”

focus of much of his work at the medi¬

Students learn that in medicine, there

cal school, where he teaches, listens,

often are no easy answers.

counsels and involves students in eye¬
opening activities.
Medical school chaplain Alan Mermann's new
book explores the importance of the human
connection in medicine.

As chairman of the pediatric bioethics
committee at Yale-New Haven Hospital,

He points out that at Yale, where stu¬

He also hopes to show students that
medicine is not something to practice
competitively. Collegiality and the shar¬

dents may hold any, or no, religious be¬

ing of knowledge are most important.

liefs, his work usually has little to do

“We’re in this together,” he tells them.

with formal religion. It has everything
to do with helping students understand

His essays touch on many books—in¬
cluding the Bible, Walden and Cry, the

what it means—and what it takes—to

Beloved Country—that along with vari¬

be a good doctor.

ous experiences have shown him what

Students want to become “caring,
compassionate physicians,” he says, but

needs to be done. He tells of his deci¬
sions to become a pediatrician and a

they worry about losing compassion as

minister, and to take action amidst

they train in hectic hospital settings

such plagues as disease, poverty, racism

(where the patient may seem less a per¬

and war.

son than the subject of clinical labora¬

He hopes that his work can help stu¬

tory reports). He aims to help students

dents awaken to what lies around and

keep on caring.

before them. “Physicians,” he says,

One essay in his new book deals with

“need to be alert.”

Albert Camus’ 1956 novel, The Plague. A
major character is a physician who never
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abandons the plague victims, and Dr.

Carolyn Battista is a writer in Waterford,

Mermann points out that a major

Conn.
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For the new dean, a welcome to Yale
Symposium stresses crucial links between science and health

F

our of Yale’s leading research scientists and physicians
presented findings and an overview of their work at an
October symposium welcoming David A. Kessler,

M.D., to the school as dean. On a day focused on the applica¬
tion of research to clinical medicine, their reports were fol¬
lowed by a discussion among leaders of several of the world’s
top private-sector research operations.
Advancing the Public’s Health Through Research included
presentations by Marie E. Egan, M.D., assistant professor of
pediatrics (respiratory); Erol Fikrig, M.D., associate professor
of medicine (rheumatology); David B. Simon, M.D., assistant
professor of medicine (nephrology); and Tian Xu, Ph.D., as¬
sistant professor of genetics and an investigator at the Howard
Hughes Medical Institute. It was moderated by Richard P.
Lifton, M.D., Ph.D., professor of medicine, genetics and mo¬
lecular biophysics and biochemistry, and an investigator at the
Howard Hughes Medical Institute.
The presentations—on work related to cystic fibrosis,
Dean Kessler spoke of a new unity: “We must bind

Lyme disease, hypertension and cancer—were followed by a

ourselves together.”

roundtable discussion by senior research executives at five
major pharmaceutical and technology companies. The speak¬
ers—Michael J. Berendt, Ph.D., of Bayer Corp.; George M.

Remarks by David A. Kessler, M.D.

Milne, Ph.D., of Pfizer; Peter Mueller, Ph.D., of BoehringerIngelheim, Inc.; Mark C. Rogers, Ph.D., of Perkin Elmer; and

It gives me enormous pleasure to stand before you as the 15th

Peter S. Ringrose, Ph.D., of Bristol-Myers Squibb—discussed

dean of the Yale School of Medicine. It is an honor to have

Creating a Positive Relationship Between Academia and Indus¬

been chosen to lead this institution into the next century.

try: Promise and Challenges. The discussion was moderated by

There is no better place I’d rather be than here at Yale. I am

Gregory E. Gardiner, Ph.D., director of the Yale Office of

particularly honored to stand here tonight among two of our

Cooperative Research.

former distinguished deans, Jerry Burrow and Bob Berliner.

At the end of the day, Dr. Kessler shared some of his
thoughts about what it means to be dean at this juncture in

I accept the responsibility of continuing their stewardship.
It is a source of satisfaction to know that I have come to a

the school’s history, and what it means to pursue scientific

place that has maintained its standards of excellence in a

discovery at an academic health center. His remarks follow.

world of ever-changing perspectives. But it is also an exciting
challenge to contemplate the work that lies ahead. For excel¬
lence is elastic, it knows no limits, and it is maintained not

“The days are gone when any one

only by the preservation of the best of the past, but by the
need to dare, and the willingness to embrace both innovation

aspect of a great university could

and experimentation.

successfully exist without a

vation of that wealth is a notion that is cherished at Yale. This

passionate interaction of all the

Excellence is a reflection of spiritual wealth, and the conser¬

Yale idea of excellence is composed of two impulses that are
interwoven. The first is the diversity of our institution, our
schools and the departments within them, each intellectually
independent and protective of that independence. The second

parts with the whole.”

is the universal purpose of the institution as a whole, which
binds together the various parts and makes them greater than
each would be standing alone.
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A

ristotle said that man is by

I have come to Yale from the public

nostics, and therapeutics of high and

nature a social animal. We go to

sector. 1 always have been, and will con¬

low blood pressure, to discoveries in the

schools, we marry, have families,

tinue to be, a staunch supporter of pub¬

genetics of tumor suppression.

join churches and clubs together in dis¬

lic service. But 1 must tell you that the

crete bundles that are stabilized, for the

transition from the public sector to the

most part, by a morality of our own

private has presented me with fewer

nisms of human disease. So we drew

making. This morality, this moral glue

problems than I would have thought,

lines between basic sciences and clinical

Decades ago, we did not have the
tools to study the underlying mecha¬

that binds us together, comes from di¬

for 1 see no difference in the goals that

research. Those lines are being erased by

verse sources. It comes from within us,

occupied me there, and the commit¬

advances of scientific understanding.

from family teaching, from our religious

ments that will occupy me here. I am

institutions and our centers of learning.

speaking about the commitment to pre¬

and clinical science, we must include a

To truly erase the lines between basic

But it also comes from a central pur¬

serve and strengthen the health of the

vision of expanded clinical excellence.

pose, a shared goal that can be achieved

public through discovery, through the

We must advance the clinical agenda of

when the parts of the whole are meshed

care of patients, and through the educa¬

the medical school across a broad front

together and working toward that end.

tion of our future physicians.

In a great university, there must be a

But none of these commitments is at¬

to fulfill our mission of providing exem¬
plary models of care to the public and of

sense of union between the diverse

tainable without a strong team to strive

parts and the whole. But this union is

toward the common goal. My thanks go

that end, I am committed to continuing

something that we are inclined to dis¬

out the deputy deans, Joe Warshaw and

to build the most outstanding clinical

trust. We tend to fear that a common

Carolyn Slayman, for their strong sup¬

faculty who are focused on the study of

identity or a common cause might con¬

port and dedication during the transi¬

human disease. I am committed to

ceal important differences between us,

tion period and for their willingness to

working with our partners in the hospi¬

might repress our particular interests

continue in their most important ca¬

tal and health system to advance jointly

and principles. We are tempted to with¬

pacities; to the chairs, faculty and stu¬

an agenda of clinical excellence at the

draw behind parochial barricades, pre¬

dents who made me feel at home from

medical center.

ferring a smaller loyalty to that of a

the very first day; to our provost, Alison

larger and seemingly impersonal power.

Richard; to our deputy provost,

And when this happens, when the

Stephanie Spangler.

privileges of the parts become more im¬
portant than the larger structure of the
institution, then the glow of our excel¬
lence is dimmed, and we are all the los¬
ers. Without in any way diminishing the
independent methods of any school,

educating our students at every level. To

D

uring this year’s White Coat

I

Ceremony, I told the first-year
class that, as we all know, a

learned in Washington that an

doctor does not become a healer by vir¬

agency head could get things done.

tue of a medical degree. I told them that

But I also learned that when an

each one of them will be a healer if the

department or individual, we must bind

agency head linked up with the presi¬

identifiable purposes of their lives are

ourselves together.

dent, you could tackle the impossible.

forever bound up with the relief of suf¬

In short, we must be one. For the

And I believe it is the same way at Yale.

days are gone when any one aspect of a

It is no secret that I came to Yale in

fering, with the forestalling of death,
and the creation of conditions that are

great university could successfully exist

major part because of Rick Levin. Any

conducive to a more flourishing exist¬

without a passionate interaction of all

one dean can accomplish only so much.

ence for their patients.

the parts with the whole.

A dean and a president, working to¬

The basic science departments and
the clinical departments.
The health system, the hospital, and
the medical school.
The community physicians and the
full-time faculty.
The School of Public Health and the
School of Medicine.
The School of Management and the
Faculty of Arts and Sciences.
And the medical school within the
University.

gether, is something all together differ¬

I am committed to making the name
of the Yale School of Medicine synony¬

ent; working together to sustain the

mous with clinical innovation and ex¬

greatness of what is Yale.

emplary clinical practice. 1 will work

The highest of our goals resides in the

with the clinical leadership to support

position of the Yale School of Medicine

that vision—not at the expense of our

as a truly great research institution. Sci¬

basic sciences, but in support of them.

ence exists in a continuing state of revi¬

In short, excellence across the board; ex¬

sion and progression, and it is this quest

cellence in every endeavor, in everything

for new knowledge that drives us toward

we do. The excellence of the Yale com¬

goals of excellence in our basic and

mitment to the educational process is of

clinical research endeavors.

great comfort to me, mainly because we

At the scientific symposium this after¬

have an outstanding faculty, and out¬

noon, we learned from several of our

standing students are attracted to such

share a united vision of the future that

junior faculty about the broad range of

men and women.

focuses on what we want to accomplish.

their research pursuits—from the role of

Without that communal outlook, we

a regulatory protein in cystic fibrosis, to

voted forever to a life in medicine. I

will never attain our highest goals. With

new treatments for Lyme disease, to in¬

want them to shine in a reflection of the

it, there are no limits.

sights into the pathophysiology, diag¬

excellence that is Yale.

All of these parts of the whole must
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1 want our young doctors to be de¬

WINTER/SPRING

1998

ALUMNI/AE

NEWS

Tobacco-control advocate named public
health chief in Massachusetts
Howard Kyongju Koh, M.D. ’77, B.A.

sumption (at a rate three times faster

’73. M.P.H., began his dudes as com¬

than the national average).

missioner of public health in Massachu¬

He also helped launch a national

setts in September. Dr. Koh, former

program of skin cancer screenings,

director of cancer prevention and con¬

which have now reached more than a

trol at Boston University Medical

million people. Dr. Koh has concen¬

Center and a professor at the BU

trated expertise in malignant melanoma,

schools of medicine and public health,

cancer prevention and control, and

has been a prominent leader of anti¬

Asian-American health issues. He and

smoking efforts in Massachusetts. He

his wife, Dr. Claudia Anne Arrigg,

helped coordinate tobacco control ac¬

live in Andover, Mass., with their

tivities in Massachusetts that are cred¬

three children.

Howard Kyongju Koh

ited for a rapid decline in cigarette con¬

CLASS

N

’30s

Robert E. Carroll, M.D. 42, B.A. ’38,

R. Wagner Endowed Fellowship Fund

emeritus professor of clinical ortho¬

to benefit graduate students in the basic

paedic surgery at the Columbia Univer¬

sciences. Dr. Wagner and his wife,

sity College of Physicians and Surgeons,

Mary, live in Charlottesville, Va.

Myron E. Wegman, M.D. ’32, HS ’32-

was presented the Distinguished Service

36, a fellow of the American Academy of

Award at a commencement ceremony in

Pediatrics and dean emeritus of the Uni¬

May for his outstanding contributions

professor of pediatrics, has been

versity of Michigan School of Public

to the medical school, hospital and the

awarded the C. Anderson Aldrich

Morris A. Wessell, M.D. ’43, clinical

Health, received the 1997 E.H.

specialty of surgery of the hand. Colum¬

Award in Child Development by the

Christopherson Lectureship Award at

bia has established the Robert E. Carroll

American Academy of Pediatrics (AAP).

the November meeting of the American

Professorship in Surgery of the Hand in

The annual award, presented in Novem¬

Academy of Pediatrics. The award is

the Department of Orthopaedic Sur¬

ber at the annual meeting of the AAP’s

given annually to one individual in rec¬

gery. Funds for this chair were provided

section of developmental and behavioral

ognition of his or her outstanding con¬

by Dr. Carroll’s friends and family.

pediatrics in New Orleans, seeks to

Jerome H. Shapiro, M.D. 48, of Bos¬

children and their development has

ton, was awarded a Gold Medal by the

been ground-breaking. Since the first

’40s

Radiological Society of North America

award was presented in 1964 there have

in December 1996 for his contributions

been 36 honorees, 17 with ties to Yale.

Class secretary Albert S. Atwood, M.D.

to teaching and his initiation of stan¬

’45, and his wife, Harriet, made a trip

dards in radiology representing excel¬

with class agent Richard W. Breck,

lence in the field of radiology.

’50s

Westchester County’s only winery. They

Robert R. Wagner, M.D. ’46, recently

Paul Calabresi,

visited proprietors George W.

retired as chair of the department of

M.D. ’55, has been

Naumburg Jr., M.D. ’45, and his wife,

microbiology at the University of

appointed to Tufts

tributions to international child health.

honor a pediatrician whose work with

M.D. ’45, and his wife, Verne, to

Michelle, at their North Salem Vine¬

Virginia School of Medicine. His suc¬

University’s Board

yard, said Dr. Breck, who reports: “The

cessor, J. Thomas Parsons, Ph.D., and

of Overseers for

grapes had just been picked, and even

his colleagues in the basic sciences, have

the School of

the white grape juice was delicious.”

initiated an effort to create the Robert

Medicine, which
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advises the university’s president and
trustees. Dr. Calabresi is professor of

’60s

Reynold
Spector, M.D.

medicine (oncology) at Brown Univer¬

Victor J. Burner, M.D. ’65, B.A. 59, of

sity and a member of President Clinton’s

Pasadena, Calif., shares news of a musi¬

named executive

Cancer Panel. In 1995, he received the

cal trip abroad. He recently toured

vice president of

St. George Medal for distinguished ser¬

southern China with the Pasadena

clinical sciences

vice in cancer control by the American

String Quartet, performing in the con¬

at Merck Re¬

Cancer Society. He is also a master of

servatories of Canton and Heng Yang.

search Laborato¬

the American College of Physicians and

He writes: “You would think we were

ries in Rahway,

a member of the Institute of Medicine

rock stars by our heroic reception! ”

N.J. Dr. Spector

’66, has been

joined Merck in

of the National Academy of Sciences.

Reynold Spector

Philip J. DiSaia, M.D., HS ’67, chief

1987 as executive

Robert E. Shope, M.D., HS 54-58,

of the division of gynecologic oncology

director of clinical sciences. He was

served as a member of President

at the University of California at Irvine,

promoted to vice president in 1991 and

Clinton’s roundtable discussion on cli¬

has been elected vice president of the

senior vice president in 1994. In 1991

mate change July 24 at the White

American Board of Obstetrics and Gy¬

he received the prestigious Harry Gold

House. Dr. Shope, professor of pathol¬

necology. He will serve as chairman of

Award from the American Society of

ogy, microbiology and immunology at

the board’s policy committee and con¬

Pharmacology and Experimental

the University of Texas Medical Branch,

tinue to serve as member of the execu¬

Therapeutics for his research and

has devoted his career to the study of

tive committee.

teaching activities.

tropical diseases. He was a faculty mem¬
ber in epidemiology at Yale from 1965

James J. Murphy, M.D. ’64, has retired

to 1995 and also served as the director

as chief of radiology at the Asheville

of medical education in the [department

(N.C.) Veterans Medical Center after 25

of Epidemiology and Public Health

years of federal service.

David A. Adler, M.D. ’73, professor of
psychiatry at Tufts University School of

and director of the Yale Arbovirus
Research Unit.

’70s

R. John C. Pearson, M.P.H. ’60, HS

Medicine (TUSM), received a five-year

’61-62, stepped down as chairman of

National Institute of Mental Health

community medicine at the West Vir¬

grant to study ways of improving detec¬

ginia University Health Science Center/

tion and treatment of depression in pri¬

Morgantown in September 1996 and

mary care practices. He also recently

took a sabbatical to travel to South Af¬

completed a term as chairman of the

rica from June to October 1997.

TUSM faculty senate and is chairman

Victor Burner and fellow members of the
Pasadena String Quartet thread their way
by boat though the mountains of Gweilin,
China, last spring.
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of the publication board at the Group
for the Advancement of Psychiatry. Dr.

medical director of the Joslin Center for
Diabetes at New Britain General Hospi¬

Adler is senior psychiatrist and director
at the Mental Health Services Research

tal and director of the section of endo¬
crinology, metabolism and diabetes.

Group at New England Medical Center.
Richard Doud Bey, M.D. ’79, and his
wife, Cheryl, of Winston-Salem, N.C.,
are the parents of a new daughter, Maris
McCammon Bey, born Oct. 30.

Jonathan A.S. Sherman, who attended
the School of Medicine for three years
as a member of the Class of 1988,
phoned as Yale Medicine was going to

press to report that his loving wife
Karen Avenoso died of cancer Feb. 25.
She was a graduate of Dartmouth Col¬
lege, a Rhodes scholar and a reporter for
the Boston Globe. Mr. Sherman, who
went on to graduate from Harvard Busi¬
ness School, is a senior manager of mar¬
keting at Johnson & Johnson and lives
in Westfield, N.J.

James R. Gonzales, M.P.H. ’78, of
Nutley, N.J., chief operating officer and
executive vice president of the East Or¬
ange General Hospital, has advanced to
diplomate status in the American Col¬

Institute of Medicine adds Yale alumni/ae
to its rolls

lege of Healthcare Executives.
Four Yale University School of Medicine
Frederick L, Greene, M.D., HS ’70-76,

alumni/ae have been elected to the Insti¬

has been named chairman of the depart¬

tute of Medicine.

ment of general surgery and program di¬
rector of the surgical residency program

Three of the new members are
Jennifer R. Niebyl, M.D. ’67, professor

at Carolinas Medical Center in Char¬

and head of the department of obstetrics

lotte, N.C. Dr. Green was previously

and gynecology at the University of

professor of surgery at the University of
South Carolina in Columbia.

Iowa Hospitals and Clinics in Iowa

Anthony V.

City; Helen L. Smits, M.D. ’67,
president and medical director of
HealthRight Inc. in Meriden, Conn.;
and Mark R. Cullen, M.D. ’76,

Proto, M.D. ’71,
chairman of the

(See Faculty News). In addition, Aaron

department of ra¬

T. Beck, M.D. ’46, the University

diology at the

Professor Emeritus of Psychiatry at the

Medical College

University of Pennsylvania School of

of Virginia, Vir¬
ginia Common¬
wealth University

Medicine, was elected to senior mem¬
bership. [Dr. Beck also received the
Anthony V. Proto

in Richmond, has

Cummings PSYCHE Award in Septem¬
ber from the Nicholas & Dorothy

been named editor of Radiology by the

Cummings Foundation, which cited

Radiological Society of North America.
The journal is celebrating its 75th year.

him as “one of the major figures of
20th-century psychotherapy.” The
award, made in cooperation with the
Institute for Behavioral Healthcare in

’80s

Portola Valley, Calif, included a cash
prize of $50,000 and a bronze statute

Evangeline Franklin, M.D. ’82, M.P.H.

of the Greek goddess Psyche.]

Jennifer R. Niebyl

’82, recently left University MEDNET
in Cleveland to become network medi¬
cal director at Aetna/U.S. Healthcare
in Louisiana and Arkansas. At
MEDNET, she worked as director of
the immediate care department, as
medical director of the call center,
which she implemented for computer¬
ized telephone triage, and as chair of

Alumni Fund Report will include campaign highlights
The 1996-97 annual report of the Medical School
Alumni Fund will be published separately and mailed

the Clinical Practices Council.

this spring. It will include a final report on the School
William A. Petit Jr., M.D., HS ’85-89,
of Plainville, Conn., has been named
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extensively on preoperative cardiovascu¬

sory member of many national derma¬

lar evaluation procedure prior to cardiac

tology organizations and at NIH. He

Kim A. Eagle, M.D., HS ’79-8}, was

or non-cardiac surgery. In the evolving

has published widely in the dermatology

guest lecturer at Medical Grand Rounds

era of managed health care, Dr. Eagle

literature.

on Nov. 20, where his topic was The

has been part of a Consultative Task

Perspective Cardiac Evaluation of Patients

Force of the American Heart Associa¬

The late Dr. Neville Kirsch, HS ’40-42,

Preoperatively. Dr. Eagle is the Albion

tion attempting to provide practice

whom the department honored with the

Walter Hewlett Professor of Medicine

guidelines in this area.

annual lectureship, had a long and dis¬
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(Section of Cardiology) at the Univer¬

tinguished career both in New York and

sity of Michigan School of Medicine.

Paul A. Khavari, M.D., Ph.D. ’88, HS

at the Hartford area hospitals before his

Following his Yale training, he com¬

’88-90, was the Neville & Lucille Kirsch

death in 1991. Besides having had an ac¬

pleted a cardiology fellowship at

Guest Lecturer Dec. 3 in the Depart¬

tive consultative practice he published

Harvard University and remained on

ment of Dermatology. Dr. Khavara,

widely in the medical literature. Publi¬

the faculty in Cambridge until moving

assistant professor of dermatology at

cations included studies of foreign body

to Michigan in 1994. Dr. Eagle also pre¬

Stanford, spoke on Cutaneous Gene

granulomas and veterinary dermatology.

sented at Cardiology Grand Rounds,

Therapy, then delivered grand rounds on

The lectureship is sponsored by his wife

where a dialogue on health care in the

Gene Regulatory Mechanisms of Epithelial

Lucille Kirsch in memory of his vigor¬

current setting of managed care ensued.

Growth. His special interests include

ous teaching and clinical career.

Dr. Eagle reminisced on The Environ¬
ment for Learning the Tradition of

insights into gene therapy, molecular
mechanisms of disease and molecular

Training, which warmly colored the

foundations of anti-cancer therapies.

recollection of his New Haven years.

The recipient of many awards while at

to Nicholas P.R. Spinelli, M.D. ’44, in

Dr. Eagle has published and lectured

Yale and since, Dr. Khavari is an advi¬

care of Yale Medicine.

Send news of Alumni/ae On Campus

Alumni/ae Summit

5°

MELANIE STENGEL (3)

Dean David A. Kessler, M.D., above right, met with alumni at the Oct. 25
meeting of the Association of Yale Alumni in Medicine. The informal discus¬
sion ranged from the dean’s thoughts about Yale and current affairs in medi¬
cine and health to ways in which alumni/ae leaders can help mobilize sup¬
port for increased financial aid. Above: AYAM members listen as Samuei D.
Kushlan, M.D. ’35, asks Dr. Kessler a question. Right: Also joining in the dis¬
cussion were Jocelyn S. Malkin, M.D. ’51, and Howard Minners, M.D. ’57, both
of whom traveled from Washington to attend the meeting.
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STUDENT

NEWS

Auction raises funds for
homeless shelters and
food pantries

T

he Fifth Annual Hunger and Homelessness Benefit
Auction raised more than $20,000 for New Haven
homeless shelters and food pantries. Proceeds from

the Nov. 21 event were donated to Life Haven, FISH of
Greater New Haven, Loaves and Fishes, Rachel’s Table, the
Downtown Evening Soup Kitchen and the Community
Health Care Van. Some noteworthy bids: Last minute
negotiating and $500 dollars bought Dean David A.
Kessler, M.D., and Director of Admissions Lynne Wootton
parts in thesecond-year show. For $1,250 six students will
spend a long weekend in the Martha’s Vineyard summer
home of Drs. Keith Joiner and Jo Ellen Schweinle. Four
students, their wallets $1,100 lighter, will tour the White
House Oval Office and meet with U.S. Rep. Henry
Waxman. One lucky winner will have her dog jogged (yes,
jogged) five times for a mere $20. Strangely, no one bid on
the “Fish Tank Servicing,” in which fish and tank were
not included.
—Gregory Raskin, Class of 1998

Second-year student Melissa S. Ellis makes an offer.

S T U D E N T

N 0 T E S

Rajani P, Nadkarni, M.D., postdoctoral fellow in oncology
and hematology at Yale, has joined the oncology and hematol¬
ogy practice of Drs. Sorcinelli and Tansino of Meriden, Conn.

Jing Zang Tao, M.D., a postdoctoral fellow in diagnostic radi¬
ology, is working with Kevin Johnson, M.D. in nuclear mag¬
netic resonance.

Above left: Robert H. Gifford, M.D., associate dean for medical educa¬
tion and student affairs, takes a bid during the Fifth Annual Hunger and
Homelessness Benefit Auction last November in Mary S. Harkness Audi¬
torium. The event raised more than $20,000 for New Haven homeless
shelters and food pantries.
Left: Second-year medical student Jennifer L. Dorosz, left, and Anne F.
Pistell, assistant dean for student affairs at EPH, solicit bids for a bottle
of wine at the auction.

51

School of Medicine Dean David A. Kessler, M.D., helps first-year medical student Emmanuelle M.
Clerisme into the white jacket that signifies service to others at the White Coat Ceremony held
at the start of the academic year. Merle Waxman, associate dean for academic development,
looks on.

Photographs by Gale Zucker
The Class of 2001 required 101 seats for the
students from five continents. They’re the first
class to enter the school under Dr. Kessler’s
tenure as dean.
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The White Coat
Ceremony is a
first-year student’s
initiation into
medicine.
Freshmen Sandeep Bansal, Fred Aslan, Monica E. Lopez, Steven A. Farmer and Analene J.
Pentopoulos gather at the end of the ceremony.

Aaron S. Covey with his mother, Susan Covey.

Frederick C. Cobey, with his father, James C.
Cobey, a house staff officer here from 1973
to 1976.

First-year student Avery S. Grauer smiles with
her father, Leonard Grauer, M.D., a 1968
graduate of the School of Medicine. Ms.
Grauer’s brother, Jonathan, received his Yale
M.D. degree in 1997 and is a resident in
orthopaedics at Yale-New Haven Hospital.

Andrea L. Ciaranello, Damani A. Piggott, Karl A.
Lozanne and Vivian A. Lombillo applaud Dr.
Kessler’s remarks at the annual ceremony, a
welcome to the profession of medicine. “You are
a healer,” Dr. Kessler told the incoming class, “if
the relationship between you and your patient is
a covenant of faith, not a business contract, an
article of trust, not an exchange of services.”
YALE
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VIEWPOINT

Cost vs. caring
A medical students financial dilemma
By Ashish Patel

B

efore last spring’s Medical Stu¬

Rise in medical school cost

dent Council elections, the can¬
didates were asked to name the

issue of highest concern to the student
body. The answer that resonated with
every student was financial aid. When
the new dean, David A. Kessler, M.D.,
asked the same question at the start of
this academic year, the answer again was
financial aid. When members of the

Year

Tuition ($)

Total ($)

■11,750.19>C5
93/94. 20,650.32,910
94/95. 22,000.33,435
95/96. ■ 23,300.35,825
85/86 ..7.

96/97 . 24.700 . 37,700
97/98 . 26.700 . 40,515

Student Council presented their report
to the Association of Yale Alumni in

Source: YSM Financial Aid Office

Medicine in late September, once again
they pointed to the urgent need lor Yale

school factors into its calculations.

ment during the residency years with

to seriously look at a medical student’s

Grant money is limited. Furthermore,

the result that many residents are hard

medical students are discouraged from

pressed to keep up with their payments.

financial burden.
Medical students at Yale face an in¬

working because of the intensity of the

The most disturbing concern stems

creasing and ominous threat of excessive

program, though some do work to

from the rapidly changing face of man¬

indebtedness that may very well affect

meet expenses.

aged care medicine. On average, a resi¬

their choice of a professional field of

More than half the cost of a Yale

medicine. Lack of financial aid funds

medical education, therefore, is bor¬

Yale medical graduates generally train

also puts Yale at a competitive disadvan¬

rowed. When members of the Class of

for four to seven years past their medical

tage among its peer institutions.

1997 walked off Harkness Courtyard af¬

school education. Once this training is

ter Commencement last May, they car¬

complete, the young physicians are ex¬

The cost of medical education has

dent or a fellow earns $35,000 annually.

continually risen. Ten years ago, the cost

ried an average debt of $76,644. The

pected to cope with a managed care en¬

of attending Yale was $21,239 Per year

largest debt owed by a member of the

vironment that has already squeezed out

for tuition, room, board and related

class was $159,855. Over the course of a

every possible penny from income.

expenses. Today that figure has nearly

10-year repayment schedule with inter¬

With an estimated physician surplus of

doubled, to $40,515. Tuition alone for

est, a student ultimately pays more than

more than 30 percent under managed

the current academic year rose by

half a million dollars.

care, even the once-safe assumption of

$2,000 to $26,700, an increase of

What appears to make this level of

guaranteed employment is no longer

debt justifiable is a false assumption

valid. What promises to remain is a

made by policy-makers within the fed¬

huge indebtedness on the part of the

personal savings, family contributions,

eral government. They assume that all

students, which still has to be paid.

scholarship grants established by

medical students will earn an extraordi¬

alumni/ae, and loans. A majority have

narily large income directly out of

physician’s career—being forced to con¬

little savings, if any, especially after the

school. The U.S. Department of Health

sider cost in choosing a field of medi¬

first year of medical school. Most have

and Human Services has eliminated all

cine—stems from such a difficult finan¬

left their parents’ home and do not re¬

educational loans based on need. Only

cial scenario. Yale School of Medicine

ceive the family contribution that the

those students who give up the freedom

has always been fortunate to attract

to choose their field by signing on to a

highly qualified students who are dedi¬

8 percent.
Students meet these costs using

The greatest threat to a young

Ashish Patel, a second-year student, is

primary care practice receive loans with

cated to the profession of healing. Yale

president of the Medical Student

deferment support. The federal Stafford

students are expected, and for the most

Council.

loan program has stopped its loan defer¬

part do, choose their fields based on
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their interest and motivation. One has

Free tuition may not be necessary.

to wonder, however, whether it is pos¬

What is required, however, is a serious

sible to make a residency decision with¬

effort outlining specific cost-reduction

out considering financial compensation.

objectives. The funds currently available

More importantly, is it really possible to

for financial aid all come from the en¬

practice medicine in one of the noblest

dowment established in part by our gen¬

fashions, such as practicing in an

erous alumni/ae. Those who choose to

underserved area, after incurring formi¬

give to Yale School of Medicine may

dable education debts?

consider financial aid as a prime option.

The proof that the financial burden is

Contribute to the
School of Medicine’s
Future and Invest in
Your Own

Until our endowment rises, we are faced

a real concern comes from the fact that

with the fact that spending everything

many medical schools have already

we can from the current endowment for

taken steps to alleviate the problem by

financial aid is inadequate in keeping

actively bolstering their financial aid

Yale competitive.

program. Most schools not only draw

Those of us who love Yale School of

on their endowment, as Yale does, but

Medicine came to Yale for the enthusi¬

actively fund financial aid through their

asm and energy of student life at

operating budgets, something Yale does

school. This energy has to be constantly

not do. The University of Pennsylvania

nourished, for without it, the spirit of

is working to make much of its program

Yale Medicine cannot survive. To keep

tuition free by the year 2005. Consider¬

this energy alive, something has to be

ing the fact that tuition accounts for less

done to help the financial costs incurred

than 5 percent of the typical medical

by the students. Tuition increases have

school’s budget (4 percent at Yale), this

to be halted and financial aid has to

revolutionary goal is not impossible.

be increased.

Average debt for Class of ’97

Yale University’s life income
program offers graduates of the
School of Medicine the oppor¬
tunity to:

Help ensure the future
of a great institution
■ Receive quarterly
income payments
for life
■ Increase your income
from low-yielding stock with¬
out incurring capital gains
taxes
• Reduce federal and
state taxes
■

Please call or write to see if
you can use these benefits to
the mutual advantage of you
and the School of Medicine.

Yale

Stamford

Harvard

Cornell

Washington Johns
Univ
Hopkins

Yale scholarships compared to other medical schools
Yale University
School of Medicine

$14,000
$12,048

$12,000

Office of Planned Giving

$10,000

P.O. Box 2038
New Haven, CT 06521-2038

$8,000
$6,000

1-800-445-6086
$4,000

Fax: 1-203-432-7901

$2,000
$0
Yale

Stamford

Johns
Hopkins

Duke

Cornell

Columbia Rochester

Harvard

Penn

Washington
Univ

Source: YSM Financial Aid Office
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DEVELOPMENT

Looking ahead, giving back
Common dreams and feelings of gratitude connect the generations

By David Davison

T

he dilemma ol managing

that students who prefer to come to

combined several major gifts to ini¬

financial stress along with

Yale are accepting offers from other

tiate a scholarship endowment. The

medical schools because of better fi¬

Class of 1959 did the same for its

a career in medicine is a theme that

the demands ol preparing for

nancial aid packages. On the na¬

35th reunion. A gift of $75,000 is

spans the generations. As Ashish

tional level, research indicates that

needed to establish a named scholar¬

Patel describes in the preceding

when burdened by a large debt,

ship fund, although many are at

commentary, most of todays stu¬

many young physicians forego a

much higher levels. Recent examples

dents are saddled with many tens of

promising career in research and

of new named lunds include the

thousands of dollars ol debt. It is a

teaching in order to make an income

Freshwater/Class of 1972 Scholarship

serious problem and a story that

that will enable them to pay off their

Fund and the Donna and Jack

should resonate with many Yale

heavy loans much sooner.

Ogilvie Scholarship Fund. “We need

School of Medicine alumni/ae.

Dean David A. Kessler, M.D., is

And while figures from the

working with a student-run commit¬

brightest candidates are not dis¬

to make sure that the best and

1940s might seem quaint today,

tee to address the need lor providing

suaded Irom attending Yale because

some alumni/ae ol that era can recall

more financial aid. At a meeting of

of the prospect of a large debt,” Felix

$600 tuition bills that they could

the Association of Yale Alumni in

Freshwater, M.D. ’72, wrote in an

not alford to meet. After all, these

Medicine in October, he made it

appeal letter to his classmates.

were the war years and the economy

clear that this is an urgent priority.

was still coming out of the Great

“When tuition rose during my

“We have about $1.4 million

years as a student, Yale gave me a

Depression. The scholarships they

available from endowment for finan¬

loan so I could afford to continue
my studies and graduate,” said

received got them through medical

cial aid,” Dr. Kessler said, “but that

school and into the medical profes¬

is not nearly enough. We need to

Nicholas Passarelli, M.D. ’59. “My

sion. It is not surprising that when it

raise more to stay competitive with

classmates and I are attuned to the

comes to directing their gifts to the

other medical schools.”

needs of today’s students and we

school, many alumni/ae—from all

Yale School of Medicine is

eras—want to support financial aid.

among the best in the world, but in

There is probably no more pure ves¬

the category of scholarships and

want to perpetuate the tradition of
giving.”

The legacy of a Yale medical

sel into which an alumnus can

loans available to students, it falls

education is passed on in many

choose to pour a contribution.

short compared to other prominent

ways, through teaching and training.

institutions such as Columbia, Johns

A legacy of gratitude and generosity

the pressure on students to finance

Today, with tuition rates rising,

Hopkins, Stanford and Harvard.

also connects students and alumni/

their medical education can seriously

Each ol those schools has approxi¬

ae across the generations. The aspira¬

affect the course ol their careers,

mately three times as much funding

tion to become a physician, and

starting with their choice of medical

available for financial aid. Yale ad¬

the deep feeling of gratitude for

schools. Yale’s own research shows

David Davison is director of

mits students strictly on merit and

the opportunity, remain a common

offers financial aid solely based on

experience.

need. Schools that can offer students

The students who benefit from

development at the School of Medicine.

a tuition-free education make it dif¬

scholarship funds regularly commu¬

Write to him at the Office of Medical

ficult to compete for the best and

nicate with our donors. The follow¬

Development, P.0. Box 7611, New

the brightest.

ing is an excerpt from a letter sent to

Haven, CT 06519-1714, or via e-mail:
david.davison@yale.edu.
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To help celebrate their 50th re¬
union, members of the Class of 1944

Dr. Passarelli, that was shared with
fellow members of the Class of 1959
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who contributed to the class scholar¬

quest of my dreams. You have done

ship fund. The student grew up de¬

this while requesting nothing in

termined to help humankind, but

return. However, I offer you this

she lacked the financial means to at¬

promise: I intend to return scholar¬

tend college and medical school

ship money to Yale University School

TO GIVE AWAY MONEY IS

of Medicine once I become finan¬

AN EASY MATTER AND IN

without help.

Since I was a young child, my dream

cially situated. ...I know that there

ANY MAN’S POWER. BUT

was always of medicine—and Yale.

are others like myself who want only

TO DECIDE TO WHOM TO

... You have provided me with much

to be given the means to obtain

needed scholarship funding in the

their dream.

GIVE IT, AND HOW LARGE
AND WHEN, AND FOR
WHAT PURPOSE AND HOW,
IS NEITHER IN EVERY
MAN’S POWER NOR AN

THE PROGRAM FOR HUMANITIES IN MEDICINE
Lectures at 5

pm

EASY MATTER.

on Thursday in the BEAUMONT ROOM, Yale University

School Medicine, 333 Cedar Street, New Haven. Refreshments at 4:30

Aristotle

pm.

The lectures are free and open to the public. For more information, call
Howard Spiro or Clara Gyorgyey at (203) 785-5494.

APRIL 9
OLD MAPS: GUIDES TO THE GEOGRAPHY
OFTHE EARTH, BODY & MIND
Harold L. Osher, MD
Cardiologist, Cartographer
& Director of Osher Map Library
University of Southern Maine
Portland, Maine

APRIL 16
SENSIBILITY, MEDICINE &THE SPECTACLE OFTHE BREAST

Assuming you would
consider the School of
Medicine as one of your
intended beneficiaries,
we stand ready to help you with
when, for what purpose, and
how.

Planned giving
is one of our specialties.

IN THE 18TH-CENTURY NOVELS
Nina A. Prytula, MPhil
Doctoral Candidate, Department of English
Yale University

APRIL 30
RICHARD SELZER: POET OFTHE BODY
Mahaia Yates Stripling, PhD
Texas Christian University
Fort Worth, Texas

MAY 7
JAMES JOYCE: MANIC GENIUS &THE FAMILY TRIANGLE
James R Merikangas, MD
Clinical Professor of Psychiatry & Neurology
Yale University School of Medicine

Yale University
School of Medicine
Office of Planned Giving
RO. Box 2038
New Haven, CT 06521-2038

MAY 14
THE EMERGING OF A PHOTOGRAPHIC EYE
Barbara Young, M D

1-800-445-6086
Fax: 1-203-432-7901

Assistant Professor Emeritus of Psychiatry & Photographer
John Hopkins University
Baltimore, Maryland
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OBITUARIES

Clarence W. Bushnell
Clarence W. Bushnell,

1952 and also was a fellow at Yale’s
of

Bridgeport, Conn., died Oct. 28. He
was 81.
Mr. Bushnell was born in
Lowville, N.Y., and received his
nursing degree from Hudson River
State Hospital in New York in 1937
before serving in the Coast Guard
during World War II. In 1947 he
earned his bachelor’s degree from
New York University and in 1951 re¬
ceived a master’s degree in public
health from Yale.
From 1951 to 1962, he was the
assistant administrator lor Massa¬

Berkeley College.
In 1952, he joined the University
of North Carolina at Chapel Hill as
the First professor and chairman ol

ton. From 1962 to 1981, he served

tors, enabling intensive management
ol newborns.
Dr. Gluck also helped develop a
test of the amniotic fluid to deter¬

its new pediatrics department. In

mine whether the lungs ol a fetus

i960, Dr. Curnen became the

were mature. He later developed a

Carpentier Professor and chairman

similar intensive-care program at

of the department of pediatrics at

the University of California at San

the Columbia College ol Physicians

Diego. Dr. Gluck was also a profes¬

and Surgeons and director ol Babies

sor at the College of Medicine at the

Hospital. He was a fellow of the

University of California at Irvine.

American Academy of Pediatrics
and also served as chairman ol its
committee on the control of infec¬
tious diseases.

chusetts Memorial Hospital in Bos¬
as administrator lor Bridgeport Hos¬

big open room, Filled with incuba¬

John C. Haley
John C. Haley, M.D., died Sept. 13
at his home in Cheshire, Conn.

Gladys J. Goldman

He was 83.
Dr. Haley, born in Long Beach,

pital in Connecticut and, from 1963

Gladys Jacoby Goldman, M.P.H., of

to 1981, was a lecturer in public

Clinton, Conn., died Oct. 3 at Yale-

in 1937 and received his medical de¬

health and hospital administration

New Haven Hospital. She was 87.

gree from Yale in 1941. During

at Yale.

Mrs. Goldman was born in
Woodside, N.Y. She received her
master’s degree in public health from

Edward C. Curnen Jr.
Edward Charles Curnen Jr., M.D.,
ol Bethany, Conn., died Dec. 1 at
the age ol 88.

in 1931 and received his medical de¬

Dr. Haley interned at Massachu¬

New Haven for many years. She was

from 1940 to 1941, was a senior in¬

also a department head at New York

tern at Montreal General Hospital

Hospital/Cornell Medical Center.

until 1942 and served his residency
in obstetrics and gynecology at
Grace-New Haven Hospital from

Louis Gluck
Louis Gluck, M.D., died of cancer

served his internship and residency

on Nov. 29 at Saddleback Memorial

at the Infant’s and Children’s Hospi¬

Hospital in Laguna Hills, Calif.

tal in Boston and was a research fel¬

He was 73.
Born in Newark, N.J., Dr.

the staff ol Rockefeller Institute for

Gluck graduated from Rutgers Uni¬

Medical Research, now Rockefeller

versity in 1948 and received his

University.

medical degree from the University

Dr. Curnen served in the Naval

surgeon in the Army Air Corps.
setts Memorial Hospital in Boston

gree from Harvard in 1935. He

low at Harvard. In 1939, he joined

World War II, he served as a flight

Yale in 1947 and taught nursing in

Born in Yonkers, N.Y., Dr.
Curnen graduated from Yale College

Calif., graduated from Yale College

1945 until 1948. He joined the fac¬
ulty at Yale medical school as a clini¬
cal instructor of obstetrics and gyne¬
cology in 1951, became clinical
associate in 1974 and advanced to as¬
sistant clinical professor in 1974.

Kathleen H. Howe

of Chicago. He joined the faculty at

Kathleen Hara Howe, M.P.H., died

Reserve Medical Corps during

Yale in i960 as an assistant professor

Dec. 3 of cancer at Connecticut

World War II and retired as com¬

ol pediatrics and was associate pro¬

Hospice in Branford. She was 85.
Born in Ontario, Dr. Howe

mander. He joined the faculty at

fessor of pediatrics from 1964 until

Yale after the war, as assistant profes¬

1968, when he moved to the Univer¬

graduated from Rollins College in

sor of preventive medicine and

sity of Miami. While at Yale he de¬

1933 and earned her master’s degree

worked with the Yale Poliomyelities

veloped a new design for a nursery

in public health from Yale in 1956.

Study Unit. Dr. Curnen was director

for premature infants and ill full-

After graduation she joined the fac¬

of the bacteriology laboratories at

term babies. Dr. Gluck’s design for a

ulty at Yale and until 1979 served as

Grace-New Haven Hospital until

neonatal intensive care unit was one

an assistant professor and assistant
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dean in the Department of Epidemi¬

Jonathan Edwards College, he

ology and Pubic Health. After her

played the French horn with the

retirement a scholarship fund was es¬

New Haven Symphony Orchestra.

tablished in her name. In 1990 she

Dr. Hutchinson continued his

was awarded the Yale Medal and was

research in mutagenesis as part of

later honored by President Bush as

the radiology laboratory at the

one of the “thousand points of light”

School of Medicine until his death.

A Charitable
Annuity:
The YSM gift
that rates

for her volunteerism with Connecti¬
cut Hospice from 1979 to 1997.
Mrs. Howe was the first recipi¬
ent of the Distinguished Alumni/ae
Award in 1988 from the Association
of Yale Alumni of Public Health.
She also received the Chairman’s
Award of the Yale Alumni Fund, the
Rotary Club Community Service
Award, and the Ira V. Hiscock
Award of the Connecticut Public
Health Association.

Warren M. Jones

$5,000 or more, the School of

Warren Mead Jones, M.D., died

Medicine can offer you, or you

July 31 at in home in Flourtown, Pa.

and your spouse, a fixed annual

He was 72.

income for life.

Born in West Pittston, Pa., Dr.
Jones received his bachelor’s degree

Your age(s) and market

from Lafayette College, his law de¬

rates of interest determine

gree from the University of Pennsyl¬

your income level.

vania and, in 1961, his medical de¬
gree from Yale.
Dr. Jones was an ophthalmolo¬

Franklin Hutchinson III

In exchange for a gift of

gist in Flourtown. He was past presi¬
dent of the Montgomery County

Current sample rates*
Age(s)

Rate

One life

Franklin Hutchinson III, M.D., died

Medical Society and was a liaison

55

4.5%

Oct. 24 at Yale-New Haven Hospi¬

between the Pennsylvania Medical

66

5.6%

Society and the Pennsylvania Bar As¬

77

7.8%

tal. He was 77.
A native of Brooklyn, N.Y., Dr.

sociation.

Hutchinson received his bachelor’s

Two lives

degree in 1942 from the Massachu¬

66/65

setts Institute of Technology and his
Ph.D. degree in physics in 1948 from
Yale. He joined the radiation labora¬
tory at MIT during World War II,
developing radar technology for the
military. Dr. Hutchinson holds three
patents in microwave electronics.
He began his 42-year tenure at
Yale in 1948 as an instructor in radi¬
ology and biophysics. Dr.
Hutchinson became assistant profes¬
sor of physics in 1951, associate pro¬
fessor of biophysics in 1957, and pro¬
fessor of biophysics in i960. He
served as chairman of the biophysics
department for eight years, as well as
director of graduate studies and di¬
rector of undergraduate studies in
biophysics. Dr. Hutchinson retired
as professor emeritus in 1990.
He was also a consultant in radi¬
ology at Yale-New Haven Hospital
and had been a member of the advi¬
sory committee of the Atomic Bomb
Casualty Commission. A fellow of
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Thomas J. Keenan
Thomas J. Keenan, M.D., of Ply¬
mouth and Duxbury, Mass., died
Oct. 15 in Jordan Hospital in Ply¬

4.6%

75/74

5.6%

82/79

6.9%

* Yale will maintain these rates until
at least May 311998.

mouth. He was 71.
Born in Glenrock, Wyo., Dr.
Keenan served in the Navy before
graduating from Whittier College in
Spokane, Wash. He received his

Please allow us to tailor
a proposal to your
philanthropic
and financial goals.

medical degree in 1957 from the
Medical College of Wisconsin. He
interned at St. Mary’s Hospital in
San Francisco and served his resi¬
dency in anesthesiology at Massa¬
chusetts General Hospital in Boston.
During that residency, Dr. Keenan
was on the house staff of Yale-New
Haven Hospital. In 1959 he joined

Yale University
School of Medicine

the staff and was a clinical anesthesi¬

Office of Planned Giving

ologist at Massachusetts General

RO. Box 2038

Hospital. Dr. Keenan was on the

New Haven, CT 06521-2038

staff of the Massachusetts Eye and

1-800-445-6086

Ear Infirmary from 1969 until his

Fax: 1-203-432-7901

retirement.
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Henry V. Kogut
Henry V. Kogut, M.D., of Stratford,
Conn., died Oct. 18 in Bridgeport
Hospital. He was 79.
Born in Bridgeport, Dr. Kogut
received his medical degree from
New York Medical College and com¬
pleted a residency in ophthalmology
at Yale in 1948. During World War
II, he was a captain in the Army,

serving as a flight surgeon in the

ogy, and the American Society of

United States and Germany.

Contemporary Ophthalmology.

Dr. Kogut practiced ophthal¬
mology in Bridgeport and Stratford
for 49 years. In 1979, he received the

Helen P. Langner

Physician Recognition Award from
the American Medical Association.
Dr. Kogut was also a fellow of the
American College of Surgeons, the
American Academy of Ophthalmol¬

The School of Medicine’s oldest
alumna, Helen P. Langner, M.D.,
died Dec. 10 at her home in Milford,
Conn. She was 105.
Born in Meriden, Conn., the
oldest of six children, Dr. Langner
grew up in Milford and graduated
from Milford High School in 1910.

Doctor,; how can I
thank you?”

H

ow many times have you heard this question from
your patients? Your answer can lead to a way to
help the Yale School of Medicine. A gift from your
patient to the School honors you and guarantees
the continuation of our tradition of excellence in
teaching and patient care into the 21st century.

“Yale School of Medicine was and remains
extremely important to me in the ongoing development of
my busy practice. I am proud of my close relationship with the School,

even though I am geographically far from New Haven. My patients
regularly take an interest in my research and clinical activities, and I
am more than happy

for Yale

to share with them my fondness

in order to stimulate their interest in the School’s mission.”
Dudley Seth Danoff, M.D. ’63, F.A.C.S.
Beverly Hills, California

She attended Hunter College in
New York at a time when no
Connecticut college would open its
doors to her as a woman. After
graduating from Hunter in 1914,
she taught high school biology in
New York.
She returned to Connecticut
and was admitted to the Yale School
of Medicine. The only woman in her
class, Dr. Langner received her medi¬
cal degree from Yale in 1922. She was
the fourth woman to graduate from
the medical school.
She took her residency training
at a state hospital on Wards Island in
New York City, before traveling
around the United States to set up
child guidance clinics. In 1929, she
joined the faculty at Vassar College

I am a proud graduate of Yale
Medicine and an active participant in the teaching

“My patients know that

School

Of

program. They also know that one of the best ways to make me
happy is

health. She later established a private

to give to my alma mater.”
Mary Jane Minkin, M.D. 75
New Haven, Connecticut

Brochures promoting the School are available for
display in your office, to generate the revenue
needed to continue our standard of excellence.
Free copies are available from:
Bonnie Sargent
Office of Development
Yale University School of Medicine
P.0. Box 7611
New Haven, Connecticut 06519-1714
Or call:
203.785.6760

in Poughkeepsie, N.Y., where she
was the head of undergraduate
psychiatry practice in New York
City, commuting from her home in
Milford. In addition to seeing pri¬
vate patients, she treated patients at
New York Hospital Cornell Medical
Center and worked part time in the
New York City school system.
In 1970 at age 78, she retired
from full-time practice but contin¬
ued to see patients well into her 90s.
She served as a consultant both to
the Milford health department and
at Milford Hospital. She returned
annually to the School of Medicine
for Alumni Reunion Weekend, cel¬
ebrating her 75th reunion last June.
Her report from the event was pub-

60

WINTER/SPRING

1998

lished in the Fall 1997 issue of

Mr. Simjian was born in Turkey

graduated from Boston College in

to well-to-do parents of Armenian

1942 and received his medical degree

descent. According to a 1934 Wash¬

from Yale in 1945 and his L.L.D.

environmental causes, including

ington Post article, his mother and

from St. Anselm College in 1973. Dr.

projects to improve the Milford har¬

three sisters were massacred in Tur¬

Stanton was on the staff of Boston

bor and to create a nature preserve in

key and he was separated from his

University School of Medicine from

the salt marshes at nearby Smith’s

father. He came to the United States

1946 to 1951. He then joined the staff

Point. The area is now a federal

in the early 1920s, settling in New

of Tufts University School of Medi¬

wildlife preserve and borders the

Haven with an uncle, and eventually

cine as an instructor until 1958 and

Audubon Coastal Center.

was reunited with his father.

as associate clinical professor of

Yale Medicine.
Dr. Langner dedicated herself to

In 1994, she was inducted as an

Mr. Simjian worked as a pho¬

medicine from 1958 until his retire¬

tographer at Yale, where he had

ment in 1985. Dr. Stanton devoted

1998 by then-Dean Gerard N.

hoped to pursue an interest in medi¬

his energies to internal medicine and

Burrow, M.D. ’58. At a memorial

cine. But his success as a photogra¬

research on hypertension.

service for Dr. Langner Feb. 9, her

pher and inventor swept aside his

second Yale medical diploma was

medical aspirations. He eventually

State legislature legalized abortion,

presented posthumously and ac¬

patented nearly 200 inventions, in¬

he became active in the anti-abor¬

cepted by her younger brother,

cluding an autofocus camera in 1932,

tion movement. Dr. Stanton

Gustave Langner, 95.

a color X-ray machine in 1934, an

founded the Massachusetts Citizens

early flight simulator, a teleprompter

for Life and the Value of Life Com¬

honorary member of the Class of

James D. Prokop
James D. Prokop, M.D., died Dec. 1
of cardiac arrest at Greenwich Hos¬
pital. He was 64.
Born in Bridgeport, Conn., Dr.
Prokop graduated from Yale College
in 1955 and from the School of
Medicine in 1959. He served his in¬
ternship and residency, and was chief
resident of neurosurgery at New
York Hospital Cornell Medical Cen¬
ter from 1959 to 1961. Dr. Prokop
was clinical associate at the National
Institute of Neurological Diseases
and Blindness in Bethesda, Md.,
from 1961 until 1963.
Dr. Prokop was director of the
Department of Neurosurgery at
Stamford Hospital and St. Joseph
Medical Center from 1976 to 1981.
He also headed neurosurgery at
Stamford Hospital in 1994-95.

In 1970, after the New York

and a mechanical precursor to the

mittee of Massachusetts. He was

automatic teller machine.

also chief archivist and historian of

According to Richard G. Snyder,

Massachusetts Citizens for Life.

the current president of Reflectone
Inc., the Tampa, Fla., company Mr.
Simjian founded in Connecticut in
1939, Mr. Simjian was considered
“the second Thomas A. Edison” in
many quarters. His medical inven¬
tions included a supersonic explor¬
ing device for ultrasound and the
color X-ray machine, which assigned
color values to varying shades of
gray. He also envisioned linking the
machine electronically to remote
sites, making the diagnostic images
available to physicians hundreds of
miles away. In 1978, he received the
Eli Whitney Award from the Con¬
necticut Patent Law Association.
The Photography Department he di¬
rected is known today as Biomedical
Communications.

G. Pierce Taylor
Grosvenor Pierce Taylor, M.P.H., of
Shelburne, Mass., died June 7 at
Franklin Medical Center in
Greenfield, Mass. He was 79.
Mr. Taylor graduated from
Amherst College in 1942, then re¬
turned to work on his family’s apple
orchards in Shelburne. He later took
a job as a purchasing agent for Pro¬
fessional Equipment Co. of New
Haven, Conn., and received his
master’s degree in public health from
Yale in 1961. Mr. Taylor then served
as administrator of the Southwestern
Michigan Hospital Council and as
executive director of the Connecti¬
cut Hospital Planning Commission.
He retired in 1974.

Joseph R. Stanton
Luther George Simjian
Joseph Robert Stanton, M.D.,
Luther George Simjian, the first di¬

L.L.D., of Needham, Mass., died

Seth U. Thaler

rector of the School of Medicine’s

Sept. 9 at Needham nursing home in

Seth U. Thaler, M.D., died Aug. 20

Photography Department and the

Wingate. He was 77.

at Arden Hill Hospital in Goshen,

inventor of dozens of devices, some

Born in Brighton, Mass., Dr.

N.Y. He was 59.

of them for medicine, died Oct. 23

Stanton was stricken with polio as a

at his home in Fort Lauderdale, Fla.

teen-ager and did not pursue his

Thaler graduated from Amherst Col¬

He was 92.

dream of becoming a surgeon. He

lege and received his medical degree
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Born in New York City, Dr.
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from Yale in 1962. He practiced oto¬

IN

MEMORIAM

laryngology in Goshen lor many
years. Dr. Thaler also was medical
director at Arden Hill Hospital and a
lellow ol the American College ol

The School of Medicine has received
notification ol the death of the
loliowing persons:

Surgeons and the American Associa¬
tion ol Otolaryngologists.

1997-98

Association of Yale
Alumni in Medicine

William B. Barry, M.D., Med ’36
August 27, 1997

Officers

Robert E. Waugh

Frank A. Carone, M.D. ’52
October 3, 1997

Robert E. Waugh, M.D., ol
Farmington, Conn., died Aug. 1.
He was 64.
Born in Willimantic, Conn.,
Dr. Waugh was a graduate of
medical degree from Yale in 1959. He

May 10, 1996

Secretary
July 24, 1997

Lycurgus M. Davey, M.D. ’43
Past President

Lee E. Farr, M.D. ’33
July 16, 1997

Executive Committee
Joseph F.J. Curi, M.D. ’64

residency training in anesthesiology

George T. Furlong, M.P.H. ’53

at Grace-New Haven Hospital from

October 2, 1997

1961 to 1962.
the Navy as an anesthesiologist at

Vice President
Peter N. Herbert, M.D. ’67

Marvin B. Day, M.D., Med ’38

fornia at Los Angeles, and took his

Dr. Waugh served two years in

President
Gilbert F. Hogan, M.D. ’57

Jean Parker Cobb, M.P.H. ’69

Dartmouth College and received his
was an intern at University of Cali¬

Nicholas M. Passarelli, M.D. ’59

Mary V. Digangi, M.D. ’64
John W. Foster Jr., M.D. ’71
R. Leonard Kemler, M.D. ’43

Gladys Jacoby Goldman, M.P.H. ’47
October 3, 1997

Robert J. Kerin, M.D. ’47
Jocelyn S. Malkin, M.D. ’51

the Portsmouth Naval Hospital in
Virginia. In 1964, he joined the staff

John C. Haley, M.D. ’40
September 13, 1997

ol New Britain (Conn.) General
Hospital and at the time of his re¬
tirement in 1991 was the medical di¬

Lynn W. Reiser, M.D. ’70

July 31, 1997
Ex-officio
Perry W. Nadig, M.D., HS ’54-57
March 12, 1997

Marion Redmond, M.P.H. ’41
October 21, 1992

10 at a nursing home in La Jolla,
was 93.

David A. Kessler, M.D.
Dean
William K. Jenkins

Inez E. Wilber

Calif., after sulfering a stroke. She

Donald E. Moore, M.D., M.P.H. ’81

Warren Mead Jones, M.D. ’61

rector of its ambulatory surgery unit.

Inez Edith Wilber, M.D., died May

Dwight F. Miller, M.D. ’56

Managing Director, Alumni Affairs
Daniel L. Arons, M.D. ’67
Chair, YSM Alumni Fund

Dorothy A. Rice, M.P.H. ’77

Samuel D. Kushian, M.D. ’35

December 23, 1993

YSM Bequest and Endowment

Dr. Wilber was born in Los An¬
geles and was raised in Needles, Calif.

Edwin D. Rogers, M.D. ’41

She received her medical degree from

May 9, 1995

the University of Michigan in 1932
and served her internship and resi¬
dency at Yale Irom 1932 to 1935. She
practiced ophthalmology in Washing¬
ton, D.C., from 1939 until she retired

Joseph R. Stanton, M.D.’45
September 9, 1997

nor ol the women’s professional or¬

October 20, 1997

tion of University Women.

6z

Frank R. Coughlin Jr., M.D. ’52
Martin E. Gordon, M.D. ’46

Benjamin E. Lyons, M.D. ’38
Theoharis C. Theoharides, M.D.,
Ph.D. ’83

Seth U. Thaler, M.D. ’62
August 20, 1997

ganization Zonta International and a
member of the American Associa¬

Association of Yale Alumni

Michael Kashgarian, M.D. ’58
Meritt W. Stark, M.D., HS ’43-44

and moved to California in 1977.
Dr. Wilber was a district gover¬

Representatives to the

AYAM Representative,
Medical School Council

Robert E. Waugh, M.D. ’59
August 11, 1997

Peter N. Herbert, M.D. ’67
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F R I DAY,

JUNE

5

t>

School of Medicine Alumni Fund Class Agents and Reunion Gift Chairs Luncheon

D>

Class Reunion Programs

l>

Association of Yale Alumni in Medicine Executive Committee Meeting

t>

Opening Remarks
Nicholas M. Passarelli, M.D. ’59, President, AYAM
David A. Kessler, M.D., Dean, School of Medicine

\>

Special Presentation
The Yale System, its Evolution, Strengths and Problems
Robert H. Gifford, M.D., Associate Dean for Medical Education
and Student Affairs

t>

Dean’s Reception

O

New England Clambake

FRIDAY

AND

SATURDAY,

SYMPOSIUM HONORING
JOHN P. PETERS, M.D.
John Punnett Peters, M.D.,
(1887-1955) was a legendary
member of the Yale medical
faculty, revered for his skill
and warmth with patients as
well as the new scientific
ground he broke, especially
in the area of metabolism.
The seminar will explore
these contributions to
medicine, as well as the
political controversy that surrounded Dr. Peters,
an early advocate of socialized medicine who
was targeted by conservatives in the late 1940s
and early '50s.

JUNE

SATURDAY,
I>

5

AND

JUNE

6,

1998

6

Annual Meeting of the Association of Yale Alumni in Medicine
Greetings by Nicholas M. Passarelli, M.D. ’59, President, AYAM
Remarks: Dean David A. Kessler, M.D.
Presentation of the Distinguished Alumni Service Award

t>

Sherry/Buffet Luncheon

t>

Guided Tours
Yale University Art Gallery
Historic Sections of New Haven/Eli Whitney Museum

TOPICS

Yale-New Haven Children’s Hospital/Medical Center

The Committee of 430 Physicians
George D. Lundberg, M.D.
Editor in Chief
Journal of the American Medical Association

John Peters, McCarthyism and the
Supreme Court Decision

D>

Individual Class Parties and Dinners for the five-year
reunion classes

D>

Friends of the 50th Dinner (Honoring the Classes of 1948,

1933’ 1938, 1943. and 1993)

Catherine G. Roraback, LL.B/48
Attorney-at-Law
Canaan, Conn.

Contributions to Nephrology
Franklin H. Epstein, M.D. '47
Professor of Medicine
Harvard Medical School and Beth Israel Hospital

Contributions to Diabetes Mellitus
Phillip Gorden, M.D., HS '61-66
Director
National Institute of Diabetes and Digestive
and Kidney Diseases

FOR

INFORMATION,

CONTACT

William K. Jenkins, Managing Director
Reflections of a Student of Peters
Donald W. Seldin, M.D. '43
Professor of Internal Medicine
University of Texas Southwest Medical Center

Office of Alumni Affairs
P.O. Box 7613, New Haven, CT 06519-0613
(203) 785-4674,

FAX

(203) 737-5H3

LETTERS

One nation, two views

lated to the drug culture that so bur¬
dens our inner cities here. I learned
much from their grace, dignity, co¬

To the Editor:
I spent a month on the same Navajo

hesiveness and natural wisdom. I

reservation as Gregory Raskin [Notes

can’t wait to return for another stint

From a Navajo Winter, Fall 1997]. I

of service in March, and am taking

found parts of his description dis¬

with me another Yale medical stu¬

concerting because it seemed at

dent. My family only fears that I

times as though he were looking

may not return.

down on the people he was treating.

Susan Richman, M.D., HS ’79-83

I must assume that the percep¬

Assistant Clinical Professor

tions differ because I have been a cli¬

Obstetrics and Gynecology

nician for 15 years, and he is still in
the learning process. I was sad to
leave New Mexico. The Indian

To the Editor:

Health Service, a branch of the U.S.

Gregory Raskin’s Notes From a

Public Health Service, is medicine as

health care—the entity we all sup¬

Navajo Winter was terrific because of

it used to be practiced, as I believe it

posedly fear.

its common-sense approach to the

was meant to be practiced. It is com¬

As far as the Navajos themselves,

big questions, especially “How long

pletely patient-care oriented, with

I found them to be marvelous pa¬

could I go without a bagel?” (I may

emphasis on the word care. Every¬

tients. The majority are farmers and

be biased in this.) I can confirm that

thing about the system is designed

ranchers, living a busy and

Nepal, at least regarding the Lender’s

for the convenience of the cli¬

physically demanding out¬

entele. Every clerk and secre¬

door existence. They are

product, is a bagel-free zone.
Murray Lender

tary makes certain the “grand¬

strong individually and

mother” won’t wait in line

communally, with good

H. Lenders & Sons

self-esteem. I he transla¬

Woodbridge, Conn.

and gets kind, courteous, effi¬

tors pose no problem at

cient treatment. Each Navajo
has a family practitioner over¬
seeing the totality of his or her

Chairman

all. It turned out that most
of the elderly understood me

Doctor, see thyself

care. Sub-specialists are utilized ap¬

perfectly, but preferred the comfort

propriately, and all are represented

of speaking in their own language.

To the Editor:

on-site.

Compliance was no better or worse

I enjoyed reading Medicine at the

than among patients anywhere else.

Movies in the Special Report edition

There is no insurance company
involved—no denial of treatment,

Because illegal drug use is so

of Yale Medicine [Fall 1997]. I suggest

medication, hospitalization, or

rare, there is very little of the crime,

you add another film to the sug¬

surgery if the clinician has deemed

violence and secondary diseases re-

gested list for doctors and those in

it appropriate. If a postop or post¬

training to view. The Doctor with

partum patient needs a week to re¬

William Hurt tells the story of a

cover in-house before the long ride
home, there is no utilization review
worker to say otherwise. Social
workers are amply available to be
sure the home stay is safe. Medicines
are dispensed directly in the clinic,
eliminating middleman markup and
another trip for the patient to get it
as is the case with the pharmacy sys¬

physician who is stricken with can¬

How to reach us
Yale Medicine welcomes news
and commentary. Please send
letters to the editor and news
items to

Yale Medicine, P.0. Box

7612, New Haven, CT 065190612, or via electronic mail to
ymm@yale.edu, and include a
daytime telephone number.

tem. The full range of preventative

Submissions may be edited for

and rehabilitative services are avail¬

length, style and content.

cer and has to endure all the indigni¬
ties that his patients endure in his
hospital. The experience changes his
perspective and understanding of
sick people. I believe all doctors
should participate in this vicarious
experience.
Joan Gourley
Milford, Conn.

able on-site. This is government-run
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Continuing Medical
Education at Yale

June 3
Wednesday

11th Annual Lyme Disease Conference

A

Course Director: Robert Schoen, M.D.
Focus on clinical topics and scientific advances
Mary S. Harkness Auditorium

June 19
Friday

Yale Ophthalmology Spring Symposium:

B

The Distinguished Alumnus Lecture by Lee Jampol, M.D., Professor & Chairman
Northwestern University Department of Ophthalmology
Course Directors: Craig Sklar, M.D., and Bruce Shields, M.D.
New Haven Lawn Club, New Haven, CT

September 12,13
Saturday - Sunday

Yale at Mystic: An Ultrasound Review

c

Course Director: Kenneth J.W. Taylor, M.D., Ph.D.
Furthering acquaintance with the most useful applications
for the latest technical advances in diagnostic ultrasound
Mystic Hilton, Mystic, CT

September 17 20
Thursday - Sunday

22nd Yale Physician Assistant Certification/
Recertification Preparatory Conference

D

Course Coordinator: Christiana Nockels, P.A.
Mary S. Harkness Auditorium
October 23, 24
Friday - Saturday

Health and Spirituality Conference

E

Co-sponsors: Albert Schweitzer Institute for the Humanities and
the Program for Humanities in Medicine at Yale
Jane Ellen Hope Building, Room 110

ongoing

Pain Management Programs
Course Director: Lloyd Saberski, M.D.
Individually tailored tutorials for physicians in the clinical management of pain
Center for Pain Management, 40 Temple St., New Haven, CT

For information, contact the Office of Postgraduate and Continuing Education,Yaie University School
of Medicine, 333 Cedar St., P.O. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578
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First Lady praises Child Study Center Program

I

n an April 30 address at Harkness Audito¬
rium during a symposium celebrating the
30th anniversary of the School Develop¬

ment Program, First Lady Hillary Rodham
Clinton praised the program's founder, James P.
Comer, M.D. Dr. Comer, whose model has been
implemented in more than 700 schools across
the country, is the Maurice Falk Professor of
Child Psychiatry In the Child Study Center. Mrs.
Clinton recognized his “lifelong vision, passion
and mission to make us understand what edu¬
cation is really all about. Today we celebrate a
man who has committed his personal and
professional life and the work of this center to
fulfilling that vision.” In her 20-minute speech,
Mrs. Clinton recalled her research on the
medical and legal issues surrounding child
abuse while she was in law school, and lauded
the Child Study Center, in which she was a
fellow working with Albert J. Solnit, M.D., and
the late Sally Provence, M.D. “The impact of
the center’s work can be seen in improved
test scores and higher self esteem in schools
nationwide,” said Mrs. Clinton, who wrote about
her experience as a center fellow in her recent
book, It Takes a Village.

house staff/fellow

and professional activities, for publication in Yale Medicine.
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A life of engagement
Until her death last December at 105, Helen Langner was the
school’s oldest graduate. “If you live long enough,” she told friends,
“you get recognition, whether you deserve it or not.” In her case,
the recognition spanned a century and marked an exceptional life.

By John Curtis

22

Factoring in gender
How do gender differences affect the progress and treatment of
disease? It’s often hard to say, since for decades women were excluded
from many clinical trials. A new Yale program in women’s health
research will explore this largely uncharted territory.

Page 22

By Michael Fitzsousa
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A path for prevention
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When 20,000 of the world’s top AIDS researchers gathered in Geneva
in late June, one clear message emerged: Prevention is still better than
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Hunting down HIV
A Yale professor has engineered a virus
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LETTERS

Rule of law, not men

thought the gelatin plates were defec¬

To the Editor:

tive and repeatedly returned them to
Ilford, England’s largest manufacturer

As a graduate ol Yale College but not
the medical school, I was pleased to

ol photographic plates, with a vitriolic
note. It took a scientist of Roentgen’s
caliber to realize what was occurring

begin receiving Yale Medicine. How¬
ever, drawing upon my Yale education
as a major in American history, 1 have

and to publish an account of his ex¬

always believed in the American tradi¬

periments. Hence, we attribute this
great discovery to Roentgen.

tion stating that we are a nation of
laws, not men.

It is much the same with the first

Thus, 1 read with interest the ar¬
ticle and the quotation attributed to

(clinical) X-ray in the United States.
After reading a detailed description of

the medical school’s new dean in your

Roentgen’s discovery of the X-ray in
the New York Sun, a prominent local

Fall 1997 issue. As a non-smoking
physician, I share Dr. Kessler’s view of

man and a member ol the Dartmouth

smoking and the tobacco companies.
However, the deals being forced on

scientific society, Howard H. Langell,
inspired Frank Austin, an assistant in

the tobacco companies are unconstitu¬
tional and an attack on the rule of law.

the Dartmouth physics laboratory, to
test a dozen or so Crookes vacuum

In a recent issue of The Freeman,
Robert A. Levy makes the case that
we can’t ignore the constitutional in¬
firmities just because the industry

rettes than the cost for their care; and

tubes in the Dartmouth collection to

that Congress should first eliminate all
subsidies to tobacco before resorting

see if any of them would produce X-

to a legislated settlement.

very date you describe, Jan. 27, that

I hope that Dean Kessler will en¬

rays. It was probably on or before the
Langell and Austin produced images
of coins and keys in a wooden box

consents to them; that tobacco is not
a special case and that other industries

courage those in training to under¬

should be fearful; that prohibition as

stand that a superb education with

and perhaps even of Austin’s hand.

favored by Drs. Kessler and Koop

free choice and not a paternalistic atti¬

They then reported this event to

would lead to a black market; that in

tude is the essence of a Yale education.

Edwin Frost, a professor of astronomy
at Dartmouth.

fact cigarette smokers already pay

Robert H. Potts Jr., M.D.
Copper Mountain, Colo.

more through the taxes on their ciga-

On Monday, Feb. 3, Edwin’s
brother, Gilman Frost, M.D., chief of

To tell the truth

staff at the Mary Hitchcock Memorial

To the Editor:

Hospital, brought 14-year-old Eddie
McCarthy to the physics building at

The AYAM makes web debut

I came across your very nice article

At the Association of Yale Alumni in

on the history of radiology at Yale

Dartmouth college. Eddie had fallen a

Medicine website, you will find informa¬

[.Medicines new eyes, Winter/Spring

week or so before while skating on the

tion about the activities, goals, and struc¬

1998]. I applaud your department, its

Connecticut River and had a clinical

ture of the AYAM and the Yale School of

innovations and your enthusiasm lor

diagnosis ol a “colies” fracture. Utiliz¬

Medicine Alumni Affairs Office. The site

its capabilities. At the same time, I

ing the tube that Austin had experi¬

contains a brief history of the School of

question the statements you make on

mented with, the Frost brothers pro¬

Medicine, the history and goals of the

attributing “the first X-ray image in

ceeded to produce an X-ray of

AYAM, AYAM constitution, a listing of the

the United States” to Yale physicist

alumni officers, class secretaries, staff,
outreach program and events. Visit us at

Arthur W. Wright. Sometimes issues
like this are a matter of semantics.

http://www.med.yale.edu/ayam

Although we attribute the “discovery”

Yale Medicine on the web

of X-rays and the first image to
Roentgen, Crookes (and others)

Yale Medicine and other medical school

actually made X-rays and inadvert¬

publications can be found on the
World Wide Web at http://
info.med.yale.edu/ymm

ently exposed X-ray plates in his labo¬
ratory well before Roentgen developed
an understanding of what was going
on. As you may be aware, Crookes

How to reach us
Yale Medicine welcomes news and com¬
mentary. Please send letters to the edi¬
tor and news items to Yale Medicine, P.O.
Box 7612, New Haven, CT 06519-0612,
or via electronic mail to ymm@yale.edu,
and include a daytime telephone number.
Submissions may be edited for length,
style and content.
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that of Nathan Smith, founder of

McCarthy’s wrist showing the frac¬

claim that Yale physicist Arthur W.

ture. Frost reported this in an article

Wright made the first X-ray image in

Dartmouth Medical School in 1797

dated Feb. 4 and submitted it to the

the United States on Jan. 27, 1896,

and co-founder of Yale Medical

journal Science. Reports in the same

just one day after an article entitled

School over a decade later.

issue of Science by Drs. Pupin of Co¬

The New Photography appeared in the
New York Sun newspaper describing

lumbia and Goodspeed of Pennsylva¬
nia described clinical X-rays that were

Roentgen’s discovery of X-rays on

made three and five days later.

November 8,1895.

If Yale’s physicist, Arthur Wright,
pre-empted the Dartmouth group,
it remains unreported and unsub¬

John D. Bullock, M.D.
Professor and Chair
Department of Ophthalmology
Wright State University School of Medicine
Dayton, Ohio

In the Winter 1995 issue of

Dartmouth Medicine an article ap¬
peared describing the first clinical Y-

Class agent syndrome

stantiated, at least in the scientific

ray in America: of the wrist of Eddie

literature. The Dartmouth group

McCarthy, a 14-year-old boy who fell

To the Editor:
A syndrome described in the Decem¬

went one step further. The taking

while ice skating on the Connecticut

ber 1997 Atlantic Monthly attracted

of the first clinical X-ray in America

River in Hanover, N.H. This first

my gaze. Now I know what causes my

was captured by photographer Henry

clinical Y-ray was taken at Reed Hall

swollen legs: economy class syndrome,

H. Barrett and so remains the first

at Dartmouth College on Feb. 3, 1896,

interestingly first described by Profes¬

scientific experiment recorded by

and reported in an article published in

sor Jennett of Glasgow University!

Science dated Feb. 4, 1896. Physics

As an American of Scottish descent,

professor Edwin Frost (and brother

I now understand the connection be¬

deserto, “strong on the Tux’, weak on

of Dr. Gilman Frost, a professor at

tween my ethnic heritage, the legend¬

the ‘Veritas’.”

Dartmouth Medical School and

ary gift for thrift and my puffy ankles

physician of Eddie McCarthy) wrote:

after a bargain flight.

photographic means.
In a word, from Vox Clamantis in

Peter K. Spiegel, M.D.
Professor and Chair
Department of Diagnostic Radiology
Dartmouth-Hitchcock Medical Center
Lebanon, N.H.

“It was possible yesterday to test the

Another, which I call class agent

method on a broken arm. After an

syndrome, much more pleasant, is

exposure of 20 minutes, the plate on

often seen in Yale medical alumni class

development showed the fracture in

agents after many years on the job.

the ulna very distinctively. Comment

This condition may be experienced all

You’re both right

upon the numerous applications of

year, depending on correspondence

To the Editor:

the new method in the sciences and

with classmates, but predominates

Because of my mixed medical heritage

arts would be superfluous.”

(B.M.S. Dartmouth Medical School,

Yale’s first X-ray image combined

each fall and peaks sharply every five
years. Manifestations: frequent memo¬

M.D. Harvard Medical School, and

with Dartmouth's first clinical X-ray

ries and thoughts (even dreams) of

ophthalmology residency at Yale), I re¬

shows that these two institutions were

classmates, living and dead. Enjoyable.

ceive the alumni bulletins of all three

(and continue to be) on the cutting

Seriously desire to know if other class

institutions. I read with great interest

edge of medical technology. It should

agents have noted same.

your excellent article Medicines new

also be remembered that Dartmouth

eyes. I was greatly impressed by the

and Yale share a common heritage,

Richard W. Breck, M.D. '45
Wallingford, Conn.

From the Edito
Thanks for the magazines
he magazine you are holding

development, alumni affairs and pub¬

Vanderbilt University in Nashville.

would be a good deal less inter¬

lic information activities. During the

It’s hard to imagine him trading

esting were it not for a person

months that followed, Bob made it a
priority to nurture the Alumni Bulletin

Mory’s for the Grand Ole Opry but
then again you don’t have to. Not

whose association with Yale began as
a lanky freshman in Berkeley College

of the School of Medicine into a lively

only does he remain tried-and-true

42 years ago. Many people have

Yale blue, but, without doubt, he’ll

helped make Yale Medicine a better

and varied school magazine, while still
making it a better alumni publication

publication during the last four years,

through expanded class notes, cover¬

but Robert Feldman, B.A. ’60, J.D.

age of alumni activities, and as a
forum for alumni communication.

’63, is the one who made it possible.
In the spring of 1994, he returned
to Yale to oversee the medical school’s

YALE
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This spring he left New Haven to

take to Tennessee and it will take to
him. We wish him good luck and
good cheer.
Michael Fitzsousa

become associate vice chancellor of

3
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Yale spins off five biotech firms

U

ntil a decade ago, Yale’s participation in technol¬

Office of Cooperative Research. “Aside from creating

ogy transfer, the movement of basic science ad¬

new jobs, the five companies are developing drugs and

vances into the commercial marketplace, was

diagnostic techniques that have the potential to signifi¬

negligible. That has changed dramatically {Yale Medicine,
Fall 1997), and the change delights budget makers,
among others. Two years ago, Yale’s annual income from

cantly benefit human health throughout the world.”
The five new companies formed in partnership with
Yale are:

royalties and licenses for University-developed projects

Molecular Staging Inc., which is generating DNA

had grown to $3 million. Yale expects those earnings to

amplification techniques useful for detecting,

soar phenomenally, reaching $38 million for the fiscal

characterizing and assessing the severity, or stage,

year that ended June 30 and placing it among a handful

of disease. MSI will focus on developing new and

of the universities leading in annual royalty and licensing

more powerful technologies for diagnosing cancer

income. More than three-quarters of the income has

and infectious diseases.

come from royalties from the AIDS medication Zerit,

polyGenomics Inc., which is developing methods for

developed at Yale. A Yale-developed Lyme disease

analyzing population genetics to discover new genes

vaccine is expected to boost royalty income further in

using many of the same techniques employed by

the coming years.

Molecular Staging. This could help researchers find

There’s more good news. The Office of Cooperative

the causes of complex diseases that involve defects in

Research has announced the formation of five new bio¬

a number of genes, including psychiatric disorders

technology companies based on spin-off technologies

such as panic disorders and schizophrenia and

from School of Medicine research.

hypertension-associated kidney failure.

Each of the new ventures plans to es¬

Transmolecular Sciences Inc., which is relocating

released in April, biomedical

tablish research and development fa¬

to New Haven from the University of Alabama at

research and biotechnology

cilities in the New Haven area, creat¬

Birmingham. The company is studying neuro¬

industry have the strong sup¬

ing an anticipated 70 or more new

transmitters involved in chronic pain as targets for

port of the vast majority of

jobs in their first year of operations.

developing powerful non-narcotic analgesic agents.

“Yale is taking a more active role

The firm is also focusing on the diagnosis, imaging

According to results of a poll

Connecticut residents. Most
would even be willing to pay a

in forming new ventures in an effort

surcharge on various health

to make sure the New Haven area

L2 Diagnostics, which was established with School of

services or increased taxes if

reaps economic benefits from the

Medicine investment funds as a spin-off from its own

the money went to biomedical

University’s research.” says Gregory

Lyme/Lupus Diagnostics Laboratory. The new diag¬

research. The survey was com¬

E. Gardiner, Ph.D., director of the

missioned by the national bio¬

and treatment of malignant brain tumors.

nostic methods developed by the laboratory will help
distinguish patients infected with Lyme disease from

medical research-advocacy or¬

those who have been vaccinated. In May, an FDA

ganization ResearchlAmerica

advisory panel recommended approval of a Yale-

and released by Connecticut

developed vaccine.

United for Research Excel¬

Cellular Genomics, which will explore ways in which

lence, Inc. (CURE), coalition

changing patterns of gene expression affect how a cell

supporting biomedical re¬

looks and behaves. By focusing in on cells of the im¬

search and education. Among

mune system, the company hopes to find new ways

its findings, the poll indicated

to treat autoimmune diseases such as juvenile-onset

that 80 percent of the respon¬

diabetes and multiple sclerosis, and to prevent

dents said they are more likely

transplant rejection.

to think a hospital is “good" if

Formation of the new companies exceeds the

they know it is engaged in re¬

University’s goals of spinning off three to four

search and training of medical

biotech companies each year, according to Jon

students and residents.

Soderstrom, Ph.D., associate director of the Office
of Cooperative Research.
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Budget, space concerns addressed in school’s
strategic facilities plan

W

hen David A. Kessler, M.D., began speaking with
faculty and top administrators in early 1997 before
coming to the School of Medicine as dean, he

found two issues on everyone’s mind: a mounting budget
deficit and a critical shortage of space that threatened the
school’s ability to recruit and retain the best faculty and stu¬
dents. Both problems demanded immediate attention, and,
as the new dean soon learned, they were intricately linked.
“Depending on how you calculate, the school had a
deficit of $23 million or more for the 1997-98 budget year,”
Dr. Kessler said in an interview in late June. Flaws in the
school’s computerized billing system, combined with lower
revenues from managed care, had contributed to the deficit.
The lack of laboratory space had been recognized since at

formed a committee to address the issue, but plans for a
new building stalled in the mid-1990s. A second committee,
chaired by faculty members Carolyn W. Slayman, Ph.D.,
and Arthur E. Broadus, M.D., was formed to consider
educational and programmatic goals in greater detail before
new construction was proposed.
Dean Kessler, with the participation of the school’s lead¬
ership, set about the task of crafting solutions to both prob¬
lems, spending much of his first year at Yale quietly analyz¬

The need for additional
research space has been a
long-standing concern at the
medical school, and faculty,
administration and staff are
looking forward to a proposed
expansion of laboratory
facilities. "This is about more
than bricks and mortar,” says
Dean David Kessler, right.
“It's about people and ideas,
and the creation of an environ¬
ment for research.”

MICHAEL MARSLAND

least 1989, when then-Dean Leon E. Rosenberg, M.D.,

ing the circumstances that produced them. The result of
that process was apparent in two state-of-the-school presen¬
tations in late spring and early summer. In a series of meet¬

room space are also part of the new construction, which

ings with department chairs, senior faculty, administrators

would total 201,000 net square feet.

and, ultimately, the Yale Corporation, the dean released

Still in the earliest stages of development, the plan will

a detailed account of the school’s finances and presented a

require the approval of city planning agencies and in-depth

plan to balance the budget by Jan. 1, 1999, six months

discussion by the medical school, the University and their

earlier than he promised when he took office. Then in June,

New Haven partners, including the mayor, Board of

Dr. Kessler proposed a strategic facilities plan to meet a

Aldermen and the Hill Development Corporation. Once

large portion of the school’s space needs. After reviewing the

planning is complete, the school will return to the Yale

draft proposal at its June 19 meeting, the Yale Corporation

Corporation for approval of construction funding. The

approved funds to begin the formal planning process for

project is only possible, Dean Kessler said, if the school

renovations and new construction.

secures significant funds from philanthropic sources.

The centerpiece of the plan is a proposed building at the
corner of Congress Avenue and Cedar Street that would
provide 139,000 square feet of laboratory space for disease-

A portion of that total already has been committed by
foundations and private donors.
According to Dr. Kessler, balancing the budget was

oriented research. The $160 million complex, one of the

and will remain the key to University support. “Getting

largest building projects ever undertaken at Yale, also would

our fiscal house in order was the first step toward

house a Magnetic Resonance Center to enable expansion of

gaining the backing of the Corporation. They asked

Yale’s cutting-edge capability in imaging, which is driving

some hard questions and thanks to the chairs, the deputy

advanced research in nearly every discipline. Also included

deans, the faculty and the administration, we were well-

is space for offices, animal care, laboratory support and a

prepared,” Dean Kessler said. “The key to this is living

teaching facility to replace the school’s overcrowded and

up to our responsibility.”

outmoded gross anatomy laboratory in Sterling Hall of
Medicine. State-of-the-art teaching laboratories and ciass-

YALE
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Balancing the budget has been an across-the-board
effort, with strategic cuts in the coming year’s expenses

5

"More than ever this is an opportunity for us to ensure that Yale creates the
environment for collaboration between basic and clinical scientists around
disease-oriented research.”
Ralph I. Horwitz, M.D.
Chair of Internal Medicine

made by the departments, administra¬
tive offices and the Yale Psychiatric

vere shortage of space, would benefit

the teaching component of the pro¬
posed building “will make a huge dif¬

Institute, one of the clinical entities

significantly from the new building,

ference for students, in particular dur¬

hardest hit by managed health
care. “It required the entire school

which would house programs in eight
areas, according to the facilities plan.

ing the first two years of medical
school." The school’s current anatomy

coming together,” Dr. Kessler said.

However, the building is not envi¬

laboratory, built in the 1930s to ac¬

“The chairs did it, the senior leader¬

sioned as a departmental structure, Dr.

commodate a class of 50, has been

ship in the faculty did it, and it
wasn’t without hardship. It took

Kessler said, but rather as one orga¬

stretched past capacity for decades and

nized around program goals, similar to

real sacrifice.”

the Boyer Center for Molecular Medi¬

now, and is currently used by 130
medical and physician associate stu¬

cine, which was completed in 1991.

dents. “We will have an anatomy lab

Driving the strategic facilities plan
is a concise statement of four aca¬

cine, which faces perhaps the most se¬

“More than ever this is an opportu¬

that is state-of-the-art, rather than one

demic goals for the coming decade

nity for us to ensure that Yale creates

that places increased emphasis on the
clinical enterprise. The goals are to

the environment for collaboration be¬

building would also consolidate other

tween basic and clinical scientists

student teaching facilities now scat¬

strengthen disease-related research in

around disease-oriented research,” said
Ralph I. Horwitz, M.D., chair of In¬

tered across the campus.
For Dr. Kessler, who would like

the clinical departments, to sustain

of the oldest in the nation.” The new

the high quality of basic science re¬

ternal Medicine. “It will enable the

the see the new building completed

search, to promote research in epide¬

school to remain at the forefront, and

miology and public health, and to

to recruit and retain the world-class

in four years, the strategic facilities
plan is about “more than bricks and

upgrade core facilities needed for bio¬

physician-scientists needed to pursue
this research.”

mortar. It is not about a building.

medical research throughout the
University. The plan also calls for

According to Sally E. Shaywitz,

creation o! an environment for re¬

It’s about people and ideas, and the

capital spending for renovations of

M.D., a leading brain researcher and

search,” he said. “By having the

$50 million a year for the next 10 years

pediatrician who specializes in the
study of dyslexia, the Congress Avenue

clear sense of focus on disease, I

Building’s proposed magnetic reso¬
nance facility would effectively double

impact both individuals and the
health of the public. Our goal is to

new building. That “backfill” plan ul¬

the medical school’s current capacity

advance the scientific basis of the

timately will group together research¬

to image brain activity. “It means we

ers from various departments who

can enter the next century,” said

practice of medicine.”
He recalled talking about the plan

share scientific and clinical interests.
Renovation of the Laboratory of

Dr. Shaywitz, who in 1995 with her

with W. Maxwell Cowan, M.D.,

colleague and husband Bennett A.

Ph.D., vice president and chief scien¬

Shaywitz, M.D., produced the first
evidence of gender differences in brain

tific officer of the Howard Hughes
Medical Institute, when Dr. Cowan

activity. “It means we can do the kind

visited Yale recently. “We took a walk
and I showed him the site where we

and outlines a process for upgrading
and filling in space vacated by the
laboratories that would move to the

Epidemiology and Public Health
will also continue. Other important
priorities include upgrading the space
of the Yale Cancer Center in coopera¬

think we will see real advances that

tion with Yale-New Haven Hospital,

of work that will allow us to under¬
stand better how people think and

making improvements to the Yale

learn and read—and to learn why

it was an ambitious plan, and not

Physicians Building, and expanding
the space available for clinical

some very bright people have diffi¬
culty learning to read.”

without difficulty,” Dr. Kessler said.
“Max turned to me and said, ‘David,

neurosciences.
The Department of Internal Medi¬

deputy dean for education, said that
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Robert H. Gifford, M.D., HS ’67,

envision all this happening. I told him

this may well be the best investment
Yale will ever make.’ ”
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Lab testing may allow earlier
cancer diagnosis
If promising research at the Yale Cancer
Center is proven effective, a simple
blood or tissue test may be able to pro¬
vide earlier diagnosis of breast cancer

cancerous,” said Jose Costa, M.D., the
Cancer Center deputy director under

eye rash. Lyme disease can cause flu¬
like symptoms, swelling of the knees

whose supervision the new laboratory

and, in very unusual cases, arthritis,
facial paralysis and neurological disor¬

falls. “These are the patients on whom
we will ultimately want to test new
cancer-preventing therapies.”

later-stage manifestations normally
respond to antibiotic therapy.
According to the Yale study,

than is now possible with mammo¬
grams. To pursue this new technology,
the Cancer Center last fall established
a new specialized laboratory with
$500,000 in seed money provided
by Los Angeles philanthropist
Marcia Israel.
Investigators are developing new
tests capable of detecting very small
clusters of cells before they become vis¬

ders. A single course of antibiotics
usually eradicates the disease and even

Worry about Lyme disease
may be worse than the illness
Lyme disease was first identified and
named by researchers at Yale more than
a decade ago. Now, Yale investigators

however, many patients don’t
believe it, or believe they
have the disease when
they do not. Out of 209

*!

patients evaluated for this
infectious disorder, 60 percent

have shown that fear of Lyme disease

turned out not to have Lyme disease at
all. Yet they still made an average of

ible on a mammogram. New technolo¬

may in some cases cause more prob¬
lems than the disease itself. According

gies already make it possible to deter¬
mine mutations in single cells as well as

to a study published in the Annals of
Internal Medicine in March, anxiety

in genetic material extracted from a

about possibly getting Lyme disease

antibiotic treatment.
High levels of depression (42 per¬

very small number of cells. The bio¬

following a deer tick bite can result in

cent) and stress (45 percent) were

logical materials obtained through such
methods as fine needle aspiration can

over-treatment by doctors and is associ¬

present in those who turned out not to

ated with a high incidence of depres¬

have the disease and more than half

then be analyzed with great sensitivity

sion and stress among patients. That
worry is often unfounded and may re¬

reported adverse drug reactions after
taking antibiotics. Assistant professor

ations that are the hallmark of cancer¬
ous cells. New technologies also make

sult in harm, especially from overuse of

of medicine M. Carrington Reid,

antibiotics.

M.D., who co-authored the study with

it possible to look for mutated cancer

Lyme disease is caused by bacteria
spread through extended feeding on

clinical professor of medicine Robert T.

and specificity for the genetic alter¬

molecules in the blood of patients.
“Researchers at the Yale Cancer

seven visits to the doctor, had four
blood tests and underwent 42 days of

Schoen, M.D., says, “Were not helping

human blood by the tiny deer tick. The

these patients if we simply give them a

Center have hopes not only of improv¬

tick must be embedded in the flesh for

label of Lyme disease.” The study

ing the detection of small cancers, but

at least 24 hours to spread the bacteria

also of being able to identify women

into the host. In the vast majority of

points to the need for better informa¬
tion for patients and physicians about

whose breast tissue is about to become

cases, an infected bite will cause a bull’s

Lyme disease.

Bringing public health education to a changing China
The explosive growth of the economy
of the People’s Republic of China
brings with it many benefits—and a
set of daunting new public health

Union School curriculum in public
health law, health economics, environ¬

ease and sexually transmitted diseases
such as AIDS. In addition, 70 percent

mental health, smoking control and

of adult men in China smoke, creat¬

other areas. The grant will also fund

ing a huge need for anti-smoking

challenges. Already closely allied with

summer internships in China for Yale

campaigns organized by public health

efforts to improve public health edu¬
cation in China, Yale faculty and stu¬

students in public health.

workers.”
Yale first collaborated with Union

dent efforts will expand significantly
as a result of a five-year, $400,000

range of problems. “Fundamental

School in 1996 when University fac¬

grant from The Procter & Gamble

political and economic changes,” says
Michael H. Merson, M.D., dean of

ulty helped develop a public health
law curriculum. Part of the new col¬

Co. The funds will support a collabo¬
ration between the Department of

public health and director of the YaleUnion collaboration, “are presenting

laboration will involve refining that

Epidemiology and Public Health and

China with not only many health

Beijing’s 10-year-old Union School of

risks associated with developing

faculties at some 30 other public
health schools in China. Procter &

Public Health, the nation’s first gradu¬
ate-level public health training pro¬

nations—such as infectious and para¬
sitic diseases—but also rising rates of

gram. The main focus of the collabo¬
ration will be on strengthening the

diseases associated with lifestyle
changes, including cancer, heart dis¬
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Those students will face a broad

curriculum and disseminating it to

Gamble’s chairman and chief execu¬
tive officer, John E. Pepper, is a mem¬
ber of the Yale Corporation, the gov¬
erning board of the University.
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Discovery of how a brain tumor travels may pave way to treatment
Yale researchers have discovered a
molecule that speeds the growth and
spread of a form of brain cancer that
afflicts some 20,000 Americans annu¬
ally and proves lethal in half of the
cases within 18 months. Glioma, as
the form of cancerous brain tumors is
termed, is particularly resistant to
standard treatments such as surgery

(BEHAB), or reduces a tumor cell’s
ability to generate it, may slow
tumor progression.
Dr. Hockfeld’s study, which was
published in the April 1 issue of The
Journal of Neuroscience, provides the
first clear understanding of how glioma
cells invade healthy brain tissue. The
work also resulted in a new animal

because its cells zoom through normal

model for the disease that can be used

brain tissue to other sites where new
tumors can grow rapidly. According to

to evaluate future therapies. “One ap¬
proach to controlling the cancer,” says

a study directed by neurobiologist
Susan Hockfleld, Ph.D., gliomas

Graduate School of Arts and Sciences,

Dr. Hockfield, the new dean of the

move through healthy brain tissue

“would be to block the glioma cells’

with the help of a tumor-specific pro¬

ability to travel, without harming

tein, which acts like a set of wheels on

healthy cells.” She notes that BEHAB

the cancer cells. The researchers hope

may prove a prime candidate for this

that a therapy that blocks the function
of the protein molecule, called brain-

type of therapy because it exists in
glioma tumors but not in other kinds

enriched hyaluronan binding protein

of brain tumors or tissue in the body.

Wider use of medication
could prevent many strokes
An irregular heartbeat, or atrial

When a fragment of BEHAB protein is ex¬
pressed in experimental brain tumors (dark
mass at upper right), the tumors show a
marked increase in their ability to invade the
neighboring normal brain tissue (lighter re¬
gion). The clusters of dark tumor cells are
found scattered throughout the normal tis¬
sue shortly after they are grafted into the
host brain. When the BEHAB protein is not
expressed in these tumor cells, they do not
invade the normal tissue.

ongoing efforts to enhance clinical

nity is not getting this therapy to all of
the patients who need it.” The results

practice in the Center for Outcomes
Research and Evaluation at Yale-New

of the study appeared in the Decem¬
ber issue of Stroke and are part of the

Haven Hospital, Dr. Brass says.

fibrillation, affects some 2.5 million
Americans. Clot formation associated
with atrial fibrillation is believed to
be a contributing factor in about 15

A web of New Haven health information

percent of the 740,000 strokes that
occur each year in the United States,
yet very few of the people who would

non-digital holdings, and historical
images. Browsers will find links to re¬

Already an important tool for public
health investigators, the World Wide
Web now offers a new site for one-

lated sites and a listserv for the discus¬

atrial fibrillation receive it. According
to a study directed by Lawrence M.

stop local research in the field:

sion of public health research. Go to

New Haven Health. The Cushing/

<http://www.med.yale.edu/

Brass, M.D., professor of neurology

Whitney Medical Library received a

newhavenhealth/>.

and chief of the neurology service at

grant from the National

the VA Connecticut Healthcare
System in West Haven, only 38

past winter “to create a pub¬

percent of patients who had atrial

licly accessible Web site that

benefit from a medication to treat

Library of Medicine this

New Haven Health Statistics - Netscape
Fie Edt View Go Commcrscatoi Help
Reload

Back

fibrillation received warfarin, a blood

will function as a central re¬

thinner used to reduce the tendency

pository for information

for blood to form clots. Researchers

about public health in the
greater New Haven area.

believe that if more patients took
warfarin, tens of thousands of strokes
could be prevented, saving thousands
of lives each year. “We have a medica¬
tion that has been shown to be highly
effective,” says Dr. Brass, “but we
have found that the medical commu¬

’ Bookmark:

new
1

Documents

h

Search

Guide

FTm

3

Secuity

//vwAv med.yale eckiynewhavenhealth/statobc^'

a

v

e

n

h

e

Communication

Organizations

a

1

t

About NHH

h

^

R^f

£

Home / Search / Suggestions

Statistics and Data

The Web site includes vital
and health statistics, current

Accidents and Injuries
F alahty Analysis Rep oiling
System

Driver's ZIP code. County of
accident

N alional Highway Traffic
Safety Admimstraticm

1973-1989

US County

via CDC Wonder

1982-1996

US. MSA

CDC AIDS DataSet

1995-1996

Chronic and Noninfectious Diseases

and historical public health
documents, community
organization listings, aids
in the search for related

Statistics

Home

Location.

SEER Data Cancer Statistics

1

Communicable Diseases
AIDS Cases

SUMMER

1998

Yale physicians link up with Everest expedition

I

n May, several dozen seasoned
climbers set their sites on
Everest, the world’s highest moun¬

tain. As one group labored up the
treacherous and often deadly slopes,
Yale physicians made medical history
in an experiment linking the remote
expedition to the clinical resources of
a medical center 8,000 miles away.

tioning equipment to measure the
mountain’s subtle shifts in elevation.
Dr. Ronald Merrell, chairman of
surgery and director of the Yale
Commercial Space Center, and Dr.
Richard Satava, professor of surgery
and a leading expert in telemedicine,
initiated the Everest expedition’s
medical experiments.

Vincent Grasso, M.D., a postdoc¬
toral associate in the Department of
Surgery, directed care at Everest as
colleagues in New Haven monitored

Right: Vincent Grasso and climbing sherpa Ang
Sherring talk to physicians at Yale from the
base camp at Mt. Everest.

the climbers’ adjustment to high alti¬
tude and thin air. Vest-like biopacks
transmitted vital data from the slopes
of the 29,028-foot mountain to the
base camp at 17,000 feet, relaying
the information to Yale by satellite
phone and the Internet. A video con¬
nection allowed the two groups of phy¬
sicians to talk face to face as, for ex¬
ample, Dr. Grasso examined a sherpa
guide who was experiencing abdomi¬
nal pain. Taking full advantage of the
technology, images from a portable ul¬
trasound unit were transmitted simul¬
taneously allowing Dr. Grasso and the
New Haven-based team to rule out
major illness.
“This exercise will allow us to get a
better understanding of changes in
people’s bodies as they are going
through altitude changes. Hopefully
we will begin recognizing predictive
patterns,” says Peter B. Angood, M.D.,
assistant professor of surgery and
New Haven-based medical director for
the expedition. Dr. Angood and other
Yale researchers participated in daily
videoconferences with the expedition
team and scientists at the MIT Media
Lab, the U.S. Army, NASA and AT&T. In
addition to testing the biopacks, the
climbers have installed meteorological
devices to transmit weather reports

Above: The New Haven team, led by Peter Angood, second from
left, listen and watch from a medical school conference room.
For detailed maps, photographs and reports from the expedition
see <http://yalesurgery.med.yale.edu/CSC/everest.htm> and
<http://everest.mountainzone.com/98/> on the World Wide Web.

from Everest’s slopes and global posi¬
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“Tobacco Wars” began with a simple question: Why not?

O

n a Wednesday evening in
early April, David Kessler is
telling the story of The Tobacco

apart as Congress sought a higher

you go about doing that?”

amount and curbs on immunity from
future litigation). Dr. Kessler has left

patents to develop nicotine substitutes

The search began with industry

Wars to a room full of about 50

Washington to become dean of the

people. The account is equal parts
public health analysis, investigative

School of Medicine, remaining vocal
on the issue and advocating, along

journalism and detective story, with a

with former surgeon general C.

few elements that are decidedly cloakand-dagger: an informant code-named

Everett Koop, for a tough settlement.

Cigarette, industry documents leaked

tobacco wars as a faculty member en¬

in a plain white envelope, and pains¬
taking searches through patents and

gaging a class. “How do you look at

levels were high, nicotine levels would
be high, the industry claimed. But the

Tonight, Dr. Kessler talks about the

and add nicotine to wrappings and fil¬
ters. Although the industry officials
insisted they were not manipulating
nicotine, a study of low-tar cigarettes
suggested otherwise. The industry said
that nicotine was linked to tar. If tar

customs declarations.
The opening chapter takes place in

the problem?” he asks the audience at
the Slifka Center for Jewish Life at

cigarettes, for example, had more

FDA found that one maker’s ultralight

Yale. “What do you have to show?”

nicotine than the same brand’s regular

Washington, where as Food and Drug

From a regulatory standpoint, the

cigarettes. “I would argue that can’t

Administration commissioner in 1991,

problem was to define tobacco as a

Dr. Kessler asked his staff why the

drug and place it under FDA jurisdic¬

happen without some degree of ma¬
nipulation,” Dr. Kessler says.

FDA did not regulate tobacco. After

tion. What stymied regulators was the

But a theory is not proof. An im¬

all, it was clearly an addictive sub¬

definition of a drug as an article other

portant bit of evidence came from a

stance responsible for as many as

than food that is intended to affect

surprising source, a tobacco lobbyist

400,000 deaths a year in the United

the function or structure of the body.

bragging at a Washington reception

States alone. Why not try to prevent

“It took us two years to think

illness and death? Because 90 percent

through the question of how to ap¬

wrong places. “What he said was, ‘It

of smokers started in their teens, he

proach that definition. What we con¬

all begins in the fields,’ ” Dr. Kessler

also saw it as a pediatric health con¬

cluded, and it was a subtle difference

says. “What he didn’t realize was that

cern. Why not try to prevent young

that made all the difference in the

the person standing next to him

people from starting? The answer

world, was that the article was the

was direct, he recalls. “ ‘Because that’s

nicotine,” Dr. Kessler says, noting

would call us the next day.”
That information and another tip

one industry you can’t take on. It’s

that one of the definition’s key words

led the FDA to foreign patents and to

too powerful.’ ’’

is intended. “The physiological effects

Brazil, where an American company

of nicotine on the central nervous

was developing genetically engineered

Seven years later, the conventional

that the FDA was looking in the

wisdom has changed. The tobacco

system certainly are sufficient to

tobacco with twice the normal con¬

companies have offered to pay $368.5

affect the structure and function of

centration of nicotine. The industry

billion to settle a series of class-action

the body. You have to show intent,

claimed the new tobacco was simply a

lawsuits (a deal that subsequently fell

the manufacturer’s intent. How do

blending device.

Attention deficit study
finds no evidence of
overdiagnosis

more than the last two decades

Association {JAMA), studies published

and concluded that those worries

from 1975 through March 1997 were

are unfounded. The council’s chair-

reviewed and analyzed. The council
found little evidence of widespread

elect, Myron Genel, M.D., professor

The number of children being

of pediatrics and associate dean of

overdiagnosis or misdiagnosis of

diagnosed and treated for attention

government and community affairs
at the School of Medicine, says,

ADHD, or of widespread over¬

“The preponderance of evidence is

commonly prescribed drug for

that ADHD is not diagnosed lightly.
ADHD is one of the best studied

treatment of ADHD.
The council concluded:
“Epidemiologic studies using stan¬

deficit/hyperactivity disorder
(ADHD) has risen sharply in recent
years, and parents and child-health
advocates have raised concerns about
possible overdiagnosis of the disorder.

and characterized disorders.”

the American Medical Association

For the council’s report, which
appeared in the April 8 issue of The

reviewed studies in the field over

Journal of the American Medical

The Council on Scientific Affairs of

1 o

prescription of Ritalin, the most

dardized diagnostic criteria suggest
that 3 percent to 6 percent of the
school-aged population may have
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McCain, an Arizona Republican who
chairs the Senate Commerce Com¬
mittee, proposed tougher restrictions in¬
cluding a $i.io-per-pack price hike to be
phased in over five years; a $516 billion
payment from the industry; no ban on
lawsuits; and additional penalties if
companies failed to reduce youth smok¬
ing. That proposal, approved by the
commerce committee in a 19-1 vote, led
the tobacco industry to walk out on the
previous settlement.
Dr. Kessler learned of the walkout
a few hours before giving his talk at
the Slifka Center. “Congress,” he tells
the audience, “does not have to ask
the industry for permission to act.”
Congressional efforts to craft some
David Kessler answers questions after speaking at the Slifka Center in April.

type of settlement fell apart, however,
leaving states to negotiate individually
with the tobacco industry.

“The strongest evidence was yet to
come and it focused on industry

In 1996, the FDA declared nicotine

He closes his talk with the recollec¬
tion of the question that was consid¬

knowledge of tobacco products,”

a drug and placed restrictions on to¬
bacco ads and sales. A year later, the

ered naive. “Everyone at that time
said it was a fool’s errand,” Dr. Kessler
says. Tonight, this once-invincible

Dr. Kessler says. Documents from the

industry struck a deal with 41 state at¬

1960s proved that tobacco officials

torneys general who were suing to re¬

industry is on the defense, hard-

knew nicotine was addictive. Others
from the 1970s proved the tobacco

cover smoking-related health care

pressed even to find candidates who
will accept its campaign contribu¬

industry was marketing to young

$368.5 billion over 25 years to settle

tions. In Dr. Kessler’s eyes, it was

people. “Realistically,” reads an indus¬
try memo, “if our company is to

the claims, but would be immune

persistence and preparation—as well

from future class-action suits. Dr.

as imagination—that made the differ¬

survive and prosper over the long

Kessler and Dr. Koop, a visiting pro¬

ence. “Sometimes, just sometimes,”

term we must get our share of the

fessor of public health at Yale last year,

he says, “you can take on the

youth market.”

called that deal too weak. Sen. John

impossible.”

ADHD. The percentage of U.S.
youth being treated for ADHD is

and to ignore, or fail to learn to re¬

and irrelevant stimuli.

spond to, other stimuli. Otherwise, a

“In order to adapt to its environ¬

survival-threatening confusion could
result. A team of investigators, includ¬

ment,” says Dr. Kim, an assistant pro¬
fessor of psychology, “an animal must

ing Yale neuroscientist Jeansok J. Kim,
Ph.D., has found a neurological expla¬

ably predict biologically significant

nation for this phenomenon called

events, such as food availability. In the

blocking, and has identified the brain
structure involved in the blocking

animals must avoid forming associa¬

at most at the lower end of this
prevalence range.”

A brain structure that keeps
confusion at bay
Animals are constantly gathering sig¬
nals from the surrounding environ¬
ment, yet somehow they learn to fo¬
cus on stimuli important to survival
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costs. The industry would agree to pay

process. Dr. Kim and colleagues found
that when they chemically severed a
brain structure called the inferior olive

respond selectively to stimuli that reli¬

interest of efficiency and simplicity,
tions with other stimuli that provide
no new information. Blocking appears
to circumvent such redundant learn¬

in rabbits, blocking disappeared and

ing.” The study appeared in the

the animals responded to redundant

journal Science.

pany, he cited the

New York City and an expanded run¬
way at Tweed-New Haven Airport.

New Haven and Yale University have

importance of the
medical school to
the region’s and

portionate share of social ills such as
poverty have hobbled development in

New Haven’s mayor visits
medical school
never had better relations. Mayor

the city’s economy.

John DeStefano told students and
faculty during a visit to the medical

“I think that find¬
ing a way to grow

school March 5. “ 1 he University
and the city understand their need
to grow together,” he said at a Medi¬

the medical school

John DeStefano

towards the central

A lack of space, an unwarranted
image as crime-ridden, and a dispro¬

New Haven, he said. Since the 1950s
the city has lost residents and busi¬
nesses to the suburbs. Restrictive zon¬
ing laws and the lack of affordable

campus of Yale is a good idea.”
Mr. DeStefano said he has plans for

housing in the suburbs and a higher

Beaumont Room. “1 feel better about
understanding each other and sup¬

developing downtown New Haven

proportion of multi-family dwellings

porting each other than I have in

going to see the growth south of

my lifetime.”
Noting that the largest taxpayers

Howard Avenue towards Church

tion of poor people in the city, he
said. Median income, which in 1950

Street South and the train station,”

was about the same in the city and its

he said. He is also trying to improve
transportation by promoting ferry ser¬

suburbs, has shifted. For every dollar

vice to Long Island, a fast rail link to

Haven has 67 cents. “The fact of

cal School Council lunch in the

and employers in two neighboring
communities are a pharmaceutical
company and a medical research com¬

and Long Wharf.

“I

think you’re

in the city lead to a larger concentra¬

of income in neighboring towns, New

Using art to sharpen
observational skills
Medical education took an artistic
turn for a group of Yale students
this past spring. Professor Irwin M.
Braverman, M.D. ’55, and museum
curator Linda Friedlaender combined
their expertise to produce a tutorial
using works of art to sharpen the
observational skills of aspiring
physicians.
In a collaboration between the
medical school and the Yale Center
for British Art, 56 medical students
spent time looking at selected paint¬
ings, described them for the group
and made thoughtful judgments
about what was being communicated
visually. Students were assigned a
painting and given time to observe
and study it—“like a rash that has
been framed,” says Dr. Braverman,

Linda Friedlaender and Irwin Braverman developed a tutorial that uses paintings at the Yale
Center for British Art to train students to notice clinical details that are often overlooked.
“In the old days, before the advent of modern medical imaging technology, doctors had to
rely on the connection between the eyes and the brain,” Braverman says. “I hope this tutorial
can restore some of those skills.”

a dermatologist.
The goal of the exercise is to pro¬
duce more careful observers by train¬

He came upon the idea last

tion, chaired by her husband, Gary E.

ing students to decode an object’s

November while thinking of ways to

meaning and to extract useful infor¬
mation. Physicians with superior ob¬

teach his dermatology residents to no¬

Friedlaender, M.D.
The students who participated in

tice more in the clinic. He discussed
the idea with Mrs. Friedlaender, cura¬

step in their training. “Like very de¬

tor of education at the Yale Center for
British Art, who had been thinking

tailed paintings, the human body is
complex,” says Leo Kim, a first-year

about the same kind of observational

servational skills ask the questions
necessary to diagnose illness without
relying excessively on tests, says Dr.
Braverman, adding, “Doctors have to

the tutorial found it to be a significant

be taught to pick up on details that

exercise for residents in the Depart¬

student. “Learning to look at, and re¬
ally see, all the details of a painting

are often overlooked.”

ment of Orthopaedics and Rehabilita¬

helps in diagnosing patients.”
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housing segregation and the racial and
economic isolation that flows out of
that is a real challenge,” he said.
On top of its economic woes, the
city is unfairly portrayed as a place ol
crime and that keeps people away, he
said. He said that in 1994, Bridgeport
had 54 murders, nine of which made
the front page of the newspapers.
Hartford had 61 murders, with seven
making the front page. All but one of

health and law enforcement in
New Haven has given us a unique
opportunity to think about violence

Exercise science soars on
human powered wings

from many perspectives,” says Dr.

As a physiologist, Ethan Nadel, Ph.D.,

Marans, who helped launch the
program in 1991 with center Director

knows a great deal about what happens

Donald J. Cohen, M.D. ’66, and
city police leaders. “We have gained
an awful lot of experience over the
last seven years.”
During his two days in Jonesboro,

to the body during exertion and the
causes of fatigue. Even he didn’t know
just what to expect, however, when he
helped to plan a world-record, humanpowered flight. In his March 27 lec¬
ture, Dr. Nadel, professor of cellular
and molecular physiology and of epi¬

New Haven’s 34 murders that year
were front-page news. ’‘New Haven is

Dr. Marans talked with counselors,
parents, teachers and students and at¬

the murder capital of the state not be¬

tended a meeting of about 500 stu¬

cause we had the most murders,” Mr.
DeStefano said, “but because we did
the best job of publicizing them.”

dents and parents. “They have a very

described the challenges planners faced

arduous task at hand, which is to
mourn the loss of life and to mourn

when preparing the pilot 10 years ago

their loss of friends and children,” says

reenactment of the mythical Greek
inventor Daedulus’ 74-mile passage

Since 1990 crime has dropped by

demiology and director of the Yaleaffiliated John B. Pierce Laboratory,

for Project Daedalus, a modern day

nearly 40 percent, Mayor DeStefano

Dr. Marans, the Harris Assistant Pro¬

said, noting that in early 1998 the
city’s murder rate was the lowest in

fessor of Child Psychoanalysis. Those

between the Greek islands of Crete

who saw the shootings or lost friends

and Santorini. Dr. Nadel selected the

generations. “Real growth will occur

may experience depression, eating and

pilot team and developed a drink to

when we move past perceptions and

sleeping disorders, a sense of disbelief,
psychological numbing and a degree

prevent dehydration and boost the

of fearfulness. Children may be more

ing but ultimately successful flight.

ignorance,” he said.

clinging and dependent and needy
than they are typically.

Child Study Center aids
Arkansas town after
shootings

The town of 50,000 people is left
to wonder why two children would set
out to kill other children. “Having the

pilot’s energy supply during the gruel¬
His talk inaugurated a new series of
campus lectures, along with a new
summer research internship program
for seven Yale College students, spon¬
sored by Gatorade Inc.

easy availability of guns and inad¬

The day after four girls and a teacher

equate supervision has been a potent

were shot to death at a middle school

and lethal combination. But every

in Arkansas, Yale psychologist Steven

human being has anger and feelings

Marans, Ph.D., was on a plane.

of rage at times and longings for at¬

Two boys, ages 11 and 13, were ac¬
cused of setting off a fire alarm on

tention. Those feelings that are com¬

March 25, then ambushing school¬

expression in murdering one another,”
says Dr. Marans. “We know this

In today’s managed care world, con¬
solidation of health care delivery ser¬

As the small city of Jonesboro tried to

behavior is not typical in the majority

vices is the order of the day, including

make sense of the incident, one of
nearly a dozen violent outbursts in

of children, and our children need to
know that as well.”

the practices of Yale faculty members.
The Yale Cardiology Network, a

mates as they ran from the building.

mon to all of us do not typically find

Cardiologists combine
to form statewide
network

schools around the nation this past
school year, Dr. Marans was sum¬

faculty-practice organization, has
merged with CardioNet of Connecti¬

moned as an observer and consultant.
The reason was Yale’s Child Devel¬

cut, LLC, a community-practice
group, to form a statewide heart-care

opment-Community Policing Pro¬
gram, a unique collaboration between
mental health professionals at the

network. Its more than 90 universityand community-based physicians, car¬
diologists and cardiac surgeons also

Child Study Center and New Haven’s
police department. The CDCP Pro¬

serve parts of Rhode Island and New
York. The network, the first of its kind
in Connecticut, will operate under the

gram, which provides counseling and
other support to children who have

name of the Yale Cardiology Network

witnessed violence, has been replicated
in four U.S. cities with funding from

and will be headed by an executive
committee chaired by Barry Zaret,
M.D., chief of the section of cardio¬

the U.S. Department of Justice.
“The partnership between mental
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A genetic intervention for
children with rare disease

The only reported side effect among
the children has been a high fever that

Probing the hazards of
autobody work

Yale investigators are evaluating a po¬

is typical of gene therapies and easily
treated, said Dr. Seashore, professor of

tential therapy lor Canavan disease, a
rare neurological disorder in children

genetics and pediatrics.
Treatment starts with the insertion

that is usually fatal. Eight children

of a 2-inch-wide rubber reservoir
under the scalp. A slender catheter

customers out of work areas, but paint¬
ers and repairers must stay in that envi¬

part of a clinical trial to test the safety
of the treatment, which uses gene

carries the gene to synthesize asparto-

ronment for hours each day. Although

acylase (ASPA), an enzyme missing in

therapy techniques to replace a critical

Canavan disease, into the ventricle of
the brain. Although researchers are

most shops take safety precautions,
research shows that exposure to chemi¬

have been cared for at Yale this year as

enzyme in the brain.
Children with Canavan disease
cannot hold their heads up, have
trouble eating and may suffer seizures.

still trying to understand the exact
mechanism, without ASPA a chemical

Walk into an autobody shop and you
may be greeted by a curious cocktail
of chemical fumes. Posted signs keep

cals in autobody paint can trigger
respiratory ailments.

called N-acetylaspartic acid builds

To determine how exposure to a class
of chemicals known as isocyanates

Few live past the age of io. The

up and myelin, the “white matter”

causes asthma, researchers at Yale’s

genetic disease strikes children of

that protects nerves and allows

Occupational and Environmental Medi¬

all ethnic groups, occurring most
frequently among Ashkenazi Jews.

messages to be transmitted to and
from the brain, becomes deficient.

cine Program have launched a study of

Researchers hope their therapy will

study, called the Survey of Painters and
Repairers in Autobodies by Yale, or

According to Margretta R.

shops in two Connecticut counties. The

Seashore, M.D., the principal investi¬

stimulate the brain to produce ASPA

gator in the study, the current phase

and slow down or reverse the progress

of the trial will assess its safety. Yale’s
Human Investigation Committee

of the disease.
Parents recognize that the therapy

and its Biosafety Committee are also

is experimental and may not help

posed to many potentially harmful

monitoring the study. A ninth child

their children. “There will either be a

materials, such as paints and solvents.

is undergoing the therapy at Thomas

benefit or there will be nothing,” said

Paints often contain isocyanates, which

Jefferson University Hospital in

Howard Gluckman of Johannesburg,

SPRAY, is also directed at finding better
ways of protecting workers’ health.
Workers in autobody shops are ex¬

Philadelphia. If the procedure proves

South Africa, who calls his son,

are highly reactive chemicals known to
induce respiratory symptoms and

safe, the FDA may allow researchers

Asher, 9, the granddaddy of the

asthma. According to Mark R. Cullen,

to add six more children to the trial.

group. The youngest child in the

M.D., director of the Occupational and

Although the Phase I trial is fo¬

group is 19 months. “At least they’re

Environmental Medicine Program and

cused on the safety of the procedure,

not in danger from the procedure.”

the study’s principal investigator, isocy¬

researchers are watching for signs of

“It’s a first step,” said Matthew
During, M.D., a visiting professor

anates account for the highest number
of reported cases of occupational asthma

at the medical school who conducted
previous gene therapy trials in

oped countries. Approximately 5 to 10

improvement in the children. “It’s re¬
ally too early to know whether we’ve
got some encouraging signs of thera¬

in the United States and other devel¬

peutic effect,” said Maurice J.

New Zealand. “It gives us a level

percent of workers exposed to isocyan¬

Mahoney, M.D., a member of the
Human Investigation Committee.

of comfort and confidence in

ates may be affected nationally.
SPRAY, which is funded by a

moving forward.

Focus on fitness
The Yale Conference on Women’s Health & Fitness in May brought to¬
gether some of the nation’s leading experts on physical activity, meno¬
pause, cancer and nutrition to discuss the latest findings for the treat¬
ment of women and the diseases that affect their health. Keynote
addresses were given by Stephen Blair, director of epidemiology and clini¬
cal applications at the Cooper Institute for Aerobics Research in Dallas
and author of the surgeon general’s report on physical activity; and
Rebecca and Ruthann Lobo, co-authors of Home Team: of Mothers,
Daughters & American Champions. The Lobos spoke about how they
handled Rebecca’s success on the basketball court and Ruthann’s battle
with breast cancer. Pictured at a reception at the Yale Sports Medicine
Center are (back row, from left) Larry Matthews, Ph.D., conference co¬
chair; Rebecca and Ruthann Lobo; and (front row, from left) conference
co-chairs Ann Cowlin and Peggy DeZinno.
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Yale appeals verdict in Dr. Doe case
In December a New Haven jury

procedure only three times before the

pensation benefits through the hospital.

awarded $12.2 million to a former

accident and that the supervising physi¬

Both sides in the case expect to file

medical resident who became HIV¬

cian, a third-year resident, failed to

briefs this summer and present argu¬

positive after an accidental needle stick

monitor the procedure properly.

ments later this year.

in 1988. The resident, known in court

The University is challenging the

As of December 1996, 52 health care

documents as “Dr. Doe,” sued Yale, al¬

jury’s verdict in two areas. First, its ap¬

workers around the country had ac¬

leging that inadequate training and su¬

peal argues that Connecticut law does

quired HIV through occupational

pervision caused the accident. The Uni¬

not recognize such a claim for educa¬

transmission, 24 of whom developed

versity is appealing the verdict.

tional malpractice. It also argues that

AIDS, according to the federal Centers
for Disease Control and Prevention

Dr. Doe, then 25, was a first-year

the University should not be held liable

resident seven weeks into her internship

because, as an employee and resident at

(CDC) in Atlanta. Another 111 may

at Yale-New Haven Hospital when she

Yale-New Haven Hospital, Dr. Doe’s

have acquired HIV on the job, but the

pricked her right thumb while inserting

exclusive remedy is a workers’ compen¬

source of transmission hasn’t been de¬

a line into the artery of a patient with

sation claim rather than a civil suit. Dr.

termined in those cases, according to

AIDS. Dr. Doe said she had tried the

Doe is already receiving workers’ corn-

the CDC.

five-year, $2 million grant from the

tanned hue and has skin cancer-protec¬

Public Health. The series is part of the

National Institute for Occupational

tive qualities similar to real melanin.

Safety and Health, provides participat¬

In an added bonus, it also has re¬

Pew Urban Health Program, a research
and teaching collaboration among stu¬

ing autobody shops with free industrial

markable chameleon-like characteris¬

dents and faculty from the schools of

hygiene evaluations. Yale researchers

tics that cause it to blend its hue to

medicine, public health and nursing.

evaluate the working environments in

that of the individual’s surrounding

several shops for isocyanate exposure,

skin. To Dr. Pawelek’s surprise, follow¬

Addressing an audience of Yale
and New Haven community members,

make recommendations to reduce their

ing early publicity about the product,

the three principal speakers focused on

exposure to chemicals, and give workers

he has received a flood of inquiries

different aspects of the issue of domes¬

free respiratory health evaluations.

from people who suffer from vitiligo,

tic violence. Sujata Warrier, Ph.D., di¬

a skin disorder causing a progressive

rector of the New York City Program

loss of pigmentation cells that affects

of the New York State Office for the

1 percent of the world’s population.

Prevention of Domestic Violence,

San-Mar Laboratories Inc., which li¬

spoke about ways to assist victims

With skin cancer rates soaring, derma¬

censed the discovery from Yale, will be

from a variety of ethnic and social

tologists have been warning people to

producing cosmetic products contain¬

backgrounds. Donna Edward, J.D.,

protect themselves from the sun, but

ing it for marketing worldwide before

executive director of the National

A “natural” tan to beat the sun

the popularity of tanning means the

year’s end “It may prevent many cases

Network to End Domestic Violence,

advice often goes unheeded. Thanks to

of skin cancer,” says Dr. Pawelek “and

discussed new federal legislation aimed

a new cosmetic tanning lotion devel¬

should bring relief to at least some

at curbing violence against women.

oped by Yale senior research scientist

people with vitiligo.’’

Yolanda Haywood, M.D., an associate

John M. Pawelek, Ph.D., tanners will

professor of emergency medicine at

soon be able to get that sun-soaked

George Washington University

look without sitting under the sun or

Medical Center, who treats domestic

Confronting violence
in the home

violence victims, was herself in an

on therapies for melanoma and other

Domestic violence is rarely thought of

struggles she faced in leaving that

forms of skin cancer. While doing basic

as a public health issue, yet it has a

violent situation, she sought to provide

research with professor of dermatology

massive impact on the health care sys¬

attendees with a clearer understanding

Jean Bolognia, M.D., on melanocytes,

tem, accounting, for instance, for more

of the complex motivations that under¬

the pigment cells that color skin and pro¬

than a third of all women seeking

lie domestic violence.

vide protection from the sun, he came

emergency treatment from U.S. hospi¬

in a tanning booth.
Dr. Pawelek’s medical research focuses

abusive relationship. By recounting the

upon a method for producing a water

tals. Understanding the phenomenon

soluble form of melanin derived from the

and seeking ways to reduce its inci¬

Contributors: Susan Alksnis,

aloe vera plant. The extract, which is

dence were among the topics explored

Cynthia Atwood, John Curtis,

chemically indistinguishable from natural

at the third annual Domestic Violence

Michael Fitzsousa, Katie Krauss,

human melanin, immediately changes

Seminar Series, held this spring by the

the skin’s color to a natural-looking

Department of Epidemiology and

Helaine Patterson, Karen Peart,
Marc Wortman.
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Lack of women’s bathrooms at the School of Medicine building at 150 York Street, above, since
torn down, would help keep women out until Henry Farnam offered to build one, allowing his
daughter and two other women to gain admission in 1916. Mr. Farnam, a Yale economics professor,
wrote this letter, top, to Yale president Arthur Hadley offering to provide the funds to build the
needed women’s bathroom.
After graduating, Dr. Louise Farnam, above left, spent ten years as a medical missionary and
practitioner at the Yale-affiliated Yali Hospital in China. When she removed a bad tooth from the
mouth of Chinese leader Chiang Kai-shek, she got her picture on the cover of the program’s
journal. After Louise Farnam and two other women entered in 1916, the next medical school
class accepted only one woman, Ella Clay Wakeman, pictured at left with her classmates.
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any factors stymied the arrival of women at the
Yale School of Medicine, including societal
roles, self-assessment and certainly prejudice

among men on the faculty and in the wider University
community. By 1916, however, only one thing seemed to
stand in the way of women gaining admission: the lack
of proper bathroom facilities for women. It would take a
father’s money and influence and a daughter’s determi¬
nation to overcome that last barrier.

Susan J. Baserga

While Johns Hopkins University was founded as a
coeducational institution in 1893, most other prestigious

Apparently some behind the scenes wrangling did

Eastern medical schools were slow to welcome female

ensue and in a letter of March 31, 1916, to then-Yale

students. According to research on women in medicine

president Arthur Hadley, Professor Farnam, recognizing

that Susan J. Baserga, M.D., Ph.D. ’88, pursued as a Yale

the matter of the lack of facilities was “considered a seri¬

College undergraduate, Yale would wait nearly a quarter

ous one,” offered to pay for “suitable lavatory arrange¬

century before admitting women. Harvard held out the

ments.” President Hadley agreed, and, in the next term,

longest, until 1945.

Louise Farnam and two other women, Helen May

By the turn of the century, however, women could

Scoville and Lillian Lydia Nye, became the first women

study in the Yale Graduate School, and Vassar College

admitted to the School of Medicine. Dr. Farnam gradu¬

graduate Louise Farnam took a Ph.D. in physiological

ated in 1920, winning the Campbell Gold Prize for the

chemistry there in 1916. An exceptional student, she

highest rank in examinations. After further training at

was also intent on studying medicine so that she could

Johns Hopkins, she spent the next ten years at the new

travel as a medical missionary to China. “She had

medical school and hospital established by the Yale-

incredible fortitude,” says Dr. Baserga, herself now an

China Association, Yali, in Changsha.

assistant professor of therapeutic radiology and genetics.
“She was very religious and was driven by her faith.

The year following Dr. Farnam’s admission to
Yale saw only one woman, Ella Clay Wakeman, in

Fortunately, she also had a philanthropist father.”

the class. Female graduates of the era were well

Louise Farnam came from a family with close ties to

aware of the story behind the school’s lone women’s

Yale, going back to the early 1700s and continuing

bathroom, which was quickly dubbed the Louise

with her father, Henry Farnam. Farnam pere was a

Farnam Memorial.

Yale graduate, a professor of economics, a New Haven
and Yale benefactor, and a member of the board
overseeing New Haven Hospital.
When his eldest daughter announced her intention
to study medicine at what, until then, had been an

Women continued to be admitted to the School
of Medicine after those first classes in numbers kept
deliberately small by the school. Other than during
World War II, until the 1960s no class counted more
than 10 percent women among its members. Helen P.

all-male medical school, the medical school informed

Langner, M.D., who graduated in 1922, was the school's

her that an insurmountable barrier prevented her

oldest alumna when she died last December at age 105

enrollment. There was no women's bathroom in the

(See A life of engagement).

school, which was then housed in a building, since torn

Louise Farnam would be pleased with her legacy.

down, at 150 York Street. Whether the issue of the

Today, the right of women to enter the School of

bathroom was a genuine obstacle to the presence of

Medicine without prejudice is beyond challenge. In fact,

women in the school—or a last ditch effort to keep

this year’s graduating class was the first ever to arrive at

them out—isn’t clear from the historical record,

Yale with more women than men among its members.

according to Dr. Baserga.

“Physicians like Dr. Farnam and Dr. Langner helped
pave the way for many younger women,” says Merle
Waxman, M.A., associate dean and director of the
Office of Women in Medicine. “I think they and their

Marc Wortman is a freelance writer.
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of engagement

Helen Langner entered medicine 80 years ago, as the doors of the profession
were first opening to women. She made good use of her 1922 Yale degree.

By John Curtis
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hen Helen P. Langner, M.D. ’22, died last
December at age 105, one of her many friends
observed that the least remarkable thing about

her was her age. “I think she was bewildered by the
accolades, the things that people said about her,” said
Helen Trainor, a nurse-psychotherapist who trained
and worked with Dr. Langner from 1983 until her death.
“Her answer was, ‘If you live long enough you get
recognition, whether you deserve it or not.’ ”
Dr. Langner’s life spanned nearly all of the 20th cen¬
tury and was filled with accomplishments that had noth¬
ing to do with her years but everything to do with her
times. She was the fourth woman to graduate from the
Yale School of Medicine. She marched in one of the first
women’s suffrage rallies. She was an early practitioner in
the emerging field of child psychiatry. And at Yale medi¬
cal school reunions and other ceremonial events, she was
honored and celebrated as the school’s oldest alumna.
She died just a few months before she was to receive

As a medical student, Helen Langner, in white hat, second from left,
became close friends with Ella Wakeman, right, who had entered the
School of Medicine a year earlier, and Ella's brothers Maurice and
Edward. The woman at the left is unidentified.
Left: Helen Langner, Yale’s oldest living graduate until her death last
December at age 105, witnessed a century of dramatic change in
medicine but held fast to old-fashioned common sense. She told
friends the key to longevity was to have a reason for living.

her second medical diploma from Yale as an honorary
member of the Class of 1998, the first Yale medical
class to enter with more women than men. Dr. Langner

EARLY OBSTACLES

was inducted with the class four years ago at the White

Dr. Langner marched in an early suffrage rally, but no

Coat Ceremony welcoming students to the profession

one recalls her expressing anger or bitterness at the ob¬

of medicine.

stacles she faced as a woman in medicine. She believed

Who was this frail centenarian who radiated not

hard work would see her through. “The first hurdle was

only wisdom, but common sense and calm? Friends and

finding a medical school that would accept you,” said

colleagues remember a slight, white-haired woman who

Susan J. Baserga, M.D., Ph.D. ’88, who has written

believed having good reasons for living was the key to

about the history of women in medicine (See Gallery)

longevity, and who kept her mind active even as her

and who knew Dr. Langner. “The problem after that

body came to rely on canes, walkers and finally a wheel¬

was getting a residency because there weren’t too many

chair. She continued working until she was well into her

programs that accepted women.”

90s. Invitations to meetings and reunions at Yale often

Her path to a career in psychiatry began during

came with offers, which she rejected, of a car and driver

World War I when she had an administrative job at St.

to collect her and take her home. She preferred walking

Luke’s Hospital in New York City. She’d gone to New

from her house on Shipyard Lane in nearby Milford,

York a few years earlier to attend Hunter College, which,

Conn., to the center of town, where she could take the

unlike colleges in Connecticut, accepted women. After

bus to New Haven. She routinely walked the three-quar¬

graduation in 1914 she taught high school biology, work

ters of a mile from her white two-story house overlook¬

that didn’t satisfy her, before moving on to the hospital.

ing the harbor to Milford Hospital and the city health

She considered a career in nursing, but her father urged

department, where she began a second career at the age

her to apply to the Yale medical school, which had be¬

of 78. “To see her there was to feel all was right with the

gun to accept women.

world ... as long as she was in it,” said Alan Jepson,
Milford’s city clerk.

For the next four years she lived at the home in
Milford where she’d grown up, the first and only daugh¬
ter of a baker and his wife, and big sister to five brothers.

John Curtis is a staff writer.
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Every morning she caught an early train from Milford to
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After graduation from
medical school in
1922, Dr. Langner
trained in psychiatry
in New York City,
then worked to es¬
tablish child guid¬
ance clinics around
the United States be¬
fore becoming direc¬
tor of health services
at Vassar College.
This undated portrait
of Helen Langner was
taken during her days
in New York City,
when she had her
own psychiatric prac¬
tice and worked at
Cornell-New York
Medical Center.

New Haven, walked from Union Station to her classes,
and then returned home in the afternoon to study late
into the night. In the little time she had for recreation,
she sailed on Long Island Sound or listened to operas
like The Magic Flute and Die Fledermaus. When she
came home to visit during her undergraduate days in
New York, her mother, who also loved opera, would slip
her an extra dollar so she could attend a performance,
her brother Gustave Langner remembered.
Although she was the only woman in her medical
school class, friends say she felt supported by her fellow
students, particularly Edward and Maurice Wakeman,
twin brothers whose lather was a physician and whose
sister, Ella, had entered the school the year before.
Maurice died while doing research in Africa, but
Dr. Langner maintained her friendship with Edward

c/5
ID
O

and Ella. From medical school Dr. Langner went to a
residency at Wards Island, a state mental hospital in
New York City.
It was made clear to Dr. Langner in her first job
after her residency, setting up child guidance clinics

seem to be able to pick out the people who are warm
and safe and approachable. She was very approachable.”
Ms. Trainor recalls how Dr. Langner helped a 5-

around the country, that a man was preferred. Fine, she

year-old boy, the son of friends, who had been diagnosed

said. She offered to start the clinics, then step aside if a

as hyperactive. Dr. Langner saw the boy not as a patient,

man came along. After a few months in Richmond, Va.,

but as a guest in her home. She encouraged curiosity in

she went to a privately funded clinic in Indianapolis,

children, and like all children who visited her, the boy

where she stayed two years until the stock market

was allowed to explore the house. Dr. Langner con¬

craned and funding ran out.

cluded that he had too long an attention span to be

She took over as director of undergraduate health

hyperactive. “In her inimitable way,” Ms. Trainor says,

services at Vassar College when her predecessor took a

“she did not say the diagnosis was wrong. She just sug¬

maternity leave. Although Dr. Langner never married,

gested that this was a situation that could be remedied

she was a strong advocate not only for women in medi¬

by setting certain limits.”

cine, but also for women who combined family and pro¬
fession. Dr. Langner told Merle Waxman, director of the

A Milford woman took her io-year-old son to
Dr. Langner for counseling about 25 years ago. “He was

medical school’s Office for Women in Medicine, that

daydreaming, off in another world,” says the woman.

she was very excited about the increasing numbers of

The boy also had slight difficulties with hand-eye

women entering the field. “She greatly admired women

coordination. “She played games with him and learned

who devoted their careers to science and to medicine,

about his abilities and weaknesses.” Dr. Langner, she

Ms. Waxman says. “She was a strong supporter of the

says, played to the boy’s strengths with advice to take up

concept of an Office for Women in Medicine here, and

“big muscle” activities such as swimming and running.

was an important friend of the office.”

“We had to know his limitations so we didn’t push him

After io years at Vassar, her interest in psychiatry led
her to New York City, a private practice and an appoint¬
ment at The New York Hospital-Cornell Medical Cen¬

into things he shouldn’t be pushed into,” the boy’s
mother says.
While she was gentle and flexible, she could also be

ter. She opened her office the month Japan attacked

quite firm. “I sat behind a screen one time at Wards Is¬

Pearl Harbor. She also moved into the family home

land when she was discharging a patient,” her brother

overlooking the harbor at Milford and commuted to

said, recalling an incident that occurred more than half a

New York by train. Friends wonder if child psychiatry

century ago. “She laid it into the husband who was go¬

appealed to Dr. Langner because of her role as the older

ing to take his wife home and told him what he was go¬

sister who had a hand in raising her five brothers. Even

ing to have to do so she wouldn’t have to come back to

as a centenarian, friends say, she drew children to her be¬

the hospital. He was very meek and mild, ‘Yes, Doctor.

cause she listened to them. “Kids won’t go near people

Yes, Doctor. I will, Doctor.’ I was grinning ear to ear

they sense aren’t receptive,” says Ms. Trainor. “They

behind the screen.”

2 O

SUMMER

1998

p. xmnn. m

r

c u,SSB^ltHOSOR^^l'^A *WNU

y

Dr. Langner closed the chapter on her second career
at Milford’s hospital and health department at the age of

m V^SIS CCXCV7,

In 1994, Dr. Langner entered medical school for the second
time, joining the Class of 1998 as an honorary member at
age 102 during the traditional White Coat Ceremony. She
did not live long enough to attend commencement but her
brother Gustave accepted her honorary degree at a memo¬
rial service in February.

98. During the preceding two decades she had accepted
no payment for her work, and it was only with difficulty
that George Kraus, M.D., M.P.H. ’51, director of

Dr. Langner was a mentor. “She would have read it,

Milford’s health department, convinced her to let him

given it to me to read and then we would discuss that

pay her licensing fees and professional dues.

particular article.”

“She saw people with problems who could not af¬
ford private psychiatric care,” Dr. Kraus said, adding

In her hometown Dr. Langner became an ardent
preservationist, campaigning to save historic buildings

that she was particularly helpful with elderly patients.

and the harbor and sound where she’d sailed in her

“She would tell them that she was a psychiatrist who

youth. “Every time they were going to demolish an old

came to examine them. But they regarded her as a

building in Milford that had historical significance,” said

friend and a helper. As a result we were able to elicit

Nicholas P. Spinelli, M.D. ’44, “there she was. She al¬

information that we could otherwise not get.”

ways had a petition: ‘You will not destroy this place.’ ”

Even after her second retirement, she tried to keep

Dr. Langner was renowned as the oldest resident of

up with medical practices by reading medical journals

Milford and the only survivor of her medical school

and attending conferences and reunions. “I would bring

class. Newspapers often carried stories about her and

a case to her and the next time I saw her she would

Cable News Network featured her in a report about

have found an article in a journal that pertained to

centenarians. Although her longevity brought a degree

that particular case,” recalled Ms. Trainor, for whom

of celebrity, it was her vibrant, active mind that drew
people to her. “I suddenly was aware of this little old
lady in the back of the room at reunions,” recalled
Dr. Spinelli, the medical school’s former director of
alumni affairs, who remembers meeting Dr. Langner
about 15 years ago. “She was 90 going on 25. You
would talk to her and you thought she was a college
student planning to go to medical school next year,
she was so enthusiastic.”
And while she never liked to be fussed over, about
80 friends, relatives and colleagues gathered at the First
United Church of Christ in Milford in early February to
remember her. Youngest brother Gustave, 94, accepted
the honorary degree that would have come to his sister

In 1997 Dr. Langner returned to Yale for her 75th reunion. She was
the only surviving member of the Class of 1922. “The company and
conversation of my alumni is always pleasant and enlightening,"
she wrote in her class report. “After a long, wonderful day, I return
home with all my memories to recuperate.”
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in May. Speaking at the memorial service, Deputy Dean
Robert PL Gifford, HS ’67, said that her contribution to
education was profound. “She became an inspiration to
hundreds of medical students, particularly women.”

EE]

Factoring
in
Yale research on womens healthy bolstered by
a landmark $6.5 million grant, draws
together scientists from many disciplines.

By Michael Fitzsousa

Carolyn Mazure directs the newly established
Ethel F. Donaghue Women’s Health
Investigator Program at Yale.

U

ntil 1993, when Congress passed legislation
changing the way clinical trials are conducted, it
was possible to bring a drug or device to market

without including women in its evaluation. For many
years, it was the rule, rather than the exception, to ex¬
clude women from the studies that are required to prove
the safety and effectiveness of new treatments.
Two seemingly reasonable ideas in particular con¬
tributed to this gap in data. One was that women of
child-bearing age should not be exposed to experimental
risk. The other was that the hormonal changes associ¬
ated with the reproductive cycle would add a level of
complexity to trials that would be unmanageable. Yet ex¬

Dr. Mazure with members of the Donaghue Program staff, from left:
Data manager Paul Falzer, Ph.D., research assistant Beth Ruff and
program coordinator Mona Gregg.

cluding women has left major areas of human health un¬
explored, says Carolyn M. Mazure, Ph.D., a professor of

about gender in the research they are actively pursuing,

psychiatry who heads the research arm of the Women’s

and think more about research collaborations to answer

Health Program at Yale. “It is essential to study women,”

relevant questions.”

she says, “because the treatments and procedures devel¬
oped on men may not always be appropriate for
women.” And while cyclic variation does bring complex¬

AN

ity to many research questions, scientific methods have

The Donaghue funding was announced at a press con¬

EVOLUTION

evolved to better handle that complexity. In fact, since

ference in Yale’s Medical Historical Library, a balconied

enactment of the 1993 legislation, the inclusion of

room with a 50-foot ceiling, leather sofas, reading tables,

women in trials must be carefully considered when

a massive stone fireplace and books lining every square

federal dollars are used.

foot of wall space. “This is the perfect setting for this

Just how far has the issue evolved during the past

special event,” Dean David A. Kessler, M.D., told the

decade? At Yale, one indication came in February with

group. “Research has always been central to the school’s

the announcement of a $6.5 million grant for women’s

academic mission. That commitment will continue

health research. The five-year award from The Patrick

to be at the very core of all we do here in the future.”

and Catherine Weldon Donaghue Medical Research

The Donaghue support, he added, provides the oppor¬

Foundation ofWest Hartford, Conn., will support

tunity to expand that commitment “while building on

interdisciplinary research that advances knowledge in

an already exemplary program in women’s health.”

women’s health. One of the most exciting aspects of the

In addition to its research component, the Women’s

new program is its potential to bring together research¬

Health Program at Yale has developed new models for

ers from a wide range of scientific fields, each with a

patient care and the training of physicians, and in 1996

unique perspective on how gender may factor into

was designated by the U.S. Public Health Service as one

disease processes and health. “We don’t want people to

of the first six Centers of Excellence for women’s health

think that women’s health must be a separate area of

nationally. According to Director Janet B. Henrich,

research,” says Dr. Mazure, who directs the Ethel F.

M.D., advances in women’s health overall will depend to

Donaghue Women’s Health Investigator Program at

a large extent on good science. “We want to add to the

Yale, the new entity created by the grant. “Instead, the

knowledge base,” she says, “with the ultimate goal of

hope is that more and more investigators will think

improving care for women. The goal is to integrate these
elegant findings from the laboratory into practice.”
During late winter and spring, Donaghue program

Michael Fitzsousa is the editor of Yale Medicine.
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staff sent out requests for applications to researchers

i 3

around the medical school, University and at each of the
Yale-affiliated hospitals. In total, 81 applications were
submitted by investigators in 15 medical school depart¬

big difference in terms of comfort and morbidity.”
Another researcher who received program support is
endocrinologist Karl L. Insogna, M.D., who studies the

ments and other corners of Yale including the School of

underlying mechanisms of osteoporosis. This weakening

Nursing, departments of chemistry, sociology and psy¬

of the skeleton, more common among women than

chology, the Institute for Social and Policy Studies and

men, occurs at a rate three to four times faster after

the John B. Pierce Laboratory. “If we were able to fund

menopause than in younger women. Hormone replace¬

all of them,” says Dr. Mazure, “we would need $10 mil¬

ment therapy has been proven to slow and even halt

lion.” Among the topics: the influence of sex-related

the damage. Because estrogen therapy is known to

hormones in a variety of disorders including cardiovas¬

carry health risks as well as benefits, the search is under

cular disease and osteoporosis, the molecular mecha¬

way for more specific agents that might interfere with

nisms of breast, cervical and ovarian cancer, gender

bone breakdown.

differences in surgical recovery, HIV risk behavior in

For the last several years, Dr. Insogna and colleagues

women, the relationship between health and employ¬

have been working to explain the mechanism by which

ment in women, the relationship of breast cancer to en¬

bone loss occurs. Starting with the knowledge that

vironmental exposure variables, and the biological basis

parathyroid hormone (PTH) regulates bone breakdown

for a variety of psychiatric conditions that women expe¬

and the metabolism of calcium, they looked for clues to

rience at a higher rates than men, such as depression,

how estrogen is involved in that process. Last year they

eating disorders and post-traumatic stress disorder

identified a molecule produced by osteoblasts, the cells

following abuse. The program’s scientific review com¬

that form bone tissue, that appears to play an important

mittee was to meet in July, with the first awards expected

role. Interleuken-6 (IL-6), says Dr. Insogna, is required

in August. Subsequent requests for research applications

in order for parathyroid hormone to break down bone.

will go out each year to encourage new work.

With support from the Women’s Health Program, he

“It is essential to study women, because the treatments and procedures
developed on men may not always be appropriate for women.”
THREE PILOT PROJECTS

and his colleagues published data correlating high

Even before the Donaghue program was announced in

blood levels of IL-6 with higher rates of bone breakdown

February, women’s health research at Yale was off and

in women with disturbances in parathyroid function

running, supported by modest startup grants during the

and are chasing down new leads that may one day

1997'9% academic year. Three of those projects, co-spon-

improve treatment.

sored by the Department of Diagnostic Radiology, the

Allen E. Bale, M.D., associate professor of genetics,

Claude D. Pepper Older Americans Independence Cen¬

is searching for genes associated with hereditary breast

ter and the Yale Liver Center, illustrate the kinds of re¬

cancer. He has developed automated technology for

search topics Dr. Mazure and her colleagues hope to

determining the DNA sequence of BRCAi and BRCA2,

shed light on.

two genes that are frequently altered in families with

Diagnostic radiologist Liane E. Philpotts, M.D., saw

breast cancer. In analyzing a large series of breast cancer

a difficult clinical problem affecting breast cancer pa¬

kindreds, he found that a significant number lacked mu¬

tients and has used the women’s health funding to look

tations in these genes, and he is searching for new genes

for a solution to improve diagnosis and quality of life.

that may underlie the disease.

Because the disease often spreads to the axillary nodes

One possible candidate is the gene for Cowden syn¬

(glands in the armpit), patients usually have the nodes

drome, a rare disorder associated with breast, thyroid

removed surgically as a precaution. The complications of

and skin cancer. Dr. Bale thinks that mild mutations in

surgery include swelling, significant pain and decreased

the Cowden syndrome gene might cause breast cancer

range of motion. Dr. Philpotts is evaluating how well

alone without thyroid or skin disease. “Beside the

magnetic resonance imaging may be able to show the

Cowden gene, there must be other genes we haven’t yet

spread of cancer cells to the nodes. “If we can say they

discovered,” says Dr. Bale. “We’re continuing to look for

look fine, maybe we won’t have to take them out in the

them so we can offer diagnostic testing and early detec¬

future,” she says. “To the patient, it could make a fairly

tion of breast cancer to more families.”
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Women’s health came into focus at Yale in the early
1990s, as more women entered the faculty and as Yale
practitioners in internal medicine, obstetrics and gyne¬
cology, and other specialties began discussing the need
for a streamlined clinical service where women could
receive care in a more coordinated fashion. At about the
same time, the issue of women’s health was coming
sharply into locus in Washington. The General Account¬
ing Office issued a detailed report in 1990 documenting
the disparity between women and men as subjects in
federally funded clinical research. The same year, the
National Institutes of Health created the Office of
Research on Women’s Health, followed in 1991 by the
establishment of the Office of Women’s Health at the
U.S. Public Health Service. Meanwhile, the N1H was
launching the Women’s Health Initiative, a long-term
study of more than 100,000 women that will seek to
document the causes of disease and premature death in
women from all social and economic groups.
Dr. Kessler, who was the Food and Drug Adminis¬
tration commissioner from 1990 to 1997, recalls asking

Ruth Katz and Raymond Andrews talk before the press conference
announcing the establishment of the Ethel F. Donaghue Women’s
Health Investigator Program at Yale. Mr. Andrews is a trustee of the

his staff in the early ’90s, “ ‘Should we have required
women to be included in the clinical trials?’ Some of the

Patrick arid Catherine Weldon Donaghue Medical Research
Foundation, which is providing $6.5 million in funding.

agency’s best reviewers said no, that the pharmacokinet¬
ics and pharmacodynamics of the drugs worked the
same in men as in women,” Dr. Kessler recalls. “But
later, as more studies were done, they started looking at

In its first incarnation as the Women’s Health Initia¬
tive at Yale, the program provided a one-stop service ca¬

the data and saying it really did make a difference.”

tering to women throughout New Haven and Fairfield

Perhaps the most influential piece of legislation relevant

counties. Led by Dr. Henrich and Florence Comite,

to women’s health is contained in the NIH Revitaliza¬

M.D. ’76, HS ’76-78, it also brought together a diverse

tion Act of 1993, which requires that an appropriate

group at the medical center who were focused on

number of women be included in clinical trials that are

women’s health issues and who began discussing the

federally funded. One of the people who shepherded the

framework for a broader program. Gerard N. Burrow,

act through Congress was Ruth J. Katz, J.D., M.P.H.,

M.D. ’58, then the medical school dean and now a spe¬

now the School of Medicine’s associate dean for admin¬

cial advisor to President Levin for health affairs, saw a

istration. As counsel to the U.S. House of Representa¬

need to combine the clinical progress with advances in

tives subcommittee on health and the environment, she

education and research. “The exclusion of women was

organized the hearings for the act and helped write the

so ingrained,” he recalls ol his own research training in

legislation that President Clinton signed into law. When

the 1950s, “that even as students working in the lab, we

she arrived at Yale last July, one of the first projects she

were told not to include female mice.” But over the last

was given was to help pull together the agreement that

several decades that attitude has changed, and not only

became the basis for the Donaghue Foundation grant.

in the lab. Yale established the Office of Women in

The Donaghue research initiative is a key compo¬
nent of a highly active Yale program that drew the atten¬

Medicine in 1975 and began actively recruiting women
to the faculty and student body. Four years ago, the

tion of Health and Human Services Secretary Donna

medical school enrolled more women than men in its

Shalala, who named it one of the first six Centers of

entering class for the first time in its history. “The last

Excellence in Women’s Health. This spring, the designa¬

20 years,” says Merle Waxman, M.A., associate dean and

tion and funding were renewed for a second 18-month

director of the Office of Women in Medicine, “has seen

period, allowing the faculty here to focus in greater

the dissolution of many of the barriers that hindered the

depth on issues concerning patient care and physician

entry of women into some of the specialties.” As a result,

education as well as research.

says Dr. Henrich, more women are in a position to pur-
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Janet Henrich leads the Women’s Health Program at Yale and teaches an undergraduate course in
women's health at Yale College.

sue research that is relevant to women, which may in

nal Medicine, Obstetrics and Gynecology, and Psychia¬

part explain the groundswell of interest that bubbled to

try. Similar plans are being considered for residency

the surface in 1990.

training. “The idea,” says Dr. Henrich, “is to have the

According to Dr. Henrich, who spent 18 months
at the NIH working with the Office of Research on

internal medicine residents learn more about reproduc¬
tive issues and the ob/gyn residents better prepared to

Women’s Health, one of the major challenges in deliver¬

recognize and treat hypertension, diabetes and thyroid

ing care to women stems from a division that dates

disease. The goal is to increase the knowledge base.”

hack 75 years or more. “There’s a fragmentation that
has developed more around women than around men,

That seems to be happening at Yale over a relatively
short period of time. Lawrence S. Cohen, M.D., HS

with both internal medicine and obstetrics and gynecol-

’58-65, a cardiology professor and special advisor to the

ogy providing primary care,” she says. “What this has

dean, was among those involved in the school’s early

done is separate reproductive and non-reproductive

discussions of women health and served on the commit¬

issues in a way that became institutionalized early in

tee appointed by Dean Burrow in 1992. “They’ve more

the century.” This schism produces gaps in care due to

than exceeded the expectations in a very short period of

a lack of communication, Dr. Henrich says. “There’s

time. Women’s health is off to a great start.” The true

been a lot of talk about developing a women’s health

test of the research program’s success, says director

specialty,” she adds. “I have a strong bias against that

Mazure, will be seen in the clinical setting several years

because 1 think it would only lead to greater fragmenta¬

down the road. “Politically, a lot has happened to move

tion of care. We need the expertise of diverse specialties.”
In early 1996, the Yale activities were reorganized as

this all forward,” she says, “but the science has changed,
too. Everybody knows that with most diseases, there isn’t

the Women’s Health Program at Yale, with Dr. Henrich

just one factor that influences onset or treatment out¬

as its leader. She and many of her medical school and

come—rather there are many factors. Now we have tools

hospital colleagues have spent long hours hashing out

to understand multiple variables in health outcomes.”

new methods for organizing women’s care. A committee

What will be the practical value of this investment in

chaired by ob/gyn associate professor Ervin E. Jones,

research? “There’s the promise of very significant transfer

M.D., Ph.D., and assistant clinical professor of psychia¬

of this knowledge to clinicians and to the community,”

try Robert M. Rohrbaugh, M.D., is developing a pro¬

says Dr. Mazure. “This initial funding will help us

posal for a required medical school clerkship in women’s

generate a lot of new research that can change both the

health that would draw from the departments of Inter¬

health and health care of women. ” QE]
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1998-1999

LECTURE

Lectures, free and open to the
public, begin at 5 p.m. in the
Beaumont Room, 333 Cedar
Street. Refreshments at 4:30 p.m.
For information call Howard Spiro or
Clara Gyorgyey at (203) 785-5494.

SERIES

MARCH 4

Cultural Competence? Immigrant
Patients American Doctors
DECEMBER 17

Covert Communication in Clinics,
Classrooms, Corporations & Courtrooms
The Bayer Lecture
Robert Rosenthal, Ph.D.
Edgar Pierce Professor of Psychology
Harvard Medical School

SEPTEMBER 24

JANUARY 7

Medicine, Ethics & the Third Reich

Conflict In Classical Arabic Medicine

John J. Michalczyk, Ph.D.
Professor of Fine Arts & Films
Boston College

Dimitri Gutas, Ph.D.
Professor of Arabic Languages & Literature
Yale University

OCTOBER 8

JANUARY 21

AIDS & the Poetry of Healing

From Quarantine to Condoms:
HIV Control in Cuba*

Rafael Campo, M.D.
Associate Professor of Medicine
Harvard Medical School

Helena Hansen, MS
M.D./Ph.D. Candidate
Yale University School of Medicine

Vincent A. deLuise, M.D.
Clinical Assistant Professor of Ophthalmology
Yale University School of Medicine

MARCH 18

Eye of Doctors: Enhancing Observational
Skills With Fine Arts
Irwin M. Braverman, M.D.
Professor of Dermatology
Yale University School of Medicine
APRIL 1

Meeting the Challenge of
Alternative Medicine
Joseph J. Jacobs M.D., MBA
Former Director
Office of Alternative Medicine at NIH
APRIL 15

When a Patient Wants to Die

JANUARY 28

Charles F. McKhann, M.D.
Professor of Surgery
Yale University School of Medicine

My Brother, Madness & Survival:
Memoir

APRIL 29

OCTOBER 22

The Artists’ Vision: An Ophthalmologist
Looks at Art

The Robert Penn Warren Lecture
Anne Fadiman, BA
Editor of The American Scholar

Jay Neugeboren, Ph.D.
Professor of English/Writer in Residence
University of Massachusetts

NOVEMBER 5

Forty Years of Medical Education at Yale
Howard Levitin, M.D.
Professor of Internal Medicine
Yale University School of Medicine

Freud’s Dream Theory—
One Hundred Years Later

FEBRUARY 4

Hygeia Revisited: Lessons to Comfort

MAY 6

Harry Fiss, Ph.D.
Professor or Psychology
University of Hartford

Michael Berman, M.D.
Clinical Professor of Obstetrics & Gynecology
Yale University School of Medicine

Carlo Levi, MD & the Italian Anti-Fascist
Movement

NOVEMBER 19

FEBRUARY 11

Call For The Doctor:
A History of Country Blues Piano

Young Cushing: The Right Stuff

David Ward, Ph.D.
Associate Professor of Italian
Wellesley College

M. David Tilson, M.D.
Professor of Surgery
Columbia University School of Medicine

Robert M. Crowell, M.D.
Professor of Neurosurgery
University of Massachusetts Medical School

“Bellevue”: Machinations of an
Urban Hospital
Mark Siegel, M.D.
Clinical Professor of Internal Medicine
New York University Medical Center
DECEMBER 10

The Human Encounters in Medicine
The McGovern Lecture
John Stone, M.D.
Professor of Cardiology
Emory University School of Medicine

MAY 13

A Surprise
FEBRUARY 25

DECEMBER 3

Harvey Mandell, M.D.
Retired Internist

Match Day: Stories of Adoption
& Reunion

Jacques Pepin, MA
Master Chef, Columnist, Author, Teacher
PBS-TV Host

Morris A. Wessel, M.D.
Clinical Professor Emeritus of Pediatrics
Yale University School of Medicine

Note: Lectures marked by an asterisk (*) are co¬
sponsored by the Office of Multiclutural Affairs.

Diana K.R. Jowdy, MA
Ph.D. Candidate
American Culture
University of Michigan
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prevention
With better treatments for HIV infection and increasing hope for a cure,
are we becoming complacent about the spread of AIDS? Not if the architects
of Yales new interdisciplinary research center have a say in the matter.
By John Curtis

I

Above: Human immunodeficiency virus, seen through the elec¬
tron microscope, has infected 30.6 million people worldwide
over the last two decades, and caused 11.7 million deaths.
Right: Maria Martinez, an outreach worker, and Scott Wilson,
an anthropologist, walk through abandoned buildings, crack
houses and shooting galleries to make contacts and observe
the social interactions of people using drugs. They hope to
learn enough about behavior in high-risk drug sites to devise
measures to prevent HIV infection.

n a vacant apartment building in Hartford’s Charter
Oak neighborhood, within walking distance of
Connecticut’s state capitol and several of the world’s
largest insurance companies, anthropologist D. Scott
Wilson, Ph.D., points the toe of his boot at a spent
syringe. The last person to use it has bent the needle to
prevent its re-use and the possibility of infection with
HIV. “You see this a lot, which is a very good thing,”
says Dr. Wilson, an AIDS prevention researcher working
on a Yale-affiliated research project. Also strewn amid
the glass and rubbish are small plastic bottles that once
contained bleach or water and were part of needle-clean¬
ing kits that Dr. Wilson and his colleague, outreach
worker Maria Martinez, hand out on the streets.
They are one of two teams that roam abandoned
buildings, crack houses and shooting galleries in Hart¬
ford, with the aim of learning the rules that govern be¬
havior there. Ultimately they hope to persuade drug us¬
ers to adapt those rules to include HIV prevention
methods. Their work is one of lour projects under the
umbrella ol Yale’s Center for Interdisciplinary Research
on AIDS, or CIRA. Established last September with a
$10.8 million grant Irom the National Institute of Men¬
tal Health and the National Institute on Drug Abuse,
CIRA is a four-year effort centered in the Department
John Curtis is a staff writer.
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“Preventing infection,” Michael Merson says, “is still better
than any cure.”
ol Epidemiology and Public Health, an accredited

began, 11.7 million people have died of AIDS, according

school of public health. Its goal is to change risky behav¬

to UNAIDS, the worldwide AIDS program of the

iors and stem the spread of AIDS. Yale’s CIRA joins

United Nations. T he bulk of the world’s cases are in sub-

centers at UCLA, Columbia University, the Medical

Saharan Africa, where an estimated 20.8 million people

College of Wisconsin and the University of California

have been infected. Every day, UNAIDS reports, 16,000

at San Francisco as the fifth federally funded AIDS

people become infected with HIV. More than 90 percent

prevention center in the country. While most of CIRA’s

of those new infections occur in developing countries.

research will take place in Connecticut, the center is

In Africa, the hardest-hit continent, AIDS travels pre¬

expected to develop prevention strategies that can be

dominantly through heterosexual contact. In Botswana

applied throughout the country and world.

last year, 43 percent of pregnant women tested in one

“ There is still a potential for the epidemic to spread
even more dramatically than it has already in some
populations,” says CIRA Director Michael H. Merson,
M.D. “In many ways the worst is still to come.”
The former head of the World Health Organization’s
Geneva-based Global Programme on AIDS, Dr. Merson

urban center were HIV-positive. One in five adults in
Zimbabwe are believed to be HIV-positive.
China, Asia’s largest country, is facing two epidemics,
one among drug users in the southwestern part of the
country and another among heterosexuals along the
coast where prostitution is re-emerging. In Thailand,

became Yale’s first dean of public health in 1995. Since

there is evidence of a drop in new infections, thanks to

his return to the United States, he has sounded a

prevention efforts that promote condom use, discourage

persistent warning that advances in the treatment of

visits to sex workers and offer young women opportuni¬

HIV, while a great step forward, carry with them the

ties other than commercial sex.
Although doctors have vastly better weapons to fight

risk of complacency.
Around the world, an estimated 30.6 million people

it, including new anti-viral treatments developed at Yale

live with AIDS or HIV infection, most of whom prob¬

(See Hunting down HIV), AIDS remains a deadly dis¬

ably have no idea they are infected. Since the epidemic

ease. In the United States, 820,000 people were living
with HIV or AIDS as of the
end of 1997, according to
UNAIDS. According to the

Among young people, a sense of immortality

organization’s Report on the

A

released in June at an interna¬

Global HIV/AIDS Epidemic,
lthough young people are acutely

drugs, alcohol and other health-related

aware of the risks of HIV infection,

risks,” says Michael H. Merson, M.D., dean

most believe it won’t happen to

of public health and director of CIRA.

tional conference in Geneva,
an estimated 410,000 people
have died of AIDS in the

them, according to a survey of 12- to 34-

The study found that 45 percent of

year-olds conducted by CIRA researchers.

unmarried respondents have engaged in

United States. For most of the

That attitude prevails even though 20

sex one or more times without using con¬

1990s, acquired immune defi¬

percent of them have lost a friend or

doms. Of those unmarried respondents

ciency syndrome was the lead¬

acquaintance to AIDS.

fewer than half use condoms when they

While only slightly more than half of

have sex with a new person and 23 per¬

ing killer of people between 25
and 44. Now, with the first ef¬

the young people surveyed used con¬

cent fail to use birth control. Yet 63 per¬

doms, almost 90 percent said they were

cent of the total survey cited condoms

fective therapies in place, AIDS

not at risk of HIV infection. The survey,

and safe sex as ways to prevent AIDS.

has dropped to second place,

released in December by Yale and the

Fifty-three percent of respondents used

below accidents. But the path

MTV music television network, queried

a condom the last time they had sex.

770 people on their attitudes toward
sex, health and AIDS.
"This study tells us that, despite the

Although only 2 percent of whites
considered themselves at risk for the
virus, 16 percent of Hispanics and 11

of the infection has shifted as
well. “The epidemic in the
United States had been con¬

information that’s out there, young people

percent of African Americans said they

fined historically to gay men.

have not internalized the dangers of AIDS,

were vulnerable to HIV infection.

It’s becoming more and more
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Researchers at six of Yale’s graduate and professional schools have joined forces under the umbrella of CIRA to find
ways to limit the spread of AIDS. Headed by Michael Merson, left, a physician whose life’s work has been in public health,
and Peter Salovey, right, a psychologist, CIRA brings together 55 researchers in disciplines ranging from medicine to
anthropology to law to management science.

an epidemic of injecting drug users and their sex part¬

nant women—transmission has become a function of

ners,” Dr. Merson says. The net effect, he says, will be

behavior, occurring through unprotected sex or needle

more and more heterosexual transmission.

sharing. Yet for those at most risk of contracting AIDS,
preventing HIV infection often takes a back seat to daily
survival—finding a place to sleep, getting a meal or

A FOCUS ON

BEHAVIOR

Avoiding AIDS is as simple, and complicated, as avoid¬
ing risky behaviors. In the United States, blood screen¬

procuring drugs.
CIRA’s four initial projects are designed to help
people who appear to be most vulnerable to HIV infec¬

ing has virtually eliminated transfusions as a factor in

tion—the inner-city poor, adolescents and drug users.

the spread of HIV. Except among infants born to HIV-

The anthropologists and outreach workers in Hartford

infected mothers—an increasingly rare occurrence in the

hope to devise prevention measures for high-risk drug

United States due to the use of antiviral drugs by preg¬

use sites. A team of psychologists is developing messages
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Among those most vulnerable to HIV infection are injecting drug users, adolescents, minorities—and women. Susan, 28,
and her daughter, Anna, were diagnosed HIV-positive in 1994. She believes she was infected by a former boyfriend in 1988.
With her daughter and husband, Roy, Susan posed for this photograph from the book A Positive Life [1997, Running Press,
Philadelphia], The collection of interviews by River Huston and photographs by Mary Berridge, who holds a masters degree
in fine arts from Yale, tells the stories of women with HIV.

to change risky sexual behavior and evaluating which

a management expert and physicians. “To really under¬

approaches are most likely to succeed. Another team is

stand how we’re going to prevent HIV, you have to look

looking for ways to prevent both pregnancy and sexually

at it from various perspectives,” he says. CIRA has cre¬

transmitted disease in teenagers. The fourth team is

ated a community advisory committee whose members

studying needle exchange programs to determine

include community leaders who also serve on an execu¬

whether their benefits, such as reduced risk of infection

tive committee that advises the center on policy and re¬

and increased access to treatment, travel beyond the

search priorities. Dominick Maldonado, an AIDS educa¬

immediate participants.
Ellen Stover, Ph.D., director of the division of mental

tion coordinator for the City of New Haven, is
chairman of CIRA’s community advisory committee.

disorders, behavioral research and AIDS at the NIMH in

“In the past,” he says, “research was done and those of

Bethesda, Md., says that CIRA stands out because of its

us in the community felt like guinea pigs.” This time

focus on drug users and adolescents. “It’s unique and it’s

things are different. Mr. Maldonado and Matthew F.

where the direction oi research is going,” she said. “In

Lopes, M.RH. ’77, a member of the Mayor’s Task Force

the AIDS area, we have always encouraged behavioral

on AIDS and member of CIRA’s executive committee,

scientists to work with public health experts and infec¬

see a real effort to involve local groups. “We hope that

tious disease experts.”

we will come up with some interesting and novel ways
of prevention that will be demonstrated to a wider
population,” says Mr. Lopes, director of the AIDS

INVOLVING THE COMMUNITY

division at the city health department, “not just in

The CIRA team includes psychologists, epidemiologists,

New Haven, but around the country.”

anthropologists, lawyers, molecular virologists, ethicists,

3
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Statistics compiled by Connecticut’s health depart-
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A new era in AIDS treatment

I

n the 17 years he’s been treating
people with AIDS, never has Gerald H.
Friedland, M.D., been more optimistic.

need a whole system of care to help

interactions of

people benefit.”

anti-retroviral
agents and

Dr. Friedland first encountered AIDS at

New therapies such as protease and re¬

Montefiore Hospital in the Bronx in 1981,

methadone

verse transcriptase inhibitors are thwart¬

when he saw injecting drug users mani¬

in substance

ing the onset of full-biown AIDS in HIV-in¬

festing the symptoms of an illness then

abuse

fected people, slowing the progress of

believed to afflict only gay men. At Monte¬

programs.

the disease and offering patients more

fiore he brought not just physicians and

hope than ever before.

nurses into the care of AIDS patients, but

“This is a
wonderful time

social workers, mental health workers,

in the history

changed the way doctors care for people

clergy and others. That same multidis¬

of the AIDS

with AIDS and shifted treatment strate¬

ciplinary approach is at work at the Yale

gies to outpatient and community set¬

program, which opened in 1983 and was

tings. “Because there are fewer deaths

the first clinic dedicated to AIDS in the

and because people are living longer, in

state. In addition to clinical care for HIV¬

Those therapies, however, have

Gerald H. Friedland

epidemic in
the United
States," says

Dr. Friedland, professor of medicine and

some ways the clinical burden of care,

positive patients the program offers

epidemiology. “There are potent and ef¬

the resources needed to produce care,

counseling, testing and outreach pro¬

fective therapies. They are very compli¬

have increased,” says Dr. Friedland,

grams and does prevention work in city

cated and difficult but their benefit is un¬

director of the Yale AIDS Program since

schools. There’s also a community health

questioned at this point in preserving

1991. “The benefit of these therapies is

care van carrying counselors and out¬

and prolonging life. However, difficulties in

very dependent upon all the clinical sys¬

reach workers into New Haven’s neighbor¬

providing therapies to all who can benefit

tems that have been put in place to care

hoods. Physicians and other research

from them remain, as does their still un¬

for people with HIV disease. It’s not just

staff are performing clinical trials of new

known durability. This is a time for intensi¬

writing a prescription and that's it. You

anti-retroviral therapies and studying the

fied therapeutic effort, not relaxation.”

Odds for children at risk for AIDS begin to improve

O

ne of the mysteries of HIV is why
it doesn’t surface in all the chil¬
dren born to infected mothers.

before the virus becomes very virulent."
Dr. Andiman directs the pediatric AIDS
program at Yale-New Haven Hospital and

diseases emerge. “These kids are fol¬
lowed primarily to provide clinical care.
At the same time we have very careful

Even at its worst, notes Warren A.

is studying the virus to find ways to pre¬

observation of the history of the disease.

Andiman, M.D., professor of pediatrics

vent and treat infection. His research led

The primary reason for seeing them is to

and epidemiology, it only struck about

him to participate in an international

take care of them, not because we’re

20 percent of children of HIV-positive

study evaluating Caesarean section as a

doing the study," he says.

mothers. Prevention programs and use

means of protecting newborns from infec¬

of AZT have reduced the figure in New

tion. Many infections occur during pas¬

Haven from between 16 and 18 percent

sage through the birth canal.

to about 2 percent.
A related riddle is why some strains of

A current laboratory-based study ex¬
plores how biological characteristics of

Children with AIDS suffer learning dis¬
abilities, problems with motor functions
and cognitive skills, cognitive retardation,
fungal infections of the esophagus and
various viral and bacterial infections. The

the virus found in the mother emerge in

the virus affect clinical outcomes. Are

problem becomes one of managing the

the child and others don’t. “Is there a

there specific behaviors of the virus that

disease, far more difficult in children than
adults. “The medicines taste nasty. The

pattern to the kind of strain that a baby

determine whether an infected child suf¬

gets from among the strains that the

fers a rapid progression of disease or be¬

pills are very big. There are side effects,”

mother has? Is there a selective process

comes a long-term survivor? If so, can

says Dr. Andiman. “We have a lot of kids

that goes on which determines whether

less virulent strains of the virus be iso¬

in their early teenage years who were in¬

a certain kind of virus is being transmit¬

lated and used in vaccines? Or can differ¬

fected when they were infants, with many

ted from the mother to the baby?” Dr.

ent viruses with useful traits be com¬

medical problems. Most of them are not

Andiman asks. “It will be useful to learn

bined into a single vaccine?

something about how rapidly the virus

The 75 HIV-infected children in the

robust children." But he adds, “It has truly
turned into a chronic disease. If children

changes. It would give us a sense of

AIDS program are part of a long-term ob¬

don’t succumb to the disease in the first

when an intervention might still be worth¬

servational study to determine their sur¬

three years of life, they really become

while. You would want to provide therapy

vival and to find out what opportunistic

long-term survivors.”
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CIRA’s four projects

W

hen Public Health Dean Michael

of CIRA, is conducting a study based on

Merson began discussing AIDS

prospect theory, which proposes that

prevention with colleagues at

both negative- and positive-framed mes¬

Yale several years ago, it occurred to him

sages can work in different situations. For

that prevention research had to follow the

example, Dr. Salovey theorizes that ac¬

path of the epidemic. A disease that had

centuating the negative works best for

already mobilized the gay community,

detection behavior: If you don’t get a

AIDS was becoming an ever-increasing
threat to the poor, minorities, women and

blood test, you won't find out you are sick
and get the treatment you need. Positive

injecting drug users. The four projects

messages, he believes, will work best for

that ultimately became the focus of the

prevention behaviors: Wear a condom

Center for Interdisciplinary Research

and you'll stay healthy.

on AIDS are concentrating on those
at-risk groups.

Michael Merson

elRA

His study, which comprises three ex¬
periments, will compare the effects of

CIRA stands out for its interdiscipli¬

four videos about detection measures, in¬

nary approach, bringing together physi¬

cluding HIV-testing, and prevention behav¬

cians, psychologists, anthropologists,

iors, such as condom use. Each experi¬

reach worker to probe drug networks in

ment will follow about 500 poor Latina

the city. Could people who control drug

toward the common goal of preventing

and African-American women recruited at

sites distribute clean needles or discour¬

AIDS. "If you really want to have effective

community health centers in New Haven

age needle sharing? The research will

prevention measures," Dr. Merson says,

to determine whether positive- or nega¬

take place over three years at 16 sites

“you need the skills of all those people."

tive-framed videos work best and whether

where people use drugs. “Typically we go

participants take HIV tests, abstain from

with them to the site to see how they are

lawyers, statisticians and others to work

risky sex or use condoms as a result.

using drugs and what goes on there,"
says D. Scott Wilson, Ph.D., one of the

Message framing

anthropologists working on the study.
Convincing the most vulnerable to avoid

High-risk drug sites

risky sexual activity is the task of Peter

Benefits of needle exchange

Salovey, Ph.D., a Yale psychologist who

Anthropologists and outreach workers in

with colleague John D. Mayer developed

Hartford want to find out whether there

the theory of emotional intelligence

are rules of conduct in places where

A related project will track the spread of

popularized in a recent book by author

people use drugs—crack houses, shoot¬

benefits from needle exchange programs.

Daniel Goleman.

ing galleries and abandoned buildings.

Studies have shown that needle ex¬

“Can we make use of the fact that there

changes slow the spread of HIV and

are rules to establish other rules for AIDS

hepatitis B, draw drug users into treat¬

“Clearly our traditional AIDS messages
aren't reaching certain people," says Dr.
Salovey, professor of psychology and of

prevention?” asks Margaret R. Weeks,

ment programs and serve as a vehicle to

epidemiology and public health. “The field

Ph.D., associate director of the Institute

disseminate information about AIDS. The

has done a lot of work on delivering edu¬

for Community Research and director of

researchers want to determine how

cational messages to people about HIV

this project. The Hispanic Health Council

deeply those benefits penetrate into

and safer sex, but they have not paid at¬

in Hartford is also working on the project.

communities of drug users.

tention to the nature of those messages.”

The institute and the council are each

Dr. Salovey, who is also the co-director

providing an anthropologist and an out-

ment show increased rates of heterosexual infection

“We already know the people who
use the exchange benefit from it," says

Since 1990 white males have dropped from 48 percent

and infection through intravenous drug use. Injecting

to 38 percent of the state’s AIDS cases among men. Afri¬

drug users made up 51 percent of the 9,941 AIDS cases

can Americans account for 38 percent of the AIDS cases

reported in Connecticut as of the end of May. That

in men, an increase from 35 percent reported in 1990.

percentage is twice the national average. Men having

Of females with AIDS, 47 percent are African American,

sex with men constituted 24 percent of the cases and

fewer than the 51 percent reported in 1990, but up from

heterosexual intercourse was the mode of transmission

the 1994 rate of 44 percent. Hispanic women make up

in 15 percent, according to the state Department of

25 percent of the state’s women with AIDS.

Public Health.
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“This is increasingly a disease of minority popula-
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The Road Less Traveled
Not every 8o-year-old is at risk behind the wheel. How can we fine-tune
driving skills —and predict who may have a problem?

For many Americans, the automobile is a

driving. It requires some creativity to come

symbol of independence and an essential link

up with strategies people can use to maintain

with the outside world. Yet as people age,

their mobility if they have to stop driving.”

driving can become hazardous for them and

In a study funded by the NIH, the research¬

others. Richard A. Marottoli, M.D., M.P.H.,

ers are trying to determine whether improv¬

and Emily D. Richardson, Ph.D., are develop¬

ing physical abilities will help prolong safe

ing ways to assess and improve driving skills in

driving among older persons. Dr. Marottoli is

older persons at risk of having accidents.
In earlier studies of predictors of driving

also refining predictors so physicians can use
them to identify candidates for more detailed

difficulty, they demonstrated that people who

testing. Dr. Richardson, an associate research

have foot problems, don’t walk regularly and

scientist in medicine, is studying ways to im¬

perform poorly on tests of visual attention are

prove visual attention, by training participants

at higher risk of having crashes or

to respond to stimuli on a computer screen.

moving violations.
Driving impairment is a special concern
because of its impact on others. “There are

“If we can improve visual attention, does that
translate into improved driving performance?”
she asks. She hopes the training will improve

safety implications not just for the driver, but

poor dnving habits such as changing lanes

also potentially for the general public,” says

without first checking left and right.

Dr. Marottoli, associate professor of medicine

Predictors of driving difficulty include
foot problems, infrequent walking
and poor performance on tests of
visual attention.

“The goal of our research,” says Dr.

at Yale and senior research associate at the VA

Richardson, “is to identify and correct factors

Connecticut Healthcare System. “In general,

that contribute to driving problems so that

older people do a very good job of knowing

older persons, can, if possible, continue to

INSIDE

when to stop and when to cut back on their

drive safely.”

Lessons of Recovery Is a broken hip the
first step in a downward spiral? Not neces¬
sarily, says a Yale physician who studies
why certain older patients do better than
others after an illness or injury. Page 2

For Older Patients, Attention to the Many Facets of Good Health

Geriatrics: The Next Generation Better
training for young doctors means better care
A second question I am fre¬

We hope you’ll enjoy this inaugural issue of the Yale
Letter on Aging, a new publication launched by the

for older Americans. The important thing is

quently asked is, “Why is interest

to ask the right questions. Page 2

School of Medicine to provide up-to-date information

in geriatrics increasing?” The an¬

about health care for older patients. As are many geriatri¬

swer is simple—the baby boomers.

Healthy in the Hospital Yale New Haven
Hospital’s Elder Life program focuses
attention on the needs of older patients.

cians, I am frequently asked, “What exactly is geriatrics?”

Now well into middle age, baby

This question is perhaps best illustrated by an example.

boomers are caring for their

If an 8o-year-old man tells his cardiologist that he’s been

increasingly frail parents while

having chest pain, the cardiologist will attempt to diag¬
nose the cause of the pain, then prescribe the appropri¬

facing their own aging. This

ate treatments. Before deciding how to pursue the causes
of the chest pain, the geriatrician will consider the man’s

•:vm
By Mary E. Tinetti, M.D.

Page 3
Quiz for Doctors Your patient would

increased awareness of, and

rather be a) in the hospital or b) at home?

interest in, aging has coincided

Unless you ask, there’s no right answer.

with an emerging understanding of the management and

Page 3

other health problems and factors such as family sup¬

prevention of many of the diseases, impairments and

port, socioeconomic constraints and psychological is¬
sues. In other words, the geriatrician is concerned with

disabilities faced by older persons. Problems such as fall¬

Profile Social worker Nanne
Scholhamer helps families balance the

ing, chronic pain, urinary incontinence and sleeplessness,

complex demands of caring for an older

a patient’s overall functioning and well-being, as well

which only a decade ago were considered inevitable parts

as the diagnosis and treatment of individual diseases.

of aging, are now readily diagnosable and preventable.

Older adults often have multiple chronic diseases and

While much remains to be learned, geriatricians, through

relative. Page 4
Bones, Joints and Muscles Musculoskel¬
etal problems, because they relate to the
basic mechanics of getting around, can have

experience difficulty with one or more activities of daily

the benefits of research and training, are increasingly

life. Rather than working atone, therefore, as do most

equipped to help older persons age successfully.

other physicians, geriatricians often use an interdiscipli¬
nary approach, working with a coordinated team of

Mary E. Tinetti, M.D., is Chief of the Section of Geriatrics

Preventing Falls Simple, inexpensive

at Yale University School of Medicine and Yale-New

precautions in the home greatly reduce the

Haven Hospital.

likelihood of an older person falling. Page 6

nurses, social workers, physical therapists, occupational
therapists and others.

a profound impact on quality of life. Page 5

2
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Back in the Swing
A broken hip, says the conventional wisdom, is the start of a downward spiral.
But new research on elder disability holds clues to reversing that trend.
Eating well, keeping in shape and remaining

prevention plan that focuses on muscle

mentally active are factors that help older

strength, balance and gait training, the use of

people recover basic activities of daily living

adaptive devices and removal of environmen¬

such as walking, bathing, dressing and getting

tal hazards. He plans to study 160 older per¬

out of bed. In a 1997 study of people who had

sons, half of whom will be enrolled in a pre¬

lost such abilities due to illness or accident,

ventive care program. Researchers will assess

Thomas M. Gill, M.D., found that 28 percent

participants’ balance, strength, range of mo¬

regained independent functions over two

tion, ability to walk and ability to move from

years. “There is a misperception that once

sitting to standing. “If someone takes longer

older people become disabled it’s a ticket to a

than 10 seconds to walk 10 feet forward and

nursing home,” says Dr. Gill, assistant profes¬

10 feet back at a rapid pace,” says Dr. Gill,

sor of medicine.
Although age played a decisive role in pre¬
dicting exactly who would recover, Dr. Gill
identified other important factors in the study,

“that places them at much greater risk for
becoming disabled. This simple walking test
is one of the best markers of frailty.”
Another study will follow 500 to 600 older

the first to attempt to identify factors other

persons living in the New Haven area for two

than age. Dr. Gill and colleagues looked into

years to determine why people become dis¬

diet, physical condition and cognitive func¬

abled. Initial evaluations will assess partici¬

tion, and found that only 5 percent of those

pants’ risks for becoming disabled. “Some

over age 85 recovered independence, but 28

people at low risk become disabled and some

percent of those between 72 and 85 years

people at high risk do not,” Dr. Gill says.

learned to bathe, walk and perform other

“We have gained a lot of knowledge in terms

functions on their own again.
Now Dr. Gill, with support from the NIHfunded Yale Pepper Center, is working on a

Older people who remain active are
most likely to recover from injury
and illness.

of what puts older persons at risk of beconnng
disabled. Now we need to figure out why
they become disabled.”

Teaching Geriatrics
Physicians-in-training learn to look for details that make a difference
in the care of older patients.
Margaret A. Drickamer, M.D., says she knows

eral problems occurring at once, they require

her teaching has reached students when they

an approach that inverts the conventional

call for advice on treating older patients.

medical wisdom of seeking out the unifying

“Those questions wouldn’t even have gotten

cause for all the ailments. Instead, geriatricians

asked before the geriatrics rotation,” she says

must look at the symptoms, sometimes treat¬

of the queries she receives from interns who

ing them independently of their underlying

have gone on to other rotations or clinics.

cause. “In geriatrics we try to find out what is

Those questions, in turn, mean a more sensi¬

threatening the patient’s equilibrium and what

tive approach to caring for the multiple

the contributing causes are,” Dr. Drickamer

problems of older persons. “Taking care of a

says. “Which of those can we alter?”

90-year-old is different from taking care of a

In their geriatric rotations residents and

40-year-old, whether you’re an ophthalmolo¬

medical students, Dr. Drickamer says, learn

gist or a dietician,” says Dr. Drickamer, an as¬

two facets of caring for older persons. First,

sociate professor of medicine who teaches ge¬

physicians must focus on the problems, such

riatrics and ethics and heads the geriatrics unit

as falling, cognitive decline or inability to per¬

at the VA Connecticut Healthcare System.

form certain activities of daily living. The next

Because geriatric cases so often involve sev¬

> 5

Physicians-in-training need to look
beyond symptoms, says Margaret
Drickamer, right. “Rather than focusing
on illness or disease, they need to find
out what’s bothering their patient.”
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Keeping Older Patients
Healthy in the Hospital
An independent, 78-year-old woman enters
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PROFILE

Briefly Noted

Nanne Scholhamer, Case Manager

Sharon K. Inouye, M.D.,

A simple observation about older persons leads to

Facts About Aging

the hospital for treatment of angina. The

presented the 1998 Otsuka/American

a new model of care.

Geriatrics Society (AGS) Outstanding

treatment is successful but on the second day
[>

of her stay she becomes delirious. By the
fourth day she is incontinent. By the ninth day

A child born in 1900 could expect

Scientific Achievement for Clinical In¬

to live 47 years. A child born in

vestigation Award by the AGS at its

In the early 1980s Nanne

1997 has a life expectancy of

she can no longer walk or care for herself.

Scholhamer, M.S.W., saw a pattern in

76.2 years.

Her decline is largely due to complications

some of the families who came into

of care such as prolonged bed rest and side

[>

effects from medication.
t>

older patients,” says Sharon K. Inouye, M.D.,
who in 1995 launched Elder Life, an inter¬
disciplinary program designed to prevent

the Emergency Department at YaleNew Haven Hospital. “It was a

of older adults as a physician inves¬

worn-out family saying: ‘We can’t

tigator who is actively involved in

do this any more. We have been

direct patient care.

One of the fastest growing

The number of centenarians

incontinent, agitated and not sleep¬

has increased 16-fold since 1940,

ing,’” says Ms. Scholhamer, a

named to the editorial board of the

from 3,700 to 61,000 today.

social worker and case manager.

Journal of the American Geriatrics

Ms. Scholhamer cared for older

Society. Dr. Gill, an assistant profes¬

patients in nursing homes before

sor of medicine, began his three-

starting her career at Yale-New

year term on the board July 1. He

Haven Hospital almost two decades

has also recently been named a

ago. Working in the Emergency

Robert Wood lohnson scholar, a

hospital patients. The program relies on a staff
that includes Elder Life specialists, geriatric
nurse specialists, a geriatric chaplain, geriatri¬

about 800 older people a year.

[>

The 13 percent of the population
that is 65 or older accounts for

At the heart of the program are about 40

44 percent of all days spent in a

cians, rehabilitation specialists, dieticians

volunteers who chat and walk with patients,

and pharmacists.

assist at meal time, and help them get answers

to physicians and a third of the

to their questions. Patients can refer to an

nation’s health care expenditures.

Two years after the program began,
Dr. Inouye and her colleagues reported that

hospital, 40 percent of all visits

Nanne Scholhamer helps families
care for older relatives—and
themselves.

orientation board in their rooms listing the

patients in the Elder Life program were less

names of their doctors, nurses and volunteers.

likely to be re-hospitalized or to enter a

Also noted is a schedule of the day’s activities.

t>

addressing the health care problems

up three nights with Mom, who is

is the 100-plus age group.

physical and mental decline among older

Dr. Inouye was recognized for her
achievements in clinical research,

in this country turns 50.

segments of the older population
At Yale-New Haven Hospital, Elder Life
volunteers spend time with patients and
help them with meals and questions.

annual meeting in May in New York.

Every 15 seconds a baby boomer

“Our goal is to improve hospital care for
M.P.H., associate professor of medicine,

associate professor of medicine, was

Effective strategies against
many disorders common to
older persons, such as dementia,

Department, she saw the opportunity

Paul Beeson faculty scholar in aging,

to help older patients and their

and an NIH academic awardee.

caregivers by organizing their care around a formal program in geriatrics.
Along with Leo M. Cooney, M.D., Andrea Schaffner, M.D., and Ronald

nursing home and more likely to maintain

“They really have a sense of what’s going to

functional abilities. Last October Yale-New

happen that day,” says Leslie Hurst, M.S., an

and falls, could yield huge

Dorothy Adler Geriatric Assessment Center, the hospital’s outpatient

Haven Hospital’s board approved Elder Life

Elder Life specialist who coordinates activities

financial savings while enhancing

facility for older persons.

as a permanent program. The program serves

for patients. “It’s very reassuring to people.”

well-being.

urinary incontinence, osteoporosis

L. Miller, M.D., Ms. Scholhamer helped establish what is today the

“What we proposed to do was find a preventive approach to treating
older persons rather than reacting to situations,” says Ms. Scholhamer.
Many of the people who come to the Adler Center need help for de¬
mentia and its symptoms. The center staff also helps persons and families
address financial, legal and behavioral issues related to aging, and to plan
for the management of care.

Would the Patient Rather be at Home? Not Always.

Thomas M. Gill, M.D., has been

An essential element of treatment, says Ms. Scholhamer, is the

Terri L. Fried, M.D., has received two
grants to support a project called
A Longitudinal Study of Communica¬
tion and Preferences in End-of-Life
Care. This study of older patients,
their families and physicians will ex¬
amine communication about progno¬
sis and treatment alternatives as
well as the treatment preferences of
patient and family regarding end-oflife care. Dr. Fried received the VA
Health Services Research Career De¬

Older patients must often choose between the

they want to receive treatment. Next on the

acknowledgement that the psychological and physical problems that

velopment Award and a grant from

security of a hospital and the comforts of

list of factors are patients’ perceptions about

afflict some older persons also affect their families. “We often identify

the Paul Beeson Physician Faculty

home, when it comes to treatment of acute

the process of care. Their social support,

depression in the caregiver,” she says. “How do you juggle a full-time

Scholars in Aging Research Program.

illnesses. Most want treatment at the place that

religious beliefs, self-reliance and past experi¬

career and three teenagers and a husband and your mom? How do you

offers the best chance of survival, according to

ences with illness help shape those percep¬

form a division of labor with your siblings so you are not the anointed

a recent study by Terri L. Fried, M.D., and

tions. Some people prefer being at home with

one, the only one providing care?”

colleagues. Dr. Fried, assistant professor of

friends and family at hand, while others choose

medicine, found that if survivability is en¬

the hospital so they won’t be a burden on

sured, slightly more than half of the older

loved ones. Patients tend to feel, however,

people she studied prefer hospital treatment.

that treatment at home can only be a “low-

Although preference for location should

intensity service,” which is not necessarily

a physician, and together they craft a plan of care that often includes

Society. This paper describes pa¬

true, given the increased availability of tech¬

referrals to social service agencies. “What happens between visits to the

tients in the medical house calls

play a role in treatment decisions, “it’s often at

As a case manager, Ms. Scholhamer assesses patients’ mental faculties,
determines how well they function and interviews family members to
In her research, Terri Fried found that
older patients like both the security
of hospitals and the familiarity of
home care.

Mary E. Tinetti, M.D. and Terri L.
Fried, M.D., are among the authors
of When the Patient Cannot Come to
the Doctor: A Medical House Calls

identify problems. Can patients cook their own meals? Can he or she

Program, published recently in the

move from a chair to a bed? Ms. Scholhamer presents her evaluation to

Journal of the American Geriatric

nology in the home. Dr. Fried says. She be¬

Adler Center is that the case manager is in very close contact with the

program and the medical problems

the bottom of the list in terms of deciding fac¬

family at home,” she says. “What we have come to learn and to realize

that could be handled in the home

tors,” says Dr. Fried. The availability of ser¬

lieves physicians need to determine what pa¬
tients “want in terms of both the process of

is that one of the most important things is educating and supporting

and those that required transfer to

vices and the potential outcomes rank as the

the caregiving system.”

the hospital.

highest priority when patients consider where

care and its outcomes. We’ve got to ask.”
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Strengthening the Weakest Links

New Haven, CT 06519-0612

The leg bone-like all the others-is connected to quality of life.
The classroom is an inpatient corridor at the

chanical issues may suggest solutions to more

VA Connecticut Healthcare System campus

general problems and have a far-reaching im¬

in West Haven, a few miles from the Yale

pact on the quality of life. “The real issue is

School of Medicine.

not whether they need a walker or a cane or a

Leo M. Cooney Jr., M.D., has asked an 80

crutch,” Dr. Cooney says. “It’s whether they

year-old patient to walk up and down the hall¬

can get by without another person being there

way. The older man is helping to train a group

all the time.”

Yale Letter on Aging

of 10 residents, interns, nursing students and

He begins his examinations at bedside. In

physicians who observe his balance and gait.

this case he has asked the patient at the VA a

Volume 1, Number 1

The Yale Letter on Aging is a publication

series of questions about his ability to move

of the Section of Geriatrics/Department

says Dr. Cooney, the Humana Professor of

and whether he gets dizzy when he stands up.

of Internal Medicine and Yale Medicine

Medicine. “He is always leading with his right

Then he watches for clues to what’s wrong.

leg and following with his left, but the more

“You watch them try to get off the chair. You

he walks, the less time he is spending on his

watch them get off the bed. You watch them

right leg.” Later, after a bedside examination,

walk,” says Dr. Cooney, who is chiefof the

Dr. Cooney speculates that a nerve root prob¬

Section of General Internal Medicine and di¬

lem in the patient’s back is causing his limp.

rector of care coordination and the Continu¬

Yale University School of Medicine

ing Care Unit at Yale-New Haven Hospital.

20 York Street, 023 DCB

“There are a couple of things to notice,”

The examination is typical of Dr. Cooney’s
approach to musculoskeletal problems in older
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Publications. The Section of Geriatrics is a
joint program of Yale University School of

Therapy, he says, varies with the patient

Medicine, Yale-New Haven Hospital and the
Leo Cooney looks to the bones
and muscles for clues to
dysfunction.

Veterans Administration Healthcare System in
West Haven.

Section of Geriatrics

Basement stairs, multiple medications and slippery baths all increase the risk of a fall.

New Haven, CT 06504
Telephone: 203 688 5238

patients. “My focus is on why a person is hav¬

and the ailment. “The key challenge is not

ing problems getting in and out of bed, walk¬

what therapeutic models you’re going to

ing, brushing their teeth, combing their hair,

use. It’s to identify the larger causes of the

Sidney T. Bogardus Jr., M.D.

using their upper and lower extremities.”

patient’s dysfunction.” In this case therapy

Leo M. Cooney Jr., M.D.

These are among what are called activities of

is, to a large degree, in the patient’s hands.

Laura J. Davis, M.D.

daily living, ADLs in the jargon of geriatric

He will have to adhere to a regimen of physi¬

Terri L. Fried, M.D.

Each year in the United States, more than a

Dr. Tinetti assesses the patient’s hearing,

medicine. Treating older persons is often a

cal therapy, adjust to using a wheelchair and

Thomas M. Gill, M.D.

third of older persons fall. One in 10 of those

balance, gait, blood pressure and list of

battle to maintain ADLs in order to maintain

adapt his home to accommodate his lack of

Jacqueline Henchel, M.D.

falls causes a serious injury. But even if no

medications. Individual treatment plans

Richard A. Marottoli, M.D., M.I’.H.

injuries result, a fall can damage an older

may include a removal of environmental

Emily D. Richardson, Ph.D.

person’s confidence in his or her ability

hazards and a change in medications. Physical

to function.

therapists teach patients how to do exercises

Fax: 203 688 4209
Denise Acampora, M.I’.H.

Before the Fall
Common-sense approach can help prevent this most common of injuries
and preserve an older person’s independence.

Margaret A. Drickamer, M.D.

Sharon K. Inouye, M.D., M.P.H.

the patient’s independence. “If you can’t get

mobility. “Sometimes we can fix things,”

out of a bed or chair by yourself then it’s very

says Dr. Cooney. “Probably 90 percent of

difficult to be by yourself all day long.”

the time things are not fixable. They are

James Tenney, M.D,

Dr. Cooney focuses on the functions of the

things that need to be identified so we can

Mary E. Tinetti, M.D.

bones, muscles and joints that drive the body’s

make plans for the family or the patient to

movements. Understanding those purely me¬

help care for him or herself.”

“Quite often it can be the beginning of loss
Yale Medicine Publications

of functional independence,” says Mary E.

Yale University School of Medicine

Tinetti, M.D., professor of medicine and Epi¬

P.O. Box 7612

niors they may take an elective in geriatrics.

step is to select the appropriate in- or outpa¬

In their first and third years, residents have a

tient treatment for the patient.

four-week geriatric rotation. Yale also offers a

Geriatricians work as part of a team that

Telephone: 203 785 5824

have had a fall are much more likely to come

example, an older person whose washing

Fax: 203 785 4327

to the emergency room, to be admitted to the

machine is in the basement is encouraged to

E-mail: ymm@yale.edu

hospital, or to use nursing homes or home

bundle dirty clothes in a bag and throw it

services.” Like all geriatricians. Dr. Tinetti’s

down the stairs. Clean laundry should be

World Wide Web: http://info.med.yale.edu/ymm

Director

goal is to keep older persons as independent as

placed in small piles and moved up the stain

John Curtis

possible. For the past eight years she has stud¬

step by step. Home improvements include

ied why and how falls occur, and has devel¬

placing grab bars in strategic locations such as

oped a protocol of simple measures that have

the bathroom and eliminating glare by remov¬

been found to reduce falls by 30 percent.

ing direct lighting.

Staff Writer

includes physicians, social workers, clinical

clinical geriatrics followed by up to two years

fellows, and nurse practitioners. Many people

of geriatrics research.

in those areas are seeking training in geriatrics,

“We teach people how to take care of

Claire M. Bessinger
Editorial Assistant/Office Manager
Cheryl R. Violante
Senior Administrative Assistant

Dr. Drickamer says. “I think they realize

people in different settings—nursing homes,

that once in practice, they will need to know

subacute care settings, homes, hospices,”

how to take care of a geriatric population,”

Dr. Drickamer says. “Rather than focusing

Cheryl Violante Distribution: Claire Bessinger

she says.

on an illness or a disease, they need to find

Design: Jeanne Criscola Photography: John

out what’s bothering their patient, what’s

Curtis, Photodisc, Margaret Gottschalk

For physicians, training begins in medical

Fall prevention starts with an inventory
Contributors Faculty liaison: Emily Richardson

putting that patient at risk and finding causes

atrics during their outpatient rotation. As se¬

for that.”

“We wanted to select things that people

of risk factors in the home, including the

can do pretty readily and inexpensively,”

presence of stairs, throw rugs and step stools.

Dr. Tinetti says.

Editorial: John Curtis. Michael Fitzsousa,

Printing: W.E. Andrews of Connecticut, Inc.

school, where third-year students study geri¬

The team also recommends simple and
inexpensive measures to prevent falls. For

Michael Fitzsousa

geriatric fellowship that starts with a year of

and walking.

demiology and Public Health. “People who

New Haven, CT 06519-0612
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at home that improve balance, strength
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Peter Salovey

Robert Heimer

Margaret Weeks

Jeannette Ickovics

Robert Heimer, Ph.D., associate professor

needle’s street life dropped from about

focuses on 600 girls ranging in age from

of epidemiology. “There’s no question

two weeks to a few days and that usage

14 to 19, half of whom will be pregnant.

about that. The question is, ‘Is this benefit

dropped from an average of eight to

“I think the question, particularly for ado¬

available only to people who come and ex¬

12 times per needle to between one

lescents, is whether or not pregnancy is

change needles directly?’ " Using color-

and five times. The study also showed

by choice, by chance or by coercion," says

banded syringes that will be distributed to

lower percentages of syringes with blood

Dr. Ickovics, assistant professor of epide¬

150 injecting drug users in Hartford, 150

from HIV-infected people and hepatitis

miology and psychology. “The very behav¬

in Oakland and 240 in Chicago, they’ll

B-infected people. Dr. Heimer’s research

ior that put them at risk for pregnancy—

track usage patterns over four years. They

has shown that the virus can survive in

unprotected intercourse—also puts them

plan to follow a total of 5 million needles

a syringe for up to a month, depending

at risk for sexually transmitted diseases.”

from index participants in exchanges to a

on how much blood is in the syringe

second level of drug users who don’t par¬

and how much of the virus is present

of her study at hospitals or health cen¬

ticipate but know people who do. They will

in the blood.

ters in Hartford, Bridgeport and New

continue to track the needles to see

“What is left to do," he says, “is to

She plans to recruit the subjects

Haven. Dr. Ickovics said she will ask how

whether they penetrate a third level of

determine who benefits and who doesn’t

many sexual partners they’ve had, how

drug users who neither use the exchange

from needle exchange programs, to

often they have sex and whether the

directly nor know anyone who does.

determine where operations can be

sex was protected.

Dr. Heimer and Edward H. Kaplan,
Ph.D., professor of management sciences

improved to maximize their impact, and

“Past behavior is the best predictor

to create enhanced needle exchange

for future behavior,” Dr. Ickovics says.

and of public health, previously concluded

programs that target people who are

The study will follow the teens over two

that New Haven’s needle exchange pro¬

at highest risk.”

years to determine whether those who

gram reduced the rate of new infections

are pregnant become pregnant again

by a third. In one of the first federally

and whether others become pregnant

Pregnancy and disease

for the first time.

tributed, who received them, when and

Jeannette R. Ickovics, Ph.D., is examining

mation to develop interventions that will

where they were returned and who re¬

how adolescent relationships bear on

limit and reduce the risk of adolescent

turned them. They then checked the used

pregnancy, risky sexual behavior and

women for both pregnancy and sexually

syringes for HIV. They found that a

sexually transmitted diseases. Her study

transmitted diseases.”

funded studies of needle exchanges, they
logged when and where needles were dis¬

“We certainly hope to use the infor¬

tions,” says Gerald H. Friedland, M.D., who directs
the Yale AIDS Program, a treatment center for people

As HIV spreads through a marginalized population,
Dr. Merson finds a disturbing lack ol political will to

with AIDS. He has been tracking the disease since the

implement proven prevention strategies. Politicians

early 1980s, when as a physician at Montefiore Hospital

won’t support needle exchange programs for fear of be¬

in the Bronx, he was among the first to notice it among

ing perceived as soft on drugs (See Politics 1; science 0).

drug users. “The epidemic in New Haven and the

The teaching of safe sex in schools raises social and reli¬

entire Northeast has been an epidemic of vulnerable

gious objections. All this, Dr. Merson notes, while tele¬

populations. That is increasingly the character of the

vision news anchors open their broadcasts with specula¬

epidemic nationally.”

tion about oral sex in the Oval Office. “Good public
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health policy is based on science. Unlortunately, when it

federal government would fund another AIDS center.

comes to AIDS, science has too often been ignored," he

Dr. Merson persisted, got an encouraging response to his

says, adding that AIDS never surlaced as an issue in the

initial proposal from the NIMH, and submitted a plan.

1996 presidential campaign. “It was the leading cause of

Last September Yale President Richard C. Levin an¬

death in our young people and neither candidate wanted

nounced the $10.8 million grant from the NIMH and

to talk about it.”

NIDA. The funding will keep CIRA going for about

With those concerns in mind early in his tenure at

four years, but those involved foresee a life beyond that.

Yale, Dr. Merson began discussing AIDS with colleagues

“Our vision for the center was that we would continue

in various disciplines. Yale had already been at the fore¬

to have 15 to 20 domestic and international projects as¬

front of treatment programs with the Yale AIDS Pro¬

sociated with it in one way or another, for a decade or

gram, and Yale researchers had conducted one of the

more,” Dr. Merson said. “I would hope we could serve

first federally funded studies to evaluate the efficacy

as an international resource in HIV prevention.” Among

of needle exchange programs as an AIDS prevention

the projects envisioned are training in prevention re¬

measure, but Dr. Merson felt even more could be done.

search for scientists, developing research capabilities at

He found enthusiasm for an AIDS prevention project

community-based organizations and analyzing policies

among his colleagues, but also some doubts that the

that relate to HIV prevention.

Adults and children estimated to be living with AIDS

Western Europe
530,000

Eastern Europe &
Central Asia
150,000
East Asia &
Pacific
440,040

A

North Africa &
Middle East
210,000

South &
South East Asia
6.0 million

fl

K

Sub-Sahara
Africa
20.8 million

Australia & ;
New Zealand

SOURCE: UNAIDS JUNE 199 8 GLOBAL REPORT; FIGURES AS OF END OF 1997
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CIRA combines the efforts of more than 55 research¬
ers from six Yale schools and departments as well as two
Hartford-based partners, the Institute for Community
Research and the Hispanic Health Council. Activities
are centered around four major research projects and
three “cores,” organizational units that support the
work. One core handles administrative chores, another
compiles the data collected and the third explores legal
and ethical issues. Researchers are also working on 13
projects affiliated with CIRA, including studies of drug
abuse among children and high-risk behavior of drug us¬
ers infected with HIV.
Keeping everything organized falls to Caroline Roan,
associate director of the center. She is in charge ol set¬
ting up CIRA’s infrastructure. “When I started, I was
working on a laptop sitting on the floor,” she says. She
relies on e-mail and telephones to keep people in touch,
but also schedules regular committee meetings, brown
bag lunches and evening seminars.

SHARING IDEAS
The interdisciplinary nature of the project becomes ap¬
parent at an evening seminar in mid-February. As Peter
Salovey, Ph.D., a psychologist who is co-director of
CIRA and director of the project on framing persuasive
messages, is explaining how to get the message out on
Drug use in Eastern Europe has led to a rapid increase in the inci¬

risky sex, needles, condom use and HIV testing, Edward

dence of HIV infection since the breakup of the Soviet Union. Most

H. Kaplan, Ph.D., a management sciences expert who

cases are found among drug users and their sex partners. CIRA is

led the study of New Haven’s needle exchange program,

about to begin a five-year, $2 million program to bring Russian
scientists to New Haven for training in HIV prevention research.

picks up a piece of chalk and begins to apply math¬
ematical modeling to Dr. Salovey’s theories. The topic is
the not-always-logical thought process behind risky

tific reasons to compile such a list, Dr. Novick says, but

sexual behavior. Wearing a condom will produce a fairly

equally compelling privacy issues. “You want to count

certain result, says Dr. Kaplan. Not wearing a condom

people who are infected.

offers two possible results—getting infected or not get¬

care. They’re all potentially infectious to others,’’ he

ting infected. He charts the possibilities on a blackboard

adds. “You could mandate the testing of everyone and

7’hey’re

all going to need health

and begins writing formulas. “It could be perfectly ratio¬

then you’d have perfect surveillance. We would have to

nal for people not to use condoms if risk is perceived

ask eventually whether it was the least invasive.”

as small,” Dr. Kaplan concludes.
At a CIRA conference in late May, Alvin Novick,

At CIRA’s first brown bag lunch in February, another
ethical question surfaces. The topic is informed consent.

M.D., professor of ecology and evolutionary biology

How do researchers secure the cooperation of people

and director of the center’s law, policy and ethics core,

they’re studying, explain what they’re doing and spell

leads a discussion on surveillance of AIDS cases and

out their rights? “They have to know the purpose of

HIV infections. He poses a rhetorical question: Does the

what you are doing,” says Robert J. Levine, M.D., HS

public health benefit of tracking cases ol HIV infection

’63, professor of medicine and co-director ol the law,

outweigh individual rights to privacy?

policy and ethics core, who leads the discussion. “They

Some states report only cases of AIDS, while others

have to understand the risks. They have to understand

report cases of HIV infection. Fear of having their names

the benefits. They have to know the alternatives.” The

on a list of those infected with HIV has made people re¬

discussion turns to another question. Can researchers

luctant to get tested for the virus. There are valid scien-
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EXCERPT

Dispatch from the front lines
In his new book, Yale physician Peter Selwyn describes the early days of the epidemic.

I

si i r\ TV 111ST
have become an "AIDS doctor,” an
outcome I never could have antici¬
pated when I graduated from medical

school in 1981. I have been involved in
the care of more than a thousand pa¬
tients with HIV infection, and for almost
ten years these have been my only pa¬
tients. I have been fundamentally
changed by this experience, and my his¬
tory is now indelibly linked with the faces
and histories of my patients, especially
the many hundreds who have died. This
story is their story, and mine.
The beginning of the AIDS epidemic
in the Bronx in the early 1980s was a
time without recent precedent, a time
when a fatal blood-borne disease spread,
without warning and with grim efficiency
through an unsuspecting and vulnerable
population. This same insidious pattern

Fresh out of Harvard Medical School in 1981, Peter A. Selwyn,
^0
M.D., began his career at the Montefiore Medical Center in the
Bronx. As an intern he saw the AIDS epidemic run rampant
IVtor \. ScIwmi
with a (orrwo»d by SHcrwir M. f»<U'
through a community already challenged by poverty and drug
addiction. In Surviving the Fall: The Personal Journey of an AIDS
Doctor, published this spring by Yale University Press, Dr. Selwyn
describes his experiences, the people he treated and how their
lives, and deaths, helped him confront grief in his own life.
Dr. Selwyn, associate professor of medicine and of epidemiology and public
health, came to Yale in 1992 as associate director of the Yale AIDS Program.
He is the medical director of Leeway, a 30-bed skilled nursing facility for AIDS
patients, many of whom are in the late stages of the disease. The center, which
opened in October 1995, recently received state health department approval to
add 10 beds, which will be geared to the special needs of patients with HIV and
co-existing mental illness.
Dr. Selwyn recently received a faculty scholar’s award from the Project on
Death in America of the Open Society Institute, which is intended to enhance
end-of-life care, teaching and research at Yale-New Haven Hospital and Yale
School of Medicine.

was unfolding in Harlem, Brooklyn, and
many other poor, inner-city communities
in the United States and around the

cide—of my father when I was an infant.
Surrounded by dying young parents, I

or other escapes. Sometimes, working
with our patient population, it was easy to

world. In these communities AIDS was

slowly came to understand, for the first

affecting poor, minority populations, pri¬

time in my life, what it meant to have a

neediness, and with the feeling that no

marily intravenous drug users, their sex¬

father, and to be one. This process of

matter what you did, it would never be

become overwhelmed with this sea of

ual partners, and children, in addition to

awakening led me to come to terms with

enough. Nelson was not like that, and as

gay men. I have long felt that this history

my personal history, along with the

a result he tended to draw staff to him in

and these stories need to be told, to help

stigma and the family secrets that it had

a way that made it clear that they were

honor and take notice of all the uncele¬

engendered, and finally, with my own role

getting as much emotional support and

brated men, women, and children who

as a son, as a husband, as a father to

positive energy from him as they were

lived and died with this unforgiving

two young children, and as a physician. It

giving in return.

plague. Statistics have been described

was, for me, a journey of healing in the

as human beings with the tears washed

midst of the epidemic, a reclaiming of life

him to all of his medical visits, was also

off. In this narrative, I have tried to re¬

in the midst of death.

gentle, composed, and a model of grace

store some humanity to the statistics.

His wife, Marilinda, who accompanied

under pressure. Their only child, Manuel,

This book describes both the first

was 12, and it was clear that his parents

wave of the AIDS epidemic in the Bronx

I remember Nelson most vividly, less be¬

and the gradual process by which I also

cause we shared the same birthday than

ing him from the overriding influence of

became aware of my own unfinished busi¬

for the gentle sweetness of his soul. In

the street, in their neighborhood not far

ness. Absorbed in the pain and losses of

our population of methadone program pa¬

from Yankee Stadium, south of the Cross-

my patients and their families, I slowly be¬

tients, in which the patients with the

Bronx Expressway. This close-knit family

gan to acknowledge the grief that I had

most extreme personality disorders

of father, mother, and only child stirred

carried unknowingly for decades following

seemed to require the most attention,

something in me that I did not identify

the sudden death—and apparent sui-

Nelson stood out in his sincerity, thought¬

consciously at the time. It was an image

fulness, and calm. Unlike many other pa¬

of the ideal family that I had never experi¬

tients, he had an emotional maturity that

enced, or had experienced only too briefly

enabled him to talk about his fears, con¬

before it was erased from my memory.

Excerpted from Surviving the Fall: The Personal
Journey of an AIDS Doctor by Peter A. Selwyn,
M.D. Copyright © 1998 by Peter A. Selwyn.
Reproduced by permission of Yale University Press
[http://www.yale.edu/yup/]. All rights reserved.
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cerns, and feelings about the disease
without taking refuge in further drug use

had been successful thus far in protect¬

Nelson was the first patient for whom
I wrote a prescription for AZT, the first
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week that the drug became available, in

thing sacred about the way she washed

room with red velour walls and dark

spring 1987. I remember carefully writing

his body with such long, methodical, and

wooden chairs. I approached the casket,

the words on the prescription, foreseeing

loving movements; it seemed as if she

stood and bowed my head for a moment

that this would be the first of thousands

knew that this would be the last time she

and saw that they had done a nice job

of such prescriptions that I would write.

would touch his living body, and that she

preparing him. He was wearing a pressed

Nelson and I had both been anticipating

wanted to linger over it all the more. He

dark brown suit, hair neatly combed,

the arrival of AZT, and indeed for every¬

died in his sleep that night.

one involved in the epidemic at the time

A few months before his final illness,

hands clasped in front holding a rosary. I
wondered, as I always do in such situa¬

this was a momentous event: it repre¬

Nelson had told me that he had one un¬

sented, for the first time,the possibility

fulfilled wish: to return to Puerto Rico and

tions, where he really was at the moment,
and wished him well wherever he was. I

that this virus could be treated. Every¬

ride his motorcycle again. He had an old

turned away from the casket, saw

thing that we had done up to then was

Harley-Davidson, which he had restored

Marilinda, gave her a hug, and then no¬

supportive care. With the advent of AZT,

from parts and kept stored in a friend’s

ticed his parents, whom I had briefly met

we were at last fighting back at the virus

garage on the island. He giggled as he

in the hospital. Nelson’s father, misty-eyed,

itself, however crudely or ineffectively.

conjured up the image of himself, already

pressed my hands clumsily between his

beginning to look a little emaciated, rac¬

and said in Spanish, "Thank you, we will

Both of us knew, at the moment I
handed him the prescription, that this

ing over hills and around steep mountain

never forget what you did for our son.’’

would probably not be enough to keep

bends near his family’s home in the cen¬

These words, spoken to me from a father

him alive much longer, that this was prob¬

tral coffee-growing region of Maricao. Not

about his son, touching on death, and re¬

ably going to be, for him, too little too

being certain that he could tolerate such

membrance, and love, moved me greatly

late. Yet for both of us, at that same

a trip, but realizing that it was important

and reaffirmed for me as I walked out into

moment, AIDS suddenly lost a little bit

for him to go regardless, we arranged for

the night that I had chosen the work I

of its terror and mystery.
After doing well on AZT for about six

Nelson to have enough medication for

needed to do. I still did not realize how

several weeks, and local medical backup

close to home these words would come in

months, Nelson started to fail, first losing

if he needed it. He sent me a postcard

my own life, how much they would touch

weight, then starting to lose his balance

and returned several weeks later, bronzed

my long-dormant feelings about the loss of

and coordination, and then becoming

from the sun and laughing, saying matter-

my father and his memory. Words from a

more apathetic and withdrawn. One day,

of-factly that there was nothing else he

father about his son, spoken in gratitude

he had a seizure in the clinic and was

had left to do. (I remember thinking at

to another man’s son who had grown up

rushed to the North Central Bronx Hospi¬

the time how wonderful it must be to

without his father. As I watched this family

tal emergency room, where a CAT scan re¬

have that feeling.) It was soon after that

confront the loss of its father, husband,

vealed a large circular lesion in one of the

trip that he began to descend rapidly into

and son—seeing Nelson’s life reflected in

frontal lobes of his brain. This was likely

his final illness.

either cerebral toxoplasmosis or lym¬

I went to Nelson’s funeral one rainy

relation to his survivors—it stirred some¬
thing in me that was both numb and pain¬

phoma but the diagnosis could be made

evening, at a small funeral parlor in East

ful, something which would eventually lead

only be performing a brain biopsy. At that

Harlem. He was lying in an open coffin in a

me back to my childhood history.

time, it was virtually impossible to find
surgical consult- ants at our hospital who
were willing to perform procedures on
AIDS patients, and this case was no
exception. In addition, both Nelson and
his wife had decided that if he were to
become sick again, they would not want
further aggressive treatment if the quality
of his life would be unlikely to improve.
We treated him empirically for a week
with medication that would be effective
against toxoplasmosis, if that were in
fact his diagnosis, but he showed no
improvement. His mental status contin¬
ued to decline, and he began to slip in
and out of consciousness.
The last time I saw him, I sat by his
bedside and took his hand. He opened
his eyes, smiled weakly, said, "Thank you
for being here,” and squeezed my hand
briefly. Marilinda, who had been sitting
nearby, began to cry softly. I talked with
her a little while and then watched as
she gave him a sponge bath. I had never

Yale physician Peter Selwyn examines a patient at Leeway, a skilled nursing facility in New

been to a baptism, but there was some¬

Haven for people with AIDS, where he is medical director.
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guarantee confidentiality to drug
risers who have reason to fear the
law? What obligations do they have
to report illegal activities to authori¬
ties? “These are not the sorts of is¬
sues that have clear answers,” says
Dr. Levine, chairman of the medical
school’s Human Investigation
Committee. He and others note
that CIRA is covered by a federal
certificate that guarantees interview
subjects confidentiality.
During an interview in her
Hartford office, Margaret R. Weeks,
Ph.D., associate director of the In¬
stitute for Community Research
and director of CIRA’s study of
high-risk drug sites, says researchers
are required to report child abuse.
They will also act in life-threatening
situations, such as overdosing.
“Often it’s a judgment call out in
the field,” she says. Outreach work¬
ers will also make referrals lor drug
users who seek treatment and will
offer health kits. “The benefits of
understanding these places, in order
to protect health for the public
good, justifies our research. If we go
in there to intervene, either to im¬
pose the law upon them or impose
something else upon them, we undo

Mobile health unit
extends AIDS care

I

n 1993, an 18-foot van loaded with cli¬
nicians, social workers, counselors
and outreach workers began winding
its way down New Haven’s streets to offer
medical services, HIV testing and coun¬
seling and referrals to substance abuse
programs. The van, since replaced by a
36-foot model with two exam rooms, a
counseling room and a waiting area, is
linked to the city’s needle exchange pro¬
gram. Funded by a $3 million grant from
the National Institute on Drug Abuse, the
health care van's operation is a collabora¬
tion among the medical school, the City
of New Haven, Yale-New Haven Hospital
and the Hospital of St. Raphael, and sev¬
eral community health centers. Although
it operates in conjunction with the city’s
needle exchange program, it has sepa¬
rate funding.
“We traveled everywhere the needle
exchange went,” says Frederick L. Altice,
M.D., HS ’87, director of the van project.
“I realized this would be an important
method to provide medical care and pre¬
vention services to drug users.” It also
provides medical care to people who are
homeless and lack medical insurance,
providing acute care and referrals to com¬
munity-based health care providers. In its
first three years of operation the van
treated more than 1,800 people, many of
whom had HIV/AIDS.

our ability to do research.”
Page 44

Prison program offers
opportunities for
prevention

O

ne of the ironies of the criminal
justice system is that it brings
many people into contact with
regu-lar health care for the first time in
their lives, says Frederick L. Altice, M.D.,
HS '87, assistant professor of medicine
and a CIRA-affiliated researcher. Because
they’re under constant penal surveillance,
they can also be placed under close
medical watch.
“It’s an important opportunity to de¬

tect disease and to initiate treatment,"
says Dr. Altice, who has served in recent
years as a consultant to Connecticut’s
Department of Corrections, treating in¬
mates with AIDS. “For those who are at
risk for HIV and are still negative, it’s a
place where HIV risk reduction interven¬
tions should be introduced, in order to
decrease their risk for getting HIV at a
later time.”
Cases of AIDS, he says, can be found
in prisons at a significantly higher rate
than in the general population. “The war
on drugs has basically instituted wide¬
spread mandatory sentences on drug
users and it is drug users who are at
risk for HIV,” he says. “It’s the behavior
that’s occurring just before people
come in to prison that is the riskiest.
It is unprotected sex and sharing of
injection equipment.”
Nationwide, according to Bureau of
justice statistics, AIDS cases were six
times more prevalent in the prison popu¬
lation than in the general population. At
the end of 1995, there were 5,099 con¬
firmed AIDS cases in prisons, and AIDS
was the cause of 34 percent of all in¬
mate deaths. Unfortunately, most cases
of HIV go undetected within the prison
system, Dr. Altice says.
Dr. Altice has developed programs
that link HIV-infected inmates to commu¬
nity health care when they leave prison.
“The most basic and difficult problems

Peter Salovey describes prospect theory
during a presentation at a CIRA meeting.
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zon for many, our focus is shifting from
acute symptom management to interven¬

Closer to home, Professor Williams
and Dr. Angoff are looking at strategies to

tions directed at the problems raised by

improve patient-provider communication

care van, dedicated

living with a chronic condition."

about end of life care and advance direc¬

in 1996, follows a
route through New

gator for the School of Nursing-based

under way at the School of Nursing illus¬

GRACE project, or Gynecologic Regimens

trates the global challenge posed by this

medical care, HIV
testing and counsel¬

Addressing Candida Events. GRACE was

epidemic and the importance of strong

ing and referrals to

funded by the National Institute for Nurs¬

interdisciplinary collaborations.

substance abuse

ing Research to examine the efficacy of

programs.

three nursing interventions to prevent

A 36-foot health

Haven to provide

Professor Williams is principle investi¬

tives. The range of AIDS nursing research

Candida vaginitis, a common and dis¬
tressing problem for women with AIDS.
“Now that the study is complete,” she
says, ‘‘we are turning our attention to new
challenges such as strategies to improve
medication adherence and screening for
anal cancer. Neither of these issues were
on our radar screen earlier, when our goal
was limited to helping people feel better
and live as long as possible."
Professor Williams, who also serves
such as stable housing and food,” Dr.
Altice says, "are things that destabilize our
patients when they return to the commu¬
nity. Stable housing remains one of the
most crucial and unavailable unmet needs.
The best we can do is get them into a shel¬
ter. Sometimes you have to put a Band-Aid
on one wound while you’re dealing with
other wounds, such as accessing drug
treatment and medical care."

and around the world

Y

very fall incoming
freshmen can ex¬
pect invitations to

one of 36 safer-sex work¬
shops held during their
first week of school.

dents, was pleased that the dissertation

Also offered at cultural

research for the nursing school’s first

houses, fraternities and

doctoral graduate, Wantana Limkulpong,

sororities, the workshops

D.N.Sc. ’98, was a study of safer-sex

are led by 27 peer edu¬

Sally Rinaldi

practices among commercial sex workers

cators who talk about

in Thailand. Ms. Limkulpong discovered

the risks of unprotected sex, which in¬

that although knowledge levels were

clude sexually transmitted diseases and

high, financial pressures and lack of

pregnancy. Overseeing the program is

self-confidence prevented many women

Sally Rinaldi, R.N., M.P.H. ’82, who coordi¬

from initiating condom use. Limkulpong

nates health education programs for Yale

is returning to a faculty post at Mahidol

University Health Services.

continue her research.

improves care locally

E

as an advisor for School of Medicine stu¬

University in Bangkok, where she will

Nursing research

For college students,
a focus on safer sex

The Nursing School’s global reach is

“Mostly we talk about why students
need this information, why it is impor¬
tant,” Ms. Rinaldi says. “You may not

extended by its collaborations with the

need it today, but you might need it down

Yale-China Association. Under one such

the road. Even if you feel you don’t need

project, Jane Burgess, director of the YSN-

the information for yourself you might

based Connecticut AIDS Education and

need it for your roommate or your friends."

Training Center, traveled to Hunan Prov¬

She relies on health advocates among

ale AIDS researchers from the

ince in May. In a program supported by

graduate students to inform their peers,

School of Nursing can be found in¬

the World AIDS Foundation, Ms. Burgess

who are more scattered in housing.

terviewing sex workers in Thai broth¬

and Professor Williams, along with Nancy

els and drug users in Poland, conducting

Angoff, M.P.H. ’81, M.D. '90, are conduct¬

Every year, health educators hand out
about 40,000 condoms to graduate and

clinical trials to prevent gynecologic com¬

ing a series of workshops to prepare

undergraduate students. Undergraduates

plications in New Haven women infected

Chinese nurses to respond to the

can get them from freshmen counselors

with HIV, and teaching AIDS treatment and

growing threat of an HIV epidemic in the

or peer educators. On Valentine’s Day the

prevention to nurses in China and Vietnam.

world’s most populous country. In asso¬

program gives away safe sex kits which

ciation with the workshops, Professor

include condoms, lubricant, information

est days of the epidemic,” says Ann Will¬

Williams and Dr. Angoff will study HIV

on how to use them and information

iams, M.S.N. '81, “was that nursing care

seroprevalence in a storefront STD clinic

on abstinence.

made a huge difference. In the begin¬

in Changsha. Although HIV testing is not

ning—and it’s still true for most of the

widely available, a skyrocketing incidence

abstinence," says Ms. Rinaldi. “There

world—exquisite nursing care was all we

of anogenital HPV infections and genital

are people who are sexually active and

had to offer people with HIV. Now, with the

ulcer disease suggests that the risk is

people who plan to abstain. It's not

promise of long-term survival on the hori¬

extremely high.

always the same for everyone.”

“What became apparent from the earli¬
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DISCOVERY

Hunting down HIV
Yale research produced two of the current crop of AIDS drugs and a promising new line of inquiry.
It may take a virus to kill a virus, if genetic approach is proven effective.

By John Curtis

I

t is perhaps testimony to HIV's resil¬
ience and versatility that physicians
celebrate drugs that do no more than

slow the virus’s progress in the human
body. HIV hides and mutates in order to
dodge the medications sent to stop it.
And while these agents are limited in
their therapeutic value, so far they have
provided the only hope in the treatment
of AIDS.
Researchers at Yale have played key
roles in developing two of these com¬
JOHN CURTIS (2)

pounds, the reverse transcriptase inhibi¬
tor d4T, known commercially as Zerit, and
3TC, known as Epivir. Both are key ingre¬
dients of the so-called drug cocktail that
has fundamentally changed the nature of
AIDS therapy during the past three years.

William Prusoff and his late collaborator, Tai-Shun Lin, discovered that d4T, although it was a
poor anticancer agent, could slow the production of HIV.

They not only inhibit the reverse tran¬
scriptase enzyme, but more importantly,
by terminal incorporation into the growing
proviral DNA, a precursor to the virus,

Zerit (d4T)

they prevent the reproduction of the vi¬
rus. These compounds are frequently
combined with other inhibitors which in¬
hibit the viral enzyme protease, whose
activity is essential for the formation of
an infectious virus.
In addition to contributing to tradi¬
tional, small-molecule pharmaceutical
development, Yale scientists are exploring
new avenues in the fight against AIDS,
in particular the potential of biological
agents to effect a cure. One novel ap¬
proach has resulted in a genetically
engineered virus that attacks and kills
HIV-infected cells in culture while leaving
other cells unharmed. Whether it will do
so in humans, or even animals, remains
to be evaluated.
William Prusoff, Ph.D., professor
emeritus of pharmacology, has spent a
45-year career at Yale investigating poten¬
tial antiviral and anticancer compounds,
part of the traditional, small-molecule ap¬
proach. In the late 1950s he synthesized
idoxurine, an analog of thymidine, which

4
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Yung-Chi (Tommy) Cheng’s laboratory looks
for ways to reduce the toxicity of drugs that
work against AIDS. He found that 3TC could
reduce side effects when used in
combination with AZT.
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was the first antiviral compound ap¬
proved by the FDA for therapy in humans.
It was used to treat herpes infection of
the eye. Dr. Prusoff and his long-time col¬
laborator, the late Tai-Shun Lin, Ph.D., dis¬
covered in the 1980s that a thymidine
analog, reported in scientific literature as
a poor anticancer agent, was very effec¬
tive in slowing the production of HIV. This
compound is known as d4T or stavudine.
How does d4T work? “It gets incorpo¬
rated into the growing viral DNA chain
and synthesis of proviral DNA is
stopped,” Dr. Prusoff says. HIV’s mecha¬
nism for reproducing is simply turned off.
Bristol-Myers Squibb developed the
drug under the trade name Zerit and
brought it to market in 1994. Almost
single-handedly, d4T has boosted Yale’s
annual patent royalty income nearly ten¬
fold, to $34 million for the year ending
June 30. [AZT, the first medication shown
to slow the progress of HIV, was created

John Rose converted a cattle virus into a hunter and destroyer of HIV-infected human
T-cells in culture.

by a Burroughs Wellcome team led by
(1) Altered VSV with human CD4 and

Yale alumnus David W. Barry, M.D. '69, HS

CXCR4 receptor molecules

’69-72. (Yale Medicine, Fall 1997)]
(3) gpl20/41, a

“They are very potent in decreasing

protein produced

the viral load in the bloodstream,” says

by HIV, attracts

Dr. Prusoff, referring to the limitations

(2) Altered VSV seeks out HIV-

of the currently available anti-viral

infected T-cell in culture

medications, “but you don’t really elimi¬

the altered virus
to the surface
of the T-cell

nate the viral load in the cell where the
virus is hiding. This is critical for an
eventual cure.”

Stalking HIV
John Rose and his collaborators altered a
cattle virus known as VSV so that it seeks
out human cells infected with HIV. They in¬
serted into VSV the human genes that pro¬

The combination approach

duce CD4 and CXCR4, receptor molecules

Two hurdles in AIDS pharmacology are

where HIV begins its infection. With those

toxicity and drug resistance. As with can¬

receptor molecules (1) in place, the altered
virus, (2), is drawn to gpl20/41 (3), a pro¬

cer chemotherapy, AIDS medications can

tein produced by HIV that appears on the

make people very sick. For example, d4T

surface of infected human cells. VSV attacks

can cause peripheral neuropathy, tingling,

and destroys only HIV-infected cells while

numbness and pain in the extremities;

ignoring healthy cells. In tissue cultures the
engineered VSV has reduced the viral load

ddl can cause lethal pancreatitis; and

by 10,000-fold. The new virus (4) reproduces,

AZT is toxic to the bone marrow and can

going on to attack other HIV-infected cells.

cause anemia, headaches and nausea. In
addition, HIV often mutates when chal¬

(4) Budding VSV separates from T-cell

lenged by a single therapeutic agent, cre¬
ating drug-resistant strains of the virus

to attack other HIV-infected cells

Yung-Chi (Tommy) Cheng, Ph.D., the

that foil treatment. By prescribing AIDS

Henry Bronson Professor of Pharmacol¬

drugs in combinations, the physician can

ogy, has worked on a parallel course to
“If we know the mechanism for the

reduce individual dosages and minimize

Dr. Prusoff. While Dr. Prusoff found drugs

both side effects and the potential for re¬

that work against AIDS, Dr. Cheng has

toxicity, we may be able to prevent the

sistance. “There are dozens of different

sought ways to reduce their toxicity. Long¬

toxicity by either making a new compound

combinations,” Dr. Prusoff says. “Resis¬

term usage, Dr. Cheng says, leads to a

or by combination with other drugs,” says

tance develops to all of those com¬

decline in the mitochondrial DNA of cer¬

Dr. Cheng, whose laboratory team studies

pounds.” Resistance to d4T has been

tain organs, affecting their ability to func¬

the behaviors of virus-specific proteins in

found with laboratory strains of HIV, but

tion properly. After a month or two of use,

order to exploit them. "The next question

mutant forms resistant to d4T have not

anti-retroviral agents such as AZT, ddl

is, ‘Can we find a drug that will be active

been observed in patients being treated

and DDC can cause problems in nerves,

against the virus but will have no toxicity

with d4T, Prusoff says.

the pancreas, muscles and the liver.

to the mitochondrial DNA?’
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That drug turned out to be 3TC, a compound that has
positive and negative forms that mirror one another. Origi¬
nally synthesized by a Canadian researcher and identified
as an antiviral agent, samples were sent to Dr. Cheng for
study of its toxicity. He found that 3TC’s negative form re¬

i Page 41
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THE

STREET

"Outreach workers. Kits and condoms,” shouts Dr.
Wilson, one of: the anthropologists studying drug sites,

duced side effects when used in combination with AZT. The

as he and Ms. Martinez climb the stairs of an abandoned

combination increases 3TC’s efficiency at inhibiting reverse

building back in Hartford’s Charter Oak neighborhood.

transcriptase, an enzyme HIV uses to reproduce its genetic

Before leaving their office, they stuff their pockets and

material. Dr. Cheng identified 3TC as an agent that would

shoulder bags with condoms and kits that include

be less toxic to mitochondrial DNA than DDC, ddl or d4T.
"We are increasing the antiviral effects, decreasing the
side effects. This may be a key mechanism of the combina¬

small vials of bleach and water for cleaning needles.
They also carry flashlights to help them find their way

tion protocol against HIV," he says. “In the meantime we

through abandoned buildings and avoid needles, feces

also discovered the same compound is active against the

and debris.

hepatitis B virus. The results were very promising.” So far,
3TC has been approved for HIV treatment and is in clinical
trials for use against hepatitis B.

The condoms and bleaching kits serve two functions.
They provide an opportunity for outreach workers to
introduce themselves to drug users. But as an AIDS
prevention tool, bleaching has a mixed record. It

Search and destroy

requires filling the syringe with bleach and holding

A new approach to AIDS may grow out of work led by John

the bleach inside for 30 seconds, then repeating the

K. Rose, Ph.D., professor of pathology and cell biology. The
agent he developed, based on a common virus found in
cattle, has killed HIV-infected cells in culture. Scientists in
the Rose lab are trying to develop a form of the engineered

process three times. After bleaching, the needle should
be rinsed with water. If done correctly, the procedure
disinfects the needle and syringe, but some addicts

virus that will work against SIV, the simian form of HIV, for

don’t hold the bleach inside for the required 30 seconds.

use in animal trials. If it is proven safe and effective in ani¬

Although they’re not always used properly, Dr. Wilson

mals, human trials could follow.

believes there is a benefit to distributing the kits.

Dr. Rose’s discovery was the result of efforts to deter¬
mine how viruses are constructed. “Once we know that, it
becomes possible to change the components,” he says.
The strategy was to trick HIV-infected cells into binding with
another virus that would destroy them. He exploited the
affinity between an HIV protein and its human targets—
molecules on the surface of T-cells that allow HIV to enter
and infect them. Infection begins when the HIV protein,
gpl20/41, is drawn to the receptor molecule CD4 and

“If anyone’s using them at all," he says, “it’s better
than no one using them.”
What researchers and, indeed, the entire CIRA
project are up against becomes clear on Irving Street in
Hartford’s Upper Albany neighborhood. On a busy
street corner between a police substation and a commu¬
nity health center the signs of drugs are all about. “Got a

the co-receptor molecule CXCR4. “What we did was to
reverse that process,” Dr. Rose says.
Dr. Rose deleted glycoprotein genes from the cattle virus
known as vesicular stomatitis virus (VSV) and replaced
them with the human genes that produce CD4 and CXCR4.

Two teams, each with an anthropologist and an outreach worker, are
studying the rules that govern drug use in abandoned buildings and

With gpl20/41 on human cell surfaces as its prey, the re¬

other sites in Hartford. They hope to slow the spread of HIV by con¬

ceptor-laden virus becomes a hunter drawn to HIV-infected

vincing drug users not to share needles. Maria Martinez, Glenn Scott,

cells like a magnet. “It doesn't completely eliminate HIV," Dr.

Scott Wilson and Stephen Cabral visit an abandoned building in the

Rose says. “It reduces the viral load 10,000-fold in tissue

Charter Oak neighborhood.

culture cells. In the best of all possible worlds it might pre¬
vent people from progressing to AIDS.”
He also sees the possibility of developing an AIDS vac¬
cine, using recombinant VSV as a vaccine vector. “You can
create a live virus vaccine, which might express protein from
a virus that you want to immunize against.” Dr. Rose's group
has already shown that VSV vectors expressing influenza
virus proteins can protect against influenza.
“The ideal situation," says Dr. Prusoff, “would be to de¬
velop a vaccine to prevent infection and at the same time
find drugs which not only decrease the virus in the blood
stream, but also get in to the hiding places of the virus in
the various parts of the body. Eventually the source of the
virus will be killed and you prevent new infections from
taking place."
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kit? Got a couple of rubbers?” two men ask as they
approach anthropologist Stephen Cabral, Ph.D., and
his colleague, outreach worker Glenn Scott. Both work
at the Hispanic Health Council and are working on
the high-risk drug sites project in Hartford. A moment
later, a stocky man of medium height walks by. “I got
what you need! ” he says, assuming strangers have come
to the neighborhood for only one thing. He doesn’t miss

Politics 1; science 0

E

vidence of the political nature of AIDS prevention
became apparent in April. The Clinton administration
acknowledged what research has long established;

needle exchange programs reduce the spread of HIV
infection, serve as a conduit into treatment programs and
don’t encourage drug abuse. Yet despite the scientific evi¬
dence, the federal govern¬

a beat when he learns he has offered drugs to outreach

ment would not fund needle

workers. He smiles, shrugs his shoulders and turns

exchanges, officials decided.

down their offer of free condoms. He lingers to tell
them that the last time he took them his girlfriend ac¬
cused him of cheating. Meanwhile Mr. Scott talks with

“It’s politics rather than
science driving policy,” Dr.
Merson said. “It’s but an¬
other example of why this

Jeffrey, a tall, skinny man on his way to a Chinese take¬

epidemic continues to grow

out restaurant. Jeffrey has been in and out of drug treat¬

and be as serious as it is.”

ment programs and laments some of the losses in his
life, particularly a once-fine wardrobe. “I know what I’m
doing is wrong,” says Jeffrey. “I’ve got to find something
to replace it with.”
Down a side street Dr. Cabral and Mr. Scott wait

Clinton Endorses
Needle Exchanges
But Not Funding
By Amy Goldstein
IPushin/pon Post Staff Writer
The Clinton administration declared yesterday that
needle exchange programs can help curb the AIDS
epidemic without fostering the use of illegal drugs, huL.

Robert Heimer, Ph.D.,
whose 1990 study with
Edward H. Kaplan, Ph.D., found that needle exchanges
reduced HIV infection by 30 percent, also decried the
decision. “It is quite clear from the scientific evidence that
needle exchanges can slow the transmission of HIV and

outside a garage. Inside are two men who a few minutes

other infectious diseases as well as serve as a conduit for

earlier approached them on the street to ask for bleach¬

getting people into substance abuse treatment,” Dr. Heimer

ing kits. One of the men comes out, and, embarrassed,

said. “The foolishness has gone on long enough. When

says he and the other man are only using the garage to
relieve themselves. After they have gone, Dr. Cabral and

politics goes ahead of public health everybody suffers."
Laws governing syringes and needle exchanges vary
from state to state. Eight states prohibit dispensing sy¬

Mr. Scott look around to find the floor littered with

ringes without a prescription and another 10 place restric¬

pastel-colored glassine envelopes that once contained

tions on the sale of syringes without a prescription. In all

heroin. Before leaving, Mr. Scott places a fresh bleach¬

but a few states, laws barring drug paraphernalia make

ing kit on top of some broken furniture in the hope that
someone will use it.
The kit remains as a symbol of CIRA’s goal—evaluat¬

possession of needles a crime. The 110 needle exchanges
operating in the United States do so under a variety of
legal conditions. Six states and the District of Columbia
have created exemptions to paraphernalia laws to allow

ing and implementing prevention measures that will

needle exchanges. Other states tolerate them and in some

stop the spread of AIDS. “Hopefully,” says Dr. Merson,

states the needle exchanges operate illegally. None of them

“we can make a real difference in the nation in how we

receive federal funding.

deal with this disease.” SMI
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ate the school’s needs in the area of

Medical school

education. Dr. Gifford’s previous re¬
sponsibilities, education and student

creates new deputy

affairs, will be divided under the new

dean position for

plan and an internal search has already
been launched to fill the associate
dean position.

education

Dr. Gifford had planned to retire

R

in June 1997 to begin a new career as a
biology teacher in an inner-city school

obert H. Gifford, M.D., H.S.
67, who has served as associate

district. Dr. Kessler, however, asked
him to remain during the 1997-98 aca¬

dean for medical education
and student affairs for the past 12

demic year to ease the transition to a

years, became the School of

new administration. This spring Dr.

Medicine’s first deputy dean for
education on July 1.

Gifford decided to stay on for one
more year as deputy dean.

The appointment was announced
by Dean David A. Kessler, M.D., who
said the new position stresses the im¬
portance of education among the

He received his medical degree
from Tufts University School of Medi¬
cine in 1961. He interned at Boston
Robert Gifford

school’s three core missions. Deputy
dean positions for research and patient
care were created in 1995. “There
should be no doubt that the teaching

City Hospital and was a senior assis¬
tant resident at Yale-New Haven Hos¬

person to move that mission forward."
Dr. Gifford, who is delaying his re¬

pital from 1966 to 1967. In 1969, he
was appointed assistant professor of

tirement for a second time, will serve

medicine at Yale. Three years later he

and educational mission of the school

in the new position for a year. During

was appointed associate professor of

is certainly on a par with both clinical
affairs and scientific affairs,” Dean

that year he will establish a framework

clinical medicine and in 1976 became

for the post while a nationwide search

a professor of medicine. In 1985 he

Kessler said. “Nor is there doubt in

is conducted for a successor. He will

was named associate dean for educa¬

anyone’s mind that Bob Gifford is the

also set and prioritize goals and evalu¬

tion and student affairs.

Neurobiologist selected to lead graduate school

S

usan Hockfield, Ph.D., profes¬
sor of neurobiology at the

graduate studies for the section of

an assistant
professor in

Dr. Hockfield served as director of

School of Medicine, has been
appointed dean of the Graduate

neurobiology from 1986 to 1994, and

1985, said,

has been involved with improving

School of Arts and Sciences, Yale

graduate training in the biological and

“I am deeply
honored to

President Richard C. Levin has

biomedical sciences throughout her

be entrusted

announced.

tenure at Yale. She has served on the

with the chal¬

The Graduate School of Arts and
Sciences is the largest of Yale’s 11

executive committee of the graduate
school and on a committee to improve

lenge of guid¬

graduate and professional schools.

linkages among the biomedical sci¬

As dean, Dr. Hockfield will oversee

ences. She has also had a role in the

Susan Hockfield

world’s finest
graduate

academic and administrative policies

development of the new Biological
and Biomedical Sciences Graduate

schools. Yale awarded the nation’s

for the school and its 2,300 students.
She succeeds Thomas Appelquist, the
Eugene Higgins Professor of Physics,

Program, a collaboration among most

who returned to his teaching and

of the biological science departments
of the University.

research responsibilities on July 1.

Dr. Hockfield, who joined Yale as
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ing one of the

first doctoral degree more than a cen¬
tury ago, and I am eager to work with
our gifted students and dedicated fac¬
ulty toward more ‘firsts’ for graduate
education at Yale.”
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Sciences, Myron Genel, M.D., associ¬
ate dean for government and commu¬

tion of Connecti¬
cut in May. The

Vincent T. DeVitaJr., M.D., director

nity affairs and professor of pediatrics/

of the Yale Cancer Center and profes¬

pediatric endocrinology; Martin E.
Gordon, M.D. ’46, clinical professor

award recognizes
medical profession¬

FACULTY

N

sor of internal medicine (oncology)
and of epidemiology and public
health, has been awarded the
Commendatore Order of Merit of the
Republic of Italy. The medal, a high
honor bestowed by the Italian govern¬
ment, was presented at a ceremony in
March at the Yale Club in New York.
Dr. DeVita received the award for his

the quality of
Michael Kashgarian

c

1

medicine (endocrinology); and in
the Section of Biological Sciences,

lire ror renal or
urologic patients. Dr. Kashgarian is

Walter F. Boron, M.D., chair

editor-in-chief of Yale Medicine.

and professor of cellular and
molecular physiology. The pre¬
sentation was made at the

significant contributions to the treat¬
ment and cure of cancer in Italy, the

AAAS annual meeting in

United States and throughout the
world. Dr. DeVita also was named to

Among the speakers at the
Philadelphia meeting were

serve on the Scientific Advisory Coun¬
cil of the Doris Duke Clinical Scien¬

sor of internal medicine (infec¬

February in Philadelphia.

Keith A. Joiner, M.D., profes¬

tist Award Program of the Doris Duke

tious disease), cell biology, and

Charitable Foundation. The newly-

epidemiology and public health;
Gregory E. McCarthy, M.D.,

established program is designed to fill
a gap in funding young investigators

als who have sub¬
stantially improved

of medicine; and Karl L. Insogna,
M.D., associate professor of internal

M.P.H., associate professor of

for clinical research in cancer, heart

neurosurgery and neurology;

disease and AIDS. Dr. DeVita is one
of two nationally known cancer ex¬

and Richard M. Satava, M.D.,
professor of surgery (general).

perts who have been invited to sit on
the council.

Peter M. Glazer, M.D., associ¬
ate professor of therapeutic radi¬

Robert M. Donaldson Jr., M.D.,
David Paige Smith Emeritus Professor
of Medicine, was honored in April

ology, received the Michael Fry
Young Investigator award at the

when the VA Connecticut Healthcare

annual meeting of the Radiation
Research Society in April. This is

System West Haven Campus named
the new education center in his honor

by the society.

the most prestigious award made

for his contribution to education in
the service ol patients.

and chief of cardiothoracic surgery,
was elected a founding director of the

unveiling ceremony.

medicine, was presented the
1998 Otsuka/American Geriat¬
rics Society (AGS) Outstanding

Heritage Foundation, which subsumes

Scientific Achievement for

the former New York, Connecticut and

Clinical Investigation Award by

New Jersey Chapters of the American
Heart Association. He is the only sur¬

the AGS at their annual meeting

geon on the board. Dr. Elefteriades
also delivered an honorary address on

was recognized for her achieve¬
ments in clinical research ad¬

the Perspectives of the Thoracic Aorta

dressing health care problems of

from the Yale Center for Thoracic Aortic
Disease in Tokyo in February at the

older adults as a physician inves¬

in May in New York. Dr. Inouye

joint meeting of the Asian Cardiovas¬

tigator who is actively involved
in direct patient care.

cular Society and the Japanese Society
for Cardiovascular Surgery.

Michael Kashgarian, M.D.,
professor of pathology and

The American Association for the Ad¬
vancement of Science (AAAS) elected
as fellows in the Section of Medical
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portrait glass, stands before his likeness at the

Sharon K. Inouye, M.D.,
M.P.H., associate professor of

John A. Elefteriades, M.D., professor

Fourteenth Dean Gerard Burrow, his face reflected by

biology, received the James
Colangelo Achievement Award
by the National Kidney Founda¬

Moment of reflection
In a ceremony Feb. 11 in the Beaumont Room
University officials unveiled a portrait of Gerard
N. Burrow, M.D., '58, H.S. ’66, who stepped
down last year after five years as dean of the
School of Medicine. New Haven artist Steven R.
DiGiovanni painted the portrait. Dr. Burrow met
the artist at the Creative Arts Workshop where
the former dean does metal sculpture. During
their sessions, Mr. DiGiovanni set up a mirror so
Dr. Burrow could watch him paint. Addressing
the crowd that gathered in the Beaumont Room
for the unveiling, University Provost Alison F.
Richard, Ph.D., said: “Thanks to the artist and
to the subject I think people will pause and say,
‘He looks like a really wonderful person,’ and
they’ll be right.” Added current Dean David A.
Kessler, M.D.: “As the 14th dean of Yale School
of Medicine, Dean Burrow personified a tradi¬
tion of excellence with a degree of great and
distinguished service that we all can admire.”
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Daniel M. Koenigsberg, M.D., asso¬

The Yale Cancer Center has inaugu¬

ciate clinical professor in rhe Child
Study Center, was promoted to vice

rated a revolutionary bone marrow
transplantation procedure between

chairman of psychiatry at the Hospital
of St. Raphael, where he is also section

partially mismatched, related donors.
Joseph R McGuirk, D.O., associate
research scientist in internal medicine

chief of the hospital’s child and ado¬
lescent psychiatry division.

(oncology), has been named assistant
director for Allogeneic Bone Marrow

Robert G. LaCamera, M.D., clinical

and Stem Cell Transplantation at the
Yale Cancer Center.

professor of pediatrics and pediatric
nurse practitioner program (primary
care), was presented the second
annual Children’s Health and
Wellbeing Award by ConnectiCare
Inc. Dr. LaCamera, who retired from

Ira Mellman, Ph.D., professor of cell
biology and immunology and director
Richard Lifton, right, works at a gene
loader in his laboratory with Chris Bositis,
a former student.

of the Program in Biological and Bio¬
medical Sciences, has been awarded the

private practice last year as a New
Haven pediatrician devoted to caring

Newton-Abraham Visiting Professor¬

for children with disabilities. He has

ship in Medical, Biological and Chemi¬

also been the medical director of the

genetics. His laboratory uses genetic

cal Sciences at the University of Oxford
for the 1998-1999 academic year. Dr.

Easter Seal-Goodwill Industries
Rehabilitation Center in New Haven

approaches to identify inherited
causes of hypertension, renal and

several times to deliver a series of pub¬

since 1956.

cardiovascular disease. To date the

lic and scientific lectures at the Sir

Mellman plans to travel to England

group has identified the molecular

William Dunn School of Pathology.

Richard R Lifton, M.D., Ph.D.,

basis of a dozen such diseases, which

professor of medicine, genetics and

have provided important insight

Previous recipients of the professorship
include James D. Watson, Ph.D.

molecular biophysics and biochemis¬
try, has been named this year’s recipi¬

into disease causation, diagnosis
and treatment.

Victor J. Navarro, M.D., assistant

ent of the Homer Smith Award of the

professor of medicine, was honored in

American Society of Nephrology for

Bruce McClennan, M.D., professor

April by the American Liver Founda¬

his laboratory’s research into the mo¬

of diagnostic radiology, was elected

tion for his contributions to the work

lecular genetics of hypertension and

secretary of the American Roentgen

of its Connecticut chapter.

kidney disease. The award, the

Ray Society at the society’s 98th

society’s highest scientific prize, was
announced this month and will be

annual scientific and education meet¬

presented at the society’s annual meet¬
ing in Philadelphia in October. Dr.

McClennan began his five-year term
April 30. The American Roentgen

Child Study Center and the School of

Lifton received his M.D. degree from

Ray Society was founded in 1900 and

Zero to Three, a national nonprofit

Stanford University in 1982 and re¬
ceived his Ph.D. there in 1986. He

is dedicated to the goal of educating

organization of pediatricians and child

radiologists and to the advancement

development specialists who share

joined the Yale faculty in 1993 as an

of medicine through radiology and its

new knowledge about children’s early

assistant professor of medicine and

allied sciences.

development with parents, policy

ing in San Francisco in April. Dr.

Kyle D. Pruett, M.D., clinical profes¬
sor of child psychiatry at the Yale
Nursing, has been named president of

Portrait of a pioneer
A portrait recently added to the walls of the School of Medicine honors Dorothy M. Horstmann,
M.D., Sc.D., the John Rodman Paul Professor Emeritus of Epidemiology and Pediatrics. In 1961
she was the first woman named as a professor and eight years later was named to the endowed
professorship. The portrait is a color photograph, taken by James C. Niederman, M.D., H.S. ’50,
clinical professor of epidemiology, that has been printed on linen rather than photographic paper.
The framed portrait hangs near the Beaumont Room on the second floor of the Sterling Hall of
Medicine. Dr. Horstmann came to Yale in 1942 as the Commonwealth Fund Fellow in preventive
medicine. She worked with Dr. Paul, for whom her endowed chair was named. In 1944 she re¬
turned to the University of California at San Francisco, where she pursued her medical studies,
and joined the Yale faculty in 1945. She played a major role in developing and evaluating vac¬
cines for poliomyelitis and German measles.
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One less car on the road
For the past four years Raymond Aten, Ph.D., a re¬
search scientist in obstetrics and gynecology, has
commuted to work from his home in Hamden on a
bicycle. The state of Connecticut recently named
him Commuter of the Month for his example.
“It’s sort of an ideal commute,” Dr. Aten says of
his four-mile, 15-minute trip from the Whitneyville
section of Hamden. “I can make it in about the
same time as someone driving.” Dressed in
shorts, T-shirt, helmet and goggles equipped with
a rear-view mirror, Dr. Aten carries in his saddle¬
bags a change of clothes, paperwork, a spare in¬
ner tube, reflective gear for night driving and a
laptop computer. He rides his bicycle to work
year-round, regardless of the weather. “It’s one
less car on the road,” says Dr. Aten, who is presi¬
dent of the Connecticut Bicycle Coalition.

searchers inducted into the National
Academy of Sciences in April. Dr.
Ward has developed techniques called
fluorescence in situ hybridization,
known as FISH, that are widely used to
analyze human chromosomes as well as
to detect infectious, genetic and cancer¬
ous diseases. Among his accomplish¬
ments is the complete genetic mapping
of chromosome 12, which contains
genes implicated in a variety of dis¬
eases, including diabetes and several
forms oi cancer. Dr. Ward received his
Ph.D. degree from Rockefeller Univer¬
sity in 1969 and was a Leukemia
Society of America Fellow 1969-1971
at Imperial Cancer Research Fund,
London. He joined the Yale faculty
in 1971. The National Academy of
Sciences, a private organization of sci¬
entists and engineers dedicated to the

makers and other professionals. Dr.
Pruett is nationally known for his
work with traumatized children and
for research on how fathers influence
their young children’s development.
Dr. Pruett says the issues of quality
medical and day care will be a primary
focus of his work for Zero to Three,

talk about are the matters that mean the

furtherance of science for the general

most to us. The shame that has no vent

welfare, was established in 1863.

in words makes other organs weep.”
According to Dr. Spiro, current officials
of the University of Vienna are attempt¬
ing to recover information that has
either been hidden or destroyed and

•

•

•

John C. Baldwin, M.D., former

professor and chief of cardiothoracic
surgery at Yale, has been named dean

which is under the auspices of the

trying to locate former faculty who
were interned and exiled. “There is a

National Center for Infants, Toddlers

new generation that has taken over,”

vice president for health affairs,

and Families.

says Dr. Spiro, “and they are not afraid

effective July 1. Dr. Baldwin is the
DeBakey-Bard professor and chair of

to look into these atrocities.”
Carolyn W. Slayman, Ph.D., Sterling

oi Dartmouth Medical School and

the Department oi Surgery at Baylor

Professor of Genetics and Cellular and

David C. Ward, Ph.D., professor of

College oi Medicine and chief of

Molecular Physiology and deputy

genetics and molecular biophysics and
biochemistry, was one of three Yale re¬

Surgical Services at the Methodist
Hospital in Houston.

dean for academic and scientific af¬
fairs, has been appointed to a 15 mem¬
ber panel that will analyze the peer-re¬
view system at the National Institutes
of Health. The system includes study
sections which evaluate and score
most grant applications submitted by
researchers at colleges and universities.
Recommendations from the panel are
expected to be made within a year.
Howard M. Spiro, M.D., director of

the Program for Humanities in Medi¬
cine and professor of internal medicine
(digestive diseases), was among noted
speakers at a March 2 convocation in
Vienna marking the 60th anniversary of
the dismissal of Jewish faculty members
from the Vienna Medical School. In his
address, The Silence ofWords, Dr. Spiro
said, “the things that we avoid and don’t

Dean David A. Kessler,
M.D., right, was the key¬
note speaker at the
spring meeting of the
New York Academy of
Medicine. His topic was
The Tobacco Wars, chroni¬
cling the FDA’s efforts to
regulate tobacco (See
Scope, page 10). The pre¬
vious year’s speaker was
former Surgeon General
C. Everett Koop. Left,
Academy President
Jeremiah A. Barondess,
M.D., thanks Dr. Kessler
at the podium.

NEW

BOOKS

Against the Spirit of System: The French
Impulse in Nineteenth-Century Ameri¬

Treatment Program and Thomas R.

can Medicine by John Harley Warner,
Ph.D., professor of history of medi¬

psychiatry and chief of psychiatry
both at the VA Connecticut
Healthcare System in West Haven,

cine and American studies, Princeton
University Press (N.J.) 1998.

Kosten, M.D., HS ’81, professor of

Guilford Press (N.Y.) 1997.

Antoine Lavoisier: The Next Crucial

The Portraitby Charles Atkins, M.D.,

Year or, the Sources of His Quantitative

assistant clinical professor of psychia¬

Method in Chemistry by Frederic
Lawrence Holmes, Ph.D., Avalon

try, St. Martin’s Press (N.Y.) 1998.

Professor of the History of Medicine,
Princeton University Press (N.J.) 1998.

Skin Signs of Systemic Disease by Irwin
M. Braverman, M.D. ’55, HS ’56,

Biochemistry and Disease: Bridging
Basic Science and Clinical Practice by
Robert M. Cohn, M.D. ’65 and Karl

recognizing, treating,
and preventing eh
and adolescent depression

.d

professor of dermatology and in the
Cancer Center, W.B. Saunders Co.
(Penn.) third edition 1997.

S. Roth, M.D., Williams & Wilkins
(Baltimore, Md.) 1996.

Surviving the Fall: The Personal Journey
of an AIDS Doctor by Peter A. Selwyn,

Captain of Death: The Story ofTuber-

M.D., associate professor of medicine
in the AIDS Program, Yale University

culosis by Thomas M. Daniel, M.D.,

Press 1998.

B.S. ’51, University of Rochester Press
(N.Y.) 1997.
Terror in the Medical Office by
Norman F. Moon, M.D. ’56, Kabel
Chain of Custody by Harry A. Levy,
M.D., M.P.H. ’82, Random House

Publishers (Rockville, Md.) 1998.

(N.Y.) 1998.
The Therapeutic Narrative: Fictional
Relationships and the Process of Psycho¬
Help Me, I’m Sad: Recognizing, Treat¬
ing, and Preventing Childhood and

logical Change by Barbara Almond,
M.D. ’63 and Richard Almond, M.D.

Adolescent Depression by David G.

’63, HS ’66, Praeger Division of

Fassler, M.D. ’82, Viking Penguin
(N.Y.) 1997.

Greenwood Publishing Group
(Westport, Conn.) 1996.

Improve, Perfect, and Perpetuate:

The Therapeutic Perspective: Medical

Dr. Nathan Smith and Early American

Practice, Knowledge, and Identity in

Medical Education by the late Oliver
S. Hayward, M.D., and Constance E.

America, i820-i88y by John Harley

Putnam, University Press of New
England (N.H.) 1998.

Warner, Ph.D., professor of history
of medicine and American studies,
Princeton University Press (N.J.)
paperback edition 1998.

New Treatments in Opiate Dependence
edited by Susan M. Stine, M.D.,
Ph.D., assistant clinical professor of
psychiatry and director of the Opiate
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DEVELOPMENT

New associate dean leads medical school’s
advancement program

J

ane E. Reynolds, Ed.M., who

established a national reputation
as dean of admission at Amherst

College over the past nine years, has
been appointed associate dean at the
School of Medicine. She will oversee
the school’s program in institutional
advancement with responsibility
for development, alumni affairs
and publications.
“I cannot imagine having anyone

core facility space for expanded capa¬
bility in magnetic resonance imaging.
(See Scope.)
Other likely fund-raising goals,
Ms. Reynolds said, will be to increase
the amount of financial aid available
to students, and to establish addi¬
tional endowed chairs to mark the
University’s 300th anniversary in 2001.
Dean Kessler said her background
in admissions and the reputation she
has established nationally and interna¬

more effective and more experienced
on our team,” Dean David A. Kessler,

tionally, will serve her well in her Yale

M.D., said in announcing her ap¬

role. “She is one of the most respected

pointment. “I am thrilled she decided

figures in the admissions world and

to come to Yale.”
Ms. Reynolds holds an Ed.M.

we’re lucky to have her here,” he said.

degree from Harvard in administra¬

Ms. Reynolds, who says she was
drawn to Yale “by David Kessler’s in¬

Jane Reynolds

tion, planning and social policy, and

tellectual energy and his vision for the

a B.A. from the College of the Holy

school,” is eager to apply that experi¬

Cross. Over the past 20 years, she has
held increasingly responsible positions

ence. “The most kindred talents are

at Harvard, Trinity College, Tufts

tion, being able to understand what
makes an institution tick, and getting

strong financial shape, Mr. Pagnam

led the admissions program from 1989
to 1998. According to Dr. Kessler,

out to the appropriate constituency to

said it needs to raise about $200 mil¬

tell that story,” she says. “You have to

lion every year. “We still have to raise

whom she met at Amherst when he

be able to relate to a wide variety of

received an honorary degree from
his alma mater, “She helped diversify

publics to achieve the goal.”
In her new position, Ms. Reynolds

significant money to continue the
project of refurbishing the facilities,”

the student body at Amherst and en¬

will work closely with Charles J.

University and Amherst, where she

couraged an international approach
to recruitment.”
The next several months will be a
period of assessment and action, Ms.
Reynolds said. As this issue of Yale
Medicine went to press, medical

being a spokesperson for an institu¬

Pagnam, who became the University’s

Although the University is in

he said, adding that another top prior¬
ity is financial aid for students.
He is aware of the medical school’s

vice president for development on
Jan. 1. Mr. Pagnam, one of seven

financial needs as well, he says, and

officers of the university, began his
career in development in 1977, when

ment strategy with Ms. Reynolds. Part

plans to work out a dynamic develop¬

he joined The Campaign for Yale.

of his job is to coordinate fund-raising
efforts among the college and Yale’s 11

school administrators were pleased to

Mr. Pagnam assumed increasing

graduate and professional schools.

hear that the Yale Corporation had

responsibilities over the subsequent

given preliminary approval for a stra¬
tegic facilities plan for the School of

two decades and in 1995 became
director of development for the

Medicine. The centerpiece of the plan

University. He played a pivotal role

is a proposal for a new Congress

in the “... and for Yale” campaign,

Avenue Building providing modern
laboratory space for disease-specific

which raised $1.7 billion over a five-

not a matter of remembering what

year period ending June 30, 1997.
He succeeds Terry Holcombe, who

New Haven was like. It’s more what
New Haven can be. It’s a small com¬

retired at the end of last year.

munity that cares about itself.”

research, a state-of-the-art anatomy
laboratory and histology labs, and
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As a Hamden native and current
resident of North Haven, Mr. Pagnam
also takes an active interest in New
Haven affairs. “It is to our benefit to
have a very healthy city,” he says. “It’s
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Just what the doctor ordered
With The Rx Files, the second-year class writes a prescription
for (kind) humiliation and high honors.

N

o cow was too sacred for the
Class of 2000, as it lam¬

pooned deans, beloved faculty
members and lowly first-year students
with equal relish in the second-year
show, The Rx Files. Not even the
lunchtime food vendors on Cedar
Street were spared their barbs.
The plot followed the exploits of
fictional FBI agents Mulder and
Scully from The Rx Files as they
tracked down a missing collection of
brains (The Cushing Brain Tumor
Registry) and made bizarre discoveries
about the faculty and student body.
First-year students, the agents re¬
ported, lack reproductive organs.
Anatomy professors are weird.
As always, being satirized was the
highest tribute. From its opening
moments, the show set its sights on
Robert H. Gifford, M.D., HS ’67,
who has served for
more than a decade
as associate dean of
medical education
and student affairs.
“Dr. Gifford, you
will be sorely missed.
(We think this time
he might really mean
it.),” the program read,
referring to what had
been his second ex¬
pected retirement at the
end of the school year.
As it happens, he
didn’t. (See Faculty news)

thumbs up or down on the wannabe

Other faculty members, including
William Stewart, Frank Bia, John

dancers, later portrayed on stage
by students.

Rizzolo and Emil Boulpeap, joined in

The cast pounced on the English

a videotaped spoof of the comic film

pronunciation of Pietro De Camilli,

The Full Monty. The professors tried
out for a dance team to raise money to

the recently appointed chair of the

balance the medical school’s budget.

Department of Cell Biology, who was
born in Italy. “What are you saying?

Dean Kessler and Dr. Gifford gave

Is it GTP or GDP?” asked student
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The Medical Student Council elected
new officers in April: For president,
Sharon Chekijian, A.B., Smith

College; for vice president, Jen Chow,
B.S., B.A., University of Arizona;
and for treasurer, Rockman Ferrigno,
B.A., Fairfield University. The three
first-year students delivered speeches
at the April 1 meeting prior to
the election.
Joanne Band, was awarded the

1997 Paul H. D'Amour Founder’s
Fellowship by Big Y Foods Inc. The
1) Students take on infectious disease—the administrative section, that is, while performing
Master of the Bugs, from the second act of The Rx Files. 2) John Abraham portrays Robert
Gifford and Darren Lish portrays David Kessler in a musical number from the second-year-show.
3) Alison Gruen plays a game show hostess in a gentle parody spoofing Arthur Crovatto’s
anatomy instruction. 4) The real David Kessler dances a la Michael Flatley in a segment titled
Deans of the Dance. 5) Not even the food vendors on Cedar Street escaped ribbing from the
cast of The Rx Files, who poked fun while singing No Greasy, No Oily with apologies to Bobby
McFerrin.

Natalie Holt, playing agent Scully.

Flatley in a parody of the traveling ex¬

But even she has trouble with medical
jargon from native speakers of

travaganza Lord of the Dance. With 22

English. “I can’t take it any more!”

around them Dr. Kessler swirled direc¬
tor of admissions Lynne M. Wootton

she screams during a scene set at a

dancers clad in black and step-dancing

faculty tea in the Beaumont Room.

around the stage in a number called

“I haven’t understood a single word

Deans of the Dance.

anybody has said here tonight!’’
A scene on Cedar Street poked fun
while it paid tribute to the vendors

The show’s finale had the entire
Class of 2000, dressed in their white
jackets, taking the stage and singing

who offer food at lunchtime from

Do You Hear the Beepers Ring.I to the

their mobile stands. The cast sang

tune of Do You Hear the People Sing?'
from the musical Les Miserables-.

No Greasy, No Oily to the tune of
Don’t Worry, Be Happy.
Bean curd make your mouth a
water?

Do you hear the beepers ring loud in
the middle of the night?
It is the music of a people who are

award honors the most academically
outstanding graduate student in Big
Y’s marketing area and includes a
$1,000 stipend.
Two students received awards for
creative writing and community
service at a faculty/student tea in the
Beaumont Room on May 5. Maie
Rahman St. John, a sixth-year stu¬

dent in the M.D./Ph.D. program re¬
ceived the Lerner Award and $250 for
her poem about her travels around the
world as a child. The late Marguerite
Rush Lerner, a professor of clinical
dermatology who also wrote children’s
stories, established the Lerner Award.
Caroline Harada, a first-year student,

accepted the Novartis Pharmaceuticals
Corp. Award on behalf of COVS, the
Committee on Volunteer Services,
which she chairs. The annual award, a
complete io-volume set of the Netter
Atlas, recognizes community service

turning wrong to right

by students. The COVS coordinates

The yaki soba on my right

For the students on the wards there is
a redness in their eyes

volunteer efforts by students in public
health, nursing and medicine.

Eat it, you get a parasite.
No greasy. No oily.

Before the longest call will end and
the sun will rise.

You get two pieces for a quarter.
No greasy. No oily.

After Dr. Gifford, Dr. Kessler was

Linda Maxwell, who produced the

the target of countless gags and oneliners on his work to regulate tobacco

show with Lalisa Anderson, called it

as commissioner of the Food and

ences of medical school. It is a last

Drug Administration. Student
Darren Lish, portraying Dr. Kessler

chance for second-year students to get
to know each other before they split

on stage, leaned back in his chair and
lit a cigarette.

pital rotations. “We saw people really

Dr. Kessler appeared as himself in
one of the show’s final scenes, imper¬
sonating bare-chested prancer Michael
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one of the most memorable experi¬

up into teams for their third-year hos¬
come out of their shells,” Ms. Maxwell
said. “People really put their hearts
into it.”

Award-winning students Maie Rahman St.
John and Caroline Harada with Deputy Dean
Robert Gifford.
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Match Day reveals a trend toward generalism

C

heers and applause erupted a
few minutes before noon as the
stack of envelopes made its way

from the registrar’s office into the
mailroom in Edward S. Harkness Hall.
Inside were residency assignments, keys
to the futures of a throng of waiting
fourth-year students.
As part of the National Residency
Matching Program, medical students all
around the United States learned of their
placements simultaneously on March 18.
According to Deputy Dean for Education
Robert H. Gifford, M.D., 60 percent of the
Yale students received their first choice
of residency and 80 percent got one of
their top three choices. Registrar Cynthia
A. Andrien said only six of the 104 se¬
niors didn't participate in this year's
match. Three chose not to participate and
three are entering the military, she said.
How important was the match?

ized programs and toward residencies in

"Residency determines where you train,

internal medicine and pediatrics. Forty

how you train, who trains you and what

percent of this year’s seniors went into

opportunities are available to you,” said

three-year medicine programs, up from

Joseph Skowron, who placed in ortho¬

22 percent last year. Pediatrics drew 17

paedics at Harvard.

percent of the current graduating class,

Placements this year reflected a trend
at Yale away from the most highly special-

up from 8 percent last year.
“I do think there’s a recognition on
the part of students that there’s more
and more of a need for people in the

Top: Tobias Lee and

primary care specialties,” Dr. Gifford

Sheela Magge peer in

said. “Some of the highly specialized

their mailboxes for the
letters that will spell
their future for the next

areas are overpopulated. Managed care
is using them less and using primary

two or three years.

care doctors more."
Middle: Victoria
Catenacci smiles to

As noon struck, the waiting students

learn she has been

cheered, hugged and otherwise released

accepted at Yale, where

the tension and anxiety of the morning.

she wanted to study
internal medicine.

Victoria A. Catenacci was thrilled to be
staying at Yale in internal medicine. “I

Right: Scott Porter
hugs a friend as they
get the news of their
assignments.

like the program. I like the people. I’m
very happy here,” she said. Said Childsy
Robinson before opening her letter: “I’m
very excited. I’ve been telling myself over
and over that I can be happy anywhere."
She got her first choice: pediatrics
at Stanford.
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1998 residency placements for Yale medical students
The Office of Student Affairs has provided the following list, which outlines the results of the
National Resident Matching Program for Yale’s medical school graduates.

CALIFORNIA
LAC-USC Medical Center
Gregory Chin, surgery, otolaryngology
San Diego Naval Base
Helen Chun, internal medicine
Stanford Health Services
Chrysalyne Del ling, medicine
Mark Homicz, surgery
Kent Huston, internal medicine
Michelle Parker, emergency medicine
Childsy Robinson, pediatrics
UCLA Medical Center
Matthew Bui, urology
University of California (Davis)
Medical Center, Sacramento
Kevin Daly, emergency medicine
University of California - San Diego
Mark Homicz, otolaryngology
Jessica Kingston, obstetrics and
gynecology

University of California - San Francisco
Te Ning Chang, plastic surgery
Karen Earle, internal medicine
Peter Hunt, internal medicine
Lisa Lipschitz, obstetrics and
gynecology

Sushrut Waikar, internal medicine
UCSF/Mt. Zion Medical Center
Anna Bloxham, internal medicine/
primary

Yale-New Haven Hospital
Victoria Catenacci, internal medicine
Monica Chacon, pediatrics
David Chang, plastic surgery
Marcoli Cyrille, internal medicine
Jennifer Eras, internal medicine
Andrew Gumbs, general surgery
Charles Hong, internal medicine
Hahnah Kasowski, surgery,
neurosurgery

Lynda Kauls, pediatrics, dermatology
Susan Kim, internal medicine
Jason Klenoff, surgery, otolaryngology
Srinivas Rao, internal medicine
Jeffrey Reynolds, internal medicine
Nirav Shah, internal medicine
Lisa Surer, internal medicine
Mona Zain, internal medicine

GEORGIA
Emory University School of Medicine,
Atlanta
Reshma Chugani, pediatrics

MARYLAND
Johns Hopkins Hospital, Baltimore
Hans Agrawal, pediatrics
Kamal Bharucha, pediatrics
Alan Cheng, internal medicine
Nirit Weiss, surgery, neurosurgery
Tong-Yi Yao, pediatrics

COLORADO
University of Colorado School of
Medicine, Denver
Henry Fischer, internal medicine
Paul Pottinger, internal medicine

Brigham & Women’s Hospital, Boston
Daniel Hurwitz, medicine
Linda Lee, internal medicine
Gregory Schwartz, internal medicineI
primary

Cambridge Hospital
Pieter Cohen, internal medicine/
primary

Harvard/Children’s Hospital, Boston
Monica Chacon, pediatric neurology
Nicole Ullrich, pediatric neurology
Harvard Medical School, Boston
James O’Holleran, orthopaedics
Joseph Skowron, orthopaedics
Massachusetts General Hospital,
Boston
Joanne Band, pediatrics
Kendall Lee, neurology
Brandy McMahon, anesthesiology
Olivia Okereke, medicine
Massachusetts General Hospital/
McLean, Boston
Olivia Okereke, psychiatry
Lisa Price, psychiatry
Mount Auburn, Cambridge
Lisa Price, medicine

MICHIGAN
University of Michigan Hospitals,
Ann Arbor
Christi Cavaliere, plastic surgery
Catherine Curtin, plastic surgery

MASSACHUSETTS
Beth Israel Deaconess Medical Center,
Boston
Katherine Auerswald, internal
medicine

MISSISSIPPI
Kessler Air Force Base, Gulf Coast
Michael Yerkey, internal medicine

Bernice Ruo, internal medicine
CONNECTICUT
Griffin Hospital, Derby
Brandy McMahon, medicine
Hospital of Saint Raphael, New Haven
Kendall Lee, medicine
Jason Oliphant, medicine

Boston Combined Residency Program
in Pediatrics (Children’s Hospital)
Sheela Magge, pediatrics
Nicole Ullrich, pediatrics
Boston University Medical Center
Tobias Lee, internal medicineI
primary
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MISSOURI
Barnes-Jewish Hospital, St. Louis
Jason Oliphant, diagnostic radiology

NEW

YORK

Einstein/Montefiore Medical Center,
Bronx

Sydney Butts, surgery; otolaryngology
Marcia Dover, medicine, neurology
Hospital lor Special Surgery, New York

Russel Huang, orthopaedics
Ashley Wivel, orthopaedics
Mary Intogene Bassett, Cooperstown

Eric Shmookler, medicine
1 he Mount Sinai Hospital, New York

James Borin, surgery, urology
Naomi Donnelley, internal medicine
The New York Hospital

Gary Brendel, psychiatry
Russel Huang, surgery
William Pao, internal medicine
Ashley Wivel, surgery
New York University Medical Center

Chrysalyne Delling, dermatology
Gregory Raskin, internal medicine
Monica Chacon, Maurice Garrido and John Forman welcome the news of their assignments

Presbyterian Hospital, New York

with hugs and smiles.

Marjory Alabre, internal medicine
Mauricio Garrido, general surgery
Kimara Leibowitz, pediatrics

NORTH

CAROLINA

Carolinas Medical Center, Charlotte

Scott Porter, orthopaedics
Duke University Medical Center,
Durham

Todd Atkinson, orthopaedics
William Duvall, internal medicine
Jaimie Nathan, general surgery
Eleanor Rhee, obstetrics and
gynecology
University of North Carolina Hospital,
Chapel Hill

Amy Taylor, pediatrics

PENNSYLVANIA

TEXAS

Allegheny University Hospital,

University of Texas SW Medical

Philadelphia

School, Dallas

Merle Carter, general surgery
Children’s Hospital of Philadelphia

Daniel Coghlin, pediatrics
Barbara McGee, pediatrics
Samir Shah, pediatrics
Hospital of the University of
Pennsylvania, Philadelphia

Naomi Botkin, internal medicine
Henry Chen, internal medicine
Carl Edelen, internal medicine
Kent Hu, internal medicine
Ellen Komisaruk, obstetrics and
gynecology

Joanne Quinones, obstetrics and
gynecology

OHIO
Surnma Health System/Neoucom,
Akron

Marc Jones, transitional

University Health Center - Pittsburgh

WASHINGTON
University of Washington Affiliated
Hospitals, Seattle

Michelle Barton, pediatrics
Albert Chong, general surgery
John Forman, internal medicine
Robert Kalus, internal medicine
Heather Lynch, pediatrics
University of Washington, Seattle

Seth Schwartz, surgery, otolaryngology

Makunda Abdul, obstetrics and
gynecology

Kent Chou, orthopaedics
Joon Yung Lee, orthopaedics

University Hospitals of Cleveland

Andrew Kroger, pediatrics

Tara Bruce, obstetrics and gynecology
Daniel Hurwitz, dermatology
Patricia Stanford, pediatrics

Some names appear twice because the graduate
is entering a one-year program before beginning

Wills Eye Hospital, Philadelphia

a specialty residency.

Marc Jones, ophthalmology
The transitional designation is a one-year
program with three-month rotations in
different specialties.
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A focus on clinical research

L

awrence E. Shulman, Ph.D. 45, M.D. 49, retired

oriented research career de¬

from rhe NIH in 1994 after serving for nine years

velopment award, the mid¬

as the first director of the National Institute of

career investigator award in

Arthritis and Musculoskeletal and Skin Diseases. Shortly
thereafter, NIH Director Harold E. Varmus, M.D., ap¬

patient-oriented research,
and the clinical research

pointed him as NIH emissary for clinical research to the

curriculum award.

academic health centers. “My assignment,” Dr. Shulman

“There’s been a growing

reports, “was to hold in-depth discussions to learn the
views, concerns and suggestions to strengthen clinical
research in the nation.”
Dr. Shulman visited 21 medical schools including
Yale, where he met with then-Dean Gerard N. Burrow,

concern by many that
clinical research has not
developed and fared as
well as has basic laboratory
Lawrence E. Shulman

M.D. ’58, and several members of the faculty. During his

research," says Dr.
Shulman, who received a

travels he evaluated current support mechanisms and for¬

mastership from the American College of Physicians last

mulated recommendations for new programs. Then in

March. “These new programs should provide a major

April of this year, the NIH announced the establishment

investment by which discoveries from the laboratory

of three new award categories for developing talented

may be translated into new and effective treatments

and skilled clinical researchers: the mentored, patient-

for patients.”

CLASS

N

’30s

Robert E. Cooke, M.D. 44, HS

digitizing 12,000 slides on these

'44-50, in retirement in Florida,

topics for the Internet.

remains active with the Kennedy
Foundation in Washington which
has guided federal legislation on the

Harvey Chenault, M.D., HS

care of mentally retarded children.

Edith M. Jurka, M.D. ’44, is active
on the lecture circuit on topics in

’39-41, of Paris, Ky., retired from

Noetic Medicine and has conducted

practice as a neurosurgeon approxi¬

symposia on intuitive reasoning

mately 10 years ago. He says that
he is now relaxing in the quiet

Robert W. Frelick, M.D. 44, HS

of the country and fishing in a

’44-45, remains active in retirement
as a member of the advisory board

man-made lake he built on his

of the National Cancer Institute.

16-acre homestead.

Dr. Frelick received a grant for
smoking prevention/cessation in a
target high school in Wilmington,

’40s

Del. His wife Jane, ’44 Nursing,

Thomas L. Bucky, M.D. ’43, HS
’44-49, ofWeston, Conn., retired

remains active after three major

and creativity.

Jerome J. Kaye, M.D. ’44, reports
that his daughter, Judy, is currently
performing the historic character
of Emma Goldman in the musical
Ragtime on Broadway. Judy received

a Tony award some years ago for her
role in the Phantom of the Opera.

joint replacements, tutoring
G.E.D. students and supervising
smoking cessation among prisoners.

David E. Morton, M.D. ’48, HS

Dr. Bucky and his wife, Doris,

’49-55, retired in 1993, is working on

enjoy traveling to Florida to visit
their two grandchildren. Last fall

Howard B. Hamilton, M.D. ’44,

his second novel. The first con¬
tained a major scene at Yale-New

they also spent two weeks in Venice

retired, lectures on Japanese litera¬

and Padua, Italy. He says that he is
grateful for his Yale education and

ture and the Noh Theater as an

from practice in 1996 after 40 years.

is relaxing and reflecting in his
retirement years.
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American resource person for the
Japan Society. He is currently
assisting the Library of Congress in

Haven Hospital. He and his wife,
Kayoko, visited Italy in September
just missing the great Assisi earth¬
quakes. They traveled to Nagano,
Japan in February where Kayoko
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was nurse-interpreter at the Winter
Olympic Games.

Vaisseaux et du Sang in Paris,
France, studying megakaryocytes
and the regulation of platelet
production.

’50s
Robert N. Hamburger, M.D.

51,

a portion of a $3 million gift given
by Mrs. Samuel M.V. Hamilton to
Thomas Jefferson University to
honor three physicians who cared
for her late husband.

Norman F. Moon, M.D. ’56, writes

HS ’53-54, received his fourth

to say he has retired from his full¬

James J. Murphy, M.D. ’64, retired

patent in July 1997, titled Allergen
Detector: System and Method. Dr.

time orthopaedic surgery practice

in September from his position as
chief of radiology at the Asheville

Hamburger celebrated his 75th
birthday in January, skiing and

and has written of his experiences as
a treating physician in a book,

Asheville, N.C., after 25 years of
federal service.

flying in Alta, Borego, Mexico, and

lished this year by Kabel Publishers

San Diego (La Jolla), Calif. He and

in Rockville, Md. Dr. Moon says

his wife Sonia attended the Associa¬
tion ol Yale Alumni Education

that the publishers, of which Karel
Bedrich Absolon, Ph.D., M.D. 52,

Program, Ancient Civilizations of

is president, have been excellent to

Peru, in September and thought it

deal with.

Timothy A. Pedley, M.D. 69, has

been appointed the Henry and Lucy
Moses Professor of Neurology and
chairman of the department of

was an exceptional and wonderful
experience.

Veterans Medical Center in

Terror in the Medical Office, pub¬

neurology at Columbia University.
David Weinstein, M.D., HS 59-

He will also serve as director of the

60, writes that as he approaches

neurology service and neurologist-

age 70, he is still working 9 to 5,
five days per week, in the practice

in-chief of the Neurological Insti¬
tute of Presbyterian Hospital,

has been elected to the board of
governors of the Association of Yale

of developmental medicine, neurol¬

Columbia-Presbyterian Medical

ogy and epilepsy. Dr. Weinstein

Center in New York City.

Alumni. He is the only medical
school faculty member currently

dabbles in neuroscience, conscious¬
ness and cognition. He sold his

named to the board, which has 21

boat but is enjoying being a grand¬

members and four officers. The

parent and comments that his
grown children are all respectable

Michael Kashgarian, M.D.

58,

professor of pathology and biology,

members serve staggered terms,
with seven members elected each
year. Dr. Kashgarian begins his
three-year term July 1. In addition
to general governance, the board
elects AYA officers and selects
nominees for the position of alumni
fellow to the Yale Corporation.

Jack Levin, M.D.

57, HS ’57-65, is

on sabbatical at the Institut des

members of society.

Edward F. Wilson, M.D.

63, after

nine years as full-time medical ex¬
aminer in Portland, Ore., moved to
Delaware County, Pa., in February
as part-time medical examiner. Prior
to Oregon, Dr. Wilson worked two
years in Pesamar, Pakistan and

’60s

Abha, Saudi Arabia; 15 years in

Robert L. Capizzi, M.D., HS 66-

Eugene, Ore., in hospital pathology

69, was honored by the establish¬

and as county medical examiner;

ment of the Robert L. Capizzi

two years in Utah as deputy chief

Professorship in Medicine at

medical examiner; and his first two

Jefferson Medical College. The

years in Baltimore, Md., as assistant

professorship was made possible by

state medical examiner.

Armenia’s health minister
Gagik Stamboltsian, M.D., HS '90-91, was appointed
minister of health of Armenia in last July by President Levon
Ter-Petrossian. Dr. Stamboltsian is chief of the Armenian
General Benevolent Union Plastic and Reconstructive Surgery
Center (PRSC). The PRSC, of which Dr. Stamboltsian remains
chief, was established after the 1988 earthquake in Armenia
in collaboration with Stephen Ariyan, M.D., HS '70-76, then
professor and chief of plastic surgery at Yale. Dr. Stamboltsian
was a member of a team of two surgeons, two anesthesiolo¬
gists and 10 nurses that spent 12 months in training at Yale
from 1990 to 1991. The unit opened in 1992. Since taking on
his new role as minister of health he has continued to help
reconstruct the wounds of victims of the earthquake.
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awarded the 1997 Lewis Rudin
Glaucoma Prize by the New York
Academy of Medicine for outstand¬
ing glaucoma research published in
1996. Dr. Caprioli received the
$50,000 prize for his research paper
Investigative Ophthalmology and
Visual Science, which explored the

possibility that the body’s own
defense mechanisms could help
protect the optic nerve cells against
damage during times of stress.

Francis L. Crowley, M.P.H. ’82,
was appointed director of the public
health department for the Town of
Groton, Conn., in October.
Records and tools of Harvey Cushing, M.D., are on display in the foyer outside the Cushing/
Whitney Medical Library. Out of Sight, Not Out of Mind: Renaissance of the Cushing Brain Tumor
Registry, includes photographs and hospital records from more than 2,000 neurosurgical case

Richard D. Gibbs, M.D. 86,

studies from 1898 to 1936.

and Patricia H. Gibbs, M.D. 87,
HS ’87-90, founders of the San
award for outstanding contributions

’70s

to the health and well-being of

Francis S. Collins, M.D., Ph.D.

the children of Stamford, Conn.

74, postdoctoral fellow ’81-84 in
human genetics and pediatrics,

He helped found and develop
Stamford’s School-Based Health

Director of the National Human
Genome Research Institute, led a

Center Program. Dr. Romanowitz
was also appointed by Governor

slate of speakers at the first AMA

John Rowland as a permanent

Genetics conference in New

member of Connecticut’s Child

Orleans, La. on March 13-15.

Advocate Advisory Committee.

The title of the conference was

Francisco Free Clinic, were named
California Family Physicians of
the Year in February by the Public
Outreach Committee of the
California Academy of Family
Practice Board of Directors.
The award is a high honor in
primary care medicine and this is
the first time that the award has
been given jointly to two physicians
and the first time to a husband
and wife team. The mission of the

Genetics Medicine and the

Barry Solof, M.D. ’74, of Los

clinic, founded in 1993, is to take

Practicing Physician.

Angeles, is currently the medical

care of patients without insurance,

director of Outpatient Chemical

families caught between welfare

Edward S. Curry, M.D. 78,

Dependency Service at New Begin¬

and employer-provided health

chief of pediatrics at the Kaiser

nings Hospital in Lakewood,
medical director of the Washington

insurance.

Permanente Fontana Medical
Center, was appointed to the board

Medical Center Recovery Unit in

of directors ofThe Southern
California Permanente Medical

Culver City, and the medical

Group in March. Dr. Curry is a

Angeles, Calif.

director of Pride Solutions in Los

Robert O. Kenet, M.D. ’81, Ph.D.
’83, and Stephanie Seligman were
married in December at the Carlyle
Hotel in New York City.

fellow in the American Academy
of Pediatrics.

Richard N.W. Wohns, M.D. ’77, a
practicing neurosurgeon in Tacoma,

Michael K. Lindsay, M.D. ’79,

Wash., graduated from the Execu¬

associate professor of obstetrics and
gynecology at Emory University

tive MBA Program at the University
of Washington in June 1997.

School of Medicine, was named
director of the division of maternal
fetal medicine in January.

’80s

David R. Marks, M.D. ’89, has
been hired as a health reporter for
WVIT Channel 30, the NBC tele¬
vision station in Connecticut. He
contributes two to three stories a
week for the station while maintain¬
ing a practice as medical director of
the New England Center lor Head¬

Joseph Caprioli, M.D., HS ’79-83,

ache in Stamford, Conn. He was

Harry S. Romanowitz, M.D. ’73, is

professor of ophthalmology at the

the recipient of Student Health

University of California, Los
Angeles School of Medicine, was

also a recent guest on the Today
Showw\\eve he discussed new

Services of Stamford Hospital’s
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treatments for migraines.
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Phillip Chung-Ming Yang, M.D.

’89, is completing a cardiology
fellowship at Stanford University.
Dr. Yang was married in August
1997 to Mariko Yoshihara.

named to the first class ol the
Association ol Professors of Gyne¬
cology and Obstetrics/Solvay
Pharmaceuticals Educational
Schools Development Program
participants. The 15-month pro¬
gram, which began in January, is
designed to help OB/GYN profes¬

90s
Sonya S.
Erickson, M.D.,

’91, associate in
the department
of obstetrics and
gynecology at
the University of

Sonya S. Erickson
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Lee Goldman, M.D. ’73, M.P.H. ’73,

the Julius R. Krevans Distinguished
Professor of Medicine, associate dean
for clinical affairs and the chair of
the department of medicine at

sors teach women’s health more

the University of California, San
Francisco, was presented the Out¬

effectively and focuses on four
major components: curriculum and

standing Alumnus Award by Yale
Cardiovascular Medicine at the annual

instruction; measurement and
evaluation; research and statistics;

Friendly Hearts Award Dinner last
Fall. Dr. Goldman has also been

and leadership and management.

named the new editor-in-chief of the
American Journal of Medicine by the

Iowa College of

James Hicks, M.D. ’91, HS ’92-95,

Medicine, was

is completing a fellowship in

one of 20

forensic psychiatry at New York

physicians

University.

Association of Professors of Medicine
Search Committee.

Stephen H. Moffic, M.D. ’71,
executive vice chair for managed care
at the Medical College of Wisconsin,
Department of Psychiatry and
Behavioral Medicine, presented at
Yale’s Department of Psychiatry
Grand Rounds in December on the
topic The Ethical Practice of Managed
Care: Is There A Way. Dr. Moffic has

also published a book titled The
Ethical Way: Challenges and Solutions
for Managed Behavioral Healthcare.

Pedro Rossello,
M.D. ’70, gover¬
nor of Puerto
Rico, made the
case for the
JOHN CURTIS (2)

island’s statehood
during an address

Pedro Rossello

at the School of
Law March 28.
He spoke at a

James C. Rosser Jr., IV!.D., right, director of endolaparoscopic surgery and assistant professor of
surgery, gave a talk on 21st Century Solutions
to Challenging Healthcare Problems at a Feb. 24
reception for the Association of Yale Alumni in
Medicine. With accompanying videos, Dr. Rosser
described his application of modern communica¬
tions technology to surgery. From a studio in New
Haven, he has supervised procedures in Ohio and
Hawaii. He has also developed software that lets
medical staff transmit information from house calls
to the office via a laptop computer and a portable
telephone. His technology is in use in a mobile
van that brings health care to remote villages in
Ecuador and Honduras.

6 o

two-day conference titled Foreign in a
Domestic Sense: Reflections on the Cen¬
tenary of the United States Acquisition
of Puerto Rico.

This fall voters on the island are ex¬
pected to vote in a referendum on the

James C. Rosser Jr.

island’s status. They may choose
among the current commonwealth
status, statehood and independence.
Dr. Rossello, now in his second
term as governor, argued that as a state
Puerto Rico would create a bilingual
and bicultural bridge between the
United States and emerging markets
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gued, would convert Puerto Rico from

Mary Ann Shafer, M.D. ’73, profes¬
sor of pediatrics at the University

a “disenfranchised outpost into an
ever more valuable asset.”

of California at San Francisco and
accociate director of adolescent medi¬

in Latin America. Statehood, he ar¬

cine at the University of California,
Gualberto Ruano,
M.D. ’93, Ph.D. ’89,
co-founder, chief ex¬

Gualberto Ruano

1997-98
Association of Yale
Alumni in Medicine

was a guest at a tea in February at the
Yale Calhoun College master’s house.
She is also medical director at the
Mission High School Clinic.

Officers
Nicholas M. Passarelli, M.D. ’59

ecutive officer and
chief scientific officer

activities have focused on the interre¬

Gilbert F. Hogan, M.D. ’57

of Genaissance
Pharmaceuticals Inc.

lationships among risky behaviors of
adolescents and young adults, includ¬

Peter N. Herbert, M.D. ’67

in New Haven, was
a speaker at the Yale-New Haven

Dr. Shafer’s academic and clinical

President

Vice President

ing such problems as sexually trans¬

Secretary

Biotechnology Enterprise Forum

mitted diseases (STD), alcohol abuse
and eating disorders. She has devel¬

Lycurgus M. Davey, M.D. ’43

series in April. The forum was spon¬

oped STD and other risk prevention

sored by The Biotech Committee of

programs for high school students and

Greater Haven and the Yale University
Office of Cooperative Research. Dr.

military personnel and acts as a con¬

Past President

Executive Committee
Frank R. Coughlin, Jr., M.D. ’52

Ruano’s topic was Genomic Strategies

sultants to the Center for Disease
Control, the military and the Califor¬

Arthur C. Crovatto, M.D. ’54

and Drug Discovery.

nia State Department of Health re¬

Mary V. Digangi, M.D. ’64

An announcement of a research
and development collaboration

garding STD/HIV prevention.
The American Academy of Pediat¬

John W. Foster Jr., M.D. 71

agreement between Genaissance

rics awarded Dr. Shafer its Adele D.
Hoffmann Award for her work in

Pharmaceuticals, Inc. and Terrapin
Technologies of San Francisco was
made in February at the Second

adolescent health.

Annual Cambridge Healthtech

Send news of Alumni/ae on Campus to Nicholas

R. Leonard Kemler, M.D. ’43
Robert J. Kerin, M.D. ’47
Francis M. Lobo, M.D. ’92
Jocelyn S. Malkin, M.D. ’51

PR. Spinelli, M.D. '44, in care of the Office of

Dwight F. Miller, M.D. ’56

Institute Conference on Gene Func¬

Alumni Affairs, P.O. Box 7613, New Haven, CT

tional Analysis in San Francisco.

Romeo A. Vidone, M.D. ’57

06519-0613.

Ex-officio

AYAM

Outreach

David A. Kessler, M.D.
Dean

William K. Jenkins

Dean Kessler in Washington

Managing Director, Alumni Affairs

Daniel L. Arons, M.D. ’67

Dean David A. Kessler, M.D., will speak at a reception Sept. 15 hosted by the

Chair, YSM Alumni Fund

Association of Yale Alumni in Medicine in conjunction with the Yale Club of
Washington, D.C. A reception will follow Dr. Kessler’s lecture, which is

Samuel D. Kushlan, M.D. ’35
YSM Bequest and Endowment

scheduled to begin at 6:30 p.m. in Room G50 of the Everett M. Dirksen
Senate Building, First and Constitution streets NE, in Washington. To
reserve seats for the lecture and reception, contact Terry Watson, 4323
Cathedral Ave., NW, Washington, D.C. 20016 or the Alumni Affairs office
at (203) 785-4674.

Representatives to the
Association of Yale Alumni
Martin E. Gordon, M.D. ’46
Joseph F.J. Curi, M.D. ’64

Reunion ’99: Save the date
Plan to join us in New Haven June 4 and 5, 1999, to celebrate the Association
of Yale Alumni in Medicine Annual Spring Reunion Weekend. Classes whose
years end in 4 and 9 will be celebrating reunions, but alumni from all years
are welcome to attend the festivities, symposia, historical programs, campus
tours and other special events. Contact the Association of Yale Alumni in
Medicine, Office of Alumni Affairs, P.O. Box 7613, New Haven, CT 065190613. Telephone (203) 785-4674; fax (203) 737-5153.

Felix M. Freshwater, M.D. ’72
Donald E. Moore, M.D., M.P.H. 81
Benjamin E. Lyons, M.D. ’38
Theoharis C. Theoharides, Ph.D. ’78,
M.D. ’83

AYAM Representative,
Medical School Council
Peter N. Herbert, M.D. ’67
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OBITUARIES

CLIFFORD C. BEEBE

THOMAS E. CARSON

Clifford C. Beebe, M.P.H., formerly

Thomas E. Carson, M.D., died Oct.

of Milford, Conn., died Feb. 6 at the

1, 1997, after an apparent heart attack
at his home in North Warren, Pa. He

Masonic Home and Hospital in
Wallingford. He was 89.
Born in New Haven, Mr. Beebe
received a bachelor’s degree from
Lafayette College in Easton, Pa., a
master’s degree in public health from
Yale in 1946 and a master’s degree in
education from the University of
Bridgeport. He was a consultant for 31

fessor of surgery at the University of
Hawaii John Burns School of Medi¬
cine and served two years as an Air
Force captain.

was 63.
Dr. Carson graduated from Yale
College in 1956 and the School of

WARREN P. CORDES

Medicine in i960. He completed his

Warren Platts Cordes, M.D., formerly

internships at Strong Memorial
Hospital in Rochester, N.Y., and

of Chatham, Mass., died Feb. 11 in
Raleigh, N.C. He was 93.
Dr. Cordes was born in

McKeesport Hospital in Pennsylvania.
He was on the staff and medical direc¬

Northhampton, Mass., and was a

years at the Connecticut Department
of Education in the vocational reha¬

tor at Warren State Hospital for the

graduate of Colgate University. He re¬

last 15 years and had previously

ceived his medical degree from Yale in

bilitation department until he retired

worked at Torrance State Hospital

1933. He served in the Massachusetts

in 1975.

in Pennsylvania.
Dr. Carson was a member and dea¬

National Guard from 1936 to 1939 and
also in the U.S. Navy Medical Corps

con of the First Presbyterian Church.

during World War II, stationed at

He was a past board member of the

New Caledonia in the South Pacific,
reaching the rank of commander.

MAXWELL BOGIN
Maxwell Bogin, M.D., a prominent
Connecticut pediatrician, died Dec. 2.
He was 95.
Dr. Bogin graduated from Yale

American Cancer Society’s Warren
County Unit and a member of the
Warren County Medical Society.

In 1950, Dr. Cordes was appointed
superintendent of the Gardner State
Hospital. His specialties were psychia¬
try and neurology. He retired in 1973.

College in 1923 and the School of
Medicine in 1926. He was chief of

STANLEY M.K. CHUNG

pediatrics at Bridgeport Hospital from

Stanley M.K. Chung, M.D., of

1948 to 1967 and a former state chair¬

Honolulu, Hawaii, died April 21.

man of the Connecticut Chapter of

He was 62.

the Academy of Pediatrics and presi¬
dent of the Hezekiah Beardsley

Northwestern University and earned

Pediatric Society.

his medical degree from Yale in i960.

Dr. Chung was a graduate of

Dr. Cordes was a member of the
Massachusetts Medical Society for 50
years. He was also active in both the
Boy Scouts of America and the Massa¬
chusetts Archeological Society.

He began his postgraduate training at

WILLIAM H. DRUCKEMILLER SR.

rics of Bridgeport Hospital instituted

the Cornell Medical Center and was a

William H. Druckemiller Sr., M.D.,

the annual Maxwell Bogin, M.D.,

fellow in orthopaedic surgery at the

died Sept. 25 at his home in Fairview,

Lectureship in Pediatrics, which car¬
ries course credit for health profes¬

Mayo Clinic. He completed his resi¬

Pa. He was 83.
Dr. Druckemiller, born in Sunbury,

In 1978 the Department of Pediat¬

sionals. Dr. Bogin served as chairman

dency in orthopaedic surgery at the
University of Pennsylvania. While in

of the medical advisory board of the
Rehabilitation Center of Fairfield

Philadelphia, Dr. Chung was picked
by C. Everett Koop, M.D., as a mem¬

County and as consultant in pediatrics
to the Connecticut State Department

ber of the first team to separate con¬

Pa., graduated from Bucknell Univer¬
sity in 1935 and received his medical
degree from Yale in 1939. He served as
a general surgeon in the U.S. Navy
and then as a neurosurgeon from

of Health. He was a founding partner

joined twins.
Dr. Chung, who devoted much of

of the Children’s Medical Group in

his career to treating children, became

1946 to i960. He was chief of neuro¬
surgery at the National Naval Medical

Bridgeport and supervised pediatric

a member of the medical staff at the

Center in Bethesda, Md., and retired

clinics in Easton and Monroe. He was
also a member of the Fairfield County

Kapiolani Medical Center for Women

from the Navy in i960 with the rank

and Children in 1978. He was named

of captain.
Dr. Druckemiller entered private

Medical Association, the Connecticut
State Medical Society, and the Ameri¬
can Medical Association.

chief of the Medical Center’s depart¬
ment of pediatric surgery in 1989, and
in 1992 he served as chairman of or¬
thopaedics in the surgery department.
Dr. Chung was also an associate pro¬
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practice in Erie, Pa., and was chief of
neurosurgery at Saint Vincent Health
Center from i960 to 1977. He also
served as chief military consultant of
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the National Aeronautics and Space
Administration’s Mercury Project
from 1958 to i960.

SUMMER GOLDENTHAL
Summer Goldenthal, M.D., formerly
of New Haven, died April 24 at the
Brian Health Care Center in
Canton, Ga.
Dr. Goldenthal, a World War II
Army veteran, graduated from the
School of Medicine in 1951 and served
his residency at Yale-New Haven Hos¬
pital and at Johns Hopkins. He was a
clinical instructor at Yale in 1956 and
on the staff at Grace-New Haven
Hospital. In 1959 he set up a private
radiology practice in New Haven. He
was also a radiologist for the Fannin
Regional Hospital in Blue Ridge, Ga.,
and the Copper Basin Medical Center
in Copperhill, Tenn.

and received his medical degree in
1945 at the age of 21. Dr. Hirata was a
member of the Alpha Omega Alpha

southern city of Fukuoka; one of his
father’s brothers was a physician and
two others had been in the Japanese

Honor Society. He completed his resi¬
dency in general surgery at Grace-

navy and army. She was able to locate
members of the family, and in 1992

New Haven Hospital in 1950 and
practiced in New Haven.

Dr. Hirata and his wife, Mary Keeler

Dr. Hirata was secretary ol the
medical staff at Yale-New Haven Hos¬
pital from 1956 to 1972, and the Yale
football team physician from 1956 to

markable ancestry ol 20 generations of
physicians. At a banquet in his honor
with 40 of his relatives, he listened to

1971. While at Yale he held the posi¬
tions of surgeon in chief of the

his cousin tell the story of the first

assistant clinical prolessor at the
School of Medicine. In 1972 he ac¬
cepted the position of director of stu¬

Herbert S. Hurwitz, M.D., of
Scarsdale, N.Y., died Dec. 20. He

of South Carolina, which he held un¬
til he retired in 1988. He served as

was 68.

president of the American College
Health Association from 1979-80.
Dr. Hirata, whose Japanese-born
medical school, told classmates at his
50th that he was glad to have been at
Yale during World War II, when lile

H. Patterson Harris Jr., M.D.,

in the United States was difficult for
Japanese-Americans. Following the
war, he served in the Army until
1953, at which time he returned to

Born in Baltimore, Dr. Harris re¬
ceived a bachelor’s degree from Yale

New Haven.

University in 1932, a medical degree

ended, Dr. Hirata saw classmate Alice

from Duke University School of

Shepard Cary, M.D., at their 1990
class reunion in New Haven. Dr. Cary

Medicine in 1938, and a master’s de¬
gree in public health from Yale in
1965. He served as assistant supervisor
at Fairfield Hills Hospital in
Newtown, Conn.
Dr. Harris had recently retired as
medical examiner in Fairfield, and
prior to that was a school physician,
the director of public health for

Forty-five years after the war

had lived in Kyoto for most of those
45 years, moving to Japan just after
the war. He told her that he had fam¬
ily in Japan he had never met. She of¬
fered to look them up.
Besides not speaking Japanese, the
largest obstacle to finding the other

Fairfield, and a medical internist

branch of Hiratas was that Dr. Hirata
knew next to nothing about them.

in private practice for more than
20 years.

sensitive that they did not want ever

“During the war, my parents were so
to talk about the family in Japan,” he
said in a 1995 Yale Medicine interview.

ISAO HIRATA JR.
Isao Hirata Jr., M.D., died Feb. 25 at
Providence Hospital of Columbia,
S.C. He was 74.
Dr. Hirata, who was born and
raised in New Haven, earned a
bachelor’s degree from Yale in 1943,

HERBERT S. HURWITZ

dent health services at the University

M.P.H., of Southport, Conn., died
Jan. 5 at Bridgeport Hospital in
Bridgeport, Conn. He was 87.

Hirata healers in the mid-i6oos.

University’s department of health and

father was a 1912 graduate of the

H. PATTERSON HARRIS JR.

Hirata, were reunited with his Japa¬
nese relatives and learned of his re¬

“My mother wouldn’t tell me any¬
thing about my relatives. She didn’t

Dr. Hurwitz graduated from
Harvard College in 1950 and from the
Yale School of Medicine in 1954. He
completed his internship and resi¬
dency at the Johns Hopkins Hospital
and Boston Children’s Hospital.
After military service in Bordeaux,
France, Dr. Hurwitz entered private
pediatric practice in White Plains,
N.Y., from which he retired in 1992.
Dr. Hurwitz was on the staff ol the
White Plains Hospital Medical Center
and St. Agnes Hospital. He was a fac¬
ulty member at Babies Hospital, Co¬
lumbia University, and the State Uni¬
versity of New York at Purchase.
Dr. Hurwitz was a recognized poi¬
soning prevention expert and the New
York area chairman of the American
Academy of Pediatrics Accident Pre¬
vention Committee, which was re¬
sponsible for the development and
implementation of child-resistant
bottle caps for medical packaging. He
played a prominent role in the crusade
for legislation and public education to
ensure universal acceptance of this
safety device.
Dr. Hurwitz was a past president of
the Harvard Club of Westchester
County, N.Y.

even want to admit we had any.” And
so the matter rested for decades.
When Dr. Cary returned home to

WILLIAM P. KOUGHAN

Japan after the reunion, she took with

William P. Koughan, M.P.H., died on

her the few details Dr. Hirata had
gathered: The family was from the

April 6. He was 56.
Mr. Koughan graduated from

Boston College and received a master’s
degree in public health from Yale in
1971. He served lor four years as vice
president of Lawrence General Hospi¬
tal in Lawrence, Mass.
Mr. Koughan served 10 years as ex¬
ecutive director ol Wing Memorial
Hospital and Medical Centers and
president and CEO ol Wing Health
Systems in Palmer, Mass. During his
tenure at Wing Memorial Hospital, he
expanded access to health care services
within the greater Quaboag Valley. He
brought primary care to the towns
surrounding Palmer, beginning in
1976 and was instrumental in the
foundation of Palmer ambulance.
He also served as president and
CEO at North Hills Passavant Health
Corporation in Pittsburgh, Pa., and
president and CEO of Horizon
Health System, Inc. in Bethlehem, Pa.
In 1991 he moved to Watertown, N.Y.,
to serve as president and CEO of
Samaritan Health Systems.

Hospital and served as medical direc¬
tor and president for years.

Dr. O’Connor received a bachelor’s
degree from the University of Notre
Dame in 1931 and his medical degree
from Yale in 1935. He served his in¬

ROBERT R. MCDONNELL
Robert R. McDonnell, M.D., of New
Haven, Conn., died Dec. 11 in New
Haven. He was 78.
Dr. McDonnell graduated from
Colby College in Waterville, Maine,
in 1942 and received his medical de¬
gree Lorn lelferson Medical College in
Philadelphia in 1945. He was a captain
in the Army from 1946 to 1948 and he
completed residencies in neurosurgery
at New Haven Hospital and at the
Hartford Hospital from 1948 to 1952.
Dr. McDonnell was an attending
physician at Yale-New Haven Hospital
and the Hospital of Saint Raphael
from 1952 until his retirement in
December 1996. He also served as
treasurer of the Connecticut State
Medical Society and was a member
of the New England Neurological

ternship at Martland Medical Center
in Newark, N.J. During World War II
he was a lieutenant commander in the
Navy Medical Corps.
Dr. O’Connor practiced general
surgery in Newark for 52 years before
retiring in 1989. He was on the staff at
St. Michael’s Medical Center and the
Presbyterian Hospital, both in New¬
ark, and St. Mary’s Hospital in Or¬
ange. He also served as the senior
police surgeon for the Newark Police
Department from 1954 to 1992.
Dr. O’Connor, nicknamed Ducky,
was a halfback on the 1929 and 1930
Notre Dame national championship
football teams under the legendary
coach Knute Rockne. He played him¬
self as a football player in the motion
picture Spirit of Notre Dame, which
was released in the 1940s.

Society and the American Medical
Association.
NELSON K. ORDWAY

PAUL R. LIGHTFOOT
Paul R. Lightfoot, M.D., of
Claremont, Calif, died April 4.
He was 59.
Dr. Lightfoot graduated from
Fordham College in New York in i960
and received his medical degree from
Yale in 1964. He worked throughout
his career at Kaiser Hospital in
Fontana, Calif, serving as chief,
director and chairman of critical care
in the department of cardiology.

Nelson K. Ordway, M.D., died of
STEPHEN F. NAGYFY
Stephen F. Nagyfy, M.D., died Dec.
28, at Wilson Memorial Hospital in
Johnson City, N.Y. He was 86.
Dr. Nagyfy received his bachelor’s
degree from Yale in 1932 and his medi¬
cal degree from the School of Medi¬
cine in 1936. He later taught at Iowa
State University. During World War
II, Dr. Nagyfy served in the Navy as a
lieutenant commander in the Medical

OLGA A.G. LITTLE

Corps. He moved to Binghamton,
N.Y., after the war and served as phy¬

Olga A. Gavriluk Little, M.D., died in

sician for the Endicott Johnson Corp.

Willimantic, Conn., on Nov. 30. She

Dr. Nagyfy later went into private

was 87.

practice associated with Wilson Me¬

Dr. Little received her medical de¬
gree from Boston University, com¬

morial Hospital-UHS and also served

pleted an internship in pediatrics at
Yale from 1935 to 1937, continued her

as chairman of obstetrics and gynecol¬
ogy. He retired in 1985.

met in medical school and worked to¬
gether throughout their careers. In
1954 they helped found Natchaug
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Scottsdale, Ariz. He was 85.
Dr. Ordway, a native of Maine, at¬
tended Yale College and was a 1938
graduate of the School of Medicine.
His postgraduate training was done at
the New Haven Hospital and the
Hospital of the University of Pennsyl¬
vania. During World War II he was a
research assistant in pathology at Yale,
where he conducted research on de¬
fenses against chemical warfare. In
1945 he joined the pediatrics faculty at
Yale as an instructor. In 1947, he was
invited to help a fellow Yale alumnus,
Myron E. Wegman, M.D. ’32,
M.P.H., rebuild the pediatrics depart¬
ment at Louisiana State University
Medical School in New Orleans and
became department chair in 1952.
According to Dr. Wegman,

post-graduate training in psychiatry at
Fairfield Hills Hospital in Newtown,
Conn. She and her husband, Mervyn,

prostate/bladder cancer on Dec. 31 in

PAUL A. O’CONNOR
Paul A. O’Connor, M.D., of
Hackettstown, N.J., died Jan. 2 at
Mountainside Hospital in Glen
Ridge, N.J. He was 89.

“Nelson brought to our budding de¬
partment a dimension of Yale-bred
laboratory competence and research
that led us to fantasize about building
a miniature New Haven in New
Orleans.” But while at LSU, Dr.
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Ordway ran afoul of then-rampant
McCarthyism when he rose to the de¬

at the Children’s Hospital in Boston

world, Dr. Spock explained the

from 1950 to i960. He also taught at

different stages of child development

fense of a colleague who had refused
to sign a loyalty oath. Dr. Ordway

the University of New Hampshire’s
School of Allied Health Services, the
University of Southern Maine,

so parents could act on that knowl¬
edge. He challenged then-current

maintained that political views were
irrelevant to his colleagues compe¬

and New Hampshire Vocational

notions that parents should neither
coddle nor kiss their children. Two

tence as a teacher. The colleague was
forced to resign and Dr. Ordway was

Technical Institute.
Dr. Shattuck practiced pediatrics in

decades later, he linked pediatrics and
politics by denouncing nuclear weap¬

told that pediatrics would receive no
funding as long as he remained chair¬

Portsmouth from 1950 until 1986 and

ons and the war in Vietnam, stands

was chief of medical staff, medical

that brought him to a federal court in
1968. His conviction on charges of

man. He then joined the faculty of the
University of North Carolina and re¬
turned to Yale in 1958 as professor
of pediatrics.
In 1967, he served a year as a

services and pediatrics at Portsmouth
Regional Hospital. He was also a se¬
nior pediatrician for Kron Medical
Corp. in Chapel Hill, N.C., from

Spiro Agnew and others blamed the

1986 to 1988.

youth revolt of the 1960s on his
“permissive” child rearing advice,

HUGH A. SMITH

doctor who offered practical advice

Rockefeller Foundation visiting pro¬
fessor at the Universidad del Valle, in
Cali, Colombia, then moved to the
University of Oklahoma, where he re¬
mained until 1974. He periodically
taught and lectured in Latin America.
Throughout his career, he placed an
emphasis on direct care of infants and

but parents and pediatricians saw a

Hugh Allan Smith, M.D., of
Damariscotta Mills, Maine, died Jan.
5 at Heritage Manor, Winthrop.
He was 88.
Dr. Smith received his bachelor’s

children. The chance to do more of
this led him to join the Indian Health

degree from Western Reserve Univer¬

Service in 1974, first in Gallup, N.M.,
and then in Phoenix, Ariz., where he
eventually retired in 1985.

gree in 1936 from Yale. From 1936 to
1940, he completed his residency in

Dr. Ordway, as a member of Physi¬
cians for Social Responsibility, was ar¬
rested protesting against continued
testing of nuclear weapons in Arizona.
He was a lover of music and an avid
hiker who at 16 climbed the Jungfrau
in the Swiss Alps. At age 64, he
trekked with granddaughter Nancy in
the Himalayas to a level of almost
19,000 feet. He was still camping,
with the aid of a walker, within a few
months of his death.

helping young men avoid the draft
was reversed on appeal. Vice President

sity in 1932 and earned his medical de¬

radiology at Strong Memorial Hospi¬
tal in Rochester, N.Y., and, from 1940
to 1942, served as an instructor in ra¬
diology at Yale. He then entered pri¬
vate practice in Hartford, Conn.
In 1946 Dr. Smith moved to
Maine, where he practiced as an asso¬
ciate radiologist at Eastern Maine
General Hospital and, in 1949, he was
named chief of the department of ra¬
diology. He held the post until 1972
and continued to serve the depart¬
ment until his retirement in 1977.

in simple terms.
Morris A. Wessel, M.D. ’43, met
Dr. Spock in 1947 at the Mayo Clinic,
where Dr. Wessel had a fellowship. He
recalls: “If you were seeing a child and
having some difficulty about what was
going on, he would come in and talk
to the parent and make some sense
out ol it. I wanted to be that kind ol
pediatrician." According to Dr.
Wessel, Dr. Spock came to defy the
upper-crust culture into which he was
born in New Haven in 1903. His fa¬
ther was a lawyer ior a railroad com¬
pany. “His moral feelings about the
war and nuclear weapons were not the
pattern of New England aristocrats,”
Dr. Wessel said.
He started his medical studies at
Yale, but after two years switched to
the Columbia University College of
Physicians and Surgeons. Alter serving
as a psychiatrist in the naval reserve

GERALD B. SHATTUCK
Gerald B. Shattuck, M.D., of
Portsmouth, N.H., died Dec. 7.
He was 74.
Dr. Shattuck received a bachelor’s
degree from Dartmouth College in
1943 and a medical degree from Yale
in 1946. He was a pediatric intern
and assistant resident at the University
of Rochester Strong Memorial Hospi¬
tal in N.Y. from 1946 to 1949, and an
assistant at Harvard Medical School
from 1949 to 1950. Dr. Shattuck was
on the clinical faculty at Harvard and

BENJAMIN M. SPOCK

during World War II, he completed
writing his book.
“He liberated families from the
kind of rigid authoritarianism that so

Benjamin M. Spock, M.D., who revo¬
lutionized the child-rearing philoso¬

characterized child rearing in the first

phy of his day by encouraging parents

decades of this century,” said Joseph

to show their children both affection

Warshaw, M.D., deputy dean and

and firmness, died March 15 at the
age of 94.

chair of pediatrics at the School of

A 1925 graduate of Yale College,
Dr. Spock completed the first two

Medicine. “So much ol what he did
and what he talked about became part
of the conventional wisdom that it is

years of medical school at Yale. He

hard to really appreciate the impact

came to national prominence in 1946
with the publication of Baby and

that he had. He basically empowered
families to use common sense and

Child Care. In his book, which has

take a more relaxed approach.”

sold 50 million copies around the

OLIVER G. STONINGTON
Oliver G. Stonington, M.D., of
Breckenridge, Colo., died of cancer
Feb. 4. He was 82.
Born in Staten Island, N.Y., Dr.
Stonington graduated in 1933 from
St. Paul’s School in Concord, N.H.
and went to Princeton University.
In 1939, he took a pre-medical year at
Harvard University and then went on
to graduate from Yale School of Medi¬

Dr. Ward serving as chair until 1981.
In 1976, Dr. Ward founded the

school. “It was wonderful to be with
her when she went to the opening,

UW’s Northwest Regional Epilepsy
Center, which he directed until 1986.

and to have her see the students al¬
ready in the library and using the li¬

He was chief of the Neurosurgical Ser¬
vice at UW and Harborview Medical
Center. Dr. Ward was president of the

brary. It was very, very gratifying to
her that she brought this about,” said

American Academy of Neurological
Surgery and editor of the journal

tured my mother’s involvement was
her excitement and her desire to be in¬

Epilepsia.

volved in the actual design and the de¬
tails of the new building for the li¬
brary and the renovation of some of

cine in 1943. Dr. Stonington did his
residency training in urologic surgery
as an Army captain at Hines Veterans
Hospital in Chicago.
In 1956, Dr. Stonington joined the
faculty of the Colorado University
Health Sciences Center in Denver.

PATRICIA WANNING WATSON

the old spaces. It gave her enormous

Patricia Wanning Watson, M.D., of

pleasure to be a part of that.”
In endowing the library, Mrs.

New Paltz, N.Y., died Dec. 19, at her
home. She was 85.
Dr. Watson, born in Cambridge,
Mass., graduated from Radcliffe

During his tenure as professor, he was

College and received her medical de¬

honored nine times as the Outstand¬
ing Clinical Teacher of the Year. Dr.

gree from Yale in 1940. She practiced

Stonington also received the American

time out to raise four children. Dr.

Urologic Association Award for Most
Outstanding Research in 1975 for his

Watson worked as a specialist in or¬

work on prostate cancer. He retired in
1977 as head of urology in the Depart¬
ment of Surgery at CU. Always active

as a pediatrician in Boston, then took

ganic causes of mental disorders and
in bio-feedback in Kingston, N.Y.
She had a lifetime interest in the brain
and the mind.

in sports. Dr. Stonington celebrated

JR.

Whitney carried on a family philan¬
thropic tradition. Her husband hon¬
ored his father by donating funds to
pay for Payne Whitney Gym. Her fa¬
ther, along with his friends and col¬
leagues John F. Fulton, M.D., and
Arnold C. Klebs, M.D., bequeathed
rare medical manuscripts and books to
the library. The resulting collection
was the nucleus of the Medical His¬
torical Library, which opened in 1941.
Dr. Cushing’s design for the library, a
Y-shaped wing that jutted from the
back of Sterling Hall of Medicine, was

his 80th birthday skiing.

ARTHUR A. WARD

Kate Whitney. “The thing that cap¬

BETSEY CUSHING WHITNEY

adopted and completed after he died
in 1939. The design of the new library

Betsey Cushing Whitney, the philan¬

maintained that concept.

thropist who in 1985 provided $8

Mrs. Whitney was born in 1908,

Arthur A. Ward Jr., M.D., of Seattle,

million to expand the Yale Medical

Wash., died Dec. 23 of complications
following surgery. He was 81.

Library in honor of her father and

also had two brothers. In 1930 Mrs.

her husband, died March 25 at the

Whitney married James Roosevelt,
the oldest son of Franklin Delano

Dr. Ward was born in Ceylon

age of 89.

the second of three daughters. She

(present-day Sri Lanka) and came to

Her father was Harvey Cushing,

the United States at the age of 15. He

M.D., the pioneering neurosurgeon

graduated from Yale College in 1938

and graduate of Yale College who

ended in divorce. In 1942, Mrs.

and from the School of Medicine in
1942. Dr. Ward did his residency at

came to the medical school to teach
in 1933. Her husband was John Hay

Whitney married John Hay Whitney.

Montreal Neurological Institute, then

Whitney, known as Jock, a 1924 Yale

taught at Yale as an instructor in

College alumnus and fellow who pub¬

ter-in-law and she frequently served

physiology in 1945. He also taught at

lished the Herald- Tribune, served as

the University of Illinois and the
University of Louisville.

ambassador to Great Britain, backed

as a hostess at White House functions.
In 1983 she established the Greentree

In 1948, Dr. Ward was invited to
develop a neurological division at the
University of Washington Medical
School. Without even a building, he
helped design the laboratories and
created the research and teaching pro¬

Roosevelt. Their marriage produced
two daughters, Sara and Kate, but

Mrs. Whitney was said to be
President Roosevelt’s favorite daugh¬

Hollywood movies and Broadway

Foundation, named after her 438-acre

shows, raced horses and collected art.
After Mr. Whitney died in 1982,

estate on Long Island’s Gold Coast.

Mrs. Whitney sought a way to bring

community groups.
In 1995, she returned to the medi¬

together in memoriam her husband
and her father, who had never met, ac¬

The foundation assisted local

cal school for an exhibit of surgical

grams. He then developed the clinical

cording to her daughter Kate Whitney
of New York City. Her endowment

tools, papers and photographs from
her father’s archives and collection.

program. Gradually he set up the epi¬
lepsy center for research. In 1965, the

of the Harvey Cushing/John Hay

“She came up in a wheelchair and ac¬

Whitney Medical Library was at that

division became a department with

time the largest individual gift to the

tually stood and went around all the
cases,” recalled former Dean Gerard
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N. Burrow, M.D. ’58, who described
Mrs. Whitney as “an absolutely

IN

MEMORIAM

wonderful woman.”
The School of Medicine has received notification of the death of the following persons:

GEORGE L. WILSON
John B. Barnes, M.D. ’79

D. Bruce McLean, Med ’36

Fla., and Derby, Conn., died on May

September 16, 1997

January 26, 1998

2 at his home in Naples. He was 75.
Born in Everett, Mass., Dr. Wilson

Clifford C. Beebe, M.P.H. ’46

Frances S. Miller, M.P.H. ’39

February 7, 1998

June 16, 1996

Maxwell Bogin, M.D. ’26

Stephen F. Nagyfy, M.D. ’36

December 2, 1997

December 28, 1997

WynthaT. Boothe, M.P.H. ’61

Paul A. O’Connor, M.D. ’35

February 14, 1995

January 2, 1998

Ormond Y Brody, M.D. ’60

Nelson K. Ordway, M.D. ’38

August 13, 1996

December 31,1997

Lewis H. Bronson Jr., M.D. ’37

Joseph T. Prekup, M.P.H. ’61

April 1, 1988

January 1, 1997

Clarence William Bushnell, M.P.H. ’51

James D. Prokop, M.D. ’59

October 28, 1997

December 1, 1997

Cynthia D. Buder, M.P.H. ’76

Joseph P. Rossi, M.D., HS ’60

February 6, 1991

June 7, 1996

Thomas E. Carson, M.D. ’60

Roger N. Ryley, M.D. ’39

October 1, 1997

November 1, 1992

George B. Corcoran Jr., M.D. ’44

Gerald B. Shattuck, M.D. ’46

August 28, 1997

December 7, 1997

Warren P. Cordes, M.D. ’33

Hugh Allen Smith, M.D. ’36

February 11, 1998

January 5, 1998

William H. Druckemiller, M.D. ’39

Benjamin Spock, M.D., Med ’29

September 25, 1997

March 15, 1998

H. Patterson Harris Jr., M.D.,

Myra D. Tyler, M.D. ’50

M.P.H. ’65

January 13, 1998

George L. Wilson, M.D., of Naples,

attended Harvard University and re¬
ceived his medical degree from Tufts
University in 1947. He was a corpsman at Chelsea Naval Hospital during
World War II and served as a Naval
surgeon in Korea and Japan during
the Korean conflict.
Dr. Wilson practiced thoracic sur¬
gery at the Hospital of St. Raphael in
New Haven from 1956 until his retire¬
ment in 1992. He was also a clinical
instructor of thoracic surgery at Yale.
He served on the Board of Trustees
and was president of the Medical Staff
at the Hospital of St. Raphael. He was
also on the Board at Quinnipiac
College and was a member of the
parents council at Davidson College.

CHARLES ZIGUN
Charles Zigun, M.D., of Fairfield,
Conn., died March 5 in Bridgeport
Hospital. He was 68.
Born in Bridgeport, Dr. Zigun was
a graduate of Yale College in 1952 and
the School of Medicine in 1956. He
was in private practice in Fairfield for
over 30 years and was affiliated with
the greater Bridgeport Mental Health
Center as a staff psychiatrist for five
years. Dr. Zigun was a past president
of the Congregation Rodeph Sholom,

January 5, 1998
Patricia E. Wanning, M.D. ’40
Isao Hirata Jr., M.D. ’45

Arthur A. Ward Jr., M.D. ’42

the Jewish Family Service and the
Connecticut Region of the United
Synagogue of America.

December 19, 1997

February 25, 1998
George L. Hoffmann, M.D. ’53

December 23, 1997

May 16, 1997
Jane L. White, M.P.H. ’43
Kathleen H. Howe, M.P.H. ’56

October 10, 1997

December 3, 1997
Richard Y Worthington, M.D. ’38
Herbert S. Hurwitz, M.D. ’54

November 29, 1997

December 20, 1997
Charles Zigun, M.D. ’56
Henry V. Kogut, M.D., HS ’48

March 5, 1998

October 18, 1997
The designation Med. indicates the deceased at¬

Olga A.G. Litde, M.D., HS ’37

November 30, 1997
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tended the School of Medicine for a portion of his
or her education.
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The four humors weren’t that funny

L

aughter, they say, is the best medicine.
But can laughter cure Methicillin-Resis-

write—and I don’t want to be disrespectful.
For example, when I rotated through surgery,

tanr Staphylococcus Aureus? Let me put

we amputated an unfortunate gentleman’s

that another way ...

toe which had become gangrenous. Would

Once, when I was a young boy, there lived
an alarming bit of eczema on my face. I

the patient whose toe I amputated appreciate
it if he knew I was telling the above amputa¬

itched, I whined, and my annoyed mother was

tion-related humorous anecdote? Is it OK,

forced ro drag me to the doctor’s office. Upon

but only if he never finds out? Should I hang
up my word processor forever? Because of

inspecting my grill, the pediatrician looked at
my mother gravely, shook his head, and deadpanned: “I rhink we’ll have to amputate.”
Petrified, I turned to my mother. Strangely,

By
Gregory Raskin

she was smiling. I was confused for a moment,
but then I understood. This man, my doctor, had just made
a joke under what was surely the gravest of circumstances.

such erhical dilemmas, future columns of
mine dealing with possibly taboo subjects
will appear under the pseudonym “Galen,”
or possibly “Assistant Dean for Admissions

Thomas Lentz.”
Humor in medicine can also have value that goes beyond

He had wielded his irony and slain two unhappy people. In

the obvious. In a word: cost-effectiveness. HMO executives

their places were a smirking mom and a beaming, reverent

and even the hospital president will be eating out of your

(although still quite blemished) boy.
Can you see that this real-life example points to an
important issue? If you are thinking, “Yes! Eczema can be

latex-gloved hands when your cheery parients leave the
hospital in record time. Numerous studies have shown

cured by amputation,” you may have missed the point

shorter hospital stays for patients treated by funny doctors
than for those who have brooding doctors who wear black,

entirely. Also, you are hopefully not a dermatologist. What

quote Soren Kierkegaard and pipe Wagner into their

you should have gleaned is that humor in medicine has an
important role, one that is often overlooked.

hospital ward.
You’re thinking, fine, this will work if I’m a genuinely

Toward the beginning of my clinical training, I was ner¬
vous around my patients. I ended up being very serious,

funny person, but what about my colleagues who are dull as
a three-week-old scalpel? HMOs will still approve. If you’re

both out of anxiety and respect. However, being serious all

not that funny but still attempt humorous intervention,

the time is not inherent to my character, and 1 think by try¬

you may drive your patients from the hospital, saving

ing to act a certain way I ended up appearing even more

society countless dollars. If all else fails, feel free to try a

awkward than I really am. While medical school at Yale

variation of the following (nearly foolproof) gag:

stresses the importance of the doctor-patient relationship,

After a medical conference where attendees were plied
with material from pharmaceutical firms, I ended up with a

I never appreciated how humor can be used to one’s advan¬
tage. It can distract a patient who is self-absorbed and de¬
pressed, help a patient to be on your side, and may turn a
stressful situation into one of friendly rapport.
As my clinical training progressed, I developed a differ¬

sample capsule from a drug company. It looks just like a
normal blue and white capsule, except that it’s about 8
inches long and 3 inches in diameter. Occasionally I’ll put it
in my breast pocket, enter a patient’s room, say “Good

ent way to think about respect. I feel that doctors should

morning, Mrs. (ones, it’s time for your medicine,” and then

regard patients as though they are normal people. This is
sometimes hard for a beginning medical student. I think

produce this enormous pill.

that the majority of my patients do better when they do not

Usually this is met by a laugh, although I’m sure to scout
out my audience before I try such a trick. I never do it on

feel they are being treated as extremely fragile. On rhe other

anyone who’s recently had abdominal sutures.

hand, one cannot be perceived as cavalier or immature.

I wouldn’t want to split any sides.

Humor walks a razor’s edge: ir is vital to feel out the situa¬
tion to determine whether or not, in the words of Woody
Allen, “This is not the right crowd for this joke.” In short,

Gregory Raskin, M.D. '98, invites all interested physicians

don’t tell a knee-slapper to a guy with patellar tendinitis.

to call him up for more good gags to use on the job. He is a

I also have the particular concern that I tend to write
often—in forums where plenty of people can read what I

first-year resident in internal medicine at New York University
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Continuing Medical
Education at Yale
Sept. 12,13
Saturday-Sunday

Yale at Mystic: An Ultrasound Review

A

Course Director: Kenneth J. Taylor, M.D., Ph.D.
Furthering acquaintance with the most useful applications of the latest
technical advances in diagnostic ultrasound
Mystic Hilton, Mystic, CT

Sept. 16 20

Wednesday-Sunday

The 22nd Yale Physician Assistant Certification/
Recertification Preparatory Conference

B

Course Coordinator: Christiane G. Nockels, P.A.
Omni Hotel, New Haven, CT

Sept. 25
Friday

Death of Neurons

C

Course Director: Pierre Fayad, M.D.
Harkness Auditorium

Oct. 1, 2
Thursday-Friday

AIDS Conference

D

Course Director: Gerald H. Friedland, M.D.
Omni Hotel, New Haven, CT

Oct. 10
Saturday

Second Annual Michael S. Voynick Lecture in Neuro-Oncology

E

Course Director: Joseph M. Piepmeier, M.D.
Hope 110

Oct. 14
Wednesday

8th Annual Dual Diagnosis Committee Conference

F

Course Director: Douglas Ziedonis, M.D.
Harkness Auditorium

Oct. 16,17
Friday-Saturday

Digestive Disease Review for the Primary Care Provider

G

Course Director: Victor J. Navarro, M.D.
Harkness Auditorium

Oct. 23, 24
Friday-Saturday

Health and Spirituality Conference
Albert Schweitzer Institute for the Humanities
Directed to a multidisciplinary audience of practitioners and graduate students in
medicine, divinity, public health and social work. Dedicated to the memory of
Dr. Albert Schweitzer’s son-in-law, Dr. David Miller.
Hope 110

For information, contact the Office of Postgraduate and Continuing Education, Yale University School of
Medicine, 333 Cedar Street, P.O. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578

H

Yale Medicine
P.O. Box 7612
New Haven, CT 06519-0612
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Discovering the Leeward
Islands
January 30-February 6, 1999

Faces
The Amazon and the Orinoco:
South America's Wild Rivers
April 2-17, 1999
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Found in translation
A cell is a cell is a cell, researchers say, as Drosophila, yeast
and other model organisms yield clues to human illness—
and increasingly suggest paths to improved treatments.
Translational research at Yale has been enriched by unusually
good crosstalk between basic scientists and clinicians.

page 14

By Neeraja Sankaran

Hl’HiHiliH
A vision for vision
Two years into his tenure as chair,
Bruce Shields is building a new
program around disorders of the retina
and tackling the financial challenges
presented by managed care. Against
this backdrop: spectacular work in
basic visual science, a new laser center
and other advances in treatment.

page 20
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Association of Yale
Alumni in Medicine

Yale should divest itself
of tobacco stocks

Early X-rays, continued

To the Editor:

Missing from the extended debate on

To the Editor:

It was discouraging to learn of the Yale

whether Yale or Dartmouth produced

Corporation’s April decision not to

the first X-ray after Roentgen (Letters,

divest its considerable holdings in

Summer 1998) is one significant piece

tobacco stocks. I urge the medical

of information.

school to lobby in favor of divestiture.
Physicians need to be more

Peter Spiegel wrote, “If Yale’s

the Dartmouth group, it remains un¬

hol and cigarettes. The late Dr. John

reported and unsubstantiated, at least

Knowles, former president of the

in the scientific literature.” In fact.

Rockefeller Foundation, said we could

Dr. Wright’s report was published in

cut the nation’s health bill by 50 per¬

the Feb. 1, 1896, issue of Engineering

cent if everyone stopped smoking

and Mining Journal and in Electrical
Engineer ot February 5.

My father graduated from the

Wright wrote an additional report

School of Medicine in 1934 and our

with more experiments in the March

family enjoys your magazine.

issue of the American Journal of

Edward T. O’Donnell Jr.
Wilmington, Del.

Longevity and talent

Nicholas M. Passarelli, M.D. ’59
President
Gilbert F. Hogan, M.D. ’57
Vice President

physicist, Arthur Wright pre-empted

outspoken about the dangers of alco¬

and drinking!

Officers

Science. It is ironic that Wright’s report

Peter N. Herbert, M.D. ’67
Secretary
Lycurgus M. Davey, M.D. ’43
Past President

Executive Committee
Frank R. Coughlin, Jr., M.D. ’52
Arthur C. Crovatto, M.D. ’54
Mary V. Digangi, M.D. ’64
John W. Foster Jr., M.D. ’71

antedated a report from Harvard by

R. Leonard Kemler, M.D. ’43

four days.

Robert J. Kerin, M.D. ’47

Raymond A. Gagliardi, MD '45, HS ’48-51

Francis M. Lobo, M.D. ’92

Historian, the American Roentgen Ray Society

Jocelyn S. Malkin, M.D. ’51

Bloomfield Hills, Mich.

Dwight F. Miller, M.D. ’56

To the Editor:
Romeo A. Vidone, M.D. ’57

Like Helen Langner (A Life of Engage¬

ment, Summer 1998), I grew up in

Class act

Ex-officio

Milford and know the Langner family.
While Helen was admired and re¬

To the Editor:

vered, she was not the only talented

Thank you for the most recent update

member of the family. Her “kid

on the traditional second year class

brother” Gustave, now 94, who was

show. It has been almost 30 years since

consulted for your article, is a com¬

the Class of 1972 performed in Guaiac

petitive swimmer and still wins senior

Positive to rave reviews. After all these

titles internationally. If Dr. Langner

years the memories of the skits, the

were of the modern generation, she

songs and the class shenanigans di¬

would probably say: “Our talent must

rected toward the “New Curriculum”

he in our genes.”

of 1968 stand out as some of the most

David Rosenbaum, B.A. '47
Milford, Conn.

David A. Kessler, M.D.

Director, Alumni Affairs
Daniel L. Arons, M.D. ’67
Chair, YSM Alumni Fund
Samuel D. Kushlan, M.D. ’35
YSM Bequest and Endowment Officer

unforgettable and enjoyable episodes

Representatives to the

of my Yale experience. (How often

Association of Yale Alumni

in a medical career does one get to

Martin E. Gordon, M.D. ’46

lampoon his professors, portray

Joseph F.J. Curi, M.D. ’64

immunologist Byron Waksman and

How to reach us

Dean
William K. Jenkins

Felix M. Freshwater, M.D. ’72

be applauded at the same time?)
Donald E. Moore, M.D., M.P.H. ’81

Yale Medicine welcomes news and com¬

Kudos and congratulations to the

mentary. Please send letters to the edi¬

most recent keepers of the tradition.

Benjamin E. Lyons, M.D. ’38

tor and news items to Yale Medicine, P.0.

Indeed, I hope that in 2028 the cur¬

Theoharis C. Theoharides, Ph.D. ’78,

Box 7612, New Haven, CT 06519-0612,

rent class can look back on this bond¬

or via electronic mail to ymm@yale.edu,

ing experience with their colleagues

and include a daytime telephone number.

with the same fondness and joy that

Submissions will be edited for length,

my classmates and I share now.

style and content.

Lawrence P. Temkin, M.D. '12, HS '72-77

M.D. ’83

AYAM Representative,
Medical School Council
Peter N. Herbert, M.D. ’67

Tucson, Ariz.
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SCOPE
For a world of emerging diseases,
a revived program in microbiology

T

Jorge Galan

hree decades ago, it seemed that modern medicine

Roy, Ph.D., and Norma W. Andrews, Ph.D., will

had virtually eliminated many infectious diseases.

carry out research on bacteria and parasites and

Armed with antibiotics, vaccines and a sense of vic¬

teach first- and second-year medical students. In ad¬

tory in the war against microbes, medical schools began to

dition, the new chair plans to apply for a training

look at the discipline of microbiology in a different light,

grant to further strengthen the microbiology track.

and in 1972 Yale joined others in disbanding its department.
By the 1980s, however, such deadly microbes as HIV,

Over the next few years, the section is expected to
grow to a total of six faculty members.
Caroline W. Slayman, Ph.D., deputy dean for

Ebola, Marburg, and Legionnaires’ disease surfaced to re¬
mind physicians that infectious diseases were still alive and

academic and scientific affairs and chair of the task

represented very real public health threats. Moreover, some

force that recommended the section, said Dr. Galan

of the older pathogens had developed resistance to drugs

was selected as chair because he is one of the world’s

that had once been effective.

leading researchers in the area of bacterial patho¬

With this in mind, faculty at the School of Medicine be¬

gens. “His selection,” she said, “reflects the feeling of

gan work several years ago to reestablish a formal program

the search committee that the real challenge is to

in the microbiology of infectious disease. In July, those

work with pathogens and study their interactions

plans came to fruition with the appointment of Jorge E.

with their host cells.”

Norma Andrews

Keith A. Joiner, M.D., professor of medicine and epide¬

Galan, D.V.M., Ph.D., as the first chair of a new Section of
Microbial Pathogenesis. Support for the program came

miology, and a member of the search committee, said Dr.

from The Esther A. and Joseph Klingenstein Fund Inc. and

Galan was recruited not only for his work in bacterial
pathogenesis, but also for his broad scientific perspective,

the Lucille P. Markey Charitable Trust.
“Times change,” Dr. Galan said in an interview. “With

which will facilitate interactions with colleagues in related

the new emerging infections, and with others making a

fields such as cell biology, immunology, epidemiology, in¬

comeback as you would expect in any kind of biological

fectious diseases and structural biology.
Dr. Andrews, a faculty member in cell biology for the

cycle, there is a new interest in infectious disease. I hope
that interest is here to stay.”

past four years, is an authority on parasite-host interactions.

Microbial Pathogenesis is the fifth autonomous section
at the medical school and the first created since 1988, when

Dr. Roy worked in the same department as Dr. Galan at the
State University of New York at Stony Brook and was re¬

the Section of Immunobiology was founded. Dr. Galan and

cruited to Yale to continue his research on bacterial patho¬

his colleagues will focus their research on the interactions

genesis. Using Legionella pneumophila as a medium. Dr. Roy

that occur between pathogens and their hosts, an increas¬

studies mechanisms by which bacteria subvert the normal

ingly rich and fruitful area of research. The section also will

functioning of human cells.

become the academic and administrative home to a fouryear-old graduate track in microbiology now administered

Dr. Galan believes the idea that infectious diseases will
one day be completely eradicated is mistaken. “We will

as part of the Biomedical and Biological Sciences Program.

never, ever be able to conquer infectious diseases,” he said.

The microbiology track, which has 25 students this year,

“We may learn how to deal with a given pathogen but even¬

was created in anticipation of the new section’s founding.

tually other pathogens will emerge. This is going to be a

Dr. Galan and his two colleagues in the section, Craig R.

battle forever, there is no question about it.”

mnunn

Physician associates
gain their master’s

The Class of 1999 will be the first

choosing other schools to get a

since the program started in 1971 to

master’s,” Ms. Grant says.

receive master’s degrees.
Starting next year, graduates of the

The change comes, says Elaine E.

Four years ago, in response to new
standards for accreditation, the cur¬

physician associate program will re¬

Grant, PA-C, M.P.H. ’92, assistant

riculum was amended to include re¬

ceive master’s degrees instead of the

dean and director of the physician

search methodology, biostatistics and

graduate professional degree now

associate program, as the profession

epidemiology. The 25-month course

awarded. The Yale Corporation

debates whether a degree or a title is

includes 10 months of classroom stud¬

approved the change in June in recog¬

more appropriate. Students themselves

ies and 15 months of clinical training.

nition of the program’s curriculum,

have made their preference clear. “We

For graduation, students must success¬

long considered to be of master’s level.

started seeing more and more students

fully complete 12 four-week rotations,

YALE

MEDICINE

3

Lyme disease vaccines prove effective

C

“Ticked off” about Lyme disease treatment:
While physicians discussed therapies, vaccines and
research at a Yale symposium on Lyme disease in

linical trials conducted at Yale

early June, several dozen people took to Cedar

over the past two years have

Street to protest what they called improper diagno¬

proven the effectiveness of two

sis and treatment of the tick-borne illness by Yale

Lyme disease vaccines—one developed

clinicians and researchers. According to the protest¬

by Yale faculty—the first such drugs

ers, who carried placards and distributed flyers say¬

of their kind. Advisory panels have

ing they were "ticked off” at Yale, medical school

now endorsed both vaccines and the

physicians minimize the severity and frequency of

pharmaceutical companies that own

the illness. “Many of us have gone undiagnosed and

the drugs are awaiting FDA approval

untreated because of the Yale protocol,” said

to begin marketing them.

Maureen Albertson of Bridgeport.

In studies at Yale and other centers

Physicians at Yale have maintained that many

involving more than 20,000 people

cases of Lyme disease cannot be verified. "Lyme dis¬

over two Lyme disease seasons, the

ease has become a magnet for people who do not

vaccines were found to prevent the

feel well," said Stephen E. Malawista, M.D., a profes¬

disease in a majority of cases. The Yale

sor of medicine and one of two researchers who

vaccine, LYMErix, was found to pre¬
vent 76 percent after three injections.

identified Lyme disease in 1975. “No one doubts
Stephen Malawista, left, and Robert Schoen

SmithKline Beecham has obtained ex¬

respond to reporters’ questions during a

clusive licensing to the Yale vaccine.

press conference on Lyme disease.

are suffering from Lyme disease. There is a differ¬
ence between hope or belief and hard clinical evi¬

ImuLyme, a vaccine developed

dence. A danger is that some other condition will be

by Pasteur Merieux Connaught of

borne disease in the United States,”

Swiffwater, Pa., was found to prevent

said Robert T. Schoen, M.D., clinical

Lyme disease in 68 percent of cases

professor of internal medicine and a

after two injections and 92 percent of

member of the team that studied the

cases after a third dose. Differences in

Yale vaccine.

efficacy between the two vaccines

that they are suffering. The question is whether they

Lyme disease was first identified by

ignored while the possibility of Lyme disease, how¬
ever remote, is being endlessly pursued.”

D.V.M., Ph.D. This work was sup¬

could be due to varying methods of

Yale researchers Stephen E. Malawista,

ported by grants from the National

surveillance. ImuLyme excluded

M.D., and Allen C. Steere, M.D., in

Institute of Health and the Centers for

people over 65, while LYMErix in¬

1975. The vaccine was derived from

Disease Control, as well as a generous

cluded all adult age groups.

basic research performed at the School

grant from the Mathers Foundation.

The results of the studies were

of Medicine by a team including

Both vaccines stimulate immune

published in the July 23 issue of The

Richard A. Flavell, Ph.D., professor

responses to produce antibodies

New England Journal of Medicine.

and chair, section of immunobiology,

against Lyme disease. The vaccines not

“These two studies demonstrate

Fred S. Kantor, M.D., the Paul B.

only provide immunity, but also may

that vaccination can be an important

Beeson Professor of Medicine, Erol

kill the spirochete, the bacterium in

new approach to preventing Lyme dis¬

Fikrig, M.D., associate professor of

the mid gut of the tick that causes

ease, which is the most common tick-

medicine, and Stephen W. Barthold,

Lyme disease.

which expose them to primary and

The Yale program’s first class of five

emergency care. To ensure that stu¬

students graduated in 1973; in August,

dents understand the profession they

36 students in the Class of 2000 began

11 grants awarded
to advance research
in women’s health

are entering, Ms. Grant said appli¬

their studies. Students learn to take

cants must have worked as emergency

medical histories, perform physical

medical technicians, nurses, hospital

examinations, order and interpret lab

The Ethel F. Donaghue Women’s
Health Investigator Program at Yale

volunteers, research assistants or medi¬

tests, diagnose and treat illnesses, assist

announced its first round of grants in

cal technicians or had other health

in surgery and counsel patients. “The

August for studies of women’s health.

care experience.

profession has been successful because

These are the first awards made since

Physician associates, generally

the generalist educational component

the program received a $6.5 million

known as physician assistants, are li¬

has allowed the profession to be flex¬

grant in February from The Patrick

censed health care professionals who

ible in fulfilling the health care needs

and Catherine Weldon Donaghue

work with physicians. In most states

of the country,” Ms. Grant said.

Medical Research Foundation. The

they are licensed to prescribe medica¬

“Physician associates have been able

new program was created to advance

tions and most work in primary care.

to shift as needs have shifted.”

women’s health research and develop
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new cutting edge areas of investigation

standing of the molecular mechanisms

edge will enhance the use of these

that will result in direct practical ben¬

of estrogen action, which may lead to

agents in clinical settings, and hope¬

efit for women.

development of improved estrogenic

fully improve the outcome of patients

substances providing more targeted

suffering from ovarian cancer.

variety of research interests in women’s

cardiovascular interventions for

► Marc Galloway, M.D., associate

health, and provide an exciting cor¬

women.

professor of orthopaedics and rehabili¬

nerstone for our program,” said

► Linda M. Bartoshuk, Ph.D., pro¬

tation, is investigating how to improve

Carolyn Mazure, Ph.D., professor of

fessor of surgery, will study burning

the surgical recovery of women

psychiatry and director of the research

mouth syndrome, an intense oral pain

athletes who undergo knee surgery.
Laboratory studies suggest that pain

“These projects represent a wide

program. “The funded areas of study

that afflicts about one in six post¬

address unanswered questions in

menopausal women. The study will

threshold and immune responses vary

women’s health and begin the process

identify and characterize those at risk,

according to the menstrual cycle.

of changing both the health and

and test a drug therapy which may

This study will determine if surgical

health care of women.”

provide effective treatment to ease the

outcomes can be improved by corre¬

pain of this syndrome.

lating surgical procedures with the

1998 DONAGHUE WOMEN’S HEALTH

► Priscilla S. Dannies, Ph.D., profes¬

time of the menstrual cycle. The study

INVESTIGATOR AWARD RECIPIENTS

sor of pharmacology, is seeking ways

will also examine differences in social

► Aydin Arici, M.D., associate pro¬

to improve the survival rate of women

support and adherence to exercise

fessor of obstetrics and gynecology,

suffering from ovarian cancer. Specifi¬

regimens for men and women, both

will study how estrogen protects the

cally, she will study whether certain

of which have been shown to influ¬

blood vessel walls from degeneration

estrogen antagonists combined with

ence the rate of recovery.

in women with cardiovascular disease.

chemotherapeutic agents can induce

The goal is to develop a better under¬

ovarian cancer cell death. This knowl¬

A high school link to the
Human Genome Project

had read about a researcher at the

W

Bruce G. Haffty, M.D., associate
professor of therapeutic radiology, is

to her students in March of 1997. She

University of Washington in Seattle
ith the help of a Yale geneti¬

who taught high school students to se¬

cist, some New Haven-area

quence chromosome fragments. That

high school students have

researcher put her in touch with Dr.

been advancing the frontiers of mo¬

Bonds here in New Haven. The ef¬

lecular biology. For the past year and a

forts of Dr. Bonds and Sister Paolella

half Yale geneticist Wesley Bonds Jr.,

have been incorporated into a course

Ph.D., has worked with the students

on biotechnology, with 11 students

from the Sacred Heart Academy in

this academic year. Those 11 students

Hamden and their teacher to teach

have learned to mentor students and

DNA sequencing. Since then the stu¬

teachers from urban and suburban

dents themselves have gone on to

high schools at the marathon sequenc¬

teach sequencing workshops to teach¬

ing days they offer twice a year. They

ers and other students, attended the

are also part of the High School Hu¬

International Conference on Gene

man Genome Project, a miniature of

ing that is part of the High School Human

Mapping and Sequencing and estab¬

the National Human Genome Project,

Genome Project.

lished what may be the country’s first

which is working to map all of the 3.2

high school gene bank.

billion pairs of DNA molecules that

systems usually approached in other

comprise the human genome.

ways. Because DNA sequences are now

“The students are getting a unique,
hands-on introduction to modern

“The same sequencing theories and

Wesley Bonds Jr. and Sister Mary Jane
Paolella, a biology teacher at Sacred Heart
Academy in nearby Hamden, Conn., have cre¬
ated an innovative course in gene sequenc¬

readily available over the Internet,

molecular biology,” says Dr. Bonds, an

problems in finding a gene are identi¬

Sister Paolella and Dr. Bonds believe

associate research scientist in genetics.

cal to the national project,” says Dr.

that many other high schools should

“DNA sequencing is the perfect way

Bonds. “The students are doing the

be able to involve themselves in geno¬

to introduce students to scientific

same things, but on a smaller scale

mics, even if they don’t have access to

experiments because it is repetitive

with less equipment.”

sequencing equipment themselves.

work and can be easily evaluated.”
Sister Mary Jane Paolella, a biology

DNA sequencing is a unique teach¬
ing tool, Dr. Bonds believes, in that it

“Our hope is to get other high
schools and universities working to¬

teacher at the school, first became in¬

allows students to use current research

gether to change the focus of high

terested in teaching DNA sequencing

techniques to understand biological

school biology,” says Sister Paolella.
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Trjir
trying to determine whether women

ance. Researchers suspect that female

who carry the genetic mutations

sex hormones increase disease suscep¬

medications to treat breast cancer, ease
the symptoms of menopause and

BRCAi and BRCA2 have a higher risk

tibility and progression in post-meno¬

prevent unwanted pregnancies.

of local recurrences in conservatively-

pausal women. Understanding of

treated breast cancer. The results will

body fluid regulation could lead to the

available to the worldwide research

provide information to women diag¬

eventual prevention or treatment of a

community through the Protein

nosed with early stage breast cancer

variety of chronic diseases that specifi¬

Data Bank at Brookhaven National

who carry the genetic mutations, so

cally affect women.

Laboratories on Long Island. Paul B.

they can make more informed deci¬

► Suzanne Swan, Ph.D., associate

Sigler, M.D., Ph.D., professor of mo¬

sions about options lor treatment.
Harvey Kliman, M.D., Ph.D., a

The Yale scientists’ data are

research scientist in the department

lecular biophysics and biochemistry,

of psychiatry, plans to study the

and his colleagues are the first to make

research scientist in obstetrics and

conditions under which women use

the structure of the estrogen-receptor

gynecology, is seeking predictors of

violence in domestic relationships.

complex available to scientists

successful embryo implantation in

Evidence suggests women become

through the data bank.

infertile couples. More than 10

violent in self-defense, out of fear,

percent of reproductive age couples

and as a response to violence perpe¬

comparison of the estrogen and

suffer from infertility, and in 20

trated against them; however, such

progesterone receptors binding—

to 25 percent of such couples there

action often results in more violent

prepared in collaboration with

is no proven cause. Implantation

retaliation. Dr. Swan hopes to

Yale graduate student David M.

success predictors are likely to lead

understand these patterns in order

Tanenbaum and postdoctoral

to a better understanding of the causes

to develop and implement domestic

associates Shawn P. Williams, Ph.D.,

of infertility in women and to

violence intervention and prevention

and Yong Wang, Ph.D.—was pub¬

improved efficacy and reliability

programs for women.

lished in the May 26 issue of the

of embryo transfer.

Viola Vaccarino, M.D., Ph.D.,

Dr. Sigler’s detailed atomic

Proceedings of the National Academy

assistant professor of epidemiology

of Sciences. A separate report by Dr.

sor ot pediatrics, is studying whether a

and public health, will study whether

Sigler and Dr. Williams on the proges¬

volunteer-based, home-visit program

women benefit from coronary bypass

terone receptor alone was published

can improve the health, social func¬

surgery to the same extent as men in

May 28 in the journal Nature.

tioning, and parenting of young in¬

terms of symptom relief and func¬

ner-city mothers. Trained volunteers,

tional and psychosocial recovery.

who will be matched with pregnant

This study will improve the ability

receptor and block the uptake of

women between the ages 15 to 25 who

of healthcare professionals to counsel

estrogen have been shown in recent

are receiving care at Yale-New Haven

female patients, enhance decision¬

studies to be effective in treating and

Hospital, will provide practical advice

making for women considering bypass

even preventing breast cancer. How¬

about parenting and meeting the

surgery, and develop interventions to

ever, even more effective estrogen

mother’s social and economic needs.

improve women’s recovery after

blockers could be created using the

Ihe study will determine if this type

bypass surgery.

three-dimensional, computerized

John M. Leventhal, M.D., profes¬

of intervention can improve the
success of these young mothers.
Mark J. Mamula, Ph.D., associate

These projects are led by Yale

Drugs such as tamoxifin and
raloxifene that bind to the estrogen

“snapshot” of the estrogen receptor

investigators with collaborators across

captured at Yale, said Dr. Sigler, a

departments and disciplines, in

Howard Hughes Medical Institute

professor ot medicine (rheumatology),

conjunction with researchers front

investigator at Yale. Tailor-made medi¬

is investigating systemic lupus erythe¬

other major institutions, and with

cations that improve the uptake of

matosus (SLE), an immunologic

the help of community clinicians.

estrogen instead of blocking it could

disease of unknown causes that afflicts

I he program will publish its second

help relieve menopausal symptoms.

primarily women. The study will

request for applications this fall.

“Our work with the progesterone

examine how specific cellular proteins

receptor has given us by far the

or antigens become targeted for attack

highest resolution, that is, the

by the immune system. Dr. Mamula
hopes to identify autoantigenic candi¬
dates that may initiate this autoim¬

Estrogen studies
yield hope of breast
cancer treatment

clearest look we have ever had, of

Yale University researchers have

X-ray crystallography, the researchers

mune cascade and provide a first step
for intervention in this disease.
Nina S. Stachenfeld, Ph.D., re¬

the chemistry that underlies a steroid
binding to its receptor,” said Dr.
Sigler. Using a technique called

visualized in atomic detail how two

generated an image of progesterone

search scientist in the John B. Pierce

important female sex hormones,

bound snugly in its receptor’s specific

Laboratory, is examining the actions

progesterone and estrogen, bind to

binding pocket at a resolution of

of estrogen and progesterone on the

their receptors—an accomplishment

1.8 angstroms, which is roughly the

systems that regulate body fluid bal¬

that could help scientists design better

distance between two atoms.
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Building a town-gown partnership, from high school
to medical school

Weighing privacy and
progress, Congress
considers limits on
patient data
Advances in genedc screening abilities
have put the medical world on alert

A

five-year collabora¬
tion between Yale
University and

about threats to patient privacy. In
August, Sen. Christopher Dodd, DConn., came to the medical school to
ask faculty about ways to ensure the

New Haven’s Career High
School entered a new phase
in September, as students
and teachers moved to a

privacy of genetic records.
Sen. Dodd, who is sponsoring leg¬

new building a few blocks
away from the medical cen¬

islation that would bar insurers and
employers from discriminating based

ter. The proximity, as well
as a new shuttle bus, will

on genetic predisposition to disease,
told reporters, “The last thing I would
want is any suggestion that we are try¬
ing to limit the importance of moving

bring students closer to the
anatomy classes they take
and their internships at the
medical school and Yale-

forward with genetic technology.”
Several faculty members who met

New Haven Hospital.
Career High—or Hill

with Sen. Dodd agreed. Maurice J.

Regional Allied Health and

Mahoney, M.D., J.D., prolessor of
genetics, pediatrics and obstetrics and
gynecology, pointed to the importance

New Haven Mayor John DeStefano visits a science lab on the first
day of school at the new Hill Regional Allied Health and Business
Career High School.

Business Career High
School, as the school will
be known in its new building—was

of the flow of information to physi¬

New Haven public schools. Medical

created in 1983 to introduce students

faculty and staff have advised Career

to careers in health, business and

staff on computer networks and

computer technology. Until this year

laboratory equipment. The new

the magnet school and its 450 students

school will have 650 networked

occupied a former elementary school

computers with links to the Yale

information within the profession,

on Wooster Square that was originally

computer network.

that is to the detriment of health care.

built to handle only 300 students.

cians and family members. “One has
to reach a balance,” he said. “We don’t
want to inhibit that kind of flow. If
we develop a culture in which we are
fearful of the consequences of sharing

“What’s exciting about the partner¬

The new 165,000-square-foot building

ship is that it goes beyond simply try¬

allowing medical information to flow

at 140 Legion Ave. opened this year

ing to inspire kids to become a physi¬

freely in the economic structures of

with 600 students. It will admit a full

cian or a nurse or researcher,” says

our society and government.”

complement of 750 next year.

On the other hand, I have fears about

The school’s relationship with

Sen. Dodd told the gathering,

Claudia Merson, Ed.M., Coordinator
of Career High School Partnership at

Yale began in 1993 when Career

the medical school. “We work with

to strike a balance here in pursuing

students came to the medical school

the faculty to provide opportunities

that, while, at the same time, offering

for anatomy lessons given by medical

for students to acquire the skills and

people some sense of security that this

students and William B. Stewart,

discipline they are going to need to

information is not going to be used to

Ph.D., associate professor of surgery

get there.”

deprive them of insurance or employ¬

and section chief for anatomy and ex¬

ment.” According to Sen. Dodd,

perimental surgery. Since then it has

has been the opportunity for every

discussions with constituents showed

grown into a multifaceted program

student to take advantage of at least

strong concerns about privacy. “The

that two years ago became a formal

one of a series of internships offered at

public response to that issue dwarfed

partnership. The School of Nursing has

the hospital and medical school. Stu¬

every other issue.”

provided mentors and internships, and

dents spend two days a week working

“It seems to me we ought to be able

“Another facet of the collaboration

medical library staff have trained teach¬

in a clinical or laboratory setting while

were patients and families concerned

ers in the use of the Internet. This past

gaining academic credit for their

about the potential economic and

summer 15 Career students participated

work. These internships give our stu¬

professional consequences of the

in a two-week program on the campus

dents the chance to apply and expand

genetic diseases they carry. Peter

of the medical school, living in

upon skills learned in the classrooms

Przybylski said his n-year-old daugh¬

Harkness Hall and studying biology

at a first-rate medical center,” says

ter Ashley has carbamoyl phosphate

and chemistry with faculty from the

school principal Charles Williams.

medical school, Yale College and the

“The kids love it.”

Also present at the press conference
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synthase deficiency, in which blood
ammonia levels can become lethal
without proper management. “I

Brain surgery, without opening the skull

would hate to see her have to take a
position based on her medical cover¬
age, as opposed to what she wanted
to do,” he said.

A new tool to combat
cocaine addiction

Neurosurgeons
Juan Bartolomei
and Alain

Yale researchers have found that a com¬

deLotbiniere

bination of medication and counseling

prepare the

can be effective in treating cocaine ad¬

gamma knife to
specify the pre¬

diction, a significant finding given the

cise location in

lack to date of any generally effective

the brain where
radiation will be

medication to treat cocaine depen¬

concentrated.

dence. The research also suggests a

By varying

promising strategy involving treatment

which of the

of those who abuse a combination of

helmet's 201
openings are

drugs, such as alcohol and cocaine.

plugged, sur¬

The study, led by Kathleen M.

geons exercise
fine control over

Carroll, Ph.D., associate professor of

the target

psychiatry, and researchers at the Sub¬
stance Abuse Treatment Unit at the
Department of Psychiatry, compared
different treatments for alcohol and

F

beams.

or decades neurosurgeons have treated diseases of the brain by beaming

cocaine abusing patients. Some pa¬

radiation inside the skull, sidestepping the need to cut through scalp and

tients received a combination of disul-

bone. The arrival ol a 30-ton gamma knife at Yale in July enables this

firam and one of three types of coun¬
seling while others received counseling

intricate form of brain surgery with a previously unmatched precision.
The Swedish-made gamma knife beams up to 201 gamma rays around a single

but no medication. Because most

point in the brain, letting the radiation accumulate on that point without

cocaine-dependent people also abuse

disturbing surrounding tissue. Individually, the rays do no harm, but when they

alcohol, the application of disulfiram,

converge on their target the concentration of radiation can destroy lesions,

also known as antabuse, could have

tumors and blood vessel malformations. Based at the Temple Medical Center,

broad implications in the treatment

the $2.9 million instrument :s the first of its kind in Connecticut and one of

of cocaine abuse. The researchers’

only 35 in the whole country.

findings were published this year in

Treatment with the gamma knile requires placing the patient in a fixed frame

Addiction. The National Institute on

that keeps the head absolutely steady during the procedure. Once ready, the

Drug Abuse sponsored the study.

patient lies inside the gamma knife for between 15 minutes and two hours.

The best outcomes in the 12-week
study of 122 people who abused both
cocaine and alcohol occurred among

The radiation treatment is accurate to within .3 millimeters. After the treatment
the radiation can take days or weeks to achieve the desired effect.
Because it is more accurate and easier to use, the gamma knife has largely

those who received both disulfiram

replaced its precursor, the linear accelerator which beams X-rays into the brain.

and psychotherapies which encouraged

The linear accelerator was accurate to within plus or minus 1 millimeter and

them to get involved in self-help

could take hours to do what the gamma knife does in minutes.

groups or taught them skills for coping
with situations in which they were
likely to use illicit drugs.
Alcohol dependence is often a prob¬

“With the gamma knife,” said Alain deLotbiniere, M.D., associate clinical
professor of neurosurgery and director of radiosurgery at Yale-New Haven
Hospital and of the Gamma Knife Surgery Center, “we can destroy abnormal
tissue very precisely without damaging adjacent normal brain tissue and without

lem among cocaine users, according to

subjecting patients to the trauma of surgery. The gamma knife enables us to

the authors. A 1990 study found that

destroy tumors in areas of the brain that are inaccessible to the surgeon’s scalpel

85 percent of those considered cocaine-

or so close to vital structures, such as the optic nerve, that surgery could irrepara¬

dependent also met standards for alco¬

bly harm normal brain tissue.”

hol abuse. Also, once use of both sub¬
stances becomes a pattern, it is hard to
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abstain from one without renouncing

The findings, published in the Aug.

childhood epilepsy. This study shows

both. Researchers have begun new

7 issue of Cell, were the result of obser¬

that Caspase-9 is essential for cell

studies to determine the best combi¬

vations of mice bred with defective

death and therefore gives new insight

nation of antabuse and counseling to

copies of the Caspase-9 gene. The

into how the brain develops in normal

reduce cocaine use and craving.

Caspase family of genes plays a role in

and pathological conditions.”

programmed cell death, called

A new strategy for stroke
and Alzheimer's?

In experiments with mice lacking

apoptosis, a necessary element of nor¬

Caspase-9, the investigators found

mal biological processes. “The balance

that the absence of the gene blocked

between cell production and cell death

neuronal apoptosis. Abnormal activa¬

is important for normal brain devel¬

tion of cell death is implicated in

Researchers at the School of Medicine

opment,” said Pasko Rakic, M.D.,

many human diseases and specific

have found that blocking an enzyme

SC.D., the Dorys McConnell Duberg

caspases have been linked to a handful

known to be involved in cell death

Professor of Neurobiology. “Too

of diseases. The research suggests that

could help treat Alzheimer’s disease,

much or too little cell death can cause

a therapy could be designed to stop

Parkinson’s disease, strokes and other

severe malformations leading to disor¬

Caspase-9 from triggering apoptosis,

age-related neurological diseases.

ders such as mental retardation and

thereby blocking cell death linked to

Dissecting the body with the click of a mouse

E

xploring the depths of the hu¬
man body is one of the hall¬
marks of the first year of medi¬

cal school. Through new computer
software that offers three-dimensional
views of human anatomy, Yale stu¬
dents can now dissect the body with
the click of a mouse.
The new computer teaching tool
provides a complement to standard
anatomy training in the cadaver lab.
Based on data from the National
Library of Medicine’s Visible Human
Project, the software called the Divis¬
ible Human allows students to view
three different images of the same

Anatomy professor William Stewart instructs students Ron Samet and Fred Cobey in the
use of Divisible Human software.

body part simultaneously on a com¬
puter monitor. “This is the first time
that the Visible Human data has been

said John A. Paton, Ph.D., director of

cross-sectional slice images of the ana¬

available in a form where students can

academic computing at the school,

tomy, at any orientation and in any

actually manipulate and learn some¬

describing the software developed by

combination. Although each slice im¬

thing from it,” said William B.

Shane Dunne, Ph.D., a computer

age is two-dimensional, the program

Stewart, Ph.D., associate professor of

scientist from Kingston, Ontario.

presents multiple slices in a three-di¬

surgery and section chief for anatomy

“It means people can explore much

mensional format which clearly illus¬

and experimental surgery. “What one

more effectively than they could

trates relative position and orienta¬

can do is pick a plane and dissect into

before.” Adds Dr. Stewart “This is

tion. Other commercial and academic

it. From the anatomist’s point of view

the way that in the future they will

software using the visible human al¬

one of the most critical skills you can

be viewing radiology.” Dr. Stewart is

low access only in two dimensions, in

teach students is how to reason and

the first anatomy instructor in the

standard orientations and much more

problem solve in three dimensions.”

country to use the software and also

slowly. And while most programs tend

“The difference in technology be¬
tween moving from plane to plane
and true animation is extraordinary,”

YALE

MEDICINE

has developed laboratory exercises to

to be difficult to learn, Dr. Dunne

use with it.

says his software is “as quick and easy

The new software allows access to

to use as a video game.”
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Personal warmth,
hostile slogans
for medical
delegation to Iran

O

n their arrival at a hotel in the
Iranian desert city of Shiraz,
members of a medical delega¬

tion from the West, including three
Yale physicians, were greeted by a ban¬
ner declaring, in English, “Down with
USA.” Inside the hotel, however, a
friendlier reception awaited. “You’re
from the United States?” the clerk

The delegation toured the ancient city of Persepolis near the desert city of Shiraz.

asked the physicians. “It’s nice to have
Dr. Finkelstein and Dr. Rastegar

you here.”

first met in Iran in 1978, when Dr.

The physicians were members of a
delegation sent by the International

Finkelstein was visiting on a three-

Society of Nephrology in March.

month exchange. Five years later, Dr.

It was the first exchange involving

Rastegar left when religious funda¬

nephrologists since the society spon¬

mentalists dismissed him from a uni¬

sored an exploratory trip three years

versity post. Over the past nine years,

ago. Other scientific exchanges are

however, he has made regular visits to

planned over the next two years.

Iran to maintain contact with Iranian
physicians and to see his family.

“There had been a lot ol concern

“Iranian scientists look to the

in Iran about scientific isolation,” said

United States and many of them have

Asghar Rastegar, M.D., associate chair
Members of the delegation in the lobby of

for academic affairs in the department

their hotel in Shiraz, where an unfriendly

of medicine, who three years ago

banner belied the warmth of the staff.

trained here,” he said.
Dr. Kashgarian offered a mixed
assessment of Iranian medicine. “The

made the exploratory trip on behalf of
the society. “The society then decided

quality of care is probably equivalent

to support scientific exchanges with

country, met with fellow nephrologists

to care anywhere in the West,” he

Iran.” The March trip was at the

and gave lectures at nephrology and

said. “Some of the facilities are not

invitation of the Iranian Society of

pathology conferences in Tehran

quite up to date. Their access to the

Nephrology and was timed to coin¬

and Shiraz.

latest drugs is more restricted.”

cide with their annual scientific
conference in Tehran.
The delegation included Dr.

Although a U.S.-imposed eco¬

The physicians said the Islamic

nomic embargo never barred scientific

regime’s dictates have changed the

exchanges, American academics have

teaching of medicine. The student

Rastegar, Fredric O. Finkelstein,

been reluctant to travel to Iran over

body is of mixed caliber, Dr.

M.D., clinical professor of medicine;

fears about conditions there and a

Kashgarian said, because it is divided

Michael Kashgarian, M.D., ’58, pro¬

perceived hostility towards Americans.

into students who compete for admis¬

fessor of pathology and biology; Saeed

The embargo has also denied the

sion and those who are admitted,

Fatenejad, M.D., assistant professor of

country the economic wherewithal to

under lower standards, because of

medicine; Bernd Sterzel, M.D., chair

import modern medical equipment.

links to religious or revolutionary

of nephrology at the University of

“Medicine in Iran has always

organizations. Also, because the

Erlangen in Germany. Also on the trip

been very sophisticated,” said Dr.

were Dr. Finkelstein’s wife, Susan H.

Finkelstein. “ There is an artistic tradi¬

the number of medical schools from

Finkelstein, M.S.W., an assistant

tion and education is really revered in

seven to 34 and the number of

clinical professor of social work and

Iran. The problem is the rigidity of

graduates from 800 to 5,000 each

psychiatry, and Dr. Sterzel’s daughter,

the Islamic government and the limits

year, the quality of education has

Fdannah. During their two weeks in

placed on Iranian access to knowledge

fallen, Dr. Rastegar said.

Iran, the physicians traveled about the

from the outside world.”

1 o

Islamic government rapidly expanded

The role of women in medicine has
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also changed because of religious dic¬
tates. Only women should examine

certain neurological diseases.
“When mitochondria, the energy

trary, the report acknowledges the
study yielded no evidence of harm or
abuse to patients.”

women, according to religious leaders.

factories of cells, are damaged,

As a result, more than half the medical

Caspase-9 is activated, leading to cell

students are female. They are expected

death,” said Richard A. Flavell, M.D.,

schools have been required to follow

For the past two decades, medical

to enter certain specialties such as ob¬

professor of immunobiology and biol¬

federal regulations for in-house insti¬

stetrics and gynecology, but Dr. Raste-

ogy, and one of the researchers. “In

tutional review boards. Any federally

gar noted that women also study neu¬

cells lacking Caspase-9 this damage

funded research involving human sub¬

rosurgery. “It has opened certain doors

did not give rise to cell death.”

jects must pass through several layers
of review by the school’s board.

and closed certain doors,” he said.

While Dr. Levine disagreed with

Medicine is not the only area
where women’s status has changed.
Ms. Finkelstein contrasted the oppres¬
sion she felt as a woman with the

Yale ethicist defends
safeguards in human
investigations

many of the reports’ findings, he did
agree with some recommendations for
improving the existing system. He
concurred that IRBs, in which partici¬

vibrant, intelligent Iranian women
she met there. On the plane to Iran,

Is the pace of medical advances mov¬

pation is voluntary, face tremendous

she said, women wore fashionable

ing beyond existing safeguards regard¬

workloads and would benefit from

Western clothing—until they entered

ing the use of human subjects in ex¬

greater resources. Requiring IRB re¬

Iranian air space. “Out came the

perimentation? A series of recent

view after funding has been approved

scarves and the coats,” she said, refer¬

federal reports to the U.S. Congress

would reduce the workload, he said,

ring to the clothing women, including

asserted just that. Responding to the

and ensure that research involving

foreign visitors, must wear in Iran.

reports, Yale faculty member Robert J.

humans has been reviewed. He also

Even in a Tehran hotel she was ex¬

Levine, M.D., told Congress in June

agreed that training for investigators

pected to cover all but her face every

that the present methods and guide¬

and IRB members is essential.

time she ventured outside her room.

lines employed by medical schools to

Some Iranian women, she said, turn

assure the safe and ethical use of hu¬

overworked and short of resources,

their clothing into a political state¬

mans in investigations are “working

he said, “By any standards of realistic

ment by including brighter colors

very well.”

than religious law permits or wearing

According to four reports recently

scarves looser than allowed. “Things

issued by the inspector general’s office

are loosening up a little bit,” she said.

of the Department of Health and Hu¬

“There really is a kind of cohesive so¬

man Services, the system designed to

ciety, wonderful family life, wonderful

protect human subjects in clinical tri¬

Although he described IRBs as

performance the IRB system works
very well.”

Children thrive when
fathers stay at home

food, a rich culture that people really

als has failed to keep pace with ad¬

enjoy and appreciate. There is a lot

vances in medicine such as gene

Fathers can play the traditional child-

there that is truly very positive.”

therapy. “Our total effort reveals a

rearing role of mothers with no detri¬

According to Dr. Rastegar, to

brittle system and even a few cracks,”

ment to the children, according to a

understand the attitudes of Iranians

George Grab, deputy inspector gen¬

12-year Yale study. The study, led by

one must place the events of the past

eral for evaluations and inspections,

Kyle D. Pruett, M.D., who presented

20 years in the context of the revolu¬

testified in June on his office’s year¬

his findings last December at the
American Psychoanalytic Society’s an¬

tionary changes that have occurred.

long inquiry before the House Gov¬

Although he is quick to acknowledge

ernment Reform and Oversight Sub¬

nual meeting in New York City, found

that Iran is not a democracy, he finds

committee on Human Resources.

that stay-at-home fathers raise “vital

that debate about the nature of politics

Not so, said Dr. Levine, a professor

and vigorous” children while enhanc¬

and society is more open than it was

of medicine and lecturer in pharma¬

ing their own capacities for intimacy

under the repressive regime of the Shah

cology, who testified in rebuttal on be¬

and self-regard. The study followed 18

Mohamad Reza Pahlavi. Television

half of the Association of American

Hispanic, white and African-Ameri¬

images of mobs storming the U.S.

Medical Colleges. Dr. Levine, who

can children from two-parent house¬

Embassy, however, have created a

chairs the Human Investigation Com¬

holds of various income levels.

“scar” that taints American perceptions

mittee at the School of Medicine, said,

of Iran and defines relations. “For the

the reports “created the impression

professor in the Child Study Center

American people to deal with that scar

that the IRB [Institutional Review

and psychiatry, the fathers initially

they had to demonize the people be¬

Board] system is a disaster just looking

feared they would become intellectu¬

hind it,” says Dr. Rastegar. “This can

for a place to happen.

ally bored and overweight, lose physi¬

only be broken if there is face to face

“It would be easy to infer there is a

According to Dr. Pruett, clinical

cal prowess and become more isolated

contact between individuals. This trip

systemic threat to patients,” Dr.

socially. They confronted problems

was a step in that direction.”

Levine testified. “Yet, quite to the con¬

such as a baby’s persistent crying by
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wondering whar their wives would do.
Then, according to the report, within

HIV drug resistance
an increasing threat

ing about antiretroviral therapy.
Researchers have identified
viruses resistant to the antiviral agents

io days to a few months later the fa¬
thers developed their own care-giving

Despite the clinical gains a new

longest in use, according to the

styles. The children thrived and, on

generation of AIDS medications

report. Current methods for detecting

average, exceeded norms on standard

have yielded, drug-resistant strains

HIV resistance may be inadequate

development tests, especially those

of HIV and the frequency of their

and resistance may be more wide¬

measuring problem-solving skills.

transmission increasingly threaten

spread than previously thought.

Researchers, who conducted biennial

public health efforts to thwart the

They also found that failure to adhere

evaluations over 12 years, reported

spread of AIDS, according to an

to just one of three medications in

no signs of intellectual or emotional

analysis co-authored by the director

a regimen can lead to a resistance to

trouble among the children. “They

ol the Yale AIDS Program.

all three.

felt a zest for life, were both assertive

“Prevention of both development

The authors call for increased

ol HIV drug resistance as well as

emphasis on adherence to medications

a vigorous drive for mastery and ex¬

transmission of drug-resistant variants

and population-based studies of the

pressed the usual childhood worries

is a central issue of public health im¬

prevalence, mechanisms and transmis¬

for boys and girls,” the report said.

portance,” wrote Gerald H. Friedland,

sion rates of drug-resistant strains

and comfortably dependent, showed

The fathers’ involvement stimulated

M.D., professor of medicine and epi¬

ol HIV. “In the meantime,” they

the emotional attachment that is vital

demiology and director ol the Yale

wrote, “prevention of both occurrence

to development of personality in the

AIDS Program, and Mark A.Wainberg,

and transmission ol drug-resistant

early years, according to the report.

Ph.D., of the McGill University AIDS

HIV is important in the public health

Center in Montreal. In their report,

arena. These subjects must be ad¬

in a variety of journals and lay publi¬

published in the June 24 issue of

dressed if antiviral therapy is to play

cations, including The Psychoanalytic

The Journal of the American Medical

its optimal role in blunting and alter¬

Association, the two sounded a warn¬

ing the course of the HIV pandemic.”

I he findings have been published

Study of the Child.

Seeing the whole person instead of the disease

T

racing the rise of medical tech¬

X-rays to peer inside the body without

nology from ancient examples of

violating it. But, he argued, technol¬

trepanation to the advent of the

ogy shifted emphasis from the patient

X-ray, John H. Lienhard, Ph.D., host

to the disease. “Handling a bedpan is

of a popular National Public Radio

no less essential to the healing process
than transplanting a human heart,”

science program, urged physicians to
look at the whole human rather than

he said.
The following morning Dr.

individual ailments. The keynote
speaker at the 50th annual meeting
of Associates of the Cushing/Whitney

Lienhard returned to the relationship
between technology and medicine at

Medical Library at Yale University

Grand Rounds in the Fitkin Amphi¬

on May 6, Dr. Lienhard spoke on the

theater. He praised computers and

dangers of reducing the person to an
illness during treatment. He is the
M.D. Anderson Professor of Mechani¬
cal Engineering and History at the

their use in medicine, but cautioned
Before giving his talk in the Historical
Library, John H. Lienhard, left, chats with
former deputy dean Arthur Ebbert Jr.,

that they affect human thought by
creating on a two-dimensional screen

professor emeritus of medicine.

what “the mind’s eye” once had to
imagine. Medieval architects, he said,

University of Houston.

Our Ingenuity, describes the way art,

designed Gothic cathedrals, not with

to the tough problem of curing the

technology and ideas have shaped

advanced mathematics or detailed

whole body instead of just pieces of

mankind.

drawings, but from a vision in their
minds. “See to it that your children in

“Medicine has to find its way back

it, ’ Dr. Lienhard said during his talk,

According to Dr. Lienhard, 18th

The Lesion Within: What Happened to

century physicians discovered how

public schools aren’t allowed to avoid

Medicine When 19th Century Ingenuity
Seized Upon an 18th Century Percep' v'V His radio program, Engines of

“specific disorders caused suffering

thought by pushing buttons,” he said.

and death” and in the 19th century

“Believe me, the eye of the mind is

physicians invented stethoscopes and

under attack.”
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GALLERY

A medieval
oculist
Bartisch’s manual of eye surgery shows
how far medicine has progressed.

F

rom glass spheres that magnify letters to laserdriven radial keratotomy that corrects myopia,
physicians through the centuries have sought

devices and procedures to protect, restore and improve
sight. Not all their ideas worked—ophthalmologists
enjoyed a dubious reputation as “eye-destroyers” during
the Renaissance—but one of their number, Georg
Bartisch, wrote and illustrated what would be hailed
as the first modern work on eye surgery.
Published in 1583, Augendienst includes 91 woodcuts
based on drawings by Bartisch that illustrate ailments
and their treatments in often gruesome detail. The
woodcuts show not only ophthalmological procedures
prevalent in the Renaissance, but the latest fashions in
waistcoats, caps, jewelry, coiffures and other finery. The
author served as oculist, the medieval term for ophthal¬
mologist, to the court of Lord Augustus I of Saxony and
was the first eye surgeon to practice extirpation of the
bulbus in cancer of the eye.
A copy of the book, from its original printing in
1583, is part of the legacy of neurosurgeon Harvey
Top right The medieval volume Augendienst by royal oculist Georg

Cushing, M.D., who bequeathed it to the library with

Bartisch of Saxony described many ophthalmological procedures,

his collection of historical medical volumes. Also in the

including a method of removing a cataract. A needle should be drawn
across the pupil and uvea, he wrote, and then the cataract pushed
out of the way as shown on the right hand side of the drawing.

Above Bartisch went on to recommend that the patient be seated
lower than the surgeon, braced by an assistant. Prior to the
surgery, the patient should be purged and abstain from drink and
“conjugal deeds.”
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library’s collection are assorted ophthalmological tools
from the past, including wood and leather cases contain¬
ing antique scalpels for removing cataracts and refraction
lenses for measuring vision.
—-John Curtis
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DISCOVERY

Found in

tram

Studying the genetics of fruit flies, nematodes
and other model organisms may greatly speed
the search for cures for human disease.

By Neeraja Sankaran

8

o.

z

i
The collaboration of Allen Bale, left, and Tian Xu has led to a new
understanding of basal cell carcinoma, the most common form of
skin cancer.

W

hen cancer researcher Alien Bale, M.D., and
his team discovered a gene associated with the
development of basal cell carcinoma in 1996,
he decided that if he really wanted this new knowledge
to help his patients, the thing to do was learn more
about fruit flies. So the associate professor of genetics
and medicine and director of the DNA Diagnostics
Laboratory went to work studying the genetics of
Drosophila melanogaster in the laboratory of his genetics
department colleague Tian Xu, Ph.D,
Until less than a decade ago, Dr. Bale’s move from
humans to Drosophila would have seemed startling.
“Those connections just weren’t made,” he says. “People
were working on fruit flies and people were working on
humans, but they weren’t working on both/’ Today,
moving between species has emerged as an increasingly
necessary part of scientific research and an ever more
common path at Yale. The result in Dr. Bale’s case was
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that he was able to open up entirely new ways of looking
at the most common form of skin cancer in humans.
Although Dr. Bale’s laboratory had found a link
between the occurrence of basal cell carcinoma and the
gene—which they named NBCCS (for nevoid basal cell
carcinoma syndrome)—they had no idea how this
association gave rise to the cancer. Moreover, its function
in a normal human ceil was a complete mystery. With¬
out this information, it -was virtually impossible to assess
how the cancer might be triggered through the workings
of NBCCS. Pinpointing the function of a single gene in
humans would be a monumental and expensive task. So
Dr. Bale turned to Dr. Xu and Drosophila melanogaster,
the tiny fruit fly.

Neeraja Sankaran is a first-year graduate student in the
History of Medicine program.
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By comparing the genetic se¬
quence of NBCCS against other

Cell biologist Peter
Novick works in

previously identified genes of the

yeast, left, to draw

fruit fly, Dr. Bale eventually was

lessons about human

able to find that it was structur¬

function. “The funda¬

ally similar to a gene called

that makes a cell a

Patched. Patched was known to

cell,” he says, “is es¬

mental machinery

sentially the same in

produce a protein that controls

all living organisms.”

the development of distinct ante¬
rior and posterior segments of

Below Michael Stern's discoveries in the
species of worm known as C. elegans have

the fly. Using this information,

had important implications for understand¬

Dr. Bale had the key he needed

ing how cancers grow. The top image

to direct his own investigations

shows a normal worm; the smaller one

into the human version of the

controls the migration of muscle cells.

below has mutation in the gene that

gene. “Once we could show the human gene was similar

similarities among species—from single-cell organisms

to Patched," he says, “we knew what other genes it would

to humans-are far greater than the differences.

be likely to function with.” The NBCCS gene is now

By understanding the genetics of the simpler organism,

widely recognized as the key gene that causes basal cell

investigators believe they can identify and understand

carcinoma. Moreover, researchers have found that muta¬

the functioning of the shared genes in humans. Translat¬

tions in these other genes are also responsible for other

ing the complex activities of human genes into the

cancers. Dr. Bale’s laboratory is now looking at the ways

activities of similar genes in simpler species makes it far

existing medicines for basal cell carcinoma affect the

easier to interpret the biology of humans and especially

Patched gene in hopes of coming up with more effective

human diseases.

treatments and, one day, a cure.
Dr. Bale’s approach—to switch hunting grounds
from the human genome to that of the fruit fly—is an

“Simple cells have much to teach us,” says Carolyn
Slayman, Ph.D., a geneticist who is deputy dean for
academic and scientific affairs at the medical school.

example of an ever-increasing trend within the medical

“It is becoming increasingly clear that the basic pathways

community to use simple model systems to learn about

of cell growth and development arose very early in

the function and behavior of our own genes. Transla¬

evolution and have remained virtually unchanged since.”

tional research, as this growing body of work has come

The increasing availability of genome sequence informa¬

to be known, is based on the notion that the genetic

tion coming in from all over the world has provided a

i6
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major impetus for the recent explosion in translational

organism with its counterpart from another. Moreover,

research. Scientists now believe that some 80 percent

experimentation on humans in most of these cases is

of all human genes appear to have a functional counter¬

simply not feasible, making animal models a necessary

part in the fruit fly. The nematode Caenorhabditis

substitute. Using animal models can vastly speed up re¬

elegans, whose genome size is comparable to Drosophila,

searchers’ capacities to analyze new genes and mutations

and even the single-cell yeast Saccharomyces cerevisiae are

associated with a huge range of human diseases. The

some other widely used model organisms for which most

savings can be tremendous. Where the estimated time

genes have human equivalents.

and cost for the completion of a genetic experiment on

The resemblance goes beyond mere structural simi¬

a mammalian system might typically run one year at a

larities of genes to entire networks and pathways inside

cost of $10,000 and take about five to io technicians,

the cells of different organisms. Like jigsaw puzzles that

the same test on C. elegans or Drosophila systems can

become more difficult and time-consuming as the

take a single person a matter of weeks to complete at a

number of pieces increases, complex organisms contain

fraction of the cost.

more genes than simpler organisms do. But the links be¬

“As recently as io years ago we only had indications

tween these pieces appear to be the same. So by learning

that the mechanisms used by these different organisms

how the pieces fit together in simpler puzzles, scientists

were related, but this is now an established fact,” says

are putting together a map to guide them through the

Michael Stern, Ph.D., associate professor of genetics in

labyrinth of human genetics as well. “The fundamental

the Boyer Center for Molecular Medicine and a pioneer

machinery that makes a cell a cell is essentially the same

in demonstrating the importance of those relations.

in all living organisms,” says cell biologist Peter Novick,

During his postdoctoral research at the Massachusetts

Ph.D. “If one can understand the basic working of a

Institute of Technology, he studied the migration of

simpler system such as the yeast, then the rest is just a

post-embryonic precursor muscle cells to their eventual

matter of specialization.”

locations in the adult nematode. After he arrived at Yale,
he learned that SEM-5, a gene product of one of the

A SIMPLER APPROACH

crucial members of this pathway, looked much like a

The high degree of evolutionary conservation among

protein known to be important in human cell-to-cell

all species allows scientists to substitute a gene in one

communication. Probing into the sequence and struc-

From worms and yeast, clues about human disease

A %,

Model System

Gene

Human Homologue

Function

Potential disease target

Yeast

SEC 4

Rab

Molecular switch to control
membrane traffic

Blindness

Saccharomyces
cerevisiae

GDI

GDI

Localization cycle necessary
for polarization

Mental retardation

Nematode

sem-5

GRB2

Cell-to-cell communication

Cancer

Fruitfly

Drk

GRB2

Cell-to-cell communication

Cancer

Drosophila
melanogaster

Hif-1

Human Hit analog

Activation of p53 oncogene

Hypoxia

Lats

Human Lats

Tumor suppression

Cancer

Myosin V

Myosin V

Cytoskeletal rearrangement

Gricelli’s disease

Patched

NBCCS

Distinguishes anterior and
posterior segments in the
developing fly

Basal cel! carcinoma syndrome

Caenorhabditis
elegans

cure of the gene, Dr. Stern found that the gene bore a

researchers around Yale. Much of the credit goes to Dr.

remarkable resemblance to a human gene called C1RB2

Xu, who is an associate professor of genetics in Yale’s

(Growth factor Receptor Binding protein) and also to a

Boyer Center and an assistant investigator in the

fly gene named Drk.
The finding was useful in learning about the conser¬

Howard Hughes Medical Institute. In his own work, he
employs fruit flies and mice to understand the molecular

vation of these pathways among different species, and it

mechanisms of human diseases. With a new genetic

also had important implications for understanding how

approach that he developed during his postdoctoral

cancers grow. Further investigation showed that these

research at the University of California Berkeley, Dr.

genes helped activate the human ./for gene, which is

Xu developed fruit fly models that develop tumors and

found to be mutated in some 30 percent of human can¬

neurodegenerative disease. He then demonstrated that

cers. What was perhaps most surprising of all was that

mice and humans also contain homologues of the fly

either the human gene or the fly gene could functionally

genes that he identified, and that mice lacking these

replace the worm gene. “This underscored the remark¬

genes also develop these diseases. These models, Dr. Xu

able conservation of entire pathways that are important

says, are useful not only to study the function of known

for cellular communication,” says Dr. Stern. “The know¬

proteins, but also to discover important regulators not

ledge that we gain about how these pathways work in

yet revealed by other methods.

both systems can now be used to derive a comprehensive
understanding of the pathway in humans. This will help

OXYGEN AND THE BRAIN

us put together the pieces of a jumbled genetic puzzle

Cancer is not the only domain in which translational

that we didn’t know would fit together so elegantly.”

research holds promise. Gabriel Haddad, M.D., chief of

By moving genes from one model organism to an¬
other as Dr. Stern is doing, investigators can get an ever

respiratory medicine in the Department of Pediatrics,
frequently sees children experiencing breathing difficul¬

more precise understanding of the fundamentals of cell

ties and associated problems due to respiratory ailments.

life and, from there, cell dysfunction and human disease.

Also a professor of cellular and molecular physiology, he

This multi-lane, two-way street between humans

has long been exploring how and why the different types

and simple models has become a familiar path for other

of cells in the body respond differently to a lack of oxy¬
gen. “Nerve cells in particular are sensitive to oxygen
deprivation,” he says. “The brain for example will suffer
irreversible damage if the oxygen or blood supply is cut
off for even five to 10 minutes. In contrast, the cells of a
newly born animal and cancer cells show considerable
tolerance to the lack of oxygen.”
In the hope of developing ways to prevent or
minimize the damage to brain cells under conditions of
hypoxia (low oxygen), such as happens during a stroke,
Dr. Haddad began to investigate the molecular pathways

- tl.

Gabriel Haddad, left, turned to the Xu lab to learn about Drosophila
genetics in an effort to better explain how nerve cells respond to
oxygen deprivation. The research relates directly to stroke and
respiratory disease. Above: Drosophila chromosomes taken from
the salivary glands.
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triggered by these conditions. “We were able to carry out
some tests in tissue cultures but in order to understand
the true progression of events we needed living systems,”
he recalls. He began his studies on a species of turtle able
to withstand oxygen deprivation for several months.
His aim was to understand how its cells could withstand
such a long period without oxygen. While these animals
were useful for figuring out some of the physiological
aspects of tissue hypoxia, they were not easily amenable
JOHN CURTIS

to advanced molecular approaches. Consequently, he
considered alternative models. Six years ago, he began
looking into the Drosophila system. “It not only had
the advantage of being an ideal genetic system,” he
says, “but also was extremely tolerant to hypoxia—

Lynn Cooley’s study of the
development of the fruit fly

demonstrating the ability to recover even after hours

cytoskeleton has fundamental

of oxygen deprivation.”

implications for cancer
metastasis.

A clinician by training, Dr. Haddad needed to
broaden his knowledge. Like Dr. Bale, he turned to Dr.
Xu’s lab to learn the practicalities of working with the
fruit fly before launching a full scale investigation in
his own laboratory. He is now investigating the hypoxia

been identified. “Once we are able to see what a gene

response on the fruit fly model via a number of

does in the yeast,” says cell biologist Dr. Novick, “we

approaches. He explains: “One of the methods is to

can apply principles of reverse genetics to look for the

try and identify genes that help the flies recover from

function of the homologues.”

oxygen depletion. To this end, we have selected for

Dr. Novick’s own research explores the mechanisms

mutants that are highly sensitive to oxygen deprivation

by which the yeast cell secretes different proteins from

and we are zooming in at the moment on a few muta¬

specific locations on the cell membrane. “This property

tions that produce this effect.” His laboratory is also

of cellular polarization has very obvious relevance in cells

trying to identify similar genes in the mammalian and

like neurons and epithelial cells,” he says. “For instance,

human genome. “Given the fact that flies and mammals

if an epithelial cell in the lining of the digestive tract were

have very similar genes for so many different functions

to secrete the enzymes in the wrong direction, you would

such as ion channels and embryonic development, it is

destroy your own tissues rather than digest the food.”

quite likely that they will also share genes in pathways
that are relevant to oxygen deprivation.” Eventually, Dr.

To date, his investigations in yeast have turned up
more than a dozen genes with human homologues for

Haddad envisions the development of biochemical

polarization alone. Six of these genes are produced as

therapies for stroke and other conditions that could

one big complex, which have been found to be involved

induce anoxia tolerance in human cells to minimize

in the polarization of cells in the lining of the kidney.

damage in sensitive areas of the body.

Mutations in other proteins that interact with these

Basic researchers also find they can benefit from

gene products have been implicated in diseases such as

switching between model systems. Lynn Cooley, Ph.D.,

retinal degeneration leading to blindness and one form

associate professor of genetics, studies the building of

of mental retardation.

the cytoskeleton during development in fruit flies. Her
findings may have fundamental implications in under¬

What of the future? By all indications the different
model systems continue to yield useful results with

standing the behavior of cancer cells in humans, because

increasing relevance to many human diseases. Says Dr.

they undergo significant rearrangements in their struc¬

Slayman: “These days a researcher who finds a new

ture during the growth and metastasis of a tumor. “To

human gene will immediately look for homologues

understand the underlying biology,” she says, “one really

in fruit flies, yeasts or nematodes where functional

has no choice but to turn to a model system.”

experiments are much easier. Conversely, a scientist who

Even the most basic, one-cell organism shares fun¬

finds a new yeast or nematode gene will rush to find a

damental genetic properties with humans. The complete

human homologue which may offer a clue to a known

yeast genome sequence is now available. Furthermore

human disease.” Its all there, it seems, if only the right

most of the expressed genes of mammalian cells have

translations can be found. DEI
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A vision for vision
With new emphasis on retinal disease, research and the community,
Yales ophthalmology departmentfinds its focus.

N NOVEMBER 1996, when Bruce Shields arrived

among community ophthalmologists, Yale-New Haven

as the new chair of the Department of Ophthalmology

Hospital and the School of Medicine led to the estab¬

and Visual Science, he had his work cut out for him.

lishment this summer of the Yale-New Haven Eye Laser

While Yale remained a world leader in vision research

Center, which specializes in refractive surgery to correct

and the treatment of glaucoma, the department had sig¬

nearsightedness and astigmatism. The department has

nificant problems to solve. With the advent of managed

transformed its residents clinic—a concept that has be¬

health care, reimbursement rates for clinical services

come outmoded in modern academic medicine—into a

were dropping, with no end in sight. At the same time,

comprehensive eye service that has solved part of the pri¬

insurers began moving to redirect all but the most com¬

mary care-referral problem while eliminating a two-

plex eye-care cases back to primary care physicians. Fac¬

tiered system that had channeled indigent patients to the

ulty had to increase their patient load to compensate for

care of physicians-in-training. Another initiative has

the reimbursement deficit, and the more difficult

been the establishment of a low-vision center to offer

caseload had begun to cut sharply into teaching time.

practical help to patients whose poor vision cannot be

“Ophthalmology,” says Dr. Shields, “was hit as hard as

improved. Meanwhile, Dr. Shields is cultivating alumni

any specialty.”

of the residency program to increase their involvement

Meanwhile, the future of funding for all biomedical
research was under fierce debate in Washington. As aca¬
demic medicine faced its most serious challenges in de¬

in departmental activities, enhancing continuing medi¬
cal education, and devoting time to fund-raising.
An authority in glaucoma like his predecessor, Dr.

cades, the ophthalmology department was without per¬

Shields speaks enthusiastically about maintaining excel¬

manent leadership. Two acting chairs forged ahead as

lence in glaucoma research and specialized care. His own

Yale searched for a successor to glaucoma pioneer

research has been devoted to the development of new la¬

Marvin Sears, who had stepped down as chair in 1993.

ser treatments for advanced forms of the disease. Focus¬

Two years after Dr. Shields’ arrival, the department

ing on retina, too, makes sense not only financially, he

still faces challenges but a plan is in place. Faculty have

says, but also in terms of public service. “When we

worked together to define a concise mission for the de¬

talked with ophthalmologists in the community, one of

partment, which has launched new programs and re¬

their messages was that Yale should strive to offer ser¬

cruited promising young faculty to its ranks. One of Dr.

vices that aren’t readily available elsewhere,” he says.

Shields’ first decisions was to strengthen Yale’s expertise

“Glaucoma and disorders of the retina are two major

in retina care and research, with the goal of creating a

disciplines in ophthalmology that account for most of

world-class program as the department has done with

the blinding disorders in this country. They also repre¬

glaucoma since the 1960s.

sent areas of significant technological advances and the

Other new programs are in the works. Cooperation

2 O

promise of better care.”
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The retina
From the smallest infants to the oldest patients,
new approaches to retinal disease are
repairing disorders of this delicate layer
of sight-giving tissue.

By Julie Miller

B

orn more than three months prematurely in April
1997, twins Rosalie and Alexander Comfort
weighed a pound and a half each, suffered from
respiratory distress and faced the serious possibility of
losing all or most ol their sight. Along with their early
delivery at only 24 weeks came exposure to a rare condi¬
tion known as retinopathy of prematurity, in which
normal formation of blood vessels in the retina is
interrupted. “The worst case,” says their father, Tim
Comfort, a chief petty officer in the Navy, “was that
they would be able to see only shapes. The best was that
with surgery, they would have very good, useable vision.”
Until recently, little could be done to prevent retin¬
opathy of prematurity, or ROP. Although 80 percent of
cases typically resolve themselves without intervention,
more than 500 infants a year are blinded by this disorder,
in which the retina can be torn from its base by the pres¬
sure of rampaging capillaries. But with better screening
in place, physicians are able to identify most infants at
risk for the syndrome and prepare for a critical 72-hour
window in which preventive treatment can be given.
In the Comfort family’s case, that moment came in
late July 1997, when their ophthalmologist in New
London saw the first signs of impending retinal detach¬
ment and referred them to Yale. Two days later, associate
professor Kathleen Stoessel, M.D., performed a proce¬
dure called cryopexy on the tiny infants, then only
eight weeks old and still a month shy of their due date.
One of several tools in the ophthalmologist’s arsenal,
cryopexy freezes the rear portion of the retina, causing
the threatening vessels to shrivel harmlessly away. The
twins left Yale for Lawrence and Memorial Hospital in
Julie Miller is a writer in North Stonington, Conn.

New London, and returned home to rural Uncasville,
Conn., soon after with their sight intact.
The retina, a critical link in the complex chain that
turns light into sight, is the thin layer of tissue that
generates nerve impulses from the stimulus of light and
dark. When all is in good working order, words on a
page or the view from our window reach the brain with
perfect clarity. When retinal problems arise, the cause
most often is the abnormal growth of the minute blood
vessels within the retina. While not all cases are revers¬
ible, many once-discouraging cases respond to advanced
techniques being applied at Yale, including cryopexy and
laser surgery. Moreover, new diagnostic tools such as
digital angiography are enabling ophthalmologists to
diagnose retinal disorders earlier and more precisely than
ever before—and to intervene before sight is lost.
More than any other group of vision disorders, reti¬
nal disease affects patients along an extremely wide span
of ages. Retinopathy of prematurity affects tens of thou¬
sands of infants born in the United States every year, al¬
though it spares most of them the loss of sight. Diabetic
retinopathy, which is more widespread, is the leading
cause of serious visual impairment among Americans be¬
tween the ages of 20 and 64. And age-related macular
degeneration is the chief cause of moderate to profound
visual loss among adults over age 60 in the United States.
►
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Facts about vision loss
►

Almost all blindness in the United States is the
result of common eye diseases. Less than 3
percent is the result of injuries.

►

100 million Americans are visually
disabled without corrective lenses (70
million are myopic). 14 million have
severe visual conditions not
correctable by glasses.

►

80 million people in the United
States alone are afflicted
with potentially blinding eye
disorders and the majority
are visually disabled
without glasses.

►

12 million are handicapped
by motor sensory diseases
such as amblyopia and
strabismus.

►
Retinal disorders, which are among the leading causes of blindness in
the United States, span the generations from infancy to the later years
of life. Twins Rosalie and Alexander Comfort, top right, were born with
retinopathy of prematurity while Theresa Kalman, above, developed the
disease in midlife as a complication of diabetes. Eighty-six-year-old
Hazel Swift, top left, was treated by Kathleen Stoessel for macular
degeneration.
Right The retina lines the inside of the eyeball with photoreceptive
cells, known as rods and cones, that convert light into nerve im¬
pulses. The macula distinguishes fine detail at the center of the
field of vision.

11 million experience corneal
disorders including
herpes and dry eye.

►
►

►

5.5 million have cataracts
that obstruct vision.
2.8 million are colorblind.
2.3 million endure visual loss from
inflammatory diseases such as uveitis.

►

1.1 million are legally blind.

All statistics refer to United States
Source: Research to Prevent Blindness
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IN MIDLIFE, AN ASSAULT FROM DIABETES

The Comfort children’s bout with retinopathy demon¬

grandson’s face. “It was amazing,” she says. “I cried.”
Faser and surgical treatments have reduced the

strates the fragility of the retina early in life, when

incidence of legal blindness in patients with severe dia¬

immature vessels are most at risk for disturbance. In

betic retinopathy from 50 percent to less than 5 percent,

midlife, retinal disease occurs most often among people

Dr. Pieramici notes, adding that Yale helped develop

with diabetes. Excessively high blood-sugar levels can

many ol the advanced laser techniques during the past

damage small blood vessels in the eye, particularly in the

20 years as a center for clinical trials. In addition, trials

retina, says Dante Pieramici, M.D., assistant professor of

are being designed for surgical techniques to treat

ophthalmology. Some of the blood vessels close com¬

patients with chronic swelling of the retina that fails

pletely, while others leak fluid or blood into the retina.

to respond to laser treatment.

The retina becomes wet and swollen and fails to work

As remarkable as these interventions are compared

properly. New vessels grow abnormally in the places

to what was available to patients only a few years ago,

where others have closed, causing further bleeding, scar¬

the laser is still an invasive tool and can damage the

ring and retinal detachment that can result in blindness.

retina. As molecular biology provides more tools for

In some ways, this process is a mystery. “We don’t

drug development, ophthalmologists are hopeful that

know the actual connection between diabetes and dis¬

new medications will provide less damaging ways of

ease of the small blood vessels. What we have learned is

treating abnormal blood vessel growth.

that keeping tight control over blood sugar levels signifi¬
cantly reduces the chances of diabetes complications in

A PUZZLE OF THE AGING PROCESS

the eye, and if you have complications already, it reduces

One day four years ago, Hazel Swift noticed a blurring of

the chances ol their becoming worse,” Dr. Pieramici says.

vision in her left eye. When an exam revealed swelling in

Theresa Kalman was not prepared lor the damage

the macula near the center of the retina, Mrs. Swift, now

diabetes did to her eyesight. The 53-year-old woman, who

86, went to see Dr. Stoessel. An angiogram confirmed

also has cardiovascular and kidney problems, awoke one

the presence of an abnormal blood vessel in the macula,

morning unable to see. Her only warning had come the

the area responsible for central vision and the sharp,

day before, when vision in one eye was cloudy. For the

fine-detail sight that is crucial to reading and driving.

next several months, family members helped her negoti¬

Age-related macular degeneration is the most com¬

ate a suddenly unfamiliar house and tend to the daily

mon cause of vision loss among people over 65. In Mrs.

necessities of living. A series of visits to local doctors pro¬

Swift’s case, the presence of the abnormal blood vessel

duced no clear explanation for the sudden loss of sight.
Dr. Pieramici’s diagnosis was severe diabetic retin¬
opathy in both eyes. He surgically removed a portion of

indicated the more destructive “wet” form of the disease
in her left eye. “Dry” macular degeneration was diag¬
nosed in the right. In the wet form, errant vessels from

the vitreous gel, along with the abnormal blood vessels

the wall of the eye make their way through the pigment

and scar tissue. Once cleared of debris, the retina could

layer and can slip under the retina. The vessels leak fluid

be reattached. The surgeon also removed a cataract and

or blood around the macula and damage sight. The hall¬

placed an artificial lens in one eye. While the chances for

mark of the more common dry macular degeneration Is

partial success were good, he says, “We weren’t sure how

the atrophy of pigment cells, which appears as yellow

much vision she would get back. We had to see how

spots in the retina.

much damage there was to the retina.”
Mrs. Kalman’s recovery was the happy kind. Several

During the delicate laser surgery that followed, Dr.
Stoessel cauterized the abnormal vessel in Mrs. Swift’s

days after surgery, she could see well enough to read,

left eye in an attempt to prevent further damage. But

watch television and care for herself again. For the first

over the past several years, additional laser treatments

time in five months she saw her 16-month-old

►
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Retinopathy and
macular degeneration
A normal eye, far left, is compared to those
damaged by diabetic retinopathy, middle,
and macular degeneration, left. Errant blood
vessels in the patient with diabetes leak fluid
or blood into the retina, threatening sight.
In macular degeneration, injury to the macula
appears as a sea of small yellow spots.
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Lessons from the lab
From the eyes of newts to the green glow of the jellyfish,
clues to the mystery of sight.

F

'ifty years ago, a Yale scientist named Leon

Stone made a remarkable discovery about
the vision of newts. If the eye is dislodged

and then reattached, the retina not surprisingly
is destroyed. But in the newt, unlike humans,
the cells of the retina grow back and sensitivity
to light returns. Dr. Stone’s newts could regen¬
erate retinal cells even when the eyes were com¬
pletely removed and then put back.
Why should newts regain their sight while
humans and other mammals lose it forever to
injury or disease? What other clues
from simpler organisms might there
be to lead us to new treatments for
vision loss? And on a much more ba¬
sic level, how is it that we are able to
convert the patterns of a million pho¬
tons into images in our mind’s eye?
These questions drive the work of
the Visual Neuroscience Program at
Yale, where basic scientists pursue
knowledge that may some day provide
new and better treatments for retinal

Colin Barnstable, director of research at the Yale Eye Center, is apply¬
ing molecular tools to a discovery made 50 years ago by Yale anato¬
mist Leon Stone, left. Stone’s research in newts suggested a means
of restoring retinal cells.

disorders. In addition to the explosion in molecular biol¬
ogy and genetics that promises to shed light on all hu¬

pigmentosa are caused by mutations in rod photorecep¬

man disease, basic research in ophthalmology benefits

tor genes associated with the conversion of light energy

from an extremely rich base of knowledge generated over

into electrical nerve signals.

the past 150 years.
“More is known about the vision pathway than any

“We’re asking how a change in the protein leads to
the death of the cell. Once we understand the sequence

other part of the nervous system,” says Colin Barnstable,

of events, we can design therapies to stop the death of

D.Phil., professor of neuroscience and director of re¬

the photoreceptor,” says Dr. Barnstable. Much of his

search at the Yale Eye Center. “Because vision is so im¬

research centers on transcription factors, proteins that

portant to us as humans, it has led to a fascination of

regulate the expression of other genes in photoreceptors.

how sight works. Scientists have been at it for centuries.”

Scientists around the world have isolated transcription

Basic research at Yale is relevant to many of the

factors in which mutations may be causing photorecep¬

degenerative diseases that rob sight. In their efforts to

tors to degenerate. Dr. Barnstable and M.D./Ph.D. stu¬

learn more about retinal disorders, researchers at Yale are

dent Julian Martinez recently isolated a transcription

focusing much of their attention on the photoreceptor

factor named Erx that regulates the expression of

cells, known as rods and cones, that process light energy.

rhodopsin, the light sensing molecule in rods. It is pos¬

Macular degeneration involves the loss of cone photore¬

sible that mutations in Erx itself may cause some forms

ceptors in the central part of the visual field, and retini¬

of retinitis pigmentosa. On a broader level understand¬

tis pigmentosa is caused by loss of rod photoreceptors

ing how genes like Erx work may lead to identification

that are used for night vision. Many forms of retinitis

of new targets for drug or gene therapy.
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A time-lapse series of images, left,
shows the movement of a protein
known as Sec 3 during the life of a
yeast. By tagging the proteins with
a fluorescent reporter produced in
jellyfish, Thomas Hughes, below,
and colleagues are able to discern
the function of certain genes
relevant to vision more quickly
than ever before.

A FLUORESCENT MARKER

science, and of neurobiology. “Having all the sequences

Five years ago, scientists at Columbia University found

is comparable to having all the books in a library. The

they could use an unusual substance produced by jelly¬

problem is, we don’t have a card catalog. We don’t know

fish to follow the activities of gene products within cells.

what the genes do yet, just that they’re there.”

This green fluorescent protein, or GFP as it is known to

Dr. Hughes and his team have tacked GFP onto the

researchers today, showed enormous potential as a re¬

proteins expressed by genes in cells from organisms as

porter—a detectable molecule that allows scientists to

varied as yeast and human and watched them light up

take a snapshot of a cell and determine the movement

as they travel to the nucleus, the cell surface, or the

and function of proteins within it.

cytoskeleton, for example. “By fusing GFP to these

What was new about GFP was that for the first

proteins,” he says, “we can learn where these genes are

time one could study function without killing the cell,

in the cell and how they are used—in a matter of two

as previous reporter techniques based on antibodies had

days instead of the months it used to take.”

required. Instead of a snapshot, scientists now had a
movie to study for clues to the inner working of genes

POTENTIAL FOR TRANSPLANTATION

and the proteins they expressed.

While a better understanding of transcription factors

Yale scientist Thomas Hughes, Ph.D., was among
the first to recognize the potential of the GFP reporter

and gene products may someday help prevent degenera¬
tive diseases that destroy sight, another strategy is

and to develop techniques for its use, in particular for

needed to help the large group of patients who have

the study of mammalian genes. “The [NIH-sponsored]

already lost the photoreceptor cells that make vision

Human Genome Project promises to reveal the sequence

possible. One avenue being explored is the transplanta¬

of every human gene by the year 2005,” says Dr.

tion of cells to rebuild the damaged retina. For this to

Hughes, associate professor of ophthalmology and visual

work, a source of photoreceptors needs to be identified.

Thomas Hughes

Dr. Barnstable had long known of the work of Leon
Stone with newts and wondered how the retina could
regenerate. What genes might humans hold in common?
Would it be possible, he wondered, to transform the
pigmented cells that lie behind the retina and turn them
into functioning photoreceptors?
Working in mice, the early results of research in this
area have been encouraging. “So far,” Dr. Barnstable
says, “we have been able to take these cells and turn
them into retinal cells using a cocktail of growth factors.
We also have a mouse strain in which a single mutation
causes this to happen spontaneously.”
Understanding how to control this process might
allow some degree of vision restoration for patients who
have lost their sight. And while transforming pigment
cells into functioning photoreceptors that can detect
light might sound fantastic, it’s not that far-fetched. “The
trillions of cells that make up the human body,” says Dr.
Barnstable, “were initially derived from a single cell.”
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have been required to treat abnormal vessels that devel¬

blood vessels to learn what growth factors regulate nor¬

oped from the underlying macular degeneration. Al¬

mal blood vessel growth. “What’s exciting,” he says, “is

though her left-eye vision is blurred, management of her

that one molecule has been implicated in both normal

right eye has been more successful. Despite its progres¬

angiogenesis and the abnormal blood-vessel growth that

sion from dry to wet form of the disease, the right eye

occurs in retinal disease. We’re getting closer to a much

has responded well to laser treatment. Two years ago, a

better understanding of the process.”

buildup of blood and fluid in the macula of her right eye

More than a year has passed since Rosalie and

was treated promptly with laser, and her blurred vision

Alexander Comfort’s eyes were treated with cryopexy.

has improved and been stable for more than a year.

The retinal vessels have regressed, and the children, now

Mrs. Swift, who lives alone, has a life filled with

17 months old in late September, are doing well. Alex

friends, church activities and three grandchildren. With

had surgery at the end of August on his eye muscles.

the help of glasses, her eyes still work. She lives indepen¬

He is doing well but is frustrated at having to wear eye¬

dently, drives a car, cooks, reads and enjoys watching

glasses for nearsightedness, which is common among

birds at the feeder in her back yard. Her sight is gener¬

children with retinopathy. “Now the biggest challenge is

ally good, she feels, despite the loss of central vision on

keeping his glasses on. He has the habit of flinging them

the left side. “When I put my glasses on,” she says, “I’m

off,” says his mother, Diana Comfort. They keep two

not really aware of it.”

pairs around the house because they never know where

More than 90 percent of patients with macular de¬
generation have the dry form, for which there is no ef¬
fective treatment, according to the National Eye Insti¬

his glasses will end up.
Rosalie doesn’t wear glasses and didn’t need the sur¬
gery. Like her brother, her development seems to have

tute. Laser treatment, the only proven therapy for the wet

been delayed slightly by weaker eyesight, but both chil¬

form, is most effective if the condition is diagnosed early.

dren seem to be catching up. The Comforts, who also

The incidence of macular degeneration increases

have a 4-year-old daughter, are happy with the twins’

dramatically with age. Whereas fewer than 10 percent of

progress. And while they had hoped Alex wouldn’t need

people have significant macular changes at age 65, nearly

glasses, they feel good about his future. “He’ll be able to

50 percent have some degree of change at age 80, says

see. Without some kind of vision, he would be very lim¬

clinical faculty member David Parke, M.D. “The impor¬

ited,” says his father, who looks forward to introducing

tance of these figures takes on even greater meaning as

his son one day to the outdoor pursuits he enjoys. “I like

we tend to live longer.”

to hunt and fish, and I want to take him along.” QE]

Many people in their 70s and 80s develop signifi¬
cant macular disease, while others show little evidence
of it. “If we knew which variables were involved in pre¬
venting macular degeneration in some patients, there is
the potential that they could be used as a treatment to
prevent the growth of abnormal vessels,” says Dr.
Stoessel. “We have to examine the growth factors that
allow blood vessels to develop normally and the factors
that prevent too much blood vessel growth. We need to
understand these better in order to learn what goes
wrong when children are born prematurely with stunt¬
ing of the retinal blood vessels. The growth factors in
retinopathy of prematurity may turn out to be similar
to the growth factors in macular degeneration.”
LOOKING TO THE FUTURE

The chief of the department’s retinal service is looking at
precisely that question in the laboratory. Like his coun¬
terparts in other disciplines including cancer biology and
cardiovascular research, Ray Gariano, M.D., Ph.D., is
interested in the process of angiogenesis—the formation
and differentiation of blood vessels—as a potential area
for intervention. His approach as an ophthalmologist
has been to study in utero the development of retinal
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A year after his initial treatment for retinopathy, Alexander Com¬
fort sees well with the aid of corrective lenses. “Now the biggest
challenge is keeping his glasses on,” his mother says fondly. “He
has the habit of flinging them off.”
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Q&A:BRUCE

SHIELDS

Over a few short decades,
dazzling advances in the
study of vision

T

he advances in medical technology that have
taken place over the past century would have
dazzled the physician of the early 1900s, says

M. Bruce Shields, M.D., chair of the Department of
Ophthalmology and Visual Science. Comparing his
early days as a physician with the era in which his grandlather, a physician in Oklahoma, began his practice,
Dr. Shields says: “My grandlather made house calls on
horseback. I began practicing medicine in the U.S.
Navy on a nuclear submarine.”
Dr. Shields, who is 57 and a trim 6 feet 2 inches tall,
was born and raised in Oklahoma. He is one of five
physicians in his family. In addition to his grandfather,

“The linkage of computers with lasers has been truly remarkable,”
says department chair Bruce Shields, “allowing us to perform
diagnostic procedures that were impossible before."

his brother is a physician in rehabilitative medicine, and
two uncles were ophthalmologists.
ders in this country. Over the past year, I surveyed
You came to Yale in November 1996. What has changed in

ophthalmologists around the state to learn how we can

the department since then? Because retinal diseases such

provide better services in the community. A frequent

as diabetic retinopathy and macular degeneration are

response was that we need to provide clinical services

among the leading causes ol blindness in this country,

that are not readily available in the community. That's

our plan has been to broaden our emphasis significantly

one of the things were trying to do.

in this area ol ophthalmology. We’ve added to our
clinical laculty and strengthened the clinical service with

What lies ahead? Well, first, to continue the aspects

support Irom our group ol researchers. Retinal diseases

of the department that have been historically strong.

and glaucoma encompass the majority ol blinding disor-

Yale has been known for its excellence in research, so

A history of ophthalmology at Yale

1876
Yale School of
Medicine intro¬
duces ophthalmol¬
ogy as a separate
subject in the
;||||§&^m. Arthur
" BrooRyh lectures
the medical
students.

is

1884

1895

1935

1948

1951

1961

The New Haven
Dispensary orga¬
nizes a separate
eye clinic under
William Carmalt.
who also practices
general surgery.

Henry W. Ring
becomes chief of
the Section of
Ophthalmology.

Eugene Blake
assumes leader¬
ship of the section.
Dr. Blake has a
special interest in
glaucoma and will
organize major
glaucoma screen¬
ing programs in
Connecticut.

Yale anatomy
professor Leon
Stone publishes
studies in newts
demonstrating
that retinal cells
are capable of
regenerating.

Rocko Fasanella
becomes chief of
the ophthalmology
section and estab¬
lishes the first
residency training
program. Gregory
Flynn is the first
trainee.

Marvin Sears joins
as the first full-time
chief of ophthal¬
mology. still a
section in the
Department of
Surgery.

1914
Arthur Ailing is
made section
chief.
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one of our goals for the future is to expand that area.

macology, especially in glaucoma treatment. There are

Secondly, I’m devoting a large amount of time to

now six categories of eye drops for treating glaucoma,

making our education programs for residents, fellows

most of which have been developed since the pioneering

and medical students among the best in the country.

work with timolol in the 1970s in which Dr. Sears

We also plan to continue increasing our clinical services

played a major role. Other advances in ocular pharma¬

to the community. Were growing in stature as the

cology include new medications to treat infection and

tertiary center in Connecticut for eye problems, and

inflammatory disorders of the eye.

we’re trying to structure that in a way that will be
What interests you most about your work? My life’s work

financially sound for the institution.

has centered on my chosen subspecialty, glaucoma,
What are some of the current trends in ophthalmology?

which represents a large group of disorders. After my

What strikes me is the progress in technology, specifi¬

residency in ophthalmology at Duke, I completed a

cally laser technology. So much of the surgery we do

fellowship in glaucoma at Massachusetts Eye and Ear

today is with a laser beam rather than a scalpel. Eye

Infirmary in Boston. Then I returned to Duke, where

surgeons were the first to apply this technology to medi¬

I was a member of the faculty for 22 years and director

cine, first in the treatment of retinal disorders and then

of Duke’s glaucoma service. In recent years, I have been

in the management of glaucoma. Later applications have

developing laser treatments for the most advanced types

included surgery of the eyelids and refractive surgery, in

of glaucoma. If there’s one thing I’ve enjoyed most about

which we reshape the front of the eye to eliminate the

my profession, it’s teaching.

need for glasses or contact lenses.
The application of computer technology represents

How did you come to be a physician? I was born in

another major advance for functions such as measuring a

Okmulgee, a small town just outside Tulsa, Okla.

patient’s field of vision. The linkage of lasers with com¬

My family moved to Enid when I was 4, and I grew

puters has been truly remarkable, allowing us to perform

up there. The wide, open spaces and wheat fields of

diagnostic procedures that were impossible before. One

Oklahoma were a good place for a boy to grow up.

example is image analysis ol the optic nerve for diagnos¬

I met my wife, Sharon, while I was attending

ing glaucoma, in which a laser beam scans the nerve

Oklahoma University School of Medicine, and she was

tissue, while a computer analyzes the data and creates

a student at the university’s nursing school. We married

three-dimensional images of the tissue. Computers are

after graduation in 1966 and have two children. Sarah,

also used to guide therapeutic laser beams for delicate

25, is a student at Elon College in North Carolina, and

reshaping of the cornea in refractive surgery.

John, 24, attends Tulane University in New Orleans.

The development of optical systems has allowed us

We live in Hamden.

to diagnose eye conditions more precisely than before

As for entering medicine, I thought about many

and to perform delicate operations by providing infor¬

things, including law and business, but felt that being a

mation that cannot be obtained with the naked eye.

physician was the most challenging thing I could do

There also have been remarkable advances in phar¬

with my life.

1971

1978

1979

1986

1993

1995

1996

Dr. Sears creates
the Department of
Ophthalmology and
Visual Sciences
and serves as the
first chair.

Timolol, based
on Dr. Sears’
research, is
approved by the
FDA for glaucoma
treatment.

Establishment of
the Connecticut
Lions Glaucoma
Research Center
for advanced
glaucoma
research.

Opening of the
Yale Eye Center.

Joseph Caprioli
appointed acting
chair.

Caleb Gonzalez
appointed acting
chair.

Bruce Shields
joins as chair
and the Marvin
Sears Professor of
Ophthalmology.
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Explaining glaucoma
LENS

New studies in gene expression,
neural signaling add to a solid core
of basic research.

W

hen Marvin Sears, M.D., came to Yale in 1961
to head the eye service, ophthalmology occu¬
pied 130 square feet in the Department of

Surgery and had one full-time faculty member: a young
recruit from Hopkins named Marvin Sears.
Under his leadership during the next three decades,
ophthalmology developed into a full-fledged department
with top-flight research and clinical care, culminating in
the opening of the Yale Eye Center in 1986. Under Dr.
Sears, Yale turned out specialists in eye care and visual
science who went on to lead their own departments
around the United States, Europe and Japan.
Much of that excellence revolved around glaucoma,
a disease that affects 3 million Americans and has
blinded more than 120,000 people in the United States
alone. Dr. Sears started the glaucoma service at Yale and
has devoted his research to explaining how glaucoma in¬
creases pressure within the eye with such devastating re¬
sults. His work in adrenergic pharmacology made Yale
an international center for glaucoma treatment and led
to the development, and FDA approval in 1978, of
timolol, the first useful topical medication for glaucoma
since 1908. He also developed two innovative
surgical procedures for clot removal and tumor removal
from the eye, used worldwide.
Although Yale is now branching out into other areas
of ophthalmology—retinal treatment and research in
particular—new department chair Bruce Shields is a
dyed-in-the-wool glaucoma specialist, and pupil of
Sears. “When I was studying to become an ophthal¬
\

FLUID EXITS HERE
FLUID FORMS HERE

mologist, his writings and teachings were already part of
the foundation of our understanding,” says Dr. Shields,
who headed the glaucoma service at Duke before com¬
ing to Yale in 1996. Dr. Shields was named the first Sears
Professor of Ophthalmology and Visual Science in 1997.
Glaucoma damages vision in most cases by increas¬
ing pressure inside the eye through the buildup of fluid

Glaucoma can result from a buildup of pressure within
the eye when fluid between the iris and cornea is un¬

known as the aqueous humor. In the most common

able to drain freely, ultimately damaging the optic nerve.

form, open-angle glaucoma, fluid between the iris and
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cornea is unable to drain freely and
ultimately exerts pressure on the optic
nerve at the rear of the eye. If this
pressure is not relieved over time, pe¬
ripheral vision begins to fade and can
progress to blindness.
Dr. Shields says that despite new
areas of focus, “we are very committed
to maintaining excellence in glaucoma
and continuing to build there.” Physi¬
cians and scientists in the department
are exploring several promising lines
of research. For example, Yale re¬
searchers have found that mutations
in a gene called myocilin (also known
as TIGR) affect the drainage of aque¬
ous humor from the eye in many pa¬
tients with glaucoma. Yale scientists
also have found expression of the gene
YALE OPHTHALMOLOGY

in the ciliary body, which produces
the aqueous humor.
The myocilin gene encodes a pro¬
tein critical to structures in the eye
that regulate pressure. Its discovery
may be useful in identifying people at
risk for glaucoma before they begin to
lose their sight. Because symptoms of

Glaucoma research pioneer Marvin Sears at the bench in the 1970s, when his work in
pharmacology made possible the development of timolol.

glaucoma often do not appear until
the disease has progressed, early diag¬
humor flow in both humans and rabbits. This informa¬

nosis is important. “In the future there may be great
value in detecting whether or not a person carries

tion is being used to study the interaction between cat¬

these gene mutations,” says Miguel Coca-Prados, Ph.D.,

echolamines and the cells that produce aqueous humor.
Glaucoma results specifically from the loss of nerve

professor of ophthalmology and visual science, in
whose laboratory the myocilin gene research is

cells in the retina known as ganglion cells. And while

being conducted.

glaucoma is most often characterized by increased pres¬
sure within the eye, a significant number of patients

Pressure within the eye follows a circadian rhythm,

with this disease have normal intraocular pressure, says

rising during the day and falling at night. Research sci¬
entist Douglas Gregory, Ph.D., and colleagues have

Colin Barnstable, D.Phik, professor of neuroscience and

found that catecholamines, substances that function as

director of research in the department. If one could dis¬

neurotransmitters, are important in controlling aqueous

cover what causes these ganglion cells to die, he suggests,
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it might be possible to help patients with normal
pressure glaucoma.
Dr. Barnstable, who has been studying the
formation of retinal ganglion cells for many years, is
testing the theory that a high concentration of
the neurotransmitter glutamate may be the cause of
ganglion cell death. Because glutamate in high concen¬
trations is thought to be the cause of brain damage in
strokes, cell death in glaucoma could be similar to
other brain injuries and diseases.
This hypothesis is being tested by isolating ganglion
cells, growing them in culture and studying the effects
of glutamate on the cells. A system has been designed
to study the effects of drugs that may block the damage
caused by glutamate. Dr. Barnstable is also examining
whether increasing any of the factors important in
the growth of retinal ganglion cells allows the cells
to withstand high concentrations of glutamate.
According to Dr. Barnstable, growth factors can be
supplied that allow the cells to survive for extended
periods in culture.
Yale is one of n centers participating in the
Advanced Glaucoma Intervention Study, a clinical trial
Miguel Coca-Prados has found that mutations in the myocilin gene
affect the drainage of fluid in glaucoma.

to determine the optimum surgical intervention when
medical therapy is no longer adequate. Eydie Miller,
M.D., associate professor of ophthalmology, is the
principal investigator at the Yale site. Although argon
laser surgery decreases resistance to aqueous outflow, the
results last only about five years,
and repeating the procedure is less
effective, says Marc Weitzman,
M.D., assistant professor of oph¬
thalmology. “The AGIS study
should give us answers to ques¬
tions about when to use argon la¬
normal phasel
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ser surgery in advanced glaucoma
and what types of patients are the
best candidates for it.”
Among the newest instru¬
ments in glaucoma treatment are
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the semiconductor diode lasers, which have recently
been obtained at Yale and are being evaluated in the
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patients with advanced forms of glaucoma. Over the
past io years, Dr. Shields has studied the effectiveness of
laser surgical techniques to reduce the pressure in eyes by
destroying portions of the ciliary body. “This has been a
major advance,” says Dr. Weitzman, “because there is

5 ns per Division
PHOTOPIC UHITE 0 dB

hope of finding better therapies to prevent blindness in

30 Hz Flicker

Clockwise from top left: Linking lasers with computers has enabled

much less pain and inflammation, and there are fewer
complications than with similar, earlier procedures.”

much earlier diagnosis of glaucoma through analysis of the optic
nerve head. Other technological advances allow ophthalmologists
to measure a patient's field of vision and the response of the rod
and cone cells to flickering light.
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For the myopic among us,
a new center for laser surgery

I

magine a clear, gel-filled orb that captures light and

those with astigmatism. In this procedure, the excimer

projects it on a screen. Through it unfold a million

laser, which produces a beam of ultraviolet light in

small dramas as well as the important scenes that

pulses that last a few billionths of a second, removes mi¬
croscopic portions of cor¬

make up life.

neal tissue to reshape the

That light-refracting

front corneal surface.

structure is the eye, and,

LASIK, a more ad¬

when it is misshapen, sight

vanced procedure for treat¬

is distorted or impaired.
For centuries, artificial

ing myopia and astigma¬

lenses—in monocles, eye¬

tism, is particularly

glasses and other devices—

effective for patients with

have corrected poor vision.

higher degrees of nearsight¬

Now, thanks to the refine¬

edness and has been shown

ment of laser techniques

in recent research to be ef¬

during the past decade,

fective treatment for all

people with nearsighted¬

forms of refractive error,

ness and certain other

says Shachar Tauber, M.D.,

disorders have another

director of refractive sur¬

option.

gery at the new laser center.
In LASIK surgery, a flap is

Laser vision correction
permanently reshapes the

made in the cornea with an

front of the cornea, alter¬

instrument called a

ing the focus of light on

g keratome.

the retina. The procedure

t

is used to correct myopia,

o plied to the cornea under

The laser beam is ap-

or nearsightedness, and

the flap, treating the cor¬

astigmatism. Myopia oc¬

neal tissue as it does in
PRK. The flap is then re¬

curs when the cornea is ei¬
ther highly curved or the eyeball is abnormally long.

placed in its natural position, where it protects the newly

People who are nearsighted see near objects clearly, but

treated cornea. Both procedures are performed on an

distant objects are blurry. In astigmatism, the cornea is

outpatient basis and take just minutes to complete,

curved more in one direction than another. Light rays

according to Dr. Tauber. Many patients recover their

that enter the eye are unequally bent, creating a dis¬

vision quickly and experience little postoperative

torted image.

discomfort from the procedures.

The Yale-New Haven Eye Laser Center opened in
July of this year at Temple Medical Center in downtown

Laser vision correction can greatly improve the
life of the firefighter who wears contact lenses and the

New Haven, as a cooperative effort of the School of

police officer who worries he may lose his glasses in a

Medicine and Yale-New Haven Hospital. David

scuffle and won’t be able to protect his partner or him¬

Silverstone, M.D., assistant chief of ophthalmology at

self. It also makes a great difference in the lives of people

YNHH, played a principal role in the concept and suc¬

who are excluded from jobs in industries that do not

cess of the project. The center offers two surgical proce¬

hire employees who wear contact lenses or glasses.

dures to reshape the cornea: PRK (photorefractive kera¬

“That’s where the laser has become a true workhorse,”

tectomy) and LASIK (laser in situ keratomileusis). PRK

says Dr. Tauber. “It really has revolutionized the field of

helps patients with mild to moderate myopia as well as

refractive surgery.”

Improving the odds, and quality of life,
for AIDS patients

I

An ultrasound

n surveys, iear oi vision loss has ranked consistently

image shows

as the leading quality-of-life concern among people

detachment of

living with AIDS—and with good reason. Among

the retina, arrow,
a blinding condi¬

the opportunistic infections that often accompany the

tion that can

disease is a blinding disorder known as cytomegalovirus

result from

retinitis. One in lour patients with AIDS develops CMV

CMV retinitis
in patients
with AIDS.

retinitis, which attacks and destroys the retina and leads
to irreversible loss of sight il left untreated.
A decade ago, the only treatment for this form of
viral retinitis was daily intravenous therapy, an expensive
and unpleasant ordeal that carried with it the serious
side-effects of kidney toxicity and reduced immune
function—less than ideal for patients with HIV.

procedure must be repeated.

That picture has brightened somewhat since the
introduction of new medications and surgical interven¬

Although the implant is effective in the majority of
patients, says Ray Gariano, M.D., Ph.D., chief of the

tions during the past several years. Yale is among a

retinal service at Yale, it can cause retinal detachment or

handful of centers evaluating a new delivery system for

bleeding in the eye. Some patients develop resistance to

the antiviral agent ganciclovir, one of a half-dozen drugs

the drug while others, with no systemic agent working

now available to treat CMV retinitis. Concentrated into

against CMV, are left vulnerable elsewhere in the body,

tiny pellets in slow-release form, ganciclovir is implanted

especially in the colon and lungs.

into the vitreous cavity of the eye, where it bathes the

Even without the implant, retinal detachment

retina for as long as eight months before the implant

occurs frequently among patients with CMV. Ophthal-

‘We teach patients to see all over again’

I

f you’re curious what it’s like to
read a book one word at a time,
pay a visit to the Lions Low

Vision Center at Yale.

impairment can regain a high degree

Monocular telescopes, small

of function, says David Parke, M.D.,

enough to carry in a pocket or purse,

associate clinical professor of oph¬

help people with limited vision to spot

thalmology and a consultant in the

a bus, read the writing on signs in a

low-vision clinic. “Many people with

supermarket or watch television.

a high-powered magnifier pressed

near-blindness live alone and are

Low-power magnifying glasses, used

I was and I did. With one end of
against my eye, I placed the other

independent. You’d be surprised at

by people with moderately low vision,

end against a copy of A Tale of

how innovative people can be when

encompass a column of newsprint.

Two Cities then slowly moved the

they’re motivated.”

Closed-circuit television units magnify

page sideways.
It. Was. The. Best. Of. Times.

The center’s staff trains people

print, pictures and maps up to 60

with impaired vision to use their re¬

times their original size and can be

It. Was. The. Worst. Of. Times.

maining visual abilities to the fullest

equipped with voice output. The Lions

Finding my visual sphere reduced

with magnification, glare control, pro¬

Clubs subsidize the cost ofvisual aids

to a circle of glass, I became impa¬

per lighting and special reading tech¬

for people living on small incomes.

tient and soon gave up. I wondered

niques. Telescopic devices, fitted to a

how long it would take to read several

pair of glasses, expand the field of vi¬

process the limited information it

hundred pages by grasping a word,

sion, enabling a person whose periph¬

receives from impaired eyes. It per¬

instead of a sentence, at a time.

Time is needed for the brain to

eral vision has been lost to walk

ceives the world in an entirely new

through a doorway without hitting the

way. The compensatory skills the pa¬

more patient. In fact, with time and

doorjamb or to shop for groceries

tient must acquire are improved only

support most people with visual

without jostling people in the aisles.

by diligent, systematic practice, ac-

Others, out of necessity, are
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mologists are now able to correct

Three thieves of sight

the condition by surgically remov¬
ing a portion of the vitreous humor

Retinal disease, macular degeneration and glaucoma are among the

at the back of the eye and replacing

leading causes of blindness in the United States. Some statistics:

it with clear, silicone oil. The oil
pushes the retina back against the

RETINAL

inside wall of the eye and holds it in

► 14 million diabetics are prime targets for

place. In 80 percent of the surgeries,
the retina remains in place, and the
patient’s vision is improved.
“Despite the fact that we have
these options, none is perfect,” Dr.
Gariano says. “We’re always looking

DISEASE

blinding disorders.
► 1.8 million have severe visual impair¬
ment from retinal disease.
► 700,000 diabetics are presently at risk
of blindness.
► 100,000 have retinitis pigmentosa, a

for less toxic, more effective anti-

family of progressive inherited diseases

CMV medications than have been

that cause deterioration of the retina

studied in the past.”

and blindness.

One encouraging note is that

► 65,000 diabetics each year develop

with the partial success of a new

proliferative retinopathy, the most

generation of AIDS medications,

sight-threatening stage.

better immune function has begun

► 30,000 working-age Americans with

to offset the incidence of viral re¬

diabetic retinopathy could preserve their

tinitis. Nowhere is this more appar¬

vision by having timely laser therapy.

ent than among the youngest AIDS

► 25,000 cases of retinal detachment are

patients. Of 70 children with con¬

treated each year (7,000 suffer irrepa¬

genital HIV followed at Yale during

rable damage)

the past three years, none has shown

► 8,000 new cases of blindness are
caused annually by complications of

signs of viral retinitis.

diabetes.

MACULAR
cording to Dr. Parke. “Learning to re¬
align their eyes correctly to avoid blind
spots and to use subtle visual clues
represents a new talent. We teach
patients to see all over again.”
In addition to evaluation at the
Yale center, occupational therapists
visit patients’ homes and suggest

DEGENERATION

► 21 million Americans (a third of those
over age 50) are at risk of developing
macular degeneration.
► 10 million suffer visual loss due to
macular degeneration.
► 200,000 people develop neovascular
macular degeneration each year.
► 104,000 are legally blind from the
disease.

Compared to normal sight (1),
glaucoma (2) causes the loss
of peripheral vision as shown
in these simulations. Diabetic
retinopathy (3) causes vision

improvements, like better lighting, to

to blur, while macular degen¬

meet their needs. Mobility experts

of one’s field of view.

eration (4) attacks the center

teach patients to move about with
limited vision, and social workers refer
them to other supportive agencies.
“Patients need to know that
there will not be a return to the quality
of vision they once enjoyed," Dr.
Parke says, “but they must be

GLAUCOMA
► 10 million people have above-normal intraocular pressure that may lead to
glaucoma.
► 2.6 million glaucoma-related office visits are made to doctors each year.
► 2 million are visually impaired by glaucoma; 1 million more have the disease
but don’t know it.

encouraged to believe that their

► 120,000 are presently blind from glaucoma.

visual performance can be measur¬

► 5,500 become blind each year from the disease.

ably improved.”
—Julie Miller
Source: Research to Prevent Blindness
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Dennis Spencer
Since the first scalpel was applied to the
brain in the late 19th century, neurosurgery
has evolved in ways that are truly
remarkable. The chair of Yales newly
established department talks about Harvey
Cushings legacy, the lessons ofiepilepsy
and the view from a Harley.

D

ennis Spencer, M.D., is a tall man with
glasses and a thick beard. He laughs easily and
looks comfortable in casual clothes, which often

include a black leather vest and cowboy boots. The walls
and shelves of his cramped office are lined with photo¬
graphs and memorabilia reflecting his professional inter¬
est in the history of neurosurgery and a passion for
Harley-Davidson motorcycles. His easy-going manner
belies his prominence as one of the foremost neurosur¬
geons in the country and his position as the Harvey and
Kate Cushing Professor and chair of the newly estab¬
lished Department of Neurosurgery. He has been at Yale
since 1971, where he has pioneered surgical procedures
that have now become standard in operations for treat¬
ing severe epileptic and other seizure disorders. Shortly
before the interview with Contributing Editor Marc
Wortman began in the department’s conference room, he
had completed surgery on a io-year-old boy with epilepsy
and was awaiting the report from the recovery room.
Could you describe a bit of what you did in surgery today?
We operated on a young boy who has seizures that be¬
gan in the areas of his brain controlling his left foot and
leg and had then spread to the rest of his brain. Initially,
we identified on an fMRI scan—functional magnetic
resonance imaging—the relative positions of his motor
and sensory cortex and then, using a grid of electrodes
implanted beneath the skull, determined where the sei¬
zures were beginning. After we recorded a number of
seizures in the epilepsy unit, we then stimulated between
electrode contact points on the grid to more precisely lo¬
calize movement and sensation—to determine precisely
which square inch or so of brain tissue controls them.
Then we mapped these regions relative to the area where
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the seizures begin and where there are cortical develop¬

A famous English neurologist, Hughlings Jackson,

mental abnormalities. Those small sections of the cortex

thought that the effect of electrical stimulation was very

are what we removed during surgery today.

much like focal seizures that he had seen in his patients.

We performed an additional procedure called mul¬

He thought that it probably represented the same kind

tiple subpial transection, in which we separate superficial

of phenomenon that happened when somebody had a

layers ol the brain, interrupting the connection so that

motor seizure of the hand, for instance. He speculated

the seizures can't spread. Seizures spread across the sur¬

that the seizure probably represented a local area of the

face ol the brain, or from cortical cell to cortical cell. By

brain on the opposite side that was diseased and excit¬

cutting these connections with a fine knife underneath

able. This is very logical today, but it was a revolutionary

the brain’s surface, you interrupt the short connecting

concept a hundred years ago. Sir Victor Horsley was the

fibers and you destroy their ability to communicate.

leading neurosurgeon in England at the time. Working

This interrupts the initial spread of the seizure.

with Jackson in the late 1880s, he operated on a patient

In operating on the brain in this way, what sort of risks do

whether somebody had a specific disease of the nervous

you run of causing other problems? Regarding multiple

system and no way of knowing where that disease was

who had a focal seizure. They had no way of knowing

subpial transections, the risks are primarily when operat¬

located or how to get there. Horsley exposed the sus¬

ing in the language association cortex. Transections may

pected motor area of the brain, found the tumor and

cause some difficulties in naming things, but the extent

removed it, and the patient’s seizures went away. That

ol the loss varies from patient to patient. The younger

was really the beginning, not only of thinking about

patients are most likely to regain lull function. For

surgery for epilepsy and a radical treatment for tumors,

example, we have a few-month-old baby in our service

but it was also the beginning of learning about the brain

right now who has a developmental abnormality ol the

and localization of function.

entire brain. She has seizures that cause her to live in a
dazed state. But they involve just one hemisphere, so we

How did neurosurgery arrive at Yale? Not long after

will actually remove the back half of the brain. 11 a baby

Horsley did his first operation, Harvey Cushing was an

has a stroke at birth or has developed a bad hemisphere

undergraduate at Yale. He became fascinated by brain

before birth—or in fact any time up until the age of

physiology and, after graduation in 1891, went to Johns

i year—all functions can transfer from one hemisphere

Hopkins to study medicine. Following up on Horsley’s

to the other except for fine finger movement and toe

work, he began to explore neurosurgery in the United

movement. Up until the age of i, you can transfer

States. During his general surgery training at Hopkins,

language, sensation and cognitive functions completely.

he started the first laboratory for the investigation of
neuroscientific issues there. After he finished his

How did surgeons begin to think about cutting open the

training, he went to the Peter Bent Brigham Hospital

living brain to treat disorders? Much of what we under¬

in Boston, where he spent most of his active career.

stand about the human brain today has actually come

He removed many brain tumors during his career with a

from epilepsy surgery over the years. Other than now,

morbidity and mortality rate that rivals modern practice

I think the time to be alive in the history of medicine

statistics. He’s known in the United States as our father

would have been the end of the 19th century. Until then,

of modern neurosurgery.

the brain was thought to be a rather homogeneous
organ. How do you know how to parcel out a portion

Neurosurgery continued at Yale while Cushing was
at Brigham. Sam Harvey was the first chairman of the

of the brain into a specific function or put those parcels

Department of Surgery here in 1924. He had been trained

together as more complicated functions? Nobody really

by Cushing as a neurosurgeon, but like all of the early

did. They thought that the brain behaved in a holistic

neurosurgeons, he was a general surgeon too. He was the

fashion because of animal experiments in which investi¬

first neurosurgeon to head a general surgery department,

gators would cut out pieces of the brain and the animal

however, and so the first surgery department at Yale

would still function fine. Then the development of elec¬

trained individuals in both disciplines. One of his first

trical stimulation led scientists to stimulate the surface

students, Bill German, also had spent a year training with

of an animal’s brain. 1 his caused movement on the op¬

Cushing in neurosurgery. Harvey appointed him the first

posite side of the body, and they found that there was an

chief of what would become the Section of Neurosurgery.

area of the brain that they could stimulate and elicit the
same movement and reproduce the results. For the first

Didn’t Cushing eventually come back to Yale? Yes, when

time, they began to think about localization of function.

he retired from the Brigham in 1934, he came to Yale

38

FALL

1998

as a professor of neurology and neurosurgery. He brought

physiologist at Yale at that time and a good friend of his,

everything with him, all of his records and his collection

put their book collections together and began what is

of brains and tumors in bottles. Cushing photographed

now the medical library’s world-renowned historical

every patient whom he ever saw. There are 15,000

library. They also started the first journal in the field

five-by-seven photographs stored here at Yale. They’re

here at Yale, The Journal of Neurosurgery, which is still

really incredible pieces that document neurological

our principal academic journal.

disease and the early days of neurosurgery. Right now,
we are procuring resources to again preserve all of the

Bill Collins came to Yale in 1967 as the second chief
of neurosurgery and put true academic credibility into

brains and to archive the photographs and to get them

the program. He began the process of subspecialization

safely put away in a museum-like surrounding. The

within neurosurgery, started a basic laboratory in the

collection is housed in the John Fulton House, a mansion

study of pain, and obtained the first spinal cord injury

just outside New Haven that is provided by the Axion

grant, which is still ongoing in the department. I came

Foundation to the medical school library. Cushing was

as a resident in 1971 and became a faculty member in

a bibliophile as well. He and Fulton, who was a famous

1977. Ten years later, I became chief of the section.

Dennis Spencer, center, in the operating room during epilepsy surgery. Advances in imaging, combined with increased knowledge of the brain,
allow surgeons to operate on areas of the brain linked to specific anatomical and metabolic functions.

Researching the whole brain

T

he father of neurosurgery in

medical school, he has been looking

dency program who is internationally

America, Harvey Cushing,

at pathways and projections of the

recognized for his genetic analysis of

was a Yale undergraduate who

central nervous system and how spe¬

cerebrovascular malformations.

returned to New Haven to join the

cific connections can be functionally

One of the most technologically

medical school faculty late in his

altered. The work holds promise for

complex fields, neurosurgery is

career. He brought with him a vast

developing new ways to help spinal

constantly dealing with and evaluat¬

collection ol papers, case records,

cord injury patients regain function.

photographs, medical illustrations—

Beyond his regular administrative

ing new equipment. Part of the
departments research efforts include
studying and applying new technol¬

even tumor specimens and bottled

and teaching duties and surgical

brains accumulated during his years

schedule, Dr. Spencer directs the

ogy in the operating room. Clinical

at the Peter Bent Brigham Hospital in

departments epilepsy research pro¬

vice-chairman, Joseph Piepmeier,

Boston. Cushing brought not only

gram, working with investigators

M.D., directs the state-of-the-art

a wealth of knowledge but also an

Anne Williamson, Ph.D., and Nihal

neuro-oncology program. Issam

appreciation for inquiry and research

de Lanerolle, Ph.D. The program is

Awad, M.D., heads the neurovascular

in neurosurgery. The recently estab¬

unique in the world for its studies of

program, dedicated to the epidemiol¬

lished Department of Neurosurgery

the human tissue surgically removed

ogy of hemorrhagic stroke and basic
research on angiogenesis.

at Yale, which had been a section

to treat epilepsy. Dr. Spencer says,

within the Department of Surgery, is

“Anatomical and electrophysiological

regarded as one of the worlds premier

study of this tissue is beginning to un¬

therapy is one of the most challenging

research centers.

ravel the mechanisms of how seizures

fields in medicine. The departments

are maintained in humans.”

cellular transplant program, sup¬

Under the leadership of Charles
Greer, Ph.D., vice chairman for

Many of the departments re¬

Gene and cell replacement

ported by the basic research of D.

research, the department’s numerous

search areas have an emerging com¬

Eugene Redmond Jr., Ph.D., who

research programs have followed a

mon theme in molecular genetics,

is also a professor of psychiatry, com¬

general principle of studying how the

including gene therapy. “This field,”

pleted the first organized approach to

brain and spinal cord respond in both

says Dr. Spencer, “will be of critical

cell transplants for Parkinsons disease.

restorative and pathologic ways to

importance to the understanding of

Recently, the department launched a

trauma and disease. Dr. Greer himself

basic disease mechanisms, which must

clinical trial to replace the gene miss¬

is a leader in spinal cord research.

precede rational therapy.” The depart¬

ing in the fatal childhood disease of

Along with colleagues Anthony van

ment recently added a new faculty

Canavan, with Charles Duncan,

den Pol, Ph.D., and Carole LaMotte,

member, Murat Gunel, M.D., an

M.D., chief of pediatric neurosurgery,

Ph.D., and others from around the

alumnus of the departments resi¬

providing neurosurgical support.

The section of neurosurgery separated completely

example, growing 10-fold over a io-year period. Our

from the Department of Surgery last year and became

vision, therefore, required more freedom to form the

a free-standing department. Why did that happen?

interdisciplinary programs essential to caring for

Departmental status has historically emerged from a

patients with diseases of the nervous system. Thus, with

specific discipline’s academic maturity. The ways of

solid support by the Department of Surgery and the

treating and researching nervous system disease has

academic and clinical deans, we became a department

wandered far from general surgery principles and

in January of 1997.

stands more as an interdisciplinary field, sharing a
knowledge base primarily with the basic neurosciences,

Subspecialization seems to be an even more important

neurology, psychology and psychiatry. Our section had

professional pathway in neurosurgery than other special¬

received national and international recognition in

ties. Why is that? It’s clear that patients gain the most

clinical and basic neuroscience, NIH funding, for

and do the best with individuals who do the same tech-
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nologically difficult things every day. Subspecialization is

brain. We could then watch a spontaneous seizure and

a natural evolution in neurosurgery, which seems so sub¬

correlate that with the electrical source. We began to

specialized in itself, yet is enhanced when concentrating

identify that in certain of these patients we could find

on subdivisions of the very complicated nervous system.

scars, tumors, vascular lesions and other abnormal areas
that were sources of seizures.

Your subspecialty is epilepsy. How has that developed as
a field? The study and treatment of epilepsy have much

Magnetic resonance imaging, or MRI, came along
in the mid-1980s. Early on, we adapted the computer

of their origins here at Yale, in the late 1960s and 70s.

to our imaging systems. Two Yale undergraduate

One of the first epilepsy monitoring units in the world

students worked with Greg McCarthy and me to

was established by Richard Mattson at the VA hospital

design the first computerized imaging work station

in West Haven, where cameras were placed to study the

anywhere in neurosurgery. We wished to replace our

behavior of patients, coupled with electrodes that had

old system, which was based on plain X-rays coupled

been locally constructed and then implanted in the

with injecting air into the brain’s fluid cavities and

Harvey Cushing photographed every patient who came to him, collecting a life's
work of images that not only tell the story of modern neurosurgery but reveal
Cushing's skill as a visual interpreter. His illustrations, left, sketched from sur¬
gery, were elegant as well as finely detailed.
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drive. Often, it destroys their socializa¬
tion, so they don’t establish normal rela¬
tionships and often don’t get married,
maintaining dependency on their fami¬
lies. It’s estimated that there are 250,000
to 300,000 patients in the United States
who could be helped with the surgical
treatment of epilepsy. This is a group of
patients in whom you can identify the
source of the seizures and, by removing
it, can cure their epilepsy. You may cure
epilepsy overnight. It is the only
chronic disease that can be cured in
the operating room.
Imaging is an increasingly important
part of neurosurgery. What are its
A neurosurgical operating room at Yale-New Haven Hospital is represented in this exhibit

advantages? Imaging is absolutely criti¬

at The Computer Museum in Boston, recreating the occasion in 1972 when a DEC PDP-8

cal for growth in neurosurgery right

computer was used to guide a procedure. For the first time, a programmable lab computer
was small enough to put on a cart and wheel into surgery.

now. We re still in an experimental stage.
Jim Duncan, senior physicist in the
Department of Diagnostic Radiology,

dye localization of cerebral arteries. Combining

and I have formed the Laboratory of Image-Guided

stereotaxy with the MRI using the computer, we could

Neurosurgery. It brings together the investigators from

then create a virtual image of where our electrodes were

spectroscopy, functional MR, neuropsychology, linguis¬

to go along specific trajectories within the brain. MRI

tics and physicists to provide graphic analysis. Through

also allowed such detailed anatomical views of the brain

interdisciplinary methods, we can enhance learning

that more subtle brain developmental abnormalities

about brain functions and real-time imaging during brain

could be viewed as easily as the more discrete lesions,

surgery. Were still at the beginning of what we envision

such as tumors and vascular anomalies.

as a long-term collaboration. We are combining the MR

We’ve made enormous advances since then.

image with measurements of the brain in the operating

Now, we can see epileptogenic developmental and

room so that we can more precisely predict dynamic

atrophic areas of brain. Many patients no longer even

changes during brain surgery. We can do a variety of

have electrodes implanted at all. They can have an

anatomical, metabolic and functional localizations that

image correlated with scalp recordings and then go

were never possible before. We need to superimpose all

directly to surgery. It all goes back to what we talked

of those images and data when we go to the operating

about originally, localizing function of the brain. Now

room so that we know what to resect and how to operate

we have better localization techniques, but electrical

without harming critical brain structures. The purpose is

stimulation has remained the best technique for identi¬

to make neurosurgery safer and less invasive. You can

fying brain function. It’s not very long ago, 1978, that

minimize cranial openings if you know your position

we were injecting air into people’s heads to identify

precisely before you have to open the skull. That greatly

structures and to help place homemade electrodes.

decreases morbidity and costs.

Boston has a computer museum in which our original
operating room from the 1970s has been set up to

What’s on the horizon for neurosurgery? We think that

illustrate the first utilization of computers to localize

regional brain perfusion of drugs or genes or stimulation

function in brain surgery.

is going to be the next step for delivering treatment to
patients. One of the problems with drug treatments

What attracted you to work on epilepsy? Epilepsy surgery

for nervous system diseases is that drugs are relatively

is my passion. I spend all my clinical and research time

non-specific in many instances. Drug treatment of a

with these patients. Epilepsy affects one percent of the

convulsive state slows the entire brain. Not only does

population. It’s a chronic problem, primarily in young

it help suppress the seizure focus, it suppresses many nor¬

people. It destroys their lives. They can’t work, they can’t

mal activities. Now that we’re able to localize diseases

4 2
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within regions of the brain, our next step is to develop

As a brain surgeon, you deal with the core of what

a probe system that will allow us to sense and measure

makes us humans and individuals. That must be a heady

biochemical changes, and then to provide focused,

experience. Neurosurgeons have a tendency to be prima

measured delivery of therapies. It may be delivery of

donnas because of what they do, but the residents we

genes or drugs or electrical stimulation for instance, but

train and the patients we treat do more to humanize us

through an implantable source that is varied and that

than anything else. The patients whom we take care of,

doesn’t require being connected to the outside. We’re

in my case, the epilepsy patients, make us focus on

working on such a device that can regionally deliver

giving back health. We all become more human in the

these drugs without affecting the rest of the brain.

process. We have the smartest and most talented resident

Then the next step might be to deliver a gene that will

staff of any neurosurgical department in the country.

help regulate that cell so that it would behave itself

Every time you make a clinical decision or touch a
patient, the headiness disappears and is replaced by the

Your wife, Susan Spencer, is a neurologist. It is interesting

responsibility of mentoring the next generation and

that you two work together so closely. Yes. We both be¬

helping another person in grave need. You cannot be

gan our work at about the same time. For 20 years we’ve

selfish and do that job well. QE1

been publishing papers together. She is the medical co¬
director of the epilepsy program and now the director of
the monitoring unit that we have in the hospital. In fact,
beginning July 1999, she’s the next president of the
American Epilepsy Society. She sees most ol the epilepsy
patients when they come in and establishes who needs
new drugs and who may be a candidate for surgery.
We have a two-hour conference in the Department of
Neurosurgery every Monday afternoon, to which we
bring patient histories and their relatively complicated
evaluations involving PET and SPECT scans and
readings from depth electrodes and such. We have about
25 people who come representing psychiatry, neuropsy¬
chology, neurology, etc.
You’ve got what sounds like an incredibly demanding life,
between the stress of surgery and the demands of re¬
search and running a major medical department. How do
you manage? On the back of a Harley, a hog. Dr. Greer,
Charles Greer, the department’s vice chairman for
research, and I spend occasional Sunday mornings
terrorizing the Connecticut countryside.
You drive a motorcycle? That’s not the typical image of a
brain surgeon. No. I recently gave a talk to the Hospital’s
Board ofTrustees, where Joe Zaccagnino [President and
Chief Executive Officer ofYale-New Haven Hospital]
introduced me to this roomful of prominent officials, as
the Harvey and Kate Cushing Professor of Neurosurgery,
chairman of the department and so on. Then he added
that I was the only person who showed up at our hospital
retreat in full leathers on a Harley. It was really not the
introduction that I expected. My love before Harleys is
actually my children, the mystery and wonder of raising
them—and water lilies. I have two ponds, and in the
summertime what I like to do is gardening—gardening
and riding hogs.
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The brain surgeon in a resting state, on the back of a hog.
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High honors for psychiatric research
Mental health awards recognize cutting-edge work.

N

ine School ol Medicine re¬
searchers have been awarded
grants from the National Alli¬

ance for Research on Schizophrenia
and Depression (NARSAD). Two of
the researchers are among 16 scientists
around the world to receive the 1998
Distinguished Investigators Award,
NARSAD’s highest honor. Seven of
the Yale researchers are among 130
scientists worldwide to receive the
1998 Young Investigators Award Irom
NARSAD. The non-profit organiza¬

patients with schizophrenia. Dr. Roth

study ways of reducing the side

is studying the psychiatric symptoms

effects of drugs used to improve
the voluntary motor skills of

associated with marijuana abuse.
Additionally, NARSAD announced
in May that Gerald A. Conway and
his wife Martine, trustees for The
Fairfax Foundation, have pledged to
support NARSAD and Yale with a
cumulative gift totaling $30,000.

schizophrenic patients.
Sheena Josselyn, Ph.D.,
postdoctoral associate in psychiatry,
will investigate the neural basis of
inhibition of fear and/or anxiety.
Karen Y. Mechanic, M.D.,

The funds are to be applied toward
the support of a 1999 Young Investiga¬

postgraduate year IV resident in psy¬

tor conducting research at the School

between cocaine dependence and
depression.

of Medicine.

chiatry, will examine the relationship

Recipients of the 1998 Young

Marc N. Potenza, M.D. ’94,

research into the causes and potential

Investigators Award will receive

Ph.D. ’93, postgraduate year IV

treatments of mental illness.
George R. Heninger, M.D., pro¬

$30,000 for two years to help support
their research. The winners and their

resident in psychiatry, will study the

fessor of psychiatry, and Robert H.
Roth Jr., Ph.D., professor of psychia¬

research projects are:
John P. Alsobrook, Ph.D., associ¬

and the onset of mental illness.
Alexander A. Stevens, Ph.D.,

try and pharmacology, were awarded
the 1998 Distinguished Investigators

ate research scientist in the Child

postdoctoral associate in diagnostic

Study Center, will analyze genes that

Award, which supports their work
with $100,000 for one year. Dr.

may be associated with obsessive-

radiology, will map areas of the
brain responsible for language to

compulsive disorder.

gain a better understanding of how

tion, based in Great Neck, N.Y., funds

Heninger's research aims to identify
the immune abnormalities in some

Noboru Hiroi, Ph.D., associate
research scientist in psychiatry, will

link between the response to stress

schizophrenia affects language
processing.

Pathology chair becomes department’s
first Yesner Professor
Jon S. Morrow, M.D., professor and

S fundamental to an
understanding of

chair of pathology, and professor of
molecular, cellular and developmental
biology, has been named the

4a

Raymond Yesner Professor of Pathol¬

I well as cancer
causation and

ogy. Dr. Morrow has led pioneering
studies to define the structure and
function of the membrane-associated
cytoskeleton. His work led to an
understanding of the origin of several
inherited blood diseases of children.
In addition, his studies on the regula¬
tion of cell-cell adhesion receptors
Li«tve revealed molecular mechanisms
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.

I fetal growth and
I development, as

Jon

JBH metastasis control.
■ j| JmM Other research he
Morrow
has conducted has

implications for
understanding brain disorders and for
treating neonatal brain injury, epi¬
lepsy, Alzheimer’s disease and AIDS
dementia and other disorders.

Active in the field of medical
informatics, Dr. Morrow has been an
advocate of the early translation of
basic science advances to clinical
medicine. He headed the team that
designed the pathology department’s
computerized patient information
system, and established the medical
school’s Critical Technologies
Program, which facilitates physicians’
access to basic science advances and
assists basic scientists in the extension
of their studies to problems of
human relevance.
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Nancy Angoff named associate dean for student affairs

N

a family when

ancy R. Angoff, M.RH. ’81,

M.D. ’90, H.S. ’90-93, an
assistant clinical professor of
medicine who began her career in
medicine after raising a family and
working as a teacher and guidance
counselor, has been named associate
dean for student affairs.

women didn’t

“You haven’t told me one reason why
you can’t.” Her husband, Ronald

become doctors.

Angoff, M.D., a pediatrician on Yale’s

They married
doctors but they

clinical faculty, also encouraged her
medical studies.

didn’t become
Nancy Angoff

doctors. I was
told that I

Dr. Angoff’s appointment con¬
cludes an internal search that began
earlier this year when the duties of

Dr. Angoff specializes in treatment
of patients with HIV and will con¬

should become a
teacher, that I would have some¬

Robert H. Gifford, M.D., H.S. ’67,

tinue to see patients at the Nathan
Smith Clinic. She joined the faculty in

thing to fall back on when my kids
were in school.”

tion and student affairs, were divided
into two jobs. Dr. Gifford became the

1993 after completing her residency
here. She obtained a degree in public

Reserve University in 1968 and re¬

tion on July 1. As associate dean for

health from Yale in 1981 and her medi¬

ceived a master’s degree in education

student affairs, Dr. Angoff handles

cal degree, also from Yale, in 1990. She
has served as course director of inte¬

from the University of Cincinnati in
1971. Although she started out in

student needs and concerns. Her du¬
ties include counseling, writing rec¬

grative clinical medicine, chaired a
working group on death and dying,

education, her interest in medicine
led her into public health in 1981. A

ommendation letters for students, or¬
ganizing events such as Match Day

co-chaired a working group on end-

few years later a lunchtime conversa¬

and Commencement, working with

of-life care and co-taught a course in

tion with a colleague provided the

student organizations and handling
disciplinary problems.

medical ethics at the divinity school.
She has been an attending physician at
Yale-New Haven Hospital and the
Nathan Smith Clinic.
In 1990 she received the Miriam
Kathleen Dasey Award, presented to
the student who, by strength of char¬

She graduated from Case Western

spark for her career in medicine.
When her colleague asked what she
truly wanted to do, Dr. Angoff said

then associate dean for medical educa¬

school’s first deputy dean for educa¬

“From the moment I set foot here I

she wanted to study medicine, then

have been devoted to this place. It’s an
incredible institution. It’s home for

ticked off a list of obstacles. “I was too
old. It cost too much money. I had

her appointment with a standing ova¬

kids. I had never taken a science

tion. “If I can help any of you to love

me,” she told students, who greeted

acter, personal integrity and academic

course in my life,” Dr. Angoff recalled

medicine as much as I do, I will have

achievement, gives promise of fulfill¬

telling her colleague, who answered,

fulfilled my duty.”

ing the ideal of the compassionate
physician. Highly regarded for her
clinical knowledge and compassionate
treatment of patients, she has three

Judah Folkman speaks at Grand Rounds

times received the Meyer Etkind Prize,

Speaking to a standing-room-only audience in Fitkin Amphitheater in June, angiogenesis

awarded by house staff to the physi¬
cian who embodies those qualities.

pioneer Judah Folkman, M.D., second from right, described the application of his discover¬

“Like many Yale students her back¬
ground is not traditional,” said Dean
David A. Kessler, M.D., as he an¬
nounced Dr. Angoff’s appointment at

ies about blood vessel formation to the treatment of certain cancers. Dr. Folkman delivered
the Massimo Calabresi Lecture in the Yale Cancer Center as well as a talk titled New

Directions in Angiogenesis Research during Grand Rounds in the Section of Cardiovascular
Medicine. A cancer researcher at Children’s Hospital in Boston who teaches anatomy and
cell biology at Harvard Medical School, Dr. Folkman was the Farr lecturer at Yale in 1997
and gained worldwide attention earlier this year when news of his successful anti-cancer
experiments
in mice were

a luncheon for second-year students in
September. “She was a working

those attending

mother when she went to medical

the lecture were

school and did her residency. She
knows Yale from the inside out, from
a number of different vantage
points—as a student, as a resident, as
a practitioner, as a teacher.”
In her remarks after Dr. Kessler’s
announcement, Dr. Angoff de¬
scribed her path to medicine. “I

reported. Among

Dean David A.
Kessler, left, a
former student
of Dr. Folkman
at Harvard, and
Paul and Guido
Calabresi, in
whose father’s
memory the lec¬
</)

ture series was
established.

grew up,” she said, “at a time and in
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Richard J. Antaya,
M.D., an authority in
skin disorders affecting

annual meeting of the International

ber, is in charge of statistical analysis

Medical Society of Paraplegia in June
in Brazil. The theme of the talk was

for the study.

current and future prospects for the
pharmacologic treatment of acute spi¬

Joseph F. Hoffman, Ph.D., Eugene

nal cord injury.

children, joined the
faculty of the depart¬
ments of Dermatology
Richard Antaya

and Pediatrics in Sep¬

tember. Dr. Antaya received his B.S.
degree in chemistry from Rensselaer
Polytechnic Institute in 1985, and re¬

Higgins Professor of Physiology and a
member of the faculty since 1965, was
honored for his work studying mem¬

Erol Fikrig, M.D., associate professor
of internal medicine, was a recipient
of a $750,000, five-year grant from
the Burroughs Wellcome Fund. The
Clinical Scientist Awards were given
for the first time this year and went to

brane transport and cellular physiol¬
ogy in April with the Yale Science and
Engineering Association Award for the
Advancement of Basic and Applied
Science.

ceived his M.D. degree at Tufts Uni¬

10 U.S. and Canadian researchers to

Peter J. Hotez, M.D., associate

versity in 1989. He completed his resi¬

foster the transfer of knowledge be¬

dency training in pediatrics at Tripler
Army Medical Center in Honolulu in

tween basic research and the treat¬

professor of epidemiology and
pediatrics (infectious diseases), was

ment of patients.

named visiting professor at the Peking

1992, and spent the following three

Union Medical College in Beijing in

years practicing general pediatrics in
the Army at Fort Polk, La. There he

Heidi L. Gaspary,

February. In 1996 he was also named

M.D., Gilbert

visiting professor at the Institute of

served as chief of the pediatrics service
and chief of the department of medi¬

Glaser Fellow in
Epilepsy and chief

Parasitic Diseases, Chinese Academy
of Preventive Medicine. Dr. Hotez,

cine. Dr. Antaya completed a second

resident in neurol¬

an expert on hookworm infection,

residency in dermatology at Duke

ogy at Yale-New

is working to develop a vaccine

University, where he worked closely
under the direction of the internation¬

Haven Hospital,

against the parasite, which is prevalent

ally recognized pediatric dermatologist
Neil S. Prose.

Heidi Gaspary

has been named
the 10th annual winner of the Hugh

in China.

Dwyer Award. The award, presented

Dean David A. Kessler, M.D., has

by Dr. Dwyer’s widow, Dorothea

accepted an invitation from the

Michael B. Bracken, Ph.D., M.P.H.

Peck, M.D. ’43, is given each year

Mayday Fund to serve as honorary

’70, professor and head of chronic dis¬

to a senior resident who consistently

chair of its newly formed National

ease epidemiology and professor of
neurology, obstetrics and gynecology,

demonstrates characteristics exempli¬

Advisory Committee. Mayday, a

fied by Dr. Dwyer: dedication,

New York-based philanthropy, is

gave the keynote speech at the 37th

sound judgment, sharp diagnostic

dedicated to reducing the profound

skills, compassion, the pursuit of
continuing education and achieve¬

human problems associated with pain

ment in practicing the art and

and its consequences. In his role as
honorary chair, Dr. Kessler will

science of medicine.

advocate increased attention to the

An international, multicenter study

States by working with medical pro¬

headed by Roberto J. Groszmann,

fessionals and public policy leaders
whose intervention could help

undertreatment of pain in the United

M.D., F.R.C.P., professor of medicine
at Yale and chief of the digestive dis¬
ease section at the VA Connecticut
Healthcare System, will be funded by
a $2.5 million grant from the National
Institute of Diabetes and Digestive
Yale Cancer Center Director Vincent T. DeVita
Jr., H.S. '66, professor of medicine, epidemi¬
ology and public health, received an award
from David S. Rosenthal, M.D., president of
the American Cancer Society, during the
13th Annual Excaliber Round Table, held in
New Haven and Greenwich in August. The
jade glass work was in honor of Dr. DeVita's
efforts on behalf of the round table and the
cancer society. During the three-day sympo¬
sium, researchers discussed various topics
including dendritic cells, peptidomimetic
therapy and thyroid cancer.
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alleviate unnecessary pain for millions
of Americans.
Associate Clinical Professor of Medi¬
cine Siegfried J. Kra, M.D., F.A.C.P.,

and Kidney Diseases. The five-year
grant will support continuation of a
study of the prevention of esophageal

was a guest lecturer at the Trumbull

varices by beta-adrenergic blockers.
Co-investigator for the project is

Leaders That Changed Our World, is
also the subject of his 13th book which

Guadalupe Garcia-Tsao, M.D., assis¬

is in preparation. He also toured the

tant professor of medicine (digestive
diseases). Robert Makuch, Ph.D., as¬
sociate professor of public health (bio¬

country in late 1997, discussing his
book What Every Woman Must Know

statistics) and a Cancer Center mem-

College Fellows Luncheon in April.
His talk entitled III and Deranged

about Heart Disease, published in 1996
and now available in paperback.

FALL

1998

Marc I. Lorber, M.D.,
B

professor of surgery and

*

chief of the section of
organ transplantation
and immunology in the

Marc Lorber

Department of Surgery,
was elected in June to

institution chartered by the

(NCEWH), for a series of studies on
how women veterans use Veterans
Administration mental health services,

Connecticut General Assembly in
1976 and patterned after the National

Carolyn Mazure, M.D., director of

Academy of Sciences. Dr. Waxman

research for the women’s health pro¬
gram and the NCEWH at Yale, pre¬

also serves as director of the PVA/
EPVA Neuroscience Research Center

sented the awards.

in the VA Connecticut Healthcare
System in West Haven.

serve a two-year term on the board of
The Society for the Ad¬

directors of the United Network for
Organ Sharing (UNOS). A private,

vancement of Women’s
Health Research gave

nonprofit organization, UNOS unifies
transplantation activities nationwide
by establishing policies to govern or¬
gan procurement, distribution and
transplantation. Dr. Lorber also serves

Barry L. Zaret, M.D., the Robert W.
Berliner Professor of Medicine, profes¬
sor of radiology and chief of cardio¬

Professor of Pediatrics
Sally Shaywitz, M.D.,
Sally Shaywitz

the 1998 Clinical Ser¬
vice Award for her work

vascular medicine, received the 1998
Solomon A. Berson Medical Alumni
Achievement Award in Clinical Sci¬

as treasurer of the American Society of

in the science of reading and for her

Transplant Surgeons.

advancements in the scientific under¬

University School of Medicine. The

standing of gender differences in brain
organization and function. Dr.

award ceremony was part of the
school’s April alumni day celebration.

Frederick Nafitolin, M.D., D.Phil.,
professor and chairman of obstetrics

ence from his alma mater, New York

Shaywitz is co-director of the National

In February, Dr. Zaret was a guest lec¬

and gynecology, and director of the
Center for Research in Reproductive

Institute of Child Health and Development-Yale Center for the Study of

turer at the 25th anniversary of the

Biology, was admitted to Britain’s

Learning and Attention and founder

Cairo. He spoke on Clinical Relevance

Royal College of Obstetricians &
Gynaecologists in September. Dr.

and director of the Yale Learning Dis¬

of Myocardial Perfision Imaging and

Naftolin was also elected president of

orders Unit. The award was presented
at a ceremony in Washington in June.

Mental Stress and Myocardial Ischemia.
Dr. Zaret was also a guest speaker at

the North American Menopause Soci¬
ety in September.

Stephen G. Waxman, M.D., Ph.D.,

ology which was held in June in

professor of neurology and pharma¬

Rosario, Argentina.

Eric J. Nestler, Ph.D. ’82, M.D. ’83,

cology and chair of the Department

HS ’83-87, the Elizabeth Mears and
House Jameson Professor of Psychia¬

of Neurology, was elected a member
of the Connecticut Academy of

Egyptian Society of Cardiology in

the XVII Congress of Nuclear Cardi¬

Daniel Zelterman, Ph.D. ’83, profes¬

try, Pharmacology and Neurobiology,

Science and Engineering (CASE) on

sor of medicine (EPH), was elected a
Fellow of the American Statistical As¬

was one of three recipients of the 1997
Robert J. and Claire Pasarow Founda¬

the basis of his internationally recog¬

sociation in August. This honor recog¬

nized research. He is an authority in

nizes his development of models of

tion Medical Research Award. Recipi¬

the molecular architecture of nerve

human longevity and his continuing

ents received a $35,000 prize from the
Beverly Hills-based foundation and

fibers and the glial cells that surround

service to the statistical profession.

delivered a lecture at a ceremony and
scientific symposium held at the Uni¬
versity of Southern California’s health

them, and the mechanisms by which
nerve fibers in the brain and spinal

Fewer than one third of one percent

cord adapt to injury. CASE is a

of all members of the American Statis¬
tical Association can be elected fellows

private, nonprofit public-service

in any year.

sciences campus in June. Dr. Nestler
was recognized for his research into
neuropsychiatric disorders. In a talk
entitled Towards a Molecular Psychia¬
try, Dr. Nestler spoke about his cur¬
rent research into the connection be¬
tween neurobiology and behavior.
Two Yale researchers, Robert
Rosenheck, M.D., clinical professor

Gordon Shepherd, M.D., D.Phil., pro¬
fessor of neuroscience in the section of
neurobiology, has been elected editor-inchief of the Journal of Neuroscience, pub¬
lished by the Society of Neuroscience.
He will begin his five-year term as editor
on Jan. 1. The journal is published every

of psychiatry and Rani A. HofF, M.P.H

two weeks in both printed and electronic

’91, Ph.D., postdoctoral fellow in the

versions, comprising some 10,000 pages
annually. On the Yale faculty since 1967,

Child Study Center, received the 1997
Excellence in Women’s Health Re¬
search Award from the National Cen¬

he has previously served as editor-inchief of The Journal of Neurophysiology.

ter of Excellence in Women’s Health
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‘Do some good
in the world,’
dean exhorts
Class of 1998

A

s the 106 members of the Class
of 1998 received their medical
degrees in May, Dean David A.

Kessler, M.D., urged them to think
back to the altruism that guided and
propelled them as they made the deci¬
sion to become doctors. “You wanted
to do some good in the world,” he
said, “and you were able to say those
words flat out, without any embarrass¬
ment or hesitation.”
The 1998 Commencement was
Dr. Kessler’s first at Yale and the first
in recent memory to be conducted

1) Three generations take to the podium

in pouring rain, which drove gradu¬

at Commencement. Katherine Auerswald,

ates and their families under a tent

holding her daughter, Cecilia, receives her
diploma accompanied by her father Benjamin

on Harkness Lawn. After ceremonies

Bunney, psychiatry chair. 2) Jennifer Eras

on the main campus, graduates

smiles under the tent. 3) Banner-bearer

followed bagpiper Glenn Pryor as he

Merle Carter leads the procession with
bagpiper Glenn Pryor. 4) Deans David

led the class along College Street to

Kessler and Robert Gifford speak before

the medical school Commencement

the ceremony. 5) Sydney Butts and Merle

under the tent.

Carter applaud during the ceremony.

“This is a teacher’s dream,” said
Dr. Kessler, “a last chance to exhort,
challenge and inspire.” His own ex¬

sleep that comes to those who have

hortation was that students remain

done their best. ... The most fortu¬

true to the idealism that comes with

nate among you will be able to say,

being a healer. “You are a healer when

'I occupied some space on Earth and

you understand that the amount of

I did some good. I was a healer.’ ”

health you can actually promote is

Before the presentation of diplo¬

relatively small when weighed on the

mas, students and faculty received

scale of human mortality,” he said.

awards for work of distinction in

“You are a healer when you throw

research, education and clinical care.

► The Leah M. Lowenstein Award:

inch of health, against the odds, as if
immortality were embedded in your

FACULTY

fingertips. And you are a healer if you

► Bohmfalk Prizes: Stuart D. Flynn,

In closing, Dr. Kessler offered the
graduates warm wishes for the future.
“I wish you mornings of great prom¬

Ervin E. Jones, M.D., associate pro¬
fessor of obstetrics and gynecology

away that scale and fight for every

know when it’s time to quit.”

► Dean’s Medical Education Farr Prize:

AWARDS

M.D., associate professor of pathol¬

Ronnie A. Rosenthal, M.D., associ¬
ate professor of surgery
► The Francis Gilman Blake Award:

ogy, and Richard J. Gusberg, M.D.,

Richard Belitsky, M.D., assistant

professor of surgery

clinical professor of psychiatry

► NBI Humanism in Medicine Faculty

► The Betsy Winters House Staff

ise,” he said, “evenings of pleasant

Award: Jack Van Hoff, M.D., associ¬

Award: Anju Nohria, M.D., instruc¬

weariness and nights filled with the

ate professor of pediatrics

tor in medicine
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► Lauren Weinstein Award:
Joanne M. Quinones
► The Winternitz Prize in Pathology:
John Tilton
► Endocrine Society Medical Student
Achievement Award:
Christi M. Cavaliere
► William U. Gardner Thesis Prize:
Alan Cheng
► Louis G. Welt Prize:
Jeffrey T. Reynolds
► American Cancer Society Prize:
John P. Forman
► Peter F. Curran Prize: Nirit Weiss
► M.D./Ph.D. Thesis Prize:
Nicole Ullrich
► Association for Academic Surgery
Research Award: David J. Chang
► The Dr. Louis H. Nahum Prize:

STUDENT

AWARDS

► Parker Prize: Hahnah J. Kasowski
► The Miriam Kathleen Dasey Award:
Michelle A. Barton
► The Norma Bailey Berniker Prize:
Matthew H.T. Bui
► The Dean’s Prize for Community
Service: Heather J. Lynch
► NBI Healthcare Foundation
Humanism in Medicine Student
Award: Lynda S. Kauls
► The Campbell Prize:
Russel C. Huang
► The Perkins Prize: Russel C. Huang
► Merck Book Awards: Lynda S. Kauls
and Ellen A. Komisaruk
► Lange Book Award: James F. Borin

YALE
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► M.D./Ph.D. Award: Matthew H.T
Bui and Charles C. Hong
► Connecticut Society of American
Board of Obstetricians and
Gynecologists Prize:
Ellen A. Komisaruk
► New England Pediatric Society Prize:
Daniel T. Coghlin
► The Society for Academic Emer¬
gency Medicine Award:
Kevin P. Daly
► Connecticut Society of American
Board Surgeons Prize:
Hahnah J. Kasowski
► Peter A.T. Grannum Award: Sydney
C. Butts, Merle A. Carter and
Olivia I. Okereke

Helen M. Chun
► The Harold H. Lamport Biomedical
Research Prize: Robert M. Kalus
► The Ferris Prize:
Kent Kwasind Huston
► The International Health Prize:
Kent Kang Hu
► The Nicholas J. Giarman Prize:
James D. O’Holleran
► Transfusion Medicine/Laboratory
Medicine Award: Tobias T.P. Lee
► Vernon W. Lippard Prize:
Samir S. Shah
► The John P. Peters Prize:
Katherine B. Auerswald
► The Keese Prize:
Naomi S. Donnelley
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Health is a
global affair, EPH
graduates are told
at Commencement

P

eople entering the field of pub¬
lic health face issues that are
becoming more complex by the

day, journalist Laurie Garrett told
graduating students at the EPH Com¬
mencement Day in May. “Your work
will by necessity be global. It will
probably have to be executed with
fewer resources than you have today.”
Ms. Garrett, a medical writer for
Newsday and author of The Coming

Plague: Newly Emerging Diseases in a
World Out of Balance, won the 1996

become true,” she said. “It is the loss

Pulitzer Prize for explanatory journal¬

of the traditional role of public health

fast becoming “one massive, human

ism for her coverage of the Ebola virus

Government no longer wishes to pay

petri dish." Public health workers will

outbreak in Africa. She began her

for it.”

also find themselves dealing with

Commencement remarks by citing the

And in that time, she said, health

with ease across the globe, which is

people whose native languages are
spoken by only a few thousand people

optimism that reigned in public

problems have become more compli¬

health 20 years ago. There was hope,

cated as the population ages, HIV

in remote pockets of the Third World.

she said, that many diseases would be

continues to spread and illness travels

“How do you say 'push’ to a woman

eradicated, changing the role of public

in labor who just came to San Diego

health workers. “For the last 20 years

from a small village in Guatemala?”

at least one aspect of that scenario has

she asked. “Spanish won’t do. No mat¬
ter how many languages you speak, it
isn’t enough.”

Above Commencement speaker Laurie

Graduates cheered and applauded

Garrett chats with professors Lowell Levin

when she criticized the federal

and Elizabeth Claus after the ceremony.

government’s refusal to fund needle

Right Speaker Laurie Garrett.

exchange programs. Students taped

Below Susie Tanefo receives her diploma from

syringes to their mortarboards in a

Dean Michael H. Merson, M.D.

gesture of support for the programs.
As they advance in their careers,
she said, graduates will absorb foreign
languages and cultures, learn how gov¬
ernment works, teach people about
public health and learn to survive
“monsoons” like the one that blew in
during Commencement. Graduates,
friends and families gathered under a
tent on the lawn for the ceremony.
Echoing Ms. Garrett’s thoughts,
Dean Michael H. Merson, M.D.,
said, “This is a time when challenges
to our profession have never been so
many and the needs so great.”
In her class address, student
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speaker Andrea Kim stressed what she

Stock
Options

considered to be the unique quality of
the class. “There is a feeling of
camraderie and respect among all of
us,” she said as she urged her class¬
mates to abandon “comfort zones”
and try get to know others. “Some¬
times we completely miss the oppor¬
tunity to get to know someone be¬
cause of the walls we build around us.

Awash in
appreciation?

Public health is a field where relating
to people is essential.”
Some graduates are continuing
their education and plan to obtain
M.D. or Ph.D. degrees. Others have

Let us keep you from
drowning in capital
gains taxes.

obtained jobs in health care manage¬
ment consulting firms, managed
care firms or organizations such as
the Inter-American Development
Bank and Centers for Disease
Control.

Students taped

In addition to 107 M.P.H.

syringes to their
mortarboards

graduates, two students received

to show their

doctor of public health degrees

support for needle

and 10 students received Ph.D.s.

exchange pro¬
grams, which the

The graduates honored Elizabeth

Clinton administra¬

Claus, Ph.D., M.D., with the

tion had recently

award for excellence in teaching.

declined to fund.

Physician associates celebrate

If the recent bull market
has been good to you, you
will be liable for substantial
capital gains taxes when
you sell your stocks. A gift
to Yale of appreciated stock
owned more than one year
will avoid capital gains
taxes, offer you a significant
charitable tax deduction,
and could provide income
benefits as well.

w

Thirty-two graduates of the Physician Associate Program celebrate in late August in Harkness

Yale University
Office of Planned Giving

Auditorium. U.S. Rep. Nancy Johnson, a Republican who represents Connecticut's 6th district,
urged the new practioners to use their knowledge to transform themselves and their communi¬
ties. She also urged them to treat the whole patient, not a person with symptoms. "Restoring a
holistic approach is extremely important,” she said. “We are struggling with it as a society even
to the point where Congress is legislating—always a dangerous sign.”
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Smiles of relief after the boards

N

A team of three Yale Physician Associ¬
ate students took first prize in the
medical challenge bowl playoffs held
in March at the annual American
Academy ol Physician Assistants
(AAPA) Northeast Regional Meeting
on the campus of the University of
Medicine and Dentistry ol New Jer¬
sey. The meeting was sponsored by the
New Jersey State Society ol Physician
Assistants and the Northeast Consor¬
tium of PA Programs. Teams from 14
regional PA programs competed. The
Yale program was represented by firstyear students Tony Barrett, Broheen

Strawberries and champagne greeted members of the Class of 2000 in June as they emerged from

Elias and Debra Strigun and by a
second-year team composed ol Aviva

their board examinations in Harkness Auditorium. The refreshments, and a barbecue that followed

Asnis, Grace Barresi and Joe Castro,

on Harkness lawn, were gifts from the Class of 2001.

who were last year’s champions. The
Barrett-Elias-Strigun team took first
place against a team from Rutgers
University and moved onto the annual

In doctor’s black bag, decades

Student Academy of the AAPA/Searle
National Medical Challenge Bowl in

of family history

I

Salt Lake City, where they reached the
semi-finals May 24.

n choosing a medical career,

bearing the initials JL to Providence

many budding physicians receive

ophthalmologist Frank Dimmit, M.D.

friendly bits of advice and the occa¬

In 1954, Dr. Dimmitt passed the bag

sional keepsake from established phy¬

on to a young family friend who then

sicians hoping to encourage them in

was beginning medical school at Yale.

their pursuits. When Alison Days

The student, Gerard N. Burrow, even¬

received just such encouragement as

tually would become dean of the

a second-year medical student in the

School of Medicine from 1992

form of a battered old medical bag last

to 1997.

year, she also got a piece of her own

When Dr. Burrow’s daughter,

family’s past. How she came to receive

Sarah, entered medical school, he

the bag involved a remarkable series

handed the bag down to her. She later

of coincidences.

returned it to the Dimmitt family in

When Ms. Days’ grandfather John

Providence, entrusting the bag to her

Langdon, M.D., a Providence pedia¬

father’s childhood friend, Sterling

trician, died more than 40 years ago,

Dimmitt, the son of Frank Dimmit.

his wife gave his black medical bag

Mr. Dimmit, not a doctor him¬

The Yale champions, from left: Strigun,
Barrett and Elias

self, recalled that the granddaughter
of the original JL was herself an
aspiring pediatrician. He decided
that Alison Days should have the
bag. So, the historic, much traveled
medical bag returned to its original
family and Ms. Days now guards the
family treasure.

Shannon Turley was presented the
1998 Richard K. Gershon Pre- and
Postdoctoral Fellowship Award.
This award in the amount of $16,750,
will support her research project

Functional Pathways of Antigen
Processing in Dendritic Cells. She is
a graduate student in the laboratory

Alison Days with former Dean Gerard Burrow
and her parents, Ann R. Langdon and Drew S.
Days III.

5 i

of Ira Mellman, Ph.D., in the
Department of Cell Biology.
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Holding on to idealism

Stock
Option #1

A Yale medical student surveys her classmates
and finds that cynicism is actually on the wane.
By Rachel Engers

“If you anticipate that you can save

seeing all these sick people,’’ Dr. Eron

every patient, you’re bound to be
disappointed. ”

said during a telephone interview

F

— A medical school professor

from his home, in Michigan. “But it
was not a successful defense, because
they became more anxious, more

or decades, medical educators
have wrestled with a phenom¬
enon that goes to the core of

cynical and less humanitarian.”
When Dr. Sanders entered medical
school in 1993, she had some concern

training young physicians. Most, if

that the experience would harden her.

not all, enter medical school filled

“One of the things everyone going to

An OUTRIGHT gift
of stock to Yale can be
deducted at todays fair
market value and you
can replace that stock or,
if you wish, diversify your
portfolio while avoiding
capital gains tax.

with youthful idealism and the desire

medical school hears about is what it

to help others. Many leave four years

does to you—that it is this intensely

later more cynical about medicine and

molding experience,” she recalled.

their ability to make a difference.

Her faculty advisor, Alvan R.

Your 1990

Feinstein, M.D., encouraged her to

purchase price:

One might think, in this costconscious era in health care, that

Here’s how it works:

$4,000

make the subject her thesis topic. She

cynicism would be on the rise. But

presented her work at Student Re¬

the current generation of medical

search Day in 1997.

Today's market
value/your tax

students has baffled the conventional

From the start, Dr. Sanders as¬

wisdom. Comparing attitudes in the

sumed her classmates would be much

deduction:

$10,000

1990s to opinions recorded in 1955

more cynical than the students tested

Dollar savings from

and 1957 surveys at Yale, Lisa Sanders,

in Dr. Eron’s study, because she be¬

tax deduction:

M.D. ’97, found cynicism to be in

lieved cynicism to be more prevalent

$3,960
(39.6%)

fact declining.

in American culture today than it was

Net cost to you:

$6,040

Mental illness, suicide and chemi¬

in the 1950s. She expected that beliefs

cal dependency occur in higher fre¬

such as When you come right down to

quency among physicians than in the

it, medicine is a business, and it’s up to

Cost basis in newly

general population. Studies at Yale

the doctor to sell his skills for as much as

acquired stock:

and elsewhere have shown that the

the market will bear might be more

medical school experience promotes

common sentiments now than 40

cynicism among at least a portion of
the student body. Leonard D. Eron,
Ph.D., now a professor of psychology

Capital gains

years ago.
Her results showed little difference

tween students in 1957 and 1995. But

for Social Research at the University

statistically, her survey indicated that

of Michigan in Ann Arbor, studied the

most tended to become either slightly

topic in depth while on the Yale psy¬

more cynical or much less cynical in

chology faculty during the late 1950s.

1995. Dr. Eron’s 1957 study, on the

His survey analysis showed not only

other hand, showed the opposite

that medical students became increas¬

trend: Most students then became ei¬

ingly cynical over the course of their

ther much more cynical or slightly less

education, but also that the phenom¬

cynical. Dr. Sanders’ reaction? “I was

enon was peculiar to the discipline.

astonished.”
Dr. Eron wasn’t. “I would expect

same time by Dr. Eron did not exhibit

them to be less cynical,” he said, “be¬

increased cynicism.

cause medicine has made so much

How did he explain it? “Students
just defended against the anxiety of

YALE

MEDICINE

tax avoided:
$1,680
(28% of $6,000)

in the average level of cynicism be¬

and a research scientist at the Institute

Nursing and law students tested at the

$10,000

progress in the last 40 years.”
55 ►
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Nobelist returns to New Haven for Student Research Day

G

rowing up in New Haven as
the son of a Yale pharmacolo¬
gist, Allred G. Gilman, M.D.,

Ph.D., recalls feeling at home in the
laboratory from an early age. “My fa¬
ther was spectacularly good at show¬
ing me the joy of science,” said Dr.
Gilman, who also pursued a career in
pharmacology and in 1994 won the
Nobel Prize for his research into G
proteins. He discussed research into
the proteins, his own and that of other
scientists, during the nth Annual Lee
E. Farr, M.D., Lecture on Student
Research Day, in May.

“G proteins mediate everything
from sex in yeast to cognition in
humans,” said Dr. Gilman, the
Raymond and Ellen Willie Distin¬
guished Chair in Molecular Neuro¬
pharmacology, Regental Professor and
Chairman, Department of Pharmacol¬
Above Matthew Bui explains his re¬
search The Regulation of Nuclear Trans¬

ogy at University of Texas Southwest¬
ern Medical Center in Dallas. The

port of Influenza vRNPs to Eric Hughes.

proteins have been likened to a

Left For her paper, Motherhood and

switchboard operator who receives

Medicine: A Study of Women from Yale

messages and makes sure they reach

School of Medicine 1922-1999, Ruth
Potee, M.D., '99, researched women

the proper recipient. Failure in that

who balanced the demands of careers
in medicine with their roles as mothers.
Below Sydney Butts explains her re¬
search The Correlation Between the
Glutomate Receptor GluR2 and

task can cause disease. Researchers
have linked malfunctioning G pro¬
teins to alcoholism, diabetes, cancer¬
ous tumors and cholera. Dr. Gilman

Calbindin D-28K in the Developing

and Martin Rodbell, Ph.D., a scientist

Gerbil Cochlear Nucleus to Alfred

emeritus at the National Institute of

Gilman, who received the 1994 Nobel
Prize for his research into G proteins.
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Environmental Health Sciences in
North Carolina, shared the Nobel

cally at the literature.”
“It changes your perspective

Prize for identifying G proteins and

when you’re in a clinical situation to

their role in the signaling process.

have that research perspective,” said

John N. Forrest Jr., M.D., director
of the Office of Student Research, said
the day “celebrates 159 years of a tradi¬

Nicole Ullrich, another award¬
winning student.
This year students prepared 63

tion unique in American medicine.”

posters showing the results of their

Yale requires medical students to write

studies. Five students made oral pre¬

a thesis on a research project in order

sentations of their award-winning

to graduate. “The value of the thesis,”

theses. They were: Dr. Reynolds,

Dr. Forrest said, “is not the concept of

Phenotypic Expression of Glucorticoid-

trying for a scientific career, but to

Remediable Aldosteronism in a Large

teach that all physicians are scientists.”
“This is the day that a lot of us

Kindred (Internal Medicine); Alan
Cheng, JAK3 and the Pathogenesis of

look forward to,” said Dean David

Severe Combined Immunodeficiency:

A. Kessler, M.D., “because it really

Insights into Structure and Function

defines us as a school.”
“Being in a laboratory situation
and working with a leading scientist

(Immunobiology); John Forman,

Recombinant Vesicular Stomatitis Vi¬

A LIFE-INCOME gift of
stock to Yale may enable
you to increase your
income, reduce and defer
capital gains tax, and entitle
you to a tax deduction
equal to approximately
half your stock’s value.

ruses Expressing HIV-i Gag and Env

in the field of interest is really a

Genes Generate HIV-Like Particles

critical part of my medical educa¬

and Elicit Anti-HIV Immune Re¬

tion,” said Jeffrey Reynolds, one of

sponses in Mice (Pathology); Nirit

Five students who won awards for

Weiss, Carotid Body Chemoreceptors:

their theses. “I feel that, having

Mechanisms of Neurotransmitter Re¬

done this project, I have access intel¬

lease (Pediatrics); and Dr. Ullrich,
Properties and Function of Chloride

lectually to most of the things I can

Stock
Option #2

read in the literature. Without it, I

Channels in Human Glial Tumors

wouldn’t really be able to look criti¬

(Neurobiology).

Here’s how it works:
A 75-year-old graduate
with a 73-year-old spouse
contributes $10,000 of
stock currendy yielding
2.0% to a charitable gift
annuity.
Donor and spouse
receive: a guaranteed
annual income:
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she found that the class of 1995

In addition, the advent of managed

(5.5%)

showed a disturbing tendency to

health care and falling physician in¬

blame the patient for the illness. “Stu¬

comes may serve as a screening

dents,” she wrote, “seem to have both

A tax deduction of: $5,000

mechanism, scaring off those who

unrealistic expectations of patients

Capital gains tax

would enter medicine for less than al¬

and excessive faith, not currently sup¬

due in year of gift:

truistic reasons. “Knowing that the

ported by scientific evidence, in the

field has some problems and still

efficacy ol lifestyle changes.”

wanting to make a difference—is

Dr. Sanders’ research also showed

there a better definition of idealism

that students became less discouraged

than that?” Dr. Sanders says of her

and more humanitarian with in¬

classmates.
Still, her research showed that the

during her studies at Yale and at¬
tributes this in part to what the study

have become more cynical in the

of medicine taught her about evaluat¬

course of their education. Of the 72

ing problems and to simply growing

students (or 77 percent of the class)

up. “Adulthood is a decynicizing pro¬

participating in her study, 49 reported

cess,” Dr. Sanders says. “The essence

increased cynicism.

of cynicism is a suspicion of ‘them’—
them as being different from you. The

cine at Yale-New Haven Hospital, Dr.

process of adulthood teaches us how

Sanders hopes next year to further

similar we really are.”

study the connection between cyni¬
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Please allow us to
send you a proposal.

creased teaching from attending phy¬

dents continue to believe that they

cism and blame-laying. In the survey,

$0

sicians. She hersell became less cynical

majority of graduating medical stu¬

Now a resident in internal medi¬

$550

xiiKv?
Yale University
Office of Planned Giving
P.O. Box 2038
New Haven, CT 06521
(800) 445-6086
planned.giving@yale.edu

Rachel Engers is a free-lance writer.
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NEW

BOOKS

Atlas on the Surgical Anatomy of Laryn¬
geal Cancer by John A. Kirchner,

Between the Raindrops by David V.

oi medicine,

Pecora, M.D. ’41, HS ’49, Vantage

Yale University

M.D., professor emeritus of surgery

Press, Inc. (N.Y.) 1998.

Press 1998.

Clinical Electrocardiography: A

The Surgeons

Simplified Approach by Ary L.

Surgeon:
Theodor Bilroth

(otolaryngology), Singular Publishing
Group Inc. (San Diego/London) 1998.

The Beach by Lena Lencek and

Goldberger, M.D. ’74, HS ’77,

Gideon Bosker, M.D., assistant clini¬

Mosby (St. Louis) 1998.

cal professor of surgery (emergency
medicine). Viking (N.Y.) 1998.

The Bends: Compressed Air in the His¬
tory of Science, Diving, and Engineering
by John L. Phillips, M.D. ’92, Yale
University Press 1998.

Guilty by Reason of Insanity: A
Psychiatrist Explores the Minds of Killers
by Dorothy O. Lewis, M.D. ’63, HS
’65, Fawcett (N.Y.) 1998.

(1829-1894) vol¬
ume IVby Karel
B. Abolson,

GUILTY

M.D. ’52, Kabel

by REASON
of INSANITY

Publishers (Rockville,
Md.) 1998.

The Power of Hope: A Doctor's Perspective by Howard Spiro, M.D., professor

The Program for Humanities in Medicine
1998-1999

LECTURE

SERIES

Lectures, free and open to the public, begin at 5 p.m. in the Beaumont Room, 333 Cedar Street. Refreshments at

4:30 p.m. For information call Howard Spiro or Clara Gyorgyey at (203) 785-5494.
DECEMBER 10

FEBRUARY 4

APRIL 1

The Human Encounters
in Medicine
The McGovern Lecture

Hygeia Revisited: Lessons to Comfort
Michael Berman, M.D.

Meeting the Challenge of
Alternative Medicine

Clinical Professor of Obstetrics & Gynecology

Joseph J. Jacobs M.D., MBA

John Stone, M.D.

Yale University School of Medicine

Professor of Cardiology
Emory University School of Medicine

Former Director
Office of Alternative Medicine at NIH

FEBRUARY 11

Young Cushing: The Right Stuff

APRIL 15

DECEMBER 17

Robert M. Crowell, M.D.

When a Patient Wants to Die

Covert Communication in Clinics,
Classrooms, Corporations
& Courtrooms
The Bayer Lecture

Professor of Neurosurgery

Charles F. McKhann, M.D.

University of Massachusetts Medical School

Professor of Surgery
Yale University School of Medicine

FEBRUARY 25

Edgar Pierce Professor of Psychology

Match Day: Stories of Adoption
& Reunion

Harvard Medical School

Morris A. Wessel, M.D.

Howard Levitin, M.D.

Clinical Professor Emeritus of Pediatrics

Professor of Internal Medicine

JANUARY 7

Yale University School of Medicine

Yale University School of Medicine

Conflict In Classical Arabic Medicine

Diana K.R. Jowdy, MA

Robert Rosenthal, Ph.D.

APRIL 29

Forty Years of Medical Education at Yale

Dimitri Gutas, Ph.D.

Ph.D. Candidate

MAY 6

Professor of Arabic Languages & Literature

American Culture

Yale University

University of Michigan

Carlo Levi, MD & the Italian Anti-Fascist
Movement

JANUARY 21

MARCH 4

From Quarantine to Condoms:
HIV Control in Cuba*

Cultural Competence? Immigrant
Patients American Doctors

Harvey Mandell, M.D.

Helena Hansen, MS

The Robert Penn Warren Lecture

M.D./Ph.D. Candidate

Anne Fadiman, BA

Yale University School of Medicine

Editor of The American Scholar

JANUARY 28

MARCH

My Brother, Madness & Survival:
Memoir

Eye of Doctors: Enhancing Observational
Skills With Fine Arts

18

Jay Neugeboren, Ph.D.

Irwin M. Braverman, M.D.

Professor of English/Writer in Residence

Professor of Dermatology

University of Massachusetts

Yale University School of Medicine

Retired Internist
David Ward, Ph.D.
Associate Professor of Italian
Wellesley College
MAY 13

A Surprise
Jacques Pepin, MA
Master Chef, Columnist, Author, Teacher
PBS-TV Host
Note: Lectures marked by an asterisk (*) are co¬
sponsored by the Office of Multiclutural Affairs.
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NEWS

included Roger Hollan, M.D. ’45

’40s
Hunter H. Comly, M.D. ’43, retired
from practice in 1992 following the

third most cited life scientist. He has

’45 from Cape Cod. William Jenney,

trained over 25 young investigators,

M.D. ’45, and his wife Marge came

many of whom are recognized experts

from Massachusetts as well, while

in their fields. Dr. Dinarello was the

Dick Breck, M.D., ’45 came from

winner of the Borden Undergraduate

Connecticut.

death of his wife, Mary Ellen, and
moved to San Diego. He reports
doing some locum tenens work and six
days per month of child psychiatry.
He travels regularly to see theater and
opera in Oregon and Utah and
returned to New Haven in June for
his 55th reunion. He writes: “Hope to
see more classmates for the 60th!”

’50s
Chief of surgery at

Asa Barnes Jr., M.D. ’59, HS ’65,
reports hearing from missionary and
medical colleagues in Nairobi, about

Brunswick, N.J.,

Ralph S. Greco,

after 18 years as clinical professor of

Californ2ia at Irvine, has made three
trips to Kenya on behalf of the World

doctor of science degree for his long,

Medical Mission. While there he

multifaceted career as a pediatrician.

serves as pathologist for the Kijabe

Retired from practice since 1992, Dr.

Medical Center, which analyzes

Wessel remains a clinical professor of

specimens for 42 hospitals in coun¬

pediatrics at Yale.

tries along Africa’s eastern coast. “The

Richard W. Breck, M.D. 45 wrote

packed with patients and bodies,’’

with news of his classmates. James

says Dr. Barnes, who heard about the

R. Mason, M.D. ’45, of Ormond

bombing Irom his colleagues in Africa

hospitals, including Kijabe, were

of his home. A tornado also came

Hospital in New

there. Dr. Barnes, who retired in 1995

Connecticut College awarded Morris

summer that came within 100 yards

the Robert Wood
Johnson University

the bombing of the U.S. Embassy

A. Wessel, M.D. ’43, an honorary

days during the wildfires of early

Research Award in Medicine in 1969
for his medical school thesis.

pathology at the University of

Beach, Fla., was evacuated for several

Information listed him as the world’s

from Texas, Charles McLean, M.D.

by e-mail. He has also traveled to
Vietnam, where he arranges exchange

M.D. '68, HS ’73,
keeps his hands
and eyes nimble by
producing abstract
and representa¬
tional art in stone
and wood. His
work was exhibited

o
O

in the spring at the

g

Quietude Gallery

|

in East Brunswick.
He has shown at several other
galleries and in the Johnson &
Johnson Worldwide Corporate
Headquarters.

trips for American physicians and
donations of used medical equipment

close to his home this year. Elliot R.

such as cardiopulmonary bypass

Reiner, M.D. ’45, and his wife,

machines and pediatric respirators.

’70s

When not traveling, Dr. Barnes and

Richard D. Bey, M.D. ’79, was

his wife, Jean, live on their ranch on

named outstanding teacher

England in June 1997. Alice Shepard

the East Fork of the Gila River in

for 1998 by the residents in

Carey, M.D. ’45, retired from medical

New Mexico.

family medicine at Wake Forest

Catherine, traveled on a Smithsoniansponsored tour to Scotland and

University Medical School,

practice in Japan and now lives in
Oakland, Calif. She returned three

’60s

Winston-Salem, N.C.

times to Japan during the past year,
and traveled to Turkey as well. Six

Charles A. Dinarello, M.D. ’69,

Robert B. Diasio, M.D. ’71, chair

1945 classmates attended the John P.

professor of medicine at the Univer¬

of the department of pharmacology

Peters, M.D., Symposium, June 5 and

sity of Colorado School of Medicine

and toxicology and director of the

6, during their reunion. (See related

in Denver, was elected to the Na¬

division of clinical pharmacology at

article in Reunion section.) Richard

tional Academy of Sciences in April.

the University of Alabama (UAB)

Peters, M.D., ’45 son of the Yale

Dr. Dinarello is a world expert in

School of Medicine, was one of 55

professor, came from California and

cytokines, clinically important

physician-scientists elected recently

provided reflections on his father’s life

molecules that regulate the immune

to the Association of American

as an early advocate of socialized

and inflammatory responses. He was

Physicians. Dr. Diasio was also

medicine who was attacked by

one of the first scientists to work on

recently named associate director

conservatives during the late 1940s

the molecular biology and cloning of

for basic science research in the UAB

and early ’50s. Others attending

cytokines. The Institute for Scientific

Comprehensive Cancer Center.
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Edward C. Halperin, M.D. 79,

outpatient group practice, and the co¬

daughter, Connie, was also born in

has been named the L.R. Prosnitz

author of seven books for children

New Haven. Dr. Tan, newly board

Professor of Radiation Oncology at

and parents.

certified in pathology, is now an
oncological pathology fellow at

the Duke University Medical Center,
where he chairs the department of
radiation oncology and is professor of
pediatrics. The third edition of

Pediatric Radiation Oncology, which
he co-authored with three colleagues,
will be published this year. The first
Russian language edition will be
published in 1999.

Eric P. Winer, M.D. ’83, HS ’87,
B.A. 78, was named director of the
Breast Oncology Center at DanaFarber Cancer Institute/Brigham and

First it was marriage and then

Women’s Hospital in Boston. For the

graduation for Amy E. Taylor, M.D.

previous six years. Dr. Winer served

’98, B.A. ’93, and Jaimie D. Nathan,

as co-director of the Multidisciplinary

M.D. ’98, B.S. ’93, who married in

Breast Program at Duke University

Buffalo in early May before their

Medical Center in North Carolina.

graduation from the medical school

Jesse B. Jupiter, M.D. ’72, director
of the Orthopaedic Hand Surgery

Memorial Sloan-Kettering
Cancer Center.

at month’s end. Dr. Taylor began
a residency in pediatrics at the

Service at the Massachusetts General

’90s

Hospital, has been named professor

Michael C. Brown, M.D. 93,

Hospital and Dr. Nathan began a

of orthopaedic surgery at Harvard

married Melissa A. Brown in March

general surgical residency at the

in New York City. Dr. Brown is a

Duke University Hospital.

Medical School.

University of North Carolina

gastroenterology fellow at the
Professor of Psychiatry Charles

University of Washington Medical

“Chip” E Reynolds III, M.D. ’73,

Center. His wife is a television

was appointed senior associate dean

news producer.

at the University of Pittsburgh School

Marc A. Weinstein, M.D. ’93, and
Kristine M. Medina married in
March in West Orange, N.J. Dr.
Weinstein is a resident in orthopedic

of Medicine overseeing faculty affairs

Imtiaz A. Chaudhry, M.D., Ph.D.,

and monitoring the development of

HS ’94-98, has been accepted as a

His wife is a senior account director

the curriculum. He is also director of

fellow in oculoplastic-surgery in the

at Pharmadesign, a pharmaceutical
marketing firm.

the Sleep and Chronobiology Center

Department of Ophthalmology at

and of the NIMH-General CRC on

Baylor College of Medicine in

Late-Life Mood Disorders.

Houston.

’80s

Andreas Eicher, M.P.H. ’96, M.F.

surgery at Yale-New Haven Hospital.

Associate professor of surgery and
public health sciences at the

Kathleen M. Craig, M.PH. ’85, of
Bronxville, N.Y., recently became
director of consulting services for
NewSolutions Inc., an information
services company serving the health
care industry in New Jersey, New
York and Pennsylvania. She is the

’96, director of Disha, which means

University of Toronto, James G.
Wright, M.P.H. ’91, has been

“direction” in Hindi, a community

awarded the 1998 Annual Gold Medal

health and development program,

for Research in Surgery of the Royal

works out of the Nav Jivan Hospital

College of Physicians and Surgeons

in Bihar in eastern India. He was

of Canada. He was also recipient of

visited recently by classmates Bindo

the 1998 J. Edouard Samson Award

Mahanti, M.P.H. ’96, and Rachel

of the Canadian Orthopaedic

Salks, M.P.H. ’96.

past president of the New York

Foundation/Canadian Orthopaedic
Association (their highest research

Society for Health Planning, an
It was a May wedding for David L.S.

award), and a five-year Scientist

organization of health professionals
in the greater New York area.

Morales, M.D. ’95, and Mary

Award of the Medical Research

Elizabeth Collins in Saddle River,

Council of Canada.

N.J. Dr. Morales is a resident in
Burlington psychiatrist and Univer¬
sity of Vermont College of Medicine
clinical associate professor David

Fassler, M.D. ’82, received the 1998
Annual Exemplary Psychiatrist Award

general surgery at Columbia-Presbyterian Medical Center in New York.
His wife is a pediatric case manager in
AIDS health services at the Jersey
City Medical Center.

from the National Alliance for the
Mentally Ill (NAMI). The award was
presented at the American Psychiatric

Before recently moving to New York

' ssociation’s annual meeting in

City, DonfengTan, M.D., HS ’94-

loronto in June. Dr. Fassler is clinical

98, and Hong Zou, M.P.H., had a

director of Otter Creek Associates, an

58

baby daughter, Christina. Their first
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OBITUARIES

FRANK R. ALLEN

MELVIN J. COHEN

Frank R. Allen, M.D. ’51, of

Professor emeritus of biology Melvin

Wolfeboro, N.H., died in Huggins

J. Cohen, Ph.D., died Feb. 22 in

Hospital on July 17. He was 76.

Berkeley, Calif. A member ol the

Dr. Allen graduated from Yale

National Academy of Sciences, he was

School of Medicine after serving as a

69 and had been affiliated as a neuro¬

pilot in the Naval Air Corps during

biologist with Yale for 29 years.

World War II. He practiced family

Dr. Cohen joined the Yale faculty

medicine in Wolfeboro for 38 years

in 1969. His research focused on ele¬

and was chief of medicine at Huggins

ments influencing the shape of nerve

Hospital. In 1984, he was voted

cells and the pattern of synaptic con¬

Wolfeboro’s Citizen of the Year.

nections between them, especially in

Retiring from family practice in

injured neurons. His work has dem¬

1986, Dr. Allen moved to Tucson,

onstrated that axonal die-back follow¬

Dr. Glorig helped develop smaller
and more effective hearing aids and
set standards for noise levels on the
job. He was the founder, in 1973, of
the American Auditory Society, an as¬
sociation of professionals working to
improve understanding and treatment
of hearing and ear disorders. Follow¬
ing service in the Army during World
War II, Dr. Glorig was an assistant
professor at Yale, leaving in 1948 to set
up a hearing disorders center at Walter
Reed Army Hospital.

Ariz., where he practiced emergency

ing spinal injury is caused primarily

medicine at the Davis-Morrison

by excess amounts of calcium ions,

HARRIET P. LEACH

Air Force Base Hospital until 1991.

which can be blocked by direct elec¬

Harriet P. Leach, M.D. ’35, died at the

He returned to Wolfeboro in 1992 to

tric current.

Shaughnessy-Kaplan Rehabilitation

lull retirement.

Hospital in Salem, Mass., on May 25.
She was 93.

EDWARD F. EDINGER
ALBERT S. ATWOOD
Albert S. Atwood, M.D. ’45, of

Considered one of the leading Jungian
analysts in America, Edward F.

Stonington, Conn., died Aug. 8. He

Edinger, M.D. ’46, HS 51, died of

was 77 years old. He was active in

cancer on July 17 at his home in Los

medical school alumni affairs until his

Angeles. He was 75.

death, serving on the executive com¬

Dr. Edinger published numerous

mittee of the Association of Yale

books on the interplay between sym¬

Alumni in Medicine and as secretary

bols and psychology, drawing on the

for his class.

concepts of Carl Jung. Dr. Edinger

Raised in West Hartford, Conn.,

was a supervising psychiatrist at

Dr. Atwood attended the University

Rockland State Hospital in

of Connecticut, where he played foot¬

Orangeburg, N.Y., and later was a

ball and held the rank of captain in

founding member of the C.G. Jung

the ROTC. In 1945, he graduated

Foundation in Manhattan and the

from the School of Medicine and

C.G. Jung Institute of New York. He

went on to serve in the United States

was president of the institute from

Medical Corps in Japan. He did his

1968 until 1979, when he moved to

orthopaedic surgery residency at

Los Angeles. There, he continued his

Grace-New Haven Hospital and prac¬

practice and his writings until shortly

ticed orthopaedics at Charlotte

before his death.

Dr. Leach was a general
practitioner in private practice in
Chelmsford and Billerica, Mass., for
nearly 50 years before retiring a decade
ago. When she opened her practice in
1940, she found herself covering for
numerous physicians in her area who
had gone on to service during World
War II. According to the nephew with
whom she lived at the time of her
death, she ran her practice out of her
own house and charged very modest
fees. Dr. Leach was associated with
Lowell General Hospital, St. Joseph’s
Hospital and St. John’s Hospital, all in
Lowell, Mass. An active member of
the Appalachian Mountain Club, she
climbed 40 of the 48 4,000-foot
mountains in New Hampshire. She
also never lost her interest in zoology,
which was her undergraduate major at
Smith College.

Hungerford Hospital in Litchfield
County, Conn., for 25 years.
In 1977, he was named the first

ARAM GLORIG

chair of the Department of Rehabili¬
tation at Lawrence and Memorial
Hospitals in New London. After retir¬
ing from practice in 1987, he worked
as a surveyor for the national organi¬
zation, the Joint Commission for the
Accreditation of Hospitals.
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ROBERT A. MACKEY

Aram Glorig, M.D., HS ’46-47, a
leading expert on the effects of work¬
place noise and a former Yale faculty
member, died June 22 at the South
Coast Medical Center in San
Clemente, Calif. He was 92.

Robert A. Mackey, M.D. ’71, died
April 19 in York, Maine, where he had
lived for 22 years. He was 52.
After completing his residency at
LJniversity Hospitals in Cleveland, he
served as a major in the U.S. Air

5 9

Force, as a pediatrician. Dr. Mackey

Standish joined the surgical staff at

from Columbia College and a medi¬

then set up a pediatric practice and

Hartford Hospital, where he spent his

cal degree from the College of Phy¬

was on the medical staff at York Hos-

entire career, except during World

sicians and Surgeons of Columbia

pital. An avid sports enthusiast, he

War II when he served in the Navy.

University. Dr. Zuger did his resi¬

was nicknamed the “Voice of York”

He started the surgical residency

dency training in pediatrics at Yale-

for his work as the sports announcer

program at the hospital and served as

New Haven Hospital and the

for York High School.

director of surgery. He was former

Brooklyn Jewish Hospital, and in

president of the New England

psychiatry at Bellevue Flospital.

Surgical Society.

In addition to maintaining a pri¬
vate practice in child and adult psy¬

JOHN G. MARTIN

chiatry in New York City, he was staff
John Garthwaite Martin, M.D. ’33,
B.S. ’29, of Scotland, Conn., died

KENNETH C. STEELE

hospitals and for 30 years at the

at Windham Hospital on May 3.

Kenneth C. Steele, M.D. ’45, HS ’46,

He was 90.

M. S. ’42, died July 11 at St. Luke's

After completing medical school at

psychiatrist at Roosevelt and Bellevue

Memorial Hospital Center in New

Yale and interning at Hartford Hospi¬

Hartford, N.Y. He was 79 years old.

tal, he began a family practice in West

Following his graduation from

Hartford, Conn., in 1933, which he

Yale, he served as a Captain in the

continued, except for service as a

U.S. Army Medical Corps. In 1956, he

medical officer in the Army Air Corps

established a surgical practice in Utica,

from 1942 to 1946. Dr. Martin retired

N. Y. After retiring from practice, he

in 1983 and pursued his varied inter¬

served as medical director of Mohawk

ests in gardening, bird watching, pho¬

Valley General Hospital.

Greenwich Hospital in Connecticut.
Dr. Zuger was a pioneer in the study of
male homosexuality, arguing for 30
years that the condition is present from
birth, the result of innate biochemical
or genetic factors. Much of his work
on gender identity has since been vali¬
dated by more sophisticated studies.

IN

MEMORIAM

tography and his grandchildren.

ROBERT L. STEIN
CLIFFORD B. REIFLER

Robert L. Stein, M.D. ’54, died of

Clifford B. Reifler, M.D. ’57, died at

cancer at his home in Pleasant Hill,

Strong Memorial Hospital in Roches¬

Calif., on May 10, 1997. He was 68.

ter, N.Y., on May 12. He was 66.

The School of Medicine has received
notification of the death of the
following persons:

’60

Stanley M.K. Chung, M.D.

While at Yale, he was the only

April 21, 1998

medical student in the Yale March¬

Aram Glorig, M.D., HS ’46-47

University Health Service at the Uni¬

ing Band, playing the clarinet. Dr.

June 22, 1998

versity of Rochester from 1970 until

Stein did a straight surgical intern¬

his retirement in 1994 and held several

ship at the University of North

Dr. Reifler served as director of the

positions at Strong Memorial Hospital

Carolina in Chapel Hill. He spent 12

including that of medical director

years in the Army as a general prac¬

from 1983 to 1985. He was considered

titioner. After resigning his commis¬

a leader in helping to establish a pub¬

sion with the rank of lieutenant-

lic health model for college health ser¬

colonel in 1967, he spent a year as a

vices, directing resources toward pre¬

National Institutes of Health fellow

vention and improving the living and

in neuroradiology at the University

working environments of students.

of California, San Francisco. Follow¬

Dr. Reifler served as president of the

ing two years as a radiologist at the

American College Health Association

VA hospital in San Francisco, he be¬

for 1977-78. He was senior editor of

gan private practice in radiology,

the Journal of American College Health

which he continued for 16 years un¬

from 1983 to 1996.

til his retirement in 1994.

April 24, 1998

April 6, 1998

BERNARD ZUGER

April 19, 1998
John G. Martin, M.D.

’33

May 3, 1998

’31

Rhoda M. Mickey, M.D.
February 3, 1998

’57

Clifford B. Reifler, M.D.
May 12, 1998

’54
’25

W. Adams Standish, M.D.
May 29, 1998

B.A. ’22, died on May 29 in West

Bernard Zuger, M.D., HS ’32-33, died

Hartford, Conn. He was 98.

of a stroke on April 19 at the age of 92.
Dr. Zuger was born in Russia and

dency at Barnes Hospital in St. Louis,

emigrated to New York City at age

following his studies at Yale, Dr.

8. He received his bachelor’s degree

6o

’71

Robert A. Mackey, M.D.

July 11, 1998

W. ADAMS STANDISH

After completing a surgical resi¬

’71

William P. Koughan Jr., M.P.H.

John Keith Rose, M.D.

Welles Adams Standish, M.D. ’25,

’51

Sumner Goldenthal, M.D.

Charles F. Stroebel, M.D.

’72

April 10, 1998
Douglas R. Wilkie, M.D.

’43

May 21, 1998
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Back on Cedar Street, 600 celebrate
John Peters, the Yale System and reunions
By John Curtis

M

ore than 400 medical alumni and friends and
close to 200 public health alumni gathered in
New Haven June 5 and 6 for a reunion week¬

end that featured a New England clambake, the roasting
of retiring public health professor Lowell Levin, D.Ed.,
and a symposium on John P. Peters, M.D., a legendary
Yale professor accused of disloyalty in the McCarthy era.
Alumni began trickling into the school Lriday, June
5, for a series of lectures sponsored by the Yale Surgical
Society in the Hope Building. Alumni also toured the
historical library and Yale-New Haven Hospital. AYAM
President Nicholas M. Passarelli, M.D. ’59, opened the
weekend with welcoming remarks in the Hope Building.
Robert H. Gifford, M.D., deputy dean for education,
made a presentation on The Yale System, Its Evolution,

Its Strengths and Problems.
At a symposium Saturday morning, speakers de¬
scribed the life and achievements of Dr. Peters, known
for his pioneering work in metabolism and his fight to
clear his name during the McCarthy era, when his loy¬
alty was questioned by a review board.
Before a buffet luncheon in Harkness Hall, alumni
attended presentations on research at Yale by three pro¬
fessors who discussed new lines of inquiry in hyperten¬
sion, women’s health and molecular psychiatry.

IN THIS REPORT

John Peters’ legacy 62
Class reunion reports 64
The Yale System revisited 66
A global perspective at EPH 68
Surgical society bestows honors 69
A glimpse into the lab 71
Distinguished alumnus 71
REUNION 1999: JUNE 4 AND 5

Toby Appel leads alumni on a tour of the Historical Library.

Symposium honors a hero of metabolism
research who fell victim to McCarthy

A

t a symposium on John P. Peters, M.D., speakers
paid tribute to one of the nation’s leading experts
in metabolism who stood up to McCarthyism in

the 1950s.
A nephrologist who taught at Yale from 1922 until
his death in 1955, Dr. Peters came to national attention
in the 1930s as secretary of the Committee of 430 Physi¬
cians, a group that advocated reforms that have become
standard features of modern medicine. They believed
that the health of the public should be a concern of gov¬
ernment and that government should be involved in
providing medical care. During the McCarthy era, Dr.
Peters’ views and his signature on open letters espousing
liberal causes surfaced as evidence of his alleged disloy¬
alty to the United States. Although loyalty boards twice
dismissed the case against him, a third board found his
loyalty questionable and he was removed as a member of
a study section of the Division of Research Grants and
Fellowships of the National Institutes of Health.

Dr. Peters was distinguished by his persistent efforts
to apply scientific advances to the treatment of patients.
“At the same time this was incorporated in a context of
moral dignity so that the application of science to the
patient was associated with kindness, with a great deal of
concern and followup,” said Donald W. Seldin, M.D.

Franklin H. Epstein, M.D. ’47, discussed John P. Peters, whose image is
in the background, and his contributions to the study of renal disease.

’43, Professor Emeritus of Internal Medicine at the Uni¬
versity of Texas Southwest Medical Center, in his talk,
Reflections of a Student of Peters. “The plain fact of the

matter is that he was a courageous man and a morally
dignified man. He did for the profession what the pro¬
fession needs, self-criticism, self-policing. Now, hope¬
fully, Dr. Peters’ vision of medicine available to all the
people and at high quality will be reinstituted.”
The discussion ranged from his medical contribu¬
tions to his legal and moral battles. Catherine G.
Roraback, LL.B. ’48, a Yale-educated attorney who rep¬
resented dissenters in the 1950s, noted that Dr. Peters be¬
came a target of loyalty boards not because he broke a
law, but because he exercised his right of free speech and
association. George D. Lundberg, M.D., editor-in-chief
of the fournal of the American Medical Association, traced
the longstanding acrimony between the Committee of
430 Physicians and the AMA, which vehemently op¬

More than a dozen members of Peters’ family, including his son
and two granddaughters, came to New Haven for the symposium
in his honor.

6 2

posed the reforms the committee proposed. Many of
those reforms, he said, are now integral pieces of medical
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practice in this country, such as federal support of medi¬
cine and programs such as Medicaid and Medicare.
Richard M. Peters, M.D. ’45, one of Dr. Peters’
sons, described how the loyalty hearings absorbed his
father’s final years and, his family believes, shortened his
life. Close to a dozen family members traveled to New
Haven including Dr. Peters’ granddaughter, Barbara
Ann Peters, M.D. ’79.
Franklin H. Epstein, M.D. ’47, professor of medi¬
cine at Harvard Medical School and Beth Israel Hospi¬
tal, cited Dr. Peters’ contributions to the study of renal
disease, noting that Dr. Peters was interested in the
chemical derangements of disease. “It was the measure¬
ment of the chemical constituents of body fluids that
provided the first of three solid foundation blocks, the
cornerstones of Peters’ approach,” Dr. Epstein said.
“He understood and appreciated the importance of
accurate, impeccable measurement.”
Dr. Peters’ most enduring technical achievement
was the introduction into the clinic of the flame pho¬
tometer, which made possible within minutes accurate

Dr. Peters was secretary of the Committee of 430 Physicians, a
group dedicated to reforming their profession. They believed govern¬

measurements of sodium and potassium in serum or

ment should care for the poor and finance medical facilities, research

urine samples. He used those measurements, an exact¬

and education. The committee felt that responsibility for health care
fell on local, state and federal governments and volunteer agencies.

ing analysis of diet, urine and feces, to treat his patients.

With the advent of Medicare, Medicaid, Veterans Administration

Colleagues and students marveled at his ability to take

hospitals and the Food and Drug Administration, many of their goals
have been realized.

the raw data and synthesize it into a logical framework.
“His associates might experiment on animals, but he
preferred to concentrate on examining disordered physi¬
A"0„,

ology at the bedside with accurate chemical techniques
and the power of logical inference,” said Dr. Epstein.
According to Phillip Gorden, M.D., HS ’61-66,
the director of the National Institute of Diabetes and
body water, electrolytes, and acid-base balance were

ML D

extremely important in the management of patients
with diabetes mellitus.
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Digestive and Kidney Diseases, Dr. Peters’ studies of
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Connecticut College in May. Morris

REPORTS

was also honored by the American
Academy of Pediatrics with the C.

1938

other senior gatherings. He has been a
great help in tracking down our class¬

Development. Bill Davey called atten¬

Charles J. Petrillo

mates. Many thanks Ben.

tion to his own second career as a

The Class of 1938 held its 60th reunion

Charlie Petrillo, who married Mary

in a publication of the Farm Credit

on June 5 and 6. Of the 48 students

Sullivan in 1995, likes to boast that be¬

who matriculated in September 1934, 39

tween his and her families, he is now

graduated in 1938. According to my

Anderson Aldrich Award in Child

farmer, details of which were contained

the proud grandfather of 23, and by the

Bank of Texas, Growing Grapefruit,
Doctor-Turned-Farmer Pursues Child¬
hood Dream. Dee Peck spoke briefly

records, eight are still living, and two

time this report appears in print, it

about her limitations resulting from

were able to attend the reunion, Ben

could be 24. He is well and keeps busy

two lengthy hospitalizations in the past

Lyons and Charlie Petrillo. At our

with golf, gardening, bowling and

few months. She had been teaching

55th reunion, 15 were known to be alive.

entertaining grandchildren.

Yale medical students basic principles
of X-ray interpretation. Lennie Kemler

In the intervening five-year period, our
class was reduced almost by half.

Jim Radcliff and his wife both have

said that he decided to give up his

had open heart surgery and are unable

practice and has taken a position as

As usual the alumni office had arranged

to travel any distance. Jack

medical director at Aetna Life Insur¬

an excellent program of lectures, semi¬

McGillicuddy is in poor health and

ance. Sophie Trent has turned more

nars, receptions, luncheons and tours.

also unable to travel.

seriously to her first love and obtained

Congratulations and thanks to its staff.
No reunion activities had been planned

a master’s degree in art from Central
1 hope to be able to give a more cheer¬

Connecticut State University. She is

ful report next year.

docent at the American Museum of

for our class. The grand finale on Satur¬

Modern Art in New Britain, Conn.

day night was the dinner at the Gradu¬

Jerry Fountain has turned to art as a

ate Club hosted by the School of Medi¬
cine and the AYAM. Present were Ben
and his wile Blanche, and Charlie with
his daughter Terri Connolly.

1943
March

form of expression and paints almost
every day. He, too, is a museum docent
but also has returned to his college
major of languages.

Dorothea Peck Dwyer and
Ben and I have attempted to contact

Lycurgus M. Davey

Mark Sanford finally found the time

Ten members ol the Class of 1943

Spitz is devoting his time to watching

those classmates who were not present.
Ed Roberge, who has overcome several

to do creative woodworking, and Hilly

major medical problems, is presently

March showed up and seven members

and helping his grandchildren in their

doing well and keeps busy with garden¬

brought their wives along. Transporta¬

athletic endeavors. Hank Markley, for

ing and numerous other garden and

tion and escort services were provided

the past few years, has been director of

house chores. He regrets that he, and

in a timely and helpful fashion. In place

the home care department of Green¬

his wife, Genevieve, were not able to

of a class dinner for Friday night, we

wich Hospital, an activity he started in

join us.

joined the other reunion classes for a

1956 on a part-time basis. Stu Joslin,

superb clambake in the courtyard of the

after a successful career as a pediatri¬

Lester Wallman reported that he is

Harkness dormitory. Dean Kessler

cian, went back to school and has been

in good health, is on the admissions

made every effort to meet and greet our

a pediatric psychiatrist for the past 20

committee of the University of Ver¬

returning alumni. On Saturday night

years. Rocko Fasanella has taken up

mont Medical School, gives an occa¬

we were included at the Friends of the

the ideal golf game—no score and no

sional anatomy lecture, and keeps an

50th Dinner at the Graduate Club.

rules. He has maintained interest in

who is a radiologist in California, two

Highlighting our activities was the

spasm. He reminded us of our

daughters and four grandchildren.

Friday afternoon seminar entitled

teacher, Dr. Leon Stone, and his experi¬

interest in medical history. He has a son

macular degeneration and blepharo¬

Our Second Life. Morris Wessel started

ments of transplanting the eye of the

Ben is quite busy with many interests.

the conversation with a recital of his ef¬

salamander. He spoke of his concern

He is one of six medical school del¬

forts both at the hospital and in the

about the long-term potential complica¬

egates to the Association of Yale

community to orient our medical stu¬

tions of refractive eye surgery. We were

Alumni and in that capacity is in con¬

dents and house staff toward some of

sorry to miss John Brobeck who had to

stant contact with the University and

the more humanistic aspects of medical

cancel his trip at the last minute.

with the medical school. Ben also re¬

practice. Bill Davey then read, some¬

ports that he keeps his interest in the

what to Morris’ embarrassment, the

Hank Riedel felt that he wasn’t up

arts. He sings with a group of 25 retired

citation conferring an honorary degree

to making the transcontinental trip.

people who give recitals at AARP and

of doctor of science to Morris front

Bob Wyatt has just moved to a new
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condominium in Delray Beach, Fla.

Jeffrey (Larchmont, N.Y.); Anne

Our Saturday morning was devoted to

Nick Stahl has moved ro Charlestown,

Godley St. Goar and husband, Dr.

the symposium on John P. Peters, M.D.

R.I., where he is having some difficulty

Walter St. Goar (Brookline, Mass.);

The reunion was climaxed by our final

adjusting to medication to improve

Paul Goldstein and wife, Betty

dinner at the Graduate Club, hosted by

his eyesight, but is enjoying local staples

(Branford, Conn.); Paul Koehler and

the Alumni Association and called the

such as lobster, fish and clams. Bob

wife, Margaret (Newbury, N.H.); Bob

Friends oi the 50th. A souvenir reunion

Turner, Jess Goerner, Doug Lindsey

Lempke and wife, Mary (Indianapolis,

booklet containing autobiographical

and Phil Loge wrote to say they were

Ind.); Arden Miller and wife, Helen

sketches of 25 classmates, most with

sorry not to be able to attend. Edward

(Chapel Hill, N.C.); John Morrison

current, color photographs, was pro¬

Rabe wrote to say that despite fractures

and wife, Gerry (Orange, Conn.);

vided to each classmate. Dick Hannah

of the hip and pelvis he was well enough

Dave Morton and wife, Kayo (Pueblo,

and Sylvia Preston Griffiths, who

to take a river trip in

Colo.); Dick Peterson (Stratford,

could not attend, wrote interesting let¬

Central Europe with his wife, Emily.

Conn.); Jane Rivers (Columbus, Ga.);

ters for this booklet.

Bud Rowland and wife, Esther (New
After the Saturday seminar for John P.

York, N.Y.); Ben Rush Jr. and wife

Peters, M.D., we assembled in front of

Norah (Summit, N.J.); Jerry Shapiro

In conclusion, the 50th reunion was in¬
formative and entertaining. Anne

the Sterling Hall of Medicine for our

and wife, Meredith (Boston); Bill

Godley St. Goar, class agent for many

class photograph and then were off to

Sibley (Tucson, Ariz.); and Howie

years and to whom we owe our sincere

the traditional Saturday luncheon on

Simon (Rye, N.Y.). Classmates were

gratitude, will be succeeded by Ben

the Elarkness lawn.

particularly grateful and appreciative

Rush Jr. It was a memorable get-to¬

that two members of the class, Julie

gether, but we truly missed our 15 de¬

Frieden and John Morrison, had

ceased classmates: Russ Barrnett, Lee

1943

made very special efforts to attend

Brown, Art Coleman, Brad Colwell,

our 50th reunion.

Bob Downie, Vic Drill, Boy Frame,

December

Friday evening, our class dinner was

Jim Leslie, Bob Maurer, Bernie Naab,

Robert F Bradley and

held at the New Haven Lawn Club.

Gerry Nowlis and Gabe Saviano.

Thomas L. Bucky

For entertainment, each classmate,

A1 Green, Ray Johnson, Bob Lawson,

randomly selected, made an extempora¬
Five members of the Class of 1943

neous, two-minute talk on some

December attended the reception—

humorous, sad or memorable event

1953

Hunter H. Comly and Rita Iannaci;

that had happened in their life follow¬

Harold D. Bomstein Jr.

Robert F. Bradley and his son, David;

ing graduation from medical school,

Donald W. Seldin and Ellen Taylor;

or during their four years ol formal

Our 45th reunion was almost identical

Jane B. Cadbury; Thomas L. Bucky

training at Yale. Most of those

in turnout to our 40th, and would

and his wife, Doris. They report that

presentations were truly outstanding

have exceeded it except for a few last-

the Friday evening clambake was lots of

and entertaining.

minute cancellations due to illness.

fun and the food was great.

1948

gK«j

Paul B. Koehler
Beautiful, refreshingly cool weather on
June 5 and 6 graced our 50th reunion.
Those in attendance were: George
Batten and wife, Barbara (Carmichael,
Calif); Edith Beck (Greenwich,
Conn.); “Jock” Bishop (Minneapolis,
Minn.); Al Bridge and wife, Charline
(Moreno Valley, Calif); Dick Buker,
and wife, Jean, and daughter, Candace
Chang (Chester, Mont., and Boston);
Elizabeth Fuller Eisner and husband,
Bob (Ester, Ark. and Assonet, Mass.);
Al Fisk and wife, Ruth (Sonoma,
Calif.); Tom Frei and wife, Dori
(Boston); Julie Frieden and son,
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Yale System thriving, says new deputy dean

A

lthough it is alternately misunderstood, revered,
tolerated and adored, the Yale System is alive and
well, Robert H. Gifford, M.D., deputy dean for

education, told alumni gathered in the Hope Building
during reunion weekend. Dr. Gifford noted that “the
wheel has simply come round again” and cited F.R
Underhill, who chaired the school's curriculum commit¬
tee in 1922. “The student,” Dr. Underhill complained at
the time," has become the defenseless recipient of an
overwhelming mass of facts.”
Reaffirming the goals of Milton C. Winternitz,
Robert Gifford

M.D., who served as dean of the medical school from
1920 to 1935, Dr. Gifford said,
“Memorization of a 'mass of

What did the Yale
System mean to you?
We’re preparing an article
for Yale Medicine on The
Yale System Through the

facts’ was far less important

societies such as Alpha Omega Alpha, which recognizes

than a well-rounded education

only the top students in each class, have somewhat un¬

in fundamental principles,

dermined the Yale System’s traditional opposition to

training in methods of investi¬

class rankings, he said.
The freedom accorded to students brings with it a

Decades and invite letters,

gation and acquisition of the

thoughts and memories
from alumni. In particular,

scientific habit of mind.” Bur¬

responsibility that is at times ignored, Dr. Gifford said.

dening the students with a

He took students to task for what he described as a

we would like to explore

heavy curriculum discourages

“cavalier” attitude towards small group seminars which

which essential threads of
Yale’s approach to medical

independence and initiative and

depend on student to student interaction. Attendance,

leaves little time for electives,

he said, tends to drop, particularly around the time of

education have remained

independent thought or reading

the second year show in February and national board

unchanged over the years,
as well as the evolution of

in the library, Dr. Gifford said.

examinations in the spring.

the tradition from genera¬
tion to generation.

is the presumption that gradu¬

said, a minority “look at it with some derision as a way

ate students are mature indi¬

for students to slip by without academic rigor, to be self-

viduals with a strong motiva¬

indulgent, spoiled, entitled to do anything they want.”

Letters should be brief, no
more than 250 words, and

Underlying the Yale System

tion to learn. As a result,

While most of the faculty support the system, he

Dr. Gifford also took on the issue of payment of fac¬
ulty who assume major teaching burdens. Most faculty,

touch on one major facet of

attendance is not taken at lec¬

the Yale System specific to
the era in which the author

tures, small group teaching is

those who give lectures or moderate seminars, receive no

emphasized and there are no

remuneration, and that is appropriate. “But asking

experienced it as a stu¬

grades or class rankings. Al¬

someone to be a course coordinator, to organize a new

dent, faculty member or in
some other capacity.

though examinations remain

course, to chair a curriculum committee, to organize and

Please send letters to Edi¬
tor, Yale Medicine, P.0. Box
7612, New Haven, CT
06519-0612 [or via e-mail
to ymm@yale.edu] and
include a daytime phone
number. A representative
selection of essays will be
published in a future issue.
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anonymous, a qualifying exam

run a new course is a very different matter,” Dr. Gifford

must be passed in every course

said, “and, in my judgment, should be accompanied by

and all students must write a

partial salary support.” He proposed enlarging an educa¬

thesis based on original research

tional fund so that those who shoulder unusual time

in order to graduate. According

commitments to teaching can receive a portion of their

to Dr. Gifford, the school still

salary for their efforts.

adheres to these principles, but

Noting the curriculum requires attendance at too

the number of lectures has

many lectures, Dr. Gifford called for more case-based

gradually increased. And honor

conferences as an alternative.
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was organized and moderated by Jerry
Burrow and Mike Kashgariau. Jerry
retired from the deanship last year and
was the recipient of this year’s Distin¬
guished Alumni Service Award. After
the morning formalities, the bridge
Mafia of Hartmann, Kislak, Muggia
and Schlaepfer retired to their ongoing
series of bridge contests. Most of the
rest of us boarded a bus loaded with box
lunches and beverages and headed off to
Mystic Marinelife Aquarium where
aquarium trustee Burrow and staff
took us behind the scenes of the opera¬
tion and provided us with some close
contact with bottlenose dolphins and
beluga whales. The ability of these sea
mammals to entertain us was such that
we all felt they should be made honor¬
ary members of our class. Upon return
to New Haven, we reassembled at the
Friday afternoon, we met for a spirited

Guercios and the Lanes had to leave,

gabfest without a formal seminar.

we added Andrea and Seth Abramson

Friday’s dinner, in what has become a

from New York City and Howie Smith

tradition, was held at our home. There

joined the rest of us. After dinner each

were 32 people in attendance:

attendee shared autobiographical com¬

Manhattan’s Claude Bloch; Maureen

ments with the assemblage. We had

and Hal Bornstein, the hosts; Jeanne

communications from Claude Ander¬

and Remi Cadoret, who always arrive

son, Bill Chaffee, Jack Doppman,

from Iowa; Joan and AI Chetrick, now

Doe Dunn, Jack Durell, Irv Goldberg,

residing in Branford, Conn.;

Al Keroack, Dick Knowles (who had

Phildelphian Rex Conn; Lou Del

planned to come), Bob Nolan, Rhoda

Guercio ot Larchmont, N.Y.; Fielen

and Ed Powsner (who also had hoped

and Don Etzwiler from Minnesota; de¬

to attend), Paul Quie, Jose Ramirez

pendable Betty and Tom Gentsch from

Rivera, (normally a regular). Matt

the mountains of North Carolina;

Tandysh, and Bill Vandervort. We

Robin and Bob Hamlisch from Ithaca

look forward to an even larger gather¬

with their delightful son, Eliot; Barbara

ing for our 50th in 2003.

New Haven Lawn Club for our class
dinner which was attended by George
Aghajanian, Don Amren, John Arnot,
Gerard Burrow, John Creatura,
Robert Donohue, Lawrence Dubin,
Donald Duncan, Raymond Gaito,
Ernest Hartmann, Michael
Kashgarian, Jay Kislak, Marcia Kraft,
Myron Lotz, Jack Love, William
McClanahan, Andrew McGowan,
Frank McKegney, Thomas Mauro,
Richard Miller, Albert Muggia, Rob¬
ert Neuwirth, Carol Phillips, William
Schlaepfer, John Wood and Pauline
Wood. Also present in spirit but not in
person were Bill Radcliffe, Paul
Rudnick and Ray Turner, all of whom

and Dave Holman, our travel champs

had written with good excuses for their

from San Francisco; Carol and Fred

absence.

Lane of New York City; Hyla and Bob
Melnick, regulars also from

1958

Larchmont; New Jerseyites Betty Th¬

Michael Kashgarian

The dinner ended with unveiling of the
architectural plans of the Class of 1958

ompson and Harvey Peck; Joann and

fitness center, which is part of the on¬

Wick Potter, who tooled down from

The 40th reunion of the Class of 1958

going renovations of Harkness Dormi¬

Wellesley, Mass.; Barbara and Irv

was an outstanding event. Some 26

Rosenberg of Maine; Manhattanite

members of our class attended, nearly

Ora Smith; and Mary Lou and Fred

50 percent of those remaining from our

Young from Lancaster, Pa. Maureen’s

class, which started out as 80 in the

dinner was superb, Hyla contributed

year we entered and was 72 in the year

delicious cookies, and conversation

we graduated.

never ceased.
The reunion was a special one in many
Our Saturday dinner was at the elegant

ways. The principal Saturday morning

Quinnipiack Club with cocktails and

event was a symposium honoring John

picture-taking in the library, followed

Punnett Peters. Our class was the last to

by an excellent meal in the Board of

have had contact with him as a teacher

Governors Room. Though the Del

and it was fitting that the symposium
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tory, of which our class was among the
first inhabitants.

1963
Jon Michael Fessel
The 35th reunion began where the 30th
ended, with a discussion of the Yale
System. Deputy Dean Robert Gifford,
delivered an amusing and thoroughly
reassuring discussion of the current
health of the system. The Dean’s recep-
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At EPH reunion, a global perspective

P

ublic health has become a global affair, John Ashton,
M.D., told alumni of Epidemiology and Public
Health who gathered for their annual reunion on

He noted a danger in the concentration in cities of large
numbers of young men with no stake in their communities.
“The events in Jakarta over the last two weeks are the tip of

June 5. Today’s pressing issues—HIV and AIDS, drugs, food

an iceberg which we have yet to see,” he said, referring to ri¬

technology, genetic engineering—know no boundaries, said

ots in Indonesia in May. “Is it too late to save the cities? In

Dr. Ashton, the keynote speaker for the reunion. Although

many ways that is the wrong question. The fate of our cities

he is regional director of public health in Liverpool, En¬

is indivisible from the fate of the planet.”

gland, Dr. Ashton said he felt like a “virtual alumnus” of

Many of those at the reunion had come to bid farewell to

Yale, because of his work over the past decade with Lowell

Dr. Levin, who started teaching public health at Yale in 1963

Levin, M.P.H., ’60, D.Ed., who retired this year.

and plans to continue teaching part-time in his retirement.

Dr. Ashton made his reference to Dr. Levin during his
talk, Health Threats to Urban Life; Is It Too Late to Save Our

“It’s unfortunate that it takes Lowell threatening to leave
that brings us all together,” Dean Michael H. Merson, M.D.,

Children? “We need a public health response which is a glo¬

joked before turning reflective. “We would never want

bal public health response,” Dr. Ashton said, contrasting

Lowell to leave us. He will be a major part of our school for

the present with the past. “The cities of 150 years ago could

many years, even though he claims to be retiring.”

quite happily think of themselves as self-contained. We are

Friends and colleagues took turns telling tales about

now at the point where the majority of the world’s people

Dr. Levin at a Lriday evening roast under a tent on the lawn

will be living in large cities and towns. Most babies are be¬

in front of the EPH building. Dr. Merson described Dr.

ing born into large towns and cities for the first time.” In¬

Levin’s unorthodox approach to founding the school’s inter¬

creased speed of travel and the increased urbanization of the

national division. “There is no record of this division ever

planet often divorce health issues front their local origins

being created,” the dean joked, noting that he can find no

and deny public health workers local solutions, he said.

memos, no paperwork, nothing to trace the division’s his¬
tory. Mr. Levin simply created it, he said. “Lowell just took
advantage of people being out of town and on sabbatical.”
About 200 people came to the roast and reunion.
“Maybe this time you’ve come to see if he’s really going to
do what he keeps threatening to do—say bye-bye to Yale,”
Joel Kavet, M.P.H. ’67, master of ceremonies, told the

Public Health Dean Michael Merson, M.D., addresses alumni
at a luncheon.

Lowell Levin receives a toast from colleagues
and alumni to honor him at his retirement.
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Kessler met, Dr. Korper had been in Washington for about
three years. Dr. Korper worked at the Department of
Health and Human Services and the National Institutes of
Health, where he was director of the division of legislative
analysis. He now serves as senior advisor to the Substance
Abuse and Mental Health Services Administration.
In his talk to alumni. Dr. Korper offered a mixed view
of the state of public health in this country. Too lew gradu¬
ates are seeking long-term careers in the public health, he
lamented. On the other hand, he added, “the opportunities
in public health, in both the public and private sectors,
from the molecular to the global, are truly breathtaking.”
The ethos of public health, he noted, includes public
Samuel Korper, M.P.H. '69, was honored as this
year's distinguished alumnus.

service, usefulness and altruism. It is, he said, “a profession
that has an incredible array of critically important
responsibilities.”

crowd. “We risk the prospect of turning Lowell Levin loose
on an unsuspecting world.”
Friday morning, alumni attended a series of seminars on
a variety of public health issues, including HIV/AIDS, ur¬
ban health, alcohol and asthma. In the afternoon, alumni
panels described their experiences and discussed the rel¬
evance of programs to public health practice.
For many alumni, the reunion was more than a coming
together of former classmates—many had crossed paths in
their professional lives. “It’s striking,” said David A. Kessler,
M.D., dean of the medical school, at a Friday afternoon
luncheon for EPH alumni. “There are so many ol you that

Karl Smith, M.P.H. '65, chats with

I know and have grown up with.”

Max Pepper, M.P.H. '59, during the

Dr. Kessler singled out one alumnus who served as his

reunion of public health alumni.

mentor in Washington in the 1980s: Samuel P. Korper,
MPFi ’69, Ph.D. ’76, was honored as this year’s distin¬
guished alumnus. “I decided, on a volunteer basis,” Dr.
Kessler recalled, “to spend some time on the Hill. I walked

Surgical society meets during reunion

in in 1981 and I knew nothing. I had no idea ol how that

The Yale Surgical Society held its third annua! spring alumni re¬

town worked.” Working as an unpaid aide to the Senate’s
labor and human resources committee, Dr. Kessler was as¬
signed to reauthorize three programs. “I had no idea what
to do. It was at that time I was fortunate enough to meet
Sam.” Dr. Kessler, of course, went on to become commis¬
sioner of the Food and Drug Administration. “I could not
have been in a position to contribute and function in that
town had I not been trained by Sam Korper. He has shown
throughout his career such tremendous dedication to im¬
proving the health of our country.”
Dr. Korper started his career as a Peace Corps volunteer

union in conjunction with the medical school reunions. The June
4 and 5 gathering included the second C. Elton Cahow Memorial
Lecture given by Arnold Diethelm as part of the Grand Rounds
schedule. All except emergency activities of the Department of
Surgery were suspended on Friday, June 5, to permit attendings,
house officers and medical students to participate in the day’s
events. These included papers honoring William Glenn, M.D.,
Charles Ohse Professor Emeritus of Surgery, and John Kirschner,
M.D., past chairs of cardiothoracic and ear, nose and throat sur¬
gery respectively, and general papers and reports encompassing
the entire department.

in Nyasaland in central Africa. By the time he and Dr.
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tion, which followed, gave us an oppor¬

implanted in the Harkness lawn. The

tunity to renew acquaintances with

food was great, and renewing acquain¬

old faculty friends including Howard

tances was even better. Mary and Victor

Levitin and Arthur Ebbert. After a

Pappoe were proud to announce that

Saturday of varied activities, we con¬

they have a daughter presently at the

vened in the Captain's Room at Mory’s

medical school. Rick Boland, and Kip

for a collegial dinner and conversation.

and Maureen Doran all showed up

Attending the dinner were Arthur and

looking younger than they did in 1973.

Carol Ackerman, David and Cheryl

They also showed us pictures of lots of

Cross, Michael and Kathy Fessel,

beautiful daughters. Chris Kull Walsh

David and Carol Fulmer, Alex and

dragged poor Shawn to yet another re¬

Chris Gaudio, Craig Llewellyn,

union.

Jay and Farida Pomerantz, and
Helen Walsh.

Also up to their elbows in lobsters were

1968

Chassin, Lynne Liptay, Jane Ferguson,

Lee Goldman, Barbara and Marvin

Donald O. Lyman

and Sue and Harold Mancusi-Ungaro.
It was great to have this time to chat
after not seeing many for 25 years. Later

Eight classmates gathered in New Ha¬

we sipped champagne at the top of

ven for the 30th reunion of the Class of

New Haven’s new Omni Hotel. Harold

1968. These included Grace and Larry

suggested the bubbly and his taste has

Boxer, Alan Finesilver, Richard and

gotten more expensive since he became

Paula Getnick, Peter and Linda Jokl,

a plastic surgeon.

J. Allen and Emily McCutchan,
Charles and Bonnie Post, Joseph and

On Saturday people went off on various

Rosemary Renda and Bruce and Lynn

tours and seminars, all except for Lee

Wenger. Sounds like things are pretty

Goldman who claimed he shot in the

much status quo for most of us. Peter

low 80s at the Yale Golf Course. Oh,

Jokl is now vice-chair of orthopaedic

and also Joe Simeone, who promised to

surgery at Yale, Chuck Post is a pilot

come to the Saturday dinner if he could

flying here and there around the coun¬

come to my two boys’ baseball games

try, while Bruce Wenger and his wife

that afternoon. He, along with my wife

still do body-heat related research for

Anne and

the Army in Massachusetts. Frank

cessfully. Joe’s Anne was left home pre¬

1

cheered them both on suc¬

Lucente is now vice president of the

paring for their son’s high school gradu¬

American Academy of Otolaryngol¬

ation on Sunday.

ogy—Head and Neck Surgery and
vice dean for graduate medical educa¬

Karen and Rob Sirota, Sandy and

tion at SUNY Brooklyn in addition to

George Lister, Rita and Jim Sullivan,

his ongoing ENT responsibilities.

Carole Stashwick, Laura, Eli and Jerry

Meanwhile on the West Coast, Gordon

Nagler, Rich and Dotty Young, joined

and Joanne Sasaki and Donald and

all of the above at the Graduate Club

Betsey Lyman joined the wedding

for our class reunion dinner. Dean

celebration for Harmon and Edie

Kessler stopped by and said hello. Many

Michelson’s daughter Abby in Napa,

photos and lots of stories were ex¬

Calif. We mourn the death of Kevin

changed. We partied to the wee hours

Hennessey of colon cancer.

and then the first 25 years were com¬
plete. Make your reservations early for
the 30th.

1973
1978

A small but enthusiastic group from the

Seth M. Powsner

Class of 1973 gathered to celebrate our
a seafood feast held under a huge tent

Managed care and missing classmates
were roundly criticized during a select
seminar Friday and Saturday, June 5 and

70

Friday evening outside Harkness Hall.
There was much catching up and
cholesterol. Saturday, John and Duke
had to head home, but Eric Einstein,
Linda Hall, Marcia Wade, and Steve
Schick joined us for a dinner session at
the Graduate Club on Elm Street across
from New Haven's Green. For those of
you who did not demonstrate a suitable
mastery of the material, a make-up
session is scheduled for June 2003.

1983
Judy Melin
One ... singular sensation, Yale Medi¬
cal Class of 1983 ... Fifteen years later,
and it still feels like just yesterday we
were together for the first time in the
Beaumont Room for our introduction
to med school, to the Yale System and
to each other. And then fast forward
through the first anatomy lab, our first
encounter with a patient, our unsur¬
passed second year show, boards part I,
clerkships, subinternships, boards part
II, our theses, our fourth year show and
then goodbye for five, then 10, and
now ... 15 years!
Attending our 15th YSM reunion were

Thomas F. Sweeney

25th reunion. The weekend began with

6. Duke Cameron, John Wagner and
Seth Powsner presented themselves

Elena Citkowitz, M.D. (head of the
cardiac rehabilitation and lipid pro¬
grams and teaching attending at the
Hospital of Saint Raphael, New Ha¬
ven); Rob Homer, M.D. (pathology
faculty, Yale); Don Johns, M.D., (neu-
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Yale scientists offer glimpse of cutting edge research
U \

K

I e are in the midst of one of the great

1/
w

V

oped for men also worked for women,” said Dr. Mazure.

revolutions in the history of medicine,”

“We now have a growing body of significant data to

Richard P. Lilton, M.D., Ph.D., told

cause us to revisit those assumptions.”

medical school alumni during the reunion weekend,

Dr. Nestler’s laboratory, in a study of gene expres¬

referring to progress in charting the human genome.

sion using transgenic mice, has found that turning on

Dr. Lifton, professor of medicine, genetics and

certain genes recreates biochemical and behavioral

molecular biophysics and biochemistry, was one of

changes characteristic of addiction. Dr. Nestler is trying

three faculty researchers who highlighted their work to

to understand lasting effects of addiction on the brain.

alumni. Joining him were Carolyn Mazure, Ph.D.,

Scientists believe these changes are regulated by gene ex¬

professor of psychiatry and director of the Donaghue

pression in neurons in areas of the brain known as the

Women’s Health Investigator Program at Yale; and

mesolimbic dopamine system.

Eric J. Nestler, M.D., Ph.D., director of the molecular

“We can examine an animal,” said Dr. Nestler,

psychiatry program. Dr. Nestler studies genetic and

“study molecular changes in specific brain regions, dem¬

biomedical links to addiction.

onstrate that those changes are important for the behav¬

Dr. Lifton searches for genetic causes of diseases

ior of addiction in our animal models, and then use that

such as hypertension. Underlying the medical revolution

information to come up with ways to perturb that sys¬

he described are tools that include genetic maps of hu¬

tem in people.” This information is critical to the under¬

man chromosomes and the development of complete

standing of relapse and recurring addictive behavior, and

physical maps of the genome.
“With these tools we can begin to unravel the source

may very likely provide the basis for new treatments for
addiction in the next five to 10 years.

of those diseases,” Dr. Lifton said. “Ultimately it gives us
some insight to develop new strategies to treat those dis¬
orders.” He cited a family in which high blood pressure
was identified in 23 members and was subsequently

Former dean recognized
for alumni service

linked to a single gene, one of 10 genes he and members
of his team have isolated that regulate blood pressure.
After more than five years of exciting progress in this
work, his lab is poised to apply the knowledge to more
common forms of the disease affecting at least 50 million

Gerard N. Burrow, M.D. ’58,
the School of Medicine’s
14th dean, received this
year’s Distinguished Alumni
Service Award at reunion.
“I am proud to acknowl¬

achievements as a bio¬
medical investigator and

cific treatment tailored to the genetic abnormality,” Dr.

edge your many contribu¬

Lifton said. “This has really accelerated the pace of bio¬

tions to the medical

authority on thyroid dis¬
ease. Dr. Burrow now

medical research. We can apply those tools coming out

school,” said classmate

serves on the faculty and

of the Human Genome Project to the investigation of

Michael Kashgarian, M.D.
’58, in presenting the

as a special advisor to Yale
President Richard C. Levin.

award. “You have worked to
preserve the Yale System

that Dr. Burrow had a vari¬

people in this country alone. “We can offer them spe¬

disorders such as hypertension.”
Women, noted Dr. Mazure, live about six years
longer than men on average but spend more time in the
hospital. “We do need to know more about how to keep
women healthy,” she said. “We need more data for un¬
derstanding and treating the disorders which women

of medical education in
this chaotic period of
change in the delivery of

Dr. Kashgarian also noted
ety of interests outside of
medicine, including, to the
delight of the audience,

health care.” The AYAM
cited Dr. Burrow’s service

the attainment of a black
belt in judo. “You have

as dean from 1992 to 1997,
his dedication as a mentor

demonstrated you are not a

women in federally-funded research projects, that was
not always the case. “The assumption frequently was

to students and his

Kashgarian said.

present.”
Although federal regulations require the inclusion of

one-dimensional man,” Dr.

made that treatment and procedures which were devel¬
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rology faculty, Beth Israel Deaconess/
Harvard); Lois Morton, M.D. (psy¬
chiatry, Greenwich, Conn.) with hus¬
band Tony Alieva and son Christopher;
David Norton, M.D. (pediatric prac¬
tice and teaching, Baystate Medical
Center, Massachusetts) with Claire
Norton; Dan Oren, M.D. (psychiatry
(acuity, Yale); Alan Reznik, M.D. (or¬
thopedics/sports medicine, Greater
New Haven, and recent MBA, Univer¬
sity of New Haven) with Liz Reznik;
Michael Tom, M.D. (ear, nose and
throat, Westchester County, N.Y.) with
Linda Tom. And participating via re¬
mote (portable telephone, courtesy of
Mory’s) due to a spring flu was Judy
Melin, M.D. (internal medicine, Lahey
Clinic, and clinical faculty. Harvard
Medical School).
Other classmates heard from, or at least
about, recently (with hopefully recent
location info) include Peter Blier,
M.D., (pediatrics, Western Massachu¬
setts); April Chang-Miller, M.D.
(rheumatology, Mayo Clinic, Roches¬
ter); Michael Choti, M.D., (Johns
Hopkins); Tammy Harris, M.D., (fam¬
ily practice, Southboro, Mass.); David
Helfgott, M.D., (internal medicine, in¬
fectious diseases, New York City);
Elizabeth Nolan, M.D., (software developer/ER game, writer); Harlan
Pinto, M.D., (medical oncology fac¬
ulty, Stanford); Susan Seward, M.D.
(internal medicine, MGH, and faculty,
Harvard Medical School); Daniel
Sosin, M.D., (Centers for Disease
Control, Atlanta); Nancy Terrell,
M.D., (internal medicine clinical fac¬
ulty, Columbia Presbyterian, New York
City). You, too, may see your name in
print if you write to Judith.A.Melin@
Lahey.org. or Judy Melin, M.D., Medi¬
cal Director, Managed Care, Lahey
Clinic, Burlington, MA 01805.
We owe a special thanks to David
Helfgott, M.D., co-reunion coordina¬
tor, William Jenkins, managing director
of Office of Alumni Affairs, who
oversees the entire event; Sharon
McManus, who arranged all the details
to make our reunion a success; and
Claire Bessinger of Yale Medicine.
Hope to see us all together at our
20th reunion in 2003!

1988
Michael Rigsby
Nearly 20 members of the Class of 1988
gathered in New Haven for our 10th
reunion. For many of us, it was the
first time we had seen each other
since graduation, so there was a lot of
catching up to do. Our class family is
definitely growing. Kathleen CarneyGodley and Lisa Murphy both had
children with them. (The dean offered
Lisa’s io-year-old son a spot in the
class of 2015.) Many others had stories
and pictures of their youngsters. Find¬
ing ways to balance the demands of
family and career seemed to be high
on the minds of many like Joi Barrett,
who shares a primary care practice
with another medical mom in the
Sacramento area.
Re-exploring old haunts in and around
New Haven occupied much of the
weekend for some out-of-towners.
Peter Merkel and Laura Dember, both
faculty members at Boston University,
spent much of Saturday morning reac¬
quainting themselves with Hope no,
where they attended the John Peters
symposium. In case you didn’t know,
Laura and Peter are married and re¬
cently bought a home in Newton.
Nicole Davis and Alex Vukasin are an¬
other married couple from within our
class ranks. Nicole and Alex live and
practice (gynecology and urology, re¬
spectively) in Princeton, N.J., and occa¬
sionally manage to operate together.
Now there’s a creative way of solving
the problem of two-career families!
Many of our classmates have remained
in the Northeast. Lance Markbreiter
practices orthopedic surgery near the
Jersey shore; Rhonda Karol has a solo
dermatology practice on Long Island
and Robert Kim has only gone as far as
Fairfield County, Conn. Martha
Brochin, Leslie Jacobsen, Michael
DiGiovanni and I all remain in the
New Haven area. Martha has a pediat¬
ric practice and two children of her
own while the rest of us are all on the
full time faculty at Yale.

We also heard some recent bulletins
from class members who could not at¬
tend the reunion. Sue Valley wrote to
say that she couldn't attend because of a
family wedding, but that she still has
her costume from the second year show
and will wear it to our 15th. Steven
Dobscha couldn’t attend because he’s
busy moving himself and his family
back to the West Coast (Oregon) after
several years in Massachusetts. Joi
Barrett brought pictures from a visit
with Peggy Liao and Terry Yee at their
home in Hawaii. Looks idyllic!
Also sighted at the clambake (which I
could not attend) were Steve Slovic
and his family. My apologies and best
wishes to Steve and any others in town
for the weekend whom I was not able
to speak with for this report. Hope to
see you all again at the next reunion.
Thanks to all who attended for helping
to make this a memorable weekend.

1993
Michael Kaiser and Lisa Kotler
Five years after graduation, members of
the Class of 1993 are seeking fellow¬
ships, completing their residencies or
making the transition to attending phy¬
sicians, obligations that kept many
away from the reunion. Five members
of the class met in New Haven for an
off-campus reunion. Michael Kaiser is
training in neurosurgery at ColumbiaPresbyterian Medical Center in New
York; Dave Tendler is at Beth Israel
Hospital in Boston; Stephen Solomon
is at Johns Hopkins; Myles Greenberg
is an emergency room attending at Beth
Israel; and Ed Weaver is a resident at
Yale-New Haven Hospital. Lisa Kotler,
a child psychiatry research fellow in eat¬
ing disorders at Columbia-Presbyterian
Medical Center in New York City, at¬
tended the reunion with her husband,
Howard Shafer, who is an attorney.
Also attending were Stephen
Marshalko, a resident in internal medi¬
cine at Yale-New Haven Hospital, and
his wife, Lisa Amerino-Marshalko,
M.P.H. ’91.
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Continuing Medical
Education at Yale
Ongoing
1998

Pain Management Programs
Course Director: Lloyd Saberski, M.D.
Individually tailored tutorials for physicians in the clinical management of pain.
Center for Pain Management, 40 Temple St., New Haven

Jan. 22-23
Friday-Saturday

Workshop on Positron Coincidence Imaging
Course Directors: Chin Ng, Ph.D. and Holly Dey, M.D.
New Haven Hotel, New Haven

Jan. 22-24
Friday-Sunday

Anesthesia Conference
Course Directors: Ed Delgado, M.D. and Raymond Sinatra, M.D.
Technological and Pharmaceutical information regarding patient care.
Stratton Mountain, Vt.

Feb. 26-27
Friday-Saturday

Workshop on Positron Coincidence Imaging
Course Directors: Chin Ng, Ph.D. and Holly Dey, M.D.
New Haven Hotel

March 6
Saturday

New Diagnostic Therapeutic and Assessment
Approaches to Epilepsy in Children and Adults
Course Director: Susan Spencer, M.D.
Foxwoods, Ledyard, Conn.

March 12-13
Friday-Saturday

Autism
Course Director: Fred Volkmar,

I.D.

Omni Hotel, New Haven

For information, contact the Office of Postgraduate and Continuing Education, Yale University School of
Medicine, 333 Cedar Street, P.O. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578
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London Theater Seminar
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May 6-19, 1999
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